PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jia, XM; Zheng, SH; Xie, XX; Zhang, YJ; Wang, WZ; Wang, ZS; Zhang, Y; Wang, JR; Gao, M; Hou, YL				Jia, Xiaomeng; Zheng, Shaohua; Xie, Xinxing; Zhang, Yujiao; Wang, Weizong; Wang, Zhongsu; Zhang, Yong; Wang, Jiangrong; Gao, Mei; Hou, Yinglong			MicroRNA-1 Accelerates the Shortening of Atrial Effective Refractory Period by Regulating KCNE1 and KCNB2 Expression: An Atrial Tachypacing Rabbit Model	PLOS ONE			English	Article							CARDIAC POTASSIUM CURRENT; MUSCLE-SPECIFIC MICRORNA; K+ CHANNEL; DOWN-REGULATION; FIBRILLATION; MYOCYTES; GENES; PROFILES; K(V)LQT1; PROTEINS	Background: The potential mechanisms of microRNA-1 (miR-1) in the electrical remodeling of atrial fibrillation remain unclear. The purpose of this study was to evaluate the effects of miR-1 on the atrial effective refractory period (AERP) in a right atrial tachypacing model and to elucidate the potential mechanisms. Methods and Results: QRT-PCR and western blot were used to detect the expression of the miR-1, KCNE1, and KCNB2 genes after 1-week of right atrial tachypacing in New Zealand white rabbits. The AERP was measured using a programmable multichannel stimulator, and atrial fibrillation was induced by burst stimulation in vivo. The slowly activating delayed rectifier potassium current (IKs) and AERP in atrial cells were measured by whole cell patch clamp in vitro. Right atrial tachypacing upregulated miR-1 expression and downregulated KCNE1 and KCNB2 in this study, while the AERP was decreased and the atrial IKs increased. The downregulation of KCNE1 and KCNB2 levels was greater when miR-1 was further upregulated through in vivo lentiviral infection. Electrophysiological tests indicated a shorter AERP, a great increase in the IKs and a higher atrial fibrillation inducibility. In addition, similar results were found when the levels of KCNE1 and KCNB2 were downregulated by small interfering RNA while keeping miR-1 level unaltered. Conversely, knockdown of miR-1 by anti-miR-1 inhibitor oligonucleotides alleviated the downregulation of KCNE1 and KCNB2, the shortening of AERP, and the increase in the IKs. KCNE1 and KCNB2 as the target genes for miR-1 were confirmed by luciferase activity assay. Conclusions: These results indicate that miR-1 accelerates right atrial tachypacing-induced AERP shortening by targeting potassium channel genes, which further suggests that miR-1 plays an important role in the electrical remodeling of atrial fibrillation and exhibits significant clinical relevance as a potential therapeutic target for atrial fibrillation.	[Jia, Xiaomeng; Zheng, Shaohua; Xie, Xinxing; Zhang, Yujiao; Wang, Weizong; Wang, Zhongsu; Zhang, Yong; Wang, Jiangrong; Gao, Mei; Hou, Yinglong] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Hou, YL (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China.	black.berry.1984@163.com	WANG, WEIZONG/A-2039-2012	WANG, WEIZONG/0000-0002-6022-1441	Ph.D. Programs Foundation of Ministry of Education of China [20110131110063]; National Natural Science Foundation of China [81270237]; Science and Technology Development Planning of Shandong Province [2011GSF11837]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning of Shandong Province	This work was supported by the Ph.D. Programs Foundation of Ministry of Education of China (No. 20110131110063), the National Natural Science Foundation of China (No. 81270237) and the Science and Technology Development Planning of Shandong Province (No. 2011GSF11837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brahmajothi MV, 1996, CIRC RES, V78, P1083, DOI 10.1161/01.RES.78.6.1083; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Cooley N, 2012, PHYSIOL GENOMICS, V44, P211, DOI 10.1152/physiolgenomics.00111.2011; Frey BW, 2000, NEUROGASTROENT MOTIL, V12, P509, DOI 10.1046/j.1365-2982.2000.00225.x; Gelband CH, 1999, CIRC RES, V84, P352, DOI 10.1161/01.RES.84.3.352; Girmatsion Z, 2009, HEART RHYTHM, V6, P1802, DOI 10.1016/j.hrthm.2009.08.035; GROSS GJ, 1995, CARDIOVASC RES, V29, P112, DOI 10.1016/0008-6363(96)88555-5; Heck A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029337; Heerdt PM, 2012, J MOL CELL CARDIOL, V53, P350, DOI 10.1016/j.yjmcc.2012.05.010; Kamiyama N, 1998, JPN CIRC J, V62, P837, DOI 10.1253/jcj.62.837; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2010, CELL PHYSIOL BIOCHEM, V25, P571, DOI 10.1159/000315076; Murphy NF, 2007, HEART, V93, P606, DOI 10.1136/hrt.2006.107573; Ninio DM, 2005, J CARDIOVASC ELECTR, V16, P1189, DOI 10.1111/j.1540-8167.2005.50007.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Temple J, 2005, CIRC RES, V97, P62, DOI 10.1161/01.RES.0000173047.42236.88; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Thibault K, 2012, PAIN, V153, P1636, DOI 10.1016/j.pain.2012.04.016; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Workman AJ, 1999, CARDIOVASC RES, V43, P974, DOI 10.1016/S0008-6363(99)00166-2; Xiao L, 2008, CIRCULATION, V118, P983, DOI 10.1161/CIRCULATIONAHA.107.758672; Xu CL, 1999, AM J PHYSIOL-GASTR L, V277, pG1055, DOI 10.1152/ajpgi.1999.277.5.G1055; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597; Yang BF, 2008, CARDIOVASC RES, V79, P571, DOI 10.1093/cvr/cvn181; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yu JH, 2011, CELL PHYSIOL BIOCHEM, V28, P87, DOI 10.1159/000331717; Yu LL, 2012, HEART RHYTHM, V9, P804, DOI 10.1016/j.hrthm.2011.12.023; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	33	20	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85639	10.1371/journal.pone.0085639	http://dx.doi.org/10.1371/journal.pone.0085639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386485	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700144
J	Kohler, EE; Wary, KK; Li, F; Chatterjee, I; Urao, N; Toth, PT; Ushio-Fukai, M; Rehman, J; Park, C; Malik, AB				Kohler, Erin E.; Wary, Kishore K.; Li, Fei; Chatterjee, Ishita; Urao, Norifumi; Toth, Peter T.; Ushio-Fukai, Masuko; Rehman, Jalees; Park, Changwon; Malik, Asrar B.			Flk1+and VE-Cadherin plus Endothelial Cells Derived from iPSCs Recapitulates Vascular Development during Differentiation and Display Similar Angiogenic Potential as ESC-Derived Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PROGENITOR CELLS; BONE-MARROW; EXPRESSION; MESODERM; INDUCTION; BLOOD; VASCULOGENESIS; LETHALITY; PRECURSOR	Rationale: Induced pluripotent stem (iPS) cells have emerged as a source of potentially unlimited supply of autologous endothelial cells (ECs) for vascularization. However, the regenerative function of these cells relative to adult ECs and ECs derived from embryonic stem (ES) cells is unknown. The objective was to define the differentiation characteristics and vascularization potential of Fetal liver kinase (Flk)1(+) and Vascular Endothelial (VE)-cadherin(+) ECs derived identically from mouse (m) ES and miPS cells. Methods and Results: Naive mES and miPS cells cultured in type IV collagen (IV Col) in defined media for 5 days induced the formation of adherent cell populations, which demonstrated similar expression of Flk1 and VE-cadherin and the emergence of EC progenies. FACS purification resulted in 100% Flk1(+) VE-cadherin(+) cells from both mES and miPS cells. Emergence of Flk1(+) VE-cadherin(+) cells entailed expression of the vascular developmental transcription factor Er71, which bound identically to Flk1, VE-cadherin, and CD31 promoters in both populations. Immunostaining with anti-VE-cadherin and anti-CD31 antibodies and microscopy demonstrated the endothelial nature of these cells. Each cell population (unlike mature ECs) organized into well-developed vascular structures in vitro and incorporated into CD31(+) neovessels in matrigel plugs implanted in nude mice in vivo. Conclusion: Thus, iPS cell-derived Flk1(+) VE-cadherin(+) cells expressing the Er71 are as angiogenic as mES cell-derived cells and incorporate into CD31(+) neovessels. Their vessel forming capacity highlights the potential of autologous iPS cells-derived EC progeny for therapeutic angiogenesis.	[Kohler, Erin E.; Wary, Kishore K.; Li, Fei; Chatterjee, Ishita; Urao, Norifumi; Ushio-Fukai, Masuko; Rehman, Jalees; Park, Changwon; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Kohler, Erin E.; Wary, Kishore K.; Li, Fei; Chatterjee, Ishita; Urao, Norifumi; Ushio-Fukai, Masuko; Rehman, Jalees; Park, Changwon; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Chicago, IL USA; [Toth, Peter T.] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Rehman, Jalees] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wary, KK (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.	kkwary@uic.edu	Rehman, Jalees/GVU-1981-2022; Rehman, Jalees/J-8258-2012; Urao, Norifumi/O-7313-2015	Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292; Urao, Norifumi/0000-0001-9750-8406; Wary, Kishore/0000-0001-8851-8565; Malik, Asrar/0000-0002-8205-7128; Toth, Peter/0000-0003-2168-0124	National Institutes of Health [HL079356, HL112293, GM094220, HL090152]; American Heart Association [12PRE1208000, 12GRNT12070159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090152, R21HL112293, R01HL079356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to KKW (HL079356), MUF (HL112293), JR (GM094220), and ABM (HL090152), and awards from the American Heart Association to EEK (12PRE1208000) and KKW (12GRNT12070159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2013, STEM CELL REP, V1, P105, DOI 10.1016/j.stemcr.2013.06.007; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chappell JC, 2013, ARTERIOSCL THROM VAS, V33, P1952, DOI 10.1161/ATVBAHA.113.301805; Choi K, 1998, DEVELOPMENT, V125, P725; Chun CZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014732; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Faber JE, 2012, CIRC RES, V110, P192, DOI 10.1161/CIRCRESAHA.111.261495; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Levenberg S, 2007, BLOOD, V110, P806, DOI 10.1182/blood-2006-08-019190; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Park C, 2013, CIRC RES, V112, P1380, DOI 10.1161/CIRCRESAHA.113.301078; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; van Bueren KL, 2012, CURR OPIN HEMATOL, V19, P199, DOI 10.1097/MOH.0b013e3283523e07; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wary KK, 2009, STEM CELLS, V27, P3112, DOI 10.1002/stem.241; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yin LY, 2012, CIRC RES, V110, P241, DOI 10.1161/CIRCRESAHA.111.250126; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	27	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85549	10.1371/journal.pone.0085549	http://dx.doi.org/10.1371/journal.pone.0085549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386480	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700140
J	Wang, Q; Hu, WN; Lei, MM; Wang, Y; Yan, B; Liu, J; Zhang, R; Jin, YZ				Wang, Qi; Hu, Weina; Lei, Mingming; Wang, Yong; Yan, Bing; Liu, Jun; Zhang, Ren; Jin, Yuanzhe			MiR-17-5p Impairs Trafficking of H-ERG K+ Channel Protein by Targeting Multiple ER Stress-Related Chaperones during Chronic Oxidative Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; LONG QT SYNDROME; HEART-FAILURE; PHARMACOLOGICAL RESCUE; CARDIAC-HYPERTROPHY; ATRIAL-FIBRILLATION; RAT CARDIOMYOCYTES; POTASSIUM CHANNEL; HERG TRAFFICKING; MUTANT CHANNELS	Background: To investigate if microRNAs (miRNAs) play a role in regulating h-ERG trafficking in the setting of chronic oxidative stress as a common deleterious factor for many cardiac disorders. Methods: We treated neonatal rat ventricular myocytes and HEK293 cells with stable expression of h-ERG with H2O2 for 12 h and 48 h. Expression of miR-17-5p seed miRNAs was quantified by real-time RT-PCR. Protein levels of chaperones and h-ERG trafficking were measured by Western blot analysis. Luciferase reporter gene assay was used to study miRNA and target interactions. Whole-cell patch-clamp techniques were employed to record h-ERG K+ current. Results: H-ERG trafficking was impaired by H2O2 after 48 h treatment, accompanied by reciprocal changes of expression between miR-17-5p seed miRNAs and several chaperones (Hsp70, Hsc70, CANX, and Golga2), with the former upregulated and the latter downregulated. We established these chaperones as targets for miR-17-5p. Application miR-17-5p inhibitor rescued H2O2-induced impairment of h-ERG trafficking. Upregulation of endogenous by H2O2 or forced miR-17-5p expression either reduced h-ERG current. Sequestration of AP1 by its decoy molecule eliminated the upregulation of miR-17-5p, and ameliorated impairment of h-ERG trafficking. Conclusions: Collectively, deregulation of the miR-17-5p seed family miRNAs can cause severe impairment of h-ERG trafficking through targeting multiple ER stress-related chaperones, and activation of AP1 likely accounts for the deleterious upregulation of these miRNAs, in the setting of prolonged duration of oxidative stress. These findings revealed the role of miRNAs in h-ERG trafficking, which may contribute to the cardiac electrical disturbances associated with oxidative stress.	[Wang, Qi; Hu, Weina; Lei, Mingming; Wang, Yong; Yan, Bing; Liu, Jun; Zhang, Ren; Jin, Yuanzhe] China Med Univ, Affiliated Hosp 4, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Jin, YZ (corresponding author), China Med Univ, Affiliated Hosp 4, Shenyang, Liaoning Provin, Peoples R China.	cmujyz@gmail.com						Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Baaklini I, 2012, J BIOL CHEM, V287, P41939, DOI 10.1074/jbc.M112.413278; Bai YL, 2007, CELL PHYSIOL BIOCHEM, V20, P429, DOI 10.1159/000107527; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Byrne JA, 2003, ARCH MAL COEUR VAISS, V96, P214; Carrillo ED, 2011, J CARDIOVASC PHARM, V58, P470, DOI 10.1097/FJC.0b013e31822a789b; Delisle BP, 2009, J BIOL CHEM, V284, P2844, DOI 10.1074/jbc.M807289200; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Elmen J, 2005, NUCLEIC ACIDS RES, V33, P439, DOI 10.1093/nar/gki193; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Grieve David J, 2004, Heart Lung Circ, V13, P132, DOI 10.1016/j.hlc.2004.02.008; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650; Maurel M, 2013, AM J PHYSIOL-CELL PH, V304, pC1117, DOI 10.1152/ajpcell.00061.2013; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; PENG M, 1995, CELL MOL BIOL RES, V41, P189; Peterson LB, 2012, MOL PHARMACEUT, V9, P1841, DOI 10.1021/mp300138n; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Robertson GA, 2006, HANDB EXP PHARMACOL, V171, P349; Serva A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052555; Smith JL, 2011, AM J PHYSIOL-CELL PH, V301, pC75, DOI 10.1152/ajpcell.00494.2010; Staudacher I, 2010, CURR OPIN DRUG DISC, V13, P23; Thomas M, 2012, RNA BIOL, V9, P1088, DOI 10.4161/rna.21165; Townsend Claire, 2013, Curr Protoc Pharmacol, VChapter 10, DOI 10.1002/0471141755.ph1016s61; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029885; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhang YQ, 2006, AM J PHYSIOL-HEART C, V291, pH1446, DOI 10.1152/ajpheart.01356.2005; Zhang YQ, 2011, CELL PHYSIOL BIOCHEM, V28, P97, DOI 10.1159/000331718; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200	49	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84984	10.1371/journal.pone.0084984	http://dx.doi.org/10.1371/journal.pone.0084984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386440	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700125
J	Wong, VK; Pickard, DJ; Barquist, L; Sivaraman, K; Page, AJ; Hart, PJ; Arends, MJ; Holt, KE; Kane, L; Mottram, LF; Ellison, L; Bautista, R; McGee, CJ; Kay, SJ; Wileman, TM; Kenney, LJ; MacLennan, CA; Kingsley, RA; Dougan, G				Wong, Vanessa K.; Pickard, Derek J.; Barquist, Lars; Sivaraman, Karthikeyan; Page, Andrew J.; Hart, Peter J.; Arends, Mark J.; Holt, Kathryn E.; Kane, Leanne; Mottram, Lynda F.; Ellison, Louise; Bautista, Ruben; McGee, Chris J.; Kay, Sally J.; Wileman, Thomas M.; Kenney, Linda J.; MacLennan, Calman A.; Kingsley, Robert A.; Dougan, Gordon			Characterization of the yehUT Two-Component Regulatory System of Salmonella enterica Serovar Typhi and Typhimurium	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; CARBON STARVATION GENE; ESCHERICHIA-COLI K-12; RESPONSE REGULATORS; FUNCTIONAL-CHARACTERIZATION; SEROTYPE TYPHIMURIUM; CHROMOSOMAL GENES; CROSS-REGULATION; CYCLIC-AMP; IN-VITRO	Proteins exhibiting hyper-variable sequences within a bacterial pathogen may be associated with host adaptation. Several lineages of the monophyletic pathogen Salmonella enterica serovar Typhi (S. Typhi) have accumulated non-synonymous mutations in the putative two-component regulatory system yehUT. Consequently we evaluated the function of yehUT in S. Typhi BRD948 and S. Typhimurium ST4/74. Transcriptome analysis identified the cstA gene, encoding a carbon starvation protein as the predominantly yehUT regulated gene in both these serovars. Deletion of yehUT had no detectable effect on the ability of these mutant Salmonella to invade cultured epithelial cells (S. Typhi and S. Typhimurium) or induce colitis in a murine model (S. Typhimurium only). Growth, metabolic and antimicrobial susceptibility tests identified no obvious influences of yehUT on these phenotypes.	[Wong, Vanessa K.; Pickard, Derek J.; Barquist, Lars; Page, Andrew J.; Kane, Leanne; Mottram, Lynda F.; Ellison, Louise; Bautista, Ruben; McGee, Chris J.; Kay, Sally J.; Wileman, Thomas M.; Kingsley, Robert A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Wong, Vanessa K.; Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Barquist, Lars; Sivaraman, Karthikeyan] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Sivaraman, Karthikeyan] Posit Biosci Ltd, Bombay, Maharashtra, India; [Hart, Peter J.; MacLennan, Calman A.] Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England; [Hart, Peter J.; MacLennan, Calman A.] Univ Birmingham, Clin Immunol Serv, Inst Biomed Res, Sch Immun & Infect,Coll Med & Dent Sci, Birmingham, W Midlands, England; [Arends, Mark J.] Univ Edinburgh, Western Gen Hosp, Div Pathol, Edinburgh Canc Res Ctr,Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Holt, Kathryn E.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Holt, Kathryn E.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Mottram, Lynda F.; MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Kenney, Linda J.] Natl Univ Singapore, Mechanobiol Inst, T Lab, Singapore 117548, Singapore; [Kenney, Linda J.] Univ Illinois, Dept Microbiol & Immunol MC 790, Chicago, IL USA	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Birmingham; University of Birmingham; University of Edinburgh; University of Melbourne; University of Melbourne; Novartis; National University of Singapore; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kingsley, RA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	rak@sanger.ac.uk	Jung, Kirsten/K-4196-2014; Barquist, Lars/H-6529-2019; MacLennan, Calman A/L-9343-2014; Holt, Kathryn E/A-8108-2012	Jung, Kirsten/0000-0003-0779-6841; Barquist, Lars/0000-0003-4732-2667; MacLennan, Calman A/0000-0001-9694-0846; Holt, Kathryn E/0000-0003-3949-2471; Page, Andrew/0000-0001-6919-6062; Wileman, Thomas/0000-0002-5211-5016; Kingsley, Robert/0000-0002-0194-6485	Wellcome Trust [09805]; MRC [G9818340] Funding Source: UKRI; Medical Research Council [G9818340] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Wellcome Trust (Grant no: 09805; http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BLUM PH, 1990, J BACTERIOL, V172, P3813, DOI 10.1128/jb.172.7.3813-3820.1990; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; DIZDAROGLU M, 1993, BIOCHEMISTRY-US, V32, P12105, DOI 10.1021/bi00096a022; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Ghany MA, 2007, INFECT IMMUN, V75, P1835, DOI 10.1128/IAI.01655-06; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hirakawa H, 2003, J ANTIMICROB CHEMOTH, V52, P576, DOI 10.1093/jac/dkg406; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; House D, 2001, CURR OPIN INFECT DIS, V14, P573, DOI 10.1097/00001432-200110000-00011; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JONES PW, 1988, VET REC, V123, P536, DOI 10.1136/vr.123.21.536; Kao KC, 2004, P NATL ACAD SCI USA, V101, P641, DOI 10.1073/pnas.0305287101; KASHKET ER, 1969, BIOCHIM BIOPHYS ACTA, V193, P294, DOI 10.1016/0005-2736(69)90190-4; Khil PP, 2004, PROTEINS, V54, P371, DOI 10.1002/prot.10430; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kraxenberger T, 2012, J BACTERIOL, V194, P4272, DOI 10.1128/JB.00409-12; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MAEBA P, 1969, J BIOL CHEM, V244, P2549; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Nikolskaya AN, 2002, NUCLEIC ACIDS RES, V30, P2453, DOI 10.1093/nar/30.11.2453; Noriega CE, 2010, MOL MICROBIOL, V75, P394, DOI 10.1111/j.1365-2958.2009.06987.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Perkins TT, 2013, MOL MICROBIOL, V87, P526, DOI 10.1111/mmi.12111; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; PICKARD D, 1994, INFECT IMMUN, V62, P3984, DOI 10.1128/IAI.62.9.3984-3993.1994; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Richardson EJ, 2011, J BACTERIOL, V193, P3162, DOI 10.1128/JB.00394-11; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHULTZ JE, 1988, J BACTERIOL, V170, P3903, DOI 10.1128/jb.170.9.3903-3909.1988; SCHULTZ JE, 1991, J MOL BIOL, V218, P129, DOI 10.1016/0022-2836(91)90879-B; Smyth GK., 2005, LIMMA LINEAR MODELS; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; Wolanin PM, 2002, GENOME BIOL, V3; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhang HF, 2012, CURR MICROBIOL, V64, P283, DOI 10.1007/s00284-011-0066-3; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	68	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84567	10.1371/journal.pone.0084567	http://dx.doi.org/10.1371/journal.pone.0084567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386394	Green Published, gold			2022-12-27	WOS:000329194700111
J	Zaim, M; Ali, A; Joseph, J; Khan, F				Zaim, Mohammad; Ali, Ashif; Joseph, Jomon; Khan, Feroz			Serological and Molecular Studies of a Novel Virus Isolate Causing Yellow Mosaic of Patchouli [Pogostemon cablin (Blanco) Benth]	PLOS ONE			English	Article							POTYVIRUSES	Here we have identified and characterized a devastating virus capable of inducing yellow mosaic on the leaves of Patchouli [Pogostemon cablin (Blanco) Benth]. The diagnostic tools used were host range, transmission studies, cytopathology, electron microscopy, serology and partial coat protein (CP) gene sequencing. Evidence from biological, serological and sequence data suggested that the causal virus belonged to genus Potyvirus, family Potyviridae. The isolate, designated as Patchouli Yellow Mosaic Virus (PaYMV), was transmitted through grafting, sap and the insect Myzus persicae (Sulz.). Flexuous rod shaped particles with a mean length of 800 nm were consistently observed in leaf-dip preparations from natural as well as alternate hosts, and in purified preparation. Cytoplasmic cylindrical inclusions, pinwheels and laminar aggregates were observed in ultra-thin sections of infected patchouli leaves. The purified capsid protein has a relative mass of 43 kDa. Polyclonal antibodies were raised in rabbits against the coat protein separated on SDS - PAGE; which were used in ELISA and western blotting. Using specific antibodies in ELISA, PaYMV was frequently detected at patchouli plantations at Lucknow and Bengaluru. Potyvirus-specific degenerate primer pair (U335 and D335) had consistently amplified partial CP gene from crude preparations of infected tissues by reverse transcription polymerase chain reaction (RT-PCR). Comparison of the PCR product sequence (290 bp) with the corresponding regions of established potyviruses showed 78-82% and 91-95% sequence similarity at the nucleotide and amino acid levels, respectively. The results clearly established that the virus under study has close homology with watermelon mosaic virus (WMV) in the coat protein region and therefore could share a common ancestor family. Further studies are required to authenticate the identity of PaYMV as a distinct virus or as an isolate of WMV.	[Zaim, Mohammad; Ali, Ashif] Cent Inst Med & Aromat Plants, CSIR, Crop Protect Div, Lucknow 226016, Uttar Pradesh, India; [Joseph, Jomon] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Khan, Feroz] Cent Inst Med & Aromat Plants, CSIR, Div Plant Biol, Lucknow 226016, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Zaim, M (corresponding author), Cent Inst Med & Aromat Plants, CSIR, Crop Protect Div, Lucknow 226016, Uttar Pradesh, India.	zaimm2001@yahoo.com; f.khan@cimap.res.in	Khan, Feroz/AHC-3474-2022; Joseph, Jomon/C-1397-2009	Khan, Feroz/0000-0002-2704-5925; Joseph, Jomon/0000-0002-3042-6286	Council of Scientific and Industrial Research (CSIR), New Delhi [BSC0203]	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi for financial support through 'ChemBio' project (BSC0203) at CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anonymous, 1977, KO HSUEH TUNG PAO, V22, P318; [Anonymous], 1994, POTYVIRIDAE; Baum RH, 1980, THESIS U FLORIDA US, P99, DOI DOI 10.5962/BHL.TITLE.42365); Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Fauquet CM, 2005, 8 INT COMM TAX VIR, P1259; Gama MICS, 1979, THESIS BRASILIA, P72; Gama MICS, 1980, FITOPATOL BRAS, V8, P395; GLAUERT AM, 1958, J BIOPHYS BIOCHEM CY, V4, P191, DOI 10.1083/jcb.4.2.191; KITAJIMA E W, 1979, Fitopatologia Brasileira, V4, P55; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGEVELD SA, 1991, J GEN VIROL, V72, P1531, DOI 10.1099/0022-1317-72-7-1531; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Meissner Filho Paulo E., 1997, Fitopatologia Brasileira, V22, P569; Meissner FO, 1992, FITOPATOL BRAS, V17, P179; Meissner PE, 2002, ANN APPL BIOL, V141, P267, DOI 10.1111/j.1744-7348.2002.tb00218.x; Milne R. G., 1988, PLANT VIRUSES FILAME, V4, P333; NATSUAKI KT, 1994, PLANT DIS, V78, P1094, DOI 10.1094/PD-78-1094; RAO BLS, 1986, PHYTOPATHOLOGY, V76, P1109; Ravi KS, 1997, PLANT DIS, V81, P673, DOI 10.1094/PDIS.1997.81.6.673; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASTRY KS, 1981, CURR SCI INDIA, V50, P767; Sharma R, 2003, MED PLANTS INDIA ENC, P197; SHUKLA DD, 1989, ADV VIRUS RES, V36, P273, DOI 10.1016/S0065-3527(08)60588-6; Singh MK, 2009, J PLANT DIS PROTECT, V116, P2, DOI 10.1007/BF03356278; Singh RP, 1996, J VIROL METHODS, V59, P189, DOI 10.1016/0166-0934(96)02043-5; VAN REGENMORTEL M. H. V., 1962, Phytopathologische Zeitschrift, V45, P205; WANG YY, 1993, ARCH VIROL, V129, P93, DOI 10.1007/BF01316887; WARD CW, 1991, INTERVIROLOGY, V32, P269, DOI 10.1159/000150211; Zaim M, 1999, NAT S CHANG PROSP PL	33	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83790	10.1371/journal.pone.0083790	http://dx.doi.org/10.1371/journal.pone.0083790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386278	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700069
J	Zigouris, J; Schaefer, JA; Fortin, C; Kyle, CJ				Zigouris, Joanna; Schaefer, James A.; Fortin, Clement; Kyle, Christopher J.			Phylogeography and Post-Glacial Recolonization in Wolverines (Gulo gulo) from across Their Circumpolar Distribution	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; CRYPTIC GLACIAL REFUGIA; POPULATION HISTORY; GENETIC-STRUCTURE; WIDE PHYLOGEOGRAPHY; NORTH-AMERICA; HOME-RANGE; MITOCHONDRIAL; DNA; CONSERVATION	Interglacial-glacial cycles of the Quaternary are widely recognized in shaping phylogeographic structure. Patterns from cold adapted species can be especially informative - in particular, uncovering additional glacial refugia, identifying likely recolonization patterns, and increasing our understanding of species' responses to climate change. We investigated phylogenetic structure of the wolverine, a wide-ranging cold adapted carnivore, using a 318 bp of the mitochondrial DNA control region for 983 wolverines (n = 209 this study, n = 774 from GenBank) from across their full Holarctic distribution. Bayesian phylogenetic tree reconstruction and the distribution of observed pairwise haplotype differences (mismatch distribution) provided evidence of a single rapid population expansion across the wolverine's Holarctic range. Even though molecular evidence corroborated a single refugium, significant subdivisions of population genetic structure (0.01 < Phi(ST) < 0.99, P < 0.05) were detected. Pairwise Phi(ST) estimates separated Scandinavia from Russia and Mongolia, and identified five main divisions within North America - the Central Arctic, a western region, an eastern region consisting of Ontario and Quebec/Labrador, Manitoba, and California. These data are in contrast to the nearly panmictic structure observed in northwestern North America using nuclear microsatellites, but largely support the nuclear DNA separation of contemporary Manitoba and Ontario wolverines from northern populations. Historic samples (c. 1900) from the functionally extirpated eastern population of Quebec/Labrador displayed genetic similarities to contemporary Ontario wolverines. To understand these divergence patterns, four hypotheses were tested using Approximate Bayesian Computation (ABC). The most supported hypothesis was a single Beringia incursion during the last glacial maximum that established the northwestern population, followed by a west-to-east colonization during the Holocene. This pattern is suggestive of colonization occurring in accordance with glacial retreat, and supports expansion from a single refugium. These data are significant relative to current discussions on the conservation status of this species across its range.	[Zigouris, Joanna] Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada; [Schaefer, James A.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Fortin, Clement] Carcajou Quebec, Stoneham Et Tewkesbury, PQ, Canada; [Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada	Trent University; Trent University; Trent University	Zigouris, J (corresponding author), Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada.	joannazigouris@gmail.com		Schaefer, James/0000-0002-3416-1748	Ontario Living Legacy Trust; Wildlife Conservation Society Canada; Wolverine Foundation, Inc.; Ontario Ministry of Natural Resources; Mountain Equipment Co-op Research Grant; Natural Sciences and Engineering Research Council of Canada	Ontario Living Legacy Trust; Wildlife Conservation Society Canada; Wolverine Foundation, Inc.; Ontario Ministry of Natural Resources; Mountain Equipment Co-op Research Grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this study was provided by the Ontario Living Legacy Trust, Wildlife Conservation Society Canada, The Wolverine Foundation, Inc., Ontario Ministry of Natural Resources, Mountain Equipment Co-op Research Grant, and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada to JAS and CJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Abramov A, 2009, IUCN RED LIST THREAT; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; ANDERSON E, 1977, Bulletin of the Museum of Comparative Zoology, V148, P1; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Aubry KB, 2007, J WILDLIFE MANAGE, V71, P2147, DOI 10.2193/2006-548; Aubry KB, 2009, MOL ECOL, V18, P2668, DOI 10.1111/j.1365-294X.2009.04222.x; BANCI V, 1990, HOLARCTIC ECOL, V13, P195; Banci V, 1994, RM2541184 USDA FOR E; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beatty GE, 2010, MOL ECOL, V19, P5009, DOI 10.1111/j.1365-294X.2010.04859.x; Beaumont MA, 2002, GENETICS, V162, P2025; Bermond G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050129; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Bowman J, 2010, CAN J ZOOL, V88, P454, DOI 10.1139/Z10-019; BRYANT HN, 1987, CAN J EARTH SCI, V24, P654, DOI 10.1139/e87-063; Cassel-Lundhagen A, 2009, ECOGRAPHY, V32, P591, DOI 10.1111/j.1600-0587.2008.05685.x; Cegelski CC, 2006, CONSERV GENET, V7, P197, DOI 10.1007/s10592-006-9126-9; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Chappell DE, 2004, CONSERV GENET, V5, P759, DOI 10.1007/s10592-004-1976-4; Copeland JP, 2010, CAN J ZOOL, V88, P233, DOI 10.1139/Z09-136; Cornuet J-M, BIOINFORMATICS UNPUB; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; COSEWIC, 2003, COSEWIC ASS UPD STAT; COSEWIC (Committee on the Status of Endangered Species in Canada), 2004, GUID REC DES UN; Cossios D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-68; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Davison A, 2001, MOL ECOL, V10, P2479, DOI 10.1046/j.1365-294X.2001.01381.x; Dawson FN, 2010, CAN FIELD NAT, V124, P139, DOI 10.22621/cfn.v124i2.1052; Diedrich Cajus G., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V110A, P123; Doeppes D., 2001, Cadernos Laboratorio Xeoloxico de Laxe, V26, P479; Drew RE, 2003, MOL ECOL, V12, P51, DOI 10.1046/j.1365-294X.2003.01715.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fedorov VB, 2001, P ROY SOC B-BIOL SCI, V268, P809, DOI 10.1098/rspb.2001.1584; Flagstad O, 2003, EVOLUTION, V57, P658; Fleming MA, 2002, MOL ECOL, V11, P795, DOI 10.1046/j.1365-294X.2002.01472.x; Fortin C., 2005, NATL RECOVERY PLAN W; Frances J., 2008, THESIS U NEW MEXICO; Fu YX, 1997, GENETICS, V147, P915; GARDNER CL, 1986, J MAMMAL, V67, P603, DOI 10.2307/1381300; GASTON KJ, 1990, BIOL REV, V65, P105, DOI 10.1111/j.1469-185X.1990.tb01185.x; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holder K, 1999, EVOLUTION, V53, P1936, DOI 10.1111/j.1558-5646.1999.tb04574.x; Huck S, 2009, J BIOGEOGR, V36, P1588, DOI 10.1111/j.1365-2699.2009.02096.x; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Klutsch CFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052661; Koen EL, 2008, SURVEYING MONITORING; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Kutschera VE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-114; Kyle CJ, 2002, J MAMMAL, V83, P1141, DOI 10.1644/1545-1542(2002)083<1141:COPACP>2.0.CO;2; Kyle CJ, 2001, MOL ECOL, V10, P337, DOI 10.1046/j.1365-294x.2001.01222.x; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Landa A, 2000, COUNC EUR CONV CONS; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Loehr J, 2006, J EVOLUTION BIOL, V19, P419, DOI 10.1111/j.1420-9101.2005.01027.x; Lofroth EC, 2007, J WILDLIFE MANAGE, V71, P2159, DOI 10.2193/2007-094; MANTEL N, 1967, CANCER RES, V27, P209; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; National Geographic Society, 2002, WOLV RANG; Norwegian Biodiversity Information Centre, 2010, RED LIST SPEC FACT S; Oomen RA, 2013, MOL ECOL RESOUR, V13, P103, DOI 10.1111/1755-0998.12027; Peterman WE, 2013, BIOL CONSERV, V158, P351, DOI 10.1016/j.biocon.2012.07.028; Pielou EC, 1991, ICE AGE RETURN LIFE; PORTER L, 1988, ARCTIC, V41, P303; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; Rambaut A., 2009, BAYESIAN EVOLUTIONAR; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Sato JJ, 2009, MOL PHYLOGENET EVOL, V53, P907, DOI 10.1016/j.ympev.2009.08.019; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schneider S, 1999, GENETICS, V152, P1079; Schreiber A., 1989, WEASELS CIVETS MONGO; Schwartz MK, 2007, J WILDLIFE MANAGE, V71, P2170, DOI 10.2193/2007-026; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SLATKIN M, 1990, GENETICS, V126, P249; Slough BG, 2007, WILDLIFE BIOL, V13, P76, DOI 10.2981/0909-6396(2007)13[76:SOTWGG]2.0.CO;2; Steele CA, 2006, MOL ECOL, V15, P2477, DOI 10.1111/j.1365-294X.2006.02950.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stuart AJ, 2004, NATURE, V431, P684, DOI 10.1038/nature02890; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TAJIMA F, 1989, GENETICS, V123, P585; Tougard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003532; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Walker CW, 2001, MOL ECOL, V10, P53, DOI 10.1046/j.1365-294X.2001.01184.x; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Wilson D.E., 1982, P644; Wilson GM, 2000, J MAMMAL, V81, P186, DOI 10.1644/1545-1542(2000)081<0186:GVOWGG>2.0.CO;2; Zigouris J, 2012, CONSERV GENET, V13, P1543, DOI 10.1007/s10592-012-0399-x	113	21	21	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83837	10.1371/journal.pone.0083837	http://dx.doi.org/10.1371/journal.pone.0083837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386287	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700071
J	Boone-Heinonen, J; Diez-Roux, AV; Goff, DC; Loria, CM; Kiefe, CI; Popkin, BM; Gordon-Larsen, P				Boone-Heinonen, Janne; Diez-Roux, Ana V.; Goff, David C.; Loria, Catherine M.; Kiefe, Catarina I.; Popkin, Barry M.; Gordon-Larsen, Penny			The Neighborhood Energy Balance Equation: Does Neighborhood Food Retail Environment plus Physical Activity Environment = Obesity? The CARDIA Study	PLOS ONE			English	Article							BODY-MASS INDEX; ARTERY RISK DEVELOPMENT; BUILT ENVIRONMENT; LONGITUDINAL-ASSOCIATIONS; HEALTHY FOODS; DIET QUALITY; URBAN SPRAWL; LAND-USE; WEIGHT; DENSITY	Background: Recent obesity prevention initiatives focus on healthy neighborhood design, but most research examines neighborhood food retail and physical activity (PA) environments in isolation. We estimated joint, interactive, and cumulative impacts of neighborhood food retail and PA environment characteristics on body mass index (BMI) throughout early adulthood. Methods and Findings: We used cohort data from the Coronary Artery Risk Development in Young Adults (CARDIA) Study [n=4,092; Year 7 (24-42 years, 1992-1993) followed over 5 exams through Year 25 (2010-2011); 12,921 person-exam observations], with linked time-varying geographic information system-derived neighborhood environment measures. Using regression with fixed effects for individuals, we modeled time-lagged BMI as a function of food and PA resource density (counts per population) and neighborhood development intensity (a composite density score). We controlled for neighborhood poverty, individual-level sociodemographics, and BMI in the prior exam; and included significant interactions between neighborhood measures and by sex. Using model coefficients, we simulated BMI reductions in response to single and combined neighborhood improvements. Simulated increase in supermarket density (from 25th to 75th percentile) predicted inter-exam reduction in BMI of 0.09 kg/m(2) [estimate (95% CI): -0.09 (-0.16, -0.02)]. Increasing commercial PA facility density predicted BMI reductions up to 0.22 kg/m(2) in men, with variation across other neighborhood features [estimate (95% CI) range: -0.14 (-0.29, 0.01) to -0.22 (-0.37, -0.08)]. Simultaneous increases in supermarket and commercial PA facility density predicted inter-exam BMI reductions up to 0.31 kg/m(2) in men [estimate (95% CI) range: -0.23 (-0.39, -0.06) to -0.31 (-0.47, -0.15)] but not women. Reduced fast food restaurant and convenience store density and increased public PA facility density and neighborhood development intensity did not predict reductions in BMI. Conclusions: Findings suggest that improvements in neighborhood food retail or PA environments may accumulate to reduce BMI, but some neighborhood changes may be less beneficial to women.	[Boone-Heinonen, Janne] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Diez-Roux, Ana V.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Goff, David C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Loria, Catherine M.] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; [Kiefe, Catarina I.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Popkin, Barry M.; Gordon-Larsen, Penny] Univ N Carolina, Carolina Populat Ctr, Dept Nutr, Chapel Hill, NC 27599 USA	Oregon Health & Science University; University of Michigan System; University of Michigan; Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; University of North Carolina Chapel Hill	Gordon-Larsen, P (corresponding author), Univ N Carolina, Carolina Populat Ctr, Dept Nutr, Chapel Hill, NC 27599 USA.	gordon_larsen@unc.edu	Popkin, Barry/T-6633-2019	popkin, barry/0000-0001-9495-9324	National Heart, Lung, and Blood Institute (NHLBI); University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]; Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; NHLBI [AG0005]; National Institutes of Health [R01 HL104580, R01- HL114091]; UNC-CH Clinic Nutrition Research Center [NIH DK56350]; Carolina Population Center [R24HD050924]; University of Alabama at Birmingham Coordinating Center [N01-HC-95095]; University of Alabama at Birmingham Field Center [N01-HC-48047]; University of Minnesota Field Center [N01-HC-48048]; Northwestern University Field Center [N01-HC-48049]; Kaiser Foundation Research Institute from the National Heart, Lung and Blood Institute [N01-HC-48050]; Interdisciplinary Obesity Training postdoctoral fellowship [T32MH075854-04]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048047, N01HC048049, N01HC048050, N01HC095095, N01HC048048] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, K12HD043488] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114091, R01HL104580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH075854] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham; Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC-CH Clinic Nutrition Research Center; Carolina Population Center; University of Alabama at Birmingham Coordinating Center; University of Alabama at Birmingham Field Center; University of Minnesota Field Center(University of Minnesota System); Northwestern University Field Center; Kaiser Foundation Research Institute from the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Interdisciplinary Obesity Training postdoctoral fellowship; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201300025C & HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content. Funding for this study comes from the National Institutes of Health: (R01 HL104580, R01- HL114091). Additional funding has come from the UNC-CH Clinic Nutrition Research Center (NIH DK56350) and the Carolina Population Center (R24HD050924); from contracts with the University of Alabama at Birmingham Coordinating Center, N01-HC-95095; University of Alabama at Birmingham Field Center, N01-HC-48047; University of Minnesota Field Center, N01-HC-48048; Northwestern University Field Center, N01-HC-48049; and Kaiser Foundation Research Institute, N01-HC-48050 from the National Heart, Lung and Blood Institute. Analysis was supported by the Interdisciplinary Obesity Training postdoctoral fellowship (T32MH075854-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchincloss AH, 2008, EPIDEMIOLOGY, V19, P146, DOI 10.1097/EDE.0b013e31815c480; Bauer KW, 2012, SOC SCI MED, V75, P496, DOI 10.1016/j.socscimed.2012.03.026; Black C, 2012, HEALTH PLACE, V18, P1292, DOI 10.1016/j.healthplace.2012.09.003; Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x; Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244; Bodor JN, 2010, J URBAN HEALTH, V87, P771, DOI 10.1007/s11524-010-9460-6; Boone JE, 2008, ANN EPIDEMIOL, V18, P371, DOI 10.1016/j.annepidem.2007.11.008; Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283; Boone-Heinonen J, 2011, SOC SCI MED, V72, P641, DOI 10.1016/j.socscimed.2010.12.013; Boone-Heinonen J, 2011, PSYCHOL SPORT EXERC, V12, P54, DOI 10.1016/j.psychsport.2009.09.003; Boone-Heinonen J, 2010, HEALTH PLACE, V16, P1280, DOI 10.1016/j.healthplace.2010.06.015; Boone-Heinonen J, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-70; Boone-Heinonen J, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-45; Cameron A.C., 2005, MICROECONOMICS METHO; Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; Cerin E, 2011, APPETITE, V56, P693, DOI 10.1016/j.appet.2011.02.006; Cervero R, 1997, TRANSPORT RES D-TR E, V2, P199, DOI 10.1016/S1361-9209(97)00009-6; Chaix B, 2009, SOC SCI MED, V69, P1306, DOI 10.1016/j.socscimed.2009.07.018; Cummins S, 2005, BRIT MED J, V330, P683, DOI 10.1136/bmj.330.7493.683; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; DOL (U.S. Department of Labor), CONS PRIC IND; DOL (U.S. Department of Labor), SIC MAN; Dubowitz T, 2012, OBESITY, V20, P862, DOI 10.1038/oby.2011.141; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; Dykes J, 2004, INT J OBESITY, V28, P262, DOI 10.1038/sj.ijo.0802523; Eid J, 2008, J URBAN ECON, V63, P385, DOI 10.1016/j.jue.2007.12.002; ESRI, 2010, ESRI DAT MAPS STREET; ESRI, 2000, ESRI ARCVIEW STREETM; ESRI, 2005, ESRI STREETMAP PRO 2; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Forsyth A, 2008, URBAN STUD, V45, P1973, DOI 10.1177/0042098008093386; Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Gary-Webb TL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-312; Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Gustafson A, 2013, J HUNGER ENVIRON NUT, V8, P362, DOI 10.1080/19320248.2013.816993; Hendricks K, 2009, J PHYS ACT HEALTH, V6, P690, DOI 10.1123/jpah.6.6.690; Hou NQ, 2010, HEALTH PLACE, V16, P1206, DOI 10.1016/j.healthplace.2010.08.005; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Inagami S, 2009, J URBAN HEALTH, V86, P683, DOI 10.1007/s11524-009-9379-y; Jeffery RW, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-2; Kestens Y, 2010, AM J PREV MED, V39, P33, DOI 10.1016/j.amepre.2010.03.014; Krizek KJ, 2003, J AM PLANN ASSOC, V69, P265, DOI 10.1080/01944360308978019; Laraia BA, 2004, PREV MED, V39, P869, DOI 10.1016/j.ypmed.2004.03.018; Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1757, DOI 10.1017/S1368980010001564; Lee IM, 2009, AM J PREV MED, V37, P293, DOI 10.1016/j.amepre.2009.06.007; Leung CW, 2011, AM J PREV MED, V41, P43, DOI 10.1016/j.amepre.2011.03.013; Leung CW, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-52; Li FZ, 2009, AM J HEALTH PROMOT, V23, P203, DOI 10.4278/ajhp.071214133; Li F, 2009, AM J EPIDEMIOL, V169, P401, DOI 10.1093/aje/kwn398; Liese AD, 2010, AM J EPIDEMIOL, V172, P1324, DOI 10.1093/aje/kwq292; Longacre MR, 2011, J AM DIET ASSOC, V111, P577, DOI 10.1016/j.jada.2011.01.008; Lopez RP, 2007, OBESITY, V15, P2111, DOI 10.1038/oby.2007.251; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004; Oakes J Michael, 2007, Epidemiol Perspect Innov, V4, P16, DOI 10.1186/1742-5573-4-16; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Powell LM, 2007, AM J PREV MED, V33, pS292, DOI 10.1016/j.amepre.2007.07.002; Rodriguez DA, 2006, J AM PLANN ASSOC, V72, P43, DOI 10.1080/01944360608976723; Rodriguez DA, 2009, AM J PREV MED, V37, P397, DOI 10.1016/j.amepre.2009.07.008; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Sharkey JR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-10; Spielman SE, 2009, SOC SCI MED, V68, P1098, DOI 10.1016/j.socscimed.2008.12.048; StataCorp, 2005, STAT STAT SOFTW REL; U.S. Census Bureau, CENS BUR MEAS POV; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Wheeler SM, 2008, J PLAN EDUC RES, V27, P400, DOI 10.1177/0739456X08315889; Zamora D, 2010, AM J CLIN NUTR, V92, P784, DOI 10.3945/ajcn.2010.29161; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001; Zenk SN, 2009, AM J HEALTH PROMOT, V23, P255, DOI 10.4278/ajhp.071204127; Zick CD, 2009, SOC SCI MED, V69, P1493, DOI 10.1016/j.socscimed.2009.08.032	73	48	48	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85141	10.1371/journal.pone.0085141	http://dx.doi.org/10.1371/journal.pone.0085141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386458	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900126
J	Valerio, G; Maffeis, C; Balsamo, A; Del Giudice, EM; Brufani, C; Grugni, G; Licenziati, MR; Brambilla, P; Manco, M				Valerio, Giuliana; Maffeis, Claudio; Balsamo, Antonio; Del Giudice, Emanuele Miraglia; Brufani, Claudia; Grugni, Graziano; Licenziati, Maria Rosaria; Brambilla, Paolo; Manco, Melania		Italian Soc Pediat Endocrinology	Severe Obesity and Cardiometabolic Risk in Children: Comparison from Two International Classification Systems	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; ADOLESCENT OVERWEIGHT; METABOLIC SYNDROME; PREVENTION; BMI; RECOMMENDATIONS; CURVE	Objectives: There is no agreed-upon definition for severe obesity (Sev-OB) in children. We compared estimates of Sev-OB as defined by different cut-points of body mass index (BMI) from the Centers for Disease Control and Prevention (CDC) or the World Health Organization (WHO) curves and the ability of each set of cut-points to screen for the presence of cardiometabolic risk factors. Research Design and Methods: Cross-sectional, multicenter study involving 3,340 overweight/obese young subjects. Sev-OB was defined as BMI >= 99th percentile or >= 1.2 times the 95th percentile of the CDC or the WHO curves. High blood pressure, hypertriglyceridemia, low High Density Lipoprotein -cholesterol and impaired fasting glucose were considered as cardiometabolic risk factors. Results: The estimated prevalence of Sev-OB varied widely between the two reference systems. Either using the cut-point >= 99th percentile or >= 1.2 times the 95th percentile, less children were defined as Sev-OB by CDC than WHO (46.8 vs. 89.5%, and 63.3 vs. 80.4%, respectively p < 0.001). The CDC 99th percentile had lower sensitivity (58.5 vs 94.2), higher specificity (57.6 vs 12.3) and higher positive predictive value (34.4 vs 28.9) than WHO in identifying obese children with >= 2 cardiometabolic risk factors. These differences were mitigated using the 1.2 times the 95th percentile (sensitivity 73.9 vs. 88.1; specificity 40.7 vs. 22.5; positive predictive value 32.1 vs. 30.1). Substantial agreement between growth curves was found using the 1.2 times the 95th percentile, in particular in children <= 10 years. Conclusions: Estimates of Sev-OB and cardiometabolic risk as defined by different cut-points of BMI are influenced from the reference systems used. The 1.2 times the 95th percentile of BMI of either CDC or WHO standard has a discriminatory advantage over the 99th percentile for identifying severely obese children at increased cardiometabolic risk, particularly under 10 years of age.	[Valerio, Giuliana] Univ Napoli Parthenope, Dipartimento Sci Motorie & Benessere, Naples, Italy; [Maffeis, Claudio] Univ Verona, Unita Operativa Complessa Diabetol Nutr Clin & Ob, I-37100 Verona, Italy; [Balsamo, Antonio] Univ Bologna, Dipartimento Sci Med & Chirurg, Programma Endocrinol Pediat, Unita Operativa Pediat,Policlin S Orsola Malpighi, Bologna, Italy; [Del Giudice, Emanuele Miraglia] Univ Naples 2, Dipartimento Donna Bambino & Chirurg Gen & Specia, Naples, Italy; [Brufani, Claudia] Osped Pediat Bambino Gesu, Unita Operativa Complessa Endocrinol & Diabetol, Rome, Italy; [Grugni, Graziano] Ist Auxol Italiano, Div Auxol, Oggebbio, Verbania, Italy; [Licenziati, Maria Rosaria] Azienda Osped Rilevanza Nazl Santobono Pausilipon, Unita Operativa Complessa Auxol & Endocrinol, Dipartimento Pediat Sistemat & Specialist, Naples, Italy; [Brambilla, Paolo] Ist Sci San Raffaele, Dipartimento Pediat, Milan, Italy; [Brambilla, Paolo] Azienda Sanit Locale 2, Milan, Italy; [Manco, Melania] Osped Pediat Bambino Gesu, Direz Sci, Area Ric Malattie Multifattoriali Obesita & Diabe, Rome, Italy	Parthenope University Naples; University of Verona; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Bambino Gesu; Universita della Campania Vanvitelli; IRCCS Bambino Gesu; IRCCS Istituto Auxologico Italiano; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Bambino Gesu	Valerio, G (corresponding author), Univ Napoli Parthenope, Dipartimento Sci Motorie & Benessere, Naples, Italy.	giuliana.valerio@uniparthenope.it	Maffeis, Claudio/AAG-5347-2020; del Giudice, Emanuele Muraglia/AAC-2824-2019; Balsamo, Antonio/AAN-9917-2021; Balsamo, Antonio/I-8089-2012; Licenziati, Maria Rosaria/AAC-7689-2022; Grugni, Graziano/AAA-6172-2020; Manco, Melania/M-1058-2013	Balsamo, Antonio/0000-0002-9313-263X; Grugni, Graziano/0000-0003-4708-2544; Manco, Melania/0000-0002-6581-975X; Valerio, Giuliana/0000-0001-5063-4333				Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5&lt;649::AID-SIM371&gt;3.0.CO;2-H; Calcaterra V, 2008, CLIN ENDOCRINOL, V68, P868, DOI 10.1111/j.1365-2265.2007.03115.x; Cameron N., 1986, HUMAN GROWTH, V3, P3; Choi BCK, 1998, AM J EPIDEMIOL, V148, P1127; Cole TJ, 2010, AM J CLIN NUTR, V91, P814, DOI 10.3945/ajcn.2009.28928; Daniels SR, 2009, PEDIATRICS, V124, pS35, DOI 10.1542/peds.2008-3586F; Danielsson P, 2012, ARCH PEDIAT ADOL MED, V166, P1103, DOI 10.1001/2013.jamapediatrics.319; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Flegal KM, 2011, ADV NUTR, V2, p159S, DOI 10.3945/an.111.000307; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Gulati AK, 2012, PEDIATRICS, V130, P1136, DOI 10.1542/peds.2012-0596; Jolliffe D, 2004, INT J OBESITY, V28, P4, DOI 10.1038/sj.ijo.0802421; Kakinami L, 2012, CAN MED ASSOC J, V184, pE539, DOI 10.1503/cmaj.110797; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Lobstein T, 2006, INT J PEDIATR OBES, V1, P7; MERTENS TE, 1993, LANCET, V342, P418, DOI 10.1016/0140-6736(93)92820-J; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Rank M, 2013, J PEDIATR-US, V163, P137, DOI 10.1016/j.jpeds.2013.01.020; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Spear BA, 2007, PEDIATRICS, V120, pS254, DOI 10.1542/peds.2007-2329F; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Whitlock EP, 2010, PEDIATRICS, V125, pE396, DOI 10.1542/peds.2009-1955	28	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83793	10.1371/journal.pone.0083793	http://dx.doi.org/10.1371/journal.pone.0083793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386280	gold, Green Submitted, Green Published			2022-12-27	WOS:000329117900059
J	Gravel, A; Sinnett, D; Flamand, L				Gravel, Annie; Sinnett, Daniel; Flamand, Louis			Frequency of Chromosomally-Integrated Human Herpesvirus 6 in Children with Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							TELOMERASE MUTATIONS; APLASTIC-ANEMIA; HUMAN-HERPESVIRUS-6; GENOME; BLOOD; MONONUCLEAR; HHV-6; IDENTIFICATION; QUANTITATION; INFECTIONS	Introduction: Human herpesvirus 6 (HHV-6) is a ubiquitous pathogen infecting nearly 100% of the human population. Of these individuals, between 0.2% and 1% of them carry chromosomally-integrated HHV-6 (ciHHV-6). The biological consequences of chromosomal integration by HHV-6 remain unknown. Objective: To determine and compare the frequency of ciHHV-6 in children with acute lymphoblastic leukemia to healthy blood donors. Methodology: A total of 293 DNA samples from children with pre-B (n = 255), pre-pre-B (n = 4), pre-T (n = 26) and undetermined (n = 8) leukemia were analyzed for ciHHV-6 by quantitative TaqMan PCR (QPCR) using HHV-6 specific primers and probe. As control, DNA samples from 288 healthy individuals were used. Primers and probe specific to the cellular GAPDH gene were used to estimate integrity and DNA content. Results: Out of 293 DNA samples from the leukemic cohort, 287 contained amplifiable DNA. Of these, only 1 (0.35%) contained ciHHV-6. Variant typing indicates that the ci-HHV-6 corresponds to variant A. None of the 288 DNA samples from healthy individuals contained ciHHV-6. Conclusion: The frequency of ciHHV-6 in children with acute lymphoblastic leukemia is similar (p = 0.5) to that of healthy individuals. These results suggest that acute lymphoblastic leukemia does not originate as a consequence to integration of HHV-6 within the chromosomes.	[Gravel, Annie; Flamand, Louis] CHU Quebec Res Ctr, Div Infect Dis & Immun, Quebec City, PQ, Canada; [Sinnett, Daniel] Univ Montreal, Dept Pediat, Ctr Rech, Serv Hematol Oncol,CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Flamand, Louis] Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Laval University	Flamand, L (corresponding author), CHU Quebec Res Ctr, Div Infect Dis & Immun, Quebec City, PQ, Canada.	Louis.flamand@crchul.ulaval.ca	sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676; Flamand, Louis/0000-0001-5010-4586; Gravel, Annie/0000-0001-5229-5750	CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a CIHR grant awarded to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Bates M, 2009, J MED VIROL, V81, P779, DOI 10.1002/jmv.21455; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boutolleau D, 2006, J CLIN VIROL, V35, P257, DOI 10.1016/j.jcv.2005.08.002; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Daibata M, 1999, BLOOD, V94, P1545, DOI 10.1182/blood.V94.5.1545.417a25_1545_1549; Flamand L, 2008, J CLIN MICROBIOL, V46, P2700, DOI 10.1128/JCM.00370-08; Gautheret-Dejean A, 2002, J VIROL METHODS, V100, P27, DOI 10.1016/S0166-0934(01)00390-1; Geraudie B, 2012, J CLIN VIROL, V53, P151, DOI 10.1016/j.jcv.2011.10.017; Hall CB, 2008, PEDIATRICS, V122, P513, DOI 10.1542/peds.2007-2838; Hall CB, 2004, J PEDIATR-US, V145, P472, DOI 10.1016/j.jpeds.2004.06.017; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hubacek P, 2009, J MED VIROL, V81, P258, DOI 10.1002/jmv.21371; Kaufer BB, 2011, J EXP MED, V208, P605, DOI 10.1084/jem.20101402; Leong HN, 2007, J MED VIROL, V79, P45, DOI 10.1002/jmv.20760; LUPPI M, 1994, LEUKEMIA, V8, pS41; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; Luppi M, 1998, LANCET, V352, P1707, DOI 10.1016/S0140-6736(05)61483-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10; Nacheva EP, 2008, J MED VIROL, V80, P1952, DOI 10.1002/jmv.21299; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Qazilbash MH, 1997, ACTA HAEMATOL-BASEL, V97, P164; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Seror E, 2008, J MED VIROL, V80, P689, DOI 10.1002/jmv.21118; Tanaka-Taya K, 2004, J MED VIROL, V73, P465, DOI 10.1002/jmv.20113; TORELLI G, 1995, J MED VIROL, V46, P178, DOI 10.1002/jmv.1890460303; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Ward KN, 2006, J CLIN MICROBIOL, V44, P1571, DOI 10.1128/JCM.44.4.1571-1574.2006; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; YAMANISHI K, 1988, LANCET, V1, P1065	44	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84322	10.1371/journal.pone.0084322	http://dx.doi.org/10.1371/journal.pone.0084322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386368	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700103
J	Guevara, E; Berti, R; Londono, I; Xie, NS; Bellec, P; Lesage, F; Lodygensky, GA				Guevara, Edgar; Berti, Romain; Londono, Irene; Xie, Ningshi; Bellec, Pierre; Lesage, Frederic; Lodygensky, G. A.			Imaging of an Inflammatory Injury in the Newborn Rat Brain with Photoacoustic Tomography	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; RESTING-STATE NETWORKS; CORPUS-CALLOSUM SIZE; WHITE-MATTER INJURY; PRETERM INFANTS; BORN PRETERM; GLOBAL SIGNAL; NEONATAL-RAT; CHILDREN; ENDOTOXIN	Background: The precise assessment of cerebral saturation changes during an inflammatory injury in the developing brain, such as seen in periventricular leukomalacia, is not well defined. This study investigated the impact of inflammation on locoregional cerebral oxygen saturation in a newborn rodent model using photoacoustic imaging. Methods: 1 mg/kg of lipopolysaccharide(LPS) diluted in saline or saline alone was injected under ultrasound guidance directly in the corpus callosum of P3 rat pups. Coronal photoacoustic images were carried out 24 h after LPS exposure. Locoregional oxygen saturation (SO2) and resting state connectivity were assessed in the cortex and the corpus callosum. Microvasculature was then evaluated on cryosection slices by lectin histochemistry. Results: Significant reduction of SO2 was found in the corpus callosum; reduced SO2 was also found in the cortex ipsilateral to the injection site. Seed-based functional connectivity analysis showed that bilateral connectivity was not affected by LPS exposure. Changes in locoregional oxygen saturation were accompanied by a significant reduction in the average length of microvessels in the left cortex but no differences were observed in the corpus callosum. Conclusion: Inflammation in the developing brain induces marked reduction of locoregional oxygen saturation, predominantly in the white matter not explained by microvascular degeneration. The ability to examine regional saturation offers a new way to monitor injury and understand physiological disturbance non-invasively.	[Guevara, Edgar; Berti, Romain; Lesage, Frederic] Ecole Polytech, Dept Elect Engn, Montreal, PQ H3C 3A7, Canada; [Guevara, Edgar; Berti, Romain; Lesage, Frederic; Lodygensky, G. A.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Londono, Irene; Xie, Ningshi; Lodygensky, G. A.] Univ Montreal, Dept Pediat, Res Ctr CHU Ste Justine, Montreal, PQ H3C 3J7, Canada; [Bellec, Pierre] Univ Montreal, Geriatr Inst Res Ctr, Montreal, PQ, Canada; [Bellec, Pierre] Univ Montreal, Dept Comp Sci & Operat Res DIRO, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Lodygensky, GA (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.	ga.lodygensky@umontreal.ca	Guevara, Edgar/B-1414-2010; Lodygensky, Gregory/N-6576-2016	Guevara, Edgar/0000-0002-2313-2810; Lesage, Frederic/0000-0003-3699-1283; Bellec, Pierre/0000-0002-9111-0699	Canadian Institutes of Health Research - Institute of Human Development, Child and Youth Health (IHDCYH) [126790]; CONACYT [304501]; Fonds de recherche du Quebec - Sante; NSERC; CIHR	Canadian Institutes of Health Research - Institute of Human Development, Child and Youth Health (IHDCYH); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	Research reported in this publication was supported by start-up grant from the Canadian Institutes of Health Research - Institute of Human Development, Child and Youth Health (IHDCYH) # 126790. E. Guevara was supported in part by CONACYT scholarship No. 304501. G. A. Lodygensky is supported partly by salary award from Fonds de recherche du Quebec - Sante. F. Lesage is supported by a NSERC Discovery and CIHR Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy LJ, 2004, PEDIATR RES, V55, P884, DOI 10.1203/01.PDR.0000117843.21534.49; Allin M, 2007, ARCH PEDIAT ADOL MED, V161, P1183, DOI 10.1001/archpedi.161.12.1183; Anderson NG, 2006, PEDIATRICS, V118, P951, DOI 10.1542/peds.2006-0553; Benjak V, 2008, COLLEGIUM ANTROPOL, V32, P25; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenthal I, 2004, EUR J PEDIATR, V163, P435, DOI 10.1007/s00431-004-1477-y; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Born AP, 2000, NEUROPEDIATRICS, V31, P24, DOI 10.1055/s-2000-15402; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Caldu X, 2006, J CHILD NEUROL, V21, P406, DOI 10.1177/08830738060210050801; Choi Ehn-Kyoung, 2011, Lab Anim Res, V27, P77, DOI 10.5625/lar.2011.27.2.77; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Clark CAC, 2013, NEUROPSYCHOLOGY, V27, P364, DOI 10.1037/a0032273; CLAWSON CC, 1966, J COMP NEUROL, V127, P183; Dalitz P, 2003, J SOC GYNECOL INVEST, V10, P283, DOI 10.1016/S1071-5576(03)00090-X; Damaraju E, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00023; Dammann O, 2004, EARLY HUM DEV, V79, P1, DOI 10.1016/j.earlhumdev.2004.04.009; Dammann O, 2002, MENT RETARD DEV D R, V8, P46, DOI 10.1002/mrdd.10005; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Duncan JR, 2006, J SOC GYNECOL INVEST, V13, P87, DOI 10.1016/j.jsgi.2005.12.003; Ephrat P, 2012, PHOTOACOUSTIC IMAGIN; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Friston KJ, 2006, STAT PARAMETRIC MAPP; Grant PE, 2009, J CEREBR BLOOD F MET, V29, P1704, DOI 10.1038/jcbfm.2009.90; Guevara E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076021; Hagberg H, 2005, BJOG-INT J OBSTET GY, V112, P16, DOI 10.1111/j.1471-0528.2005.00578.x; Honore JC, 2013, ARTERIOSCL THROM VAS, V33, P954, DOI 10.1161/ATVBAHA.112.300943; Hudson J, 2013, ATLAS SMALL ANIMAL U, P3; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Liu WC, 2008, BRAIN RES, V1223, P42, DOI 10.1016/j.brainres.2008.05.054; Lodygensky GA, 2010, BRAIN BEHAV IMMUN, V24, P759, DOI 10.1016/j.bbi.2009.11.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narberhaus A, 2007, J CHILD NEUROL, V22, P761, DOI 10.1177/0883073807304006; Nie LM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.110506; Nie LM, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3595842; Nosarti C, 2004, BRAIN, V127, P2080, DOI 10.1093/brain/awh230; OLEARY MA, 1995, OPT LETT, V20, P426, DOI 10.1364/OL.20.000426; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ramachandra R., 2011, ATLAS NEONATAL RAT B; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Seghier ML, 2006, SEMIN FETAL NEONAT M, V11, P479, DOI 10.1016/j.siny.2006.07.007; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Sirinyan M, 2006, STROKE, V37, P2807, DOI 10.1161/01.STR.0000245082.19294.ff; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Smyser CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068098; Smyser CD, 2011, NEUROIMAGE, V56, P1437, DOI 10.1016/j.neuroimage.2011.02.073; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Thorvaldsen S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-573; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Verhagen EA, 2009, PEDIATRICS, V124, P294, DOI 10.1542/peds.2008-2057; Volpe J.J., 2008, NEUROLOGY NEWBORN; Wang KC, 2013, NEUROSCIENCE, V234, P146, DOI 10.1016/j.neuroscience.2012.12.049; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Xiang LZ, 2013, NEUROIMAGE, V66, P240, DOI 10.1016/j.neuroimage.2012.10.077; YOUNG RSK, 1983, PEDIATR RES, V17, P349, DOI 10.1203/00006450-198305000-00008; Zhang HF, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3122362; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	71	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83045	10.1371/journal.pone.0083045	http://dx.doi.org/10.1371/journal.pone.0083045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386140	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700024
J	Kear, BP; Rich, TH; Vickers-Rich, P; Ali, MA; Al-Mufarreh, YA; Matari, AH; Al-Massari, AM; Nasser, AH; Attia, Y; Halawani, MA				Kear, Benjamin P.; Rich, Thomas H.; Vickers-Rich, Patricia; Ali, Mohammed A.; Al-Mufarreh, Yahya A.; Matari, Adel H.; Al-Massari, Abdu M.; Nasser, Abdulaziz H.; Attia, Yousry; Halawani, Mohammed A.			First Dinosaurs from Saudi Arabia	PLOS ONE			English	Article							SAUROPOD DINOSAUR; DENTAL MORPHOLOGY; THEROPODA; PHYLOGENY; TOOTH; OSTEOLOGY; EVOLUTION; REPTILES; TRACKS; TEETH	Dinosaur remains from the Arabian subcontinent are exceedingly rare, and those that have been documented manifest indeterminate affinities. Consequently the discovery of a small, but diagnostic, accumulation of elements from Campanian-Maastrichtian (similar to 75 Ma) deposits in northwestern Saudi Arabia is significant because it constitutes the first taxonomically identifiable dinosaur material described from the Arabian Peninsula. The fossils include a series of possible lithostrotian titanosaur caudal vertebrae, and some isolated theropod marginal teeth that share unique character states and metric parameters (analyzed using multivariate statistical methods) with derived abelisaurids - this is the first justifiable example of a non-avian carnivorous dinosaur clade from Arabia. The recognition of titanosaurians and abelisaurids from Saudi Arabia extends the palaeogeographical range of these groups along the entire northern Gondwanan margin during the latest Cretaceous. Moreover, given the extreme paucity of coeval occurrences elsewhere, the Saudi Arabian fossils provide a tantalizing glimpse into dinosaurian assemblage diversity within the region.	[Kear, Benjamin P.] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Rich, Thomas H.] Museum Victoria, Dept Palaeontol, Melbourne, Vic, Australia; [Vickers-Rich, Patricia] Monash Univ, Sch Geosci, Melbourne, Vic 3004, Australia; [Ali, Mohammed A.; Al-Mufarreh, Yahya A.; Matari, Adel H.; Al-Massari, Abdu M.; Nasser, Abdulaziz H.; Attia, Yousry; Halawani, Mohammed A.] Saudi Geol Survey, Jeddah, Saudi Arabia	Uppsala University; Museum Victoria; Monash University; Saudi Geological Survey	Kear, BP (corresponding author), Uppsala Univ, Dept Earth Sci, Uppsala, Sweden.	benjamin.kear@geo.uu.se			Saudi Geological Survey	Saudi Geological Survey	Funding for this work was provided by the Saudi Geological Survey. As a standard requirement of their duties, staff from the Saudi Geological Survey participated in data collection, preparation of the manuscript, and the decision to publish.	AVNIMELECH M, 1962, NATURE, V196, P264, DOI 10.1038/196264a0; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E, 2006, NATURWISSENSCHAFTEN, V93, P440, DOI 10.1007/s00114-006-0124-z; Buffetaut Eric, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P3; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; Dalla Vecchia FM, 2002, J VERTEBR PALEONTOL, V22, P856; Fanti F, 2007, ACTA PALAEONTOL POL, V52, P155; Filatoff J, 1996, J AFR EARTH SCI, V22, P535, DOI 10.1016/0899-5362(96)00035-8; Grainger DJ, 2007, GEOLOGIC EVOLUTION S; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holtz Jr T. R., 2000, GAIA, V15, P5; HOOIJER DA, 1968, PROC K NED AKAD B-PH, V71, P150; Hughes GWA, 2005, GEOARABIA, V10, P49; Jacobs LL, 1999, FOSSIL VERTEBRATES OF ARABIA, P454; Kaddumi H.F., 2005, AMBER JORDAN OLDEST; Kear BP, 2008, GEOL MAG, V145, P648, DOI 10.1017/S0016756808005062; Kear BP, 2009, CRETACEOUS RES, V30, P1164, DOI 10.1016/j.cretres.2009.05.002; LARSON D, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0054329; Mannion PD, 2011, PALAEOGEOGR PALAEOCL, V299, P529, DOI 10.1016/j.palaeo.2010.12.003; Martill David M., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V3, P147; Mateus O, 2011, AN ACAD BRAS CIENC, V83, P221, DOI 10.1590/S0001-37652011000100012; McKinney M.L., 1990, P75; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Samman T, 2005, ACTA PALAEONTOL POL, V50, P757; SCHLEE D, 1973, Journal fuer Ornithologie, V114, P207, DOI 10.1007/BF01641171; Schulp A.S., 2008, SULTAN QABOOS U J SC, V13, P27; Schulp AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002243; Schulp AS, 2000, CRETACEOUS RES, V21, P851, DOI 10.1006/cres.2000.0235; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith JB, 2007, J VERTEBR PALEONTOL, V27, P103, DOI 10.1671/0272-4634(2007)27[103:DMAVIM]2.0.CO;2; Smith JB, 2006, J AFR EARTH SCI, V46, P240, DOI 10.1016/j.jafrearsci.2006.05.007; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; Soto M, 2008, J VERTEBR PALEONTOL, V28, P439, DOI 10.1671/0272-4634(2008)28[439:ACDTFT]2.0.CO;2; Suberbiola XP, 2004, J AFR EARTH SCI, V40, P81, DOI 10.1016/j.jafrearsci.2004.07.002; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; Turner AH, 2012, B AM MUS NAT HIST, P5; Weishampel DB., 2004, DINOSAURIA; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson J, 2006, J VERTEBR PALEONTOL, V26, p140A	49	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84041	10.1371/journal.pone.0084041	http://dx.doi.org/10.1371/journal.pone.0084041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386326	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700094
J	Lai, FJ; Chiu, CC; Yang, TH; Huang, YM; Wu, WS				Lai, Fu-Jou; Chiu, Chia-Chun; Yang, Tzu-Hsien; Huang, Yueh-Min; Wu, Wei-Sheng			Identifying Functional Transcription Factor Binding Sites in Yeast by Considering Their Positional Preference in the Promoters	PLOS ONE			English	Article							REGULATORY ELEMENTS; GENE-EXPRESSION; IDENTIFICATION; MICROARRAY; LANDSCAPE; NETWORKS; DATABASE; REVEALS; TARGETS	Transcription factor binding site (TFBS) identification plays an important role in deciphering gene regulatory codes. With comprehensive knowledge of TFBSs, one can understand molecular mechanisms of gene regulation. In the recent decades, various computational approaches have been proposed to predict TFBSs in the genome. The TFBS dataset of a TF generated by each algorithm is a ranked list of predicted TFBSs of that TF, where top ranked TFBSs are statistically significant ones. However, whether these statistically significant TFBSs are functional (i.e. biologically relevant) is still unknown. Here we develop a post-processor, called the functional propensity calculator (FPC), to assign a functional propensity to each TFBS in the existing computationally predicted TFBS datasets. It is known that functional TFBSs reveal strong positional preference towards the transcriptional start site (TSS). This motivates us to take TFBS position relative to the TSS as the key idea in building our FPC. Based on our calculated functional propensities, the TFBSs of a TF in the original TFBS dataset could be reordered, where top ranked TFBSs are now the ones with high functional propensities. To validate the biological significance of our results, we perform three published statistical tests to assess the enrichment of Gene Ontology (GO) terms, the enrichment of physical protein-protein interactions, and the tendency of being co-expressed. The top ranked TFBSs in our reordered TFBS dataset outperform the top ranked TFBSs in the original TFBS dataset, justifying the effectiveness of our post-processor in extracting functional TFBSs from the original TFBS dataset. More importantly, assigning functional propensities to putative TFBSs enables biologists to easily identify which TFBSs in the promoter of interest are likely to be biologically relevant and are good candidates to do further detailed experimental investigation. The FPC is implemented as a web tool at http://santiago.ee.ncku.edu.tw/FPC/.	[Lai, Fu-Jou; Huang, Yueh-Min] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan; [Chiu, Chia-Chun; Yang, Tzu-Hsien; Wu, Wei-Sheng] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, 1 Univ Rd, Tainan 70101, Taiwan.	wessonwu@gmail.com	Wu, Wei-Sheng/P-5367-2019	Yang, Tzu-Hsien/0000-0001-9420-196X	College of Electrical Engineering and Computer Science, National Cheng Kung University; Taiwan National Science Council [NSC 99-2628-B-006-015-MY3]	College of Electrical Engineering and Computer Science, National Cheng Kung University; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by College of Electrical Engineering and Computer Science, National Cheng Kung University and Taiwan National Science Council NSC 99-2628-B-006-015-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chang DTH, 2013, GENE, V518, P26, DOI 10.1016/j.gene.2012.11.089; Chang DTH, 2011, NUCLEIC ACIDS RES, V39, pD647, DOI 10.1093/nar/gkq1086; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Gyenesei A, 2007, BIOINFORMATICS, V23, P1927, DOI 10.1093/bioinformatics/btm276; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hansen L, 2010, NUCLEIC ACIDS RES, V38, P1772, DOI 10.1093/nar/gkp1195; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hohmann S, 2003, YEAST STRESS RESPONS; Holloway Dustin T, 2005, Genome Inform, V16, P83; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Klimova NV, 2006, MOL BIOL+, V40, P454, DOI 10.1134/S0026893306030125; Kolchanov NA, 2007, BRIEF BIOINFORM, V8, P266, DOI 10.1093/bib/bbm027; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lin ZG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-581; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Meierhans D, 1997, NUCLEIC ACIDS RES, V25, P4537, DOI 10.1093/nar/25.22.4537; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; ONEILL MC, 1991, NUCLEIC ACIDS RES, V19, P313, DOI 10.1093/nar/19.2.313; Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; STARR DB, 1995, J MOL BIOL, V250, P434; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Tronche F, 1997, J MOL BIOL, V266, P231, DOI 10.1006/jmbi.1996.0760; Wu WS, 2011, BIOINFORM BIOL INSIG, V5, P1, DOI 10.4137/BBI.S6362; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; Yang TH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-102; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	39	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83791	10.1371/journal.pone.0083791	http://dx.doi.org/10.1371/journal.pone.0083791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386279	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700077
J	Panic, N; Leoncini, E; de Belvis, G; Ricciardi, W; Boccia, S				Panic, Nikola; Leoncini, Emanuele; de Belvis, Giulio; Ricciardi, Walter; Boccia, Stefania			Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; ADOPTION	Introduction: PRISMA statement was published in 2009 in order to set standards in the reporting of systematic reviews and meta-analyses. Our aim was to evaluate the impact of PRISMA endorsement on the quality of reporting and methodological quality of systematic reviews and meta-analyses, published in journals in the field of gastroenterology and hepatology (GH). Methods: Quality of reporting and methodological quality were evaluated by assessing the adherence of papers to PRISMA checklist and AMSTAR quality scale. After identifying the GH journals which endorsed PRISMA in instructions for authors (IA), we appraised: 15 papers published in 2012 explicitly mentioning PRISMA in the full text (Group A); 15 papers from the same journals published in 2012 not explicitly mentioning PRISMA in the full text (Group B); 30 papers published the year preceding PRISMA endorsement from the same journals as above (Group C); 30 papers published in 2012 on the 10 highest impact factor journals in GH which not endorsed PRISMA (Group D). Results: PRISMA statement was referred in the IA in 9 out of 70 GH journals (12.9%). We found significant increase in overall adherence to PRISMA checklist (Group A, 90.1%; Group C, 83.1%; p = 0.003) and compliance to AMSTAR scale (Group A, 85.0%; Group C, 74.6%; p = 0.002), following the PRISMA endorsement from the nine GH journals. Explicit referencing of PRISMA in manuscript was not associated with increase in quality of reporting and methodological quality (Group A vs. B, p = 0.651, p = 0.900, respectively). Adherence to PRISMA checklist, and the compliance with AMSTAR were significantly higher in journals endorsing PRISMA compared to those not (Groups A+B vs. D; p = 0.003 and p = 0.016, respectively). Conclusion: The endorsement of PRISMA resulted in increase of both quality of reporting and methodological quality. It is advised that an increasing number of medical journals include PRISMA in the instructions for authors.	[Panic, Nikola; Leoncini, Emanuele; de Belvis, Giulio; Ricciardi, Walter; Boccia, Stefania] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Sect Hyg, Rome, Italy; [Panic, Nikola] Univ Belgrade, Fac Med, Belgrade, Serbia; [Panic, Nikola] Univ Clin Hosp Ctr Dr Dragisa Misovic Dedinje, Belgrade, Serbia; [Boccia, Stefania] IRCCS San Raffaele Pisana, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Belgrade; IRCCS San Raffaele Pisana	Boccia, S (corresponding author), Univ Cattolica Sacro Cuore, Inst Publ Hlth, Sect Hyg, Rome, Italy.	sboccia@rm.unicatt.it	Boccia, Stefania/AAB-9533-2022; Ricciardi, Walter/AAB-2056-2019; Boccia, Stefania/AFN-1666-2022; Ricciardi, Walter/K-3342-2018; , emanuele/A-5466-2010	Boccia, Stefania/0000-0002-1864-749X; Ricciardi, Walter/0000-0002-5655-688X; Boccia, Stefania/0000-0002-1864-749X; , emanuele/0000-0002-7669-8535	ERAWEB project; European Community; Fondazione Veronesi	ERAWEB project; European Community(European Commission); Fondazione Veronesi(Fondazione Umberto Veronesi)	The work of Nikola Panic was supported by the ERAWEB project, funded with support of the European Community. The work of Dr Emanuele Leoncini was supported by Fondazione Veronesi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 2009, BRIT J DERMATOL, V161, P1159, DOI 10.1111/j.1365-2133.2009.09382.x; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Han C, 2009, CONTEMP CLIN TRIALS, V30, P116, DOI 10.1016/j.cct.2008.11.004; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; MULROW CD, 1987, ANN INTERN MED, V106, P485, DOI 10.7326/0003-4819-106-3-485; Murthy L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009401.pub2; Poorolajal J, 2011, EPIDEMIOL HEALTH, V33, DOI 10.4178/epih/e2011005; Rennie D, 1996, JAMA-J AM MED ASSOC, V276, P649, DOI 10.1001/jama.276.8.649; Sacks HS, 1996, MT SINAI J MED, V63, P216; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Tao KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027611; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	19	497	505	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83138	10.1371/journal.pone.0083138	http://dx.doi.org/10.1371/journal.pone.0083138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386151	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700031
J	Postle, BR; Awh, E; Serences, JT; Sutterer, DW; D'Esposito, M				Postle, Bradley R.; Awh, Edward; Serences, John T.; Sutterer, David W.; D'Esposito, Mark			The Positional-Specificity Effect Reveals a Passive-Trace Contribution to Visual Short-Term Memory	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; WORKING-MEMORY; RECOGNITION MEMORY; PREFRONTAL CORTEX; NEURAL MECHANISMS; REPETITION; FMRI; REPRESENTATIONS; MODULATIONS; RESPONSES	The positional-specificity effect refers to enhanced performance in visual short-term memory (VSTM) when the recognition probe is presented at the same location as had been the sample, even though location is irrelevant to the match/nonmatch decision. We investigated the mechanisms underlying this effect with behavioral and fMRI studies of object change-detection performance. To test whether the positional-specificity effect is a direct consequence of active storage in VSTM, we varied memory load, reasoning that it should be observed for all objects presented in a sub-span array of items. The results, however, indicated that although robust with a memory load of 1, the positional-specificity effect was restricted to the second of two sequentially presented sample stimuli in a load-of-2 experiment. An additional behavioral experiment showed that this disruption wasn't due to the increased load per se, because actively processing a second object - in the absence of a storage requirement - also eliminated the effect. These behavioral findings suggest that, during tests of object memory, position-related information is not actively stored in VSTM, but may be retained in a passive tag that marks the most recent site of selection. The fMRI data were consistent with this interpretation, failing to find location-specific bias in sustained delay-period activity, but revealing an enhanced response to recognition probes that matched the location of that trial's sample stimulus.	[Postle, Bradley R.; Sutterer, David W.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Postle, Bradley R.; Sutterer, David W.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Awh, Edward] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Serences, John T.] Univ Calif San Diego, Dept Psychol, San Diego, CA 92103 USA; [D'Esposito, Mark] Univ Calif Berkeley, Wills Neurosci Inst, Berkeley, CA 94720 USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Oregon; University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Postle, BR (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	postle@wisc.edu	Sutterer, David/J-7833-2019	Sutterer, David/0000-0001-7977-6861; Awh, Edward/0000-0002-5211-5278	NIH [MH064498, NS01762, AG13483, AG00255]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901, R01MH064498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013483] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by NIH MH064498, NS01762, AG13483, AG00255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; ASHBURNER J, 1996, NEUROIMAGE, V3, pS111; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dill M, 1999, VISION RES, V39, P3752, DOI 10.1016/S0042-6989(99)00068-1; Dill M, 1998, PERCEPT PSYCHOPHYS, V60, P65, DOI 10.3758/BF03211918; Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009; Ewbank MP, 2011, J NEUROSCI, V31, P5635, DOI 10.1523/JNEUROSCI.5013-10.2011; FOSTER DH, 1985, BIOL CYBERN, V51, P305, DOI 10.1007/BF00336917; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fuster JM, 1995, MEMORY CEREBRAL CORT; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Johnson JS, 2013, PSYCHOL SCI IN PRESS; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Miller EK, 1996, J NEUROSCI, V16, P5154; Postle BR, 2005, COGN NEUROPSYCHOL, V22, P921, DOI 10.1080/02643290442000464; Postle BR, 2004, COGNITIVE BRAIN RES, V20, P194, DOI 10.1016/j.cogbrainres.2004.02.008; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; PROCTOR RW, 1986, PSYCHOL REV, V93, P473, DOI 10.1037/0033-295X.93.4.473; RATCLIFF R, 1985, PSYCHOL REV, V92, P212, DOI 10.1037/0033-295X.92.2.212; RICHES IP, 1991, J NEUROSCI, V11, P1763; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Soto D, 2007, P NATL ACAD SCI USA, V104, P17186, DOI 10.1073/pnas.0703706104; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; TALAIRACH J, 1988, COPLANER STEREOTAXIC; Talsma D, 2001, PSYCHOPHYSIOLOGY, V38, P425; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; van Dijk H, 2010, P NATL ACAD SCI USA, V107, P900, DOI 10.1073/pnas.0908821107; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	46	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83483	10.1371/journal.pone.0083483	http://dx.doi.org/10.1371/journal.pone.0083483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386212	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700055
J	Slight, SP; Seger, DL; Nanji, KC; Cho, I; Maniam, N; Dykes, PC; Bates, DW				Slight, Sarah P.; Seger, Diane L.; Nanji, Karen C.; Cho, Insook; Maniam, Nivethietha; Dykes, Patricia C.; Bates, David W.			Are We Heeding the Warning Signs? Examining Providers' Overrides of Computerized Drug-Drug Interaction Alerts in Primary Care	PLOS ONE			English	Article							PHYSICIAN ORDER ENTRY; DECISION-SUPPORT-SYSTEMS; HUMAN-FACTORS PRINCIPLES; MEDICATION SAFETY; IMPLEMENTATION; ACCEPTANCE	Background: Health IT can play a major role in improving patient safety. Computerized physician order entry with decision support can alert providers to potential prescribing errors. However, too many alerts can result in providers ignoring and overriding clinically important ones. Objective: To evaluate the appropriateness of providers' drug-drug interaction (DDI) alert overrides, the reasons why they chose to override these alerts, and what actions they took as a consequence of the alert. Design: A cross-sectional, observational study of DDI alerts generated over a three-year period between January 1st, 2009, and December 31st, 2011. Setting: Primary care practices affiliated with two Harvard teaching hospitals. The DDI alerts were screened to minimize the number of clinically unimportant warnings. Participants: A total of 24,849 DDI alerts were generated in the study period, with 40% accepted. The top 62 providers with the highest override rate were identified and eight overrides randomly selected for each (a total of 496 alert overrides for 438 patients, 3.3% of the sample). Results: Overall, 68.2% (338/496) of the DDI alert overrides were considered appropriate. Among inappropriate overrides, the therapeutic combinations put patients at increased risk of several specific conditions including: serotonin syndrome (21.5%, n=34), cardiotoxicity (16.5%, n=26), or sharp falls in blood pressure or significant hypotension (28.5%, n=45). A small number of drugs and DDIs accounted for a disproportionate share of alert overrides. Of the 121 appropriate alert overrides where the provider indicated they would "monitor as recommended", a detailed chart review revealed that only 35.5% (n=43) actually did. Providers sometimes reported that patients had already taken interacting medications together (15.7%, n=78), despite no evidence to confirm this. Conclusions and Relevance: We found that providers continue to override important and useful alerts that are likely to cause serious patient injuries, even when relatively few false positive alerts are displayed.	[Slight, Sarah P.; Cho, Insook; Dykes, Patricia C.; Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, Boston, MA 02115 USA; [Slight, Sarah P.] Univ Durham, Sch Med Pharm & Hlth, Durham, England; [Slight, Sarah P.; Nanji, Karen C.; Cho, Insook; Bates, David W.] Harvard Univ, Sch Med, Boston, MA USA; [Seger, Diane L.; Maniam, Nivethietha; Dykes, Patricia C.; Bates, David W.] Partners Healthcare Syst Inc, Boston, MA USA; [Nanji, Karen C.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Cho, Insook] Inha Univ, Dept Nursing, Inchon, South Korea	Harvard University; Brigham & Women's Hospital; Durham University; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Inha University	Slight, SP (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, 75 Francis St, Boston, MA 02115 USA.	sslight@partners.org	Bates, David/AAE-7283-2019	Slight, Sarah P/0000-0002-0339-846X; Cho, Insook/0000-0002-5152-9567	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by a grant from the Agency for Healthcare Research and Quality (AHRQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Berner ES., 2009, CLIN DECISION SUPPOR, V09-0069-EF; Canas F, 1999, ARCH INTERN MED, V159, P363, DOI 10.1001/archinte.159.4.363; Chertow GM, 2001, JAMA-J AM MED ASSOC, V286, P2839, DOI 10.1001/jama.286.22.2839; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Kaushal R, 2006, J AM MED INFORM ASSN, V13, P261, DOI 10.1197/jamia.M1984; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Peterson J F, 2001, J Am Pharm Assoc (Wash), V41, P159; Phansalkar S, 2013, J AM MED INFORM ASSN, V20, P489, DOI 10.1136/amiajnl-2012-001089; Phansalkar S, 2012, J AM MED INFORM ASSN, V19, P735, DOI 10.1136/amiajnl-2011-000612; Phansalkar S, 2010, J AM MED INFORM ASSN, V17, P493, DOI 10.1136/jamia.2010.005264; Seidling HM, 2011, J AM MED INFORM ASSN, V18, P479, DOI 10.1136/amiajnl-2010-000039; Shah NR, 2006, J AM MED INFORM ASSN, V13, P5, DOI 10.1197/jamia.M1868; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; Zachariah M, 2011, J AM MED INFORM ASSN, V18, pI62, DOI 10.1136/amiajnl-2011-000362	18	60	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85071	10.1371/journal.pone.0085071	http://dx.doi.org/10.1371/journal.pone.0085071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386447	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700130
J	Zhan, M; Liu, S; He, ZW				Zhan, Meng; Liu, Shuai; He, Zhiwei			Matching Rules for Collective Behaviors on Complex Networks: Optimal Configurations for Vibration Frequencies of Networked Harmonic Oscillators	PLOS ONE			English	Article							SYNCHRONIZATION; SYSTEMS; CHAOS	The structure-dynamics-function has become one of central problems in modern sciences, and it is a great challenge to unveil the organization rules for different dynamical processes on networks. In this work, we study the vibration spectra of the classical mass spring model with different masses on complex networks, and pay our attention to how the mass spatial configuration influences the second-smallest vibrational frequency (omega(2)) and the largest one (omega(N)). For random networks, we find that omega(2) becomes maximal and omega(N) becomes minimal if the node degrees are point-to-point-positively correlated with the masses. In these cases, we call it point-to-point matching. Moreover, omega(2) becomes minimal under the condition that the heaviest mass is placed on the lowest-degree vertex, and omega(N) is maximal as long as the lightest mass is placed on the highest-degree vertex, and in both cases all other masses can be arbitrarily settled. Correspondingly, we call it single-point matching. These findings indicate that the matchings between the node dynamics (parameter) and the node position rule the global systems dynamics, and sometimes only one node is enough to control the collective behaviors of the whole system. Therefore, the matching rules might be the common organization rules for collective behaviors on networks.	[Zhan, Meng; Liu, Shuai; He, Zhiwei] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance, Wuhan, Peoples R China; [Liu, Shuai; He, Zhiwei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhan, M (corresponding author), Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance, Wuhan, Peoples R China.	zhanmeng@wipm.ac.cn	Zhan, Meng/A-9926-2008	Zhan, Meng/0000-0002-2331-2002	National Natural Science Foundation of China [11075202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant No. 11075202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/40005; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2010, FUNDAMENTALS COMPUTA; [Anonymous], 2009, NETWORKS INTRO; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Ashcroft W., 1976, SOLID STATE PHYS; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Baptista MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048118; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2000, PHYS REP, V329, P103, DOI 10.1016/S0370-1573(99)00096-4; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Boccaletti S., 2008, SYNCHRONIZED DYNAMIC; BRAIMAN Y, 1995, NATURE, V378, P465, DOI 10.1038/378465a0; Brandt SF, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034104; Brede M, 2008, PHYS LETT A, V372, P2618, DOI 10.1016/j.physleta.2007.11.069; Chung F, 2003, P NATL ACAD SCI USA, V100, P6313, DOI 10.1073/pnas.0937490100; Cui Q., 2010, NORMAL MODE ANAL THE; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; ERDOS P, 1960, B INT STATIST INST, V38, P343; Estrada E, 2012, PHYS REP, V514, P89, DOI 10.1016/j.physrep.2012.01.006; Estrada E, 2010, BIOPHYS J, V98, P890, DOI 10.1016/j.bpj.2009.11.017; Goldstein H, 2002, CLASSICAL MECH; Jiao QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066020; Kim BJ, 2003, J PHYS A-MATH GEN, V36, P6329, DOI 10.1088/0305-4470/36/23/304; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Morin D., 2008, INTRO CLASSICAL MECH; Motter AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016116; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Ren J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051922; Rigoutsos I, 2006, SYSTEMS BIOL; Serdyuk IN, 2007, METHODS IN MOLECULAR BIOPHYSICS: STRUCTURE, DYNAMICS, FUNCTION, P1; Tessone CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.194101; Wang XG, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056205; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei GW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.284103; Woodman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064339; Wu Y, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/40005; Yan G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218703; Yang JZ, 1998, PHYS REV LETT, V80, P496, DOI 10.1103/PhysRevLett.80.496; Zhan M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036203; Zhou CS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034101; Zou W, 2011, CHAOS, V21; Zou W, 2009, FRONT PHYS CHINA, V4, P97, DOI 10.1007/s11467-009-0009-7	45	7	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82161	10.1371/journal.pone.0082161	http://dx.doi.org/10.1371/journal.pone.0082161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386088	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700005
J	Zhang, BY; Wang, O; Qin, JC; Liu, SS; Sun, S; Liu, HT; Kuang, J; Jiang, GH; Zhang, W				Zhang, Boyan; Wang, Ou; Qin, Jingchao; Liu, Shuaishuai; Sun, Sheng; Liu, Huitu; Kuang, Jian; Jiang, Guohua; Zhang, Wei			cis-Acting Elements and trans-Acting Factors in the Transcriptional Regulation of Raf Kinase Inhibitory Protein Expression	PLOS ONE			English	Article							RNA-POLYMERASE-II; CELL-PROLIFERATION; ALZHEIMERS-DISEASE; CANCER-THERAPY; BREAST-CANCER; LESS PROMOTER; B-RAF; P300; GENE; INITIATION	The Raf kinase inhibitory protein (RKIP) is down-regulated in multiple types of human cancers. Decreased RKIP transcription activity may be one of the major mechanisms responsible for the downregulation of RKIP expression in human diseases. To test this hypothesis, we need to gain basic knowledge of the transcriptional regulation of RKIP. To achieve this objective, we made a systematic effort to identify cis-acting elements and trans-acting factors that control RKIP promoter activity. We found that full RKIP promoter activity requires the region -56 to +261 relative to the transcription start site. Within the full promoter region, there are two motifs rich in G/C that responded to transcription factor Sp1, one cAMP-responsive element that responded to the transcription factor CREB, and one docking site for the histone acetylase p300. In human melanoma A375 cells and human cervical cancer HeLa cells, mutation or deletion of each of these cis-acting elements decreased promoter activity. In A375 cells, knockdown of the corresponding transcription factors Sp1, CREB, or p300 decreased RKIP promoter activity, whereas overexpression of CREB and p300 increased RKIP promoter activity. The results obtained with HeLa cells also supported the idea that Sp1 and CREB play positive roles in the regulation of RKIP transcription. These findings suggest that regulators of the expression or activity of Sp1, CREB, and p300 are involved in regulating RKIP transcription.	[Zhang, Boyan; Wang, Ou; Qin, Jingchao; Liu, Shuaishuai; Liu, Huitu; Zhang, Wei] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat, Beijing 100875, Peoples R China; [Sun, Sheng; Kuang, Jian] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Jiang, Guohua] Beijing Normal Univ, Anal & Testing Ctr, Beijing 100875, Peoples R China	Beijing Normal University; University of Texas System; UTMD Anderson Cancer Center; Beijing Normal University	Jiang, GH (corresponding author), Beijing Normal Univ, Anal & Testing Ctr, Beijing 100875, Peoples R China.	jgh@bnu.edu.cn; zhangwei@bnu.edu.cn	Liu, Shuaishuai/AAB-3256-2020	Zhang, Boyan/0000-0001-7112-9870	National Natural Science Foundation of China [30300173]; Beijing Talents Foundation [20071D0503100293]; Beijing Natural Science Foundation [5132021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Talents Foundation; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Grant 30300173 (W Zhang) from National Natural Science Foundation of China, Grant 20071D0503100293 (W Zhang) from Beijing Talents Foundation and Grant 5132021 from Beijing Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Emami KH, 1998, NUCLEIC ACIDS RES, V26, P839, DOI 10.1093/nar/26.3.839; FABER PW, 1993, J BIOL CHEM, V268, P9296; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hahn S, 1998, CELL, V95, P579, DOI 10.1016/S0092-8674(00)81625-6; Kaiser FJ, 2003, J BIOL CHEM, V278, P38780, DOI 10.1074/jbc.M306259200; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Li HZ, 2009, MOL CANCER RES, V7, P832, DOI 10.1158/1541-7786.MCR-08-0403; LUI JX, 1994, J BIOL CHEM, V269, P5391; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Martinho O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030769; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Mladenova V, 2009, BIOTECHNOL BIOTEC EQ, V23, P1044, DOI 10.1080/13102818.2009.10817609; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Okita K, 2009, BIOCHEM BIOPH RES CO, V379, P272, DOI 10.1016/j.bbrc.2008.12.037; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Szerlong HJ, 2010, J BIOL CHEM, V285, P31954, DOI 10.1074/jbc.M110.148718; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; VARGAWEISZ PD, 1995, FEBS LETT, V369, P118, DOI 10.1016/0014-5793(95)00549-O; Wu SY, 2001, J BIOL CHEM, V276, P34235, DOI 10.1074/jbc.M102463200; XING LP, 1995, J BIOL CHEM, V270, P17488, DOI 10.1074/jbc.270.29.17488; Xinzhou H, 2010, MOL BIOL, V45, P1004; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	41	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83097	10.1371/journal.pone.0083097	http://dx.doi.org/10.1371/journal.pone.0083097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386147	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700028
J	Zheng, Z; Zhang, C; Yan, JH; Ruan, YP; Zhao, XY; San, XT; Mao, YL; Sun, QH; Zhang, KZ; Fan, ZJ				Zheng, Ze; Zhang, Chao; Yan, Jianhua; Ruan, Yanping; Zhao, Xiaoyi; San, Xingting; Mao, Yilei; Sun, Qinghua; Zhang, Kezhong; Fan, Zhongjie			Diabetes Mellitus Is Associated with Hepatocellular Carcinoma: A Retrospective Case-Control Study in Hepatitis Endemic Area	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; LARGE COHORT; B-VIRUS; RISK; POPULATION; DISEASE; STRESS; IMPACT	Background: A number of case-control patient studies have been conducted to investigate the association between diabetes mellitus (DM) and hepatocellular carcinoma (HCC). Despite some controversial reports, it has been suggested that DM is associated with HCC. The previous studies on this subject vary in the selection of populations, sample sizes, methodology, and analysis results. Therefore, it is necessary to further delineate the involvement of DM, together with other related risk factors, in HCC with large sample size and strict analysis methodology. Methods: We conducted a hospital-based retrospective case-control study at Perking Union Medical College Hospital, China. A total of 1,568 patients with liver diseases were enrolled in the statistical study to evaluate the association of DM and other risk factors with HCC. Among these patients, 716 of them were diagnosed with benign liver diseases, and 852 patients were diagnosed as HCC. We utilized binary logistic regression and stepwise logistic regression to investigate the associations among DM, hypertension, fatty liver, cirrhosis, gallstone, HBV infection, HCV infection, and HCC. Results: Statistical analysis through the stepwise regression model indicated that the prevalence of DM, male gender, cirrhosis, HCV infection, or HBV infection is higher in the HCC patient group compared to the control group. However, the prevalence of gallstone is negatively associated with HCC cases. DM co-exists with HBV infection, male gender, and age in the HCC cases. Binary logistic regression analysis suggested that DM may synergize with HBV infection in HCC development. Conclusion: DM is strongly associated with the increased risk of HCC regardless of the prevalence of HBV infection, HCV infection, cirrhosis, male gender, and age. However, the synergistic interaction between DM and HBV in HCC occurrence is significant. Therefore, DM patients with HBV infection represent a very high HCC risk population and should be considered for HCC close surveillance program.	[Yan, Jianhua; Ruan, Yanping; Zhao, Xiaoyi; Fan, Zhongjie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China; [Yan, Jianhua; Ruan, Yanping; Zhao, Xiaoyi; San, Xingting; Mao, Yilei; Fan, Zhongjie] Peking Union Med Coll, Beijing 100730, Peoples R China; [Sun, Qinghua] Ohio State Univ, Coll Med, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Sun, Qinghua] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Zheng, Ze; Zhang, Chao; Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [San, Xingting; Mao, Yilei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hepatol, Beijing 100730, Peoples R China; [Zhang, Kezhong] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Wayne State University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Wayne State University	Sun, QH (corresponding author), Ohio State Univ, Coll Med, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	sun.224@osu.edu; kzhang@med.wayne.edu; Fan@pumch.cn		Zheng, Ze/0000-0002-4453-224X; Zhang, Kezhong/0000-0002-6062-235X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090313] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adami HO, 1996, J NATL CANCER I, V88, P1472, DOI 10.1093/jnci/88.20.1472; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Fujino Y, 2001, DIABETES-METAB RES, V17, P374, DOI 10.1002/dmrr.214; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2012, ARCH IRAN MED, V15, P508, DOI 012158/AIM.0014; Ko WH, 2012, HEPATOL RES, V42, P774, DOI 10.1111/j.1872-034X.2012.00979.x; Koh WP, 2013, BRIT J CANCER, V108, P1182, DOI 10.1038/bjc.2013.25; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Li Q, 2012, INT J CANCER, V131, P1197, DOI 10.1002/ijc.27337; Lu SN, 2006, INT J CANCER, V119, P1946, DOI 10.1002/ijc.22045; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Parikh S, 2007, AM J MED, V120, P194, DOI 10.1016/j.amjmed.2006.11.020; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Polesel J, 2009, ANN ONCOL, V20, P353, DOI 10.1093/annonc/mdn565; Shen Jianzhao, 2008, J Data Sci, V6, P515; Shimada M, 2002, J HEPATOL, V37, P154, DOI 10.1016/S0168-8278(02)00099-5; Tung HD, 2010, AM J GASTROENTEROL, V105, P624, DOI 10.1038/ajg.2009.711; Turati F, 2013, BRIT J CANCER, V108, P222, DOI 10.1038/bjc.2012.492; Wang CS, 2009, CANCER EPIDEM BIOMAR, V18, P2054, DOI 10.1158/1055-9965.EPI-08-1131; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; YU MC, 1991, JNCI-J NATL CANCER I, V83, P1820, DOI 10.1093/jnci/83.24.1820; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009	33	22	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84776	10.1371/journal.pone.0084776	http://dx.doi.org/10.1371/journal.pone.0084776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386416	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700118
J	Christen, L; Lai, CT; Hartmann, B; Hartmann, PE; Geddes, DT				Christen, Lukas; Lai, Ching Tat; Hartmann, Ben; Hartmann, Peter E.; Geddes, Donna T.			The Effect of UV-C Pasteurization on Bacteriostatic Properties and Immunological Proteins of Donor Human Milk	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOFERRIN; IDENTIFICATION; LIGHT; IRON; TERM	Background: Human milk possesses bacteriostatic properties, largely due to the presence of immunological proteins. Heat treatments such as Holder pasteurization reduce the concentration of immunological proteins in human milk and consequently increase the bacterial growth rate. This study investigated the bacterial growth rate and the immunological protein concentration of ultraviolet (UV-C) irradiated, Holder pasteurized and untreated human milk. Methods: Samples (n=10) of untreated, Holder pasteurized and UV-C irradiated human milk were inoculated with E. coli and S. aureus and the growth rate over 2 hours incubation time at 37 C was observed. Additionally, the concentration of sIgA, lactoferrin and lysozyme of untreated and treated human milk was analyzed. Results: The bacterial growth rate of untreated and UV-C irradiated human milk was not significantly different. The bacterial growth rate of Holder pasteurized human milk was double compared to untreated human milk (p<0.001). The retention of sIgA, lactoferrin and lysozyme after UV-C irradiation was 89%, 87%, and 75% respectively, which were higher than Holder treated with 49%, 9%, and 41% respectively. Conclusion: UV-C irradiation of human milk preserves significantly higher levels of immunological proteins than Holder pasteurization, resulting in bacteriostatic properties similar to those of untreated human milk.	[Christen, Lukas; Lai, Ching Tat; Hartmann, Peter E.; Geddes, Donna T.] Univ Western Australia, Fac Sci, Sch Chem & Biochem, Crawley, WA, Australia; [Christen, Lukas] Carag AG, Baar, Switzerland; [Hartmann, Ben] King Edward Mem Hosp, Perron Rotary Express Milk Bank, Subiaco, WA, Australia; [Hartmann, Ben] Univ Western Australia, Ctr Neonatal Res & Educ, Crawley, WA, Australia	University of Western Australia; King Edward Memorial Hospital; University of Western Australia; University of Western Australia	Christen, L (corresponding author), Univ Western Australia, Fac Sci, Sch Chem & Biochem, Crawley, WA, Australia.	lukas.christen@carag.com	; Geddes, Donna/H-9254-2014; Lai, ching tat/M-2452-2018	Hartmann, Peter/0000-0002-7709-0740; Geddes, Donna/0000-0002-0431-7078; Lai, ching tat/0000-0002-9025-4922	Medela AG, Baar, Switzerland	Medela AG, Baar, Switzerland	Funding for this study was provided by an unrestricted research grant from Medela AG, Baar, Switzerland http://www.medela.com/IW/en/breastfeeding.html?force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 1994, GUIDELINES ESTABLISH; Atkinson S.A., 1995, HDB MILK COMPOSITION, P351; Bergman T.L., 2007, FUNDAMENTALS HEAT MA, V6th; Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1; BOESMANFINKELSTEIN M, 1985, FEMS MICROBIOL LETT, V27, P167, DOI 10.1111/j.1574-6968.1985.tb00661.x; CHANDAN RC, 1968, J DAIRY SCI, V51, P606, DOI 10.3168/jds.S0022-0302(68)87036-5; Christen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068120; Cohen RS, 2012, BREASTFEED MED, V7, P282, DOI 10.1089/bfm.2011.0055; Czank C, 2009, PEDIATR RES, V66, P374, DOI 10.1203/PDR.0b013e3181b4554a; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; de Ferrer PAR, 2000, J AM COLL NUTR, V19, P370; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Drago-Serrano ME, 2010, IMMUNOL LETT, V134, P35, DOI 10.1016/j.imlet.2010.08.007; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Ewaschuk JB, 2011, APPL PHYSIOL NUTR ME, V36, P175, DOI [10.1139/H11-008, 10.1139/h11-008]; FRANSSON GB, 1980, J PEDIATR-US, V96, P380, DOI 10.1016/S0022-3476(80)80676-7; Gao XL, 2012, J PROTEOME RES, V11, P3897, DOI 10.1021/pr3004002; Goldman A.S., 1995, HDB MILK COMPOSITION, V1st ed., P727; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8; Hanson LA, 2004, ACTA PAEDIATR, V93, P154, DOI 10.1080/08035250310022586; Hartmann BT, 2007, EARLY HUM DEV, V83, P667, DOI 10.1016/j.earlhumdev.2007.07.012; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jay J M, 2000, MODERN FOOD MICROBIO, V2nd; Kreith F., 2001, PRINCIPLES HEAT TRAN, V6th; Kristo E, 2012, J AGR FOOD CHEM, V60, P6204, DOI 10.1021/jf300278k; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Losnedahl K, 1998, ANTIMICROBIAL FACTOR, P1; Manzoni P, 2012, PEDIATRICS, V129, P116, DOI 10.1542/peds.2011-0279; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Molinari CE, 2012, J PROTEOME RES, V11, P1696, DOI 10.1021/pr2008797; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Mosquito S, 2010, BIOMETALS, V23, P515, DOI 10.1007/s10534-010-9325-1; National Collaborating Centre for Mental Health, 2010, CLIN GUIDELINE, P1; Ochoa TJ, 2009, BIOCHIMIE, V91, P30, DOI 10.1016/j.biochi.2008.04.006; Ovali F, 2006, J PERINATOL, V26, P761, DOI 10.1038/sj.jp.7211610; Pammi M, 2011, COCHRANE DB SYST REV, V10, P1; Pellegrini A, 1999, BBA-GEN SUBJECTS, V1426, P439, DOI 10.1016/S0304-4165(98)00165-2; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; ROGERS HJ, 1978, IMMUNOLOGY, V34, P19; Sarkar D., 2008, LATTICE LATTICE GRAP; Schanler RJ, 2005, PEDIATRICS, V116, P400, DOI 10.1542/peds.2004-1974; Shama G., 1999, ULTRAVIOLET LIGHT EN; Shin K, 2000, J NUTR BIOCHEM, V11, P94, DOI 10.1016/S0955-2863(99)00082-0; Silvestre D, 2008, J HUM LACT, V24, P371, DOI 10.1177/0890334408319158; Silvestre D, 2006, BRIT J BIOMED SCI, V63, P59, DOI 10.1080/09674845.2006.11732721; SPIK G, 1978, IMMUNOLOGY, V35, P663; Team TRC, 2008, R LANG ENV STAT COMP; THOMPSON AR, 1954, BIOCHIM BIOPHYS ACTA, V14, P581, DOI 10.1016/0006-3002(54)90246-2; Tully D B, 2001, J Hum Lact, V17, P152, DOI 10.1177/089033440101700212; Van Gysel M, 2012, EUR J PEDIATR, V171, P1231, DOI 10.1007/s00431-012-1750-4; Wight N E, 2001, J Perinatol, V21, P249, DOI 10.1038/sj.jp.7200533; WILLS ME, 1982, EARLY HUM DEV, V7, P71, DOI 10.1016/0378-3782(82)90009-3; Zlotkin S., 2005, NUTR PRETERM INFANT, P333	55	63	66	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85867	10.1371/journal.pone.0085867	http://dx.doi.org/10.1371/journal.pone.0085867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376898	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000193
J	Briot, K; Paternotte, S; Kolta, S; Eastell, R; Felsenberg, D; Reid, DM; Gluer, CC; Roux, C				Briot, Karine; Paternotte, Simon; Kolta, Sami; Eastell, Richard; Felsenberg, Dieter; Reid, David M.; Glueer, Claus-C.; Roux, Christian			FRAX (R): Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CLINICAL RISK-FACTORS; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURE; HIP FRACTURE; MEN; DENSITOMETRY; ASSOCIATION; MANAGEMENT; MODELS	Purposes: The aim of this study was to analyse how well FRAX (R) predicts the risk of major osteoporotic and vertebral fractures over 6 years in postmenopausal women from general population. Patients and methods: The OPUS study was conducted in European women aged above 55 years, recruited in 5 centers from random population samples and followed over 6 years. The population for this study consisted of 1748 women (mean age 74.2 years) with information on incident fractures. 742 (43.1%) had a prevalent fracture; 769 (44%) and 155 (8.9%) of them received an antiosteoporotic treatment before and during the study respectively. We compared FRAX (R) performance with and without bone mineral density (BMD) using receiver operator characteristic (ROC) c-statistical analysis with ORs and areas under receiver operating characteristics curves (AUCs) and net reclassification improvement (NRI). Results: 85 (4.9%) patients had incident major fractures over 6 years. FRAX (R) with and without BMD predicted these fractures with an AUC of 0.66 and 0.62 respectively. The AUC were 0.60, 0.66, 0.69 for history of low trauma fracture alone, age and femoral neck (FN) BMD and combination of the 3 clinical risk factors, respectively. FRAX (R) with and without BMD predicted incident radiographic vertebral fracture (n = 65) with an AUC of 0.67 and 0.65 respectively. NRI analysis showed a significant improvement in risk assignment when BMD is added to FRAX (R). Conclusions: This study shows that FRAX (R) with BMD and to a lesser extent also without FN BMD predict major osteoporotic and vertebral fractures in the general population.	[Briot, Karine; Paternotte, Simon; Kolta, Sami; Roux, Christian] Paris Descartes Univ, Dept Rheumatol, Cochin Hosp, Paris, France; [Eastell, Richard] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Felsenberg, Dieter] Free & Humboldt Univ, Charite Univ Med Berlin, Ctr Muscle & Bone Res, Berlin, Germany; [Reid, David M.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Glueer, Claus-C.] Univ Klinikum Schleswig Holstein, Radiol Diagnost Klin, Kiel, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Sheffield; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Aberdeen; University of Kiel; Schleswig Holstein University Hospital	Briot, K (corresponding author), Paris Descartes Univ, Dept Rheumatol, Cochin Hosp, Paris, France.	karine.briot@cch.aphp.fr	Glüer, Claus-Christian/C-9752-2010; Eastell, Richard/G-5851-2011; Kolta, Sami/P-3076-2016; Briot, Karine/P-2116-2016	Glüer, Claus-Christian/0000-0003-3539-8955; Eastell, Richard/0000-0002-0323-3366; Briot, Karine/0000-0002-6238-2601	Eli Lilly; Sanofi-Aventis; Procter and Gamble Pharmaceuticals; Hoffman-La Roche; Pfizer; Novartis; Medical Research Council [MR/K006312/1] Funding Source: researchfish; MRC [MR/K006312/1] Funding Source: UKRI	Eli Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Procter and Gamble Pharmaceuticals(Procter & Gamble); Hoffman-La Roche; Pfizer(Pfizer); Novartis(Novartis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The OPUS cohort was sponsored by Eli Lilly, Sanofi-Aventis, Procter and Gamble Pharmaceuticals, Hoffman-La Roche, Pfizer and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author and coauthors did not receive any funding from these commercial sources.	Albrand G, 2003, BONE, V32, P78, DOI 10.1016/S8756-3282(02)00919-5; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Burger H, 1999, BONE, V25, P369, DOI 10.1016/S8756-3282(99)00173-8; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Donaldson MG, 2009, J BONE MINER RES, V24, P1793, DOI 10.1359/jbmr.090511; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Finigan J, 2008, J BONE MINER RES, V23, P75, DOI 10.1359/JBMR.070814; Gluer CC, 2004, J BONE MINER RES, V19, P782, DOI 10.1359/JBMR.040304; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Johansson H, 2011, OSTEOPOROSIS INT, V22, P453, DOI 10.1007/s00198-010-1218-1; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2395, DOI 10.1007/s00198-011-1713-z; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P809, DOI 10.1007/s00198-010-1524-7; Kanis JA, 2002, BONE, V30, P251, DOI 10.1016/S8756-3282(01)00653-6; KELSEY JL, 1992, AM J EPIDEMIOL, V135, P477, DOI 10.1093/oxfordjournals.aje.a116314; Leslie WD, 2003, OSTEOPOROSIS INT, V14, P334, DOI 10.1007/s00198-003-1375-6; Leslie WD, 2012, J BONE MINER RES, V27, P1243, DOI 10.1002/jbmr.1582; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McGrother CW, 2002, OSTEOPOROSIS INT, V13, P89, DOI 10.1007/s198-002-8343-6; Miller PD, 2002, J BONE MINER RES, V17, P2222, DOI 10.1359/jbmr.2002.17.12.2222; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Papaioannou A, 2005, OSTEOPOROSIS INT, V16, P568, DOI 10.1007/s00198-004-1735-x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pluijm SMF, 2009, J BONE MINER RES, V24, P768, DOI [10.1359/JBMR.081244, 10.1359/jbmr.081244]; Pluskiewicz W, 2010, BONE, V46, P1661, DOI 10.1016/j.bone.2010.02.012; Pressman AR, 2011, J CLIN DENSITOM, V14, P407, DOI 10.1016/j.jocd.2011.06.006; Roux C, 2009, CALCIFIED TISSUE INT, V84, P13, DOI 10.1007/s00223-008-9188-4; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Samelson EJ, 2006, J BONE MINER RES, V21, P1207, DOI 10.1359/JBMR.060513; Sandhu SK, 2010, OSTEOPOROSIS INT, V21, P863, DOI 10.1007/s00198-009-1026-7; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Sornay-Rendu E, 2010, J BONE MINER RES, V25, P2101, DOI 10.1002/jbmr.106; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Tremollieres FA, 2010, J BONE MINER RES, V25, P1002, DOI 10.1002/jbmr.12; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215	44	31	33	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83436	10.1371/journal.pone.0083436	http://dx.doi.org/10.1371/journal.pone.0083436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386199	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700041
J	Heath, JP; Borowski, P				Heath, Joel P.; Borowski, Peter			Quantifying Proportional Variability	PLOS ONE			English	Article							TEMPORAL VARIABILITY; SIZE; POPULATIONS; ABUNDANCES; PATTERNS	Real quantities can undergo such a wide variety of dynamics that the mean is often a meaningless reference point for measuring variability. Despite their widespread application, techniques like the Coefficient of Variation are not truly proportional and exhibit pathological properties. The non-parametric measure Proportional Variability (PV) [1] resolves these issues and provides a robust way to summarize and compare variation in quantities exhibiting diverse dynamical behaviour. Instead of being based on deviation from an average value, variation is simply quantified by comparing the numbers to each other, requiring no assumptions about central tendency or underlying statistical distributions. While PV has been introduced before and has already been applied in various contexts to population dynamics, here we present a deeper analysis of this new measure, derive analytical expressions for the PV of several general distributions and present new comparisons with the Coefficient of Variation, demonstrating cases in which PV is the more favorable measure. We show that PV provides an easily interpretable approach for measuring and comparing variation that can be generally applied throughout the sciences, from contexts ranging from stock market stability to climate variation.	[Heath, Joel P.; Borowski, Peter] Univ British Columbia, Dept Math, Vancouver, BC, Canada	University of British Columbia	Heath, JP (corresponding author), Univ British Columbia, Dept Math, Vancouver, BC, Canada.	heath.joel@gmail.com			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC Post Doctoral Fellowship to JPH and Supervisor funding to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2009, THESIS U WASHINGTON; Corbineau A, 2008, AQUAT LIVING RESOUR, V21, P277, DOI 10.1051/alr:2008045; Dochtermann NA, 2010, J ANIM ECOL, V79, P888, DOI 10.1111/j.1365-2656.2010.01686.x; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Heath JP, 2006, OIKOS, V115, P573; Johnson N.L., 1994, WILEY SERIES PROBABI, V1-2; Jovani R, 2011, ANIM BEHAV, V82, P1027, DOI 10.1016/j.anbehav.2011.07.037; Kokko H, 1999, AM NAT, V154, P358, DOI 10.1086/303235; Lamb RJ, 2011, CAN ENTOMOL, V143, P91, DOI 10.4039/n10-053; MARTIN JD, 1971, AM SOCIOL REV, V36, P496, DOI 10.2307/2093089; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Pimm SL, 1991, BALANCE NATURE ECOLO; Rouyer T, 2010, PROG OCEANOGR, V86, P267, DOI 10.1016/j.pocean.2010.04.025; Sen A., 1973, EC INEQUALITY; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Wikipedia, 2013, MEAN DIFF	18	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84074	10.1371/journal.pone.0084074	http://dx.doi.org/10.1371/journal.pone.0084074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386334	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700090
J	Kochi, T; Imai, Y; Takeda, A; Watanabe, Y; Mori, S; Tachi, M; Kodama, T				Kochi, Takashi; Imai, Yoshimichi; Takeda, Atsushi; Watanabe, Yukiko; Mori, Shiro; Tachi, Masahiro; Kodama, Tetsuya			Characterization of the Arterial Anatomy of the Murine Hindlimb: Functional Role in the Design and Understanding of Ischemia Models	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; SUSTAINED DELIVERY; MOUSE MODEL; PERFUSION; ARTERIOGENESIS; LIMB; COLLATERALS; DISEASE; GENE	Rationale: Appropriate ischemia models are required for successful studies of therapeutic angiogenesis. While collateral routes are known to be present within the innate vasculature, there are no reports describing the detailed vascular anatomy of the murine hindlimb. In addition, differences in the descriptions of anatomical names and locations in the literature impede understanding of the circulation and the design of hindlimb ischemia models. To understand better the collateral circulation in the whole hindlimb, clarification of all the feeding arteries of the hindlimb is required. Objective: The aim of this study is to reveal the detailed arterial anatomy and collateral routes in murine hindlimb to enable the appropriate design of therapeutic angiogenesis studies and to facilitate understanding of the circulation in ischemia models. Methods and Results: Arterial anatomy in the murine hindlimb was investigated by contrast-enhanced X-ray imaging and surgical dissection. The observed anatomy is shown in photographic images and in a schema. Previously unnoticed but relatively large arteries were observed in deep, cranial and lateral parts of the thigh. The data indicates that there are three collateral routes through the medial thigh, quadriceps femoris, and the biceps femoris muscles. Furthermore, anatomical variations were found at the origins of the three feeding arteries. Conclusions: The detailed arterial anatomy of murine hindlimb and collateral routes deduced from the anatomy are described. Limitations on designs of ischemia models in view of anatomical variations are proposed. These observations will contribute to the development of animal studies of therapeutic angiogenesis using murine hindlimb ischemia models.	[Kochi, Takashi; Imai, Yoshimichi; Tachi, Masahiro] Tohoku Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sendai, Miyagi 980, Japan; [Takeda, Atsushi] Tohoku Univ Hosp, Dept Plast & Reconstruct Surg, Sendai, Miyagi, Japan; [Kochi, Takashi; Watanabe, Yukiko; Mori, Shiro; Kodama, Tetsuya] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Mori, Shiro] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kodama, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan.	kodama@bme.tohoku.ac.jp	Perry, George/A-8611-2009; Kodama, Tetsuya/T-2246-2019; Imai, Yoshimichi/H-6719-2019	Perry, George/0000-0002-6547-0172; Imai, Yoshimichi/0000-0001-5360-958X; Kodama, Tetsuya/0000-0003-4727-9558	Japanese Society for the Promotion of Science;  [23592638];  [24659884];  [20015005];  [23300183];  [18650140];  [24650286]; Grants-in-Aid for Scientific Research [23592638] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) (23592638) awarded to A. Takeda, a Grant-in-Aid for JSPS Fellows awarded to Y. Watanabe; a Grant-in-Aid for Challenging Exploratory Research (24659884) awarded to S. Mori; and a Grant-in-Aid for Scientific Research on Priority Area (20015005), a Grant-in-Aid for Scientific Research (B) (23300183) and a Grant-in-Aid for Challenging Exploratory Research (18650140, 24650286) awarded to T. Kodama. All funding was provided by the Japanese Society for the Promotion of Science (URL:http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Arredondo J, 2013, J FELINE MED SURG, V15, P111, DOI 10.1177/1098612X12462704; ASAHARA T, 1995, CIRCULATION, V92, P365, DOI 10.1161/01.CIR.92.9.365; Bobek V, 2006, VASC PHARMACOL, V44, P395, DOI 10.1016/j.vph.2006.03.009; Botnar RM, 2012, PROG MOL BIOL TRANSL, V105, P227, DOI 10.1016/B978-0-12-394596-9.00008-1; Budras K. D., 2007, ANATOMY DOG; Budras K.D., 2012, ANATOMY HORSE, V6th ed.; Couffinhal T, 1998, AM J PATHOL, V152, P1667; COYLE P, 1982, ANAT REC, V203, P397, DOI 10.1002/ar.1092030309; Crouch JE, 1969, TEXT ATLAS CAT ANATO; Evans HE, 2010, GUIDE DISSECTION DOG; Fiebig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031179; Hardy B, 2008, BIOCHEM PHARMACOL, V75, P891, DOI 10.1016/j.bcp.2007.10.008; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Hiraoka K, 2003, CIRCULATION, V108, P2689, DOI 10.1161/01.CIR.0000093275.78676.F4; HOULIND K, 2013, ARTERY BYPASS, pCH24; Hua J, 2005, CIRCULATION, V111, P3255, DOI 10.1161/CIRCULATIONAHA.104.485029; Jang HS, 2004, MOL THER, V9, P464, DOI 10.1016/j.ymthe.2003.12.002; *JAP ASS VET AN, 2000, TERM VET AN HIST EMB; Jeon O, 2006, BIOMATERIALS, V27, P1617, DOI 10.1016/j.biomaterials.2005.09.009; Jeon O, 2006, J ENDOVASC THER, V13, P175, DOI 10.1583/05-1713MR.1; Kawamura I, 2011, J CARDIOVASC PHARM, V57, P416, DOI 10.1097/FJC.0b013e31820c9776; Konig H.E., 2006, VET ANATOMY DOMESTIC, V3rd; Lee JS, 2007, BIOCHEM BIOPH RES CO, V360, P752, DOI 10.1016/j.bbrc.2007.06.120; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998; Negishi Y, 2011, PHARM RES-DORDR, V28, P712, DOI 10.1007/s11095-010-0286-4; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; REIGHARD J, 1935, ANATOMY CAT; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; Senthilkumar A, 2007, ARTERIOSCL THROM VAS, V27, P1947, DOI 10.1161/ATVBAHA.107.147421; Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013; Sisson S, 1953, ANATOMY DOMESTIC ANI, V3; Sun QH, 2005, PHARM RES-DORDR, V22, P1110, DOI 10.1007/s11095-005-5644-2; Tang G, 2004, J VASC SURG, V40, P786, DOI 10.1016/j.jvs.2004.07.012; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje; Waters RE, 2004, J APPL PHYSIOL, V97, P773, DOI 10.1152/japplphysiol.00107.2004; Westvik TS, 2009, J VASC SURG, V49, P464, DOI 10.1016/j.jvs.2008.08.077; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006	41	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84047	10.1371/journal.pone.0084047	http://dx.doi.org/10.1371/journal.pone.0084047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386328	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700087
J	Li, GL; Lian, LL; Wan, L; Zhang, JR; Zhao, XQ; Jiang, Y; Zhao, LL; Liu, HC; Wan, KL				Li, Guilian; Lian, Lu-lu; Wan, Li; Zhang, Jingrui; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin			Antimicrobial Susceptibility of Standard Strains of Nontuberculous Mycobacteria by Microplate Alamar Blue Assay	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; IN-VITRO ACTIVITIES; TUBERCULOSIS; ABSCESSUS; IDENTIFICATION; CIPROFLOXACIN; CAPREOMYCIN; RESISTANCE; DIAGNOSIS; COMPLEX	In this study, 24 standard nontuberculous mycobacteria (NTM) species strains including 12 slowly growing mycobacteria strains and 12 rapidly growing mycobacteria strains were subjected to drug susceptibility testing using microplate Alamar Blue assay-based 7H9 broth. The most active antimicrobial agents against the 24 NTM strains were streptomycin, amikacin, the fluoroquinolones, and the tetracyclines. Mycobacterium chelonae, Mycobacterium abscessus, Mycobacterium bolletii, and Mycobacterium simiae are resistant to most antimicrobial agents. The susceptibility results of this study from 24 NTM standard strains can be referenced by clinicians before susceptibility testing for clinical isolates is performed or when conditions do not allow for susceptibility testing. The application of broth-based methods is recommended by the Clinical and Laboratory Standards Institute, and the documentation of the susceptibility patterns of standard strains of mycobacteria can improve the international standardization of susceptibility testing methods.	[Li, Guilian; Lian, Lu-lu; Wan, Li; Zhang, Jingrui; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Li, Guilian; Lian, Lu-lu; Wan, Li; Zhang, Jingrui; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Guilian; Zhao, Xiuqin; Jiang, Yi; Zhao, Li-li; Liu, Haican; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Lian, Lu-lu; Wan, Kanglin] Univ South China, Pathogen Biol Inst, Hengyang, Hunan, Peoples R China; [Zhang, Jingrui; Wan, Kanglin] Wenzhou Med Coll, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of South China; Wenzhou Medical University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	wankanglin@icdc.cn			National Key Programme of Mega Infectious Diseases [2013ZX10003002-001, 2011ZX10004-001]	National Key Programme of Mega Infectious Diseases	This work was financially supported by the projects 2013ZX10003002-001 and 2011ZX10004-001 of the National Key Programme of Mega Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry A, 2000, ANTIMICROB AGENTS CH, V44, P3133, DOI 10.1128/AAC.44.11.3133-3136.2000; Bicmen C, 2011, J CLIN MICROBIOL, V49, P2874, DOI 10.1128/JCM.00612-11; Bicmen C, 2010, NEW MICROBIOL, V33, P399; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Cavusoglu C, 2012, NEW MICROBIOL, V35, P73; Chauca JA, 2007, INT J TUBERC LUNG D, V11, P820; Colombo RE, 2008, SEMIN RESP CRIT CARE, V29, P577, DOI 10.1055/s-0028-1085709; David S, 2001, J ANTIMICROB CHEMOTH, V47, P203, DOI 10.1093/jac/47.2.203; Fernandez-Roblas R, 2008, ANTIMICROB AGENTS CH, V52, P4184, DOI 10.1128/AAC.00695-08; Garcia-Agudo L, 2009, REV MED CHILE, V137, P912, DOI /S0034-98872009000700008; Gayathri R, 2010, J POSTGRAD MED, V56, P19, DOI 10.4103/0022-3859.65278; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Huang YC, 2010, J MICROBIOL IMMUNOL, V43, P401, DOI 10.1016/S1684-1182(10)60063-1; Leonard B, 2008, J CLIN MICROBIOL, V46, P3526, DOI 10.1128/JCM.02083-07; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; Park S, 2008, J KOREAN MED SCI, V23, P49, DOI 10.3346/jkms.2008.23.1.49; Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x; Richter E, 2006, J CLIN MICROBIOL, V44, P1769, DOI 10.1128/JCM.44.5.1769-1775.2006; Shen GH, 2007, ANTIMICROB AGENTS CH, V51, P1849, DOI 10.1128/AAC.01551-06; van Ingen J, 2010, INT J ANTIMICROB AG, V35, P169, DOI 10.1016/j.ijantimicag.2009.09.023; Vanitha JD, 2004, DIAGN MICR INFEC DIS, V49, P179, DOI 10.1016/j.diagmicrobio.2004.04.003; WALLACE RJ, 1990, ANTIMICROB AGENTS CH, V34, P65, DOI 10.1128/AAC.34.1.65; WALLACE RJ, 1991, ANTIMICROB AGENTS CH, V35, P773, DOI 10.1128/AAC.35.4.773; Wallace RJ, 2002, ANTIMICROB AGENTS CH, V46, P3164, DOI 10.1128/AAC.46.10.3164-3167.2002; WHO, 2011, WHO GLOBAL TUBERCULO; World Health organization, 2008, POL GUID DRUG SUSC T; Yang SC, 2003, ANTIMICROB AGENTS CH, V47, P1958, DOI 10.1128/AAC.47.6.1958-1962.2003	27	43	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84065	10.1371/journal.pone.0084065	http://dx.doi.org/10.1371/journal.pone.0084065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386332	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700089
J	Meinhardt, S; Manley, MW; Parente, DJ; Swint-Kruse, L				Meinhardt, Sarah; Manley, Michael W., Jr.; Parente, Daniel J.; Swint-Kruse, Liskin			Rheostats and Toggle Switches for Modulating Protein Function	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; LAC REPRESSOR; SPECIFICITY DETERMINANTS; SEQUENCE; RESIDUES; FAMILY; PURR; IDENTIFICATION; CONSERVATION; PREDICTION	The millions of protein sequences generated by genomics are expected to transform protein engineering and personalized medicine. To achieve these goals, tools for predicting outcomes of amino acid changes must be improved. Currently, advances are hampered by insufficient experimental data about nonconserved amino acid positions. Since the property "nonconserved" is identified using a sequence alignment, we designed experiments to recapitulate that context: Mutagenesis and functional characterization was carried out in 15 LacI/GalR homologs (rows) at 12 nonconserved positions (columns). Multiple substitutions were made at each position, to reveal how various amino acids of a nonconserved column were tolerated in each protein row. Results showed that amino acid preferences of nonconserved positions were highly context-dependent, had few correlations with physico-chemical similarities, and were not predictable from their occurrence in natural LacI/GalR sequences. Further, unlike the "toggle switch" behaviors of conserved positions, substitutions at nonconserved positions could be rank-ordered to show a "rheostatic", progressive effect on function that spanned several orders of magnitude. Comparisons to various sequence analyses suggested that conserved and strongly co-evolving positions act as functional toggles, whereas other important, nonconserved positions serve as rheostats for modifying protein function. Both the presence of rheostat positions and the sequence analysis strategy appear to be generalizable to other protein families and should be considered when engineering protein modifications or predicting the impact of protein polymorphisms.	[Meinhardt, Sarah; Manley, Michael W., Jr.; Parente, Daniel J.; Swint-Kruse, Liskin] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center	Swint-Kruse, L (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA.	lswint-kruse@kumc.edu	Parente, Daniel/AAM-3887-2021	Parente, Daniel/0000-0002-7990-4576; Swint-Kruse, Liskin/0000-0002-5925-9741	National Institutes of Health [GM079432]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health (GM079432 and the American Recovery and Reinvestment Act) and by donations from private citizens. Aside from the financial contributions from the corresponding author, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington TA, 2013, J MOL BIOL, V425, P1378, DOI 10.1016/j.jmb.2013.01.034; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvidson DN, 1998, NAT STRUCT BIOL, V5, P436, DOI 10.1038/nsb0698-436; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Benitez-Paez A, 2012, BRIEF BIOINFORM, V13, P329, DOI 10.1093/bib/bbr052; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHEN J, 1992, J BIOL CHEM, V267, P13843; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; DeBartolo J, 2012, J MOL BIOL, V422, P124, DOI 10.1016/j.jmb.2012.05.022; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Francke C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-145; GILBERT W, 1973, P NATL ACAD SCI USA, V70, P3581, DOI 10.1073/pnas.70.12.3581; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gray VE, 2012, BIOINFORMATICS, V28, P2093, DOI 10.1093/bioinformatics/bts336; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Kc DB, 2011, IEEE ACM T COMPUT BI, V8, P226, DOI 10.1109/TCBB.2009.60; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Mazin PV, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-29; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Meinhardt S, 2012, NUCLEIC ACIDS RES, V40, P11139, DOI 10.1093/nar/gks806; Meinhardt S, 2008, PROTEINS, V73, P941, DOI 10.1002/prot.22121; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; Schumacher MA, 1997, J BIOL CHEM, V272, P22648, DOI 10.1074/jbc.272.36.22648; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Starita LM, 2013, P NATL ACAD SCI USA, V110, pE1263, DOI 10.1073/pnas.1303309110; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swint-Kruse L, 2002, PROTEIN SCI, V11, P778, DOI 10.1110/ps.4050102; Taraban M, 2008, J MOL BIOL, V376, P466, DOI 10.1016/j.jmb.2007.11.067; Tungtur S, 2007, PROTEINS, V68, P375, DOI 10.1002/prot.21412; Tungtur S, 2011, BIOPHYS CHEM, V159, P142, DOI 10.1016/j.bpc.2011.06.005; Tungtur S, 2011, PROTEINS, V79, P1589, DOI 10.1002/prot.22985; Tungtur S, 2010, J MOL BIOL, V395, P785, DOI 10.1016/j.jmb.2009.10.001; WEICKERT MJ, 1992, J MOL BIOL, V226, P69, DOI 10.1016/0022-2836(92)90125-4; Wilkins AD, 2012, CURR OPIN STRUC BIOL, V22, P316, DOI 10.1016/j.sbi.2012.05.001; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Zhan HL, 2008, BIOCHEMISTRY-US, V47, P8058, DOI 10.1021/bi800443k	53	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83502	10.1371/journal.pone.0083502	http://dx.doi.org/10.1371/journal.pone.0083502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386217	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700047
J	Pivodic, L; Pardon, K; Van den Block, L; Van Casteren, V; Miccinesi, G; Donker, GA; Alonso, TV; Alonso, JL; Aprile, PL; Onwuteaka-Philipsen, BD; Deliens, L				Pivodic, Lara; Pardon, Koen; Van den Block, Lieve; Van Casteren, Viviane; Miccinesi, Guido; Donker, Ge A.; Vega Alonso, Tomas; Lozano Alonso, Jose; Aprile, Pierangelo Lora; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc		EURO IMPACT	Palliative Care Service Use in Four European Countries: A Cross-National Retrospective Study via Representative Networks of General Practitioners	PLOS ONE			English	Article							OF-LIFE CARE; CANCER-PATIENTS; END; NETHERLANDS; HEALTH; POPULATION; PATIENT; DEATH	Background: Due to a rising number of deaths from cancer and other chronic diseases a growing number of people experience complex symptoms and require palliative care towards the end of life. However, population-based data on the number of people receiving palliative care in Europe are scarce. The objective of this study is to examine, in four European countries, the number of people receiving palliative care in the last three months of life and the factors associated with receiving palliative care. Methods: Cross-national retrospective study. Over two years (2009-2010), GPs belonging to representative epidemiological surveillance networks in Belgium, the Netherlands, Italy, and Spain registered weekly all deaths of patients (>= 18 years) in their practices and the care they received in the last three months of life using a standardized form. Sudden deaths were excluded. Results: We studied 4,466 deaths. GPs perceived to have delivered palliative care to 50% of patients in Belgium, 55% in Italy, 62% in the Netherlands, and 65% in Spain (p<.001). Palliative care specialists attended to 29% of patients in the Netherlands, 39% in Italy, 45% in Spain, and 47% in Belgium (p<.001). Specialist palliative care lasted a median (inter-quartile range) of 15 (23) days in Belgium to 30 (70) days in Italy (p<.001). Cancer patients were more likely than non-cancer patients to receive palliative care in all countries as were younger patients in Italy and Spain with regard to specialist palliative care. Conclusions: Although palliative care is established in the countries studied, there are considerable differences in its provision. Two potentially underserved groups emerge non-cancer patients in all countries and older people in Italy and Spain. Future research should examine how differences in palliative care use relate to both patient characteristics and existing national health care policies.	[Pivodic, Lara; Pardon, Koen; Van den Block, Lieve; Deliens, Luc] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Pivodic, Lara; Pardon, Koen; Van den Block, Lieve; Deliens, Luc] Univ Ghent, Brussels, Belgium; [Van Casteren, Viviane] Sci Inst Publ Hlth, Hlth Serv Res Unit, Brussels, Belgium; [Miccinesi, Guido] Canc Prevent & Res Inst, Clin & Descript Epidemiol Unit, Florence, Italy; [Donker, Ge A.] Netherlands Inst Hlth Serv Res, NIVEL, Dutch Sentinel Gen Practice Network, Utrecht, Netherlands; [Vega Alonso, Tomas; Lozano Alonso, Jose] Reg Minist Hlth, Publ Hlth Gen Directorate, Valladolid, Spain; [Aprile, Pierangelo Lora] Italian Soc Gen Med, Florence, Italy; [Onwuteaka-Philipsen, Bregje D.; Deliens, Luc] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Vrije Universiteit Brussel; Ghent University; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Pivodic, L (corresponding author), Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium.	lara.pivodic@vub.ac.be	miccinesi, guido/AAB-5476-2022; Caraceni, Augusto/C-1012-2017; Donker, Gé/AAX-8564-2021; Van den Block, Lieve/D-1247-2011; Pivodic, Lara/C-8588-2014	miccinesi, guido/0000-0002-7452-9594; Caraceni, Augusto/0000-0002-0375-6204; Van den Block, Lieve/0000-0002-7770-348X; Pivodic, Lara/0000-0002-8825-3699; Pardon, Koen/0000-0002-0571-709X; Harding, Richard/0000-0001-9653-8689; Deliens, Luc/0000-0002-8158-2422; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248; Lozano Alonso, Jose Eugenio/0000-0003-2589-0671; Donker, Ge/0000-0001-6314-9249	Institute for the Promotion of Innovation by Science and Technology in Flanders [SBO IWT 050158]; Italian Ministry of Health; European Union [264697]	Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission)	Funding for the study came from the Institute for the Promotion of Innovation by Science and Technology in Flanders (http://www.iwt.be) as a Strategic Basic Research project (SBO) (contract SBO IWT 050158) (2006-2010), as part of the 'Monitoring Quality of End-of-Life Care (MELC) Study', a collaboration between the Vrije Universiteit Brussel, Ghent University, Antwerp University, the Scientific Institute for Public Health, Belgium, and VU University Medical Center Amsterdam, the Netherlands. Funding also came from the Italian Ministry of Health (http://www.salute.gov.it) through the 'Evaluation, testing and implementation of supportive care, care interventions, integrated programs and improving the quality of care for cancer patients' program ('Integrated Oncology Project no 6, years 2008-2011') led by Massimo Costantini (IRCCS AOU San Martino-IST, Genoa), from the annual budgets of the Autonomous Community of Castilla y Leon (http://www.jcyl.es) and Comunitat Valenciana (http://www.gva.es) and from EURO IMPACT: European Intersectorial and Multidisciplinary Palliative Care Research Training, funded by the European Union Seventh Framework Programme (FP7/2007-2013, under grant agreement no [264697], http://ec.europa.eu/research/fp7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PAIN SYMPTOM MANAG, V41, P436, DOI 10.1016/j.jpainsymman.2010.04.016; Abarshi E, 2010, AGE AGEING, V39, P716, DOI 10.1093/ageing/afq097; Addington-Hall J, 1998, SOC SCI MED, V46, P1011, DOI 10.1016/S0277-9536(97)10021-1; Addington-Hall J, 1998, PALLIATIVE MED, V12, P417, DOI 10.1191/026921698676924076; Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; [Anonymous], 2010, WHO DEF PALL CAR; Beccaro M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-66; Beccaro M, 2013, J PAIN SYMPTOM MANAG, V46, P335, DOI 10.1016/j.jpainsymman.2012.08.020; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Borgsteede SD, 2006, PALLIATIVE MED, V20, P63, DOI 10.1191/0269216306pm1112oa; Brandt HE, 2005, ARCH INTERN MED, V165, P314, DOI 10.1001/archinte.165.3.314; Centeno C, 2007, PALLIATIVE MED, V21, P463, DOI 10.1177/0269216307081942; Clark D, 2000, PALLIATIVE MED, V14, P479, DOI 10.1191/026921600701536408; Clark D, 2007, J PAIN SYMPTOM MANAG, V33, P542, DOI 10.1016/j.jpainsymman.2007.02.010; Cohen J, 2011, J PAIN SYMPTOM MANAG, V42, P839, DOI 10.1016/j.jpainsymman.2011.02.017; Costantini M, 2006, ANN ONCOL, V17, P853, DOI 10.1093/annonc/mdl028; Currow DC, 2008, PALLIATIVE MED, V22, P43, DOI 10.1177/0269216307085182; DAVIES E, 2004, PALLIATIVE CARE SOLI; Deckers J, 2004, HLTH INFORM PRIMARY; Evans N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057965; Fleming DM, 2003, EUR J PUBLIC HEALTH, V13, P80, DOI 10.1093/eurpub/13.suppl_1.80; Francke A. L, 2003, PALLIATIVE CARE TERM; Francke AL, 2000, PATIENT EDUC COUNS, V41, P23, DOI 10.1016/S0738-3991(00)00112-9; Garcia-Armesto S, 2010, HLTH SYSTEMS TRANSIT; Gerkens S, 2010, HLTH SYSTEMS TRANSIT; Hall S., 2011, PALLIATIVE CARE OLDE; Hasselaar J, 2012, BMJ SUPPORT PALLIAT, V2, P334, DOI 10.1136/bmjspcare-2011-000162; Janssen DJA, 2008, PALLIATIVE MED, V22, P938, DOI 10.1177/0269216308096906; Keirse E, 2009, KCE REPORTS C, V115C; Ko W, 2013, EUR J CANCER, V49, P1967, DOI 10.1016/j.ejca.2013.01.006; Kuin A, 2004, J PAIN SYMPTOM MANAG, V27, P53, DOI 10.1016/j.jpainsymman.2003.06.001; Lo Scalzo ADA, 2009, HLTH SYST TRANSIT, V11, P1; Meeussen K, 2011, J CLIN ONCOL, V29, P4327, DOI 10.1200/JCO.2011.34.9498; Menaca A, 2012, CRIT REV ONCOL HEMAT, V82, P387, DOI 10.1016/j.critrevonc.2011.06.002; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National Council for Palliative Care, 2011, NAT SURV PAT ACT DAT; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Ottenbacher KJ, 2004, J CLIN EPIDEMIOL, V57, P1147, DOI 10.1016/j.jclinepi.2003.05.003; PIJNENBORG L, 1995, ARCH INTERN MED, V155, P286, DOI 10.1001/archinte.155.3.286; ROCAFORT J, 2008, EAPC REV PALLIATIVE; Rosenwax LK, 2005, PALLIATIVE MED, V19, P556, DOI 10.1191/0269216305pm1067oa; Schafer W., 2010, HLTH SYSTEMS TRANSIT; Rio-Valle JS, 2009, J PALLIAT CARE, V25, P191, DOI 10.1177/082585970902500306; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; The National Health System Palliative Care Strategy, 2007, NAT HLTH SYST PALL C; Van den Block L, 2008, ARCH INTERN MED, V168, P1747, DOI 10.1001/archinte.168.16.1747; Van den Block L, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-73; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; Vega Alonso Agustin Tomas, 2006, Gac Sanit, V20 Suppl 3, P52, DOI 10.1157/13101090	49	65	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84440	10.1371/journal.pone.0084440	http://dx.doi.org/10.1371/journal.pone.0084440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386381	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700108
J	Van den Bogert, B; Boekhorst, J; Herrmann, R; Smid, EJ; Zoetendal, EG; Kleerebezem, M				Van den Bogert, Bartholomeus; Boekhorst, Jos; Herrmann, Ruth; Smid, Eddy J.; Zoetendal, Erwin G.; Kleerebezem, Michiel			Comparative Genomics Analysis of Streptococcus Isolates from the Human Small Intestine Reveals their Adaptation to a Highly Dynamic Ecosystem	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; BACTERIAL SAMPLES; TRANSPORT-SYSTEM; MICROBIOTA; COMPETENCE; SEQUENCE; DNA; IDENTIFICATION; LACTOBACILLUS; TRANSCRIPTION	The human small-intestinal microbiota is characterised by relatively large and dynamic Streptococcus populations. In this study, genome sequences of small-intestinal streptococci from S. mitis, S. bovis, and S. salivarius species-groups were determined and compared with those from 58 Streptococcus strains in public databases. The Streptococcus pangenome consists of 12,403 orthologous groups of which 574 are shared among all sequenced streptococci and are defined as the Streptococcus core genome. Genome mining of the small-intestinal streptococci focused on functions playing an important role in the interaction of these streptococci in the small-intestinal ecosystem, including natural competence and nutrient-transport and metabolism. Analysis of the small-intestinal Streptococcus genomes predicts a high capacity to synthesize amino acids and various vitamins as well as substantial divergence in their carbohydrate transport and metabolic capacities, which is in agreement with observed physiological differences between these Streptococcus strains. Gene-specific PCR-strategies enabled evaluation of conservation of Streptococcus populations in intestinal samples from different human individuals, revealing that the S. salivarius strains were frequently detected in the small-intestine microbiota, supporting the representative value of the genomes provided in this study. Finally, the Streptococcus genomes allow prediction of the effect of dietary substances on Streptococcus population dynamics in the human small-intestine.	[Van den Bogert, Bartholomeus; Herrmann, Ruth; Smid, Eddy J.; Zoetendal, Erwin G.; Kleerebezem, Michiel] TIFN, Wageningen, Netherlands; [Van den Bogert, Bartholomeus; Herrmann, Ruth; Zoetendal, Erwin G.; Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Boekhorst, Jos] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Boekhorst, Jos; Kleerebezem, Michiel] NIZO Food Res BV, Ede, Netherlands; [Smid, Eddy J.] Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Radboud University Nijmegen; NIZO Food Research; Wageningen University & Research; Wageningen University & Research	Kleerebezem, M (corresponding author), TIFN, Wageningen, Netherlands.	michiel.kleerebezem@wur.nl	Kleerebezem, Michiel/AAT-2078-2021	Kleerebezem, Michiel/0000-0001-8552-2235; Boekhorst, Jos/0000-0002-4807-7838	Top Institute Food and Nutrition, Wageningen, The Netherlands; Netherlands Bioinformatics Centre (NBIC)	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government); Netherlands Bioinformatics Centre (NBIC)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands and by the Netherlands Bioinformatics Centre (NBIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Busuioc M, 2009, J BACTERIOL, V191, P7315, DOI 10.1128/JB.00425-09; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Claverys JP, 1998, MOL MICROBIOL, V29, P1126, DOI 10.1046/j.1365-2958.1998.01005.x; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Croucher NJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-120; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Detmers FJM, 1998, BIOCHEMISTRY-US, V37, P16671, DOI 10.1021/bi981712t; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Giammarinaro P, 1999, MICROBIOL-UK, V145, P1859, DOI 10.1099/13500872-145-8-1859; Glaser P, 2001, SCIENCE, V294, P849; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Havarstein LS, 2010, MOL MICROBIOL, V78, P541, DOI 10.1111/j.1365-2958.2010.07380.x; HUTKINS RW, 1991, APPL ENVIRON MICROB, V57, P941, DOI 10.1128/AEM.57.4.941-944.1991; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KANDLER O, 1983, A VAN LEEUW J MICROB, V49, P209, DOI 10.1007/BF00399499; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kant R, 2011, MICROB BIOTECHNOL, V4, P323, DOI 10.1111/j.1751-7915.2010.00215.x; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kleerebezem M, 2004, PEPTIDES, V25, P1405, DOI 10.1016/j.peptides.2003.10.021; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; Kunji ERS, 1998, MOL MICROBIOL, V27, P1107, DOI 10.1046/j.1365-2958.1998.00769.x; Lahtinen S, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lessard C, 2003, J BACTERIOL, V185, P6764, DOI 10.1128/JB.185.23.6764-6772.2003; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; ROGERS AH, 1973, ARCH ORAL BIOL, V18, P227, DOI 10.1016/0003-9969(73)90142-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schleifer K.H., 2009, BERGEYS MANUAL SYSTE, VVolume 3; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Simpson CL, 1998, J BACTERIOL, V180, P4711, DOI 10.1128/JB.180.17.4711-4717.1998; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Van den Bogert B, 2011, HDB MOL MICROBIAL EC, VII, P170; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van Kraaij C, 1999, NAT PROD REP, V16, P575, DOI 10.1039/a804531c; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144; WHITEHEAD TR, 1995, CURR MICROBIOL, V30, P143, DOI 10.1007/BF00296199; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143; Zoetendal EG, 2006, NAT PROTOC, V1, P870, DOI 10.1038/nprot.2006.142; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	77	34	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83418	10.1371/journal.pone.0083418	http://dx.doi.org/10.1371/journal.pone.0083418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386196	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700040
J	Wang, YH; Wei, W; Kang, DM; Ma, KP				Wang, Ying-hao; Wei, Wei; Kang, Ding-ming; Ma, Ke-ping			Seed Coat Microsculpturing Is Related to Genomic Components in Wild Brassica juncea and Sinapis arvensis	PLOS ONE			English	Article							NAPUS; COLOR; MICROSATELLITE; IDENTIFICATION; INHERITANCE; CRUCIFERAE; TAXONOMY; MARKER; RAPA	It has been reported that wild Brassica and related species are widely distributed across Xinjiang, China, and there has been an argument for species identification. Seed coat microsculpturing (SCM) is known to be an excellent character for taxonomic and evolutionary studies. By identifying collections from Xinjiang, China, and combining SCM pattern, flow cytometry, and genome-specific DNA markers as well as sexual compatibility with known species, this study aimed to detect potential relationships between SCM and genomic types in wild Brassica and related species. Three wild collections were found to be tetraploid with a SCM reticulate pattern similar to B. juncea, and containing A and B genome-specific loci, indicating relatively high sexual compatibility with B. juncea. The others were diploid, carrying S-genome-specific DNA markers, and having relatively high sexual compatibility with Sinapis arvensis. Moreover, their SCM was in a rugose pattern similar to that of S. arvensis. It was suggested that SCM, as a morphological characteristic, can reflect genomic type, and be used to distinguish B-genome species such as B. juncea from the related S. arvensis. The relationship between SCM and genomic type can support taxonomic studies of the wild Brassica species and related species.	[Wang, Ying-hao; Kang, Ding-ming] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Wang, Ying-hao; Wei, Wei; Ma, Ke-ping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS	Wei, W (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiwei@ibcas.ac.cn; kdm@pku.edu.cn	, Weiwei/B-2681-2008	, Weiwei/0000-0002-1815-9314	Natural Science Foundation of China [31370357, 31270578]; China-European Union cooperation special project of the Ministry of Science and Technology of China [0807]; China-UK Sustainable Agriculture Innovation Network (SAIN project: CWR China)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-European Union cooperation special project of the Ministry of Science and Technology of China; China-UK Sustainable Agriculture Innovation Network (SAIN project: CWR China)	This work was supported by two projects of the Natural Science Foundation of China (grant no. 31370357 and no. 31270578) and partially by the China-European Union cooperation special project of the Ministry of Science and Technology of China (contract 0807) and the China-UK Sustainable Agriculture Innovation Network (SAIN project: CWR China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Beeckman T, 2000, J PLANT RES, V113, P139, DOI 10.1007/PL00013924; BUTH G M, 1987, Phytomorphology, V37, P341; BUTH G M, 1981, Phytomorphology, V31, P69; CHEN BY, 1992, EUPHYTICA, V59, P157, DOI 10.1007/BF00041268; Corner E. J. H., 1976, SEEDS DICOTYLEDONS; Dean G, 2011, MOL PLANT, V4, P1074, DOI 10.1093/mp/ssr040; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Ford-Lloyd BV, 2011, BIOSCIENCE, V61, P559, DOI 10.1525/bio.2011.61.7.10; Guan ChunYun, 1996, Acta Agronomica Sinica, V22, P214; Hu Q, 2002, PLANT CELL REP, V21, P147, DOI 10.1007/s00299-002-0491-7; Koul KK, 2000, ANN BOT-LONDON, V86, P385, DOI 10.1006/anbo.2000.1197; Lei L, 2010, THESIS CHINESE ACAD; Lersten N. R., 1979, Proceedings of the Iowa Academy of Science, V86, P102; Liu XL, 2001, THESIS HUNAN AGR U C; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Lowe AJ, 2002, MOL ECOL NOTES, V2, P7, DOI 10.1046/j.1471-8286.2002.00126.x; Mao SF, 2012, HEREDITAS, V149, P86, DOI 10.1111/j.1601-5223.2012.02248.x; MULLIGAN GA, 1975, CAN J PLANT SCI, V55, P171, DOI 10.4141/cjps75-026; MULLIGAN GA, 1976, ECON BOT, V30, P143, DOI 10.1007/BF02862959; MURLEY MR, 1951, AM MIDL NAT, V46, P1, DOI 10.2307/2421948; Pankin AA, 2011, AM J BOT, V98, pE54, DOI 10.3732/ajb.1000422; Qian XiuZhen, 1998, Acta Agronomica Sinica, V24, P338; Raybould AF, 1999, GENET RESOUR CROP EV, V46, P351, DOI 10.1023/A:1008658630440; REJDALI M, 1990, BOT J LINN SOC, V103, P317, DOI 10.1111/j.1095-8339.1990.tb00193.x; Ren CW, 1998, SEED SCI RES, V8, P385, DOI 10.1017/S0960258500004311; Schelfhout CJ, 2004, THEOR APPL GENET, V109, P917, DOI 10.1007/s00122-004-1713-x; SCHWETKA A, 1982, THEOR APPL GENET, V62, P161, DOI 10.1007/BF00293352; Snowdon RJ, 2000, THEOR APPL GENET, V101, P1008, DOI 10.1007/s001220051574; SzewcMcFadden AK, 1996, THEOR APPL GENET, V93, P534, DOI 10.1007/BF00417944; U. N., 1935, Japanese Journal of Botany, V7, P389; VANDEYNZE AE, 1995, GENOME, V38, P534, DOI 10.1139/g95-069; VAUGHAN JG, 1971, BOT J LINN SOC, V64, P383, DOI 10.1111/j.1095-8339.1971.tb02153.x; Wan LL, 2002, PLANT J, V30, P1, DOI 10.1046/j.1365-313X.2002.01262.x; WANG L, 1982, Acta Botanica Yunnanica, V4, P367; WARWICK SI, 1993, CAN J BOT, V71, P906, DOI 10.1139/b93-102; Wei WH, 2010, THEOR APPL GENET, V120, P1089, DOI 10.1007/s00122-009-1236-6; Wu XiaoMing, 2001, Chinese Journal of Oil Crop Sciences, V23, P1; Zeng CL, 2004, ANN BOT-LONDON, V93, P555, DOI 10.1093/aob/mch080; Zhou TY, 2001, FLORA CHINA, V8	40	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83634	10.1371/journal.pone.0083634	http://dx.doi.org/10.1371/journal.pone.0083634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386242	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700054
J	Wu, X; Xu, TD; Li, DY; Zhu, SS; Chen, QP; Hu, WJ; Pan, DF; Zhu, H; Sun, H				Wu, Xin; Xu, Tongda; Li, Dongye; Zhu, Shasha; Chen, Qiuping; Hu, Wenjing; Pan, Defeng; Zhu, Hong; Sun, Hong			ERK/PP1a/PLB/SERCA2a and JNK Pathways Are Involved in Luteolin-Mediated Protection of Rat Hearts and Cardiomyocytes following Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CULTURED CARDIAC MYOCYTES; ACTIVATED PROTEIN-KINASES; CONTRACTILE FUNCTION; MYOCARDIAL-ISCHEMIA; PROMOTES SURVIVAL; INDUCED APOPTOSIS; INFARCT SIZE; P38 MAPK; INHIBITION	Luteolin has long been used in traditional Chinese medicine for treatment of various diseases. Recent studies have suggested that administration of luteolin yields cardioprotective effects during ischemia/reperfusion (I/R) in rats. However, the precise mechanisms of this action remain unclear. The aim of this study is to confirm that luteolin-mediated extracellular signal regulated kinase (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways are responsible for their cardioprotective effects during I/R. Wistar rats were divided into the following groups: (i) DMSO group (DMSO); (ii) I/R group (I/R); (iii) luteolin+I/R group (Lut+I/R); (iv) ERK1/2 inhibitor PD98059+I/R group (PD+I/R); (v) PD98059+luteolin+I/R group (PD+Lut+I/R); and (vi) JNK inhibitor SP600125+I/R group (SP+I/R). The following properties were measured: contractile function of isolated heart and cardiomyocytes; infarct size; the release of lactate dehydrogenase (LDH); the percentage of apoptotic cells; the expression levels of Bcl-2 and Bax; and phosphorylation status of ERK1/2, JNK, type 1 protein phosphatase (PP1a), phospholamban (PLB) and sarcoplasmic reticulum Ca2+-ATPase (SERCA2a). Our data showed that pretreatment with luteolin or SP600125 significantly improved the contraction of the isolated heart and cardiomyocytes, reduced infarct size and LDH activity, decreased the rate of apoptosis and increased the Bcl-2/Bax ratio. However, pretreatment with PD98059 alone before I/R had no effect on the above indexes. Further, these consequences of luteolin pretreatment were abrogated by co-administration of PD98059. We also found that pretreatment with PD98059 caused a significant increase in JNK expression, and SP600125 could cause ERK1/2 activation during I/R. In addition, we are the first to demonstrate that luteolin affects PP1a expression, which results in the up-regulation of the PLB, thereby relieving its inhibition of SERCA2a. These results showed that luteolin improves cardiomyocyte contractile function after I/R injury by an ERK1/2-PP1a-PLB-SERCA2a-mediated mechanism independent of JNK signaling pathway.	[Wu, Xin; Li, Dongye; Zhu, Shasha; Chen, Qiuping; Hu, Wenjing; Pan, Defeng; Zhu, Hong] Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China; [Xu, Tongda; Li, Dongye] Nanjing Tradit Chinese Med Univ, Dept Clin Coll 1, Nanjing, Jiangsu, Peoples R China; [Sun, Hong] Xuzhou Med Coll, Dept Physiol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China.	ldy@xzmc.edu.cn; sunh@xzmc.edu.cn	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020		Ministry of Education of China [20123237110006]	Ministry of Education of China(Ministry of Education, China)	This work was supported by Doctoral Fund of Ministry of Education of China (Grant No. 20123237110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anwar A, 2008, PFLUG ARCH EUR J PHY, V457, P485, DOI 10.1007/s00424-008-0520-7; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; El-Armouche A, 2004, CARDIOVASC RES, V61, P87, DOI 10.1016/j.cardiores.2003.11.005; Fang F, 2011, PHARMACOLOGY, V88, P149, DOI 10.1159/000330068; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gross TJ, 2007, J IMMUNOL, V177, P1636; Grote-Wessels S, 2008, CARDIOVASC RES, V79, P464, DOI 10.1093/cvr/cvn113; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; Gutierrez-Venegas G, 2006, EUR J PHARMACOL, V541, P95, DOI 10.1016/j.ejphar.2006.03.069; Gutierrez-Venegas G, 2010, INT IMMUNOPHARMACOL, V10, P1003, DOI 10.1016/j.intimp.2010.05.012; Hao YL, 2009, J CARDIOVASC PHARM, V54, P3, DOI 10.1097/FJC.0b013e3181a91410; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hu F, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-249; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Khan M, 2006, AM J PHYSIOL-HEART C, V290, pH2136, DOI 10.1152/ajpheart.01072.2005; Kobayashi M, 2006, HEPATO-GASTROENTEROL, V53, P243; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Liu HR, 2004, BRIT J PHARMACOL, V142, P627, DOI 10.1038/sj.bjp.0705847; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Peng TQ, 2009, CARDIOVASC RES, V81, P733, DOI 10.1093/cvr/cvn336; Qi LL, 2011, EUR J PHARMACOL, V668, P201, DOI 10.1016/j.ejphar.2011.06.020; Qian J, 2011, CIRC RES, V108, P1429, DOI 10.1161/CIRCRESAHA.110.237644; Quevedo C, 2003, J BIOL CHEM, V278, P16579, DOI 10.1074/jbc.M212936200; Sasaki K, 2013, BEHAV BRAIN RES, V238, P86, DOI 10.1016/j.bbr.2012.10.010; Shtil AA, 1999, ONCOGENE, V18, P377, DOI 10.1038/sj.onc.1202305; Stephanou A, 2002, FASEB J, V16, P1841, DOI 10.1096/fj.02-0150fje; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070956; Wu Q, 2008, EXP PHYSIOL, V93, P1034, DOI 10.1113/expphysiol.2007.041939; Yin X, 2012, EXP DIABETES RES, DOI 10.1155/2012/198048; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhao ZQ, 2002, CARDIOVASC RES, V55, P438, DOI 10.1016/S0008-6363(02)00442-X	41	48	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82957	10.1371/journal.pone.0082957	http://dx.doi.org/10.1371/journal.pone.0082957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386130	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700019
J	Biffi, E; Regalia, G; Menegon, A; Ferrigno, G; Pedrocchi, A				Biffi, Emilia; Regalia, Giulia; Menegon, Andrea; Ferrigno, Giancarlo; Pedrocchi, Alessandra			The Influence of Neuronal Density and Maturation on Network Activity of Hippocampal Cell Cultures: A Methodological Study	PLOS ONE			English	Article							PATTERNS	It is known that cell density influences the maturation process of in vitro neuronal networks. Neuronal cultures plated with different cell densities differ in number of synapses per neuron and thus in single neuron synaptic transmission, which results in a density-dependent neuronal network activity. Although many authors provided detailed information about the effects of cell density on neuronal culture activity, a dedicated report of density and age influence on neuronal hippocampal culture activity has not yet been reported. Therefore, this work aims at providing reference data to researchers that set up an experimental study on hippocampal neuronal cultures, helping in planning and decoding the experiments. In this work, we analysed the effects of both neuronal density and culture age on functional attributes of maturing hippocampal cultures. We characterized the electrophysiological activity of neuronal cultures seeded at three different cell densities, recording their spontaneous electrical activity over maturation by means of MicroElectrode Arrays (MEAs). We had gather data from 86 independent hippocampal cultures to achieve solid statistic results, considering the high culture-to-culture variability. Network activity was evaluated in terms of simple spiking, burst and network burst features. We observed that electrical descriptors were characterized by a functional peak during maturation, followed by a stable phase (for sparse and medium density cultures) or by a decrease phase (for high dense neuronal cultures). Moreover, 900 cells/mm(2) cultures showed characteristics suitable for long lasting experiments (e.g. chronic effect of drug treatments) while 1800 cells/mm(2) cultures should be preferred for experiments that require intense electrical activity (e.g. to evaluate the effect of inhibitory molecules). Finally, cell cultures at 3600 cells/mm(2) are more appropriate for experiments in which time saving is relevant (e.g. drug screenings). These results are intended to be a reference for the planning of in vitro neurophysiological and neuropharmacological experiments with MEAs.	[Biffi, Emilia; Regalia, Giulia; Ferrigno, Giancarlo; Pedrocchi, Alessandra] Politecn Milan, Neuroengn & Med Robot Lab, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Biffi, Emilia; Menegon, Andrea] Ist Sci San Raffaele, Adv Light & Electron Microscopy Bioimaging Ctr, Expt Imaging Ctr, I-20132 Milan, Italy	Polytechnic University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Biffi, E (corresponding author), IRCCS Eugenio Medea, Bioengn Lab, Inst Sci, Bosisio Parini, Lecco, Italy.	emilia.biffi@polimi.it	Ferrigno, Giancarlo/O-5833-2015; Pedrocchi, Alessandra/A-6634-2012; menegon, andrea/AAN-3736-2020; Biffi, Emilia/B-7982-2012; Pedrocchi, Alessandra/AAF-2655-2019; Biffi, Emilia/AAO-9249-2020	Ferrigno, Giancarlo/0000-0001-5913-9451; Pedrocchi, Alessandra/0000-0001-9957-2786; menegon, andrea/0000-0002-2396-756X; Pedrocchi, Alessandra/0000-0001-9957-2786; Biffi, Emilia/0000-0002-2568-9735				Akum BF, 2004, NAT NEUROSCI, V7, P145, DOI 10.1038/nn1179; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Biffi E, 2012, BIOTECHNOL BIOENG, V109, P2553, DOI 10.1002/bit.24526; Biffi E, 2011, J NEUROSCI METH, V199, P321, DOI 10.1016/j.jneumeth.2011.05.010; Biffi E, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3699975; Biffi E, 2012, BIOTECHNOL BIOENG, V109, P166, DOI 10.1002/bit.23310; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Morin FO, 2005, J BIOSCI BIOENG, V100, P131, DOI 10.1263/jbb.100.131; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P947, DOI 10.1016/j.bbi.2010.10.004; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11	15	77	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83899	10.1371/journal.pone.0083899	http://dx.doi.org/10.1371/journal.pone.0083899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386305	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900068
J	Leung, L; Radulovich, N; Zhu, CQ; Wang, D; To, C; Ibrahimov, E; Tsao, MS				Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Wang, Dennis; To, Christine; Ibrahimov, Emin; Tsao, Ming-Sound			Loss of Canonical Smad4 Signaling Promotes KRAS Driven Malignant Transformation of Human Pancreatic Duct Epithelial Cells and Metastasis	PLOS ONE			English	Article							ONCOGENIC K-RAS; TUMOR BIOLOGY; DPC4 GENE; CANCER; EXPRESSION; ADENOCARCINOMA; PROGRESSION; INVASION; SUPPRESSION; RESTORATION	Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in North America. Activating KRAS mutations and Smad4 loss occur in approximately 90% and 55% of PDAC, respectively. While their roles in the early stages of PDAC development have been confirmed in genetically modified mouse models, their roles in the multistep malignant transformation of human pancreatic duct cells have not been directly demonstrated. Here, we report that Smad4 represents a barrier in KRAS-mediated malignant transformation of the near normal immortalized human pancreatic duct epithelial (HPDE) cell line model. Marked Smad4 downregulation by shRNA in KRAS(G12V) expressing HPDE cells failed to cause tumorigenic transformation. However, KRAS-mediated malignant transformation occurred in a new HPDE-TGF-beta resistant (T beta R) cell line that completely lacks Smad4 protein expression and is resistant to the mito-inhibitory activity of TGF-beta. This transformation resulted in tumor formation and development of metastatic phenotype when the cells were implanted orthotopically into the mouse pancreas. Smad4 restoration re-established TGF-beta sensitivity, markedly increased tumor latency by promoting apoptosis, and decreased metastatic potential. These results directly establish the critical combination of the KRAS oncogene and complete Smad4 inactivation in the multi-stage malignant transformation and metastatic progression of normal human HPDE cells.	[Leung, Lisa; Tsao, Ming-Sound] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Radulovich, Nikolina; Tsao, Ming-Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Wang, Dennis; To, Christine; Ibrahimov, Emin; Tsao, Ming-Sound] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON M5S 1A1, Canada; [Leung, Lisa; Radulovich, Nikolina; Zhu, Chang-Qi; Wang, Dennis; To, Christine; Ibrahimov, Emin; Tsao, Ming-Sound] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tsao, MS (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	Ming.Tsao@uhn.on.ca	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; Zhu, ChangQi/0000-0002-9992-0258; Wang, Dennis/0000-0003-0068-1005	Canadian Institutes of Health Research [MOP-49585]; Canadian Cancer Society Research Institute [700809]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	Supported by the Canadian Institutes of Health Research grant MOP-49585, and Canadian Cancer Society Research Institute grant 700809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbunag C, 2004, CANCER RES, V64, P5659, DOI 10.1158/0008-5472.CAN-04-0807; Ahmed MM, 2002, J BIOL CHEM, V277, P2234, DOI 10.1074/jbc.M110168200; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Dai JL, 1999, P NATL ACAD SCI USA, V96, P1427, DOI 10.1073/pnas.96.4.1427; Duda DG, 2003, ONCOGENE, V22, P6857, DOI 10.1038/sj.onc.1206751; Furukawa T, 1996, AM J PATHOL, V148, P1763; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HAHN SA, 1995, CANCER RES, V55, P4670; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Lefter LP, 2002, GENE CHROMOSOME CANC, V34, P234, DOI 10.1002/gcc.10060; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046677; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lohr M, 2001, VIRCHOWS ARCH, V438, P581, DOI 10.1007/s004280100397; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazur PK, 2012, GUT, V61, P1488, DOI 10.1136/gutjnl-2011-300756; Oshima M, 2013, ANN SURG, V258, P336, DOI 10.1097/SLA.0b013e3182827a65; Peng BL, 2002, CLIN CANCER RES, V8, P3628; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Radulovich N, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-24; Radutovich N, 2008, METHOD ENZYMOL, V439, P1, DOI 10.1016/S0076-6879(07)00401-6; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schutte M, 1996, CANCER RES, V56, P2527; Shin SH, 2013, PANCREAS, V42, P216, DOI 10.1097/MPA.0b013e31825b6ab0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Wilentz RE, 2000, CANCER RES, V60, P2002; Yasutome M, 2005, CLIN EXP METASTAS, V22, P461, DOI 10.1007/s10585-005-2891-x; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412	43	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84366	10.1371/journal.pone.0084366	http://dx.doi.org/10.1371/journal.pone.0084366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386371	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900090
J	Nishimura, S; Ishii, K; Iwamoto, K; Arita, Y; Matsunaga, S; Ohno-Iwashita, Y; Sato, SB; Kakeya, H; Kobayashi, T; Yoshida, M				Nishimura, Shinichi; Ishii, Kumiko; Iwamoto, Kunihiko; Arita, Yuko; Matsunaga, Shigeki; Ohno-Iwashita, Yoshiko; Sato, Satoshi B.; Kakeya, Hideaki; Kobayashi, Toshihide; Yoshida, Minoru			Visualization of Sterol-Rich Membrane Domains with Fluorescently-Labeled Theonellamides	PLOS ONE			English	Article							CHOLESTEROL; TRANSPORT; GLYCOPEPTIDE; SWINHOEI; PEPTIDE; BINDING; PROTEIN; CELLS; RAFTS	Cholesterol plays important roles in biological membranes. The cellular location where cholesterol molecules work is prerequisite information for understanding their dynamic action. Bioimaging probes for cholesterol molecules would be the most powerful means for unraveling the complex nature of lipid membranes. However, only a limited number of chemical or protein probes have been developed so far for cytological analysis. Here we show that fluorescently-labeled derivatives of theonellamides act as new sterol probes in mammalian cultured cells. The fluorescent probes recognized cholesterol molecules and bound to liposomes in a cholesterol-concentration dependent manner. The probes showed patchy distribution in the plasma membrane, while they stained specific organelle in the cytoplasm. These data suggest that fTNMs will be valuable sterol probes for studies on the role of sterols in the biological membrane under a variety of experimental conditions.	[Nishimura, Shinichi; Arita, Yuko; Yoshida, Minoru] RIKEN Ctr Sustainable Resource Sci, Chem Genom Res Grp, Saitama, Japan; [Nishimura, Shinichi; Kakeya, Hideaki] Kyoto Univ, Div Bioinformat & Chem Genom, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Ishii, Kumiko; Iwamoto, Kunihiko; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Saitama, Japan; [Matsunaga, Shigeki] Univ Tokyo, Lab Aquat Nat Prod Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Ohno-Iwashita, Yoshiko] Iwaki Meisei Univ, Fac Pharm, Iwaki, Fukushima 970, Japan; [Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto, Japan	RIKEN; Kyoto University; RIKEN; University of Tokyo; Iwaki Meisei University; Kyoto University	Nishimura, S (corresponding author), RIKEN Ctr Sustainable Resource Sci, Chem Genom Res Grp, Saitama, Japan.	nshin@pharm.kyoto-u.ac.jp; yoshidam@riken.jp	Yoshida, Minoru/C-8049-2014; KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015; Nishimura, Shinichi/AGE-1316-2022; Kakeya, Hideaki/B-3527-2012	Yoshida, Minoru/0000-0002-4376-5674; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Nishimura, Shinichi/0000-0002-5998-3780; Kakeya, Hideaki/0000-0002-4293-7331	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Chemical Genomics Research Project, RIKEN Advanced Science Institute; Grants-in-Aid for Scientific Research [24657143, 25702048] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chemical Genomics Research Project, RIKEN Advanced Science Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science, and the Chemical Genomics Research Project, RIKEN Advanced Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; BEWLEY CA, 1994, J ORG CHEM, V59, P4849, DOI 10.1021/jo00096a028; Boutte Y, 2011, NAT PROTOC, V6, P446, DOI 10.1038/nprot.2011.323; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6; Espiritu RA, 2013, BIOCHEMISTRY; Espiritu RA, 2013, BIOCHEMISTRY-US, V52, P2410, DOI 10.1021/bi4000854; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Ishiwata H, 1997, BBA-MOL CELL RES, V1359, P123, DOI 10.1016/S0167-4889(97)00061-X; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Iwamoto M, 1997, BBA-BIOMEMBRANES, V1327, P222, DOI 10.1016/S0005-2736(97)00061-8; Kasai Y, 2008, CHEM-EUR J, V14, P1178, DOI 10.1002/chem.200701256; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; LISCUM L, 1989, J BIOL CHEM, V264, P11796; MATSUNAGA S, 1995, J ORG CHEM, V60, P1177, DOI 10.1021/jo00110a020; MATSUNAGA S, 1989, J AM CHEM SOC, V111, P2582, DOI 10.1021/ja00189a035; MILLER RG, 1984, CELL BIOL INT REP, V8, P519, DOI 10.1016/0309-1651(84)90050-X; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nishimura S, 2010, NAT CHEM BIOL, V6, P519, DOI [10.1038/nchembio.387, 10.1038/NCHEMBIO.387]; Ohno-Iwashita Y, 2010, SUBCELL BIOCHEM, V51, P597, DOI 10.1007/978-90-481-8622-8_22; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Schmidt EW, 1998, J ORG CHEM, V63, P1254, DOI 10.1021/jo9718455; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798	28	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83716	10.1371/journal.pone.0083716	http://dx.doi.org/10.1371/journal.pone.0083716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386262	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900056
J	Rementer, CW; Wu, MT; Buranaphatthana, W; Yang, HYL; Scatena, M; Giachelli, CM				Rementer, Cameron W.; Wu, Meiting; Buranaphatthana, Worakanya; Yang, Hsueh-Ying L.; Scatena, Marta; Giachelli, Cecilia M.			An Inducible, Ligand-Independent Receptor Activator of NF-kappa B Gene to Control Osteoclast Differentiation from Monocytic Precursors	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CELL THERAPY; CALCIFICATION; PROLIFERATION; INHIBITION; GROWTH	Osteoclasts are bone-resorbing cells that are critical for the normal formation and maintenance of teeth and skeleton. Osteoclast deficiency can contribute to heterotopic ossification (HO), a pathology that is particularly detrimental to the mechanical functions of joints, valves and blood vessels. On the other hand, osteoclast over-activity is a major cause of osteoporosis. A reliable method for controlled generation of osteoclasts would be useful as a potential autologous cell therapy for HO, as well as high-throughput drug screening for anti-osteoporotic drugs. In this report, we describe the development of a cell engineering approach to control monocytic precursor cell differentiation to osteoclasts. Oligomerization of receptor activator of nuclear factor kappa B (RANK) is known to be essential for osteoclast differentiation from monocyte/macrophage precursors. We engineered a murine monocytic cell line, RAW264.7 to express a fusion protein comprising the intracellular RANK signaling domain and FK506-derived dimerization domains that bind to a small molecule chemical inducer of dimerization (CID). Virally infected cells expressing this fusion protein were treated with CID and dose-dependent induction of tartrate-resistant acid phosphatase activity, as well as multinucleated osteoclast formation were observed. Furthermore, NF-kappa B signaling was upregulated in a CID-dependent fashion, demonstrating effective RANK intracellular signaling. Functionally CID-induced osteoclasts had robust mineral resorptive activity in both two-dimensional and three-dimensional in vitro resorption assays. In addition, the CID-induced osteoclasts have the same life span as native RANKL-induced osteoclasts. Most importantly and crucially, the engineered cells differentiated into osteoclasts that were resistant to the potent osteoclast inhibitor, osteoprotegerin. Taken together, these studies are the first to describe a method for inducible control of monocytic precursor differentiation to osteoclasts that may be useful for future development of an engineered autologous cell therapy as well as high-throughput drug testing systems to treat diseases of osteoclast over-activity that are independent of osteoprotegerin.	[Rementer, Cameron W.; Wu, Meiting; Yang, Hsueh-Ying L.; Scatena, Marta; Giachelli, Cecilia M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Buranaphatthana, Worakanya] Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Giachelli, CM (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	ceci@uw.edu			Life Sciences Discovery Fund [2361524]; NIH [R01HL114611-01, T32EB001650]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER	Life Sciences Discovery Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by Life Sciences Discovery Fund 2361524, NIH grant R01HL114611-01 and NIH training grant T32EB001650. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; BOYDE A, 1984, BRIT DENT J, V156, P216, DOI 10.1038/sj.bdj.4805313; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; Courter DL, 2005, J BIOL CHEM, V280, P12145, DOI 10.1074/jbc.M412555200; Dismuke AD, 2009, BIOL PROCED ONLINE, V11, P130, DOI 10.1007/s12575-009-9014-z; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8; Hashem R, 2011, CANCER RADIOTHER, V15, P261, DOI 10.1016/j.canrad.2010.10.003; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Iwamoto K, 2004, BIOCHEM BIOPH RES CO, V325, P229, DOI 10.1016/j.bbrc.2004.10.024; Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788; Jin LQ, 1998, BLOOD, V91, P890, DOI 10.1182/blood.V91.3.890.890_890_897; Simpson CL, 2007, CARDIOVASC PATHOL, V16, P29, DOI 10.1016/j.carpath.2006.07.001; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lippuner K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13624; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Neff T, 2001, BLOOD, V97, P2535, DOI 10.1182/blood.V97.9.2535; Ollivere B, 2012, J BONE JOINT SURG BR, V94B, P10, DOI 10.1302/0301-620X.94B1.28047; Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030; Paparodis R, 2013, ENDOCR PRACT, V21, P1; Pichardo SE, 2012, J CRANIOMAXILLOFAC S, V41, pe65; Pohjolainen V, 2008, HUM PATHOL, V39, P1695, DOI 10.1016/j.humpath.2008.04.015; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Shehab D, 2002, J NUCL MED, V43, P346; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Susa Mira, 2004, J Transl Med, V2, P6, DOI 10.1186/1479-5876-2-6; Tey SK, 2007, BIOL BLOOD MARROW TR, V13, P913, DOI 10.1016/j.bbmt.2007.04.005; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van den Wyngaert T, 2011, SUPPORT CARE CANCER, V19, P2035, DOI 10.1007/s00520-010-1061-0; Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166; Weinreich MA, 2006, BLOOD, V108, P3713, DOI 10.1182/blood-2006-01-012278; Whitney ML, 2001, J BIOL CHEM, V276, P41191, DOI 10.1074/jbc.M103191200; Zeng H, 2001, BLOOD, V98, P328, DOI 10.1182/blood.V98.2.328	39	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84465	10.1371/journal.pone.0084465	http://dx.doi.org/10.1371/journal.pone.0084465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386387	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900097
J	Suzaki, Y; Katsuki, M; Miyatake, T; Okada, Y				Suzaki, Yu; Katsuki, Masako; Miyatake, Takahisa; Okada, Yasukazu			Male Courtship Behavior and Weapon Trait as Indicators of Indirect Benefit in the Bean Bug, Riptortus pedestris	PLOS ONE			English	Article							CLAVATUS THUNBERG HETEROPTERA; SEXUAL SELECTION; MALE COMPETITION; MATE CHOICE; GENETIC CORRELATIONS; FEMALE PREFERENCE; MATING SUCCESS; BODY-SIZE; MULTIPLE; COSTS	Females prefer male traits that are associated with direct and/or indirect benefits to themselves. Male-male competition also drives evolution of male traits that represent competitive ability. Because female choice and male-male competition rarely act independently, exploring how these two mechanisms interact is necessary for integrative understanding of the evolution of sexually selected traits. Here, we focused on direct and indirect benefits to females from male attractiveness, courtship, and weapon characters in the armed bug Riptortus pedestris. The males use their hind legs to fight other males over territory and perform courtship displays for successful copulation. Females of R. pedestris receive no direct benefit from mating with attractive males. On the other hand, we found that male attractiveness, courtship rate, and weapon size were significantly heritable and that male attractiveness had positive genetic covariances with both courtship rate and weapon traits. Thus, females obtain indirect benefits from mating with attractive males by producing sons with high courtship success rates and high competitive ability. Moreover, it is evident that courtship rate and hind leg length act as evaluative cues of female choice. Therefore, female mate choice and male-male competition may facilitate each other in R. pedestris. This is consistent with current basic concepts of sexual selection.	[Suzaki, Yu; Miyatake, Takahisa] Okayama Univ, Grad Sch Environm Sci, Okayama, Japan; [Katsuki, Masako] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Miyatake, Takahisa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Okada, Yasukazu] Univ Tokyo, Dept Gen Syst Studies, Tokyo, Japan	Okayama University; University of Tsukuba; Okayama University; University of Tokyo	Suzaki, Y (corresponding author), Okayama Univ, Grad Sch Environm Sci, Okayama, Japan.	gev421204@s.okayama-u.ac.jp	Miyatake, Takahisa/B-6580-2017; Okada, Yasukazu/B-1590-2014	Miyatake, Takahisa/0000-0002-5476-0676; Okada, Yasukazu/0000-0003-4528-2980	Japan Society for the Promotion of Science [245168, 23570027]; Grants-in-Aid for Scientific Research [13J01662] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by Grant-in-Aid for JSPS Fellows (245168) to YS and Grant-in-Aid for Scientific Research (KAKENHI 23570027) to TM, both from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001739; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson M, 2006, ESSAYS ANIMAL BEHAV, P255; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Arnqvist Goran, 2005, pUnpaginated; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; Barth M, 1997, ANIM BEHAV, V53, P25, DOI 10.1006/anbe.1996.0275; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Boake CRB, 1998, EVOLUTION, V52, P1487, DOI 10.1111/j.1558-5646.1998.tb02030.x; Bonduriansky R, 2003, EVOLUTION, V57, P2046, DOI 10.1111/j.0014-3820.2003.tb00384.x; Bretman A, 2011, CURR BIOL, V21, P617, DOI 10.1016/j.cub.2011.03.008; Cameron E, 2003, J EVOLUTION BIOL, V16, P1055, DOI 10.1046/j.1420-9101.2003.00584.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2005, P ROY SOC B-BIOL SCI, V272, P47, DOI 10.1098/rspb.2004.2932; Candolin U, 2004, EVOLUTION, V58, P1861; Charlesworth B., 1987, Life Sciences Research Report, V39, P21; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS; Eberhard W.G., 1979, P231; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Etges WJ, 2002, GENETICA, V116, P151, DOI 10.1023/A:1021284426383; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; Fisher RA, 1930, GENETICAL THEORY NAT; Grafen A., 2002, MODERN STAT LIFE SCI; HAINES SE, 1994, NATURE, V370, P512, DOI 10.1038/370512a0; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; HOELZER GA, 1989, ANIM BEHAV, V38, P1067, DOI 10.1016/S0003-3472(89)80146-0; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Houde E, 1997, SEX COLOR MATE CHOIC; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Kamano S, 1991, REARING METHODS INSE, P46; Kimura S, 2008, JPN J APPL ENTOMOL Z, V52, P13, DOI 10.1303/jjaez.2008.13; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kotiaho JS, 2002, BEHAV ECOL, V13, P791, DOI 10.1093/beheco/13.6.791; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lailvaux SP, 2010, ECOLOGY, V91, P1530, DOI 10.1890/09-0963.1; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lynch M., 1998, GENETICS ANAL QUANTI; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Natuhara Y, 1985, SEIKATSU EISEI, V29, P102; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; NUMATA H, 1986, APPL ENTOMOL ZOOL, V21, P119, DOI 10.1303/aez.21.119; NUMATA H, 1990, APPL ENTOMOL ZOOL, V25, P144, DOI 10.1303/aez.25.144; Okada K, 2011, J EVOLUTION BIOL, V24, P1737, DOI 10.1111/j.1420-9101.2011.02303.x; Okada K, 2013, BEHAV ECOL SOCIOBIOL, V67, P53, DOI 10.1007/s00265-012-1424-2; Okada K, 2011, ZOOL SCI, V28, P659, DOI 10.2108/zsj.28.659; Okada Y, 2012, ANIM BEHAV, V83, P1001, DOI 10.1016/j.anbehav.2012.01.021; Omae Y, 2012, APPL ENTOMOL ZOOL, V47, P157, DOI 10.1007/s13355-012-0103-0; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; PRICE T, 1993, BIOL J LINN SOC, V48, P187, DOI 10.1111/j.1095-8312.1993.tb00887.x; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Roff Derek, 2002, pi; Ronning B, 2007, J EVOLUTION BIOL, V20, P1815, DOI 10.1111/j.1420-9101.2007.01384.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Sakurai G, 2008, ANIM BEHAV, V75, P1367, DOI 10.1016/j.anbehav.2007.09.010; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Shuster SM, 2003, MATING SYSTEM STRATE, P553; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2011, BIOL LETTERS, V7, P419, DOI 10.1098/rsbl.2010.0976; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054; Thornhill R., 1983, pi; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Yamane T, 2010, P ROY SOC B-BIOL SCI, V277, P1705, DOI 10.1098/rspb.2009.2017	85	15	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83278	10.1371/journal.pone.0083278	http://dx.doi.org/10.1371/journal.pone.0083278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386170	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900030
J	Ahmad, N; Nayak, S; Jadun, C; Natarajan, I; Jain, P; Roffe, C				Ahmad, Nasar; Nayak, Sanjeev; Jadun, Changez; Natarajan, Indira; Jain, Palbha; Roffe, Christine			Mechanical Thrombectomy for Ischaemic Stroke: The First UK Case Series	PLOS ONE			English	Article							ENDOVASCULAR TREATMENT; THROMBOLYSIS; RECANALIZATION; THERAPY; TRIAL; SITE	Background and Purpose: Endovascular treatments have the potential to accelerate reperfusion in acute ischaemic stroke with large vessel occlusion. In the UK only a few stroke centres offer this interventional option. The University Hospital of North Staffordshire (UHNS) has treated the largest number of cases in the UK. Results of the first 106 endovascular treatments (EVT) are presented here. Methods: All patients treated with EVT (intra-arterial thrombolysis (IAT), mechanical thrombectomy (MT) or both, or an attempt at intervention) for acute stroke at UHNS, Stoke-on-Trent, UK, were entered into a prospective register. Baseline demographic and clinical data, the National Institutes for Health Stroke Scale (NIHSS), imaging results including Thrombolysis in Cerebral Infarction (TICI) score, and complications were recorded. Mortality, and modified Rankin score (mRS) were assessed at 90 days. Results: From December 2009 to January 2013 106 patients (mean age 64 years, median baseline NIHSS 18) were treated with EVT (thrombectomy +/- IAT 83%, IAT alone 13%, neither 4%). Seventy-eight per cent of occlusions were in the anterior circulation. Intravenous bridging thrombolysis was performed in 81%. Revascularization was successful (TICI 2b/3) in 84%. The median time from stroke onset to the end of the procedure was 6 h 03 min. A good outcome (mRS <= 2) at 90 days was achieved in 48% with a mortality of 15%. Fatal or nonfatal symptomatic intracranial haemorrhage (sICH) within 10 days occurred in 9%. The median length of stay was 14 days (31% discharged home <= 7 days). Conclusions: EVT led to good clinical outcomes in almost 50% of patients with severe strokes.	[Ahmad, Nasar; Natarajan, Indira] Univ Hosp North Staffordshire, Stoke On Trent, Staffs, England; [Nayak, Sanjeev; Jadun, Changez] Univ Hosp North Staffordshire, Dept Intervent Neuroradiol, Stoke On Trent, Staffs, England; [Jain, Palbha] Keele Univ, Sch Med, Keele ST5 5BG, Staffs, England; [Roffe, Christine] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Roffe, Christine] North Staffordshire Combined Healthcare Trust, Stoke On Trent, Staffs, England	Keele University; Keele University	Roffe, C (corresponding author), Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England.	christine.roffe@northstaffs.nhs.uk	Roffe, Christine/AAT-5611-2020	Roffe, Christine/0000-0002-5259-6649	Boehringer	Boehringer(Boehringer Ingelheim)	C. Roffe has received free thrombectomy devices for in-vitro thrombectomy experiments from device manufacturers, e. g. Concentric Medical, Codman, Acandis, and EV3. Acandis also loaned testing equipment. C. Roffe has also spoken at events organized and/or sponsored by Concentric Medical, Codman, Acandis, and EV3 and has received travel expenses to conferences and medical events, as well as honoraria for lectures and sponsorship for conferences and lectures from Boehringer, the manufacturer of alteplase. S. Nayak has advised on device design and had a consultant contract with Covidien, Codman and Acandis. He was not paid any regular salary by any of these companies. I. Natarajan has received travel expenses to conferences and medical events, as well as honoraria for lectures and sponsorship for conferences and lectures form Boehringer, the manufacturer of alteplase. N. Ahmad attended conferences/ lectures organized and/or sponsored by Boehringer, the manufacturer of alteplase, and also received travel expenses and accommodation for one conference from Boehringer. C. Jadun was once sponsored for an animal lab educational workshop by EV3 for stroke thrombectomy to Karolinska. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2013, SAF IMPL TREATM STRO; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Galimanis A, 2012, STROKE, V43, P1052, DOI 10.1161/STROKEAHA.111.639112; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Intercollegiate Stroke Working Party (ICSWP), 2013, SINAP STROK IMPR NAT; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lally F, 2013, CNS NEUROL DISORD-DR, V12, P170; Mazighi M, 2012, STROKE, V43, P2998, DOI 10.1161/STROKEAHA.112.658849; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Mortimer AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e857; National Institute for Clinical Effectiveness (NICE), 2013, MECH CLOT RETR TREAT; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Perrilla G, 2012, AM J NEURORADIOL, V33, P1791, DOI 10.3174/ajnr.A3044; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Sanyal R, 2013, INT J STROKE; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Shi ZS, 2010, STROKE, V41, P1185, DOI 10.1161/STROKEAHA.109.568451; The British Association of Stroke Physicians Clinical Standards Committee, 2012, BASP NHS IMPR CONS S; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wahlgren N, 2008, STROKE, V39, P3316, DOI 10.1161/STROKEAHA.107.510768; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	23	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82218	10.1371/journal.pone.0082218	http://dx.doi.org/10.1371/journal.pone.0082218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386090	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700007
J	Hung, CH; Hwang, TS; Chang, YY; Luo, HR; Wu, SP; Hsu, CH				Hung, Chih-Hung; Hwang, Tzann-Shun; Chang, Yu-Yung; Luo, Huei-Ru; Wu, Szu-Pei; Hsu, Chun-Hua			Crystal Structures and Molecular Dynamics Simulations of Thermophilic Malate Dehydrogenase Reveal Critical Loop Motion for Co-Substrate Binding	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; OVEREXPRESSION; PURIFICATION; GENE; EVOLUTION; CLONING; ENZYME	Malate dehydrogenase (MDH) catalyzes the conversion of oxaloacetate and malate by using the NAD/NADH coenzyme system. The system is used as a conjugate for enzyme immunoassays of a wide variety of compounds, such as illegal drugs, drugs used in therapeutic applications and hormones. We elucidated the biochemical and structural features of MDH from Thermus thermophilus (TtMDH) for use in various biotechnological applications. The biochemical characterization of recombinant TtMDH revealed greatly increased activity above 60 degrees C and specific activity of about 2,600 U/mg with optimal temperature of 90 degrees C. Analysis of crystal structures of apo and NAD-bound forms of TtMDH revealed a slight movement of the binding loop and few structural elements around the co-substrate binding packet in the presence of NAD. The overall structures did not change much and retained all related positions, which agrees with the CD analyses. Further molecular dynamics (MD) simulation at higher temperatures were used to reconstruct structures from the crystal structure of TtMDH. Interestingly, at the simulated structure of 353 K, a large change occurred around the active site such that with increasing temperature, a mobile loop was closed to co-substrate binding region. From biochemical characterization, structural comparison and MD simulations, the thermal-induced conformational change of the co-substrate binding loop of TtMDH may contribute to the essential movement of the enzyme for admitting NAD and may benefit the enzyme's activity.	[Hung, Chih-Hung; Chang, Yu-Yung; Hsu, Chun-Hua] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan; [Hwang, Tzann-Shun; Luo, Huei-Ru] Chinese Culture Univ, Grad Inst Biotechnol, Taipei, Taiwan; [Wu, Szu-Pei] Yuanpei Univ, Dept Biotechnol, Hsinchu, Taiwan; [Hsu, Chun-Hua] Natl Taiwan Univ, Ctr Syst Biol, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan	National Taiwan University; Chinese Culture University; National Taiwan University	Hsu, CH (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan.	andyhsu@ntu.edu.tw	HSU, CHUN-HUA/W-4554-2019	HSU, CHUN-HUA/0000-0002-0008-7383	National Science Council, Taiwan [NSC-96-2313-B-214-001, NSC101-2113-M-002-017, NSC102-2113-M-002-005]; National Taiwan University [NTU-ERP-101R8600-1, NTU-ICRP-102R7560-5]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	The work was supported by grants from the National Science Council, Taiwan, to Tzann-Shun Hwang (NSC-96-2313-B-214-001) and Chun-Hua Hsu (NSC101-2113-M-002-017 and NSC102-2113-M-002-005), and partial grants from National Taiwan University to Chun-Hua Hsu (NTU-ERP-101R8600-1 and NTU-ICRP-102R7560-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLDREAD RM, 1995, BIOCHEM J, V305, P539, DOI 10.1042/bj3050539; BIRKTOFT JJ, 1989, BIOCHEMISTRY-US, V28, P6065, DOI 10.1021/bi00440a051; Chang YY, 2013, ACTA CRYSTALLOGR F, V69, P1249, DOI 10.1107/S174430911302472X; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ge YD, 2010, BIOSCI BIOTECH BIOCH, V74, P2194, DOI 10.1271/bbb.100357; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Hara S, 2006, J BIOL CHEM, V281, P32065, DOI 10.1074/jbc.M605784200; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Hsu CH, 2010, PROTEIN PEPTIDE LETT, V17, P759, DOI 10.2174/092986610791190264; Irimia A, 2003, J MOL BIOL, V326, P859, DOI 10.1016/S0022-2836(02)01450-X; JAENICKE R, 1979, BIOPHYS STRUCT MECH, V6, P57, DOI 10.1007/BF00537595; Kawakami R, 2009, BBA-PROTEINS PROTEOM, V1794, P1496, DOI 10.1016/j.bbapap.2009.06.014; KELLY CA, 1993, BIOCHEMISTRY-US, V32, P3913, DOI 10.1021/bi00066a010; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li GX, 1996, ANN NY ACAD SCI, V799, P476, DOI 10.1111/j.1749-6632.1996.tb33243.x; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Madern D, 2002, J MOL EVOL, V54, P825, DOI 10.1007/s00239-001-0088-8; MCALISTERHENN L, 1987, NUCLEIC ACIDS RES, V15, P4993, DOI 10.1093/nar/15.12.4993; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIYAMA M, 1986, J BIOL CHEM, V261, P14178; Oikawa T, 2005, BIOSCI BIOTECH BIOCH, V69, P2146, DOI 10.1271/bbb.69.2146; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Sanyal SC, 2002, EUR J BIOCHEM, V269, P3856, DOI 10.1046/j.1432-1033.2002.03085.x; Schepens I, 2000, J BIOL CHEM, V275, P20996, DOI 10.1074/jbc.M002066200; Shinagawa E, 2002, BIOSCI BIOTECH BIOCH, V66, P298, DOI 10.1271/bbb.66.298; SUNDARAM TK, 1980, BIOCHEMISTRY-US, V19, P2017, DOI 10.1021/bi00551a002; THORNE CJR, 1963, J BIOL CHEM, V238, P1861; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wynne SA, 1996, BIOCHEM J, V317, P235, DOI 10.1042/bj3170235	37	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83091	10.1371/journal.pone.0083091	http://dx.doi.org/10.1371/journal.pone.0083091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386145	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700027
J	McLenachan, S; Zhang, D; Palomo, ABA; Edel, MJ; Chen, FK				McLenachan, Samuel; Zhang, Dan; Alvarez Palomo, Ana Belen; Edel, Michael J.; Chen, Fred K.			mRNA Transfection of Mouse and Human Neural Stem Cell Cultures	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; NEUROSPHERE CELLS; GENERATION; PLURIPOTENCY; DIFFERENTIATION; EFFICIENT; BRAIN	The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs provides an effective method for inducing transient gene expression in cell cultures without genetic modification. Delivery of mRNA has been proposed as a safer alternative to viral vectors in the induction of pluripotent cells for regenerative therapies. Although mRNA transfection of fibroblasts, dendritic and embryonic stem cells has been described, mRNA delivery to neurosphere cultures has not been previously reported. Here we sought to establish an efficient method for delivering mRNA to primary neurosphere cultures. Neurospheres derived from the subventricular zone of adult mice or from human embryonic stem cells were transfected with EGFP mRNA by lipofection and electroporation. Transfection efficiency and expression levels were monitored by flow cytometry. Cell survival following transfection was examined using live cell counting and the MTT assay. Both lipofection and electroporation provided high efficiency transfection of neurospheres. In comparison with lipofection, electroporation resulted in increased transfection efficiencies, but lower expression per cell and shorter durations of expression. Additional rounds of lipofection renewed EGFP expression in neurospheres, suggesting this method may be suitable for reprogramming applications. In summary, we have developed a protocol for achieving high efficiency transfection rates in mouse and human neurosphere cell culture that can be applied for future studies of gene function studies in neural stem cells, such as defining efficient differentiation protocols for glial and neuronal linages.	[McLenachan, Samuel; Zhang, Dan; Chen, Fred K.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia; [McLenachan, Samuel; Zhang, Dan; Chen, Fred K.] Lions Eye Inst, Ocular Tissue Engn Lab, Nedlands, WA, Australia; [Alvarez Palomo, Ana Belen; Edel, Michael J.] Univ Barcelona, Mol Genet Res Grp, Control Pluripotency Lab, Dept Physiol Sci 1, Barcelona, Spain; [Edel, Michael J.] Univ Sydney, Fac Med, Westmead Childrens Hosp, Div Pediat & Child Hlth,Sch Med, Sydney, NSW 2006, Australia; [Chen, Fred K.] Royal Perth Hosp, Dept Ophthalmol, Perth, WA 6001, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; University of Barcelona; University of Sydney; Royal Perth Hospital; University of Western Australia	McLenachan, S (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia.	smclenachan@lei.org.au	, Fred/B-8158-2013; Edel, Michael J/L-1954-2014	, Fred/0000-0003-2809-9930; Edel, Michael J/0000-0002-5619-8680; McLenachan, Samuel/0000-0001-5732-7387	University of Western Australia; Lions Eye Institute National Health & Medical Research Council of Australia; MINECO Ramon y Cajal Grant [RYC-2010-06512]; MINECO [BFU-2011-26596]	University of Western Australia; Lions Eye Institute National Health & Medical Research Council of Australia; MINECO Ramon y Cajal Grant; MINECO(Spanish Government)	Funding sources included The University of Western Australia (www.uwa.edu.au), Lions Eye Institute (www.lei.org.au) National Health & Medical Research Council of Australia (http://www.nhmrc.gov.au) Early Career Fellowship, MINECO Ramon y Cajal Grant RYC-2010-06512 and MINECO Grant BFU-2011-26596 (http://www.idi.mineco.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ahmadi N, 2012, TISSUE CELL, V44, P87, DOI 10.1016/j.tice.2011.11.006; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Balasubramanian S, 2009, STEM CELLS, V27, P3053, DOI 10.1002/stem.242; Boczkowski D, 2009, CANCER GENE THER, V16, P900, DOI 10.1038/cgt.2009.39; Chen XL, 2012, BRIT J OPHTHALMOL, V96, P1431, DOI 10.1136/bjophthalmol-2012-301546; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Joo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025936; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Liu XW, 2011, J LARYNGOL OTOL, V125, P686, DOI 10.1017/S0022215110002914; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Ma K, 2011, NEUROL RES, V33, P1083, DOI 10.1179/1743132811Y.0000000053; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; McLenachan S, 2009, GROWTH HORM IGF RES, V19, P212, DOI 10.1016/j.ghir.2008.09.003; McLenachan S, 2007, GENOMICS, V89, P708, DOI 10.1016/j.ygeno.2007.02.006; McLenachan S, 2012, STEM CELLS DEV, V21, P2891, DOI 10.1089/scd.2012.0190; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Narsinh KH, 2011, NAT PROTOC, V6, P78, DOI 10.1038/nprot.2010.173; Navarro-Quiroga I, 2006, J COMP NEUROL, V497, P833, DOI 10.1002/cne.21037; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022; Shih CC, 2002, LEUKEMIA LYMPHOMA, V43, P2263, DOI 10.1080/1042819021000040215; Song Y, 2009, BJU INT, V104, P257, DOI 10.1111/j.1464-410X.2009.08352.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	28	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83596	10.1371/journal.pone.0083596	http://dx.doi.org/10.1371/journal.pone.0083596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386231	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700060
J	Shimizu, F; Shiiba, M; Ogawara, K; Kimura, R; Minakawa, Y; Baba, T; Yokota, S; Nakashima, D; Higo, M; Kasamatsu, A; Sakamoto, Y; Tanzawa, H; Uzawa, K				Shimizu, Fumie; Shiiba, Masashi; Ogawara, Katsunori; Kimura, Ryota; Minakawa, Yasuyuki; Baba, Takao; Yokota, Satoshi; Nakashima, Dai; Higo, Morihiro; Kasamatsu, Atsushi; Sakamoto, Yosuke; Tanzawa, Hideki; Uzawa, Katsuhiro			Overexpression of LIM and SH3 Protein 1 Leading to Accelerated G2/M Phase Transition Contributes to Enhanced Tumourigenesis in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INFLUENCES ZYXIN LOCALIZATION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; OVARIAN-CANCER; BREAST-CANCER; CYCLE CONTROL; LASP-1; MIGRATION; PROLIFERATION	Background: LIM and SH3 protein 1 (LASP-1) is a specific focal adhesion protein involved in several malignant tumors. However, its role in oral squamous cell carcinoma (OSCC) is unknown. The aim of this study was to characterize the role and molecular status/mechanism of LASP-1 in OSCC. Methods: We evaluated LASP-1 mRNA and protein expressions in OSCC-derived cell lines and primary OSCCs. Using an shRNA system, we analyzed the effect of LASP-1 on the biology and function of the OSCC cell lines, HSC-3 and Ca9-22. The cells also were subcutaneously injected to evaluate tumor growth in vivo. Data were analyzed by the Fisher's exact test or the Mann-Whitney U test. Bonferroni correction was used for multiple testing. Results: Significant up-regulation of LASP-1 was detected in OSCC-derived cell lines (n = 7, P<0.007) and primary OSCCs (n = 50, P<0.001) compared to normal controls. LASP-1 knockdown cells significantly inhibited cellular proliferation compared with shMock-transfected cells (P<0.025) by arresting cell-cycle progression at the G2 phase. We observed dramatic reduction in the growth of shLASP-1 OSCC xenografts compared with shMock xenografts in vivo. Conclusion: Our results suggested that overexpression of LASP-1 is linked closely to oral tumourigenicity and further provide novel evidence that LASP-1 plays an essential role in tumor cellular growth by mediating G2/M transition.	[Shimizu, Fumie; Kimura, Ryota; Minakawa, Yasuyuki; Baba, Takao; Yokota, Satoshi; Nakashima, Dai; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Clin Oncol, Chiba, Japan; [Ogawara, Katsunori; Higo, Morihiro; Kasamatsu, Atsushi; Sakamoto, Yosuke; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chiba, Japan	Chiba University; Chiba University; Chiba University	Ogawara, K (corresponding author), Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chiba, Japan.	katsunori.ogawara@faculty.chiba-u.jp; uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859				Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Chiyomaru T, 2012, UROL ONCOL-SEMIN ORI, V30, P434, DOI 10.1016/j.urolonc.2010.05.008; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Collins I, 2005, CURR OPIN PHARMACOL, V5, P366, DOI 10.1016/j.coph.2005.04.009; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hsu LC, 2006, ONCOGENE, V25, P5517, DOI 10.1038/sj.onc.1209563; Ignatov T, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-51; Ruiz EJ, 2010, CURR BIOL, V20, P717, DOI 10.1016/j.cub.2010.02.050; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Kudo V, 1998, CANCER, V83, P2447, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2447::AID-CNCR7>3.0.CO;2-A; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Lombardi DP, 1999, CANCER RES, V59, P5724; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Schultz J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-53; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shao Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-51; Shi Y, 2009, GUT, V58, P1443, DOI 10.1136/gut.2009.181735; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shubbar E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-1; Sun Meiqian, 2010, Front Biosci (Schol Ed), V2, P1127; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Wang H, 2013, EUR J CANCER, V49, P974, DOI 10.1016/j.ejca.2012.09.032; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739	38	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83187	10.1371/journal.pone.0083187	http://dx.doi.org/10.1371/journal.pone.0083187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386158	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700034
J	Zhang, SY; Edwards, H; Yates, P; Guo, QH; Li, CB				Zhang, Shuying; Edwards, Helen; Yates, Patsy; Guo, Qihao; Li, Chunbo			Partial Mediation Role of Self-Efficacy between Positive Social Interaction and Mental Health in Family Caregivers for Dementia Patients in Shanghai	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PHYSICAL HEALTH; STRESS PROCESS; SYMPTOMS; QUESTIONNAIRE; VALIDATION; SUPPORT; PEOPLE	We explored the mediation effect of caregiver self-efficacy on the influences of behavioral and psychological symptoms (BPSD) of dementia care recipients (CRs) or family caregivers' (CGs) social supports (informational, tangible and affectionate support and positive social interaction) on CGs' mental health. We interviewed 196 CGs, using a battery of measures including demographic data of the dyads, CRs' dementia-related impairments, and CGs' social support, self-efficacy and the Medical Outcome Study (MOS) Short-Form (SF-36) Health Survey. Multiple regression analyses showed that gathering information on self-efficacy and managing CG distress self-efficacy were the partial mediators of the relationship between positive social interaction and CG mental health. Managing caregiving distress self-efficacy also partial mediated the impact of BPSD on CG mental health. We discuss implications of the results for improving mental health of the target population in mainland China.	[Zhang, Shuying] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Guo, Qihao] Fudan Univ, Dept Neurol, Shanghai 200433, Peoples R China; [Guo, Qihao] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Inst Neurol,Huashan Hosp, Shanghai 200433, Peoples R China; [Edwards, Helen; Yates, Patsy] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Li, Chunbo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Mental Hlth, Dept Biol Psychiat,Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Tongji University; Fudan University; Fudan University; Queensland University of Technology (QUT); Shanghai Jiao Tong University	Guo, QH (corresponding author), Fudan Univ, Dept Neurol, Shanghai 200433, Peoples R China.	dr.guoqihao@126.com	Edwards, Helen/GPX-3511-2022	Yates, Patsy/0000-0001-8946-8504; Edwards, Helen/0000-0002-4451-0577	National Natural Science Foundation of China [81171019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The data analysis and preparation of this manuscript were funded by the National Natural Science Foundation of China (ID: 81171019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2013, ALZH DIS FACTS FIG; Au A, 2010, CLIN GERONTOLOGIST, V33, P298, DOI 10.1080/07317115.2010.502817; Au A, 2009, AGING MENT HEALTH, V13, P761, DOI 10.1080/13607860902918223; Ballard C, 2008, INT REV PSYCHIATR, V20, P396, DOI 10.1080/09540260802099968; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Crellin N, 2011, AGING MENT HEALTH, V15, P28; Depp C, 2005, AM J GERIAT PSYCHIAT, V13, P787, DOI 10.1176/appi.ajgp.13.9.787; Finkel S, 1997, INT J GERIATR PSYCH, V12, P1060; Fortinsky RH, 2002, AGING MENT HEALTH, V6, P153, DOI 10.1080/13607860220126763; Fuh J L, 1999, Int Psychogeriatr, V11, P181, DOI 10.1017/S1041610299005736; Fuh JL, 1999, DEMENT GERIATR COGN, V10, P186, DOI 10.1159/000017118; Gallo JL, 2008, DEMENTIA, V7, P397; Gilliam CM, 2006, AGING MENT HEALTH, V10, P79, DOI 10.1080/13607860500310658; Gottlieb BH, 2003, CAN J AGING, V22, P95, DOI 10.1017/S0714980800003767; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Lasprilla JCA, 2009, AM J ALZHEIMERS DIS, V24, P384, DOI 10.1177/1533317509341465; Li Lu, 2002, Zhonghua Yufang Yixue Zazhi, V36, P109; Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027; Mok CCM, 2005, DEMENT GERIATR COGN, V20, P112, DOI 10.1159/000086612; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Rabinowitz YG, 2007, J AGING HEALTH, V19, P946, DOI 10.1177/0898264307308559; Rabinowitz YG, 2006, AM J GERIAT PSYCHIAT, V14, P642, DOI 10.1097/01.JGP.0000192496.73673.e5; Roth DL, 2003, PSYCHOL AGING, V18, P906, DOI 10.1037/0882-7974.18.4.906; Shaji K S, 2009, Indian J Psychiatry, V51, P45, DOI 10.4103/0019-5545.44905; Shyu YIL, 2006, NURS RES, V55, P411, DOI 10.1097/00006199-200611000-00005; Sobel M.E, 1986, SOCIOL METHODOL, V16, P159, DOI DOI 10.2307/270922; Son J, 2007, J AGING HEALTH, V19, P871, DOI 10.1177/0898264307308568; Spitznagel MB, 2006, J GERIATR PSYCH NEUR, V19, P16, DOI 10.1177/0891988705284713; Steffen A. M., 2002, J GERONTOL B-PSYCHOL, V57, P74, DOI [DOI 10.1093/GERONB/57.1.P74, DOI 10.1093/GER0NB/57.1.P74]; Zeiss A., 1999, J CLIN GEROPSYCHOL, V5, P221, DOI [DOI 10.1023/A:1022955817074, 10.1023/A:1022955817074]; Zhang SY, 2013, AGING MENT HEALTH, V17, P630, DOI 10.1080/13607863.2013.771615; Zhang SY, 2012, INT J MENT HEALTH NU, V21, P358, DOI 10.1111/j.1447-0349.2011.00791.x	35	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83326	10.1371/journal.pone.0083326	http://dx.doi.org/10.1371/journal.pone.0083326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386178	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700041
J	Badosa, E; Moiset, G; Montesinos, L; Talleda, M; Bardaji, E; Feliu, L; Planas, M; Montesinos, E				Badosa, Esther; Moiset, Gemma; Montesinos, Laura; Talleda, Montserrat; Bardaji, Eduard; Feliu, Lidia; Planas, Marta; Montesinos, Emilio			Derivatives of the Antimicrobial Peptide BP100 for Expression in Plant Systems	PLOS ONE			English	Article							IMMUNE-SYSTEM; MELITTIN; IDENTIFICATION; INHIBITION; PROTEIN; RICE; UNDECAPEPTIDES; ANTIBACTERIAL; LANTIBIOTICS; INDOLICIDIN	Production of antimicrobial peptides in plants constitutes an approach for obtaining them in high amounts. However, their heterologous expression in a practical and efficient manner demands some structural requirements such as a minimum size, the incorporation of retention signals to assure their accumulation in specific tissues, and the presence of protease cleavage amino acids and of target sequences to facilitate peptide detection. Since any sequence modification may influence the biological activity, peptides that will be obtained from the expression must be screened prior to the synthesis of the genes for plant transformation. We report herein a strategy for the modification of the antimicrobial undecapeptide BP100 that allowed the identification of analogues that can be expressed in plants and exhibit optimum biological properties. We prepared 40 analogues obtained by incorporating repeated units of the antimicrobial undecapeptide, fragments of natural peptides, one or two AGPA hinges, a Gly or Ser residue at the N-terminus, and a KDEL fragment and/or the epitope tag54 at the C-terminus. Their antimicrobial, hemolytic and phytotoxic activities, and protease susceptibility were evaluated. Best sequences contained a magainin fragment linked to the antimicrobial undecapeptide through an AGPA hinge. Moreover, since the presence of a KDEL unit or of tag54 did not influence significantly the biological activity, these moieties can be introduced when designing compounds to be retained in the endoplasmic reticulum and detected using a complementary epitope. These findings may contribute to the design of peptides to be expressed in plants.	[Badosa, Esther; Montesinos, Laura; Montesinos, Emilio] Univ Girona, Inst Food & Agr Technol CIDSAV XaRTA, Plant Pathol Lab, Girona, Spain; [Moiset, Gemma; Talleda, Montserrat; Bardaji, Eduard; Feliu, Lidia; Planas, Marta] Univ Girona, Dept Chem, LIPPSO, Girona, Spain	Universitat de Girona; Universitat de Girona	Planas, M (corresponding author), Univ Girona, Dept Chem, LIPPSO, Campus Montilivi, Girona, Spain.	marta.planas@udg.edu; emonte@intea.udg.edu	/H-7643-2015; BARDAJI, EDUARD/I-1211-2015; Montesinos, Emili/H-5246-2015; Romañó, Esther Badosa/H-3342-2015; Planas, Marta/E-4145-2015; Feliu, Lidia/H-8285-2015	/0000-0003-4291-1227; BARDAJI, EDUARD/0000-0001-6281-3646; Montesinos, Emili/0000-0003-4455-8332; Romañó, Esther Badosa/0000-0001-7776-8286; Planas, Marta/0000-0003-4988-4970; Feliu, Lidia/0000-0001-9792-6106	MICINN of Spain [AGL2006-13564/AGR, AGL2009-13255-C02-02/AGR, ERA-NET PLANT-KBBE Euroinvestigacion EUI2008-03572]	MICINN of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants AGL2006-13564/AGR, AGL2009-13255-C02-02/AGR, and ERA-NET PLANT-KBBE Euroinvestigacion EUI2008-03572 from MICINN of Spain. The LIPPSO and CIDSAV groups are recognized as 2009SGR182 and 2009SGR182 by the Catalonian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2010, J PEPT SCI, V16, P171, DOI 10.1002/psc.1217; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Badosa E, 2009, APPL ENVIRON MICROB, V75, P5563, DOI 10.1128/AEM.00711-09; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Basanta A, 2009, APPL ENVIRON MICROB, V75, P2382, DOI 10.1128/AEM.01476-08; Biemelt S, 2004, MOL FARMING PLANTS; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Cavallarin L, 1998, MOL PLANT MICROBE IN, V11, P218, DOI 10.1094/MPMI.1998.11.3.218; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Coca M, 2006, PLANTA, V223, P392, DOI 10.1007/s00425-005-0069-z; Company N, 2013, PLANT BIOTECHNOL J, V11, P1, DOI [10.1111/pbi.12036, DOI 10.1111/PBI.12036.PUBMED:24102775]; Conrad U, 1998, PLANT MOL BIOL, V38, P101, DOI 10.1023/A:1006029617949; Cooksey K, 2000, ACS SYM SER, V753, P17; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Degenkolb T, 2003, J PEPT SCI, V9, P666, DOI 10.1002/psc.497; Diaz M, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue2-fulltext-4; Eggenberger K, 2011, CHEMBIOCHEM, V12, P132, DOI 10.1002/cbic.201000402; Ferre R, 2006, APPL ENVIRON MICROB, V72, P3302, DOI 10.1128/AEM.72.5.3302-3308.2006; Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]; Fischer R, 2000, TRANSGENIC RES, V9, P279, DOI 10.1023/A:1008975123362; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Gopal R, 2011, J PEPT SCI, V17, P329, DOI 10.1002/psc.1369; Guell I, 2011, APPL ENVIRON MICROB, V77, P2667, DOI 10.1128/AEM.02759-10; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Jack RW, 2000, CURR OPIN CHEM BIOL, V4, P310, DOI 10.1016/S1367-5931(00)00094-6; Juvvadi P, 1996, J AM CHEM SOC, V118, P8989, DOI 10.1021/ja9542911; Juvvadi P, 1999, J PEPT RES, V53, P244, DOI 10.1034/j.1399-3011.1999.00020.x; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lopez-Garcia B, 2012, ACS SYM SER, V1095, P263; Makovitzki A, 2007, APPL ENVIRON MICROB, V73, P6629, DOI 10.1128/AEM.01334-07; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Miyashita M, 2011, CHEMBIOCHEM, V12, P1323, DOI 10.1002/cbic.201000694; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Montesinos E, 2012, ACS SYM SER, V1095, P235; Morin KM, 2006, APPL MICROBIOL BIOT, V70, P698, DOI 10.1007/s00253-005-0132-5; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Ng TB, 2004, PEPTIDES, V25, P1055, DOI 10.1016/j.peptides.2004.03.013; Pagny S, 1999, J EXP BOT, V50, P157, DOI 10.1093/jexbot/50.331.157; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Rasche S., 2011, Open Biotechnology Journal, V5, P1; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Schillberg S, 1999, TRANSGENIC RES, V8, P255, DOI 10.1023/A:1008937011213; Schillberg S, 2003, CELL MOL LIFE SCI, V60, P433, DOI 10.1007/s000180300037; Streatfield SJ, 2007, PLANT BIOTECHNOL J, V5, P2, DOI 10.1111/j.1467-7652.2006.00216.x; Takagi H, 2005, P NATL ACAD SCI USA, V102, P17525, DOI 10.1073/pnas.0503428102; Teli NP, 2004, PLANT CELL TISS ORG, V79, P125, DOI 10.1007/s11240-004-0653-0; Tincu JA, 2004, ANTIMICROB AGENTS CH, V48, P3645, DOI 10.1128/AAC.48.10.3645-3654.2004; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Tossi A, 2000, BIOPOLYMERS, V55, P4; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	56	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85515	10.1371/journal.pone.0085515	http://dx.doi.org/10.1371/journal.pone.0085515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376887	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000187
J	Banerjee, A; Rathee, V; Krishnaswamy, R; Bhattacharjee, P; Ray, P; Sood, AK; Sengupta, K				Banerjee, Avinanda; Rathee, Vikram; Krishnaswamy, Rema; Bhattacharjee, Pritha; Ray, Pulak; Sood, Ajay K.; Sengupta, Kaushik			Viscoelastic Behavior of Human Lamin A Proteins in the Context of Dilated Cardiomyopathy	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; EMBRYONIC STEM-CELLS; F-ACTIN SOLUTIONS; B-TYPE LAMINS; NUCLEAR-ENVELOPE; MECHANICAL-PROPERTIES; FILAMENT NETWORKS; CARDIAC MYOCYTES; IN-VITRO; A-TYPE	Lamins are intermediate filament proteins of type V constituting a nuclear lamina or filamentous meshwork which lines the nucleoplasmic side of the inner nuclear membrane. This protein mesh provides a supporting scaffold for the nuclear envelope and tethers interphase chromosome to the nuclear periphery. Mutations of mainly A-type lamins are found to be causative for at least 11 human diseases collectively termed as laminopathies majority of which are characterised by aberrant nuclei with altered structural rigidity, deformability and poor mechanotransduction behaviour. But the investigation of viscoelastic behavior of lamin A continues to elude the field. In order to address this problem, we hereby present the very first report on viscoelastic properties of wild type human lamin A and some of its mutants linked with Dilated cardiomyopathy (DCM) using quantitative rheological measurements. We observed a dramatic strain-softening effect on lamin A network as an outcome of the strain amplitude sweep measurements which could arise from the large compliance of the quasi-cross-links in the network or that of the lamin A rods. In addition, the drastic stiffening of the differential elastic moduli on superposition of rotational and oscillatory shear stress reflect the increase in the stiffness of the laterally associated lamin A rods. These findings present a preliminary insight into distinct biomechanical properties of wild type lamin A protein and its mutants which in turn revealed interesting differences.	[Banerjee, Avinanda; Bhattacharjee, Pritha; Ray, Pulak; Sengupta, Kaushik] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, W Bengal, India; [Rathee, Vikram; Sood, Ajay K.] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Krishnaswamy, Rema] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore, Karnataka, India	Saha Institute of Nuclear Physics; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Sengupta, K (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1 AF Bidhannagar, Kolkata, W Bengal, India.	kaushik.sengupta@saha.ac.in	Sood, Anoop Kumar/A-7344-2013; Rathee, V./AAQ-3746-2020; bhattacharjee, pritha/I-5171-2019	Sood, Anoop Kumar/0000-0001-5702-4108; Bhattacharjee, Pritha/0000-0002-2146-4408; Krishnaswamy, Rema/0000-0002-8835-5564	University Grants Council, Government of India; Council of Scientific and Industrial Research (Government of India); Department of Science and Technology, Government of India	University Grants Council, Government of India; Council of Scientific and Industrial Research (Government of India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	AB thanks University Grants Council, Government of India for the fellowship. AKS thanks Council of Scientific and Industrial Research, (Government of India) Bhatnagar Fellowship for support. RK thanks support under Ramanujan Fellowship, Department of Science and Technology, Government of India. KSG thanks MMDDA and BARD projects of Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, VISCOELASTIC PROPERT; Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bhattacharjee P, 2013, BIOCHEMISTRY-US, V52, P4229, DOI 10.1021/bi400337t; BRIDGER JM, 1993, J CELL SCI, V104, P297; Broers JLV, 2005, EXP CELL RES, V304, P582, DOI 10.1016/j.yexcr.2004.11.020; Butler JT, 2009, J CELL BIOCHEM, V107, P609, DOI 10.1002/jcb.22183; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Delbarre E, 2006, HUM MOL GENET, V15, P1113, DOI 10.1093/hmg/ddl026; Esue O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008855; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gisler T, 1999, PHYS REV LETT, V82, P1606, DOI 10.1103/PhysRevLett.82.1606; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Goldberg MW, 2008, BIOCHEM SOC T, V36, P1339, DOI 10.1042/BST0361339; GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hofmann I, 1997, EUR J CELL BIOL, V72, P122; HOZAK P, 1995, J CELL SCI, V108, P635; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kolb T, 2011, NUCLEUS-PHILA, V2, P425, DOI 10.4161/nucl.2.5.17765; Kroy K, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/416; Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005; Lammerding J, 2003, IEEE ENG MED BIOL, V22, P124, DOI 10.1109/MEMB.2003.1256282; Lammerding J, 2007, METHOD CELL BIOL, V83, P269, DOI 10.1016/S0091-679X(07)83011-1; Lammerding Jan, 2005, V264, P264, DOI 10.1002/0470093765.ch18; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P443; Lin YC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058101; LUDERUS MEE, 1992, EUR J BIOCHEM, V208, P235, DOI 10.1111/j.1432-1033.1992.tb17178.x; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; MOIR RD, 1991, J CELL SCI, V99, P363; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; MORI Y, 1982, J POLYM SCI POL PHYS, V20, P2111, DOI 10.1002/pol.1982.180201112; NEMOTO N, 1975, BIOPOLYMERS, V14, P409, DOI 10.1002/bip.1975.360140213; NEWPORT JW, 1987, ANNU REV BIOCHEM, V56, P535; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Panorchan P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041906; Panorchan P, 2004, J BIOL CHEM, V279, P43462, DOI 10.1074/jbc.M402474200; Pasotti M, 2008, J AM COLL CARDIOL, V52, P1250, DOI 10.1016/j.jacc.2008.06.044; Pawelzyk P, 2013, SOFT MATTER, V9, P8871, DOI 10.1039/c3sm51999f; Perrot A, 2009, BASIC RES CARDIOL, V104, P90, DOI 10.1007/s00395-008-0748-6; Puckelwartz MJ, 2011, NUCLEUS-PHILA, V2, P162, DOI [10.4161/nucl.2.3.16003, 10.1083/jcb.201101046]; Radmacher M, 2007, METHOD CELL BIOL, V83, P347, DOI 10.1016/S0091-679X(07)83015-9; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; Schape J, 2009, BIOPHYS J, V96, P4319, DOI 10.1016/j.bpj.2009.02.048; Schirmer EC, 2004, J BIOL CHEM, V279, P42811, DOI 10.1074/jbc.M407705200; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Sebillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Watanabe TM, 2012, BIOCHEM BIOPH RES CO, V418, P742, DOI 10.1016/j.bbrc.2012.01.091; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yao NY, 2008, J RHEOL, V52, P1013, DOI 10.1122/1.2933171; Zhang CM, 1996, J CELL SCI, V109, P2275	66	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83410	10.1371/journal.pone.0083410	http://dx.doi.org/10.1371/journal.pone.0083410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386194	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000329194700039
J	Hernandez-Saldana, H				Hernandez-Saldana, H.			Results on Three Predictions for July 2012 Federal Elections in Mexico Based on Past Regularities	PLOS ONE			English	Article							DEMOCRACY; LAWS	The Presidential Election in Mexico of July 2012 has been the third time that PREP, Previous Electoral Results Program works. PREP gives voting outcomes based in electoral certificates of each polling station that arrive to capture centers. In previous ones, some statistical regularities had been observed, three of them were selected to make predictions and were published in arXiv:1207.0078 [physics.soc-ph]. Using the database made public in July 2012, two of the predictions were completely fulfilled, while, the third one was measured and confirmed using the database obtained upon request to the electoral authorities. The first two predictions confirmed by actual measures are: (ii) The Partido Revolucionario Institucional, PRI, is a sprinter and has a better performance in polling stations arriving late to capture centers during the process. (iii) Distribution of vote of this party is well described by a smooth function named a Daisy model. A Gamma distribution, but compatible with a Daisy model, fits the distribution as well. The third prediction confirms that errare humanum est, since the error distributions of all the self-consistency variables appeared as a central power law with lateral lobes as in 2000 and 2006 electoral processes. The three measured regularities appeared no matter the political environment.	Univ Autonoma Metropolitana Azcapotzalco, Dept Ciencias Basicas, Mexico City 13, DF, Mexico	Universidad Autonoma Metropolitana - Mexico	Hernandez-Saldana, H (corresponding author), Univ Autonoma Metropolitana Azcapotzalco, Dept Ciencias Basicas, Mexico City 13, DF, Mexico.	hhs@correo.azc.uam.mx		Hernandez-Saldana, Hugo/0000-0001-5937-0469	PROMEP/SEP; CONACyT	PROMEP/SEP; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by PROMEP/SEP and CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araripe LE, 2009, PHYSICA A, V388, P4167, DOI 10.1016/j.physa.2009.06.023; Araripe LE, 2006, INT J MOD PHYS C, V17, P1809, DOI 10.1142/S0129183106010200; Araujo NAM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012446; BEYER WH, 1987, CRC STANDARD MATH TA; Borghesi C, 2012, PLOS ONE, V7; Borghesi C, 2009, ARXIV09054578V1PHYSI; Borghesi C, 2009, ARXIV09062692V1PHYSI; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chatterjee A, 2013, NATURE, V3, P1049; Costa RN, 2003, PHYSICA A, V322, P698, DOI 10.1016/S0378-4371(02)01823-X; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Hernandez-Saldana Hugo, 2010, Traveling Salesman Problem, Theory and Applications, P283; Hernandez-Saldana H, 2009, PHYSICA A, V388, P2699, DOI 10.1016/j.physa.2009.03.016; Hernandez-Saldana H, 1999, PHYS REV E, V60, P449, DOI 10.1103/PhysRevE.60.449; Hernandez-Saldana H, 2012, ARXIV12070078PHYSICS; Hernandez-Zapata E, 2012, REV MEX FIS S, V58, P0032; Ibarra Lopez I, IN PRESS; Klesner JL, 2007, ELECT STUD, V26, P803, DOI 10.1016/j.electstud.2007.04.002; Klimek P, 2012, P NATL ACAD SCI USA, V109, P16469, DOI 10.1073/pnas.1210722109; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; Mendez-Sanchez R, 2006, ARXIVPHYSICS0609144; Pliego Carrasco F, 2007, MITO FRAUDE ELECTORA, P218; Tumminello M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058910; Weisstein E. W., GAMMA DISTRIBUTION	25	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82584	10.1371/journal.pone.0082584	http://dx.doi.org/10.1371/journal.pone.0082584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386103	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700011
J	Bolin, K; Sandling, JK; Zickert, A; Jonsen, A; Sjowall, C; Svenungsson, E; Bengtsson, AA; Eloranta, ML; Ronnblom, L; Syvanen, AC; Gunnarsson, I; Nordmark, G				Bolin, Karin; Sandling, Johanna K.; Zickert, Agneta; Jonsen, Andreas; Sjowall, Christopher; Svenungsson, Elisabet; Bengtsson, Anders A.; Eloranta, Maija-Leena; Ronnblom, Lars; Syvanen, Ann-Christine; Gunnarsson, Iva; Nordmark, Gunnel			Association of STAT4 Polymorphism with Severe Renal Insufficiency in Lupus Nephritis	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR-5; RISK HAPLOTYPE; RHEUMATOID-ARTHRITIS; T-CELLS; ERYTHEMATOSUS; IRF5; SLE; SUSCEPTIBILITY; POPULATION; VARIANTS	Lupus nephritis is a cause of significant morbidity in systemic lupus erythematosus (SLE) and its genetic background has not been completely clarified. The aim of this investigation was to analyze single nucleotide polymorphisms (SNPs) for association with lupus nephritis, its severe form proliferative nephritis and renal outcome, in two Swedish cohorts. Cohort I (n = 567 SLE cases, n = 512 controls) was previously genotyped for 5676 SNPs and cohort II (n = 145 SLE cases, n = 619 controls) was genotyped for SNPs in STAT4, IRF5, TNIP1 and BLK. Case-control and case-only association analyses for patients with lupus nephritis, proliferative nephritis and severe renal insufficiency were performed. In the case-control analysis of cohort I, four highly linked SNPs in STAT4 were associated with lupus nephritis with genome wide significance with p = 3.7x10(-9), OR 2.20 for the best SNP rs11889341. Strong signals of association between IRF5 and an HLA-DR3 SNP marker were also detected in the lupus nephritis case versus healthy control analysis (p<0.0001). An additional six genes showed an association with lupus nephritis with p<0.001 (PMS2, TNIP1, CARD11, ITGAM, BLK and IRAK1). In the case-only meta-analysis of the two cohorts, the STAT4 SNP rs7582694 was associated with severe renal insufficiency with p = 1.6x10(-3) and OR 2.22. We conclude that genetic variations in STAT4 predispose to lupus nephritis and a worse outcome with severe renal insufficiency.	[Bolin, Karin; Eloranta, Maija-Leena; Ronnblom, Lars; Nordmark, Gunnel] Uppsala Univ, Dept Med Sci, Rheumatol Sect, Uppsala, Sweden; [Sandling, Johanna K.; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sandling, Johanna K.; Ronnblom, Lars; Syvanen, Ann-Christine] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Zickert, Agneta; Svenungsson, Elisabet; Gunnarsson, Iva] Karolinska Univ Hosp, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Zickert, Agneta; Svenungsson, Elisabet; Gunnarsson, Iva] Karolinska Inst, Stockholm, Sweden; [Jonsen, Andreas; Bengtsson, Anders A.] Lund Univ, Dept Clin Sci, Rheumatol Sect, Lund, Sweden; [Sjowall, Christopher] Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden	Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Lund University; Linkoping University	Nordmark, G (corresponding author), Uppsala Univ, Dept Med Sci, Rheumatol Sect, Uppsala, Sweden.	gunnel.nordmark@medsci.uu.se	Sandling, Johanna K/B-2973-2016; Sandling, Johanna/AAG-6376-2019; Sjöwall, Christopher/C-9678-2009	Sandling, Johanna K/0000-0003-1382-2321; Sandling, Johanna/0000-0003-1382-2321; Sjöwall, Christopher/0000-0003-0900-2048; Svenungsson, Elisabet/0000-0003-3396-3244	Swedish Research Council for Medicine; Knut and Alice Wallenberg Foundation; Swedish Rheumatism Foundation; King Gustav V 80-year Foundation; Ragnar Soderberg Foundation; Combine; County Council of Ostergotland; Swedish Society for Medical Research; Ingrid Asp Research Foundation; Swedish Heart-Lung foundation; Stockholm County Council; Karolinska Institutet (ALF); Foundation in memory of Clas Groschinsky; Swedish Society of Medicine	Swedish Research Council for Medicine; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Rheumatism Foundation; King Gustav V 80-year Foundation; Ragnar Soderberg Foundation; Combine; County Council of Ostergotland; Swedish Society for Medical Research; Ingrid Asp Research Foundation; Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Karolinska Institutet (ALF)(Karolinska Institutet); Foundation in memory of Clas Groschinsky; Swedish Society of Medicine	This study was supported by the Swedish Research Council for Medicine, the Knut and Alice Wallenberg Foundation, the Swedish Rheumatism Foundation, the King Gustav V 80-year Foundation, the Ragnar Soderberg Foundation, Combine, the County Council of Ostergotland, Swedish Society for Medical Research, the Ingrid Asp Research Foundation, The Swedish Heart-Lung foundation, Stockholm County Council and Karolinska Institutet (ALF), The Foundation in memory of Clas Groschinsky and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045356; Bates JS, 2009, GENES IMMUN, V10, P470, DOI 10.1038/gene.2009.31; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; CHURG J, 1995, RENAL DIS CLASSIFICA, P151; Clendenning M, 2008, J MED GENET, V45, P340, DOI 10.1136/jmg.2007.056150; Contreras G, 2005, LUPUS, V14, P890, DOI 10.1191/0961203305lu2238oa; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Iwata Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/594809; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Jonsen A, 2007, RHEUMATOLOGY, V46, P1417, DOI 10.1093/rheumatology/kem167; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Kawasaki A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3134; Kelly JA, 2008, GENES IMMUN, V9, P187, DOI 10.1038/gene.2008.4; Kim-Howard X, 2010, ANN RHEUM DIS, V69, P1329, DOI 10.1136/ard.2009.120543; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lofstrom B, 2007, ANN RHEUM DIS, V66, P1627, DOI 10.1136/ard.2006.067108; Malafronte P, 2010, J RHEUMATOL, V37, P776, DOI 10.3899/jrheum.090681; Morimoto S, 2007, RHEUMATOLOGY, V46, P1083, DOI 10.1093/rheumatology/kem097; Ortega LM, 2010, LUPUS, V19, P557, DOI 10.1177/0961203309358187; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Prokunina L, 2004, ARTHRITIS RHEUM, V50, P327, DOI 10.1002/art.11442; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin LX, 2010, NEPHROLOGY, V15, P710, DOI 10.1111/j.1440-1797.2010.01327.x; Ramos PS, 2010, SEMIN NEPHROL, V30, P164, DOI 10.1016/j.semnephrol.2010.01.007; Reddy MVPL, 2007, HUM GENET, V121, P721, DOI 10.1007/s00439-007-0367-6; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009; Sanchez E, 2011, ANN RHEUM DIS, V70, P1752, DOI 10.1136/ard.2011.154104; Sandling JK, 2011, EUR J HUM GENET, V19, P479, DOI 10.1038/ejhg.2010.197; Santos MJ, 2011, CLIN RHEUMATOL, V30, P409, DOI 10.1007/s10067-010-1640-y; Shin HD, 2007, ARTHRITIS RES THER, V9, pR32; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Suresh S, 2009, J RHEUMATOL, V36, P315, DOI 10.3899/jrheum.080482; Svenungsson E, 2010, ANN RHEUM DIS, V69, P834, DOI 10.1136/ard.2009.115535; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Taylor KE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000084; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Wang C, 2013, EUR J HUM GENET, V21, P994, DOI 10.1038/ejhg.2012.277; Yang WL, 2009, HUM MOL GENET, V18, P2063, DOI 10.1093/hmg/ddp118; Zickert A, 2011, ARTHRITIS RHEUM, V63, pS648	47	65	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84450	10.1371/journal.pone.0084450	http://dx.doi.org/10.1371/journal.pone.0084450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386384	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900096
J	Dorazio, RM				Dorazio, Robert M.			Bayes and Empirical Bayes Estimators of Abundance and Density from Spatial Capture-Recapture Data	PLOS ONE			English	Article							HIERARCHICAL MODEL; INFERENCE	In capture-recapture and mark-resight surveys, movements of individuals both within and between sampling periods can alter the susceptibility of individuals to detection over the region of sampling. In these circumstances spatially explicit capture-recapture (SECR) models, which incorporate the observed locations of individuals, allow population density and abundance to be estimated while accounting for differences in detectability of individuals. In this paper I propose two Bayesian SECR models, one for the analysis of recaptures observed in trapping arrays and another for the analysis of recaptures observed in area searches. In formulating these models I used distinct submodels to specify the distribution of individual home-range centers and the observable recaptures associated with these individuals. This separation of ecological and observational processes allowed me to derive a formal connection between Bayes and empirical Bayes estimators of population abundance that has not been established previously. I showed that this connection applies to every Poisson point-process model of SECR data and provides theoretical support for a previously proposed estimator of abundance based on recaptures in trapping arrays. To illustrate results of both classical and Bayesian methods of analysis, I compared Bayes and empirical Bayes esimates of abundance and density using recaptures from simulated and real populations of animals. Real populations included two iconic datasets: recaptures of tigers detected in camera-trap surveys and recaptures of lizards detected in area-search surveys. In the datasets I analyzed, classical and Bayesian methods provided similar - and often identical - inferences, which is not surprising given the sample sizes and the noninformative priors used in the analyses.	US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL USA	United States Department of the Interior; United States Geological Survey	Dorazio, RM (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL USA.	bdorazio@usgs.gov			U.S. Geological Survey, Southeast Ecological Science Center	U.S. Geological Survey, Southeast Ecological Science Center	Funded by U.S. Geological Survey, Southeast Ecological Science Center. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2011, STAT SPATIOTEMPORAL; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; Flegal JM, 2011, CH CRC HANDB MOD STA, P175; Flegal JM, 2010, ANN STAT, V38, P1034, DOI 10.1214/09-AOS735; Gardner B, 2010, ECOLOGY, V91, P3376, DOI 10.1890/09-0804.1; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; LAIRD NM, 1987, J AM STAT ASSOC, V82, P739, DOI 10.2307/2288778; Marques TA, 2011, ECOLOGY, V92, P526, DOI 10.1890/10-1440.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2012, J ORNITHOL, V152, pS521, DOI 10.1007/s10336-010-0619-4; Royle JA, 2011, METHODS ECOL EVOL, V2, P602, DOI 10.1111/j.2041-210X.2011.00116.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sollmann R, 2013, ECOLOGY, V94, P553, DOI 10.1890/12-1256.1	28	5	6	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84017	10.1371/journal.pone.0084017	http://dx.doi.org/10.1371/journal.pone.0084017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386325	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900072
J	Gakhar, G; Navarro, VN; Jurish, M; Lee, GY; Tagawa, ST; Akhtar, NH; Seandel, M; Geng, Y; Liu, H; Bander, NH; Giannakakou, P; Christos, PJ; King, MR; Nanus, DM				Gakhar, Gunjan; Navarro, Vicente N.; Jurish, Madelyn; Lee, Guang Yu; Tagawa, Scott T.; Akhtar, Naveed H.; Seandel, Marco; Geng, Yue; Liu, He; Bander, Neil H.; Giannakakou, Paraskevi; Christos, Paul J.; King, Michael R.; Nanus, David M.			Circulating Tumor Cells from Prostate Cancer Patients Interact with E-Selectin under Physiologic Blood Flow	PLOS ONE			English	Article							CUTANEOUS LYMPHOCYTE ANTIGEN; MAJOR E-SELECTIN; SIALYL-LEWIS-X; ENDOTHELIAL-CELLS; MEMBRANE ANTIGEN; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE RECRUITMENT; ADHESION; EXPRESSION; METASTASIS	Hematogenous metastasis accounts for the majority of cancer-related deaths, yet the mechanism remains unclear. Circulating tumor cells (CTCs) in blood may employ different pathways to cross blood endothelial barrier and establish a metastatic niche. Several studies provide evidence that prostate cancer (PCa) cell tethering and rolling on microvascular endothelium via E-selectin/E-selectin ligand interactions under shear flow theoretically promote extravasation and contribute to the development of metastases. However, it is unknown if CTCs from PCa patients interact with E-selectin expressed on endothelium, initiating a route for tumor metastases. Here we report that CTCs derived from PCa patients showed interactions with E-selectin and E-selectin expressing endothelial cells. To examine E-selectin-mediated interactions of PCa cell lines and CTCs derived from metastatic PCa patients, we used fluorescently-labeled anti-prostate specific membrane antigen (PSMA) monoclonal antibody J591-488 which is internalized following cell-surface binding. We employed a microscale flow device consisting of E-selectin-coated microtubes and human umbilical vein endothelial cells (HUVECs) on parallel-plate flow chamber simulating vascular endothelium. We observed that J591-488 did not significantly alter the rolling behavior in PCa cells at shear stresses below 3 dyn/cm(2). CTCs obtained from 31 PCa patient samples showed that CTCs tether and stably interact with E-selectin and E-selectin expressing HUVECs at physiological shear stress. Interestingly, samples collected during disease progression demonstrated significantly more CTC/E-selectin interactions than samples during times of therapeutic response (p=0.016). Analysis of the expression of sialyl Lewis X (sLe(x)) in patient samples showed that a small subset comprising 1.9-18.8% of CTCs possess high sLe(x) expression. Furthermore, E-selectin-mediated interactions between prostate CTCs and HUVECs were diminished in the presence of anti-E-selectin neutralizing antibody. CTC-Endothelial interactions provide a novel insight into potential adhesive mechanisms of prostate CTCs as a means to initiate metastasis.	[Gakhar, Gunjan; Jurish, Madelyn; Lee, Guang Yu; Tagawa, Scott T.; Akhtar, Naveed H.; Giannakakou, Paraskevi; Nanus, David M.] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY USA; [Navarro, Vicente N.; Tagawa, Scott T.; Liu, He; Bander, Neil H.; Nanus, David M.] Weill Cornell Med Coll, Dept Urol, New York, NY USA; [Tagawa, Scott T.; Bander, Neil H.; Giannakakou, Paraskevi; Nanus, David M.] Weill Cornell Med Coll, Weill Cornell Canc Ctr, New York, NY USA; [Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Geng, Yue; King, Michael R.] Cornell Univ, Dept Biomed Engn, New York, NY 10021 USA; [Christos, Paul J.] Weill Cornell Med Coll, Div Biostat & Epidemiol, Dept Publ Hlth, New York, NY USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Nanus, DM (corresponding author), Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY USA.	dnanus@med.cornell.edu		Tagawa, Scott/0000-0003-2777-8587; Giannakakou, Paraskevi/0000-0001-7378-262X	Department of Defense-Prostate Cancer Research Program [W81XWH-12-1-0124]; National Cancer Institute [U54CA143876]; David H. Koch Foundation; Robert Dow Foundation; National Science Foundation Graduate Research Fellowship; U.S. NIH [R01 CA137020-01]; Charles H. Leach, II Foundation; Robert H. McCooey Genitourinary Oncology Research Fund; Clinical Translational Science Center, National Center for Advancing Translational Sciences [UL1-TR000457-06]; NATIONAL CANCER INSTITUTE [U54CA143876, R01CA137020] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	Department of Defense-Prostate Cancer Research Program(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); David H. Koch Foundation; Robert Dow Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Leach, II Foundation; Robert H. McCooey Genitourinary Oncology Research Fund; Clinical Translational Science Center, National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a postdoctoral training award from Department of Defense-Prostate Cancer Research Program (W81XWH-12-1-0124, to G. Gakhar); U54CA143876 from the National Cancer Institute (to D.M. Nanus and M.R. King); David H. Koch Foundation and Robert Dow Foundation (to N.H. Bander); National Science Foundation Graduate Research Fellowship (to Y. Geng); from the U.S. NIH (R01 CA137020-01, to P. Giannakakou); The Charles H. Leach, II Foundation, and the Robert H. McCooey Genitourinary Oncology Research Fund; from the Clinical Translational Science Center, National Center for Advancing Translational Sciences (UL1-TR000457-06, to P.J. Christos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar NH, 2012, ADV UROL, DOI DOI 10.1155/2012/973820; Barthel SR, 2008, GLYCOBIOLOGY, V18, P806, DOI 10.1093/glycob/cwn070; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Barthel SR, 2013, CANCER RES, V73, P942, DOI 10.1158/0008-5472.CAN-12-3264; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; Biancone L, 1996, J EXP MED, V183, P581, DOI 10.1084/jem.183.2.581; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; Conant CG, 2011, JALA-J LAB AUTOM, V16, P148, DOI 10.1016/j.jala.2010.10.005; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Dimitroff CJ, 2005, CANCER RES, V65, P5750, DOI 10.1158/0008-5472.CAN-04-4653; Dimitroff CJ, 2004, CANCER RES, V64, P5261, DOI 10.1158/0008-5472.CAN-04-0691; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Fusi A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-52; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Hsu JW, 2011, AM J PATHOL, V178, P872, DOI 10.1016/j.ajpath.2010.10.036; Hughes AD, 2012, CLIN CHEM, V58, P846, DOI 10.1373/clinchem.2011.176669; Idikio HA, 1997, GLYCOCONJUGATE J, V14, P875, DOI 10.1023/A:1018502424487; Inaba Y, 2003, INT J CANCER, V107, P949, DOI 10.1002/ijc.11513; Kannagi R, 2003, GLYCOCONJUGATE J, V20, P353, DOI 10.1023/B:GLYC.0000033631.35357.41; Khatib AM, 2002, CANCER RES, V62, P5393; Khatib AM, 1999, CANCER RES, V59, P1356; Kim MB, 2004, MICROCIRCULATION, V11, P55, DOI 10.1080/10739680490266199; Kitayama J, 2000, EUR J CANCER, V36, P121, DOI 10.1016/S0959-8049(99)00228-2; Kobayashi K, 2000, CANCER RES, V60, P3978; Kohler S, 2010, BRIT J CANCER, V102, P602, DOI 10.1038/sj.bjc.6605492; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lee D, 2007, J BIOL CHEM, V282, P4812, DOI 10.1074/jbc.M609994200; Liu H, 1997, CANCER RES, V57, P3629; Liu H, 1998, CANCER RES, V58, P4055; Mannweiler S, 2009, PATHOL ONCOL RES, V15, P167, DOI 10.1007/s12253-008-9104-2; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Osborne JR, 2013, UROL ONCOL-SEMIN ORI, V31, P144, DOI 10.1016/j.urolonc.2012.04.016; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Rahman A, 1998, AM J PHYSIOL-LUNG C, V275, pL533, DOI 10.1152/ajplung.1998.275.3.L533; Rana K, 2012, MOL PHARMACEUT, V9, P2219, DOI 10.1021/mp300073j; Rana K, 2009, BIOTECHNOL BIOENG, V102, P1692, DOI 10.1002/bit.22204; Remuzzi A, 1999, METH MOL B, V96, P153; ROSSITER H, 1994, EUR J IMMUNOL, V24, P205, DOI 10.1002/eji.1830240132; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; SAWADA R, 1994, J BIOL CHEM, V269, P1425; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Tagawa ST, 2013, CLIN CANCER RES, V19, P5182, DOI 10.1158/1078-0432.CCR-13-0231; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Tremblay PL, 2008, CANCER RES, V68, P5167, DOI 10.1158/0008-5472.CAN-08-1229; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Xing YF, 2008, CANCER BIOL THER, V7, P1839, DOI 10.4161/cbt.7.11.6862; Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028	54	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85143	10.1371/journal.pone.0085143	http://dx.doi.org/10.1371/journal.pone.0085143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386459	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900127
J	Jeffries, AR; Collier, DA; Vassos, E; Curran, S; Ogilvie, CM; Price, J				Jeffries, Aaron R.; Collier, David A.; Vassos, Evangelos; Curran, Sarah; Ogilvie, Caroline M.; Price, Jack			Random or Stochastic Monoallelic Expressed Genes Are Enriched for Neurodevelopmental Disorder Candidate Genes	PLOS ONE			English	Article							AUTISM-SPECTRUM DISORDERS; COPY-NUMBER VARIATION; GENOME-WIDE SCREEN; ALLELIC EXPRESSION; STEM-CELLS; ARRAY CGH; ASSOCIATION; DISEASES; REVEALS; VARIANT	Random or stochastic monoallelic expressed genes (StMA genes) represent a unique form of monoallelic expression where allelic choice is made at random early in development. The consequential clonal diversity provides opportunity for functional heterozygosity in tissues such as the brain, and can impact on both development and disease. We investigate the relationship of StMA expressed genes previously identified in clonal neural stem cells with the neurodevelopmental disorders autism and schizophrenia. We found that StMA genes show an overrepresentation of schizophrenia risk candidates identified by genome wide association studies from the genetic association database. Similar suggestive enrichment was also found for genes from the NHGRI genome-wide association study catalog and a psychiatric genetics consortium schizophrenia dataset although these latter more robust gene lists did not achieve statistical significance. We also examined multiple sources of copy number variation (CNV) datasets from autism and schizophrenia cohorts. After taking into account total gene numbers and CNV size, both autism and schizophrenia associated CNVs appeared to show an enrichment of StMA genes relative to the control CNV datasets. Since the StMA genes were originally identified in neural stem cells, bias due to the neural transcriptome is possible. To address this, we randomly sampled neural stem cell expressed genes and repeated the tests. After a significant number of iterations, neural stem cell expressed genes did not show an overrepresentation in autism or schizophrenia CNV datasets. Therefore, irrespective of the neural derived transcriptome, StMA genes originally identified in neural stem cells show an overrepresentation in CNVs associated with autism and schizophrenia. If this association is functional, then the regulation (or dysregulation) of this form of allelic expression status within tissues such as the brain may be a contributory risk factor for neurodevelopmental disorders and may also influence disease discordance sometimes observed in monozygotic twins.	[Jeffries, Aaron R.; Price, Jack] Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England; [Collier, David A.] Eli Lilly & Co Ltd, Discovery Neurosci Res, Windlesham, Surrey, England; [Collier, David A.; Vassos, Evangelos; Curran, Sarah] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Ogilvie, Caroline M.] Guys & St Thomas NHS Fdn Trust, Dept Cytogenet, London, England	University of London; King's College London; Eli Lilly; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Jeffries, AR (corresponding author), Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England.	Aaron.R.Jeffries@kcl.ac.uk	Price, Jack/G-9510-2011; Vassos, Evangelos/F-9825-2013; Jeffries, Aaron/D-1256-2014; curran, sarah/D-1027-2009; Ogilve, Caroline/AAW-3793-2021; Collier, David A/D-1649-2011	Vassos, Evangelos/0000-0001-6363-0438; Jeffries, Aaron/0000-0002-1235-8291; Collier, David A/0000-0003-4087-1559; Price, Jack/0000-0003-2235-9180	National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institute for Health Research (NIHR); Innovative Medicines Initiative; European Union	National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Innovative Medicines Initiative; European Union(European Commission)	The authors acknowledge the financial support of the National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreements n degrees 115439, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007 - 2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Jeffries AR, 2012, STEM CELLS, V30, P1938, DOI 10.1002/stem.1155; Kopsida E, 2011, HORM BEHAV, V59, P375, DOI 10.1016/j.yhbeh.2010.04.005; Li SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031751; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Prendergast JGD, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-6; PRICE J, 1988, DEVELOPMENT, V104, P473; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	27	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85093	10.1371/journal.pone.0085093	http://dx.doi.org/10.1371/journal.pone.0085093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386451	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900124
J	Marthaler, AG; Tiemann, U; Arauzo-Bravo, MJ; Wu, GM; Zaehres, H; Hyun, JK; Han, DW; Scholer, HR; Tapia, N				Marthaler, Adele G.; Tiemann, Ulf; Arauzo-Bravo, Marcos J.; Wu, Guangming; Zaehres, Holm; Hyun, Jung Keun; Han, Dong Wook; Schoeler, Hans R.; Tapia, Natalia			Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate	PLOS ONE			English	Article							SPINAL-CORD-INJURY; DEFINED FACTORS; EPIGENETIC MEMORY; HUMAN FIBROBLASTS; GENE-EXPRESSION; NEURONS; MOUSE; DIFFERENTIATION; CONVERSION; RECOVERY	Transcription factor-based reprogramming can lead to the successful switching of cell fates. We have recently reported that mouse embryonic fibroblasts (MEFs) can be directly reprogrammed into induced neural stem cells (iNSCs) after the forced expression of Brn4, Sox2, Klf4, and Myc. Here, we tested whether iNSCs could be further reprogrammed into induced pluripotent stem cells (iPSCs). The two factors Oct4 and Klf4 were sufficient to induce pluripotency in iNSCs. Immunocytochemistry and gene expression analysis showed that iNSC-derived iPSCs (iNdiPSCs) are similar to embryonic stem cells at the molecular level. In addition, iNdiPSCs could differentiate into cells of all three germ layers, both in vitro and in vivo, proving that iNdiPSCs are bona fide pluripotent cells. Furthermore, analysis of the global gene expression profile showed that iNdiPSCs, in contrast to iNSCs, do not retain any MEF transcriptional memory even at early passages after reprogramming. Overall, our results demonstrate that iNSCs can be reprogrammed to pluripotency and suggest that cell fate can be redirected numerous times. Importantly, our findings indicate that the induced pluripotent cell state may erase the donor-cell type epigenetic memory more efficiently than other induced somatic cell fates.	[Marthaler, Adele G.; Tiemann, Ulf; Arauzo-Bravo, Marcos J.; Wu, Guangming; Zaehres, Holm; Schoeler, Hans R.; Tapia, Natalia] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Hyun, Jung Keun] Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan, South Korea; [Hyun, Jung Keun] Dandook Univ, Dept Rehabil Med, Cheonan, South Korea; [Han, Dong Wook] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Dankook University; Konkuk University; Konkuk University Medical Center; University of Munster	Tapia, N (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	ntapia@mpi-muenster.mpg.de	Hyun, Jung Keun/ABB-2173-2020; , HS/AAB-4434-2019; Tiemann, Ulf/N-8037-2015; Marcos, Arauzo-Bravo/A-1706-2011; Tapia, Natalia/H-5500-2012	Hyun, Jung Keun/0000-0001-9254-4424; , HS/0000-0003-2643-5136; Tiemann, Ulf/0000-0002-3919-1663; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Tapia, Natalia/0000-0003-0226-1952; Wu, Guangming/0000-0003-1923-7609	International Max Planck Research School, Molecular Biomedicine	International Max Planck Research School, Molecular Biomedicine	A.G.M. and U.T. are supported by a fellowship of the International Max Planck Research School, Molecular Biomedicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bowles J, 2003, CYTOGENET GENOME RES, V101, P261, DOI 10.1159/000074346; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapia N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2229; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797	24	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85138	10.1371/journal.pone.0085138	http://dx.doi.org/10.1371/journal.pone.0085138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386457	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900125
J	Zhang, J; Franks, RG; Liu, X; Kang, M; Keebler, JEM; Schaff, JE; Huang, HW; Xiang, QY				Zhang, Jian; Franks, Robert G.; Liu, Xiang; Kang, Ming; Keebler, Jonathan E. M.; Schaff, Jennifer E.; Huang, Hong-Wen; Xiang, Qiu-Yun (Jenny)			De novo Sequencing, Characterization, and Comparison of Inflorescence Transcriptomes of Cornus canadensis and C. florida (Cornaceae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; FLORAL TRANSCRIPTOME; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; GENE-EXPRESSION; S. L.; EVOLUTION; LEAFY; ELONGATION; DOGWOOD	Background: Transcriptome sequencing analysis is a powerful tool in molecular genetics and evolutionary biology. Here we report the results of de novo 454 sequencing, characterization, and comparison of inflorescence transcriptomes of two closely related dogwood species, Cornus canadensis and C. florida (Cornaceae). Our goals were to build a preliminary source of genome sequence data, and to identify genes potentially expressed differentially between the inflorescence transcriptomes for these important horticultural species. Results: The sequencing of cDNAs from inflorescence buds of C. canadensis (cc) and C. florida (cf), and normalized cDNAs from leaves of C. canadensis resulted in 251799 (ccBud), 96245 (ccLeaf) and 114648 (cfBud) raw reads, respectively. The de novo assembly of the high quality (HQ) reads resulted in 36088, 17802 and 21210 unigenes for ccBud, ccLeaf and cfBud. A reference transcriptome for C. canadensis was built by assembling HQ reads of ccBud and ccLeaf, containing 40884 unigenes. Reference mapping and comparative analyses found 10926 sequences were putatively specific to ccBud, and 6979 putatively specific to cfBud. Putative differentially expressed genes between ccBud and cfBud that are related to flower development and/or stress response were identified among 7718 shared sequences by ccBud and cfBud. Bidirectional BLAST found 87 (41.83% of 208) of Arabidopsis genes related to inflorescence development had putative orthologs in the dogwood transcriptomes. Comparisons of the shared sequences by ccBud and cfBud yielded 65931 high quality SNPs between two species. The twenty unigenes with the most SNPs are listed as potential genetic markers for evolutionary studies. Conclusions: The data provide an important, although preliminary, information platform for functional genomics and evolutionary developmental biology in Cornus. The study identified putative candidates potentially involved in the genetic regulation of inflorescence evolution and/or disease resistance in dogwoods for future analyses. Results of the study also provide markers useful for dogwood phylogenomic studies.	[Zhang, Jian] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Zhang, Jian; Franks, Robert G.; Liu, Xiang; Xiang, Qiu-Yun (Jenny)] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Kang, Ming; Huang, Hong-Wen] Chinese Acad Sci, CAS Key Lab Plant Resource Conservat & Sustainabl, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Keebler, Jonathan E. M.; Schaff, Jennifer E.] N Carolina State Univ, Bioinformat Analyst & Consultant Genom Sci Lab, Raleigh, NC 27695 USA	Chinese Academy of Sciences; Institute of Botany, CAS; University of North Carolina; North Carolina State University; Chinese Academy of Sciences; South China Botanical Garden, CAS; University of North Carolina; North Carolina State University	Huang, HW (corresponding author), Chinese Acad Sci, CAS Key Lab Plant Resource Conservat & Sustainabl, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	huanghw@mail.scbg.ac.cn; jenny_xiang@ncsu.edu	Kang, Ming/M-2368-2019; Xiang, Jenny/ADU-6318-2022	Xiang, Jenny/0000-0002-9016-0678; Franks, Robert G./0000-0002-3978-1030	National Nature Science Foundation of the United States [IOS-1024629]; CAS/SAFEA International Partnership Program for Creative Research Teams from China; National Nature Science Foundation of China [31100171]	National Nature Science Foundation of the United States; CAS/SAFEA International Partnership Program for Creative Research Teams from China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Nature Science Foundation of the United States grant (IOS-1024629) and a CAS/SAFEA International Partnership Program for Creative Research Teams from China. This study was also benefited from a National Nature Science Foundation of China (grant no. 31100171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ALVAREZ J, 1992, PLANT J, V2, P103, DOI 10.1111/j.1365-313X.1992.00103.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benlloch R, 2007, ANN BOT-LONDON, V100, P659, DOI 10.1093/aob/mcm146; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Brown Daniel A., 1996, Journal of Arboriculture, V22, P83; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chuvarine P, 2012, PLOS ONE, V7; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Eric H, 2006, THESIS U FLORIDA; EYDE RH, 1988, BOT REV, V54, P233, DOI 10.1007/BF02868985; Fan CZ, 2003, AM J BOT, V90, P1357, DOI 10.3732/ajb.90.9.1357; Fan CZ, 2001, AM J BOT, V88, P1131, DOI 10.2307/2657096; Feng CM, 2012, NEW PHYTOL, V196, P631, DOI 10.1111/j.1469-8137.2012.04255.x; Feng CM, 2011, NEW PHYTOL, V191, P850, DOI 10.1111/j.1469-8137.2011.03716.x; Feng CM, 2009, PLANT CELL TISS ORG, V97, P27, DOI 10.1007/s11240-009-9495-0; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hanzawa Y, 2000, EMBO J, V19, P4248, DOI 10.1093/emboj/19.16.4248; Hanzawa Y, 1997, PLANT J, V12, P863, DOI 10.1046/j.1365-313X.1997.12040863.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Karlson DT, 2004, PLANT PHYSIOL, V135, P1654, DOI 10.1104/pp.103.037473; Komeda Y, 1998, J PLANT RES, V111, P283, DOI 10.1007/BF02512185; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Liu J, 2013, ANN BOT, DOI [10.1093/aob/mct202, DOI 10.1093/A0B/MCT202]; Liu X, 2013, BOT SOC AM C NEW ORL; Liu X, 2013, PLANT CELL REP, V32, P77, DOI 10.1007/s00299-012-1341-x; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lu PL, 2012, GENOME RES, V22, P508, DOI 10.1101/gr.127522.111; Manzanilla V, 2012, MOL PHYLOGENET EVOL, V65, P149, DOI 10.1016/j.ympev.2012.05.035; Martinez-Barnetche J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-207; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MURRELL ZE, 1993, SYST BOT, V18, P469, DOI 10.2307/2419420; Murrell ZE, 1996, SYST BOT, V21, P273, DOI 10.2307/2419659; MURRELL ZE, 1994, SYST BOT, V19, P539, DOI 10.2307/2419776; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rebocho AB, 2008, DEV CELL, V15, P437, DOI 10.1016/j.devcel.2008.08.007; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Roger AJ, 1999, MOL BIOL EVOL, V16, P218, DOI 10.1093/oxfordjournals.molbev.a026104; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; SHANNON S, 1993, PLANT CELL, V5, P639, DOI 10.1105/tpc.5.6.639; Sherald JL, 1996, PLANT DIS, V80, P310, DOI 10.1094/PD-80-0310; Souer E, 2008, PLANT CELL, V20, P2033, DOI 10.1105/tpc.108.060871; Terabayashi Y, 2012, APPL MICROBIOL BIOT, V93, P305, DOI 10.1007/s00253-011-3767-4; Teshiba R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065141; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torii KU, 2003, MORPHOGENESIS AND PATTERN FORMATION IN BIOLOGICAL SYSTEMS: EXPERIMENTS AND MODELS, P153; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Waters AJ, 2011, PLANT CELL, V23, P4221, DOI 10.1105/tpc.111.092668; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Wu XL, 2005, CURR BIOL, V15, P436, DOI 10.1016/j.cub.2004.12.079; Xiang Q-Y, 2005, FLORA CHINA, V14, P206; Xiang QY, 2008, J SYST EVOL, V46, P349, DOI 10.3724/SP.J.1002.2008.08056; Xiang QY, 2011, MOL PHYLOGENET EVOL, V59, P123, DOI 10.1016/j.ympev.2011.01.016; Xiang QY, 2008, MOL PHYLOGENET EVOL, V49, P327, DOI 10.1016/j.ympev.2008.07.010; Xiang QY, 1996, SYST BOT, V21, P515, DOI 10.2307/2419612; Xiang QY, 1989, B BOT RES, V9, P125; Xiang QYJ, 2006, TAXON, V55, P9, DOI 10.2307/25065525; Xu T, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/269191; Zhang WH, 2008, MOL PHYLOGENET EVOL, V47, P175, DOI 10.1016/j.ympev.2007.12.022; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082	74	10	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82674	10.1371/journal.pone.0082674	http://dx.doi.org/10.1371/journal.pone.0082674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386108	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900013
J	Huang, YJ; Danis, RP; Pak, JW; Luo, SY; White, J; Zhang, X; Narkar, A; Domalpally, A				Huang, Yijun; Danis, Ronald P.; Pak, Jeong W.; Luo, Shiyu; White, James; Zhang, Xian; Narkar, Ashwini; Domalpally, Amitha			Development of a Semi-Automatic Segmentation Method for Retinal OCT Images Tested in Patients with Diabetic Macular Edema	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; AUTOMATED SEGMENTATION; LAYERS; DEGENERATION	Purpose: To develop EdgeSelect, a semi-automatic method for the segmentation of retinal layers in spectral domain optical coherence tomography images, and to compare the segmentation results with a manual method. Methods: SD-OCT (Heidelberg Spectralis) scans of 28 eyes (24 patients with diabetic macular edema and 4 normal subjects) were imported into a customized MATLAB application, and were manually segmented by three graders at the layers corresponding to the inner limiting membrane (ILM), the inner segment/ellipsoid interface (ISe), the retinal/retinal pigment epithelium interface (RPE), and the Bruch's membrane (BM). The scans were then segmented independently by the same graders using EdgeSelect, a semi-automated method allowing the graders to guide/correct the layer segmentation interactively. The inter-grader reproducibility and agreement in locating the layer positions between the manual and EdgeSelect methods were assessed and compared using the Wilcoxon signed rank test. Results: The inter-grader reproducibility using the EdgeSelect method for retinal layers varied from 0.15 to 1.21 mu m, smaller than those using the manual method (3.36-6.43 mu m). The Wilcoxon test indicated the EdgeSelect method had significantly better reproducibility than the manual method. The agreement between the manual and EdgeSelect methods in locating retinal layers ranged from 0.08 to 1.32 mu m. There were small differences between the two methods in locating the ILM (p = 0.012) and BM layers (p<0.001), but these were statistically indistinguishable in locating the ISe (p = 0.896) and RPE layers (p = 0.771). Conclusions: The EdgeSelect method resulted in better reproducibility and good agreement with a manual method in a set of eyes of normal subjects and with retinal disease, suggesting that this approach is feasible for OCT image analysis in clinical trials.	[Huang, Yijun; Danis, Ronald P.; Pak, Jeong W.; Luo, Shiyu; White, James; Narkar, Ashwini; Domalpally, Amitha] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Fundus Photograph Reading Ctr, Madison, WI 53706 USA; [Huang, Yijun; Danis, Ronald P.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA; [Zhang, Xian] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Yale University	Huang, YJ (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Fundus Photograph Reading Ctr, Madison, WI 53706 USA.	yhuang@rc.ophth.wisc.edu	Domalpally, Amitha/B-2367-2015	Domalpally, Amitha/0000-0002-8145-9619	Research to Prevent Blindness Foundation	Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB))	This research was supported by an unrestricted fund provided by Research to Prevent Blindness Foundation to Department of Ophthalmology, University of Wisconsin - Madison; the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors were grateful that the data was collected and provided by DRCR.net for analysis; DRCR.net has no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Ahlers C, 2008, BRIT J OPHTHALMOL, V92, P197, DOI 10.1136/bjo.2007.120956; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Browning DJ, 2008, OPHTHALMOLOGY, V115, P1366, DOI 10.1016/j.ophtha.2007.12.004; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Han IC, 2010, OPHTHALMOLOGY, V117, P1177, DOI 10.1016/j.ophtha.2009.10.029; Ho J, 2009, OPHTHALMOLOGY, V116, P1960, DOI 10.1016/j.ophtha.2009.03.034; Hood DC, 2011, OPTOMETRY VISION SCI, V88, P113, DOI 10.1097/OPX.0b013e3181fc3625; Huang YJ, 2012, INVEST OPHTH VIS SCI, V53, P2133, DOI 10.1167/iovs.11-8755; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Krebs I, 2010, OPHTHALMOLOGY, V117, P1577, DOI 10.1016/j.ophtha.2010.04.032; Lammer J, 2011, RETINA-J RET VIT DIS, V31, P48, DOI 10.1097/IAE.0b013e3181e095a4; Lim JI, 2008, AM J OPHTHALMOL, V146, P417, DOI 10.1016/j.ajo.2008.05.018; NEMA, 2013, DIG IM COMM MED DICO; Nolan R, 2013, NEUROLOGY, V80, P139, DOI 10.1212/WNL.0b013e31827b9132; Rogowska J, 2009, HANDBOOK OF MEDICAL IMAGE PROCESSING AND ANALYSIS, 2ND EDITION, P73; Sadda SR, 2006, OPHTHALMOLOGY, V113, P285, DOI 10.1016/j.ophtha.2005.10.005; Sadda SR, 2007, INVEST OPHTH VIS SCI, V48, P839, DOI 10.1167/iovs.06-0554; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; SIEGEL S., 1956, NONPARAMETRIC STAT B; Sniedovich M, 2006, CONTROL CYBERN, V35, P599; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Vermeer KA, 2011, BIOMED OPT EXPRESS, V2, P1743, DOI 10.1364/BOE.2.001743; Yang Q, 2011, BIOMED OPT EXPRESS, V2, P2493, DOI 10.1364/BOE.2.002493	26	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82922	10.1371/journal.pone.0082922	http://dx.doi.org/10.1371/journal.pone.0082922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386127	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700021
J	Krimmer, D; Ichimaru, Y; Burgess, J; Black, J; Oliver, B				Krimmer, David; Ichimaru, Yukikazu; Burgess, Janette; Black, Judith; Oliver, Brian			Exposure to Biomass Smoke Extract Enhances Fibronectin Release from Fibroblasts	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY SMOOTH-MUSCLE; HUMAN LUNG FIBROBLASTS; EXTRACELLULAR-MATRIX PROTEINS; EPITHELIAL-CELL MIGRATION; CIGARETTE-SMOKE; GENE-EXPRESSION; INCREASED RISK; COPD; ERK	COPD induced following biomass smoke exposure has been reported to be associated with a more fibrotic phenotype than cigarette smoke induced COPD. This study aimed to investigate if biomass smoke induced extracellular matrix (ECM) protein production from primary human lung fibroblasts in vitro. Primary human lung fibroblasts (n = 5-10) were stimulated in vitro for up to 72 hours with increasing concentrations of biomass smoke extract (BME) or cigarette smoke extract (CSE) prior to being assessed for deposition of ECM proteins, cytokine release, and activation of intracellular signalling molecules. Deposition of the ECM proteins perlecan and fibronectin was upregulated by both CSE (p<0.05) and BME (p<0.05). The release of the neutrophilic chemokine IL-8 was also enhanced by BME. ERK1/2 phosphorylation was significantly upregulated by BME (p<0.05). Chemical inhibition of ERK signalling molecules partially attenuated these effects (p<0.05). Stimulation with endotoxin had no effect. This study demonstrated that BME had similar effects to CSE in vitro and had the capacity to directly induce fibrosis by upregulating production of ECM proteins. The mechanisms by which both biomass and cigarette smoke exposure cause lung damage may be similar.	[Krimmer, David; Ichimaru, Yukikazu; Burgess, Janette; Black, Judith; Oliver, Brian] Woolcock Inst Med Res, Sydney, NSW, Australia; [Krimmer, David; Ichimaru, Yukikazu; Burgess, Janette; Black, Judith; Oliver, Brian] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney	Oliver, B (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	brian.oliver@sydney.edu.au	Burgess, Janette/M-7117-2019; Oliver, Brian/E-7939-2010; Burgess, Janette K/A-3597-2010	Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966	National Health and Medical Research Council Australia; Australian Respiratory Council; NHMRC Career Development Fellowship [1032695, 1026880]; NHMRC Senior Principal Research Fellowship [571098]	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Respiratory Council; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Australia, and the Australian Respiratory Council. JKB was supported by a NHMRC Career Development Fellowship #1032695. JLB was supported by a NHMRC Senior Principal Research Fellowship #571098. BGO was supported by a NHMRC Career Development Fellowship #1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency USEP, 1993, SUMM EM CHAR NONC RE; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Calabrese C, 2006, RESP MED, V100, P1415, DOI 10.1016/j.rmed.2005.11.009; Chin BY, 1998, AM J PHYSIOL-LUNG C, V275, pL942, DOI 10.1152/ajplung.1998.275.5.L942; de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6; Dekkers BGJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1405, DOI 10.1152/ajplung.00331.2006; Desalu OO, 2010, J BRAS PNEUMOL, V36, P441, DOI 10.1590/S1806-37132010000400008; Deveci F, 2004, RESPIRATION, V71, P602, DOI 10.1159/000081761; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Freyer AM, 2001, AM J RESP CELL MOL, V25, P569, DOI 10.1165/ajrcmb.25.5.4605; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Gupta J, 2011, CANCER BIOL THER, V11, P311, DOI 10.4161/cbt.11.3.14096; Han SW, 2005, CANCER LETT, V219, P71, DOI 10.1016/j.canlet.2004.07.040; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kargin R, 2011, ECHOCARDIOGR-J CARD, V28, P52, DOI 10.1111/j.1540-8175.2010.01278.x; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kim HJ, 1997, AM J PHYSIOL-LUNG C, V273, pL134, DOI 10.1152/ajplung.1997.273.1.L134; Kim YJ, 2009, RESP MED, V103, P757, DOI 10.1016/j.rmed.2008.11.011; Kranenburg AR, 2006, AM J CLIN PATHOL, V126, P725, DOI 10.1309/JC477FAEL1YKV54W; Krimmer DI, 2012, AM J RESP CELL MOL, V46, P34, DOI 10.1165/rcmb.2010-0426OC; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; MENENDEZ R, 1995, RESPIRATION, V62, P312; Mercer Becky, 2006, Proc Am Thorac Soc, V3, P477, DOI 10.1513/pats.200603-041MS; Moir LM, 2008, J ALLERGY CLIN IMMUN, V121, P1034, DOI 10.1016/j.jaci.2007.12.1159; Moon HJ, 2007, INT J BIOCHEM CELL B, V39, P1224, DOI 10.1016/j.biocel.2007.03.017; Morissette MC, 2008, AM J RESP CRIT CARE, V178, P240, DOI 10.1164/rccm.200710-1486OC; Mourgeon E, 1999, AM J PHYSIOL-LUNG C, V277, pL142, DOI 10.1152/ajplung.1999.277.1.L142; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Park JW, 2010, J TOXICOL SCI, V35, P33, DOI 10.2131/jts.35.33; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; Pignatti P, 2005, J ALLERGY CLIN IMMUN, V115, P88, DOI 10.1016/j.jaci.2004.08.048; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Profita M, 2005, ALLERGY, V60, P1361, DOI 10.1111/j.1398-9995.2005.00892.x; Rivera RM, 2008, INT J TUBERC LUNG D, V12, P972; Roman J, 2005, AM J PHYSIOL-LUNG C, V288, pL975, DOI 10.1152/ajplung.00003.2004; Roman J, 2004, FASEB J, V18, P1436, DOI 10.1096/fj.03-0826fje; Salvi S, 2010, CHEST, V138, P3, DOI 10.1378/chest.10-0645; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Sood A, 2010, AM J RESP CRIT CARE, V182, P1098, DOI 10.1164/rccm.201002-0222OC; Stockley RA, 2002, CHEST, V121, p151S, DOI 10.1378/chest.121.5_suppl.151S; Tsukagoshi H, 2002, TOXICOL APPL PHARM, V184, P127, DOI 10.1006/taap.2002.9514; Wang T, 2010, AM J RESP CELL MOL, V42, P442, DOI 10.1165/rcmb.2008-0402OC; Zhang J, 2011, CYTOKINE, V54, P289, DOI 10.1016/j.cyto.2011.02.018; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC	57	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83938	10.1371/journal.pone.0083938	http://dx.doi.org/10.1371/journal.pone.0083938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386310	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700089
J	Talha, SM; Hytonen, J; Westhorpe, A; Kumar, S; Khanna, N; Pettersson, K				Talha, Sheikh M.; Hytonen, Jukka; Westhorpe, Adam; Kumar, Sushil; Khanna, Navin; Pettersson, Kim			Europium Nanoparticle-Based High Performing Immunoassay for the Screening of Treponemal Antibodies	PLOS ONE			English	Article							LABORATORY DIAGNOSIS; SYPHILIS; PALLIDUM; TESTS; LIPOPROTEIN; TRANSFUSION; ANTIGEN; DISEASE; TIME	Treponema pallidum subspecies pallidum (Tp) is the causative agent of syphilis which mainly spreads through sexual contact, blood transfusion and perinatal route. In order to curtail the spread of the infection and to clinically manage the disease, timely, accurate and reliable diagnosis is very important. We have developed an immunoassay for the detection of treponemal antibodies in human serum or plasma samples. In vivo biotinylated and non-biotinylated versions of the recombinant antigen were designed by the fusion of three Tp-specific antigens namely Tp15, Tp17 and Tp47. These fusion antigens were expressed in E. coli and purified using single-step metal affinity chromatography. Biotinylated fusion antigen immobilized on streptavidin coated plate was used to capture the treponemal antibodies and the non-biotinylated antigen coated on europium nanoparticles was used as tracer. Assays with two different incubation times of 10 min and 1 h were developed, and following the incubation the europium fluorescence was measured using time-resolved fluorometry. The developed time-resolved fluorometric (TRF) immunoassays were evaluated with in-house and commercial serum/plasma sample panels. For well-established treponemal antibodies positive or negative samples, the sensitivity of TRF immunoassay with 10 min incubation time was 97.4%, and of TRF immunoassay with 1 h incubation time was 98.7%, and the specificities of both the TRF immunoassays were 99.2%. For the samples with discordant results with the reference assays, both the TRF immunoassays showed better specificity than the Enzygnost syphilis enzyme immunoassay as a screening test. The two different incubation times did not have any significant effect on the signal to cutoff (S/Co) ratios obtained with the two immunoassays (p = 0.06). Our results indicate that the developed immunoassay with a short incubation time of 10 min has the potential to be used in clinical laboratories and in blood-bank settings as a screening test for treponemal antibodies.	[Talha, Sheikh M.; Pettersson, Kim] Univ Turku, Dept Biotechnol, Turku, Finland; [Hytonen, Jukka] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Westhorpe, Adam] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Kumar, Sushil; Khanna, Navin] Int Ctr Genet Engn & Biotechnol, Recombinant Gene Prod Grp, New Delhi, India	University of Turku; University of Turku; University of Surrey; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Talha, SM (corresponding author), Univ Turku, Dept Biotechnol, Turku, Finland.	talshe@utu.fi	; KUMAR, SUSHIL/T-8493-2017	Hytonen, Jukka/0000-0002-0585-9338; Khanna, Navin/0000-0003-1208-614X; KUMAR, SUSHIL/0000-0001-8481-9221; Talha, Sheikh Mohammad/0000-0003-1997-9530	Finnish Funding Agency for Technology and Innovation (TEKES), Finland; Department of Biotechnology (DBT), Government of India	Finnish Funding Agency for Technology and Innovation (TEKES), Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work has been carried out under a bilateral Indo-Finnish collaborative research programme, and was supported by funding from the Finnish Funding Agency for Technology and Innovation (TEKES), Finland, and Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra G, 2010, PROTEIN EXPRES PURIF, V74, P99, DOI 10.1016/j.pep.2010.04.017; Baughn RE, 1996, J IMMUNOL, V157, P720; Baughn RE, 1996, INFECT IMMUN, V64, P2457, DOI 10.1128/IAI.64.7.2457-2466.1996; Binnicker MJ, 2012, J CLIN MICROBIOL, V50, P148, DOI 10.1128/JCM.05636-11; Clyne B, 2000, J EMERG MED, V18, P361, DOI 10.1016/S0736-4679(99)00230-9; Harma H, 2001, CLIN CHEM, V47, P561; Herremans T, 2010, EUR J CLIN MICROBIOL, V29, P495, DOI 10.1007/s10096-010-0900-8; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Kiss Szilard, 2005, Semin Ophthalmol, V20, P161, DOI 10.1080/08820530500232092; Kubio C, 2012, TRANSFUSION, V52, P2161, DOI 10.1111/j.1537-2995.2012.03709.x; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Loeffelholz MJ, 2012, J CLIN MICROBIOL, V50, P2, DOI 10.1128/JCM.06347-11; Marangoni A, 2009, J CLIN LAB ANAL, V23, P1, DOI 10.1002/jcla.20268; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; NORRIS SJ, 1993, MICROBIOL REV, V57, P750, DOI 10.1128/MMBR.57.3.750-779.1993; Pallavi P, 2011, INDIAN J HEMATOL BLO, V27, P1, DOI 10.1007/s12288-010-0047-x; Rostopira N, 2003, FOLIA MICROBIOL, V48, P549, DOI 10.1007/BF02931339; Schmidt PJ, 2001, TRANSFUSION, V41, P1069, DOI 10.1046/j.1537-2995.2001.41081069.x; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; Soukka T, 2001, ANAL CHEM, V73, P2254, DOI 10.1021/ac001287l; Stoner BP, 2007, CLIN INFECT DIS, V44, pS130, DOI 10.1086/511426; Sun AH, 2009, CLIN CHEM LAB MED, V47, P321, DOI 10.1515/CCLM.2009.071; Talha SM, 2011, J VIROL METHODS, V173, P24, DOI 10.1016/j.jviromet.2011.01.001; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; World Health Organization website, SCREEN DON BLOOD TRA; World Health Organization website, 2008, GLOB INC PREV SEL CU	26	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84050	10.1371/journal.pone.0084050	http://dx.doi.org/10.1371/journal.pone.0084050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386329	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700095
J	Tao, ZX; Zhang, Y; Liu, Y; Xu, AQ; Lin, XJ; Yoshida, H; Xiong, P; Zhu, SL; Wang, ST; Yan, DM; Song, LZ; Wang, HY; Cui, N; Xu, WB				Tao, Zexin; Zhang, Yong; Liu, Yao; Xu, Aiqiang; Lin, Xiaojuan; Yoshida, Hiromu; Xiong, Ping; Zhu, Shuangli; Wang, Suting; Yan, Dongmei; Song, Lizhi; Wang, Haiyan; Cui, Ning; Xu, Wenbo			Isolation and Characterization of a Type 2 Vaccine-Derived Poliovirus from Environmental Surveillance in China, 2012	PLOS ONE			English	Article							SHANDONG PROVINCE; SEWAGE	Environmental surveillance of poliovirus on sewage has been conducted in Shandong Province, China since 2008. A type 2 vaccine-derived poliovirus (VDPV) with 7 mutations in VP1 coding region was isolated from the sewage collected in the city of Jinan in December 2012. The complete genome sequencing analysis of this isolate revealed 25 nucleotide substitutions, 7 of which resulted in amino acid alteration. No evidence of recombination with other poliovirus serotypes was observed. The virus did not lose temperature sensitive phenotype at 40 degrees C. An estimation based on the evolution rate of the P1 coding region suggested that evolution time of this strain might be 160-176 days. VP1 sequence analysis revealed that this VDPV strain is of no close relationship with other local type 2 polioviruses (n = 66) from sewage collected between May 2012 and June 2013, suggesting the lack of its circulation in the local population. The person who excreted the virus was not known and no closely related virus was isolated in local population via acute flaccid paralysis surveillance. By far this is the first report of VDPV isolated from sewage in China, and these results underscore the value of environmental surveillance in the polio surveillance system even in countries with high rates of OPV coverage.	[Tao, Zexin; Liu, Yao; Xu, Aiqiang; Lin, Xiaojuan; Xiong, Ping; Wang, Suting; Song, Lizhi; Wang, Haiyan] Shandong Univ, Acad Prevent Med, Jinan 250100, Peoples R China; [Tao, Zexin; Liu, Yao; Xu, Aiqiang; Lin, Xiaojuan; Xiong, Ping; Wang, Suting] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xu, Aiqiang] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Yoshida, Hiromu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Cui, Ning] Shandong Univ Tradit Chinese Med, Coll Basic Med Sci, Dept Prevent Med, Jinan, Peoples R China	Shandong University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Shandong University; National Institute of Infectious Diseases (NIID); Shandong University of Traditional Chinese Medicine	Xu, AQ (corresponding author), Shandong Univ, Acad Prevent Med, Jinan 250100, Peoples R China.	aqxuepi@163.com; wenbo_xu1@aliyun.com		Tao, Zexin/0000-0002-1747-2034; Yoshida, Hiromu/0000-0002-1488-8309; Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [81302481]; Ministry of Health, Labor and Welfare of Japan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the National Natural Science Foundation of China (project no. 81302481)(http://www.nsfc.gov.cn) and a grant for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P110; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Chen P, 2013, J MED VIROL, V85, P483, DOI 10.1002/jmv.23478; El Bassioni L, 2003, AM J EPIDEMIOL, V158, P807, DOI 10.1093/aje/kwg202; Grassly NC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0140; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Iwai M, 2006, APPL ENVIRON MICROB, V72, P6381, DOI 10.1128/AEM.02621-05; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kew Olen M., 2012, Morbidity and Mortality Weekly Report, V61, P741; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Roberts L, 2009, SCIENCE, V323, P702, DOI [10.1126/science.323.5915.702, 10.1126/science.323.5915.705]; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2012, EMERG INFECT DIS, V18, P1865, DOI 10.3201/eid1811.120090; Tao ZX, 2011, APPL ENVIRON MICROB, V77, P3786, DOI 10.1128/AEM.03044-10; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; World Health Organization, 2003, GUID ENV SURV POL CI; World Health Organization, 2004, POL LAB MAN, V4th; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Yoshida H, 2002, J GEN VIROL, V83, P1107, DOI 10.1099/0022-1317-83-5-1107; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	28	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83975	10.1371/journal.pone.0083975	http://dx.doi.org/10.1371/journal.pone.0083975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386319	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700092
J	Bonitz, T; Zubeil, F; Grond, S; Heide, L				Bonitz, Tobias; Zubeil, Florian; Grond, Stephanie; Heide, Lutz			Unusual N-Prenylation in Diazepinomicin Biosynthesis: The Farnesylation of a Benzodiazepine Substrate Is Catalyzed by a New Member of the ABBA Prenyltransferase Superfamily	PLOS ONE			English	Article							NATURAL-PRODUCT; AROMATIC PRENYLTRANSFERASES; ASPERGILLUS-FUMIGATUS; MECHANISM; IDENTIFICATION; TRYPTOPHAN; MOLECULES; TLN-4601; REVEALS; PATHWAY	The bacterium Micromonospora sp. RV115, isolated from a marine sponge, produces the unusual metabolite diazepinomicin, a prenylated benzodiazepine derivative. We have cloned the prenyltransferase gene dzmP from this organism, expressed it in Escherichia coli, and the resulting His8-tagged protein was purified and investigated biochemically. It was found to catalyze the farnesylation of the amide nitrogen of dibenzodiazepinone. DzmP belongs to the ABBA prenyltransferases and is the first member of this superfamily which utilizes farnesyl diphosphate as genuine substrate. All previously discovered members utilize either dimethylallyl diphosphate (C-5) or geranyl diphosphate (C-10). Another putative diazepinomicin biosynthetic gene cluster was identified in the genome of Streptomyces griseoflavus Tu4000, suggesting that the formation of diazepinomicin is not restricted to the genus Micromonospora. The gene cluster contains a gene ssrg_00986 with 61.4% identity (amino acid level) to dzmP. The gene was expressed in E. coli, and the purified protein showed similar catalytic properties as DzmP. Both enzymes also accepted other phenolic or phenazine substrates. ABBA prenyltransferases are useful tools for chemoenzymatic synthesis, due to their nature as soluble, stable biocatalysts. The discovery of DzmP and Ssrg_00986 extends the isoprenoid substrate range of this superfamily. The observed prenylation of an amide nitrogen is an unusual biochemical reaction.	[Bonitz, Tobias; Heide, Lutz] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Zubeil, Florian; Grond, Stephanie] Univ Tubingen, Inst Organ Chem, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Heide, L (corresponding author), Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	heide@uni-tuebingen.de		Grond, Stephanie/0000-0002-7549-4936; Heide, Lutz/0000-0001-7809-7453	German Federal Ministry of Education and Research (GenBioCom)	German Federal Ministry of Education and Research (GenBioCom)	This work was supported by a grant from the German Federal Ministry of Education and Research (GenBioCom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2012, MAR DRUGS, V10, P2208, DOI 10.3390/md10102208; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AUZI AA, 1994, PHYTOCHEMISTRY, V36, P535, DOI 10.1016/S0031-9422(00)97111-5; Bachmann BO, 2006, US Patent, Patent No. [7101872B2, 7101872]; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Boufaied N, 2010, ANTI-CANCER DRUG, V21, P543, DOI 10.1097/CAD.0b013e328337f373; BREMS DN, 1977, J AM CHEM SOC, V99, P8351, DOI 10.1021/ja00467a055; Charan RD, 2004, J NAT PROD, V67, P1431, DOI 10.1021/np040042r; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cui GL, 2007, BIOCHEMISTRY-US, V46, P1303, DOI 10.1021/bi062076z; Feng XD, 2009, BIOORGAN MED CHEM, V17, P2154, DOI 10.1016/j.bmc.2008.10.073; Floss HG, 2011, J ANTIBIOT, V64, P35, DOI 10.1038/ja.2010.139; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gourdeau H, 2008, CANCER CHEMOTH PHARM, V61, P911, DOI 10.1007/s00280-007-0544-2; Grundmann A, 2008, CHEMBIOCHEM, V9, P2059, DOI 10.1002/cbic.200800240; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Igarashi Y, 2005, J ANTIBIOT, V58, P350, DOI 10.1038/ja.2005.44; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Keller M, 2012, ACTA CRYSTALLOGR C, V68, pO240, DOI 10.1107/S0108270112019622; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kikuchi H, 2010, TETRAHEDRON, V66, P6000, DOI 10.1016/j.tet.2010.06.029; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Li SM, 2009, PHYTOCHEMISTRY, V70, P1746, DOI 10.1016/j.phytochem.2009.03.019; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Lima WC, 2009, MOL BIOL EVOL, V26, P399, DOI 10.1093/molbev/msn261; Mason WP, 2012, J NEURO-ONCOL, V107, P343, DOI 10.1007/s11060-011-0747-6; McAlpine JB, 2008, J NAT PROD, V71, P1585, DOI 10.1021/np800376n; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; Metzger U, 2010, J MOL BIOL, V404, P611, DOI 10.1016/j.jmb.2010.09.067; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Ohkuma H., 1996, Patent Appl., Patent No. 5541181; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Ratnayake AS, 2009, J NAT PROD, V72, P496, DOI 10.1021/np800664u; Rottig M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000636; Saleh O, 2012, MEDCHEMCOMM, V3, P1009, DOI 10.1039/c2md20045g; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J., 2001, MOL CLONING LAB MANU; Schuller JM, 2012, J MOL BIOL, V422, P87, DOI 10.1016/j.jmb.2012.05.033; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Seeger K, 2011, MICROB BIOTECHNOL, V4, P252, DOI 10.1111/j.1751-7915.2010.00234.x; Silakowski B, 2000, EUR J BIOCHEM, V267, P6476, DOI 10.1046/j.1432-1327.2000.01740.x; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Woodside A. B., 1993, ORG SYNTH, V8, P616; Yin WB, 2007, CHEMBIOCHEM, V8, P1154, DOI 10.1002/cbic.200700079; Zocher G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048427; Zummo FP, 2012, APPL MICROBIOL BIOT, V94, P719, DOI 10.1007/s00253-011-3833-y	54	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85707	10.1371/journal.pone.0085707	http://dx.doi.org/10.1371/journal.pone.0085707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376894	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000192
J	Jiao, WW; Liu, ZG; Han, R; Zhao, XQ; Dong, F; Dong, HY; Huang, HR; Tian, JL; Li, QJ; Lian, LL; Yin, QQ; Song, WQ; Wan, KL; Shen, AD				Jiao, Weiwei; Liu, Zhiguang; Han, Rui; Zhao, Xiuqin; Dong, Fang; Dong, Haiyan; Huang, Hairong; Tian, Jianling; Li, Qinjing; Lian, Lulu; Yin, Qingqin; Song, Wenqi; Wan, Kanglin; Shen, A-dong			A Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China	PLOS ONE			English	Article							BEIJING GENOTYPE; STRAINS; EPIDEMIOLOGY; PROVINCES	Background: Tuberculosis (TB) is still a big threat to human health, especially in children. However, an isolation of Mycobacterium tuberculosis culture from pediatric cases remains a challenge. In order to provide some scientific basis for children TB control, we investigated the genotyping and drug resistance characteristics of M. tuberculosis isolates from pediatric cases in China. Methodology/Principal Findings: In this study, a total of 440 strains including 90 from children (<15 years), 159 from adolescents (15-18 years) and 191 from adults (>18 years) isolated in 25 provinces across China were subjected to spoligotyping and drug susceptibility testing. As a result, Beijing family strains were shown to remain predominant in China (85.6%, 81.1% and 75.4% in three above groups, respectively), especially among new children cases (91.0% vs. 69.6% in previously treated cases, P = 0.03). The prevalence of the Beijing genotype isolates was higher in northern and central China in the total collection (85.1% in northern and 83.9% in central vs. 61.6% in southern China, P<0.001) and a similar trend was seen in all three age groups (P = 0.708, <0.001 and 0.025, respectively). In adolescents, the frequencies of isoniazid (INH)-resistant and ethambutol (EMB)-resistant isolates were significantly higher among Beijing strains compared to non-Beijing genotype strains (P = 0.028 for INH and P = 0.027 for EMB). Furthermore, strong association was observed between resistance to rifampicine (RIF), streptomycin (STR) and multidrug resistance (MDR) among Beijing compared to non-Beijing strains in previously treated cases of children (P = 0.01, 0.01 and 0.025, respectively). Conclusion/Significance: Beijing family was more prevalent in northern and central China compared to southern China and these strains were predominant in all age groups. The genetic diversity of M. tuberculosis isolates from children was similar to that found in adolescents and adults. Beijing genotype was associated with RIF, STR and MDR resistance in previously treated children.	[Jiao, Weiwei; Han, Rui; Dong, Fang; Tian, Jianling; Li, Qinjing; Yin, Qingqin; Song, Wenqi; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Key Lab Major Dis Children, Minist Educ,Beijing Pediat Res Inst, Beijing, Peoples R China; [Jiao, Weiwei; Han, Rui; Dong, Fang; Tian, Jianling; Li, Qinjing; Yin, Qingqin; Song, Wenqi; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Natl Key Discipline Pediat, Minist Educ,Beijing Pediat Res Inst, Beijing, Peoples R China; [Liu, Zhiguang; Zhao, Xiuqin; Dong, Haiyan; Lian, Lulu; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liu, Zhiguang; Zhao, Xiuqin; Dong, Haiyan; Lian, Lulu; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Huang, Hairong] Capital Med Univ, Beijing Chest Hosp, Natl TB Clin Lab, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Capital Medical University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn; shenad16@hotmail.com		Song, Wenqi/0000-0002-2660-8992	Capital Health Research and Development of Special Grant [2011-1007-01, 2011-2009-05]; National Science and Technology Major Project of China [2013ZX10003003]; Open Project of Beijing Key Laboratory of Capital Medical University [2013NYJH02]; National Natural Science Foundation of China [81271889]	Capital Health Research and Development of Special Grant; National Science and Technology Major Project of China; Open Project of Beijing Key Laboratory of Capital Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Capital Health Research and Development of Special Grant (No. 2011-1007-01, No. 2011-2009-05), National Science and Technology Major Project of China (2013ZX10003003), Open Project of Beijing Key Laboratory of Capital Medical University (2013NYJH02) and National Natural Science Foundation of China (No. 81271889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EMERG INFECT DIS, V12, P736, DOI [10.3201/eid1205.050400, DOI 10.3201/EID1205.050400]; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Guo YL, 2011, INT J TUBERC LUNG D, V15, P789, DOI 10.5588/ijtld.10.0403; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Li Liang, 2004, Zhonghua Yi Xue Za Zhi, V84, P1678; Liu Bin-Bin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P158; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Tsenova L, 2007, VACCINE, V25, P5126, DOI 10.1016/j.vaccine.2006.11.024; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Word Health Organization, GLOB TUB REP 2012; World Health Organization, GUID SURV DRUG RES T; Xing L, 2012, EUR J CLIN MICROBIOL, V31, P1735, DOI 10.1007/s10096-011-1494-5; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670	21	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84315	10.1371/journal.pone.0084315	http://dx.doi.org/10.1371/journal.pone.0084315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386365	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700102
J	Piontek, T; Ciemniewska-Gorzela, K; Szulc, A; Naczk, J; Wardak, M; Trzaska, T; Dudzinski, W; Grygorowicz, M				Piontek, Tomasz; Ciemniewska-Gorzela, Kinga; Szulc, Andrzej; Naczk, Jakub; Wardak, Martyna; Trzaska, Tadeusz; Dudzinski, Witold; Grygorowicz, Monika			Arthroscopically Assisted Combined Anterior and Posterior Cruciate Ligament Reconstruction with Autologous Hamstring Grafts-Isokinetic Assessment with Control Group	PLOS ONE			English	Article							AUTOGENOUS SEMITENDINOSUS; SURGICAL-TREATMENT; KNEE; STRENGTH	Objective: The aim of the study was to: 1) evaluate the differences in pre-post operative knee functioning, mechanical stability, isokinetic knee muscle strength in simultaneous arthroscopic patients after having undergone an anterior cruciate ligament (ACL) and the posterior cruciate ligament (PCL) with hamstring tendons reconstruction, 2) compare the results of ACL/PCL patients with the control group. Design: Controlled Laboratory Study. Materials and Methods: Results of 11 ACL/PCL patients had been matched with 22 uninjured control participants (CP). Prior to surgery, and minimum 2 years after it, functional assessment (Lysholm and IKDC 2000), mechanical knee joint stability evaluation (Lachman and "drawer'' test) and isokinetic tests (bilateral knee muscle examination) had been performed. Different rehabilitation exercises had been used: isometric, passive exercises, exercises increasing the range of motion and proprioception, strength exercises and specific functional exercises. Results: After arthroscopy no significant differences had been found between the injured and uninjured leg in all isokinetic parameters in ACL/PCL patients. However, ACL/PCL patients had still shown significantly lower values of strength in relative isokinetic knee flexors (p = 0.0065) and extensors (p = 0.0171) compared to the CP. There were no differences between groups regarding absolute isokinetic strength and flexors/extensors ratio. There was statistically significant progress in IKDC 2000 (p = 0.0044) and Lysholm (p = 0.0044) scales prior to (44 and 60 points respectively) and after the reconstruction (61 for IKDC 2000 and 94 points for Lysholm). Conclusions: Although harvesting tendons of semitendinosus and/or gracilis from the healthy extremity diminishes muscle strength of knee flexors in comparison to the CP, flexor strength had improved. Statistically significant improvement of the knee extensor function may indicate that the recreation of joint mechanical stability is required for restoring normal muscle strength. Without restoring normal muscle function and strength, surgical intervention alone may not be sufficient enough to ensure expected improvement of the articular function.	[Piontek, Tomasz; Ciemniewska-Gorzela, Kinga; Naczk, Jakub; Wardak, Martyna; Dudzinski, Witold] Rehasport Clin, Dept Orthopaed, Poznan, Poland; [Piontek, Tomasz; Ciemniewska-Gorzela, Kinga; Szulc, Andrzej] Poznan Univ Med Sci, Dept Pediat Orthopaed & Traumatol, Poznan, Poland; [Trzaska, Tadeusz] Univ Sch Phys Educ, Dept Traumatol, Chair Sports Med, Poznan, Poland; [Grygorowicz, Monika] Rehasport Clin, Dept Res & Dev, Poznan, Poland	Poznan University of Medical Sciences	Grygorowicz, M (corresponding author), Rehasport Clin, Dept Res & Dev, Poznan, Poland.	monika.grygorowicz@rehasport.pl	Grygorowicz, Monika/GWU-5803-2022; Grygorowicz, Monika Małgorzata/A-1357-2012	Grygorowicz, Monika/0000-0002-9575-2074; Grygorowicz, Monika Małgorzata/0000-0002-9575-2074				Azar FM, 2003, OPER TECHN SPORT MED, V11, P248, DOI 10.1016/S1060-1872(03)00048-0; Carter TR, 1999, ARTHROSCOPY, V15, P169, DOI 10.1053/ar.1999.v15.0150161; Chuang TY, 2006, ARTHROSCOPY, V22, DOI 10.1016/j.artho.2005.11.012; Elkousy HA, 2003, OPER TECHN SPORT MED, V11, P286, DOI 10.1016/S1060-1872(03)00039-X; Elmlinger BS, 2006, ARTHROSCOPY, V22, P650, DOI 10.1016/j.arthro.2006.03.010; Fanelli GC, 2005, ARTHROSCOPY, V21, P471, DOI 10.1016/j.arthro.2005.01.001; Fanelli GC, 2003, OPER TECHN SPORT MED, V11, P263, DOI 10.1016/S1060-1872(03)00036-4; Fanelli GC, 1996, ARTHROSCOPY, V12, P5, DOI 10.1016/S0749-8063(96)90213-3; Ferretti A, 2008, ARTHROSCOPY, V24, P786, DOI 10.1016/j.arthro.2008.02.010; Hara K, 1999, ARTHROSCOPY, V15, P871, DOI 10.1053/ar.1999.v15.015087; Ibrahim SAR, 2008, ARTHROSCOPY, V24, P178, DOI 10.1016/j.arthro.2007.08.007; Jenkins PJ, 2011, INJURY, V42, P1426, DOI 10.1016/j.injury.2011.03.026; Kartus J, 2001, ARTHROSCOPY, V17, P971, DOI 10.1053/jars.2001.28979; Keays SL, 2000, CLIN ORTHOP RELAT R, P174; Klimkiewicz JJ, 1999, OPER TECHN SPORT MED, V7, P150, DOI 10.1016/S1060-1872(99)80012-4; Martinek V, 2000, Am J Knee Surg, V13, P74; Nakamura E, 2004, ARTHROSCOPY, V20, P360, DOI 10.1016/j.arthro.2004.01.032; Ohkoshi Y, 1998, ARTHROSCOPY, V14, P580, DOI 10.1016/S0749-8063(98)70053-2; Piontek Tomasz, 2008, Chir Narzadow Ruchu Ortop Pol, V73, P289; Schenck R, 2003, OPER TECHN SPORT MED, V11, P193, DOI 10.1053/otsm.2003.35918; Strobel MJ, 2006, ARTHROSCOPY, V22, P182, DOI 10.1016/j.arthro.2005.11.001; Wascher DC, 2003, OPER TECHN SPORT MED, V11, P235, DOI 10.1053/otsm.2003.35908; Weiss NG, 2003, OPER TECHN SPORT MED, V11, P218, DOI 10.1053/otsm.2003.35921; Zhao JZ, 2006, ARTHROSCOPY, V22, P497, DOI 10.1016/j.arthro.2005.12.031	24	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82462	10.1371/journal.pone.0082462	http://dx.doi.org/10.1371/journal.pone.0082462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386099	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700008
J	Ros, C; Gullmar, D; Stenzel, M; Mentzel, HJ; Reichenbach, JR				Ros, Christian; Guellmar, Daniel; Stenzel, Martin; Mentzel, Hans-Joachim; Reichenbach, Juergen Rainer			Atlas-Guided Cluster Analysis of Large Tractography Datasets	PLOS ONE			English	Article							OPTIMIZED FIBER TRACKING; WHITE-MATTER; QUANTITATIVE-ANALYSIS; DTI TRACTOGRAPHY; BRAIN; SEGMENTATION; QUANTIFICATION; RECONSTRUCTION; PARCELLATION; PATHWAYS	Diffusion Tensor Imaging (DTI) and fiber tractography are important tools to map the cerebral white matter microstructure in vivo and to model the underlying axonal pathways in the brain with three-dimensional fiber tracts. As the fast and consistent extraction of anatomically correct fiber bundles for multiple datasets is still challenging, we present a novel atlas-guided clustering framework for exploratory data analysis of large tractography datasets. The framework uses an hierarchical cluster analysis approach that exploits the inherent redundancy in large datasets to time-efficiently group fiber tracts. Structural information of a white matter atlas can be incorporated into the clustering to achieve an anatomically correct and reproducible grouping of fiber tracts. This approach facilitates not only the identification of the bundles corresponding to the classes of the atlas; it also enables the extraction of bundles that are not present in the atlas. The new technique was applied to cluster datasets of 46 healthy subjects. Prospects of automatic and anatomically correct as well as reproducible clustering are explored. Reconstructed clusters were well separated and showed good correspondence to anatomical bundles. Using the atlas-guided cluster approach, we observed consistent results across subjects with high reproducibility. In order to investigate the outlier elimination performance of the clustering algorithm, scenarios with varying amounts of noise were simulated and clustered with three different outlier elimination strategies. By exploiting the multithreading capabilities of modern multiprocessor systems in combination with novel algorithms, our toolkit clusters large datasets in a couple of minutes. Experiments were conducted to investigate the achievable speedup and to demonstrate the high performance of the clustering framework in a multiprocessing environment.	[Ros, Christian; Guellmar, Daniel; Reichenbach, Juergen Rainer] Univ Jena, Jena Univ Hosp, Med Phys Grp, Inst Diagnost & Intervent Radiol 1, Jena, Germany; [Ros, Christian; Stenzel, Martin; Mentzel, Hans-Joachim] Univ Jena, Jena Univ Hosp, Inst Diagnost & Intervent Radiol 1, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Ros, C (corresponding author), Univ Jena, Jena Univ Hosp, Med Phys Grp, Inst Diagnost & Intervent Radiol 1, Jena, Germany.	mail@christian-ros.de	Reichenbach, Jürgen R./B-4333-2011; Guellmar, Daniel/AAG-1899-2020	Reichenbach, Jürgen R./0000-0002-2640-0630; Guellmar, Daniel/0000-0001-8693-8099	BMBF [01GW0740]; BMBF Bernstein Group for Computational Neuroscience [01GQ0703]	BMBF(Federal Ministry of Education & Research (BMBF)); BMBF Bernstein Group for Computational Neuroscience(Federal Ministry of Education & Research (BMBF))	This study was supported by the BMBF (Grant No.: 01GW0740) and the BMBF Bernstein Group for Computational Neuroscience (Grant No.: 01GQ0703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Attalla E, 2005, PATTERN RECOGN, V38, P2229, DOI 10.1016/j.patcog.2005.02.009; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Batchelor PG, 2006, MAGN RESON MED, V55, P894, DOI 10.1002/mrm.20858; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Breunig MM, 2000, SIGMOD REC, V29, P93, DOI 10.1145/335191.335388; Brun A, 2004, LECT NOTES COMPUT SC, V3216, P368; Chao TC, 2009, MAGN RESON IMAGING, V27, P681, DOI 10.1016/j.mri.2008.09.004; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Corouge I, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P344; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Ding ZH, 2003, MAGNET RESON MED, V49, P716, DOI 10.1002/mrm.10415; Drachman DA, 2005, NEUROLOGY, V64, P2004, DOI 10.1212/01.WNL.0000166914.38327.BB; DURSTENFELD R, 1964, COMMUN ACM, V7, P420, DOI 10.1145/364520.364540; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P16; Fisher R.A., 1948, STAT TABLES BIOL AGR; Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Guevara P, 2012, NEUROIMAGE, V61, P1083, DOI 10.1016/j.neuroimage.2012.02.071; Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028; Guha S, 2001, INFORM SYST, V26, P35, DOI 10.1016/S0306-4379(01)00008-4; Gullmar D, 2008, P INT SOC MAG RESON, V16; Heid O, 2000, P INT SOC MAG RESON, V8; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Karlsson Bjorn, 2005, C STANDARD LIB INTRO; Karypis G, 1999, COMPUTER, V32, P68, DOI 10.1109/2.781637; Lanyon LJ., 2012, NEUROIMAGING METHODS, V1, P137; Lazar M, 2005, NEUROIMAGE, V24, P524, DOI 10.1016/j.neuroimage.2004.08.050; LEBIHAN D, 1985, CR ACAD SCI II, V301, P1109; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017; Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003; Mentzel HJ, 2011, MONATSSCHR KINDERH, V159, P325, DOI 10.1007/s00112-010-2319-9; Moberts B, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P65; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; O'Donnell LJ, 2006, AM J NEURORADIOL, V27, P1032; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2007, LECT NOTES COMPUT SC, V4792, P161; O'Donnell LJ, 2013, NEUROIMAGE, V80, P283, DOI 10.1016/j.neuroimage.2013.04.066; Owens JD, 2008, P IEEE, V96, P879, DOI 10.1109/JPROC.2008.917757; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Ros C, 2012, BIOMED ENG-BIOMED TE, V57, P530, DOI 10.1515/bmt-2012-4458; Ros C, 2011, P INT SOC MAG RESON, V19; Ros C, 2012, P INT SOC MAG RESON, V20; Ros C, 2010, P INT SOC MAG RESON, V18; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stadlbauer A, 2007, NEUROIMAGE, V34, P949, DOI 10.1016/j.neuroimage.2006.08.051; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Visser E, 2011, NEUROIMAGE, V54, P303, DOI 10.1016/j.neuroimage.2010.07.038; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang Q, 2013, HUM BRAIN MAPP, V34, P2089, DOI 10.1002/hbm.22051; Wang R., 2007, P INT SOC MAGNETIC R; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wassermann D, 2010, NEUROIMAGE, V51, P228, DOI 10.1016/j.neuroimage.2010.01.004; Wu X, 2012, MAGN RESON IMAGING, V30, P485, DOI 10.1016/j.mri.2011.12.017; Xu R, 2008, CLUSTERING; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang S, 2008, IEEE T VIS COMPUT GR, V14, P1044, DOI 10.1109/TVCG.2008.52; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	67	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83847	10.1371/journal.pone.0083847	http://dx.doi.org/10.1371/journal.pone.0083847			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386292	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700074
J	Xue, LQ; Pan, CM; Gu, ZH; Zhao, SX; Han, B; Liu, W; Yang, SY; Yu, SS; Sun, YX; Liang, J; Gao, GQ; Zhang, XM; Yuan, GY; Li, CG; Du, WH; Chen, G; Chen, JL; Song, HD				Xue, Liqiong; Pan, Chunming; Gu, Zhaohui; Zhao, Shuangxia; Han, Bing; Liu, Wei; Yang, Shaoying; Yu, Shasha; Sun, Yixuan; Liang, Jun; Gao, Guanqi; Zhang, Xiaomei; Yuan, Guoyue; Li, Changgui; Du, Wenhua; Chen, Gang; Chen, Jialun; Song, Huaidong			Genetic Heterogeneity of Susceptibility Gene in Different Ethnic Populations: Refining Association Study of PTPN22 for Graves' Disease in a Chinese Han Population	PLOS ONE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; AUTOIMMUNE THYROID-DISEASE; SINGLE-NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; JAPANESE POPULATION; IDENTIFIES 2; SNPS; RECEPTOR; HAPLOTYPES	In our previous studies, we presumed subtypes of Graves' disease (GD) may be caused by different major susceptibility genes or different variants of a single susceptibility gene. However, more evidence is needed to support this hypothesis. Single-nucleotide polymorphism (SNP) rs2476601 in PTPN22 is the susceptibility loci of GD in the European population. However, this polymorphism has not been found in Asian populations. Here, we investigate whether PTPN22 is the susceptibility gene for GD in Chinese population and further determine the susceptibility variant of PTPN22 in GD. We conducted an imputation analysis based on the results of our genome-wide association study (GWAS) in 1,536 GD patients and 1,516 control subjects. Imputation revealed that 255 common SNPs on a linkage disequilibrium (LD) block containing PTPN22 were associated with GD (P<0.05). Nine tagSNPs that captured the 255 common variants were selected to be further genotyped in a large cohort including 4,368 GD patients and 4,350 matched controls. There was no significant difference between the nine tagSNPs (P>0.05) in either the genotype distribution or allelic frequencies between patients and controls in the replication study. Although the combined analysis exhibited a weak association signal (P-combined = 0.003263 for rs3811021), the false positive report probability (FPRP) analysis indicated it was most likely a false positive finding. Our study did not support an association of common SNPs in PTPN22 LD block with GD in Chinese Han population. This suggests that GD in different ethnic population is probably caused by distinct susceptibility genes.	[Xue, Liqiong; Pan, Chunming; Gu, Zhaohui; Zhao, Shuangxia; Liu, Wei; Yang, Shaoying; Yu, Shasha; Song, Huaidong] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Sch Med, Shanghai 200030, Peoples R China; [Gu, Zhaohui] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Zhao, Shuangxia; Chen, Jialun; Song, Huaidong] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrinol & Metab, Sch Med, Shanghai 200030, Peoples R China; [Han, Bing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Endocrinol, Sch Med, Shanghai 200030, Peoples R China; [Sun, Yixuan] Tongji Univ, Sch Med, East Hosp, Dept Geriatr Med, Shanghai 200092, Peoples R China; [Liang, Jun] Xuzhou Med Coll, Cent Hosp Xuzhou, Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China; [Gao, Guanqi; Du, Wenhua] Linyi Peoples Hosp, Dept Endocrinol, Linyi, Shandong, Peoples R China; [Zhang, Xiaomei] Bengbu Med Coll, Hosp 1, Dept Endocrinol, Bengbu, Anhui, Peoples R China; [Yuan, Guoyue] Jiangsu Univ, Dept Endocrinol, Zhenjiang, Jiangsu, Peoples R China; [Li, Changgui] Qingdao Univ, Med Sch Hosp, Dept Endocrinol, Qingdao 266071, Shandong, Peoples R China; [Li, Changgui] Qingdao Univ, Med Sch Hosp, Gout Lab, Qingdao 266071, Shandong, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Fujian Province, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; Xuzhou Medical University; Bengbu Medical College; Jiangsu University; Qingdao University; Qingdao University; Fujian Provincial Hospital	Song, HD (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Sch Med, Shanghai 200030, Peoples R China.	huaidong_s1966@163.com	Gu, Zhaohui/L-8586-2015		National Natural Science Foundation of China [81200568, 30971595, 81101444, 81270864, 81100553, 81270863, 81370965, 81370888]; Shanghai Science and Technology Committee [10JC1410400]; Program for Graves' Disease Innovative Research Team of Shanghai Municipal Education Commission; SJTU School of Medicine [BK2009208, BXG201208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Program for Graves' Disease Innovative Research Team of Shanghai Municipal Education Commission; SJTU School of Medicine	This work was supported in part by the National Natural Science Foundation of China [81200568, 30971595, 81101444, 81270864, 81100553, 81270863, 81370965, 81370888], Shanghai Science and Technology Committee [10JC1410400], Program for Graves' Disease Innovative Research Team of Shanghai Municipal Education Commission. Innovation Fund of SJTU School of Medicine (BK2009208) (BXG201208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ban Y, 2005, THYROID, V15, P1115, DOI 10.1089/thy.2005.15.1115; Ban Y, 2010, THYROID, V20, P893, DOI 10.1089/thy.2010.0104; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Brix TH, 1998, THYROID, V8, P727, DOI 10.1089/thy.1998.8.727; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Chen X, 2000, CHIN J ENDOCRINOL ME, V18; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Gu LQ, 2010, CLIN ENDOCRINOL, V72, P248, DOI 10.1111/j.1365-2265.2009.03617.x; Heward JM, 2007, J CLIN ENDOCR METAB, V92, P685, DOI 10.1210/jc.2006-2064; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu Z, 2013, NAT GENET; Huang MJ, 1999, CLIN ENDOCRINOL, V50, P503, DOI 10.1046/j.1365-2265.1999.00686.x; Ichimura M, 2008, THYROID, V18, P625, DOI 10.1089/thy.2007.0353; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jurecka-Lubieniecka B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059349; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee HS, 2011, DIABETES-METAB RES, V27, P878, DOI 10.1002/dmrr.1265; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Owen CJ, 2007, J CLIN ENDOCR METAB, V92, P1106, DOI 10.1210/jc.2006-2183; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2013, NAT GENET, V45, P918, DOI 10.1038/ng.2687; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Skorka A, 2005, CLIN ENDOCRINOL, V62, P679, DOI 10.1111/j.1365-2265.2005.02279.x; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Song HD, 2009, HUM MOL GENET, V18, P1156, DOI 10.1093/hmg/ddn442; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; Zhao SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009821; Zhao SX, 2013, HUM MOL GENET; Zhebrun D, 2011, AGING-US, V3, P368, DOI 10.18632/aging.100305	43	13	13	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84514	10.1371/journal.pone.0084514	http://dx.doi.org/10.1371/journal.pone.0084514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386393	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700110
J	Deng, C; He, XM; Hsueh, AJW				Deng, Cheng; He, Ximiao; Hsueh, Aaron J. W.			A Single-Nucleotide Polymorphism of Human Neuropeptide S Gene Originated from Europe Shows Decreased Bioactivity	PLOS ONE			English	Article							INHIBITS FOOD-INTAKE; HUMAN GENOME; RAT-BRAIN; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; RECEPTOR ACTIVATION; EXPRESSING NEURONS; COCAINE-SEEKING; MICE; POPULATION	Using accumulating SNP (Single-Nucleotide Polymorphism) data, we performed a genome-wide search for polypeptide hormone ligands showing changes in the mature regions to elucidate genotype/phenotype diversity among various human populations. Neuropeptide S (NPS), a brain peptide hormone highly conserved in vertebrates, has diverse physiological effects on anxiety, fear, hyperactivity, food intake, and sleeping time through its cognate receptor-NPSR. Here, we report a SNP rs4751440 (L-6-NPS) causing non-synonymous substitution on the 6th position (V to L) of the NPS mature peptide region. L-6-NPS has a higher allele frequency in Europeans than other populations and probably originated from European ancestors similar to 25,000 yrs ago based on haplotype analysis and Approximate Bayesian Computation. Functional analyses indicate that L-6-NPS exhibits a significant lower bioactivity than the wild type NPS, with similar to 20-fold higher EC50 values in the stimulation of NPSR. Additional evolutionary and mutagenesis studies further demonstrate the importance of the valine residue in the 6th position for NPS functions. Given the known physiological roles of NPS receptor in inflammatory bowel diseases, asthma pathogenesis, macrophage immune responses, and brain functions, our study provides the basis to elucidate NPS evolution and signaling diversity among human populations.	[Deng, Cheng; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Ob Gyn, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA; [He, Ximiao] NCI, NIH, Bethesda, MD 20892 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Deng, C (corresponding author), Stanford Univ, Sch Med, Dept Ob Gyn, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA.	cdeng@stanford.edu; aaron.hsueh@stanford.edu	He, Ximiao/C-1292-2010; He, Ximiao/AFM-6566-2022	He, Ximiao/0000-0003-1253-5275; He, Ximiao/0000-0003-1253-5275; deng, cheng/0000-0002-5296-8879				Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; [Anonymous], 2003, NATURE, V426, P789; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Beaumont MA, 2002, GENETICS, V162, P2025; Ben-Shlomo I, 2007, MOL ENDOCRINOL, V21, P2009, DOI 10.1210/me.2007-0087; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Beste C, 2013, NEUROIMAGE, V71, P1, DOI 10.1016/j.neuroimage.2013.01.004; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Camarda V, 2013, PEPTIDES, V48, P27, DOI 10.1016/j.peptides.2013.07.018; Camarda V, 2009, J PHARMACOL EXP THER, V328, P549, DOI 10.1124/jpet.108.143867; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; Cannella N, 2013, PROG NEUROBIOL, V100, P48, DOI 10.1016/j.pneurobio.2012.09.005; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Cifani C, 2011, PEPTIDES, V32, P44, DOI 10.1016/j.peptides.2010.10.018; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060219; Enquist J, 2012, NEUROPSYCHOPHARMACOL, V37, P2436, DOI 10.1038/npp.2012.102; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Filaferro M, 2013, PEPTIDES, V39, P16, DOI 10.1016/j.peptides.2012.10.013; Ghazal P, 2013, PEPTIDES, V46, P6, DOI 10.1016/j.peptides.2013.05.001; Glotzbach-Schoon E, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00031; Gonzalez CR, 2012, BRAIN RES, V1450, P40, DOI 10.1016/j.brainres.2012.02.024; Guerrini R, 2009, J MED CHEM, V52, P524, DOI 10.1021/jm8012294; Han RW, 2013, NEUROPHARMACOLOGY, V70, P261, DOI 10.1016/j.neuropharm.2013.02.002; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Jungling K, 2012, J PHYSIOL-LONDON, V590, P3701, DOI 10.1113/jphysiol.2011.226423; Kallupi M, 2013, PSYCHOPHARMACOLOGY, V226, P347, DOI 10.1007/s00213-012-2910-y; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; KIMURA M, 1973, GENETICS, V75, P199; Klein RG, 2009, P NATL ACAD SCI USA, V106, P16007, DOI 10.1073/pnas.0908719106; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kumsta R, 2013, BIOL PSYCHOL, V93, P304, DOI 10.1016/j.biopsycho.2013.02.018; Lappalainen J, 2002, ARCH GEN PSYCHIAT, V59, P825, DOI 10.1001/archpsyc.59.9.825; Lennertz L, 2013, INT J NEUROPSYCHOPH, V16, P1951, DOI 10.1017/S1461145713000382; Leonard SK, 2008, PSYCHOPHARMACOLOGY, V197, P601, DOI 10.1007/s00213-008-1080-4; Liu XB, 2011, J COMP NEUROL, V519, P1847, DOI 10.1002/cne.22603; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; Niimi M, 2006, ENDOCRINE, V30, P75, DOI 10.1385/ENDO:30:1:75; Okamura N, 2008, J PHARMACOL EXP THER, V325, P893, DOI 10.1124/jpet.107.135103; Okamura N, 2007, STRESS, V10, P221, DOI 10.1080/10253890701248673; Peng YL, 2010, PEPTIDES, V31, P2259, DOI 10.1016/j.peptides.2010.08.015; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulga A, 2012, EUR J NEUROSCI, V36, P3531, DOI 10.1111/j.1460-9568.2012.08265.x; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Ren W, 2013, J NEUROPHYSIOL; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; Roth AL, 2006, J BIOL CHEM, V281, P20809, DOI 10.1074/jbc.M601846200; Ruzza C, 2012, PEPTIDES, V34, P404, DOI 10.1016/j.peptides.2012.01.024; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmoutz CD, 2012, PHARMACOL BIOCHEM BE, V103, P332, DOI 10.1016/j.pbb.2012.09.003; Shao YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062089; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Smith KL, 2006, ENDOCRINOLOGY, V147, P3510, DOI 10.1210/en.2005-1280; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorsell A, 2013, J NEUROSCI, V33, P10132, DOI 10.1523/JNEUROSCI.4742-12.2013; Todisco A, 1997, AM J PHYSIOL-GASTR L, V273, pG891, DOI 10.1152/ajpgi.1997.273.4.G891; Wang CJ, 2009, BIOSENS BIOELECTRON, V24, P2298, DOI 10.1016/j.bios.2008.11.023; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zhao P, 2012, NEUROSCIENCE, V207, P218, DOI 10.1016/j.neuroscience.2012.01.022	72	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83009	10.1371/journal.pone.0083009	http://dx.doi.org/10.1371/journal.pone.0083009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386135	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900017
J	Hwang, CF; Shiu, LY; Su, LJ; Yin, YF; Wang, WS; Huang, SC; Chiu, TJ; Huang, CC; Zhen, YY; Tsai, HT; Fang, FM; Huang, TL; Chen, CH				Hwang, Chung-Feng; Shiu, Li-Yen; Su, Li-Jen; Yin, Yu-Fang; Wang, Wei-Sheng; Huang, Shun-Chen; Chiu, Tai-Jan; Huang, Chao-Cheng; Zhen, Yen-Yi; Tsai, Hsin-Ting; Fang, Fu-Min; Huang, Tai-Lin; Chen, Chang-Han			Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; TUMOR PROGRESSION; IN-VIVO; INVASION; EXPRESSION; CANCER; PROLIFERATION; MIGRATION; GROWTH; OVEREXPRESSION	Background: Nasopharyngeal carcinoma (NPC) is known for its high metastatic potential and locoregional recurrence, although the molecular alterations that are driving NPC metastasis remain unclear at this time. This study aimed to examine the expression of fibulin-5 in NPC, correlate the results with clinicopathological variables and survival, and to investigate the role of fibulin-5 in human NPC cell lines. Material and Methods: Standard semi-quantitative-RT-PCR, quantitative-RT-PCR, immunoblotting, and immunohistochemistry were used to investigate the mRNA and protein expression profiles of fibulin-5 in normal and NPC tissues. Immunohistochemistry of fibulin-5 was correlated with clinicopathological characteristics by univariate analyses. NPC cells overexpressing fibulin-5 or fibulin-5-siRNA cells were generated by stable transfection to characterize the molecular mechanisms of fibulin-5-elicited cell growth and metastasis. Results: Our results demonstrated that fibulin-5 overexpression in NPC specimens and significantly correlated with advanced tumor metastasis indicating a poor 5-year overall survival. Fibulin-5 was mainly expressed in the nucleus in human NPC specimens and cell lines. Functionally, fibulin-5 overexpression yielded fast growth in NPC cells. In addition, fibulin-5 promotes cell metastasis in NPC cells through increased FLJ10540 and phosphor-AKT activity. In contrast, siRNA depletion of fibulin-5 suppressed FLJ10540 expression and phosphor-AKT activity. Suppression of either fibulin-5 or FLJ10540 can cause significant inhibition with regards to cell motility in NPC cells. Finally, immunohistochemical analysis of human aggressive NPC specimens showed a significant and positive correlation between fibulin-5 and FLJ10540 expression. Conclusion: Higher fibulin-5 expression is not only an important indicator of poor survival, but also contributes to the development of new therapeutic strategies in the FLJ10540/AKT pathway for NPC treatment.	[Hwang, Chung-Feng; Yin, Yu-Fang; Wang, Wei-Sheng; Tsai, Hsin-Ting; Chen, Chang-Han] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Hwang, Chung-Feng; Yin, Yu-Fang; Wang, Wei-Sheng; Huang, Chao-Cheng; Tsai, Hsin-Ting; Fang, Fu-Min; Chen, Chang-Han] Kaohsiung Chang Gung Mem Hosp, Kaohsiung Chang Gung Head & Neck Oncol Grp, Kaohsiung, Taiwan; [Shiu, Li-Yen] Show Chwan Mem Hosp, Dept Med Res & Dev, Changhua, Taiwan; [Shiu, Li-Yen] Chang Bing Show Chwan Mem Hosp, Changhua, Taiwan; [Su, Li-Jen] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Huang, Shun-Chen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chiu, Tai-Jan; Huang, Tai-Lin] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan; [Zhen, Yen-Yi] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Zhen, Yen-Yi] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Fang, Fu-Min] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Chen, Chang-Han] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Show Chwan Memorial Hospital; Chang Bing Show Chwan Memorial Hospital; National Central University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan.	chench7@gmail.com	Hwang, Chung-Feng/ABC-1138-2021		NSC [98-2314-B-182A-046-MY3 (NMRPG886051-3), 101-2314-B-182A-138 (NMRPG8B0214), 102-2314-B-182A-115 (NMRPG8C0271), 100-2320-B-182A-001 (NMRPG8A0011), 102-2320-B-182A-010 (NMRPG8C0141)];  [CMRPG890461-2];  [CMRPG8A0871];  [CMRPG8A0391-2];  [CMRPG890921];  [CMRPG8B1251]	NSC(Ministry of Science and Technology, Taiwan); ; ; ; ; 	This study was funded by grants obtained by Dr. Chung-Feng Hwang (CMRPG890461-2, CMRPG8A0871, NSC 98-2314-B-182A-046-MY3 (NMRPG886051-3), NSC 101-2314-B-182A-138 (NMRPG8B0214), and NSC 102-2314-B-182A-115 (NMRPG8C0271)), and by Dr. Chang-Han Chen (CMRPG8A0391-2, CMRPG890921, CMRPG8B1251, NSC 100-2320-B-182A-001 (NMRPG8A0011), and NSC 102-2320-B-182A-010 (NMRPG8C0141)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig Allan R, 2005, Future Oncol, V1, P23, DOI 10.1517/14796694.1.1.23; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Bhattacharya N, 2010, INT J CANCER, V127, P404, DOI 10.1002/ijc.25054; Chen CH, 2008, BRIT J CANCER, V99, P1453, DOI 10.1038/sj.bjc.6604698; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen CH, 2013, AM J PATHOL, V182, P516, DOI 10.1016/j.ajpath.2012.10.023; Chen CH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-93; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fang FM, 2001, INT J RADIAT ONCOL, V50, P961, DOI 10.1016/S0360-3016(01)01531-0; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Hu Z, 2011, UROL ONCOL-SEMIN ORI, V29, P430, DOI 10.1016/j.urolonc.2009.06.004; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Kasahara M, 2000, CLIN CANCER RES, V6, P2707; Lai JM, 2010, METHODS MOL BIOL, V623, P231, DOI 10.1007/978-1-60761-588-0_15; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; LIN CT, 1990, LAB INVEST, V62, P713; Ma BBY, 2008, CANCER SCI, V99, P1311, DOI 10.1111/j.1349-7006.2008.00836.x; Makitie AA, 2003, CLIN CANCER RES, V9, P2177; Moller HD, 2011, MOL CANCER RES, V9, P553, DOI 10.1158/1541-7786.MCR-11-0093; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Sakai M, 2006, ONCOGENE, V25, P480, DOI 10.1038/sj.onc.1209051; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yang HJ, 2001, HEAD NECK-J SCI SPEC, V23, P629, DOI 10.1002/hed.1089; Yoshizaki T, 2012, AURIS NASUS LARYNX, V39, P137, DOI 10.1016/j.anl.2011.02.012; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zhang WL, 2009, ACTA BIOCH BIOPH SIN, V41, P414, DOI 10.1093/abbs/gmp025; Zhou XF, 2007, COMP FUNCT GENOM, DOI 10.1155/2007/57513	39	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84218	10.1371/journal.pone.0084218	http://dx.doi.org/10.1371/journal.pone.0084218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386352	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900085
J	Kainerstorfer, JM; Polizzotto, MN; Uldrick, TS; Rahman, R; Hassan, M; Najafizadeh, L; Ardeshirpour, Y; Wyvill, KM; Aleman, K; Smith, PD; Yarchoan, R; Gandjbakhche, AH				Kainerstorfer, Jana M.; Polizzotto, Mark N.; Uldrick, Thomas S.; Rahman, Rafa; Hassan, Moinuddin; Najafizadeh, Laleh; Ardeshirpour, Yasaman; Wyvill, Kathleen M.; Aleman, Karen; Smith, Paul D.; Yarchoan, Robert; Gandjbakhche, Amir H.			Evaluation of Non-Invasive Multispectral Imaging as a Tool for Measuring the Effect of Systemic Therapy in Kaposi Sarcoma	PLOS ONE			English	Article							INDEPENDENT-COMPONENT ANALYSIS; GROWTH-FACTOR; AIDS; RECOGNITION; HERPESVIRUS; MODEL; PCA; HIV	Diffuse multi-spectral imaging has been evaluated as a potential non-invasive marker of tumor response. Multi-spectral images of Kaposi sarcoma skin lesions were taken over the course of treatment, and blood volume and oxygenation concentration maps were obtained through principal component analysis (PCA) of the data. These images were compared with clinical and pathological responses determined by conventional means. We demonstrate that cutaneous lesions have increased blood volume concentration and that changes in this parameter are a reliable indicator of treatment efficacy, differentiating responders and non-responders. Blood volume decreased by at least 20% in all lesions that responded by clinical criteria and increased in the two lesions that did not respond clinically. Responses as assessed by multi-spectral imaging also generally correlated with overall patient clinical response assessment, were often detectable earlier in the course of therapy, and are less subject to observer variability than conventional clinical assessment. Tissue oxygenation was more variable, with lesions often showing decreased oxygenation in the center surrounded by a zone of increased oxygenation. This technique could potentially be a clinically useful supplement to existing response assessment in KS, providing an early, quantitative, and non-invasive marker of treatment effect.	[Kainerstorfer, Jana M.; Rahman, Rafa; Hassan, Moinuddin; Najafizadeh, Laleh; Ardeshirpour, Yasaman; Gandjbakhche, Amir H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Analyt & Funct Biophoton, NIH, Bethesda, MD USA; [Polizzotto, Mark N.; Uldrick, Thomas S.; Wyvill, Kathleen M.; Aleman, Karen; Yarchoan, Robert] NCI, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA; [Smith, Paul D.] Natl Inst Biomed Imaging & Bioengn, Biomed Instrumentat & Multiscale Imaging Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Gandjbakhche, AH (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Analyt & Funct Biophoton, NIH, Bethesda, MD USA.	amir@helix.nih.gov		Polizzotto, Mark/0000-0002-6446-183X; Rahman, Rafa/0000-0002-3291-1621	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; NCI, National Institutes of Health [HHSN26120080001E]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008882, ZIAHD000261] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011500] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was funded by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Biomedical Imaging and Bioengineering, and the National Cancer Institute. Additional funding provided by the NCI, National Institutes of Health under Contract No. HHSN26120080001E. Bevacizumab was provided to the NCI through a Cooperative Research and Development Agreements with Genentech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto H, 2007, SKIN RES TECHNOL, V13, P49, DOI 10.1111/j.1600-0846.2006.00188.x; Attas M, 2001, SKIN RES TECHNOL, V7, P238, DOI 10.1034/j.1600-0846.2001.70406.x; Bubman D, 2003, HEMATOL ONCOL CLIN N, V17, P717, DOI 10.1016/S0889-8588(03)00044-3; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Demos SG, 1997, APPL OPTICS, V36, P150, DOI 10.1364/AO.36.000150; Du Q, 2008, INT J HIGH PERFORM C, V22, P438, DOI 10.1177/1094342007088380; ENSOLI B, 1994, J CLIN INVEST, V94, P1736, DOI 10.1172/JCI117521; Fadzil M. H. Ahmad, 2009, Journal of Medical Engineering & Technology, V33, P101, DOI 10.1080/03091900802454459; Ferraz A, 1998, WORLD J MICROB BIOT, V14, P487, DOI 10.1023/A:1008875730177; Gasperini P, 2008, J LEUKOCYTE BIOL, V84, P994; Hassan M, 2004, TECHNOL CANCER RES T, V3, P451, DOI 10.1177/153303460400300506; Jacques SL, 2002, J BIOMED OPT, V7, P329, DOI 10.1117/1.1484498; Kainerstorfer JM, 2011, BIOMED OPT EXPRESS, V2, P1040, DOI 10.1364/BOE.2.001040; Kainerstorfer JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470094; Kainerstorfer JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463010; Kainerstorfer JM, 2009, QUANTITATIVE ASSESSM; Krown SE, 2003, HEMATOL ONCOL CLIN N, V17, P763, DOI 10.1016/S0889-8588(03)00042-X; Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085; Mantis G, 2009, APPL OPTICS, V48, P3490, DOI 10.1364/AO.48.003490; Masood R, 1997, P NATL ACAD SCI USA, V94, P979, DOI 10.1073/pnas.94.3.979; Miyamae Y, 2008, APPL SPECTROSC, V62, P677, DOI 10.1366/000370208784658156; Moon H, 2001, PERCEPTION, V30, P303, DOI 10.1068/p2896; NUGROHO H, 2007, C P IEEE ENG MED BIO, P3442; Sakakibara S, 2011, J INTERF CYTOK RES, V31, P791, DOI 10.1089/jir.2011.0043; Shiels MS, 2011, JAMA-J AM MED ASSOC, V305, P1450, DOI 10.1001/jama.2011.396; Tseng SH, 2009, OPT EXPRESS, V17, P14599, DOI 10.1364/OE.17.014599; Tsumura N, 1999, J OPT SOC AM A, V16, P2169, DOI 10.1364/JOSAA.16.002169; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Uldrick TS, 2012, J CLIN ONCOL, V30, P1476, DOI 10.1200/JCO.2011.39.6853; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798; Uldrick TS, 2010, HIV ASS MALIGNANCIES; Vogel A, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2801718; Zakian C, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982536	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83887	10.1371/journal.pone.0083887	http://dx.doi.org/10.1371/journal.pone.0083887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386302	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900066
J	Li, HY; Li, Y; Liu, D; Sun, HZ; Su, DM; Yang, FQ; Liu, JG				Li, Hangyu; Li, Yan; Liu, Dan; Sun, Hongzhi; Su, Dongming; Yang, Fuquan; Liu, Jingang			Extracellular HSP70/HSP70-PCs Promote EpithelialMesenchymal Transition of Hepatocarcinoma Cells	PLOS ONE			English	Article							METASTASIS; PROTEINS; CANCER; HSP70	Background: Extracellular heat shock protein 70 and peptide complexes (eHSP70/HSP70-PCs) regulate a variety of biological behaviors in tumor cells. Whether eHSP70/HSP70-PCs are involved in the epithelial-mesenchymal transition (EMT) of tumor cells remains unclear. Aims: To determine the effects of eHSP70/HSP70-PCs on EMT of hepatocarcinoma cells. Methods: The expressions of E-cadherin, HSP70, alpha-smooth muscle actin protein (alpha-SMA) and p-p38 were detected immunohistochemically in liver cancer samples. Immunofluorescence, western blotting and real-time RT-PCR methods were used to analyze the effects of eHSP70/HSP70-PCs on the expressions of E-cadherin, alpha-SMA and p38/MAPK in vivo. Results: HSP70, E-cadherin, alpha-SMA and p-p38 were elevated in hepatocellular carcinoma tissues. The expression of HSP70 was positively correlated with malignant differentiated liver carcinoma. The expressions of HSP70, alpha-SMA and p-p38 correlated with recurrence-free survival after resection. eHSP70/HSP70-PCs significantly promoted the expressions of alpha-SMA and p-p38 and reduced the expressions of E-cadherin in vivo. The effect was inhibited by SB203580. Conclusion: The expressions of HSP70, E-cadherin, alpha-SMA and p-p38 may represent indicators of malignant potential and could discriminate the malignant degree of liver cancer. eHSP70/HSP70-PCs play an important role in the EMT of hepatocellular carcinoma via the p38/MAPK pathway.	[Li, Hangyu; Li, Yan; Liu, Dan; Yang, Fuquan; Liu, Jingang] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China; [Sun, Hongzhi] Liaoning Med Coll, Hosp 1, Dept Gen Surg, Jinzhou, Peoples R China; [Su, Dongming] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Jiangsu, Peoples R China	China Medical University; Jinzhou Medical University; Nanjing Medical University	Liu, JG (corresponding author), China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China.	liujg51347@hotmail.com		Li, Hangyu/0000-0002-2570-1642	National Natural Science Foundation of China [81071955]; Scientific Research from Educational Department of Liaoning Province, China [L2010634]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research from Educational Department of Liaoning Province, China	This work was supported by the National Natural Science Foundation of China (No. 81071955) and the Scientific Research from Educational Department of Liaoning Province, China (No. L2010634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Gao Q, 2012, CANCER RES, V72, P3546, DOI 10.1158/0008-5472.CAN-11-4032; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Gos Monika, 2009, Postepy Biochem, V55, P121; Hu QD, 2012, CANCER LETT, V325, P207, DOI 10.1016/j.canlet.2012.07.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li H, 2007, DIGEST LIVER DIS, V39, P663, DOI 10.1016/j.dld.2007.03.011; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; Nakagawa Hayato, 2012, Patholog Res Int, V2012, P172894, DOI 10.1155/2012/172894; Oyanagi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053209; Rerole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16; Salamatu S, 2006, J IMMUNOL, V2006, P7849; Schildkopf P, 2011, RADIOTHER ONCOL, V101, P109, DOI 10.1016/j.radonc.2011.05.056; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Sui C, 2006, WORLD CHINESE J DIGE, V14, P1775; Tanaka S, 2012, INT J CANCER, V131, P2537, DOI 10.1002/ijc.27575; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Wu FH, 2012, CANCER LETT, V317, P157, DOI 10.1016/j.canlet.2011.11.020	21	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84759	10.1371/journal.pone.0084759	http://dx.doi.org/10.1371/journal.pone.0084759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386414	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900110
J	Moncelet, D; Bouchaud, V; Mellet, P; Ribot, E; Miraux, S; Franconi, JM; Voisin, P				Moncelet, Damien; Bouchaud, Veronique; Mellet, Philippe; Ribot, Emeline; Miraux, Sylvain; Franconi, Jean-Michel; Voisin, Pierre			Cellular Density Effect on RGD Ligand Internalization in Glioblastoma for MRI Application	PLOS ONE			English	Article							INTEGRIN ALPHA(V)BETA(3); MALIGNANT GLIOMA; PLASMA-MEMBRANE; EXPRESSION; RECEPTOR; KINASE; ACTIN; NANOPARTICLES; MICROTUBULES; DELIVERY	Cellular density is a parameter measured for glioma grade and invasiveness diagnosis. The characterization of the cellular density can be performed, non invasively, by magnetic resonance imaging (MRI), since, this technique displays a good resolution. Nevertheless MRI sensitivity is critical. Development of smart contrast agents appears useful to increase MRI signal to noise ratio (SNR). Tumor invasiveness is correlated with high expression of integrins that can be targeted by RGD motif. In this study, MRI contrast agents or fluorescent probes linked to RGD-peptides were used, in a glioma model, to assess the relation between RGD uptake/signal improvement/cell density and consequently tumor invasiveness. Experiments were performed in vitro with U87-MG glioma cells. Flow cytometry and microscopy experiments with RGD and iRGD-alexa488 demonstrated that cell internalization was dependent on cell density. The internalization involved a clathrin-dependent endocytosis. Cytoskeleton and particularly the microtubules were concerned. Actin filaments played a minor role. The internalization was also dependent on the glycolysis and the oxidative phosphorylations. The cellular density modulated the importance of the endocytosis pathways and of the metabolism but not the cytoskeleton contribution. The internalization of the RGD-peptide associated to gadolinium chelate increased the SNR of U87 cells. Moreover, following the cell density augmentation, the SNR increased with a low amplitude but a trend was clearly determined. In conclusion, RGD-peptide internalization appeared, in vitro, as a marker of cellular density. In perspective, the combination of these peptides with contrast agents associated to more sensitive MRI techniques could improve the MRI signal allowing the characterization of cellular density for tumor diagnosis.	[Moncelet, Damien; Bouchaud, Veronique; Mellet, Philippe; Ribot, Emeline; Miraux, Sylvain; Franconi, Jean-Michel; Voisin, Pierre] Univ Bordeaux Segalen, CNRS, UMR 5536, CRMSB, Bordeaux, France; [Mellet, Philippe] Univ Bordeaux Segalen, INSERM, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Voisin, P (corresponding author), Univ Bordeaux Segalen, CNRS, UMR 5536, CRMSB, Bordeaux, France.	pierre.voisin@rmsb.u-bordeaux2.fr	Miraux, Sylvain/AAF-1023-2019	RIBOT, Emeline/0000-0002-3063-1263; Miraux, Sylvain/0000-0002-3642-2390; Mellet, Philippe/0000-0001-5499-9735	Bordeaux Segalen university; CNRS; Regional Aquitaine Council	Bordeaux Segalen university; CNRS(Centre National de la Recherche Scientifique (CNRS)); Regional Aquitaine Council(Region Nouvelle-Aquitaine)	Bordeaux Segalen university, CNRS, Regional Aquitaine Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Bai RY, 2011, TRENDS MOL MED, V17, P301, DOI 10.1016/j.molmed.2011.01.011; Barajas Jr RF, 2013, AJNR AM J NEURORADIO; Bohn LM, 2000, J NEUROCHEM, V74, P574, DOI 10.1046/j.1471-4159.2000.740574.x; Brat DJ, 2008, J NEURO-ONCOL, V89, P287, DOI 10.1007/s11060-008-9618-1; Burtea C, 2008, CARDIOVASC RES, V78, P148, DOI 10.1093/cvr/cvm115; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Gu GZ, 2013, BIOMATERIALS, V34, P5138, DOI 10.1016/j.biomaterials.2013.03.036; Jaiswal JK, 2009, CELL, V137, P1308, DOI 10.1016/j.cell.2009.04.064; Kinoshita M, 2012, J NUCL MED, V53, P1701, DOI 10.2967/jnumed.112.104992; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Martin M, 1998, J BIOENERG BIOMEMBR, V30, P565, DOI 10.1023/A:1020584517588; Merilahti P, 2012, ADV VIROL, V2012, DOI 10.1155/2012/547530; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Montet X, 2006, NEOPLASIA, V8, P214, DOI 10.1593/neo.05769; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Okita Y, 2010, NEUROIMAGE, V49, P2977, DOI 10.1016/j.neuroimage.2009.11.024; Pasdois P, 2003, J BIOENERG BIOMEMBR, V35, P439, DOI 10.1023/A:1027391831382; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Sancey L, 2009, MOL THER, V17, P837, DOI 10.1038/mt.2009.29; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Schnell O, 2008, BRAIN PATHOL, V18, P378, DOI 10.1111/j.1750-3639.2008.00137.x; Schnell O, 2009, NEURO-ONCOLOGY, V11, P861, DOI 10.1215/15228517-2009-024; Struewing IT, 2007, EXP CELL RES, V313, P3526, DOI 10.1016/j.yexcr.2007.07.012; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Sunada H, 1991, Growth Factors, V5, P45, DOI 10.3109/08977199109000270; Vandecandelaere A, 1997, BIOCHEM J, V323, P189, DOI 10.1042/bj3230189; Wang X, 2013, BIOMATERIALS, V34, P4667, DOI 10.1016/j.biomaterials.2013.03.008; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Ye YP, 2011, BIOORG MED CHEM LETT, V21, P1146, DOI 10.1016/j.bmcl.2010.12.112; Zhang CF, 2007, CANCER RES, V67, P1555, DOI 10.1158/0008-5472.CAN-06-1668; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zi Z, 2007, FEBS LETT, V581, P4589, DOI 10.1016/j.febslet.2007.08.047	42	17	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82777	10.1371/journal.pone.0082777	http://dx.doi.org/10.1371/journal.pone.0082777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386117	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900016
J	Sattayasai, J; Chaonapan, P; Arkaravichie, T; Soi-ampornkul, R; Junnu, S; Charoensilp, P; Samer, J; Jantaravinid, J; Masaratana, P; Suktitipat, B; Manissorn, J; Thongboonkerd, V; Neungton, N; Moongkarndi, P				Sattayasai, Jintana; Chaonapan, Pongsatorn; Arkaravichie, Tarinee; Soi-ampornkul, Rungtip; Junnu, Sarawut; Charoensilp, Patcharakajee; Samer, Jutima; Jantaravinid, Jiraporn; Masaratana, Patarabutr; Suktitipat, Bhoom; Manissorn, Juthatip; Thongboonkerd, Visith; Neungton, Neelobol; Moongkarndi, Primchanien			Protective Effects of Mangosteen Extract on H2O2-Induced Cytotoxicity in SK-N-SH Cells and Scopolamine-Induced Memory Impairment in Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE INHIBITORS; ANTIOXIDANT; TOXICITY; CLEAVAGE; PERICARP; BIOLOGY; AGE	Mangosteen extracts (ME) contain high levels of polyphenolic compounds and antioxidant activity. Protective effects of ME against beta-amyloid peptide (A beta), induced cytotoxicity have been reported. Here, we further studied the protective effects of ME against oxidative stress induced by hydrogen peroxide (H2O2) and polychlorinated biphenyls (PCBs), and demonstrated the protection against memory impairment in mice. The cytoprotective effects of ME were measured as cell viability and the reduction in ROS activity. In SK-N-SH cell cultures, 200 mu g/ml ME could partially antagonize the effects of 150 or 300 mu M H2O2 on cell viability, ROS level and caspase-3 activity. At 200, 400 or 800 mu g/ml, ME reduced AChE activity of SK-N-SH cells to about 60% of the control. In vivo study, Morris water maze and passive avoidance tests were used to assess the memory of the animals. ME, especially at 100 mg/kg body weight, could improve the animal's memory and also antagonize the effect of scopolamine on memory. The increase in ROS level and caspase-3 activity in the brain of scopolamine-treated mice were antagonized by the ME treatment. The study demonstrated cytoprotective effects of ME against H2O2 and PCB-52 toxicity and having AChE inhibitory effect in cell culture. ME treatment in mice could attenuate scopolamine-induced memory deficit and oxidative stress in brain.	[Sattayasai, Jintana; Chaonapan, Pongsatorn; Arkaravichie, Tarinee] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Soi-ampornkul, Rungtip; Junnu, Sarawut; Charoensilp, Patcharakajee; Jantaravinid, Jiraporn; Masaratana, Patarabutr; Suktitipat, Bhoom; Neungton, Neelobol] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Samer, Jutima; Moongkarndi, Primchanien] Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok 10700, Thailand; [Manissorn, Juthatip; Thongboonkerd, Visith] Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, Bangkok 10700, Thailand	Khon Kaen University; Mahidol University; Mahidol University; Mahidol University	Moongkarndi, P (corresponding author), Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok 10700, Thailand.	primchanien.moo@mahidol.ac.th	Thongboonkerd, Visith/C-6920-2009; Suktitipat, Bhoom/H-4239-2019	Thongboonkerd, Visith/0000-0001-7865-0765; Suktitipat, Bhoom/0000-0001-8034-7757; , Patarabutr/0000-0001-7228-7176	Graduate Research, Faculty of Medicine Siriraj Hospital; Mahidol University; Thai Traditional Medical Knowledge Fund; Ministry of Public Health, Thailand; Thailand Research Fund; Thai government	Graduate Research, Faculty of Medicine Siriraj Hospital; Mahidol University; Thai Traditional Medical Knowledge Fund; Ministry of Public Health, Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Thai government	This work was supported by Siriraj Grant for Graduate Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Thai Traditional Medical Knowledge Fund, Ministry of Public Health, Thailand, and the Thailand Research Fund. The grants belong to the Thai government support for scientific merit-study and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OME, 2013, EXCLI J, V12, P193; Ancelin ML, 2007, DEMENT GERIATR COGN, V24, P1, DOI 10.1159/000102567; [Anonymous], 2008, CMU J NATL SCI; BARTUS RT, 1985, PHARMACOL BIOCHEM BE, V23, P125, DOI 10.1016/0091-3057(85)90139-X; BECKER JT, 1988, ARCH NEUROL-CHICAGO, V45, P263, DOI 10.1001/archneur.1988.00520270037018; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chantarasriwong O, 2010, CHEM-EUR J, V16, P9944, DOI 10.1002/chem.201000741; Chivapat S, 2011, THAI J VET MED, V41, P45; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Deiana S, 2009, PSYCHOPHARMACOLOGY, V202, P53, DOI 10.1007/s00213-008-1394-2; Driver AS, 2000, NEUROTOXICOL TERATOL, V22, P175, DOI 10.1016/S0892-0362(99)00069-0; Fischbein A, 1979, Ann N Y Acad Sci, V320, P703, DOI 10.1111/j.1749-6632.1979.tb13188.x; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Giridharan VV, 2011, FOOD FUNCT, V2, P320, DOI 10.1039/c1fo10037h; Goverdhan Puchchakayala, 2012, Int J Alzheimers Dis, V2012, P974013, DOI 10.1155/2012/974013; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hatip-Al-Khatib I, 2005, BRIT J PHARMACOL, V145, P1035, DOI 10.1038/sj.bjp.0706288; Hutadilok-Towatana N, 2010, J MED PLANTS RES, V4, P969; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Jung HA, 2006, J AGR FOOD CHEM, V54, P2077, DOI 10.1021/jf052649z; Kim DH, 2010, ARCH PHARM RES, V33, P1685, DOI 10.1007/s12272-010-1019-2; Kosem N, 2013, J NAT MED-TOKYO, V67, P255, DOI 10.1007/s11418-012-0673-8; Kosem Nuttavut, 2007, ScienceAsia, V33, P283, DOI 10.2306/scienceasia1513-1874.2007.33.283; Marquez-Valadez B, 2009, NUTR NEUROSCI, V12, P35, DOI 10.1179/147683009X388850; MOLCHAN SE, 1992, BRAIN RES REV, V17, P215, DOI 10.1016/0165-0173(92)90017-G; Moongkarndi P, 2010, J PROTEOME RES, V9, P2076, DOI 10.1021/pr100049v; Mukherjee PK, 2007, PHYTOMEDICINE, V14, P289, DOI 10.1016/j.phymed.2007.02.002; Ngawhirunpat T, 2010, PHARM BIOL, V48, P55, DOI 10.3109/13880200903046138; Onoue S, 2002, PEPTIDES, V23, P1471, DOI 10.1016/S0196-9781(02)00085-2; Pachauri SD, 2012, J ETHNOPHARMACOL, V139, P34, DOI 10.1016/j.jep.2011.09.057; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; RUSTED JM, 1988, PSYCHOPHARMACOLOGY, V96, P145; Sanchez-Perez Y, 2010, CHEM-BIOL INTERACT, V188, P144, DOI 10.1016/j.cbi.2010.06.014; Sekler Alejandra, 2008, Neuropsychiatr Dis Treat, V4, P715; Tabet N, 2006, AGE AGEING, V35, P336, DOI 10.1093/ageing/afl027; Vassar R, 2007, NEURON, V54, P671, DOI 10.1016/j.neuron.2007.05.018; WESNES K, 1988, HUMAN PSYCHOPHARMACO, V3, P27, DOI DOI 10.1002/HUP.470030106; World Health Organization, 2000, US; Yang Dongren, 2010, Curr Neurobiol, V1, P70	41	36	37	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85053	10.1371/journal.pone.0085053	http://dx.doi.org/10.1371/journal.pone.0085053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386444	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900120
J	Yoshioka, S; Abe, H; Sakumoto, R; Okuda, K				Yoshioka, Shin; Abe, Hironori; Sakumoto, Ryosuke; Okuda, Kiyoshi			Proliferation of Luteal Steroidogenic Cells in Cattle	PLOS ONE			English	Article							BOVINE CORPUS-LUTEUM; CORPORA-LUTEA; GRANULOSA-CELLS; ANGIOGENESIS; EXPRESSION; GROWTH; PROGESTERONE; REGULATORS; DIFFERENTIATION; IDENTIFICATION	The rapid growth of the corpus luteum (CL) after ovulation is believed to be mainly due to an increase in the size of luteal cells (hypertrophy) rather than an increase in their number. However, the relationship between luteal growth and the proliferation of luteal steroidogenic cells (LSCs) is not fully understood. One goal of the present study was to determine whether LSCs proliferate during CL growth. A second goal was to determine whether luteinizing hormone (LH), which is known have roles in the proliferation and differentiation of follicular cells, also affects the proliferation of LSCs. Ki-67 (a cell proliferation marker) was expressed during the early, developing and mid luteal stages and some Ki-67-positive cells co-expressed HSD3B (a steroidogenic marker). DNA content in LSCs isolated from the developing CL increased much more rapidly (indicating rapid growth) than did DNA content in LSCs isolated from the mid CL. The cell cycle-progressive genes CCND2 (cyclin D2) and CCNE1 (cyclin E1) mRNA were expressed more strongly in the small luteal cells than in the large luteal cells. LH decreased the rate of increase of DNA in LSCs isolated from the mid luteal stage but not in LSCs from the developing stage. LH suppressed CCND2 expression in LSCs from the mid luteal stage but not from the developing luteal stage. Furthermore, LH receptor (LHCGR) mRNA expression was higher at the mid luteal stage than at the developing luteal stage. The overall results suggest that the growth of the bovine CL is due to not only hypertrophy of LSCs but also an increase in their number, and that the proliferative ability of luteal steroidogenic cells decreases between the developing and mid luteal stages.	[Yoshioka, Shin; Okuda, Kiyoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Abe, Hironori; Okuda, Kiyoshi] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Sakumoto, Ryosuke] Natl Inst Agrobiol Sci, Reprod Biol Res Unit, Tsukuba, Ibaraki, Japan	Okayama University; Okayama University; National Institute of Agrobiological Sciences - Japan	Okuda, K (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	kokuda@cc.okayama-u.ac.jp	OKUDA, Kiyoshi/AAC-8606-2020		Japan Society for the Promotion Science (JSPS) [25-612, 24380155]	Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Grants-in-Aid for Japan Society for Promotion of Science fellows (No. 25-612) and for Scientific Research (No. 24380155) from the Japan Society for the Promotion Science (JSPS; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-zi'abil MO, 2003, REPRODUCTION, V125, P259, DOI 10.1530/rep.0.1250259; ALILA HW, 1984, BIOL REPROD, V31, P1015, DOI 10.1095/biolreprod31.5.1015; ALILA HW, 1988, J REPROD FERTIL, V82, P645, DOI 10.1530/jrf.0.0820645; Baird D, 1984, OVARY; Cannon JD, 2005, ENDOCRINOLOGY, V146, P414, DOI 10.1210/en.2004-0581; Chaffin CL, 2003, ENDOCRINOLOGY, V144, P1249, DOI 10.1210/en.2002-220664; Ciuffreda L, 2012, J MOL MED, V90, P667, DOI 10.1007/s00109-011-0844-1; FITZ TA, 1982, BIOL REPROD, V27, P703, DOI 10.1095/biolreprod27.3.703; Hampl A, 2000, BIOL REPROD, V62, P1393, DOI 10.1095/biolreprod62.5.1393; Hansel W, 1996, THERIOGENOLOGY, V45, P1267, DOI 10.1016/0093-691X(96)00098-2; Hazzard TM, 2000, BEST PRACT RES CL OB, V14, P883, DOI 10.1053/beog.2000.0133; JABLONKASHARIFF A, 1993, ENDOCRINOLOGY, V133, P1871, DOI 10.1210/en.133.4.1871; Jirawatnotai S, 2003, J BIOL CHEM, V278, P17021, DOI 10.1074/jbc.M301206200; Kayani AR, 2009, REPRODUCTION, V137, P67, DOI 10.1530/REP-08-0198; Koos R, 1981, LARGE SMALL CELLS BO; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEI ZM, 1991, BIOL REPROD, V44, P1148, DOI 10.1095/biolreprod44.6.1148; LEMON M, 1982, J REPROD FERTIL, V64, P315, DOI 10.1530/jrf.0.0640315; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; MCCLELLAN MC, 1975, CELL TISSUE RES, V164, P291, DOI 10.1007/BF00223011; Meidan R, 1999, J REPROD FERTIL, P217; MEYER GT, 1979, ANAT REC, V193, P823, DOI 10.1002/ar.1091930406; Miyamoto Y, 2000, BIOL REPROD, V62, P1109, DOI 10.1095/biolreprod62.5.1109; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MOSS S, 1954, ANAT REC, V120, P409, DOI 10.1002/ar.1091200205; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; OKUDA K, 1992, BIOL REPROD, V46, P1001, DOI 10.1095/biolreprod46.6.1001; OSHEA JD, 1989, J REPROD FERTIL, V85, P483, DOI 10.1530/jrf.0.0850483; OSHEA JD, 1979, J ANAT, V128, P239; Pate JL, 1996, THERIOGENOLOGY, V45, P1381, DOI 10.1016/0093-691X(96)00102-1; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Reynolds Lawrence P., 1994, Progress in Growth Factor Research, V5, P159, DOI 10.1016/0955-2235(94)90003-5; Richards JS, 1998, MOL CELL ENDOCRINOL, V145, P47, DOI 10.1016/S0303-7207(98)00168-3; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Sakumoto R, 2006, DOMEST ANIM ENDOCRIN, V31, P246, DOI 10.1016/j.domaniend.2005.11.001; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sugino N, 2005, J CLIN ENDOCR METAB, V90, P6141, DOI 10.1210/jc.2005-0643; Suzuki T, 1998, HUM REPROD, V13, P953, DOI 10.1093/humrep/13.4.953; TAMURA H, 1987, BIOL REPROD, V36, P1149, DOI 10.1095/biolreprod36.5.1149; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Young FM, 2000, HUM REPROD, V15, P557, DOI 10.1093/humrep/15.3.557; ZHENG J, 1994, BIOL REPROD, V51, P623, DOI 10.1095/biolreprod51.4.623	46	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84186	10.1371/journal.pone.0084186	http://dx.doi.org/10.1371/journal.pone.0084186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386349	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900082
J	Debuisson, D; Mari, N; Denanglaire, S; Leo, O; Andris, F				Debuisson, Delphine; Mari, Nathalie; Denanglaire, Sebastien; Leo, Oberdan; Andris, Fabienne			Myor/ABF-1 Mrna Expression Marks Follicular Helper T Cells but Is Dispensable for Tfh Cell Differentiation and Function In Vivo	PLOS ONE			English	Article							HELIX TRANSCRIPTION FACTOR; LYMPHOCYTE DEVELOPMENT; LINEAGE COMMITMENT; IMMUNE-RESPONSES; B-CELLS; IL-21; PROTEINS; MYOR; INTERLEUKIN-21; GENERATION	Follicular T helper cells (Tfh) are crucial for effective antibody responses and long term T cell-dependent humoral immunity. Although many studies are devoted to this novel T helper cell population, the molecular mechanisms governing Tfh cell differentiation have yet to be characterized. MyoR/ABF-1 is a basic helix-loop-helix transcription factor that plays a role in the differentiation of the skeletal muscle and Hodgkin lymphoma. Here we show that MyoR mRNA is progressively induced during the course of Tfh-like cell differentiation in vitro and is expressed in Tfh responding to Alum-precipitated antigens in vivo. This expression pattern suggests that MyoR could play a role in the differentiation and/or function of Tfh cells. We tested this hypothesis using MyoR-deficient mice and found this deficiency had no impact on Tfh differentiation. Hence, MyoR-deficient mice developed optimal T-dependent humoral responses to Alum-precipitated antigens. In conclusion, MyoR is a transcription factor selectively up-regulated in CD4 T cells during Tfh cell differentiation in vitro and upon response to alum-protein vaccines in vivo, but the functional significance of this up-regulation remains uncertain.	[Debuisson, Delphine; Mari, Nathalie; Denanglaire, Sebastien; Leo, Oberdan; Andris, Fabienne] Univ Libre Brussels, Immunobiol Lab, Gosselies, Belgium		Andris, F (corresponding author), Univ Libre Brussels, Immunobiol Lab, Gosselies, Belgium.	fandris@ulb.ac.be			Belgian Program in Interuniversity Poles of Attraction; Research Concerted Action of the Communaute francaise de Belgique; European Regional Development Fund; Walloon Region; FNRS, Belgium; GlaxoSmithKline Biologicals s.a.; Belgian State, Prime Minister's office, Science Policy Programming	Belgian Program in Interuniversity Poles of Attraction; Research Concerted Action of the Communaute francaise de Belgique; European Regional Development Fund(European Commission); Walloon Region; FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); GlaxoSmithKline Biologicals s.a.(GlaxoSmithKline); Belgian State, Prime Minister's office, Science Policy Programming	This work was supported by The Belgian Program in Interuniversity Poles of Attraction Initiated by the Belgian State, Prime Minister's office, Science Policy Programming, by a Research Concerted Action of the Communaute francaise de Belgique and by a grant from the European Regional Development Fund and the Walloon Region. FA is a Research Associate at the National Fund for Scientific Research, FNRS, Belgium and DD was supported by a Televie grant from the FNRS, Belgium. FA and OL received research grants from GlaxoSmithKline Biologicals s.a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2012, IMMUNOL REV, V247, P133, DOI 10.1111/j.1600-065X.2012.01117.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Pham D, 2012, J IMMUNOL, V189, P832, DOI 10.4049/jimmunol.1200854; Eddahri F, 2006, EUR J IMMUNOL, V36, P855, DOI 10.1002/eji.200535500; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Glimcher LH, 2000, GENE DEV, V14, P1693; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hishikawa K, 2005, J CELL BIOL, V169, P921, DOI 10.1083/jcb.200412167; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kamiura N, 2013, AM J PHYSIOL-RENAL, V304, pF1159, DOI 10.1152/ajprenal.00510.2012; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Liu ZD, 2009, J IMMUNOL, V183, P6320, DOI 10.4049/jimmunol.0900975; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Mari N, 2013, EUR J IMMUNOL, V43, P1489, DOI 10.1002/eji.201242938; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pham D., 2013, J BIOL CHEM; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Robb L, 1998, MECH DEVELOP, V76, P197, DOI 10.1016/S0925-4773(98)00122-1; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Youngblood B, 2013, IMMUNOLOGY, V139, P277, DOI 10.1111/imm.12074; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu LM, 2003, EXP CELL RES, V289, P162, DOI 10.1016/S0014-4827(03)00252-0; Zhu JF, 2010, IMMUNOL CELL BIOL, V88, P244, DOI 10.1038/icb.2009.114; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	60	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84415	10.1371/journal.pone.0084415	http://dx.doi.org/10.1371/journal.pone.0084415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386375	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700106
J	van der Walt, A; Kolbe, SC; Wang, YJE; Klistorner, A; Shuey, N; Ahmadi, G; Paine, M; Marriott, M; Mitchell, P; Egan, GF; Butzkueven, H; Kilpatrick, TJ				van der Walt, Anneke; Kolbe, Scott C.; Wang, Yejun E.; Klistorner, Alexander; Shuey, Neil; Ahmadi, Gelareh; Paine, Mark; Marriott, Mark; Mitchell, Peter; Egan, Gary F.; Butzkueven, Helmut; Kilpatrick, Trevor J.			Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes	PLOS ONE			English	Article							CONTRAST LETTER ACUITY; MULTIPLE-SCLEROSIS; FIBER LAYER; DEGENERATION; DISABILITY; DYSFUNCTION; IMPAIRMENT; ATROPHY; MYELIN	Background: Early markers of axonal and clinical outcomes are required for early phase testing of putative neuroprotective therapies for multiple sclerosis (MS). Objectives: To assess whether early measurement of diffusion tensor imaging (DTI) parameters (axial and radial diffusivity) within the optic nerve during and after acute demyelinating optic neuritis (ON) could predict axonal (retinal nerve fibre layer thinning and multi-focal visual evoked potential amplitude reduction) or clinical (visual acuity and visual field loss) outcomes at 6 or 12 months. Methods: Thirty-seven patients presenting with acute, unilateral ON were studied at baseline, one, three, six and 12 months using optic nerve DTI, clinical and paraclinical markers of axonal injury and clinical visual dysfunction. Results: Affected nerve axial diffusivity (AD) was reduced at baseline, 1 and 3 months. Reduced 1-month AD correlated with retinal nerve fibre layer (RNFL) thinning at 6 (R=0.38, p=0.04) and 12 months (R=0.437, p=0.008) and VEP amplitude loss at 6 (R=0.414, p=0.019) and 12 months (R=0.484, p=0.003). AD reduction at three months correlated with high contrast visual acuity at 6 (rho = -0.519, p = 0.001) and 12 months (rho = -0.414, p=0.011). The time-course for AD reduction for each patient was modelled using a quadratic regression. AD normalised after a median of 18 weeks and longer normalisation times were associated with more pronounced RNFL thinning and mfVEP amplitude loss at 12 months. Affected nerve radial diffusivity (RD) was unchanged until three months, after which time it remained elevated. Conclusions: These results demonstrate that AD reduces during acute ON. One month AD reduction correlates with the extent of axonal loss and persistent AD reduction at 3 months predicts poorer visual outcomes. This suggests that acute ON therapies that normalise optic nerve AD by 3 months could also promote axon survival and improve visual outcomes.	[van der Walt, Anneke; Kolbe, Scott C.; Wang, Yejun E.; Ahmadi, Gelareh; Kilpatrick, Trevor J.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [van der Walt, Anneke; Marriott, Mark; Butzkueven, Helmut; Kilpatrick, Trevor J.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [van der Walt, Anneke; Shuey, Neil; Paine, Mark] Royal Victorian Eye & Ear Hosp, Dept Neuroophthalmol, Melbourne, Vic 3002, Australia; [Klistorner, Alexander] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Mitchell, Peter] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Egan, Gary F.] Monash Univ, Melbourne, Vic 3004, Australia; [van der Walt, Anneke; Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic 3050, Australia	University of Melbourne; Royal Melbourne Hospital; Royal Victorian Eye & Ear Hospital; University of Sydney; Royal Melbourne Hospital; Monash University; Royal Melbourne Hospital; University of Melbourne	van der Walt, A (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia.	anneke.vanderwalt@mh.org.au	Egan, Gary F./A-1381-2013	Kolbe, Scott/0000-0003-4685-1380; Egan, Gary/0000-0002-3186-4026; Klistorner, Alexander/0000-0003-0361-6399; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727	National MS Society [RG4211A4/2]; National Health and Medical Research Council of Australia [628415]; Bayer Australia; Biogen Idec; Merck Serono; GlaxoSmithKline	National MS Society(National Multiple Sclerosis Society); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Bayer Australia; Biogen Idec(Biogen); Merck Serono(Merck & Company); GlaxoSmithKline(GlaxoSmithKline)	This research was supported by the National MS Society (Grant RG4211A4/2#) and the National Health and Medical Research Council of Australia (Grant 628415). The authors received small unrestricted grants from Bayer Australia, Biogen Idec, Merck Serono and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Balcer LJ, 2007, NEUROLOGY, V68, P1299, DOI 10.1212/01.wnl.0000259521.14704.a8; Balcer LJ, 2003, NEUROLOGY, V61, P1367, DOI 10.1212/01.WNL.0000094315.19931.90; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Beck RW, 2004, AM J OPHTHALMOL, V137, P77, DOI 10.1016/S0002-9394(02)00862-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brusa A, 2001, BRAIN, V124, P468, DOI 10.1093/brain/124.3.468; Cleary PA, 1997, J NEURO-OPHTHALMOL, V17, P18; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2009, J NEUROL SCI, V281, P74, DOI 10.1016/j.jns.2009.02.354; de la Cruz J, 2006, BRIT J OPHTHALMOL, V90, P551, DOI 10.1136/bjo.2005.085399; Fraser CL, 2006, OPHTHALMOLOGY, V113, P315, DOI 10.1016/j.ophtha.2005.10.017; Frohman EM, 2008, ARCH NEUROL-CHICAGO, V65, P26, DOI 10.1001/archneurol.2007.10; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; HALLIDAY AM, 1972, LANCET, V1, P982; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P298, DOI 10.1016/j.ophtha.2007.05.027; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Hickman SJ, 2005, AM J NEURORADIOL, V26, P951; Ishihara S, 1982, ISHIHARAS TESTS COLO; Jenkins TM, 2010, ANN NEUROL, V67, P99, DOI 10.1002/ana.21823; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2007, INVEST OPHTH VIS SCI, V48, P4549, DOI 10.1167/iovs.07-0381; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Kolbe SC, 2012, INVEST OPHTH VIS SCI, V53, P825, DOI 10.1167/iovs.11-8864; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; O'riordan J, 1998, BRAIN; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rocca MA, 2005, MULT SCLER J, V11, P537, DOI 10.1191/1352458505ms1213oa; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Van der Walt A, 2010, PHARMACOL THERAPEUT, V126, P82, DOI 10.1016/j.pharmthera.2010.01.006; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052291; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029	39	38	38	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83825	10.1371/journal.pone.0083825	http://dx.doi.org/10.1371/journal.pone.0083825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386285	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700081
J	Lei, BN; Amar, A; Koeslag, A; Gous, TA; Tate, GJ				Lei, Bonnie; Amar, Arjun; Koeslag, Ann; Gous, Tertius A.; Tate, Gareth J.			Differential Haemoparasite Intensity between Black Sparrowhawk (Accipiter melanoleucus) Morphs Suggests an Adaptive Function for Polymorphism	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; AVIAN BLOOD PARASITES; COLOR POLYMORPHISM; IMMUNE-RESPONSE; SEXUAL-DIMORPHISM; PLUMAGE COLOR; EVOLUTION; BIRDS; TESTOSTERONE; GENETICS	Recent research suggests that genes coding for melanin based colouration may have pleiotropic properties, in particular conveying raised immune function. Thus adaptive function of polymorphism may be associated with parasite resistance. The black sparrowhawk Accipiter melanoleucus is a polymorphic raptor with two morphs. Over most of its range the light morph is commonest, however within the recently colonised Western Cape of South Africa the dark morph predominates. The species breeds in winter throughout South Africa, however unlike in the rest of the species' South African range, the Western Cape experiences a winter rainfall regime, where arthropod vectors which transmit haematozoan parasites may be more abundant. We hypothesise that the higher frequency of dark morph birds in this region may be due to their improved parasite resistance, which enables them to cope with higher parasite pressure. If so, we predict that dark morph black sparrowhawks would have lower parasite burdens than light morph birds. Within our population the prevalence of the two most common haematozoan parasites was high, with 72% of adults infected with Haemoproteus nisi and 59% of adults infected with Leucocytozoon toddi. We found no difference in prevalence for either parasite between adult morphs, or between chicks of different parental morphs. However, within adults infected with H. nisi, infection intensity was significantly higher in light morphs than dark morphs. This suggests that dark morphs have lower parasite loads than light morphs due to resistance rather than morph-specific habitat exploitation. Greater resistance to Haemoproteus parasites may therefore be one of the mechanisms through which dark morph black sparrowhawks have a selective advantage in this region and may explain why they are most common in our study area. In other regions, the cost to benefit ratio may be in favour of the light morph, where parasites are less abundant or virulent.	[Lei, Bonnie; Amar, Arjun; Koeslag, Ann; Tate, Gareth J.] Univ Cape Town, Percy FitzPatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Lei, Bonnie] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	National Research Foundation - South Africa; University of Cape Town; Harvard University	Amar, A (corresponding author), Univ Cape Town, Percy FitzPatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa.	arjun.amar@uct.ac.za	Amar, Arjun/L-4493-2019; Arjun, Amar/F-3815-2011	Arjun, Amar/0000-0002-7405-1180	Weismann International Internship Program; UCT's University Research Council	Weismann International Internship Program; UCT's University Research Council	Funding for the project was partially provided through a Weismann International Internship Program to BL and through UCT's University Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar A, 2013, J ZOOL, V289, P60, DOI 10.1111/j.1469-7998.2012.00963.x; Amar A, 2011, J APPL ECOL, V48, P220, DOI 10.1111/j.1365-2664.2010.01896.x; Andersen GN, 2001, CLIN EXP IMMUNOL, V126, P441, DOI 10.1046/j.1365-2249.2001.01604.x; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Berger D. D., 1959, Bird-Banding, V30, P18, DOI 10.2307/4510726; Boerner M, 2009, BEHAV ECOL, V20, P180, DOI 10.1093/beheco/arn132; CATANIA A, 1993, ENDOCR REV, V14, P564, DOI 10.1210/er.14.5.564; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Cowling RM, 1996, BIODIVERS CONSERV, V5, P527, DOI 10.1007/BF00137608; Dawson RD, 2000, CONDOR, V102, P814, DOI 10.1650/0010-5422(2000)102[0814:RSOAKT]2.0.CO;2; Dreiss AN, 2012, J EVOLUTION BIOL, V25, P103, DOI 10.1111/j.1420-9101.2011.02407.x; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; EARLE RA, 1991, S AFR J WILDL RES, V21, P47; Ferguson-Lees J, 2001, RAPTORS WORLD; Galeotti P, 2004, BIOL J LINN SOC, V82, P237, DOI 10.1111/j.1095-8312.2004.00355.x; Galeotti P, 2003, J ZOOL, V261, P91, DOI 10.1017/S0952836903003960; Galvan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013369; Gangoso L, 2011, J EVOLUTION BIOL, V24, P2055, DOI 10.1111/j.1420-9101.2011.02336.x; Garvin MC, 2003, J WILDLIFE DIS, V39, P170, DOI 10.7589/0090-3558-39.1.170; Gasparini J, 2009, J ANIM ECOL, V78, P608, DOI 10.1111/j.1365-2656.2008.01521.x; Gershwin, 1985, NUTR IMMUNITY; Hockey PAR, 2009, OSTRICH, V80, P29, DOI 10.2989/OSTRICH.2009.80.1.4.762; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Horvathova T, 2012, P ROY SOC B-BIOL SCI, V279, P163, DOI 10.1098/rspb.2011.0663; Jacquin L, 2011, J AVIAN BIOL, V42, P11, DOI 10.1111/j.1600-048X.2010.05120.x; Johnson JA, 2012, J HERED, V103, P315, DOI 10.1093/jhered/ess023; Karell P, 2011, J EVOLUTION BIOL, V24, P1783, DOI 10.1111/j.1420-9101.2011.02308.x; Kittilsen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034281; Krone O, 2001, ACTA PROTOZOOL, V40, P281; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lopez-Rull I, 2011, FUNCT ECOL, V25, P500, DOI 10.1111/j.1365-2435.2010.01783.x; Loser K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008958; Maccoll ADC, 2013, BIOL J LINN SOC, V108, P882, DOI 10.1111/bij.12009; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Mettke-Hofmann C, 2012, ETHOLOGY, V118, P906, DOI 10.1111/j.1439-0310.2012.02079.x; Meunier J, 2011, BEHAV ECOL SOCIOBIOL, V65, P559, DOI 10.1007/s00265-010-1092-z; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Oettle E.E., 1994, Promerops, V212, P7; PEIRCE MA, 1983, J NAT HIST, V17, P813, DOI 10.1080/00222938300770621; Poulin R, 2012, EVOL ECOL, V26, P1169, DOI 10.1007/s10682-011-9544-0; Redpath SM, 2002, ECOGRAPHY, V25, P533, DOI 10.1034/j.1600-0587.2002.250503.x; Robertson A.S., 1986, Raptor Research, V20, P51; Roulin A, 2001, BEHAV ECOL, V12, P103, DOI 10.1093/oxfordjournals.beheco.a000371; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P937, DOI 10.1098/rspb.2000.1093; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Roulin A, 2004, IBIS, V146, P509, DOI 10.1111/j.1474-919x.2004.00292.x; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; SAS Institute, 2008, SAS STAT US GUID; Sebele L, 2012, THESIS U CAPE TOWN; Sol D, 2000, ECOGRAPHY, V23, P307, DOI 10.1034/j.1600-0587.2000.d01-1639.x; Stjernman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002463; Stoehr AM, 2006, BEHAV ECOL, V17, P751, DOI 10.1093/beheco/ark018; Taherzadeh S, 1999, AM J PHYSIOL-REG I, V276, pR1289, DOI 10.1152/ajpregu.1999.276.5.R1289; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 1997, ACTA ZOOLOGICA LITUA, V3-5; Veiga JP, 1998, OIKOS, V82, P313, DOI 10.2307/3546971; Webster LMI, 2011, MOL ECOL, V20, P920, DOI 10.1111/j.1365-294X.2010.04906.x; Zysling DA, 2006, HORM BEHAV, V50, P200, DOI 10.1016/j.yhbeh.2006.03.004	63	22	23	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81607	10.1371/journal.pone.0081607	http://dx.doi.org/10.1371/journal.pone.0081607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391707	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200004
J	Galli, G; Shukla, A; Simmons, AN; Davenport, PW; Paulus, MP				Galli, Giulia; Shukla, Akanksha; Simmons, Alan N.; Davenport, Paul W.; Paulus, Martin P.			Sex Differences in the Neural Processing of Aversive Interoceptive Events: The Benefit of Relief	PLOS ONE			English	Article							GENDER-DIFFERENCES; INSULAR CORTEX; BRAIN ACTIVATION; OPPONENT-PROCESS; AIR HUNGER; PERCEPTION; PAIN; DYSPNEA; FMRI; AWARENESS	Do men and women process and experience unpleasant bodily states differently? We used fMRI to determine brain processing before, during and after an aversive respiratory stimulation. No sex difference emerged during anticipation or stimulation. However, after the offset of the stimulation, men but not women showed enhanced activation of brain regions that are important for interoception and reward processing. Moreover, this activation was highest in those males who rated the preceding stimulation as most unpleasant. These results indicate that men are particularly sensitive to reward associated with the termination of an aversive event, which may signal relief.	[Shukla, Akanksha; Simmons, Alan N.; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Simmons, Alan N.; Paulus, Martin P.] Vet Affairs Hlth Care Syst, San Diego, CA USA; [Davenport, Paul W.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Galli, Giulia] Azienda Osped Univ Senese, Dipartimento Sci Neurol & Neurosensoriali, Siena, Italy	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of Florida; University of Siena; University Hospital of Siena	Paulus, MP (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.	mpaulus@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112; Galli, Giulia/0000-0001-9894-3514	National Institute on Drug Abuse [R01-DA016663, P20-DA027834, R01-DA027797, R01-DA018307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027797, R01DA016663, R01DA018307] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (Grant Nos. R01-DA016663, P20-DA027834, R01-DA027797, and R01-DA018307 to Martin Paulus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Miller S, 2010, BIOL PSYCHOL, V84, P147, DOI 10.1016/j.biopsycho.2010.03.004; Anderson K, 2009, CEREB CORTEX, V19, P2131, DOI 10.1093/cercor/bhn234; AXEN K, 1984, J APPL PHYSIOL, V56, P175, DOI 10.1152/jappl.1984.56.1.175; Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Banzett RB, 2000, NEUROREPORT, V11, P2117, DOI 10.1097/00001756-200007140-00012; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Biele G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001089; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; DAVENPORT PW, 1986, J APPL PHYSIOL, V60, P1843, DOI 10.1152/jappl.1986.60.6.1843; Denton D, 1999, P NATL ACAD SCI USA, V96, P5304, DOI 10.1073/pnas.96.9.5304; Eddy WF, 1996, MAGNET RESON MED, V36, P923, DOI 10.1002/mrm.1910360615; Evans KC, 2002, J NEUROPHYSIOL, V88, P1500, DOI 10.1152/jn.2002.88.3.1500; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Galli G, 2011, J NEUROSCI, V31, P12364, DOI 10.1523/JNEUROSCI.1619-11.2011; GOTTFRIED SB, 1978, CHEST, V73, P286, DOI 10.1378/chest.73.2.286; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; HARVER A, 1993, PSYCHOPHYSIOLOGY, V30, P223, DOI 10.1111/j.1469-8986.1993.tb03347.x; KATKIN ES, 1981, J PERS SOC PSYCHOL, V40, P1095, DOI 10.1037/0022-3514.40.6.1095; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Leknes S, 2008, EUR J NEUROSCI, V28, P794, DOI 10.1111/j.1460-9568.2008.06380.x; Leknes S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017870; Lighthall NR, 2012, SOC COGN AFFECT NEUR, V7, P476, DOI 10.1093/scan/nsr026; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; LOPATA M, 1977, AM REV RESPIR DIS, V115, P73; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Nishino T, 2005, JPN J PHYSIOL, V55, P117, DOI 10.2170/jjphysiol.R2088; Pappens M, 2010, BIOL PSYCHOL, V84, P98, DOI 10.1016/j.biopsycho.2010.02.006; Paulus MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029394; Peiffer C, 2001, AM J RESP CRIT CARE, V163, P951, DOI 10.1164/ajrccm.163.4.2005057; Peiffer C, 2008, AM J RESP CRIT CARE, V177, P440, DOI 10.1164/rccm.200612-1774OC; Peiffer C, 2009, RESP PHYSIOL NEUROBI, V167, P61, DOI 10.1016/j.resp.2009.04.001; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Schon D, 2008, PSYCHOPHYSIOLOGY, V45, P1064, DOI 10.1111/j.1469-8986.2008.00704.x; Seo D, 2011, HUM BRAIN MAPP, V32, P1998, DOI 10.1002/hbm.21165; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; Spreckelmeyer KN, 2009, SOC COGN AFFECT NEUR, V4, P158, DOI 10.1093/scan/nsn051; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Suschinsky KD, 2012, ARCH SEX BEHAV, V41, P199, DOI 10.1007/s10508-012-9931-9; Talairach J., 1988, COPLANAR STEREOTAXIC; Thayer JF, 2003, COGNITIVE THER RES, V27, P349, DOI 10.1023/A:1023922618287; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; von Leupoldt A, 2005, CHEST, V128, P3345, DOI 10.1378/chest.128.5.3345; Von Leupoldt A, 2006, PSYCHOPHYSIOLOGY, V43, P641, DOI 10.1111/j.1469-8986.2006.00453.x; Younger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013309; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	56	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84044	10.1371/journal.pone.0084044	http://dx.doi.org/10.1371/journal.pone.0084044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386327	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700086
J	Ghobakhlou, A; Laberge, S; Antoun, H; Wishart, DS; Xia, JG; Krishnamurthy, R; Mandal, R				Ghobakhlou, Abdollah; Laberge, Serge; Antoun, Hani; Wishart, David S.; Xia, Jianguo; Krishnamurthy, Ramanarayan; Mandal, Rupasri			Metabolomic Analysis of Cold Acclimation of Arctic Mesorhizobium sp Strain N-33	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LEGUMINOSARUM BV VICIAE; MUTATIONAL ANALYSIS; LOW-TEMPERATURES; STRESS-RESPONSE; RHIZOBIUM SP.; GENES; SEQUENCE; GENOME; ADAPTATION	Arctic Mesorhizobium sp. N-33 isolated from nodules of Oxytropis arctobia in Canada's eastern Arctic has a growth temperature range from 0 degrees C to 30 degrees C and is a well-known cold-adapted rhizobia. The key molecular mechanisms underlying cold adaptation in Arctic rhizobia remains totally unknown. Since the concentration and contents of metabolites are closely related to stress adaptation, we applied GC-MS and NMR to identify and quantify fatty acids and water soluble compounds possibly related to low temperature acclimation in strain N-33. Bacterial cells were grown at three different growing temperatures (4 degrees C, 10 degrees C and 21 degrees C). Cells from 21 degrees C were also cold-exposed to 4uC for different times (2, 4, 8, 60 and 240 minutes). We identified that poly-unsaturated linoleic acids 18:2 (9, 12) & 18: 2 (6, 9) were more abundant in cells growing at 4 or 10 degrees C, than in cells cultivated at 21 degrees C. The mono-unsaturated phospho/neutral fatty acids myristoleic acid 14:1(11) were the most significantly overexpressed (45-fold) after 1hour of exposure to 4 degrees C. As reported in the literature, these fatty acids play important roles in cold adaptability by supplying cell membrane fluidity, and by providing energy to cells. Analysis of water-soluble compounds revealed that isobutyrate, sarcosine, threonine and valine were more accumulated during exposure to 4 degrees C. These metabolites might play a role in conferring cold acclimation to strain N-33 at 4 degrees C, probably by acting as cryoprotectants. Isobutyrate was highly upregulated (19.4-fold) during growth at 4 degrees C, thus suggesting that this compound is a precursor for the cold-regulated fatty acids modification to low temperature adaptation.	[Ghobakhlou, Abdollah; Laberge, Serge] Agr & Agri Food Canada, Soils & Crops Res & Dev Ctr, Quebec City, PQ, Canada; [Ghobakhlou, Abdollah; Antoun, Hani] Univ Laval, Dept Soils & Agri Food Engn, Quebec City, PQ, Canada; [Wishart, David S.; Xia, Jianguo; Krishnamurthy, Ramanarayan; Mandal, Rupasri] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Wishart, David S.] Natl Inst Nanotechnol NINT, Natl Res Council, Edmonton, AB, Canada	Agriculture & Agri Food Canada; Laval University; University of Alberta; University of Alberta; National Research Council Canada	Laberge, S (corresponding author), Agr & Agri Food Canada, Soils & Crops Res & Dev Ctr, Quebec City, PQ, Canada.	serge.laberge@agr.gc.ca; hani.antoun.1@ulaval.ca	Wishart, David Scott/ABI-3181-2020; Xia, Jianguo/Z-1935-2019	Xia, Jianguo/0000-0003-2040-2624; Antoun, Hani/0000-0001-9309-420X; Wishart, David S/0000-0002-3207-2434	National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the following: National Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/index_eng. asp; and The Cellulosic Biofuel Network, http://www.cellulosic-biofuel.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakermans C, 2012, POLAR MICROBIOLOGY L, P126, DOI DOI 10.1128/9781555817183.CH6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Boumahdi M, 2001, ANTON LEEUW INT J G, V79, P73, DOI 10.1023/A:1010291818304; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Campanaro S, 2011, ENVIRON MICROBIOL, V13, P2018, DOI 10.1111/j.1462-2920.2010.02367.x; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Chattopadhyay MK, 2002, TRENDS MICROBIOL, V10, P311, DOI 10.1016/S0966-842X(02)02395-8; CHLUMSKY LJ, 1995, J BIOL CHEM, V270, P18252, DOI 10.1074/jbc.270.31.18252; Christie W. W., 2003, LIPID ANAL ISOLATION, V15; Cloutier J, 1996, MOL PLANT MICROBE IN, V9, P720, DOI 10.1094/MPMI-9-0720; Cloutier J, 1997, MOL PLANT MICROBE IN, V10, P401, DOI 10.1094/MPMI.1997.10.3.401; Cloutier J, 1996, MOL PLANT MICROBE IN, V9, P523, DOI 10.1094/MPMI-9-0523; Drouin P, 2000, FEMS MICROBIOL ECOL, V32, P111; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Galinski E A, 1995, Adv Microb Physiol, V37, P272, DOI 10.1016/S0065-2911(08)60148-4; GRAY JX, 1990, J BACTERIOL, V172, P193, DOI 10.1128/JB.172.1.193-203.1990; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; Kawahara Hidehisa, 2008, P229, DOI 10.1007/978-3-540-74335-4_14; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; KNEEN BE, 1983, APPL ENVIRON MICROB, V45, P340, DOI 10.1128/AEM.45.1.340-342.1983; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; MANDELSTAM J, 1963, ANN NY ACAD SCI, V102, P621, DOI 10.1111/j.1749-6632.1963.tb13664.x; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Merlo ME, 2011, BIOANALYSIS, V3, P2443, DOI [10.4155/BIO.11.248, 10.4155/bio.11.248]; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Mrozik A, 2004, POL J ENVIRON STUD, V13, P487; Mykytczuk NC, 2013, ISME J; ORGAMBIDE GG, 1993, LIPIDS, V28, P975, DOI 10.1007/BF02537117; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Piette F, 2011, ENVIRON MICROBIOL, V13, P1924, DOI 10.1111/j.1462-2920.2011.02436.x; PREVOST D, 1987, FEMS MICROBIOL ECOL, V45, P205, DOI 10.1016/0378-1097(87)90053-X; PREVOST D, 1987, PLANT SOIL, V98, P313, DOI 10.1007/BF02378352; Price PB, 2012, POLAR MICROBIOLOGY L, P243; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; RAY MK, 1994, J BACTERIOL, V176, P4243, DOI 10.1128/jb.176.14.4243-4249.1994; Reaves ML, 2011, CURR OPIN BIOTECH, V22, P17, DOI 10.1016/j.copbio.2010.10.001; Roessner U, 2009, PLANT METABOLIC NETWORKS, P39, DOI 10.1007/978-0-387-78745-9_3; Roessner U, 2009, BIOTECHNIQUES, V46, P363, DOI 10.2144/000113133; Russell Nicholas J., 2008, P177, DOI 10.1007/978-3-540-74335-4_11; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Theberge MC, 1996, NEW PHYTOL, V134, P657, DOI 10.1111/j.1469-8137.1996.tb04931.x; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; van der Werf MJ, 2007, ANAL BIOCHEM, V370, P17, DOI 10.1016/j.ab.2007.07.022; Vincent JM, 1970, IBP HDB; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; WILLETTS NS, 1967, BIOCHEM J, V103, P453, DOI 10.1042/bj1030453; Wishart DS, 2008, TRAC-TREND ANAL CHEM, V27, P228, DOI 10.1016/j.trac.2007.12.001; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Zhu K, 2005, MICROBIOL-SGM, V151, P615, DOI 10.1099/mic.0.27634-0	58	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84801	10.1371/journal.pone.0084801	http://dx.doi.org/10.1371/journal.pone.0084801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386418	Green Published, gold			2022-12-27	WOS:000329194700118
J	Hara, ES; Ono, M; Eguchi, T; Kubota, S; Pham, HT; Sonoyama, W; Tajima, S; Takigawa, M; Calderwood, SK; Kuboki, T				Hara, Emilio Satoshi; Ono, Mitsuaki; Eguchi, Takanori; Kubota, Satoshi; Hai Thanh Pham; Sonoyama, Wataru; Tajima, Shoji; Takigawa, Masaharu; Calderwood, Stuart K.; Kuboki, Takuo			miRNA-720 Controls Stem Cell Phenotype, Proliferation and Differentiation of Human Dental Pulp Cells	PLOS ONE			English	Article							SIDE POPULATION CELLS; MESENCHYMAL STROMAL CELLS; CANCER-CELLS; IN-VIVO; MICRORNA; EXPRESSION; DNA; MOUSE; PLURIPOTENCY; METHYLATION	Dental pulp cells (DPCs) are known to be enriched in stem/progenitor cells but not well characterized yet. Small non-coding microRNAs (miRNAs) have been identified to control protein translation, mRNA stability and transcription, and have been reported to play important roles in stem cell biology, related to cell reprogramming, maintenance of stemness and regulation of cell differentiation. In order to characterize dental pulp stem/progenitor cells and its mechanism of differentiation, we herein sorted stem-cell-enriched side population (SP) cells from human DPCs and periodontal ligament cells (PDLCs), and performed a locked nucleic acid (LNA)-based miRNA array. As a result, miR-720 was highly expressed in the differentiated main population (MP) cells compared to that in SP cells. In silico analysis and a reporter assay showed that miR-720 targets the stem cell marker NANOG, indicating that miR-720 could promote differentiation of dental pulp stem/progenitor cells by repressing NANOG. Indeed, gain-and loss-of-function analyses showed that miR-720 controls NANOG transcript and protein levels. Moreover, transfection of miR-720 significantly decreased the number of cells positive for the early stem cell marker SSEA-4. Concomitantly, mRNA levels of DNA methyltransferases (DNMTs), which are known to play crucial factors during stem cell differentiation, were also increased by miR-720 through unknown mechanism. Finally, miR-720 decreased DPC proliferation as determined by immunocytochemical analysis against ki-67, and promoted odontogenic differentiation as demonstrated by alizarin red staining, as well as alkaline phosphatase and osteopontin mRNA levels. Our findings identify miR-720 as a novel miRNA regulating the differentiation of DPCs.	[Hara, Emilio Satoshi; Ono, Mitsuaki; Hai Thanh Pham; Sonoyama, Wataru; Kuboki, Takuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama 7008530, Japan; [Eguchi, Takanori; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiat Oncol,Div Mol & Cellular Biol, Boston, MA 02215 USA; [Kubota, Satoshi; Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama 7008530, Japan; [Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka 565, Japan	Okayama University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Okayama University; Osaka University	Kuboki, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama 7008530, Japan.	kuboki@md.okayama-u.ac.jp	Hara, Emilio S/B-3922-2017; Hara, Emilio Satoshi/ABA-9954-2021; Sonoyama, Wataru/B-2160-2011	Hara, Emilio S/0000-0001-7374-3487; Hara, Emilio Satoshi/0000-0001-7374-3487; Kuboki, Takuo/0000-0003-3756-2835; Pham, Hai Thanh/0000-0002-7226-9346; Eguchi, Takanori/0000-0002-3297-6126	Japan Society for the Promotion of Science [22249064, 23659899, 25670818]; Grants-in-Aid for Scientific Research [22249064] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (#22249064, #23659899 and #25670818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hara ES, 2013, BIOCHIMIE, V95, P374, DOI 10.1016/j.biochi.2012.10.016; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Kawanabe N, 2012, EXP CELL RES, V318, P453, DOI 10.1016/j.yexcr.2012.01.008; Kubota S, 1999, FEBS LETT, V450, P84, DOI 10.1016/S0014-5793(99)00480-9; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Motohashi N, 2012, STEM CELLS DEV, V21, P3031, DOI 10.1089/scd.2011.0721; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Robertson KD, 2000, NUCLEIC ACIDS RES, V28, P2108, DOI 10.1093/nar/28.10.2108; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shinozuka E, 2013, BIOCHEM BIOPH RES CO, V430, P101, DOI 10.1016/j.bbrc.2012.11.005; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; TAKAGI H, 1995, EUR J BIOCHEM, V231, P282, DOI 10.1111/j.1432-1033.1995.tb20698.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	38	54	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83545	10.1371/journal.pone.0083545	http://dx.doi.org/10.1371/journal.pone.0083545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386225	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700049
J	Huang, Y; He, Q; Zhan, L; Yang, M				Huang, Yu; He, Qing; Zhan, Lei; Yang, Min			Sarcoplasmic Phospholamban Protein Is Involved in the Mechanisms of Postresuscitation Myocardial Dysfunction and the Cardioprotective Effect of Nitrite during Resuscitation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; IN-VIVO; IMPROVES OUTCOMES; OXIDE; RETICULUM; MICE; SURVIVAL; MODEL	Objectives: Sarcoplasmic reticulum (SR) Ca2+-handling proteins play an important role in myocardial dysfunction after acute ischemia/reperfusion injury. We hypothesized that nitrite would improve postresuscitation myocardial dysfunction by increasing nitric oxide (NO) generation and that the mechanism of this protection is related to the modulation of SR Ca2+-handling proteins. Methods: We conducted a randomized prospective animal study using male Sprague-Dawley rats. Cardiac arrest was induced by intravenous bolus of potassium chloride (40 mu g/g). Nitrite (1.2 nmol/g) or placebo was administered when chest compression was started. No cardiac arrest was induced in the sham group. Hemodynamic parameters were monitored invasively for 90 minutes after the return of spontaneous circulation (ROSC). Echocardiogram was performed to evaluate cardiac function. Myocardial samples were harvested 5 minutes and 1 hour after ROSC. Results: Myocardial function was significantly impaired in the nitrite and placebo groups after resuscitation, whereas cardiac function (i.e., ejection fraction and fractional shortening) was significantly greater in the nitrite group than in the placebo group. Nitrite administration increased the level of nitric oxide in the myocardium 5 min after resuscitation compared to the other two groups. The levels of phosphorylated phospholamban (PLB) were decreased after resuscitation, and nitrite increased the phosphorylation of phospholamban compared to the placebo. No significant differences were found in the expression of sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) and ryanodine receptors (RyRs). Conclusions: postresuscitation myocardial dysfunction is associated with the impairment of PLB phosphorylation. Nitrite administered during resuscitation improves postresuscitation myocardial dysfunction by preserving phosphorylated PLB protein during resuscitation.	[Huang, Yu; He, Qing] Chongqing Med Univ, Affiliated Hosp Chengdu 2, Peoples Hosp Chengdu 3, Chengdu, Peoples R China; [He, Qing; Zhan, Lei; Yang, Min] Sichuan Univ, West China Hosp, Dept Resp Dis, Chengdu 610064, Peoples R China; [Yang, Min] Anhui Med Univ, Hosp 2, Dept Intens Care Unit, Hefei, Anhui, Peoples R China	Chongqing Medical University; Sichuan University; Anhui Medical University	He, Q (corresponding author), Chongqing Med Univ, Affiliated Hosp Chengdu 2, Peoples Hosp Chengdu 3, Chengdu, Peoples R China.	kk555888@126.com			Natural Science Foundation of China [81071539]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Natural Science Foundation of China (81071539). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Y, 2005, CARDIOVASC RES, V66, P123, DOI 10.1016/j.cardiores.2005.01.007; Abdallah Y, 2006, CARDIOVASC RES, V70, P346, DOI 10.1016/j.cardiores.2006.02.020; Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Angelos MG, 2008, RESUSCITATION, V77, P101, DOI 10.1016/j.resuscitation.2007.10.017; Boucher JL, 1999, CELL MOL LIFE SCI, V55, P1015, DOI 10.1007/s000180050352; Champion HC, 2004, CIRC RES, V94, P657, DOI 10.1161/01.RES.0000119323.79644.20; Chang WT, 2007, INTENS CARE MED, V33, P88, DOI 10.1007/s00134-006-0442-9; Chohan PK, 2006, CARDIOVASC RES, V69, P152, DOI 10.1016/j.cardiores.2005.07.016; Dezfulian C, 2007, CARDIOVASC RES, V75, P327, DOI 10.1016/j.cardiores.2007.05.001; Dezfulian C, 2009, CIRCULATION, V120, P897, DOI 10.1161/CIRCULATIONAHA.109.853267; Elrod JW, 2006, ARTERIOSCL THROM VAS, V26, P1517, DOI 10.1161/01.ATV.0000224324.52466.e6; Gonzalez FM, 2008, CIRCULATION, V117, P2986, DOI 10.1161/CIRCULATIONAHA.107.748814; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Idris AH, 1996, RESUSCITATION, V33, P69, DOI 10.1016/S0300-9572(96)01055-6; Jung KH, 2006, STROKE, V37, P2744, DOI 10.1161/01.STR.0000245116.40163.1c; Kasseckert SA, 2009, CARDIOVASC RES, V83, P381, DOI 10.1093/cvr/cvp065; Kim SJ, 2001, CIRC RES, V89, P831, DOI 10.1161/hh2101.098547; Lim G, 2008, CARDIOVASC RES, V77, P256, DOI 10.1093/cvr/cvm012; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Minamishima S, 2011, CIRCULATION, V124, P1645, DOI 10.1161/CIRCULATIONAHA.111.025395; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Modin A, 2001, ACTA PHYSIOL SCAND, V171, P9, DOI 10.1046/j.1365-201x.2001.171001009.x; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nishida T, 2009, CRIT CARE MED, V37, P256, DOI 10.1097/CCM.0b013e318192face; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Piper HM, 2008, CARDIOVASC RES, V77, P234, DOI 10.1093/cvr/cvm066; Piper HM, 2006, CARDIOVASC RES, V70, P170, DOI 10.1016/j.cardiores.2006.03.010; Prunier F, 2008, CIRCULATION, V118, P614, DOI 10.1161/CIRCULATIONAHA.108.770883; Seddon M, 2007, CARDIOVASC RES, V75, P315, DOI 10.1016/j.cardiores.2007.04.031; Singh RB, 2004, J MOL CELL CARDIOL, V37, P101, DOI 10.1016/j.yjmcc.2004.04.009; Tripatara P, 2007, J AM SOC NEPHROL, V18, P570, DOI 10.1681/ASN.2006050450; Valverde CA, 2010, CARDIOVASC RES, V85, P671, DOI 10.1093/cvr/cvp371; Yannopoulos D, 2011, CRIT CARE MED, V39, P1269, DOI 10.1097/CCM.0b013e31820ed8a6; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang T, 2010, CIRC RES, V106, P354, DOI 10.1161/CIRCRESAHA.109.207423; Zhong WL, 2010, DIABETES RES CLIN PR, V89, P38, DOI 10.1016/j.diabres.2010.03.013	38	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82552	10.1371/journal.pone.0082552	http://dx.doi.org/10.1371/journal.pone.0082552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386101	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700009
J	Minakawa, Y; Kasamatsu, A; Koike, H; Higo, M; Nakashima, D; Kouzu, Y; Sakamoto, Y; Ogawara, K; Shiiba, M; Tanzawa, H; Uzawa, K				Minakawa, Yasuyuki; Kasamatsu, Atsushi; Koike, Hirofumi; Higo, Morihiro; Nakashima, Dai; Kouzu, Yukinao; Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Kinesin Family member 4A: A Potential Predictor for Progression of Human Oral Cancer	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; SQUAMOUS-CELL CARCINOMA; MICROTUBULE DYNAMICS; TUMOR-FORMATION; BUDDING YEAST; MOTOR PROTEIN; KIF4; ACTIVATION; EXPRESSION	Background: Kinesin family member 4A (KIF4A), a microtubule-based motor protein, was implicated in regulation of chromosomal structure and kinetochore microtubule dynamics. Considering the functions of KIF4A, we assumed that KIF4A is involved in progression of oral squamous cell carcinomas (OSCCs) via activation of the spindle assembly checkpoint (SAC). However, little is known about the relevance of KIF4A in the behavior of OSCC. We investigated the KIF4A expression status and its functional mechanisms in OSCC. Methods: The KIF4A expression levels in seven OSCC-derived cells were analyzed by quantitative reverse transcriptase-polymerase chain reaction and immunoblotting analyses. Using a KIF4A knockdown model, we assessed the expression of (SAC)-related molecules (BUB1, MAD2, CDC20, and cyclin B1), cell-cycle, and cellular proliferation. In addition to in vitro data, the clinical correlation between the KIF4A expression levels in primary OSCCs (n = 106 patients) and the clinicopathologic status by immunohistochemistry (IHC) also were evaluated. Results: KIF4A mRNA and protein were up-regulated significantly (P < 0.05) in seven OSCC-derived cells compared with human normal oral keratinocytes. In the KIF4A knockdown cells, SAC activation was observed via increased BUB1 expression on the kinetochores, appropriate kinetochore localization of MAD2, down-regulation of CDC20, up-regulation of cyclin B1, and cell-cycle arrested at G2/M phase. The results showed that cellular proliferation of KIF4A knockdown cells decreased significantly (P < 0.05) compared with control cells. IHC showed that KIF4A expression in primary OSCCs was significantly (P < 0.05) greater than in the normal oral counterparts and that KIF4A-positive OSCCs were correlated closely (P < 0.05) with tumoral size. Conclusions: Our results proposed for the first time that KIF4A controls cellular proliferation via SAC activation. Therefore, KIF4A might be a key regulator for tumoral progression in OSCCs.	[Minakawa, Yasuyuki; Nakashima, Dai; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Kasamatsu, Atsushi; Koike, Hirofumi; Higo, Morihiro; Kouzu, Yukinao; Sakamoto, Yosuke; Ogawara, Katsunori; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent & Oral Maxillofacial Surg, Chiba, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan	Chiba University; Chiba University; Chiba University	Uzawa, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, 1-8-1 Inohana, Chiba, Japan.	uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859				Bernasconi P, 2008, J NEUROPATH EXP NEUR, V67, P624, DOI 10.1097/NEN.0b013e318177e5fd; Bin OY, 2002, CLIN ENDOCRINOL, V56, P341, DOI 10.1046/j.1365-2265.2002.01475.x; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Castillo A, 2007, BIOCHEM BIOPH RES CO, V357, P694, DOI 10.1016/j.bbrc.2007.04.021; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gao J, 2011, TUMOR BIOL, V32, P53, DOI 10.1007/s13277-010-0090-0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ibrado AM, 1998, LEUKEMIA, V12, P1930, DOI 10.1038/sj.leu.2401218; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Izawa D, 2012, J CELL BIOL, V199, P27, DOI 10.1083/jcb.201205170; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kanehira M, 2007, CANCER RES, V67, P3276, DOI 10.1158/0008-5472.CAN-06-3748; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Koike H, 2005, CONNECT TISSUE RES, V46, P117, DOI 10.1080/03008200591008437; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Lombardi DP, 1999, CANCER RES, V59, P5724; Loyo M, 2011, INT J CANCER, V128, P1393, DOI 10.1002/ijc.25443; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; Miki H, 2003, GENOME RES, V13, P1455, DOI 10.1101/gr.984503; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Oki E, 2012, J GASTROENTEROL, V47, P351, DOI 10.1007/s00535-012-0565-4; PINDBORG JJ, 1997, WHO CLASSIFICATION T; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Saitoh S, 2008, MOL BIOL CELL, V19, P3885, DOI 10.1091/mbc.E08-03-0298; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Shimo A, 2007, CANCER SCI, V98, P174, DOI 10.1111/j.1349-7006.2006.00381.x; Sobin L, 2009, TNM CLASSIFICATION M; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; Taniuchi K, 2005, CANCER RES, V65, P105; Taniwaki M, 2007, CLIN CANCER RES, V13, P6624, DOI 10.1158/1078-0432.CCR-07-1328; Thirthagiri E, 2007, CANCER LETT, V258, P276, DOI 10.1016/j.canlet.2007.09.008; Usukura K, 2013, J CANCER RES CLIN, V139, P123, DOI 10.1007/s00432-012-1307-y; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Vitrat N, 1998, BLOOD, V91, P3711; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wang XH, 2002, CANCER RES, V62, P1662; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Zhang CP, 2010, CARCINOGENESIS, V31, P1676, DOI 10.1093/carcin/bgq134; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	69	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85951	10.1371/journal.pone.0085951	http://dx.doi.org/10.1371/journal.pone.0085951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386490	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700147
J	Mir, K; Neuhaus, K; Bossert, M; Schober, S				Mir, Katharina; Neuhaus, Klaus; Bossert, Martin; Schober, Steffen			Short Barcodes for Next Generation Sequencing	PLOS ONE			English	Article							ERROR; PRIMERS	We consider the design and evaluation of short barcodes, with a length between six and eight nucleotides, used for parallel sequencing on platforms where substitution errors dominate. Such codes should have not only good error correction properties but also the code words should fulfil certain biological constraints (experimental parameters). We compare published barcodes with codes obtained by two new constructions methods, one based on the currently best known linear codes and a simple randomized construction method. The evaluation done is with respect to the error correction capabilities, barcode size and their experimental parameters and fundamental bounds on the code size and their distance properties. We provide a list of codes for lengths between six and eight nucleotides, where for length eight, two substitution errors can be corrected. In fact, no code with larger minimum distance can exist.	[Mir, Katharina; Bossert, Martin; Schober, Steffen] Univ Ulm, Inst Commun Engn, D-89069 Ulm, Germany; [Neuhaus, Klaus] Tech Univ Munich, Chair Microbial Ecol, Freising Weihenstephan, Germany	Ulm University; Technical University of Munich	Schober, S (corresponding author), Univ Ulm, Inst Commun Engn, D-89069 Ulm, Germany.	steffen.schober@uni-ulm.de		Neuhaus, Klaus/0000-0002-6020-2814	DFG [BO867/23-1, SCHE316/3-1]	DFG(German Research Foundation (DFG))	This work has been funded by the DFG (BO867/23-1, SCHE316/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bosma W, 1997, J SYMB COMPUT, V24, P235, DOI 10.1006/jsco.1996.0125; Bossert M., 1999, CHANNEL CODING TELEC; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gallager R., 1968, INFORM THEORY RELIAB; Grassl M, 2006, ALGORITHM COMP MATH, V19, P287; Grassl Markus, 2007, BOUNDS MINIMUM DISTA; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Kao WC, 2009, GENOME RES, V19, P1884, DOI 10.1101/gr.095299.109; Krishnan AR, 2011, ELECTRON LETT, V47, P236, DOI 10.1049/el.2010.3546; MacWilliams FJ, 1992, THEORY ERROR CORRECT; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027	19	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82933	10.1371/journal.pone.0082933	http://dx.doi.org/10.1371/journal.pone.0082933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386128	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700017
J	Ramkissoon, KR; Miller, JK; Ojha, S; Watson, DS; Bomar, MG; Galande, AK; Shearer, AG				Ramkissoon, Kevin R.; Miller, Jennifer K.; Ojha, Sunil; Watson, Douglas S.; Bomar, Martha G.; Galande, Amit K.; Shearer, Alexander G.			Rapid Identification of Sequences for Orphan Enzymes to Power Accurate Protein Annotation	PLOS ONE			English	Article							DOLICHOL-PHOSPHATE-MANNOSE; GLUCOSE-DEHYDROGENASE; LINKED OLIGOSACCHARIDE; SYNTHASE; PURIFICATION; CELLS	The power of genome sequencing depends on the ability to understand what those genes and their proteins products actually do. The automated methods used to assign functions to putative proteins in newly sequenced organisms are limited by the size of our library of proteins with both known function and sequence. Unfortunately this library grows slowly, lagging well behind the rapid increase in novel protein sequences produced by modern genome sequencing methods. One potential source for rapidly expanding this functional library is the "back catalog" of enzymology-"orphan enzymes," those enzymes that have been characterized and yet lack any associated sequence. There are hundreds of orphan enzymes in the Enzyme Commission (EC) database alone. In this study, we demonstrate how this orphan enzyme "back catalog" is a fertile source for rapidly advancing the state of protein annotation. Starting from three orphan enzyme samples, we applied mass-spectrometry based analysis and computational methods (including sequence similarity networks, sequence and structural alignments, and operon context analysis) to rapidly identify the specific sequence for each orphan while avoiding the most time-and labor-intensive aspects of typical sequence identifications. We then used these three new sequences to more accurately predict the catalytic function of 385 previously uncharacterized or misannotated proteins. We expect that this kind of rapid sequence identification could be efficiently applied on a larger scale to make enzymology's "back catalog" another powerful tool to drive accurate genome annotation.	[Ramkissoon, Kevin R.; Miller, Jennifer K.; Ojha, Sunil; Watson, Douglas S.; Bomar, Martha G.; Galande, Amit K.] SRI Int, Biosci Div, Harrisonburg, VA USA; [Shearer, Alexander G.] Clover Collect, Mountain View, CA USA	SRI International	Shearer, AG (corresponding author), Clover Collect, Mountain View, CA USA.	agshearer@clovercollective.com			National Institute of General Medical Sciences [GM086755]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086755] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant GM086755 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEYAMA M, 1981, J BACTERIOL, V145, P814, DOI 10.1128/JB.145.2.814-823.1981; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Banerjee DK, 2004, GLYCOCONJUGATE J, V21, P479, DOI 10.1007/s10719-004-5538-2; Banerjee DK, 2005, J BIOL CHEM, V280, P4174, DOI 10.1074/jbc.M406962200; Barrett Alan J., 1997, European Journal of Biochemistry, V250, P1; Bork P, 1996, TRENDS GENET, V12, P425, DOI 10.1016/0168-9525(96)60040-7; Colussi PA, 1997, P NATL ACAD SCI USA, V94, P7873, DOI 10.1073/pnas.94.15.7873; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Forsee WT, 1997, EUR J BIOCHEM, V244, P953, DOI 10.1111/j.1432-1033.1997.00953.x; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Hamamatsu N, 2006, APPL MICROBIOL BIOT, V73, P607, DOI 10.1007/s00253-006-0521-4; Lamani E, 2006, GLYCOBIOLOGY, V16, P666, DOI 10.1093/glycob/cwj104; Lespinet O, 2005, SCIENCE, V307, P42; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MATSUSHITA K, 1989, J BIOCHEM, V105, P633, DOI 10.1093/oxfordjournals.jbchem.a122716; MIDGLEY M, 1973, BIOCHEM J, V132, P141, DOI 10.1042/bj1320141; Pouliot Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-244; Rush Jeffrey S., 2006, V347, P13; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SHIROKANE Y, 1995, FEBS LETT, V367, P177, DOI 10.1016/0014-5793(95)00524-D; Tomita S, 1998, J BIOL CHEM, V273, P9249, DOI 10.1074/jbc.273.15.9249; Urushibata Y, 2008, EXTREMOPHILES, V12, P665, DOI 10.1007/s00792-008-0173-7	24	7	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84508	10.1371/journal.pone.0084508	http://dx.doi.org/10.1371/journal.pone.0084508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386392	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700109
J	Sharp, L; Cotton, S; Little, J; Gray, NM; Cruickshank, M; Smart, L; Thornton, A; Waugh, N; Walker, L				Sharp, Linda; Cotton, Seonaidh; Little, Julian; Gray, Nicola M.; Cruickshank, Margaret; Smart, Louise; Thornton, Alison; Waugh, Norman; Walker, Leslie		TOMBOLA Grp	Psychosocial Impact of Alternative Management Policies for Low-Grade Cervical Abnormalities: Results from the TOMBOLA Randomised Controlled Trial	PLOS ONE			English	Article							5-YEAR FOLLOW-UP; HOSPITAL ANXIETY; EVENT SCALE; PSYCHOLOGICAL IMPACT; DEPRESSION SCALE; LONG-TERM; WOMEN; COLPOSCOPY; BORDERLINE; CYTOLOGY	Background: Large numbers of women who participate in cervical screening require follow-up for minor cytological abnormalities. Little is known about the psychological consequences of alternative management policies for these women. We compared, over 30-months, psychosocial outcomes of two policies: cytological surveillance (repeat cervical cytology tests in primary care) and a hospital-based colposcopy examination. Methods: Women attending for a routine cytology test within the UK NHS Cervical Screening Programmes were eligible to participate. 3399 women, aged 20-59 years, with low-grade abnormal cytology, were randomised to cytological surveillance (six-monthly tests; n = 1703) or initial colposcopy with biopsies and/or subsequent treatment based on colposcopic and histological findings (n = 1696). At 12, 18, 24 and 30-months post-recruitment, women completed the Hospital Anxiety and Depression Scale (HADS). A subgroup (n = 2354) completed the Impact of Event Scale (IES) six weeks after the colposcopy episode or first surveillance cytology test. Primary outcomes were percentages over the entire follow-up period of significant depression (>= 8) and significant anxiety (>= 11; "30-month percentages''). Secondary outcomes were point prevalences of significant depression, significant anxiety and procedure-related distress (>= 9). Outcomes were compared between arms by calculating fully-adjusted odds ratios (ORs) for initial colposcopy versus cytological surveillance. Results: There was no significant difference in 30-month percentages of significant depression (OR = 0.99, 95% CI 0.80-1.21) or anxiety (OR = 0.97, 95% CI 0.81-1.16) between arms. At the six-week assessment, anxiety and distress, but not depression, were significantly less common in the initial colposcopy arm (anxiety: 7.9% vs 13.4%; OR = 0.55, 95% CI 0.38-0.81; distress: 30.6% vs 39.3%, OR = 0.67 95% CI 0.54-0.84). Neither anxiety nor depression differed between arms at subsequent time-points. Conclusions: There was no difference in the longer-term psychosocial impact of management policies based on cytological surveillance or initial colposcopy. Policy-makers, clinicians, and women themselves can be reassured that neither management policy has a significantly greater psychosocial cost.	[Sharp, Linda] Natl Canc Registry Ireland, Cork, Ireland; [Cotton, Seonaidh; Cruickshank, Margaret] Univ Aberdeen, Aberdeen, Scotland; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Gray, Nicola M.; Thornton, Alison] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland; [Smart, Louise] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland; [Waugh, Norman] Univ Warwick, Sch Med, Coventry CV4 7AL, W Midlands, England; [Walker, Leslie] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Aberdeen; University of Ottawa; University of Aberdeen; University of Aberdeen; University of Warwick; University of Hull	Sharp, L (corresponding author), Natl Canc Registry Ireland, Cork Airport Business Pk,Kinsale Rd, Cork, Ireland.	linda.sharp@ncri.ie	Little, Julian/AAR-6117-2020	Little, Julian/0000-0001-5026-5531; Cruickshank, Margaret/0000-0002-8893-8620; Gray, Nicola M/0000-0001-8497-394X	Medical Research Council [G9700808]; NHS in England; NHS in Scotland; MRC [G9700808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS in England; NHS in Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TOMBOLA was funded by the Medical Research Council (Grant Number G9700808) and the NHS in England and Scotland. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrea H, 2004, SOC PSYCH PSYCH EPID, V39, P637, DOI 10.1007/s00127-004-0797-6; BELL S, 1995, PREV MED, V24, P610, DOI 10.1006/pmed.1995.1096; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Broen AN, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-18; *CERV SCREEN WAL, 2010, KC53 61 65 STAT REP; Cotton S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578007; Cotton SC, 2006, CONTEMP CLIN TRIALS, V27, P449, DOI 10.1016/j.cct.2006.04.001; CRAIG KJ, 2000, PSYCHOPHARMACOLOGY 4; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Cruickshank M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2546; Cruickshank M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2548; Cruickshank M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2549; DROLET M, 2011, PSYCHOONCOLOGY; Gray NM, 2006, BRIT J CANCER, V94, P1253, DOI 10.1038/sj.bjc.6603086; Groenvold M, 1999, J CLIN EPIDEMIOL, V52, P523, DOI 10.1016/S0895-4356(99)00022-0; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HOSMER DW, 1989, APPL LOGISTIC REGRES; International Agency for Research on Cancer, 2005, CERV CANC SCREEN IAR; *ISD SCOTL, 2010, ANN WORKL DAT 31 MAR; Johnson CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016491, 10.1371/journal.pone.0021046, 10.1371/journal.pone.0019210]; Jones MH, 1996, J ROY SOC MED, V89, P257, DOI 10.1177/014107689608900506; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; KAIDA A, J WOMENS HLTH LARCHM, V17, P1175; Kitchener HC, 2004, BJOG-INT J OBSTET GY, V111, P63, DOI 10.1046/j.1471-0528.2003.00007.x; Korfage IJ, 2010, EUR J CANCER, V46, P134, DOI 10.1016/j.ejca.2009.07.003; Kurman RJ, 1996, BETHESDA SYSTEM REPO; Lester H, 1999, BRIT J GEN PRACT, V49, P223; Lopes A., 1994, Journal of Obstetrics and Gynaecology (Abingdon), V14, P197, DOI 10.3109/01443619409004075; Maissi E, 2004, BMJ-BRIT MED J, V328, P1293, DOI 10.1136/bmj.328.7451.1293; NHS Cervical Screening Programme, 2010, NHSCSP PUBL, V20; *NHS NAT STAT, 2010, CERV SCREEN PROGR; PARASKEVAIDIS E, 1993, PSYCHO-ONCOLOGY, V2, P195; Raffle AE, 2007, SCREENING EVIDENCE P; Rana DN, 2004, CYTOPATHOLOGY, V15, P263, DOI 10.1111/j.1365-2303.2004.00194.x; RODIN G, 2006, MANAGEMENT DEPRESSIO; Rogstad KE, 2002, BJOG-INT J OBSTET GY, V109, P364, DOI 10.1111/j.1471-0528.2002.99023.x; Salvesen KA, 1997, ULTRASOUND OBST GYN, V9, P80, DOI 10.1046/j.1469-0705.1997.09020080.x; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Sharp L, 2012, CYTOPATHOLOGY, V23, P150, DOI 10.1111/j.1365-2303.2011.00848.x; SHARP L, 2011, PSYCHOONCOLOGY; Sharp L, 2012, EUR J OBSTET GYN R B, V165, P318, DOI 10.1016/j.ejogrb.2012.08.001; Sharp L, 2009, BJOG-INT J OBSTET GY, V116, P1506, DOI 10.1111/j.1471-0528.2009.02263.x; Shireman TI, 2001, INT J TECHNOL ASSESS, V17, P146, DOI 10.1017/S0266462301104137; Smith MCG, 2006, BJOG-INT J OBSTET GY, V113, P1321, DOI 10.1111/j.1471-0528.2006.01065.x; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Sundin EC, 2003, PSYCHOSOM MED, V65, P870, DOI 10.1097/01.PSY.0000084835.46074.F0; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; *TOMBOLA GROUP, 2006, J LOW GENIT TRACT DI, V10, P26; Vigod SN, 2011, ARCH WOMEN MENT HLTH, V14, P159, DOI 10.1007/s00737-011-0210-x; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Woolley C, 2007, INT J TECHNOL ASSESS, V23, P232, DOI 10.1017/S026646230707016X; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P201, DOI 10.1097/LGT.0b013e3181585870; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e80092	10.1371/journal.pone.0080092	http://dx.doi.org/10.1371/journal.pone.0080092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386076	Green Published, gold			2022-12-27	WOS:000329194700003
J	Lazic, MM; Kaliontzopoulou, A; Carretero, MA; Crnobrnja-Isailovic, J				Lazic, Marko M.; Kaliontzopoulou, Antigoni; Carretero, Miguel A.; Crnobrnja-Isailovic, Jelka			Lizards from Urban Areas Are More Asymmetric: Using Fluctuating Asymmetry to Evaluate Environmental Disturbance	PLOS ONE			English	Article							DEVELOPMENTAL STABILITY; INCUBATION-TEMPERATURE; INBREEDING DEPRESSION; GENETIC-VARIATION; PODARCIS-MURALIS; LACERTID LIZARD; STRESS; FITNESS; PERFORMANCE; INDICATOR	The increase in human activities that leads to wildlife decline and species extinction poses an urgent need for simple indicators of environmental stress in animal populations. Several studies have suggested that fluctuating asymmetry (FA) can be an easy, direct measure of developmental instability because it is associated to environmental stress and, as such, it can be a useful indicator of population disturbance. We examined three different morphological traits in urban and rural populations of the common wall lizard (Podarcis muralis) to test whether anthropogenic disturbance causes an increase in FA. Compared to rural populations, urban ones showed higher levels of FA in all analyzed traits, thus providing evidence that FA can respond to anthropogenic disturbance. However, we also found significant differences in FA among traits, where femoral pores and subdigital lamellae, traits with a functional relevance, were more stable developmentally compared to supracilliar granules which have no evident function. Unsigned FA [abs(right-left)] exhibited significant, but weak, positive correlations among traits, indicating that developmental noise does not have a uniform effect across characters and thus questioning the view of developmental stability as an organism-wide property. The degree of signed FA (right-left) was more similar between structurally associated traits, possibly as an outcome of morphological integration. In conclusion, our results demonstrate that FA can be a reliable indicator of disturbance provided that it is analyzed on multiple traits simultaneously and examined at the population level.	[Lazic, Marko M.; Crnobrnja-Isailovic, Jelka] Univ Nis, Fac Sci & Math, Dept Biol & Ecol, Nish, Serbia; [Kaliontzopoulou, Antigoni; Carretero, Miguel A.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Kaliontzopoulou, Antigoni] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA	University of Nis; Universidade do Porto; Iowa State University	Lazic, MM (corresponding author), Univ Nis, Fac Sci & Math, Dept Biol & Ecol, Nish, Serbia.	markol@pmf.ni.ac.rs	Kaliontzopoulou, Antigoni/AAF-6921-2022; Kaliontzopoulou, Antigoni/L-8345-2013; Carretero, Miguel A/A-1472-2013; Kaliontzopoulou, Antigoni/AFJ-9860-2022	Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Carretero, Miguel A/0000-0002-2335-7198; Kaliontzopoulou, Antigoni/0000-0002-7897-7204; Crnobrnja-Isailovic, Jelka/0000-0003-4292-5995	Ministry of Education, Science and Technological Development of Republic of Serbia [173025]; MESTD (Serbia); FCT (Portugal);  [PTDC/BIA-BEC/101256/2008];  [SFRH/BPD/68493/2010)]	Ministry of Education, Science and Technological Development of Republic of Serbia; MESTD (Serbia); FCT (Portugal)(Portuguese Foundation for Science and Technology); ; 	The work of MML and JCI was supported by the Grant no. 173025 funded by Ministry of Education, Science and Technological Development of Republic of Serbia (http://www.mpn.gov.rs/). MAC and AK were supported by project PTDC/BIA-BEC/101256/2008 and AK by a postdoctoral grant (SFRH/BPD/68493/2010), all funded by FCT (Portugal)(http://www.fct.pt/). The collaboration between the Portuguese and Serbian teams was also supported by an integrated action co-funded by FCT (Portugal) and MESTD (Serbia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AC, 1992, PHYSIOL BEHAV, V51, P729, DOI 10.1016/0031-9384(92)90109-F; Aleksic I., 2001, ARCH BIOL SCI, V53, P73; Amaral MJ, 2012, CHEMOSPHERE, V87, P757, DOI 10.1016/j.chemosphere.2011.12.075; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Arnold E.N., 2004, P11; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bonn A, 1996, OECOLOGIA, V108, P596, DOI 10.1007/BF00329031; Brana F, 2000, J EXP ZOOL, V286, P422, DOI 10.1002/(SICI)1097-010X(20000301)286:4<422::AID-JEZ10>3.0.CO;2-D; Carretero M. A., 1993, Historia Animalium, V2, P77; Carter AJR, 2009, HEREDITY, V102, P563, DOI 10.1038/hdy.2009.13; Clarke G.M., 1995, PAC CONSERV BIOL, V2, P146, DOI DOI 10.1071/PC960146); Clarke GM, 1998, HEREDITY, V80, P553, DOI 10.1046/j.1365-2540.1998.00326.x; CLARKE GM, 1986, AUST J BIOL SCI, V39, P145, DOI 10.1071/BI9860145; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Clarke GM, 1998, AM NAT, V152, P762, DOI 10.1086/286207; Cooper W.E. Jr, 2004, P83; Crnobrnja-Isailovic J, 2005, AMPHIBIA-REPTILIA, V26, P149, DOI 10.1163/1568538054253500; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; Djordjevic A. V., 2008, QUALITATIVE QUANTITA; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; DOYLE WJ, 1977, GROWTH, V41, P183; Ducic V., 2005, CLIMATE SERBIA; Eeva T, 2000, FUNCT ECOL, V14, P235, DOI 10.1046/j.1365-2435.2000.00406.x; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Garcia-Munoz E, 2010, ACTA HERPETOL, V5, P259; Gasc J. P., 1997, ATLAS AMPHIBIANS REP, P496; Gherghel I, 2009, ACTA HERPETOL, V4, P183; Gilligan DM, 2000, ANIM CONSERV, V3, P97, DOI 10.1017/S1367943000000792; Glossip D, 1997, HERPETOLOGICA, V53, P192; Gomendio M, 2000, P ROY SOC B-BIOL SCI, V267, P875, DOI 10.1098/rspb.2000.1084; Gomez A., 1993, P213; Hardersen S, 2000, ECOL ENTOMOL, V25, P45, DOI 10.1046/j.1365-2311.2000.00204.x; Hughes J.B., 1997, SCIENCE, V278, P689, DOI DOI 10.1126/science.278.5338.689; Ivanovic R., 2011, GLASNIK SRPSKOG GEOG, V91, P83; Jarvis A, 2008, HOLE FILLED SEAMLESS; Ji X, 2002, J EXP ZOOL, V292, P649, DOI 10.1002/jez.10101; Jovanovi B., 2011, BIOL NYSSANA, V2, P1; Kaliontzopoulou A, 2012, ZOOL J LINN SOC-LOND, V164, P173, DOI 10.1111/j.1096-3642.2011.00760.x; Kleinow K, 1999, SETAC SP P, P9; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Knierim U, 2007, PHYSIOL BEHAV, V92, P398, DOI 10.1016/j.physbeh.2007.02.014; Kozlov MV, 1996, J APPL ECOL, V33, P1489, DOI 10.2307/2404787; Kurbalija Z, 2010, EVOL ECOL, V24, P839, DOI 10.1007/s10682-009-9342-0; Lailvaux SP, 2006, ETHOLOGY, V112, P707, DOI 10.1111/j.1439-0310.2006.01210.x; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2002, CONSERV BIOL, V16, P479, DOI 10.1046/j.1523-1739.2002.00516.x; LEUNG B, 2001, DEV INSTABILITY CAUS, P415; Lopez P, 2002, BIOL J LINN SOC, V77, P201, DOI 10.1046/j.1095-8312.2002.00103.x; Marco A, 2004, B ENVIRON CONTAM TOX, V72, P983, DOI 10.1007/s00128-004-0340-1; Marco A, 2004, B ENVIRON CONTAM TOX, V73, P125, DOI 10.1007/s00128-004-0403-3; Marco A, 2004, CAN J ZOOL, V82, P60, DOI [10.1139/z03-209, 10.1139/Z03-209]; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2001, PHYSIOL BIOCHEM ZOOL, V74, P619, DOI 10.1086/322925; McCarthy J.F., 1990, BIOMARKERS ENV CONTA, DOI DOI 10.1201/9781351070263; MOLLER AP, 1992, J EVOLUTION BIOL, V5, P691, DOI 10.1046/j.1420-9101.1992.5040691.x; Moller AP, 1996, OIKOS, V77, P189, DOI 10.2307/3546057; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; MOLLER AP, 1995, POULTRY SCI, V74, P1761, DOI 10.3382/ps.0741761; Moller AP, 1997, ASYMMETRY DEV STABIL; Mpho M, 2002, HEREDITY, V88, P307, DOI 10.1038/sj.hdy.6800045; Nikic D, 2009, TURKISH J PEDIATR, V51, P257; Nosil P, 2001, EVOLUTION, V55, P712, DOI 10.1554/0014-3820(2001)055[0712:TANCAS]2.0.CO;2; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; Oyekunle J. A. O., 2012, African Journal of Environmental Science and Technology, V6, P458; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pertoldi C, 2006, HEREDITY, V96, P122, DOI 10.1038/sj.hdy.6800777; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; POLAK M, 1993, GENETICA, V89, P255, DOI 10.1007/BF02424519; Polak M, 2002, ENVIRON POLLUT, V118, P19, DOI 10.1016/S0269-7491(01)00281-0; Polak M., 2003, CAUSES CONSEQUENCES; Polak Michal, 2003, P81; Qualls CP, 1999, BIOL J LINN SOC, V67, P353, DOI 10.1006/bijl.1998.0307; Sarre S, 1996, RES POPUL ECOL, V38, P57, DOI 10.1007/BF02514971; Savage A, 1999, HYDROBIOLOGIA, V411, P139, DOI 10.1023/A:1003857919472; Schulte U., 2008, MAUEREIDECHSE ERFOLG; SCIULLI PW, 1979, AM J PHYS ANTHROPOL, V50, P279, DOI 10.1002/ajpa.1330500218; Skrbic B, 2002, J ENVIRON SCI HEAL A, V37, P7, DOI 10.1081/ESE-100108478; Skrbic B, 2002, J ENVIRON SCI HEAL A, V37, P1029, DOI 10.1081/ESE-120004520; SOULE M, 1973, EVOLUTION, V27, P593, DOI 10.1111/j.1558-5646.1973.tb00708.x; SOULE ME, 1973, NATURE, V242, P191, DOI 10.1038/242191a0; Stamenkovic S., 2003, ARCH BIOL SCI, V55, P133; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V255, P147, DOI 10.1098/rspb.1994.0021; Tull JC, 2007, J WILDLIFE MANAGE, V71, P1944, DOI 10.2193/2006-397; Unkagevic M, 2009, GEOGR PANNONICA, V13, P4, DOI 10.5937/GeoPan0901004U; Unkasevic M, 2001, THEOR APPL CLIMATOL, V68, P67, DOI 10.1007/s007040170054; VANDAMME R, 1992, HERPETOLOGICA, V48, P220; Warner DA, 2006, OIKOS, V114, P126; Wilsey BJ, 1998, ECOLOGY, V79, P2092, DOI 10.1890/0012-9658(1998)079[2092:LFAIWH]2.0.CO;2; Wordjevic AV, 2011, THERM SCI, V15, P293, DOI 10.2298/TSCI110114033D; Zhdanova Nadezhda P., 2006, P209	98	54	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84190	10.1371/journal.pone.0084190	http://dx.doi.org/10.1371/journal.pone.0084190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386350	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900083
J	Li, Y; Chen, YL; Xie, YT; Zheng, LY; Han, JY; Wang, H; Tian, XX; Fang, WG				Li, Yan; Chen, Yi-Lin; Xie, Yun-Tao; Zheng, Li-Yuan; Han, Ji-Yuan; Wang, Hui; Tian, Xin-Xia; Fang, Wei-Gang			Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women	PLOS ONE			English	Article							CELL LUNG-CANCER; GENOME-WIDE ASSOCIATION; GENETIC POLYMORPHISMS; MESSENGER-RNA; CYCLIN B1; RISK; LOCALIZATION; MICROARRAY; YEAST	The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with each other and are involved in cell cycle regulation, centrosome duplication and chromosome segregation. This study aimed to investigate whether the genetic variants in these two genes may affect breast cancer (BC) susceptibility, progression, and survival in Chinese Han population using haplotype-based analysis. A total of ten tSNPs spanning from 2kb upstream to 2kb downstream of these genes were genotyped in 1204 cases and 1204 age-matched cancer-free controls. The haplotype blocks were determined according to our genotyping data and linkage disequilibrium (LD) status of these SNPs. For CCNB1, rs2069429 was significantly associated with increased BC susceptibility under recessive model (OR=2.352, 95% CI=1.480-3.737), so was the diplotype TAGT/TAGT (OR=1.947 95% CI=1.154-3.284, P=0.013). In addition, rs164390 was associated with Her2-negative BC. For CDK1, rs2448343 and rs1871446 were significantly associated with decreased BC risk under dominant models, so was the haplotype ATATT. These two SNPs also showed a dose-dependent effect on BC susceptibility. Using stratified association analysis, we found that women with the heterozygotes or minor allele homozygotes of rs2448343 had much less BC susceptibility among women with BMI<23. In CDK1, three closely located SNPs, rs2448343, rs3213048 and rs3213067, were significantly associated with tumor's PR status: the heterozygotes of rs2448343 were associated with PR-positive tumors, while the minor allele homozygotes of rs3213048 and heterozygotes of rs3213067 were associated with PR-negative BC tumors. In survival analysis, rs1871446 was associated with unfavorable event-free survival under recessive model, so was the CDK1 diplotype ATATG/ATATG, which carried the minor allele homozygote of rs1871446. Our study indicates that genetic polymorphisms of CCNB1 and CDK1 are related to BC susceptibility, progression, and survival in Chinese Han women. Further studies need to be performed in other populations as an independent replication to verify these results.	[Li, Yan; Chen, Yi-Lin; Zheng, Li-Yuan; Han, Ji-Yuan; Wang, Hui; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci,Minist Educ, Dept Pathol,Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Xie, Yun-Tao] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Breast Ctr, Beijing 100871, Peoples R China	Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci,Minist Educ, Dept Pathol,Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China.	tianxinxia@163.com; wgfang@bjmu.edu.cn	Li, Yan/ABA-2108-2020	Li, Yan/0000-0002-4658-2080	National Natural Science Foundation of China [81171961]; Ministry of Education of China [20110001110060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (No 81171961) and Doctoral Fund of Ministry of Education of China (No 20110001110060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaniodt R, 2009, GASTROENT RES PRACT, V2009; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Cai H, 2011, AM J EPIDEMIOL, V173, P1263, DOI 10.1093/aje/kwr002; Che CL, 2013, INT J CLIN EXP PATHO, V6, P1538; Chen H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-29; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Corral-Debrinski M, 2000, MOL CELL BIOL, V20, P7881, DOI 10.1128/MCB.20.21.7881-7892.2000; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ding SL, 2009, CARCINOGENESIS, V30, P43, DOI 10.1093/carcin/bgn233; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ghoussaini M, 2009, FUTURE ONCOL, V5, P689, DOI [10.2217/fon.09.29, 10.2217/FON.09.29]; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Han JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049296; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Kang HF, 2013, GENE, V531, P97, DOI 10.1016/j.gene.2013.08.052; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Lin WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068578; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Ma HX, 2011, LUNG CANCER, V73, P32, DOI 10.1016/j.lungcan.2010.11.001; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Narod SA, 2011, LANCET ONCOL, V12, P415, DOI 10.1016/S1470-2045(11)70084-5; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Qi C, 1999, BIOCHEM BIOPH RES CO, V263, P265, DOI 10.1006/bbrc.1999.1328; Ruan Y, 2011, J PATHOL, V225, P535, DOI 10.1002/path.2902; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; THIREOS G, 1984, P NATL ACAD SCI-BIOL, V81, P5096, DOI 10.1073/pnas.81.16.5096; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang ZM, 2013, GENE, V532, P94, DOI 10.1016/j.gene.2013.09.050; Yang ZC, 2013, GENET TEST MOL BIOMA, V17, P700, DOI 10.1089/gtmb.2013.0122; Zempolich K, 2008, GYNECOL ONCOL, V109, P275, DOI 10.1016/j.ygyno.2008.01.027; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhong SL, 2013, GENE, V527, P510, DOI 10.1016/j.gene.2013.06.054	45	18	22	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84489	10.1371/journal.pone.0084489	http://dx.doi.org/10.1371/journal.pone.0084489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386390	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900099
J	Walser, M; Fischer, R; Goschke, T; Kirschbaum, C; Plessow, F				Walser, Moritz; Fischer, Rico; Goschke, Thomas; Kirschbaum, Clemens; Plessow, Franziska			Intention Retrieval and Deactivation Following an Acute Psychosocial Stressor	PLOS ONE			English	Article							PROSPECTIVE MEMORY RETRIEVAL; SALIVARY ALPHA-AMYLASE; HPA AXIS; COGNITIVE FLEXIBILITY; CORTISOL RESPONSES; PREFRONTAL CORTEX; WORKING-MEMORY; TIME; IMPROVES; HUMANS	We often form intentions but have to postpone them until the appropriate situation for retrieval and execution has come, an ability also referred to as event-based prospective memory. After intention completion, our cognitive system has to deactivate no-more-relevant intention representations from memory to avoid interference with subsequent tasks. In everyday life, we frequently rely on these abilities also in stressful situations. Surprisingly, little is known about potential stress effects on these functions. Therefore, the present study aimed to examine the reliability of event-based prospective memory and of intention deactivation in conditions of acute psychosocial stress. To this aim, eighty-two participants underwent the Trier Social Stress Test, a standardized stress protocol, or a standardized control situation. Following this treatment, participants performed a computerized event-based prospective memory task with non-salient and focal prospective memory cues in order to assess prospective memory performance and deactivation of completed intentions. Although the stress group showed elevated levels of salivary cortisol as marker of a stress-related increase in hypothalamus-pituitary-adrenal axis activity throughout the cognitive testing period compared to the no-stress group, prospective memory performance and deactivation of completed intentions did not differ between groups. Findings indicate that cognitive control processes subserving intention retrieval and deactivation after completion may be mostly preserved even under conditions of acute stress.	[Walser, Moritz; Fischer, Rico; Goschke, Thomas; Kirschbaum, Clemens; Plessow, Franziska] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany	Technische Universitat Dresden	Walser, M (corresponding author), Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany.	moritz.walser@tu-dresden.de; franziska.plessow@tu-dresden.de	Fischer, Rico/S-3823-2017; Kirschbaum, Clemens/AAB-1752-2020; Goschke, Thomas/I-2479-2014; Plessow, Franziska/AAE-8754-2019	Fischer, Rico/0000-0002-7142-1756	German Research Foundation (DFG) [SFB 940/1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG, SFB 940/1 Project B5 Plessow/Kirschbaum and Project A3 Fischer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Beck SM, 2014, NEUROPSYCHOLOGIA, V52, P37, DOI 10.1016/j.neuropsychologia.2013.10.020; Beste C, 2013, BEHAV BRAIN RES, V252, P260, DOI 10.1016/j.bbr.2013.06.013; Boisard P, 2003, TIME WORK WORK INTEN; Bugg J., 2013, OXFORD HDB COGNITIVE; Chajut E, 2003, J PERS SOC PSYCHOL, V85, P231, DOI 10.1037/0022-3514.85.2.231; Cornelisse S, 2011, PSYCHONEUROENDOCRINO, V36, P569, DOI 10.1016/j.psyneuen.2010.09.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Einstein GO, 2000, PSYCHOL AGING, V15, P671, DOI 10.1037//0882-7974.15.4.671; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Grundgeiger T, 2014, MEMORY, V22, P679, DOI 10.1080/09658211.2013.812220; Het S, 2009, PSYCHONEUROENDOCRINO, V34, P1075, DOI 10.1016/j.psyneuen.2009.02.008; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kirschbaum C, 1997, J CLIN ENDOCR METAB, V82, P1101, DOI 10.1210/jc.82.4.1101; Kliegel M., 2002, PSYCHOL BEITR, V44, P303; Kofman O, 2006, COGNITION EMOTION, V20, P577, DOI 10.1080/02699930500270913; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Miller R, 2013, PSYCHONEUROENDOCRINO, V38, P941, DOI 10.1016/j.psyneuen.2012.09.013; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, NEUROBIOL LEARN MEM, V86, P344, DOI 10.1016/j.nlm.2006.04.006; Paoli P., 2005, 10 YEARS WORKING CON; Perlman WR, 2007, NEUROBIOL AGING, V28, P447, DOI 10.1016/j.neurobiolaging.2006.01.010; Plessow F, 2012, COGN AFFECT BEHAV NE, V12, P557, DOI 10.3758/s13415-012-0098-6; Plessow F, 2012, EXP BRAIN RES, V216, P397, DOI 10.1007/s00221-011-2943-1; Plessow F, 2011, J COGNITIVE NEUROSCI, V23, P3218, DOI 10.1162/jocn_a_00024; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Rohleder N, 2006, INT J PSYCHOPHYSIOL, V59, P236, DOI 10.1016/j.ijpsycho.2005.10.012; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Rummel J, 2012, COGNITION EMOTION, V26, P351, DOI 10.1080/02699931.2011.574873; Sanchez MM, 2000, J NEUROSCI, V20, P4657, DOI 10.1523/JNEUROSCI.20-12-04657.2000; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schoofs D, 2013, BEHAV BRAIN RES, V241, P144, DOI 10.1016/j.bbr.2012.12.004; Scullin MK, 2012, PSYCHOL AGING, V27, P46, DOI 10.1037/a0026112; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Steinhauser M, 2007, PSYCHOL SCI, V18, P540, DOI 10.1111/j.1467-9280.2007.01935.x; Steyer, 1997, MEHRDIMENSIONALE BEF; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Walser M., 2013, PSYCHOL RES; Walser M, 2012, J EXP PSYCHOL LEARN, V38, P1030, DOI 10.1037/a0027000; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013	52	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85685	10.1371/journal.pone.0085685	http://dx.doi.org/10.1371/journal.pone.0085685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386486	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900132
J	Castillo-Carandang, NT; Sison, OT; Grefal, ML; Sy, RG; Alix, OC; Llanes, EJB; Reganit, PFM; Gumatay, AWG; Punzalan, FER; Velandria, FV; Tai, ES; Wee, HL				Castillo-Carandang, Nina T.; Sison, Olivia T.; Grefal, Mary Lenore; Sy, Rody G.; Alix, Oliver C.; Llanes, Elmer Jasper B.; Reganit, Paul Ferdinand M.; Gumatay, Allan Wilbert G.; Punzalan, Felix Eduardo R.; Velandria, Felicidad V.; Tai, E. Shyong; Wee, Hwee-Lin			A Community-Based Validation Study of the Short-Form 36 Version 2 Philippines (Tagalog) in Two Cities in the Philippines	PLOS ONE			English	Article							SF-36 HEALTH SURVEY; SCALING ASSUMPTIONS; DATA QUALITY; RELIABILITY; VALIDITY; TESTS; WOMEN; MEN	Objective: To evaluate the validity and reliability of the Philippines (Tagalog) Short Form 36 Health Survey version 2 (SF-36v2 (R)) standard questionnaire among Filipinos residing in two cities. Study Design and Setting: The official Philippines (Tagalog) SF-36v2 standard (4-week recall) version was pretested on 30 participants followed by formal and informal cognitive debriefing. To obtain the feedback on translation by bilingual respondents, each SF-36v2 question was stated first in English followed by Tagalog. No revisions to the original questionnaire were needed except that participants thought it was appropriate to incorporate "po" in the instructions to make it more polite. Face-to-face interviews of 562 participants aged 20-50 years living in two barangays (villages) in the highly urbanized city of Makati City (Metro Manila) and in urban and rural barangays in Tanauan City (province of Batangas) were subsequently conducted. Content validity, item level validity, reliability and factor structure of the SF-36v2 (Tagalog) were examined. Results: Content validity of the SF-36v2 was assessed to be adequate for assessing health status among Filipinos. Item means of Philippines (Tagalog) SF-36v2 were similar with comparable scales in the US English, Singapore (English and Chinese) and Thai SF-36 version 1. Item-scale correlation exceeded 0.4 for all items except the bathing item in PF (correlation: 0.31). In exploratory factor analysis, the US two-component model was supported. However, in confirmatory factor analysis, the Japanese three-component model fit the Tagalog data better than the US two-component model. Conclusions: The Philippines (Tagalog) SF-36v2 is a valid and reliable instrument for measuring health status among residents of Makati City (Metro Manila) and Tanauan City (Province of Batangas).	[Castillo-Carandang, Nina T.; Sison, Olivia T.] Univ Philippines, Coll Med, Dept Clin Epidemiol, Manila, Philippines; [Castillo-Carandang, Nina T.; Sison, Olivia T.] Univ Philippines, Inst Clin Epidemiol, Natl Inst Hlth, Manila, Philippines; [Castillo-Carandang, Nina T.; Sison, Olivia T.; Grefal, Mary Lenore; Sy, Rody G.; Alix, Oliver C.; Llanes, Elmer Jasper B.; Reganit, Paul Ferdinand M.; Gumatay, Allan Wilbert G.; Punzalan, Felix Eduardo R.; Velandria, Felicidad V.] UP Manila, LIFEcourse Study CARdiovasc Dis Epidemiol LIFECAR, Lipid Res Unit, UP Philippine Gen Hosp, Manila, Philippines; [Sy, Rody G.] Cardinal Santos Med Ctr, San Juan City, Metro Manila, Philippines; [Tai, E. Shyong] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Wee, Hwee-Lin] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Wee, Hwee-Lin] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore	University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; National University of Singapore; National University of Singapore; Singapore General Hospital	Wee, HL (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.	phawhl@nus.edu.sg	Wee, Hwee Lin/D-4126-2012	Wee, Hwee Lin/0000-0002-7150-1801; Castillo-Carandang, Nina/0000-0001-5360-1801; Sison, Olivia/0000-0002-0929-3052; Tai, E Shyong/0000-0003-2929-8966	Pfizer Pte Ltd Investigator Initiated Grant for the LIFECARE study; Department of Health, Philippine Council for Health Research and Development; Diabetes Philippines in Philippines; Philippine Society of Hypertension in Philippines; Philippine Lipid and Atherosclerosis Society in Philippines	Pfizer Pte Ltd Investigator Initiated Grant for the LIFECARE study; Department of Health, Philippine Council for Health Research and Development; Diabetes Philippines in Philippines; Philippine Society of Hypertension in Philippines; Philippine Lipid and Atherosclerosis Society in Philippines	The authors would like to acknowledge seed funding from Pfizer Pte Ltd Investigator Initiated Grant for the LIFECARE study which began in 2007. Pfizer Pte Ltd and Pfizer Philippine had no input on study design, execution, analysis, interpretation and writing of the manuscript. The authors would also like to acknowledge their academic sponsors. The LIFECARE Philippines study team raised additional funds from government agencies (Department of Health, Philippine Council for Health Research and Development) and professional medical associations in the Philippines (Diabetes Philippines, Philippine Society of Hypertension, and the Philippine Lipid and Atherosclerosis Society). The authors would also like to acknowledge the in-kind contribution of University of the Philippines Manila for providing office space and utilities.	[Anonymous], 2011, COMM BAS MON SYST 20; Birn R, 2003, INT HDB MARKET RES T; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Go CL, 2011, INT J NEUROSCI, V121, P137, DOI 10.3109/00207454.2010.537414; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Lim LLY, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-52; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Navarra SV, 2013, LUPUS, V22, P262, DOI 10.1177/0961203312474086; Rigby W, 2011, ARTHRIT CARE RES, V63, P711, DOI 10.1002/acr.20419; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Tai ES, 2009, CVD PREVENTION CONTR, V4, P93, DOI DOI 10.1016/S1875-4570(09)60339-9; Thumboo J, 2001, QUAL LIFE RES, V10, P175, DOI 10.1023/A:1016701514299; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008	16	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83794	10.1371/journal.pone.0083794	http://dx.doi.org/10.1371/journal.pone.0083794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386281	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700078
J	Um, SJ; Lam, S; Coxson, H; Man, SFP; Sin, DD				Um, Soo Jung; Lam, Stephen; Coxson, Harvey; Man, Shu Fan Paul; Sin, Don D.			Budesonide/Formoterol Enhances the Expression of Pro Surfactant Protein-B in Lungs of COPD Patients	PLOS ONE			English	Article							SP-A; PULMONARY; BIOMARKERS	Rationale & Aim: Pulmonary surfactants are essential components of lung homeostasis. In chronic obstructive pulmonary disease (COPD), surfactant expression decreases in lungs whereas, there is a paradoxical increase in protein expression in plasma. The latter has been associated with poor health outcomes in COPD. The purpose of this study was to determine the relationship of surfactants and other pneumoproteins in bronchoalveolar lavage (BAL) fluid and plasma to airflow limitation and the effects of budesonide/formoterol on this relationship. Methods: We recruited (clinical trials. gov identifier: NCT00569712) 7 smokers without COPD and 30 ex and current smokers with COPD who were free of exacerbations for at least 4 weeks. All subjects were treated with budesonide/formoterol 400/12 mu g twice a day for 4 weeks. BAL fluid and plasma samples were obtained at baseline and the end of the 4 weeks. We measured lung-predominant pneumoproteins: pro-Surfactant Protein-B (pro-SFTPB), Surfactant Protein-D (SP-D), Club Cell Secretory Protein-16 (CCSP-16) and Pulmonary and Activation-Regulated Chemokine (PARC/CCL-18) in BAL fluid and plasma. Results: BAL Pro-SFTPB concentrations had the strongest relationship with airflow limitation as measured by FEV1/FVC (Spearman rho = 0.509; p = 0.001) and FEV1% of predicted (Spearman rho = 0.362; p = 0.028). Plasma CCSP-16 concentrations were also significantly related to airflow limitation (Spearman rho = 0.362; p = 0.028 for FEV1% of predicted). The other biomarkers in BAL fluid or plasma were not significantly associated with airflow limitation. In COPD subjects, budesonide/formoterol significantly increased the BAL concentrations of pro-SFTPB by a median of 62.46 ng/ml (p = 0.022) or 48.7% from baseline median value. Conclusion: Increased severity of COPD is associated with reduced Pro-SFTPB levels in BAL fluid. Short-term treatment with budesonide/formoterol increases these levels in BAL fluid. Long term studies will be needed to determine the clinical relevance of this observation.	[Um, Soo Jung; Coxson, Harvey; Man, Shu Fan Paul; Sin, Don D.] Univ British Columbia, St Pauls Hosp Providence Hlth Care, UBC James Hogg Res Ctr Cardiovasc & Pulm Res, Vancouver, BC V5Z 1M9, Canada; [Lam, Stephen; Sin, Don D.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada; [Lam, Stephen] Univ British Columbia, BC Canc Agcy, Vancouver, BC V5Z 1M9, Canada; [Coxson, Harvey] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Um, Soo Jung] Dong A Univ, Dept Med, Div Resp Med, Pusan, South Korea	St. Paul's Hospital; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Dong A University	Sin, DD (corresponding author), Univ British Columbia, St Pauls Hosp Providence Hlth Care, UBC James Hogg Res Ctr Cardiovasc & Pulm Res, Vancouver, BC V5Z 1M9, Canada.	don.sin@hli.ubc.ca	Sin, Don/AAC-2219-2021; Coxson, Harvey O/A-9861-2017	Coxson, Harvey O/0000-0001-5750-9711	AstraZeneca	AstraZeneca(AstraZeneca)	This study was supported by AstraZeneca. The funder, however, had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Barnes PJ, 2006, AM J RESP CRIT CARE, V174, P6, DOI 10.1164/rccm.200510-1659PP; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; LAM S, 1985, CHEST, V87, P740, DOI 10.1378/chest.87.6.740; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Miles PR, 1999, AM J PHYSIOL-LUNG C, V276, pL186, DOI 10.1152/ajplung.1999.276.1.L186; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray E, 2002, INFECT IMMUN, V70, P1481, DOI 10.1128/IAI.70.3.1481-1487.2002; Nguyen AB, 2011, ARTERIOSCL THROM VAS, V31, P2136, DOI 10.1161/ATVBAHA.111.228692; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; Pryhuber GS, 1998, MOL GENET METAB, V64, P217, DOI 10.1006/mgme.1998.2722; Robin M, 2002, EUR RESPIR J, V20, P1152, DOI 10.1183/09031936.02.02042001; RUBIO S, 1995, J BIOL CHEM, V270, P12162, DOI 10.1074/jbc.270.20.12162; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Tokieda K, 1999, PEDIATR RES, V46, P708, DOI 10.1203/00006450-199912000-00012; Tzortzaki EG, 2007, CURR MED CHEM, V14, P1037, DOI 10.2174/092986707780362943; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC; WHITSETT JA, 1986, PEDIATR RES, V20, P460, DOI 10.1203/00006450-198605000-00016; WHO, 2008, WORLD HLTH STAT; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	23	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83881	10.1371/journal.pone.0083881	http://dx.doi.org/10.1371/journal.pone.0083881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386300	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700085
J	Volokhina, EB; Grijpstra, J; Beckers, F; Lindh, E; Robert, V; Tommassen, J; Bos, MP				Volokhina, Elena B.; Grijpstra, Jan; Beckers, Frank; Lindh, Erika; Robert, Viviane; Tommassen, Jan; Bos, Martine P.			Species-Specificity of the BamA Component of the Bacterial Outer Membrane Protein-Assembly Machinery	PLOS ONE			English	Article							ESCHERICHIA-COLI; OMP85 FAMILY; YAET COMPLEX; BIOGENESIS; DOMAIN; POTRA; MITOCHONDRIA; SUPERFAMILY; FLEXIBILITY; VIABILITY	The BamA protein is the key component of the Bam complex, the assembly machinery for outer membrane proteins (OMP) in gram-negative bacteria. We previously demonstrated that BamA recognizes its OMP substrates in a species-specific manner in vitro. In this work, we further studied species specificity in vivo by testing the functioning of BamA homologs of the proteobacteria Neisseria meningitidis, Neisseria gonorrhoeae, Bordetella pertussis, Burkholderia mallei, and Escherichia coli in E. coli and in N. meningitidis. We found that no BamA functioned in another species than the authentic one, except for N. gonorrhoeae BamA, which fully complemented a N. meningitidis bamA mutant. E. coli BamA was not assembled into the N. meningitidis outer membrane. In contrast, the N. meningitidis BamA protein was assembled into the outer membrane of E. coli to a significant extent and also associated with BamD, an essential accessory lipoprotein of the Bam complex. Various chimeras comprising swapped N-terminal periplasmic and C-terminal membrane-embedded domains of N. meningitidis and E. coli BamA proteins were also not functional in either host, although some of them were inserted in the OM suggesting that the two domains of BamA need to be compatible in order to function. Furthermore, conformational analysis of chimeric proteins provided evidence for a 16-stranded beta-barrel conformation of the membrane-embedded domain of BamA.	[Bos, Martine P.] Univ Utrecht, Dept Mol Microbiol, Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, Utrecht, Netherlands	Utrecht University; Utrecht University	Bos, MP (corresponding author), Univ Utrecht, Dept Mol Microbiol, Utrecht, Netherlands.	M.Bos@uu.nl	Volokhina, Elena/L-4725-2015; Tommassen, Jan/I-1690-2016	Volokhina, Elena/0000-0002-4294-8460; Tommassen, Jan/0000-0001-7633-4945	Netherlands Research Council for Chemical Sciences (CW) of the Netherlands Organization for Scientific Research (NWO); Netherlands Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO)	Netherlands Research Council for Chemical Sciences (CW) of the Netherlands Organization for Scientific Research (NWO); Netherlands Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO)	This work was supported by the Netherlands Research Councils for Chemical Sciences (CW) and Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold T, 2010, J BIOL CHEM, V285, P18003, DOI 10.1074/jbc.M110.112516; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Lenhart TR, 2010, MOL MICROBIOL, V75, P692, DOI 10.1111/j.1365-2958.2009.07015.x; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Stork M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000969; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Tashiro Y, 2008, J BACTERIOL, V190, P3969, DOI 10.1128/JB.02004-07; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wunder T, 2009, CELL RES, V19, P20	37	10	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85799	10.1371/journal.pone.0085799	http://dx.doi.org/10.1371/journal.pone.0085799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376896	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100210
J	Inspector, M; Manor, D; Amir, N; Kushnir, T; Karni, A				Inspector, Michael; Manor, David; Amir, Noam; Kushnir, Tamar; Karni, Avi			A Word by Any Other Intonation: FMRI Evidence for Implicit Memory Traces for Pitch Contours of Spoken Words in Adult Brains	PLOS ONE			English	Article							FUNCTIONAL MRI; PERCEPTUAL SPECIFICITY; REPETITION; CORTEX; RECOGNITION; PROSODY; LATERALIZATION; IDENTIFICATION; SUPPRESSION; ACTIVATION	Objectives: Intonation may serve as a cue for facilitated recognition and processing of spoken words and it has been suggested that the pitch contour of spoken words is implicitly remembered. Thus, using the repetition suppression (RS) effect of BOLD-fMRI signals, we tested whether the same spoken words are differentially processed in language and auditory brain areas depending on whether or not they retain an arbitrary intonation pattern. Experimental design: Words were presented repeatedly in three blocks for passive and active listening tasks. There were three prosodic conditions in each of which a different set of words was used and specific task-irrelevant intonation changes were applied: (i) All words presented in a set flat monotonous pitch contour (ii) Each word had an arbitrary pitch contour that was set throughout the three repetitions. (iii) Each word had a different arbitrary pitch contour in each of its repetition. Principal findings: The repeated presentations of words with a set pitch contour, resulted in robust behavioral priming effects as well as in significant RS of the BOLD signals in primary auditory cortex (BA 41), temporal areas (BA 21 22) bilaterally and in Broca's area. However, changing the intonation of the same words on each successive repetition resulted in reduced behavioral priming and the abolition of RS effects. Conclusions: Intonation patterns are retained in memory even when the intonation is task-irrelevant. Implicit memory traces for the pitch contour of spoken words were reflected in facilitated neuronal processing in auditory and language associated areas. Thus, the results lend support for the notion that prosody and specifically pitch contour is strongly associated with the memory representation of spoken words.	[Inspector, Michael; Manor, David; Karni, Avi] Univ Haifa, Lab Brain Imaging & Learning Res, IL-31999 Haifa, Israel; [Manor, David; Kushnir, Tamar; Karni, Avi] Chaim Sheba Med Ctr, MRI Unit, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; [Amir, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Commun Disorders, IL-69978 Tel Aviv, Israel; [Inspector, Michael; Manor, David] Rambam Med Ctr, MRI Unit, Haifa, Israel	University of Haifa; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Inspector, M (corresponding author), Univ Haifa, Lab Brain Imaging & Learning Res, IL-31999 Haifa, Israel.	hadass2@013.net		Amir, Noam/0000-0002-1704-8444				Badgaiyan RD, 2001, NEUROIMAGE, V13, P272, DOI 10.1006/nimg.2000.0693; BASSILI JN, 1989, Q J EXP PSYCHOL-A, V41, P439, DOI 10.1080/14640748908402375; Belin P, 1996, NEUROLOGY, V47, P1504, DOI 10.1212/WNL.47.6.1504; Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; Boersma P, 1992, PRAAT 4 3 04; Boucard CC, 2005, NEUROREPORT, V16, P1335, DOI 10.1097/01.wnr.0000175242.05343.50; Brett M, 2002, NEUROIMAGE, V16; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Chen HC, 1997, COGNITIVE PROCESSING OF CHINESE AND RELATED ASIAN LANGUAGES, P77; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; CUTLER A, 1979, COGNITION, V7, P49, DOI 10.1016/0010-0277(79)90010-6; DALESSANDRO C, 1994, J ACOUST SOC AM, V95, P1617, DOI 10.1121/1.408548; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; DEMB JB, 1995, J NEUROSCI, V15, P5870; Desmond JE, 1995, BRAIN, V118, P1411, DOI 10.1093/brain/118.6.1411; Dogil G, 2002, J NEUROLINGUIST, V15, P59, DOI 10.1016/S0911-6044(00)00021-X; Elman JL, 2004, TRENDS COGN SCI, V8, P301, DOI 10.1016/j.tics.2004.05.003; Friedrich CK, 2004, COGNITIVE BRAIN RES, V20, P300, DOI 10.1016/j.cogbrainres.2004.03.007; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Gandour J, 2003, BRAIN LANG, V84, P318, DOI 10.1016/S0093-934X(02)00505-9; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Goodglass H., 1993, UNDERSTANDING APHASI; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamburger M, 1994, J ACOUST SOC AM, V95, P2973; Hasson U, 2006, J COGNITIVE NEUROSCI, V18, P2013, DOI 10.1162/jocn.2006.18.12.2013; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hon N, 2006, J NEUROSCI, V26, P9805, DOI 10.1523/JNEUROSCI.3165-06.2006; Johnson Keith, 1997, TALKER VARIABILITY S, P145; Kato K., 1988, Journal of the Acoustical Society of Japan, V44, P180; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Lindfield KC, 1999, BRAIN LANG, V68, P312, DOI 10.1006/brln.1999.2094; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Marsolek CJ, 1996, MEM COGNITION, V24, P539, DOI 10.3758/BF03201082; Matsumoto A, 2005, NEUROIMAGE, V24, P624, DOI 10.1016/j.neuroimage.2004.09.008; McLennan CT, 2005, J EXP PSYCHOL LEARN, V31, P306, DOI 10.1037/0278-7393.31.2.306; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Muller RA, 2004, BRAIN LANG, V89, P329, DOI 10.1016/S0093-934X(03)00346-8; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orfanidou E, 2006, J COGNITIVE NEUROSCI, V18, P1237, DOI 10.1162/jocn.2006.18.8.1237; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; Plante E, 2006, BRAIN LANG, V97, P332, DOI 10.1016/j.bandl.2005.12.004; Poppel D, 2003, SPEECH COMMUN, V41, P425; POSNER MI, 1964, PSYCHOL REV, V71, P491, DOI 10.1037/h0041120; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; SCHACTER DL, 1994, MEMORY, V2, P295, DOI 10.1080/09658219408258950; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; Sommers MS, 1999, J EXP PSYCHOL LEARN, V25, P1236; Taylor KI, 2006, P NATL ACAD SCI USA, V103, P8239, DOI 10.1073/pnas.0509704103; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Versace R, 1998, CAH PSYCHOL COGN, V17, P533; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wennerstorm AK, 2001, MUSIC EVERYDAY SPEEC; Wingfield A, 1997, APPL PSYCHOLINGUIST, V18, P85, DOI 10.1017/S0142716400009887; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593	60	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82042	10.1371/journal.pone.0082042	http://dx.doi.org/10.1371/journal.pone.0082042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391713	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200010
J	Benoist, S; Garel, M; Cugnasse, JM; Blanchard, P				Benoist, Stephanie; Garel, Mathieu; Cugnasse, Jean-Marc; Blanchard, Pierrick			Human Disturbances, Habitat Characteristics and Social Environment Generate Sex-Specific Responses in Vigilance of Mediterranean Mouflon	PLOS ONE			English	Article							PREDATION RISK; GROUP-SIZE; OVIS-GMELINI; BIGHORN SHEEP; BEHAVIOR; AGE; POPULATION; PREY; GAME; ELK	In prey species, vigilance is an important part of the decision making process related to predation risk effects. Therefore, understanding the mechanisms shaping vigilance behavior provides relevant insights on factors influencing individual fitness. We investigated the role of extrinsic and intrinsic factors on vigilance behavior in Mediterranean mouflon (Ovis gmelini musimonxOvis sp.) in a study site spatially and temporally contrasted in human pressures. Both sexes were less vigilant in the wildlife reserve compared to surrounding unprotected areas, except for males during the hunting period. During this period, males tended to be less strictly restricted to the reserve than females what might lead to a pervasive effect of hunting within the protected area, resulting in an increase in male vigilance. It might also be a rutting effect that did not occur in unprotected areas because males vigilance was already maximal in response to human disturbances. In both sexes, yearlings were less vigilant than adults, probably because they traded off vigilance for learning and energy acquisition and/or because they relied on adult experience present in the group. Similarly, non-reproductive females benefited of the vigilance effort provided by reproductive females when belonging to the same group. However, in the absence of reproductive females, non-reproductive females were as vigilant as reproductive females. Increasing group size was only found to reduce vigilance in females (up to 17.5%), not in males. We also showed sex-specific responses to habitat characteristics. Females increased their vigilance when habitat visibility decreased (up to 13.8%) whereas males increased their vigilance when feeding on low quality sites, i.e., when concomitant increase in chewing time can be devoted to vigilance with limited costs. Our global approach was able to disentangle the sex-specific sources of variation in mouflon vigilance and stressed the importance of reserves in managing and conserving wild sheep populations.	[Benoist, Stephanie; Garel, Mathieu] Off Natl Chasse & Faune Sauvage, Ctr Natl Etud & Rech Appl Faune Montagne, Gieres, France; [Cugnasse, Jean-Marc] Off Natl Chasse & Faune Sauvage, Direct Etud & Rech, Toulouse, France; [Blanchard, Pierrick] Univ Toulouse, CNRS, ENFA, Lab Evolut & Diversite Biol,UMR 5174, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Garel, M (corresponding author), Off Natl Chasse & Faune Sauvage, Ctr Natl Etud & Rech Appl Faune Montagne, Gieres, France.	mathieu.garel@oncfs.gouv.fr			Languedoc-Roussilon region	Languedoc-Roussilon region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine)	This project was financially supported by the Languedoc-Roussilon region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arenz CL, 2000, ANIM BEHAV, V59, P535, DOI 10.1006/anbe.1999.1345; Beauchamp G, 2003, BEHAV PROCESS, V63, P111, DOI 10.1016/S0376-6357(03)00002-0; Bednekoff PA, 2009, BEHAV ECOL, V20, P1111, DOI 10.1093/beheco/arp104; Benhaiem S, 2008, ANIM BEHAV, V76, P611, DOI 10.1016/j.anbehav.2008.03.012; BERGER J, 1978, J MAMMAL, V59, P620, DOI 10.2307/1380240; Bergerud A.T., 1974, IUCN Publs (New Series), VNo. 24, P552; Blanchard P, 2007, OIKOS, V116, P1603, DOI 10.1111/j.2007.0030-1299.15799.x; BON R, 1992, ACTA THERIOL, V37, P63, DOI 10.4098/AT.arch.92-7; BON R, 1993, J MAMMAL, V74, P752, DOI 10.2307/1382298; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cabannel A, 1999, ARVICOLA, V1, P11; Carter AJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P237, DOI 10.1007/s00265-009-0840-4; Cazau M, 2011, J WILDLIFE MANAGE, V75, P967, DOI 10.1002/jwmg.117; Cederna A., 1985, P216; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Cransac N, 1997, REV ECOL-TERRE VIE, V52, P21; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Cugnasse Jean-Marc, 2000, Ornithos, V7, P188; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; DIMOND S, 1974, BRAIN BEHAV EVOLUT, V9, P60, DOI 10.1159/000123655; DOUGLAS MJW, 1971, NEW ZEAL J SCI, V14, P507; Dubois M, 1995, BEHAV PROCESS, V35, P93, DOI 10.1016/0376-6357(95)00044-5; DUBOIS M, 1993, ACTA THERIOL, V38, P185, DOI 10.4098/AT.arch.93-17; Festa-Bianchet M, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P191; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Garel M, 2005, EUR J WILDLIFE RES, V51, P69, DOI 10.1007/s10344-004-0075-7; Garel M, 2005, J ZOOL, V266, P65, DOI 10.1017/S0952836905006667; Garel M, 2007, ECOL APPL, V17, P1607, DOI 10.1890/06-0898.1; Garel M, 2006, WILDLIFE SOC B, V34, P300, DOI 10.2193/0091-7648(2006)34[300:EIADOM]2.0.CO;2; Garel M, 2009, J MAMMAL, V90, P954, DOI 10.1644/08-MAMM-A-287.1; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Grignolio S, 2011, BIOL CONSERV, V144, P641, DOI 10.1016/j.biocon.2010.10.022; Hamel S, 2007, CAN J ZOOL, V85, P933, DOI 10.1139/Z07-080; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Harrell FE, 2001, REGRESSION MODELING; Hipfner J. Mark, 2012, Marine Ornithology, V40, P39; Hofer D, 2002, TECHNICAL REPORT; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hopewell L, 2005, BEHAV PROCESS, V70, P186, DOI 10.1016/j.beproc.2005.04.009; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LAZARUS J, 1979, BEHAVIOUR, V71, P127, DOI 10.1163/156853979X00133; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Li CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032607; Liao JG, 2003, AM STAT, V57, P161, DOI 10.1198/0003130031964; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loehr J, 2005, CAN J ZOOL, V83, P1602, DOI 10.1139/Z05-162; LUDWIG D, 1990, AM NAT, V135, P686, DOI 10.1086/285069; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Marchand P, 2013, MAMMAL REV, V43, P275, DOI 10.1111/mam.12000; Martinetto K, 1998, GIBIER FANE SAUVAGE - GAME AND WILDLIFE, VOL 15 (SPECIAL NUMBER PTS 2 AND 3) 1998, P905; Martins AG, 2002, J ZOOL, V258, P27, DOI 10.1017/S0952836902001176; MAUBLANC ML, 1992, ONGULES / UNGULATES 91, P611; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Pays O, 2012, OECOLOGIA, V169, P419, DOI 10.1007/s00442-011-2218-3; Periquet S, 2012, BEHAV ECOL, V23, P970, DOI 10.1093/beheco/ars060; PFEFFER P, 1967, MAMMALIA S, V31, P1; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Rieucau G, 2008, OIKOS, V117, P501, DOI 10.1111/j.0030-1299.2008.16274.x; Rieucau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044801; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; Shackleton D.M., 1997, P9; Smith TS, 1999, WILDLIFE SOC B, V27, P840; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; SULLIVAN KA, 1988, ECOLOGY, V69, P118, DOI 10.2307/1943166; Toigo C, 1999, CAN J ZOOL, V77, P1060, DOI 10.1139/cjz-77-7-1060; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; Tolon V, 2012, ECOL APPL, V22, P648, DOI 10.1890/11-0422.1; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Venables WN., 2002, MODERN APPL STAT S 4; Watson M, 2007, J ANIM ECOL, V76, P211, DOI 10.1111/j.1365-2656.2006.01194.x; Whittingham MJ, 2004, OIKOS, V106, P377, DOI 10.1111/j.0030-1299.2004.13132.x	83	17	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82960	10.1371/journal.pone.0082960	http://dx.doi.org/10.1371/journal.pone.0082960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386131	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700020
J	Cao, ZQ; Zhang, G; Wang, FL; Liu, HB; Liu, L; Han, YL; Zhang, J; Yuan, JL				Cao, Zhiqiang; Zhang, Geng; Wang, Fuli; Liu, Hongbao; Liu, Long; Han, Yaling; Zhang, Jian; Yuan, Jianlin			Protective Effects of Mesenchymal Stem Cells with CXCR4 Up-Regulation in a Rat Renal Transplantation Model	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; PROGENITOR CELLS; IMMUNOGLOBULIN PRODUCTION; PROLONG SURVIVAL; KIDNEY; THERAPY; MIGRATION; DIFFERENTIATION; GROWTH	The homing of mesenchymal stem cells to injured tissue, which is important for the correction of conditions such as ischemia-reperfusion injury (IRI) and immunolesions, has been performed previously, but with poor efficiency. Substantial improvements in engraftment are required to derive clinical benefits from MSC transplantation. Chemokines are the most important factors that control cellular migration. Stromal derived factor-1 (SDF-1) is up-regulated during tissue/organ ischemia damage, and its cognate receptor, chemokine receptor 4 (CXCR4), is involved in stem cell migration. The aim of our study was to investigate CXCR4 expression in MSCs and to validate both its role in mediating migration to transplanted kidneys and its immunoregulatory effects in renal protection. Specifically, the present study was designed to investigate the short-term tissue homing of MSCs carrying genetically modified CXCR4 in a rat renal transplantation model. We tested the hypothesis that MSCs with CXCR4 over-expression can more efficiently regulate immunological reactions. Lentiviral vectors were used to over-express CXCR4 or to introduce a short hairpin ribonucleic acid (shRNA) construct targeting endogenous CXCR4 in rat MSCs. MSCs were labeled with enhanced green fluorescent protein (eGFP). After cell sorting, recipient kidneys were regionally perfused; recipient animals were injected with transduced MSCs, native MSCs, or PBS via tail vein following renal transplantation; and the effects of MSC injection were observed.	[Cao, Zhiqiang; Zhang, Geng; Wang, Fuli; Han, Yaling; Yuan, Jianlin] Fourth Mil Med Univ, Xijing Hosp, Dept Urinary Surg, Xian 710032, Peoples R China; [Liu, Hongbao] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China; [Liu, Long; Han, Yaling] Gen Hosp Shenyang Mil Reg, Dept Urinary Urol & Cardiol, Liaoning Prov Translat Med Lab, Shenyang, Peoples R China; [Zhang, Jian] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Han, YL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urinary Surg, Xian 710032, Peoples R China.	hanyaling2013@aliyun.com; biozhangj@hotmail.com; yuanjianlin2013@aliyun.com			National Natural Science Foundation of China (NSFC) [30872583]; Shanxi Social Development Project of Science and Technology [2009K01-60-03, 2012k16-08-02]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanxi Social Development Project of Science and Technology	This study was supported by the grants from National Natural Science Foundation of China (NSFC)(No. 30872583 to Yuan) and the Shanxi Social Development Project of Science and Technology (No. 2009K01-60-03 and No. 2012k16-08-02 to Yuan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aldinucci A, 2010, J IMMUNOL, V185, P5102, DOI 10.4049/jimmunol.1001332; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bochev I, 2008, CELL BIOL INT, V32, P384, DOI 10.1016/j.cellbi.2007.12.007; Bonig H, 2006, BLOOD, V107, P79, DOI 10.1182/blood-2005-05-2023; Bryan CF, 2001, TRANSPLANTATION, V71, P875, DOI 10.1097/00007890-200104150-00009; Chabannes D, 2007, BLOOD, V110, P3691, DOI 10.1182/blood-2007-02-075481; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097; De Martino M, 2010, TRANSPL P, V42, P1331, DOI 10.1016/j.transproceed.2010.03.079; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Gheisari Y, 2012, STEM CELLS DEV, V21, P2969, DOI 10.1089/scd.2011.0588; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Gupta S, 2010, AM J PHYSIOL-RENAL, V298, pF209, DOI 10.1152/ajprenal.00451.2009; Hara Y, 2011, TRANSPL INT, V24, P1112, DOI 10.1111/j.1432-2277.2011.01328.x; Hoogduijn MJ, 2010, TRANSPLANTATION, V90, P124, DOI 10.1097/TP.0b013e3181ea4240; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Karlsson H, 2008, BLOOD, V112, P532, DOI 10.1182/blood-2007-10-119370; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kim K, 2008, INT J CLIN EXP PATHO, V1, P232; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; LARRICK JW, 1987, BLOOD, V69, P640; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee PT, 2010, STEM CELLS, V28, P573, DOI 10.1002/stem.310; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Martinet L, 2009, EUR J IMMUNOL, V39, P752, DOI 10.1002/eji.200838812; Masereeuw R, 2009, Minerva Urol Nefrol, V61, P373; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Patel SA, 2010, J IMMUNOL, V184, P5885, DOI 10.4049/jimmunol.0903143; Pino CJ, 2010, TRANSL RES, V156, P161, DOI 10.1016/j.trsl.2010.07.005; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Rafei M, 2008, BLOOD, V112, P4991, DOI 10.1182/blood-2008-07-166892; Reinders MEJ, 2010, NEPHROL DIAL TRANSPL, V25, P17, DOI 10.1093/ndt/gfp552; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Riella LV, 2012, JAMA-J AM MED ASSOC, V308, P130, DOI 10.1001/jama.2012.6370; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Schantz JT, 2007, TISSUE ENG, V13, P2615, DOI 10.1089/ten.2006.0438; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Shyu WC, 2006, FRONT BIOSCI-LANDMRK, V11, P899, DOI 10.2741/1846; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Sordi V, 2009, TRANSPLANTATION, V87, pS42, DOI 10.1097/TP.0b013e3181a28533; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Szczypka MS, 2005, STEM CELLS, V23, P44, DOI 10.1634/stemcells.2004-0111; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; van der Woude FJ, 2004, J INVEST MED, V52, P323, DOI 10.1136/jim-52-05-32; Vatazin A V, 2012, Ross Fiziol Zh Im I M Sechenova, V98, P906; Wood KJ, 2003, TRANSPLANTATION, V75, p17S, DOI 10.1097/01.TP.0000067946.90241.2F; Xu GW, 2007, CELL RES, V17, P240, DOI 10.1038/cr.2007.4; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Zhuang Y, 2009, CHINESE MED J-PEKING, V122, P183, DOI 10.3760/cma.j.issn.0366-6999.2009.02.014; Zonta S, 2010, TRANSPL P, V42, P1336, DOI 10.1016/j.transproceed.2010.03.081	99	49	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82949	10.1371/journal.pone.0082949	http://dx.doi.org/10.1371/journal.pone.0082949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386129	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700018
J	Garcia, M; Charlton, BD; Wyman, MT; Fitch, WT; Reby, D				Garcia, Maxime; Charlton, Benjamin D.; Wyman, Megan T.; Fitch, W. Tecumseh; Reby, David			Do Red Deer Stags (Cervus elaphus) Use Roar Fundamental Frequency (F0) to Assess Rivals?	PLOS ONE			English	Article							SOURCE-FILTER THEORY; BABOON LOUD CALLS; BODY-SIZE; ACOUSTIC FEATURES; MALE QUALITY; VOICE PITCH; VOCAL COMMUNICATION; INDICATE LARGER; MENS VOICES; CUES	It is well established that in humans, male voices are disproportionately lower pitched than female voices, and recent studies suggest that this dimorphism in fundamental frequency (F0) results from both intrasexual (male competition) and intersexual (female mate choice) selection for lower pitched voices in men. However, comparative investigations indicate that sexual dimorphism in F0 is not universal in terrestrial mammals. In the highly polygynous and sexually dimorphic Scottish red deer Cervus elaphus scoticus, more successful males give sexually-selected calls (roars) with higher minimum F0s, suggesting that high, rather than low F0s advertise quality in this subspecies. While playback experiments demonstrated that oestrous females prefer higher pitched roars, the potential role of roar F0 in male competition remains untested. Here we examined the response of rutting red deer stags to playbacks of re-synthesized male roars with different median F0s. Our results show that stags' responses (latencies and durations of attention, vocal and approach responses) were not affected by the F0 of the roar. This suggests that intrasexual selection is unlikely to strongly influence the evolution of roar F0 in Scottish red deer stags, and illustrates how the F0 of terrestrial mammal vocal sexual signals may be subject to different selection pressures across species. Further investigations on species characterized by different F0 profiles are needed to provide a comparative background for evolutionary interpretations of sex differences in mammalian vocalizations.	[Garcia, Maxime; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Charlton, Benjamin D.; Wyman, Megan T.; Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Vienna; University of Sussex	Reby, D (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	reby@sussex.ac.uk		Charlton, Benjamin/0000-0002-0218-7177; Reby, David/0000-0001-9261-1711; Garcia, Maxime/0000-0003-2014-7387	University of Vienna	University of Vienna	Funding organization: University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson BM, 1994, SEXUAL SELECTION; [Anonymous], 1998, PRINCIPLES ANIMAL CO; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; BECKFORD NS, 1985, ANN OTO RHINOL LARYN, V94, P634, DOI 10.1177/000348948509400622; Bee MA, 1999, BEHAV ECOL SOCIOBIOL, V45, P177, DOI 10.1007/s002650050551; Bee MA, 2002, BEHAV ECOL, V13, P109, DOI 10.1093/beheco/13.1.109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boersma P., 2013, PRAAT DOING PHONETIC; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, BEHAV ECOL SOCIOBIOL, V66, P969, DOI 10.1007/s00265-012-1345-0; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020329; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Cynx J, 2005, HORM BEHAV, V47, P446, DOI 10.1016/j.yhbeh.2004.11.018; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Fant G, 1971, 2 ACOUSTIC THEORY SP; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fitch W. Tecumseh, 2002, TRANSITION LANGUAGE, P21; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Hardouin LA, 2007, AM NAT, V169, P552, DOI 10.1086/512136; Hardouin LA, 2009, ANIM BEHAV, V78, P907, DOI 10.1016/j.anbehav.2009.07.016; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Herbst CT, 2012, SCIENCE, V337, P595, DOI 10.1126/science.1219712; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233, DOI 10.1002/j.1538-7305.1972.tb02651.x; Kidjo N, 2008, BIOACOUSTICS, V18, P159, DOI 10.1080/09524622.2008.9753598; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; Kreutzer M, 1999, BEHAVIOUR, V136, P1325, DOI 10.1163/156853999500749; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; Lindenfors Patrik, 2007, P16; Malo AF, 2009, P R SOC B, V276, P971, DOI 10.1098/rspb.2008.1367; Martin-Vivaldi M, 1998, J ORNITHOL, V139, P287, DOI 10.1007/BF01653339; MASATAKA N, 1994, FOLIA PRIMATOL, V63, P115, DOI 10.1159/000156803; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Minami Masato, 1992, Journal of the Mammalogical Society of Japan, V17, P71; MITANI JC, 1985, ANIM BEHAV, V33, P272, DOI 10.1016/S0003-3472(85)80141-X; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Neumann C, 2010, ANIM BEHAV, V79, P187, DOI 10.1016/j.anbehav.2009.10.026; OWREN MJ, 1990, J COMP PSYCHOL, V104, P20; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Richardson C, 2010, P ROY SOC B-BIOL SCI, V277, P1247, DOI 10.1098/rspb.2009.1836; RYALLS JH, 1982, J ACOUST SOC AM, V72, P1631, DOI 10.1121/1.388499; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Stopher KV, 2011, BEHAV ECOL, V22, P808, DOI 10.1093/beheco/arr052; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Titze IR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000897; TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; Titze IR, 1994, PRINCIPLES VOICE PRO; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Vignal C, 2007, P ROY SOC B-BIOL SCI, V274, P479, DOI 10.1098/rspb.2006.3744; WAGNER WE, 1989, BEHAV ECOL SOCIOBIOL, V25, P429, DOI 10.1007/BF00300189; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; Wyman MT, 2012, ANIM BEHAV, V84, P1381, DOI 10.1016/j.anbehav.2012.08.037; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	89	10	12	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83946	10.1371/journal.pone.0083946	http://dx.doi.org/10.1371/journal.pone.0083946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386312	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700079
J	Golemba, MD; Culasso, ACA; Villamil, FG; Bare, P; Gadano, A; Ridruejo, E; Martinez, A; Di Lello, FA; Campos, RH				Golemba, Marcelo D.; Culasso, Andres C. A.; Villamil, Federico G.; Bare, Patricia; Gadano, Adrian; Ridruejo, Ezequiel; Martinez, Alfredo; Di Lello, Federico A.; Campos, Rodolfo H.			Hepatitis C Virus Diversification in Argentina: Comparative Analysis between the Large City of Buenos Aires and the Small Rural Town of O'Brien	PLOS ONE			English	Article							GENOTYPE 1B; HEPATOCELLULAR-CARCINOMA; MOLECULAR EPIDEMIOLOGY; GENETIC HISTORY; HIGH PREVALENCE; INFECTION; HCV; DIVERSITY; TRANSMISSION; NOMENCLATURE	Background: The estimated prevalence of HCV infection in Argentina is around 2%. However, higher rates of infection have been described in population studies of small urban and rural communities. The aim of this work was to compare the origin and diversification of HCV-1b in samples from two different epidemiological scenarios: Buenos Aires, a large cosmopolitan city, and O'Brien, a small rural town with a high prevalence of HCV infection. Patients and Methods: The E1/E2 and NS5B regions of the viral genome from 83 patients infected with HCV-1b were sequenced. Phylogenetic analysis and Bayesian Coalescent methods were used to study the origin and diversification of HCV-1b in both patient populations. Results: Samples from Buenos Aires showed a polyphyletic behavior with a t(MRCA) around 1887-1900 and a time of spread of infection approximately 60 years ago. In contrast, samples from OBrien showed a monophyletic behavior with a t(MRCA) around 1950-1960 and a time of spread of infection more recent than in Buenos Aires, around 20-30 years ago. Conclusion: Phylogenetic and coalescence analysis revealed a different behavior in the epidemiological histories of Buenos Aires and OBrien. HCV infection in Buenos Aires shows a polyphyletic behavior and an exponential growth in two phases, whereas that in O'Brien shows a monophyletic cluster and an exponential growth in one single step with a more recent t(MRCA). The polyphyletic origin and the probability of encountering susceptible individuals in a large cosmopolitan city like Buenos Aires are in agreement with a longer period of expansion. In contrast, in less populated areas such as O'Brien, the chances of HCV transmission are strongly restricted. Furthermore, the monophyletic character and the most recent time of emergence suggest that different HCV-1b ancestors (variants) that were in expansion in Buenos Aires had the opportunity to colonize and expand in O'Brien.	[Golemba, Marcelo D.; Culasso, Andres C. A.; Di Lello, Federico A.; Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Villamil, Federico G.] Hosp Britan Buenos Aires, Unidad Trasplante Hepat, Buenos Aires, DF, Argentina; [Villamil, Federico G.] Hosp El Cruce, Unidad Trasplante Hepat, Buenos Aires, DF, Argentina; [Bare, Patricia] Acad Nacl Med Buenos Aires, Sec Virol, Buenos Aires, DF, Argentina; [Gadano, Adrian] Hosp Italiano Buenos Aires, Hepatol Unit, Buenos Aires, DF, Argentina; [Ridruejo, Ezequiel; Martinez, Alfredo] CEMIC, Ctr Educ Med & Invest Clin Norberto Quirno, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Britanico de Buenos Aires; Buenos Aires National Academy of Medicine; Hospital Italiano de Buenos Aires; University of Buenos Aires; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC)	Campos, RH (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar	Ridruejo, Ezequiel/H-7965-2019	Ridruejo, Ezequiel/0000-0002-3321-0683; Di Lello, Federico Alejandro/0000-0001-9771-9705	Universidad de Buenos Aires [SECyT-UBA 2008, B037]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP2009, 01169]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2004, 25355]; Fundacion para la Docencia e Investigacion de las Enfermedades del Higado (FUNDIEH)	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Fundacion para la Docencia e Investigacion de las Enfermedades del Higado (FUNDIEH)	This work was supported by grants from Universidad de Buenos Aires (SECyT-UBA 2008, B037, www.ffyb.uba.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP2009, 01169, www.conicet.gov.ar) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICT2004, 25355, www.agencia.mincyt.gov.ar), Fundacion para la Docencia e Investigacion de las Enfermedades del Higado (FUNDIEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Bessone F, 2005, ACTA GASTROENTEROLOG, V35; Cochrane A, 2002, J INFECT DIS, V186, P1212, DOI 10.1086/344314; Demetriou VL, 2009, J MED VIROL, V81, P238, DOI 10.1002/jmv.21370; Di Lello F, 2008, J MED VIROL, V80, P619, DOI 10.1002/jmv.21112; Di Lello FA, 2009, J MED VIROL, V81, P1887, DOI 10.1002/jmv.21607; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ferraro D, 2008, J MED VIROL, V80, P1723, DOI 10.1002/jmv.21276; Golemba MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008751; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Halfon P, 2002, J CLIN MICROBIOL, V40, P1541, DOI 10.1128/JCM.40.4.1541-1545.2002; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kershenobich D, 2011, LIVER INT, V31, P18, DOI 10.1111/j.1478-3231.2011.02538.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Mengarelli S, 2006, ACTA GASTROENTEROLOG, V3; Mengarelli S, 2006, ACTA GASTROENTEROLOG, V36; Mizokami M, 2004, CANCER CHEMOTH PHARM, V54, pS83, DOI 10.1007/s00280-004-0892-0; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Njouom R, 2009, J GEN VIROL, V90, P2452, DOI 10.1099/vir.0.011981-0; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Picchio GR, 2006, LIVER INT, V26, P660, DOI 10.1111/j.1478-3231.2006.01290.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Quarleri Jorge F., 2007, Acta Gastroenterologica Latinoamericana, V37, P76; Ramadan A, 2006, ACTA GASTROENTEROLOG, V36; Re VE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019471; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84007	10.1371/journal.pone.0084007	http://dx.doi.org/10.1371/journal.pone.0084007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386322	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700084
J	Goncalves, AI; Rodrigues, MT; Lee, SJ; Atala, A; Yoo, JJ; Reis, RL; Gomes, ME				Goncalves, Ana I.; Rodrigues, Marcia T.; Lee, Sang-Jin; Atala, Anthony; Yoo, James J.; Reis, Rui L.; Gomes, Manuela E.			Understanding the Role of Growth Factors in Modulating Stem Cell Tenogenesis	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; FACTOR-BB; IN-VITRO; TGF-BETA; TENDON; PROLIFERATION; REPAIR; DIFFERENTIATION; BIOMECHANICS	Current treatments for tendon injuries often fail to fully restore joint biomechanics leading to the recurrence of symptoms, and thus resulting in a significant health problem with a relevant social impact worldwide. Cell-based approaches involving the use of stem cells might enable tailoring a successful tendon regeneration outcome. As growth factors (GFs) powerfully regulate the cell biological response, their exogenous addition can further stimulate stem cells into the tenogenic lineage, which might eventually depend on stem cells source. In the present study we investigate the tenogenic differentiation potential of human-amniotic fluid stem cells (hAFSCs) and adipose-derived stem cells (hASCs) with several GFs associated to tendon development and healing; namely, EGF, bFGF, PDGF-BB and TGF-beta 1. Stem cells response to biochemical stimuli was studied by screening of tendon-related genes (collagen type I, III, decorin, tenascin C and scleraxis) and proteins found in tendon extracellular matrix (ECM) (Collagen I, III, and Tenascin C). Despite the fact that GFs did not seem to influence the synthesis of tendon ECM proteins, EGF and bFGF influenced the expression of tendon-related genes in hAFSCs, while EGF and PDGF-BB stimulated the genetic expression in hASCs. Overall results on cellular alignment morphology, immunolocalization and PCR analysis indicated that both stem cell source can be biochemically induced towards tenogenic commitment, validating the potential of hASCs and hAFSCs for tendon regeneration strategies.	[Goncalves, Ana I.; Rodrigues, Marcia T.; Reis, Rui L.; Gomes, Manuela E.] Univ Minho, Dept Polymer Engn, Res Grp 3B, Headquarters European Inst Excellence Tissue Engn, Guimaraes, Portugal; [Goncalves, Ana I.; Rodrigues, Marcia T.; Reis, Rui L.; Gomes, Manuela E.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Lee, Sang-Jin; Atala, Anthony; Yoo, James J.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Universidade do Minho; Wake Forest University	Gomes, ME (corresponding author), Univ Minho, Dept Polymer Engn, Res Grp 3B, Headquarters European Inst Excellence Tissue Engn, Guimaraes, Portugal.	megomes@dep.uminho.pt	Yoo, James J./L-4850-2017; Lee, Sang Jin/S-4056-2019; I., Gonçalves A./P-6809-2017; Rodrigues, Marcia/AAB-5242-2020; Reis, Rui L./A-8938-2008; Rodrigues, Márcia T./O-8152-2015	Lee, Sang Jin/0000-0002-3899-1909; I., Gonçalves A./0000-0002-0466-9292; Rodrigues, Marcia/0000-0002-4483-5689; Reis, Rui L./0000-0002-4295-6129; Rodrigues, Márcia T./0000-0002-4483-5689; UMinho, 3B's Research Group/0000-0002-5195-3456; Atala, Anthony/0000-0001-8186-2160	Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/102972/2008, SFRH/BPD/86775/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	Authors thank the Portuguese Foundation for Science and Technology (FCT) for the research project BIBS (PTDC/CVT/102972/2008) and for the post-doc fellowship grant: SFRH/BPD/86775/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Canty EG, 2006, J BIOL CHEM, V281, P38592, DOI 10.1074/jbc.M607581200; Cheng MT, 2010, TISSUE ENG PT A, V16, P2237, DOI 10.1089/ten.TEA.2009.0664; Cheng MT, 2009, TISSUE ENG PT A, V15, P3979, DOI [10.1089/ten.tea.2009.0172, 10.1089/ten.TEA.2009.0172]; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Eagan MJ, 2012, J TISSUE ENG REGEN M; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198; Hee CK, 2012, TISSUE ENG PART B-RE, V18, P225, DOI [10.1089/ten.teb.2011.0603, 10.1089/ten.TEB.2011.0603]; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Klein MB, 2002, J HAND SURG-AM, V27A, P615, DOI 10.1053/jhsu.2002.34004; Liu GP, 2008, CRYOBIOLOGY, V57, P18, DOI 10.1016/j.cryobiol.2008.04.002; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Rada T, 2009, J TISSUE ENG REGEN M, V3, P158, DOI 10.1002/term.141; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Reed SA, 2013, CYTOTECHNOLOGY; Rodrigues MT, 2012, TISSUE ENG PT A, V18, P2518, DOI 10.1089/ten.tea.2011.0672; Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013; Rodrigues MT, 2011, J TISSUE ENG REGEN M; Sakiyama-Elbert SE, 2008, J HAND SURG-AM, V33A, P1548, DOI 10.1016/j.jhsa.2008.05.030; Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444; Thomopoulos S, 2010, ANN BIOMED ENG, V38, P225, DOI 10.1007/s10439-009-9844-5; Tucker RP, 2009, BBA-MOL CELL RES, V1793, P888, DOI 10.1016/j.bbamcr.2008.12.012; Uysal AC, 2010, CURR STEM CELL RES T, V5, P161; Uysal CA, 2012, J PLAST RECONSTR AES, V65, P1712, DOI 10.1016/j.bjps.2012.06.011; Villegas SN, 2010, J CELL BIOCHEM, V110, P10, DOI 10.1002/jcb.22536; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Woo YK, 2007, J ORTHOP RES, V25, P73, DOI 10.1002/jor.20266; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	33	72	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83734	10.1371/journal.pone.0083734	http://dx.doi.org/10.1371/journal.pone.0083734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386267	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700061
J	Mironova, N; Patutina, O; Brenner, E; Kurilshikov, A; Vlassov, V; Zenkova, M				Mironova, Nadezhda; Patutina, Olga; Brenner, Evgenyi; Kurilshikov, Alexander; Vlassov, Valentin; Zenkova, Marina			MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; CELL-PROLIFERATION; REDUCED EXPRESSION; HUMAN ANGIOGENIN; TRANSFER-RNA; RT-PCR; ONCONASE; INHIBITION; IDENTIFICATION; CANCER	Novel data showing an important role of microRNAs in mediating tumour progression opened a new field of possible molecular targets for cytotoxic ribonucleases. Recently, antitumour and antimetastatic activities of pancreatic ribonuclease A were demonstrated and here genome-wide profiles of microRNAs in the tumour and blood of mice bearing Lewis lung carcinoma after treatment with RNase A were analysed by high-throughput Sequencing by Oligonucleotide Ligation and Detection (SOLiD (TM)) sequencing technology. Sequencing data showed that RNase A therapy resulted in the boost of 116 microRNAs in tumour tissue and a significant drop of 137 microRNAs in the bloodstream that were confirmed by qPCR. The microRNA boost in the tumour was accompanied by the overexpression of microRNA processing genes: RNASEN (Drosha), xpo5, dicer1, and eif2c2 (Ago2). Ribonuclease activity of RNase A was shown to be crucial for the activation of both microRNA synthesis and expression of the microRNA processing genes. In the tumour tissue, RNase A caused the upregulation of both oncomirs and tumour-suppressor microRNAs, including microRNAs of the let-7 family, known to negatively regulate tumour progression. Our results suggest that the alteration of microRNA signature caused by RNase A treatment leads to the attenuation of tumour malignancy.	[Mironova, Nadezhda; Patutina, Olga; Brenner, Evgenyi; Kurilshikov, Alexander; Vlassov, Valentin; Zenkova, Marina] Russian Acad Sci, Lab Nucle Acids Biochem, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Zenkova, M (corresponding author), Russian Acad Sci, Lab Nucle Acids Biochem, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	marzen@niboch.nsc.ru	Patutina, Olga/F-9159-2013; Zenkova, Marina A./H-4666-2014; Kurilshikov, Alexander/GWC-1519-2022; Zenkova, Marina A/G-5088-2013; Vlassov, Valentin/F-4720-2013	Kurilshikov, Alexander/0000-0003-2541-5627; Zenkova, Marina/0000-0003-4044-1049; Vlassov, Valentin/0000-0003-2845-2992; Mironova, Nadezhda/0000-0003-4375-0269	RAS; Russian Foundation for Basic Research [11-04-01012, 11-04-01429]; Russian Federation [2307.2012.4];  [2972.2012.4]	RAS(Russian Academy of SciencesRegione Sardegna); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); 	This work was supported by RAS Programs "Molecular and Cellular Biology" and "Fundamental sciences to medicine 2012-24", by grant "Scientific Schools" #2972.2012.4, by Russian Foundation for Basic Research grants 11-04-01012 and 11-04-01429, and by Fellowship of the President of Russian Federation 2307.2012.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barbarotto E, 2008, INT J CANCER, V122, P969, DOI 10.1002/ijc.23343; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEINTEMA JJ, 1988, BIOCHEMISTRY-US, V27, P4530, DOI 10.1021/bi00412a046; BOND MD, 1990, BIOCHEM BIOPH RES CO, V171, P988, DOI 10.1016/0006-291X(90)90781-H; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Costanzi J, 2005, CANCER INVEST, V23, P643, DOI 10.1080/07357900500283143; CURRAN TP, 1993, BIOCHEMISTRY-US, V32, P2307, DOI 10.1021/bi00060a023; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Goparaju CM, 2011, ONCOGENE, V30, P2767, DOI 10.1038/onc.2010.643; Haigis MC, 2003, NUCLEIC ACIDS RES, V31, P1024, DOI 10.1093/nar/gkg163; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ilinskaya O, 2001, TOXICOLOGY, V156, P101, DOI 10.1016/S0300-483X(00)00335-8; Iordanov MS, 2000, CANCER RES, V60, P1983; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; KURACHI K, 1985, BIOCHEMISTRY-US, V24, P5494, DOI 10.1021/bi00341a032; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee I, 2000, J SURG ONCOL, V73, P164, DOI 10.1002/(SICI)1096-9098(200003)73:3<164::AID-JSO10>3.3.CO;2-U; Lee JE, 2008, BIODRUGS, V22, P53, DOI 10.2165/00063030-200822010-00006; Lee JE, 2005, BIOCHEMISTRY-US, V44, P15760, DOI 10.1021/bi051668z; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu JI, 2005, BIOCHEM BIOPH RES CO, V334, P319, DOI 10.1016/j.bbrc.2005.05.206; MASTRONICOLA MR, 1995, EUR J BIOCHEM, V230, P242, DOI 10.1111/j.1432-1033.1995.tb20557.x; Mironova NL, 2013, CELL CYCLE, V12, P2120, DOI 10.4161/cc.25164; Mitkevich VA, 2011, CELL CYCLE, V10, P4090, DOI 10.4161/cc.10.23.18210; Mitkevich VA, 2010, FEBS J, V277, P186, DOI 10.1111/j.1742-4658.2009.07471.x; NITTA K, 1994, CANCER RES, V54, P920; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; Patutina OA, 2010, ACTA NATURAE, V2, P88, DOI 10.32607/20758251-2010-2-1-88-93; Patutina O, 2011, BIOCHIMIE, V93, P689, DOI 10.1016/j.biochi.2010.12.011; Qiao M, 2012, CELL RES, V22, P1199, DOI 10.1038/cr.2012.67; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ran S, 2002, CANCER RES, V62, P6132; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Sevcik J, 2002, J BIOL CHEM, V277, P47325, DOI 10.1074/jbc.M208425200; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; Shklyaeva OA, 2008, DOKL BIOCHEM BIOPHYS, V420, P108, DOI 10.1134/S1607672908030034; STRYDOM DJ, 1985, BIOCHEMISTRY-US, V24, P5486, DOI 10.1021/bi00341a031; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Torres AG, 2012, NUCLEIC ACIDS RES, V40, P2152, DOI 10.1093/nar/gkr885; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vallee BL, 1997, CELL MOL LIFE SCI, V53, P803, DOI 10.1007/s000180050101; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028797; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhao H, 2008, CELL CYCLE, V7, P3258, DOI 10.4161/cc.7.20.6855	64	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83482	10.1371/journal.pone.0083482	http://dx.doi.org/10.1371/journal.pone.0083482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386211	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700044
J	Son, M; Baek, A; Sakkiah, S; Park, C; John, S; Lee, KW				Son, Minky; Baek, Ayoung; Sakkiah, Sugunadevi; Park, Chanin; John, Shalini; Lee, Keun Woo			Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations	PLOS ONE			English	Article							PARTICLE MESH EWALD; BIOLOGICAL-ACTIVITY; CATALYTIC PORTION; STRUCTURAL MECHANISM; CRYSTAL-STRUCTURE; DRUG DISCOVERY; DESIGN; LIGAND; LACTONES; INSIGHTS	3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) is a rate-controlling enzyme in the mevalonate pathway which involved in biosynthesis of cholesterol and other isoprenoids. This enzyme catalyzes the conversion of HMG-CoA to mevalonate and is regarded as a drug target to treat hypercholesterolemia. In this study, ten qualitative pharmacophore models were generated based on chemical features in active inhibitors of HMGR. The generated models were validated using a test set. In a validation process, the best hypothesis was selected based on the statistical parameters and used for virtual screening of chemical databases to find novel lead candidates. The screened compounds were sorted by applying drug-like properties. The compounds that satisfied all drug-like properties were used for molecular docking study to identify their binding conformations at active site of HMGR. The final hit compounds were selected based on docking score and binding orientation. The HMGR structures in complex with the hit compounds were subjected to 10 ns molecular dynamics simulations to refine the binding orientation as well as to check the stability of the hits. After simulation, binding modes including hydrogen bonding patterns and molecular interactions with the active site residues were analyzed. In conclusion, four hit compounds with new structural scaffold were suggested as novel and potent HMGR inhibitors.	[Son, Minky; Baek, Ayoung; Park, Chanin; John, Shalini; Lee, Keun Woo] GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, Gazwa Dong, Jinju, South Korea; [Sakkiah, Sugunadevi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Lee, KW (corresponding author), GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, Gazwa Dong, Jinju, South Korea.	kwlee@gnu.ac.kr		Sakkiah, Suguna Devi/0000-0002-8337-9348	Basic Science Research Program through the National Research Foundation of Korea (NRF) [2012R1A1A4A01013657]; Pioneer Research Center Program through the National Research Foundation of Korea (NRF) [2009-0081539]; Management of Climate Change Program through the National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Pioneer Research Center Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Management of Climate Change Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education of Republic of Korea(Ministry of Education (MOE), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK G, 1990, J MED CHEM, V33, P52, DOI 10.1021/jm00163a010; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BONE EA, 1992, J MED CHEM, V35, P3388, DOI 10.1021/jm00096a015; BOUMENDIL E, 1995, EPIDEMIOLOGY, V6, P322, DOI 10.1097/00001648-199505000-00023; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cai ZY, 2007, BIOORGAN MED CHEM, V15, P7809, DOI 10.1016/j.bmc.2007.08.044; Chen X, 2002, BIOINFORMATICS, V18, P130, DOI 10.1093/bioinformatics/18.1.130; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ENDO A, 1992, J LIPID RES, V33, P1569; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; FRYE LL, 1993, J MED CHEM, V36, P410, DOI 10.1021/jm00055a012; HARTMAN GD, 1992, J MED CHEM, V35, P3813, DOI 10.1021/jm00099a009; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2002, AM HEART J, V144, pS27, DOI 10.1067/mhj.2002.130300; Istvan ES, 2001, CURR OPIN STRUC BIOL, V11, P746, DOI 10.1016/S0959-440X(01)00276-7; Istvan ES, 2000, BBA-MOL CELL BIOL L, V1529, P9, DOI 10.1016/S1388-1981(00)00134-7; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; J Alvarez, 2005, VIRTUAL SCREENING DR; JENDRALLA H, 1990, J MED CHEM, V33, P61, DOI 10.1021/jm00163a011; JENDRALLA H, 1991, J MED CHEM, V34, P2962, DOI 10.1021/jm00114a004; John S, 2012, J BIOMOL STRUCT DYN, V29, P921, DOI 10.1080/07391102.2012.10507419; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim HJ, 2008, J CHEM INF MODEL, V48, P197, DOI 10.1021/ci700160t; LARSEN SD, 1994, J MED CHEM, V37, P2343, DOI 10.1021/jm00041a013; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Medina-Franco JL, 2005, BIOORG MED CHEM LETT, V15, P989, DOI 10.1016/j.bmcl.2004.12.046; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pak VV, 2010, BIOORGAN MED CHEM, V18, P4300, DOI 10.1016/j.bmc.2010.04.090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pfefferkorn JA, 2007, BIOORG MED CHEM LETT, V17, P4538, DOI 10.1016/j.bmcl.2007.05.096; Pfefferkorn JA, 2007, BIOORG MED CHEM LETT, V17, P4531, DOI 10.1016/j.bmcl.2007.05.097; PHAN T, 1995, J NEUROL NEUROSUR PS, V58, P625, DOI 10.1136/jnnp.58.5.625; PROKSCH E, 1995, HAUTARZT, V46, P76, DOI 10.1007/s001050050213; Reddy AS, 2007, CURR PROTEIN PEPT SC, V8, P329; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sarver RW, 2008, J MED CHEM, V51, P3804, DOI 10.1021/jm7015057; SIT SY, 1992, BIOORG MED CHEM LETT, V2, P1085, DOI 10.1016/S0960-894X(00)80623-X; SLISKOVIC DR, 1992, J MED CHEM, V35, P2095, DOI 10.1021/jm00089a022; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Suzuki M, 2001, BIOORG MED CHEM LETT, V11, P1285, DOI 10.1016/S0960-894X(01)00203-7; Tabernero L, 1999, P NATL ACAD SCI USA, V96, P7167, DOI 10.1073/pnas.96.13.7167; Tabernero L, 2003, J BIOL CHEM, V278, P19933, DOI 10.1074/jbc.M213006200; Thangapandian S, 2011, EUR J MED CHEM, V46, P2469, DOI 10.1016/j.ejmech.2011.03.035; Thilagavathi R, 2005, BIOORG MED CHEM LETT, V15, P1027, DOI 10.1016/j.bmcl.2004.12.042; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Walters WP, 1998, DRUG DISCOV TODAY, V3, P160, DOI 10.1016/S1359-6446(97)01163-X; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Zhao SK, 2009, BIOORGAN MED CHEM, V17, P7915, DOI 10.1016/j.bmc.2009.10.021	57	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83496	10.1371/journal.pone.0083496	http://dx.doi.org/10.1371/journal.pone.0083496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386216	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700046
J	Aston, E; Channon, A; Day, C; Knight, CG				Aston, Elizabeth; Channon, Alastair; Day, Charles; Knight, Christopher G.			Critical Mutation Rate Has an Exponential Dependence on Population Size in Haploid and Diploid Populations	PLOS ONE			English	Article							ERROR THRESHOLDS; FINITE POPULATIONS; DIGITAL ORGANISMS; ROBUSTNESS; EVOLUTION; EVOLVABILITY; SELECTION; SURVIVAL; FLATTEST; FITNESS	Understanding the effect of population size on the key parameters of evolution is particularly important for populations nearing extinction. There are evolutionary pressures to evolve sequences that are both fit and robust. At high mutation rates, individuals with greater mutational robustness can outcompete those with higher fitness. This is survival-of-the-flattest, and has been observed in digital organisms, theoretically, in simulated RNA evolution, and in RNA viruses. We introduce an algorithmic method capable of determining the relationship between population size, the critical mutation rate at which individuals with greater robustness to mutation are favoured over individuals with greater fitness, and the error threshold. Verification for this method is provided against analytical models for the error threshold. We show that the critical mutation rate for increasing haploid population sizes can be approximated by an exponential function, with much lower mutation rates tolerated by small populations. This is in contrast to previous studies which identified that critical mutation rate was independent of population size. The algorithm is extended to diploid populations in a system modelled on the biological process of meiosis. The results confirm that the relationship remains exponential, but show that both the critical mutation rate and error threshold are lower for diploids, rather than higher as might have been expected. Analyzing the transition from critical mutation rate to error threshold provides an improved definition of critical mutation rate. Natural populations with their numbers in decline can be expected to lose genetic material in line with the exponential model, accelerating and potentially irreversibly advancing their decline, and this could potentially affect extinction, recovery and population management strategy. The effect of population size is particularly strong in small populations with 100 individuals or less; the exponential model has significant potential in aiding population management to prevent local ( and global) extinction events.	[Aston, Elizabeth; Channon, Alastair; Day, Charles] Keele Univ, Res Inst Environm Phys Sci & Appl Math, Keele ST5 5BG, Staffs, England; [Knight, Christopher G.] Univ Manchester, Manchester, Greater Manches, England	Keele University; University of Manchester	Aston, E (corresponding author), Keele Univ, Res Inst Environm Phys Sci & Appl Math, Keele ST5 5BG, Staffs, England.	e.j.aston@keele.ac.uk	Knight, Chris/AAM-3228-2020	Knight, Chris/0000-0001-9815-4267	EPSRC [EP/H031936/1]; Wellcome Trust [082453/Z/07/Z]; Engineering and Physical Sciences Research Council [EP/H031936/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC grant EP/H031936/1; CGK was supported by a fellowship from the Wellcome Trust (082453/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves D, 1997, J PHYS A-MATH GEN, V30, P2601, DOI 10.1088/0305-4470/30/8/009; Beslon G, 2010, BIOSYSTEMS, V102, P32, DOI 10.1016/j.biosystems.2010.07.009; Bloom JD, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-29; Boerlijst MC, 1996, P ROY SOC B-BIOL SCI, V263, P1577, DOI 10.1098/rspb.1996.0231; Bornberg-Bauer E, 2010, HFSP J, V4, P105, DOI 10.2976/1.3404403; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Campbell NA, 2005, FDN GENETIC ALGORITH; Campos PRA, 1999, J PHYS A-MATH GEN, V32, pL1, DOI 10.1088/0305-4470/32/1/001; Channon A, 2011, ADV ARTIFICIAL LIFE, P117; Comas I, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-5; Domingo E, 2009, EMBO REP, V10, P444, DOI 10.1038/embor.2009.61; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; Eigen M, 1979, HYPERCYCLE; Fisher RA, 1930, GENETICAL THEORY NAT; Forst CV, 1995, LECT NOTES ARTIF INT, V929, P128; Gonzalez A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0404; Hutter B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-116; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Jones J, 2006, GECCO 2006: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P143; KIMURA M, 1966, GENETICS, V54, P1337; Kimura M., 1983, NEUTRAL THEORY MOL E; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Lorenz DM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022704; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Moran P., 1962, STAT PROCESSES EVOLU; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NOWAK M, 1989, J THEOR BIOL, V137, P375, DOI 10.1016/S0022-5193(89)80036-0; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ochoa G, 1999, LECT NOTES ARTIF INT, V1674, P54; Ochoa G, 2006, LECT NOTES COMPUT SC, V4193, P890; Ochoa G, 2006, EVOL COMPUT, V14, P157, DOI 10.1162/evco.2006.14.2.157; Orr HA, 2010, PHILOS T R SOC B, V365, P1195, DOI 10.1098/rstb.2009.0282; Park JM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011902; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Sardanyes J, 2008, J THEOR BIOL, V250, P560, DOI 10.1016/j.jtbi.2007.10.027; Schuster P, 2009, EUR REV, V17, P281, DOI 10.1017/S1062798709000787; Strelioff CC, 2010, J THEOR BIOL, V266, P584, DOI 10.1016/j.jtbi.2010.07.025; Takeuchi N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-15; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Tannenbaum E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021903; Tejero H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-2; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; WIEHE T, 1995, J THEOR BIOL, V177, P1, DOI 10.1006/jtbi.1995.0220; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44; Wilke CO, 2001, EVOLUTION, V55, P2412; Wilke CO, 2001, B MATH BIOL, V63, P715, DOI 10.1006/bulm.2001.0244; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wright S, 1932, P 6 INT C GEN, P355	52	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83438	10.1371/journal.pone.0083438	http://dx.doi.org/10.1371/journal.pone.0083438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386200	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000329117900035
J	Konikoff, J; Brookmeyer, R; Longosz, AF; Cousins, MM; Celum, C; Buchbinder, SP; Seage, GR; Kirk, GD; Moore, RD; Mehta, SH; Margolick, JB; Brown, J; Mayer, KH; Koblin, BA; Justman, JE; Hodder, SL; Quinn, TC; Eshleman, SH; Laeyendecker, O				Konikoff, Jacob; Brookmeyer, Ron; Longosz, Andrew F.; Cousins, Matthew M.; Celum, Connie; Buchbinder, Susan P.; Seage, George R., III; Kirk, Gregory D.; Moore, Richard D.; Mehta, Shruti H.; Margolick, Joseph B.; Brown, Joelle; Mayer, Kenneth H.; Koblin, Beryl A.; Justman, Jessica E.; Hodder, Sally L.; Quinn, Thomas C.; Eshleman, Susan H.; Laeyendecker, Oliver			Performance of a Limiting-Antigen Avidity Enzyme Immunoassay for Cross-Sectional Estimation of HIV Incidence in the United States	PLOS ONE			English	Article							INCIDENCE RATES; TYPE-1 SEROCONVERSION; INFECTION; COHORT; ASSAYS; CHALLENGES; ACCURACY; EPIDEMIC; THERAPY; PLASMA	Background: A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for cross-sectional HIV incidence estimation. We evaluated the performance of the LAg-Avidity assay alone and in multi-assay algorithms (MAAs) that included other biomarkers. Methods and Findings: Performance of testing algorithms was evaluated using 2,282 samples from individuals in the United States collected 1 month to >8 years after HIV seroconversion. The capacity of selected testing algorithms to accurately estimate incidence was evaluated in three longitudinal cohorts. When used in a single-assay format, the LAg-Avidity assay classified some individuals infected >5 years as assay positive and failed to provide reliable incidence estimates in cohorts that included individuals with long-term infections. We evaluated >500,000 testing algorithms, that included the LAg-Avidity assay alone and MAAs with other biomarkers (BED capture immunoassay [BED-CEIA], BioRad-Avidity assay, HIV viral load, CD4 cell count), varying the assays and assay cutoffs. We identified an optimized 2-assay MAA that included the LAg-Avidity and BioRad-Avidity assays, and an optimized 4-assay MAA that included those assays, as well as HIV viral load and CD4 cell count. The two optimized MAAs classified all 845 samples from individuals infected >5 years as MAA negative and estimated incidence within a year of sample collection. These two MAAs produced incidence estimates that were consistent with those from longitudinal follow-up of cohorts. A comparison of the laboratory assay costs of the MAAs was also performed, and we found that the costs associated with the optimal two assay MAA were substantially less than with the four assay MAA. Conclusions: The LAg-Avidity assay did not perform well in a single-assay format, regardless of the assay cutoff. MAAs that include the LAg-Avidity and BioRad-Avidity assays, with or without viral load and CD4 cell count, provide accurate incidence estimates.	[Konikoff, Jacob; Brookmeyer, Ron; Laeyendecker, Oliver] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Longosz, Andrew F.] NIAID, NIH, Bethesda, MD 20892 USA; [Cousins, Matthew M.; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie] Univ Washington, Dept Med, Seattle, WA USA; [Buchbinder, Susan P.] San Francisco Dept Hlth, San Francisco, CA USA; [Laeyendecker, Oliver] UCSF, Dept Epidemiol, San Francisco, CA USA; [Laeyendecker, Oliver] UCSF, Dept Med, San Francisco, CA USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kirk, Gregory D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Moore, Richard D.; Mehta, Shruti H.; Laeyendecker, Oliver] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Margolick, Joseph B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Brown, Joelle] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Mayer, Kenneth H.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Koblin, Beryl A.] New York Blood Ctr, New York, NY 10021 USA; [Justman, Jessica E.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Hodder, Sally L.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; New York Blood Center; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Laeyendecker, O (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA.	olaeyen1@jhmi.edu	Justman, Jessica/AAA-3572-2020	Cousins, Matthew/0000-0003-0067-9087; Laeyendecker, Oliver/0000-0002-6429-4760	HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH); Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services [UM1-AI068613, R01-AI095068]; Division of Intramural Research, NIAID, NIH; HIV Network for Prevention Trials (HIVNET); NIAID, NIH, DHHS [N01-AI35176, N01-AI-45200, AI-45202]; NIDA [R01-DA-04334, R01-DA12568, R01-DA011602]; NIAID; National Cancer Institute; National Heart, Lung and Blood Institute [U01-AI35042, U01-AI35043, U01-AI35039, U01-AI35040, U01-AI35041, UL1-RR025005]; National Institute of Alcohol Abuse and Alcoholism [R01-AA016893]; NIH [UM1-AI068613, HPTN 061, HPTN 064, UM1-AI068619, UM1-AI068617]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042, U01AI035043, UM1AI068613, ZIAAI000361, UM1AI068619, UM1AI069470, U01AI035041, U01AI035040, R01AI095068, N01AI035176, N01AI045200, U01AI035039, UM1AI069419, UM1AI068617, P30AI027763, R13AI145202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012568, R01DA011602, R01DA004334, U01DA036297] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH); Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HIV Network for Prevention Trials (HIVNET); NIAID, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by: (1) the HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), and the Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services (UM1-AI068613 to SE); (2) R01-AI095068 (to SE and RB); and (3) the Division of Intramural Research, NIAID, NIH. The funders had no role in the design and conduct of the study, data collection and analysis, preparation of the manuscript, or the decision to publish. Support for the studies that provided samples for this project was as follows: the HIVNET 001/001.1 study was funded by the HIV Network for Prevention Trials (HIVNET) and sponsored by the NIAID, NIH, DHHS (N01-AI35176, N01-AI-45200, and AI-45202); the ALIVE study is funded by NIDA (R01-DA-04334 and R01-DA12568; the MACS is funded by the NIAID, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute (U01-AI35042, U01-AI35043, U01-AI35039, U01-AI35040, U01-AI35041, and UL1-RR025005); the JHHCC is funded by NIDA (R01-DA011602 to RDM) and the National Institute of Alcohol Abuse and Alcoholism (R01-AA016893 to RDM); HPTN 061 and HPTN 064 were funded by the NIH (see above; UM1-AI068619, UM1-AI068617, and UM1-AI068613). Role of the funders: None of the funders had a role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation, review, or approval of the manuscript.	Brookmeyer R, 1997, J ROY STAT SOC A STA, V160, P127, DOI 10.1111/1467-985X.00049; BROOKMEYER R, 1995, AM J EPIDEMIOL, V142, P709, DOI 10.1093/oxfordjournals.aje.a117700; Brookmeyer R, 2013, JAIDS-J ACQ IMM DEF, V63, pS233, DOI 10.1097/QAI.0b013e3182986fdf; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Brookmeyer R, 2010, JAIDS-J ACQ IMM DEF, V54, P406, DOI 10.1097/QAI.0b013e3181dc6d2c; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Cousins MM, 2012, 19 C RETR OPP INF MA; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fogel JM, 2013, J INFECT DI IN PRESS; Freiden T, 2013, 20 C RETR OPP INF AT; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Hodder SL, 2013, ANN INTERN MED, V158, P10, DOI 10.7326/0003-4819-158-1-201301010-00004; Kahle EM, 2013, J ACQUIR IM IN PRESS; Kaplan EH, 1999, OPER RES, V47, P29, DOI 10.1287/opre.47.1.29; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kassanjee R, 2013, 20 C RETR OPP INF MA; Koblin B, 2013, PLOS ONE IN PRESS; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Masciotra S, 2010, 17 C RETR OPP INF FE; Masciotra S, 2013, 20 C RETR OPP INF MA; Mastro TD, 2013, J INFECT DIS, V207, P204, DOI 10.1093/infdis/jis661; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Mullis CE, 2013, AIDS RES HUM RETROVI; Murphy G, 2008, EUROSURVEILLANCE, V1, P13; Parekh B, 2012, 19 INT AIDS C JUL 22; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Sedia Biosciences Corporation, 2013, SED HIV 1 LAG AV EIA; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sullivan AK, 2013, SEX TRANSM INFECT, V89, P120, DOI 10.1136/sextrans-2012-050801; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	40	47	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82772	10.1371/journal.pone.0082772	http://dx.doi.org/10.1371/journal.pone.0082772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386116	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900015
J	Firmino, AAP; Fonseca, FCD; de Macedo, LLP; Coelho, RR; de Souza, JDA; Togawa, RC; Silva, OB; Pappas, GJ; da Silva, MCM; Engler, G; Grossi-de-Sa, MF				Pereira Firmino, Alexandre Augusto; de Assis Fonseca, Fernando Campos; Pepino de Macedo, Leonardo Lima; Coelho, Roberta Ramos; Antonino de Souza, Jose Dijair, Jr.; Togawa, Roberto Coiti; Silva-Junior, Orzenil Bonfim; Pappas-, Georgios Joannis, Jr.; Mattar da Silva, Maria Cristina; Engler, Gilbert; Grossi-de-Sa, Maria Fatima			Transcriptome Analysis in Cotton Boll Weevil (Anthonomus grandis) and RNA Interference in Insect Pests	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHITIN-SYNTHESIS; CLUSTAL-W; GENE; COLEOPTERA; BEETLE; EXPRESSION; PRINCIPLES; SYNTHASES; SURVIVAL	Cotton plants are subjected to the attack of several insect pests. In Brazil, the cotton boll weevil, Anthonomus grandis, is the most important cotton pest. The use of insecticidal proteins and gene silencing by interference RNA (RNAi) as techniques for insect control are promising strategies, which has been applied in the last few years. For this insect, there are not much available molecular information on databases. Using 454-pyrosequencing methodology, the transcriptome of all developmental stages of the insect pest, A. grandis, was analyzed. The A. grandis transcriptome analysis resulted in more than 500.000 reads and a data set of high quality 20,841 contigs. After sequence assembly and annotation, around 10,600 contigs had at least one BLAST hit against NCBI non-redundant protein database and 65.7% was similar to Tribolium castaneum sequences. A comparison of A. grandis, Drosophila melanogaster and Bombyx mori protein families' data showed higher similarity to dipteran than to lepidopteran sequences. Several contigs of genes encoding proteins involved in RNAi mechanism were found. PAZ Domains sequences extracted from the transcriptome showed high similarity and conservation for the most important functional and structural motifs when compared to PAZ Domains from 5 species. Two SID-like contigs were phylogenetically analyzed and grouped with T. castaneum SID-like proteins. No RdRP gene was found. A contig matching chitin synthase 1 was mined from the transcriptome. dsRNA microinjection of a chitin synthase gene to A. grandis female adults resulted in normal oviposition of unviable eggs and malformed alive larvae that were unable to develop in artificial diet. This is the first study that characterizes the transcriptome of the coleopteran, A. grandis. A new and representative transcriptome database for this insect pest is now available. All data support the state of the art of RNAi mechanism in insects.	[Pereira Firmino, Alexandre Augusto; de Assis Fonseca, Fernando Campos; Pepino de Macedo, Leonardo Lima; Coelho, Roberta Ramos; Antonino de Souza, Jose Dijair, Jr.; Togawa, Roberto Coiti; Silva-Junior, Orzenil Bonfim; Mattar da Silva, Maria Cristina; Grossi-de-Sa, Maria Fatima] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Pereira Firmino, Alexandre Augusto] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Grad Program Cellular & Mol Biol, Porto Alegre, RS, Brazil; [de Assis Fonseca, Fernando Campos; Coelho, Roberta Ramos; Antonino de Souza, Jose Dijair, Jr.; Pappas-, Georgios Joannis, Jr.] Univ Brasilia, Grad Program Biol Mol, Brasilia, DF, Brazil; [Pepino de Macedo, Leonardo Lima; Grossi-de-Sa, Maria Fatima] Univ Catolica Brasilia, Grad Program Genom Sci & Biotechnol, Brasilia, DF, Brazil; [Engler, Gilbert] INRA, Sophia Antipolis, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Rio Grande do Sul; Universidade de Brasilia; Universidade Catolica de Brasilia; INRAE	Firmino, AAP (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	alexfirm@gmail.com; fatima.grossi@embrapa.br	Fonseca, Fernando/AAX-6839-2021; de Souza, Jose Dijair Antonino/I-1028-2014; Silva-Junior, Orzenil/B-3488-2013; Grossi-de-Sa, Maria Fatima/N-7856-2017; Pappas, Georgios J./N-8071-2019	Fonseca, Fernando/0000-0001-6434-5954; de Souza, Jose Dijair Antonino/0000-0002-4992-0698; Silva-Junior, Orzenil/0000-0002-2104-2010; Pappas, Georgios J./0000-0002-1100-976X; Togawa, Roberto/0000-0001-7179-3210; GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599	CAPES; EMBRAPA; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CAPES (http://www.capes.gov.br/), EMBRAPA (http://www.embrapa.br/), and CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2003, CONT T ENT, P145; Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; [America NCCo US and Northern Mexico], 2009, PEST MAN BOLL WEEV E; Arakane Y, 2008, INSECT BIOCHEM MOLEC, V38, P959, DOI 10.1016/j.ibmb.2008.07.006; Arakane Y, 2011, INSECT BIOCHEM MOLEC, V41, P42, DOI 10.1016/j.ibmb.2010.09.011; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Calvo D, 2008, ANN ENTOMOL SOC AM, V101, P881, DOI 10.1603/0013-8746(2008)101[881:HCWAID]2.0.CO;2; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Consortium ikI, 2012, ARTHROPOD GENOMES; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freire EC, 2011, ALGODAO CERRADO; Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Grossi-de-Sa MF, 2012, METODO COMPOSICOES C; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Lange CE, 2009, J PARASITOL, V95, P976, DOI 10.1645/GE-1923.1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legrand S, 2010, GENE, V450, P55, DOI 10.1016/j.gene.2009.10.004; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; MCLAUGHLIN RE, 1966, J ECON ENTOMOL, V59, P401, DOI 10.1093/jee/59.2.401; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Merzendorfer H, 2011, EUR J CELL BIOL, V90, P759, DOI 10.1016/j.ejcb.2011.04.014; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Monnerat R. G., 2000, COMUN TECNICO EMBRAP, V46; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Ostrowski S, 2002, GENETICS, V161, P171; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Posnien N, 2009, COLD SPRING HARB PRO, V2009; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sappington TW, 2000, ANN ENTOMOL SOC AM, V93, P610, DOI 10.1603/0013-8746(2000)093[0610:PTFASD]2.0.CO;2; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wilson TG, 1997, J EXP ZOOL, V278, P37, DOI 10.1002/(SICI)1097-010X(19970501)278:1&lt;37::AID-JEZ4&gt;3.0.CO;2-7; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	67	46	48	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85079	10.1371/journal.pone.0085079	http://dx.doi.org/10.1371/journal.pone.0085079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386449	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900123
J	Issman, L; Brenner, B; Talmon, Y; Aharon, A				Issman, Liron; Brenner, Benjamin; Talmon, Yeshayahu; Aharon, Anat			Cryogenic Transmission Electron Microscopy Nanostructural Study of Shed Microparticles	PLOS ONE			English	Article							INDUCED PLATELET MICROPARTICLES; CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; BLOOD; EXOSOMES; CELLS; SURFACTANT; CRYOPRESERVATION; TEMPERATURE; GENERATION	Microparticles (MPs) are sub-micron membrane vesicles (100-1000 nm) shed from normal and pathologic cells due to stimulation or apoptosis. MPs can be found in the peripheral blood circulation of healthy individuals, whereas elevated concentrations are found in pregnancy and in a variety of diseases. Also, MPs participate in physiological processes, e. g., coagulation, inflammation, and angiogenesis. Since their clinical properties are important, we have developed a new methodology based on nano-imaging that provides significant new data on MPs nanostructure, their composition and function. We are among the first to characterize by direct-imaging cryogenic transmitting electron microscopy (cryo-TEM) the near-to-native nanostructure of MP systems isolated from different cell types and stimulation procedures. We found that there are no major differences between the MP systems we have studied, as most particles were spherical, with diameters from 200 to 400 nm. However, each MP population is very heterogeneous, showing diverse morphologies. We investigated by cryo-TEM the effects of standard techniques used to isolate and store MPs, and found that either high-g centrifugation of MPs for isolation purposes, or slow freezing to -80 degrees C for storage introduce morphological artifacts, which can influence MP nanostructure, and thus affect the efficiency of these particles as future diagnostic tools.	[Issman, Liron; Talmon, Yeshayahu] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Issman, Liron; Talmon, Yeshayahu] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, Haifa, Israel; [Brenner, Benjamin; Aharon, Anat] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Brenner, Benjamin; Aharon, Anat] Rambam Hlth Care Campus, Dept Hematol, Thrombosis & Hemostasis Unit, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus	Issman, L (corresponding author), Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.	Icey77@gmail.com; ishi@tx.technion.ac.il	Talmon, Yeshayahu/N-1076-2019	Talmon, Yeshayahu/0000-0002-9854-3972	Technion Russell Berrie Nanotechnology Institute (RBNI) through a Nevet grant	Technion Russell Berrie Nanotechnology Institute (RBNI) through a Nevet grant	The authors thank the Technion Russell Berrie Nanotechnology Institute (RBNI) for financial support through a Nevet grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aass HCD, 2011, CYTOM PART A, V79A, P990, DOI 10.1002/cyto.a.21147; ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; Brodsky SV, 2008, J GASTROINTEST LIVER, V17, P261; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Golan S, 2011, LANGMUIR, V27, P6615, DOI 10.1021/la200450x; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hoyer FF, 2012, J CELL MOL MED, V16, P2777, DOI 10.1111/j.1582-4934.2012.01595.x; Issman L, 2012, J MICROSC-OXFORD, V246, P60, DOI 10.1111/j.1365-2818.2011.03587.x; Jaiswal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061515; Katayama Y, 1997, BONE MARROW TRANSPL, V19, P283, DOI 10.1038/sj.bmt.1700644; Katzenell S, 2012, THROMB RES; Keuren JF, 2006, BRIT J HAEMATOL, V134, P307, DOI 10.1111/j.1365-2141.2006.06167.x; Koh CG, 2010, J CONTROL RELEASE, V141, P62, DOI 10.1016/j.jconrel.2009.08.019; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Meziani F, 2008, PHARMACOL REP, V60, P75; MILLER DD, 1987, J PHYS CHEM-US, V91, P674, DOI 10.1021/j100287a036; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pizzey CL, 2008, J PHYS CHEM B, V112, P5849, DOI 10.1021/jp7103903; Redman CWG, 2007, J REPROD IMMUNOL, V76, P61, DOI 10.1016/j.jri.2007.03.008; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Shah MD, 2008, PLATELETS, V19, P365, DOI 10.1080/09537100802054107; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Shomer E, 2013, HYPERTENSIO IN PRESS; Simak J, 2004, BRIT J HAEMATOL, V125, P804, DOI 10.1111/j.1365-2141.2004.04974.x; Talmon Y, 1999, SURF SCI SERIES, V83, P147; TALMON Y, 1979, REV SCI INSTRUM, V50, P698, DOI 10.1063/1.1135920; Talmon Y, 1996, BER BUNSEN PHYS CHEM, V100, P364, DOI 10.1002/bbpc.19961000322; TALMON Y, 1983, J COLLOID INTERF SCI, V93, P366, DOI 10.1016/0021-9797(83)90420-4; Talmon Y, 2007, SURFACTANT SCI SER, V140, P163; Toth B, 2007, AM J REPROD IMMUNOL, V58, P389, DOI 10.1111/j.1600-0897.2007.00532.x; Trummer A, 2009, BLOOD COAGUL FIBRIN, V20, P52, DOI 10.1097/MBC.0b013e32831be9c5; Tsimerman G, 2011, THROMB HAEMOSTASIS, V106, P310, DOI 10.1160/TH10-11-0712; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Waisman D, 2007, CLIN PHYSIOL FUNCT I, V27, P375, DOI 10.1111/j.1475-097X.2007.00763.x; Xiao HY, 2002, CRYOBIOLOGY, V44, P179, DOI 10.1016/S0011-2240(02)00024-X; Yuana Y, 2010, J THROMB HAEMOST, V8, P315, DOI 10.1111/j.1538-7836.2009.03654.x; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595; Zheng Y, 2000, J PHYS CHEM B, V104, P5263, DOI 10.1021/jp0002998; Zheng Y, 1999, J PHYS CHEM B, V103, P10331, DOI 10.1021/jp9923264	50	57	59	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83680	10.1371/journal.pone.0083680	http://dx.doi.org/10.1371/journal.pone.0083680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386253	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700069
J	Saito, S; Ohno, K; Sakuraba, H				Saito, Seiji; Ohno, Kazuki; Sakuraba, Hitoshi			Comparative Study of Structural Changes Caused by Different Substitutions at the Same Residue on alpha-Galactosidase A	PLOS ONE			English	Article							ANDERSON-FABRY-DISEASE; CLINICAL MANIFESTATIONS; ENERGY; REPLACEMENT; VARIANT; IMPACT; SAFETY; COHORT	Missense mutations in the alpha-galactosidase A (GLA) gene comprising the majority of mutations responsible for Fabry disease result in heterogeneous phenotypes ranging from the early onset severe "classic'' form to the "later-onset'' milder form. To elucidate the molecular basis of Fabry disease from the viewpoint of structural biology, we comprehensively examined the effects of different substitutions at the same residue in the amino acid sequence of GLA on the structural change in the enzyme molecule and the clinical phenotype by calculating the number of atoms affected and the root-mean-square-distance value, and by coloring of the atoms influenced by the amino acid replacements. The results revealed that the severity of the structural change influences the disease progression, i.e., a small structural change tends to lead to the later-onset form and a large one to the classic form. Furthermore, the study revealed the residues important for expression of the GLA activity, i.e., residues involved in construction of the active site, a disulfide bond or a dimer. Structural study from such a viewpoint is useful for elucidating the basis of Fabry disease.	[Saito, Seiji] Hokkaido Informat Univ, Dept Med Management & Informat, Ebetsu, Hokkaido, Japan; [Ohno, Kazuki] Not For Profit Org Promot Res Intellectual Proper, Dept Res, Chiyoda Ku, Tokyo, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Meiji Pharmaceutical University	Sakuraba, H (corresponding author), Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan.	sakuraba@my-pharm.ac.jp			Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [09-15]; Japan Society for the Promotion of Science (JSPS) [23659527]	Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for Research on Intractable Diseases of Health and Labor Science Research (to HS); the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (ID: 09-15, to HS); and the Japan Society for the Promotion of Science (JSPS ID: 23659527, to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, METABOLIC MOL BASES; DUDEK MJ, 1995, J COMPUT CHEM, V16, P791, DOI 10.1002/jcc.540160702; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2007, ACTA PAEDIATR, V96, P6, DOI 10.1111/j.1651-2227.2007.00198.x; Hwu WL, 2009, HUM MUTAT, V30, P1397, DOI 10.1002/humu.21074; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P827, DOI DOI 10.1107/S0567739476001873; KABSH W, 1978, ACTA CRYSTALLOGR A, V34, P922; Kong Y, 1997, J CHEM PHYS, V107, P481, DOI 10.1063/1.474409; KUNDROT CE, 1991, J COMPUT CHEM, V12, P402, DOI 10.1002/jcc.540120314; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Nakamura K, 2011, AM J MED GENET C, V157C, P63, DOI 10.1002/ajmg.c.30291; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Nance CS, 2006, ARCH NEUROL-CHICAGO, V63, P453, DOI 10.1001/archneur.63.3.453; Pappu RV, 1998, J PHYS CHEM B, V102, P9725, DOI 10.1021/jp982255t; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Saito S, 2008, MOL GENET METAB, V93, P419, DOI 10.1016/j.ymgme.2007.11.017; Saito S, 2010, J HUM GENET, V55, P175, DOI 10.1038/jhg.2010.5; Sakuraba H, 2004, J HUM GENET, V49, P1, DOI 10.1007/s10038-003-0098-z; Sakuraba H, 2002, J HUM GENET, V47, P176, DOI 10.1007/s100380200020; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Sugawara K, 2008, J HUM GENET, V53, P812, DOI 10.1007/s10038-008-0316-9; Togawa T, 2012, MOL GENET METAB, V105, P615, DOI 10.1016/j.ymgme.2012.01.010	27	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84267	10.1371/journal.pone.0084267	http://dx.doi.org/10.1371/journal.pone.0084267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386359	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700101
J	Smit, PW; Haanpera, M; Rantala, P; Couvin, D; Lyytikainen, O; Rastogi, N; Ruutu, P; Soini, H				Smit, Pieter Willem; Haanpera, Marjo; Rantala, Pirre; Couvin, David; Lyytikainen, Outi; Rastogi, Nalin; Ruutu, Petri; Soini, Hanna			Molecular Epidemiology of Tuberculosis in Finland, 2008-2011	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMIGRATION; IMPACT	In industrialized countries the majority of tuberculosis (TB) cases are linked to immigration. In Finland, most cases are still Finnish born but the number of foreign born cases is steadily increasing. In this 4-year population based study, the TB situation in Finland was characterized by a genotypic analysis of Mycobacterium tuberculosis isolates. A total of 1048 M. tuberculosis isolates (representing 99.4% of all culture positive cases) were analyzed by spoligotyping and MIRU. Spoligotype lineages belonging to the Euro-American family were predominant among the Finnish isolates, particularly T (n=346, 33.0%) and Haarlem (n=237, 22.6%) strains. The lineage signature was unknown for 130 (12.4%) isolates. Out of the 17 multi-drug resistant TB strains, 10 (58.8%) belonged to the Beijing lineage. In total, 23 new SIT designations were given and 51 orphan strains were found, of which 58 patterns were unique to Finland. Phylogeographical TB mapping as compared to neighboring countries showed that the population structure in Finland most closely resembled that observed in Sweden. By combining spoligotyping and MIRU results, 98 clusters comprising 355 isolates (33.9%) were found. Only 10 clusters contained both Finnish and foreign born cases. In conclusion, a large proportion of the M. tuberculosis isolates were from Finnish born elderly patients. Moreover, many previously unidentified spoligotype profiles and isolates belonging to unknown lineages were encountered.	[Smit, Pieter Willem] European Ctr Dis Prevent & Control ECDC, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden; [Smit, Pieter Willem; Haanpera, Marjo; Rantala, Pirre; Lyytikainen, Outi; Ruutu, Petri; Soini, Hanna] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, TB & Mycobacteria Unit, Abymes, France	European Centre for Disease Prevention & Control; Finland National Institute for Health & Welfare	Smit, PW (corresponding author), European Ctr Dis Prevent & Control ECDC, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden.	Pieter.smit@thl.fi	RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023				[Anonymous], 1955, Bull World Health Organ, V12, P211; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Brudey K, 2004, J CLIN MICROBIOL, V42, P3046, DOI 10.1128/JCM.42.7.3046-3051.2004; Chernyaeva E, 2012, EUR J CLIN MICROBIOL, V31, P1753, DOI 10.1007/s10096-011-1497-2; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Easterbrook PJ, 2004, J CLIN MICROBIOL, V42, P4536, DOI 10.1128/JCM.42.10.4536-4544.2004; Groenheit R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046848; Kamper-Jorgensen Z, 2012, J CLIN MICROBIOL, V50, P2660, DOI 10.1128/JCM.06358-11; Kinander W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008373; Makinen J, 2011, EUR J CLIN MICROBIOL, V30, P1119, DOI 10.1007/s10096-011-1200-7; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Puustinen K, 2003, J CLIN MICROBIOL, V41, P1525, DOI 10.1128/JCM.41.4.1525-1528.2003; Svensson E, 2011, CLIN MICROBIOL INFEC, V17, P881, DOI 10.1111/j.1469-0691.2010.03358.x; Vasankari T, 2012, CLIN RESPIR J, V6, P35, DOI 10.1111/j.1752-699X.2011.00242.x; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351	17	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85027	10.1371/journal.pone.0085027	http://dx.doi.org/10.1371/journal.pone.0085027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386443	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700127
J	Tokar, T; Ulicny, J				Tokar, Tomas; Ulicny, Jozef			The Mathematical Model of the Bcl-2 Family Mediated MOMP Regulation Can Perform a Non-Trivial Pattern Recognition	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; SIGNAL-TRANSDUCTION; APOPTOSIS; ACTIVATION; PATHWAYS; PROTEINS; BAX; BISTABILITY; CANCER; MITOCHONDRIA	Interactions between individual members of the B-cell lymphoma 2 (Bcl-2) family of proteins form a regulatory network governing mitochondrial outer membrane permeabilization (MOMP). Bcl-2 family initiated MOMP causes release of the inter-membrane pro-apoptotic proteins to cytosol and creates a cytosolic environment suitable for the executionary phase of apoptosis. We designed the mathematical model of this regulatory network where the synthesis rates of the Bcl-2 family members served as the independent inputs. Using computational simulations, we have then analyzed the response of the model to up-/downregulation of the Bcl-2 proteins. Under several assumptions, and using estimated reaction parameters, a non-linear stimulus-response emerged, whose characteristics are associated with bistability and switch-like behavior. Interestingly, using the principal component analysis (PCA) we have shown that the given model of the Bcl-2 family interactions classifies the random combinations of inputs into two distinct classes, and responds to these by one of the two qualitatively distinct outputs. As we showed, the emergence of this behavior requires specific organization of the interactions between particular Bcl-2 proteins.	[Tokar, Tomas; Ulicny, Jozef] Safarik Univ, Dept Biophys, Kosice, Slovakia	University of Pavol Jozef Safarik Kosice	Ulicny, J (corresponding author), Safarik Univ, Dept Biophys, Kosice, Slovakia.	jozef.ulicny@upjs.sk	Uličný, Jozef/AAX-4278-2021	Ulicny, Jozef/0000-0003-2853-8227	Slovak Research and Development Agency [APVV-0242-11]; project SEPO-II [ITMS 26220120039]; project Technicom [ITMS 26220220182]; Scientific Grant Agency of the Ministry of Education of the Slovak Republic [VEGA-1/4019/07];  [316310 - CELIM]	Slovak Research and Development Agency(Slovak Research and Development Agency); project SEPO-II; project Technicom; Scientific Grant Agency of the Ministry of Education of the Slovak Republic; 	This work was funded by Slovak Research and Development Agency, grant no. APVV-0242-11, from the project SEPO-II, grant no. ITMS 26220120039, project Technicom, grant no. ITMS 26220220182, FP7-REGPOT-2012-2013-1 grant No. 316310 - CELIM and from the Scientific Grant Agency of the Ministry of Education of the Slovak Republic, grant no. VEGA-1/4019/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Burz C, 2009, ACTA ONCOL, V48, P811, DOI 10.1080/02841860902974175; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cui J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001469; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dejean LM, 2010, BBA-BIOENERGETICS, V1797, P1231, DOI 10.1016/j.bbabio.2010.01.007; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Elkholi R, 2011, GENES CANC, V2; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Green D R, 1998, Results Probl Cell Differ, V24, P45; Harrington H, 2008, THEOR BIOL MED MODEL, V90, P1546; Haykin S, 1999, P842; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Jain A., 2000, IEEE T PATTERN ANAL, V22; Kulikov AV, 2012, CELL MOL LIFE SCI, V69, P1787, DOI 10.1007/s00018-011-0895-z; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Landes T, 2011, BBA-MOL CELL RES, V1813, P540, DOI 10.1016/j.bbamcr.2011.01.021; Mace PD, 2010, CURR OPIN CELL BIOL, V22, P828, DOI 10.1016/j.ceb.2010.08.004; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; Martinez-Ruiz G, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-48; Mattson MP, 2006, ANTIOXIDANTS REDOX S, V8; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nagata S, 2010, ANN NY ACAD SCI, V1209, P10, DOI 10.1111/j.1749-6632.2010.05749.x; Olivier BG, 2005, BIOINFORMATICS, V21, P560, DOI 10.1093/bioinformatics/bti046; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Perez-Paya E, 2011, MED RES REV, V31, P649, DOI 10.1002/med.20198; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Rautureau GJP, 2010, PROTEINS, V78, P2181, DOI 10.1002/prot.22728; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sun TZ, 2010, FEBS LETT, V584, P954, DOI 10.1016/j.febslet.2010.01.034; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TATE RF, 1954, ANN MATH STAT, V25, P603, DOI 10.1214/aoms/1177728730; Tokar T, 2012, PHYSICA A, V391, P6212, DOI 10.1016/j.physa.2012.07.006; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Ulukaya E, 2011, CELL BIOCHEM FUNCT, V29, P468, DOI 10.1002/cbf.1774; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5	53	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e81861	10.1371/journal.pone.0081861	http://dx.doi.org/10.1371/journal.pone.0081861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386084	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700003
J	Turkalo, AK; Wrege, PH; Wittemyer, G				Turkalo, Andrea K.; Wrege, Peter H.; Wittemyer, George			Long-Term Monitoring of Dzanga Bai Forest Elephants: Forest Clearing Use Patterns	PLOS ONE			English	Article							LOXODONTA-AFRICANA-CYCLOTIS; NATIONAL-PARK; SEASONAL MOVEMENTS; RAIN-FOREST; POPULATION; MATSCHIE; DENSITY; RESERVE	Individual identification of the relatively cryptic forest elephant (Loxodonta cyclotis) at forest clearings currently provides the highest quality monitoring data on this ecologically important but increasingly threatened species. Here we present baseline data from the first 20 years of an individually based study of this species, conducted at the Dzanga Clearing, Central African Republic. A total of 3,128 elephants were identified over the 20-year study (1,244 adults; 675 females, 569 males). It took approximately four years for the majority of elephants visiting the clearing to be identified, but new elephants entered the clearing every year of the study. The study population was relatively stable, varying from 1,668 to 1,864 individuals (including juveniles and infants), with increasingly fewer males than females over time. The age-class distribution for females remained qualitatively unchanged between 1995 and 2010, while the proportion of adult males decreased from 20% to 10%, likely reflecting increased mortality. Visitation patterns by individuals were highly variable, with some elephants visiting monthly while others were ephemeral users with visits separated by multiple years. The number of individuals in the clearing at any time varied between 40 and 100 individuals, and there was little evidence of a seasonal pattern in this variation. The number of elephants entering the clearing together (defined here as a social group) averaged 1.49 (range 1-12) for males and 2.67 (range 1-14) for females. This collation of 20 years of intensive forest elephant monitoring provides the first detailed, long term look at the ecology of bai visitation for this species, offering insight to the ecological significance and motivation for bai use, social behavior, and threats to forest elephants. We discuss likely drivers (rainfall, compression, illegal killing, etc.) influencing bai visitation rates. This study provides the baseline for future demographic and behavioral studies of this population.	[Turkalo, Andrea K.] Wildlife Conservat Soc, Africa Program, Bronx, NY 10460 USA; [Turkalo, Andrea K.; Wrege, Peter H.] Cornell Lab Ornithol, Elephant Listening Project, Bioacoust Res Program, Ithaca, NY USA; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Wittemyer, George] Save Elephants, Nairobi, Kenya	Wildlife Conservation Society; Cornell University; Colorado State University	Turkalo, AK (corresponding author), Wildlife Conservat Soc, Africa Program, Bronx, NY 10460 USA.	dzanga@uuplus.net	Wittemyer, George/AFQ-1840-2022		African Elephant Conservation Coordinating Group; Arbogast Foundation; Bonderman Family Foundation; Born Free; Busch Gardens; Congo Basin Forest Program; Disney Wildlife Conservation Fund; Patagonia Inc.; Sacharuna Foundation; World Wildlife Fund; Swedish Defend the Elephants Society; United States Fish and Wildlife Service [98210-5-G165, 98210-6-G157, 98219-7-G206, 98210-8-G750, 96200-9-G178, F11AP00222]	African Elephant Conservation Coordinating Group; Arbogast Foundation; Bonderman Family Foundation; Born Free; Busch Gardens; Congo Basin Forest Program; Disney Wildlife Conservation Fund; Patagonia Inc.; Sacharuna Foundation; World Wildlife Fund; Swedish Defend the Elephants Society; United States Fish and Wildlife Service(US Fish & Wildlife Service)	Financial support to AKT for this long-term study was provided by the African Elephant Conservation Coordinating Group, Arbogast Foundation, Bonderman Family Foundation, Born Free, Busch Gardens, Congo Basin Forest Program, Disney Wildlife Conservation Fund, Patagonia Inc., Sacharuna Foundation (also to PHW), World Wildlife Fund, Swedish Defend the Elephants Society, and United States Fish and Wildlife Service (grant nos. 98210-5-G165, 98210-6-G157, 98219-7-G206, 98210-8-G750, 96200-9-G178, F11AP00222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake S, 2001, AFR J ECOL, V39, P178, DOI 10.1046/j.1365-2028.2001.00296.x; Blake S., 2002, ECOLOGY FOREST ELEPH; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora) Secretariat, 2012, EL CONS ILL KILL IV; DUDLEY JP, 1992, AFR J ECOL, V30, P116, DOI 10.1111/j.1365-2028.1992.tb00485.x; Fishlock V, 2013, ANIM BEHAV, V85, P357, DOI 10.1016/j.anbehav.2012.11.004; Fishlock V, 2008, PACHYDERM, P17; Foguekem D, 2009, SCI RES ESSAYS, V4, P1423; Gessner J, 2013, AFRICAN J ECOLOGY; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Hochschild A., 1998, LEOPOLDS GHOST STORY; Inkamba-Nkulu C, 2007, STRUCTURE MOVEMENTS; Ishida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020642; Klaus G, 1998, J TROP ECOL, V14, P829, DOI 10.1017/S0266467498000595; Kolowski JM, 2010, AFRICAN J ECOLOGY, P9999; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; LEWIS DM, 1986, AFR J ECOL, V24, P227, DOI 10.1111/j.1365-2028.1986.tb00367.x; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; MERZ G, 1986, AFR J ECOL, V24, P61, DOI 10.1111/j.1365-2028.1986.tb00344.x; MERZ G, 1981, MAMMALIA, V45, P299, DOI 10.1515/mamm.1981.45.3.299; Momont L, 2007, SELECTION HABITAT OR; Morgan BJ, 2007, AFR J ECOL, V45, P519, DOI 10.1111/j.1365-2028.2007.00762.x; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Moss Cynthia, 1996, P58; POOLE J H, 1989, Oryx, V23, P188; Querouil S, 1999, AFR J ECOL, V37, P161, DOI 10.1046/j.1365-2028.1999.00157.x; Ruggiero R., 1990, PACHYDERM, V13, P42; RUGGIERO RG, 1994, AFR J ECOL, V32, P222, DOI 10.1111/j.1365-2028.1994.tb00573.x; SHORT JC, 1983, AFR J ECOL, V21, P175, DOI 10.1111/j.1365-2028.1983.tb01179.x; Turkalo AK, 2013, AFRICAN J ECOLOGY; Turkalo Andrea, 1995, Pachyderm, V20, P45; Turkalo Andrea K., 2001, P207; UN, 2012, AFR HUM DEV REP 2012; Vangroenweghe, 2006, J BELGIAN HIST REV, V36, P323; Vanleeuwe Hilde, 1997, Pachyderm, V24, P46; WHITE LJT, 1994, J TROP ECOL, V10, P121, DOI 10.1017/S0266467400007768; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wittemyer G, 2013, PLOS ONE, V8; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Wittemyer G, 2011, CONSERV BIOL, V25, P1002, DOI 10.1111/j.1523-1739.2011.01713.x; Wrege PH, 2012, AFR J ECOL, V50, P176, DOI 10.1111/j.1365-2028.2011.01310.x	47	36	38	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85154	10.1371/journal.pone.0085154	http://dx.doi.org/10.1371/journal.pone.0085154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386460	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700134
J	Tsang, PWK; Wong, APK; Yang, HP; Li, NF				Tsang, Paul Wai-Kei; Wong, Alan Pak-Kin; Yang, Hai-Ping; Li, Ngai-For			Purpurin Triggers Caspase-Independent Apoptosis in Candida dubliniensis Biofilms	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INVASIVE FUNGAL-INFECTIONS; BLOOD-STREAM INFECTIONS; CELL-DEATH; IN-VITRO; ANTIFUNGAL AGENTS; AMPHOTERICIN-B; ALBICANS; YEAST; MECHANISMS	Candida dubliniensis is an important human fungal pathogen that causes oral infections in patients with AIDS and diabetes mellitus. However, C. Dubliniensis has been frequently reported in bloodstream infections in clinical settings. Like its phylogenetically related virulent species C. albicans, C. Dubliniensis is able to grow and switch between yeast form and filamentous form (hyphae) and develops biofilms on both abiotic and biotic surfaces. Biofilms are recalcitrant to antifungal therapies and C. Dubliniensis readily turns drug resistant upon repeated exposure. More than 80% of infections are associated with biofilms. Suppression of fungal biofilms may therefore represent a viable antifungal strategy with clinical relevance. Here, we report that C. dubliniensis biofilms were inhibited by purpurin, a natural anthraquinone pigment isolated from madder root. Purpurin inhibited C. dubliniensis biofilm formation in a concentration-dependent manner; while mature biofilms were less susceptible to purpurin. Scanning electron microscopy (SEM) analysis revealed scanty structure consisting of yeast cells in purpurin-treated C. dubliniensis biofilms. We sought to delineate the mechanisms of the anti-biofilm activity of purpurin on C. Dubliniensis. Intracellular ROS levels were significantly elevated in fungal biofilms and depolarization of MMP was evident upon purpurin treatment in a concentration-dependent manner. DNA degradation was evident. However, no activated metacaspase could be detected. Together, purpurin triggered metacaspase-independent apoptosis in C. dubliniensis biofilms.	[Tsang, Paul Wai-Kei; Wong, Alan Pak-Kin; Yang, Hai-Ping; Li, Ngai-For] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tsang, PWK (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	pwktsang@hku.hk		TSANG, Paul Wai-Kei/0000-0001-9163-4217	Research Fund for the Control of Infectious Diseases, the Food and Health Bureau of the Government of the HKSAR [11100992]; Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR [12111292]; Seed Funding Programme for Basic Research from The University of Hong Kong [201211159011]	Research Fund for the Control of Infectious Diseases, the Food and Health Bureau of the Government of the HKSAR; Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR; Seed Funding Programme for Basic Research from The University of Hong Kong	This work was supported by Research Fund for the Control of Infectious Diseases, the Food and Health Bureau of the Government of the HKSAR (Project No. 11100992 to PWKT); Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR (Project No. 12111292 to PWKT); Seed Funding Programme for Basic Research from The University of Hong Kong (Project No. 201211159011 to PWKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dhaheri RS, 2010, J MED MICROBIOL, V59, P149, DOI 10.1099/jmm.0.015784-0; Andres MT, 2008, ANTIMICROB AGENTS CH, V52, P4081, DOI 10.1128/AAC.01597-07; Asmundsdottir LR, 2009, CLIN MICROBIOL INFEC, V15, P576, DOI 10.1111/j.1469-0691.2009.02840.x; Bandara HMHN, 2010, J MED MICROBIOL, V59, P1225, DOI 10.1099/jmm.0.021832-0; Barroso G, 2006, FERTIL STERIL, V85, P149, DOI 10.1016/j.fertnstert.2005.06.046; Bassetti M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-21; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Bustamante CI, 2005, CURR OPIN INFECT DIS, V18, P490, DOI 10.1097/01.qco.0000191516.43792.61; Cao YY, 2009, FUNGAL GENET BIOL, V46, P183, DOI 10.1016/j.fgb.2008.11.001; Chow JK, 2008, CLIN INFECT DIS, V46, P1206, DOI 10.1086/529435; Colombo AL, 1999, DIAGN MICR INFEC DIS, V34, P281; Corner BE, 1997, CURR BIOL, V7, pR691, DOI 10.1016/S0960-9822(06)00357-5; Dimopoulos G, 2008, ANESTH ANALG, V106, P523, DOI 10.1213/ane.0b013e3181607262; Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P201, DOI 10.1586/14787210.6.2.201; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fanci R, 2009, J CHEMOTHERAPY, V21, P105, DOI 10.1179/joc.2009.21.1.105; Garcia-Vidal C, 2013, CURR OPIN INFECT DIS, V26, P270, DOI 10.1097/QCO.0b013e32835fb920; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Hundalani S, 2013, EXPERT REV ANTI-INFE, V11, P709, DOI 10.1586/14787210.2013.811925; Jabra-Rizk MA, 2005, CLIN INFECT DIS, V41, P1064, DOI 10.1086/432943; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Kang K, 2011, FUNGAL BIOL-UK, V115, P302, DOI 10.1016/j.funbio.2011.01.001; Kang K, 2010, MED MYCOL, V48, P904, DOI 10.3109/13693781003739351; Kang K, 2010, MYCOPATHOLOGIA, V170, P391, DOI 10.1007/s11046-010-9341-2; Karbowski M, 2010, ADV EXP MED BIOL, V687, P131; Keyhani E, 2009, ANN NY ACAD SCI, V1171, P284, DOI 10.1111/j.1749-6632.2009.04682.x; Khan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032952; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Moran Gary P, 2012, Int J Microbiol, V2012, P205921, DOI 10.1155/2012/205921; Moran GP, 2012, FEMS YEAST RES, V12, P918, DOI 10.1111/j.1567-1364.2012.00841.x; Moran GP, 1997, ANTIMICROB AGENTS CH, V41, P617, DOI 10.1128/AAC.41.3.617; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pannanusorn S, 2013, MYCOSES, V56, P264, DOI 10.1111/myc.12014; Parize P, 2012, CURR INFECT DIS REP, V14, P668, DOI 10.1007/s11908-012-0296-y; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Polacheck I, 2000, J CLIN MICROBIOL, V38, P170; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Ramage G, 2001, J CLIN MICROBIOL, V39, P3234, DOI 10.1128/JCM.39.9.3234-3240.2001; Ramsdale M, 2008, BBA-MOL CELL RES, V1783, P1369, DOI 10.1016/j.bbamcr.2008.01.021; Ruhnke M, 2006, CURR DRUG TARGETS, V7, P495, DOI 10.2174/138945006776359421; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Sullivan DJ, 2005, FEMS MICROBIOL LETT, V253, P9, DOI 10.1016/j.femsle.2005.09.015; Sullivan DJ, 2004, FEMS YEAST RES, V4, P369, DOI 10.1016/S1567-1356(03)00240-X; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923; Willis AM, 2000, J ORAL PATHOL MED, V29, P86, DOI 10.1034/j.1600-0714.2000.290206.x; Zhang Jing, 2012, Commun Integr Biol, V5, P122, DOI 10.4161/cib.18833	52	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e86032	10.1371/journal.pone.0086032	http://dx.doi.org/10.1371/journal.pone.0086032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376900	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000195
J	Taktikos, J; Stark, H; Zaburdaev, V				Taktikos, Johannes; Stark, Holger; Zaburdaev, Vasily			How the Motility Pattern of Bacteria Affects Their Dispersal and Chemotaxis	PLOS ONE			English	Article							BIOFILM FORMATION; VARIABILITY	Most bacteria at certain stages of their life cycle are able to move actively; they can swim in a liquid or crawl on various surfaces. A typical path of the moving cell often resembles the trajectory of a random walk. However, bacteria are capable of modifying their apparently random motion in response to changing environmental conditions. As a result, bacteria can migrate towards the source of nutrients or away from harmful chemicals. Surprisingly, many bacterial species that were studied have several distinct motility patterns, which can be theoretically modeled by a unifying random walk approach. We use this approach to quantify the process of cell dispersal in a homogeneous environment and show how the bacterial drift velocity towards the source of attracting chemicals is affected by the motility pattern of the bacteria. Our results open up the possibility of accessing additional information about the intrinsic response of the cells using macroscopic observations of bacteria moving in inhomogeneous environments.	[Taktikos, Johannes; Zaburdaev, Vasily] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Taktikos, Johannes; Stark, Holger] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Taktikos, Johannes; Zaburdaev, Vasily] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Max Planck Society; Technical University of Berlin; Harvard University	Taktikos, J (corresponding author), Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany.	taktikos@pks.mpg.de	Zaburdaev, Vasily/B-8194-2017	Zaburdaev, Vasily/0000-0001-8234-3442	Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK [1558]	Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK(German Research Foundation (DFG))	The authors acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK 1558 "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindal T, 2011, BIOPHYS J, V100, P32, DOI 10.1016/j.bpj.2010.11.029; Barbara GM, 2003, FEMS MICROBIOL ECOL, V44, P79, DOI 10.1111/j.1574-6941.2003.tb01092.x; Barkai E, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08001; Baule A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/10002; Bennett RR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.148102; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Berg HC, 2013, NAT PHYS, V9, P460, DOI 10.1038/nphys2678; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; Clark DA, 2005, P NATL ACAD SCI USA, V102, P9150, DOI 10.1073/pnas.0407659102; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Doi M, 2001, THEORY POLYM DYNAMIC; Ebbens SJ, 2012, SOFT MATTER, V8, P3077, DOI 10.1039/c2sm07283a; Eisenbach M, 2004, CHEMOTAXIS, DOI DOI 10.1142/P303; Frank T, 1996, FOKKER PLANCK EQUATI; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamadeh A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001130; Hazelbauer GL, 2012, ANNU REV MICROBIOL, V66, P285, DOI 10.1146/annurev-micro-092611-150120; Horstmann D., 2003, JAHRESBER DTSCH MATH, V105, P103; Johansen JE, 2002, AQUAT MICROB ECOL, V28, P229, DOI 10.3354/ame028229; Kafri Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.238101; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Klafter J., 2011, 1 STEPRANDOM WALKS; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Locsei JT, 2007, J MATH BIOL, V55, P41, DOI 10.1007/s00285-007-0080-z; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; Magariyama Y, 2005, BIOPHYS J, V88, P3648, DOI [10.1529/biophysj.104.054049, 10.1529/biophsj.104.054049]; Masson JB, 2012, P NATL ACAD SCI USA, V109, P1802, DOI 10.1073/pnas.1116772109; MITCHELL JG, 1995, APPL ENVIRON MICROB, V61, P4436, DOI 10.1128/AEM.61.12.4436-4440.1995; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Romanczuk P, 2012, EUR PHYS J-SPEC TOP, V202, P1, DOI 10.1140/epjst/e2012-01529-y; SCHNITZER MJ, 1993, PHYS REV E, V48, P2553, DOI 10.1103/PhysRevE.48.2553; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; Stocker R, 2011, P NATL ACAD SCI USA, V108, P2635, DOI 10.1073/pnas.1019199108; Taktikos J, 2013, THESIS TU BERLIN; Taktikos J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041924; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Thiel F, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021117; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Vuppula RR, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026007; Vuppula RR, 2010, MOL BIOSYST, V6, P1082, DOI 10.1039/b924368b; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P1; Wu YL, 2009, P NATL ACAD SCI USA, V106, P1222, DOI 10.1073/pnas.0811662106; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108; Zaburdaev VY, 2008, J STAT PHYS, V133, P159, DOI 10.1007/s10955-008-9598-8	54	67	67	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81936	10.1371/journal.pone.0081936	http://dx.doi.org/10.1371/journal.pone.0081936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391710	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200007
J	Chung, SS; Aroh, C; Vadgama, JV				Chung, Seyung S.; Aroh, Clement; Vadgama, Jaydutt V.			Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE HTERT; NF-KAPPA-B; HUMAN TELOMERASE; INDUCED APOPTOSIS; GROWTH; PHOSPHORYLATION; ASSOCIATION; SUPPRESSION; EXPRESSION; PATHWAY	Mounting clinical data suggest that high telomerase activity is tightly associated with cancer progression and poor outcomes. Constitutively activated STAT3 is found in similar to 60% of human malignancies and shows a dismal prognosis. We previously reported that activated STAT3 promoted epithelial-mesenchymal transition (EMT) and cancer stem cell phenotype in human breast cancer. However, little is known how STAT3 is regulated in the cancer stem cell and by which mechanisms STAT3 contributes to poor prognosis in aggressive breast cancer. Here we demonstrate that STAT3 physically interacts with CD44 and NF-kB and activates the catalytic subunit of telomerase (hTERT) in human breast cancer stem cells. STAT3 plays a role as a signal transducing molecule between CD44 and NF-kB. In addition to functioning as a catalytic subunit of telomerase, hTERT has been reported to function as a transcription co-factor which drives EMT and cancer stem cell phenotype in human cancer. We observed that activated hTERT increases CD44 (+) subpopulation, whereas targeted knock-down of hTERT abolished cancer stem cell phenotype. Targeted STAT3 knock-down cells also down-regulated hTERT and decreased CD44 subpopulation. Finally, CD44 knock-down resulted in the abrogation of cancer stem cell phenotype and concurrent down-regulation of pSTAT3 and hTERT. Our study delineates the signaling pathway where STAT3 functions as a modulator for CD44 and hTERT, promoting a cancer stem cell phenotype. The constitutive activation of STAT3 signaling that leads to regulation of hTERT pathway may provide novel therapeutic targets for human breast cancer stem cells.	[Chung, Seyung S.; Aroh, Clement; Vadgama, Jaydutt V.] Charles R Drew Univ Med & Sci, Dept Internal Med, Div Canc Res & Training, Los Angeles, CA 90059 USA; [Vadgama, Jaydutt V.] David Geffen UCLA Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA	Charles R. Drew University of Medicine & Science; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vadgama, JV (corresponding author), Charles R Drew Univ Med & Sci, Dept Internal Med, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA.	jayvadgama@cdrewu.edu			NIH [NCI U56CA101599-01, CA15083-25S3, U54CA14393, NIMHD U54MD007598, NCATS CTSI UL1TR000124]; NATIONAL CANCER INSTITUTE [P30CA015083, U54CA143931, U56CA101599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: Support from NIH (Grant numbers: NCI U56CA101599-01; CA15083-25S3; U54CA14393; NIMHD U54MD007598; and NCATS CTSI UL1TR000124 to J.V.V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Assimakopoulos D, 2002, HISTOL HISTOPATHOL, V17, P1269, DOI 10.14670/HH-17.1269; Azare J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027851; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Blasco MA, 2003, TRENDS CELL BIOL, V13, P289, DOI 10.1016/S0962-8924(03)00085-0; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Glukhov AI, 2011, APPL BIOCHEM MICRO+, V47, P655, DOI 10.1134/S0003683811070039; Hartman ZC, 2011, CANCER RES, V71, P4380, DOI 10.1158/0008-5472.CAN-11-0308; Huang HH, 2012, BIOCHEM BIOPH RES CO, V418, P186, DOI 10.1016/j.bbrc.2012.01.004; Kirkpatrick KL, 2001, EUR J SURG ONCOL, V27, P754, DOI 10.1053/ejso.2001.1151; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mittra I, 2011, PREV MED, V53, P121, DOI 10.1016/j.ypmed.2011.06.010; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Rathore K, 2013, CANCER LETT, V333, P113, DOI 10.1016/j.canlet.2013.01.030; SCHWARTZ HS, 1995, CANCER, V75, P1094, DOI 10.1002/1097-0142(19950301)75:5<1094::AID-CNCR2820750507>3.0.CO;2-B; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Urquidi V, 2000, ANNU REV MED, V51, P65, DOI 10.1146/annurev.med.51.1.65; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	38	80	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83971	10.1371/journal.pone.0083971	http://dx.doi.org/10.1371/journal.pone.0083971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386318	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700083
J	de Lange, Z; Rijken, DC; Hoekstra, T; Conradie, KR; Jerling, JC; Pieters, M				de Lange, Zelda; Rijken, Dingeman C.; Hoekstra, Tiny; Conradie, Karin R.; Jerling, Johann C.; Pieters, Marlien			In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE	Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.	[de Lange, Zelda; Hoekstra, Tiny; Conradie, Karin R.; Jerling, Johann C.; Pieters, Marlien] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa; [Rijken, Dingeman C.] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands; [Hoekstra, Tiny] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	North West University - South Africa; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pieters, M (corresponding author), North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa.	marlien.pieters@nwu.ac.za	de Lange, Zelda/AAH-3529-2021	de Lange, Zelda/0000-0002-7250-2419; Jerling, Johann/0000-0003-2600-3536	SANPAD (South Africa - Netherlands Research Programme on Alternatives in Development); South African National Research Foundation (NRF GUN) [2069139, FA2006040700010, FA2006041100003]; South African Medical Research Council; North-West University, Potchefstroom, South Africa; PHRI (Population Health Research Institute), ON, Canada	SANPAD (South Africa - Netherlands Research Programme on Alternatives in Development); South African National Research Foundation (NRF GUN)(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); North-West University, Potchefstroom, South Africa; PHRI (Population Health Research Institute), ON, Canada	This work was supported by SANPAD (South Africa - Netherlands Research Programme on Alternatives in Development); South African National Research Foundation (NRF GUN numbers 2069139, FA2006040700010 and FA2006041100003. Any opinion, finding and conclusion or recommendation expressed in this material is that of the author(s) and the NRF does not accept any liability in this regard); the South African Medical Research Council; the North-West University, Potchefstroom, South Africa; and the PHRI (Population Health Research Institute), ON, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Amira C, 2006, SA HEART J, V1, P37; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; de Lange Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048881; de Willige SU, 2009, BLOOD, V114, P3994, DOI 10.1182/blood-2009-05-217968; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Demiralp DO, 2008, CLIN APPL THROMB-HEM, V14, P438, DOI 10.1177/1076029607305081; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Eriksson P, 1998, ARTERIOSCL THROM VAS, V18, P20, DOI 10.1161/01.ATV.18.1.20; Fesinmeyer MD, 2013, OBESITY, V21, P835, DOI 10.1002/oby.20268; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; Gardemann A, 1999, THROMB HAEMOSTASIS, V82, P1121; Greyling A, 2007, NUTR METAB CARDIOVAS, V17, P499, DOI 10.1016/j.numecd.2006.04.006; HAMSTEN A, 1987, LANCET, V2, P3; Henry M, 1997, ARTERIOSCL THROM VAS, V17, P851, DOI 10.1161/01.ATV.17.5.851; Hoekstra T, 2004, THROMB HAEMOSTASIS, V91, P861, DOI 10.1160/TH03-08-0546; Hoffstedt J, 2002, DIABETOLOGIA, V45, P584, DOI 10.1007/s00125-001-0774-5; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; JERLING JC, 1994, HAEMOSTASIS, V24, P364; Kinik ST, 2008, THROMB HAEMOSTASIS, V99, P352, DOI 10.1160/TH07-06-0395; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Lanfear DE, 2004, J AM COLL CARDIOL, V44, P165, DOI 10.1016/j.jacc.2004.03.053; Lisman T, 2005, BLOOD, V105, P1102, DOI 10.1182/blood-2004-08-3253; Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x; MANSFIELD MW, 1995, THROMB HAEMOSTASIS, V74, P842; McCormack LJ, 1996, DIABETOLOGIA, V39, P1512, DOI 10.1007/s001250050606; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Naran NH, 2008, ATHEROSCLEROSIS, V196, P155, DOI 10.1016/j.atherosclerosis.2007.03.024; Nordt TK, 2001, THROMB RES, V103, pS1, DOI 10.1016/S0049-3848(01)00292-4; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; OsseiGerning N, 1997, ARTERIOSCL THROM VAS, V17, P33, DOI 10.1161/01.ATV.17.1.33; PANAHLOO A, 1995, DIABETES, V44, P37, DOI 10.2337/diabetes.44.1.37; Pegoraro RJ, 2003, ACTA OBSTET GYN SCAN, V82, P313, DOI 10.1034/j.1600-0412.2003.00085.x; Pieters M, 2008, MOL NUTR FOOD RES, V52, P164, DOI 10.1002/mnfr.200700373; Pieters M, 2011, THROMB HAEMOSTASIS, V106, P448, DOI 10.1160/TH11-03-0192; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sartori MT, 2001, THROMB HAEMOSTASIS, V86, P1161; Schoenhard JA, 2008, HUM GENET, V124, P479, DOI 10.1007/s00439-008-0573-x; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Stewart S, 2011, EUR HEART J, V32, P492, DOI 10.1093/eurheartj/ehq439; Talens S, 2012, THROMB HAEMOSTASIS, V108, P640, DOI 10.1160/TH12-02-0124; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Tjarnlund A, 2003, THROMB HAEMOSTASIS, V89, P936; Tuomilehto J, 2013, BR J NUTR, V14, P1; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Van Harmelen V, 2000, THROMB HAEMOSTASIS, V83, P304; Verschuur M, 2005, ATHEROSCLEROSIS, V181, P275, DOI 10.1016/j.atherosclerosis.2005.01.036; YE S, 1995, THROMB HAEMOSTASIS, V74, P837; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	52	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83151	10.1371/journal.pone.0083151	http://dx.doi.org/10.1371/journal.pone.0083151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386152	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700025
J	Huellner, MW; Burkert, A; Strobel, K; Lago, MDP; Werner, L; Hug, U; von Wartburg, U; Seifert, B; Veit-Haibach, P				Huellner, Martin W.; Buerkert, Alexander; Strobel, Klaus; Lago, Maria del Sol Perez; Werner, Lennart; Hug, Urs; von Wartburg, Urs; Seifert, Burkhardt; Veit-Haibach, Patrick			Imaging Non-Specific Wrist Pain: Interobserver Agreement and Diagnostic Accuracy of SPECT/CT, MRI, CT, Bone Scan and Plain Radiographs	PLOS ONE			English	Article							SCAPHOID FRACTURE; MARROW EDEMA; BACK-PAIN; KNEE; REGISTRATION; SCINTIGRAPHY; BASKETBALL; PLAYERS; FUSION; FOOT	Purpose: Chronic hand and wrist pain is a common clinical issue for orthopaedic surgeons and rheumatologists. The purpose of this study was 1. To analyze the interobserver agreement of SPECT/CT, MRI, CT, bone scan and plain radiographs in patients with non-specific pain of the hand and wrist, and 2. to assess the diagnostic accuracy of these imaging methods in this selected patient population. Materials and Methods: Thirty-two consecutive patients with non-specific pain of the hand or wrist were evaluated retrospectively. All patients had been imaged by plain radiographs, planar early-phase imaging (bone scan), latephase imaging (SPECT/CT including bone scan and CT), and MRI. Two experienced and two inexperienced readers analyzed the images with a standardized read-out protocol. Reading criteria were lesion detection and localisation, type and etiology of the underlying pathology. Diagnostic accuracy and interobserver agreement were determined for all readers and imaging modalities. Results: The most accurate modality for experienced readers was SPECT/CT (accuracy 77%), followed by MRI (56%). The best performing, though little accurate modality for inexperienced readers was also SPECT/CT (44%), followed by MRI and bone scan (38% each). The interobserver agreement of experienced readers was generally high in SPECT/CT concerning lesion detection (kappa 0.93, MRI 0.72), localisation (kappa 0.91, MRI 0.75) and etiology (kappa 0.85, MRI 0.74), while MRI yielded better results on typification of lesions (kappa 0.75, SPECT/CT 0.69). There was poor agreement between experienced and inexperienced readers in SPECT/CT and MRI. Conclusions: SPECT/CT proved to be the most helpful imaging modality in patients with non-specific wrist pain. The method was found reliable, providing high interobserver agreement, being outperformed by MRI only concerning the typification of lesions. We believe it is beneficial to integrate SPECT/CT into the diagnostic imaging algorithm of chronic wrist pain.	[Huellner, Martin W.; Buerkert, Alexander; Strobel, Klaus; Lago, Maria del Sol Perez; Werner, Lennart; Veit-Haibach, Patrick] Lucerne Cantonal Hosp, Dept Radiol & Nucl Med, Luzern, Switzerland; [Hug, Urs; von Wartburg, Urs] Lucerne Cantonal Hosp, Dept Hand & Plast Surg, Luzern, Switzerland; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, Div Biostat, CH-8006 Zurich, Switzerland	Lucerne Cantonal Hospital; Lucerne Cantonal Hospital; University of Zurich	Huellner, MW (corresponding author), Univ Zurich Hosp, Clin Nucl Med, Dept Med Imaging, CH-8091 Zurich, Switzerland.	martin.huellner@usz.ch		Seifert, Burkhardt/0000-0002-5829-2478				Andreisek G, 2005, AM J ROENTGENOL, V185, P930, DOI 10.2214/AJR.04.1644; Beyer T, 2010, INSIGHTS IMAGING, P1; Breederveld RS, 2004, J TRAUMA, V57, P851, DOI 10.1097/01.TA.0000124278.29127.42; BRUNNER MC, 1989, INVEST RADIOL, V24, P72, DOI 10.1097/00004424-198901000-00015; Buck AK, 2008, J NUCL MED, V49, P1305, DOI 10.2967/jnumed.107.050195; Cruickshank J, 2007, EMERG MED AUSTRALAS, V19, P223, DOI 10.1111/j.1742-6723.2007.00959.x; Dalinka M K, 2000, Radiology, V215 Suppl, P333; De Filippo M, 2010, EUR J RADIOL, V74, P221, DOI 10.1016/j.ejrad.2009.01.023; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Fernandez-Canton G, 2003, SKELETAL RADIOL, V32, P273, DOI 10.1007/s00256-003-0622-4; Haims AH, 2004, AM J ROENTGENOL, V182, P1267, DOI 10.2214/ajr.182.5.1821267; HAWKES DJ, 1991, EUR J NUCL MED, V18, P752, DOI 10.1007/BF00956716; Henriksen OM, 2009, ACTA RADIOL, V50, P71, DOI 10.1080/02841850802562089; Huellner MW, 2012, EUR J NUCL MED MOL I; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Karlo C, 2011, EUR RADIOL, V21, P1499, DOI 10.1007/s00330-011-2078-6; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Kusano Nozomu, 2002, Tech Hand Up Extrem Surg, V6, P119, DOI 10.1097/00130911-200209000-00004; Linke R, 2010, AM J ROENTGENOL, V194, pW329, DOI 10.2214/AJR.09.3288; Major NM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790641; Memarsadeghi M, 2006, RADIOLOGY, V240, P169, DOI 10.1148/radiol.2401050412; Mohamed A, 1997, J HAND SURG-BRIT EUR, V22B, P161, DOI 10.1016/S0266-7681(97)80052-6; Pagenstert GI, 2009, J BONE JOINT SURG BR, V91B, P1191, DOI [10.1302/0301-620X.91B9, 10.1302/0301-620X.91B9.22570]; Roemer FW, 2002, SKELETAL RADIOL, V31, P615, DOI 10.1007/s00256-002-0575-z; Roolker W, 1997, J NUCL MED, V38, P1600; Rybak LD, 2001, Q J NUCL MED, V45, P53; TIELVANBUUL MMC, 1992, EUR J NUCL MED, V19, P848, DOI 10.1007/BF00168159; Utsunomiya D, 2006, RADIOLOGY, V238, P264, DOI 10.1148/radiol.2373041358; Vanhoenacker FM, 2007, EUR J RADIOL, V62, P6, DOI 10.1016/j.ejrad.2007.01.013; WHO, 2005, INT CLASS FUNCT DIS; Zanetti M, 1997, JMRI-J MAGN RESON IM, V7, P590, DOI 10.1002/jmri.1880070322	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85359	10.1371/journal.pone.0085359	http://dx.doi.org/10.1371/journal.pone.0085359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386468	Green Published, gold			2022-12-27	WOS:000329194700134
J	Jiang, M; Wu, HJ; Qin, CY				Jiang, Man; Wu, Haijian; Qin, Chengyong			Genetic Variant rs401681 at 5p15.33 Modifies Susceptibility to Lung Cancer but Not Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LEUKOCYTE TELOMERE LENGTH; RISK; LOCUS; TERT-CLPTM1L; METAANALYSIS; POLYMORPHISMS; REPLICATION; CHROMOSOMES; DYSFUNCTION	Background: The human 5p15.33 locus contains two well-known genes, the telomerase reverse transcriptase (TERT) and cleft lip and palate transmembrane 1-like (CLPTM1L) genes, which have been implicated in carcinogenesis. A common sequence variant, rs401681, located in an intronic region of CLPTM1L, has been reported to be associated with lung cancer risk based on genome-wide association study. However, subsequent replication studies in diverse populations have yielded inconsistent results. In addition, genetic variants at 5p15.33, including rs401681, have been shown to be involved in the susceptibility to multiple malignancies. Nevertheless, the role of these TERT-CLPTM1L variants in the etiology of esophageal squamous cell carcinoma (ESCC) remains unknown. Methods: We genotyped the rs401681 polymorphism using TaqMan methodology and analyzed its association with the risk of lung cancer and ESCC in a case-control study of 1,479 cancer patients (726 with lung cancer and 753 with ESCC) and 860 healthy individuals. Results: Logistic regression analyses revealed that rs401681 T genotypes were associated with a significantly decreased risk of lung cancer (CT vs. CC: adjusted OR = 0.782, 95% CI = 0.625-0.978, P = 0.031; CT/TT vs. CC: adjusted OR = 0.786; 95% CI = 0.635-0.972, P = 0.026). Stratification analysis by histology type indicated that rs401681 T genotypes were associated with a significantly reduced risk of both adenocarcinoma and squamous cell carcinoma. Furthermore, no significant association was observed between rs401681 and the risk of ESCC (CT vs. CC: adjusted OR = 0.910, 95% CI = 0.734-1.129, P = 0.392; TT vs. CC: adjusted OR = 0.897, 95% CI = 0.624-1.290, P = 0.558; CT/TT vs. CC: adjusted OR = 0.908, 95% CI = 0.740-1.114, P = 0.355). Conclusions: Our findings provide further evidence supporting rs401681 as a genetic variant associated with the risk of lung cancer. In addition, we investigated the correlation between the rs401681 variant and the risk of ESCC in a Han Chinese population, and our results suggest that this genetic variant may not be involved in ESCC risk.	[Jiang, Man; Qin, Chengyong] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China; [Wu, Haijian] Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Qin, CY (corresponding author), Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China.	cyqinsdu@126.com			Shandong Science and Technology Committee of China [2005GG3202192]	Shandong Science and Technology Committee of China	This work was supported by grant number 2005GG3202192 from the Shandong Science and Technology Committee of China (http://www.sdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063860; Asakura T, 2005, ONCOL REP, V14, P601; Bae EY, 2012, RESPIROLOGY, V17, P699, DOI 10.1111/j.1440-1843.2012.02165.x; Chen WQ, 2011, CHINESE J CANCER RES, V23, P3, DOI 10.1007/s11670-011-0003-9; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gansner JM, 2013, TRANSL RES; Gomez DE, 2012, INT J ONCOL, V41, P1561, DOI 10.3892/ijo.2012.1611; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ke JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062485; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064988; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Myneni AA, 2013, LUNG CANCER, V80, P131, DOI 10.1016/j.lungcan.2013.01.021; Ni ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052598; Perera SA, 2008, CARCINOGENESIS, V29, P747, DOI 10.1093/carcin/bgn050; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; Sirera R, 2011, J THORAC ONCOL, V6, P286, DOI 10.1097/JTO.0b013e31820189a5; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Xing JL, 2009, CANCER PREV RES, V2, P459, DOI 10.1158/1940-6207.CAPR-08-0227; Xu LF, 2013, ANNU REV PATHOL-MECH, V8, P49, DOI 10.1146/annurev-pathol-020712-164030; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yang XL, 2013, ARCH DERMATOL RES, V305, P49, DOI 10.1007/s00403-012-1275-8; Yin JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050650; Zheng YL, 2009, CANCER RES, V69, P1604, DOI 10.1158/0008-5472.CAN-08-3028; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	40	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84277	10.1371/journal.pone.0084277	http://dx.doi.org/10.1371/journal.pone.0084277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386361	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700100
J	Lai, CH; Chu, NF; Chang, CW; Wang, SL; Yang, HC; Chu, CM; Chang, CT; Lin, MH; Chien, WC; Su, SL; Chou, YC; Chen, KH; Wang, WM; Liou, SH				Lai, Ching-Huang; Chu, Nain-Feng; Chang, Chi-Wen; Wang, Shu-Li; Yang, Hsin-Chou; Chu, Chi-Ming; Chang, Chu-Ting; Lin, Ming-Huang; Chien, Wu-Chien; Su, Sui-Lung; Chou, Yu-Ching; Chen, Kang-Hua; Wang, Wei-Ming; Liou, Saou-Hsing			Androgenic Alopecia Is Associated with Less Dietary Soy, Higher Blood Vanadium and rs1160312 1 Polymorphism in Taiwanese Communities	PLOS ONE			English	Article							MALE-PATTERN BALDNESS; CORONARY-HEART-DISEASE; CLINICAL PROSTATE-CANCER; EPIDEMIOLOGIC FOLLOW-UP; GROWTH-FACTOR-I; RISK-FACTORS; EARLY-ONSET; FAMILIAL ALOPECIA; IDENTICAL-TWINS; NATIONAL-HEALTH	Background: Although the genetic basis of androgenic alopecia has been clearly established, little is known about its non-genetic causes, such as environmental and lifestyle factors. Objective: This study investigated blood and urine heavy metals concentrations, environmental exposure factors, personal behaviors, dietary intakes and the genotypes of related susceptibility genes in patients with androgenic alopecia (AGA). Design: Age, AGA level, residence area, work hours, sleep patterns, cigarette usage, alcohol consumption, betel nut usage, hair treatments, eating habits, body heavy metals concentrations and rs1998076, rs913063, rs1160312 and rs201571 SNP genotype data were collected from 354 men. Logistic regression analysis was performed to examine whether any of the factors displayed odds ratios (ORs) indicating association with moderate to severe AGA (>= IV). Subsequently, Hosmer-Lemeshow, Nagelkerke R-2 and accuracy tests were conducted to help establish an optimal model. Results: Moderate to severe AGA was associated with the AA genotype of rs1160312 (22.50, 95% CI 3.99-126.83), blood vanadium concentration (0.02, 95% CI 0.01-0.04), and regular consumption of soy bean drinks (0.23, 95% CI 0.06-0.85), after adjustment for age. The results were corroborated by the Hosmer-Lemeshow test (P = 0.73), Nagelkerke R-2 (0.59), accuracy test (0.816) and area under the curve (AUC; 0.90, 0.847-0.951) analysis. Conclusions: Blood vanadium and frequent soy bean drink consumption may provide protect effects against AGA. Accordingly, blood vanadium concentrations, the AA genotype of rs1160312 and frequent consumption of soy bean drinks are associated with AGA.	[Lai, Ching-Huang; Chu, Nain-Feng; Chu, Chi-Ming; Chang, Chu-Ting; Lin, Ming-Huang; Chien, Wu-Chien; Su, Sui-Lung; Chou, Yu-Ching; Liou, Saou-Hsing] Natl Def Med Ctr, Sch Publ Hlth, Dept Epidemiol, Taipei, Taiwan; [Chu, Nain-Feng] Taitung Hosp, Dept Hlth, Executive Yuan, Taiwan; [Chang, Chi-Wen; Chen, Kang-Hua] Chang Gung Univ, Coll Med, Sch Nursing, Tao Yuan, Taiwan; [Wang, Shu-Li; Liou, Saou-Hsing] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Miaoli, Taiwan; [Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Wang, Wei-Ming] Triserv Gen Hosp, Dept Dermatol, Taipei, Taiwan	National Defense Medical Center; Chang Gung University; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; Tri-Service General Hospital	Chu, CM (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Dept Epidemiol, Taipei, Taiwan.	chuchiming@web.de	Liou, Saou-Hsing/B-2667-2010; Yang, Hsin-Chou/AAP-2547-2021; Chen, Kang-Hua/GLR-9451-2022; Lai, Ching-Huang/ABF-9274-2021; Wang, Shu-Li/C-1367-2010	Yang, Hsin-Chou/0000-0001-6853-7881; Chu, Cordia/0000-0002-3683-5638; Chen, Kang-Hua/0000-0001-9782-3633; Su, Sui-Lung/0000-0003-3122-1116	Taichung County Government in Taiwan [5168-038]	Taichung County Government in Taiwan	This research was supported by Taichung County Government in Taiwan (5168-038). The interpretation and conclusions contained herein do not represent those of Bureau of Health, Taichung County or National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenuga P, 2012, J AM ACAD DERMATOL, V67, pE121, DOI 10.1016/j.jaad.2011.10.017; Ahouansou S, 2007, EUR J DERMATOL, V17, P220; Alfani S, 2012, ACTA DERM-VENEREOL, V92, P304, DOI 10.2340/00015555-1239; Bechard A, 2011, J AM ASSOC LAB ANIM, V50, P171; BELEZOS NK, 1965, DERMATOLOGICA, V131, P304, DOI 10.1159/000254489; Gonzalez C, 2006, MED CLIN-BARCELONA, V127, P617, DOI 10.1016/S0025-7753(06)72688-4; Cabeza M, 2003, P W PHARMACOL SOC, V46, P153; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Chen CC, 2012, J DERMATOL SCI, V66, P3, DOI 10.1016/j.jdermsci.2012.02.007; Chen W, 2007, DERMATOLOGY, V214, P199, DOI 10.1159/000099583; COLE GW, 1984, INT J DERMATOL, V23, P283, DOI 10.1111/j.1365-4362.1984.tb01251.x; Demark-Wahnefried W, 2001, CANCER EPIDEM BIOMAR, V10, P415; Diaz-Atienza F, 2011, J PSYCHOSOM RES, V71, P102, DOI 10.1016/j.jpsychores.2011.01.007; DMITRIENKO LP, 1977, VESTN DERMATOL VENER, P59; Dogra D, 1996, Indian J Dermatol Venereol Leprol, V62, P199; Ellis CN, 2002, J AM ACAD DERMATOL, V46, P541, DOI 10.1067/mjd.2002.119671; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Ellis JA, 2007, HUM GENET, V121, P451, DOI 10.1007/s00439-006-0317-8; Endres H J, 1980, Z Hautkr, V55, P14; Essah PA, 2006, CLIN DERMATOL, V24, P289, DOI 10.1016/j.clindermatol.2006.04.004; FISCHER H R, 1953, Z Haut Geschlechtskr, V15, P178; FLECK M, 1951, Dermatol Wochenschr, V123, P98; Ford ES, 1996, AM J EPIDEMIOL, V143, P651; Gatherwright J, 2012, PLAST RECONSTR SURG, V130, P1219, DOI 10.1097/PRS.0b013e31826d104f; GEDDA L, 1954, Acta Genet Med Gemellol (Roma), V3, P117; Georgala S, 2004, DERMATOLOGY, V208, P178, DOI 10.1159/000076497; Gonzalez-Gonzalez JG, 2009, CLIN ENDOCRINOL, V71, P494, DOI 10.1111/j.1365-2265.2008.03508.x; Giltay EJ, 2004, J ENDOCRINOL, V180, P107, DOI 10.1677/joe.0.1800107; GOLDSHTEIN LM, 1978, VESTN DERMATOL VENER, P36; Grybos R, 2005, POL J ENVIRON STUD, V14, P35; GUSAROVA A S, 1968, Vestnik Dermatologii i Venerologii, V42, P40; HAMILTON JB, 1959, ANN NY ACAD SCI, V83, P429; Harada N, 2007, GROWTH HORM IGF RES, V17, P408, DOI 10.1016/j.ghir.2007.04.009; Harada N, 2009, BIOSCI BIOTECH BIOCH, V73, P1456, DOI 10.1271/bbb.80883; Hardcastle NJ, 2005, J EUR ACAD DERMATOL, V19, P631, DOI 10.1111/j.1468-3083.2005.01240.x; Hawk E, 2000, CANCER EPIDEM BIOMAR, V9, P523; Hay IC, 1998, ARCH DERMATOL, V134, P1349, DOI 10.1001/archderm.134.11.1349; HENDREN OS, 1949, ARCH DERMATOL SYPH, V60, P793, DOI 10.1001/archderm.1949.01530050155015; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, NAT GENET, V40, P1279, DOI 10.1038/ng.228; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Hirsso P, 2007, DERMATOLOGY, V214, P125, DOI 10.1159/000098570; Jackow C, 1998, J AM ACAD DERMATOL, V38, P418, DOI 10.1016/S0190-9622(98)70499-2; Kang HJ, 2002, INT J GYNECOL OBSTET, V79, P195, DOI 10.1016/S0020-7292(02)00297-7; Knight DC, 1996, OBSTET GYNECOL, V87, P897; Koca R, 2005, MED SCI MONITOR, V11, pCR296; Koyama T, 2013, EUR J DERMATOL, V23, P113, DOI 10.1684/ejd.2012.1898; Kuldeep Cm, 2011, Int J Trichology, V3, P20, DOI 10.4103/0974-7753.82123; Kyei A, 2011, ARCH DERMATOL, V147, P909, DOI 10.1001/archdermatol.2011.66; Lotufo PA, 2000, ARCH INTERN MED, V160, P165, DOI 10.1001/archinte.160.2.165; Matilainen VA, 2001, J CARDIOVASC RISK, V8, P147, DOI 10.1097/00043798-200106000-00005; McElwee KJ, 2003, EXP DERMATOL, V12, P30, DOI 10.1034/j.1600-0625.2003.120104.x; McElwee KJ, 2002, J INVEST DERMATOL, V119, P1426, DOI 10.1046/j.1523-1747.2002.19620.x; Messina M, 2000, EUR J CANCER, V36, pS71; MITCHELL AJ, 1984, J AM ACAD DERMATOL, V11, P763, DOI 10.1016/S0190-9622(84)80450-8; Naginiene R, 2002, TRACE ELEM ELECTROLY, V19, P87; Nomiyama T, 2013, PEDIATR DERMATOL, V30, P105, DOI 10.1111/j.1525-1470.2011.01692.x; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Ohnemus U, 2004, J INVEST DERMATOL, V122, P7, DOI 10.1046/j.0022-202X.2003.22120.x; OMENS DV, 1946, ARCH DERMATOL SYPH, V53, P193; ORFANOS CE, 1975, HAUTARZT, V26, P367; Pathomvanich D, 2002, DERMATOL SURG, V28, P804, DOI 10.1046/j.1524-4725.2002.02036.x; Reynolds FD, 1974, CONSTRUCTING LIFE ST, P74; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Rodriguez TA, 2008, J AM ACAD DERMATOL, V59, P137, DOI 10.1016/j.jaad.2008.02.005; Rodriguez TA, 2010, J AM ACAD DERMATOL, V62, P525, DOI 10.1016/j.jaad.2009.02.006; ROENIGK HH, 1987, CUTIS, V39, P329; Rosenfield RL, 2005, J INVEST DERM SYMP P, V10, P205, DOI 10.1111/j.1087-0024.2005.10106.x; Rubisz-Brzezinska J, 1971, Przegl Dermatol, V58, P413; SCERRI L, 1992, J AM ACAD DERMATOL, V27, P766, DOI 10.1016/S0190-9622(08)80226-5; Sehgal VN, 2007, J EUR ACAD DERMATOL, V21, P473, DOI 10.1111/j.1468-3083.2006.01920.x; SEQUEIROS J, 1985, AM J MED GENET, V21, P669, DOI 10.1002/ajmg.1320210408; Severi G, 2003, BRIT J DERMATOL, V149, P1207, DOI 10.1111/j.1365-2133.2003.05565.x; Shahar E, 2008, AM J EPIDEMIOL, V167, P676, DOI 10.1093/aje/kwm365; Skalnyj A, 1999, MICROELEMENTAL DIS D, P96; SPITZER RR, 1946, P SOC EXP BIOL MED, V63, P10, DOI 10.3181/00379727-63-15472; Starka L, 2005, Endocr Regul, V39, P127; Su LH, 2007, ARCH DERMATOL, V143, P1401, DOI 10.1001/archderm.143.11.1401; Trueb RM, 2002, EXP GERONTOL, V37, P981, DOI 10.1016/S0531-5565(02)00093-1; Tsuruki T, 2005, PEPTIDES, V26, P707, DOI 10.1016/j.peptides.2005.01.010; Tsuruki T, 2004, J INVEST DERMATOL, V122, P848, DOI 10.1111/j.0022-202X.2004.22310.x; Turner R, 2004, FREE RADICAL RES, V38, P209, DOI 10.1080/10715760310001641854; Wallace ML, 1998, AM J DERMATOPATH, V20, P160, DOI 10.1097/00000372-199804000-00010; Wei HC, 1996, CARCINOGENESIS, V17, P73, DOI 10.1093/carcin/17.1.73; WEIDMAN AI, 1956, ARCH DERMATOL, V74, P424, DOI 10.1001/archderm.1956.01550100092018; Willett W., 1998, IMPLICATIONS TOTAL E, P273; Wustner H, 1974, Z Hautkr, V49, P879; Xia M., 2003, STUDIES TRACE ELEMEN, V20, P41; Yang S, 2004, BRIT J DERMATOL, V151, P16, DOI 10.1111/j.1365-2133.2004.05915.x; Zhang H, 2008, J DERMATOL, V35, P555, DOI 10.1111/j.1346-8138.2008.00523.x; Zhao JH, 2004, BIOINFORMATICS, V20, P1325, DOI 10.1093/bioinformatics/bth071; Zhao M, 2012, BRIT J DERMATOL, V166, P266, DOI 10.1111/j.1365-2133.2011.10646.x; Zhou JH, 2006, FEED IND, V27, P59; Zouboulis CC, 2004, EXP DERMATOL, V13, P5, DOI 10.1111/j.1600-0625.2004.00255.x	94	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e79789	10.1371/journal.pone.0079789	http://dx.doi.org/10.1371/journal.pone.0079789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386074	Green Published, gold			2022-12-27	WOS:000329194700001
J	Solomon, LA; Russell, BA; Makar, D; Berube, NG; Beier, F				Solomon, Lauren A.; Russell, Bailey A.; Makar, David; Berube, Nathalie G.; Beier, Frank			Loss of ATRX Does Not Confer Susceptibility to Osteoarthritis	PLOS ONE			English	Article							REDUCED CHONDROCYTE PROLIFERATION; X SYNDROME; MENTAL-RETARDATION; SKELETAL TISSUES; CRE RECOMBINASE; PROTEIN ATRX; BONE-GROWTH; SNF2 FAMILY; EXPRESSION; SURVIVAL	The chromatin remodelling protein ATRX is associated with the rare genetic disorder ATR-X syndrome. This syndrome includes developmental delay, cognitive impairment, and a variety of skeletal deformities. ATRX plays a role in several basic chromatin-mediated cellular events including DNA replication, telomere stability, gene transcription, and chromosome congression and cohesion during cell division. We have used a loss-of-function approach to directly investigate the role of Atrx in the adult skeleton in three different models of selective Atrx loss. We specifically targeted deletion of Atrx to the forelimb mesenchyme, to cartilage and to bone-forming osteoblasts. We previously demonstrated that loss of ATRX in forelimb mesenchyme causes brachydactyly while deletion in chondrocytes had minimal effects during development. We now show that targeted deletion of Atrx in osteoblasts causes minor dwarfism but does not recapitulate most of the skeletal phenotypes seen in ATR-X syndrome patients. In adult mice from all three models, we find that joints lacking Atrx are not more susceptible to osteoarthritis, as determined by OARSI scoring and immunohistochemistry. These results indicate that while ATRX plays limited roles during early stages of skeletal development, deficiency of the protein in adult tissues does not confer susceptibility to osteoarthritis.	[Solomon, Lauren A.; Berube, Nathalie G.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada; [Solomon, Lauren A.; Berube, Nathalie G.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Solomon, Lauren A.; Berube, Nathalie G.; Beier, Frank] Childrens Hlth Res Inst, London, ON, Canada; [Russell, Bailey A.; Makar, David; Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Berube, NG (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada.	nberube@uwo.ca; fbeier@uwo.ca	Beier, Frank/T-4734-2019; Beier, Frank/G-4595-2013; Berube, Nathalie G/E-3885-2015	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537; 	Canadian Institutes for Health Research; Ontario Graduate Studentship (OGS) [PRD19842319];  [MOP102539]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Studentship (OGS); 	This work was supported by an operating grant from the Canadian Institutes for Health Research to N.G.B. and F. B. [MOP102539](http://www.cihr-irsc.gc.ca), and an Ontario Graduate Studentship (OGS) (https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRD19842319.html) to L. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2007, CURR DRUG TARGETS, V8, P325, DOI 10.2174/138945007779940070; Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Appleton CTG, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2120; Aspden RM, 2008, RHEUMATOLOGY, V47, P1452, DOI 10.1093/rheumatology/ken199; Aspden RM, 2011, NAT REV RHEUMATOL, V7, P65, DOI 10.1038/nrrheum.2010.123; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Betancourt MCC, 2012, P NATL ACAD SCI USA, V109, P8218, DOI 10.1073/pnas.1119899109; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Dvir-Ginzberg M, 2013, FRONT BIOSCI-LANDMRK, V18, P343, DOI 10.2741/4105; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Huber LC, 2007, ARTHRITIS RHEUM, V56, P1087, DOI 10.1002/art.22512; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Medina CF, 2009, HUM MOL GENET, V18, P966, DOI 10.1093/hmg/ddn424; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Pollard TCB, 2008, J BONE JOINT SURG BR, V90B, P411, DOI 10.1302/0301-620X.90B4.20284; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Scheller EL, 2011, CELLS TISSUES ORGANS, V194, P268, DOI 10.1159/000324745; Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008; Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023; Solomon LA, 2013, HUM MOL GENET, V22, P5015, DOI 10.1093/hmg/ddt351; Solomon LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007106; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Wang MN, 2011, ANN NY ACAD SCI, V1240, P61, DOI 10.1111/j.1749-6632.2011.06258.x; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yan QA, 2010, ARTHRITIS RHEUM-US, V62, P2013, DOI 10.1002/art.27486; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85526	10.1371/journal.pone.0085526	http://dx.doi.org/10.1371/journal.pone.0085526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386478	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700139
J	Takahashi, K; Takigawa, I; Mamitsuka, H				Takahashi, Kei-ichiro; Takigawa, Ichigaku; Mamitsuka, Hiroshi			SiBIC: A Web Server for Generating Gene Set Networks Based on Biclusters Obtained by Maximal Frequent Itemset Mining	PLOS ONE			English	Article							TOOL	Detecting biclusters from expression data is useful, since biclusters are coexpressed genes under only part of all given experimental conditions. We present a software called SiBIC, which from a given expression dataset, first exhaustively enumerates biclusters, which are then merged into rather independent biclusters, which finally are used to generate gene set networks, in which a gene set assigned to one node has coexpressed genes. We evaluated each step of this procedure: 1) significance of the generated biclusters biologically and statistically, 2) biological quality of merged biclusters, and 3) biological significance of gene set networks. We emphasize that gene set networks, in which nodes are not genes but gene sets, can be more compact than usual gene networks, meaning that gene set networks are more comprehensible. SiBIC is available at http://utrecht.kuicr.kyoto-u.ac.jp:8080/miami/faces/index.jsp.	[Takahashi, Kei-ichiro; Takigawa, Ichigaku; Mamitsuka, Hiroshi] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Takigawa, Ichigaku] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido, Japan	Kyoto University; Hokkaido University	Takahashi, K (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan.	keiichiro@kuicr.kyoto-u.ac.jp	Takigawa, Ichigaku/B-3823-2012; Mamitsuka, Hiroshi/R-1110-2016	Takigawa, Ichigaku/0000-0001-5633-995X; Mamitsuka, Hiroshi/0000-0002-6607-5617	MEXT KAKENHI [23710233, 24300054]; JSPS KAKENHI [23710233, 244552]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported in part by MEXT KAKENHI Grant Numbers 23710233 and 24300054, and JSPS KAKENHI Grant Numbers 23710233 and 244552 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Burdick D, 2005, IEEE T KNOWL DATA EN, V17, P1490, DOI 10.1109/TKDE.2005.183; Cheng KO, 2007, BIOINFORMATICS, V23, P2342, DOI 10.1093/bioinformatics/btm338; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Han JW, 2007, DATA MIN KNOWL DISC, V15, P55, DOI 10.1007/s10618-006-0059-1; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Murali T M, 2003, Pac Symp Biocomput, P77; Okada Y, 2007, IPSJ DIGITAL COURIER, V3, P183, DOI [10.2197/ipsjdc.3.183, DOI 10.2197/IPSJDC.3.183]; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Santamaria R, 2008, BIOINFORMATICS, V24, P1212, DOI 10.1093/bioinformatics/btn076; Serin A, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-18; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tchagang A.B., 2011, HDB RES COMPUTATIONA, P148	18	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82890	10.1371/journal.pone.0082890	http://dx.doi.org/10.1371/journal.pone.0082890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386124	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700016
J	Torrazza, RM; Ukhanova, M; Wang, XY; Sharma, R; Hudak, ML; Neu, J; Mai, V				Torrazza, Roberto Murgas; Ukhanova, Maria; Wang, Xiaoyu; Sharma, Renu; Hudak, Mark Lawrence; Neu, Josef; Mai, Volker			Intestinal Microbial Ecology and Environmental Factors Affecting Necrotizing Enterocolitis	PLOS ONE			English	Article							EMPIRICAL ANTIBIOTIC-TREATMENT; FECAL MICROFLORA; PRETERM INFANTS; COMMUNITY; FLORA; OUTCOMES	Necrotizing enterocolitis (NEC) is the most devastating intestinal disease affecting preterm infants. In addition to being associated with short term mortality and morbidity, survivors are left with significant long term sequelae. The cost of caring for these infants is high. Epidemiologic evidence suggests that use of antibiotics and type of feeding may cause an intestinal dysbiosis important in the pathogenesis of NEC, but the contribution of specific infectious agents is poorly understood. Fecal samples from preterm infants <= 32 weeks gestation were analyzed using 16S rRNA based methods at 2, 1, and 0 weeks, prior to diagnosis of NEC in 18 NEC cases and 35 controls. Environmental factors such as antibiotic usage, feeding type (human milk versus formula) and location of neonatal intensive care unit (NICU) were also evaluated. Microbiota composition differed between the three neonatal units where we observed differences in antibiotic usage. In NEC cases we observed a higher proportion of Proteobacteria (61%) two weeks and of Actinobacteria (3%) 1 week before diagnosis of NEC compared to controls (19% and 0.4%, respectively) and lower numbers of Bifidobacteria counts and Bacteroidetes proportions in the weeks before NEC diagnosis. In the first fecal samples obtained during week one of life we detected a novel signature sequence, distinct from but matching closest to Klebsiella pneumoniae, that was strongly associated with NEC development later in life. Infants who develop NEC exhibit a different pattern of microbial colonization compared to controls. Antibiotic usage correlated with these differences and combined with type of feeding likely plays a critical role in the development of NEC.	[Torrazza, Roberto Murgas; Neu, Josef] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Ukhanova, Maria; Wang, Xiaoyu; Mai, Volker] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32610 USA; [Ukhanova, Maria; Wang, Xiaoyu; Mai, Volker] Univ Florida, Coll Med, Gainesville, FL USA; [Ukhanova, Maria; Wang, Xiaoyu; Mai, Volker] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Sharma, Renu; Hudak, Mark Lawrence] Univ Florida, Coll Med, Dept Pediat, Jacksonville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mai, V (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32610 USA.	vmai@ufl.edu	Neu, Josef/AAI-2799-2020; Wang, Xiaoyu/J-4101-2018	Wang, Xiaoyu/0000-0002-4504-7799	NIH [RO1 HD 059143]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH RO1 HD 059143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander VN, 2011, J PEDIATR-US, V159, P392, DOI 10.1016/j.jpeds.2011.02.035; Boccia D, 2001, EUR J PEDIATR, V160, P385, DOI 10.1007/s004310100749; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Dai D, 1999, Adv Pediatr, V46, P353; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Horbar JD, 2010, CLIN PERINATOL, V37, P29, DOI 10.1016/j.clp.2010.01.003; HOY C, 1990, ARCH DIS CHILD-FETAL, V65, P1057, DOI 10.1136/adc.65.10_Spec_No.1057; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mai V, 2006, J CLIN MICROBIOL, V44, P4550, DOI 10.1128/JCM.01542-06; Meinzen-Derr J, 2009, J PEDIATR-US, V154, P656, DOI 10.1016/j.jpeds.2008.11.002; MOLLITT DL, 1988, J PEDIATR SURG, V23, P60, DOI 10.1016/S0022-3468(88)80542-6; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Smith B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-73; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Torrazza RM, 2013, CLIN PERINATOL, V40, P93, DOI 10.1016/j.clp.2012.12.009; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weintraub AS, 2012, J PERINATOL, V32, P705, DOI 10.1038/jp.2011.180; WESTRAMEIJER CMM, 1983, ARCH DIS CHILD, V58, P523, DOI 10.1136/adc.58.7.523	32	120	126	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83304	10.1371/journal.pone.0083304	http://dx.doi.org/10.1371/journal.pone.0083304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386174	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700031
J	Holmes, KJ; Klass, DM; Guiney, EL; Cyert, MS				Holmes, Kristen J.; Klass, Daniel M.; Guiney, Evan L.; Cyert, Martha S.			Whi3, an S. cerevisiae RNA-Binding Protein, Is a Component of Stress Granules That Regulates Levels of Its Target mRNAs	PLOS ONE			English	Article							ANALYZING P-BODIES; CELL-CYCLE; PROCESSING BODIES; BUDDING YEAST; SACCHAROMYCES; GENE; CLN3; ACCUMULATION; AGGREGATION; DECAY	RNA binding proteins (RBPs) are vital to the regulation of mRNA transcripts, and can alter mRNA localization, degradation, translation, and storage. Whi3 was originally identified in a screen for small cell size mutants, and has since been characterized as an RBP. The identification of Whi3-interacting mRNAs involved in mediating cellular responses to stress suggested that Whi3 might be involved in stress-responsive RNA processing. We show that Whi3 localizes to stress granules in response to glucose deprivation or heat shock. The kinetics and pattern of Whi3 localization in response to a range of temperatures were subtly but distinctly different from those of known components of RNA processing granules. Deletion of Whi3 resulted in an increase in the relative abundance of Whi3 target RNAs, either in the presence or absence of heat shock. Increased levels of the CLN3 mRNA in whi3 Delta cells may explain their decreased cell size. Another mRNA target of Whi3 encodes the zinc-responsive transcription factor Zap1, suggesting a role for Whi3 in response to zinc stress. Indeed, we found that whi3 Delta cells have enhanced sensitivity to zinc toxicity. Together our results suggest an expanded model for Whi3 function: in addition to its role as a regulator of the cell cycle, Whi3 may have a role in stress-dependent RNA processing and responses to a variety of stress conditions.	[Holmes, Kristen J.; Guiney, Evan L.; Cyert, Martha S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Klass, Daniel M.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Klass, Daniel M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Cyert, MS (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mcyert@stanford.edu		Cyert, Martha/0000-0003-3825-7437	National Institute of Health [GM-48728, T32-GM007276]; NSF; Howard Hughes Medical Institute; NIH [CA-77097]; Tom and Susan Ford Stanford Graduate Fellowship; Stanford School of Medicine Jill and John Freidenrich Translational Medicine Fund (JEE); Donald Kennedy Endowment; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM048729] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom and Susan Ford Stanford Graduate Fellowship; Stanford School of Medicine Jill and John Freidenrich Translational Medicine Fund (JEE); Donald Kennedy Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health grants GM-48728 (MSC) and T32-GM007276 (KJH, DMK, ELG). DMK was also supported by an NSF predoctoral fellowship, by the Howard Hughes Medical Institute, and by NIH grant CA-77097 to Patrick O. Brown. ELG was also supported by the Tom and Susan Ford Stanford Graduate Fellowship (ELG), and by the Stanford School of Medicine Jill and John Freidenrich Translational Medicine Fund (JEE). KJH was also supported by the Donald Kennedy Endowment, and was a Genentech Fellow in the Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2007, CELL CYCLE, V6, P2599, DOI 10.4161/cc.6.21.4920; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Cai Y, 2013, PLOS ONE IN PRESS; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Frey AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022535; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gari E, 2001, GENE DEV, V15, P2803; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hilgers V, 2006, RNA, V12, P1835, DOI 10.1261/rna.241006; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nash RS, 2001, GENETICS, V157, P1469; Nissan T, 2008, METHOD ENZYMOL, V448, P507, DOI 10.1016/S0076-6879(08)02625-6; Ragni E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-107; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; SIKORSKI RS, 1989, GENETICS, V122, P19; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Sudbery P, 2002, SCIENCE, V297, P351, DOI 10.1126/science.1073042; Swisher KD, 2009, MOL CELL, V34, P401, DOI 10.1016/j.molcel.2009.05.008; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	49	13	13	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84060	10.1371/journal.pone.0084060	http://dx.doi.org/10.1371/journal.pone.0084060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386330	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900073
J	Mani, J; Makarevic, J; Juengel, E; Ackermann, H; Nelson, K; Bartsch, G; Haferkamp, A; Blaheta, RA				Mani, Jens; Makarevic, Jasmina; Juengel, Eva; Ackermann, Hanns; Nelson, Karen; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.			I Publish in I Edit? - Do Editorial Board Members of Urologic Journals Preferentially Publish Their Own Scientific Work?	PLOS ONE			English	Article							CONFLICT-OF-INTEREST; MEDICAL JOURNALS; IMPACT FACTOR; POLICY; INDEX	Scientists who are members of an editorial board have been accused of preferentially publishing their scientific work in the journal where they serve as editor. Reputation and academic standing do depend on an uninterrupted flow of published scientific work and the question does arise as to whether publication mainly occurs in the self-edited journal. This investigation was designed to determine whether editorial board members of five urological journals were more likely to publish their research reports in their own rather than in other journals. A retrospective analysis was conducted for all original reports published from 2001-2010 by 65 editorial board members nominated to the boards of five impact leading urologic journals in 2006. Publications before editorial board membership, 2001-2005, and publications within the period of time as an editorial board member, 2006-2010, were identified. The impact factors of the journals were also recorded over the time period 2001-2010 to see whether a change in impact factor correlated with publication locality. In the five journals as a whole, scientific work was not preferentially published in the journal in which the scientists served as editor. However, significant heterogeneity among the journals was evident. One journal showed a significant increase in the amount of published papers in the 'own' journal after assumption of editorship, three journals showed no change and one journal showed a highly significant decrease in publishing in the 'own' journal after assumption of editorship.	[Mani, Jens; Makarevic, Jasmina; Juengel, Eva; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.] Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany; [Ackermann, Hanns] Goethe Univ Frankfurt, Inst Biostat, D-60054 Frankfurt, Germany; [Nelson, Karen] Goethe Univ Frankfurt, Dept Vasc & Endovasc Surg, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Blaheta, RA (corresponding author), Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany.	Blaheta@em.uni-frankfurt.de						Bosnjak L, 2011, SCIENTOMETRICS, V86, P227, DOI 10.1007/s11192-010-0207-7; Brembs B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00291; Ferris LE, 2010, ACAD MED, V85, P739, DOI 10.1097/ACM.0b013e3181dc91b3; Graf C, 2007, INT J CLIN PRACT, V61, P1, DOI 10.1111/j.1742-1241.2006.01230.x; Haivas I, 2004, CAN MED ASSOC J, V171, P475, DOI 10.1503/cmaj.1031982; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Luty J, 2009, J MED ETHICS, V35, P200, DOI 10.1136/jme.2008.026740; Marcovitch H, 2010, CROAT MED J, V51, P7, DOI 10.3325/cmj.2010.51.7; Marcovitch H, 2009, J EPIDEMIOL COMMUN H, V63, P608, DOI 10.1136/jech.2008.086132; Nylenna M, 2006, LANCET, V367, P1882, DOI 10.1016/S0140-6736(06)68821-1; Pagel PS, 2011, BRIT J ANAESTH, V107, P357, DOI 10.1093/bja/aer191; Schiermeier Q, 2008, NATURE, V456, P432, DOI 10.1038/456432a; Smith E, 2012, J MED ETHICS, V38, P679, DOI 10.1136/medethics-2012-100524; Smith R, 2006, J ROY SOC MED, V99, P115, DOI 10.1258/jrsm.99.3.115; Soreide K, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-56	16	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83709	10.1371/journal.pone.0083709	http://dx.doi.org/10.1371/journal.pone.0083709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386258	Green Published, gold			2022-12-27	WOS:000329117900055
J	Qi, ZY; Shao, C; Huang, YL; Hui, GZ; Zhou, YX; Wang, Z				Qi, Zhen-Yu; Shao, Chuan; Huang, Yu-Lun; Hui, Guo-Zhen; Zhou, You-Xin; Wang, Zhong			Reproductive and Exogenous Hormone Factors in Relation to Risk of Meningioma in Women: A Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTOR PROFILE; BRAIN-TUMORS; REPLACEMENT THERAPY; CANCER-RISK; INTRACRANIAL MENINGIOMA; SPINAL MENINGIOMAS; ASSOCIATION; COHORT; MORTALITY; RECEPTORS	Background and Objective: A number of studies have focused on the association between oral contraceptive (OC), hormonal replacement therapy (HRT) and reproductive factors and meningioma risk, but the results were inconsistent. Thus, a meta-analysis was performed to obtain more precise estimates of risk. Methods: We conducted a literature search using PubMed and EMBASE databases to July2013, without any limitations. Random effects models were used to summarize results. Results: Twelve case-control and six cohort studies were included in this meta-analysis. We found that an increased risk of meningioma was associated with HRT use(RR = 1.19, 95% CI = 1.01-1.40), postmenopausal women(RR = 1.32, 95% CI = 1.07-1.64) and parity(RR = 1.18, 95% CI = 1.00-1.40). No significant associations were observed for OC use (RR = 0.93, 95% CI = 0.83-1.03), age at menarche(RR = 1.06, 95% CI = 0.92-1.21), age at menopause(RR = 1.03, 95% CI = 0.81-1.30), or age at first birth(RR = 0.94, 95% CI = 0.80-1.10). Conclusion: In conclusion, the results of our study support the hypothesis that longer exposure to effect of female sex hormones may increase the risk of meningioma in women, yet additional studies are warranted to confirm our findings and identify the underlying biological mechanisms.	[Qi, Zhen-Yu; Shao, Chuan; Huang, Yu-Lun; Hui, Guo-Zhen; Zhou, You-Xin; Wang, Zhong] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Qi, ZY (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China.	qizhenyu@suda.edu.cn		Shao, Chuan/0000-0001-8260-4761				ADAMI HO, 1989, INT J CANCER, V44, P833, DOI 10.1002/ijc.2910440515; Aghi MK, 2007, NEUROSURGERY, V61, P754, DOI 10.1227/01.NEU.0000298903.63635.E3; Andersen L, 2013, EUR J CANCER, V49, P3303, DOI 10.1016/j.ejca.2013.05.026; [Anonymous], 2010, Prescrire Int, V19, P120; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; Benson VS, 2010, INT J CANCER, V127, P1692, DOI 10.1002/ijc.25184; Blitshteyn S, 2008, J CLIN ONCOL, V26, P279, DOI 10.1200/JCO.2007.14.2133; CANTOR KP, 1993, CANCER CAUSE CONTROL, V4, P505, DOI 10.1007/BF00052425; Cea-Soriano L, 2012, CANCER EPIDEMIOL, V36, P198, DOI 10.1016/j.canep.2011.08.003; Chamoun R, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11220; Chiu HF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-857; Claus EB, 2013, J NEUROSURG, V118, P649, DOI 10.3171/2012.9.JNS12811; Cowppli-Bony A, 2011, CANCER CAUSE CONTROL, V22, P697, DOI 10.1007/s10552-011-9742-7; Custer B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-152; Custer BS, 2002, CANCER, V94, P1626, DOI 10.1002/cncr.10410; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickson R B, 2000, J Natl Cancer Inst Monogr, P135; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan ZX, 2013, CANCER CAUSE CONTROL, V24, P1517, DOI 10.1007/s10552-013-0228-7; Hannaford PC, 2007, BRIT MED J, V335, P651, DOI 10.1136/bmj.39289.649410.55; Hatch EE, 2005, INT J CANCER, V114, P797, DOI 10.1002/ijc.20776; Hatiboglu MA, 2008, SURG NEUROL, V69, P356, DOI 10.1016/j.surneu.2007.03.013; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsu DW, 1997, J NEUROSURG, V86, P113, DOI 10.3171/jns.1997.86.1.0113; HUNT K, 1990, BRIT J OBSTET GYNAEC, V97, P1080, DOI 10.1111/j.1471-0528.1990.tb02494.x; HUNT K, 1987, BRIT J OBSTET GYNAEC, V94, P620, DOI 10.1111/j.1471-0528.1987.tb03166.x; JAY JR, 1985, J NEUROSURG, V62, P757, DOI 10.3171/jns.1985.62.5.0757; Jhawar BS, 2003, J NEUROSURG, V99, P848, DOI 10.3171/jns.2003.99.5.0848; Johnson DR, 2011, NEURO-ONCOLOGY, V13, P1011, DOI 10.1093/neuonc/nor081; Korhonen K, 2010, CANCER CAUSE CONTROL, V21, P2149, DOI 10.1007/s10552-010-9634-2; Korhonen K, 2012, AM J EPIDEMIOL, V175, P309, DOI 10.1093/aje/kwr335; Lambe M, 1997, INT J CANCER, V72, P389; Lee E, 2006, INT J CANCER, V119, P1152, DOI 10.1002/ijc.21950; Maiuri F, 2011, CLIN NEUROL NEUROSUR, V113, P34, DOI 10.1016/j.clineuro.2010.08.017; McKinney PA, 2004, J NEUROL NEUROSUR PS, V75, P12, DOI 10.1136/jnnp.2004.040741; Michaud DS, 2010, CANCER EPIDEM BIOMAR, V19, P2562, DOI 10.1158/1055-9965.EPI-10-0447; Persson I, 1996, INT J CANCER, V67, P327, DOI 10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T; PLESKO I, 1985, INT J CANCER, V36, P529, DOI 10.1002/ijc.2910360502; PRESTONMARTIN S, 1995, CANCER EPIDEM BIOMAR, V4, P333; Rao G, 2009, NEUROSURGERY, V65, P483, DOI 10.1227/01.NEU.0000350876.91495.E0; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; RUBINSTEIN AB, 1994, J NEUROSURG, V81, P184, DOI 10.3171/jns.1994.81.2.0184; RYAN P, 1992, INT J CANCER, V51, P20, DOI 10.1002/ijc.2910510105; Sanson M, 2000, ACTA NEUROCHIR, V142, P493, DOI 10.1007/s007010050462; SCHLEHOFER B, 1992, J NATL CANCER I, V84, P1346, DOI 10.1093/jnci/84.17.1346; Schlehofer B, 1999, INT J CANCER, V82, P155, DOI 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P; Smith JS, 2005, CAN J NEUROL SCI, V32, P122, DOI 10.1017/S0317167100017017; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wigertz A, 2008, CANCER EPIDEM BIOMAR, V17, P2663, DOI 10.1158/1055-9965.EPI-08-0406; Wigertz A, 2006, AM J EPIDEMIOL, V164, P629, DOI 10.1093/aje/kwj254; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278	56	44	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83261	10.1371/journal.pone.0083261	http://dx.doi.org/10.1371/journal.pone.0083261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386167	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900028
J	Schoenfuss, HL; Maie, T; Moody, KN; Lesteberg, KE; Blob, RW; Schoenfuss, TC				Schoenfuss, Heiko L.; Maie, Takashi; Moody, Kristine N.; Lesteberg, Kelsey E.; Blob, Richard W.; Schoenfuss, Tonya C.			Stairway to Heaven: Evaluating Levels of Biological Organization Correlated with the Successful Ascent of Natural Waterfalls in the Hawaiian Stream Goby Sicyopterus stimpsoni	PLOS ONE			English	Article							FIBER TYPE DISTRIBUTION; EXTREME ENVIRONMENTS; GOBIID FISHES; PERFORMANCE; SELECTION; CHALLENGES; PROTEOMICS; MIGRATION; RESPONSES; ECOLOGY	Selective pressures generated by locomotor challenges act at the level of the individual. However, phenotypic variation among individuals that might convey a selective advantage may occur across any of multiple levels of biological organization. In this study, we test for differences in external morphology, muscle mechanical advantage, muscle fiber type and protein expression among individuals of the waterfall climbing Hawaiian fish Sicyopterus stimpsoni collected from sequential pools increasing in elevation within a single freshwater stream. Despite predictions from previous laboratory studies of morphological selection, few directional morphometric changes in body shape were observed at successively higher elevations. Similarly, lever arm ratios associated with the main pelvic sucker, central to climbing ability in this species, did not differ between elevations. However, among climbing muscles, the adductor pelvicus complex (largely responsible for generating pelvic suction during climbing) contained a significantly greater red muscle fiber content at upstream sites. A proteomic analysis of the adductor pelvicus revealed two-fold increases in expression levels for two respiratory chain proteins (NADH: ubiquinone reductase and cytochrome b) that are essential for aerobic respiration among individuals from successively higher elevations. Assessed collectively, these evaluations reveal phenotypic differences at some, but not all levels of biological organization that are likely the result of selective pressures experienced during climbing.	[Schoenfuss, Heiko L.; Lesteberg, Kelsey E.] St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA; [Maie, Takashi; Moody, Kristine N.; Blob, Richard W.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Schoenfuss, Tonya C.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA	Minnesota State Colleges & Universities; Saint Cloud State University; Clemson University; University of Minnesota System; University of Minnesota Twin Cities	Schoenfuss, HL (corresponding author), St Cloud State Univ, Aquat Toxicol Lab, St Cloud, MN 56301 USA.	hschoenfuss@stcloudstate.edu	Moody, Kristine/AAB-3913-2019	Schoenfuss, Tonya/0000-0002-8353-2226; Schoenfuss, Heiko/0000-0001-5464-992X; Lesteberg, Kelsey/0000-0002-3081-457X; Blob, Richard/0000-0001-5026-343X	NSF [IOS-0817911, IOS-0817794]; St. Cloud State University Faculty Improvement grant; Clemson University Research Investment Fund Award	NSF(National Science Foundation (NSF)); St. Cloud State University Faculty Improvement grant; Clemson University Research Investment Fund Award	This project was supported by funding from NSF grants IOS-0817911 (HLS) and IOS-0817794 (RWB), St. Cloud State University Faculty Improvement grant (HLS), and Clemson University Research Investment Fund Award (RWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Blake RW, 2006, CAN J ZOOL, V84, P1173, DOI 10.1139/Z06-105; Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x; Blob RW, 2007, J ZOOL, V273, P200, DOI 10.1111/j.1469-7998.2007.00315.x; Blob RW, 2010, INTEGR COMP BIOL, V50, P1185, DOI 10.1093/icb/icq070; Blob RW, 2008, INTEGR COMP BIOL, V48, P734, DOI 10.1093/icb/icn086; Blob RW, 2006, J ZOOL, V268, P315, DOI 10.1111/j.1469-7998.2005.00034.x; Cediel RA, 2008, ZOOLOGY, V111, P114, DOI 10.1016/j.zool.2007.06.004; Cullen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053274; DEGRAAF F, 1990, Z MIKROSK ANAT FORSC, V104, P593; Dowd WW, 2010, J EXP BIOL, V213, P210, DOI 10.1242/jeb.031781; Endler J.A., 1986, Monographs in Population Biology, pviii; Fitzsimons J. Michael, 2003, Ichthyological Exploration of Freshwaters, V14, P185; Fitzsimons J. Michael, 1993, Ichthyological Exploration of Freshwaters, V4, P1; FITZSIMONS JM, 1995, ENVIRON BIOL FISH, V43, P39, DOI 10.1007/BF00001816; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Herrel A., 2006, ECOLOGY BIOMECHANICS; Irschick DJ, 2008, EVOL ECOL RES, V10, P177; Julius ML, 2005, AQUAT ECOL, V39, P473, DOI 10.1007/s10452-005-9007-1; Karr TL, 2008, HEREDITY, V100, P200, DOI 10.1038/sj.hdy.6801008; Kawano SM, 2013, EVOL ECOL, V27, P949, DOI 10.1007/s10682-012-9621-z; Kido MH, 1996, ENVIRON BIOL FISH, V45, P199, DOI 10.1007/BF00005234; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Leonard G, 2012, J FISH BIOL, V81, P903, DOI 10.1111/j.1095-8649.2012.03352.x; Maie T, 2007, COPEIA, P755, DOI 10.1643/0045-8511(2007)2007[755:OSOBPI]2.0.CO;2; Maie T, 2013, J MORPHOL, V274, P733, DOI 10.1002/jmor.20130; Maie T, 2012, J EXP BIOL, V215, P3925, DOI 10.1242/jeb.072967; Maie T, 2011, ZOOLOGY, V114, P340, DOI 10.1016/j.zool.2011.05.005; McDowall RM, 2010, REV FISH BIOL FISHER, V20, P87, DOI 10.1007/s11160-009-9125-2; Morzel M, 2006, J AGR FOOD CHEM, V54, P2997, DOI 10.1021/jf0528759; Mykles DL, 2010, INTEGR COMP BIOL, V50, P6, DOI 10.1093/icb/icq015; Nesatyy VJ, 2007, ENVIRON SCI TECHNOL, V41, P6891, DOI 10.1021/es070561r; Pon LB, 2012, RIVER RES APPL, V28, P1266, DOI 10.1002/rra.1508; RADTKE RL, 1988, ENVIRON BIOL FISH, V23, P205, DOI 10.1007/BF00004911; Reznick David, 1996, P243; Schoenfuss Heiko L., 2007, Bishop Museum Bulletin in Cultural and Environmental Studies, V3, P125; Schoenfuss Heiko L., 1997, Micronesica, V30, P93; Schoenfuss HL, 2003, J ZOOL, V261, P191, DOI 10.1017/S0952836903004102; Sokal R.R., 2012, BIOMETRY; Volpato GL, 2009, MAR FRESHW BEHAV PHY, V42, P307, DOI 10.1080/10236240903299177; Waterman TH, 1999, J EXP ZOOL, V285, P326, DOI 10.1002/(SICI)1097-010X(19991215)285:4<326::AID-JEZ3>3.3.CO;2-K; Wilson MP, 2009, ANAT REC, V292, P935, DOI 10.1002/ar.20929	42	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84851	10.1371/journal.pone.0084851	http://dx.doi.org/10.1371/journal.pone.0084851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386424	gold, Green Published			2022-12-27	WOS:000329117900114
J	Zhou, HJ; Dan, YY; Naidoo, N; Li, SC; Yeoh, KG				Zhou, Hui Jun; Dan, Yock Young; Naidoo, Nasheen; Li, Shu Chuen; Yeoh, Khay Guan			A Cost-Effectiveness Analysis Evaluating Endoscopic Surveillance for Gastric Cancer for Populations with Low to Intermediate Risk	PLOS ONE			English	Article							HELICOBACTER-PYLORI; INTESTINAL METAPLASIA; SERUM PEPSINOGEN; CLINICOPATHOLOGICAL FEATURES; CHINESE POPULATION; UTILITY ANALYSIS; FOLLOW-UP; LESIONS; SINGAPORE; COHORT	Background: Gastric cancer (GC) surveillance based on oesophagogastroduodenoscopy (OGD) appears to be a promising strategy for GC prevention. By evaluating the cost-effectiveness of endoscopic surveillance in Singaporean Chinese, this study aimed to inform the implementation of such a program in a population with a low to intermediate GC risk. Methods: Using a reference strategy of no OGD intervention, we evaluated four strategies: 2-yearly OGD surveillance, annual OGD surveillance, 2-yearly OGD screening and 2-yearly screening plus annual surveillance in Singaporean Chinese aged 50-69 years. From a perspective of the healthcare system, Markov models were built to simulate the life experience of the target population. The models projected discounted lifetime costs ($), quality adjusted life year (QALY), and incremental cost-effectiveness ratio (ICER) indicating the cost-effectiveness of each strategy against a Singapore willingness-to-pay of $46,200/QALY. Deterministic and probabilistic sensitivity analyses were used to identify the influential variables and their associated thresholds, and to quantify the influence of parameter uncertainties respectively. Results: With an ICER of $44,098/QALY, the annual OGD surveillance was the optimal strategy while the 2-yearly surveillance was the most cost-effective strategy (ICER = $25,949/QALY). The screening-based strategies were either extendedly dominated or cost-ineffective. The cost-effectiveness heterogeneity of the four strategies was observed across age-gender subgroups. Eight influential parameters were identified each with their specific thresholds to define the choice of optimal strategy. Accounting for the model uncertainties, the probability that the annual surveillance is the optimal strategy in Singapore was 44.5%. Conclusion: Endoscopic surveillance is potentially cost-effective in the prevention of GC for populations at low to intermediate risk. Regarding program implementation, a detailed analysis of influential factors and their associated thresholds is necessary. Multiple strategies should be considered in order to recommend the right strategy for the right population.	[Zhou, Hui Jun; Naidoo, Nasheen] Natl Univ Singapore, Yong Loo Lin Sch Med, Sch Publ Hlth, Singapore 117595, Singapore; [Dan, Yock Young; Yeoh, Khay Guan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Li, Shu Chuen] Univ Newcastle, Discipline Pharm & Expt Pharmacol, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	National University of Singapore; National University of Singapore; University of Newcastle	Yeoh, KG (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.	mdcykg@nus.edu.sg	/AAR-5357-2020	Naidoo, Navindhra/0000-0001-9142-3751; Naidoo, Nasheen/0000-0001-8613-4808				Ang TL, 2005, J GASTROEN HEPATOL, V20, P1603, DOI 10.1111/j.1440-1746.2005.03898.x; [Anonymous], 2001, MACR HLTH INV HLTH E; Areia M, 2013, HELICOBACTER, V18, P325, DOI 10.1111/hel.12050; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Centers for Disease Control and Prevention NBCCEDP, 2005, POL PROC MAN; Chang HS, 2012, ASIAN PAC J CANCER P, V13, P2721, DOI 10.7314/APJCP.2012.13.6.2721; Choi KS, 2009, CANCER EPIDEM BIOMAR, V18, P1390, DOI 10.1158/1055-9965.EPI-08-0940; Dan YY, 2006, CLIN GASTROENTEROL H, V4, P709, DOI 10.1016/j.cgh.2006.03.025; Department of Statistics Singapore, 2012, YB STAT SING 2012; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Dinis-Ribeiro M, 2007, J GASTROEN HEPATOL, V22, P1594, DOI 10.1111/j.1440-1746.2007.04863.x; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Environmental Protection Agency USA, 2000, COST ILLN HDB, P1; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Gupta N, 2011, GASTROINTEST ENDOSC, V74, P610, DOI 10.1016/j.gie.2011.05.001; Hassan C, 2010, HELICOBACTER, V15, P221, DOI 10.1111/j.1523-5378.2010.00752.x; Hosokawa O, 2008, SCAND J GASTROENTERO, V43, P1112, DOI 10.1080/00365520802085395; Kang JM, 2011, WORLD J GASTROENTERO, V17, P3518, DOI 10.3748/wjg.v17.i30.3518; Kim YS, 2000, J KOREAN MED SCI, V15, P510, DOI 10.3346/jkms.2000.15.5.510; Koong HN, 1996, AUST NZ J SURG, V66, P813, DOI 10.1111/j.1445-2197.1996.tb00755.x; Kubota H, 2000, SURGERY, V128, P41, DOI 10.1067/msy.2000.106812; Kwon YM, 2009, WORLD J GASTROENTERO, V15, P3653, DOI 10.3748/wjg.15.3653; Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664; Lee YC, 2007, CANCER EPIDEM BIOMAR, V16, P875, DOI 10.1158/1055-9965.EPI-06-0758; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Liu CY, 2006, J MED SCREEN, V13, pS2; Morabito A, 2009, CRIT REV ONCOL HEMAT, V70, P216, DOI 10.1016/j.critrevonc.2008.08.005; Mukoubayashi C, 2007, INTERNAL MED, V46, P261, DOI 10.2169/internalmedicine.46.6181; Nakashima H, 2010, GASTRIC CANCER, V13, P78, DOI 10.1007/s10120-009-0538-3; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Robert G, 2000, J MED SCREEN, V7, P31, DOI 10.1136/jms.7.1.31; Shapiro J, 1982, EDUC EVAL POLICY AN, P341; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Singapore Cancer Registry Committee, 2012, TRENDS CANC INC SING; Subramanian S, 2011, EVAL PROGRAM PLANN, V34, P147, DOI 10.1016/j.evalprogplan.2010.09.005; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Tsubono Yoshitaka, 2000, Asian Pac J Cancer Prev, V1, P57; Tsuji I, 2001, Nihon Rinsho, V59 Suppl 4, P533; U. S. Environmental Protection Agency, 2010, COST ILLN HDB; Voutilainen ME, 2005, EUR J GASTROEN HEPAT, V17, P1345, DOI 10.1097/00042737-200512000-00013; Wai CT, 2002, GASTROINTEST ENDOSC, V56, P548, DOI 10.1067/mge.2002.128493; Walter LC, 2009, ANN INTERN MED, V150, P465, DOI 10.7326/0003-4819-150-7-200904070-00006; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Whiting JL, 2002, GUT, V50, P378, DOI 10.1136/gut.50.3.378; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Xie F, 2008, INT J TECHNOL ASSESS, V24, P87, DOI 10.1017/S0266462307080117; Xie Feng, 2009, J Am Coll Radiol, V6, P317, DOI 10.1016/j.jacr.2009.01.022; Yeh JM, 2010, GASTROINTEST ENDOSC, V72, P33, DOI 10.1016/j.gie.2010.01.047; Yeh JM, 2010, CANCER-AM CANCER SOC, V116, P2941, DOI 10.1002/cncr.25030; Zhou HJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-139; Zhou HJ, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-145; Zhu F, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-76	54	24	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83959	10.1371/journal.pone.0083959	http://dx.doi.org/10.1371/journal.pone.0083959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386314	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900069
J	Holme, P				Holme, Petter			Extinction Times of Epidemic Outbreaks in Networks	PLOS ONE			English	Article								In the Susceptible-Infectious-Recovered (SIR) model of disease spreading, the time to extinction of the epidemics happens at an intermediate value of the per-contact transmission probability. Too contagious infections burn out fast in the population. Infections that are not contagious enough die out before they spread to a large fraction of people. We characterize how the maximal extinction time in SIR simulations on networks depend on the network structure. For example we find that the average distances in isolated components, weighted by the component size, is a good predictor of the maximal time to extinction. Furthermore, the transmission probability giving the longest outbreaks is larger than, but otherwise seemingly independent of, the epidemic threshold.	[Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Holme, Petter] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Holme, Petter] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden	Sungkyunkwan University (SKKU); Umea University; Stockholm University	Holme, P (corresponding author), Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea.	holme@skku.edu	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education [2013R1A1A2011947]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2011947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, INFECT DIS HUMANS; Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Buckley F., 1989, DISTANCE GRAPHS, DOI [10.1007/978-0-8176-4789-6-3, DOI 10.1007/978-0-8176-4789-6-3]; Chung F, 2002, P NATL ACAD SCI USA, V99, P15879, DOI 10.1073/pnas.252631999; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Jansson S, 2013, ARXIV13085493; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liljeros F, 2004, PHYSICA A, V338, P238, DOI 10.1016/j.physa.2004.02.046; Masuda N, 2013, F1000PRIME REP; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Morris M, 2010, NETWORK EPIDEMIOLOGY; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Salathe M, 2005, J ROY SOC INTERFACE, V2, P533, DOI 10.1098/rsif.2005.0072; Szendroi B, 2004, P ROY SOC B-BIOL SCI, V271, pS364, DOI 10.1098/rsbl.2004.0188	20	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84429	10.1371/journal.pone.0084429	http://dx.doi.org/10.1371/journal.pone.0084429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386377	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700107
J	Lucky, A; Trautwein, MD; Guenard, BS; Weiser, MD; Dunn, RR				Lucky, Andrea; Trautwein, Michelle D.; Guenard, Benoit S.; Weiser, Michael D.; Dunn, Robert R.			Tracing the Rise of Ants - Out of the Ground	PLOS ONE			English	Article							AMBER HYMENOPTERA; EARLY EVOLUTION; FORMICIDAE; DIVERSIFICATION; PHYLOGENY; DIVERSITY; PONERINAE; TAXA	The evolution of ants (Hymenoptera: Formicidae) is increasingly well-understood due to recent phylogenetic analyses, along with estimates of divergence times and diversification rates. Yet, leading hypotheses regarding the ancestral habitat of ants conflict with new findings that early ant lineages are cryptic and subterranean. Where the ants evolved, in respect to habitat, and how habitat shifts took place over time have not been formally tested. Here, we reconstruct the habitat transitions of crown-group ants through time, focusing on where they nest and forage (in the canopy, litter, or soil). Based on ancestral character reconstructions, we show that in contrast to the current consensus based on verbal arguments that ants evolved in tropical leaf litter, the soil is supported as the ancestral stratum of all ants. We also find subsequent movements up into the litter and, in some cases, into the canopy. Given the global importance of ants, because of their diversity, ecological influence and status as the most successful eusocial lineage on Earth, understanding the early evolution of this lineage provides insight into the factors that made this group so successful today.	[Lucky, Andrea; Guenard, Benoit S.; Weiser, Michael D.; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Lucky, Andrea] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Trautwein, Michelle D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Trautwein, Michelle D.] North Carolina Museum Nat Sci, Nat Res Ctr, Raleigh, NC 27695 USA; [Guenard, Benoit S.] Okinawa Inst Sci & Technol, Biodivers & Biocomplex Unit, Onna Son, Okinawa, Japan; [Weiser, Michael D.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of North Carolina; North Carolina State University; State University System of Florida; University of Florida; University of North Carolina; North Carolina State University; Okinawa Institute of Science & Technology Graduate University; University of Oklahoma System; University of Oklahoma - Norman	Lucky, A (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	alucky@ufl.edu	Weiser, Michael/E-6215-2011	Weiser, Michael/0000-0001-9080-0834; /0000-0001-6782-917X; Trautwein, Michelle/0000-0003-4469-5839; Guenard, Benoit/0000-0002-7144-1175; Dunn, Robert/0000-0002-6030-4837	NSF-CAREER [0953390]; DOE-PER [DE-FG02-08ER64510]; NASA [NNX09AK22G]; Division Of Environmental Biology [0953390] Funding Source: National Science Foundation	NSF-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); DOE-PER(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AL was supported by NSF-CAREER grant 0953390; RRD was supported by the following grants: DOE-PER DE-FG02-08ER64510, NASA NNX09AK22G, NSF-CAREER 0953390. (websites: www.nsf.gov, www.doe.gov.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl S, 2011, SOIL BIOL BIOCHEM, V43, P726, DOI 10.1016/j.soilbio.2010.12.003; Barden P, 2013, ZOOTAXA, V3681, P405, DOI 10.11646/zootaxa.3681.4.5; Barden P, 2012, AM MUS NOVIT, P1; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BOLTON B., 2007, BOLTONS CATALOGUE AN; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown William L. Jr, 2000, P45; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crozier RH, 1997, NATURWISSENSCHAFTEN, V84, P22, DOI 10.1007/s001140050341; Crozier RH, 2006, P NATL ACAD SCI USA, V103, P18029, DOI 10.1073/pnas.0608880103; Darwin C., 1859, ORIGIN SPECIES MEANS, DOI [10.5962/bhl.title.82303, DOI 10.5962/BHL.TITLE.82303]; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dlussky GM, 2012, J SYST PALAEONTOL, V10, P725, DOI 10.1080/14772019.2011.628341; Dlussky GM, 2009, PALEONTOL J+, V43, P1043, DOI 10.1134/S0031030109090068; Dlussky Gennady M., 2002, Russian Entomological Journal, V11, P411; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Forel A., 1874, FOURMIS SUISSE SYSTE; Grimaldi D, 2000, P NATL ACAD SCI USA, V97, P13678, DOI 10.1073/pnas.240452097; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hof C, 2010, ECOGRAPHY, V33, P242, DOI 10.1111/j.1600-0587.2010.06309.x; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Johnson BR, 2013, CURR BIOL, V23, P1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kuck P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021031; LaPolla JS, 2013, ANNU REV ENTOMOL, V58, P609, DOI 10.1146/annurev-ento-120710-100600; Lessard J.-P., 2011, P R SOC B, V279, P266; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; McKellar RC, 2013, B GEOSCI, V88, P583, DOI 10.3140/bull.geosci.1425; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perrichot V., 2004, Geologica Acta, V2, P9; Perrichot V, 2008, NATURWISSENSCHAFTEN, V95, P85, DOI 10.1007/s00114-007-0301-8; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; Retallack GJ, 2002, PHILOS T R SOC A, V360, P659, DOI 10.1098/rsta.2001.0960; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schultz TR, 2000, P NATL ACAD SCI USA, V97, P14028, DOI 10.1073/pnas.011513798; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Wiens JJ, 2009, EVOLUTION, V63, P1217, DOI 10.1111/j.1558-5646.2009.00610.x; Wilkie KTR, 2007, NATURWISSENSCHAFTEN, V94, P725, DOI 10.1007/s00114-007-0250-2; WILSON EDWARD O., 1967, PSYCHE J ENTOMOL, V74, P1, DOI 10.1155/1967/89604; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Yu Y., 2013, RASP RECONSTRUCT ANC	44	40	41	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84012	10.1371/journal.pone.0084012	http://dx.doi.org/10.1371/journal.pone.0084012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386323	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700093
J	Mei, HX; Zhu, XF; Zhang, TZ				Mei, Hongxian; Zhu, Xiefei; Zhang, Tianzhen			Favorable QTL Alleles for Yield and Its Components Identified by Association Mapping in Chinese Upland Cotton Cultivars	PLOS ONE			English	Article							FIBER QUALITY TRAITS; GOSSYPIUM-HIRSUTUM L.; LINKAGE DISEQUILIBRIUM; SSR MARKERS; GENETIC-STRUCTURE; RIL POPULATION; GERMPLASM; PROSPECTS; PLANTS; MAIZE	Linkage disequilibrium based association mapping is a powerful tool for dissecting the genetic basis underlying complex traits. In this study, an association mapping panel consisting of 356 representative Upland cotton cultivars was constructed, evaluated in three environments and genotyped using 381 SSRs to detect molecular markers associated with lint yield and its components. The results showed that abundant phenotypic and moderate genetic diversities existed within this germplasm panel. The population could be divided into two subpopulations, and weak relatedness was detected between pair-wise accessions. LD decayed to the background (r(2) = 0.1182, P <= 0.01), r(2) = 0.1 and r(2) = 0.2 level within 12-13 cM, 17-18 cM and 3-4 cM, respectively, providing the potential for association mapping of agronomically important traits in Chinese Upland cotton. A total of 55 marker-trait associations were detected between 26 SSRs and seven lint yield traits, based on a mixed linear model (MLM) and Bonferroni correction (P <= 0.05/145, -log(10)P >= 3.46). Of which 41 could be detected in more than one environment and 17 markers were simultaneously associated with two or more traits. Many associations were consistent with QTLs identified by linkage mapping in previous reports. Phenotypic values of alleles of each loci in 41 stably detected associations were compared, and 23 favorable alleles were identified. Population frequency of each favorable allele in historically released cultivar groups was also evaluated. The QTLs detected in this study will be helpful in further understanding the genetic basis of lint yield and its components, and the favorable alleles may facilitate future high-yield breeding by genomic selection in Upland cotton.	[Mei, Hongxian; Zhu, Xiefei; Zhang, Tianzhen] Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Mei, Hongxian] Henan Acad Agr Sci, Sesame Res Ctr, Zhengzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University; Henan Academy of Agricultural Sciences	Zhang, TZ (corresponding author), Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn						Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Chen Guang, 2006, Acta Genetica Sinica, V33, P733, DOI 10.1016/S0379-4172(06)60106-6; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Guo W.Z., 1997, ACTA GOSSYPII SINICA, V9, P19; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo WZ, 2006, J INTEGR PLANT BIOL, V48, P320, DOI 10.1111/j.1744-7909.2006.00174.x; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Huang ZK, 2007, CULTIVARS THEIR PEDI; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jia LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032703; Kantartzi SK, 2008, PLANT BREEDING, V127, P173, DOI 10.1111/j.1439-0523.2008.01490.x; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2005, CROP SCI, V45, P123, DOI 10.2135/cropsci2005.0123a; LANDER ES, 1989, GENETICS, V121, P185; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu RZ, 2012, MOL BREEDING, V29, P297, DOI 10.1007/s11032-011-9547-0; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; [秦永生 QIN Yong-Sheng], 2009, [作物学报, Acta Agronomica Sinica], V35, P1812; Rakshit A, 2010, J GENET, V89, P155, DOI 10.1007/s12041-010-0055-5; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Sun FD, 2012, MOL BREEDING, V30, P569, DOI 10.1007/s11032-011-9645-z; Wang Baohua, 2007, Journal of Genetics and Genomics, V34, P35, DOI 10.1016/S1673-8527(07)60005-8; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeng LH, 2009, THEOR APPL GENET, V119, P93, DOI 10.1007/s00122-009-1020-7; Zhang H, 2008, LECT NOTES ENG COMP, P1, DOI 10.1155/2008/742304; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao Liang, 2012, Acta Agronomica Sinica, V38, P1810, DOI 10.3724/SP.J.1006.2012.01810; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	52	53	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82193	10.1371/journal.pone.0082193	http://dx.doi.org/10.1371/journal.pone.0082193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386089	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700006
J	Moehler, TM; Seckinger, A; Hose, D; Andrulis, M; Moreaux, J; Hielscher, T; Willhauck-Fleckenstein, M; Merling, A; Bertsch, U; Jauch, A; Goldschmidt, H; Klein, B; Schwartz-Albiez, R				Moehler, Thomas M.; Seckinger, Anja; Hose, Dirk; Andrulis, Mindaugas; Moreaux, Jerome; Hielscher, Thomas; Willhauck-Fleckenstein, Martina; Merling, Anette; Bertsch, Uta; Jauch, Anna; Goldschmidt, Hartmut; Klein, Bernard; Schwartz-Albiez, Reinhard			The Glycome of Normal and Malignant Plasma Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BONE-MARROW ENVIRONMENT; RISK-ADAPTED TREATMENT; MULTIPLE-MYELOMA; GROWTH-FACTOR; PROGNOSTIC-FACTOR; B-LYMPHOCYTE; TUMOR-CELLS; EXPRESSION; SYNDECAN-1	The glycome, i.e. the cellular repertoire of glycan structures, contributes to important functions such as adhesion and intercellular communication. Enzymes regulating cellular glycosylation processes are related to the pathogenesis of cancer including multiple myeloma. Here we analyze the transcriptional differences in the glycome of normal (n = 10) and two cohorts of 332 and 345 malignant plasma-cell samples, association with known multiple myeloma subentities as defined by presence of chromosomal aberrations, potential therapeutic targets, and its prognostic impact. We found i) malignant vs. normal plasma cells to show a characteristic glycome-signature. They can ii) be delineated by a lasso-based predictor from normal plasma cells based on this signature. iii) Cytogenetic aberrations lead to distinct glycan-gene expression patterns for t(11; 14), t(4; 14), hyperdiploidy, 1q21-gain and deletion of 13q14. iv) A 38-gene glycome-signature significantly delineates patients with adverse survival in two independent cohorts of 545 patients treated with high-dose melphalan and autologous stem cell transplantation. v) As single gene, expression of the phosphatidyl-inositol-glycan protein M as part of the targetable glycosyl-phosphatidyl-inositol-anchor-biosynthesis pathway is associated with adverse survival. The prognostically relevant glycome deviation in malignant cells invites novel strategies of therapy for multiple myeloma.	[Moehler, Thomas M.; Seckinger, Anja; Hose, Dirk; Bertsch, Uta; Goldschmidt, Hartmut] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany; [Moehler, Thomas M.; Willhauck-Fleckenstein, Martina; Merling, Anette; Schwartz-Albiez, Reinhard] Deutsch Krebsforschungszentrum, Heidelberg, Germany; [Seckinger, Anja; Hose, Dirk; Goldschmidt, Hartmut] Natl Ctr Tumorerkrankungen, Heidelberg, Germany; [Andrulis, Mindaugas] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Moreaux, Jerome; Klein, Bernard] INSERM, U1040, Montpellier, France; [Moreaux, Jerome; Klein, Bernard] Ctr Hosp Univ, Inst Res Biotherapy, Montpellier 3, France; [Moreaux, Jerome; Klein, Bernard] Univ Montpellier I, UFR Med, Montpellier, France; [Hielscher, Thomas] Deutsch Krebsforschungszentrum, Biostat Abt, Heidelberg, Germany; [Jauch, Anna] Heidelberg Univ, Inst Humangenet, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Schwartz-Albiez, R (corresponding author), Deutsch Krebsforschungszentrum, Heidelberg, Germany.	r.s-albiez@dkfz.de	moreaux, jerome/HGA-5649-2022; Goldschmidt, Hartmut/AAL-8069-2021; Andrulis, Mindaugas/AAN-5668-2021; J, Moreaux/ABA-2974-2021	J, Moreaux/0000-0002-5717-3207; Andrulis, Mindaugas/0000-0001-9866-4849	Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB/TR79]; Deutsche Jose Carreras Leukamie-Stiftung e.V., Munich, Germany [DJCLS R 10/32f]; German Federal Ministry of Education (BMBF) "CAMPSIM"; German Federal Ministry of Education (BMBF) CLIOMMICS"; 7th EU-framework program "OverMyR"	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie-Stiftung e.V., Munich, Germany; German Federal Ministry of Education (BMBF) "CAMPSIM"(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education (BMBF) CLIOMMICS"(Federal Ministry of Education & Research (BMBF)); 7th EU-framework program "OverMyR"	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (SFB/TR79), Bonn, Germany, to D. H., T. M., A. S., H. G. and R.S-A.; the Deutsche Jose Carreras Leukamie-Stiftung e.V., Munich, Germany (grant DJCLS R 10/32f) to R.S.-A. and H. G.; the German Federal Ministry of Education (BMBF) "CAMPSIM" to D. H. and H. G., CLIOMMICS" to D. H., H. G., and A. S., and the 7th EU-framework program "OverMyR" to D. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis M, 2012, HAEMATOL-HEMATOL J, V97, P1674, DOI 10.3324/haematol.2011.061051; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Barlogie B, 2006, BRIT J HAEMATOL, V135, P158, DOI 10.1111/j.1365-2141.2006.06271.x; Bret C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-72; Bret C, 2009, BRIT J HAEMATOL, V145, P350, DOI 10.1111/j.1365-2141.2009.07633.x; Cremer FW, 2005, GENE CHROMOSOME CANC, V44, P194, DOI 10.1002/gcc.20231; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Engelmann S, 1997, CARBOHYD RES, V302, P85, DOI 10.1016/S0008-6215(97)00115-8; ENGELMANN S, 1995, BBA-MOL CELL RES, V1267, P6, DOI 10.1016/0167-4889(95)00057-Y; Erdmann M, 2006, GLYCOCONJUGATE J, V23, P627, DOI 10.1007/s10719-006-9000-5; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Gu ZJ, 2000, LEUKEMIA, V14, P188, DOI 10.1038/sj.leu.2401632; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Hose D, 2011, HAEMATOL-HEMATOL J, V96, P87, DOI 10.3324/haematol.2010.030296; Hose D, 2009, BLOOD, V114, P128, DOI 10.1182/blood-2008-10-184226; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Irie A, 2007, BONE, V41, P165, DOI 10.1016/j.bone.2007.04.190; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kirschfink M, 1997, J IMMUNOL, V158, P1324; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Mahtouk K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-198; Meissner T, 2011, CLIN CANCER RES, V17, P7240, DOI 10.1158/1078-0432.CCR-11-1628; Mikesch JH, 2006, BBA-REV CANCER, V1766, P42, DOI 10.1016/j.bbcan.2006.04.001; Moreaux J, 2009, EUR J HAEMATOL, V83, P119, DOI 10.1111/j.1600-0609.2009.01262.x; Nair B, 2010, BLOOD, V115, P4168, DOI 10.1182/blood-2009-11-255620; Neben K, 2012, BLOOD, V119, P940, DOI 10.1182/blood-2011-09-379164; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pilobello KT, 2007, CURR OPIN CHEM BIOL, V11, P300, DOI 10.1016/j.cbpa.2007.05.002; Rebouissou C, 1998, BLOOD, V91, P4727, DOI 10.1182/blood.V91.12.4727.412k35_4727_4737; Reijmers RM, 2013, FEBS J, V280, P2180, DOI 10.1111/febs.12180; Reijmers RM, 2010, BLOOD, V115, P601, DOI 10.1182/blood-2009-02-204396; Samson D, 1998, BRIT J HAEMATOL, V102, P1115; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shaughnessy JD, 2009, BRIT J HAEMATOL, V147, P347, DOI 10.1111/j.1365-2141.2009.07864.x; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Taylor J, 2005, BIOSTATISTICS, V6, P111, DOI 10.1093/biostatistics/kxh021; Warren P, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P108; Willhauck-Fleckenstein M, 2010, ANGIOGENESIS, V13, P25, DOI 10.1007/s10456-010-9162-4; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wuilleme S, 2005, LEUKEMIA, V19, P275, DOI 10.1038/sj.leu.2403586; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zhang XG, 1998, LEUKEMIA, V12, P610, DOI 10.1038/sj.leu.2400971	56	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83719	10.1371/journal.pone.0083719	http://dx.doi.org/10.1371/journal.pone.0083719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386263	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700073
J	Pavlin, JA; Burkom, HS; Elbert, Y; Lucero-Obusan, C; Winston, CA; Cox, KL; Oda, G; Lombardo, JS; Holodniy, M				Pavlin, Julie A.; Burkom, Howard S.; Elbert, Yevgeniy; Lucero-Obusan, Cynthia; Winston, Carla A.; Cox, Kenneth L.; Oda, Gina; Lombardo, Joseph S.; Holodniy, Mark			Combining Surveillance Systems: Effective Merging of US Veteran and Military Health Data	PLOS ONE			English	Article							INFLUENZA	Background: The U. S. Department of Veterans Affairs (VA) and Department of Defense (DoD) had more than 18 million healthcare beneficiaries in 2011. Both Departments conduct individual surveillance for disease events and health threats. Methods: We performed joint and separate analyses of VA and DoD outpatient visit data from October 2006 through September 2010 to demonstrate geographic and demographic coverage, timeliness of influenza epidemic awareness, and impact on spatial cluster detection achieved from a joint VA and DoD biosurveillance platform. Results: Although VA coverage is greater, DoD visit volume is comparable or greater. Detection of outbreaks was better in DoD data for 58% and 75% of geographic areas surveyed for seasonal and pandemic influenza, respectively, and better in VA data for 34% and 15%. The VA system tended to alert earlier with a typical H3N2 seasonal influenza affecting older patients, and the DoD performed better during the H1N1 pandemic which affected younger patients more than normal influenza seasons. Retrospective analysis of known outbreaks demonstrated clustering evidence found in separate DoD and VA runs, which persisted with combined data sets. Conclusion: The analyses demonstrate two complementary surveillance systems with evident benefits for the national health picture. Relative timeliness of reporting could be improved in 92% of geographic areas with access to both systems, and more information provided in areas where only one type of facility exists. Combining DoD and VA data enhances geographic cluster detection capability without loss of sensitivity to events isolated in either population and has a manageable effect on customary alert rates.	[Pavlin, Julie A.] US Dept Def, Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20910 USA; [Burkom, Howard S.; Elbert, Yevgeniy; Lombardo, Joseph S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Lucero-Obusan, Cynthia; Winston, Carla A.; Oda, Gina] US Dept Vet Affairs, Off Publ Hlth, Washington, DC USA; [Cox, Kenneth L.] US Dept Def, US Army Inst Publ Hlth, Aberdeen Proving Ground, MD USA	United States Department of Defense; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; US Department of Veterans Affairs; United States Department of Defense	Pavlin, JA (corresponding author), US Dept Def, Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20910 USA.	julie.a.pavlin.civ@mail.mil		burkom, howard/0000-0003-0667-9467; Holodniy, Mark/0000-0002-6655-7982	Department of Veterans Affairs; Department of Defense	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense(United States Department of Defense)	This work was financially supported by intramural funding from the Departments of Veterans Affairs and Defense through the Joint Incentive Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NATL STRATEGY BIOSUR; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; Burkom HS, 2008, J HOPKINS APL TECH D, V27, P313; Centers for Disease Control and Prevention, 2012, BIOSENSE PUBL HLTH S; Centers for Disease Control and Prevention, FLUVIEW; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lucero CA, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-56; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; National Center for Veterans Analysis and Statistics US Department of Veterans Affairs, 2012, UT SEL VET HLTH ADM; Perkins BA, 2002, EMERG INFECT DIS, V8, P1015, DOI 10.3201/eid0810.020444; TRICARE Management Activity (TMA)/Office of the Chief Financial Officer (OCFO)-Defense Health Cost Assessment and Program Evaluation (DHCAPE) in the Office of the Assistant Secretary of Defense (Health Affairs) (OASD/HA), 2012, EV TRICARE PROGR FIS; Xing J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-45	12	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84077	10.1371/journal.pone.0084077	http://dx.doi.org/10.1371/journal.pone.0084077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386335	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700096
J	de Medeiros, GF; Pereira, E; Granzotto, N; Ramos, A				de Medeiros, Gabriela Ferreira; Pereira, Elayne; Granzotto, Natalli; Ramos, Andre			Low-Anxiety Rat Phenotypes Can Be Further Reduced through Genetic Intervention	PLOS ONE			English	Article							ELEVATED T-MAZE; ANIMAL-MODELS; TRANSGRESSIVE SEGREGATION; OPEN-FIELD; PLUS-MAZE; DISORDERS; BEHAVIORS; TESTS; STRAINS; STRESS	Background: A previous study using an intercross between the inbred rat strains Lewis (LEW) and Spontaneously Hypertensive Rats (SHR) identified a locus on chromosome 4, named Anxrr16, influencing an experimental index of anxiety and showing a transgressive effect, with alleles from the LEW strain (more anxious) decreasing rather than increasing anxiety. Objective: To confirm the location and isolate the effect of a rat genome region named Anxrr16 through a planned genomic recombination strategy, where the target locus in SHR rats was replaced with LEW genetic material. Methods: A new congenic strain, named SHR. LEW-Anxrr16 (SLA16), was developed from a cross between LEW (donor) and SHR (receptor) rats and then evaluated in several anxiety-related tests. The activity and attention levels of the new strain were also evaluated, since hyperactivity was observed during its construction and because SHR is a model of attention deficit hyperactivity disorder. Results: Significant effects of Anxrr16 were found for open field central locomotion, as well as for other indices of anxiety from the light/dark box, triple test and T-maze. In all cases, the low-anxiety levels of SHR rats were further reduced by the insertion of LEW alleles. Differences in locomotor activity were found only in unfamiliar (hence stressful) environments and no genetic effects were observed in indices of attention. Conclusion: The SLA16 strain can help in the identification of the molecular pathways involved in experimental anxiety and it demonstrates how apparently extreme phenotypes sometimes hide major opposite-acting genes.	[de Medeiros, Gabriela Ferreira; Pereira, Elayne; Granzotto, Natalli; Ramos, Andre] Univ Fed Santa Catarina, Ctr Ciencias Biol, Lab Genet Comportamento, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Pereira, E (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Lab Genet Comportamento, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil.	elaynepp@yahoo.com.br	RAMOS, Andre/AAL-2090-2021; Pereira, Elayne/B-7364-2014	Pereira, Elayne/0000-0002-1178-669X; de Avila Ramos, Andre/0000-0003-4449-3866	PRONEX from FAPESC/CNPq [427/2003]; CNPq [470549/2009-2]	PRONEX from FAPESC/CNPq; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by a PRONEX grant 427/2003 from FAPESC/CNPq and the CNPq grant 470549/2009-2. http://www.fapesc.sc.gov.br. http://www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; DEVICENTE MC, 1993, GENETICS, V134, P585; Dittrich-Reed DR, 2013, EVOL BIOL, V40, P310, DOI 10.1007/s11692-012-9209-0; Fehr C, 2002, J NEUROSCI, V22, P3730; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Graeff FG, 1998, NEUROSCI BIOBEHAV R, V23, P237, DOI 10.1016/S0149-7634(98)00024-4; Gross C, 2004, NEUROTOX RES, V6, P493, DOI 10.1007/BF03033286; Hall C, 1934, J COMP PSYCHOL, V22, P385; Hamilton Steven P., 2009, V23, P165; Hinojosa FR, 2006, BEHAV BRAIN RES, V168, P127, DOI 10.1016/j.bbr.2005.10.019; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kloting N, 2007, DIABETES-METAB RES, V23, P406, DOI 10.1002/dmrr.713; Lazarus RS, 1991, EMOTION ADAPTATION, P42; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Llamas B, 2005, MAMM GENOME, V16, P505, DOI 10.1007/s00335-005-0022-2; Mormede P, 2002, GENES BRAIN BEHAV, V1, P111, DOI 10.1034/j.1601-183X.2002.10206.x; Poltronieri SC, 2003, BEHAV BRAIN RES, V147, P185, DOI 10.1016/S0166-4328(03)00151-7; Ramos A, 2002, BEHAV BRAIN RES, V129, P113, DOI 10.1016/S0166-4328(01)00337-0; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Ramos A, 1999, MOL PSYCHIATR, V4, P453, DOI 10.1038/sj.mp.4000546; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Ramos A, 2008, BEHAV BRAIN RES, V193, P277, DOI 10.1016/j.bbr.2008.06.007; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Roy V, 2009, PSYCHOPHARMACOLOGY, V203, P131, DOI 10.1007/s00213-008-1378-2; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; Sagvolden T, 2009, NEUROPHARMACOLOGY, V57, P619, DOI 10.1016/j.neuropharm.2009.08.004; Silva GJJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-17; Smoller JW, 2009, DEPRESS ANXIETY, V26, P965, DOI 10.1002/da.20623; Soares VD, 2011, BEHAV BRAIN RES, V225, P590, DOI 10.1016/j.bbr.2011.08.032; Takahashi A, 2006, BEHAV GENET, V36, P763, DOI 10.1007/s10519-005-9038-3; Teixeira RC, 2000, PHARMACOL BIOCHEM BE, V65, P571, DOI 10.1016/S0091-3057(99)00261-0; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Vendruscolo LF, 2006, GENES BRAIN BEHAV, V5, P441, DOI 10.1111/j.1601-183X.2005.00177.x; Wehrmeister TD, 2010, PHARMACOL BIOCHEM BE, V97, P301, DOI 10.1016/j.pbb.2010.08.014; Weiss SM, 1998, NEUROSCI BIOBEHAV R, V23, P265, DOI 10.1016/S0149-7634(98)00027-X	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83666	10.1371/journal.pone.0083666	http://dx.doi.org/10.1371/journal.pone.0083666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386249	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700057
J	Gao, Q; Yu, M; Zhou, C				Gao, Qiong; Yu, Mei; Zhou, Chan			Detecting the Differences in Responses of Stomatal Conductance to Moisture Stresses between Deciduous Shrubs and Artemisia Subshrubs	PLOS ONE			English	Article							HYDRAULIC CONDUCTANCE; WATER RELATIONS; XYLEM CONDUCTIVITY; LAND-USE; MODEL; VULNERABILITY; PERFORMANCE; CAVITATION; CLIMATE; DESERT	Shrubs and subshrubs can tolerate wider ranges of moisture stresses in both soil and air than other plant life forms, and thus represent greater nonlinearity and uncertainty in ecosystem physiology. The objectives of this paper are to model shrub/subshrub stomatal conductance by synthesizing the field leaf gas exchanges data of 24 species in China, in order to detect the differences between deciduous shrubs and Artemisia subshrubs in their responses of stomatal conductance to changes in the moisture stresses. We revised a model of stomatal conductance by incorporating the tradeoff between xylem hydraulic efficiency and cavitation loss risk. We then fit the model at the three hierarchical levels: global (pooling all data as a single group), three functional groups (deciduous non-legume shrubs, deciduous legume shrubs, and subshrubs in Artemisia genus), and individual observations (species 6 sites). Bayesian inference with Markov Chain Monte Carlo method was applied to obtain the model parameters at the three levels. We found that the model at the level of functional groups is a significant improvement over that at the global level, indicating the significant differences in the stomatal behavior among the three functional groups. The differences in tolerance and sensitivities to changes in moisture stresses are the most evident between the shrubs and the subshrubs: The two shrub groups can tolerate much higher soil water stress than the subshrubs. The analysis at the observation level is also a significant improvement over that at the functional group level, indicating great variations within each group. Our analysis offered a clue for the equivocal issue of shrub encroachment into grasslands: While the invasion by the shrubs may be irreversible, the dominance of subshrubs, due to their lower resistance and tolerance to moisture stresses, may be put down by appropriate grassland management.	[Gao, Qiong] Beijing Normal Univ, Natl Lab Earth Surface Proc & Resources Ecol, Landscape Anal & Modeling Grp, Beijing 100875, Peoples R China; [Yu, Mei] Univ Puerto Rico Rio Piedras, Inst Trop Ecosyst Studies, San Juan, PR USA; [Zhou, Chan] Liaoning Univ, Coll Life Sci, Shenyang 110036, Peoples R China	Beijing Normal University; University of Puerto Rico; University of Puerto Rico Rio Piedras; Liaoning University	Yu, M (corresponding author), Univ Puerto Rico Rio Piedras, Inst Trop Ecosyst Studies, San Juan, PR USA.	meiyu@ites.upr.edu			National Science Foundation of China [41171445, 41321001]; National Lab of Earth Surface Processes and Resources Ecology grant [2012-TDZY-31]; National Basic Research Project [2014CB954303]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Lab of Earth Surface Processes and Resources Ecology grant; National Basic Research Project(National Basic Research Program of China)	The National Science Foundation of China grants # 41171445 and 41321001, National Lab of Earth Surface Processes and Resources Ecology grant # 2012-TDZY-31, National Basic Research Project # 2014CB954303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer S., 1994, Ecological implications of livestock herbivory in the west.., P13; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; Bohrer G, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004181; Buckley TN, 2012, PLANT CELL ENVIRON, V35, P1647, DOI 10.1111/j.1365-3040.2012.02515.x; Buckley TN, 2003, PLANT CELL ENVIRON, V26, P1767, DOI 10.1046/j.1365-3040.2003.01094.x; Choat B, 2011, NEW PHYTOL, V191, P996, DOI 10.1111/j.1469-8137.2011.03772.x; COOKE JR, 1976, T ASAE, V19, P1107, DOI 10.13031/2013.36186; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Cui XY, 2000, ACTA PHYTOECOLOGICA, V24, P541; Damunupola JW, 2011, FUNCT PLANT BIOL, V38, P614, DOI 10.1071/FP11068; [邓雄 Deng Xiong], 2002, [植物生态学报, Acta Phytoecologica Sinica], V26, P605; Emanuel RE, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008890; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Feng JC, 1997, NW BOT SINICA, V17, P135; Fichot R, 2011, J EXP BOT, V62, P2093, DOI 10.1093/jxb/erq415; Gao Q, 2005, FUNCT PLANT BIOL, V32, P583, DOI 10.1071/FP04092; Gao Q, 2004, ECOL MODEL, V172, P1, DOI 10.1016/S0304-3800(03)00250-3; Gao Q, 2002, PLANT CELL ENVIRON, V25, P1373, DOI 10.1046/j.1365-3040.2002.00926.x; GROVER HD, 1990, CLIMATIC CHANGE, V17, P305, DOI 10.1007/BF00138373; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Iovi K, 2009, TREE PHYSIOL, V29, P889, DOI 10.1093/treephys/tpp032; Jacobsen AL, 2007, ECOLOGICAL MONOGRAPH, V77; Jacobsen AL, 2009, AM J BOT, V96, P1445, DOI 10.3732/ajb.0800424; Kemp PR, 1997, WATER RESOUR RES, V33, P73, DOI 10.1029/96WR03015; Kocacinar F, 2004, OECOLOGIA, V139, P214, DOI 10.1007/s00442-004-1517-3; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Leng PS, 2000, J BEIJING AGR COLL, V15, P13; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Li J, 2000, GUIHAIA, V20, P52; Li J, 2008, BOT STUD, V49, P127; [刘振国 Liu Zhenguo], 2006, [生态学报, Acta Ecologica Sinica], V26, P475; Lopez OR, 2005, TREE PHYSIOL, V25, P1553, DOI 10.1093/treephys/25.12.1553; Lunn DJ, 2000, STAT COMPUTING, V10; Maherali H, 2000, TREE PHYSIOL, V20, P859; Medlyn BE, 1999, PLANT CELL ENVIRON, V22, P1475, DOI 10.1046/j.1365-3040.1999.00523.x; Mencuccini M, 2003, PLANT CELL ENVIRON, V26, P163, DOI 10.1046/j.1365-3040.2003.00991.x; NEILSON RP, 1986, SCIENCE, V232, P27, DOI 10.1126/science.232.4746.27; NILSEN ET, 1983, ECOLOGY, V64, P1381, DOI 10.2307/1937492; Ntzoufras I., 2009, BAYESIAN MODELING US; PELAEZ DV, 1987, J RANGE MANAGE, V40, P6, DOI 10.2307/3899351; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; R Core Team, 2018, R LANG ENV STAT COMP; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reyes-Santamaria I, 2002, SCI HORTIC-AMSTERDAM, V92, P97, DOI 10.1016/S0304-4238(01)00284-9; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Reynolds JF, 2006, STRUCTURE FUNCTION C; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Shan GuiLian, 2008, Acta Prataculturae Sinica, V17, P1; Sperry JS, 2002, FUNCT ECOL, V16, P367, DOI 10.1046/j.1365-2435.2002.00628.x; Tombesi S, 2010, ANN BOT-LONDON, V105, P327, DOI 10.1093/aob/mcp281; [仝川 Tong Chuan], 2002, [自然资源学报, Journal of Natural Resources], V17, P571; [王静 WANG Jing], 2006, [生态学报, Acta Ecologica Sinica], V26, P960; WANG Y F, 1998, ACTA AGRESTIA SIN, V6, P299; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; [熊好琴 Xiong Haoqin], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P233; Xiong XiaoGang, 2003, Acta Prataculturae Sinica, V12, P57; Yu M, 2011, ANN BOT; Zhang LP, 1996, NATURAL SCI, V32, P128; ZHANG LP, 1998, ACTA ECOL SIN, V18, P133; Zhang SR, 2003, ENVIRON EXP BOT, V49, P121, DOI 10.1016/S0098-8472(02)00063-1; Zhou Haiyan, 2000, Yingyong Shengtai Xuebao, V11, P587; Zhou HY, 2001, J DESERT RES, V21, P227; Zhou HY, 1996, ACTA PHYTOECOLOGICA, V20, P120	69	10	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84200	10.1371/journal.pone.0084200	http://dx.doi.org/10.1371/journal.pone.0084200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386351	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700095
J	Meng, P; Yang, SL; Shen, CB; Jiang, K; Rong, MQ; Lai, R				Meng, Ping; Yang, Shilong; Shen, Chuanbin; Jiang, Ke; Rong, Mingqiang; Lai, Ren			The First Salamander Defensin Antimicrobial Peptide	PLOS ONE			English	Article							PLETHODON-CINEREUS; SKIN; FROG; IDENTIFICATION; IMMUNITY	Antimicrobial peptides have been widely identified from amphibian skins except salamanders. A novel antimicrobial peptide (CFBD) was isolated and characterized from skin secretions of the salamander, Cynops fudingensis. The cDNA encoding CFBD precursor was cloned from the skin cDNA library of C. fudingensis. The precursor was composed of three domains: signal peptide of 17 residues, mature peptide of 41 residues and intervening propeptide of 3 residues. There are six cysteines in the sequence of mature CFBD peptide, which possibly form three disulfide-bridges. CFBD showed antimicrobial activities against Staphylococcus aureus, Bacillus subtilis, Candida albicans and Escherichia coli. This peptide could be classified into family of beta-defensin based on its seqeuence similarity with beta-defensins from other vertebrates. Evolution analysis indicated that CFBD was close to fish beta-defensin. As far as we know, CFBD is the first beta-defensin antimicrobial peptide from salamanders.	[Meng, Ping; Lai, Ren] Nanjing Agr Univ, Life Sci Coll, Nanjing, Jiangsu, Peoples R China; [Yang, Shilong; Shen, Chuanbin; Rong, Mingqiang; Lai, Ren] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mechanisms, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Jiang, Ke] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Lai, R (corresponding author), Nanjing Agr Univ, Life Sci Coll, Nanjing, Jiangsu, Peoples R China.	rongmingqiang@mail.kiz.ac.cn; rlai72@njau.edu.cn		Shen, Chuanbin/0000-0002-4635-5160	Chinese National Natural Science Foundation [30830021, 31070701, 31000960, 31025025, U1132601, 31200590]; Ministry of Science and Technology [2010CB529800, 2011ZX09102-002-10]; Yunnan Province [2011CI139, 2012BC009, 2013FB072]; Jiangsu Province [BK2012365, BE2012748]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Yunnan Province; Jiangsu Province	This work was supported by Chinese National Natural Science Foundation (30830021, 31025025, 31070701, 31000960, 31025025, U1132601, 31200590), the Ministry of Science and Technology (2010CB529800, 2011ZX09102-002-10), Yunnan Province (2011CI139, 2012BC009,2013FB072), Jiangsu Province (BK2012365, BE2012748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Conlon JM, 2006, PEPTIDES, V27, P2111, DOI 10.1016/j.peptides.2006.03.002; Cuesta A, 2011, MOL IMMUNOL, V48, P1432, DOI 10.1016/j.molimm.2011.03.022; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Fredericks LP, 2000, J EXP ZOOL, V287, P340, DOI 10.1002/1097-010X(20001001)287:5<340::AID-JEZ2>3.0.CO;2-9; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Jarczak J, 2013, HUM IMMUNOL; Jin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012883; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Li J, 2007, MOL CELL PROTEOMICS, V28, P969; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Liu DX, 2013, GENE, V514, P99, DOI 10.1016/j.gene.2012.11.007; Rajanbabu V, 2011, PEPTIDES, V32, P415, DOI 10.1016/j.peptides.2010.11.005; Rovito SM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-255; Ruangsri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062302; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang XM, 2012, GENE, V509, P258, DOI 10.1016/j.gene.2012.08.013; You DW, 2009, J BIOL CHEM, V284, P22079, DOI 10.1074/jbc.M109.013276; Zhang ZW, 2009, ZOOL SCI, V26, P80, DOI 10.2108/zsj.26.80	22	29	32	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83044	10.1371/journal.pone.0083044	http://dx.doi.org/10.1371/journal.pone.0083044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386139	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700024
J	Ostman, O; Bostrom, MK; Bergstrom, U; Andersson, J; Lunneryd, SG				Ostman, Orjan; Bostrom, Maria K.; Bergstrom, Ulf; Andersson, Jan; Lunneryd, Sven-Gunnar			Estimating Competition between Wildlife and Humans-A Case of Cormorants and Coastal Fisheries in the Baltic Sea	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; PERCA-FLUVIATILIS L; FISH COMMUNITIES; GREAT CORMORANTS; TEMPORAL-CHANGES; PREDATION; DIET; LAKE; IMPACT; STOCKS	Cormorants and other wildlife populations have come in real or perceived conflicts with humans over exploited fish stocks. From gut contents of cormorants, and using an extension of the Catch equation, we estimated the degree of short term competition between great cormorants and coastal fisheries in two areas along the Swedish Baltic Sea. Cormorants consumed 10 and 44%, in respective area, of the fish biomass of six fish species harvested by humans; eel, flounder, herring, perch, pike, and whitefish. On average, cormorants consumed smaller individuals than harvested in fisheries. But for perch, cod and flounder, cormorants consumed harvestable sized fish corresponding >20% of human catches. Our competition model estimated the direct decrease in fisheries catches due to cormorant predation to be <10% for all species except flounder (>30%) and perch (2-20%). When also including the indirect effects of cormorant predation on smaller fish that never reached harvestable size, the estimated decrease in fisheries catches at least doubled for perch (13-34%) and pike (8-19%). Despite large uncertainties, our model indicates that cormorants may locally have a direct impact on human catches of at least flounder, and when incorporating indirect effects also on perch and pike. The study indicates that the degree of competition between cormorants and humans varies substantially between areas. We also included economical values in the model and concluded that for the commercially most important species, eel and cod, the estimated economic impact of cormorants on fisheries was low.	[Ostman, Orjan; Bostrom, Maria K.; Bergstrom, Ulf; Andersson, Jan; Lunneryd, Sven-Gunnar] Swedish Univ Agr Sci, Dept Aquat Resources, Oregrund, Sweden	Swedish University of Agricultural Sciences	Ostman, O (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	orjan.ostman@ebc.uu.se	Östman, Örjan/ABF-8714-2020	Östman, Örjan/0000-0002-1930-0148; Bergstrom, Ulf/0000-0002-5478-0634	Swedish Environmental Protection Agency; Swedish Board of Fishery; Swedish Agency for Marine and Water Management	Swedish Environmental Protection Agency; Swedish Board of Fishery; Swedish Agency for Marine and Water Management	This study was funded by the Swedish Environmental Protection Agency (http://naturvardsverket.se/), the Swedish Board of Fishery, and Swedish Agency for Marine and Water Management (https://www.havochvatten.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjers K, 2006, BOREAL ENVIRON RES, V11, P13; Andersen SM, 2007, ICES J MAR SCI, V64, P1235, DOI 10.1093/icesjms/fsm092; [Anonymous], 2003, DOCUMENTS; Bostrom MK, 2012, ICES J MAR SCI, V69, P175, DOI 10.1093/icesjms/fss002; Bostrom MK, 2009, FISH RES, V98, P16, DOI 10.1016/j.fishres.2009.03.011; Bregnballe T, 2009, SKARVEN; Dalton CM, 2009, CAN J FISH AQUAT SCI, V66, P177, DOI 10.1139/F08-198; Diana JS, 2006, J GREAT LAKES RES, V32, P306, DOI 10.3394/0380-1330(2006)32[306:DICPTS]2.0.CO;2; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Engstrom H, 2001, ECOGRAPHY, V24, P127, DOI 10.1034/j.1600-0587.2001.240203.x; Eschbaum R., 2003, P72; Fielder DG, 2010, J GREAT LAKES RES, V36, P207, DOI 10.1016/j.jglr.2009.12.015; GREMILLET D, 1995, MAR ECOL PROG SER, V121, P1, DOI 10.3354/meps121001; HANSSON S, 1985, HYDROBIOLOGIA, V121, P3, DOI 10.1007/BF00035223; HELCOM, 2010, POP DEV BALT BIRD SP; ICES, 2013, 2013ACOM10 ICES WGBF; Jennings S., 2001, MARINE FISHERIES ECO; Jepsen N, 2010, MAR FRESHWATER RES, V61, P320, DOI 10.1071/MF09038; Johansson T, 2008, LANSSTYRELSENS MEDDE, V2008, P1; Karas P, 1996, ARCH HYDROBIOL, V138, P99; Lehikoinen A, 2011, BOREAL ENVIRON RES, V16, P61; Leopold MF, 1998, J SEA RES, V40, P93, DOI 10.1016/S1385-1101(98)00028-8; Lindell L, 1993, VAR FAGELVARLD S, V20; LINN IJ, 1992, J APPL ECOL, V29, P619, DOI 10.2307/2404470; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; Meier HEM, 2004, AMBIO, V33, P249, DOI 10.1639/0044-7447(2004)033[0249:SDOBSI]2.0.CO;2; Mustamaki N, 2013, AMBIO IN PRESS; Olsson J, 2012, ESTUAR COAST SHELF S, V97, P104, DOI 10.1016/j.ecss.2011.11.032; Ostman O, 2012, CAN J FISH AQUAT SCI, V69, P1047, DOI 10.1139/F2012-042; Putys Z, 2012, THESIS VILNIUS U; Ridgway MS, 2010, J GREAT LAKES RES, V36, P93, DOI 10.1016/j.jglr.2009.10.002; Saulamo K., 2002, FINFO, V2002, P9; Soderberg K, 2004, FINFO, V2004, P7; Stempniewicz L., 2003, P51; Swedish Agency for Marine and Water Management website, KUSTF; Swedish Agency for Marine and Water Management website, FANGSTST YRKESF; Swedish Boards of Fisheries, 2010, SMASK KUSTF; Thornqvist S, 2009, FRITIDSFISKETS UTOVA, P1; van Rijn S., 2003, VOGELWELT, V124, P15; VanDeValk AJ, 2002, T AM FISH SOC, V131, P27, DOI 10.1577/1548-8659(2002)131<0027:COAACH>2.0.CO;2; Vetemaa M, 2010, ICES J MAR SCI, V67, P1972, DOI 10.1093/icesjms/fsq113; Zydelis R, 2008, HYDROBIOLOGIA, V611, P45, DOI 10.1007/s10750-008-9460-7	42	35	35	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83763	10.1371/journal.pone.0083763	http://dx.doi.org/10.1371/journal.pone.0083763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386272	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700066
J	Tamura, R; Nishida, H; Eifuku, S; Fushiki, H; Watanabe, Y; Uchiyama, K				Tamura, Ryoi; Nishida, Hiroshi; Eifuku, Satoshi; Fushiki, Hiroaki; Watanabe, Yukio; Uchiyama, Kumiko			Sleep-Stage Correlates of Hippocampal Electroencephalogram in Primates	PLOS ONE			English	Article							THETA-OSCILLATIONS; EPISODIC MEMORY; MACACA-MULATTA; BEHAVING RAT; EEG; MOVEMENT; MONKEYS; FREQUENCY; NEOCORTEX; NETWORK	It has been demonstrated in the rodent hippocampus that rhythmic slow activity (theta) predominantly occurs during rapid eye movement (REM) sleep, while sharp waves and associated ripples occur mainly during non-REM sleep. However, evidence is lacking for correlates of sleep stages with electroencephalogram (EEG) in the hippocampus of monkeys. In the present study, we recorded hippocampal EEG from the dentate gyrus in monkeys overnight under conditions of polysomnographical monitoring. As result, the hippocampal EEG changed in a manner similar to that of the surface EEG: during wakefulness, the hippocampal EEG showed fast, desynchronized waves, which were partly replaced with slower waves of intermediate amplitudes during the shallow stages of non-REM sleep. During the deep stages of non-REM sleep, continuous, slower oscillations (0.5-8 Hz) with high amplitudes were predominant. During REM sleep, the hippocampal EEG again showed fast, desynchronized waves similar to those found during wakefulness. These results indicate that in the monkey, hippocampal rhythmic slow activity rarely occurs during REM sleep, which is in clear contrast to that of rodents. In addition, the increase in the slower oscillations of hippocampal EEG during non-REM sleep, which resembled that of the surface EEG, may at least partly reflect cortical inputs to the dentate gyrus during this behavioral state.	[Tamura, Ryoi; Uchiyama, Kumiko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Integrat Neurosci, Toyama 930, Japan; [Nishida, Hiroshi; Watanabe, Yukio] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Otorhinolaryngol, Toyama 930, Japan; [Eifuku, Satoshi] Fukushima Med Univ, Sch Med, Dept Syst Neurosci, Fukushima, Japan; [Fushiki, Hiroaki] Mejiro Univ, Fac Hlth Sci, Saitama, Japan	University of Toyama; University of Toyama; Fukushima Medical University	Tamura, R (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Integrat Neurosci, Toyama 930, Japan.	rtamura@med.u-toyama.ac.jp			Japanese Society for the Promotion of Science (JSPS) [20500356, 23500480]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23119710]; Japan Chemical Industry Association, Long-range Research Initiative [2004NT01]; Grants-in-Aid for Scientific Research [23500465] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Chemical Industry Association, Long-range Research Initiative; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (C) (Grant #: 20500356 and 23500480) from Japanese Society for the Promotion of Science (JSPS), and Grant-in-Aid for Scientific Research on Innovative Areas, "Face perception and recognition'' (Grant #: 23119710) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Japan Chemical Industry Association, Long-range Research Initiative (Grant #: 2004NT01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Asahi T, 2003, NEUROSCI RES, V47, P255, DOI 10.1016/S0168-0102(03)00202-5; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Black AH, 1975, HIPPOCAMPUS, P129; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Cantero JL, 2003, J NEUROSCI, V23, P10897; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Crowne DP, 1975, HIPPOCAMPUS, V2, P185; Daley JT, 2006, SLEEP, V29, P221; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; FREEMON FR, 1969, EXP NEUROL, V25, P129, DOI 10.1016/0014-4886(69)90076-4; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; HALGREN E, 1978, ELECTROEN CLIN NEURO, V44, P778, DOI 10.1016/0013-4694(78)90212-2; Hsieh KC, 2008, SLEEP, V31, P1239; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kusama T., 1970, STEREOTAXIC ATLAS BR; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Moroni F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000867; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pelletier JG, 2004, J NEUROPHYSIOL, V91, P2079, DOI 10.1152/jn.01197.2003; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; TAMURA R, 1992, HIPPOCAMPUS, V2, P287, DOI 10.1002/hipo.450020308; Tamura R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020006; Tamura R, 2011, HIPPOCAMPUS, V21, P565, DOI 10.1002/hipo.20773; Uchida S, 2003, J CLIN NEUROSCI, V10, P371, DOI 10.1016/S0967-5868(03)00025-0; Uchida S, 2001, BRAIN RES, V891, P7, DOI 10.1016/S0006-8993(00)03154-1; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WHISHAW IQ, 1973, BEHAV BIOL, V8, P461, DOI 10.1016/S0091-6773(73)80041-0; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; YLINEN A, 1995, J NEUROSCI, V15, P30	49	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82994	10.1371/journal.pone.0082994	http://dx.doi.org/10.1371/journal.pone.0082994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386134	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700021
J	Tasca, G; Lelievre, JY; Qiu, Q; Ritchie, K; Little, J; Trinneer, A; Barber, A; Chyurlia, L; Bissada, H; Gruslin, A				Tasca, Giorgio; Lelievre, Julien Yockell; Qiu, Qing; Ritchie, Kerri; Little, John; Trinneer, Anne; Barber, Ann; Chyurlia, Livia; Bissada, Hany; Gruslin, Andree			Characterization of IGF-II Isoforms in Binge Eating Disorder and Its Group Psychological Treatment	PLOS ONE			English	Article							GROWTH-FACTOR-II; CIRCULATING LEVELS; LONGITUDINAL DATA; INSULIN; PREVALENCE; OBESITY; WOMEN; PRO	Intro: Binge eating disorder (BED) affects 3.5% of the population and is characterized by binge eating for at least 2 days a week for 6 months. Treatment options include cognitive behavioral therapy, interpersonal psychotherapy, and pharmacotherapy which are associated with varied success. Little is known about the biology of BED. Since there is evidence that the insulin like growth factor system is implicated in regulation of body weight, insulin sensitivity and feeding behavior, we speculated it may be involved in BED. Methods: A cross-sectional comparison was made between three groups of women: overweight with BED, overweight without BED and normal weight without BED. Women were assigned to Group Psychodynamic Interpersonal Psychotherapy. Blood was collected before therapy, at completion and at 6months follow up for evaluation of IGF-II using Western blot. Results: 97 overweight women with BED contributed to the cross-sectional comparison. The two control groups comprised 53 overweight women without BED, and 50 age matched normal weight women without BED. Obese women had significantly lower Big IGF-II than normal weight women, p=.028; Overweight women with BED had higher Mature IGF-II than normal weight women, p<.05. Big IGF-II showed a significant decreasing slope from pre- to post-to six months post-group psychological treatment, unrelated to changes in BMI (p=.008). Conclusion: Levels of IGF-II isoforms differed significantly between overweight and normal weight women. Overweight women with BED display abnormal levels of circulating IGF-II isoforms. BED is characterized by elevated mature IGF-II, an isoform shown to carry significant bioactivity. This finding is not related to BMI or to changes in body weight. The results also provide preliminary evidence that BIG IGF-II is sensitive to change due to group psychological treatment. We suggest that abnormalities in IGF-II processing may be involved in the neurobiology of BED.	[Tasca, Giorgio] Univ Ottawa, Dept Psychol, Ottawa Hosp, Ottawa, ON, Canada; [Lelievre, Julien Yockell; Qiu, Qing; Gruslin, Andree] Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp, Ottawa, ON, Canada; [Ritchie, Kerri; Chyurlia, Livia] Ottawa Hosp, Dept Psychol, Ottawa, ON, Canada; [Little, John] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Gruslin, Andree] Univ Ottawa, Dept Obstet Gynaecol & Newborn Care, Ottawa Hosp, Ottawa, ON, Canada; [Lelievre, Julien Yockell; Qiu, Qing; Gruslin, Andree] OHRI, Ottawa, ON, Canada; [Barber, Ann] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Tasca, Giorgio; Trinneer, Anne; Bissada, Hany] Univ Ottawa, Dept Psychiat, Ottawa Hosp, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute	Gruslin, A (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp, Ottawa, ON, Canada.	agruslin@ottawahospital.on.ca	PAN, ZEQIANG/X-6341-2018; Little, Julian/AAR-6117-2020; Tasca, Giorgio A./AAG-1867-2019	Little, Julian/0000-0001-5026-5531; Tasca, Giorgio A./0000-0001-7596-0661	Canadian Institutes for Health Research (CIHR); Ontario Mental Health Foundation	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation	This study was funded by grants from the Canadian Institutes for Health Research (CIHR) and Ontario Mental Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED I, 1992, BRAIN RES, V595, P242, DOI 10.1016/0006-8993(92)91056-K; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Espelund U, 2005, EUR J ENDOCRINOL, V153, P861, DOI 10.1530/eje.1.02028; Feeney J., 1994, ATTACHMENT ADULTS CL; Frystyk J, 1999, DIABETES-METAB RES, V15, P314, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.0.CO;2-E; Gallop R, 2009, PSYCHOTHER RES, V19, P438, DOI 10.1080/10503300902849475; Grucza RA, 2007, COMPR PSYCHIAT, V48, P124, DOI 10.1016/j.comppsych.2006.08.002; Halmi KA, 1994, J WOMENS HEALTH, V3, P487; Hargrave SL, 2012, PHYSIOL BEHAV, V105, P975, DOI 10.1016/j.physbeh.2011.11.006; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Jeyaratnaganthan N, 2010, GROWTH HORM IGF RES, V20, P185, DOI 10.1016/j.ghir.2009.12.005; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; LAUTERIO TJ, 1993, REGUL PEPTIDES, V48, P21, DOI 10.1016/0167-0115(93)90332-3; LAUTERIO TJ, 1990, ENDOCRINOLOGY, V126, P392, DOI 10.1210/endo-126-1-392; MARKS JL, 1992, MOL CELL NEUROSCI, V3, P199, DOI 10.1016/1044-7431(92)90039-5; Morley JE, 1987, AM J PHYSL REGULATOR, V252; Qiu Q, 2005, P NATL ACAD SCI USA, V102, P11047, DOI 10.1073/pnas.0502357102; Qiu Q, 2007, ENDOCRINOLOGY, V148, P4803, DOI 10.1210/en.2007-0535; Raudenbush S.W., 2002, HIERARCHAL LINEAR MO, V2nd; SAHU A, 1995, ENDOCRINOLOGY, V136, P5718, DOI 10.1210/en.136.12.5718; Sandhu MJS, 2003, DIABETES, V52, P1403, DOI 10.2337/diabetes.52.6.1403; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; TALLY M, 1994, J CLIN ENDOCR METAB, V79, P1576, DOI 10.1210/jc.79.6.1576; Tarantino G, 2011, INT J IMMUNOPATH PH, V24, P769, DOI 10.1177/039463201102400323; Tasca G. A., 2005, FOCUS PSYCHOTHERAPY, P159; Tasca GA, 2006, PSYCHOTHER RES, V16, P106, DOI 10.1080/10503300500090928; Tasca GA, 2013, PSYCHOTHER RES, V23, P301, DOI 10.1080/10503307.2012.717309; Tasca GA, 2009, PSYCHOTHER RES, V19, P429, DOI 10.1080/10503300802641444; Tasca GA, 2009, GROUP DYN-THEOR RES, V13, P151, DOI 10.1037/a0014837; Vocks S, 2010, INT J EAT DISORDER, V43, P205, DOI 10.1002/eat.20696; Williams J, 2007, BIOMETRICS RES	32	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83019	10.1371/journal.pone.0083019	http://dx.doi.org/10.1371/journal.pone.0083019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386136	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700022
J	Tu, YC; Huang, DY; Shiah, SG; Wang, JS; Lin, WW				Tu, Yu-Cheng; Huang, Duen-Yi; Shiah, Shine-Gwo; Wang, Jang-Shiun; Lin, Wan-Wan			Regulation of c-Fos Gene Expression by NF-kappa B: A p65 Homodimer Binding Site in Mouse Embryonic Fibroblasts but Not Human HEK293 Cells	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; IKK-BETA; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; PROTEIN-KINASES; FACTOR ELK-1; SERINE 536; ACTIVATION; PHOSPHORYLATION; COMPLEX	The immediate early gene c-Fos is reported to be regulated by Elk-1 and cAMP response element-binding protein (CREB), but whether nuclear factor (NF)-kappa B is also required for controlling c-Fos expression is unclear. In this study, we determined how NF-kappa B's coordination with Elk/serum response factor (SRF) regulates c-fos transcription. We report that PMA strongly induced c-Fos expression, but tumor necrosis factor (TNF)-alpha did not. In mouse embryonic fibroblasts, the PMA induction of c-Fos was suppressed by a deficiency in IKK alpha, IKK beta, IKK gamma, or p65. By contrast, in human embryonic kidney 293 cells, PMA induced c-Fos independently of p65. In accordance with these results, we identified an NF-kappa B binding site in the mouse but not human c-fos promoter. Under PMA stimulation, IKK alpha/beta mediated p65 phosphorylation and the binding of the p65 homodimer to the NF-kappa B site in the mouse c-fos promoter. Furthermore, our studies demonstrated independent but coordinated functions of the IKK alpha/beta-p65 and extracellular signal-regulated kinase (ERK)-Elk-1 pathways in the PMA induction of c-Fos. Collectively, these results reveal the distinct requirement of NF-kappa B for mouse and human c-fos regulation. Binding of the p65 homodimer to the kappa B site was indispensable for mouse c-fos expression, whereas the kappa B binding site was not present in the human c-fos promoter. Because of an inability to evoke sufficient ERK activation and Elk-1 phosphorylation, TNF-alpha induces c-Fos more weakly than PMA does in both mouse and human cells.	[Tu, Yu-Cheng; Huang, Duen-Yi; Wang, Jang-Shiun; Lin, Wan-Wan] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Shiah, Shine-Gwo] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Lin, Wan-Wan] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; Taipei Medical University	Lin, WW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan.	wwllaura1119@ntu.edu.tw	Shiah, Shine-Gwo/D-2087-2010	Lin, Wan Wan/0000-0002-3207-734X	National Science Council of Taiwan [NSC98-2320-B-002-010-MY3, NSC98-2320-B-400-001-MY3, NSC100-2320-B-002-088-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the research grants (NSC98-2320-B-002-010-MY3, NSC98-2320-B-400-001-MY3, and NSC100-2320-B-002-088-MY3) from the National Science Council of Taiwan (www.nsc.gov.twhttp://www.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; Durchdewald M, 2009, HISTOL HISTOPATHOL, V24, P14451, DOI 10.14670/HH-24.1451; Ely HA, 2011, MOL ENDOCRINOL, V25, P669, DOI 10.1210/me.2010-0437; Eto K, 2010, MOL CELL BIOCHEM, V339, P119, DOI 10.1007/s11010-009-0375-z; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; GANCHI PA, 1993, MOL CELL BIOL, V13, P7826, DOI 10.1128/MCB.13.12.7826; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lancaster GI, 2012, BIOCHEM J, V442, P723, DOI 10.1042/BJ20112037; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Maisonnasse-Charital Y, 2009, GENE, V430, P116, DOI 10.1016/j.gene.2008.10.014; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rahman A, 1999, J IMMUNOL, V162, P5466; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sandersen C, 2001, VET IMMUNOL IMMUNOP, V80, P315, DOI 10.1016/S0165-2427(01)00329-4; Shan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011662; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099	50	13	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84062	10.1371/journal.pone.0084062	http://dx.doi.org/10.1371/journal.pone.0084062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386331	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700088
J	Bourbonnais, ML; Nelson, TA; Cattet, MRL; Darimont, CT; Stenhouse, GB				Bourbonnais, Mathieu L.; Nelson, Trisalyn A.; Cattet, Marc R. L.; Darimont, Chris T.; Stenhouse, Gordon B.			Spatial Analysis of Factors Influencing Long-Term Stress in the Grizzly Bear (Ursus arctos) Population of Alberta, Canada	PLOS ONE			English	Article							FOOTHILLS MODEL FOREST; WEST-CENTRAL ALBERTA; BANFF NATIONAL-PARK; HOME-RANGE SIZE; EXTINCTION RISK; HABITAT LOSS; FECAL GLUCOCORTICOIDS; YELLOWHEAD ECOSYSTEM; PHYSIOLOGICAL STRESS; SPECIES DISTRIBUTION	Non-invasive measures for assessing long-term stress in free ranging mammals are an increasingly important approach for understanding physiological responses to landscape conditions. Using a spatially and temporally expansive dataset of hair cortisol concentrations (HCC) generated from a threatened grizzly bear (Ursus arctos) population in Alberta, Canada, we quantified how variables representing habitat conditions and anthropogenic disturbance impact long-term stress in grizzly bears. We characterized spatial variability in male and female HCC point data using kernel density estimation and quantified variable influence on spatial patterns of male and female HCC stress surfaces using random forests. Separate models were developed for regions inside and outside of parks and protected areas to account for substantial differences in anthropogenic activity and disturbance within the study area. Variance explained in the random forest models ranged from 55.34% to 74.96% for males and 58.15% to 68.46% for females. Predicted HCC levels were higher for females compared to males. Generally, high spatially continuous female HCC levels were associated with parks and protected areas while low-to-moderate levels were associated with increased anthropogenic disturbance. In contrast, male HCC levels were low in parks and protected areas and low-to-moderate in areas with increased anthropogenic disturbance. Spatial variability in gender-specific HCC levels reveal that the type and intensity of external stressors are not uniform across the landscape and that male and female grizzly bears may be exposed to, or perceive, potential stressors differently. We suggest observed spatial patterns of long-term stress may be the result of the availability and distribution of foods related to disturbance features, potential sexual segregation in available habitat selection, and may not be influenced by sources of mortality which represent acute traumas. In this wildlife system and others, conservation and management efforts can benefit by understanding spatial-and gender-based stress responses to landscape conditions.	[Bourbonnais, Mathieu L.; Nelson, Trisalyn A.] Univ Victoria, Spatial Pattern Anal & Res Lab, Dept Geog, Victoria, BC, Canada; [Cattet, Marc R. L.] Univ Saskatchewan, Western Coll Vet Med, Canadian Cooperat Wildlife Hlth Ctr, Saskatoon, SK S7N 0W0, Canada; [Darimont, Chris T.] Univ Victoria, Appl Conservat Sci Lab, Dept Geog, Victoria, BC, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada	University of Victoria; University of Saskatchewan; University of Victoria	Bourbonnais, ML (corresponding author), Univ Victoria, Spatial Pattern Anal & Res Lab, Dept Geog, Victoria, BC, Canada.	mathieub@uvic.ca		Bourbonnais, Mathieu/0000-0002-8781-1978; Nelson, Trisalyn/0000-0003-2537-6971	Natural Sciences and Engineering Research Council of Canada; Yellowstone; Foothills Research Institute Grizzly Bear Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Yellowstone; Foothills Research Institute Grizzly Bear Program	The authors would like to thank the Natural Sciences and Engineering Research Council of Canada, the Yellowstone to Yukon Conservation Initiative, and partners from the Foothills Research Institute Grizzly Bear Program for financial support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; Andison DW, 1998, ECOGRAPHY, V21, P543, DOI 10.1111/j.1600-0587.1998.tb00446.x; Andrew ME, 2012, GLOBAL ECOL BIOGEOGR, V21, P352, DOI 10.1111/j.1466-8238.2011.00676.x; [Anonymous], 1987, BEARS BIOL MANAG; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Bechshoft TO, 2011, SCI TOTAL ENVIRON, V409, P831, DOI 10.1016/j.scitotenv.2010.10.047; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Benn B, 2002, URSUS, V13, P213; Berland A, 2008, FOREST ECOL MANAG, V256, P1875, DOI 10.1016/j.foreco.2008.07.019; Berry Sandra, 2007, Pacific Conservation Biology, V13, P120; BLANCHARD BM, 1991, BIOL CONSERV, V58, P41, DOI 10.1016/0006-3207(91)90044-A; Boulanger J, 2007, GRIZZLY BEAR POPULAT; Boulanger J, 2009, GRIZZLY BEAR POPULAT; Boulanger J, 2005, GRIZZLY BEAR POPULAT; Bowman AW, 1997, APPL SMOOTHING TECHN; Brearley G, 2012, LANDSCAPE ECOL, V27, P1407, DOI 10.1007/s10980-012-9790-8; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bryan H, 2013, PLOS ONE IN PRESS; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cattet MRL, 2002, CAN J ZOOL, V80, P1156, DOI 10.1139/Z02-103; Clark DA, 2011, POLICY SCI, V44, P1, DOI 10.1007/s11077-010-9118-y; Coops NC, 2008, ECOL INDIC, V8, P754, DOI 10.1016/j.ecolind.2008.01.007; Coops NC, 2009, J BIOGEOGR, V36, P905, DOI 10.1111/j.1365-2699.2008.02053.x; Cranston J., 2005, 2004 POPULATION INVE; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dahle B, 2006, J MAMMAL, V87, P859, DOI 10.1644/05-MAMM-A-352R1.1; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; DIGGLE P, 1985, J R STAT SOC C-APPL, V34, P138; Ecological Stratification Working Group, 1995, NAT EC FRAM CAN AGR; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fontana FMA, 2012, REMOTE SENS ENVIRON, V121, P171, DOI 10.1016/j.rse.2012.01.007; Franklin SE, 2002, INT J REMOTE SENS, V23, P4633, DOI 10.1080/01431160110113971; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Gibeau ML, 2001, URSUS-SERIES, V12, P121; Graham K, 2010, URSUS, V21, P43, DOI 10.2192/09GR010.1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; HELLGREN EC, 1993, J MAMMAL, V74, P304, DOI 10.2307/1382385; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; KNIGHT RR, 1985, ECOLOGY, V66, P323, DOI 10.2307/1940382; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Libal NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024133; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; MACHUTCHON G., 2008, GRIZZLY BEAR POPULAT; Manly B., 2007, RESOURCE SELECTION A; McDermid GJ, 2005, PROG PHYS GEOG, V29, P449, DOI 10.1191/0309133305pp455ra; Mcdermid GJ, 2005, THESIS U WATERLOO CA; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; McLellan BN, 2001, J WILDLIFE MANAGE, V65, P92, DOI 10.2307/3803280; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Morrison ML, 2001, J WILDLIFE MANAGE, V65, P613, DOI 10.2307/3803012; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nadaraya EA, 1964, THEOR PROBAB, P142; Nelson T, 2006, FOREST CHRON, V82, P243, DOI 10.5558/tfc82243-2; Nelson Trisalyn A., 2007, British Columbia Journal of Ecosystems and Management, V8, P91; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053721; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P67, DOI 10.1016/j.foreco.2004.04.015; Nielson SE, 2002, URSUS, V13, P45; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Rhemtulla JM, 2002, CAN J FOREST RES, V32, P2010, DOI 10.1139/X02-112; Rode KD, 2006, ECOLOGY, V87, P2636, DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; Roever CL, 2008, FOREST ECOL MANAG, V256, P1253, DOI 10.1016/j.foreco.2008.06.040; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sheriff MJ, 2010, ECOLOGY, V91, P2983, DOI 10.1890/09-1108.1; Stenhouse G, 2005, URSUS, V16, P31, DOI 10.2192/1537-6176(2005)016[0031:GBAATE]2.0.CO;2; Stewart BP, 2013, J WILDLIFE MANAGE, V77, P957, DOI 10.1002/jwmg.535; Stewart BP, 2012, APPL GEOGR, V34, P614, DOI 10.1016/j.apgeog.2012.03.001; Steyaert SMJG, 2013, J ANIM ECOL, V82, P836, DOI 10.1111/1365-2656.12055; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; von der Ohe CG, 2004, PHYSIOL BIOCHEM ZOOL, V77, P313, DOI 10.1086/378139; von der Ohe CG, 2002, WILDLIFE SOC B, V30, P1215; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Webb E, 2010, J ARCHAEOL SCI, V37, P807, DOI 10.1016/j.jas.2009.11.010; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Woods JG, 1999, WILDLIFE SOC B, V27, P616; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	111	41	41	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83768	10.1371/journal.pone.0083768	http://dx.doi.org/10.1371/journal.pone.0083768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386273	Green Published, gold			2022-12-27	WOS:000329117900057
J	Chen, C; Shin, D; Watanabe, H; Nakanishi, Y; Kambara, H; Yoshimura, N; Nambu, A; Isa, T; Nishimura, Y; Koike, Y				Chen, Chao; Shin, Duk; Watanabe, Hidenori; Nakanishi, Yasuhiko; Kambara, Hiroyuki; Yoshimura, Natsue; Nambu, Atsushi; Isa, Tadashi; Nishimura, Yukio; Koike, Yasuharu			Prediction of Hand Trajectory from Electrocorticography Signals in Primary Motor Cortex	PLOS ONE			English	Article							BRAIN-MACHINE INTERFACES; COMPUTER INTERFACE; MOVEMENT TRAJECTORIES; CORTICAL CONTROL; PROSTHETIC ARM; NEURONS; RECORDINGS; REGRESSION; GRASP	Due to their potential as a control modality in brain-machine interfaces, electrocorticography (ECoG) has received much focus in recent years. Studies using ECoG have come out with success in such endeavors as classification of arm movements and natural grasp types, regression of arm trajectories in two and three dimensions, estimation of muscle activity time series and so on. However, there still remains considerable work to be done before a high performance ECoG-based neural prosthetic can be realized. In this study, we proposed an algorithm to decode hand trajectory from 15 and 32 channel ECoG signals recorded from primary motor cortex (M1) in two primates. To determine the most effective areas for prediction, we applied two electrode selection methods, one based on position relative to the central sulcus (CS) and another based on the electrodes' individual prediction performance. The best coefficients of determination for decoding hand trajectory in the two monkeys were 0.4815 +/- 0.0167 and 0.7780 +/- 0.0164. Performance results from individual ECoG electrodes showed that those with higher performance were concentrated at the lateral areas and areas close to the CS. The results of prediction according with different numbers of electrodes based on proposed methods were also shown and discussed. These results also suggest that superior decoding performance can be achieved from a group of effective ECoG signals rather than an entire ECoG array.	[Chen, Chao; Koike, Yasuharu] Tokyo Inst Technol, Dept Informat Proc, Yokohama, Kanagawa 227, Japan; [Shin, Duk; Nakanishi, Yasuhiko; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan; [Watanabe, Hidenori; Isa, Tadashi; Nishimura, Yukio] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Nambu, Atsushi; Isa, Tadashi; Nishimura, Yukio] Grad Univ Adv Studies SOKENDAI, Hayama, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Koike, Yasuharu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Shin, D (corresponding author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.	shinduk@cns.pi.titech.ac.jp	Kambara, Hiroyuki/E-4546-2014; Koike, Yasuharu/E-9150-2014; Shin, Duk/G-9620-2011; NAKANISHI, Yasuhiko/E-4594-2014; Yoshimura, Natsue/E-7087-2014	Koike, Yasuharu/0000-0002-8169-0044; Yoshimura, Natsue/0000-0002-7495-9113; Chen, Chao/0000-0001-7358-4332; Watanabe, Hidenori/0000-0002-4641-9523; Nambu, Atsushi/0000-0003-2153-5445	Strategic Research Program for Brain Sciences from the MEXT of Japan	Strategic Research Program for Brain Sciences from the MEXT of Japan	This study is supported by the Strategic Research Program for Brain Sciences from the MEXT of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Bjorninen T, 2012, IEEE ANTENN WIREL PR, V11, P1663, DOI 10.1109/LAWP.2013.2239252; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026002; Chin CM, 2007, J NEURAL ENG, V4, P146, DOI 10.1088/1741-2560/4/2/014; Fagg AH, 2007, J NEUROSCI, V27, P11842, DOI 10.1523/JNEUROSCI.3516-07.2007; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Griffin DM, 2008, J NEUROPHYSIOL, V99, P1169, DOI 10.1152/jn.00906.2007; Hadjidimitriou SK, 2012, IEEE T BIO-MED ENG, V59, P3498, DOI 10.1109/TBME.2012.2217495; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Hirata M, 2011, IEICE T COMMUN, VE94B, P2448, DOI 10.1587/transcom.E94.B.2448; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054658; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Sanchez JC, 2004, IEEE T BIO-MED ENG, V51, P943, DOI 10.1109/TBME.2004.827061; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Shimoda K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036015; Shin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047992; Tankus A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/054001; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thulasidas M, 2006, IEEE T NEUR SYS REH, V14, P24, DOI 10.1109/TNSRE.2005.862695; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Watanabe H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036006; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613	45	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83534	10.1371/journal.pone.0083534	http://dx.doi.org/10.1371/journal.pone.0083534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386223	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900043
J	Cronin, O; Bradshaw, B; Iyer, V; Cunningham, M; Buttner, P; Walker, PJ; Golledge, J				Cronin, Oliver; Bradshaw, Barbara; Iyer, Vikram; Cunningham, Margaret; Buttner, Petra; Walker, Philip J.; Golledge, Jonathan			The Association of Visceral Adiposity with Cardiovascular Events in Patients with Peripheral Artery Disease	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY PARADOX; ABDOMINAL FAT; RISK-FACTORS; CORONARY; HEART; HEALTH; TISSUE; OUTCOMES; RATES	Background: Previous studies have suggested that patients with peripheral artery disease (PAD) suffer from a high incidence of cardiovascular events (CVE). Visceral adiposity has been implicated in promoting CVEs. This study aimed to assess the association of relative visceral adipose volume with incident cardiovascular events in patients with peripheral artery disease. Methods: This was a prospective cohort study including 260 patients with PAD who presented between 2003 and 2012. Cases were patients with diagnosed PAD including symptomatic lower limb athero-thrombosis and asymptomatic abdominal aortic aneurysm. All patients underwent computed tomography angiography (CTA). Abdominal visceral to total adipose volume ratio (relative visceral adipose volume) was estimated from CTAs using a previously validated workstation protocol. Cardiovascular risk factors were recorded at entry. The association of visceral adiposity with major CVEs (death, non-fatal myocardial infarction or stroke) was examined using Kaplan Meier and Cox proportional hazard analyses. Results: A total of 92 major CVEs were recorded in 76 patients during a median follow-up of 2.8 (IQR 1.2 to 4.8) years, including myocardial infarction (n = 26), stroke (n = 10) and death (n = 56). At 3 years the incidence of major CVEs stratified by relative visceral adipose volume quartiles were 15% [ Quartile (Q) 1], 17% (Q2), 11% (Q3) and 15% (Q4) (P = 0.517). Relative visceral adipose volume was not associated with major CVEs after adjustment for other risk factors. Conclusion: This study suggests that visceral adiposity does not play a central role in the predisposition for major CVEs in patients with PAD.	[Cronin, Oliver; Bradshaw, Barbara; Iyer, Vikram; Cunningham, Margaret; Buttner, Petra; Walker, Philip J.; Golledge, Jonathan] James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia; [Iyer, Vikram; Walker, Philip J.; Golledge, Jonathan] Univ Queensland, Discipline Surg, Brisbane, Qld, Australia; [Iyer, Vikram; Walker, Philip J.; Golledge, Jonathan] Univ Queensland, Sch Med, Clin Res Ctr, Brisbane, Qld, Australia; [Iyer, Vikram; Walker, Philip J.; Golledge, Jonathan] Royal Brisbane & Womens Hosp, Dept Vasc Surg, Brisbane, Qld, Australia; [Buttner, Petra] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia	James Cook University; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; James Cook University	Golledge, J (corresponding author), James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia.	jonathan.golledge@jcu.edu.au	Walker, Philip J/F-3034-2010; golledge, jonathan/I-2371-2013	Cunningham, Margaret/0000-0002-5850-9825	BUPA Foundation; NHMRC; Queensland Government; National Health and Medical Research Council, Australia; Office of Health and Medical Research	BUPA Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Office of Health and Medical Research	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by grants from the BUPA Foundation, NHMRC and Queensland Government. Professor Golledge holds a practitioner fellowship from the National Health and Medical Research Council, Australia and a Senior Clinical Research Fellowship from the Office of Health and Medical Research.	Ademi Z, 2009, CARDIOVASC THER, V27, P164, DOI 10.1111/j.1755-5922.2009.00090.x; Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Barba R, 2009, EUR J CARDIOV PREV R, V16, P457, DOI 10.1097/HJR.0b013e32832b1818; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Cacoub PP, 2011, HEART, V97, P660, DOI 10.1136/hrt.2010.213710; Cronin O, 2013, ATHEROSCLEROSIS, V228, P316, DOI 10.1016/j.atherosclerosis.2013.03.002; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Gabriella O, 2012, JAIDS-J ACQ IMM DEF, V59, P494, DOI 10.1097/QAI.0b013e31824c8397; Giugliano G, 2010, INT J OBESITY, V34, P280, DOI 10.1038/ijo.2009.244; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Golledge J, 2007, J VASC SURG, V45, P40, DOI 10.1016/j.jvs.2006.09.006; Golledge J, 2013, ATHEROSCLEROSIS, V229, P549, DOI 10.1016/j.atherosclerosis.2013.04.030; Grenon SM, 2013, VASC MED, V18, P176, DOI 10.1177/1358863X13493825; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547; Henrichot E, 2005, ARTERIOSCL THROM VAS, V25, P2594, DOI 10.1161/01.ATV.0000188508.40052.35; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Kamimura MA, 2013, NUTR METAB CARDIOVAS, V23, P891, DOI 10.1016/j.numecd.2012.06.004; Kobayashi J, 2002, INT J OBESITY, V26, P398, DOI 10.1038/sj.ijo.0801921; Krempf M, 2010, AM J CARDIOL, V105, P667, DOI 10.1016/j.amjcard.2009.10.048; Lakshmanan R, 2010, MED J AUSTRALIA, V192, P641, DOI 10.5694/j.1326-5377.2010.tb03663.x; Maurovich-Horvat P, 2007, INT J OBESITY, V31, P500, DOI 10.1038/sj.ijo.0803454; Myers J, 2011, EUR J CARDIOVASC PRE; Perk J, 2012, EUR J PREV CARDIOL, V19, P585, DOI 10.1177/2047487312450228; Powell JT, 1998, LANCET, V352, P1649; Read A, 2004, BRIT J GEN PRACT, V54, P272; Reid CM, 2012, MED J AUSTRALIA, V196, P193, DOI 10.5694/mja11.10731; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Schlett CL, 2009, INT J OBESITY, V33, P226, DOI 10.1038/ijo.2008.267; Tjandra J, 2006, TXB SURG; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Yusuf S, 2000, NEW ENGL J MED, V342, P145	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82350	10.1371/journal.pone.0082350	http://dx.doi.org/10.1371/journal.pone.0082350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386093	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329117900008
J	Huang, CF; Zhang, L; Ma, SR; Zhao, ZL; Wang, WM; He, KF; Zhao, YF; Zhang, WF; Liu, B; Sun, ZJ				Huang, Cong-Fa; Zhang, Lu; Ma, Si-Rui; Zhao, Zhi-Li; Wang, Wei-Ming; He, Ke-Fei; Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun			Clinical Significance of Keap1 and Nrf2 in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; PROLIFERATION; METASTASIS; EXPRESSION; ASSOCIATION; CYCLOPHILIN; ACTIVATION; PREVENTION; PROGNOSIS; SURVIVAL	Oxidative stress has been reported to play an important role in progression and prognostication in various kinds of cancers. However, the role and clinical significance of oxidative stress markers Keap1 and Nrf2 in oral squamous cell carcinoma (OSCC) has not been elucidated. This study aimed to investigate the correlation of oxidative stress markers Keap1 and Nrf2 expression and pathological features in OSCC by using tissue microarray. Tissue microarrays containing 17 normal oral mucosa, 7 oral epithelial dysplasia and 43 OSCC specimens were studied by immunohistochemistry. The association among these proteins and pathological features were analyzed. Expression of oxidative stress markers Keap1, Nrf2, and antioxidants PPIA, Prdx6, as well as CD147 was found to increase consecutively from normal oral mucosa to OSCC, and the Keap1, Nrf2, PPIA, Prdx6, CD147 expression in OSCC were significantly higher when compared to normal oral mucosa. Expression of Keap1, Nrf2 in tumors was not found to be significantly associated with T category, lymph node metastases, and pathological grade. Furthermore, we checked the relationship among these oxidative stress markers and found that Keap1 was significantly correlated with Nrf2, Prdx6 and CD147. Significant relationship between Nrf2 and Prdx6 was also detected. Finally, we found patients with overexpression of Keap1 and Nrf2 had not significantly worse overall survival by Kaplan-Meier analysis. These findings suggest that ROS markers are associated with carcinogenesis and progression of OSCC, which may have prognostic value and could be regarded as potential therapeutic targets in OSCC.	[Huang, Cong-Fa; Zhang, Lu; Ma, Si-Rui; Zhao, Zhi-Li; Wang, Wei-Ming; He, Ke-Fei; Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Minist Educ, Sch & Hosp Stomatol, Wuhan, Peoples R China; [Huang, Cong-Fa; Zhang, Lu; Ma, Si-Rui; Zhao, Zhi-Li; Wang, Wei-Ming; He, Ke-Fei; Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Sch & Hosp Stomatol, Wuhan, Peoples R China; [Zhao, Yi-Fang; Zhang, Wen-Feng; Liu, Bing; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Liu, B (corresponding author), Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol, Minist Educ, Sch & Hosp Stomatol, Wuhan, Peoples R China.	liubing9909@126.com; zhijundejia@163.com	zhao, zhili/F-4137-2016; Sun, Zhi-Jun/AAD-8791-2022	zhao, zhili/0000-0002-9030-1979; Sun, Zhi-Jun/0000-0003-0932-8013	National Natural Science Foundation of China [81072203, 81272963, 81272964, 81371106, 81371159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China 81072203, 81272963 (ZJS). 81272964 (WFZ), 81371106 (LZ), 81371159 (YFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang LC, 2013, APPL IMMUNOHISTOCHEM; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Dai L, 2013, AM J PATHOL, V182, P577, DOI 10.1016/j.ajpath.2012.10.011; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hartikainen JM, 2012, CANCER RES, V72, P5537, DOI 10.1158/0008-5472.CAN-12-1474; Huang CF, 2011, ORAL DIS, V17, P328, DOI 10.1111/j.1601-0825.2010.01730.x; Huang CF, 2012, HISTOPATHOLOGY, V60, P793, DOI 10.1111/j.1365-2559.2011.04130.x; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Li M, 2006, CANCER-AM CANCER SOC, V106, P2284, DOI 10.1002/cncr.21862; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paschos A, 2013, PROSTATE CANCER P D, V16, P217, DOI 10.1038/pcan.2013.13; Ronkainen H, 2009, ONCOL REP, V21, P1519, DOI 10.3892/or_00000383; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shanmugam MK, 2012, CANCER LETT, V320, P158, DOI 10.1016/j.canlet.2012.02.037; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Sun ZJ, 2012, CLIN CANCER RES, V18, P5304, DOI 10.1158/1078-0432.CCR-12-1371; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8	26	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83479	10.1371/journal.pone.0083479	http://dx.doi.org/10.1371/journal.pone.0083479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386210	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900039
J	Stahel, ABJ; Baggenstos, R; Engels, M; Friess, M; Ackermann, M				Stahel, Anina B. J.; Baggenstos, Rhea; Engels, Monika; Friess, Martina; Ackermann, Mathias			Two Different Macaviruses, ovine herpesvirus-2 and caprine herpesvirus-2, Behave Differently in Water Buffaloes than in Cattle or in Their Respective Reservoir Species	PLOS ONE			English	Article							MALIGNANT-CATARRHAL-FEVER; BISON BISON-BISON; OVINE HERPESVIRUS-2; MULTIGENIC CHARACTERIZATION; NASAL SECRETIONS; BUBALUS-BUBALIS; DAIRY-CATTLE; INFECTION; VIRUS; SHEEP	The ongoing global spread of "exotic'' farm animals, such as water buffaloes, which carry their native sets of viruses, may bear unknown risks for the animals, into whose ecological niches the former are introduced and vice versa. Here, we report on the occurrence of malignant catarrhal fever (MCF) on Swiss farms, where "exotic'' water buffaloes were kept together with "native'' animals, i.e. cattle, sheep, and goats. In the first farm with 56 water buffaloes, eight cases of MCF due to ovine herpesvirus-2 (OvHV-2) were noted, whereas additional ten water buffaloes were subclinically infected with either OvHV-2 or caprine herpesvirus-2 (CpHV-2). On the second farm, 13 water buffaloes were infected with CpHV-2 and two of those succumbed to MCF. In neither farm, any of the two viruses were detected in cattle, but the Macaviruses were present at high prevalence among their original host species, sheep and goats, respectively. On the third farm, sheep were kept well separated from water buffaloes and OvHV-2 was not transmitted to the buffaloes, despite of high prevalence of the virus among the sheep. Macavirus DNA was frequently detected in the nasal secretions of virus-positive animals and in one instance OvHV-2 was transmitted vertically to an unborn water buffalo calf. Thus, water buffaloes seem to be more susceptible than cattle to infection with either Macavirus; however, MCF did not develop as frequently. Therefore, water buffaloes seem to represent an interesting intermediate-type host for Macaviruses. Consequently, water buffaloes in their native, tropic environments may be vulnerable and endangered to viruses that originate from seemingly healthy, imported sheep and goats.	[Stahel, Anina B. J.; Engels, Monika; Friess, Martina; Ackermann, Mathias] Univ Zurich, Inst Virol, Vetsuisse Fac, Zurich, Switzerland; [Baggenstos, Rhea] Univ Zurich, Dept Farm Anim, Vetsuisse Fac, Zurich, Switzerland	University of Zurich; University of Zurich	Ackermann, M (corresponding author), Univ Zurich, Inst Virol, Vetsuisse Fac, Zurich, Switzerland.	email@vetvir.uzh.ch			Swiss National Science Foundation (SNF) [310030_130456]; Swiss Federal Veterinary Office (BVet) [1.13.08]; University of Zurich	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Federal Veterinary Office (BVet); University of Zurich	This work was supported by grant #310030_130456 from the Swiss National Science Foundation (SNF), grant #1.13.08 from the Swiss Federal Veterinary Office (BVet), and the University of Zurich. The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini S, 2003, J CLIN MICROBIOL, V41, P900, DOI 10.1128/JCM.41.2.900-904.2003; BARNARD BJH, 1990, ONDERSTEPOORT J VET, V57, P201; Baxter SIF, 1997, ARCH VIROL, V142, P823, DOI 10.1007/s007050050121; Borghese A., 2005, REU Technical Series, P1; CASTRO AE, 1984, AM J VET RES, V45, P409; Chmielewicz B, 2001, VIRUS RES, V75, P87, DOI 10.1016/S0168-1702(00)00252-5; Cissell RL, 2010, MALIGNANT CATARRHAL; Collins JK, 2000, J VET DIAGN INVEST, V12, P406, DOI 10.1177/104063870001200503; Costa EA, 2009, PESQUI VET BRASIL, V29, P395, DOI 10.1590/S0100-736X2009000500006; Crawford TB, 2002, J AM VET MED ASSOC, V221, P843, DOI 10.2460/javma.2002.221.843; Crawford TB, 2002, J AM VET MED ASSOC, V221, P7; Cunha CW, 2009, J CLIN MICROBIOL, V47, P2586, DOI 10.1128/JCM.00997-09; Daniels PW, 1988, MALIGNANT CATARRHAL, P20; David D, 2005, VET REC, V156, P118, DOI 10.1136/vr.156.4.118; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Dettwiler M, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-78; Fagiolo A., 2005, REU Technical Series, P249; Forster C, 2011, GAMMAHERPESVIREN KLE; Foyle KL, 2009, VET REC, V165, P445, DOI 10.1136/vr.165.15.445; Gailbreath KL, 2010, VET MICROBIOL, V143, P389, DOI 10.1016/j.vetmic.2009.11.026; Gasper D, 2012, VET PATHOL, V49, P492, DOI 10.1177/0300985811429306; Gatesy J, 1997, MOL PHYLOGENET EVOL, V7, P303, DOI 10.1006/mpev.1997.0402; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; HILL FI, 1993, NEW ZEAL VET J, V41, P35, DOI 10.1080/00480169.1993.35732; HOFFMANN D, 1984, AUST VET J, V61, P108, DOI 10.1111/j.1751-0813.1984.tb07201.x; Hussy D, 2001, CLIN DIAGN LAB IMMUN, V8, P123, DOI 10.1128/CDLI.8.1.123-128.2001; Keel MK, 2003, J VET DIAGN INVEST, V15, P179, DOI 10.1177/104063870301500215; Kleiboeker SB, 2002, J CLIN MICROBIOL, V40, P1311, DOI 10.1128/JCM.40.4.1311-1318.2002; Klieforth R, 2002, J CLIN MICROBIOL, V40, P3381, DOI 10.1128/JCM.40.9.3381-3390.2002; Li H, 2006, J VET DIAGN INVEST, V18, P119, DOI 10.1177/104063870601800120; Li H, 2005, VET MICROBIOL, V107, P23, DOI 10.1016/j.vetmic.2005.01.014; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; Li H, 2000, J CLIN MICROBIOL, V38, P1313, DOI 10.1128/JCM.38.4.1313-1318.2000; Li H, 2003, J VET DIAGN INVEST, V15, P46, DOI 10.1177/104063870301500110; Li H, 2001, J GEN VIROL, V82, P227, DOI 10.1099/0022-1317-82-1-227; Li H, 2008, CAN VET J, V49, P183; Li H, 2013, J ZOO WILDLIFE MED, V44, P484, DOI 10.1638/2012-0087R.1; Loken T, 2009, J VET DIAGN INVEST, V21, P257, DOI 10.1177/104063870902100216; Martucciello A., 2006, Large Animal Review, V12, P21; Matzat T, 2012, BEITRAG ZUM BOSARTIG; Moioli B., 2005, REU Technical Series, P51; Muller-Doblies UU, 2001, SCHWEIZ ARCH TIERH, V143, P173; Munday JS, 2008, NEW ZEAL VET J, V56, P89, DOI 10.1080/00480169.2008.36815; National Research Council (, 1981, WAT BUFF NEW PROSP U; O'Toole D, 2007, VET PATHOL, V44, P655, DOI 10.1354/vp.44-5-655; O'Toole D, 2002, J VET DIAGN INVEST, V14, P183, DOI 10.1177/104063870201400301; Okeson DM, 2007, J ZOO WILDLIFE MED, V38, P460, DOI 10.1638/06-046.1; Pfitzer S, 2013, TRANSBOUND IN PRESS; PLOWRIGHT W, 1960, NATURE, V188, P1167, DOI 10.1038/1881167a0; Plowright W., 1990, Virus infections of ruminants., P123; Powers JG, 2005, JAVMA-J AM VET MED A, V227, P606, DOI 10.2460/javma.2005.227.606; REID HW, 1987, VET REC, V121, P276, DOI 10.1136/vr.121.12.276; Reid HW, 1989, HERPESVIRUS DIS CATT, V9, P116; Rohlederer BS, 2010, UNTERSUCHUNGEN PRAVA; Schultheiss PC, 1998, J VET DIAGN INVEST, V10, P255, DOI 10.1177/104063879801000305; Sieber V, 2010, VET MED INT, V2010; Strohbucker S, 2005, VORKOMMEN KLIN BEDEU; Taus NS, 2007, J GEN VIROL, V88, P40, DOI 10.1099/vir.0.82285-0; Taus NS, 2006, VET MICROBIOL, V116, P29, DOI 10.1016/j.vetmic.2006.03.005; Teankam K., 2006, Thai Journal of Veterinary Medicine, V36, P19; Vikoren T, 2006, J WILDLIFE DIS, V42, P797, DOI 10.7589/0090-3558-42.4.797; WIYONO A, 1994, VET MICROBIOL, V42, P45, DOI 10.1016/0378-1135(94)90076-0; Wiyono A., 1999, Jurnal Ilmu Ternak dan Veteriner, V4, P121; Yesilbag K, 2007, TROP ANIM HEALTH PRO, V39, P363, DOI 10.1007/s11250-007-9024-2	64	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83695	10.1371/journal.pone.0083695	http://dx.doi.org/10.1371/journal.pone.0083695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386255	gold, Green Published, Green Accepted			2022-12-27	WOS:000329117900053
J	Wu, WQ; Wang, ZB; Wei, Y; Zhang, GH; Shi, SX; Gao, JF; Li, YH; Tao, M; Zhang, KR; Wang, XM; Gao, CG; Yang, LJ; Li, K; Shi, JG; Wang, G; Liu, LF; Zhang, JB; Du, B; Jiang, GQ; Shen, JH; Liu, Y; Liang, W; Sun, J; Hu, J; Liu, TB; Wang, XY; Miao, GD; Meng, HQ; Li, Y; Hu, CM; Li, Y; Huang, GP; Li, GY; Ha, BW; Deng, H; Mei, QY; Zhong, H; Gao, SG; Sang, H; Zhang, YT; Fang, X; Yu, FY; Yang, DL; Liu, TQ; Chen, YC; Hong, XH; Wu, WY; Chen, GB; Cai, M; Song, Y; Pan, JY; Dong, JC; Pan, RD; Zhang, W; Shen, ZM; Liu, ZR; Gu, DH; Wang, XP; Liu, XJ; Zhang, QW; Li, YH; Chen, YP; Kendler, KS; Flint, J; Zhang, Z				Wu, Wenqing; Wang, Zhoubing; Wei, Yan; Zhang, Guanghua; Shi, Shenxun; Gao, Jingfang; Li, Youhui; Tao, Ming; Zhang, Kerang; Wang, Xumei; Gao, Chengge; Yang, Lijun; Li, Kan; Shi, Jianguo; Wang, Gang; Liu, Lanfen; Zhang, Jinbei; Du, Bo; Jiang, Guoqing; Shen, Jianhua; Liu, Ying; Liang, Wei; Sun, Jing; Hu, Jian; Liu, Tiebang; Wang, Xueyi; Miao, Guodong; Meng, Huaqing; Li, Yi; Hu, Chunmei; Li, Yi; Huang, Guoping; Li, Gongying; Ha, Baowei; Deng, Hong; Mei, Qiyi; Zhong, Hui; Gao, Shugui; Sang, Hong; Zhang, Yutang; Fang, Xiang; Yu, Fengyu; Yang, Donglin; Liu, Tieqiao; Chen, Yunchun; Hong, Xiaohong; Wu, Wenyuan; Chen, Guibing; Cai, Min; Song, Yan; Pan, Jiyang; Dong, Jicheng; Pan, Runde; Zhang, Wei; Shen, Zhenming; Liu, Zhengrong; Gu, Danhua; Wang, Xiaoping; Liu, Xiaojuan; Zhang, Qiwen; Li, Yihan; Chen, Yiping; Kendler, Kenneth S.; Flint, Jonathan; Zhang, Zhen			Clinical Features of Patients with Dysthymia in a Large Cohort of Han Chinese Women with Recurrent Major Depression	PLOS ONE			English	Article							EARLY-ONSET DYSTHYMIA; PERSONALITY-DISORDERS; SEXUAL-ABUSE; LIFE EVENTS; SHORT-TERM; COMORBIDITY; CHRONICITY; OUTPATIENTS; FAMILY; MOOD	Background: Dysthymia is a form of chronic mild depression that has a complex relationship with major depressive disorder (MDD). Here we investigate the role of environmental risk factors, including stressful life events and parenting style, in patients with both MDD and dysthymia. We ask whether these risk factors act in the same way in MDD with and without dysthymia. Results: We examined the clinical features in 5,950 Han Chinese women with MDD between 30-60 years of age across China. We confirmed earlier results by replicating prior analyses in 3,950 new MDD cases. There were no significant differences between the two data sets. We identified sixteen stressful life events that significantly increase the risk of dysthymia, given the presence of MDD. Low parental warmth, from either mother or father, increases the risk of dysthymia. Highly threatening but short-lived threats (such as rape) are more specific for MDD than dysthymia. While for MDD more severe life events show the largest odds ratio versus controls, this was not seen for cases of MDD with or without dysthymia. Conclusions: There are increased rates of stressful life events in MDD with dysthymia, but the impact of life events on susceptibility to dysthymia with MDD differs from that seen for MDD alone. The pattern does not fit a simple dose-response relationship, suggesting that there are moderating factors involved in the relationship between environmental precipitants and the onset of dysthymia. It is possible that severe life events in childhood events index a general susceptibility to chronic depression, rather than acting specifically as risk factors for dysthymia.	[Wu, Wenqing; Wang, Zhoubing; Wei, Yan; Zhang, Guanghua; Zhang, Zhen] Jiangsu Univ, Affiliated Hosp 4, Zhenjiang, Jiangsu, Peoples R China; [Shi, Shenxun] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Shi, Shenxun] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; [Gao, Jingfang] Chinese Tradit Hosp Zhejiang, Hangzhou, Zhejiang, Peoples R China; [Li, Youhui] Zhengzhou Univ, Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Tao, Ming] Xinhua Hosp Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Kerang] Shanxi Med Univ, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Wang, Xumei] China Med Univ, ShengJing Hosp, Shenyang, Liaoning, Peoples R China; [Gao, Chengge] Xi An Jiao Tong Univ, Coll Med, Hosp 1, Xian, Shaanxi, Peoples R China; [Yang, Lijun] Jilin Brain Hosp, Siping, Jilin, Peoples R China; [Li, Kan] Mental Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China; [Shi, Jianguo] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China; [Wang, Gang] Capital Univ Med Sci, Beijing Anding Hosp, Beijing, Peoples R China; [Liu, Lanfen] Shandong Mental Hlth Ctr, Jinan, Shandong, Peoples R China; [Zhang, Jinbei] Sun Yat Sen Univ, Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Du, Bo] Hebei Mental Hlth Ctr, Baoding, Hebei, Peoples R China; [Jiang, Guoqing] Chongqing Mental Hlth Ctr, Chongqing, Peoples R China; [Shen, Jianhua] Tianjin Anding Hosp, Tianjin, Peoples R China; [Liu, Ying] China Med Univ, Hosp 1, Shenyang, Liaoning, Peoples R China; [Liang, Wei] Psychiat Hosp Henan Prov, Xinxiang, Henan, Peoples R China; [Sun, Jing] Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Hu, Jian] Harbin Med Univ, Haerbin, Heilongjiang, Peoples R China; [Liu, Tiebang] Shenzhen Kang Ning Hosp, Shenzhen, Guangdong, Peoples R China; [Wang, Xueyi] Hebei Med Univ, Hosp 1, Shijiazhuang, Hebei, Peoples R China; [Miao, Guodong] Guangzhou Psychiat Hosp, Guangzhou Brain Hosp, Guangzhou, Guangdong, Peoples R China; [Meng, Huaqing] Chongqing Med Univ, Hosp 1, Chongqing, Peoples R China; [Li, Yi] Dalian 7 Hosp, Dalian, Liaoning, Peoples R China; [Hu, Chunmei] 3 Hosp Heilongjiang Prov, Beian, Heilongjiang, Peoples R China; [Li, Yi] Wuhan Mental Hlth Ctr, Wuhan, Hubei, Peoples R China; [Huang, Guoping] Sichuan Mental Hlth Ctr, Mianyang, Sichuan, Peoples R China; [Li, Gongying] Jining Med Coll, Mental Hlth Inst, Jining, Shandong, Peoples R China; [Ha, Baowei] Liaocheng 4 Hosp, Liaocheng, Shandong, Peoples R China; [Deng, Hong] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610064, Sichuan, Peoples R China; [Mei, Qiyi] Suzhou Guangji Hosp, Suzhou, Jiangsu, Peoples R China; [Zhong, Hui] Anhui Mental Hlth Ctr, Hefei, Anhui, Peoples R China; [Gao, Shugui] Ningbo Kang Ning Hosp, Ningbo, Zhejiang, Peoples R China; [Sang, Hong] Changchun Mental Hosp, Changchun, Jilin, Peoples R China; [Zhang, Yutang] Lanzhou Univ, Hosp 2, Lanzhou, Gansu, Peoples R China; [Fang, Xiang] Fuzhou Psychiat Hosp, Fuzhou, Fujian, Peoples R China; [Yu, Fengyu] Harbin 1 Special Hosp, Haerbin, Heilongjiang, Peoples R China; [Yang, Donglin] Jining Psychiat Hosp, Jining, Shandong, Peoples R China; [Liu, Tieqiao] Zhongnan Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Chen, Yunchun] 4 Mil Med Univ, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Hong, Xiaohong] Shantou Univ, Mental Hlth Ctr, Shantou, Guangdong, Peoples R China; [Wu, Wenyuan] Tongji Univ Hosp, Shanghai, Peoples R China; [Chen, Guibing] Huaian 3 Hosp, Huaian, Jiangsu, Peoples R China; [Cai, Min] Huzhou 3 Hosp, Huzhou, Zhejiang, Peoples R China; [Song, Yan] Mudanjiang Psychiat Hosp Heilongjiang Prov, Mudanjiang, Heilongjiang, Peoples R China; [Pan, Jiyang] Jinan Univ, Hosp 1, Guangzhou, Guangdong, Peoples R China; [Dong, Jicheng] Qingdao Mental Hlth Ctr, Qingdao, Shandong, Peoples R China; [Pan, Runde] Guangxi Longquanshan Hosp, Yufeng Dist, Liuzhou, Peoples R China; [Zhang, Wei] Daqing 3 Hosp Heilongjiang Prov, Daqing, Heilongjiang, Peoples R China; [Shen, Zhenming] Tangshan 5 Hosp, Tangshan, Herts, Peoples R China; [Liu, Zhengrong] Anshan Psychiat Rehabil Hosp, Anshan, Liaoning, Peoples R China; [Gu, Danhua] Weihai Mental Hlth Ctr, Weihai, Shandong, Peoples R China; [Wang, Xiaoping] Wuhan Univ, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Liu, Xiaojuan] Tianjin First Ctr Hosp, Tianjin, Peoples R China; [Zhang, Qiwen] Hainan Anning Hosp, Haikou, Hunan, Peoples R China; [Li, Yihan; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [Chen, Yiping] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA	Jiangsu University; Fudan University; Zhengzhou University; Zhejiang Chinese Medical University; Shanxi Medical University; China Medical University; Xi'an Jiaotong University; Capital Medical University; Sun Yat Sen University; China Medical University; Harbin Medical University; Hebei Medical University; Chongqing Medical University; Jining Medical University; Sichuan University; Lanzhou University; Central South University; Air Force Military Medical University; Shantou University; Tongji University; Jinan University; Wuhan University; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; Virginia Commonwealth University	Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	jf@well.ox.ac.uk; zhangzhen601020@126.com	Kendler, Kenneth/AAF-2876-2019; Chen, Yi/HIR-2608-2022; liu, tieqiao/GSE-2327-2022	Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust [090532/Z/09/Z, 083573/Z/07/Z, 089269/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Wellcome Trust (090532/Z/09/Z, 083573/Z/07/Z, 089269/Z/09/Z) (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKISKAL HS, 1980, ARCH GEN PSYCHIAT, V37, P777; AKISKAL HS, 1982, J CLIN PSYCHIAT, V43, P266; Association A. P., 1994, DIAGNOSTIC STAT MANU; CASSANO GB, 1983, PSYCHIAT CLIN N AM, V6, P55; CERONI GB, 1984, J AFFECT DISORDERS, V7, P123, DOI 10.1016/0165-0327(84)90030-2; CORYELL W, 1994, AM J PSYCHIAT, V151, P199; Cox J.L, 1987, BRIT J PSYCHIAT, V150, P85; Dunner DL, 2005, INT REV PSYCHIATR, V17, P3, DOI 10.1080/09540260500064983; Endicott J, 1975, FAMILY HIST RES DIAG; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; Griffiths J, 2000, MOL PSYCHIATR, V5, P242, DOI 10.1038/sj.mp.4000697; HIRSCHFELD RMA, 1986, BRIT J PSYCHIAT, V148, P648, DOI 10.1192/bjp.148.6.648; Keller MB, 1997, J AFFECT DISORDERS, V45, P65, DOI 10.1016/S0165-0327(97)00060-8; KELLER MB, 1995, AM J PSYCHIAT, V152, P843; Kendler K.S., 2006, GENES ENV PSYCHOPATH, V1st ed.; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Kendler KS, 1996, AM J PSYCHIAT, V153, P11; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KLEIN DN, 1988, J ABNORM PSYCHOL, V97, P387, DOI 10.1037/0021-843X.97.4.387; Klein DN, 2000, AM J PSYCHIAT, V157, P931, DOI 10.1176/appi.ajp.157.6.931; KLEIN DN, 1995, ARCH GEN PSYCHIAT, V52, P487; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; MARKOWITZ JC, 1992, J AFFECT DISORDERS, V24, P63, DOI 10.1016/0165-0327(92)90020-7; MARTIN J, 1993, CHILD ABUSE NEGLECT, V17, P383, DOI 10.1016/0145-2134(93)90061-9; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; PARKER G, 1981, J AFFECT DISORDERS, V3, P131, DOI 10.1016/0165-0327(81)90038-0; Riso LP, 1996, AM J PSYCHIAT, V153, P900; Sang WH, 2011, J AFFECT DISORDERS, V135, P106, DOI 10.1016/j.jad.2011.06.051; SCOTT J, 1988, BRIT J PSYCHIAT, V152, P28, DOI 10.1192/bjp.152.1.28; Spalletta G, 1996, J AFFECT DISORDERS, V39, P141, DOI 10.1016/0165-0327(96)00025-0; Tiet QQ, 2001, J ABNORM CHILD PSYCH, V29, P153, DOI 10.1023/A:1005288130494; WEISSMAN MM, 1988, AM J PSYCHIAT, V145, P815	33	1	1	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83490	10.1371/journal.pone.0083490	http://dx.doi.org/10.1371/journal.pone.0083490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386213	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900040
J	Alcena, DC; Kobie, JJ; Kaminski, DA; Rosenberg, AF; Mattiacio, JL; Brewer, M; Dewhurst, S; Dykes, C; Jin, X; Keefer, MC; Sanz, I				Alcena, Danielle C.; Kobie, James J.; Kaminski, Denise A.; Rosenberg, Alexander F.; Mattiacio, Jonelle L.; Brewer, Matthew; Dewhurst, Stephen; Dykes, Carrie; Jin, Xia; Keefer, Michael C.; Sanz, Ignacio			9G4+Antibodies Isolated from HIV-Infected Patients Neutralize HIV-1 and Have Distinct Autoreactivity Profiles	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-LYMPHOCYTES; ANTIBODIES; AUTOANTIBODIES; RESPONSES; SURFACE; CELLS; IGG	Potent HIV-1 specific broadly neutralizing antibodies (BNA) are uncommon in HIV infected individuals, and have proven hard to elicit by vaccination. Several, isolated monoclonal BNA are polyreactive and also recognize self-antigens, suggesting a breach of immune tolerance in persons living with HIV (PLWH). Persons with systemic lupus erythematosus (SLE) often have elevated levels of autoreactive antibodies encoded by the VH4-34 heavy chain immunoglobulin gene whose protein product can be detected by the 9G4 rat monoclonal antibody. We have recently found that levels of these "9G4+" antibodies are also elevated in PLWH. However, the putative autoreactive nature of these antibodies and the relationship of such reactivities with HIV neutralization have not been investigated. We therefore examined the autoreactivity and HIV neutralization potential of 9G4+ antibodies from PLWH. Results show that 9G4+ antibodies from PLWH bound to recombinant HIV-1 envelope (Env) and neutralized viral infectivity in vitro, whereas 9G4+ antibodies from persons with SLE did not bind to Env and failed to neutralize viral infectivity. In addition, while 9G4+ antibodies from PLWH retained the canonical anti-i reactivity that mediates B cell binding, they did not display other autoreactivities common to SLE 9G4+ antibodies, such as binding to cardiolipin and DNA and had much lower reactivity with apoptotic cells. Taken together, these data indicate that the autoreactivity of 9G4+ antibodies from PLWH is distinct from that of SLE patients, and therefore, their expansion is not due to a general breakdown of B cell tolerance but is instead determined in a more disease-specific manner by self-antigens that become immunogenic in the context of, and possibly due to HIV infection. Further studies of 9G4+ B cells may shed light on the regulation of B cell tolerance and interface between the generation of specific autoreactivities and the induction of antiviral immunity in persons living with HIV.	[Alcena, Danielle C.; Mattiacio, Jonelle L.; Brewer, Matthew; Dewhurst, Stephen] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Alcena, Danielle C.; Kaminski, Denise A.; Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Kobie, James J.; Dykes, Carrie; Jin, Xia; Keefer, Michael C.] Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14642 USA; [Sanz, Ignacio] Emory Univ, Dept Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA	University of Rochester; University of Rochester; University of Rochester; Emory University	Sanz, I (corresponding author), Emory Univ, Dept Med, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA.	ignacio.sanz@emory.edu	Alcena-Stiner, Danielle/GVS-5132-2022; Alcéna-Stiner, Danielle C./ABG-9478-2020	Alcena-Stiner, Danielle C./0000-0002-7466-9423; Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health (NIH) [R01AI084808, R21AI078459, R37AI049660, U19 AI056363]; University of Rochester Developmental Center for AIDS Research [P30 AI078498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084808, R21AI078459, R37AI049660, P30AI078498, U19AI056363, T32AI049815] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Developmental Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work supported by National Institutes of Health (NIH) grants R01AI084808, R21AI078459, R37AI049660, and U19 AI056363 (Autoimmunity Centers of Excellence) to IS; and the University of Rochester Developmental Center for AIDS Research grant P30 AI078498 (NIH/NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat NM, 2002, J RHEUMATOL, V29, P2114; Bhat NM, 1996, CLIN EXP IMMUNOL, V105, P183, DOI 10.1046/j.1365-2249.1996.d01-733.x; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Cappione AJ, 2004, J IMMUNOL, V172, P4298, DOI 10.4049/jimmunol.172.7.4298; Chong BF, 2012, J INVEST DERMATOL, V132, P2770, DOI 10.1038/jid.2012.207; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Jenks SA, 2013, ARTHRITIS RHEUMATISM; Kobie JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035356; Kobie JJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3542; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Lindop R, 2012, IMMUNOL CELL BIOL, V90, P304, DOI 10.1038/icb.2011.108; Looney RJ, 2004, LUPUS, V13, P381, DOI 10.1191/0961203304lu1031oa; Marks SD, 2012, PEDIATR NEPHROL, V27, P1855, DOI 10.1007/s00467-011-2078-4; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mattiacio J, 2011, VACCINE, V29, P2637, DOI 10.1016/j.vaccine.2011.01.038; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MONTEFIORI DC, 2005, CURR PROTOC IMMUNOL, V12; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Olsen NJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3927; POTTER KN, 1993, J EXP MED, V178, P1419, DOI 10.1084/jem.178.4.1419; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; RIBOLDI P, 1994, BLOOD, V83, P2952, DOI 10.1182/blood.V83.10.2952.2952; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; STEVENSON FK, 1988, NOUV REV FR HEMATOL, V30, P299; STEVENSON FK, 1993, J AUTOIMMUN, V6, P809, DOI 10.1006/jaut.1993.1066; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Verkoczy L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007215	30	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85098	10.1371/journal.pone.0085098	http://dx.doi.org/10.1371/journal.pone.0085098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386452	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700132
J	Helmchen, C; Palzer, C; Munte, TF; Anders, S; Sprenger, A				Helmchen, Christoph; Palzer, Carina; Muente, Thomas F.; Anders, Silke; Sprenger, Andreas			Itch Relief by Mirror Scratching. A Psychophysical Study	PLOS ONE			English	Article							HISTAMINE-INDUCED ITCH; VISUAL FEEDBACK; RUBBER HAND; PAIN; LIMB; THERAPY; CORTEX; TOUCH; MODULATION; ACTIVATION	Objective: The goal of this study was to test whether central mechanisms of scratching-induced itch attenuation can be activated by scratching the limb contralateral to the itching limb when the participant is made to visually perceive the non-itching limb as the itching limb by means of mirror images. Methods: Healthy participants were asked to assess the intensity of an experimentally induced itch at their right forearm while they observed externally guided scratch movements either at their right (itching) or left (non-itching) forearm which were either mirrored or not mirrored. In the first experiment, a mirror placed between the participant's forearms was used to create the visual illusion that the participant's itching (right) forearm was being scratched while in fact the non-itching (left) forearm was scratched. To control visibility of the left (non-mirrored) forearm, a second experiment was performed in which unflipped and flipped real-time video displays of the participant's forearms were used to create experimental conditions in which the participant visually perceived scratching either on one forearm only, on both forearms, or no scratching at all. Results: In both experiments, scratching the non-itching limb attenuated perceived itch intensity significantly and selectively in the mirror condition, i.e., when the non-itching forearm was visually perceived as the itching limb. Discussion: These data provide evidence that the visual illusion that an itching limb is being scratched while in fact the non-itching limb contralateral to the itching limb is scratched, can lead to significant itch relief. This effect might be due to a transient illusionary intersensory perceptual congruency of visual, tactile and pruriceptive signals. "Mirror scratching" might provide an alternative treatment to reduce itch perception in focal skin diseases with persistent pruritus without causing additional harm to the affected skin and might therefore have significant clinical impact.	[Helmchen, Christoph; Palzer, Carina; Muente, Thomas F.; Anders, Silke; Sprenger, Andreas] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	University of Lubeck	Helmchen, C (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	christoph.helmchen@neuro.uni-luebeck.de	Sprenger, Andreas/C-7612-2009; Münte, Thomas/C-2077-2014	Sprenger, Andreas/0000-0001-9255-7911; 				Acerra NE, 2005, NEUROLOGY, V65, P751, DOI 10.1212/01.wnl.0000178745.11996.8c; Altschuler EL, 1999, LANCET, V353, P2035, DOI 10.1016/S0140-6736(99)00920-4; Altschuler EL, 2011, AM J PHYS MED REHAB, V90, P790, DOI 10.1097/PHM.0b013e3182241966; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Arck P, 2006, NEUROIMMUNOMODULAT, V13, P347, DOI 10.1159/000104863; Aspell J. E., 2012, NEURAL BASES MULTISE; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brodie EE, 2007, EUR J PAIN, V11, P428, DOI 10.1016/j.ejpain.2006.06.002; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Darsow U, 1996, ARCH DERMATOL RES, V288, P436, DOI 10.1007/BF02505231; Davidson S, 2012, J NEUROPHYSIOL, V108, P1711, DOI 10.1152/jn.00206.2012; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Heimchen C, 2008, HUM BRAIN MAPP, V29, P1080, DOI 10.1002/hbm.20447; Hoermann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050942; HSIEH JC, 1994, J NEUROPHYSIOL, V72, P3004, DOI 10.1152/jn.1994.72.6.3004; Kawashima N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069324; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kosteletzky F, 2009, ACTA DERM-VENEREOL, V89, P271, DOI 10.2340/00015555-0624; Leknes SG, 2007, J NEUROPHYSIOL, V97, P415, DOI 10.1152/jn.00070.2006; Maravita A, 2002, PSYCHOL SCI, V13, P350; McCabe CS, 2008, CURR PAIN HEADACHE R, V12, P103, DOI 10.1007/s11916-008-0020-7; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Mochizuki H, 2003, PAIN, V105, P339, DOI 10.1016/S0304-3959(03)00249-5; Moseley GL, 2009, PAIN, V144, P314, DOI 10.1016/j.pain.2009.04.030; MURRAY FS, 1975, J COMP PHYSIOL PSYCH, V89, P819, DOI 10.1037/h0077028; Pfab F, 2010, ALLERGY, V65, P84, DOI 10.1111/j.1398-9995.2009.02163.x; Press C, 2004, EXP BRAIN RES, V154, P238, DOI 10.1007/s00221-003-1651-x; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; Sathian K, 2000, NEUROLOGY, V54, P1866, DOI 10.1212/WNL.54.9.1866; Sathian K, 2000, NEUROREHAB NEURAL RE, V14, P73, DOI 10.1177/154596830001400109; Schmelz M, 1997, J NEUROSCI, V17, P8003; Seckel E, 2012, RELIEVING PHANTOM IT, VH89, P224; Seidel S, 2011, ROFO-FORTSCHR RONTG, V183, P1051, DOI 10.1055/s-0031-1281768; Subedi B, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/864605; Thieme H, 2012, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD008449.PUB2; Valet M, 2008, J INVEST DERMATOL, V128, P426, DOI 10.1038/sj.jid.5701002; Vierow V, 2009, J NEUROPHYSIOL, V102, P3216, DOI 10.1152/jn.00207.2009; Walter B, 2005, J INVEST DERMATOL, V125, P380, DOI 10.1111/j.0022-202X.2005.23817.x; Wilcher DG, 2011, J MED CASE REP, V5, P41, DOI DOI 10.1186/1752-1947-5-41; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162; Yosipovitch G, 2007, BRIT J DERMATOL, V156, P629, DOI 10.1111/j.1365-2133.2006.07711.x; Yosipovitch G, 2008, J INVEST DERMATOL, V128, P1806, DOI 10.1038/jid.2008.3; Yosipovitch G, 2008, DERMATOL THER, V21, P32, DOI 10.1111/j.1529-8019.2008.00167.x; Yosipovitch G, 2007, PAIN, V131, P4, DOI 10.1016/j.pain.2007.04.017	52	9	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82756	10.1371/journal.pone.0082756	http://dx.doi.org/10.1371/journal.pone.0082756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386113	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700016
J	Lian, M; Fang, JG; Han, DM; Ma, HZ; Feng, L; Wang, R; Yang, F				Lian, Meng; Fang, Jugao; Han, Demin; Ma, Hongzhi; Feng, Ling; Wang, Ru; Yang, Fan			Microarray Gene Expression Analysis of Tumorigenesis and Regional Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							DNA-REPLICATION; EIF3 P170; CANCER; MARKER; APOPTOSIS; CYCLE; PROLIFERATION; DOCETAXEL; PROGNOSIS; DIAGNOSIS	Background: Laryngeal squamous cell carcinoma (LSCC) is the most common type in head and neck squamous cell carcinoma (HNSCC), and the development and progression of LSCC are multistep processes accompanied by changes of molecular biology. Objective: The purpose of this study was to investigate the molecular basis of tumorigenesis and regional lymph node metastasis in LSCC, and provide a set of genes that may be useful for the development of novel diagnostic markers and/or more effective therapeutic strategies. Methods: A total number of 10 patients who underwent surgery for primary laryngeal squamous cell carcinoma were recruited for microarray analysis. LSCC tissues compared with corresponding adjacent non-neoplastic tissues were analysed by Illumina mRNA microarrays, and LSCC tissues with regional lymph node metastasis and LSCC tissues without regional lymph node metastasis were analyzed in the same manner. The most frequently differently expressed genes screened by microarrays were also validated by qRT-PCR in another 42 patients diagnosed for LSCC. Results: Analysed by Illumina mRNA microarrays, there were 361 genes significantly related to tumorigenesis while 246 genes significantly related to regional lymph node metastasis in LSCC. We found that the six genes (CDK1, CDK2, CDK4, MCM2, MCM3, MCM4) were most frequently differently expressed functional genes related to tumorigenesis while eIF3a and RPN2 were most frequently differently expressed functional genes related to regional lymph node metastasis in LSCC. The expressions of these genes were also validated by qRT-PCR. Conclusions: The research revealed a gene expression signature of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma. Of the total, the deregulation of several genes (CDK1, CDK2, CDK4, MCM2, MCM3, MCM4, EIF3a and RPN2) were potentially associated with disease development and progression. The result will contribute to the understanding of the molecular basis of LSCC and help to improve diagnosis and treatment.	[Lian, Meng; Fang, Jugao; Han, Demin; Ma, Hongzhi; Feng, Ling; Wang, Ru; Yang, Fan] Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China; [Han, Demin] Beijing Inst Otorhinolaryngol, Minist Educ, Key Lab Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University	Fang, JG (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China.	fangjugao@vip.sohu.com; handm@trhos.com			National Natural Science Foundation of China(NSFC) [81072204]	National Natural Science Foundation of China(NSFC)(National Natural Science Foundation of China (NSFC))	Sponsored by National Natural Science Foundation of China(NSFC) (81072204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonkitticharoen V, 2008, ARCH OTOLARYNGOL, V134, P1305, DOI 10.1001/archotol.134.12.1305; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chou LC, 2009, J GASTROENTEROL, V44, P1055, DOI 10.1007/s00535-009-0111-1; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; Cosetti M, 2008, ARCH OTOLARYNGOL, V134, P370, DOI 10.1001/archotol.134.4.370; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Fleskens SAJHM, 2010, LARYNGOSCOPE, V120, P1326, DOI 10.1002/lary.20888; Gan N, 2010, EUR J GYNAECOL ONCOL, V31, P291; Gao Shuichao, 2013, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V27, P147; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Gong Zhicheng, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P771, DOI 10.3969/j.issn.1672-7347.2010.08.001; Ha SA, 2004, CLIN CANCER RES, V10, P8386, DOI 10.1158/1078-0432.CCR-04-1029; Han JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049296; Han L, 2012, MED ONCOL, V29, P2466, DOI 10.1007/s12032-011-0152-1; Han YK, 2013, BIOCHEM BIOPH RES CO, V430, P1329, DOI 10.1016/j.bbrc.2012.10.119; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jiang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064150; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Kurashige J, 2012, BRIT J CANCER, V107, P1233, DOI 10.1038/bjc.2012.396; Li JJ, 2012, AURIS NASUS LARYNX, V39, P186, DOI 10.1016/j.anl.2011.04.003; Lim YC, 2011, J SURG ONCOL, V104, P776, DOI 10.1002/jso.21999; Liu M, 2013, HISTOL HISTOPATHOL, V28, P481, DOI 10.14670/HH-28.481; Liu YF, 2013, STAT INTERFACE, V6, P1; Liu ZQ, 2007, DIFFERENTIATION, V75, P652, DOI 10.1111/j.1432-0436.2007.00165.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0379-5; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Mallis A, 2012, EUR ARCH OTO-RHINO-L, V269, P639, DOI 10.1007/s00405-011-1625-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mehrotra P, 2006, LARYNGOSCOPE, V116, P1434, DOI 10.1097/01.mlg.0000225931.59644.93; Mielcarek-Kuchta D, 2008, EUR ARCH OTO-RHINO-L, V265, P1257, DOI 10.1007/s00405-008-0666-0; Nodin B, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-82; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Ren JY, 2010, EUR J CANCER, V46, P3409, DOI 10.1016/j.ejca.2010.07.047; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Shirali S, 2013, TUMOR BIOL, V34, P1085, DOI 10.1007/s13277-013-0650-1; Stoeber K, 2001, J CELL SCI, V114, P2027; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708; Thiele W, 2006, J BIOTECHNOL, V124, P224, DOI 10.1016/j.jbiotec.2006.01.007; Tse GM, 2009, OTOLARYNG HEAD NECK, V141, P467, DOI 10.1016/j.otohns.2009.06.747; Vargas PA, 2008, J ORAL PATHOL MED, V37, P309, DOI 10.1111/j.1600-0714.2007.00631.x; Wu HD, 2011, IUBMB LIFE, V63, P101, DOI [10.1002/iub.00417, 10.1002/iub.417]; Yim WC, 2011, MOL CELL TOXICOL, V7, P233, DOI 10.1007/s13273-011-0029-6; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Yoshida K, 2010, HEAD NECK-J SCI SPEC, V32, P646, DOI 10.1002/hed.21239; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023849	51	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84854	10.1371/journal.pone.0084854	http://dx.doi.org/10.1371/journal.pone.0084854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386425	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700120
J	Mustain, WC; Starr, ME; Valentino, JD; Cohen, DA; Okamura, D; Wang, C; Evers, BM; Saito, H				Mustain, W. Conan; Starr, Marlene E.; Valentino, Joseph D.; Cohen, Donald A.; Okamura, Daiki; Wang, Chi; Evers, B. Mark; Saito, Hiroshi			Inflammatory Cytokine Gene Expression in Mesenteric Adipose Tissue during Acute Experimental Colitis	PLOS ONE			English	Article							CROHNS-DISEASE; BACTERIAL TRANSLOCATION; REACTIVATED COLITIS; MURINE COLITIS; BOWEL-DISEASE; CREEPING FAT; MICE; PROTEIN; OBESE; PREADIPOCYTES	Background: Production of inflammatory cytokines by mesenteric adipose tissue (MAT) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Animal models of colitis have demonstrated inflammatory changes within MAT, but it is unclear if these changes occur in isolation or as part of a systemic adipose tissue response. It is also unknown what cell types are responsible for cytokine production within MAT. The present study was designed to determine whether cytokine production by MAT during experimental colitis is depot-specific, and also to identify the source of cytokine production within MAT. Methods: Experimental colitis was induced in 6-month-old C57BL/6 mice by administration of dextran sulfate sodium (2% in drinking water) for up to 5 days. The induction of cytokine mRNA within various adipose tissues, including mesenteric, epididymal, and subcutaneous, was analyzed by qRT-PCR. These adipose tissues were also examined for histological evidence of inflammation. The level of cytokine mRNA during acute colitis was compared between mature mesenteric adipocytes, mesenteric stromal vascular fraction (SVF), and mesenteric lymph nodes. Results: During acute colitis, MAT exhibited an increased presence of infiltrating mononuclear cells and fibrotic structures, as well as decreased adipocyte size. The mRNA levels of TNF-alpha, IL-1 beta, and IL-6 were significantly increased in MAT but not other adipose tissue depots. Within the MAT, induction of these cytokines was observed mainly in the SVF. Conclusions: Acute experimental colitis causes a strong site-specific inflammatory response within MAT, which is mediated by cells of the SVF, rather than mature adipocytes or mesenteric lymph nodes.	[Mustain, W. Conan; Starr, Marlene E.; Valentino, Joseph D.; Okamura, Daiki; Wang, Chi; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Mustain, W. Conan; Starr, Marlene E.; Valentino, Joseph D.; Okamura, Daiki; Evers, B. Mark; Saito, Hiroshi] Univ Kentucky, Dept Surg, Lexington, KY USA; [Cohen, Donald A.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Wang, Chi] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Saito, Hiroshi] Univ Kentucky, Dept Physiol, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Saito, H (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.	hiroshi.saito@uky.edu			National Institute of Health [R01 AG039732, RO1 DK048498]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039732] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by National Institute of Health grants (R01 AG039732 to HS, RO1 DK048498 to BME) and a grant from the Crohn's and Colitis Foundation of America (to DAC); however, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo SC, 2011, DIGEST DIS SCI, V56, P2545, DOI 10.1007/s10620-011-1644-8; Arner P, 2001, BIOCHEM SOC T, V29, P72, DOI 10.1042/bst0290072; Batra A, 2012, MUCOSAL IMMUNOL, V5, P580, DOI 10.1038/mi.2012.33; Behr MA, 2010, INFLAMM BOWEL DIS, V16, P896, DOI 10.1002/ibd.21171; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; COOPER HS, 1993, LAB INVEST, V69, P238; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; de Oliveira CC, 2009, INT IMMUNOPHARMACOL, V9, P396, DOI 10.1016/j.intimp.2008.12.015; Desreumaux P, 1999, GASTROENTEROLOGY, V117, P73, DOI 10.1016/S0016-5085(99)70552-4; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Drouet M, 2012, NUTRITION, V28, P113, DOI 10.1016/j.nut.2011.09.009; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fink C, 2012, INFLAMM BOWEL DIS, V18, P1550, DOI 10.1002/ibd.22893; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; Gambero A, 2007, INFLAMM BOWEL DIS, V13, P1357, DOI 10.1002/ibd.20222; Guffey CR, 2013, CURR OPIN CLIN NUTR, V16, P595, DOI 10.1097/MCO.0b013e328362d10b; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Herlinger H, 1998, ABDOM IMAGING, V23, P446, DOI 10.1007/s002619900377; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Karagiannides L, 2006, P NATL ACAD SCI USA, V103, P5207, DOI 10.1073/pnas.0600821103; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Martinez J, 2004, PANCREATOLOGY, V4, P42, DOI 10.1159/000077025; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; O'Rourke RW, 2009, INT J OBESITY, V33, P978, DOI 10.1038/ijo.2009.133; Olivier I, 2011, INFLAMM BOWEL DIS, V17, P747, DOI 10.1002/ibd.21413; OLSON AD, 1995, J PEDIATR GASTR NUTR, V21, P410, DOI 10.1097/00005176-199511000-00007; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Pond CM, 2001, P NUTR SOC, V60, P365, DOI 10.1079/PNS200198; Starr ME, 2013, AGING CELL, V12, P194, DOI 10.1111/acel.12040; Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Thomaz MA, 2009, PHARMACOL RES, V60, P341, DOI 10.1016/j.phrs.2009.05.003; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516; Yoshida H, 2010, AM J PATHOL, V177, P2774, DOI 10.2353/ajpath.2010.100205	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83693	10.1371/journal.pone.0083693	http://dx.doi.org/10.1371/journal.pone.0083693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386254	Green Published, gold			2022-12-27	WOS:000329116700070
J	Santos, S; Baptista, CS; Abreu, RMV; Bastos, E; Amorim, I; Gut, IG; Gartner, F; Chaves, R				Santos, Sara; Baptista, Claudia S.; Abreu, Rui M. V.; Bastos, Estela; Amorim, Irina; Gut, Ivo G.; Gaertner, Fatima; Chaves, Raquel			ERBB2 in Cat Mammary Neoplasias Disclosed a Positive Correlation between RNA and Protein Low Expression Levels: A Model for erbB-2 Negative Human Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HER2 CODON-655 POLYMORPHISM; TIME RT-PCR; SOMATIC MUTATIONS; I655V POLYMORPHISM; HAPLOTYPE ANALYSIS; KINASE DOMAIN; RISK; HER-2/NEU; TUMOR	Human ERBB2 is a proto-oncogene that codes for the erbB-2 epithelial growth factor receptor. In human breast cancer (HBC), erbB-2 protein overexpression has been repeatedly correlated with poor prognosis. In more recent works, underexpression of this gene has been described in HBC. Moreover, it is also recognised that oncogenes that are commonly amplified or deleted encompass point mutations, and some of these are associated with HBC. In cat mammary lesions (CMLs), the overexpression of ERBB2 (27%-59.6%) has also been described, mostly at the protein level and although cat mammary neoplasias are considered to be a natural model of HBC, molecular information is still scarce. In the present work, a cat ERBB2 fragment, comprising exons 10 to 15 (ERBB2_10-15) was achieved for the first time. Allelic variants and genomic haplotype analyses were also performed, and differences between normal and CML populations were observed. Three amino acid changes, corresponding to 3 non-synonymous genomic sequence variants that were only detected in CMLs, were proposed to damage the 3D structure of the protein. We analysed the cat ERBB2 gene at the DNA (copy number determination), mRNA (expression levels assessment) and protein levels (in extra-and intra protein domains) in CML samples and correlated the last two evaluations with clinicopathological features. We found a positive correlation between the expression levels of the ERBB2 RNA and erbB-2 protein, corresponding to the intracellular region. Additionally, we detected a positive correlation between higher mRNA expression and better clinical outcome. Our results suggest that the ERBB2 gene is post-transcriptionally regulated and that proteins with truncations and single point mutations are present in cat mammary neoplastic lesions. We would like to emphasise that the recurrent occurrence of low erbB-2 expression levels in cat mammary tumours, suggests the cat mammary neoplasias as a valuable model for erbB-2 negative HBC.	[Santos, Sara; Baptista, Claudia S.; Abreu, Rui M. V.; Bastos, Estela; Chaves, Raquel] Univ Tras Os Montes & Alto Douro, Ctr Genom & Biotechnol, Inst Biotechnol & Bioengn, Vila Real, Portugal; [Baptista, Claudia S.] Univ Porto, Inst Biomed Sci Abel Salazar, Vet Clin Univ Porto, P-4100 Oporto, Portugal; [Abreu, Rui M. V.] Inst Politecn Braganca, CIMO ESA, Braganca, Portugal; [Bastos, Estela; Chaves, Raquel] Univ Tras Os Montes & Alto Douro, Sch Life Sci & Environm, Dept Genet & Biotechnol, Vila Real, Portugal; [Amorim, Irina; Gaertner, Fatima] Univ Porto, Inst Pathol & Immunol, P-4100 Oporto, Portugal; [Amorim, Irina; Gaertner, Fatima] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Gut, Ivo G.] Ctr Natl Genotypage, Evry, France	University of Tras-os-Montes & Alto Douro; Universidade do Porto; Instituto Politecnico de Braganca; University of Tras-os-Montes & Alto Douro; Universidade do Porto; Universidade do Porto; CEA; UDICE-French Research Universities; Universite Paris Saclay	Chaves, R (corresponding author), Univ Tras Os Montes & Alto Douro, Ctr Genom & Biotechnol, Inst Biotechnol & Bioengn, Vila Real, Portugal.	rchaves@utad.pt	Baptista, Cláudia/F-1231-2017; Chaves, Raquel/S-2882-2019; Chaves, Raquel/K-3044-2013; Gut, Ivo/ABF-3188-2020; Amorim, Irina/F-9953-2013; Abreu, Rui/W-1800-2019; Gartner, Maria de Fatima/A-3530-2010; Santos, Sara/L-3001-2018	Baptista, Cláudia/0000-0002-8158-4743; Chaves, Raquel/0000-0002-5970-7428; Chaves, Raquel/0000-0002-5970-7428; Gut, Ivo/0000-0001-7219-632X; Amorim, Irina/0000-0002-2305-1631; Bastos, Estela/0000-0002-4490-6715; Abreu, Rui/0000-0002-7745-8015; Gartner, Maria de Fatima/0000-0002-5302-0086; Santos, Sara/0000-0002-0106-8942	Science and Technology Foundation (FCT) from Portugal [SFRH/BD/23406/2005, SFRH/BD/31754/2006];  [POCI/CVT/62940/2004]; Fundação para a Ciência e a Tecnologia [POCI/CVT/62940/2004, SFRH/BEST/135028/2017] Funding Source: FCT	Science and Technology Foundation (FCT) from Portugal(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	This work has been funded by project POCI/CVT/62940/2004 and by the PhD grants (SFRH/BD/23406/2005 and SFRH/BD/31754/2006, of the Science and Technology Foundation (FCT) from Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagossi P, 2005, BIOPHYS J, V88, P1354, DOI 10.1529/biophysj.104.046003; Baptista CS, 2012, VET J, V191, P203, DOI 10.1016/j.tvjl.2011.01.011; Benusiglio PR, 2006, BRIT J CANCER, V95, P1689, DOI 10.1038/sj.bjc.6603473; Benusiglio PR, 2005, BREAST CANCER RES, V7, pR204, DOI 10.1186/bcr982; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Bieche I, 1999, CLIN CHEM, V45, P1148; BORG A, 1990, CANCER RES, V50, P4332; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Breyer JP, 2009, CANCER EPIDEM BIOMAR, V18, P1252, DOI 10.1158/1055-9965.EPI-08-1202; Buerger H, 2000, CANCER RES, V60, P854; Burrai GP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-156; Camp RL, 2003, CANCER RES, V63, P1445; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carraro DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021022; Charpin C, 1997, BRIT J CANCER, V75, P1667, DOI 10.1038/bjc.1997.283; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clarke Robert, 2009, Breast Cancer Res, V11 Suppl 3, pS22, DOI 10.1186/bcr2441; Cooke T, 2001, EUR J CANCER, V37, pS3, DOI 10.1016/S0959-8049(00)00402-0; Cuadros M, 2010, PATHOBIOLOGY, V77, P38, DOI 10.1159/000272953; Dahabreh IJ, 2011, CANCER EPIDEMIOL, V35, P503, DOI 10.1016/j.canep.2011.01.007; De Maria R, 2005, CANCER RES, V65, P907; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dowsett M, 2000, EUR J CANCER, V36, P170, DOI 10.1016/S0959-8049(99)00264-6; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Gilcrease MZ, 2009, AM J SURG PATHOL, V33, P759, DOI 10.1097/PAS.0b013e31819437f9; Gimenez F, 2010, J FELINE MED SURG, V12, P214, DOI 10.1016/j.jfms.2010.01.004; Ginestier C, 2004, J PATHOL, V202, P286, DOI 10.1002/path.1523; Gouvêa Agostinho Pinto, 2004, J. Bras. Patol. Med. Lab., V40, P27, DOI 10.1590/S1676-24442004000100008; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gullick WJ, 1998, BREAST CANCER RES TR, V52, P43, DOI 10.1023/A:1006107016969; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Han W, 2005, CLIN CANCER RES, V11, P4775, DOI 10.1158/1078-0432.CCR-04-2208; Hanna WM, 2001, MODERN PATHOL, V14, P677, DOI 10.1038/modpathol.3880372; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hishida A, 2002, J NATL CANCER I, V94, P1807; Hu XQ, 2006, BIOCHEM BIOPH RES CO, V346, P778, DOI 10.1016/j.bbrc.2006.05.206; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; Jimenez RE, 2000, MODERN PATHOL, V13, P37, DOI 10.1038/modpathol.3880007; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Keshava C, 2001, CANCER LETT, V173, P37, DOI 10.1016/S0304-3835(01)00671-1; Klapper LN, 2000, ADV CANCER RES, V77, P25; Koletsa T, 2008, NEOPLASIA, V10, P687, DOI 10.1593/neo.08314; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Matos AJF, 2012, VET J, V193, P24, DOI 10.1016/j.tvjl.2011.12.019; Millanta F, 2005, VET PATHOL, V42, P30, DOI 10.1354/vp.42-1-30; Miller SJ, 1996, DNA CELL BIOL, V15, P749, DOI 10.1089/dna.1996.15.749; Millikan R, 2003, BREAST CANCER RES TR, V79, P355, DOI 10.1023/A:1024068525763; Millikan RC, 2005, BREAST CANCER RES TR, V89, P309, DOI 10.1007/s10549-004-2171-5; Misdorp W., 2002, Tumors in domestic animals, P575, DOI 10.1002/9780470376928.ch12; Misdorp W., 1999, HISTOLOGICAL CLASSIF; Molina MA, 2001, CANCER RES, V61, P4744; Montgomery KG, 2003, CANCER EPIDEM BIOMAR, V12, P1109; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Namba R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-275; Nelson SE, 2005, BREAST CANCER RES, V7, pR357, DOI 10.1186/bcr1004; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Ordas J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-179; Perez-Alenza MD, 2004, BREAST CANCER RES, V6, pR300, DOI 10.1186/bcr790; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Potemski P, 2006, MED SCI MONITOR, V12, pMT57; Rajasekaran R, 2008, CR BIOL, V331, P409, DOI 10.1016/j.crvi.2008.03.004; Rasotto R, 2011, J COMP PATHOL, V144, P170, DOI 10.1016/j.jcpa.2010.08.010; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Rutteman G, 2001, SMALL ANIMAL CLIN ON; Santos S, 2012, INT J MOL SCI, V13, P2783, DOI 10.3390/ijms13032783; Santos S, 2009, RES VET SCI, V86, P421, DOI 10.1016/j.rvsc.2008.08.007; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schru┬dinger L, 2011, MAESTR; Selvarajan S, 2004, ANN ACAD MED SINGAP, V33, P473; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Soares M, 2013, MICROSC MICROANAL, V19, P876, DOI 10.1017/S1431927613001529; Tao WY, 2009, BREAST CANCER RES TR, V114, P371, DOI 10.1007/s10549-008-0010-9; Teschendorff AE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2236; Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440; Tommasi S, 2004, CANCER LETT, V209, P215, DOI 10.1016/j.canlet.2003.12.014; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; WEIJER K, 1983, J NATL CANCER I, V70, P709; Winston J, 2005, Vet Comp Oncol, V3, P8, DOI 10.1111/j.1476-5810.2005.00063.x; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zappulli V, 2005, J DAIRY RES, V72, P98, DOI 10.1017/S0022029905001263	90	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83673	10.1371/journal.pone.0083673	http://dx.doi.org/10.1371/journal.pone.0083673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386251	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700068
J	Hirota, SK; Nitta, K; Suyama, Y; Kawakubo, N; Yasumoto, AA; Yahara, T				Hirota, Shun K.; Nitta, Kozue; Suyama, Yoshihisa; Kawakubo, Nobumitsu; Yasumoto, Akiko A.; Yahara, Tetsukazu			Pollinator-Mediated Selection on Flower Color, Flower Scent and Flower Morphology of Hemerocallis: Evidence from Genotyping Individual Pollen Grains On the Stigma	PLOS ONE			English	Article							PLATANTHERA-BIFOLIA ORCHIDACEAE; FLORAL SCENT; CITRINA HEMEROCALLIDACEAE; REPRODUCTIVE ISOLATION; PHENOTYPIC SELECTION; MANDUCA-SEXTA; MALE FITNESS; FULVA; PETUNIA; ADAPTATION	To trace the fate of individual pollen grains through pollination processes, we determined genotypes of single pollen grains deposited on Hemerocallis stigmas in an experimental mixed-species array. Hemerocallis fulva, pollinated by butterflies, has diurnal, reddish and unscented flowers, and H. citrina, pollinated by hawkmoths, has nocturnal, yellowish and sweet scent flowers. We observed pollinator visits to an experimental array of 24 H. fulva and 12 F2 hybrids between the two species (H. fulva and H. citrina) and collected stigmas after every trip bout of swallowtail butterflies or hawkmoths. We then measured selection by swallowtail butterflies or hawkmoths through male and female components of pollination success as determined by single pollen genotyping. As expected, swallowtail butterflies imposed selection on reddish color and weak scent: the number of outcross pollen grains acquired is a quadratic function of flower color with the maximum at reddish color, and the combined pollination success was maximal at weak scent (almost unrecognizable for human). This explains why H. fulva, with reddish flowers and no recognizable scent, is mainly pollinated by swallowtail butterflies. However, we found no evidence of hawkmoths-mediated selection on flower color or scent. Our findings do not support a hypothesis that yellow flower color and strong scent intensity, the distinctive floral characteristics of H. citrina, having evolved in adaptations to hawkmoths. We suggest that the key trait that triggers the evolution of nocturnal flowers is flowering time rather than flower color and scent.	[Hirota, Shun K.; Nitta, Kozue; Yasumoto, Akiko A.; Yahara, Tetsukazu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Suyama, Yoshihisa] Tohoku Univ, Grad Sch Agr Sci, Field Sci Ctr, Osaki, Miyagi, Japan; [Kawakubo, Nobumitsu] Gifu Univ, Fac Appl Biol Sci, Dept Environm Sci, Gifu, Japan	Kyushu University; Tohoku University; Gifu University	Hirota, SK (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	shhirscb@kyushu-u.org	Suyama, Yoshihisa/H-6115-2017	Suyama, Yoshihisa/0000-0002-3136-5489; Yasumoto, Akiko/0000-0002-8997-6768; Yahara, Tetsukazu/0000-0001-5105-7152	Japan Society for the Promotion of Science [21370013, 22.3799]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by Grant-in-Aid for Scientific Research (B) (No. 21370013) and Grant-in-Aid for JSPS Fellows (22.3799) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2008, EVOLUTION, V62, P220, DOI 10.1111/j.1558-5646.2007.00275.x; Ashman TL, 2004, P ROY SOC B-BIOL SCI, V271, P553, DOI 10.1098/rspb.2003.2642; Bloch D, 2008, ECOLOGY, V89, P2453, DOI 10.1890/06-2023.1; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Coberly LC, 2003, MOL ECOL, V12, P1113, DOI 10.1046/j.1365-294X.2003.01786.x; Conner JK, 1996, OECOLOGIA, V105, P509, DOI 10.1007/BF00330014; Conner JK, 2006, ECOLOGY EVOLUTION FL, P260; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fulton M, 1999, P ROY SOC B-BIOL SCI, V266, P2247, DOI 10.1098/rspb.1999.0915; Gelman A., 2004, BAYESIAN DATA ANAL; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P165, DOI 10.1007/BF00936404; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; GRIESBACH RJ, 1995, HORTSCIENCE, V30, P353, DOI 10.21273/HORTSCI.30.2.353; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Hasegawa M, 2006, J PLANT RES, V119, P63, DOI 10.1007/s10265-005-0241-3; Hasegawa Y, 2009, NEW PHYTOL, V182, P994, DOI 10.1111/j.1469-8137.2009.02806.x; Hirota SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039010; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; Hoballah ME, 2005, PLANTA, V222, P141, DOI 10.1007/s00425-005-1506-8; Hodgins KA, 2008, EVOLUTION, V62, P1751, DOI 10.1111/j.1558-5646.2008.00404.x; Huber FK, 2005, OECOLOGIA, V142, P564, DOI 10.1007/s00442-004-1750-9; Jurgens A, 2002, BIOCHEM SYST ECOL, V30, P383, DOI 10.1016/S0305-1978(01)00106-5; Kawano S., 1973, J COLL LIB ARTS TOYA, V6, P111; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; KLINKHAMER PGL, 1994, J ECOL, V82, P191, DOI 10.2307/2261399; Kulbaba MW, 2012, EVOLUTION, V66, P1344, DOI 10.1111/j.1558-5646.2011.01536.x; Maad J, 2004, J EVOLUTION BIOL, V17, P642, DOI 10.1111/j.1420-9101.2004.00703.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matsuki Y, 2007, MOL ECOL NOTES, V7, P194, DOI 10.1111/j.1471-8286.2006.01588.x; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Miyake T, 2006, MOL ECOL NOTES, V6, P909, DOI 10.1111/j.1471-8286.2006.01396.x; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Newman E, 2012, P ROY SOC B-BIOL SCI, V279, P2309, DOI 10.1098/rspb.2011.2375; Nitta K, 2010, AM J BOT, V97, P261, DOI 10.3732/ajb.0900001; Plepys D, 2002, OIKOS, V99, P69, DOI 10.1034/j.1600-0706.2002.990107.x; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Rodriguez-Enriquez MJ, 2012, AOB PLANTS; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Sahli HF, 2011, EVOLUTION, V65, P1457, DOI 10.1111/j.1558-5646.2011.01229.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; STAPLETON AE, 1994, PLANT PHYSIOL, V105, P881, DOI 10.1104/pp.105.3.881; STOUT A. B., 1933, BULL TORREY BOT CLUB, V60, P397, DOI 10.2307/2480493; Stout AB, 1930, ADDISONIA, V15, P3; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; Van Rossum F, 2011, OECOLOGIA, V165, P663, DOI 10.1007/s00442-010-1745-7; Warren J, 2001, NEW PHYTOL, V151, P237, DOI 10.1046/j.1469-8137.2001.00159.x; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Wilson P, 1995, BIOL J LINN SOC, V5, P355, DOI [10.1111/j.1095-8312.1995.tb01071.x, DOI 10.1111/J.1095-8312.1995.TB01071.X]; Yasumoto AA, 2008, J PLANT RES, V121, P287, DOI 10.1007/s10265-008-0152-1; Yasumoto AA, 2006, J PLANT RES, V119, P617, DOI 10.1007/s10265-006-0028-1	56	23	23	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85601	10.1371/journal.pone.0085601	http://dx.doi.org/10.1371/journal.pone.0085601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376890	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000189
J	Cai, YX; Fu, XN; Xu, QZ; Sun, W; Zhang, N				Cai, Yi-xin; Fu, Xiang-ning; Xu, Qin-zi; Sun, Wei; Zhang, Ni			Thoracoscopic Lobectomy versus Open Lobectomy in Stage I Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							ASSISTED THORACIC-SURGERY; VATS LOBECTOMY; OPEN THORACOTOMY; EXPERIENCE; MORBIDITY; PROGNOSIS; RESECTION; OUTCOMES	The objective of the present meta-analysis was to evaluate the survival, recurrence rate, and complications in patients with stage I non-small cell lung cancer (NSCLC) who received video-assisted thoracoscopic surgery (VATS) or open lobectomy. A literature search was conducted on June 31, 2012 using combinations of the search terms video-assisted thoracic surgery, open thoracotomy, lobectomy, and non-small-cell lung cancer (NSCLC). Inclusion criteria were: 1) Compared video-assisted thoracic surgery (VATS) lobectomy with open lobectomy. 2) Stage I NSCLC. 2) No previous treatment for lung cancer. 4) Outcome data included 5-year survival rate, complication, and recurrence rate. Tests of heterogeneity, sensitivity, and publication bias were performed. A total of 23 studies (21 retrospective and 2 prospective) met the inclusion criteria. VATS was associated with a longer 5-year survival (odds ratio [OR] = 1.622, 95% confidence interval [CI] 1.272 to 2.069; P<0.001), higher local recurrence rate (OR = 2.152, 95% CI 1.349 to 3.434; P = 0.001), similar distant recurrence rate (OR = 0.91, 95% CI 0.33 to 2.48; P = 0.8560), and lower total complication rate (OR = 0.45, 95% CI 0.24 to 0.84; P = 0.013) compared to open lobectomy. VATS was also associated with lower rates arrhythmias, prolonged air leakage, and pneumonia but it did not show any statistical significance. Patients with stage I NSCLC undergoing VATS lobectomy had longer survival and fewer complications than those who received open lobectomy.	[Cai, Yi-xin; Fu, Xiang-ning; Xu, Qin-zi; Sun, Wei; Zhang, Ni] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Thorac Surg, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhang, N (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Thorac Surg, Wuhan 430074, Peoples R China.	zhangnidoc@vip.163.com						Boffa DJ, 2008, J THORAC CARDIOV SUR, V135, P247, DOI 10.1016/j.jtcvs.2007.07.060; Cao C, 2013, INTERACT CARDIOV TH, V16, P244, DOI 10.1093/icvts/ivs472; Chen FF, 2013, EJSO-EUR J SURG ONC, V39, P957, DOI 10.1016/j.ejso.2013.06.016; Denlinger CE, 2010, ANN THORAC SURG, V89, P1730, DOI 10.1016/j.athoracsur.2010.02.094; Flores RM, 2009, J THORAC CARDIOV SUR, V138, P11, DOI 10.1016/j.jtcvs.2009.03.030; Ilonen IK, 2011, ACTA ONCOL, V50, P1126, DOI 10.3109/0284186X.2011.555780; Inada K, 2000, INT SURG, V85, P6; Jiang GC, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-170; Kawachi R, 2009, THORAC CARDIOV SURG, V57, P156, DOI 10.1055/s-2008-1039267; Kim HK, 2010, J THORAC CARDIOV SUR, V140, P1288, DOI 10.1016/j.jtcvs.2010.06.011; KIRBY TJ, 1995, J THORAC CARDIOV SUR, V109, P997, DOI 10.1016/S0022-5223(95)70326-8; Koizumi Kiyoshi, 2002, Jpn J Thorac Cardiovasc Surg, V50, P15; Kondo T, 1998, J THORAC CARDIOV SUR, V116, P651, DOI 10.1016/S0022-5223(98)70175-8; Li ZJ, 2012, EXP THER MED, V3, P886, DOI 10.3892/etm.2012.485; McKenna RJ, 2006, ANN THORAC SURG, V81, P421, DOI 10.1016/j.athoracsur.2005.07.078; Muraoka M, 2006, GEN THORAC CARDIOVAS, V54, P49, DOI 10.1007/BF02744600; Murthy Sudish, 2012, Cleve Clin J Med, V79 Electronic Suppl 1, peS23, DOI 10.3949/ccjm.79.s2.05; Ng CSH, 2005, J INVEST SURG, V18, P81, DOI 10.1080/08941930590926320; Nomori H, 2001, ANN THORAC SURG, V72, P879, DOI 10.1016/S0003-4975(01)02891-0; Ohbuchi T, 1998, Jpn J Thorac Cardiovasc Surg, V46, P519; Onaitis MW, 2006, ANN SURG, V244, P420, DOI 10.1097/01.sla.0000234892.79056.63; Paoletti L, 2011, CLIN CHEST MED, V32, P827, DOI 10.1016/j.ccm.2011.08.009; Park BJ, 2007, J THORAC CARDIOV SUR, V133, P775, DOI 10.1016/j.jtcvs.2006.09.022; Park Joon Suk, 2011, Korean J Thorac Cardiovasc Surg, V44, P32, DOI 10.5090/kjtcs.2011.44.1.32; Petersen RP, 2007, ANN THORAC SURG, V83, P1245, DOI 10.1016/j.athoracsur.2006.12.029; Sagawa M, 2002, ANN THORAC SURG, V73, P900, DOI 10.1016/S0003-4975(01)03409-9; Sakuraba Motoki, 2007, Interact Cardiovasc Thorac Surg, V6, P614, DOI 10.1510/icvts.2007.157701; Sawada S, 2007, SURG ENDOSC, V21, P1607, DOI 10.1007/s00464-007-9200-5; Shigemura N, 2006, J THORAC CARDIOV SUR, V132, P507, DOI 10.1016/j.jtcvs.2006.03.058; Shiraishi T, 2006, ANN THORAC SURG, V82, P1021, DOI 10.1016/j.athoracsur.2006.04.031; Sugi K, 2000, WORLD J SURG, V24, P27, DOI 10.1007/s002689910006; Sugi K, 2000, Jpn J Thorac Cardiovasc Surg, V48, P161; Sugiura H, 1999, SURG LAPARO ENDO PER, V9, P403, DOI 10.1097/00019509-199912000-00007; Tahara RW, 2000, AM J SURG, V180, P488, DOI 10.1016/S0002-9610(00)00509-2; Taioli E, 2013, EUR J CARDIOTHORAC S; Tajiri M, 2007, RESPIROLOGY, V12, P207, DOI 10.1111/j.1440-1843.2006.01024.x; Tashima T, 2005, MINIM INVASIV THER, V14, P203, DOI 10.1080/13645700510034001; Tatsumi Akitoshi, 2003, Jpn J Thorac Cardiovasc Surg, V51, P646, DOI 10.1007/s11748-003-0002-y; Whitson BA, 2007, MED HYPOTHESES, V68, P1328, DOI 10.1016/j.mehy.2006.09.063; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009; Whitson BA, 2007, ANN THORAC SURG, V83, P1965, DOI 10.1016/j.athoracsur.2007.01.049; Yan TD, 2009, J CLIN ONCOL, V27, P2553, DOI 10.1200/JCO.2008.18.2733; Yang XY, 2009, WORLD J SURG, V33, P1857, DOI 10.1007/s00268-009-0137-9; Yim APC, 2000, ANN THORAC SURG, V70, P243, DOI 10.1016/S0003-4975(00)01258-3; Zhang Z, 2013, EUR J CARDIO-THORAC	45	41	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82366	10.1371/journal.pone.0082366	http://dx.doi.org/10.1371/journal.pone.0082366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391716	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200013
J	Liang, QC; Ma, CK; Zhao, Y; Gao, GD; Ma, J				Liang, Qinchuan; Ma, Chenkai; Zhao, Yang; Gao, Guodong; Ma, Jie			Inhibition of STAT3 Reduces Astrocytoma Cell Invasion and Constitutive Activation of STAT3 Predicts Poor Prognosis in Human Astrocytoma	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME CELLS; COLORECTAL-CANCER CELLS; CYCLE ARREST; SUPPRESSES PROLIFERATION; APOPTOSIS; EXPRESSION; GROWTH; BIOLOGY; GLIOMA	Astrocytoma cells characteristically possess high invasion potentials. Recent studies have revealed that knockdown of signal transducers and activators of transcription 3 (STAT3) expression by RNAi induces apoptosis in astrocytoma cell. Nevertheless, the distinct roles of STAT3 in astrocytoma's invasion and recurrence have not been elucidated. In this study, we silenced STAT3 using Small interfering RNAs in two human glioblastoma multiforme (GBM) cell lines (U251 and U87), and investigated the effect on GBM cell adhesion and invasion. Our results demonstrate that disruption of STAT3 inhibits GBM cell's adhesion and invasion. Knockdown of STAT3 significantly increased E-cadherin but decreased N-cadherin, vascular endothelial growth factor, matrix metalloproteinase 2 and matrix metalloproteinase 9. Additionally, expression of pSTAT3(Tyr705) correlates with astrocytoma WHO classification, Karnofsky performance status scale score, tumor recurrence and survival. Furthmore, pSTAT3(Tyr705) is a significant prognostic factor in astrocytoma. In conclusion, STAT3 may affect astrocytoma invasion, expression of pSTAT3(Tyr705) is a significant prognostic factor in tumor recurrence and overall survival in astrocytoma patients. Therefore, STAT3 may provide a potential target for molecular therapy in human astrocytoma, and pSTAT3(Tyr705)could be an important biomarker for astrocytoma prognosis.	[Liang, Qinchuan; Ma, Chenkai; Zhao, Yang; Ma, Jie] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurosurg, Shanghai 200030, Peoples R China; [Liang, Qinchuan; Gao, Guodong] Fourth Mil Med Univ, Inst Funct Neurosurg PLA, Tang Du Hosp, Dept Neurosurg, Xian 710032, Shannxi Provinc, Peoples R China	Shanghai Jiao Tong University; Air Force Military Medical University	Ma, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurosurg, Shanghai 200030, Peoples R China.	majiedoc@126.com	Ma, Chenkai/AAK-4261-2020	Ma, Chenkai/0000-0003-2172-7332	National Nature Science Foundation of China [30901537]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by research grants 30901537 from the National Nature Science Foundation of China. The website is http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; BAARTDEL.EH, 1973, LANCET, V1, P892; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dehdashti Amir R, 2006, Neurosurg Focus, V20, pE6; Hecht M, 2004, CANCER RES, V64, P6109, DOI 10.1158/0008-5472.CAN-04-1014; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Kusaba T, 2006, ONCOL REP, V15, P1445; Liang QC, 2009, CANCER LETT, V273, P164, DOI 10.1016/j.canlet.2008.08.011; Lohr J, 2011, CLIN CANCER RES, V17, P4296, DOI 10.1158/1078-0432.CCR-10-2557; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; Prados MD, 2000, SEMIN ONCOL, V27, pS1; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Rasheed B K, 1999, Curr Opin Oncol, V11, P162; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Xiong H, 2012, J MOL MED, V90, P1037, DOI 10.1007/s00109-012-0869-0; Xiong H, 2009, J CELL MOL MED, V13, P3668, DOI 10.1111/j.1582-4934.2009.00661.x; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158	23	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84723	10.1371/journal.pone.0084723	http://dx.doi.org/10.1371/journal.pone.0084723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386409	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700115
J	Wang, YX; Zeng, X; Peal, L; Tang, YH; Wu, YQ; Mahalingam, R				Wang, Yixing; Zeng, Xin; Peal, Lila; Tang, Yuhong; Wu, Yanqi; Mahalingam, Ramamurthy			Transcriptome Analysis of Nodes and Buds from High and Low Tillering Switchgrass Inbred Lines	PLOS ONE			English	Article							PANICUM-VIRGATUM L.; AXILLARY MERISTEM FORMATION; PLANT DEVELOPMENT; GENE; ARABIDOPSIS; PROTEIN; MAIZE; RICE; ENCODES; BIOMASS	In the last two decades switchgrass has received increasing attention as a promising bioenergy feedstock. Biomass is the principal trait for improvement in switchgrass breeding programs and tillering is an important component of biomass yield. Switchgrass inbred lines derived from a single parent showing vast variation in tiller number trait was used in this study. Axillary buds, which can develop into tillers, and node tissues, which give rise to axillary buds, were collected from high and low tillering inbred lines growing in field conditions. RNA from buds and nodes from the contrasting inbred lines were used for transcriptome profiling with switchgrass Affymetrix genechips. Nearly 7% of the probesets on the genechip exhibited significant differential expression in these lines. Real-time PCR analysis of 30 genes confirmed the differential expression patterns observed with genechips. Cluster analysis aided in identifying probesets unique to high or low tillering lines as well as those specific to buds or nodes of high tillering lines. Rice orthologs of the switchgrass genes were used for gene ontology (GO) analysis with AgriGO. Enrichment of genes associated with amino acid biosynthesis, lipid transport and vesicular transport were observed in low tillering lines. Enrichment of GOs for translation, RNA binding and gene expression in high tillering lines were indicative of active metabolism associated with rapid growth and development. Identification of different classes of transcription factor genes suggests that regulation of many genes determines the complex process of axillary bud initiation and development. Genes identified in this study will complement the current ongoing efforts in quantitative trait loci mapping of tillering in switchgrass.	[Wang, Yixing; Zeng, Xin; Mahalingam, Ramamurthy] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Peal, Lila] Langston Univ, Dept Biol, Langston, OK USA; [Tang, Yuhong] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA; [Wu, Yanqi] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Langston University; Noble Research Institute; Oklahoma State University System; Oklahoma State University - Stillwater	Mahalingam, R (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	ramamurthy.mahalingam@okstate.edu	Mahalingam, Ramamurthy/AAP-5463-2020; Wu, Yanqi/N-8180-2016	Wu, Yanqi/0000-0003-0802-6881; Tang, Yuhong/0000-0003-2967-778X	National Science Foundation [EPS-0814361]	National Science Foundation(National Science Foundation (NSF))	This research was supported by funding from the National Science Foundation under Grant No. EPS-0814361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova KS, 1996, CROP SCI, V36, P1709, DOI 10.2135/cropsci1996.0011183X003600060049x; Angelovici R, 2011, NEW PHYTOL, V189, P148, DOI 10.1111/j.1469-8137.2010.03478.x; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Bhandari HS, 2010, CROP SCI, V50, P2355, DOI 10.2135/cropsci2010.02.0109; Boe A, 2008, CROP SCI, V48, P1306, DOI 10.2135/cropsci2007.08.0482; Boe A, 2007, CROP SCI, V47, P636, DOI 10.2135/cropsci2006.04.0260; Bouton Joe, 2008, P295, DOI 10.1007/978-0-387-70805-8_11; Burko Y, 2011, PLANT CELL PHYSIOL, V52, P518, DOI 10.1093/pcp/pcr007; Busov VB, 2008, NEW PHYTOL, V177, P589, DOI 10.1111/j.1469-8137.2007.02324.x; Dancs G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-65; Das MK, 2004, CROP SCI, V44, P443, DOI 10.2135/cropsci2004.4430; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Vivancos PD, 2010, BIOCHEM J, V431, P169, DOI 10.1042/BJ20100409; DOEBLEY J, 1995, GENETICS, V141, P333; DORWEILER J, 1993, SCIENCE, V262, P233, DOI 10.1126/science.262.5131.233; Dorweiler JE, 1997, AM J BOT, V84, P1313, DOI 10.2307/2446130; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Escamilla-Trevino LL, 2010, NEW PHYTOL, V185, P143, DOI 10.1111/j.1469-8137.2009.03018.x; Fang ZM, 2013, PLANT BIOTECHNOL J, V11, P446, DOI 10.1111/pbi.12031; Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x; Gallavotti A, 2011, PLANT CELL, V23, P1756, DOI 10.1105/tpc.111.084590; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hadfi K, 1998, DEVELOPMENT, V125, P879; Hubbard L, 2002, GENETICS, V162, P1927; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Jarillo JA, 2009, INT J DEV BIOL, V53, P1581, DOI 10.1387/ijdb.072460jj; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kellogg EA, 1997, CURR BIOL, V7, pR411, DOI 10.1016/S0960-9822(06)00204-1; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu L, 2013, MOL BREEDING; Liu LL, 2012, BIOENERG RES, V5, P662, DOI 10.1007/s12155-011-9173-z; Liu LL, 2012, G3-GENES GENOM GENET, V2, P357, DOI 10.1534/g3.111.001503; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Palmer NA, 2011, BIOENERGY RES; Paul P, 2012, FUNCT INTEGR GENOMIC, V12, P291, DOI 10.1007/s10142-012-0264-5; Potocka I, 2012, PLANT CELL REP, V31, P2031, DOI 10.1007/s00299-012-1314-0; Qiu DY, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-74; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Sharma MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033892; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Skirpan A, 2008, PLANT J, V55, P787, DOI 10.1111/j.1365-313X.2008.03546.x; Stasolla C, 2008, PLANTA, V228, P255, DOI 10.1007/s00425-008-0735-z; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; STERK P, 1991, PLANT CELL, V3, P907, DOI 10.1105/tpc.3.9.907; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Surpin M, 2004, NAT REV MOL CELL BIO, V5, P100, DOI 10.1038/nrm1311; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wright L, 2010, BIOMASS BIOENERG, V34, P851, DOI 10.1016/j.biombioe.2010.01.030; Yang DH, 2012, PLANT BIOLOGY, V14, P411, DOI 10.1111/j.1438-8677.2011.00514.x; Yang F, 2012, PLANT J, V71, P61, DOI 10.1111/j.1365-313X.2012.04970.x; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104	66	7	7	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83772	10.1371/journal.pone.0083772	http://dx.doi.org/10.1371/journal.pone.0083772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386276	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700068
J	Fei, D; Krimm, RF				Fei, Da; Krimm, Robin F.			Taste Neurons Consist of Both a Large TrkB-Receptor-Dependent and a Small TrkB-Receptor-Independent Subpopulation	PLOS ONE			English	Article							GENICULATE GANGLION NEURONS; NEUROTROPHIC FACTOR; CHORDA TYMPANI; TARGETED DISRUPTION; FUNGIFORM PAPILLAE; LINGUAL DEFICITS; NEURAL INDUCTION; SENSORY GANGLIA; MESSENGER-RNA; MICE	Brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4) are two neurotrophins that play distinct roles in geniculate (taste) neuron survival, target innervation, and taste bud formation. These two neurotrophins both activate the tropomyosin-related kinase B (TrkB) receptor and the pan-neurotrophin receptor p75. Although the roles of these neurotrophins have been well studied, the degree to which BDNF and NT-4 act via TrkB to regulate taste development in vivo remains unclear. In this study, we compared taste development in TrkB(-/-) and Bdnf(-/-) /Ntf4(-/-) mice to determine if these deficits were similar. If so, this would indicate that the functions of both BDNF and NT-4 can be accounted for by TrkB-signaling. We found that TrkB(-/-) and Bdnf(-/-) /Ntf4(-/-) mice lose a similar number of geniculate neurons by E13.5, which indicates that both BDNF and NT-4 act primarily via TrkB to regulate geniculate neuron survival. Surprisingly, the few geniculate neurons that remain in TrkB(-/-) mice are more successful at innervating the tongue and taste buds compared with those neurons that remain in Bdnf(-/-) /Ntf4(-/-) mice. The remaining neurons in TrkB(-/-) mice support a significant number of taste buds. In addition, these remaining neurons do not express the TrkB receptor, which indicates that either BDNF or NT-4 must act via additional receptors to influence tongue innervation and/or targeting.	[Fei, Da; Krimm, Robin F.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	University of Louisville	Krimm, RF (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	rfkrim01@louisville.edu	Krimm, Robin/AAK-3014-2020		National Institute on Deafness and Communication Disorders [DC009418]; National Institutes of Health [8P30GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009418] Funding Source: NIH RePORTER	National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Communication Disorders grant DC009418 to RFK. The project made use of a statistical core facility supported by National Institutes of Health grant 8P30GM103507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Al-Hadlaq SM, 2003, NEUROSCIENCE, V118, P145, DOI 10.1016/S0306-4522(02)00814-X; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BARKER PA, 1993, J BIOL CHEM, V268, P15150; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cho TT, 1999, MOL BRAIN RES, V68, P1; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; ElShamy WM, 1997, J NEUROSCI, V17, P8667; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Fan LX, 2004, DEV BRAIN RES, V150, P23, DOI 10.1016/j.devbrainres.2004.02.008; Farbman AI, 2004, J NEUROSCI RES, V78, P659, DOI 10.1002/jnr.20297; Farbman AI, 2004, J NEUROCYTOL, V33, P331, DOI 10.1023/B:NEUR.0000044194.71426.ee; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fritzsch B, 1997, INT J DEV NEUROSCI, V15, P563, DOI 10.1016/S0736-5748(96)00111-6; Guagliardo NA, 2007, J COMP NEUROL, V504, P206, DOI 10.1002/cne.21436; Harlow DE, 2011, DEV DYNAM, V240, P309, DOI 10.1002/dvdy.22527; Hoshino N, 2010, DEV NEUROSCI-BASEL, V32, P184, DOI 10.1159/000313902; HOSLEY MA, 1987, J NEUROSCI, V7, P2075; HOSLEY MA, 1987, J COMP NEUROL, V260, P224, DOI 10.1002/cne.902600206; HOSLEY MA, 1987, ANAT RECORD, V218, P216, DOI 10.1002/ar.1092180217; Huang EJ, 2003, ANN REV BIOCH; Ishida Y, 2009, J COMP NEUROL, V514, P131, DOI 10.1002/cne.22000; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Klau M, 2001, J NEUROSCI RES, V66, P327, DOI 10.1002/jnr.10007; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Krimm RF, 2001, DEV BIOL, V232, P508, DOI 10.1006/dbio.2001.0190; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Leoni C, 2002, BIOCHEM BIOPH RES CO, V291, P972, DOI 10.1006/bbrc.2002.6571; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Lopez GF, 2006, J NEUROBIOL, V66, P1033, DOI 10.1002/neu.20289; Luikart BW, 2003, NEUROSCIENCE, V117, P847, DOI 10.1016/S0306-4522(02)00719-4; Ma LQ, 2009, J NEUROSCI, V29, P3354, DOI 10.1523/JNEUROSCI.3970-08.2009; Matsumoto I, 2001, MOL BRAIN RES, V93, P105, DOI 10.1016/S0169-328X(01)00129-2; Mistretta CM, 1999, J COMP NEUROL, V409, P13; Nagato T, 1995, ACTA ANAT, V153, P301; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; Nosrat CA, 1996, J COMP NEUROL, V376, P587, DOI 10.1002/(SICI)1096-9861(19961223)376:4<587::AID-CNE7>3.0.CO;2-Y; NOSRAT CA, 1995, J COMP NEUROL, V360, P698, DOI 10.1002/cne.903600413; Nosrat CA, 1997, DEVELOPMENT, V124, P1333; Nosrat IV, 2004, J NEUROCYTOL, V33, P607, DOI 10.1007/s11068-005-3330-2; Oakley B, 1998, DEV BRAIN RES, V105, P85, DOI 10.1016/S0165-3806(97)00178-8; Patel AV, 2012, DEV BIOL, V365, P50, DOI 10.1016/j.ydbio.2012.02.008; Patel AV, 2010, J COMP NEUROL, V518, P3290, DOI 10.1002/cne.22400; Patel AV, 2010, DEV BIOL, V340, P419, DOI 10.1016/j.ydbio.2010.01.024; Sollars SI, 2005, J NEUROBIOL, V64, P310, DOI 10.1002/neu.20140; Sollars SI, 2002, J NEUROBIOL, V51, P223, DOI 10.1002/neu.10055; Stucky CL, 1998, J NEUROSCI, V18, P7040; Sun H, 2002, DEV BIOL, V242, P31, DOI 10.1006/dbio.2001.0526; Tan PK, 2007, MOL PHARMACOL, V72, P1440, DOI 10.1124/mol.107.039636; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Yamout A, 2005, DEV NEUROSCI-BASEL, V27, P288, DOI 10.1159/000086708; Zaidi FN, 2007, J NEUROSCI, V27, P13875, DOI 10.1523/JNEUROSCI.2517-07.2007	58	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83460	10.1371/journal.pone.0083460	http://dx.doi.org/10.1371/journal.pone.0083460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386206	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900038
J	Li, J; Jiang, R; Liu, WS; Liu, Q; Xu, M; Feng, QS; Chen, LZ; Bei, JX; Chen, MY; Zeng, YX				Li, Jing; Jiang, Rou; Liu, Wen-Sheng; Liu, Qing; Xu, Miao; Feng, Qi-Sheng; Chen, Li-Zhen; Bei, Jin-Xin; Chen, Ming-Yuan; Zeng, Yi-Xin			A Large Cohort Study Reveals the Association of Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio with Favorable Prognosis in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							ABSOLUTE MONOCYTE; SUPPRESSOR-CELLS; POOR SURVIVAL; LUNG-CANCER; COUNT; EXPRESSION; PROSTAGLANDIN; CHEMOTHERAPY; NEUTROPHIL; MELANOMA	Background: Nasopharyngeal carcinoma (NPC) is an endemic neoplasm in southern China. Although NPC sufferers are sensitive to radiotherapy, 20-30% of patients finally progress with recurrence and metastases. Elevated lymphocyte-to-monocyte ratio (LMR) has been reported to be associated with favorable prognosis in some hematology malignancies, but has not been studied in NPC. The aim of this study was to evaluate whether LMR could predict the prognosis of NPC patients. Methods: A retrospective cohort of 1,547 non-metastatic NPC patients was recruited between January 2005 and June 2008. The counts for peripheral lymphocyte and monocyte were retrieved, and the LMR was calculated. Receiver operating characteristic curve analysis, univariate and multivariate COX proportional hazards analyses were applied to evaluate the associations of LMR with overall survival (OS), disease-free survival (DFS), distant metastasis-free survival (DMFS) and loco-regional recurrence-free survival (LRRFS), respectively. Results: Univariate analysis revealed that higher LMR level (>= 5.220) was significantly associated with superior OS, DFS and DMFS (P values <0.001). The higher lymphocyte count (>= 2.145 x 10(9)/L) was significantly associated with better OS (P = 0.002) and DMFS (P = 0.031), respectively, while the lower monocyte count (<0.475 x 10(9)/L) was associated with better OS (P = 0.012), DFS (P = 0.011) and DMFS (P = 0.003), respectively. Multivariate Cox proportional hazard analysis showed that higher LMR level was a significantly independent predictor for superior OS (hazard ratio or HR = 0.558, 95% confidence interval or 95% CI = 0.417-0.748; P<0.001), DFS (HR = 0.669, 95% CI = 0.535-0.838; P<0.001) and DMFS (HR = 0.543, 95% CI = 0.403-0.732; P<0.001), respectively. The advanced T and N stages were also independent indicators for worse OS, DFS, and DMFS, except that T stage showed borderline statistical significance for DFS (P = 0.053) and DMFS (P = 0.080). Conclusions: The elevated pretreatment peripheral LMR level was a significant favorable factor for NPC prognosis and this easily accessed variable may serve as a potent marker to predict the outcomes of NPC patients.	[Li, Jing; Jiang, Rou; Liu, Wen-Sheng; Liu, Qing; Xu, Miao; Feng, Qi-Sheng; Chen, Li-Zhen; Bei, Jin-Xin; Chen, Ming-Yuan; Zeng, Yi-Xin] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jing; Liu, Wen-Sheng; Xu, Miao; Feng, Qi-Sheng; Chen, Li-Zhen; Bei, Jin-Xin; Zeng, Yi-Xin] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Rou; Liu, Qing; Chen, Ming-Yuan] Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Qing] Sun Yat Sen Univ, Dept Epidemiol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, MY (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	chmingy@mail.sysu.edu.cn; zengyix@mail.sysu.edu.cn	Chen, Ming/GVU-8412-2022; Bei, Jin-Xin/AAO-1259-2020; liu, wen/HGE-3071-2022		National Natural Science Foundation of China [81071890]; Fundamental Research Funds for the Central Universities; Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center, China	This work was supported by grants from the National Natural Science Foundation of China (No. 81071890), Fundamental Research Funds for the Central Universities, and Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 1998, HEMATOL ONCOL, V16, P143; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bishara S, 2008, EUR J OBSTET GYN R B, V138, P71, DOI 10.1016/j.ejogrb.2007.05.012; BRUCKNER HW, 1982, JAMA-J AM MED ASSOC, V247, P1004, DOI 10.1001/jama.247.7.1004; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Cordes C, 2011, B-ENT, V7, P43; Dworacki G, 2001, CLIN CANCER RES, V7, p947S; Flavell KJ, 2000, J CLIN PATHOL-MOL PA, V53, P262, DOI 10.1136/mp.53.5.219; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; GOODWIN JS, 1977, J EXP MED, V146, P1719, DOI 10.1084/jem.146.6.1719; GOODWIN JS, 1977, NEW ENGL J MED, V297, P963, DOI 10.1056/NEJM197711032971802; HAN T, 1980, CANCER, V46, P2416, DOI 10.1002/1097-0142(19801201)46:11<2416::AID-CNCR2820461120>3.0.CO;2-G; Hase S, 2011, ONCOL REP, V25, P1455, DOI 10.3892/or.2011.1199; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Hefler L, 1999, BRIT J CANCER, V81, P855, DOI 10.1038/sj.bjc.6690776; Huang JJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-222; HUSSAIN SP, 1994, ONCOGENE, V9, P2277; Katz MH, 2011, MULTIVARIABLE ANAL P, P95; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; LAUGHTER AH, 1977, J IMMUNOL, V119, P173; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li J, 2012, J BIOL CHEM, V287, P35484, DOI 10.1074/jbc.M112.367532; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Licitra L, 2003, CRIT REV ONCOL HEMAT, V45, P199, DOI 10.1016/S1040-8428(01)00210-4; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; NAKAMURA Y, 1988, CARCINOGENESIS, V9, P203, DOI 10.1093/carcin/9.2.203; Naranbhai V, 2013, J INFECT DIS; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porrata LF, 2013, BONE MARROW RES, DOI 10.1155/2013/658371; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; SALIM AS, 1993, INT J CANCER, V53, P1031; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Shen GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036515; Spratt DE, 2012, ONCOTARGETS THER, V5, P297, DOI 10.2147/OTT.S28032; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Sun D, 2012, AM J HEMATOL, V87, P957, DOI 10.1002/ajh.23279; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Torisu-Itakura H, 2007, J IMMUNOTHER, V30, P831, DOI 10.1097/CJI.0b013e318158795b; Tsai YD, 2013, HEAD NECK; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wilcox RA, 2011, LEUKEMIA, V25, P1502, DOI 10.1038/leu.2011.112; Wilcox RA, 2012, LEUKEMIA LYMPHOMA, V53, P575, DOI 10.3109/10428194.2011.637211; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	52	23	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83069	10.1371/journal.pone.0083069	http://dx.doi.org/10.1371/journal.pone.0083069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386144	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900020
J	Wang, GL; Chen, X; Yue, WL; Zhang, H; Li, F; Xiong, MH				Wang, Guangli; Chen, Xiao; Yue, Wenlong; Zhang, Hui; Li, Feng; Xiong, Minghua			Microbial Degradation of Acetamiprid by Ochrobactrum sp D-12 Isolated from Contaminated Soil	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; BACTERIAL STRAIN; METABOLISM; BIOTRANSFORMATION; BIODEGRADATION; PERSISTENCE; METHYL; WATER	Neonicotinoid insecticides are one of the most important commercial insecticides used worldwide. The potential toxicity of the residues present in environment to humans has received considerable attention. In this study, a novel Ochrobactrum sp. strain D-12 capable of using acetamiprid as the sole carbon source as well as energy, nitrogen source for growth was isolated and identified from polluted agricultural soil. Strain D-12 was able to completely degrade acetamiprid with initial concentrations of 0-3000 mg.L-1 within 48 h. Haldane inhibition model was used to fit the special degradation rate at different initial concentrations, and the parameters q(max), K-s and K-i were determined to be 0.6394 (6 h)(-1), 50.96 mg.L-1 and 1879 mg.L-1, respectively. The strain was found highly effective in degrading acetamiprid over a wide range of temperatures (25-35 degrees C) and pH (6-8). The effects of co-substrates on the degradation efficiency of acetamiprid were investigated. The results indicated that exogenously supplied glucose and ammonium chloride could slightly enhance the biodegradation efficiency, but even more addition of glucose or ammonium chloride delayed the biodegradation. In addition, one metabolic intermediate identified as N-methyl-(6-chloro-3-pyridyl)methylamine formed during the degradation of acetamiprid mediated by strain D-12 was captured by LC-MS, allowing a degradation pathway for acetamiprid to be proposed. This study suggests the bacterium could be a promising candidate for remediation of environments affected by acetamiprid.	[Wang, Guangli; Chen, Xiao; Yue, Wenlong; Zhang, Hui; Li, Feng; Xiong, Minghua] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China	Huaibei Normal University	Wang, GL (corresponding author), Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China.	wanf-3344@163.com			National Natural Science Foundation, P. R. China [31100083]	National Natural Science Foundation, P. R. China(National Natural Science Foundation of China (NSFC))	The authors would like to thank the financial support from the National Natural Science Foundation (No. 31100083), P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; Arther RG, 1997, AM J VET RES, V58, P848; Brunet JL, 2005, PEST MANAG SCI, V61, P742, DOI 10.1002/ps.1046; Cai S, 2013, BIORESOURCE TECHNOL, V130, P536, DOI 10.1016/j.biortech.2012.12.095; Chen SH, 2013, BIORESOURCE TECHNOL, V132, P16, DOI 10.1016/j.biortech.2013.01.002; Chen T, 2008, BIODEGRADATION, V19, P651, DOI 10.1007/s10532-007-9170-2; Dai YJ, 2010, J AGR FOOD CHEM, V58, P2419, DOI 10.1021/jf903787s; Dai YJ, 2010, BIORESOURCE TECHNOL, V101, P3838, DOI 10.1016/j.biortech.2010.01.069; Danko AS, 2004, APPL ENVIRON MICROB, V70, P6092, DOI 10.1128/AEM.70.10.6092-6097.2004; Fan XJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-33; Fitzgerald J, 2004, CROP PROT, V23, P801, DOI 10.1016/j.cropro.2003.12.005; Ford KA, 2008, J AGR FOOD CHEM, V56, P10168, DOI 10.1021/jf8020909; Holt JG, 1994, BERGEYS MANUAL DETER; Hu JY, 2003, RES MICROBIOL, V154, P623, DOI 10.1016/j.resmic.2003.09.004; Jacobs DE, 1997, AM J VET RES, V58, P1260; Khan MZ, 2011, BIORESOURCE TECHNOL, V102, P7016, DOI 10.1016/j.biortech.2011.04.057; Kim YM, 2004, J AGR FOOD CHEM, V52, P4192, DOI 10.1021/jf040047u; Liang B, 2010, CURR MICROBIOL, V61, P226, DOI 10.1007/s00284-010-9603-8; Luo W, 2008, J HAZARD MATER, V158, P208, DOI 10.1016/j.jhazmat.2008.02.115; Miller S.A., 1988, NUCLEIC ACIDS RES, V16, P3, DOI [10.1093/nar/16.3.1215, DOI 10.1093/NAR/16.3.1215]; Pramanik SK, 2006, B ENVIRON CONTAM TOX, V76, P356, DOI 10.1007/s00128-006-0929-7; Qiao L, 2010, J HAZARD MATER, V176, P220, DOI 10.1016/j.jhazmat.2009.11.016; Qiu XH, 2006, J APPL MICROBIOL, V101, P986, DOI 10.1111/j.1365-2672.2006.03016.x; Quan XC, 2001, ACTA SCIENTIAE CIRCU, V21, P416; Sanyal D, 2008, B ENVIRON CONTAM TOX, V81, P365, DOI 10.1007/s00128-008-9479-5; Seccia S, 2005, ANAL CHIM ACTA, V553, P21, DOI 10.1016/j.aca.2005.08.006; Sharma A, 2008, B ENVIRON CONTAM TOX, V81, P12, DOI 10.1007/s00128-008-9437-2; Singh DK, 2008, CHEMOSPHERE, V71, P412, DOI 10.1016/j.chemosphere.2007.11.005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HZ, 2012, PROCESS BIOCHEM, V47, P1820, DOI 10.1016/j.procbio.2012.06.008; Tomizawa M, 2000, J AGR FOOD CHEM, V48, P6016, DOI 10.1021/jf000873c; Veeranagouda Y, 2006, APPL MICROBIOL BIOT, V71, P369, DOI 10.1007/s00253-005-0157-9; Wang GL, 2013, BIORESOURCE TECHNOL, V138, P359, DOI 10.1016/j.biortech.2013.03.193; Wang JQ, 2012, APPL MICROBIOL BIOT, V93, P831, DOI 10.1007/s00253-011-3435-8; Wang JL, 2002, PROCESS BIOCHEM, V37, P831; Wen QX, 2010, J HAZARD MATER, V175, P955, DOI 10.1016/j.jhazmat.2009.10.102; Xiong RL, 2009, J TSINGHUA U SCI TEC, V49, P826; Yamamoto I., 1999, NICOTINOID INSECTICI; Yao XH, 2006, J ENVIRON SCI-CHINA, V18, P141; Yao XH, 2006, EUR J SOIL BIOL, V42, P120, DOI 10.1016/j.ejsobi.2005.12.001; Zhao YJ, 2009, BIODEGRADATION, V20, P761, DOI 10.1007/s10532-009-9264-0; Ziagova M, 2009, J HAZARD MATER, V163, P383, DOI 10.1016/j.jhazmat.2008.06.102	42	17	18	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82603	10.1371/journal.pone.0082603	http://dx.doi.org/10.1371/journal.pone.0082603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386105	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900012
J	Won, JC; Lee, YJ; Kim, JM; Han, SY; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Won, Jong Chul; Lee, Yun Jeong; Kim, Jung Min; Han, Sang Youb; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Prevalence of and Factors Associated with Albuminuria in the Korean Adult Population: The 2011 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; GENERAL-POPULATION; RISK-FACTORS; METABOLIC SYNDROME; US POPULATION; MICROALBUMINURIA; EXCRETION; HYPERTENSION; PROTEINURIA	Background: Microalbuminuria is associated with increased risk of renal disease and cardiovascular diseases even in nondiabetic subjects. High incidence rates of microalbuminuria have been found in a number of population-based studies. However, the prevalence and risk factors associated with microalbuminuria in the general population in Korea are unclear. Objectives: The present study was performed to estimate the prevalence of microalbuminuria and investigate the associated risk factors in the general adult population using the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2) data from 2011. Methods: A total of 5,202 participants (mean age, 45.6 years; men, 2,337; women, 2,865) were included in the analysis. Microalbuminuria was evaluated in participants of KNHANES V-2 based on the urine albumin-creatinine ratio. Estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease study equation. Results: The weighted prevalence of microalbuminuria was 5.2% (95% CI, 4.4-6.1) in the general population. The prevalence of albuminuria is increased with age. After adjustment for age and sex, the presence of albuminuria was associated with increased waist circumference, systolic and diastolic blood pressure, aspartate aminotransferase, triglyceride, fasting plasma glucose, and the presence of hypertension and diabetes. In logistic regression analyses, older age, female sex, diabetes, hypertension, and serum aspartate aminotransferase were independently associated with the presence of albuminuria. Conclusion: The prevalence of microalbuminuria was found to be 5.2%, and conventional risk factors for cardiovascular diseases are closely related to the presence of microalbuminuria in Korea. Microalbuminuria may be a useful marker to identify individuals with increased risk of cardiovascular disease.	[Won, Jong Chul; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Dept Internal Med, Sanggye Paik Hosp, Cardiovasc & Metab Dis Ctr,Coll Med, Seoul, South Korea; [Lee, Yun Jeong; Han, Sang Youb; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea	Inje University; Inje University	Kim, DJ (corresponding author), Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/ABD-9067-2021; Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515; Won, Jong Chul/0000-0002-2219-4083; Kim, Jung Min/0000-0002-1848-3747	Inje Research and Scholarship Foundation	Inje Research and Scholarship Foundation	This work was supported by the Inje Research and Scholarship Foundation in 2013 (DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Asselbergs FW, 2004, INT J CARDIOL, V93, P211, DOI 10.1016/j.ijcard.2003.04.001; Atkins RC, 2004, KIDNEY INT, V66, pS22, DOI 10.1111/j.1523-1755.2004.09206.x; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Belasco AG, 2002, AM J KIDNEY DIS, V39, P805, DOI 10.1053/ajkd.2002.32001; Borch-Johnsen K, 1999, ARTERIOSCL THROM VAS, V19, P1992, DOI 10.1161/01.ATV.19.8.1992; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Choi HS, 2006, CLIN NEPHROL, V65, P256; CONNELL SJ, 1994, DIABETIC MED, V11, P32, DOI 10.1111/j.1464-5491.1994.tb00226.x; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; de Jong PE, 2003, NEPHROL DIAL TRANSPL, V18, P10, DOI 10.1093/ndt/18.1.10; Farah SE, 2006, J PEDIATR ENDOCR MET, V19, P937; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Imanishi M, 1999, DIABETOLOGIA, V42, P999, DOI 10.1007/s001250051259; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Kesteloot H, 1996, J HUM HYPERTENS, V10, P245; 임수, 2009, Diabetes and Metabolism Journal, V33, P48; Kim J, 2013, J HUM NUTR DIET, V26, P171, DOI 10.1111/jhn.12098; Kim YI, 2001, DIABETES RES CLIN PR, V52, P145, DOI 10.1016/S0168-8227(01)00228-5; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; MacIsaac RJ, 2006, DIABETES CARE, V29, P1560, DOI 10.2337/dc05-1788; Marin R, 2006, J AM SOC NEPHROL, V17, pS178, DOI 10.1681/ASN.2006080912; Nettleton JA, 2008, AM J CLIN NUTR, V87, P1825, DOI 10.1093/ajcn/87.6.1825; Sato M, 2012, CLIN EXP NEPHROL, V16, P147, DOI 10.1007/s10157-011-0539-5; Son JW, 2012, AM J CARDIOL, V110, P1434, DOI 10.1016/j.amjcard.2012.07.006; Tanaka Satoru, 2013, BMC Res Notes, V6, P256, DOI 10.1186/1756-0500-6-256; TUCKER BJ, 1992, KIDNEY INT, V42, P1160, DOI 10.1038/ki.1992.400; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009	37	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83273	10.1371/journal.pone.0083273	http://dx.doi.org/10.1371/journal.pone.0083273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386169	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900029
J	Xue, M; Fang, YF; Sun, GM; Zhuo, W; Zhong, J; Qian, CJ; Wang, L; Wang, LJ; Si, JM; Chen, SJ				Xue, Meng; Fang, Yanfei; Sun, Guoming; Zhuo, Wei; Zhong, Jing; Qian, Cuijuan; Wang, Lan; Wang, Liangjing; Si, Jianmin; Chen, Shujie			IGFBP3, a Transcriptional Target of Homeobox D10, Is Correlated with the Prognosis of Gastric Cancer	PLOS ONE			English	Article							FACTOR BINDING PROTEIN-3; HOX GENE-FUNCTION; EXPRESSION; METASTASIS; CELLS; IDENTIFICATION; MIGRATION; INVASION; RECEPTOR; METHYLATION	Homeobox D10 (HoxD10) plays important roles in the differentiation of embryonic cells and progression of breast cancer. Our previous report revealed that insulin-like growth factor binding protein-3 (IGFBP3) was regulated by HoxD10 in gastric cancer cells; however, the functional roles and underlying mechanisms of IGFBP3 in gastric cancer remain unclear. Here, we found that the expression of IGFBP3 were upregulated after ectopic expression of HoxD10 in gastric cancer cells. Chromatin immunoprecipitation assay showed that HoxD10 bound to three potential regions of IGFBP3 promoter. Exogenous HoxD10 significantly enhanced the activity of luciferase reporter containing these binding regions in gastric cancer cells. Further data showed that all of these binding sites had Hox binding element "TTAT". Immunohistochemical staining results revealed that IGFBP3 expression was significantly downregulated in 86 gastric adenocarcinomas tissues relative to their adjacent non-cancerous tissues (p<0.001). Moreover, IGFBP3 expression was significantly lower in gastric tumor with lymph node metastasis compared with that without lymph node metastasis (p=0.045). Patients with high expression level of IGFBP3 showed favorable 5 year overall survival (p=0.011). Knockdown of IGFBP3 accelerated gastric cancer cell migration and invasion and induced the expression of invasive factors including MMP14, uPA and uPAR. Thus, our data suggest that HoxD10-targeted gene IGFBP3 may suppress gastric cancer cell invasion and favors the survival of gastric cancer patients.	[Xue, Meng; Fang, Yanfei; Qian, Cuijuan; Wang, Lan; Si, Jianmin; Chen, Shujie] Zhejiang Univ, Sir Runrun Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Xue, Meng; Fang, Yanfei; Sun, Guoming; Zhuo, Wei; Zhong, Jing; Qian, Cuijuan; Wang, Lan; Wang, Liangjing; Si, Jianmin; Chen, Shujie] Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Guoming; Zhong, Jing; Wang, Liangjing] Zhejiang Univ, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Chen, SJ (corresponding author), Zhejiang Univ, Sir Runrun Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	sijm@zju.edu.cn; chensj77@hotmail.com			National Natural Science Foundation of China [81302070, 81272678, 81071961]; National Basic Research Program of China (973 Program) [2012CB945004]; Research Fund for the Doctoral Program of Higher Education of China [20100101110126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (81302070, 81272678, 81071961) (http://www.nsfc.gov.cn), National Basic Research Program of China (973 Program) (2012CB945004) (www.973.gov.cn) and Research Fund for the Doctoral Program of Higher Education of China (20100101110126) (www.cutech.edu.cn/cn/kyjj). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Alpizar-Alpizar W, 2012, INT J CANCER, V131, pE329, DOI 10.1002/ijc.26417; Breitinger C, 2012, BLOOD, V120, P4018, DOI 10.1182/blood-2011-10-384685; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chen HY, 2012, CANCER SCI, V103, P73, DOI 10.1111/j.1349-7006.2011.02129.x; De Bruyne E, 2010, BLOOD, V115, P2430, DOI 10.1182/blood-2009-07-232801; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galant R, 2002, DEVELOPMENT, V129, P3115; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Gigek CO, 2010, GROWTH HORM IGF RES, V20, P234, DOI 10.1016/j.ghir.2010.02.005; Graziano F, 2010, PHARMACOGENOMICS, V11, P1247, DOI 10.2217/PGS.10.92; Hedlund E, 2004, J NEUROSCI RES, V75, P307, DOI 10.1002/jnr.10844; Howlader N, 2012, SEER CANC STAT REV; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Lee DY, 2002, BIOCHEM BIOPH RES CO, V294, P480, DOI 10.1016/S0006-291X(02)00491-6; Lei H, 2006, P NATL ACAD SCI USA, V103, P10305, DOI 10.1073/pnas.0603552103; Li AQ, 2010, ONCOL REP, V23, P1247, DOI 10.3892/or_00000757; Liu BR, 2005, CLIN CANCER RES, V11, P4851, DOI 10.1158/1078-0432.CCR-04-2160; Liu WW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-45; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Oh SH, 2012, CANCER SCI, V103, P1259, DOI 10.1111/j.1349-7006.2012.02301.x; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Thomas ZI, 2011, BRIT J CANCER, V104, P1575, DOI 10.1038/bjc.2011.133; Tomii K, 2007, INT J CANCER, V120, P566, DOI 10.1002/ijc.22341; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Wang LJ, 2012, MOL MED, V18, P389, DOI 10.2119/molmed.2011.00172; Xiang ZL, 2011, ONCOLOGIST, V16, P1028, DOI 10.1634/theoncologist.2010-0358; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yi HK, 2005, BIOCHEM BIOPH RES CO, V330, P760, DOI 10.1016/j.bbrc.2005.03.045; Zacchetti G, 2007, DEVELOPMENT, V134, P3967, DOI 10.1242/dev.010991; Zhang ZW, 2004, CANCER CAUSE CONTROL, V15, P211, DOI 10.1023/B:CACO.0000019510.96285.e9; Zhao CH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-224; Zhong J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-290	45	24	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e81423	10.1371/journal.pone.0081423	http://dx.doi.org/10.1371/journal.pone.0081423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386080	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900004
J	Zhang, JF; Xue, CY; Zhu, TQ; Vivekanandan, A; Pennathur, S; Ma, ZA; Chen, YE				Zhang, Jifeng; Xue, Changyong; Zhu, Tianqing; Vivekanandan, Anuradha; Pennathur, Subramaniam; Ma, Zhongmin Alex; Chen, Y. Eugene			A Tripeptide Diapin Effectively Lowers Blood Glucose Levels in Male Type 2 Diabetes Mice by Increasing Blood Levels of Insulin and GLP-1	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN HYDROLYSATE; AMINO-ACID; PLASMA-INSULIN; CO-INGESTION; FATTY-ACIDS; SECRETION; CARBOHYDRATE; HORMONE; TRANSCRIPTION	The prevalence of type 2 diabetes (T2D) is rapidly increasing worldwide. Effective therapies, such as insulin and Glucagon-like peptide-1 (GLP-1), require injections, which are costly and result in less patient compliance. Here, we report the identification of a tripeptide with significant potential to treat T2D. The peptide, referred to as Diapin, is comprised of three natural L-amino acids, GlyGlyLeu. Glucose tolerance tests showed that oral administration of Diapin effectively lowered blood glucose after oral glucose loading in both normal C57BL/6J mice and T2D mouse models, including KKay, db/db, ob/ob mice, and high fat diet-induced obesity/T2D mice. In addition, Diapin treatment significantly reduced casual blood glucose in KKay diabetic mice in a time-dependent manner without causing hypoglycemia. Furthermore, we found that plasma GLP-1 and insulin levels in diabetic models were significantly increased with Diapin treatment compared to that in the controls. In summary, our findings establish that a peptide with minimum of three amino acids can improve glucose homeostasis and Diapin shows promise as a novel pharmaceutical agent to treat patients with T2D through its dual effects on GLP-1 and insulin secretion.	[Zhang, Jifeng; Xue, Changyong; Zhu, Tianqing; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Vivekanandan, Anuradha; Pennathur, Subramaniam] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ma, Zhongmin Alex] Diapin Therapeut Ltd Liabil Co, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	echunum@umich.edu			National Institutes of Health [HL068878]; University of Michigan of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is partially supported by grant from National Institutes of Health (HL068878 to Y.E.C.) and startup fund at University of Michigan of Michigan for Y.E.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Chatterjee S, 2012, ANN INTERN MED, V157, DOI 10.7326/0003-4819-157-2-201207170-02013; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG1366, DOI 10.1152/ajpgi.00516.2006; Cordier-Bussat M, 1998, DIABETES, V47, P1038, DOI 10.2337/diabetes.47.7.1038; Diakogiannaki E, 2012, PHYSIOL BEHAV, V106, P387, DOI 10.1016/j.physbeh.2011.12.001; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Ganapathy V, 1996, Curr Opin Nephrol Hypertens, V5, P395, DOI 10.1097/00041552-199609000-00003; GANNON MC, 1992, METABOLISM, V41, P1137, DOI 10.1016/0026-0495(92)90300-Y; Gannon MC, 1998, DIABETES CARE, V21, P16, DOI 10.2337/diacare.21.1.16; Garber Alan J, 2011, Rev Diabet Stud, V8, P307, DOI 10.1900/RDS.2011.8.307; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hira T, 2009, AM J PHYSIOL-GASTR L, V297, pG663, DOI 10.1152/ajpgi.90635.2008; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; IKEDA H, 1994, DIABETES RES CLIN PR, V24, pS313, DOI 10.1016/0168-8227(94)90268-2; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jin TR, 1996, MOL CELL BIOL, V16, P19; Le Neve B, 2011, REGUL PEPTIDES, V167, P14, DOI 10.1016/j.regpep.2010.10.010; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Leibach FH, 1996, ANNU REV NUTR, V16, P99, DOI 10.1146/annurev.nu.16.070196.000531; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Ma J, 2009, DIABETES CARE, V32, P1600, DOI 10.2337/dc09-0723; Ma ZM, 2002, AM J PHYSIOL-ENDOC M, V282, pE820, DOI 10.1152/ajpendo.00165.2001; Manders RJF, 2006, DIABETES CARE, V29, P2721, DOI 10.2337/dc06-1424; Manders RJ, 2006, J NUTR, V136, P1294, DOI 10.1093/jn/136.5.1294; Manders RJF, 2005, AM J CLIN NUTR, V82, P76, DOI 10.1093/ajcn/82.1.76; NUTTALL FQ, 1985, J AM COLL NUTR, V4, P437, DOI 10.1080/07315724.1985.10720086; NUTTALL FQ, 1984, DIABETES CARE, V7, P465, DOI 10.2337/diacare.7.5.465; Okazaki M, 2002, EXP ANIM TOKYO, V51, P191, DOI 10.1538/expanim.51.191; PALLOTTA JA, 1968, METABOLISM, V17, P901, DOI 10.1016/0026-0495(68)90156-X; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; RABINOWITZ D, 1966, LANCET, V2, P454; Reddi A S, 1988, Adv Exp Med Biol, V246, P7; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Silk DBA, 2008, CIB FDN S 50 PEPT TR, P15; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Thomsen C, 1999, AM J CLIN NUTR, V69, P1135; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Vaag AA, 1996, EUR J ENDOCRINOL, V135, P425, DOI 10.1530/eje.0.1350425; van Loon LJC, 2000, J NUTR, V130, P2508, DOI 10.1093/jn/130.10.2508; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Verspohl EJ, 2012, PHARMACOL REV, V64, P188, DOI 10.1124/pr.110.003319	49	5	5	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83509	10.1371/journal.pone.0083509	http://dx.doi.org/10.1371/journal.pone.0083509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386218	gold, Green Submitted, Green Published			2022-12-27	WOS:000329117900041
J	Tari, LW; Li, XM; Trzoss, M; Bensen, DC; Chen, ZY; Lam, T; Zhang, JH; Lee, SJ; Hough, G; Phillipson, D; Akers-Rodriguez, S; Cunningham, ML; Kwan, BP; Nelson, KJ; Castellano, A; Locke, JB; Brown-Driver, V; Murphy, TM; Ong, VS; Pillar, CM; Shinabarger, DL; Nix, J; Lightstone, FC; Wong, SE; Nguyen, TB; Shaw, KJ; Finn, J				Tari, Leslie W.; Li, Xiaoming; Trzoss, Michael; Bensen, Daniel C.; Chen, Zhiyong; Thanh Lam; Zhang, Junhu; Lee, Suk Joong; Hough, Grayson; Phillipson, Doug; Akers-Rodriguez, Suzanne; Cunningham, Mark L.; Kwan, Bryan P.; Nelson, Kirk J.; Castellano, Amanda; Locke, Jeff B.; Brown-Driver, Vickie; Murphy, Timothy M.; Ong, Voon S.; Pillar, Chris M.; Shinabarger, Dean L.; Nix, Jay; Lightstone, Felice C.; Wong, Sergio E.; Nguyen, Toan B.; Shaw, Karen J.; Finn, John			Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents	PLOS ONE			English	Article							TOPOISOMERASE-IV PARE; GYRASE B GYRB; DNA GYRASE; PYRROLOPYRIMIDINE INHIBITORS; OPTIMIZATION; DISCOVERY; ANTIBIOTICS; VALIDATION; POTENT	Increasing resistance to every major class of antibiotics and a dearth of novel classes of antibacterial agents in development pipelines has created a dwindling reservoir of treatment options for serious bacterial infections. The bacterial type IIA topoisomerases, DNA gyrase and topoisomerase IV, are validated antibacterial drug targets with multiple prospective drug binding sites, including the catalytic site targeted by the fluoroquinolone antibiotics. However, growing resistance to fluoroquinolones, frequently mediated by mutations in the drug-binding site, is increasingly limiting the utility of this antibiotic class, prompting the search for other inhibitor classes that target different sites on the topoisomerase complexes. The highly conserved ATP-binding subunits of DNA gyrase (GyrB) and topoisomerase IV (ParE) have long been recognized as excellent candidates for the development of dual-targeting antibacterial agents with broad-spectrum potential. However, to date, no natural product or small molecule inhibitors targeting these sites have succeeded in the clinic, and no inhibitors of these enzymes have yet been reported with broad-spectrum antibacterial activity encompassing the majority of Gram-negative pathogens. Using structure-based drug design (SBDD), we have created a novel dual-targeting pyrimidoindole inhibitor series with exquisite potency against GyrB and ParE enzymes from a broad range of clinically important pathogens. Inhibitors from this series demonstrate potent, broad-spectrum antibacterial activity against Gram-positive and Gram-negative pathogens of clinical importance, including fluoroquinolone resistant and multidrug resistant strains. Lead compounds have been discovered with clinical potential; they are well tolerated in animals, and efficacious in Gram-negative infection models.	[Tari, Leslie W.; Li, Xiaoming; Trzoss, Michael; Bensen, Daniel C.; Chen, Zhiyong; Thanh Lam; Zhang, Junhu; Lee, Suk Joong; Hough, Grayson; Phillipson, Doug; Akers-Rodriguez, Suzanne; Cunningham, Mark L.; Kwan, Bryan P.; Nelson, Kirk J.; Castellano, Amanda; Locke, Jeff B.; Brown-Driver, Vickie; Ong, Voon S.; Shaw, Karen J.; Finn, John] Trius Therapeut, San Diego, CA USA; [Murphy, Timothy M.] ViviSource Labs, Waltham, MA USA; [Pillar, Chris M.; Shinabarger, Dean L.] Micromyx LLC, Kalamazoo, MI USA; [Nix, Jay] Beamline 4 2 2, Adv Light Source, Berkeley, CA USA; [Lightstone, Felice C.; Wong, Sergio E.; Nguyen, Toan B.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Tari, LW (corresponding author), Trius Therapeut, San Diego, CA USA.	ltari@triusrx.com; jfinn@triusrx.com		Shaw, Karen/0000-0003-3060-1328; Nelson, Kirk/0000-0003-1160-5251	U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344, LLNL-JRNL-565619]; National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services [HHSN272200800042C]	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Part of this work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344, LLNL-JRNL-565619. This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200800042C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum PC, 2000, INT J ANTIMICROB AG, V16, P5, DOI 10.1016/S0924-8579(00)00192-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellon S, 2004, ANTIMICROB AGENTS CH, V48, P1856, DOI 10.1128/AAC.48.5.1856-1864.2004; Bensen D., 2012, WO Patent WO, Patent No. [2012125746 (A1), 2012125746, WO/2012/125746]; Boehm HJ, 2000, J MED CHEM, V43, P2664, DOI 10.1021/jm000017s; Ceccarelli M, 2008, CURR DRUG TARGETS, V9, P779, DOI 10.2174/138945008785747770; Charifson PS, 2008, J MED CHEM, V51, P5243, DOI 10.1021/jm800318d; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Cunningham ML, 2013, J BIOMOL SCREEN, V18, P1018, DOI 10.1177/1087057113487208; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Eakin AE, 2012, ANTIMICROB AGENTS CH, V56, P1240, DOI 10.1128/AAC.05485-11; East SP, 2009, BIOORG MED CHEM LETT, V19, P894, DOI 10.1016/j.bmcl.2008.11.102; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Grossman TH, 2007, ANTIMICROB AGENTS CH, V51, P657, DOI 10.1128/AAC.00596-06; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Lafitte D, 2002, BIOCHEMISTRY-US, V41, P7217, DOI 10.1021/bi0159837; Lambert HP, 1992, COUMARINS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOINT CCP4 ESF EAMBC, V26; Liao CZ, 2009, J CHEM INF MODEL, V49, P2801, DOI 10.1021/ci900289x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mani N, 2006, ANTIMICROB AGENTS CH, V50, P1228, DOI 10.1128/AAC.50.4.1228-1237.2006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NIKAIDO H, 1993, ANTIMICROB AGENTS CH, V37, P1393, DOI 10.1128/AAC.37.7.1393; Oblak M, 2007, CURR MED CHEM, V14, P2033; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Sissi C, 2010, CELL MOL LIFE SCI, V67, P2001, DOI 10.1007/s00018-010-0299-5; Trzoss M, 2013, BIOORG MED CHEM LETT, V23, P1537, DOI 10.1016/j.bmcl.2012.11.073; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	38	66	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84409	10.1371/journal.pone.0084409	http://dx.doi.org/10.1371/journal.pone.0084409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386374	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700105
J	Wang, W; He, M; Zhou, MW; Zhang, XL				Wang, Wei; He, Miao; Zhou, Minwen; Zhang, Xiulan			Fornix-Based versus Limbus-Based Conjunctival Flap in Trabeculectomy: A Quantitative Evaluation of the Evidence	PLOS ONE			English	Article							INTRAOPERATIVE MITOMYCIN-C; FILTERING SURGERY; COMBINED PHACOEMULSIFICATION; CATARACT-SURGERY; FELLOW-EYES; GLAUCOMA; METAANALYSIS; PHACOTRABECULECTOMY; COMPLICATIONS; OUTCOMES	Objective: To evaluate the efficacy and tolerability of limbus-based (LBCF) compared with fornix-based conjunctival flaps (FBCF) for trabeculectomy in the treatment of patients with uncontrolled glaucoma. Methods: A comprehensive literature meta-analysis was performed according to the Cochrane Collaboration methodology to identify controlled clinical trials comparing LBCF with FBCF in trabeculectomy. The efficacy measures were the weighted mean differences (WMDs) for intraocular pressure reduction (IOPR), the reduction in glaucoma medications, and the relative risks (RRs) for success rates. Tolerability estimates were measured by RR for adverse events. The pooled effects were calculated using the random effects model. Results: Sixteen controlled clinical trials meeting the predefined criteria were included in the meta-analysis. A total of 1,825 eyes from 1,392 patients with medically uncontrolled glaucoma were included. The WMD of the IOPR from baseline was 1.12 (95% CI: 20.88 to 3.12) when comparing LBCF with FBCF. LBCF was associated with numerically greater but nonsignificant IOP lowering efficacy than FBCF (P = 0.270). LBCF was comparable with FBCF in the reduction of glaucoma medication, with a WMD of 0.15 (20.05 to 0.36) at the follow-up endpoint (P = 0.141). The pooled RR comparing LBCF with FBCF were 1.08 (0.94, 1.23) for the complete success rate and 1.01 (0.92, 1.10) for the qualified success rate. Rates of adverse events did not differ significantly between LBCF and FBCF. Conclusions: There is no significant difference in IOP lowering, number of glaucoma medications, or proportion of patients who reached the IOP target between LBCF and FBCF trabeculectomy. Both incision techniques may contribute equally to adverse events.	[Wang, Wei; He, Miao; Zhou, Minwen; Zhang, Xiulan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn			National Natural Science Foundation of China [81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81371008). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwitry A, 2005, EYE, V19, P631, DOI 10.1038/sj.eye.6701587; Auw-Haedrich C, 1998, OPHTHALMIC SURG LAS, V29, P575; Babushkin AE, 1990, OFTALMOLOGICHESKII Z, P280; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berestka JS, 1997, OPHTHALMOLOGY, V104, P187, DOI 10.1016/S0161-6420(97)30335-2; BRINCKER P, 1992, ACTA OPHTHALMOL, V70, P641; Cheng YC, 2012, INT EYE SCI, V12, P2405; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding Qiong, 2008, Yan Ke Xue Bao, V24, P35; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Sayyad F, 1999, J GLAUCOMA, V8, P124; Fukuchi T, 2006, JPN J OPHTHALMOL, V50, P338, DOI 10.1007/s10384-005-0323-8; Gdih GA, 2011, OPHTHALMOLOGY, V118, P71, DOI 10.1016/j.ophtha.2010.04.008; GREHN F, 1989, INT OPHTHALMOL, V13, P139, DOI 10.1007/BF02028654; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Khan A. M., 1992, Indian Journal of Ophthalmology, V40, P41; Kohl Douglas A., 2005, International Ophthalmology Clinics, V45, P107, DOI 10.1097/01.iio.0000176369.93887.65; Kozobolis VP, 2002, J CATARACT REFR SURG, V28, P1758, DOI 10.1016/S0886-3350(02)01270-1; Lemon LC, 1998, AM J OPHTHALMOL, V125, P340, DOI 10.1016/S0002-9394(99)80144-5; Lin YPK, 2007, OPHTHAL SURG LAS IM, V38, P471, DOI 10.3928/15428877-20071101-05; Lin ZJ, 2012, J OCUL PHARMACOL TH, V28, P166, DOI 10.1089/jop.2011.0117; Mandic Z, 2004, CROAT MED J, V45, P275; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Morita K, 2012, J GLAUCOMA, V21, P383, DOI 10.1097/IJG.0b013e3182120a08; MURCHISON JF, 1990, AM J OPHTHALMOL, V109, P709, DOI 10.1016/S0002-9394(14)72441-9; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Razeghinejad MR, 2012, SURV OPHTHALMOL, V57, P1, DOI 10.1016/j.survophthal.2011.07.005; REICHERT R, 1987, OPHTHALMIC SURG LAS, V18, P672; Shingleton BJ, 1999, OPHTHALMOLOGY, V106, P1152, DOI 10.1016/S0161-6420(99)90252-X; SHUSTER JN, 1984, ARCH OPHTHALMOL-CHIC, V102, P361, DOI 10.1001/archopht.1984.01040030279018; Solus JF, 2012, OPHTHALMOLOGY, V119, P703, DOI 10.1016/j.ophtha.2011.09.046; Song M S, 1996, Korean J Ophthalmol, V10, P97; STEWART WC, 1994, DOC OPHTHALMOL, V88, P141, DOI 10.1007/BF01204611; Suhr AW, 2012, J GLAUCOMA, V21, P523, DOI 10.1097/IJG.0b013e318227a565; Tezel G, 1997, OPHTHALMIC SURG LAS, V28, P551; TRAVERSO CE, 1987, AM J OPHTHALMOL, V104, P28, DOI 10.1016/0002-9394(87)90289-3; Wang W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063591, 10.1155/2013/758750, 10.1371/journal.pone.0076538]; Wells AP, 2003, OPHTHALMOLOGY, V110, P2192, DOI 10.1016/S0161-6420(03)00800-5	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83656	10.1371/journal.pone.0083656	http://dx.doi.org/10.1371/journal.pone.0083656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386246	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700067
J	Zhang, YJ; Zhu, TT; Wang, LN; Pan, YH; Zhang, SY				Zhang, Yijian; Zhu, Tengteng; Wang, Lina; Pan, Yi-Hsuan; Zhang, Shuyi			Homocysteine Homeostasis and Betaine-Homocysteine S-Methyltransferase Expression in the Brain of Hibernating Bats	PLOS ONE			English	Article							FOLIC-ACID; MAMMALIAN HIBERNATION; TAU-PHOSPHORYLATION; GENE-EXPRESSION; METABOLISM; MECHANISMS; FOLATE; VITAMIN-B12; SYNTHASE; NEURONS	Elevated homocysteine is an important risk factor that increases cerebrovascular and neurodegenerative disease morbidity. In mammals, B vitamin supplementation can reduce homocysteine levels. Whether, and how, hibernating mammals, that essentially stop ingesting B vitamins, maintain homocysteine metabolism and avoid cerebrovascular impacts and neurodegeneration remain unclear. Here, we compare homocysteine levels in the brains of torpid bats, active bats and rats to identify the molecules involved in homocysteine homeostasis. We found that homocysteine does not elevate in torpid brains, despite declining vitamin B levels. At low levels of vitamin B6 and B12, we found no change in total expression level of the two main enzymes involved in homocysteine metabolism (methionine synthase and cystathionine beta-synthase), but a 1.85-fold increase in the expression of the coenzyme-independent betaine-homocysteine S-methyltransferase (BHMT). BHMT expression was observed in the amygdala of basal ganglia and the cerebral cortex where BHMT levels were clearly elevated during torpor. This is the first report of BHMT protein expression in the brain and suggests that BHMT modulates homocysteine in the brains of hibernating bats. BHMT may have a neuroprotective role in the brains of hibernating mammals and further research on this system could expand our biomedical understanding of certain cerebrovascular and neurodegenerative disease processes.	[Zhang, Yijian; Zhu, Tengteng; Wang, Lina; Pan, Yi-Hsuan; Zhang, Shuyi] E China Normal Univ, Lab Mol Ecol & Evolut, Inst Adv Studies Multidisciplinary Sci & Technol, Shanghai 200062, Peoples R China	East China Normal University	Pan, YH (corresponding author), E China Normal Univ, Lab Mol Ecol & Evolut, Inst Adv Studies Multidisciplinary Sci & Technol, Shanghai 200062, Peoples R China.	yihsuanp@gamil.com; syzhang@bio.ecnu.edu.cn	Pan, Yi-Hsuan/ABG-6271-2020	Pan, Yi-Hsuan/0000-0001-5156-9887	Shanghai Excellent Academic Leaders Project [11XD1402000]; National Natural Science Foundation of China [31100273/C030101]	Shanghai Excellent Academic Leaders Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants of Shanghai Excellent Academic Leaders Project (Grant No. 11XD1402000) to SZ, the National Natural Science Foundation of China (Grant No. 31100273/C030101) to YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; BRATTSTROM L, 1990, ATHEROSCLEROSIS, V81, P51, DOI 10.1016/0021-9150(90)90058-Q; Brosnan JT, 2004, ACTA BIOCHIM POL, V51, P405; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Cook S, 2005, HANDB EXP PHARM, V170, P325; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Duan W, 2002, J NEUROCHEM, V80, P101, DOI 10.1046/j.0022-3042.2001.00676.x; Epperson LE, 2010, J COMP PHYSIOL B, V180, P599, DOI 10.1007/s00360-009-0422-9; ESIRI MM, 1990, J NEUROL NEUROSUR PS, V53, P161, DOI 10.1136/jnnp.53.2.161; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; FINKELSTEIN JD, 1967, J BIOL CHEM, V242, P873; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Gonzalez B, 2004, J MOL BIOL, V338, P771, DOI 10.1016/j.jmb.2004.03.005; Hartig W, 2007, EUR J NEUROSCI, V25, P69, DOI 10.1111/j.1460-9568.2006.05250.x; Hajjar KA, 1998, J BIOL CHEM, V273, P9987, DOI 10.1074/jbc.273.16.9987; HERBERT V, 1962, J CLIN INVEST, V41, P1263, DOI 10.1172/JCI104589; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Ji C, 2007, HEPATOLOGY, V46, P1586, DOI 10.1002/hep.21854; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kondo N, 2006, CELL, V125, P161, DOI 10.1016/j.cell.2006.03.017; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; LENTZ SR, 1991, J CLIN INVEST, V88, P1906, DOI 10.1172/JCI115514; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Ma YL, 2005, AM J PHYSIOL-REG I, V289, pR1297, DOI 10.1152/ajpregu.00260.2005; Medina MA, 2001, EUR J BIOCHEM, V268, P3871, DOI 10.1046/j.1432-1327.2001.02278.x; MELICHAR I, 1973, PFLUG ARCH EUR J PHY, V345, P107, DOI 10.1007/BF00585834; Miller JW, 1999, NUTR REV, V57, P126; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neuweiler G., 2000, BIOL BATS; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Pan YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062039; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Ratnam S, 2006, AM J PHYSIOL-ENDOC M, V290, pE933, DOI 10.1152/ajpendo.00498.2005; Ross R, 1993, PATHOGENESIS ATHEROS; Sachdev P, 2004, J NEUROL SCI, V226, P25, DOI 10.1016/j.jns.2004.09.006; Schwartz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058427; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; SHANE B, 1985, ANNU REV NUTR, V5, P115, DOI 10.1146/annurev.nu.05.070185.000555; SKOVBY F, 1984, J BIOL CHEM, V259, P588; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829; Su B, 2008, J NEUROCHEM, V105, P2098, DOI 10.1111/j.1471-4159.2008.05294.x; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UBBINK JB, 1993, AM J CLIN NUTR, V57, P47, DOI 10.1093/ajcn/57.1.47; VANDENBERG M, 1995, NEURORADIOLOGY, V37, P403; VANTONDER SV, 1975, BRIT J NUTR, V34, P397, DOI 10.1017/S0007114575000463; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; WANG J, 1991, CLIN CHIM ACTA, V204, P239, DOI 10.1016/0009-8981(91)90235-5; Williams KT, 2007, J NUTR, V137, P311, DOI 10.1093/jn/137.2.311; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	66	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85632	10.1371/journal.pone.0085632	http://dx.doi.org/10.1371/journal.pone.0085632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376891	Green Submitted, Green Published, gold			2022-12-27	WOS:000328882000190
J	Gancarz-Kausch, AM; Schroeder, GL; Panganiban, C; Adank, D; Humby, MS; Kausch, MA; Clark, SD; Dietz, DM				Gancarz-Kausch, Amy M.; Schroeder, Gabrielle L.; Panganiban, Clarisse; Adank, Danielle; Humby, Monica S.; Kausch, Michael A.; Clark, Stewart D.; Dietz, David M.			Transforming Growth Factor Beta Receptor 1 Is Increased following Abstinence from Cocaine Self-Administration, but Not Cocaine Sensitization	PLOS ONE			English	Article							INDUCED STRUCTURAL PLASTICITY; RAT NUCLEUS-ACCUMBENS; SUBSTANCE USE DISORDERS; DRUG-SEEKING BEHAVIOR; INDIVIDUAL-DIFFERENCES; MOLECULAR-MECHANISMS; ADULT NEUROGENESIS; SPINE PLASTICITY; AMPA RECEPTORS; ADDICTION	The addicted phenotype is characterized as a long-lasting, chronically relapsing disorder that persists following long periods of abstinence, suggesting that the underlying molecular changes are stable and endure for long periods even in the absence of drug. Here, we investigated Transforming Growth Factor-Beta Type I receptor (TGF-beta R1) expression in the nucleus accumbens (NAc) following periods of withdrawal from cocaine self-administration (SA) and a sensitizing regimen of non-contingent cocaine. Rats were exposed to either (i) repeated systemic injections (cocaine or saline), or (ii) self-administration (cocaine or saline) and underwent a period of forced abstinence (either 1 or 7 days of drug cessation). Withdrawal from cocaine self-administration resulted in an increase in TGF-beta R1 protein expression in the NAc compared to saline controls. This increase was specific for volitional cocaine intake as no change in expression was observed following a sensitizing regimen of experimenter-administered cocaine. These findings implicate TGF-b signaling as a novel potential therapeutic target for treating drug addiction.	[Gancarz-Kausch, Amy M.; Schroeder, Gabrielle L.; Panganiban, Clarisse; Adank, Danielle; Humby, Monica S.; Kausch, Michael A.; Clark, Stewart D.; Dietz, David M.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Gancarz-Kausch, Amy M.; Clark, Stewart D.; Dietz, David M.] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dietz, DM (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA.	ddietz@buffalo.edu	Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015	Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Adank, Danielle/0000-0002-8206-6702; Gancarz-Kausch, Amy/0000-0002-3231-9732	State University of New York at Buffalo; NIAAA [T32-AA007583-11]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007583] Funding Source: NIH RePORTER	State University of New York at Buffalo; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the State University of New York at Buffalo and a grant from NIAAA T32-AA007583-11 (A.M.G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; ATOR NA, 1993, PSYCHOPHARMACOLOGY, V110, P1, DOI 10.1007/BF02246943; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Caffino L, 2013, INT J NEUROPSYCHOPH, P1; Chandra R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00013; Conrad KL, 2010, NEUROSCIENCE, V169, P182, DOI 10.1016/j.neuroscience.2010.04.056; Damez-Werno D, 2012, J NEUROSCI, V32, P10267, DOI 10.1523/JNEUROSCI.1290-12.2012; Deschaux O, 2012, ADDICT BIOL, DOI 10.1111/adb.12019.; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dietz DM, 2005, PHYSIOL BEHAV, V86, P347, DOI 10.1016/j.physbeh.2005.08.005; Dow AL, 2005, J NEUROSCI, V25, P4908, DOI 10.1523/JNEUROSCI.5155-04.2005; Dworkin S I, 1986, NIDA Res Monogr, V74, P90; DWORKIN SI, 1995, PSYCHOPHARMACOLOGY, V117, P262, DOI 10.1007/BF02246100; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Gancarz AM, 2012, PSYCHOPHARMACOLOGY, V222, P215, DOI 10.1007/s00213-012-2637-9; Gipson CD, 2013, NEURON, V77, P867, DOI 10.1016/j.neuron.2013.01.005; Golden S.A., 2012, COLD SPRING HARB PER, V2; Grimm JW, 2003, J NEUROSCI, V23, P742; Guan XW, 2010, J NEUROCHEM, V115, P795, DOI 10.1111/j.1471-4159.2010.06981.x; HOOKS MS, 1991, PHARMACOL BIOCHEM BE, V38, P467, DOI 10.1016/0091-3057(91)90308-O; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kim WY, 2009, NEUROSCIENCE, V163, P501, DOI 10.1016/j.neuroscience.2009.06.067; Kourrich S, 2003, J NEUROPHYSIOL, V89, P2112, DOI 10.1152/jn.00714.2002; Kunwar AJ, 2011, P NATL ACAD SCI USA, V108, P2575, DOI 10.1073/pnas.1013891108; Li X, 2013, J NEUROSCI, V33, P1130, DOI 10.1523/JNEUROSCI.3082-12.2013; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Loweth J.A., 2013, NEUROPHARMACOLOGY; Loweth JA, 2013, CURR OPIN NEUROBIOL, V23, P500, DOI 10.1016/j.conb.2013.01.009; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mark GP, 1999, PSYCHOPHARMACOLOGY, V143, P47, DOI 10.1007/s002130050918; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McFarland K, 2003, J NEUROSCI, V23, P3531; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Otaka M, 2013, J NEUROSCI, V33, P6753, DOI 10.1523/JNEUROSCI.4577-12.2013; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Schuckit MA, 2006, ADDICTION, V101, P76, DOI 10.1111/j.1360-0443.2006.01592.x; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Wang XT, 2013, J NEUROSCI, V33, P11012, DOI 10.1523/JNEUROSCI.1097-13.2013; Zilberman ML, 2003, CAN J PSYCHIAT, V48, P5, DOI 10.1177/070674370304800103	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83834	10.1371/journal.pone.0083834	http://dx.doi.org/10.1371/journal.pone.0083834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386286	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700070
J	Keogh, E; Moore, DJ; Duggan, GB; Payne, SJ; Eccleston, C				Keogh, Edmund; Moore, David J.; Duggan, Geoffrey B.; Payne, Stephen J.; Eccleston, Christopher			The Disruptive Effects of Pain on Complex Cognitive Performance and Executive Control	PLOS ONE			English	Article							ECOLOGICAL VALIDITY; GENDER-DIFFERENCES; DEFICITS; TASKS; SEX	Pain interferes and disrupts attention. What is less clear is how pain affects performance on complex tasks, and the strategies used to ensure optimal outcomes. The aim of the current study was to examine the effect of pain on higher-order executive control processes involved in managing complex tasks. Sixty-two adult volunteers (40 female) completed two computer-based tasks: a breakfast making task and a word generation puzzle. Both were complex, involving executive control functions, including goal-directed planning and switching. Half of those recruited performed the tasks under conditions of thermal heat pain, and half with no accompanying pain. Whilst pain did not affect central performance on either task, it did have indirect effects. For the breakfast task, pain resulted in a decreased ability to multitask, with performance decrements found on the secondary task. However, no effects of pain were found on the processes thought to underpin this task. For the word generation puzzle, pain did not affect task performance, but did alter subjective accounts of the processes used to complete the task; pain affected the perceived allocation of time to the task, as well as switching perceptions. Sex differences were also found. When studying higher-order cognitive processes, pain-related interference effects are varied, and may result in subtle or indirect changes in cognition.	[Keogh, Edmund] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Keogh, Edmund; Moore, David J.; Duggan, Geoffrey B.; Eccleston, Christopher] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England; [Payne, Stephen J.] Univ Bath, Dept Comp Sci, Bath BA2 7AY, Avon, England	University of Bath; University of Bath; University of Bath	Keogh, E (corresponding author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.	e.m.keogh@bath.ac.uk		Keogh, Edmund/0000-0002-1615-3699; Moore, David/0000-0002-5228-3124; Eccleston, Christopher/0000-0003-0698-1543	Engineering and Physical Sciences Research Council, United Kingdom [EP/J501402/1]; Engineering and Physical Sciences Research Council [EP/J501402/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by an unrestricted grant (EP/J501402/1) for research from the Engineering and Physical Sciences Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey BP, 2008, ACM T COMPUT-HUM INT, V14, DOI 10.1145/1314683.1314689; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Buser T, 2012, EXP ECON, V15, P641, DOI 10.1007/s10683-012-9318-8; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; Duggan GB, 2013, INT J HUM-COMPUT ST, V71, P533, DOI 10.1016/j.ijhcs.2013.01.001; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eysenck M.W., 2015, ANXIETY COGNITIVE PE, DOI 10.4324/9780203775677; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Keogh E, 1999, EUR J PERSONALITY, V13, P209, DOI 10.1002/(SICI)1099-0984(199905/06)13:3<209::AID-PER346>3.0.CO;2-N; Keogh E, 2013, PAIN WOMEN, P94; Keogh E, 2013, PAIN MANAG, V3, P27, DOI [10.2217/PMT.12.70, 10.2217/pmt.12.70]; Keogh E, 2010, PAIN, V151, P18, DOI 10.1016/j.pain.2010.07.014; Keogh E, 2009, EUR J PAIN, V13, P629, DOI 10.1016/j.ejpain.2008.07.002; Legrain V, 2013, CORTEX, V49, P1922, DOI 10.1016/j.cortex.2012.08.014; Legrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020926; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Mailis-Gagnon A, 2012, CLIN J PAIN, V28, P542, DOI 10.1097/AJP.0b013e3182385332; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; Moore DJ, 2013, PAIN, V154, P190, DOI 10.1016/j.pain.2012.07.016; Moore DJ, 2013, PAIN, V154, P82, DOI 10.1016/j.pain.2012.09.009; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Nes LS, 2009, ANN BEHAV MED, V37, P173, DOI 10.1007/s12160-009-9096-5; Payne SJ, 2007, J EXP PSYCHOL GEN, V136, P370, DOI 10.1037/0096-3445.136.3.370; Raven J. C., 1998, RAVENS PROGR MATRICE; Raven JC, 1982, MANUAL RAVENS PRO 5A; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stevens J, 1996, APPL MULTIVARIATE ST, V3rd ed.; Sullivan MJL, 2000, COGNITIVE THER RES, V24, P121, DOI 10.1023/A:1005459110063; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Torralva T, 2013, J ATTEN DISORD, V17, P11, DOI 10.1177/1087054710389988; Torralva T, 2012, BIPOLAR DISORD, V14, P118, DOI 10.1111/j.1399-5618.2012.00987.x; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Verhoeven K, 2011, EUR J PAIN, V15, P866, DOI 10.1016/j.ejpain.2011.01.009; Zhou H, 2009, P 2009 5 INT C NAT C, P13	36	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83272	10.1371/journal.pone.0083272	http://dx.doi.org/10.1371/journal.pone.0083272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386168	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700030
J	van Gurp, TP; McIntyre, LM; Verhoeven, KJF				van Gurp, Thomas P.; McIntyre, Lauren M.; Verhoeven, Koen J. F.			Consistent Errors in First Strand cDNA Due to Random Hexamer Mispriming	PLOS ONE			English	Article							RNA; DISCOVERY; BIAS	Priming of random hexamers in cDNA synthesis is known to show sequence bias, but in addition it has been suggested recently that mismatches in random hexamer priming could be a cause of mismatches between the original RNA fragment and observed sequence reads. To explore random hexamer mispriming as a potential source of these errors, we analyzed two independently generated RNA-seq datasets of synthetic ERCC spikes for which the reference is known. First strand cDNA synthesized by random hexamer priming on RNA showed consistent position and nucleotide-specific mismatch errors in the first seven nucleotides. The mismatch errors found in both datasets are consistent in distribution and thermodynamically stable mismatches are more common. This strongly indicates that RNA-DNA mispriming of specific random hexamers causes these errors. Due to their consistency and specificity, mispriming errors can have profound implications for downstream applications if not dealt with properly.	[van Gurp, Thomas P.; Verhoeven, Koen J. F.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [McIntyre, Lauren M.] Univ Florida, Genet Inst, Gainesville, FL USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); State University System of Florida; University of Florida	van Gurp, TP (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.	t.vangurp@nioo.knaw.nl	Verhoeven, Koen JF/C-9920-2010; KNAW, NIOO-KNAW/A-4320-2012	Verhoeven, Koen JF/0000-0003-3002-4102; KNAW, NIOO-KNAW/0000-0002-3835-159X; McIntyre, Lauren/0000-0002-0077-3359	NWO Netherlands (Netherlands Organization for scientific research) [NWO-ALW 820.01.025]	NWO Netherlands (Netherlands Organization for scientific research)	This study was funded by NWO Netherlands (Netherlands Organization for scientific research) (www.nwo.nl) grant number NWO-ALW 820.01.025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Matvienko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055913; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290; Zook JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041356	14	24	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85583	10.1371/journal.pone.0085583	http://dx.doi.org/10.1371/journal.pone.0085583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386481	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700141
J	Zhu, JY; Vereshchagina, N; Sreekumar, V; Burbulla, LF; Costa, AC; Daub, KJ; Woitalla, D; Martins, LM; Kruger, R; Rasse, TM				Zhu, Jun-yi; Vereshchagina, Natalia; Sreekumar, Vrinda; Burbulla, Lena F.; Costa, Ana C.; Daub, Katharina J.; Woitalla, Dirk; Martins, L. Miguel; Krueger, Rejko; Rasse, Tobias M.			Knockdown of Hsc70-5/mortalin Induces Loss of Synaptic Mitochondria in a Drosophila Parkinson's Disease Model	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; GENETIC-ANALYSIS; MORTALIN; DYSFUNCTION; CHAPERONE; DYNAMICS; MUSCLE; IDENTIFICATION; INACTIVATION; DEGENERATION	Mortalin is an essential component of the molecular machinery that imports nuclear-encoded proteins into mitochondria, assists in their folding, and protects against damage upon accumulation of dysfunctional, unfolded proteins in aging mitochondria. Mortalin dysfunction associated with Parkinson's disease (PD) increases the vulnerability of cultured cells to proteolytic stress and leads to changes in mitochondrial function and morphology. To date, Drosophila melanogaster has been successfully used to investigate pathogenesis following the loss of several other PD-associated genes. We generated the first loss-of-Hsc70-5/mortalin-function Drosophila model. The reduction of Mortalin expression recapitulates some of the defects observed in the existing Drosophila PD-models, which include reduced ATP levels, abnormal wing posture, shortened life span, and reduced spontaneous locomotor and climbing ability. Dopaminergic neurons seem to be more sensitive to the loss of mortalin than other neuronal sub-types and non-neuronal tissues. The loss of synaptic mitochondria is an early pathological change that might cause later degenerative events. It precedes both behavioral abnormalities and structural changes at the neuromuscular junction (NMJ) of mortalin-knockdown larvae that exhibit increased mitochondrial fragmentation. Autophagy is concomitantly up-regulated, suggesting that mitochondria are degraded via mitophagy. Ex vivo data from human fibroblasts identifies increased mitophagy as an early pathological change that precedes apoptosis. Given the specificity of the observed defects, we are confident that the loss-of-mortalin model presented in this study will be useful for further dissection of the complex network of pathways that underlie the development of mitochondrial parkinsonism.	[Zhu, Jun-yi; Vereshchagina, Natalia; Sreekumar, Vrinda; Daub, Katharina J.; Rasse, Tobias M.] Univ Tubingen, Hertie Inst Clin Brain Res, Jr Res Grp Synapt Plast, Tubingen, Germany; [Zhu, Jun-yi; Sreekumar, Vrinda] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Sreekumar, Vrinda; Burbulla, Lena F.; Krueger, Rejko] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Burbulla, Lena F.; Krueger, Rejko] Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany; [Burbulla, Lena F.; Krueger, Rejko] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Costa, Ana C.; Martins, L. Miguel] MRC, Cell Death Regulat Lab, Toxicol Unit, Leicester, Leics, England; [Woitalla, Dirk] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Krueger, Rejko] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Leicester; Ruhr University Bochum; Eberhard Karls University of Tubingen	Kruger, R (corresponding author), German Ctr Neurodegenerat Dis, Tubingen, Germany.	rejko.krueger@uni-tuebingen.de; tobias.rasse@gmail.de		Krueger, Rejko/0000-0003-4258-6241; Zhu, Junyi/0000-0002-4517-101X	Fritz Thyssen Foundation [10.11.2.153, 10.12.1.192]; German Research Council [DFG] [KR2119/8-1, RA 1804/2-1]; Federal Ministry for Education and Research [BMBF, NGFNplus] [01GS08134]; China Scholarship Council; charitable Hertie Foundation; Deutsche Forschungsgemeinschaft; Tubingen University; MRC [MC_U132674518] Funding Source: UKRI; Medical Research Council [MC_U132674518] Funding Source: researchfish	Fritz Thyssen Foundation; German Research Council [DFG](German Research Foundation (DFG)); Federal Ministry for Education and Research [BMBF, NGFNplus](Federal Ministry of Education & Research (BMBF)); China Scholarship Council(China Scholarship Council); charitable Hertie Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Fritz Thyssen Foundation (10.11.2.153 to RK and 10.12.1.192 to TMR); the German Research Council [DFG, KR2119/8-1 to RK, RA 1804/2-1 to TMR]; the Federal Ministry for Education and Research [BMBF, NGFNplus; 01GS08134 to RK]. JZ was supported by a fellowship of the China Scholarship Council, LFB by a doctoral scholarship from the charitable Hertie Foundation. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Barzilai A, 2003, TRENDS MOL MED, V9, P126, DOI 10.1016/S1471-4914(03)00020-0; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; Brenman JE, 2013, GENETICS; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Burbulla LF, 2010, EUR J CLIN INVEST, V40, P1048, DOI 10.1111/j.1365-2362.2010.02354.x; Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109; Chen J, 2008, GENOME RES, V18, P123, DOI 10.1101/gr.6940108; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Coelho M, 2012, NAT REV NEUROL, V8, P435, DOI 10.1038/nrneurol.2012.126; CRAIG EA, 1987, P NATL ACAD SCI USA, V84, P4156, DOI 10.1073/pnas.84.12.4156; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; De Mena L, 2009, J NEURAL TRANSM, V116, P1289, DOI 10.1007/s00702-009-0273-2; Deocaris C, 2008, BIOGERONTOLOGY, V9, P391, DOI 10.1007/s10522-008-9174-2; Deocaris CC, 2009, PROTEIN PEPTIDE LETT, V16, P517, DOI 10.2174/092986609788167770; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Fuger P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003066; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kohler K, 2009, AUTOPHAGY, V5, P980; KOPIN IJ, 1992, ANN NY ACAD SCI, V648, P96, DOI 10.1111/j.1749-6632.1992.tb24527.x; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Moreno E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039054; Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perry RJ, 1996, CURR OPIN NEUROL, V9, P281, DOI 10.1097/00019052-199608000-00007; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Sadun A, 1998, Trans Am Ophthalmol Soc, V96, P881; Schmid Andreas, 2008, V420, P239, DOI 10.1007/978-1-59745-583-1_14; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Shi M, 2008, J NEUROPATH EXP NEUR, V67, P117, DOI 10.1097/nen.0b013e318163354a; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Yaguchi T, 2007, ANN NY ACAD SCI, V1100, P306, DOI 10.1196/annals.1395.032; Yang H, 2011, BIOCHEM BIOPH RES CO, V410, P114, DOI 10.1016/j.bbrc.2011.05.116; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5	55	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83714	10.1371/journal.pone.0083714	http://dx.doi.org/10.1371/journal.pone.0083714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386261	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700059
J	He, LL; Xu, JP; Wu, ZB				He, Lili; Xu, Jiuping; Wu, Zhibin			Coping Strategies as a Mediator of Posttraumatic Growth among Adult Survivors of the Wenchuan Earthquake	PLOS ONE			English	Article							SOCIAL SUPPORT; STRESS; CANCER; ASSOCIATION; INVENTORY; SYMPTOMS; TRAUMA	Objective: By testing the mediating effect of coping strategies on the relationship between social support (SS) and posttraumatic growth (PTG), the aim of this research was to develop a new approach for the study of post-disaster psychological intervention. Methods: A mediating effect model analysis was conducted on 2080 adult survivors selected from 19 of the counties hardest-hit by the 2008 Wenchuan earthquake. The Social Support Rating Scale and the Coping Scale were used to predict the PTG. Results: A bivariate correlation analysis showed that there was a correlation between posttraumatic growth, social support and coping strategies. The mediation analysis revealed that coping strategies played a mediating role between social support and posttraumatic growth in survivors after the earthquake. Conclusion: The results demonstrated that mental health programs for survivors need to focus on the establishment of a good social support network, which was found to be conductive to maintaining and increasing mental health levels. At the same time, adequate social support is able to assist survivors in adopting mature coping strategies, such as problem solving and asking for help. Hence, social support was found to play a vital role in balancing and protecting mental health.	[He, Lili; Xu, Jiuping; Wu, Zhibin] Sichuan Univ, Uncertainty Decis Making Lab, Chengdu 610064, Peoples R China	Sichuan University	Xu, JP (corresponding author), Sichuan Univ, Uncertainty Decis Making Lab, Chengdu 610064, Peoples R China.	xujiuping@scu.edu.cn			National Social Science Foundation of China [12 ZD217]; Sichuan Provincial Social Science Foundation of China [SC13ZD06]; Sichuan University [SKG2013001]	National Social Science Foundation of China; Sichuan Provincial Social Science Foundation of China; Sichuan University(Sichuan University)	This research was supported by the Major Bidding Program of the National Social Science Foundation of China (Grant No. 12 & ZD217), Sichuan Provincial Social Science Foundation of China (Grant No. SC13ZD06), and the research funding of Sichuan University (Grant No. SKG2013001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldwin CM, 1998, LEA SER PER CLIN PSY, P43; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Calhoun L. G., 2006, HDB POSTTRAUMATIC GR, P3; Cohen LH, 1998, LEA SER PER CLIN PSY, P23; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Dirik G, 2008, J CLIN PSYCHOL MED S, V15, P193, DOI 10.1007/s10880-008-9115-x; Feder A, 2008, PSYCHIATRY, V71, P359, DOI 10.1521/psyc.2008.71.4.359; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Ke X, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-573; Kesimci A, 2005, CURR PSYCHOL, V24, P68, DOI 10.1007/s12144-005-1005-x; Kilmer R. P., 2006, HDB POSTTRAUMATIC GR, P264; Kilmer RP, 2010, CHILD DEV, V81, P1211, DOI 10.1111/j.1467-8624.2010.01463.x; Lamela D, 2013, J PSYCHO RES; Lechner SC, 2003, PSYCHO-ONCOL, V12, P491, DOI 10.1002/pon.671; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Liu L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-219; MacKinnon D.P., 1998, ANN M SOC PREV RES P, V7, P33; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Maercker A, 2004, PSYCHOL INQ, V15, P41; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Sachs-Ericsson N, 2006, J AFFECT DISORDERS, V93, P71, DOI 10.1016/j.jad.2006.02.014; Schaefer J.A., 1992, PERSONAL COPING THEO, P149; Schaefer JA, 1998, LEA SER PER CLIN PSY, P99; Senol-Durak E, 2010, J CLIN PSYCHOL MED S, V17, P150, DOI 10.1007/s10880-010-9192-5; Shakespeare-Finch J., 2005, TRAUMATOLOGY, V11, P325, DOI [10.1177/153476560501100410, DOI 10.1177/153476560501100410]; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Taku K, 2008, J TRAUMA STRESS, V21, P158, DOI 10.1002/jts.20305; Tang CSK, 2006, J PSYCHOSOM RES, V61, P699, DOI 10.1016/j.jpsychores.2006.07.014; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, V1st; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1998, LEA SER PER CLIN PSY, P1; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Thornton AA, 2006, PSYCHO-ONCOL, V15, P285, DOI 10.1002/pon.953; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041665; Xiao J., 1996, CHINESE J MENTAL HLT, V10, P164; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Xu JP, 2011, J AFFECT DISORDERS, V133, P274, DOI 10.1016/j.jad.2011.03.034; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019; Zhao CY, 2013, QUAL LIFE RES, V22, P733, DOI 10.1007/s11136-012-0197-4; Zheng YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029404; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	47	18	18	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84164	10.1371/journal.pone.0084164	http://dx.doi.org/10.1371/journal.pone.0084164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386345	gold, Green Submitted, Green Published			2022-12-27	WOS:000329117900079
J	Newnham, L; Jordan, PW; Carballo, JA; Newcombe, S; Hoffmann, E				Newnham, Louise; Jordan, Philip W.; Carballo, Jesus A.; Newcombe, Sonya; Hoffmann, Eva			Ipl1/Aurora Kinase Suppresses S-CDK-Driven Spindle Formation during Prophase I to Ensure Chromosome Integrity during Meiosis	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; BUDDING YEAST MEIOSIS; POLO-LIKE KINASE; B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CELL-CYCLE; INTERHOMOLOG RECOMBINATION; NONEXCHANGE CHROMOSOMES; DEPENDENT KINASE	Cells coordinate spindle formation with DNA repair and morphological modifications to chromosomes prior to their segregation to prevent cell division with damaged chromosomes. Here we uncover a novel and unexpected role for Aurora kinase in preventing the formation of spindles by Clb5-CDK (S-CDK) during meiotic prophase I and when the DDR is active in budding yeast. This is critical since S-CDK is essential for replication during premeiotic S-phase as well as double-strand break induction that facilitates meiotic recombination and, ultimately, chromosome segregation. Furthermore, we find that depletion of Cdc5 polo kinase activity delays spindle formation in DDR-arrested cells and that ectopic expression of Cdc5 in prophase I enhances spindle formation, when Ipl1 is depleted. Our findings establish a new paradigm for Aurora kinase function in both negative and positive regulation of spindle dynamics.	[Newnham, Louise; Jordan, Philip W.; Carballo, Jesus A.; Newcombe, Sonya; Hoffmann, Eva] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England	University of Sussex	Hoffmann, E (corresponding author), Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	eh58@sussex.ac.uk	Carballo, Jesus/K-9899-2014; hoffmann, eva/AAM-6594-2020	Carballo, Jesus/0000-0003-2259-3743; hoffmann, eva/0000-0002-2588-0652; Jordan, Philip/0000-0003-4890-2647; Newnham, Louise/0000-0002-1627-5530	MRC Centernary Award; BBSCR [BB/E000614/1]; BBSRC [BB/E000614/1] Funding Source: UKRI; MRC [G0902043] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000614/1] Funding Source: researchfish; Medical Research Council [G0902043] Funding Source: researchfish	MRC Centernary Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSCR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EH is a MRC Senior Research Fellowship and an EMBO Young Investigator. SG was funded by a MRC Centernary Award. PJ was funded by BBSCR (BB/E000614/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta I, 2011, MOL BIOL CELL, V22, P3478, DOI 10.1091/mbc.E11-06-0482; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; DAHMANN C, 1995, GENETICS, V140, P957; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Jordan P, 2009, GENE DEV, V23, P2237, DOI 10.1101/gad.536109; Jordan PW, 2012, J CELL SCI, V125, P5061, DOI 10.1242/jcs.105015; Kim S, 2013, GENE DEV, V27, P2139, DOI 10.1101/gad.227454.113; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Mardin BR, 2011, CURR BIOL, V21, P1145, DOI 10.1016/j.cub.2011.05.047; Meyer RE, 2013, SCIENCE, V339, P1071, DOI 10.1126/science.1232518; Miller MP, 2012, ELIFE, V1, DOI 10.7554/eLife.00117; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; Newnham L, 2010, P NATL ACAD SCI USA, V107, P781, DOI 10.1073/pnas.0913435107; Okaz E, 2012, CELL, V151, P603, DOI 10.1016/j.cell.2012.08.044; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Shirk K, 2011, J CELL SCI, V124, P2891, DOI 10.1242/jcs.086652; SHUSTER EO, 1989, GENETICS, V123, P29; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523	44	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83982	10.1371/journal.pone.0083982	http://dx.doi.org/10.1371/journal.pone.0083982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386320	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900070
J	Roberge, RJ; Kim, JH; Powell, JB; Shaffer, RE; Ylitalo, CM; Sebastian, JM				Roberge, Raymond J.; Kim, Jung-Hyun; Powell, Jeffrey B.; Shaffer, Ronald E.; Ylitalo, Caroline M.; Sebastian, John M.			Impact of Low Filter Resistances on Subjective and Physiological Responses to Filtering Facepiece Respirators	PLOS ONE			English	Article							HEALTH-CARE WORKERS; AIR-FLOW RESISTANCE; BREATHING RESISTANCE; N95; PERCEPTION; LOADS; APPARATUS; DEVICES	Ten subjects underwent treadmill exercise at 5.6 km/h over one hour while wearing each of three identical appearing, cup-shaped, prototype filtering facepiece respirators that differed only in their filter resistances (3 mm, 6 mm, and 9 mm H2O pressure drop). There were no statistically significant differences between filtering facepiece respirators with respect to impact on physiological parameters (i.e., heart rate, respiratory rate, oxygen saturation, transcutaneous carbon dioxide levels, tympanic membrane temperature), pulmonary function variables (i.e., tidal volume, respiratory rate, volume of carbon dioxide production, oxygen consumption, or ventilation), and subjective ratings (i.e., exertion, thermal comfort, inspiratory effort, expiratory effort and overall breathing comfort). The nominal filter resistances of the prototype filtering facepiece respirators correspond to airflow resistances ranging from 2.1 - 6.6 mm H2O/L/s which are less than, or minimally equivalent to, previously reported values for the normal threshold for detection of inspiratory breathing resistance (6 - 7.6 mm H2O/L/sec). Therefore, filtering facepiece respirators with filter resistances at, or below, this level may not impact the wearer differently physiologically or subjectively from those with filter resistances only slightly above this threshold at low-moderate work rates over one hour.	[Roberge, Raymond J.; Kim, Jung-Hyun; Powell, Jeffrey B.; Shaffer, Ronald E.] NIOSH, Technol Res Branch, Natl Personal Protect Technol Lab, Ctr Dis Control & Prevent, Pittsburgh, PA 15236 USA; [Ylitalo, Caroline M.; Sebastian, John M.] 3M Co, Personal Safety Div, St Paul, MN 55144 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); 3M	Roberge, RJ (corresponding author), NIOSH, Technol Res Branch, Natl Personal Protect Technol Lab, Ctr Dis Control & Prevent, Pittsburgh, PA 15236 USA.	dtn0@cdc.gov	Shaffer, Ronald E/I-2134-2012; Shaffer, Ronald/ABI-6508-2020	Shaffer, Ronald/0000-0001-6352-7967	National Institute for Occupational Safety and Health (NIOSH); US Centers for Disease Control and Prevention	National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by internal operating funds from the National Institute for Occupational Safety and Health (NIOSH), part of the US Centers for Disease Control and Prevention. Raymond J. Roberge, Jung-Hyun Kim, Jeffrey B. Powell, and Ronald E. Shaffer are NIOSH employees who were involved in conducting the study, analyzing the results, and preparing the manuscript.	Antunano MJ, 1993, ALTP19920061 AIR FOR; Baig AS, 2010, AM J INFECT CONTROL, V38, P18, DOI 10.1016/j.ajic.2009.09.005; Bardsley SM, 2005, P 3 ANN REG NAT OCC, P1; Bendjelid K, 2005, CRIT CARE MED, V33, P2203, DOI 10.1097/01.CCM.0000181734.26070.26; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Bryce E, 2008, J HOSP INFECT, V68, P241, DOI 10.1016/j.jhin.2007.12.007; BURKI NK, 1981, J APPL PHYSIOL, V50, P162, DOI 10.1152/jappl.1981.50.1.162; CAMPBELL EJM, 1980, J PHYSIOL-LONDON, V309, P93, DOI 10.1113/jphysiol.1980.sp013496; Davis RR, 2011, NOISE HEALTH, V13, P93, DOI 10.4103/1463-1741.77200; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; Frank SM, 1999, J APPL PHYSIOL, V86, P1588, DOI 10.1152/jappl.1999.86.5.1588; GOTTFRIED SB, 1978, CHEST, V73, P286, DOI 10.1378/chest.73.2.286; Hailstone J, 2011, MEAS PHYS ED EXER SC, V32, P819; Harber P, 1997, AM J IND MED, V32, P408, DOI 10.1002/(SICI)1097-0274(199710)32:4<408::AID-AJIM12>3.3.CO;2-N; HARBER P, 1989, J OCCUP ENVIRON MED, V31, P681, DOI 10.1097/00043764-198908000-00014; James RH, 1976, NIOSH77161; JONES JG, 1991, AM IND HYG ASSOC J, V52, P219, DOI 10.1202/0002-8894(1991)052<0219:TPCOWA>2.0.CO;2; KILLIAN KJ, 1980, J APPL PHYSIOL, V49, P958, DOI 10.1152/jappl.1980.49.6.958; Kim JH, 2013, INT J SPORTS MED, V34, P497, DOI 10.1055/s-0032-1327661; Kim JH, 2013, AM J INFECT CONTROL, V41, P24, DOI 10.1016/j.ajic.2012.02.037; Lee HP, 2011, ANN OCCUP HYG, V55, P917, DOI 10.1093/annhyg/mer065; LERMAN Y, 1983, AM J IND MED, V4, P733, DOI 10.1002/ajim.4700040606; LOVE RG, 1977, BRIT J IND MED, V34, P126; Love RG, 1983, J INT SOC RESP PROTE, V1, P45; MAXWELL DL, 1985, RESP PHYSIOL, V61, P255, DOI 10.1016/0034-5687(85)90130-6; McVicar J, 2009, EMERG MED J, V26, P344, DOI 10.1136/emj.2007.055715; Mitchell R, 2012, AM J INFECT CONTROL, V40, P611, DOI 10.1016/j.ajic.2012.01.011; National Institute for Occupational Safety and Health (NIOSH), 2001, RESP US PRIV SECT FI; National Personal Protective Technology Laboratory (NPPTL), 2012, STAND RESP TEST PROC; Occupational Safety and Health Administration (OSHA), 1998, 1910 OSHA; Radonovich LJ, 2009, BETTER RESP EQUIPMEN; Roberge R, 2012, ANN OCCUP HYG, V56, P808, DOI 10.1093/annhyg/mes001; Roberge RJ, 2012, J OCCUP ENVIRON HYG, V9, P166, DOI 10.1080/15459624.2012.660428; Roberge RJ, 2012, ANN OCCUP HYG, V56, P102, DOI 10.1093/annhyg/mer069; Roberge RJ, 2010, ANN OCCUP HYG, V54, P671, DOI 10.1093/annhyg/meq042; Roberge RJ, 2010, RESP CARE, V55, P569; Roberge RJ, 2010, RESPIROLOGY, V15, P516, DOI 10.1111/j.1440-1843.2010.01713.x; Roy PK, 2002, INDIAN J ANAESTH, V46, P175; SHELTON DM, 1992, CLIN OTOLARYNGOL, V17, P178, DOI 10.1111/j.1365-2273.1992.tb01068.x; SILVERMAN L, 1951, AMA ARCH IND HYG OCC, V3, P461; Sinkule EJ, 2013, ANN OCCUP HYG, V57, P384, DOI 10.1093/annhyg/mes068; Smith CL, 2013, ERGONOMICS, V56, P781, DOI 10.1080/00140139.2013.777128; Vojtko MR, 2008, J INT SOC RESP PROTE, V25, P1; WILEY RL, 1966, RESP PHYSIOL, V2, P73, DOI 10.1016/0034-5687(66)90039-9	44	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84901	10.1371/journal.pone.0084901	http://dx.doi.org/10.1371/journal.pone.0084901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386434	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900117
J	Sackton, TB; Werren, JH; Clark, AG				Sackton, Timothy B.; Werren, John H.; Clark, Andrew G.			Characterizing the Infection-Induced Transcriptome of Nasonia vitripennis Reveals a Preponderance of Taxonomically-Restricted Immune Genes	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; CYTOPLASMIC INCOMPATIBILITY; ADAPTIVE EVOLUTION; HOST-DEFENSE; DRAFT GENOME; PROTEINS; PATHWAYS; BEES; MECHANISMS; RESPONSES	The innate immune system in insects consists of a conserved core signaling network and rapidly diversifying effector and recognition components, often containing a high proportion of taxonomically-restricted genes. In the absence of functional annotation, genes encoding immune system proteins can thus be difficult to identify, as homology-based approaches generally cannot detect lineage-specific genes. Here, we use RNA-seq to compare the uninfected and infection-induced transcriptome in the parasitoid wasp Nasonia vitripennis to identify genes regulated by infection. We identify 183 genes significantly up-regulated by infection and 61 genes significantly down-regulated by infection. We also produce a new homology-based immune catalog in N. vitripennis, and show that most infection-induced genes cannot be assigned an immune function from homology alone, suggesting the potential for substantial novel immune components in less well-studied systems. Finally, we show that a high proportion of these novel induced genes are taxonomically restricted, highlighting the rapid evolution of immune gene content. The combination of functional annotation using RNA-seq and homology-based annotation provides a robust method to characterize the innate immune response across a wide variety of insects, and reveals significant novel features of the Nasonia immune response.	[Sackton, Timothy B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Harvard University; University of Rochester; Cornell University	Sackton, TB (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	tsackton@oeb.harvard.edu		Werren, John/0000-0001-9353-2070; Sackton, Timothy/0000-0003-1673-9216; Clark, Andrew/0000-0001-7159-8511	NIH [R01 AI064950, R24 GM084917]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM084917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant R01 AI064950 to AGC and NIH grant R24 GM084917 to JHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2011, INSECT BIOCHEM MOLEC, V41, P968, DOI 10.1016/j.ibmb.2011.09.006; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bordenstein SR, 2003, GENETICS, V164, P223; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Brucker RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045125; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; Chafee ME, 2011, GENETICS, V187, P203, DOI 10.1534/genetics.110.120675; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cornman RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065424; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Fehlbaum P, 1996, P NATL ACAD SCI USA, V93, P1221, DOI 10.1073/pnas.93.3.1221; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Harpur BA, 2013, MOL BIOL EVOL, V30, P1665, DOI 10.1093/molbev/mst061; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; Keebaugh ES, 2012, MOL BIOL EVOL, V29, P565, DOI 10.1093/molbev/msr191; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Pal S, 2008, DEV COMP IMMUNOL, V32, P50, DOI 10.1016/j.dci.2007.04.001; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Raychoudhury R, 2012, HEREDITY, V108, P105, DOI 10.1038/hdy.2011.53; Reinhardt JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003860; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sackton TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-259; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schlenke TA, 2003, GENETICS, V164, P1471; Simola DF, 2013, GENOME RES, V23, P1235, DOI 10.1101/gr.155408.113; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Somogyi K, 2008, MOL BIOL EVOL, V25, P2337, DOI 10.1093/molbev/msn180; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Vanha-aho LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037153; Viljakainen L, 2009, MOL BIOL EVOL, V26, P1791, DOI 10.1093/molbev/msp086; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yek SH, 2013, MOL ECOL, V22, P2173, DOI 10.1111/mec.12255; Zhang ZT, 2012, DEV COMP IMMUNOL, V38, P262, DOI 10.1016/j.dci.2012.05.003; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	72	28	28	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83984	10.1371/journal.pone.0083984	http://dx.doi.org/10.1371/journal.pone.0083984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386321	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900071
J	Yang, W; Zhu, CH; Ma, XL; Li, GJ; Gan, LJ; Ng, D; Xia, K				Yang, Wei; Zhu, Changhua; Ma, Xiaoling; Li, Guijun; Gan, Lijun; Ng, Denny; Xia, Kai			Hydrogen Peroxide Is a Second Messenger in the Salicylic Acid-Triggered Adventitious Rooting Process in Mung Bean Seedlings	PLOS ONE			English	Article							NITRIC-OXIDE; ARABIDOPSIS-THALIANA; ANTIOXIDANT ENZYMES; H2O2-METABOLIZING ENZYMES; PHENOLIC-COMPOUNDS; INDOLEACETIC-ACID; METHYL JASMONATE; OXIDATIVE STRESS; OSMOTIC-STRESS; CELL-DEATH	In plants, salicylic acid (SA) is a signaling molecule that regulates disease resistance responses, such as systemic acquired resistance (SAR) and hypertensive response (HR). SA has been implicated as participating in various biotic and abiotic stresses. This study was conducted to investigate the role of SA in adventitious root formation (ARF) in mung bean (Phaseolus radiatus L) hypocotyl cuttings. We observed that hypocotyl treatment with SA could significantly promote the adventitious root formation, and its effects were dose and time dependent. Explants treated with SA displayed a 130% increase in adventitious root number compared with control seedlings. The role of SA in mung bean hypocotyl ARF as well as its interaction with hydrogen peroxide (H2O2) were also elucidated. Pretreatment of mung bean explants with N, N'-dimethylthiourea (DMTU), a scavenger for H2O2, resulted in a significant reduction of SA-induced ARF. Diphenyleneiodonium (DPI), a specific inhibitor of membrane-linked NADPH oxidase, also inhibited the effect of adventitious rooting triggered by SA treatment. The determination of the endogenous H2O2 level indicated that the seedlings treated with SA could induce H2O2 accumulation compared with the control treatment. Our results revealed a distinctive role of SA in the promotion of adventitious rooting via the process of H2O2 accumulation. This conclusion was further supported by antioxidant enzyme activity assays. Based on these results, we conclude that the accumulation of free H2O2 might be a downstream event in response to SAtriggered adventitious root formation in mung bean seedlings.	[Yang, Wei; Zhu, Changhua; Ma, Xiaoling; Li, Guijun; Gan, Lijun; Xia, Kai] Nanjing Agr Univ, Coll Life Sci, Plant Hormone Lab, Nanjing, Jiangsu, Peoples R China; [Ng, Denny] CP Bio Inc, Chino, CA USA	Nanjing Agricultural University	Xia, K (corresponding author), Nanjing Agr Univ, Coll Life Sci, Plant Hormone Lab, Nanjing, Jiangsu, Peoples R China.	xia1965@hotmail.com	MA, XIAO/HHN-5611-2022		National Natural Science Foundation of China [30871460]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30871460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able AJ, 1998, PLANT PHYSIOL, V117, P491, DOI 10.1104/pp.117.2.491; Aebi H, 1984, Methods Enzymol, V105, P121; Agarwal S, 2005, PLANT SCI, V169, P559, DOI 10.1016/j.plantsci.2005.05.004; Ali MB, 2007, MOLECULES, V12, P607, DOI 10.3390/12030607; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Anand A, 2008, PLANT PHYSIOL, V146, P703, DOI 10.1104/pp.107.111302; Ananieva EA, 2004, J PLANT PHYSIOL, V161, P319, DOI 10.1078/0176-1617-01022; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; Bellamine J, 1998, PLANT GROWTH REGUL, V26, P191, DOI 10.1023/A:1006182801823; BI YM, 1995, PLANT J, V8, P235, DOI 10.1046/j.1365-313X.1995.08020235.x; Bolwell GP, 1998, PLANT PHYSIOL, V116, P1379, DOI 10.1104/pp.116.4.1379; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Boyce C. Kevin, 2005, P479; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; Chamnongpol S, 1998, P NATL ACAD SCI USA, V95, P5818, DOI 10.1073/pnas.95.10.5818; Chen J, 2007, J ENVIRON SCI, V19, P44, DOI 10.1016/S1001-0742(07)60007-2; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; CONNELL JP, 1986, PLANT PHYSIOL, V82, P351, DOI 10.1104/pp.82.2.351; CONRATH U, 1995, P NATL ACAD SCI USA, V92, P7143, DOI 10.1073/pnas.92.16.7143; Dat JF, 1998, PLANT PHYSIOL, V118, P1455, DOI 10.1104/pp.118.4.1455; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; De Klerk GJ, 2008, PLANT GROWTH REGUL, V56, P203, DOI 10.1007/s10725-008-9301-8; De Klerk GJ, 2011, PLANT GROWTH REGUL, V63, P175, DOI 10.1007/s10725-010-9555-9; Desikan R, 1998, J EXP BOT, V49, P1767, DOI 10.1093/jexbot/49.327.1767; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; Durner J, 1996, J BIOL CHEM, V271, P28492, DOI 10.1074/jbc.271.45.28492; Echevarria-Machado I, 2007, PLANT PHYSIOL BIOCH, V45, P501, DOI 10.1016/j.plaphy.2007.04.003; ELIASSON L, 1984, PHYSIOL PLANTARUM, V61, P293, DOI 10.1111/j.1399-3054.1984.tb05911.x; Falasca G, 2004, PLANT CELL REP, V23, P17, DOI 10.1007/s00299-004-0801-3; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Geiss G, 2009, ANN PLANT REV, V37; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Gutierrez-Coronado MA, 1998, PLANT PHYSIOL BIOCH, V36, P563, DOI 10.1016/S0981-9428(98)80003-X; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Janda T, 1999, PLANTA, V208, P175, DOI 10.1007/s004250050547; JARVIS BC, 1981, PHYSIOL PLANTARUM, V53, P213, DOI 10.1111/j.1399-3054.1981.tb04489.x; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kang SM, 2004, PLANT SCI, V166, P745, DOI 10.1016/j.plantsci.2003.11.022; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Khalafalla MM, 2000, PLANT GROWTH REGUL, V32, P59, DOI 10.1023/A:1006305123585; Khan W, 2003, J PLANT PHYSIOL, V160, P485, DOI 10.1078/0176-1617-00865; Khurana JP, 1987, PLANT CELL PHYSL, V24, P907; KLESSIG DF, 1994, PLANT MOL BIOL, V26, P1439, DOI 10.1007/BF00016484; KLING GJ, 1983, HORTSCIENCE, V18, P352; KORDAN HA, 1985, ANN BOT-LONDON, V55, P267, DOI 10.1093/oxfordjournals.aob.a086899; Lanteri ML, 2008, PLANT PHYSIOL, V147, P188, DOI 10.1104/pp.107.111815; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; LEE TT, 1965, PHYSIOL PLANTARUM, V18, P386, DOI 10.1111/j.1399-3054.1965.tb06902.x; LEON J, 1995, PLANT PHYSIOL, V108, P1673, DOI 10.1104/pp.108.4.1673; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li Ling, 1995, Journal of Tropical and Subtropical Botany, V3, P67; Li SW, 2010, IN VITRO CELL DEV-PL, V46, P142, DOI 10.1007/s11627-009-9275-x; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Li SW, 2007, PLANT GROWTH REGUL, V52, P173, DOI 10.1007/s10725-007-9188-9; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Mayers CN, 2005, MOL PLANT MICROBE IN, V18, P428, DOI 10.1094/MPMI-18-0428; McDonald MP, 2003, PLANT BIOLOGY, V5, P550, DOI 10.1055/s-2003-44790; MENSUALISODI A, 1995, PLANT GROWTH REGUL, V17, P205, DOI 10.1007/BF00024727; Munne-Bosch S, 2003, PLANTA, V217, P758, DOI 10.1007/s00425-003-1037-0; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Mutui TM, 2010, PLANT GROWTH REGUL, V61, P185, DOI 10.1007/s10725-010-9464-y; Nag S, 2001, J PLANT GROWTH REGUL, V20, P182, DOI 10.1007/s003440010016; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Noctor G, 1998, J EXP BOT, V49, P623, DOI 10.1093/jexbot/49.321.623; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Pagnussat GC, 2004, PLANT PHYSIOL, V135, P279, DOI 10.1104/pp.103.038554; Pagnussat GC, 2003, PLANT PHYSIOL, V132, P1241, DOI 10.1104/pp.103.022228; Pagnussat GC, 2002, PLANT PHYSIOL, V129, P954, DOI 10.1104/pp.004036; Pancheva TV, 1996, J PLANT PHYSIOL, V149, P57, DOI 10.1016/S0176-1617(96)80173-8; Papadakis AK, 1999, PLANT PHYSIOL, V121, P197, DOI 10.1104/pp.121.1.197; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Ramirez-Carvajal GA, 2009, PLANT PHYSIOL, V150, P759, DOI 10.1104/pp.109.137505; Rao MV, 1997, PLANT PHYSIOL, V115, P137, DOI 10.1104/pp.115.1.137; RASKIN I, 1987, SCIENCE, V237, P1601, DOI 10.1126/science.237.4822.1601; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; RIOV J, 1989, PLANT GROWTH REGUL, V8, P277, DOI 10.1007/BF00025397; RIOV J, 1989, J PLANT GROWTH REGUL, V8, P131, DOI 10.1007/BF02025280; Sebastiani L., 2002, Advances in Horticultural Science, V16, P7; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; Singh S. P., 1993, Advances in Horticulture and Forestry, V3, P207; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; STILL SM, 1976, J AM SOC HORTIC SCI, V101, P34; Su GX, 2006, J INTEGR PLANT BIOL, V48, P426, DOI 10.1111/j.1744-7909.2006.00236.x; Syros T, 2004, J PLANT PHYSIOL, V161, P69, DOI 10.1078/0176-1617-00938; Tasgin E, 2006, PHYTOCHEMISTRY, V67, P710, DOI 10.1016/j.phytochem.2006.01.022; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; Tewari RK, 2011, J PLANT GROWTH REGUL, V30, P396, DOI 10.1007/s00344-011-9202-3; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; VanGestelen P, 1997, PLANT PHYSIOL, V115, P543, DOI 10.1104/pp.115.2.543; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; WU GS, 1995, PLANT CELL, V7, P1357, DOI 10.1105/tpc.7.9.1357; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhang Y, 2003, ACTA BOT SIN, V45, P1447	105	45	45	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84580	10.1371/journal.pone.0084580	http://dx.doi.org/10.1371/journal.pone.0084580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386397	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900102
J	Christe, A; Szucs-Farkas, Z; Huber, A; Steiger, P; Leidolt, L; Roos, JE; Heverhagen, J; Ebner, L				Christe, Andreas; Szucs-Farkas, Zsolt; Huber, Adrian; Steiger, Philipp; Leidolt, Lars; Roos, Justus E.; Heverhagen, Johannes; Ebner, Lukas			Optimal Dose Levels in Screening Chest CT for Unimpaired Detection and Volumetry of Lung Nodules, with and without Computer Assisted Detection at Minimal Patient Radiation	PLOS ONE			English	Article							SUBSOLID PULMONARY NODULES; AIDED DETECTION; MULTIDETECTOR CT; CONTRAST-MEDIUM; TOMOGRAPHY; ANGIOGRAPHY; PERFORMANCE; ACCURACY; GUIDELINES; PATTERNS	Objectives: The aim of this phantom study was to minimize the radiation dose by finding the best combination of low tube current and low voltage that would result in accurate volume measurements when compared to standard CT imaging without significantly decreasing the sensitivity of detecting lung nodules both with and without the assistance of CAD. Methods: An anthropomorphic chest phantom containing artificial solid and ground glass nodules (GGNs, 5-12 mm) was examined with a 64-row multi-detector CT scanner with three tube currents of 100, 50 and 25 mAs in combination with three tube voltages of 120, 100 and 80 kVp. This resulted in eight different protocols that were then compared to standard CT sensitivity (100 mAs/120 kVp). For each protocol, at least 127 different nodules were scanned in 21-25 phantoms. The nodules were analyzed in two separate sessions by three independent, blinded radiologists and computer-aided detection (CAD) software. Results: The mean sensitivity of the radiologists for identifying solid lung nodules on a standard CT was 89.7%+/- 4.9%. The sensitivity was not significantly impaired when the tube and current voltage were lowered at the same time, except at the lowest exposure level of 25 mAs/80 kVp [80.6%+/- 4.3% (p = 0.031)]. Compared to the standard CT, the sensitivity for detecting GGNs was significantly lower at all dose levels when the voltage was 80 kVp; this result was independent of the tube current. The CAD significantly increased the radiologists' sensitivity for detecting solid nodules at all dose levels (5-11%). No significant volume measurement errors (VMEs) were documented for the radiologists or the CAD software at any dose level. Conclusions: Our results suggest a CT protocol with 25 mAs and 100 kVp is optimal for detecting solid and ground glass nodules in lung cancer screening. The use of CAD software is highly recommended at all dose levels.	[Christe, Andreas; Huber, Adrian; Steiger, Philipp; Leidolt, Lars; Heverhagen, Johannes; Ebner, Lukas] Hosp & Univ Bern, Inselspital, Dept Radiol, Bern, Switzerland; [Szucs-Farkas, Zsolt] Hosp Ctr Biel, Dept Radiol, Biel, Switzerland; [Roos, Justus E.] Duke Univ, Dept Radiol, Durham, NC 27710 USA	University of Bern; University Hospital of Bern; Duke University	Christe, A (corresponding author), Hosp & Univ Bern, Inselspital, Dept Radiol, Bern, Switzerland.	andreas.christe@insel.ch	Huber, Adrian/ABA-2766-2020; Huber, Adrian/N-5713-2016	Huber, Adrian/0000-0001-6146-8238; Heverhagen, Johannes/0000-0002-5416-6650; Steiger, Philipp/0000-0001-5886-5216; Ebner, Lukas/0000-0001-5117-6047	Bernese Cancer League; Jubilee Foundation Swisslife; Swiss Fight Against Cancer Foundation	Bernese Cancer League; Jubilee Foundation Swisslife; Swiss Fight Against Cancer Foundation	This study was financed by the Bernese Cancer League, the Jubilee Foundation Swisslife and the Swiss Fight Against Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armato SG, 2002, RADIOLOGY, V225, P685, DOI 10.1148/radiol.2253011376; Aroua A, 2004, RADIAT PROT DOSIM, V111, P289, DOI 10.1093/rpd/nch343; Awai K, 2004, RADIOLOGY, V230, P347, DOI 10.1148/radiol.2302030049; Bankier AA, 2007, RADIOLOGY, V242, P898, DOI 10.1148/radiol.2423060196; Bongartz G, 2004, EUROPEAN GUIDELINES; Christe A, 2013, EUR J RADIOL, V82, pE142, DOI 10.1016/j.ejrad.2012.09.025; Christe A, 2012, EUR J RADIOL, V81, P2860, DOI 10.1016/j.ejrad.2011.06.059; Christe A, 2011, AM J ROENTGENOL, V197, P623, DOI 10.2214/AJR.10.5288; Das M, 2008, BRIT J RADIOL, V81, P841, DOI 10.1259/bjr/50635688; Das M, 2006, RADIOLOGY, V241, P564, DOI 10.1148/radiol.2412051139; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fleiss J, 1981, STAT METHODS RATES P, P38; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Goldman RN, 1985, STAT INTRO, P334; Hein PA, 2009, ROFO-FORTSCHR RONTG, V181, P1056, DOI 10.1055/s-0028-1109394; Holmquist F, 2006, EUR RADIOL, V16, P1165, DOI 10.1007/s00330-005-0117-x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JW, 2004, INVEST RADIOL, V39, P649, DOI 10.1097/00004424-200411000-00001; Li F, 2005, RADIOLOGY, V237, P684, DOI 10.1148/radiol.2372041555; Michel JL, 2001, J RADIOL, V82, P922; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Paul NS, 2007, MED PHYS, V34, P3587, DOI 10.1118/1.2768866; Rizzi EB, 2007, CLIN IMAG, V31, P178, DOI 10.1016/j.clinimag.2006.09.026; Roos JE, 2010, EUR RADIOL, V20, P549, DOI 10.1007/s00330-009-1596-y; Rusinek H, 1998, RADIOLOGY, V209, P243, DOI 10.1148/radiology.209.1.9769838; Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128; Szucs-Farkas Z, 2011, AM J ROENTGENOL, V197, pW852, DOI 10.2214/AJR.11.6750; Tack D, 2005, RADIOLOGY, V236, P318, DOI 10.1148/radiol.2361040190; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomas CK, 2006, INVEST RADIOL, V41, P668, DOI 10.1097/01.rli.0000233324.09603.dd; White CS, 2008, ACAD RADIOL, V15, P326, DOI 10.1016/j.acra.2007.09.027; Willemink MJ, 2012, AM J ROENTGENOL, V199, P1241, DOI 10.2214/AJR.12.8727; Xie XQ, 2013, EUR RADIOL, V23, P139, DOI 10.1007/s00330-012-2570-7; Yamada T, 2004, EUR J RADIOL, V51, P169, DOI 10.1016/j.ejrad.2003.09.017; Yi CA, 2003, AM J ROENTGENOL, V181, P501, DOI 10.2214/ajr.181.2.1810501; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5; Zar JH, 2010, BIOSTAT ANAL, P543; Zompatori M, 2002, Radiol Med, V104, P13	39	13	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82919	10.1371/journal.pone.0082919	http://dx.doi.org/10.1371/journal.pone.0082919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386126	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700020
J	Holtfreter, B; Empen, K; Glaser, S; Lorbeer, R; Volzke, H; Ewert, R; Kocher, T; Dorr, M				Holtfreter, Birte; Empen, Klaus; Glaeser, Sven; Lorbeer, Roberto; Voelzke, Henry; Ewert, Ralf; Kocher, Thomas; Doerr, Marcus			Periodontitis Is Associated with Endothelial Dysfunction in a General Population: A Cross-Sectional Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EAST-GERMAN REGION; CARDIOVASCULAR-DISEASE; BRACHIAL-ARTERY; EUROPEAN WORKSHOP; VASCULAR FUNCTION; POMERANIA SHIP; RISK-FACTORS; HEALTH; INFLAMMATION	A large body of evidence underlines an association between periodontal disease and cardiovascular disease. In contrast, data on its relation with endothelial dysfunction as a marker of early subclinical atherosclerosis is inconclusive and limited to patient-cohort studies. We therefore investigated the association between periodontal disease and flow-mediated dilation of the brachial artery (FMD) as a measure of endothelial dysfunction in a general population, and also addressed a possible mediation via inflammation. The study population comprised 1,234 subjects (50.5% men) aged 25-85 years from the 5-year follow-up of the Study of Health in Pomerania, a population-based cohort study. Clinical attachment loss (CAL) and pocket probing depth (PPD) as measures of periodontal disease were assessed half-mouth at four sites per tooth. Subjects were classified according to the periodontitis case definition proposed by Tonetti and Claffey (2005). Measurements of FMD and nitroglycerin-mediated dilation (NMD) were performed using standardized ultrasound techniques. High-sensitive C-reactive protein, fibrinogen and leukocyte count were measured. Fully adjusted multivariate linear regression analyses revealed significant associations of the percentage of sites with PPD >= 6 mm with FMD (p(trend)=0.048), with subjects within the highest category having a 0.74% higher FMD compared to subjects within the lowest category (p<0.05). Consistently, FMD values increased significantly across categories of the percentage of sites with CAL >= 6 mm (p(trend)=0.01) and the periodontitis case definition (p(trend)=0.006). Restrictions to subjects without antihypertensive or statin medication or current non-smokers confirmed previous results. Systemic inflammation did not seem to mediate the relation. Both PPD and CAL were not consistently associated with NMD. In contrast to previous studies, high levels of periodontal disease were significantly associated with high FMD values. This association was not mediated via systemic inflammation. This study revives the discussion on whether and how periodontitis contributes to endothelial dysfunction.	[Holtfreter, Birte; Kocher, Thomas] Univ Greifswald, Unit Periodontol, Dept Restorat Dent Periodontol & Endodontol, Univ Med, Greifswald, Germany; [Empen, Klaus; Glaeser, Sven; Ewert, Ralf; Doerr, Marcus] Univ Greifswald, Dept Internal Med, Univ Med, Greifswald, Germany; [Lorbeer, Roberto; Voelzke, Henry] Univ Greifswald, Univ Med, SHIP Clin Epidemiol Res, Inst Community Med, Greifswald, Germany; [Doerr, Marcus] Partner Site Greifswald, German Ctr Cardiovasc Res DZHK, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; German Centre for Cardiovascular Research	Holtfreter, B (corresponding author), Univ Greifswald, Unit Periodontol, Dept Restorat Dent Periodontol & Endodontol, Univ Med, Greifswald, Germany.	birte.holtfreter@uni-greifswald.de	Dörr, Marcus/F-1919-2010	Dörr, Marcus/0000-0001-7471-475X	Community Medicine Research network of the University of Greifswald, Germany; German Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701]; German Ministry of Cultural Affairs; Social Ministry of the German Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research; Ministry of Cultural Affairs of the German Federal State of Mecklenburg - West Pomerania [03IS2061A]; DZHK (German Centre for Cardiovascular Research); Kompetenznetz Asthma/COPD (Competence Network Asthma/COPD); Federal Ministry of Education and Research [FKZ 01GI0881-0888]; GABA, Switzerland	Community Medicine Research network of the University of Greifswald, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Cultural Affairs; Social Ministry of the German Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the German Federal State of Mecklenburg - West Pomerania; DZHK (German Centre for Cardiovascular Research); Kompetenznetz Asthma/COPD (Competence Network Asthma/COPD); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); GABA, Switzerland	This work was supported by the Community Medicine Research network of the University of Greifswald, Germany that is funded by the German Federal Ministry of Education and Research (01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701), the German Ministry of Cultural Affairs, as well as by the Social Ministry of the German Federal State of Mecklenburg-West Pomerania. Furthermore, this work is part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the German Federal Ministry of Education and Research and as well as by the Ministry of Cultural Affairs of the German Federal State of Mecklenburg - West Pomerania (03IS2061A). This study was further supported by the DZHK (German Centre for Cardiovascular Research) and by the Kompetenznetz Asthma/COPD (Competence Network Asthma/COPD) funded by the Federal Ministry of Education and Research (FKZ 01GI0881-0888). BH was financed by an unlimited grant from GABA, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablij Hans, 2002, Eur J Intern Med, V13, P412, DOI 10.1016/S0953-6205(02)00132-2; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Amar S, 2003, ARTERIOSCL THROM VAS, V23, P1245, DOI 10.1161/01.ATV.0000078603.90302.4A; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Beck JD, 1999, AM HEART J, V138, pS528, DOI 10.1016/S0002-8703(99)70293-0; Bergstrom Jan, 2006, J Evid Based Dent Pract, V6, P33, DOI 10.1016/j.jebdp.2005.12.018; Bergstrom Jan, 2004, Odontology, V92, P1; Blum A, 2007, EUR J INTERN MED, V18, P295, DOI 10.1016/j.ejim.2006.12.003; Bouchard P, 2010, EUR HEART J SUPPL, V12, pB13, DOI 10.1093/eurheartj/suq001; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; D'Aiuto F, 2013, J CLIN PERIODONTOL, V40, pS85, DOI [10.1902/jop.2013.134007, 10.1111/jcpe.12061]; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Demmer RT, 2008, COMMUNITY DENT ORAL, V36, P493, DOI 10.1111/j.1600-0528.2008.00435.x; Demmer RT, 2012, DIABETES CARE, V35, P2036, DOI 10.2337/dc11-2453; Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Ebersole JL, 1997, CLIN EXP IMMUNOL, V107, P347, DOI 10.1111/j.1365-2249.1997.270-ce1162.x; Elter JR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.002; Empen K, 2012, ARTERIOSCL THROM VAS, V32, P481, DOI 10.1161/ATVBAHA.111.232876; Empen K, 2010, EUR J ENDOCRINOL, V163, P617, DOI 10.1530/EJE-10-0563; Faulx MD, 2003, AM HEART J, V145, P943, DOI 10.1016/S0002-8703(03)00097-8; Fichtlscherer S, 2000, CIRCULATION, V102, P1000, DOI 10.1161/01.CIR.102.9.1000; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Hannemann A, 2011, ATHEROSCLEROSIS, V219, P875, DOI 10.1016/j.atherosclerosis.2011.09.008; Heitzer T, 2005, ARTERIOSCL THROM VAS, V25, P1174, DOI 10.1161/01.ATV.0000166516.52477.81; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Hensel E, 2003, QUINTESSENCE INT, V34, P370; Higashi Y, 2009, ATHEROSCLEROSIS, V206, P604, DOI 10.1016/j.atherosclerosis.2009.03.037; Janket SJ, 2008, ORAL SURG ORAL MED O, V105, P173, DOI 10.1016/j.tripleo.2007.06.027; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; KEIL U, 1988, ACTA MED SCAND, P119; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kingman A, 2008, J CLIN PERIODONTOL, V35, P659, DOI 10.1111/j.1600-051X.2008.01243.x; KWEIDER M, 1993, SCOT MED J, V38, P73, DOI 10.1177/003693309303800304; Li XA, 2011, J CLIN PERIODONTOL, V38, P148, DOI 10.1111/j.1600-051X.2010.01651.x; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Little RJ, 2003, STAT MED, V22, P1589, DOI 10.1002/sim.1513; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; LOOS BG, 2006, INT J DENT HYG S1, V4, P32; Lorbeer R, 2011, ATHEROSCLEROSIS, V217, P358, DOI 10.1016/j.atherosclerosis.2011.04.007; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Mercanoglu F, 2004, J PERIODONTOL, V75, P1694, DOI 10.1902/jop.2004.75.12.1694; Paraskevas KI, 2008, THROMB RES, V122, P1, DOI 10.1016/j.thromres.2007.06.003; Piconi S, 2009, FASEB J, V23, P1196, DOI 10.1096/fj.08-119578; Puranik R, 2003, PROG CARDIOVASC DIS, V45, P443, DOI 10.1053/pcad.2003.YPCAD13; Reffelmann T, 2010, ATHEROSCLEROSIS, V211, P660, DOI 10.1016/j.atherosclerosis.2010.03.023; Ridker PM, 1998, CIRCULATION, V97, P425; ROSS R, 1993, TRANSPLANT P, V25, P2041; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sanz M, 2010, EUR HEART J SUPPL, V12, pB3, DOI 10.1093/eurheartj/suq003; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Schwahn C, 2004, THROMB HAEMOSTASIS, V92, P244, DOI 10.1160/TH04-02-0092; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; Shimbo D, 2007, ATHEROSCLEROSIS, V192, P197, DOI 10.1016/j.atherosclerosis.2006.05.005; Sinisalo J, 2000, ATHEROSCLEROSIS, V149, P403, DOI 10.1016/S0021-9150(99)00333-0; Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tomiyama H, 2008, HYPERTENS RES, V31, P2019, DOI 10.1291/hypres.31.2019; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Vita JA, 2004, CIRCULATION, V110, P3604, DOI 10.1161/01.CIR.0000148821.97162.5E; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Volzke H, 2009, EUR HEART J, V30, P217, DOI 10.1093/eurheartj/ehn508	68	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84603	10.1371/journal.pone.0084603	http://dx.doi.org/10.1371/journal.pone.0084603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386401	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700112
J	Isari, S; Anto, M; Saiz, E				Isari, Stamatina; Anto, Meritxell; Saiz, Enric			Copepod Foraging on the Basis of Food Nutritional Quality: Can Copepods Really Choose?	PLOS ONE			English	Article							MARINE PLANKTONIC COPEPOD; FRESH-WATER; NUTRIENT LIMITATION; FEEDING-BEHAVIOR; PHOSPHORUS STARVATION; CALANUS-FINMARCHICUS; PARACALANUS-PARVUS; SEASONAL-VARIATION; ACARTIA-HUDSONICA; NUCLEIC-ACID	Copepods have been considered capable of selective feeding based on several factors (i.e., prey size, toxicity, and motility). However, their selective feeding behaviour as a function of food quality remains poorly understood, despite the potential impact of such a process on copepod fitness and trophodynamics. In this study, we aimed to evaluate the ability of copepods to feed selectively according to the nutritional value of the prey. We investigated the feeding performance of the calanoid copepod Acartia grani under nutritionally distinct diets of the dinoflagellate Heterocapsa sp. (nutrient-replete, N-depleted and P-depleted) using unialgal suspensions and mixtures of prey (nutrient-replete vs. nutrient-depleted). Despite the distinct cell elemental composition among algal treatments (e. g., C:N:P molar ratios) and the clear dietary impact on egg production rates (generally higher number of eggs under a nutrient-replete diet), no impact on copepod feeding rates was observed. All unialgal suspensions were cleared at similar rates, and this pattern was independent of food concentration. When the prey were offered as mixtures, we did not detect selective behaviour in either the N-limitation (nutrient-replete vs. N-depleted Heterocapsa cells) or P-limitation (nutrient-replete vs. P-depleted Heterocapsa cells) experiments. The lack of selectivity observed in the current study contrasts with previous observations, in which stronger nutritional differences were tested. Under normal natural circumstances, nutritional differences in natural prey assemblages might not be sufficiently strong to trigger a selective response in copepods based on that factor alone. In addition, our results suggest that nutritional quality might depend not only on the growing conditions but also on the inherent taxonomical properties of the prey.	[Isari, Stamatina; Anto, Meritxell; Saiz, Enric] CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona, Catalunya, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Isari, S (corresponding author), CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona, Catalunya, Spain.	misari@icm.csic.es	Isari, Stamatina/J-6987-2014; Saiz, Enric/K-4263-2014	Isari, Stamatina/0000-0003-3457-0274; Saiz, Enric/0000-0003-2611-0067	project CROA [LS8-1893]; European Social Fund (ESF); Greek State; Spanish Ministry of Economy and Competitiveness [CTM2011-23480]	project CROA; European Social Fund (ESF)(European Social Fund (ESF)); Greek State; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the project CROA (LS8-1893), implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and is co-financed by the European Social Fund (ESF) and the Greek State. M. A and E. S were funded by the project CTM2011-23480 from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2000, LIMNOL OCEANOGR, V45, P1162, DOI 10.4319/lo.2000.45.5.1162; ANDREWS JC, 1983, CAN J FISH AQUAT SCI, V40, P1293, DOI 10.1139/f83-147; Augustin CB, 2006, J PLANKTON RES, V28, P429, DOI 10.1093/plankt/fbi131; Barofsky A, 2010, J PLANKTON RES, V32, P263, DOI 10.1093/plankt/fbp121; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BERDALET E, 1994, J PLANKTON RES, V16, P303, DOI 10.1093/plankt/16.4.303; BERDALET E, 1992, HYDROBIOLOGIA, V238, P139, DOI 10.1007/BF00048782; Breteler WCMK, 2005, MAR ECOL PROG SER, V291, P125; Broglio E, 2001, MAR ECOL PROG SER, V220, P179, DOI 10.3354/meps220179; BUTLER NM, 1989, OECOLOGIA, V78, P368, DOI 10.1007/BF00379111; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Colin SP, 2003, MAR ECOL PROG SER, V248, P55, DOI 10.3354/meps248055; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; DEMOTT WR, 1989, LIMNOL OCEANOGR, V34, P140, DOI 10.4319/lo.1989.34.1.0140; DEMOTT WR, 1988, LIMNOL OCEANOGR, V33, P397, DOI 10.4319/lo.1988.33.3.0397; DEMOTT WR, 1995, OECOLOGIA, V103, P230, DOI 10.1007/BF00329085; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; Dutz J, 2008, LIMNOL OCEANOGR, V53, P225, DOI 10.4319/lo.2008.53.1.0225; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2001, ECOLOGY, V82, P898, DOI 10.1890/0012-9658(2001)082[0898:NLRFQF]2.0.CO;2; FRIEDMAN MM, 1975, P NATL ACAD SCI USA, V72, P4185, DOI 10.1073/pnas.72.10.4185; Frigstad H, 2011, BIOGEOSCIENCES, V8, P2917, DOI 10.5194/bg-8-2917-2011; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; GILL CW, 1988, MAR ECOL PROG SER, V43, P269, DOI 10.3354/meps043269; Grasshoff K, 1999, METHODS SEAWATER ANA; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; HOUDE SEL, 1987, MAR ECOL PROG SER, V40, P69, DOI 10.3354/meps040069; HUNTLEY M, 1986, MAR ECOL PROG SER, V28, P105, DOI 10.3354/meps028105; HUNTLEY ME, 1983, MAR BIOL, V74, P151, DOI 10.1007/BF00413918; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Jones RH, 2005, SCIENCE, V307, P1457, DOI 10.1126/science.1107767; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kiorboe T, 1999, MAR ECOL PROG SER, V179, P81, DOI 10.3354/meps179081; KIORBOE T, 1989, MAR ECOL PROG SER, V55, P229, DOI 10.3354/meps055229; KLEPPEL GS, 1993, MAR ECOL PROG SER, V99, P183, DOI 10.3354/meps099183; Koski M, 1998, MAR ECOL PROG SER, V170, P169, DOI 10.3354/meps170169; Kuijper LDJ, 2004, J PLANKTON RES, V26, P213, DOI 10.1093/plankt/fbh020; LATASA M, 1994, J PLANKTON RES, V16, P83, DOI 10.1093/plankt/16.1.83; Meyer B, 2002, HELGOLAND MAR RES, V56, P169, DOI 10.1007/s10152-002-0105-3; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Moore PA, 1999, LIMNOL OCEANOGR, V44, P166, DOI 10.4319/lo.1999.44.1.0166; MULLIN MM, 1963, LIMNOL OCEANOGR, V8, P239, DOI 10.4319/lo.1963.8.2.0239; PAFFENHOFER GA, 1990, J PLANKTON RES, V12, P933, DOI 10.1093/plankt/12.5.933; PAFFENHOFER GA, 1988, B MAR SCI, V43, P430; PAFFENHOFER GA, 1985, MAR ECOL PROG SER, V27, P55, DOI 10.3354/meps027055; POULET SA, 1978, SCIENCE, V200, P1403, DOI 10.1126/science.200.4348.1403; Price H.J., 1985, Advances in Limnology, V21, P115; PRICE HJ, 1988, B MAR SCI, V43, P327; ROMAN MR, 1984, LIMNOL OCEANOGR, V29, P949, DOI 10.4319/lo.1984.29.5.0949; Saba GK, 2009, MAR ECOL PROG SER, V386, P147, DOI 10.3354/meps08070; Saiz E, 2011, HYDROBIOLOGIA, V666, P181, DOI 10.1007/s10750-010-0421-6; Schultz M, 2009, J PLANKTON RES, V31, P553, DOI 10.1093/plankt/fbp010; Siuda ANS, 2010, LIMNOL OCEANOGR, V55, P2107, DOI 10.4319/lo.2010.55.5.2107; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Tang KW, 1999, OIKOS, V84, P537, DOI 10.2307/3546434; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Tiselius P, 2013, LIMNOL OCEANOGR, V58, P1657, DOI 10.4319/lo.2013.58.5.1657; TURRIFF N, 1995, MAR BIOL, V123, P55, DOI 10.1007/BF00350323; URABE J, 1992, LIMNOL OCEANOGR, V37, P244, DOI 10.4319/lo.1992.37.2.0244; UYE S, 1990, MAR ECOL PROG SER, V59, P97, DOI 10.3354/meps059097; Vanderploeg Henry A., 1994, P205; Walve J, 1999, J PLANKTON RES, V21, P2309, DOI 10.1093/plankt/21.12.2309; Yen J., 1992, Advances in Limnology, V36, P123	70	44	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84742	10.1371/journal.pone.0084742	http://dx.doi.org/10.1371/journal.pone.0084742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386411	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700117
J	Marston, M; Newell, ML; Crampin, A; Lutalo, T; Musoke, R; Gregson, S; Nyamukapa, C; Nakiyingi-Miiro, J; Urassa, M; Isingo, R; Zaba, B				Marston, Milly; Newell, Marie Louise; Crampin, Amelia; Lutalo, Tom; Musoke, Richard; Gregson, Simon; Nyamukapa, Constance; Nakiyingi-Miiro, Jessica; Urassa, Mark; Isingo, Raphael; Zaba, Basia			Is the Risk of HIV Acquisition Increased during and Immediately after Pregnancy? A Secondary Analysis of Pooled HIV Community-Based Studies from the ALPHA Network	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RURAL-POPULATION; POSTPARTUM WOMEN; PREVALENCE; INFECTION; COHORT; UGANDA; RAKAI; SURVEILLANCE; TRANSMISSION	Background: Previous studies of HIV acquisition in pregnancy have been in specific population groups, such as sero-discordant couples which have shown an increased risk of HIV acquisition during pregnancy and studies of sexually active women where the results have been ambiguous. However these studies are unable to tell us what the overall impact of pregnancy is on HIV acquisition in the general population. Methods: Data from six community-based HIV cohorts were pooled to give 2,628 sero-conversions and a total of 178,000 person years of observation. Multiple imputation was used to allow for the uncertainty of exact seroconversion date in surveillance intervals greater than the length of a pregnancy. Results were combined using Rubin's rules to give appropriate error bounds. The analysis was stratified into two periods: pre-and postwidespread availability of prevention of mother-to-child HIV transmission services. This allows us to assess whether there is reporting bias relating to a person's knowledge of their own HIV status which would become more widespread in the latter time period. Results: Results suggest that women while pregnant have a lower risk of acquiring HIV infection over all periods (HRR 0.79, 95% CI 0.70-0.89) than women who were not pregnant. There is no evidence for a difference in the rate of HIV acquisition between postpartum and non-pregnant women (HRR 0.92 95% CI 0.84-1.03). Discussion: Although there may be immunological reasons for increased risk of HIV acquisition during pregnancy, at a population level this study indicates a lower risk of HIV acquisition for pregnant women. Pregnant women may be more likely to be concordant with their current sexual partner than non-pregnant women, i. e. either already HIV positive prior to the pregnancy or if negative at the time of becoming pregnant more likely to have a negative partner.	[Marston, Milly; Crampin, Amelia; Zaba, Basia] London Sch Hyg & Trop Med, London WC1, England; [Newell, Marie Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Newell, Marie Louise] Univ Southampton, Fac Med, Fac Social & Human Sci, Southampton SO9 5NH, Hants, England; [Crampin, Amelia] Karonga Prevent Study, Chilumba, Malawi; [Lutalo, Tom; Musoke, Richard] Rakai Hlth Sci Program, Kalisizo, Rakai, Uganda; [Gregson, Simon; Nyamukapa, Constance] Univ London Imperial Coll Sci Technol & Med, London, England; [Gregson, Simon; Nyamukapa, Constance] Biomed Res & Training Inst, Harare, Zimbabwe; [Nakiyingi-Miiro, Jessica] MRC, Entebbe, Uganda; [Urassa, Mark; Isingo, Raphael] Natl Inst Med Res, TAZAMA Project, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of Kwazulu Natal; University of Southampton; Malawi Epidemiology and Intervention Research Unit; Rakai Health Sciences Program; Imperial College London; Biomedical Research Training Institute; National Institute of Medical Research	Marston, M (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	milly.marston@lshtm.ac.uk	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Crampin, Amelia/0000-0002-1513-4330; Musoke, Richard/0000-0002-2566-4191; Nyamukapa, Constance/0000-0001-6779-4069; Gregson, Simon/0000-0003-2707-0714	Henry M. Jackson Foundation; Bill and Melinda Gates Institute for Population and Reproductive Health at Johns Hopkins University; Global Fund for AIDS, TB and Malaria through the Tanzania National Coordinating Mechanism; Ministry of Health Social Welfare; Wellcome Trust; Wellcome Trust [084401/Z/07/Z, 082384/Z/07/Z, 090959/Z/09/Z]; Africa Centre surveillance cohort in Umkhanyakude;  [NIAID R01 A134265];  [NICHD RO1 HD 050180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050180] Funding Source: NIH RePORTER	Henry M. Jackson Foundation; Bill and Melinda Gates Institute for Population and Reproductive Health at Johns Hopkins University; Global Fund for AIDS, TB and Malaria through the Tanzania National Coordinating Mechanism; Ministry of Health Social Welfare; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Africa Centre surveillance cohort in Umkhanyakude; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Analysis based on data pooled by the ALPHA network, as supplied by: the Rakai study, managed by Rakai Health Sciences Program, in Uganda and supported by grants NIAID R01 A134265; NICHD RO1 HD 050180; the Henry M. Jackson Foundation and the Bill and Melinda Gates Institute for Population and Reproductive Health at Johns Hopkins University; the Kyamulibwa general population cohort, managed by MRC/UVRI, in Uganda; the Kisesa open cohort, managed by the TAZAMA programme at NIMR (Mwanza), in Tanzania with funding from the Global Fund for AIDS, TB and Malaria through the Tanzania National Coordinating Mechanism and the Ministry of Health& Social Welfare; the Karonga Prevention Study, managed by LSHTM in Malawi; principally funded by the Wellcome Trust; the Manicaland study, managed by Imperial College and the BioMedical Research Training Institute, in Zimbabwe principally funded by Wellcome Trust (grant 084401/Z/07/Z); the Africa Centre surveillance cohort in Umkhanyakude, managed by ACHPS/University of KwaZulu-Natal, in South Africa with surveillance activities funded by the Wellcome Trust (grant 082384/Z/07/Z). The ALPHA network itself is funded by the Wellcome Trust (grant 090959/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Barnighausen T, 2012, TROP MED INT HEALTH, V17, pe103, DOI 10.1111/j.1365-3156.2012.02928.x; Biraro S, 2007, JAIDS-J ACQ IMM DEF, V44, P222, DOI 10.1097/QAI.0b013e31802e2954; Black V, 2009, AIDS, V23, P2234, DOI 10.1097/QAD.0b013e328331561f; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cleland JG, 1999, AIDS, V13, P125, DOI 10.1097/00002030-199901140-00017; Crampin AC, 2012, INT J EPIDEMIOL, V41, P676, DOI 10.1093/ije/dys088; Floyd S, 2013, AIDS, V27, P233, DOI 10.1097/QAD.0b013e32835848ab; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Humphrey JH, 2006, AIDS, V20, P1437, DOI 10.1097/01.aids.0000233578.72091.09; LEROY V, 1994, AIDS, V8, P983, DOI 10.1097/00002030-199407000-00017; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Machiyama K, 2010, REEXAMINATION RECENT; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Mbizvo M T, 2001, Cent Afr J Med, V47, P115; Mepham S, 2011, PRIMARY HIV PREGNANC; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Morrison CS, 2007, AIDS, V21, P1027, DOI 10.1097/QAD.0b013e3280f00fc4; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Munjoma MW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-668; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; Nguyen RHN, 2006, INT J STD AIDS, V17, P842, DOI 10.1258/095646206779307586; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Rice BD, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-160; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Wawer M., 2005, 12 C RETR OPP INF BO	34	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82219	10.1371/journal.pone.0082219	http://dx.doi.org/10.1371/journal.pone.0082219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386091	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700008
J	Nicklas, D; Saiz, L				Nicklas, Daniel; Saiz, Leonor			Characterization of Negative Feedback Network Motifs in the TGF-beta Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ROBUSTNESS ANALYSIS; RECEPTOR; SMAD7; PHOSPHORYLATION; DETERMINANTS; MUTATIONS; DYNAMICS; CELLS	{Chung, 2009 #1} The transforming growth factor-beta (TGF-beta) superfamily of cytokines plays a fundamental role in a wide variety of cellular processes, including growth, differentiation, apoptosis, and tissue homeostasis. Its relevance is emphasized by the mutations of its core components that are associated with diverse human diseases, such as cancer and cardiovascular pathologies. A prominent regulator of the pathway is Smad7, which attenuates the signal and controls its duration in a cell-type-dependent manner through a negative feedback loop. Here, we characterize all the potential Smad7-mediated negative feedback network motifs and investigate their effects on the signaling dynamics upon stimulation with TGF-b and bone morphogenetic protein (BMP) ligands. The results show that the specific negative feedback implementation is a key determinant of both the response of the system to single and multiple ligands of the TGF-b superfamily and its robustness and sensitivity to parameter perturbations.	[Nicklas, Daniel; Saiz, Leonor] Univ Calif Davis, Dept Biomed Engn, Modeling Biol Networks Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Saiz, L (corresponding author), Univ Calif Davis, Dept Biomed Engn, Modeling Biol Networks Lab, Davis, CA 95616 USA.	lsaiz@ucdavis.edu	Saiz, Leonor/I-3557-2015	Saiz, Leonor/0000-0002-6866-9400	University of California, Davis	University of California, Davis(University of California System)	This work was supported by the University of California, Davis (to LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Bode HW, 1945, NETWORK ANAL FEEDBAC, V2, p[iii, 1]; Celliere G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-184; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Chung SW, 2009, BIOPHYS J, V96, P1733, DOI 10.1016/j.bpj.2008.11.050; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Derynck R, 2008, TGF BETA FAMILY, Vxiv; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Ho J, 2011, BIOPHYS J, V100, P164; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Jones E., 2001, SCIPY OPEN SOURCE SC; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kucherenko S, 2009, RELIAB ENG SYST SAFE, V94, P1135, DOI 10.1016/j.ress.2008.05.006; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nicklas D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0363; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Press WH, 2007, NUMERICAL RECIPES AR, pxxi; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Valdimarsdottir G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-16; Varma A, 1999, PARAMETRIC SENSITIVI, Vxvi; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Vilar JMG, 2011, BIOPHYS J, V101, P2315, DOI 10.1016/j.bpj.2011.09.035; Wegner K, 2012, BIOPHYS CHEM, V162, P22, DOI 10.1016/j.bpc.2011.12.003; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015; Zi ZK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000936; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22; Zi ZK, 2005, J COMPUT SCI TECH-CH, V20, P491, DOI 10.1007/s11390-005-0491-5; Zou XF, 2008, BIOSYSTEMS, V91, P245, DOI 10.1016/j.biosystems.2007.10.001	54	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e83531	10.1371/journal.pone.0083531	http://dx.doi.org/10.1371/journal.pone.0083531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24386222	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100124
J	Mazzillo, FFM; Shapiro, K; Silver, MW				Mazzillo, Fernanda F. M.; Shapiro, Karen; Silver, Mary W.			A New Pathogen Transmission Mechanism in the Ocean: The Case of Sea Otter Exposure to the Land-Parasite Toxoplasma gondii	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; EXOPOLYMER PARTICLES TEP; CRYPTOSPORIDIUM-PARVUM OOCYSTS; ENHYDRA-LUTRIS-NEREIS; BIOFILM; WATER; RUNOFF; TERRESTRIAL; ASSOCIATION; ATTACHMENT	Toxoplasma gondii is a land-derived parasite that infects humans and marine mammals. Infections are a significant cause of mortality for endangered southern sea otters (Enhydra lutris nereis), but the transmission mechanism is poorly understood. Otter exposure to T. gondii has been linked to the consumption of marine turban snails in kelp (Macrocystis pyrifera) forests. It is unknown how turban snails acquire oocysts, as snails scrape food particles attached to surfaces, whereas T. gondii oocysts enter kelp beds as suspended particles via runoff. We hypothesized that waterborne T. gondii oocysts attach to kelp surfaces when encountering exopolymer substances (EPS) forming the sticky matrix of biofilms on kelp, and thus become available to snails. Results of a dietary composition analysis of field-collected snails and of kelp biofilm indicate that snails graze the dense kelp-biofilm assemblage composed of pennate diatoms and bacteria inserted within the EPS gel-like matrix. To test whether oocysts attach to kelp blades via EPS, we designed a laboratory experiment simulating the kelp forest canopy in tanks spiked with T. gondii surrogate microspheres and controlled for EPS and transparent exopolymer particles (TEP - the particulate form of EPS). On average, 19% and 31% of surrogates were detected attached to kelp surfaces covered with EPS in unfiltered and filtered seawater treatments, respectively. The presence of TEP in the seawater did not increase surrogate attachment. These findings support a novel transport mechanism of T. gondii oocysts: as oocysts enter the kelp forest canopy, a portion adheres to the sticky kelp biofilms. Snails grazing this biofilm encounter oocysts as 'bycatch' and thereby deliver the parasite to sea otters that prey upon snails. This novel mechanism can have health implications beyond T. gondii and otters, as a similar route of pathogen transmission may be implicated with other waterborne pathogens to marine wildlife and humans consuming biofilm-feeding invertebrates.	[Mazzillo, Fernanda F. M.; Silver, Mary W.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Shapiro, Karen] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Santa Cruz; University of California System; University of California Davis	Mazzillo, FFM (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	mazzillo@gmail.com		Shapiro, Karen/0000-0003-2678-3851	National Science Foundation [OCE-1065990]	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation Ecology of Infectious Disease grant OCE-1065990. http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angles ML, 2007, TRENDS PARASITOL, V23, P352, DOI 10.1016/j.pt.2007.06.001; Arar EJ, 1997, METHODS DETERMINATIO; Arkush KD, 2003, INT J PARASITOL, V33, P1087, DOI 10.1016/S0020-7519(03)00181-4; Bar-Zeev E, 2012, P NATL ACAD SCI USA, V109, P9119, DOI 10.1073/pnas.1203708109; Berman T, 2007, NAT PREC, DOI [10.1038/npre.2007.1182.1, DOI 10.1038/NPRE.2007.1182.1]; Conrad PA, 2005, INT J PARASITOL, V35, P1155, DOI 10.1016/j.ijpara.2005.07.002; Decho AW, 2009, MICROSC MICROANAL, V15, P822, DOI 10.1017/S1431927609094355; DECHO AW, 1993, LIMNOL OCEANOGR, V38, P1633, DOI 10.4319/lo.1993.38.8.1633; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Sanchez-Saavedra MD, 2008, HIDROBIOLOGICA, V18, P99; DiCesare EAW, 2012, APPL ENVIRON MICROB, V78, P4187, DOI 10.1128/AEM.08026-11; Dubey JP, 1996, J PARASITOL, V82, P951, DOI 10.2307/3284205; Dubey JP, 1996, AM J VET RES, V57, P1733; Dubey JP, 1996, J PARASITOL, V82, P438, DOI 10.2307/3284082; Dumetre A, 2012, APPL ENVIRON MICROB, V78, P905, DOI 10.1128/AEM.06488-11; Engel A, 2001, MAR ECOL PROG SER, V219, P1, DOI 10.3354/meps219001; Engel A, 2002, J PLANKTON RES, V24, P49, DOI 10.1093/plankt/24.1.49; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029955; Harimawan A, 2011, J COLLOID INTERF SCI, V364, P213, DOI 10.1016/j.jcis.2011.08.021; Helmi K, 2008, APPL ENVIRON MICROB, V74, P2079, DOI 10.1128/AEM.02495-07; HOAGLAND KD, 1993, J PHYCOL, V29, P537, DOI 10.1111/j.0022-3646.1993.00537.x; Hoskins DL, 2003, MAR ECOL PROG SER, V247, P93, DOI 10.3354/meps247093; HUTCHISON WM, 1969, BMJ-BRIT MED J, V4, P806, DOI 10.1136/bmj.4.5686.806-b; Johnson CK, 2009, P NATL ACAD SCI USA, V106, P2242, DOI 10.1073/pnas.0806449106; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Krembs C, 2002, DEEP-SEA RES PT I, V49, P2163, DOI 10.1016/S0967-0637(02)00122-X; Krembs C, 2011, P NATL ACAD SCI USA, V108, P3653, DOI 10.1073/pnas.1100701108; Kreuder C, 2003, J WILDLIFE DIS, V39, P495, DOI 10.7589/0090-3558-39.3.495; Krusor C, 2012, THESIS U CALIF; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Lindsay DS, 2001, J EUKARYOT MICROBIOL, p197S; Liu Y, 2009, LANGMUIR, V25, P1594, DOI 10.1021/la803202h; Massie GN, 2010, VET PARASITOL, V169, P296, DOI 10.1016/j.vetpar.2010.01.002; MAZZELLA L, 1989, AQUAT BOT, V35, P357, DOI 10.1016/0304-3770(89)90007-7; McMillan S, 2010, TROPHIC INTERACTIONS; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Miller MA, 2002, INT J PARASITOL, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Miller Melissa A., 2008, P319; Molino PJ, 2008, BIOFOULING, V24, P365, DOI 10.1080/08927010802254583; Oates SC, 2012, J WILDLIFE DIS, V48, P654, DOI 10.7589/0090-3558-48.3.654; Pal A, 2008, INDIAN J MICROBIOL, V48, P49, DOI 10.1007/s12088-008-0006-5; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Possenti A, 2010, INT J PARASITOL, V40, P1639, DOI 10.1016/j.ijpara.2010.06.009; Ramaiah N, 2001, MAR ECOL PROG SER, V212, P79, DOI 10.3354/meps212079; Rochelle-Newall EJ, 2010, J PLANKTON RES, V32, P1433, DOI 10.1093/plankt/fbq060; Searcy KE, 2006, APPL ENVIRON MICROB, V72, P6242, DOI 10.1128/AEM.00344-06; Selbmann L, 2003, ANTON LEEUW INT J G, V84, P135, DOI 10.1023/A:1025421401536; Shapiro K, 2012, LIMNOL OCEANOGR, V57, P449, DOI 10.4319/lo.2012.57.2.0449; Shapiro K, 2012, J WILDLIFE DIS, V48, P394, DOI 10.7589/0090-3558-48.2.394; Shapiro K, 2010, APPL ENVIRON MICROB, V76, P6821, DOI 10.1128/AEM.01435-10; Shapiro K, 2010, WATER RES, V44, P893, DOI 10.1016/j.watres.2009.09.061; Shapiro K, 2009, APPL ENVIRON MICROB, V75, P1185, DOI 10.1128/AEM.02109-08; Simental JA, 2004, J SHELLFISH RES, V23, P995; Smith DJ, 2000, J PHYCOL, V36, P321, DOI 10.1046/j.1529-8817.2000.99148.x; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thornton DCO, 2002, EUR J PHYCOL, V37, P149, DOI 10.1017/S0967026202003657; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; VANDEVIVERE P, 1993, APPL ENVIRON MICROB, V59, P3280, DOI 10.1128/AEM.59.10.3280-3286.1993; VanWormer E, 2013, COMP IMMUNOL MICROB, V36, P217, DOI 10.1016/j.cimid.2012.10.006; WATANABE JM, 1984, OECOLOGIA, V62, P47, DOI 10.1007/BF00377371; Wetherbee R, 1998, J PHYCOL, V34, P9, DOI 10.1046/j.1529-8817.1998.340009.x; Wotton RS., 2004, OCEANOGR MAR BIOL, V42, P57	66	25	28	0	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82477	10.1371/journal.pone.0082477	http://dx.doi.org/10.1371/journal.pone.0082477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24386100	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300034
J	Fan, YF; Fan, YB; Li, ZY; Newman, T; Lv, CS; Zhou, Y				Fan, Yifang; Fan, Yubo; Li, Zhiyu; Newman, Tony; Lv, Changsheng; Zhou, Yi			Screening Method Based on Walking Plantar Impulse for Detecting Musculoskeletal Senescence and Injury	PLOS ONE			English	Article							ELDERLY-PEOPLE; SPEED; FOOT; PREVENTION; MUSCLE	No consensus has been reached on how musculoskeletal system injuries or aging can be explained by a walking plantar impulse. We standardize the plantar impulse by defining a principal axis of plantar impulse. Based upon this standardized plantar impulse, two indexes are presented: plantar pressure record time series and plantar-impulse distribution along the principal axis of plantar impulse. These indexes are applied to analyze the plantar impulse collected by plantar pressure plates from three sources: Achilles tendon ruptures; elderly people (ages 62-71); and young people (ages 19-23). Our findings reveal that plantar impulse distribution curves for Achilles tendon ruptures change irregularly with subjects' walking speed changes. When comparing distribution curves of the young, we see a significant difference in the elderly subjects' phalanges plantar pressure record time series. This verifies our hypothesis that a plantar impulse can function as a means to assess and evaluate musculoskeletal system injuries and aging.	[Fan, Yifang; Lv, Changsheng; Zhou, Yi] Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China; [Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing, Peoples R China; [Li, Zhiyu; Newman, Tony] Jinan Univ, Coll Foreign Studies, Guangzhou, Guangdong, Peoples R China	Guangzhou Sport University; Beihang University; Jinan University	Fan, YF (corresponding author), Guangzhou Inst Phys Educ, Ctr Sci Res, Guangzhou, Guangdong, Peoples R China.	tfyf@gipe.edu.cn; yubofan@buaa.edu.cn	Fan, Yifang/V-6281-2019	Fan, Yifang/0000-0001-5338-9847	National Natural Science Foundation of China [10925208, 10972061, 11172073]; Guangdong Natural Science Foundation [S2011010001829]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This project was funded by National Natural Science Foundation of China under the Grant Numbers 10925208, 10972061, 11172073 and by Guangdong Natural Science Foundation under the grant number S2011010001829. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/60006; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bus SA, 2009, GAIT POSTURE, V29, P618, DOI 10.1016/j.gaitpost.2009.01.003; Dangour AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001023; Don R, 2007, CLIN BIOMECH, V22, P211, DOI 10.1016/j.clinbiomech.2006.10.001; Everitt B. S., 2006, CAMBRIDGE DICT STAT; Fan YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032926; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Giacomozzi C, 1997, IEEE Trans Rehabil Eng, V5, P322, DOI 10.1109/86.650285; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Keijsers NLW, 2010, GAIT POSTURE, V31, P140, DOI 10.1016/j.gaitpost.2009.08.248; Keijsers NLW, 2009, J BIOMECH, V42, P87, DOI 10.1016/j.jbiomech.2008.09.038; Leeden MVD, 2006, RHEUMATOLOGY, V45, P465; Lim BO, 2009, AM J SPORT MED, V37, P1728, DOI 10.1177/0363546509334220; Najafi B, 2010, GAIT POSTURE, V31, P87, DOI 10.1016/j.gaitpost.2009.09.003; Olshansky SJ, 2009, MILBANK Q, V87, P842, DOI 10.1111/j.1468-0009.2009.00581.x; Orlin MN, 2000, PHYS THER, V80, P399, DOI 10.1093/ptj/80.4.399; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Stanaway FF, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7679; Titianova EB, 2004, J ELECTROMYOGR KINES, V14, P275, DOI 10.1016/S1050-6411(03)00077-4; van Zee E. H., 1997, J LEARN SCI, V6, P229, DOI 10. 1207/s15327809jls0602_3; Vaughan Christopher L., 1999, DYNAMICS HUMAN GAIT; Verhagen EALM, 2010, SPORTS MED, V40, P899, DOI 10.2165/11536890-000000000-00000; Wrobel James S, 2010, J Diabetes Sci Technol, V4, P833; Zeni JA, 2009, CLIN BIOMECH, V24, P372, DOI 10.1016/j.clinbiomech.2009.02.001	32	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83839	10.1371/journal.pone.0083839	http://dx.doi.org/10.1371/journal.pone.0083839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386288	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700072
J	Li, SJ; Wang, X; Zhou, ZS; Zhu, J; Hu, J; Zhao, YP; Zhou, GW; Huang, GH				Li, Shun-Ji; Wang, Xing; Zhou, Zhong-Shi; Zhu, Jie; Hu, Jue; Zhao, Yi-Pei; Zhou, Gui-Wei; Huang, Guo-Hua			A Comparison of Growth and Development of Three Major Agricultural Insect Pests Infected with Heliothis virescens ascovirus 3h (HvAV-3h)	PLOS ONE			English	Article							DIADROMUS PULCHELLUS; VIRUS; LEPIDOPTERA; REPLICATION; EXPRESSION; SURVIVAL; HORMONE; LARVAE; HOST; DNA	Ascoviruses are double-stranded DNA viruses that are pathogenic to lepidopteran hosts, particularly noctuid larvae. Infection of a larva is characterized by retarded growth, reduced feeding and yellowish body color. In this paper, we reported the growth and development of three major agricultural noctuid insect pests, Helicoverpa armigera (Hubner), Spodoptera exigua (Hubner) and Spodoptera litura (Fabricius), infected with Heliothis virescens ascovirus 3h (HvAV-3h). Using 10-fold serial dilutions (0 to 7) of HvAV-3h-containing hemolymph to infect S. litura larvae, we found no significant difference in larval mortalities from 0 to 10(3)-fold dilutions; however, significant differences were observed at 10(4)-fold dilution and above. Using a 10-fold dilution of HvAV-3h-containing hemolymph to infect H. armigera, S. exigua and S. litura larvae, we found that the growth and development were significantly affected. All infected larvae could not pupate; the survival times of treated H. armigera, S. litura and S. exigua larvae were significantly longer than untreated control larvae. Body weight showed significant difference between treated and untreated control group from day 1 after inoculation in H. armigera and S. exigua, but day 2 in S. litura. Additionally, food intake also showed significant difference between treated and untreated control group from day 2 after inoculation in H. armigera and S. litura, but day 3 in S. exigua.	[Li, Shun-Ji; Zhu, Jie; Hu, Jue; Zhou, Gui-Wei; Huang, Guo-Hua] Hunan Agr Univ, Inst Virol, Changsha, Hunan, Peoples R China; [Wang, Xing; Zhao, Yi-Pei] Hunan Agr Univ, Oriental Sci & Technol Coll, Dept Plant Protect, Changsha, Hunan, Peoples R China; [Zhou, Zhong-Shi] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Huang, GH (corresponding author), Hunan Agr Univ, Inst Virol, Changsha, Hunan, Peoples R China.	tineidaehgh@gmail.com			National Natural Science Foundation of China [31371995]; National Major Science and Technology Project of the twelfth Five-year Plans [2012BAD27B00]; China Postdoctoral Science Special Foundation [2012T50695]; Scientific Research Fund of Hunan Provincial Education Department [12A070]; Hunan Postgraduate Technology Innovation Project [CX2013B308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Science and Technology Project of the twelfth Five-year Plans; China Postdoctoral Science Special Foundation; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Hunan Postgraduate Technology Innovation Project	This study was supported by the National Natural Science Foundation of China (31371995), the National Major Science and Technology Project of the twelfth Five-year Plans (2012BAD27B00), China Postdoctoral Science Special Foundation (2012T50695), Scientific Research Fund of Hunan Provincial Education Department (12A070) and Hunan Postgraduate Technology Innovation Project (CX2013B308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2006, ARCH VIROL, V151, P1689, DOI 10.1007/s00705-006-0762-7; Bigot Y, 1997, J GEN VIROL, V78, P1149, DOI 10.1099/0022-1317-78-5-1149; Bigot Y, 1997, J GEN VIROL, V78, P1139, DOI 10.1099/0022-1317-78-5-1139; Bigot Y., 2011, VIRAL TAXONOMY 9 REP, V3rd ed., P147, DOI [10.1016/B978-0-12-384684-6.00011-2, DOI 10.1016/B978-0-12-384684-6.00011-2]; BURTON R L, 1970, Journal of Economic Entomology, V63, P1969, DOI 10.1093/jee/63.6.1969; CARNER GR, 1983, J INVERTEBR PATHOL, V41, P238, DOI 10.1016/0022-2011(83)90224-0; Cheng XW, 1999, J GEN VIROL, V80, P1537, DOI 10.1099/0022-1317-80-6-1537; Cheng XW, 2005, J INVERTEBR PATHOL, V89, P193, DOI 10.1016/j.jip.2005.06.011; Cheng XW, 2000, J GEN VIROL, V81, P3083, DOI 10.1099/0022-1317-81-12-3083; de Jong J, 2009, J VIROL, V83, P7440, DOI 10.1128/JVI.02390-08; DOVER BA, 1988, ARCH INSECT BIOCHEM, V8, P113, DOI 10.1002/arch.940080205; Federici BA, 2009, CURR TOP MICROBIOL, V328, P171; FEDERICI BA, 1983, P NATL ACAD SCI-BIOL, V80, P7664, DOI 10.1073/pnas.80.24.7664; FEDERICI BA, 1982, J INVERTEBR PATHOL, V40, P41, DOI 10.1016/0022-2011(82)90035-0; FEDERICI BA, 1990, J GEN VIROL, V71, P1661, DOI 10.1099/0022-1317-71-8-1661; Furlong MJ, 2010, J INVERTEBR PATHOL, V103, P89, DOI 10.1016/j.jip.2009.11.001; GOVINDARAJAN R, 1990, J INVERTEBR PATHOL, V56, P291, DOI 10.1016/0022-2011(90)90115-M; Govindarajan R, 1990, J INVERTEBR PATHOL, V56, P300, DOI [10.1016/0022-2011(90)90116-N, DOI 10.1016/0022-2011(90)90116-N.PUBMED:2250100]; Jimenez-Cortes JG, 2012, J INSECT PHYSIOL, V58, P318, DOI 10.1016/j.jinsphys.2011.11.004; HAMAMURA Y, 1966, NATURE, V212, P1386, DOI 10.1038/2121386a0; HAMM JJ, 1986, FLA ENTOMOL, V69, P524, DOI 10.2307/3495385; HIRUMA K, 1985, DEV BIOL, V110, P509, DOI 10.1016/0012-1606(85)90109-5; Huang GH, 2012, J VIROL, V86, P12467, DOI 10.1128/JVI.02342-12; Huang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040225; Krug JM, 2013, MAR ECOL PROG SER, V477, P177, DOI 10.3354/meps10144; Liu RL, 2012, APPL MICROBIOL BIOT, V93, P1703, DOI 10.1007/s00253-011-3782-5; Martinez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035081; Moreira LF, 2011, CROP PROT, V30, P1285, DOI 10.1016/j.cropro.2011.05.023; Newton IR, 2004, BIOL CHARACTERISATIO, P191; Norusis MJ, 1994, SPSS PROFESSIONAL ST; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Ohno S, 2013, MOL CELL BIOCHEM, V381, P145, DOI 10.1007/s11010-013-1697-4; Pruthi HS, 1925, NATURE, V116, P938, DOI 10.1038/116938b0; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Song YQ, 2009, SHAANXI J AGR, V55, P228; Stadelbacher EA, 1979, 37 ANN P EL MICR SOC, P52; Stasiak K, 2005, J INSECT PHYSIOL, V51, P103, DOI 10.1016/j.jinsphys.2004.07.004; Tillman PG, 2004, ENVIRON ENTOMOL, V33, P633, DOI 10.1603/0046-225X-33.3.633; TRUMAN JW, 1983, J INSECT PHYSIOL, V29, P895, DOI 10.1016/0022-1910(83)90052-5; Xue JL, 2011, J GEN VIROL, V92, P2797, DOI 10.1099/vir.0.035733-0; Yamaguchi K, 2012, INSECT BIOCHEM MOLEC, V42, P183, DOI 10.1016/j.ibmb.2011.11.009	41	28	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85704	10.1371/journal.pone.0085704	http://dx.doi.org/10.1371/journal.pone.0085704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386488	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700145
J	Yang, MH; Yu, J; Chen, N; Wang, XY; Liu, XY; Wang, S; Ding, YQ				Yang, Min-Hui; Yu, Jiang; Chen, Na; Wang, Xiao-Yan; Liu, Xiang-Yu; Wang, Shuang; Ding, Yan-Qing			Elevated MicroRNA-31 Expression Regulates Colorectal Cancer Progression by Repressing Its Target Gene SATB2	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ONCOGENIC MICRORNA; POOR-PROGNOSIS; GASTRIC-CANCER; MIR-31; METASTASIS; SIGNATURE; PROTEIN; MIRNAS	Several studies have brought about increasing evidence to support the hypothesis that miRNAs play a pivotal role in multiple processes of carcinogenesis, including cell growth, apoptosis, differentiation, and metastasis. In this study, we investigated the potential role of miR-31 in colorectal cancer (CRC) aggressiveness and its underlying mechanisms. We found that miR-31 increased in CRC cells originated from metastatic foci and human primary CRC tissues with lymph node metastases. Furthermore, the high-level expression of miR-31 was significantly associated with a more aggressive and poor prognostic phenotype of patients with CRC (p < 0.05). The stable over-expression of miR-31 in CRC cells was sufficient to promote cell proliferation, invasion, and migration in vitro. It facilitated tumor growth and metastasis in vivo too. Further studies showed that miR-31 can directly bind to the 3' untranslated region (3'UTR) of SATB2 mRNA and subsequently repress both the mRNA and protein expressions of SATB2. Ectopic expression of SATB2 by transiently transfected with pCAG-SATB2 vector encoding the entire SATB2 coding sequence could reverse the effects of miR-31 on CRC tumorigenesis and progression. In addition, ectopic overexpression of miR-31 in CRC cells induced epithelial-mesenchymal transition (EMT). Our results illustrated that the up-regulation of miR-31 played an important role in CRC cell proliferation, invasion, and metastasis in vitro and in vivo through direct repressing SATB2, suggesting a potential application of miR-31 in prognosis prediction and therapeutic application in CRC.	[Yang, Min-Hui; Wang, Xiao-Yan; Wang, Shuang; Ding, Yan-Qing] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yang, Min-Hui; Chen, Na; Wang, Xiao-Yan; Wang, Shuang; Ding, Yan-Qing] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yu, Jiang] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Wang, Xiao-Yan] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Peking University	Wang, S (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	shuangw@126.com; dyqgz@126.com			National Natural Science Foundation of China [81000953, 81172242, 81071735]; Major projects of National Natural Science Foundation of China [81090422]; State Key Program of National Natural Science Foundation of China [U1201226]; National Basic Research Program of China (973 Program) [2010CB529402]; Key Program of National Natural Science Foundation of Guangdong, China [2010B031500012]; National Natural Science Foundation of Guangdong, China [10451051501004710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of National Natural Science Foundation of China; State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Program of National Natural Science Foundation of Guangdong, China; National Natural Science Foundation of Guangdong, China	This work was supported by the National Natural Science Foundation of China (No. 81000953, 81172242, 81071735), Major projects of National Natural Science Foundation of China((No. 81090422), State Key Program of National Natural Science Foundation of China (U1201226), National Basic Research Program of China (973 Program, No. 2010CB529402), Key Program of National Natural Science Foundation of Guangdong, China (2010B031500012) and National Natural Science Foundation of Guangdong, China (10451051501004710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Donnem T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029671; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hao JM, 2010, J PATHOL, V220, P475, DOI 10.1002/path.2668; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Ma XD, 2013, CARCINOGENESIS, V34, P1216, DOI 10.1093/carcin/bgt044; Menendez P, 2013, J SURG ONCOL, V108, P369, DOI 10.1002/jso.23415; Mitamura T, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.3; Nouraee N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073009; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Saxena A, 2013, EUR J CANCER, V49, P3311, DOI 10.1016/j.ejca.2013.05.031; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Stahlhut Espinosa Carlos E, 2006, Yale J Biol Med, V79, P131; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wang S, 2013, CLIN TRANSL ONCOL, V15, P849, DOI 10.1007/s12094-013-1014-4; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang Yan-Fei, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P126; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	44	82	92	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85353	10.1371/journal.pone.0085353	http://dx.doi.org/10.1371/journal.pone.0085353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386467	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700133
J	Zaidell, LN; Mileva, KN; Sumners, DP; Bowtell, JL				Zaidell, Lisa N.; Mileva, Katya N.; Sumners, David P.; Bowtell, Joanna L.			Experimental Evidence of the Tonic Vibration Reflex during Whole-Body Vibration of the Loaded and Unloaded Leg	PLOS ONE			English	Article							MUSCLE-ACTIVITY; NEUROMUSCULAR RESPONSES; STIMULATION; EXERCISE; EXCITABILITY; FREQUENCIES; FATIGUE; TENDON	Increased muscle activation during whole-body vibration (WBV) is mainly ascribed to a complex spinal and supraspinal neurophysiological mechanism termed the tonic vibration reflex (TVR). However, TVR has not been experimentally demonstrated during low-frequency WBV, therefore this investigation aimed to determine the expression of TVR during WBV. Whilst seated, eight healthy males were exposed to either vertical WBV applied to the leg via the plantar-surface of the foot, or Achilles tendon vibration (ATV) at 25Hz and 50Hz for 70s. Ankle plantar-flexion force, tri-axial accelerations at the shank and vibration source, and surface EMG activity of m. soleus (SOL) and m. tibialis anterior (TA) were recorded from the unloaded and passively loaded leg to simulate body mass supported during standing. Plantar flexion force was similarly augmented by WBV and ATV and increased over time in a load-and frequency dependent fashion. SOL and TA EMG amplitudes increased over time in all conditions independently of vibration mode. 50Hz WBV and ATV resulted in greater muscle activation than 25Hz in SOL when the shank was loaded and in TA when the shank was unloaded despite the greater transmission of vertical acceleration from source to shank with 25Hz and WBV, especially during loading. Low-amplitude WBV of the unloaded and passively loaded leg produced slow tonic muscle contraction and plantar-flexion force increase of similar magnitudes to those induced by Achilles tendon vibration at the same frequencies. This study provides the first experimental evidence supporting the TVR as a plausible mechanism underlying the neuromuscular response to whole-body vibration.	[Zaidell, Lisa N.; Mileva, Katya N.; Sumners, David P.] London S Bank Univ, London, England; [Bowtell, Joanna L.] Univ Exeter, Exeter, Devon, England	London South Bank University; University of Exeter	Zaidell, LN (corresponding author), London S Bank Univ, London, England.	zaidelll@lsbu.ac.uk			London South Bank University	London South Bank University	No external funding was provided to carry out this research study. LZ was supported by a PhD stipend by London South Bank University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1642, DOI 10.1249/mss.0b013e318093f551; BISHOP B, 1974, PHYS THER, V54, P1273, DOI 10.1093/ptj/54.12.1273; BURKE D, 1972, J NEUROL NEUROSUR PS, V35, P477, DOI 10.1136/jnnp.35.4.477; Calvin-Figuiere S, 2000, BRAIN RES, V881, P128, DOI 10.1016/S0006-8993(00)02604-4; Cardinale M, 2003, MED SPORT, V56, P287; Cardinale M, 2003, J STRENGTH COND RES, V17, P621; Cochrane DJ, 2011, J SPORT SCI MED, V10, P19; Cochrane DJ, 2010, EUR J APPL PHYSIOL, V108, P311, DOI 10.1007/s00421-009-1215-2; Cook DP, 2011, J STRENGTH COND RES, V25, P298, DOI 10.1519/JSC.0b013e3181be3003; EKLUND G, 1966, EXP NEUROL, V16, P80, DOI 10.1016/0014-4886(66)90088-4; Forth KE, 2008, AVIAT SPACE ENVIR MD, V79, P844, DOI 10.3357/ASEM.2176.2008; Fratini A, 2009, MED ENG PHYS, V31, P1166, DOI 10.1016/j.medengphy.2009.07.014; HAGBARTH KE, 1967, ACTA SOC MED UPS, V72, P102; Hazell TJ, 2007, APPL PHYSIOL NUTR ME, V32, P1156, DOI 10.1139/H07-116; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kavounoudias A, 1998, NEUROREPORT, V9, P3247, DOI 10.1097/00001756-199810050-00021; Kiiski J, 2008, J BONE MINER RES, V23, P1318, DOI [10.1359/jbmr.080315, 10.1359/JBMR.080315]; Martin BJ, 1997, EUR J APPL PHYSIOL, V75, P504, DOI 10.1007/s004210050196; Masani K, 2013, GAIT POSTURE, V37, P72, DOI 10.1016/j.gaitpost.2012.06.006; MATTHEWS PB, 1966, J PHYSIOL-LONDON, V184, P450, DOI 10.1113/jphysiol.1966.sp007926; McBride JM, 2010, J STRENGTH COND RES, V24, P184, DOI 10.1519/JSC.0b013e31819b79cf; Mileva KN, 2009, EXP PHYSIOL, V94, P103, DOI 10.1113/expphysiol.2008.042689; Mottram CJ, 2006, J NEUROPHYSIOL, V95, P1185, DOI 10.1152/jn.00807.2005; Nordlund MM, 2007, SCAND J MED SCI SPOR, V17, P12, DOI 10.1111/j.1600-0838.2006.00586.x; Pollock RD, 2010, CLIN BIOMECH, V25, P840, DOI 10.1016/j.clinbiomech.2010.05.004; Rittweger J, 2003, CLIN PHYSIOL FUNCT I, V23, P81, DOI 10.1046/j.1475-097X.2003.00473.x; ROTHMULLER C, 1995, J PHYSIOL-LONDON, V485, P857, DOI 10.1113/jphysiol.1995.sp020775; SALE DG, 1988, MED SCI SPORT EXER, V20, pS135, DOI 10.1249/00005768-198810001-00009; Sayenko DG, 2010, NEUROSCI LETT, V482, P66, DOI 10.1016/j.neulet.2010.07.009; Suresh NL, 2011, IEEE ENG MED BIO, P2053, DOI 10.1109/IEMBS.2011.6090379; Wakeling JM, 2002, J APPL PHYSIOL, V93, P1093, DOI 10.1152/japplphysiol.00142.2002; Winter DA, 1990, BIOMECHANICS MOTOR C; Zaidell LN, 2009, P PHYSL SOC, V14, pPC26	33	58	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85247	10.1371/journal.pone.0085247	http://dx.doi.org/10.1371/journal.pone.0085247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386466	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700132
J	Aubertin, K; Bonneau, S; Silva, AKA; Bacri, JC; Gallet, F; Wilhelm, C				Aubertin, Kelly; Bonneau, Stephanie; Silva, Amanda K. A.; Bacri, Jean-Claude; Gallet, Francois; Wilhelm, Claire			Impact of Photosensitizers Activation on Intracellular Trafficking and Viscosity	PLOS ONE			English	Article							PHOTOCHEMICAL INTERNALIZATION; PHOTODYNAMIC THERAPY; SINGLET OXYGEN; SUBCELLULAR-LOCALIZATION; CELLULAR UPTAKE; GIANT VESICLES; MECHANISMS; TRANSPORT; DETERMINANTS; MICROTUBULES	The intracellular microenvironment is essential for the efficiency of photo-induced therapies, as short-lived reactive oxygen species generated must diffuse through their intracellular surrounding medium to reach their cellular target. Here, by combining measurements of local cytoplasmic dissipation and active trafficking, we found that photosensitizers activation induced small changes in surrounding viscosity but a massive decrease in diffusion. These effects are the signature of a return to thermodynamic equilibrium of the system after photo-activation and correlated with depolymerization of the microtubule network, as shown in a reconstituted system. These mechanical measurements were performed with two intracellular photosensitizing chlorins having similar quantum yield of singlet oxygen production but different intracellular localizations ( cytoplasmic for mTHPC, endosomal for TPCS2a). These two agents demonstrated different intracellular impact.	[Aubertin, Kelly; Silva, Amanda K. A.; Bacri, Jean-Claude; Gallet, Francois; Wilhelm, Claire] CNRS, Lab Mat & Syst Complexes MSC, Paris, France; [Aubertin, Kelly; Silva, Amanda K. A.; Bacri, Jean-Claude; Gallet, Francois; Wilhelm, Claire] Univ Paris Diderot, Paris, France; [Bonneau, Stephanie] Univ Paris 06, CNRS, Lab Jean Perrin, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Wilhelm, C (corresponding author), CNRS, Lab Mat & Syst Complexes MSC, Paris, France.	claire.wilhelm@univ-paris-diderot.fr	Aubertin, Kelly/A-5515-2018; Bonneau, Stéphanie/H-6918-2013; Aubertin, Kelly/N-6931-2019	Aubertin, Kelly/0000-0001-9923-0129; Bonneau, Stéphanie/0000-0003-2039-0037; Aubertin, Kelly/0000-0001-9923-0129; Wilhelm, Claire/0000-0001-7024-9627; Silva, Amanda K. A./0000-0002-7713-1813	European commission's FP7 (project Magnifyco) [NMP4-SL-2009-228622]	European commission's FP7 (project Magnifyco)	This work was supported by the by the European commission's FP7 (project Magnifyco NMP4-SL-2009-228622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.160603; Arcizet D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248103; Berg K, 1999, CANCER RES, V59, P1180; Berg K, 1997, PHOTOCHEM PHOTOBIOL, V65, P403, DOI 10.1111/j.1751-1097.1997.tb08578.x; BERG K, 1990, INT J RADIAT BIOL, V58, P475, DOI 10.1080/09553009014551821; Berg K, 2005, J MICROSC-OXFORD, V218, P133, DOI 10.1111/j.1365-2818.2005.01471.x; BERG K, 1992, BIOCHIM BIOPHYS ACTA, V1135, P147, DOI 10.1016/0167-4889(92)90130-4; Berg K, 2011, PHOTOCH PHOTOBIO SCI, V10, P1637, DOI 10.1039/c1pp05128h; Bonneau S, 2008, EXPERT OPIN THER PAT, V18, P1011, DOI 10.1517/13543776.18.9.1011; Brangwynne CP, 2009, TRENDS CELL BIOL, V19, P423, DOI 10.1016/j.tcb.2009.04.004; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Breitenbach T, 2009, PHOTOCH PHOTOBIO SCI, V8, P442, DOI 10.1039/b809049a; Bruno L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011912; Bruno L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018332; Bursac P, 2007, BIOCHEM BIOPH RES CO, V355, P324, DOI 10.1016/j.bbrc.2007.01.191; Castano AP, 2005, PHOTODIAGN PHOTODYN, V2, P91, DOI 10.1016/S1572-1000(05)00060-8; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Fayol D, 2013, ADV HEALTHC MATER, V2, P313, DOI 10.1002/adhm.201200294; Goldstein D, 2013, SOFT MATTER, V9, P7167, DOI 10.1039/c3sm50172h; Guo HL, 2006, BIOPHYS J, V90, P2093, DOI 10.1529/biophysj.105.071209; Hatz S, 2008, PHOTOCHEM PHOTOBIOL, V84, P1284, DOI 10.1111/j.1751-1097.2008.00359.x; Herold C, 2012, CHEMPHYSCHEM, V13, P1001, DOI 10.1002/cphc.201100669; Heuvingh J, 2009, BIOPHYS J, V97, P2904, DOI 10.1016/j.bpj.2009.08.056; Juarranz A, 2001, PHOTOCHEM PHOTOBIOL, V73, P283, DOI 10.1562/0031-8655(2001)073<0283:PIBZIP>2.0.CO;2; Kuimova MK, 2009, J AM CHEM SOC, V131, P332, DOI 10.1021/ja807484b; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Liu TC, 2010, CANCER LETT, V296, P106, DOI 10.1016/j.canlet.2010.04.003; Ma LW, 1996, CANCER LETT, V109, P129, DOI 10.1016/S0304-3835(96)04437-0; MacKintosh FC, 2010, CURR OPIN CELL BIOL, V22, P29, DOI 10.1016/j.ceb.2010.01.002; Marion S, 2004, J CELL SCI, V117, P3271, DOI 10.1242/jcs.01178; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mojzisova H, 2007, EUR BIOPHYS J BIOPHY, V36, P943, DOI 10.1007/s00249-007-0204-9; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Petrovajova D, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075609; Riviere C, 2007, EUR PHYS J E, V22, P1, DOI 10.1140/epje/e2007-00014-1; Robert D, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011905; Robert D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010046; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Selbo PK, 2001, INT J CANCER, V92, P761, DOI 10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4; Silva AKA, 2012, NANOMEDICINE-UK, V7, P1713, DOI [10.2217/NNM.12.40, 10.2217/nnm.12.40]; Stuhrmann B, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.020901; Tian F, 2007, BIOMACROMOLECULES, V8, P3767, DOI 10.1021/bm700687x; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verderio C, 2012, BIOL CELL, V104, P213, DOI 10.1111/boc.201100070; VIKDAL M, BIOCH PHARM; Wang JTW, 2013, PHOTOCH PHOTOBIO SCI, V12, P519, DOI 10.1039/c2pp25328c; Wilhelm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.011504; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Yow CMN, 2000, CANCER LETT, V157, P123, DOI 10.1016/S0304-3835(00)00453-5	52	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84850	10.1371/journal.pone.0084850	http://dx.doi.org/10.1371/journal.pone.0084850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386423	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900113
J	Creighton, CJ				Creighton, Chad J.			Widespread Molecular Patterns Associated with Drug Sensitivity in Breast Cancer Cell Lines, with Implications for Human Tumors	PLOS ONE			English	Article							PATHWAY	Background: Recent landmark studies have profiled cancer cell lines for molecular features, along with measuring the corresponding growth inhibitory effects for specific drug compounds. These data present a tool for determining which subsets of human cancer might be more responsive to particular drugs. To this end, the NCI-DREAM-sponsored DREAM7: Drug Sensitivity Prediction Challenge (sub-challenge 1) set out to predict the sensitivities of 18 breast cancer cell lines to 31 previously untested compounds, on the basis of molecular profiling data and a training subset of cell lines. Methods and Results: With 47 teams submitting blinded predictions, team Creighton scored third in terms of overall accuracy. Team Creighton's method was simple and straightforward, incorporated multiple expression data types (RNA-seq, gene array, RPPA), and incorporated all profiled features (not only the "best" predictive ones). As an extension of the approach, cell line data, from public datasets of expression profiling coupled with drug sensitivities (Barretina, Garnett, Heiser) were used to "predict" the drug sensitivities in human breast tumors (using data from The Cancer Genome Atlas). Drug sensitivity correlations within human breast tumors showed differences by expression-based subtype, with many associations in line with the expected (e. g. Lapatinib sensitivity in HER2-enriched cancers) and others inviting further study (e. g. relative resistance to PI3K inhibitors in basal-like cancers). Conclusions: Molecular patterns associated with drug sensitivity are widespread, with potentially hundreds of genes that could be incorporated into making predictions, as well as offering biological clues as to the mechanisms involved. Applying the cell line patterns to human tumor data may help generate hypotheses on what tumor subsets might be more responsive to therapies, where multiple cell line datasets representing various drugs may be used, in order to assess consistency of patterns.	[Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Creighton, CJ (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	creighto@bcm.edu			National Institutes of Health/National Cancer Institute [P30 CA125123, P50 CA58183-16, U24CA143843]; NATIONAL CANCER INSTITUTE [P30CA125123, P50CA058183, U24CA143843] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health/National Cancer Institute grants P30 CA125123, P50 CA58183-16, and U24CA143843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Colleoni M, 2010, J CLIN ONCOL, V28, P2966, DOI 10.1200/JCO.2009.25.9549; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349	7	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e71158	10.1371/journal.pone.0071158	http://dx.doi.org/10.1371/journal.pone.0071158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386073	gold, Green Submitted, Green Published			2022-12-27	WOS:000329117900001
J	Petrelli, F; Zaniboni, A; Coinu, A; Cabiddu, M; Ghilardi, M; Sgroi, G; Barni, S				Petrelli, Fausto; Zaniboni, Alberto; Coinu, Andrea; Cabiddu, Mary; Ghilardi, Mara; Sgroi, Giovanni; Barni, Sandro			Cisplatin or Not in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MULTICENTER PHASE-II; FOLINIC ACID; IRINOTECAN; ADENOCARCINOMA; FLUOROURACIL; CAPECITABINE; OXALIPLATIN; TRIAL; 5-FLUOROURACIL; LEUCOVORIN	Background: Cisplatin-based chemotherapy is frequently used to treat advanced gastric cancer (GC). Although it leads to increased overall survival (OS) when added to single agents or chemotherapy doublets, toxicity is also generally increased. The purpose of this meta-analysis study was to compare the efficacy of fchemotherapy with and without cisplatin in patients with advanced GC. Methods: Randomised trials that compared first-line cisplatin-based chemotherapy with regimens in which cisplatin was replaced by other agents were identified by electronic searches of PubMed, EMBASE, the Web of Science, and the Cochrane Central Register of Controlled Trials. Meta-analysis was performed using a fixed or random effects model. OS, reported as a hazard ratio (HR) and a 95% confidence interval (CI), was the primary outcome measure. Results: Fourteen trials (5 phase III and 9 phase II), including 2,981 patients, were identified. Overall, chemotherapy regimens without cisplatin significantly improved OS (HR, 0.79; 95% CI, 0.68-0.92; p = 0.003), progression-free survival (PFS) (HR, 0.77; 95% CI, 0.66-0.90; p = 0.001), and response rate (RR) (OR, 1.25; p = 0.004) when compared to cisplatin-containing regimens. A subgroup analysis according to histology, site of the primary tumour and extent of disease was not possible due to lack of data. Conclusions: Compared with cisplatin-based doublets and triplets, combinations in which cisplatin was replaced by new drugs improved outcome and RRs in randomised trials for advanced GC and therefore should be strongly considered in the metastatic setting. A limitation of this meta-analysis is that we cannot identify a subgroup of patients (according to histology, site of primary tumour or burden of metastatic disease) which could derive greater benefit from cisplatin-free chemotherapy.	[Petrelli, Fausto; Coinu, Andrea; Cabiddu, Mary; Ghilardi, Mara; Barni, Sandro] Azienda Osped Treviglio, Dept Oncol, Med Oncol Unit, Treviglio, BG, Italy; [Zaniboni, Alberto] Ist Osped Fdn Poliambulanza, Med Oncol Unit, Brescia, Italy; [Sgroi, Giovanni] Azienda Osped Treviglio, Dept Surg, Surg Oncol Unit, Treviglio, BG, Italy		Petrelli, F (corresponding author), Azienda Osped Treviglio, Dept Oncol, Med Oncol Unit, Treviglio, BG, Italy.	faupe@libero.it		Sgroi, Giovanni/0000-0003-4956-124X				Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bouche O, 2004, J CLIN ONCOL, V22, P4319, DOI 10.1200/JCO.2004.01.140; Cassidy J, 2011, ANN ONCOL, V22, P2604, DOI 10.1093/annonc/mdr031; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dank M, 2008, ANN ONCOL, V19, P1450, DOI 10.1093/annonc/mdn166; Elsaid AA, 2005, J CLIN ONCOL, V23, p311S; HEGEWISCHBECKER S, 2012, J CLIN ONCOL S, V30; Higuchi K, 2012, J CLIN ONCOL S34, V30; Huang JH, 2011, MED ONCOL, V28, P1004, DOI 10.1007/s12032-010-9594-0; Ikeda R, 2009, J CLIN ONCOL S, V27, p15s; Jeung HC, 2011, CANCER-AM CANCER SOC, V117, P2050, DOI 10.1002/cncr.25729; Mochiki E, 2012, BRIT J CANCER, V107, P31, DOI 10.1038/bjc.2012.222; Moehler M, 2010, ANN ONCOL, V21, P71, DOI 10.1093/annonc/mdp269; Montagnani F, 2011, GASTRIC CANCER, V14, P50, DOI 10.1007/s10120-011-0007-7; Oba K, 2013, EUR J CANCER, V49, P1565, DOI 10.1016/j.ejca.2012.12.016; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Popov I, 2008, J BUON, V13, P505; Pozzo C, 2004, ANN ONCOL, V15, P1773, DOI 10.1093/annonc/mdh473; Qi WX, 2013, INT J CANCER, V132, pE66, DOI 10.1002/ijc.27775; Roth AD, 2007, J CLIN ONCOL, V25, P3217, DOI 10.1200/JCO.2006.08.0135; Seng S, 2012, J CLIN ONCOL, V30, P4416, DOI 10.1200/JCO.2012.42.4358; Sym S, 2009, J CLIN ONCOL S, V27, p15s; Tesselaar ME, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.4567; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303	28	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83022	10.1371/journal.pone.0083022	http://dx.doi.org/10.1371/journal.pone.0083022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386137	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900018
J	Yang, K; Lu, L; Liu, Y; Zhang, Q; Pu, LJ; Wang, LJ; Zhu, ZB; Wang, YN; Meng, H; Zhang, XJ; Du, R; Chen, QJ; Shen, WF				Yang, Ke; Lu, Lin; Liu, Yan; Zhang, Qi; Pu, Li Jin; Wang, Lin Jie; Zhu, Zhen Bing; Wang, Ya Nan; Meng, Hua; Zhang, Xiao Jie; Du, Run; Chen, Qiu Jing; Shen, Wei Feng			Increase of ADAM10 Level in Coronary Artery In-Stent Restenosis Segments in Diabetic Minipigs: High ADAM10 Expression Promoting Growth and Migration in Human Vascular Smooth Muscle Cells via Notch 1 and 3	PLOS ONE			English	Article							MEDIATES NEOINTIMAL FORMATION; ELUTING STENT; RECEPTOR; CLEAVAGE; DISINTEGRIN; RAGE; RELEASE; PROTEIN; MATRIX	Background: This study aimed to identify major proteins in the pathogenesis of coronary artery in-stent restenosis (ISR) in diabetic minipigs with sirolimus-eluting stenting, and to investigate the roles of key candidate molecules, particularly ADAM10, in human arterial smooth muscle cells (HASMCs). Methods and Results: The stents were implanted in the coronary arteries of 15 diabetic and 26 non-diabetic minipigs, and angiography was repeated at six months. The intima of one vascular segment with significant ISR and one with non-ISR in diabetic minipigs were isolated and cultured in conditioned medium (CM). The CM was analyzed by LC-MS/MS to uncover proteins whose levels were significantly increased (>= 1.5-fold) in ISR than in non-ISR tissues. After literature searching, we focused on the identified proteins, whose biological functions were most potentially related to ISR pathophysiology. Among them, ADAM10 was significantly increased in diabetic and nondiabetic ISR tissues as compared with non-ISR controls. In cell experiments, retrovirus-mediated overexpression of ADAM10 promoted growth and migration of HASMCs. The effects of ADAM10 were more remarkable in high-glucose culture than in low-glucose culture. Using shRNA and an inhibitor of.-secretase (GSI), we found that the influences of ADAM10 were in part mediated by Notch1 and notch 3 pathway, which up-regulated Notch downstream genes and enhanced nuclear translocation of the small intracellular component of Notch1 and Notch3. Conclusions: This study has identified significantly increased expression of ADAM10 in the ISR versus non-ISR segment in diabetic minipigs and implicates ADAM10 in the enhanced neointimal formation observed in diabetes after vascular injury.	[Yang, Ke; Lu, Lin; Liu, Yan; Zhang, Qi; Pu, Li Jin; Wang, Lin Jie; Zhu, Zhen Bing; Wang, Ya Nan; Meng, Hua; Zhang, Xiao Jie; Chen, Qiu Jing; Shen, Wei Feng] Jiao Tong Univ, Inst Cardiovasc Dis, Sch Med, Shanghai 200030, Peoples R China; [Lu, Lin; Zhang, Qi; Wang, Lin Jie; Zhu, Zhen Bing; Du, Run; Shen, Wei Feng] Jiao Tong Univ, Dept Cardiol, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, WF (corresponding author), Jiao Tong Univ, Inst Cardiovasc Dis, Sch Med, Shanghai 200030, Peoples R China.	rjshenweifeng@yahoo.com.cn	wang, lin/HHM-2225-2022	Yang, Ke/0000-0002-1870-1134	Research Fund for the National Nature Science Funding of China [30871084, 3087127]	Research Fund for the National Nature Science Funding of China	This work was supported by grants from the Research Fund for the National Nature Science Funding of China (No. 30871084 and No. 3087127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Llamas G, 2007, MOL CELL PROTEOMICS, V6, P589, DOI 10.1074/mcp.M600265-MCP200; Barlis P, 2010, EUR HEART J, V31, P165, DOI 10.1093/eurheartj/ehp480; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; CAVAGI BE, 2009, MOL CELL BIOL, V29, P5679, DOI DOI 10.1128/MCB.00406-09.PUBMED:19704010; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fan CL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000901; George J, 2001, J AM COLL CARDIOL, V38, P1564, DOI 10.1016/S0735-1097(01)01579-0; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; KASTRATI A, 1993, CIRCULATION, V87, P1498, DOI 10.1161/01.CIR.87.5.1498; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Lu L, 2008, INT J EXP PATHOL, V89, P125, DOI 10.1111/j.1365-2613.2008.00579.x; Lu L, 2013, ARTERIOSCL THROM VAS, V33, P572, DOI 10.1161/ATVBAHA.112.301016; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Ruan W, 2009, J AM SOC ECHOCARDIOG, V22, P530, DOI 10.1016/j.echo.2009.02.023; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Stenestrand U, 2010, EUR HEART J, V31, P177, DOI 10.1093/eurheartj/ehp424; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Xiao T, 2005, MOL CELL PROTEOMICS, V4, P1480, DOI 10.1074/mcp.M500055-MCP200; Zhang Q, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-16; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	35	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83853	10.1371/journal.pone.0083853	http://dx.doi.org/10.1371/journal.pone.0083853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386293	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900062
J	Berger-Muller, S; Sugie, A; Takahashi, F; Tavosanis, G; Hakeda-Suzuki, S; Suzuki, T				Berger-Mueller, Sandra; Sugie, Atsushi; Takahashi, Fumio; Tavosanis, Gaia; Hakeda-Suzuki, Satoko; Suzuki, Takashi			Assessing the Role of Cell-Surface Molecules in Central Synaptogenesis in the Drosophila Visual System	PLOS ONE			English	Article							SYNAPTIC-LAYER SPECIFICITY; TRANSMEMBRANE PROTEIN; FUNCTIONAL DISSECTION; TARGET SPECIFICITY; BOUNDARY FORMATION; AXON; REFINEMENT; EXPRESSION; FLAMINGO; CADHERIN	A hallmark of the central nervous system is its spatial and functional organization in synaptic layers. During neuronal development, axons form transient contacts with potential post-synaptic elements and establish synapses with appropriate partners at specific layers. These processes are regulated by synaptic cell-adhesion molecules. In the Drosophila visual system, R7 and R8 photoreceptor subtypes target distinct layers and form en passant pre-synaptic terminals at stereotypic loci of the axonal shaft. A leucine-rich repeat transmembrane protein, Capricious (Caps), is known to be selectively expressed in R8 axons and their recipient layer, which led to the attractive hypothesis that Caps mediates R8 synaptic specificity by homophilic adhesion. Contradicting this assumption, our results indicate that Caps does not have a prominent role in synaptic-layer targeting and synapse formation in Drosophila photoreceptors, and that the specific recognition of the R8 target layer does not involve Caps homophilic axon-target interactions. We generated flies that express a tagged synaptic marker to evaluate the presence and localization of synapses in R7 and R8 photoreceptors. These genetic tools were used to assess how the synaptic profile is affected when axons are forced to target abnormal layers by expressing axon guidance molecules. When R7 axons were mistargeted to the R8-recipient layer, R7s either maintained an R7-like synaptic profile or acquired a similar profile to r8s depending on the overexpressed protein. When R7 axons were redirected to a more superficial medulla layer, the number of presynaptic terminals was reduced. These results indicate that cell-surface molecules are able to dictate synapse loci by changing the axon terminal identity in a partially cell-autonomous manner, but that presynapse formation at specific sites also requires complex interactions between pre- and post-synaptic elements.	[Berger-Mueller, Sandra; Sugie, Atsushi; Hakeda-Suzuki, Satoko; Suzuki, Takashi] Max Planck Inst Neurobiol, Res Grp Axon Guidance & Neuronal Connect, D-82152 Martinsried, Germany; [Berger-Mueller, Sandra] CNRS 5273, Unite Mixte Rech STROMALab, Toulouse, France; [Sugie, Atsushi; Tavosanis, Gaia] German Ctr Neurodegenerat Dis DZNE, Dendrite Differentiat Grp, Bonn, Germany; [Takahashi, Fumio; Hakeda-Suzuki, Satoko; Suzuki, Takashi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Max Planck Society; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Tokyo Institute of Technology	Suzuki, T (corresponding author), Max Planck Inst Neurobiol, Res Grp Axon Guidance & Neuronal Connect, D-82152 Martinsried, Germany.	suzukit@bio.titech.ac.jp	Suzuki, Takashi/D-3651-2019; Hakeda-suzuki, Satoko/AAU-5348-2020	Suzuki, Takashi/0000-0001-9093-2562; Hakeda-suzuki, Satoko/0000-0001-8749-1479; Tavosanis, Gaia/0000-0002-8679-5515	Alexander von Humboldt Foundation; Max Planck Society; Mitsubishi foundation; Tomizawa foundation; JSPS	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX); Mitsubishi foundation; Tomizawa foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Alexander von Humboldt Foundation (A. S.), the Max Planck Society, Grants-in-Aid for Scientific Research (JSPS) and Mitsubishi foundation and the Tomizawa foundation (T. S.). S.H.-S. is a Research Fellow of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Bukalo O, 2012, ADV EXP MED BIOL, V970, P97, DOI 10.1007/978-3-7091-0932-8_5; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Clements J, 2008, P NATL ACAD SCI USA, V105, P16183, DOI 10.1073/pnas.0708330105; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edwards TN, 2009, J NEUROSCI, V29, P828, DOI 10.1523/JNEUROSCI.1022-08.2009; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kohsaka H, 2009, DEVELOPMENT, V136, P1127, DOI 10.1242/dev.027920; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lu B, 2009, CURR OPIN NEUROBIOL, V19, P162, DOI 10.1016/j.conb.2009.04.004; Mao Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001827; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Newsome TP, 2000, DEVELOPMENT, V127, P851; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Sakurai KT, 2007, DEV BIOL, V309, P126, DOI 10.1016/j.ydbio.2007.07.001; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Taniguchi H, 2000, J NEUROBIOL, V42, P104, DOI 10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83732	10.1371/journal.pone.0083732	http://dx.doi.org/10.1371/journal.pone.0083732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386266	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700075
J	Claxton, JS; Sandoval, PC; Liu, G; Chou, CL; Hoffert, JD; Knepper, MA				Claxton, J'Neka S.; Sandoval, Pablo C.; Liu, Gary; Chou, Chung-Lin; Hoffert, Jason D.; Knepper, Mark A.			Endogenous Carbamylation of Renal Medullary Proteins	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEMOGLOBIN CARBAMYLATION; WATER DIURESIS; IN-VIVO; UREA; IDENTIFICATION; ACETYLATION; EXCRETION; PEPTIDES; UREMIA	Protein carbamylation is a post-translational modification that can occur in the presence of urea. In solution, urea is in equilibrium with ammonium cyanate, and carbamylation occurs when cyanate ions react with the amino groups of lysines, arginines, protein N-termini, as well as sulfhydryl groups of cysteines. The concentration of urea is elevated in the renal inner medulla compared with other tissues. Due to the high urea concentration, we hypothesized that carbamylation can occur endogenously within the rat inner medulla. Using immunoblotting of rat kidney cortical and medullary homogenates with a carbamyl-lysine specific antibody, we showed that carbamylation is present in a large number of inner medullary proteins. Using protein mass spectrometry (LC-MS/MS) of rat renal inner medulla, we identified 456 unique carbamylated sites in 403 proteins, including many that play important physiological roles in the renal medulla [Data can be accessed at https://helixweb.nih.gov/ESBL/Database/Carbamylation/Carbamylation_peptide_sorted.html]. We conclude that protein carbamylation occurs endogenously in the kidney, modifying many physiologically important proteins.	[Claxton, J'Neka S.; Sandoval, Pablo C.; Liu, Gary; Chou, Chung-Lin; Hoffert, Jason D.; Knepper, Mark A.] NHLBI, Epithelial Syst Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Knepper, MA (corresponding author), NHLBI, Epithelial Syst Biol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	knepperm@nhlbi.nih.gov	Knepper, Mark/AAF-8412-2020		Intramural budget of NHLBI [ZO1-HL001285]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006129, ZIAHL001285, ZIGHL006020, Z01HL001285] Funding Source: NIH RePORTER	Intramural budget of NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural budget of NHLBI (Project ZO1-HL001285, M. A. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Arumugam Bavani, 2010, Romanian Journal of Biochemistry, V47, P115; ATHERTON JC, 1968, J PHYSIOL-LONDON, V197, P395, DOI 10.1113/jphysiol.1968.sp008566; ATHERTON JC, 1968, J PHYSIOL-LONDON, V197, P429, DOI 10.1113/jphysiol.1968.sp008568; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FLUCKIGER R, 1981, NEW ENGL J MED, V304, P823, DOI 10.1056/NEJM198104023041406; GARCIAPEREZ A, 1989, J BIOL CHEM, V264, P16815; GONEN B, 1985, METABOLISM, V34, P10, DOI 10.1016/0026-0495(85)90052-6; Gutierrez DB, 2011, EXP EYE RES, V93, P912, DOI 10.1016/j.exer.2011.10.007; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Hoffert JD, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014613; Holzer M, 2011, ANTIOXID REDOX SIGN, V14, P2337, DOI 10.1089/ars.2010.3640; HORKKO S, 1992, KIDNEY INT, V41, P1175, DOI 10.1038/ki.1992.179; Hwang S, 2010, AM J PHYSIOL-RENAL, V299, pF559, DOI 10.1152/ajprenal.00617.2009; JARAUSCH K H, 1956, Pflugers Arch Gesamte Physiol Menschen Tiere, V262, P537; Kairaitis LK, 2000, NEPHROL DIAL TRANSPL, V15, P1431, DOI 10.1093/ndt/15.9.1431; KNEPPER MA, 1975, KIDNEY INT, V8, P303, DOI 10.1038/ki.1975.117; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; Lapko VN, 2001, PROTEIN SCI, V10, P1130, DOI 10.1110/ps.40901; Muenchbach M, 1998, BIOCHEM BIOPH RES CO, V249, P304, DOI 10.1006/bbrc.1998.9138; OIMOMI M, 1987, NEPHRON, V46, P63, DOI 10.1159/000184303; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; STARK GR, 1960, J BIOL CHEM, V235, P3177; STARK RG, 1964, J BIOL CHEM, V239, P1411; STEINBRECHER UP, 1984, J LIPID RES, V25, P1109; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tchapyjnikov D, 2010, PHYSIOL GENOMICS, V40, P167, DOI 10.1152/physiolgenomics.00148.2009; Trepanier DJ, 1996, CLIN BIOCHEM, V29, P347, DOI 10.1016/0009-9120(96)00038-0; Walker J., 1895, J CHEM SOC, V67, P746, DOI DOI 10.1039/CT8956700746; Wang GH, 2006, ANAL CHEM, V78, P5752, DOI 10.1021/ac060611v	32	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82655	10.1371/journal.pone.0082655	http://dx.doi.org/10.1371/journal.pone.0082655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386107	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700011
J	Kim, JH; Park, EC; Nam, JM; Park, S; Cho, J; Kim, SJ; Choi, JW; Cho, E				Kim, Jae-Hyun; Park, Eun-Cheol; Nam, Jung-Mo; Park, Sohee; Cho, Jaelim; Kim, Sun-Jung; Choi, Jae-Woo; Cho, Eun			The Werther Effect of Two Celebrity Suicides: an Entertainer and a Politician	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; MEDIA GUIDELINES; HONG-KONG; SEASONALITY; COVERAGE; KOREA; RATES; RISK	Purpose: Suicide is a major health problem in Korea. Extensive media exposure of celebrity suicide may induce imitative suicide, a phenomenon called the Werther effect. We examined the increased suicide risk following the suicides of an entertainer and a politician, and identified the relative suicide risks. Methods: News articles about the celebrity suicides were obtained from three major newspapers and analysed for quantitative and qualitative features. Imitative suicide risk was investigated by applying a Poisson time series autoregression model with suicide mortality data from the National Statistics Office for 1.5 years before and 1.5 years after each celebrity's suicide. The period with a significantly increased number of suicides immediately after the celebrity's suicide determined the Werther effect band. The relative risk during this period was examined for different ages, genders, and suicide methods. Results: News reports were more numerous and they contained more positive definitions about the entertainer's suicide. The risk of suicide deaths rose markedly after both celebrity suicides. However, the Werther effect band was longer for the entertainer (6 weeks) than for the politician (4 weeks). The relative suicide risk was significant for almost all ages and both genders during that of both individuals. Use of the same suicide method was a prominent risk factor after both celebrity suicides. Conclusions: Our results confirm the existence of imitative suicide behaviours, suggesting a facilitation effect of media reports. Guidelines for responsible media reporting need to be implemented to enhance public mental health in Korea.	[Kim, Jae-Hyun; Kim, Sun-Jung; Choi, Jae-Woo] Yonsei Univ, Dept Publ Hlth, Seoul 120749, South Korea; [Kim, Jae-Hyun; Park, Eun-Cheol; Kim, Sun-Jung; Choi, Jae-Woo] Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea; [Park, Eun-Cheol; Nam, Jung-Mo; Cho, Jaelim] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sohee] Yonsei Univ, Sch Publ Hlth, Seoul 120749, South Korea; [Cho, Eun] Sookmyung Womens Univ, Coll Pharm, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Sookmyung Women's University	Cho, E (corresponding author), Sookmyung Womens Univ, Coll Pharm, Seoul, South Korea.	eun-cho@sookmyung.ac.kr	Kim, Jae Hyun/AAY-8167-2020; Park, Eun-Cheol/O-5644-2019; Kim, Sun Jung/AAM-7334-2020	Kim, Jae Hyun/0000-0003-2824-0113; Park, Eun-Cheol/0000-0002-2306-5398; Kim, Sun Jung/0000-0003-1756-1376; Park, Sohee/0000-0001-8513-5163; Nam, Chung Mo/0000-0003-0985-0928	Sookmyung Women's University Research Grants [7062]	Sookmyung Women's University Research Grants	This study was supported by a grant from Sookmyung Women's University Research Grants 2013 (No. 7062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bark H-m, 2009, STUDY MEDIA REPORTS; Blood RW, 2007, CRISIS, V28, P64, DOI 10.1027/0227-5910.28.S1.64; Chen YY, 2012, SOC PSYCH PSYCH EPID, V47, P215, DOI 10.1007/s00127-010-0331-y; Chen YY, 2010, SOC PSYCH PSYCH EPID, V45, P363, DOI 10.1007/s00127-009-0075-8; Cheng ATA, 2007, INT J EPIDEMIOL, V36, P1229, DOI 10.1093/ije/dym196; Cheng ATA, 2007, J AFFECT DISORDERS, V103, P69, DOI 10.1016/j.jad.2007.01.021; Cheng ATA, 2007, J CLIN PSYCHIAT, V68, P862, DOI 10.4088/JCP.v68n0606; Cheng QJ, 2012, J AFFECT DISORDERS, V141, P270, DOI 10.1016/j.jad.2012.03.036; Cheong JH, 2005, INTERNET RES, V15, P125, DOI 10.1108/10662240510590324; Choi Na Young, 2012, [(Journal of Korean Home Economics Education Association), 한국가정과교육학회지], V24, P175; Fu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053870; Fu KW, 2009, J CLIN PSYCHIAT, V70, P869, DOI 10.4088/JCP.08m04240; Gould MS, 2001, ANN NY ACAD SCI, V932, P200; Kim JJ, 2007, KOREAN ASS SPORTS EN, V10, P21; Kim SW, 2013, J KOREAN MED SCI, V28, P345, DOI 10.3346/jkms.2013.28.3.345; Korea National Statistical Office, 2012, ANN REP CAUS DEALTH; Korea National Statistical Office, 2011, ANN REP CAUS DEATH S, P2007; Korea National Statistical Office, 2010, KOR CLASS DIS; Lee J-K, 2011, BROADCASTING COMMUNI, V12; Lin HC, 2008, NEUROPSYCHOBIOLOGY, V57, P32, DOI 10.1159/000129664; Ma J-H, 2010, COMP ANAL NEWS FRAME; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Moller-Leimkuhler AM, 2003, EUR ARCH PSY CLIN N, V253, P1, DOI 10.1007/s00406-003-0397-6; Niederkrotenthaler T, 2007, AUST NZ J PSYCHIAT, V41, P419, DOI 10.1080/00048670701266680; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060230; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; Pirkis J, 2001, Crisis, V22, P146, DOI 10.1027//0227-5910.22.4.146; Pirkis J, 2006, CRISIS, V27, P82, DOI 10.1027/0227-5910.27.2.82; Pouliot L, 2011, J AFFECT DISORDERS, V134, P488, DOI 10.1016/j.jad.2011.04.050; Romer D, 2006, J COMMUN, V56, P253, DOI 10.1111/j.1460-2466.2006.00018.x; Stack S, 2005, SUICIDE LIFE-THREAT, V35, P121, DOI 10.1521/suli.35.2.121.62877; Stack S, 2003, J EPIDEMIOL COMMUN H, V57, P238, DOI 10.1136/jech.57.4.238; STACK S, 1987, AM SOCIOL REV, V52, P401, DOI 10.2307/2095359; Tsai JF, 2012, J AFFECT DISORDERS, V136, P412, DOI 10.1016/j.jad.2011.11.010; WHO, 2001, WORLD HLTH REPORT 20; World Health Organization, 2008, PREV SUIC RES MED PR; Yip PSF, 2006, J AFFECT DISORDERS, V93, P245, DOI 10.1016/j.jad.2006.03.015; Ziegler W, 2002, NERVENARZT, V73, P41, DOI 10.1007/s115-002-8145-y	38	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84876	10.1371/journal.pone.0084876	http://dx.doi.org/10.1371/journal.pone.0084876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386428	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700122
J	Rongey, C; Shen, H; Hamilton, N; Backus, LI; Asch, SM; Knight, S				Rongey, Catherine; Shen, Hui; Hamilton, Nathan; Backus, Lisa I.; Asch, Steve M.; Knight, Sara			Impact of Rural Residence and Health System Structure on Quality of Liver Care	PLOS ONE			English	Article							C VIRUS-INFECTION; HEPATITIS-C; OF-LIFE; URBAN DISPARITIES; UNITED-STATES; VETERANS; ACCESS; MANAGEMENT; PREVALENCE; DIAGNOSIS	Background: Specialist physician concentration in urban areas can affect access and quality of care for rural patients. As effective drug treatment for hepatitis C (HCV) becomes increasingly available, the extent to which rural patients needing HCV specialists face access or quality deficits is unknown. We sought to determine the influence of rural residency on access to HCV specialists and quality of liver care. Methods: The study used a national cohort of 151,965 Veterans Health Administration (VHA) patients with HCV starting in 2005 and followed to 2009. The VHA's constant national benefit structure reduces the impact of insurance as an explanation for observed disparities. Multivariate cox proportion regression models for each quality indicator were performed. Results: Thirty percent of VHA patients with HCV reside in rural and highly rural areas. Compared to urban residents, highly rural (HR 0.70, CI 0.65-0.75) and rural (HR 0.96, CI 0.94-0.97) residents were significantly less likely to access HCV specialty care. The quality indicators were more mixed. While rural residents were less likely to receive HIV screening, there were no significant differences in hepatitis vaccinations, endoscopic variceal and hepatocellular carcinoma screening between the geographic subgroups. Of note, highly rural (HR 1.31, CI 1.14-1.50) and rural residents (HR 1.06, CI 1.02-1.10) were more likely to receive HCV therapy. Of those treated for HCV, a third received therapy from a non-specialist provider. Conclusion: Rural patients have less access to HCV specialists, but this does not necessarily translate to quality deficits. The VHA's efforts to improve specialty care access, rural patient behavior and decentralization of HCV therapy beyond specialty providers may explain this contradiction. Lessons learned within the VHA are critical for US healthcare systems restructuring into accountable care organizations that acquire features of integrated systems.	[Rongey, Catherine] Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Rongey, Catherine] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Shen, Hui; Hamilton, Nathan] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA; [Backus, Lisa I.; Asch, Steve M.] Vet Affairs Med Ctr, Dept Med, Palo Alto, CA 94304 USA; [Backus, Lisa I.] Dept Vet Affairs, Off Publ Hlth & Populat Hlth, Washington, DC USA; [Asch, Steve M.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Knight, Sara] Vet Affairs Med Ctr, Dept Psychiat, San Francisco, CA 94121 USA; [Knight, Sara] Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Knight, Sara] Dept Vet Affairs, Off Res & Dev, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Rongey, C (corresponding author), Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA.	catherine.rongey2@va.gov	Knight, Sara/AAJ-3818-2020		American Gastroenterology Association (AGA) Research Scholar Award; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI [KL2 TR000143]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER	American Gastroenterology Association (AGA) Research Scholar Award; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported by the American Gastroenterology Association (AGA) Research Scholar Award and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number KL2 TR000143. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or the AGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Arora S, 2010, HEPATOLOGY, V52, P1124, DOI 10.1002/hep.23802; Baldwin LM, 2008, J RURAL HEALTH, V24, P390, DOI 10.1111/j.1748-0361.2008.00186.x; Bruno S, 2008, ANN HEPATOL, V7, P114, DOI 10.1016/S1665-2681(19)31865-4; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Escarce JJ, 2009, J HEALTH CARE POOR U, V20, P625, DOI 10.1353/hpu.0.0178; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Kanwal F, 2011, GASTROENTEROLOGY, V140, P1182, DOI 10.1053/j.gastro.2010.12.032; Kanwal F, 2010, ANN INTERN MED, V153, P231, DOI 10.7326/0003-4819-153-4-201008170-00005; Kanwal F, 2010, CLIN GASTROENTEROL H, V8, P709, DOI 10.1016/j.cgh.2010.03.028; Kramer JR, 2011, HEPATOLOGY, V53, P42, DOI 10.1002/hep.24024; Kramer JR, 2011, AM J GASTROENTEROL, V106, P483, DOI 10.1038/ajg.2010.430; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Nelson RE, 2012, J RURAL HEALTH, V28, P192, DOI 10.1111/j.1748-0361.2011.00387.x; Ohl M, 2010, MED CARE, V48, P1064, DOI 10.1097/MLR.0b013e3181ef60c2; PHSHG. Seattle VAMC, 2010, REP VHA LIV DIS DAT; Reschovsky JD, 2005, HEALTH AFFAIR, V24, P1128, DOI 10.1377/hlthaff.24.4.1128; Rocca LG, 2004, ANN FAM MED, V2, P116, DOI 10.1370/afm.62; Rossaro L, 2008, TELEMED J E-HEALTH, V14, P1127, DOI 10.1089/tmj.2008.0029; Smith JP, 2008, PHARMACOTHERAPY, V28, P1151, DOI 10.1592/phco.28.9.1151; Sohler K B, 1970, Public Health Rep, V85, P510; Wallace AE, 2007, PSYCHIAT SERV, V58, P668, DOI 10.1176/appi.ps.58.5.668; Wallace AE, 2006, PSYCHIAT SERV, V57, P851, DOI 10.1176/appi.ps.57.6.851; Weeks WB, 2005, J HEALTHC MANAG, V50, P95, DOI 10.1097/00115514-200503000-00006; Weeks WB, 2004, AM J PUBLIC HEALTH, V94, P1762, DOI 10.2105/AJPH.94.10.1762; Weeks WB, 2006, J RURAL HEALTH, V22, P204, DOI 10.1111/j.1748-0361.2006.00033.x; Weeks WB, 2009, J RURAL HEALTH, V25, P62, DOI 10.1111/j.1748-0361.2009.00200.x; West A, 2006, J RURAL HEALTH, V22, P9, DOI 10.1111/j.1748-0361.2006.00014.x; West AN, 2010, J RURAL HEALTH, V26, P301, DOI 10.1111/j.1748-0361.2010.00298.x	33	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84826	10.1371/journal.pone.0084826	http://dx.doi.org/10.1371/journal.pone.0084826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386420	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700119
J	Shindo, S; Moore, R; Flake, G; Negishi, M				Shindo, Sawako; Moore, Rick; Flake, Gordon; Negishi, Masahiko			Serine 216 Phosphorylation of Estrogen Receptor alpha in Neutrophils: Migration and Infiltration into the Mouse Uterus	PLOS ONE			English	Article							LACTOFERRIN; EXPRESSION; GENE; RAT	Background: Whereas estrogen receptors are present in immune cells, it is not known if they are phosphorylated to regulate immune cell functions. Here we determined the phosphorylation status of estrogen receptor alpha (ER alpha) at residue serine 216 in mouse neutrophils and examined its role in migration and infiltration. Serine 216 is the conserved phosphorylation site within the DNA binding domains found in the majority of nuclear receptors. Methodology/Principal Findings: A phospho-peptide antibody specific to phosphorylated serine 216 and ER alpha KO mice were utilized in immunohistochemistry, double immuno-staining or Western blot to detect phosphorylation of ER alpha in peripheral blood as well as infiltrating neutrophils in the mouse uterus. Transwell assays were performed to examine migration of neutrophils. An anti-Ly6G antibody identified neutrophils. About 20% of neutrophils expressed phosphorylated ER alpha at serine 216 in peripheral white blood cells (WBC) from C3H/HeNCrIBR females. Phosphorylation was additively segregated between C3H/HeNCrIBR and C57BL/6 females. Only neutrophils that expressed phosphorylated ER alpha migrated in Transwell assays as well as infiltrated the mouse uterus during normal estrous cycles. Conclusions/Significance: ER alpha was phosphorylated at serine 216 in about 20% of mouse peripheral blood neutrophils. Only those that express phosphorylated ER alpha migrate and infiltrate the mouse uterus. This phosphorylation was the first to be characterized in endogenous ER alpha found in normal tissues and cells. Phosphorylated ER alpha may have opened a novel research direction for biological roles of phosphorylation in ER alpha actions and can be developed as a drug target for treatment of immune-related diseases.	[Shindo, Sawako; Moore, Rick; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Flake, Gordon] NIEHS, Pathol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	Intramural Research Program of the NIH, National Institute of Environmental Health [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health: Z01ES1005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Cunningham M, 2011, CLIN REV ALLERG IMMU, V40, P66, DOI 10.1007/s12016-010-8203-5; Daimon E, 2005, BIOL REPROD, V73, P163, DOI 10.1095/biolreprod.104.038539; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hickey DK, 2013, INNATE IMMUN-LONDON, V19, P121, DOI 10.1177/1753425912454026; KACHKACHE M, 1991, BIOL REPROD, V45, P860, DOI 10.1095/biolreprod45.6.860; Kaitu'u-Lino TJ, 2007, CELL TISSUE RES, V328, P197, DOI 10.1007/s00441-006-0358-2; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; MCMASTER MT, 1992, MOL ENDOCRINOL, V6, P101, DOI 10.1210/me.6.1.101; Molero L, 2002, CARDIOVASC RES, V56, P43, DOI 10.1016/S0008-6363(02)00505-9; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Shindo S, 2012, STEROIDS, V77, P448, DOI 10.1016/j.steroids.2012.01.001; Steffl M, 2010, ANIM REPROD SCI, V121, P159, DOI 10.1016/j.anireprosci.2010.05.018; Svenson JL, 2008, CLIN IMMUNOL, V128, P259, DOI 10.1016/j.clim.2008.03.508; Teng CT, 2002, BIOL REPROD, V67, P1439, DOI 10.1095/biolreprod.101.002089; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302	22	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84462	10.1371/journal.pone.0084462	http://dx.doi.org/10.1371/journal.pone.0084462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386386	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700109
J	Kulbicki, M; Parravicini, V; Bellwood, DR; Arias-Gonzalez, E; Chabanet, P; Floeter, SR; Friedlander, A; McPherson, J; Myers, RE; Vigliola, L; Mouillot, D				Kulbicki, Michel; Parravicini, Valeriano; Bellwood, David R.; Arias-Gonzalez, Ernesto; Chabanet, Pascale; Floeter, Sergio R.; Friedlander, Alan; McPherson, Jana; Myers, Robert E.; Vigliola, Laurent; Mouillot, David			Global Biogeography of Reef Fishes: A Hierarchical Quantitative Delineation of Regions	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; SPECIES RICHNESS; SHORE FISHES; PACIFIC; BIODIVERSITY; DIVERSITY; CONSERVATION; HOTSPOTS; PHYLOGEOGRAPHY; DASYATIDAE	Delineating regions is an important first step in understanding the evolution and biogeography of faunas. However, quantitative approaches are often limited at a global scale, particularly in the marine realm. Reef fishes are the most diversified group of marine fishes, and compared to most other phyla, their taxonomy and geographical distributions are relatively well known. Based on 169 checklists spread across all tropical oceans, the present work aims to quantitatively delineate biogeographical entities for reef fishes at a global scale. Four different classifications were used to account for uncertainty related to species identification and the quality of checklists. The four classifications delivered converging results, with biogeographical entities that can be hierarchically delineated into realms, regions and provinces. All classifications indicated that the Indo-Pacific has a weak internal structure, with a high similarity from east to west. In contrast, the Atlantic and the Eastern Tropical Pacific were more strongly structured, which may be related to the higher levels of endemism in these two realms. The "Coral Triangle'', an area of the Indo-Pacific which contains the highest species diversity for reef fishes, was not clearly delineated by its species composition. Our results show a global concordance with recent works based upon endemism, environmental factors, expert knowledge, or their combination. Our quantitative delineation of biogeographical entities, however, tests the robustness of the results and yields easily replicated patterns. The similarity between our results and those from other phyla, such as corals, suggests that our approach may be of broad utility in describing and understanding global marine biodiversity patterns.	[Kulbicki, Michel; Parravicini, Valeriano] IRD, Lab Arago, UR Labex CORAIL 227, Banyuls Sur Mer, France; [Parravicini, Valeriano] Fdn Rech Biodiversite, Ctr Synth & Anal Biodiversite, Aix En Provence, France; [Bellwood, David R.; Mouillot, David] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Bellwood, David R.; Mouillot, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Arias-Gonzalez, Ernesto] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Ecol Ecosistemas Arrecifes Coralinos, Dept Recursos Mar,Unidad Merida, Merida, Yucatan, Mexico; [Chabanet, Pascale] IRD, UR CoReUs Labex CORAIL 227, Ste Clotilde, Reunion, France; [Floeter, Sergio R.] Univ Fed Santa Catarina, Marine Macroecol & Biogeog Lab, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Friedlander, Alan] Univ Hawaii, Dept Biol, Honolulu, HI 96822 USA; [McPherson, Jana] Calgary Zool Soc, Ctr Conservat Res, Calgary, AB T2M 4R8, Canada; [McPherson, Jana] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Myers, Robert E.] Seaclicks Coral Graph, Wellington, FL USA; [Vigliola, Laurent] IRD, UR CoReUs Labex CORAIL 227, Noumea, New Caledonia; [Mouillot, David] Univ Montpellier 2, ECOSYM UMR 5119, Montpellier, France	Institut de Recherche pour le Developpement (IRD); James Cook University; James Cook University; Instituto Politecnico Nacional - Mexico; Institut de Recherche pour le Developpement (IRD); Universidade Federal de Santa Catarina (UFSC); University of Hawaii System; Simon Fraser University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Kulbicki, M (corresponding author), IRD, Lab Arago, UR Labex CORAIL 227, Banyuls Sur Mer, France.	michel.kulbicki@ird.fr	Parravicini, Valeriano/A-8539-2011; McPherson, Jana M/F-7153-2010; Chabanet, Pascale/L-9470-2017; Floeter, S. R./B-1438-2012; McPherson, Jana M/A-9900-2010; Vigliola, Laurent/J-7107-2016	McPherson, Jana M/0000-0001-6354-6404; Floeter, S. R./0000-0002-3201-6504; McPherson, Jana M/0000-0001-6354-6404; Vigliola, Laurent/0000-0003-4715-7470; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X; Chabanet, Pascale/0000-0001-7600-943X; Kulbicki, Michel/0000-0003-1258-5061; Parravicini, Valeriano/0000-0002-3408-1625	FRB (Fondation de la Recherche pour la Biodiversite)	FRB (Fondation de la Recherche pour la Biodiversite)	This work was funded by FRB (Fondation de la Recherche pour la Biodiversite) for the data analysis and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 2001, J PHYCOL, V37, P677, DOI 10.1046/j.1529-8817.2001.00176.x; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; [Anonymous], 1953, ZOOGEOGRAPHY SEA; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Berumen M., 2013, BIOL ECOLOGY BUTTERF; Borsa P, 2012, J EXP MAR BIOL ECOL, V438, P32, DOI 10.1016/j.jembe.2012.09.010; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Briggs JC, 2013, J BIOGEOGR, V40, P1023, DOI 10.1111/jbi.12082; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brosen LR, 2012, SYSTEMATICS ASS, V82; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Connolly SR, 2003, ECOLOGY, V84, P2178, DOI 10.1890/02-0254; Cowman PF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1541; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Eble JA, 2011, MAR ECOL PROG SER, V428, P245, DOI 10.3354/meps09083; Efron B, 1996, P NATL ACAD SCI USA, V93, P7085, DOI 10.1073/pnas.93.14.7085; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; GOREN M, 2008, AQABA EILAT IMPROBAB, P243; Green AL, 2008, 108 TNC COR TRIANGL; Hastings PA, 2000, ZOOL J LINN SOC-LOND, V128, P319, DOI 10.1006/zjls.1998.0196; Hobbs J-PA, 2011, THESIS; Hobbs JPA, 2012, J BIOGEOGR, V39, P130, DOI 10.1111/j.1365-2699.2011.02576.x; Hoeksema Bert W., 2007, V29, P117; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jacquez GM, 2008, ENVIRON ECOL STAT, V15, P365, DOI 10.1007/s10651-007-0062-8; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kronen M, 2012, OCEAN COAST MANAGE, V55, P63, DOI 10.1016/j.ocecoaman.2011.07.011; Kulbicki M, 2013, J BIOGEOGR; Kulbicki M, 2007, CYBIUM, V31, P275; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; MacNeil MA, 2009, ECOLOGY, V90, P252, DOI 10.1890/07-0487.1; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Parravicini V, 2013, ECOGRAPHY, V36, P1254, DOI 10.1111/j.1600-0587.2013.00291.x; Pinca S, 2012, FISH FISH, V13, P361, DOI 10.1111/j.1467-2979.2011.00425.x; Planes S, 2012, CR BIOL, V335, P417, DOI 10.1016/j.crvi.2012.04.002; Puckridge M, 2013, ECOL EVOL, V3, P217, DOI 10.1002/ece3.448; Randall JE, 1998, ZOOL STUD, V37, P227; Randall JE, 2012, SHORE FISHES E ISLAN; Randall JE, 2007, REEF SHORE FISHES HA; Randall John E., 2000, Bishop Museum Occasional Papers, V66, P1; Rao AR, 2006, J HYDROL, V318, P37, DOI 10.1016/j.jhydrol.2005.06.003; RAUP DM, 1979, J PALEONTOL, V53, P1213; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ricklefs RE, 2012, SCIENCE, V335, P464, DOI 10.1126/science.1215182; Robertson D.R., 2002, SHORE FISHES TROPICA; Robertson DR, 2009, MAR ECOL PROG SER, V380, P1, DOI 10.3354/meps07925; Robertson DR, 1998, CORAL REEFS, V17, P179, DOI 10.1007/s003380050113; Robison RA, 1979, CRETACEOUS TREATISE, P418; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Rondinini C, 2011, PHILOS T R SOC B, V366, P2591, DOI 10.1098/rstb.2011.0111; Santini F, 2002, J BIOGEOGR, V29, P189, DOI 10.1046/j.1365-2699.2002.00669.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; SPRINGER VG, 1982, SMITHSONIAN CONTR ZO, V367, P1, DOI DOI 10.5479/SI.00810282.367; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thresher R.E., 1991, P401; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Zapata FA, 2007, J BIOGEOGR, V34, P38, DOI 10.1111/j.1365-2699.2006.01586.x	78	160	163	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e81847	10.1371/journal.pone.0081847	http://dx.doi.org/10.1371/journal.pone.0081847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386083	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700004
J	Lortie, CJ; Allesina, S; Aarssen, L; Grod, O; Budden, AE				Lortie, Christopher J.; Allesina, Stefano; Aarssen, Lonnie; Grod, Olyana; Budden, Amber E.			With Great Power Comes Great Responsibility: the Importance of Rejection, Power, and Editors in the Practice of Scientific Publishing	PLOS ONE			English	Article							ECOLOGY	Peer review is an important element of scientific communication but deserves quantitative examination. We used data from the handling service manuscript Central for ten mid-tier ecology and evolution journals to test whether number of external reviews completed improved citation rates for all accepted manuscripts. Contrary to a previous study examining this issue using resubmission data as a proxy for reviews, we show that citation rates of manuscripts do not correlate with the number of individuals that provided reviews. Importantly, externally-reviewed papers do not outperform editor-only reviewed published papers in terms of visibility within a 5-year citation window. These findings suggest that in many instances editors can be all that is needed to review papers (or at least conduct the critical first review to assess general suitability) if the purpose of peer review is to primarily filter and that journals can consider reducing the number of referees associated with reviewing ecology and evolution papers.	[Lortie, Christopher J.; Grod, Olyana] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Allesina, Stefano] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Aarssen, Lonnie] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Budden, Amber E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA	York University - Canada; University of Chicago; Queens University - Canada; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Lortie, CJ (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	lortie@yorku.ca	lortie, christopher j/F-6241-2014; Allesina, Stefano/A-2255-2009; Budden, Amber/A-2829-2010	lortie, christopher j/0000-0002-4291-7023; Budden, Amber/0000-0003-2885-3980; Allesina, Stefano/0000-0003-0313-8374	National Center for Ecological Analysis and Synthesis; NSF [DEB- 0072909]	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF))	This work was conducted as part of the "Role of publication-related biases in ecology" Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (grant #DEB- 0072909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2012, IDEAS ECOL EVOL, V5, P78, DOI 10.4033/iee.2012.5b.16.f; Aarssen LW, 2010, IDEAS ECOL EVOL, V3, P28, DOI 10.4033/iee.2010.3.7.c; Arnqvist G, 2013, TRENDS ECOL EVOL, V28, P448, DOI 10.1016/j.tree.2013.05.007; Ball P., 2012, NATURE NEWS; Barto EK, 2012, OIKOS, V121, P228, DOI 10.1111/j.1600-0706.2011.19401.x; Bowers EK, 2012, SCIENCE, V338, P1029, DOI 10.1126/science.338.6110.1029-a; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Calcagno V, 2012, SCIENCE, V338, P1065, DOI 10.1126/science.1227833; Couzin-Frankel J, 2013, SCIENCE, V341, P1331, DOI 10.1126/science.341.6152.1331; Davidoff F, 2004, BRIT MED J, V328, P657, DOI 10.1136/bmj.328.7441.657; Fox J., 2010, B ECOL SOC AM, V91, P325, DOI DOI 10.1890/0012-9623-91.3.325; Grod O., 2009, FRONTIERS ECOLOGY EN, V8, P187; Grod ON, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003202; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Hampton SE, 2011, BIOSCIENCE, V61, P900, DOI 10.1525/bio.2011.61.11.9; Hochberg ME, 2010, IDEAS ECOL EVOL, V3, P8, DOI 10.4033/iee.2010.3.2.c; Lortie CJ, 2007, OIKOS, V116, P1247, DOI 10.1111/j.0030-1299.2007.15686.x; Rohr JR, 2012, TRENDS ECOL EVOL, V27, P192, DOI 10.1016/j.tree.2012.01.012; SAMUELS ML, 1993, J AM STAT ASSOC, V88, P81, DOI 10.2307/2290700; Scott A, 2007, FUTURES, V39, P827, DOI 10.1016/j.futures.2006.12.009; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Thurner S, 2011, EUR PHYS J B, V84, P707, DOI 10.1140/epjb/e2011-20545-7; Ware Mark, 2008, PUBLISHING RES CONSO, V4, P1	23	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85382	10.1371/journal.pone.0085382	http://dx.doi.org/10.1371/journal.pone.0085382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386471	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329194700135
J	Van Assche, E; Duyck, W; Hartsuiker, RJ				Van Assche, Eva; Duyck, Wouter; Hartsuiker, Robert J.			Phonological Recoding in Error Detection: A Cross-sectional Study in Beginning Readers of Dutch	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; READING ACQUISITION; EYE-MOVEMENTS; CHILDREN; ENGLISH; GERMAN; CONSISTENCY; ACTIVATION; MEANINGS; DYSLEXIA	The present cross-sectional study investigated the development of phonological recoding in beginning readers of Dutch, using a proofreading task with pseudohomophones and control misspellings. In Experiment 1, children in grades 1 to 3 rejected fewer pseudohomophones (e. g., wein, sounding like wijn 'wine') as spelling errors than control misspellings (e. g., wijg). The size of this pseudohomophone effect was larger in grade 1 than in grade 2 and did not differ between grades 2 and 3. In Experiment 2, we replicated the pseudohomophone effect in beginning readers and we tested how orthographic knowledge may modulate this effect. Children in grades 2 to 4 again detected fewer pseudohomophones than control misspellings and this effect decreased between grades 2 and 3 and between grades 3 and 4. The magnitude of the pseudohomophone effect was modulated by the development of orthographic knowledge: its magnitude decreased much more between grades 2 and 3 for more advanced spellers, than for less advanced spellers. The persistence of the pseudohomophone effect across all grades illustrates the importance of phonological recoding in Dutch readers. At the same time, the decreasing pseudohomophone effect across grades indicates the increasing influence of orthographic knowledge as reading develops.	[Van Assche, Eva; Duyck, Wouter; Hartsuiker, Robert J.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Van Assche, E (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	eva.vanassche@ugent.be	Hartsuiker, Robert J./N-1668-2019	Duyck, Wouter/0000-0003-2114-6212; Van Assche, Eva/0000-0001-5623-7144; Hartsuiker, Robert/0000-0002-3680-6765	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	EVA is a postdoctoral fellow of the Research Foundation Flanders (FWO)(www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby J, 2004, LANG COGNITIVE PROC, V19, P391, DOI 10.1080/01690960344000233; Ashby J, 2010, PSYCHON B REV, V17, P95, DOI 10.3758/PBR.17.1.95; Baayen R. H., 1993, CELEX LEXICAL DATABA; Baron J., 1977, BASIC PROCESSES READ, P175; BECKER CA, 1976, J EXP PSYCHOL HUMAN, V2, P556, DOI 10.1037/0096-1523.2.4.556; Bosman A. M., 2006, HDB ORTHOGRAPHY LITE, P135; Bosman AMT, 1996, Q J EXP PSYCHOL-A, V49, P715, DOI 10.1080/027249896392568; Bosman AMT, 2006, ANN DYSLEXIA, V56, P271, DOI 10.1007/s11881-006-0012-4; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Coltheart M., 1977, ATTENTION PERFORM, P535, DOI DOI 10.1006/BRLN.2001.2475; Coltheart M, 2005, BL HBK DEV PSYCHOL, P6, DOI 10.1002/9780470757642.ch1; COLTHEART V, 1988, J EXP PSYCHOL LEARN, V14, P387, DOI 10.1037/0278-7393.14.3.387; DAVELAAR E, 1978, MEM COGNITION, V6, P391, DOI 10.3758/BF03197471; Doctor E, 1980, MEM COGNITION, V80, P195; Duyck W, 2005, J EXP PSYCHOL LEARN, V31, P1340, DOI 10.1037/0278-7393.31.6.1340; Duyck W, 2004, BEHAV RES METH INS C, V36, P488, DOI 10.3758/BF03195595; Ehri L.C., 1992, READING ACQUISITION, P107; EHRI LC, 1987, READ RES QUART, V22, P47, DOI 10.2307/747720; Ehri LC, 2005, SCI STUD READ, V9, P167, DOI 10.1207/s1532799xssr0902_4; Ehri LC, 1998, WORD RECOGNITION IN BEGINNING LITERACY, P3; Firth I., 1972, THESIS U NEW S WALES; Frost R, 1998, PSYCHOL BULL, V123, P71, DOI 10.1037/0033-2909.123.1.71; Goswami U, 2001, J MEM LANG, V45, P648, DOI 10.1006/jmla.2001.2790; Grainger J, 2012, COGNITION, V123, P280, DOI 10.1016/j.cognition.2012.01.003; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Jared D, 1999, J EXP PSYCHOL GEN, V128, P219, DOI 10.1037/0096-3445.128.3.219; JOHNSTON RS, 1995, MEM COGNITION, V23, P749, DOI 10.3758/BF03200927; JORM AF, 1983, APPL PSYCHOLINGUIST, V4, P103, DOI 10.1017/S0142716400004380; Kyte CS, 2006, J EXP CHILD PSYCHOL, V93, P166, DOI 10.1016/j.jecp.2005.09.003; Martens VEG, 2006, BRAIN LANG, V98, P140, DOI 10.1016/j.bandl.2006.04.003; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; REITSMA P, 1983, J EXP CHILD PSYCHOL, V36, P321, DOI 10.1016/0022-0965(83)90036-X; Reitsma P., 1983, J RES READ, V6, P41, DOI [10.1111/j.1467-9817.1983.tb00237.x, DOI 10.1111/J.1467-9817.1983.TB00237.X]; Share DL, 2008, ADV CHILD DEV BEHAV, V36, P31, DOI 10.1016/S0065-2407(08)00002-5; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Share DL, 1999, J EXP CHILD PSYCHOL, V72, P95, DOI 10.1006/jecp.1998.2481; Share DL, 2004, J EXP CHILD PSYCHOL, V87, P267, DOI 10.1016/j.jecp.2004.01.001; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Sprenger-Charolles L, 2003, J EXP CHILD PSYCHOL, V84, P194, DOI 10.1016/S0022-0965(03)00024-9; Sprenger-Charolles L., 1998, SCI STUD READ, V2, P3, DOI DOI 10.1207/S1532799XSSR0201_1; Starr MS, 2001, J EXP PSYCHOL LEARN, V27, P744, DOI 10.1037/0278-7393.27.3.744; VANORDEN GC, 1988, J EXP PSYCHOL LEARN, V14, P371, DOI 10.1037/0278-7393.14.3.371; VANORDEN GC, 1987, MEM COGNITION, V15, P181, DOI 10.3758/BF03197716; VANORDEN GC, 1992, ORTHOGRAPHY PHONOLOG, P249; WIMMER H, 1994, COGNITION, V51, P91, DOI 10.1016/0010-0277(94)90010-8; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	47	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85111	10.1371/journal.pone.0085111	http://dx.doi.org/10.1371/journal.pone.0085111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386453	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700127
J	Carne, C; Semple, S; Morrogh-Bernard, H; Zuberbuhler, K; Lehmann, J				Carne, Charlotte; Semple, Stuart; Morrogh-Bernard, Helen; Zuberbuehler, Klaus; Lehmann, Julia			Predicting the Vulnerability of Great Apes to Disease: The Role of Superspreaders and Their Potential Vaccination	PLOS ONE			English	Article							SOCIAL-NETWORK ANALYSIS; INDIVIDUAL VARIATION; PAN-TROGLODYTES; NATIONAL-PARK; CONSERVATION; CHIMPANZEES; TRANSMISSION; ECOLOGY; MAHALE; POPULATION	Disease is a major concern for the conservation of great apes, and one that is likely to become increasingly relevant as deforestation and the rise of ecotourism bring humans and apes into ever closer proximity. Consequently, it is imperative that preventative measures are explored to ensure that future epidemics do not wipe out the remaining populations of these animals. In this paper, social network analysis was used to investigate vulnerability to disease in a population of wild orang-utans and a community of wild chimpanzees. Potential 'superspreaders' of disease - individuals with disproportionately central positions in the community or population - were identified, and the efficacy of vaccinating these individuals assessed using simulations. Three resident female orang-utans were identified as potential superspreaders, and females and unflanged males were predicted to be more influential in disease spread than flanged males. By contrast, no superspreaders were identified in the chimpanzee network, although males were significantly more central than females. In both species, simulating the vaccination of the most central individuals in the network caused a greater reduction in potential disease pathways than removing random individuals, but this effect was considerably more pronounced for orang-utans. This suggests that targeted vaccinations would have a greater impact on reducing disease spread among orang-utans than chimpanzees. Overall, these results have important implications for orang-utan and chimpanzee conservation and highlight the role that certain individuals may play in the spread of disease and its prevention by vaccination.	[Carne, Charlotte; Semple, Stuart; Lehmann, Julia] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England; [Morrogh-Bernard, Helen] Univ Palangka Raya, Ctr Int Cooperat Sustainable Management Trop Peat, Orang Utan Trop Peatland Project OuTrop, Palangka Raya, Central Kaliman, Indonesia; [Morrogh-Bernard, Helen] Univ Exeter, Washington Singer Labs, Coll Life & Environm Sci, Ctr Res Anim Behav, Exeter, Devon, England; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland	Roehampton University; Universitas Palangka Raya (UPR); University of Exeter; University of St Andrews; University of Neuchatel	Carne, C (corresponding author), Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England.	charlotte.carne@roehampton.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Semple, Stuart/0000-0003-0452-8104; Lehmann, Julia/0000-0001-7278-1705	University of Roehampton; Royal Zoological Society of Scotland; Budongo Conservation Field Station; Wildlife Conservation Society (WCS); US Fish and Wildlife Service Great Ape Conservation Fund; Orang-utan Tropical Peatland Project (OuTrop); Primate Conservation Inc; L.S.B. Leakey Foundation	University of Roehampton; Royal Zoological Society of Scotland; Budongo Conservation Field Station; Wildlife Conservation Society (WCS); US Fish and Wildlife Service Great Ape Conservation Fund(US Fish & Wildlife Service); Orang-utan Tropical Peatland Project (OuTrop); Primate Conservation Inc; L.S.B. Leakey Foundation	Charlotte Carne was funded by a scholarship from the University of Roehampton (http://www.roehampton.ac.uk/home/). The Royal Zoological Society of Scotland (http://www.rzss.org.uk/) provided core funding for the Budongo Conservation Field Station. The orang-utan field research was funded by the Wildlife Conservation Society (WCS: http://www.wcs.org/), the US Fish and Wildlife Service Great Ape Conservation Fund (http://www.fws.gov/international/wildlife-without- borders/great-ape-conservation-fund. html), Orang-utan Tropical Peatland Project (OuTrop: http://www. outrop. com/), Primate Conservation Inc. (http:// www.primate.org/), and the L.S.B. Leakey Foundation (http://leakeyfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ANDERSON R M, 1991; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Boesch C, 2008, AM J PRIMATOL, V70, P722, DOI 10.1002/ajp.20571; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Brochier B, 1996, REV SCI TECH OIE, V15, P947, DOI 10.20506/rst.15.3.965; Cabezas S, 2006, J WILDLIFE MANAGE, V70, P1125, DOI 10.2193/0022-541X(2006)70[1125:VSABCI]2.0.CO;2; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2009, CAM S BIO EVOL ANTHR, V57, P487; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; Clay CA, 2009, P R SOC B, V276, P1305, DOI 10.1098/rspb.2008.1693; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Craft ME, 2011, INTERDISCIPLINARY PE, V2011; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csardi G, 2006, INTERJOURNAL; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Foitova I, 2009, PARASITES THEIR IMPA; GALDIKAS BMF, 1985, AM J PRIMATOL, V9, P101, DOI 10.1002/ajp.1350090204; Genton C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037106; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; Hilser H, 2011, ASSESSMENT PRIMATE H; Huijbregts B, 2003, ORYX, V37, P437, DOI 10.1017/S0030605303000802; HUTCHINS M, 1991, J ZOO WILDLIFE MED, V22, P277; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; Kaur T, 2008, AM J PRIMATOL, V70, P729, DOI 10.1002/ajp.20569; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Lehmann J, 2008, INT J PRIMATOL, V29, P65, DOI 10.1007/s10764-007-9230-9; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lukasik-Braum M, 2008, AM J PRIMATOL, V70, P734, DOI 10.1002/ajp.20568; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Macfie Elizabeth J., 2010, Occasional Papers of the IUCN Species Survival Commission, V38, pi; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Manno TG, 2008, ANIM BEHAV, V75, P1221, DOI 10.1016/j.anbehav.2007.09.025; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Morrogh-Bernard H, 2009, ORANGUTAN BEHAV ECOL; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Newman ME, 2001, PHYS REV E, V64; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Opsahl T, 2009, STRUCTURE EVOLUTION; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pepper JW, 1999, INT J PRIMATOL, V20, P613, DOI 10.1023/A:1020760616641; Pinter-Wollman N, 2011, J R SOC INTERFACE, V8, P1562, DOI 10.1098/rsif.2011.0059; Pusey AE, 2008, AM J PRIMATOL, V70, P738, DOI 10.1002/ajp.20567; Reynolds Vernon, 2005, pi; Rodman P.S., 1973, P171; Rushmore J, 2013, J ANIMAL ECOLOGY; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Ryder TB, 2008, P ROY SOC B-BIOL SCI, V275, P1367, DOI 10.1098/rspb.2008.0205; Sandbrook C, 2006, ORYX, V40, P428, DOI 10.1017/S0030605306001323; Sauren SEB, 2009, DEV INDEPENDENCE SUM, P189; Setia Tatang Mitra, 2009, P245; Singleton I, 2002, FOLIA PRIMATOL, V73, P1, DOI 10.1159/000060415; Team R. D. C, 2011, R LANG ENV STAT COMP; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Whitehead Hal, 2008, pi; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224	70	19	19	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84642	10.1371/journal.pone.0084642	http://dx.doi.org/10.1371/journal.pone.0084642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386405	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900105
J	Lacalle-Aurioles, M; Aleman-Gomez, Y; Guzman-De-Villoria, JA; Cruz-Orduna, I; Olazaran, J; Mateos-Perez, JM; Martino, ME; Desco, M				Lacalle-Aurioles, Maria; Aleman-Gomez, Yasser; Adan Guzman-De-Villoria, Juan; Cruz-Orduna, Isabel; Olazaran, Javier; Maria Mateos-Perez, Jose; Elena Martino, Maria; Desco, Manuel			Is the Cerebellum the Optimal Reference Region for Intensity Normalization of Perfusion MR Studies in Early Alzheimer's Disease?	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CEREBRAL-BLOOD-FLOW; MEDIAL TEMPORAL-LOBE; MEAN TRANSIT-TIME; EMISSION TOMOGRAPHY; TC-99M-HMPAO SPECT; DEMENTIA; DIAGNOSIS; QUANTIFICATION; CORTEX	The cerebellum is the region most commonly used as a reference when normalizing the intensity of perfusion images acquired using magnetic resonance imaging (MRI) in Alzheimer's disease (AD) studies. In addition, the cerebellum provides unbiased estimations with nuclear medicine techniques. However, no reports confirm the cerebellum as an optimal reference region in MRI studies or evaluate the consequences of using different normalization regions. In this study, we address the effect of using the cerebellum, whole-brain white matter, and whole-brain cortical gray matter in the normalization of cerebral blood flow (CBF) parametric maps by comparing patients with stable mild cognitive impairment (MCI), patients with AD and healthy controls. According to our results, normalization by whole-brain cortical gray matter enables more sensitive detection of perfusion abnormalities in AD patients and reveals a larger number of affected regions than data normalized by the cerebellum or whole-brain white matter. Therefore, the cerebellum is not the most valid reference region in MRI studies for early stages of AD. After normalization by whole-brain cortical gray matter, we found a significant decrease in CBF in both parietal lobes and an increase in CBF in the right medial temporal lobe. We found no differences in perfusion between patients with stable MCI and healthy controls either before or after normalization.	[Lacalle-Aurioles, Maria; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain; [Lacalle-Aurioles, Maria; Aleman-Gomez, Yasser; Maria Mateos-Perez, Jose; Elena Martino, Maria; Desco, Manuel] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Lacalle-Aurioles, Maria; Aleman-Gomez, Yasser; Maria Mateos-Perez, Jose; Desco, Manuel] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain; [Adan Guzman-De-Villoria, Juan] Hosp Gen Univ Gregorio Maranon, Serv Radiodiagnost, Madrid, Spain; [Cruz-Orduna, Isabel; Olazaran, Javier] Hosp Gen Univ Gregorio Maranon, Serv Neurol, Madrid, Spain	Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital	Lacalle-Aurioles, M (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain.	mlacalle@hggm.es	Adan, Guzman-De-Villoria Juan/AAY-5733-2020; Martino, Maria-Elena/L-6898-2014; Desco, Manuel/AAD-7137-2019	Martino, Maria-Elena/0000-0003-3574-8054; Desco, Manuel/0000-0003-0989-3231; Cruz Orduna, Isabel/0000-0003-1643-0884; Aleman-Gomez, Yasser/0000-0001-6067-8639; Guzman-De-Villoria, Juan Adan/0000-0003-3653-0065	AMIT Project (Programa CENIT. Ministerio de Economia y Competitividad, Spain)	AMIT Project (Programa CENIT. Ministerio de Economia y Competitividad, Spain)	This work was funded by AMIT Project (Programa CENIT. Ministerio de Economia y Competitividad, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Borghammer P, 2008, NEUROIMAGE, V40, P529, DOI 10.1016/j.neuroimage.2007.12.057; Bozzao A, 2001, AM J NEURORADIOL, V22, P1030; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diamant M, 2002, ACTA PHYSIOL SCAND, V175, P1, DOI 10.1046/j.1365-201X.2002.00953.x; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Essig M, 2013, AM J ROENTGENOL, V201, pW495, DOI 10.2214/AJR.12.9544; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GONZALEZ RG, 1995, AM J NEURORADIOL, V16, P1763; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hanyu H, 2010, J NEUROL SCI, V290, P96, DOI 10.1016/j.jns.2009.10.022; Harris GJ, 1998, AM J NEURORADIOL, V19, P1727; Hauser T, 2013, ACAD RADIOL, V20, P705, DOI 10.1016/j.acra.2013.01.020; Henry-Feugeas MC, 2009, J NEUROL SCI, V283, P44, DOI 10.1016/j.jns.2009.02.325; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069085; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ishii K, 1997, J NUCL MED, V38, P925; Jagust W, 2001, NEUROLOGY, V56, P950, DOI 10.1212/WNL.56.7.950; JOBST KA, 1992, J NEUROL NEUROSUR PS, V55, P190, DOI 10.1136/jnnp.55.3.190; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; KARBE H, 1994, NEURORADIOLOGY, V36, P1, DOI 10.1007/BF00599183; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li XF, 2003, MAGN RESON IMAGING, V21, P503, DOI 10.1016/S0730-725X(03)00075-4; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nagata K, 2000, NEUROBIOL AGING, V21, P301, DOI 10.1016/S0197-4580(00)00130-5; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Soonawala D, 2002, NEUROIMAGE, V17, P1193, DOI 10.1006/nimg.2002.1259; Spreen O, 1998, COMPENDIUM NEUROPSYC; Talbot PR, 1998, J NEUROL NEUROSUR PS, V64, P306, DOI 10.1136/jnnp.64.3.306; TALBOT PR, 1994, EUR J NUCL MED, V21, P503; Uh J, 2010, NEUROBIOL AGING, V31, P2038, DOI 10.1016/j.neurobiolaging.2008.12.010; Wilkinson BL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.014; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	51	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e81548	10.1371/journal.pone.0081548	http://dx.doi.org/10.1371/journal.pone.0081548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386081	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900005
J	Suarez-Farinas, M; Arbeit, R; Jiang, WW; Ortenzio, FS; Sullivan, T; Krueger, JG				Suarez-Farinas, Mayte; Arbeit, Robert; Jiang, Weiwen; Ortenzio, Francesca S.; Sullivan, Tim; Krueger, James G.			Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin Inflammation	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELL; T-CELLS; PSORIASIS-VULGARIS; ANTIMICROBIAL PEPTIDES; EPIDERMAL HYPERPLASIA; SIGNALING PATHWAYS; INNATE IMMUNITY; IN-VITRO; EXPRESSION; KERATINOCYTES	Psoriasis is a complex inflammatory disease resulting from the activation of T helper (Th) 1 and Th17 cells. Recent evidence suggests that abnormal activation of Toll-like receptors (TLRs) 7, 8 and 9 contributes to the initiation and maintenance of psoriasis. We have evaluated the effects of TLR antagonists on the gene expression profile in an IL-23-induced skin inflammation model in mice. Psoriasis-like skin lesions were induced in C57BL/6 mice by intradermal injection of IL-23 in the dorsum. Two TLR antagonists were compared: IMO-3100, an antagonist of TLRs 7 and 9, and IMO-8400, an antagonist of TLRs 7, 8 and 9, both of which previously have been shown to reduce epidermal hyperplasia in this model. Skin gene expression profiles of IL-23-induced inflammation were compared with or without TLR antagonist treatment. IL-23 injection resulted in alteration of 5100 gene probes (fold change >= 2, FDR < 0.05) including IL-17 pathways that are up-regulated in psoriasis vulgaris. Targeting TLRs 7, 8 and 9 with IMO-8400 resulted in modulation of more than 2300 mRNAs while targeting TLRs 7 and 9 with IMO-3100 resulted in modulation of more than 1900 mRNAs. Both agents strongly decreased IL-17A expression (> 12-fold reduction), normalized IL-17 induced genes such as beta-defensin and CXCL1, and normalized aberrant expression of keratin 16 (indicating epidermal hyperplasia). These results suggest that IL-23-driven inflammation in mouse skin may be dependent on signaling mediated by TLRs 7, 8, and 9 and that these receptors represent novel therapeutic targets in psoriasis vulgaris and other diseases with similar pathophysiology.	[Suarez-Farinas, Mayte; Ortenzio, Francesca S.; Krueger, James G.] Rockefeller Univ, Lab Invest Dermatol, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Arbeit, Robert; Jiang, Weiwen; Sullivan, Tim] Idera Pharmaceut Inc, Cambridge, MA USA	Rockefeller University; Rockefeller University	Krueger, JG (corresponding author), Rockefeller Univ, Lab Invest Dermatol, 1230 York Ave, New York, NY 10021 USA.	kruegej@rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553	IDERA Pharmaceuticals, Inc	IDERA Pharmaceuticals, Inc	Funding for this study was provided by an unrestricted grant given to Dr. James Krueger by IDERA Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, however, they played a partial role in conception of the study and conducted the in vivo model on which this study is based.	Bhan U, 2013, J IMMUNOL, V190, P349, DOI 10.4049/jimmunol.1202225; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Farkas A, 2012, INT IMMUNOPHARMACOL, V13, P215, DOI 10.1016/j.intimp.2012.04.003; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Girolomoni G, 2012, BRIT J DERMATOL, V167, P717, DOI 10.1111/j.1365-2133.2012.11099.x; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Guiducci C, 2009, J INTERN MED, V265, P43, DOI 10.1111/j.1365-2796.2008.02050.x; Hari A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/437246; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Jiang W, 2013, J INVEST DERMATOL; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimball AB, 2013, J INVEST DERMATOL, V133, pS26; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Patel U, 2011, BRIT J DERMATOL, V164, P670, DOI 10.1111/j.1365-2133.2010.10124.x; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Roberson EDO, 2012, J INVEST DERMATOL, V132, P583, DOI 10.1038/jid.2011.348; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Suarez-Farinas M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-294; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang DQ, 2009, J MED CHEM, V52, P551, DOI 10.1021/jm8014316; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Yao Y, 2013, TYPE 1 INTERFERON AU, P185; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yu D, 2009, J MED CHEM, V52, P5108, DOI 10.1021/jm900730r; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	55	81	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84634	10.1371/journal.pone.0084634	http://dx.doi.org/10.1371/journal.pone.0084634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386404	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900104
J	Suh, M; Kang, DR; Lee, DH; Choi, YJ; Tchoe, B; Nam, CM; Kim, HJ; Lee, JK; Jun, BY; Youm, Y; Bae, GN; Lee, TY; Kim, MS; Shin, DC; Kim, C				Suh, Mina; Kang, Dae Ryong; Lee, Dong Han; Choi, Yoon Jung; Tchoe, Byongho; Nam, Chung Mo; Kim, Hyung Jung; Lee, Jong Koo; Jun, Byung Yool; Youm, Yoosik; Bae, Gwi-Nam; Lee, Tae Yong; Kim, Moon Shik; Shin, Dong Chun; Kim, Changsoo			Socioeconomic Burden of Influenza in the Republic of Korea, 2007-2010	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; COST-EFFECTIVENESS; INFECTION	Background: Although the socioeconomic burden of 2009 pandemic influenza A (H1N1) was considerable, no reliable estimates have been reported. Our aim was to compared medical costs and socioeconomic burden resulting from pandemic influenza A (H1N1) 2009 with that of previous seasonal influenza. Methods: We estimated the medical costs and socioeconomic burden of influenza from May 2007 to April 2010. We used representative national data sources(data from the Health Insurance Review Agency, the National Health Insurance Corporation, the Korea Centers for Disease Control and Prevention, and the Korean National Statistics Office) including medical utilization, prescription of antivirals, and vaccination. Uncertainty of data was explored through sensitivity analysis using Monte Carlo simulation. Results: Compared with the seasonal influenza, total medical costs (US$291.7 million) associated with pandemic (H1N1) 2009 increased more than 37-fold. Compared with the 2007-2008 season, outpatient diagnostic costs (US$135.3 million) were 773 times higher in the 2009-2010 season, and the mean diagnostic cost per outpatient visit was 58.8 times higher. Total socioeconomic burden of pandemic (H1N1) 2009 was estimated at US$1581.3 million (10%-90%: US$1436.0-1808.3 million) and those of seasonal influenza was estimated at US$44.7 million (10%-90%: US$32.4-57.9 million) in 2007-2008 season and US$42.3 million (10%-90%: US$31.5-53.8 million) in 2008-2009 season. Indirect costs accounted for 56.0% of total costs in pandemic (H1N1) 2009, and 66.48-68.09% in seasonal influenza. The largest contributors to total burden were productivity losses of caregiver in pandemic (H1N1) 2009, and productivity losses due to morbidity of outpatient in seasonal influenza. Conclusions: In the Republic of Korea, socioeconomic burden of pandemic (H1N1) 2009 were considerably higher than burden of the previous two influenza seasons, primarily because of high diagnostic costs and longer sick leave.	[Suh, Mina] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Kang, Dae Ryong; Nam, Chung Mo; Kim, Hyung Jung; Shin, Dong Chun; Kim, Changsoo] Yonsei Univ, Coll Med, Seoul, South Korea; [Lee, Dong Han; Jun, Byung Yool] Korea Ctr Dis Control & Prevent, Osong, South Korea; [Choi, Yoon Jung; Tchoe, Byongho] Helath Insurance Review & Assessment Serv, Seoul, South Korea; [Lee, Jong Koo] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Youm, Yoosik] Yonsei Univ, Dept Sociol, Seoul 120749, South Korea; [Bae, Gwi-Nam] Korea Inst Sci & Technol, Environm Sensor Syst Res Ctr, Seoul, South Korea; [Lee, Tae Yong] Chungnam Natl Univ, Dept Prevent Med & Publ Hlth, Sch Med, Taejon, South Korea; [Kim, Moon Shik] Ajou Univ, Sch Publ Hlth, Suwon 441749, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Korea Institute of Science & Technology (KIST); Chungnam National University; Ajou University	Kim, C (corresponding author), Yonsei Univ, Coll Med, Seoul, South Korea.	preman@yuhs.ac		Kim, Changsoo/0000-0002-5940-5649; Shin, Dong Chun/0000-0003-4252-2280; a, gokul/0000-0003-2226-4691; Nam, Chung Mo/0000-0003-0985-0928	Converging Research Center Program; Ministry of Education, Science and Technology [2011K000754]; Korea Centers for Disease Control and Prevention	Converging Research Center Program; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Centers for Disease Control and Prevention	This research was supported by the Converging Research Center Program funded by the Ministry of Education, Science and Technology (grant number: 2011K000754) and Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Creanga AA, 2011, AM J OBSTET GYNECOL, V204, pS38, DOI 10.1016/j.ajog.2011.02.037; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Galante M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031696; Gonzalez-Canudas J, 2011, REV PANAM SALUD PUBL, V29, P1; Homaira N, 2012, B WORLD HEALTH ORGAN, V90, P272, DOI 10.2471/BLT.11.095653; KCDC, 2009, PUBLIC HLTH WEEKLY R, V2, P293; Kim JH, 2010, J KOREAN MED SCI, V25, P1109, DOI 10.3346/jkms.2010.25.7.1109; Kim KS, 2010, SOC WORK PUBLIC HLTH, V25, P142, DOI 10.1080/19371910903547017; Korea Centers for Disease Control and Prevention, 2020, 5 KOR NAT HLTH NUTR; Korean National Assembly Budget office, 2010, COMPR AN SETTL; Lee Dong Han, 2010, J Prev Med Public Health, V43, P99, DOI 10.3961/jpmph.2010.43.2.99; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Lee JK, 2010, J KOREAN MED ASSOC, V53, P52, DOI 10.5124/jkma.2010.53.1.52; Lee YK, 2011, AM J INFECT CONTROL; Mogasale V, 2011, AUST NZ J PUBL HEAL, V35, P180, DOI 10.1111/j.1753-6405.2010.00639.x; Mota NVYVP, 2011, EMERG INFECT DIS, V17, P1421, DOI 10.3201/eid1708.101546; National Health Insurance Corporation, 2010, 2009 NAT HLTH INS ST; Samsung Economic Research Institute, 2009, CONS ATT SURV; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; World Health Organization, 2009, WORLD NOW START 2009	25	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84121	10.1371/journal.pone.0084121	http://dx.doi.org/10.1371/journal.pone.0084121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386339	gold, Green Published			2022-12-27	WOS:000329117900075
J	Dhaliwal, SS; Welborn, TA; Howat, PA				Dhaliwal, Satvinder S.; Welborn, Timothy A.; Howat, Peter A.			Recreational Physical Activity as an Independent Predictor of Multivariable Cardiovascular Disease Risk	PLOS ONE			English	Article							LIFE-STYLE; HIP RATIO; DEATH; OBESITY; ADULTS	The role of physical activity in preventing CVD has been highlighted by Professor Jerry Morris in the 1950's. We report outcome of a 15-year prospective study with the aim to identify whether physical activity showed cardiovascular benefit independent of common risk factors and of central obesity. Baseline data of 8662 subjects, with no previous history of heart disease, diabetes or stroke, were obtained from an age-and gender-stratified sample of adults in Australian capital cities and were linked with the National Death Index to determine the causes of death of 610 subjects who had died to 31 December 2004. The study consisted of 4175 males (age 42.3+/-13.1 years) and 4487 females (age 42.8+/-13.2 years). Fasting serum lipid levels, systolic and diastolic blood pressure and smoking habits at baseline were recorded. The Framingham Risk Scores of 15-year mortality due to CHD and CVD were calculated using established equations. Subjects were also asked if they engaged in vigorous exercise, less vigorous exercise or walk for recreation and exercise in the past 2 weeks. Subjects in the high recreational physical activity category were 0.16 (0.06-0.43; p<0.001) and 0.12 (0.03-0.48; p = 0.003) times as likely as subjects in the low category for CVD and CHD mortality respectively. After adjusting for both the Framingham Risk Score and central obesity (Waist circumference to Hip circumference Ratio), those in the high recreational physical activity group were 0.35 (0.13-0.98) times less likely compared to the low category for CVD mortality. Recreational physical activity independently predicted reduced cardiovascular mortality over fifteen years. A public health focus on increased physical activity and preventing obesity is required to reduce the risk of CVD and CHD.	[Dhaliwal, Satvinder S.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Welborn, Timothy A.] Sir Charles Gairdner Hosp, Dept Endocrinol, Perth, WA, Australia; [Howat, Peter A.] Curtin Univ, Ctr Behav Res Canc Control, Perth, WA 6845, Australia	Curtin University; University of Western Australia; Curtin University	Dhaliwal, SS (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia.	S.Dhaliwal@curtin.edu.au			Healthway, the Western Australian Health Promotion Foundation	Healthway, the Western Australian Health Promotion Foundation	This study was originally supported by a competitive grant from Healthway, the Western Australian Health Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Risk Factor Prevalence Study Management Committee, 1990, SURV 3 1989; BOYLE CA, 1995, AUST NZ J MED, V25, P316, DOI 10.1111/j.1445-5994.1995.tb01896.x; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; Dhaliwal SS, 2009, PREV MED, V49, P148, DOI 10.1016/j.ypmed.2009.06.023; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Liu K, 2012, CIRCULATION, V125, P996, DOI 10.1161/CIRCULATIONAHA.111.060681; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MORRIS JN, 1953, LANCET, V265, P1111; MORRIS JN, 1990, BRIT HEART J, V63, P325; Samitz G, 2011, INT J EPIDEMIOLOGY; Sesso HD, 1998, CANCER CAUSE CONTROL, V9, P433, DOI 10.1023/A:1008827903302; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; World Health Organization, 1998, INT CLASS DIS MAN IN	18	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83435	10.1371/journal.pone.0083435	http://dx.doi.org/10.1371/journal.pone.0083435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386198	gold, Green Published			2022-12-27	WOS:000329116700050
J	Huang, WX; Zheng, JB; He, Y; Luo, C				Huang, Wanxu; Zheng, Jianbo; He, Ying; Luo, Chen			Tandem Repeat Modification during Double-Strand Break Repair Induced by an Engineered TAL Effector Nuclease in Zebrafish Genome	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; CGG REPEAT; DNA; GENE; SEQUENCE; INSTABILITY; EXPANSION; TRACTS; METHYLATION; EXPRESSION	Tandem repeats (TRs) are abundant and widely distributed in eukaryotic genomes. TRs are thought to have various functions in gene transcription, DNA methylation, nucleosome position and chromatin organization. Variation of repeat units in the genome is observed in association with a number of diseases, such as Fragile X Syndrome, Huntington's disease and Friedreich's ataxia. However, the underlying mechanisms involved are poorly understood, largely owing to the technical limitations in modification of TRs at definite sites in the genome in vivo. Transcription activator-like effector nucleases (TALENs) are widely used in recent years in gene targeting for their specific binding to target sequences when engineered in vitro. Here, we show that the repair of a double-strand break (DSB) induced by TALENs adjacent to a TR can produce serial types of mutations in the TR region. Sequencing analysis revealed that there are three types of mutations induced by the DSB repair, including indels only within the TR region or within the flanking TALEN target region or simutaneously within both regions. Therefore, desired TR mutant types can be conveniently obtained by using engineered TALENs. These results demonstrate that TALENs can serve as a convenient tool for modifying TRs in the genome in studying the functions of TRs.	[Huang, Wanxu; Zheng, Jianbo; He, Ying; Luo, Chen] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Luo, C (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	luoc@zju.edu.cn		Huang, Wanxu/0000-0002-9159-3678	State Key Basic Research Project of China [2010CB126301]; Scientific Research Funds of Zhejiang Provincial Science and Technology Department [2012C12907-9]	State Key Basic Research Project of China; Scientific Research Funds of Zhejiang Provincial Science and Technology Department	This work was supported by State Key Basic Research Project of China (2010CB126301) and the Scientific Research Funds of Zhejiang Provincial Science and Technology Department (2012C12907-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunugama R, 2012, PROG MOL BIOL TRANSL, V110, P155, DOI 10.1016/B978-0-12-387665-2.00007-9; Bhakta MS, 2010, METHODS MOL BIOL, V649, P3, DOI 10.1007/978-1-60761-753-2_1; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dutreix M, 1997, J MOL BIOL, V273, P105, DOI 10.1006/jmbi.1997.1293; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gangloff S, 1996, EMBO J, V15, P1715, DOI 10.1002/j.1460-2075.1996.tb00517.x; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; HAMADA H, 1984, MOL CELL BIOL, V4, P2622, DOI 10.1128/MCB.4.12.2622; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma SS, 2011, EPIGENETICS-US, V6, P1471, DOI 10.4161/epi.6.12.18177; Martienssen R, 2004, COLD SPRING HARB SYM, V69, P371, DOI 10.1101/sqb.2004.69.371; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; MIESFELD R, 1981, NUCLEIC ACIDS RES, V9, P5931, DOI 10.1093/nar/9.22.5931; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2012, CURR OPIN BIOTECHNOL; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pollard LM, 2008, NUCLEIC ACIDS RES, V36, P489, DOI 10.1093/nar/gkm1066; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; RITCHIE RJ, 1994, HUM MOL GENET, V3, P2115, DOI 10.1093/hmg/3.12.2115; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; Wojcik EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051064; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	49	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84176	10.1371/journal.pone.0084176	http://dx.doi.org/10.1371/journal.pone.0084176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386347	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700099
J	Jensen, MM; Erichsen, KD; Bjorkling, F; Madsen, J; Jensen, PB; Sehested, M; Hojgaard, L; Kjraer, A				Jensen, Mette Munk; Erichsen, Kamille Dumong; Bjorkling, Fredrik; Madsen, Jacob; Jensen, Peter Buhl; Sehested, Maxwell; Hojgaard, Liselotte; Kjraer, Andreas			Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; KI-67 IMMUNOHISTOCHEMISTRY; INHIBITOR THERAPY; SURROGATE MARKER; THYMIDINE KINASE; F-18-FLT PET; PROLIFERATION; MANAGEMENT; CHEMOTHERAPY	Introduction: A combination of carboplatin and paclitaxel is often used as first line chemotherapy for treatment of ovarian cancer. Therefore the use of imaging biomarkers early after initiation of treatment to determine treatment sensitivity would be valuable in order to identify responders from non-responders. In this study we describe the non-invasive PET imaging of glucose uptake and cell proliferation using 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) and 3'-deoxy-3'-[F-18]fluorothymidine (FLT) for early assessment of treatment response in a pre-clinical mouse model of human ovarian cancer treated with carboplatin and paclitaxel. Methods: In vivo uptake of FLT and FDG in human ovarian cancer xenografts in mice (A2780) was determined before treatment with carboplatin and paclitaxel (CaP) and repeatedday 1, 4 and 8 after treatment start. Tracer uptake was quantified using small animal PET/CT. Tracer uptake was compared with gene expression of Ki67, TK1, GLUT1, HK1 and HK2. Results: Tumors in the CaP group was significantly smaller than in the control group (p=0.03) on day 8. On day 4 FDG SUVmax ratio was significantly lower in the CaP group compared to the control group (105 +/- 4% vs 138 +/- 9%; p=0.002) and on day 8 the FDG SUVmax ratio was lower in the CaP compared to the control group (125 +/- 13% vs 167 +/- 13%; p=0.05). On day 1 the uptake of FLT SUVmax ratio was 89 +/- 9% in the CaP group and 109 +/- 6% in the control group; however the difference was not statistically significant (p=0.08). Conclusions: Our data suggest that both FDG and FLT PET may be used for the assessment of anti-tumor effects of a combination of carboplatin and paclitaxel in the treatment of ovarian cancer. FLT provides an early and transient signal and FDG a later and more prolonged response. This underscores the importance of optimal timing between treatment and FLT or FDG imaging since treatment response may otherwise be overlooked.	[Jensen, Mette Munk; Hojgaard, Liselotte; Kjraer, Andreas] Univ Copenhagen, Fac Hlth & Med Sci, Cluster Mol Imaging, Copenhagen, Denmark; [Jensen, Mette Munk; Madsen, Jacob; Hojgaard, Liselotte; Kjraer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Erichsen, Kamille Dumong; Bjorkling, Fredrik; Jensen, Peter Buhl; Sehested, Maxwell] Topotarget AS, Copenhagen, Denmark; [Bjorkling, Fredrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Jensen, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Cluster Mol Imaging, Copenhagen, Denmark.	mettemj@sund.ku.dk	Højgaard, Liselotte/AAK-8329-2020; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547	National Advanced Technology Foundation; The John and Birthe Meyer Foundation; Danish Medical Research Council; Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society	National Advanced Technology Foundation; The John and Birthe Meyer Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rigshospitalets Research Foundation; Svend Andersen Foundation; AP Moller Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society)	Funding came from the National Advanced Technology Foundation, The John and Birthe Meyer Foundation, Danish Medical Research Council, Rigshospitalets Research Foundation, Svend Andersen Foundation, AP Moller Foundation, Novo Nordisk Foundation, Lundbeck Foundation and Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide N, 2010, J NUCL MED, V51, P1559, DOI 10.2967/jnumed.109.073288; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Atkinson DM, 2008, HEAD NECK-J SCI SPEC, V30, P790, DOI 10.1002/hed.20770; Avril N, 2005, J CLIN ONCOL, V23, P7445, DOI 10.1200/JCO.2005.06.965; Avril N, 2011, METHODS MOL BIOL, V727, P171, DOI 10.1007/978-1-61779-062-1_10; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Barthel H, 2003, CANCER RES, V63, P3791; Been LB, 2004, EUR J NUCL MED MOL I, V31, P1659, DOI 10.1007/s00259-004-1687-6; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Brepoels L, 2009, J NUCL MED; Buck AK, 2003, J NUCL MED, V44, P1426; Buck AK, 2002, CANCER RES, V62, P3331; Cejka D, 2009, BRIT J CANCER, V100, P1739, DOI 10.1038/sj.bjc.6605076; Chen W, 2005, J NUCL MED, V46, P945; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Fueger BJ, 2006, J NUCL MED, V47, P999; Guarneri V, 2011, EXPERT REV ANTICANC, V11, P49, DOI [10.1586/era.10.204, 10.1586/ERA.10.204]; Guarneri V, 2010, GYNECOL ONCOL, V117, P152, DOI 10.1016/j.ygyno.2009.11.033; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jensen MM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-168; Jensen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050618; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lee SJ, 2010, BIOCHEM PHARMACOL, V80, P1528, DOI 10.1016/j.bcp.2010.08.004; Leyton J, 2005, CANCER RES, V65, P4202, DOI 10.1158/0008-5472.CAN-04-4008; Leyton J, 2006, CANCER RES, V66, P7621, DOI 10.1158/0008-5472.CAN-05-3962; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Markman M, 2008, TRENDS PHARMACOL SCI, V29, P515, DOI 10.1016/j.tips.2008.07.007; Martoni AA, 2011, Q J NUCL MED MOL IM, V55, P81; Moroz MA, 2011, CLIN CANCER RES, V17, P1099, DOI 10.1158/1078-0432.CCR-10-1430; Mudd SR, 2011, MOL IMAGING BIOL; Munk Jensen M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053410, DOI 10.1371/J0URNAL.P0NE.0053410.PUBMED:23308217]; Perumal M, 2012, MOL IMAGING BIOL, V14, P753, DOI 10.1007/s11307-012-0554-2; Rasey JS, 2002, J NUCL MED, V43, P1210; Richard SD, 2011, NUCL MED BIOL, V38, P485, DOI 10.1016/j.nucmedbio.2010.12.003; Schwartz JL, 2003, J NUCL MED, V44, P2027; Shah C, 2009, CLIN CANCER RES, V15, P4712, DOI 10.1158/1078-0432.CCR-08-2635; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SOM P, 1980, J NUCL MED, V21, P670; Takeuchi S, 2011, ONCOL REP, V26, P725, DOI 10.3892/or.2011.1338; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; Vergez S, 2010, CLIN CANCER RES, V16, P4434, DOI 10.1158/1078-0432.CCR-09-2795; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Waldherr C, 2005, J NUCL MED, V46, P114; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	52	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85126	10.1371/journal.pone.0085126	http://dx.doi.org/10.1371/journal.pone.0085126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386456	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700133
J	Juszkat, R; Perek, B; Zabicki, B; Trojnarska, O; Jemielity, M; Staniszewski, R; Smoczyk, W; Pukacki, F				Juszkat, Robert; Perek, Bartlomiej; Zabicki, Bartosz; Trojnarska, Olga; Jemielity, Marek; Staniszewski, Ryszard; Smoczyk, Wieslaw; Pukacki, Fryderyk			Endovascular Treatment of Late Thoracic Aortic Aneurysms after Surgical Repair of Congenital Aortic Coarctation in Childhood	PLOS ONE			English	Article							LATE COMPLICATIONS; MANAGEMENT; SURGERY; GRAFTS; ADULT	Background: In some patients, local surgery-related complications are diagnosed many years after surgery for aortic coarctation. The purposes of this study were: (1) to systematically evaluate asymptomatic adults after Dacron patch repair in childhood, (2) to estimate the formation rate of secondary thoracic aortic aneurysms (TAAs) and (3) to assess outcomes after intravascular treatment for TAAs. Methods: This study involved 37 asymptomatic patients (26 female and 11 male) who underwent surgical repair of aortic coarctation in the childhood. After they had reached adolescence, patients with secondary TAAs were referred to endovascular repair. Results: Follow-up studies revealed TAA in seven cases (19%) (including six with the gothic type of the aortic arch) and mild recoarctation in other six (16%). Six of the TAA patients were treated with stentgrafts, but one refused to undergo an endovascular procedure. In three cases, stengrafts covered the left subclavian artery (LSA), in another the graft was implanted distally to the LSA. In two individuals, elective hybrid procedures were performed with surgical bypass to the supraaortic arteries followed by stengraft implantation. All subjects survived the secondary procedures. One patient developed type Ia endoleak after stentgraft implantation that was eventually treated with a debranching procedure. Conclusions: The long-term course of clinically asymptomatic patients after coarctation patch repair is not uncommonly complicated by formation of TAAs (particularly in individuals with the gothic pattern of the aortic arch) that can be treated effectively with stentgrafts. However, in some patients hybrid procedures may be necessary.	[Juszkat, Robert; Zabicki, Bartosz] Poznan Univ Med Sci, Dept Clin & Intervent Radiol, Poznan, Poland; [Perek, Bartlomiej; Jemielity, Marek] Poznan Univ Med Sci, Dept Cardiac Surg & Transplantol, Poznan, Poland; [Trojnarska, Olga] Poznan Univ Med Sci, Dept Cardiol, Poznan, Poland; [Staniszewski, Ryszard; Pukacki, Fryderyk] Poznan Univ Med Sci, Dept Gen & Vasc Surg, Poznan, Poland; [Smoczyk, Wieslaw] Poznan Univ Med Sci, Dept Pediat Radiol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Perek, B (corresponding author), Poznan Univ Med Sci, Dept Cardiac Surg & Transplantol, Poznan, Poland.	bperek@yahoo.com	Perek, Bartłomiej/AAS-6564-2021	Perek, Bartłomiej/0000-0003-2398-9571				ALAKULJU K, 1989, ANN THORAC SURG, V47, P853, DOI 10.1016/0003-4975(89)90018-0; Auriacombe L, 2002, ARCH MAL COEUR VAISS, V95, P1081; Botta L, 2009, EUR J CARDIO-THORAC, V36, P670, DOI 10.1016/j.ejcts.2009.04.056; Brueck Martin, 2006, J Interv Cardiol, V19, P539, DOI 10.1111/j.1540-8183.2006.00208.x; COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840; DESANTO A, 1987, J THORAC CARDIOV SUR, V94, P720; DOTTER CT, 1969, INVEST RADIOL, V4, P329, DOI 10.1097/00004424-196909000-00008; Dykukha S E, 1997, Klin Khir, P78; Etz CD, 2009, ANN THORAC SURG, V88, P758, DOI 10.1016/j.athoracsur.2009.04.140; Garcia-Pavia P, 2010, REV ESP CARDIOL, V63, P473, DOI 10.1016/S0300-8932(10)70068-3; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, P1509, DOI 10.1016/j.jacc.2010.02.010; Knyshov GV, 1996, ANN THORAC SURG, V61, P935, DOI 10.1016/0003-4975(95)01189-7; Kpodonu J, 2010, ANN THORAC SURG, V90, P1716, DOI 10.1016/j.athoracsur.2009.12.083; Ksiazyk J, 2004, FOLIA CARDIOL, V11, P205; Kutty S, 2008, ANN THORAC SURG, V85, P1332, DOI 10.1016/j.athoracsur.2008.01.012; Marcheix B, 2007, EUR J CARDIO-THORAC, V31, P1004, DOI 10.1016/j.ejcts.2007.02.036; Oliver JM, 2009, AM J CARDIOL, V104, P1001, DOI 10.1016/j.amjcard.2009.05.045; Maxey TS, 2003, ANN THORAC SURG, V76, P1090, DOI 10.1016/S0003-4975(03)00822-1; Olivieri Laura J, 2011, Cardiovasc Eng Technol, V2, P288; Ou P, 2004, EUR HEART J, V25, P1853, DOI 10.1016/j.ehj.2004.07.021; Ou P, 2006, J THORAC CARDIOV SUR, V132, P1105, DOI 10.1016/j.jtcvs.2006.05.061; Pace Napoleone Carlo, 2003, Ital Heart J, V4, P404; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Rokkas CK, 2002, J THORAC CARDIOV SUR, V124, P155, DOI 10.1067/mtc.2002.121494; Smaill BH, 2000, J THORAC CARDIOV SUR, V120, P1053, DOI 10.1067/mtc.2000.110187; Szmidt Jacek, 2007, Interact Cardiovasc Thorac Surg, V6, P490, DOI 10.1510/icvts.2007.152447; Vriend JWJ, 2005, INT J CARDIOL, V101, P399, DOI 10.1016/j.ijcard.2004.03.056; Wagner RH, 2006, GER MED SCI, V4; Wang Y, 2010, HEART SURG FORUM, V13, pE350, DOI 10.1532/HSF98.20101061; Webb G, 2005, SEMIN THORAC CARDIOV, V17, P139, DOI 10.1053/j.semtcvs.2005.03.001; Zipfel B, 2011, ANN THORAC SURG, V91, P85, DOI 10.1016/j.athoracsur.2010.08.053	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83601	10.1371/journal.pone.0083601	http://dx.doi.org/10.1371/journal.pone.0083601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386233	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700062
J	Pombert, JF; Otis, C; Turmel, M; Lemieux, C				Pombert, Jean-Francois; Otis, Christian; Turmel, Monique; Lemieux, Claude			The Mitochondrial Genome of the Prasinophyte Prasinoderma coloniale Reveals Two Trans-Spliced Group I Introns in the Large Subunit rRNA Gene	PLOS ONE			English	Article							ALGA OLTMANNSIELLOPSIS-VIRIDIS; DNA-SEQUENCE; HOMING ENDONUCLEASES; COMPLETE CHLOROPLAST; EVOLUTIONARY TRENDS; ULVOPHYCEAE; PLANT; ARCHITECTURE; COMPLEX; RDNA	Organelle genes are often interrupted by group I and or group II introns. Splicing of these mobile genetic occurs at the RNA level via serial transesterification steps catalyzed by the introns'own tertiary structures and, sometimes, with the help of external factors. These catalytic ribozymes can be found in cis or trans configuration, and although trans-arrayed group II introns have been known for decades, trans-spliced group I introns have been reported only recently. In the course of sequencing the complete mitochondrial genome of the prasinophyte picoplanktonic green alga Prasinoderma coloniale CCMP 1220 (Prasinococcales, clade VI), we uncovered two additional cases of trans-spliced group I introns. Here, we describe these introns and compare the 54,546 bp-long mitochondrial genome of Prasinoderma with those of four other prasinophytes (clades II, III and V). This comparison underscores the highly variable mitochondrial genome architecture in these ancient chlorophyte lineages. Both Prasinoderma trans-spliced introns reside within the large subunit rRNA gene (rnl) at positions where cis-spliced relatives, often containing homing endonuclease genes, have been found in other organelles. In contrast, all previously reported trans-spliced group I introns occur in different mitochondrial genes (rns or coxI). Each Prasinoderma intron is fragmented into two pieces, forming at the RNA level a secondary structure that resembles those of its cis-spliced counterparts. As observed for other trans-spliced group I introns, the breakpoint of the first intron maps to the variable loop L8, whereas that of the second is uniquely located downstream of P9.1. The breakpoint In each Prasinoderma intron corresponds to the same region where the open reading frame (ORF) occurs when present in cis-spliced orthologs. This correlation between the intron breakpoint and the ORF location in cis-spliced orthologs also holds for other trans-spliced introns; we discuss the possible implications of this interesting observation for trans-splicing of group I introns.	[Pombert, Jean-Francois] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Otis, Christian; Turmel, Monique; Lemieux, Claude] Univ Laval, Inst Biol Integrat & Syst, Dept Biochimie Microbiol & Bioinformat, Quebec City, PQ, Canada	Illinois Institute of Technology; Laval University	Lemieux, C (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Dept Biochimie Microbiol & Bioinformat, Quebec City, PQ, Canada.	claude.lemieux@bcm.ulaval.ca	Turmel, Monique/AAC-9752-2020; Lemieux, Claude/L-8831-2015	Turmel, Monique/0000-0001-7060-035X; Lemieux, Claude/0000-0001-9580-8042; Pombert, Jean-Francois/0000-0002-3449-8375	NSERC from the Natural Sciences and Engineering Council [2830]	NSERC from the Natural Sciences and Engineering Council	This work was supported by a NSERC-Discovery grant (no. 2830) from the Natural Sciences and Engineering Council (http://www.nserc-crsng.gc.ca/index_eng.asp) to MT and CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhocine K, 2008, RNA, V14, P1782, DOI 10.1261/rna.1083508; Bonen L, 2012, ADV BOT RES, V63, P155, DOI 10.1016/B978-0-12-394279-1.00007-7; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; Glanz S, 2009, BIOESSAYS, V31, P921, DOI 10.1002/bies.200900036; GOLDSCHMIDTCLERMONT M, 1990, MOL GEN GENET, V223, P417, DOI 10.1007/BF00264448; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Hasegawa T, 1996, PHYCOLOGIA, V35, P170, DOI 10.2216/i0031-8884-35-2-170.1; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, NUCLEIC ACIDS RES, V32, P2049, DOI 10.1093/nar/gkh520; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Jacobs J, 2013, MOL CELL PROTEOMICS, V12, P1912, DOI 10.1074/mcp.M112.026583; Jacobs J, 2011, CELL MOL LIFE SCI, V68, P735, DOI 10.1007/s00018-010-0523-3; KELLER MD, 1987, J PHYCOL, V23, P633; Knoop V, 1997, MOL GEN GENET, V255, P269, DOI 10.1007/s004380050497; KUCK U, 1987, EMBO J, V6, P2185, DOI 10.1002/j.1460-2075.1987.tb02489.x; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nadimi M, 2012, MOL BIOL EVOL, V29, P2199, DOI 10.1093/molbev/mss088; Pelin A, 2012, NEW PHYTOL, V194, P836, DOI 10.1111/j.1469-8137.2012.04072.x; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Pombert JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008954; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Qiu YL, 2004, J MOL EVOL, V59, P80, DOI 10.1007/s00239-004-2606-y; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Smith DR, 2008, MOL BIOL EVOL, V25, P487, DOI 10.1093/molbev/msm245; Smith DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023624; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Turmel M, 2010, J MOL EVOL, V70, P203, DOI 10.1007/s00239-010-9322-6; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Zhou Y, 2008, NUCLEIC ACIDS RES, V36, pD31, DOI 10.1093/nar/gkm766	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84325	10.1371/journal.pone.0084325	http://dx.doi.org/10.1371/journal.pone.0084325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386369	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700104
J	Reilly, D; Hao, K; Jensen, MK; Girman, CJ; Rimm, EB				Reilly, Dermot; Hao, Ke; Jensen, Majken K.; Girman, Cynthia J.; Rimm, Eric B.			Use of Systems Biology Approaches to Analysis of Genome-Wide Association Studies of Myocardial Infarction and Blood Cholesterol in the Nurses' Health Study and Health Professionals' Follow-Up Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK; LOCI	With the advance of genome-wide association studies and newly identified SNP (single-nucleotide polymorphism) associations with complex disease, important discoveries have emerged focusing not only on individual genes but on disease-associated pathways and gene sets. The authors used prospective myocardial infarction case-control studies nested in the Nurses' Health and Health Professionals Follow-Up Studies to investigate genetic variants associated with myocardial infarction or LDL, HDL, triglycerides, adiponectin and apolipoprotein B (apoB). Using these case-control studies to illustrate an integrative systems biology approach, the authors applied SNP set enrichment analysis to identify gene sets where expression SNPs representing genes from these sets show enrichment in their association with endpoints of interest. The authors also explored an aggregate score approach. While power limited one's ability to detect significance for association of individual loci with myocardial infarction, the authors found significance for loci associated with LDL, HDL, apoB and triglycerides, replicating previous observations. Applying SNP set enrichment analysis and risk score methods, the authors also found significance for three gene sets and for aggregate scores associated with myocardial infarction as well as for loci-related to cardiovascular risk factors, supporting the use of these methods in practice.	[Reilly, Dermot; Hao, Ke] Merck & Co Inc, Dept Mol Profiling & Res Informat, Merck Res Labs, Whitehouse Stn, NJ USA; [Jensen, Majken K.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Girman, Cynthia J.] Merck & Co Inc, Dept Epidemiol, Merck Res Labs, Whitehouse Stn, NJ 08889 USA; [Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Nutr, Channing Div Network Med, Boston, MA 02115 USA; [Rimm, Eric B.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rimm, Eric B.] Harvard Univ, Sch Med, Boston, MA USA	Merck & Company; Harvard University; Harvard T.H. Chan School of Public Health; Merck & Company; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Girman, CJ (corresponding author), Merck & Co Inc, Dept Epidemiol, Merck Res Labs, Whitehouse Stn, NJ 08889 USA.	cindy.girman@merck.com		Jensen, Majken Karoline/0000-0003-4729-7545	Merck; NIH grants, National Institutes of Health, Bethesda, Maryland [HL34594, CA87969, HL35464, CA55075]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL035464] Funding Source: NIH RePORTER	Merck(Merck & Company); NIH grants, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Genotyping was performed at Rosetta Laboratories and funded by Merck. This study was supported by NIH grants HL34594, CA87969, HL35464, and CA55075 from the National Institutes of Health, Bethesda, Maryland. Sponsors had input into the analysis and preparation of the draft manuscript, but did not have input into the study design of the Nurses Health Study or the Men's Health Professionals Follow-up study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Harpster MH, 2006, MAMM GENOME, V17, P701, DOI 10.1007/s00335-005-0120-1; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.2307/2335290; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RAO DC, 1982, AM J HUM GENET, V34, P888; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85369	10.1371/journal.pone.0085369	http://dx.doi.org/10.1371/journal.pone.0085369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386469	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700136
J	Sippert, EA; Silva, CDE; Visentainer, JEL; Sell, AM				Sippert, Emilia Angela; de Oliveira e Silva, Cleverson; Laguila Visentainer, Jeane Eliete; Sell, Ana Maria			Association of Duffy Blood Group Gene Polymorphisms with IL8 Gene in Chronic Periodontitis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; CODING SEQUENCE; INTERLEUKIN-1 GENOTYPE; RISK INDICATORS; EXPRESSION; DISEASE; ANTIGEN; CELLS; COMMON; SUSCEPTIBILITY	The antigens of the Duffy blood group system (DARC) act as a receptor for the interleukin IL-8. IL-8 plays an important role in the pathogenesis of chronic periodontitis due to its chemotactic properties on neutrophils. The aim of this study was to investigate a possible association of Duffy blood group gene polymorphisms with the -353T>A, -845T>C and -738T>A SNPs of the IL8 gene in chronic periodontitis. One hundred and twenty-four individuals with chronic periodontitis and 187 controls were enrolled. DNA was extracted using the salting-out method. The Duffy genotypes and IL8 gene promoter polymorphisms were investigated by PCR-RFLP. Statistical analyses were conducted using the Chi square test with Yates correction or Fisher's Exact Test, and the possibility of associations were evaluated by odds ratio with a 95% confidence interval. When analyzed separately, for the Duffy blood group system, differences in the genotype and allele frequencies were not observed between all the groups analyzed; and, in nonsmokers, the -845C allele (3.6% vs. 0.4%), -845TC genotype (7.3% vs. 0.7%) and the CTA haplotype (3.6% vs. 0.4%) were positively associated with chronic periodontitis. For the first time to our knowledge, the polymorphisms of erythroid DARC plus IL8 -353T>A SNPs were associated with chronic periodontitis in Brazilian individuals. In Afro-Brazilians patients, the FY*02N. 01 with IL8 -353A SNP was associated with protection to chronic periodontitis.	[Sippert, Emilia Angela] Univ Estadual Maringa, Dept Anal Clin & Biomed, Post Grad Program Biosci Appl Pharm, Maringa, Parana, Brazil; [de Oliveira e Silva, Cleverson] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil; [Laguila Visentainer, Jeane Eliete; Sell, Ana Maria] Univ Estadual Maringa, Basic Hlth Sci Dept, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Sell, AM (corresponding author), Univ Estadual Maringa, Basic Hlth Sci Dept, Maringa, Parana, Brazil.	anamsell@gmail.com	Sippert, Emilia Angela/B-3033-2013; Visentainer, Jeane Eliete Laguila/B-3510-2009; Silva, Cléverson O/G-5907-2012; Visentainer, Jeane/AAJ-1618-2021	Sippert, Emilia Angela/0000-0002-6341-3879; Visentainer, Jeane Eliete Laguila/0000-0002-5815-7903; Silva, Cléverson O/0000-0002-7103-9100; 	CAPES; Fundacao Araucaria; Laboratory of Immunogenetics LIG-UEM	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Laboratory of Immunogenetics LIG-UEM	The authors wish to thank CAPES, Fundacao Araucaria, and Laboratory of Immunogenetics LIG-UEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1997, LANCET, V349, P490, DOI 10.1016/S0140-6736(96)07524-1; Ahluwalia TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005168; Andia DC, 2011, J PERIODONTOL, V82, P893, DOI 10.1902/jop.2010.100513; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bergstrom Jan, 2004, Odontology, V92, P1; Cartron JP, 1998, VOX SANG, V74, P29, DOI 10.1111/j.1423-0410.1998.tb05397.x; Castilho L, 2004, VOX SANG, V87, P190, DOI 10.1111/j.1423-0410.2004.00554.x; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Dan HX, 2010, INFLAMMATION, V33, P76, DOI 10.1007/s10753-009-9160-0; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Estalote AC, 2005, GENET MOL RES, V4, P166; Gainet J, 1998, LAB INVEST, V78, P755; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Gonzales JR, 2004, J CLIN PERIODONTOL, V31, P384, DOI 10.1111/j.1600-051X.2004.00492.x; GOVERDHAN V, 2008, BR J OPHTHALMOL, V92, P537, DOI DOI 10.1136/BJ0.2007.123190.PUBMED:18310311; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; GROSSI SG, 1995, J PERIODONTOL, V66, P23, DOI 10.1902/jop.1995.66.1.23; Guzman S, 2003, J PERIODONTOL, V74, P1183, DOI 10.1902/jop.2003.74.8.1183; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hansell CAH, 2011, IMMUNOL CELL BIOL, V89, P197, DOI 10.1038/icb.2010.147; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Heinzmann A, 2004, J ALLERGY CLIN IMMUN, V114, P671, DOI 10.1016/j.jaci.2004.06.038; HORUK R, 1993, BIOCHEMISTRY-US, V32, P5733, DOI 10.1021/bi00073a002; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kamali-Sarvestani E, 2007, NEOPLASMA, V54, P484; Kawashima Miwako, 2005, Nippon Ganka Gakkai Zasshi, V109, P596; Kim YJ, 2009, DNA CELL BIOL, V28, P185, DOI 10.1089/dna.2008.0816; Kim YJ, 2010, CLIN CHIM ACTA, V411, P1264, DOI 10.1016/j.cca.2010.05.014; Kornman Kenneth S, 2005, J Dent Educ, V69, P498; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kyiak Iu H, 2012, Fiziol Zh, V58, P65; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lee EB, 2007, TISSUE ANTIGENS, V69, P128, DOI 10.1111/j.1399-0039.2006.00736.x; McCarron SL, 2002, CANCER RES, V62, P3369; Mealey BL, 2006, J AM DENT ASSOC, V137, p26S, DOI 10.14219/jada.archive.2006.0404; Moreira PR, 2005, J PERIODONTAL RES, V40, P306, DOI 10.1111/j.1600-0765.2005.00801.x; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; NEOTE K, 1994, BLOOD, V84, P44; NEOTE K, 1993, J BIOL CHEM, V268, P12247; Novaretti MC, 2000, REV BRAS HEMATOL HEM, V22, P23; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Papapanou PN, 2001, J CLIN PERIODONTOL, V28, P389, DOI 10.1034/j.1600-051x.2001.028005389.x; Parasol N, 1998, BLOOD, V92, P2237, DOI 10.1182/blood.V92.7.2237.2237_2237_2243; Probst CM, 2000, HUM BIOL, V72, P597; Rompler H, 2006, GENOMICS, V87, P724, DOI 10.1016/j.ygeno.2006.02.009; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; Rovin BH, 2002, KIDNEY INT, V62, P261, DOI 10.1046/j.1523-1755.2002.00438.x; Salvi GE, 1997, PERIODONTOL 2000, V14, P173, DOI 10.1111/j.1600-0757.1997.tb00197.x; Soga Y, 2003, J CLIN PERIODONTOL, V30, P524, DOI 10.1034/j.1600-051X.2003.00287.x; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Tournamille C, 1998, BLOOD, V92, P2147, DOI 10.1182/blood.V92.6.2147.418k04_2147_2156; TOURNAMILLE C, 1995, HUM GENET, V95, P407, DOI 10.1007/BF00208965; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Tuller T, 2013, GENES IMMUN, V14, P67, DOI 10.1038/gene.2012.55; Vairaktaris E, 2007, EJSO-EUR J SURG ONC, V33, P504, DOI 10.1016/j.ejso.2006.11.002; Voisine P, 2004, CIRCULATION, V110, pII280, DOI 10.1161/01.CIR.0000138974.18839.02	62	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83286	10.1371/journal.pone.0083286	http://dx.doi.org/10.1371/journal.pone.0083286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386171	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700037
J	Strle, F; Lusa, L; Ruzic-Sabljic, E; Maraspin, V; Furlan, SL; Cimperman, J; Ogrinc, K; Rojko, T; Zorman, JV; Stupica, D				Strle, Franc; Lusa, Lara; Ruzic-Sabljic, Eva; Maraspin, Vera; Furlan, Stanka Lotric; Cimperman, Joze; Ogrinc, Katarina; Rojko, Tereza; Zorman, Jerneja Videcnik; Stupica, Dasa			Clinical Characteristics Associated with Borrelia burgdorferi Sensu Lato Skin Culture Results in Patients with Erythema Migrans	PLOS ONE			English	Article							LYME-BORRELIOSIS; CASE DEFINITIONS; DIAGNOSIS; SLOVENIA; AFZELII; STRAINS; GARINII; EUROPE	Clinical characteristics associated with isolation of Borrelia burgdorferi sensu lato from skin have not been fully evaluated. To gain insight into predictors for a positive EM skin culture, we compared basic demographic, epidemiologic, and clinical data in 608 culture-proven and 501 culture-negative adult patients with solitary EM. A positive Borrelia spp. skin culture was associated with older age, a time interval of >2 days between tick bite and onset of the skin lesion, EM >= 5 cm in diameter, and location of the lesion on the extremities, whereas several other characteristics used as clinical case definition criteria for the diagnosis of EM (such as tick bite at the site of later EM, information on expansion of the skin lesion, central clearing) were not. A patient with a 15-cm EM lesion had almost 3-fold greater odds for a positive skin culture than patients with a 5-cm lesion. Patients with a free time interval between the tick bite and onset of EM had the same probability of a positive skin culture as those who did not recall a tick bite (OR=1.02); however, the two groups had >3-fold greater odds for EM positivity than patients who reported a tick bite with no interval between the bite and onset of the lesion. In conclusion, several yet not all clinical characteristics used in EM case definitions were associated with positive Borrelia spp. skin culture. The findings are limited to European patients with solitary EM caused predominantly by B. afzelii but may not be valid for other situations.	[Strle, Franc; Maraspin, Vera; Furlan, Stanka Lotric; Cimperman, Joze; Ogrinc, Katarina; Rojko, Tereza; Zorman, Jerneja Videcnik; Stupica, Dasa] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Lusa, Lara] Univ Ljubljana Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia; [Ruzic-Sabljic, Eva] Univ Ljubljana Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana	Strle, F (corresponding author), Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia.	franc.strle@kclj.si	Lusa, Lara/C-6692-2015	Lusa, Lara/0000-0002-8981-2421	Slovenian Research Agency [P3-0296, J3-3636]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The study was supported by the Slovenian Research Agency (grant numbers P3-0296 and J3-3636). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; CDC, 1997, MMWR, V46; Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; Cerar T, 2008, CLIN MICROBIOL INFEC, V14, P653, DOI 10.1111/j.1469-0691.2008.02013.x; Ciceroni L, 2001, J CLIN MICROBIOL, V39, P2254, DOI 10.1128/JCM.39.6.2254-2260.2001; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Logar M, 2004, INFECTION, V32, P15, DOI 10.1007/s15010-004-3042-z; Logar M, 1999, WIEN KLIN WOCHENSCHR, V111, P945; O'Rourke M, 2013, NY TIMES BK REV, P8; R Development Core Team R, 2009, R LANG ENV STAT COMP; Ruzic-Sabljic E, 2002, WIEN KLIN WOCHENSCHR, V114, P544; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 1996, WIEN KLIN WOCHENSCHR, V108, P741; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Strle F, 2002, WIEN KLIN WOCHENSCHR, V114, P493; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Strle F, 2011, VECTOR-BORNE ZOONOT, V11, P1253, DOI 10.1089/vbz.2010.0230; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; Zore A, 2002, WIEN KLIN WOCHENSCHR, V114, P606	21	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82132	10.1371/journal.pone.0082132	http://dx.doi.org/10.1371/journal.pone.0082132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386087	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700004
J	Xiao, Y; Fan, HH; Zhang, YP; Xing, WJ; Ping, YY; Zhao, HY; Xu, CH; Li, YQ; Wang, L; Li, F; Hu, J; Huang, T; Lv, YL; Ren, H; Li, X				Xiao, Yun; Fan, Huihui; Zhang, Yunpeng; Xing, Wenjing; Ping, Yanyan; Zhao, Hongying; Xu, Chaohan; Li, Yiqun; Wang, Li; Li, Feng; Hu, Jing; Huang, Teng; Lv, Yanling; Ren, Huan; Li, Xia			Systematic Identification of Core Transcription Factors Mediating Dysregulated Links Bridging Inflammatory Bowel Diseases and Colorectal Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; REGULATORY NETWORKS; COEXPRESSION ANALYSIS; STAT3 ACTIVATION; MICROARRAY DATA; HALLMARKS; COLITIS; CELLS; IL-6; ALGORITHMS	Accumulating evidence shows a tight link between inflammation and cancer. However, comprehensive identification of pivotal transcription factors (i.e., core TFs) mediating the dysregulated links remains challenging, mainly due to a lack of samples that can effectively reflect the connections between inflammation and tumorigenesis. Here, we constructed a series of TF-mediated regulatory networks from a large compendium of expression profiling of normal colonic tissues, inflammatory bowel diseases (IBDs) and colorectal cancer (CRC), which contains 1201 samples in total, and then proposed a network-based approach to characterize potential links bridging inflammation and cancer. For this purpose, we computed significantly dysregulated relationships between inflammation and their linked cancer networks, and then 24 core TFs with their dysregulated genes were identified. Collectively, our approach provides us with quite important insight into inflammation-associated tumorigenesis in colorectal cancer, which could also be applied to identify functionally dysregulated relationships mediating the links between other different disease phenotypes.	[Xiao, Yun; Fan, Huihui; Zhang, Yunpeng; Ping, Yanyan; Zhao, Hongying; Xu, Chaohan; Li, Yiqun; Wang, Li; Li, Feng; Hu, Jing; Huang, Teng; Lv, Yanling; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Xing, Wenjing; Ren, Huan] Harbin Med Univ, Dept Immunol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Ren, H (corresponding author), Harbin Med Univ, Dept Immunol, Harbin, Heilongjiang, Peoples R China.	huanren2009@126.com; lixia@hrbmu.edu.cn	Ren, Huan/O-5727-2017; Hu, Jing/GPC-4486-2022; Fan, Huihui/AGB-0221-2022; Hu, Jing/AAT-8707-2021; li, xia/HHZ-7468-2022; Xiao, Yun/A-8359-2013	Hu, Jing/0000-0002-5996-4889; Fan, Huihui/0000-0003-4233-5389; Hu, Jing/0000-0002-5996-4889; Ping, Yanyan/0000-0002-1810-1200; Ren, Huan/0000-0001-7114-2012	Creative Research Groups of The National Natural Science Foundation of China [81121003, 91129710, 91029717, 91229112, 31200997]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307110022]; Science Foundation of Heilongjiang Province [D200834, C201207]; Science Foundation of Heilongjiang Province Education Department [YJSCX2012-230HLJ]	Creative Research Groups of The National Natural Science Foundation of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of Heilongjiang Province; Science Foundation of Heilongjiang Province Education Department	This work was supported in part by the Creative Research Groups of The National Natural Science Foundation of China (grant numbers 81121003, 91129710, 91029717, 91229112 and 31200997), the Specialized Research Fund for the Doctoral Program of Higher Education of China (grant number 20102307110022), the Science Foundation of Heilongjiang Province (grant numbers D200834 and C201207) and the Science Foundation of Heilongjiang Province Education Department (grant number YJSCX2012-230HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bansal M., 2007, MOL SYSTEMS BIOL, V3; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen GY, 2011, GASTROENTEROLOGY, V141, P1986, DOI 10.1053/j.gastro.2011.10.002; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; He B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018516; Huttenhower C, 2009, BIOINFORMATICS, V25, P3267, DOI 10.1093/bioinformatics/btp588; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Karamanou M, 2010, J BUON, V15, P803; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Lazebnik Y, 2010, NAT REV CANCER, V10, P232, DOI 10.1038/nrc2827; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li Y, 2012, INFLAMM BOWEL DIS, V18, P1177, DOI 10.1002/ibd.21884; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Nibbe RK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000639; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Pozza A, 2011, ANN ITAL CHIR, V82, P19; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xiao Y, 2011, GENOMICS, V98, P64, DOI 10.1016/j.ygeno.2011.04.001; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	52	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83495	10.1371/journal.pone.0083495	http://dx.doi.org/10.1371/journal.pone.0083495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386215	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700056
J	Zhang, FW; Benson, C; Murphy, D; Boian, M; Scott, M; Keith, R; Xiang, J; Abbas, P				Zhang, Fawen; Benson, Chelsea; Murphy, Dora; Boian, Melissa; Scott, Michael; Keith, Robert; Xiang, Jing; Abbas, Paul			Neural Adaptation and Behavioral Measures of Temporal Processing and Speech Perception in Cochlear Implant Recipients	PLOS ONE			English	Article							AUDITORY-NERVE FIBERS; SHORT-TERM ADAPTATION; ACTION-POTENTIAL ECAP; GAP-DETECTION; MODULATION DETECTION; ADAPTIVE PATTERN; N1 WAVE; HABITUATION; RECOGNITION; NUCLEUS	The objective was to determine if one of the neural temporal features, neural adaptation, can account for the across-subject variability in behavioral measures of temporal processing and speech perception performance in cochlear implant (CI) recipients. Neural adaptation is the phenomenon in which neural responses are the strongest at the beginning of the stimulus and decline following stimulus repetition (e. g., stimulus trains). It is unclear how this temporal property of neural responses relates to psychophysical measures of temporal processing (e. g., gap detection) or speech perception. The adaptation of the electrical compound action potential (ECAP) was obtained using 1000 pulses per second (pps) biphasic pulse trains presented directly to the electrode. The adaptation of the late auditory evoked potential (LAEP) was obtained using a sequence of 1-kHz tone bursts presented acoustically, through the cochlear implant. Behavioral temporal processing was measured using the Random Gap Detection Test at the most comfortable listening level. Consonant nucleus consonant (CNC) word and AzBio sentences were also tested. The results showed that both ECAP and LAEP display adaptive patterns, with a substantial across-subject variability in the amount of adaptation. No correlations between the amount of neural adaptation and gap detection thresholds (GDTs) or speech perception scores were found. The correlations between the degree of neural adaptation and demographic factors showed that CI users having more LAEP adaptation were likely to be those implanted at a younger age than CI users with less LAEP adaptation. The results suggested that neural adaptation, at least this feature alone, cannot account for the across-subject variability in temporal processing ability in the CI users. However, the finding that the LAEP adaptive pattern was less prominent in the CI group compared to the normal hearing group may suggest the important role of normal adaptation pattern at the cortical level in speech perception.	[Zhang, Fawen; Benson, Chelsea; Murphy, Dora; Boian, Melissa; Keith, Robert] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA; [Scott, Michael] Cincinnati Childrens Hosp Med Ctr, Dept Audiol, Cincinnati, OH 45229 USA; [Xiang, Jing] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Abbas, Paul] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Iowa	Zhang, FW (corresponding author), Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA.	Fawen.Zhang@uc.edu		Xiang, Jing/0000-0003-0242-5590	National Institute of Health [NIH 1R15DC011004-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC011004] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute of Health Grant (NIH 1R15DC011004-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas PJ, 1999, EAR HEARING, V20, P45, DOI 10.1097/00003446-199902000-00005; ABBAS PJ, 1984, HEARING RES, V14, P29, DOI 10.1016/0378-5955(84)90066-2; ALCAINI M, 1994, PSYCHOPHYSIOLOGY, V31, P611, DOI 10.1111/j.1469-8986.1994.tb02354.x; Anderer P, 1998, EVOKED POTENTIAL, V108, P160, DOI 10.1016/S0168-5597(97)00080-4; Avissar M, 2007, J NEUROSCI, V27, P6461, DOI 10.1523/JNEUROSCI.5239-06.2007; BARRY RJ, 1992, INT J PSYCHOPHYSIOL, V13, P9, DOI 10.1016/0167-8760(92)90014-3; Battmer RD, 2010, INT J AUDIOL, V49, P657, DOI 10.3109/14992021003801471; Blamey P, 1996, Audiol Neurootol, V1, P293; BOETTCHER FA, 1990, HEARING RES, V48, P125, DOI 10.1016/0378-5955(90)90203-2; BOURBON WT, 1987, ELECTROEN CLIN NEURO, V66, P160, DOI 10.1016/0013-4694(87)90185-4; Brown CJ, 2000, EAR HEARING, V21, P151, DOI 10.1097/00003446-200004000-00009; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Busby PA, 1999, J ACOUST SOC AM, V105, P1841, DOI 10.1121/1.426721; BUTLER RA, 1968, J ACOUST SOC AM, V44, P945, DOI 10.1121/1.1911233; CAZALS Y, 1994, J ACOUST SOC AM, V96, P2048, DOI 10.1121/1.410146; CAZALS Y, 1991, ANN OTO RHINOL LARYN, V100, P893, DOI 10.1177/000348949110001106; Chatterjee M, 1998, J ACOUST SOC AM, V103, P2515, DOI 10.1121/1.422772; Chatterjee M, 1999, J ACOUST SOC AM, V105, P1853, DOI 10.1121/1.426722; Clay KMS, 2007, EAR HEARING, V28, P850, DOI 10.1097/AUD.0b013e318157671f; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donaldson GS, 1997, J ACOUST SOC AM, V101, P3706, DOI 10.1121/1.418330; Eggermont JJ, 2000, J NEUROPHYSIOL, V84, P1453, DOI 10.1152/jn.2000.84.3.1453; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FRUHSTOR.H, 1970, ELECTROEN CLIN NEURO, V28, P153, DOI 10.1016/0013-4694(70)90183-5; FRUHSTOR.H, 1969, ELECTROEN CLIN NEURO, V27, P346, DOI 10.1016/0013-4694(69)91443-6; FRUHSTORFER H, 1971, ELECTROEN CLIN NEURO, V30, P306, DOI 10.1016/0013-4694(71)90113-1; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Fu QJ, 2002, J ACOUST SOC AM, V112, P1664, DOI 10.1121/1.1502901; GANTZ BJ, 1988, LARYNGOSCOPE, V98, P1100; Garadat SN, 2011, HEARING RES, V275, P130, DOI 10.1016/j.heares.2010.12.011; Geurts L, 1999, J ACOUST SOC AM, V105, P2476, DOI 10.1121/1.426851; Gifford RH, 2008, AUDIOL NEURO-OTOL, V13, P193, DOI 10.1159/000113510; Gilley PM, 2006, CLIN NEUROPHYSIOL, V117, P1772, DOI 10.1016/j.clinph.2006.04.018; Guiraud J, 2007, J NEUROSCI, V27, P7838, DOI 10.1523/JNEUROSCI.0154-07.2007; Haenggeli A, 1998, AUDIOLOGY, V37, P353; HARI R, 1982, ELECTROEN CLIN NEURO, V54, P561, DOI 10.1016/0013-4694(82)90041-4; Hay-McCutcheon MJ, 2005, J ACOUST SOC AM, V118, P2444, DOI 10.1121/1.2035593; Hoppe U, 2001, SCAND AUDIOL, V30, P119, DOI 10.1080/010503901300112239; Hughes ML, 2012, HEARING RES, V285, P46, DOI 10.1016/j.heares.2012.01.010; Javel E, 1996, J ACOUST SOC AM, V99, P1040, DOI 10.1121/1.414633; Jeng FC, 2008, AUDIOL NEURO-OTOL, V13, P161, DOI 10.1159/000112424; Keith R., 2000, RGDT RANDOM GAP DETE; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kirby AE, 2010, J NEUROPHYSIOL, V103, P531, DOI 10.1152/jn.00794.2009; Kumar UA, 2011, J AM ACAD AUDIOL, V22, P5, DOI 10.3766/jaaa.22.1.2; Litvak L, 2001, J ACOUST SOC AM, V110, P368, DOI 10.1121/1.1375140; Looi V, 2008, INT J AUDIOL, V47, P257, DOI 10.1080/14992020801955237; Loquet G, 2004, AUDIOL NEURO-OTOL, V9, P144, DOI 10.1159/000077266; LU ZL, 1992, BRAIN RES, V572, P236, DOI 10.1016/0006-8993(92)90475-O; Luo X, 2008, EAR HEARING, V29, P957, DOI 10.1097/AUD.0b013e3181888f61; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; MEGELA AL, 1979, J COMP PHYSIOL PSYCH, V93, P1154, DOI 10.1037/h0077630; Meyer K, 2007, HEARING RES, V228, P144, DOI 10.1016/j.heares.2007.02.002; Morsnowski A, 2006, AUDIOL NEURO-OTOL, V11, P389, DOI 10.1159/000095966; MUCHNIK C, 1994, SCAND AUDIOL, V23, P105, DOI 10.3109/01050399409047493; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; PROSSER S, 1981, ARCH OTO-RHINO-LARYN, V233, P179, DOI 10.1007/BF00453642; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; SHANNON RV, 1989, J ACOUST SOC AM, V85, P2587, DOI 10.1121/1.397753; Sininger YS, 2008, EAR HEARING, V29, P228, DOI 10.1097/AUD.0b013e318164537b; SMITH RL, 1977, J NEUROPHYSIOL, V40, P1098, DOI 10.1152/jn.1977.40.5.1098; SMITH RL, 1982, BIOL CYBERN, V44, P107, DOI 10.1007/BF00317970; Spahr AJ, 2004, ARCH OTOLARYNGOL, V130, P624, DOI 10.1001/archotol.130.5.624; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wei CG, 2007, EAR HEARING, V28, p62S, DOI 10.1097/AUD.0b013e318031512c; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; Wilson BS, 1997, AM J OTOL, V18, pS30; Won JH, 2011, J ACOUST SOC AM, V130, P376, DOI 10.1121/1.3592521; Zhang F, 2007, JARO-J ASSOC RES OTO, V8, P356, DOI 10.1007/s10162-007-0086-7; Zhang FW, 2011, BRAIN RES, V1400, P42, DOI 10.1016/j.brainres.2011.05.036; Zhang FW, 2010, INT J AUDIOL, V49, P277, DOI 10.3109/14992020903321759; Zhang F, 2009, J AM ACAD AUDIOL, V20, P239, DOI 10.3766/jaaa.20.4.4	73	6	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84631	10.1371/journal.pone.0084631	http://dx.doi.org/10.1371/journal.pone.0084631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386403	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700113
J	Miklosz, A; Lukaszuk, B; Baranowski, M; Gorski, J; Chabowski, A				Miklosz, Agnieszka; Lukaszuk, Bartlomiej; Baranowski, Marcin; Gorski, Jan; Chabowski, Adrian			Effects of Inhibition of Serine Palmitoyltransferase (SPT) and Sphingosine Kinase 1 (SphK1) on Palmitate Induced Insulin Resistance in L6 Myotubes	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; CERAMIDE ACCUMULATION; LIPID-METABOLISM; GLUCOSE-TOLERANCE; ENERGY-METABOLISM; SPHINGOSINE-1-PHOSPHATE; SPHINGOLIPIDS; FAT; PROTEIN; ACTIVATION	Background: The objective of this study was to examine the effects of short (2 h) and prolonged (18 h) inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate (PA) induced insulin resistance in L6 myotubes. Methods: L6 myotubes were treated simultaneously with either PA and myriocin (SPT inhibitor) or PA and Ski II (SphK1inhibitor) for different time periods (2 h and 18 h). Insulin stimulated glucose uptake was measured using radioactive isotope. Expression of insulin signaling proteins was determined using Western blot analyses. Intracellular sphingolipids content [sphinganine (SFA), ceramide (CER), sphingosine (SFO), sphingosine-1-phosphate (S1P)] were estimated by HPLC. Results: Our results revealed that both short and prolonged time of inhibition of SPT by myriocin was sufficient to prevent ceramide accumulation and simultaneously reverse palmitate induced inhibition of insulin-stimulated glucose transport. In contrast, prolonged inhibition of SphK1 intensified the effect of PA on insulin-stimulated glucose uptake and attenuated further the activity of insulin signaling proteins (pGSK3 beta/GSK3 beta ratio) in L6 myotubes. These effects were related to the accumulation of sphingosine in palmitate treated myotubes. Conclusion: Myriocin is more effective in restoration of palmitate induced insulin resistance in L6 myocytes, despite of the time of SPT inhibition, comparing to SKII (a specific SphK1 inhibitor). Observed changes in insulin signaling proteins were related to the content of specific sphingolipids, namely to the reduction of ceramide. Interestingly, inactivation of SphK1 augmented the effect of PA induced insulin resistance in L6 myotubes, which was associated with further inhibition of insulin stimulated PKB and GSK3 beta phosphorylation, glucose uptake and the accumulation of sphingosine.	[Miklosz, Agnieszka; Lukaszuk, Bartlomiej; Baranowski, Marcin; Gorski, Jan; Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	Medical University of Bialystok	Miklosz, A (corresponding author), Med Univ Bialystok, Dept Physiol, Bialystok, Poland.	agnieszka.miklosz@umb.edu.pl	Miklosz, Agnieszka/S-5208-2018; Baranowski, Marcin/F-6718-2011; Lukaszuk, Bartlomiej/S-5090-2018; Chabowski, Adrian/T-2225-2018; Górski, Jan/T-4828-2018	Miklosz, Agnieszka/0000-0003-4936-3120; Baranowski, Marcin/0000-0002-3714-5815; Lukaszuk, Bartlomiej/0000-0002-4954-3431; Chabowski, Adrian/0000-0002-7407-8156; Górski, Jan/0000-0001-9886-5069	NCN [N N401 292739]; Medical University of Bialystok [124-18530 L]	NCN; Medical University of Bialystok	These studies were funded by the NCN (N N401 292739) and Medical University of Bialystok (grant 124-18530 L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2011, ADV EXP MED BIOL, V721, P99, DOI 10.1007/978-1-4614-0650-1_7; Alewijnse AE, 2008, EUR J PHARMACOL, V585, P292, DOI 10.1016/j.ejphar.2008.02.089; Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Baranowski M, 2011, ACTA PHYSIOL, V203, P373, DOI 10.1111/j.1748-1716.2011.02322.x; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Bose R, 1998, J BIOL CHEM, V273, P28852, DOI 10.1074/jbc.273.44.28852; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Bosma M, 2012, PROG LIPID RES, V51, P36, DOI 10.1016/j.plipres.2011.11.003; Bruce CR, 2013, ENDOCRINOLOGY, V154, P65, DOI 10.1210/en.2012-1847; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; Chabowski A, 2013, LIPIDS, V48, P697, DOI 10.1007/s11745-013-3769-3; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Dekker MJ, 2013, ATHEROSCLEROSIS, V228, P98, DOI 10.1016/j.atherosclerosis.2013.01.041; Dube JJ, 2011, DIABETOLOGIA, V54, P1147, DOI 10.1007/s00125-011-2065-0; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kolter T, 2011, CHEM PHYS LIPIDS, V164, P590, DOI 10.1016/j.chemphyslip.2011.04.013; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Kotelevets N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039209; Lam YY, 2011, BBA-MOL CELL BIOL L, V1811, P468, DOI 10.1016/j.bbalip.2011.04.011; Lipina C, 2011, DIABETOLOGIA, V54, P1596, DOI 10.1007/s00125-011-2127-3; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Ma MM, 2007, DIABETOLOGIA, V50, P891, DOI 10.1007/s00125-006-0589-5; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Miklosz A, 2012, J PHYSIOL PHARMACOL, V63, P403; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Podbielska M, 2012, NEUROCHEM RES, V37, P1154, DOI 10.1007/s11064-012-0728-y; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Rapizzi E, 2009, CELL MOL LIFE SCI, V66, P3207, DOI 10.1007/s00018-009-0106-3; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Seyoum B, 2011, BIOCHEM BIOPH RES CO, V410, P13, DOI 10.1016/j.bbrc.2011.05.073; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1315, DOI 10.1152/ajpendo.00561.2011; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zhang CX, 2013, BIOCHEM BIOPH RES CO, V434, P35, DOI 10.1016/j.bbrc.2013.03.070	54	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85547	10.1371/journal.pone.0085547	http://dx.doi.org/10.1371/journal.pone.0085547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376889	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000188
J	de Pedro-Cuesta, J; Garcia-Sagredo, P; Alcalde-Cabero, E; Alberquilla, A; Damian, J; Bosca, G; Lopez-Rodriguez, F; Carmona, M; de Tena-Davila, MJ; Garcia-Olmos, L; Salvador, CH				de Pedro-Cuesta, Jesus; Garcia-Sagredo, Pilar; Alcalde-Cabero, Enrique; Alberquilla, Angel; Damian, Javier; Bosca, Graciela; Lopez-Rodriguez, Fernando; Carmona, Monserrat; de Tena-Davila, Maria J.; Garcia-Olmos, Luis; Salvador, Carlos H.			Disability transitions after 30 months in three community-dwelling diagnostic groups in Spain	PLOS ONE			English	Article							HEART-FAILURE; OLDER-ADULTS; FOLLOW-UP; PREVALENCE; HEALTH; CARE; HOME; STROKE; REHABILITATION; LIMITATIONS	Background: Little is known about changes in disability over time among community-dwelling patients. Accordingly, this study sought to assess medium-term disability transitions. Patients and Methods: 300 chronic obstructive pulmonary disease (COPD), chronic heart failure and stroke patients living at home in Madrid were selected from general practitioner lists. In 2009, disability was assessed after a mean of 30 months using the World Health Organisation (WHO) Disability Assessment Schedule 2.0 (WHODAS 2.0). Follow-up was completed using death registries. Losses to follow-up were due to: death, 56; institutionalisation, 9; non-location, 18; and non-participation, 17. Changes in WHODAS 2.0 scores and life status were described and analysed using Cox and multinomial regression. Disability at end of follow-up was imputed for 56 deceased and 44 surviving patients. Results: Mean disability scores for 200 surviving patients at end of follow-up were similar to baseline scores for the whole group, higher than their own baseline scores, and rose by 16.3% when imputed values were added. The strongest Cox predictors of death were: age over 84 years, adjusted hazard ratios with 95% CI 8.18 (3.06-21.85); severe/complete vs. no/mild disability, 5.18 (0.68-39.48); and stroke compared to COPD, 1.40 (0.67-2.91). Non-participants and institutionalised patients had higher proportions with severe/complete baseline disability. A one-point change in baseline WHODAS 2.0 score predicted independent increases in risk of 12% (8%-15%) for severe/ complete disability or death. Conclusions: A considerably high proportion of community-dwelling patients diagnosed with COPD, CHF and stroke undergo medium-term changes in disability or vital status. The main features of the emerging pattern for this group appear to be as follows: approximately two-thirds of patients continue living at home with moderately reduced functional status; 1/3 die or worsen to severe/complete disability; and 1/10 improve. Baseline disability scores, age and diagnosis are associated with disability and death in the medium term.	[de Pedro-Cuesta, Jesus; Alcalde-Cabero, Enrique; Damian, Javier] Natl Ctr Epidemiol, Madrid, Spain; [de Pedro-Cuesta, Jesus; Alcalde-Cabero, Enrique; Damian, Javier] Carlos III Inst Hlth, Madrid, Spain; [Garcia-Sagredo, Pilar; Bosca, Graciela; Lopez-Rodriguez, Fernando; de Tena-Davila, Maria J.; Salvador, Carlos H.] Carlos III Inst Hlth, Telemed & Hlth Unit, Madrid, Spain; [Alberquilla, Angel] Family & Community Care Ctr, Multiprofess Educ Unit, Serv Madrileno Salud, Madrid, Spain; [Carmona, Monserrat] Puerta Hierro Univ, Teaching Hosp, Bioengn & Telemed Unit, Madrid, Spain; [Garcia-Olmos, Luis] Multiprofess Educ Unit Family & Community Care So, Serv Madrileno Salud, Madrid, Spain	Instituto de Salud Carlos III; Instituto de Salud Carlos III	de Pedro-Cuesta, J (corresponding author), Natl Ctr Epidemiol, Madrid, Spain.	jpedro@isciii.es	Carmona, Montserrat/F-7593-2010; Carmona, Montserrat/AAD-7263-2019; Rodríguez, Fernando López/A-7557-2016	Carmona, Montserrat/0000-0002-4680-7745; Carmona, Montserrat/0000-0002-4680-7745; Rodríguez, Fernando López/0000-0002-0519-9624; Damian, Javier/0000-0002-6258-8220	CENIT Program (MICINN-CDTI) [CEN-2007-1010]; Ministry of Health AMP; Consumer Affairs [FIS PI08-0435]; Fondo de Investigaciones Sanitarias [PI06/1098, PI07/90206]; Fundacion Cien/CIBERNED	CENIT Program (MICINN-CDTI); Ministry of Health AMP; Consumer Affairs; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Cien/CIBERNED	This study was partially supported by the CENIT Program (MICINN-CDTI) [CEN-2007-1010 "Digital personal environment for health and wellbeing -AmiVital" project], a grant from the Ministry of Health & Consumer Affairs [FIS PI08-0435 Definition, design, development and evaluation of services of monitoring, follow-up and control of aging people in independent life] and by projects PI06/1098 and PI07/90206 from Fondo de Investigaciones Sanitarias. Enrique Alcalde was in part supported by Fundacion Cien/CIBERNED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2013, HEART FAIL REV, V18, P529, DOI 10.1007/s10741-012-9363-6; Alonso-Coello P, 2012, THROMB HAEMOSTASIS, V108, P647, DOI 10.1160/TH12-01-0027; Capistrant BD, 2013, J AM GERIATR SOC, V61, P931, DOI 10.1111/jgs.12270; Carmona M, 2011, FAM PRACT, V28, P128, DOI 10.1093/fampra/cmq084; de Pedro-Cuesta J, 2011, GAC SANIT, V25, P21, DOI 10.1016/j.gaceta.2011.08.005; de Salud Carlos Instituto IIIwebsite, 2010, MORT CAP CAUS SEX; Dewey ME, 2000, INT J EPIDEMIOL, V29, P684; Falk H, 2013, J NURS SCHOLARSHIP, V45, P247, DOI 10.1111/jnu.12025; Garin O, 2010, HEALTH QUAL LIFE OUT, V19, P8, DOI DOI 10.1186/1477-7525-8-51.PUBMED:20482853; Gellis ZD, 2012, GERONTOLOGIST, V52, P541, DOI 10.1093/geront/gnr134; Graciani A, 2004, MATURITAS, V48, P381, DOI 10.1016/j.maturitas.2003.10.004; Greenland S, 2008, MODERN EPIDEMIOLOGY, P44; Kattainen A, 2004, J CLIN EPIDEMIOL, V57, P82, DOI 10.1016/S0895-4356(03)00252-X; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Klijs B, 2010, DISABIL REHABIL, V32, P1733, DOI 10.3109/09638281003746049; Linder SM, 2013, INT J STROKE, V8, P46, DOI 10.1111/j.1747-4949.2012.00971.x; Mastal MF, 2007, PROF CASE MANAG, V12, P27; McDaid David, 2009, Int J Integr Care, V9, pe60; McLean S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d120; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Riegel B, 2011, NAT REV CARDIOL, V8, P644, DOI 10.1038/nrcardio.2011.95; Riley PL, 2013, EUR J CARDIOVASC NUR; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Steventon A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3874; The Johns Hopkins ACG Case-Mix System, 2005, REF MAN J HOPK ACG C, P4; Thorsen AM, 2005, STROKE, V36, P297, DOI 10.1161/01.STR.0000152288.42701.a6; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Upatising B, 2013, INT J GEN MED, V6, P145, DOI 10.2147/IJGM.S40576; Vazquez-Barquero JL, 2006, WHO DIS ASS SCHED 2; Virues-Ortega J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-176; Widdershoven Jos, 2013, Curr Heart Fail Rep, V10, P244, DOI 10.1007/s11897-013-0139-7; World Health Organization, 2001, INT CLASS FUNCT DIS; Zunzunegui MV, 2006, AGING CLIN EXP RES, V18, P352, DOI 10.1007/BF03324830	35	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77482	10.1371/journal.pone.0077482	http://dx.doi.org/10.1371/journal.pone.0077482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24391687	Green Published, gold			2022-12-27	WOS:000326373800002
J	Masuda, S; Tani, N; Ueno, S; Lee, SL; Muhammad, N; Kondo, T; Numata, S; Tsumura, Y				Masuda, Shinsuke; Tani, Naoki; Ueno, Saneyoshi; Lee, Soon Leong; Muhammad, Norwati; Kondo, Toshiaki; Numata, Shinya; Tsumura, Yoshihiko			Non-Density Dependent Pollen Dispersal of Shorea maxwelliana (Dipterocarpaceae) Revealed by a Bayesian Mating Model Based on Paternity Analysis in Two Synchronized Flowering Seasons	PLOS ONE			English	Article							TORMINALIS L. CRANTZ; FOREST FRAGMENTATION; MALE FECUNDITY; TROPICAL TREE; RAIN-FOREST; REPRODUCTIVE SUCCESS; GENETIC DIVERSITY; WILDSERVICE TREE; SEED DISPERSAL; FRUIT-SET	Pollinator syndrome is one of the most important determinants regulating pollen dispersal in tropical tree species. It has been widely accepted that the reproduction of tropical forest species, especially dipterocarps that rely on insects with weak flight for their pollination, is positively density-dependent. However differences in pollinator syndrome should affect pollen dispersal patterns and, consequently, influence genetic diversity via the mating process. We examined the pollen dispersal pattern and mating system of Shorea maxwelliana, the flowers of which are larger than those of Shorea species belonging to section Mutica which are thought to be pollinated by thrips (weak flyers). A Bayesian mating model based on the paternity of seeds collected from mother trees during sporadic and mass flowering events revealed that the estimated pollen dispersal kernel and average pollen dispersal distance were similar for both flowering events. This evidence suggests that the putative pollinators - small beetles and weevils - effectively contribute to pollen dispersal and help to maintain a high outcrossing rate even during sporadic flowering events. However, the reduction in pollen donors during a sporadic event results in a reduction in effective pollen donors, which should lead to lower genetic diversity in the next generation derived from seeds produced during such an event. Although sporadic flowering has been considered less effective for outcrossing in Shorea species that depend on thrips for their pollination, effective pollen dispersal by the small beetles and weevils ensures outcrossing during periods of low flowering tree density, as occurs in a sporadic flowering event.	[Masuda, Shinsuke; Tsumura, Yoshihiko] Univ Tsukuba, Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tani, Naoki] Japan Int Res Ctr Agr Sci, Div Forestry, Tsukuba, Ibaraki, Japan; [Ueno, Saneyoshi; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 305, Japan; [Tani, Naoki; Lee, Soon Leong; Muhammad, Norwati] Forest Res Inst Malaysia, Forestry Biotechnol Div, Kepong, Selangor Darul, Malaysia; [Kondo, Toshiaki] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Hiroshima, Japan; [Numata, Shinya] Tokyo Metropolitan Univ, Fac & Grad Sch Urban Environm Sci, Hachioji, Tokyo, Japan	University of Tsukuba; Japan International Research Center for Agricultural Sciences; Forestry & Forest Products Research Institute - Japan; Institute Penyelidikan Perhutanan Malaysia; Hiroshima University; Tokyo Metropolitan University	Tani, N (corresponding author), Japan Int Res Ctr Agr Sci, Div Forestry, Tsukuba, Ibaraki, Japan.	ntani@affrc.go.jp; ytsumu@ffpri.affrc.go.jp	LEE, Soon Leong/AGZ-1887-2022; Kondo, Toshiaki/M-4939-2013; Tani, Naoki/AAB-7991-2022	Kondo, Toshiaki/0000-0001-6003-6118; 	Japan Society for the Promotion of Science [18255010]; Environment Research and Technology Development Fund from Ministry of Environment, Japan [E-091]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund from Ministry of Environment, Japan	The research budget to produce the manuscript was partly provided from agencies listed: Grant No. 18255010 of a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), Grant No. E-091 of Environment Research and Technology Development Fund from Ministry of Environment, Japan (http://www.env.go.jp/policy/kenkyu/suishin/english/index.html). There are no funders to provide research funding to produce the manuscript except the two funders listed above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; ADAMS WT, 1991, BIOCHEMICAL MARKERS IN THE POPULATION GENETICS OF FOREST TREES, P157; Appanah S., 1985, Journal of Tropical Ecology, V1, P225; APPANAH S, 1981, Malaysian Forester, V44, P234; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; AUGSPURGER CK, 1983, BIOTROPICA, V15, P257, DOI 10.2307/2387650; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Austerlitz F, 2002, GENETICS, V161, P355; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; BAWA KS, 1974, EVOLUTION, V28, P85, DOI [10.2307/2407241, 10.1111/j.1558-5646.1974.tb00729.x]; Best NG, 1995, CODA CONVERGENCE DIA; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Clark JS, 2006, TRENDS ECOL EVOL, V21, P375, DOI 10.1016/j.tree.2006.03.016; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Cloutier D, 2007, BIOTROPICA, V39, P406, DOI 10.1111/j.1744-7429.2007.00266.x; DEVLIN B, 1992, EVOLUTION, V46, P1030, DOI 10.1111/j.1558-5646.1992.tb00617.x; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; FEINSINGER P, 1991, ECOLOGY, V72, P1953, DOI 10.2307/1941550; Finger A, 2012, MOL ECOL, V21, P2369, DOI 10.1111/j.1365-294X.2012.05543.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Ghazoul J, 1998, J ECOL, V86, P462, DOI 10.1046/j.1365-2745.1998.00270.x; Hall P, 1996, CONSERV BIOL, V10, P757, DOI 10.1046/j.1523-1739.1996.10030757.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jones FA, 2008, P ROY SOC B-BIOL SCI, V275, P2759, DOI 10.1098/rspb.2008.0894; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kenta T, 2004, MOL ECOL, V13, P3575, DOI 10.1111/j.1365-294X.2004.02345.x; Kenta T, 2002, AM J BOT, V89, P60, DOI 10.3732/ajb.89.1.60; Kettle CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016111; Kitamura Keiko, 1994, Plant Species Biology, V9, P37, DOI 10.1111/j.1442-1984.1994.tb00080.x; Klein EK, 2008, MOL ECOL, V17, P3323, DOI 10.1111/j.1365-294X.2008.03809.x; Kondo T, 2011, SINGLE-POLLEN GENOTYPING, P63, DOI 10.1007/978-4-431-53901-8_6; Lourmas M, 2007, HEREDITY, V99, P151, DOI 10.1038/sj.hdy.6800976; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Masuda S, 2010, CONSERV GENET RESOUR, V2, P109, DOI 10.1007/s12686-010-9225-2; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Momose K, 1998, AM J BOT, V85, P1477, DOI 10.2307/2446404; MURAWSKI DA, 1994, BIOTROPICA, V26, P23, DOI 10.2307/2389107; MURAWSKI DA, 1994, CONSERV BIOL, V8, P997, DOI 10.1046/j.1523-1739.1994.08040997.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagamitsu T, 2001, INT J PLANT SCI, V162, P155, DOI 10.1086/317902; Naito Y, 2008, FOREST ECOL MANAG, V256, P375, DOI 10.1016/j.foreco.2008.04.031; Obayashi K, 2002, INT J PLANT SCI, V163, P151, DOI 10.1086/324549; Oddou-Muratorio S, 2005, MOL ECOL, V14, P4441, DOI 10.1111/j.1365-294X.2005.02720.x; Plummer M., 2003, JAGS PROGRAM ANAL BA, P20; Quesada M, 2004, BIOTROPICA, V36, P131, DOI 10.1111/j.1744-7429.2004.tb00305.x; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; Rocha OJ, 2001, AM J BOT, V88, P1600, DOI 10.2307/3558404; Sakai S, 1999, AM J BOT, V86, P62, DOI 10.2307/2656955; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; Symington CF, 2004, MALAYAN FOREST RECOR; Tani N, 2012, R SCRIPTS MATING MOD; Tani N, 2012, J ECOL, V100, P405, DOI 10.1111/j.1365-2745.2011.01929.x; Tani N, 2009, ANN BOT-LONDON, V104, P1421, DOI 10.1093/aob/mcp252; Ward M, 2005, HEREDITY, V95, P246, DOI 10.1038/sj.hdy.6800712; Wright S, 1943, GENETICS, V28, P114; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	62	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82039	10.1371/journal.pone.0082039	http://dx.doi.org/10.1371/journal.pone.0082039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391712	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200009
J	Okamatsu-Ogura, Y; Fukano, K; Tsubota, A; Uozumi, A; Terao, A; Kimura, K; Saito, M				Okamatsu-Ogura, Yuko; Fukano, Keigo; Tsubota, Ayumi; Uozumi, Akihiro; Terao, Akira; Kimura, Kazuhiro; Saito, Masayuki			Thermogenic Ability of Uncoupling Protein 1 in Beige Adipocytes in Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; ADAPTIVE NONSHIVERING THERMOGENESIS; DIET-INDUCED OBESITY; WHITE FAT; TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; UCP1; RECEPTOR; MOUSE; DIFFERENTIATION	Chronic adrenergic activation leads to the emergence of beige adipocytes in some depots of white adipose tissue in mice. Despite their morphological similarities to brown adipocytes and their expression of uncoupling protein 1 (UCP1), a thermogenic protein exclusively expressed in brown adipocytes, the beige adipocytes have a gene expression pattern distinct from that of brown adipocytes. However, it is unclear whether the thermogenic function of beige adipocytes is different from that of classical brown adipocytes existing in brown adipose tissue. To examine the thermogenic ability of UCP1 expressed in beige and brown adipocytes, the adipocytes were isolated from the fat depots of C57BL/6J mice housed at 24 degrees C (control group) or 10 degrees C (cold-acclimated group) for 3 weeks. Morphological and gene expression analyses revealed that the adipocytes isolated from brown adipose tissue of both the control and cold-acclimated groups consisted mainly of brown adipocytes. These brown adipocytes contained large amounts of UCP1 and increased their oxygen consumption when stimulated with norepinephirine. Adipocytes isolated from the perigonadal white adipose tissues of both groups and the inguinal white adipose tissue of the control group were white adipocytes that showed no increase in oxygen consumption after norepinephrine stimulation. Adipocytes isolated from the inguinal white adipose tissue of the cold-acclimated group were a mixture of white and beige adipocytes, which expressed UCP1 and increased their oxygen consumption in response to norepinephrine. The UCP1 content and thermogenic ability of beige adipocytes estimated on the basis of their abundance in the cell mixture were similar to those of brown adipocytes. These results revealed that the inducible beige adipocytes have potent thermogenic ability comparable to classical brown adipocytes.	[Okamatsu-Ogura, Yuko; Fukano, Keigo; Tsubota, Ayumi; Uozumi, Akihiro; Terao, Akira; Kimura, Kazuhiro; Saito, Masayuki] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Tenshi Coll, Grad Sch Nursing & Nutr, Dept Nutr, Sapporo, Hokkaido, Japan	Hokkaido University	Okamatsu-Ogura, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan.	keixxx@vetmed.hokudai.ac.jp	Kimura, Kazuhiro/A-5029-2012; Okamatsu-Ogura, Yuko/AAI-5602-2020; Terao, Akira/A-4850-2012	Terao, Akira/0000-0003-2574-1545	Ministry of Education, Culture, Sport, Science and Technology of Japan [21780261]; Akiyama Life Science Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Life Science Foundation	This work is supported in part by a Grant-in-Aid for Scientific Research (21780261) from the Ministry of Education, Culture, Sport, Science and Technology of Japan and by a grant from the Akiyama Life Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Baumruk F, 1999, FEBS LETT, V444, P206, DOI 10.1016/S0014-5793(99)00053-8; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; COUSIN B, 1992, J CELL SCI, V103, P931; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; LEE P, 2013, INT J OBES IN PRESS; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; NEDERGAARD J, 1982, AM J PHYSIOL, V242, pC250, DOI 10.1152/ajpcell.1982.242.3.C250; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Okamatsu-Ogura Y, 2011, EXP BIOL MED, V236, P1274, DOI 10.1258/ebm.2011.011143; Omachi A, 2008, RES VET SCI, V85, P214, DOI 10.1016/j.rvsc.2007.11.003; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shimada K, 2012, PEPTIDES, V34, P336, DOI 10.1016/j.peptides.2012.02.012; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; SVARTENGREN J, 1982, EUR J BIOCHEM, V128, P481; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	53	55	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84229	10.1371/journal.pone.0084229	http://dx.doi.org/10.1371/journal.pone.0084229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386355	Green Published, gold			2022-12-27	WOS:000329194700096
J	Park, SY; Jeong, MH; Wang, HY; Kim, JA; Yu, NH; Kim, S; Cheong, YH; Kang, S; Lee, YH; Hur, JS				Park, Sook-Young; Jeong, Min-Hye; Wang, Hai-Ying; Kim, Jung A.; Yu, Nan-Hee; Kim, Sungbeom; Cheong, Yong Hwa; Kang, Seogchan; Lee, Yong-Hwan; Hur, Jae-Seoun			Agrobacterium tumefaciens-Mediated Transformation of the Lichen Fungus, Umbilicaria muehlenbergii	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; T-DNA; GENETIC-TRANSFORMATION; MAGNAPORTHE-GRISEA; FUSARIUM-OXYSPORUM; ANTITUMOR-ACTIVITY; ACID; EXTRACTS; GENOME; IDENTIFICATION	Transformation-mediated mutagenesis in both targeted and random manners has been widely applied to decipher gene function in diverse fungi. However, a transformation system has not yet been established for lichen fungi, severely limiting our ability to study their biology and mechanism underpinning symbiosis via gene manipulation. Here, we report the first successful transformation of the lichen fungus, Umbilicaria muehlenbergii, via the use of Agrobacterium tumefaciens. We generated a total of 918 transformants employing a binary vector that carries the hygromycin B phosphotransferase gene as a selection marker and the enhanced green fluorescent protein gene for labeling transformants. Randomly selected transformants appeared mitotically stable, based on their maintenance of hygromycin B resistance after five generations of growth without selection. Genomic Southern blot showed that 88% of 784 transformants contained a single T-DNA insert in their genome. A number of putative mutants affected in colony color, size, and/or morphology were found among these transformants, supporting the utility of Agrobacterium tumefaciens-mediated transformation (ATMT) for random insertional mutagenesis of U. muehlenbergii. This ATMT approach potentially offers a systematic gene functional study with genome sequences of U. muehlenbergii that is currently underway.	[Park, Sook-Young; Jeong, Min-Hye; Kim, Jung A.; Yu, Nan-Hee; Cheong, Yong Hwa; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea; [Park, Sook-Young; Kim, Sungbeom; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Dept Agr Biotechnol, Fungal Bioinformat Lab, Seoul, South Korea; [Park, Sook-Young; Kim, Sungbeom; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Jeong, Min-Hye; Yu, Nan-Hee] Sunchon Natl Univ, Dept Biol, Sunchon, South Korea; [Wang, Hai-Ying] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Kang, Seogchan] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA	Sunchon National University; Seoul National University (SNU); Seoul National University (SNU); Sunchon National University; Shandong Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, YH (corresponding author), Seoul Natl Univ, Ctr Fungal Genet Resources, Dept Agr Biotechnol, Fungal Bioinformat Lab, Seoul, South Korea.	yonglee@snu.ac.kr; jshur1@sunchon.ac.kr		Kang, Seogchan/0000-0003-2291-5634	Korea National Research Resource Center Program through the National Research Foundation of Korea (NRF) [2012M3A9B8021726]; National Institute of Biological Resources (The Genetic Evaluation of Important Biological Resources) of Korea; National Research Foundation of Korea; Korea government [2008-0061897, 2013-003196, 2013-009744, 2013R1A1A2013062]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]	Korea National Research Resource Center Program through the National Research Foundation of Korea (NRF); National Institute of Biological Resources (The Genetic Evaluation of Important Biological Resources) of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); Next-Generation BioGreen 21 Program of Rural Development Administration in Korea	This work was supported by grants from the Korea National Research Resource Center Program through the National Research Foundation of Korea (NRF, 2012M3A9B8021726), the National Institute of Biological Resources (The Genetic Evaluation of Important Biological Resources) of Korea, the National Research Foundation of Korea grant funded by the Korea government (2008-0061897, 2013-003196, 2013-009744, and 2013R1A1A2013062), and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugni TS, 2009, FITOTERAPIA, V80, P270, DOI 10.1016/j.fitote.2009.03.003; Bundock P, 1996, P NATL ACAD SCI USA, V93, P15272, DOI 10.1073/pnas.93.26.15272; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Candan M, 2007, Z NATURFORSCH C, V62, P619; Candan M, 2006, Z NATURFORSCH C, V61, P319; Cansaran D, 2006, Z NATURFORSCH C, V61, P773; Chen ECF, 2009, MYCOL RES, V113, P290, DOI 10.1016/j.mycres.2008.11.007; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; CULBERSON CF, 1992, EXP MYCOL, V16, P52, DOI 10.1016/0147-5975(92)90041-O; DABOUSSI MJ, 1989, CURR GENET, V15, P453, DOI 10.1007/BF00376803; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Frandsen RJN, 2011, J MICROBIOL METH, V87, P247, DOI 10.1016/j.mimet.2011.09.004; Gagunashvili AN, 2009, MYCOL RES, V113, P354, DOI 10.1016/j.mycres.2008.11.011; Gambichler T, 2009, BRIT J DERMATOL, V161, P1136, DOI 10.1111/j.1365-2133.2009.09273.x; GOLLAPUDI SR, 1994, J NAT PROD, V57, P934, DOI 10.1021/np50109a009; Gouka RJ, 1999, NAT BIOTECHNOL, V17, P598, DOI 10.1038/9915; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HARMALA P, 1992, Fitoterapia, V63, P217; Hawksworth D.L., 1995, DICT FUNGI, V8th; HIRABAYASHI K, 1989, CHEM PHARM BULL, V37, P2410, DOI 10.1248/cpb.37.2410; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Huneck S, 1996, IDENTIFICATION LICHE; INGOLFSDOTTIR K, 1985, ANTIMICROB AGENTS CH, V28, P289, DOI 10.1128/AAC.28.2.289; Islam MN, 2012, MICROBIOL RES, V167, P332, DOI 10.1016/j.micres.2012.02.001; Ivanova V, 2010, PREP BIOCHEM BIOTECH, V40, P377, DOI 10.1080/10826068.2010.525432; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Kim HS, 2011, MOL PLANT MICROBE IN, V24, P719, DOI 10.1094/MPMI-11-10-0267; LEUNG H, 1990, CURR GENET, V17, P409, DOI 10.1007/BF00334519; Liu HW, 2009, CURR MICROBIOL, V58, P279, DOI 10.1007/s00284-008-9334-2; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Manojlovic NT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/452431; Marchand G, 2007, J MICROBIOL METH, V70, P519, DOI 10.1016/j.mimet.2007.06.014; MARMEISSE R, 1992, CURR GENET, V22, P41, DOI 10.1007/BF00351740; Maruthachalam K, 2011, MOL BIOTECHNOL, V49, P209, DOI 10.1007/s12033-011-9392-8; McDonald TR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-225; Meza TJ, 2002, NUCLEIC ACIDS RES, V30, P4556, DOI 10.1093/nar/gkf568; Mitrovic T, 2011, INT J MOL SCI, V12, P5428, DOI 10.3390/ijms12085428; Molina MD, 2000, MYCOL RES, V104, P595, DOI 10.1017/S0953756299002014; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Nash ITH, 1996, LICHEN BIOL; NISHIKAWA Y, 1970, CHEM PHARM BULL, V18, P1431; NISHIKAWA Y, 1981, CHEM PHARM BULL, V29, P3407; Paz Z, 2011, FUNGAL GENET BIOL, V48, P677, DOI 10.1016/j.fgb.2011.02.003; Rankovic B, 2010, MICROBIOLOGY+, V79, P809, DOI 10.1134/S0026261710060135; Rezanka T, 2006, NAT PROD RES, V20, P969, DOI 10.1080/14786410500218674; Rho HS, 2001, MOL CELLS, V12, P407; Rowe JG, 1999, Z NATURFORSCH C, V54, P605; Sha Y, 2004, THEOR APPL GENET, V108, P306, DOI 10.1007/s00122-003-1423-9; Sinnemann SJ, 2000, CURR GENET, V37, P333, DOI 10.1007/s002940050536; Stepanenko L. S., 1998, Chemistry of Natural Compounds, V34, P337, DOI 10.1007/BF02282419; Tanas S, 2010, J NAT MED-TOKYO, V64, P42, DOI 10.1007/s11418-009-0367-z; Tay T, 2004, Z NATURFORSCH C, V59, P384; Turk AO, 2003, Z NATURFORSCH C, V58, P850; Turk H, 2006, Z NATURFORSCH C, V61, P499; WATANABE M, 1986, CHEM PHARM BULL, V34, P2532; WINANS SC, 1992, MICROBIOL REV, V56, P12, DOI 10.1128/MMBR.56.1.12-31.1992; Yamamoto Y., 2002, CULTURE THALLUS FRAG, P34; Yilmaz M, 2005, Z NATURFORSCH C, V60, P35; Yilmaz M, 2004, Z NATURFORSCH C, V59, P249	62	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83896	10.1371/journal.pone.0083896	http://dx.doi.org/10.1371/journal.pone.0083896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386304	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700077
J	Ribeiro-dos-Santos, AM; de Souza, JES; Almeida, R; Alencar, DO; Barbosa, MS; Gusmao, L; Silva, WA; de Souza, SJ; Silva, A; Ribeiro-dos-Santos, A; Darnet, S; Santos, S				Ribeiro-dos-Santos, Andre M.; Santana de Souza, Jorge Estefano; Almeida, Renan; Alencar, Dayse O.; Barbosa, Maria Silvanira; Gusmao, Leonor; Silva, Wilson A., Jr.; de Souza, Sandro J.; Silva, Artur; Ribeiro-dos-Santos, Andrea; Darnet, Sylvain; Santos, Sidney			High-Throughput Sequencing of a South American Amerindian	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENOME SEQUENCE; MTDNA; POPULATION; HAPLOTYPES; DIVERSITY; IDENTIFICATION; COLONIZATION; RESOLUTION; ARGENTINA	The emergence of next-generation sequencing technologies allowed access to the vast amounts of information that are contained in the human genome. This information has contributed to the understanding of individual and population-based variability and improved the understanding of the evolutionary history of different human groups. However, the genome of a representative of the Amerindian populations had not been previously sequenced. Thus, the genome of an individual from a South American tribe was completely sequenced to further the understanding of the genetic variability of Amerindians. A total of 36.8 giga base pairs (Gbp) were sequenced and aligned with the human genome. These Gbp corresponded to 95.92% of the human genome with an estimated miscall rate of 0.0035 per sequenced bp. The data obtained from the alignment were used for SNP (single-nucleotide) and INDEL (insertion-deletion) calling, which resulted in the identification of 502,017 polymorphisms, of which 32,275 were potentially new high-confidence SNPs and 33,795 new INDELs, specific of South Native American populations. The authenticity of the sample as a member of the South Native American populations was confirmed through the analysis of the uniparental (maternal and paternal) lineages. The autosomal comparison distinguished the investigated sample from others continental populations and revealed a close relation to the Eastern Asian populations and Aboriginal Australian. Although, the findings did not discard the classical model of America settlement; it brought new insides to the understanding of the human population history. The present study indicates a remarkable genetic variability in human populations that must still be identified and contributes to the understanding of the genetic variability of South Native American populations and of the human populations history.	[Ribeiro-dos-Santos, Andre M.; Alencar, Dayse O.; Barbosa, Maria Silvanira; Gusmao, Leonor; Silva, Artur; Ribeiro-dos-Santos, Andrea; Darnet, Sylvain; Santos, Sidney] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Santana de Souza, Jorge Estefano; Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Reg Hemoterapia, Sao Paulo, Brazil; [Santana de Souza, Jorge Estefano; Almeida, Renan; de Souza, Sandro J.] Inst Bioinformat & Biotechnol, Sao Paulo, Brazil; [Gusmao, Leonor] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Porto, Portugal; [Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [de Souza, Sandro J.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Universidade do Porto; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte	Santos, S (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	sidneysantos@ufpa.br	Gusmão, Leonor/L-8931-2019; Almeida, Renan/ABE-2626-2020; de Souza, Sandro Jose/AAG-6270-2020; Silva Jr, Wilson Araújo/E-9487-2011; Silva, Artur/E-1474-2014; Santos, Ândrea Ribeiro dos/B-6061-2013; Gusmao, Leonor/B-3122-2013; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021; DARNET, Sylvain Henri/G-4912-2012; CTC USP, CEPID 13 18/J-8951-2014	Gusmão, Leonor/0000-0003-0432-6481; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Silva, Artur/0000-0002-4082-1132; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Gusmao, Leonor/0000-0003-0432-6481; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; DARNET, Sylvain Henri/0000-0001-6351-0903; CTC USP, CEPID 13 18/0000-0002-7123-9524	Rede Paraense de Genomica e Proteomica (Governo do Para/Secretaria de Estado de Desenvolvimento, Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)); Pro-Reitoria de Pesquisa e Pos-Graduacao/Universidade Federal do Para; Fundacao de Amparo e Desenvolvimento da Pesquisa; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); FAPESPA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES/Brasil	Rede Paraense de Genomica e Proteomica (Governo do Para/Secretaria de Estado de Desenvolvimento, Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)); Pro-Reitoria de Pesquisa e Pos-Graduacao/Universidade Federal do Para; Fundacao de Amparo e Desenvolvimento da Pesquisa; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the Rede Paraense de Genomica e Proteomica (Governo do Para/Secretaria de Estado de Desenvolvimento, Ciencia e Tecnologia/Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)), Pro-Reitoria de Pesquisa e Pos-Graduacao/Universidade Federal do Para, Fundacao de Amparo e Desenvolvimento da Pesquisa, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), FAPESPA and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. LG was supported by a grant from CAPES/Brasil. The funders had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bailliet G, 2009, AM J PHYS ANTHROPOL, V140, P578, DOI 10.1002/ajpa.21133; Balter M, 2008, SCIENCE, V320, P729, DOI 10.1126/science.320.5877.729; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bisso-Machado R, 2012, GENET MOL BIOL, V35, P365, DOI 10.1590/S1415-47572012005000027; Blanco-Verea A, 2010, FORENSIC SCI INT-GEN, V4, P187, DOI 10.1016/j.fsigen.2009.08.008; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Demarchi DA, 2004, HUM BIOL, V76, P413, DOI 10.1353/hub.2004.0043; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Forster P, 1996, AM J HUM GENET, V59, P935; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goncalves VF, 2013, P NATL ACAD SCI USA, V110, P6465, DOI 10.1073/pnas.1217905110; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gupta R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-440; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Patowary A, 2012, HUM MUTAT, V33, P1133, DOI 10.1002/humu.22091; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; RibeirodosSantos AKC, 1996, AM J PHYS ANTHROPOL, V101, P29, DOI 10.1002/(SICI)1096-8644(199609)101:1<29::AID-AJPA3>3.0.CO;2-8; Rodriguez-Delfin LA, 2000, HUM HERED, V51, P97, DOI 10.1159/000022964; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Sala A, 2010, HUM BIOL, V82, P433, DOI 10.3378/027.082.0406; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shapiro B, 2010, BIOESSAYS, V32, P388, DOI 10.1002/bies.201000026; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358; Smit A., REPEATMASKER OPEN 3; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Toscanini U, 2011, AM J PHYS ANTHROPOL, V146, P188, DOI 10.1002/ajpa.21562; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	55	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83340	10.1371/journal.pone.0083340	http://dx.doi.org/10.1371/journal.pone.0083340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386182	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700035
J	Russell, RA; Garway-Heath, DF; Crabb, DP				Russell, Richard A.; Garway-Heath, David F.; Crabb, David P.			New Insights into Measurement Variability in Glaucomatous Visual Fields from Computer Modelling	PLOS ONE			English	Article							STANDARD AUTOMATED PERIMETRY; TEST-RETEST VARIABILITY; FREQUENCY-DOUBLING TECHNOLOGY; FULL-THRESHOLD; SUSPECTED GLAUCOMA; MEASURING RATES; OPTIC NEURITIS; SHORT-TERM; SIZE III; PROGRESSION	Objective: To develop a model to simulate visual fields (VFs) in glaucoma patients, and to characterize variability of the Mean Deviation (MD) VF summary measurement using real VFs and simulations. Methods: Pointwise VF variability was previously approximated using longitudinal VF data (24-2 SITA Standard, Humphrey Field Analyzer) from 2,736 patients; these data were used to build a non-parametric model to simulate VFs. One million VF simulations were generated from 1,000 VFs (1,000 simulations per 'ground-truth' VF), and the variability of simulated MDs was characterized as a function of ground-truth MD and Pattern Standard Deviation (PSD). Results: The median (interquartile range, IQR) patient age and MD was 66 (56 to 75) years and -3.5 (-8.3 to -1.1) decibels, respectively. The inferred variability as a function of ground-truth MD and PSD indicated that variability, on average, increased rapidly as glaucoma worsened. However, the pattern of VF damage significantly affects the level of MD variability, with more than three-fold differences between patients with approximately the same levels of MD but different patterns of loss. Conclusions: A novel approach for simulating VFs is introduced. A better understanding of VF variability will help clinicians to differentiate real VF progression from measurement variability. This study highlights that, overall, MD variability increases as the level of damage increases, but variability is highly dependent on the pattern of VF damage. Future research, using VF simulations, could be employed to provide benchmarks for measuring the performance of VF progression detection algorithms and developing new strategies for measuring VF progression.	[Russell, Richard A.; Garway-Heath, David F.; Crabb, David P.] City Univ London, Dept Optometry & Visual Sci, London, England; [Russell, Richard A.; Garway-Heath, David F.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Russell, Richard A.; Garway-Heath, David F.] UCL Inst Ophthalmol, London, England	City University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Crabb, DP (corresponding author), City Univ London, Dept Optometry & Visual Sci, London, England.	david.crabb.1@city.ac.uk		Crabb, David/0000-0001-8754-3902; Garway-Heath, David/0000-0003-2907-6992	UK National Institute for Health Research (NIHR) Health Services Research program [10/2000/68]; National Institutes of Health (NIH) [R01EY007716]; Department of Health27 dB s National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Allergan, Inc.; International Glaucoma Association; NATIONAL EYE INSTITUTE [R01EY007716] Funding Source: NIH RePORTER; National Institute for Health Research [10/2000/68] Funding Source: researchfish	UK National Institute for Health Research (NIHR) Health Services Research program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health27 dB s National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Allergan, Inc.(AbbVieAllergan); International Glaucoma Association; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded in part by the UK National Institute for Health Research (NIHR) Health Services Research program (project number 10/2000/68) and the National Institutes of Health (NIH; grant number R01EY007716). RAR and DFG-H received a proportion of their funding from the Department of Health27 (22 to 30) dB s National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. RAR is supported by an Investigator Initiated Research grant from Allergan, Inc. DFG-H's chair at UCL is supported by funding from the International Glaucoma Association. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artes PH, 2011, INVEST OPHTH VIS SCI, V52, P4030, DOI 10.1167/iovs.10-6905; Artes PH, 2005, PROG RETIN EYE RES, V24, P333, DOI 10.1016/j.preteyeres.2004.10.002; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Artes PH, 2005, INVEST OPHTH VIS SCI, V46, P2451, DOI 10.1167/iovs.05-0135; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P368; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; Chauhan B C, 1994, J Glaucoma, V3 Suppl 1, pS73; CHAUHAN BC, 1993, INVEST OPHTH VIS SCI, V34, P3534; Cleveland WS, 1992, LOCAL REGRESSION MOD; Ernest PJG, 2012, ACTA OPHTHALMOL, V90, P101, DOI 10.1111/j.1755-3768.2011.02206.x; FLAMMER J, 1984, ARCH OPHTHALMOL-CHIC, V102, P704, DOI 10.1001/archopht.1984.01040030560017; Gardiner SK, 2002, BRIT J OPHTHALMOL, V86, P560, DOI 10.1136/bjo.86.5.560; Gardiner SK, 2002, INVEST OPHTH VIS SCI, V43, P1400; GLASS E, 1995, INVEST OPHTH VIS SCI, V36, P1847; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Heijl A, 1996, ARCH OPHTHALMOL-CHIC, V114, P19, DOI 10.1001/archopht.1996.01100130017003; Heijl A, 1995, Curr Opin Ophthalmol, V6, P46; HEIJL A, 1989, AM J OPHTHALMOL, V108, P130, DOI 10.1016/0002-9394(89)90006-8; Henson DB, 2000, INVEST OPHTH VIS SCI, V41, P417; Hodapp E, 1993, CLIN DECISIONS GLAUC; Jansonius NM, 2010, BRIT J OPHTHALMOL, V94, P1404, DOI 10.1136/bjo.2009.164897; JOHNSON CA, 1992, INVEST OPHTH VIS SCI, V33, P2966; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; McKean-Cowdin R, 2008, OPHTHALMOLOGY, V115, P941, DOI 10.1016/j.ophtha.2007.08.037; Montolio FGJ, 2012, INVEST OPHTH VIS SCI, V53, P7010, DOI 10.1167/iovs.12-10268; Montolio FGJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041211; Murata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058695; Nouri-Mahdavi K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1521, DOI 10.1001/archophthalmol.2011.224; PILTZ JR, 1990, AM J OPHTHALMOL, V109, P109; Quigley HA, 1996, NUMBER, V80, P389; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P5985, DOI 10.1167/iovs.12-10428; SHAPIRO LR, 1990, APPL OPTICS, V29, P1445, DOI 10.1364/AO.29.001445; Shapiro LR, 1989, KRAKEN COMPUTER SIMU, P431; Spenceley SE, 1996, BRIT J OPHTHALMOL, V80, P304, DOI 10.1136/bjo.80.4.304; Spry PGD, 2001, INVEST OPHTH VIS SCI, V42, P1404; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Tattersall CL, 2007, EYE, V21, P362, DOI 10.1038/sj.eye.6702206; Team RDC, 2010, R LANG ENV STAT COMP; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Turpin A, 2003, INVEST OPHTH VIS SCI, V44, P4787, DOI 10.1167/iovs.03-0023; Turpin A, 2007, INVEST OPHTH VIS SCI, V48, P1627, DOI 10.1167/iovs.06-1074; Wall M, 1998, ARCH OPHTHALMOL-CHIC, V116, P53, DOI 10.1001/archopht.116.1.53; Wall M, 2009, INVEST OPHTH VIS SCI, V50, P974, DOI 10.1167/iovs.08-1789; Wall M, 2013, INVEST OPHTH VIS SCI, V54, P1345, DOI 10.1167/iovs.12-10299	46	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83595	10.1371/journal.pone.0083595	http://dx.doi.org/10.1371/journal.pone.0083595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386230	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000329194700051
J	Karch, A; Manthey, H; Ponto, C; Hermann, P; Heinemann, U; Schmidt, C; Zerr, I				Karch, Andre; Manthey, Henrike; Ponto, Claudia; Hermann, Peter; Heinemann, Uta; Schmidt, Christian; Zerr, Inga			Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; PERMEABILITY; CRITERIA	Background: Since more than a decade ApoE is known to be a strong risk factor for Alzheimer's disease (AD); however, molecular pathways mediating this risk are still unclear. In recent years it has been hypothesized that ApoE might play a role in the disintegration of blood-brain barrier (BBB). In the present study we addressed the question if ApoE genotypes might be associated with BBB function measured by albumin ratio (Q(Alb)) in a large cohort of patients with different types of dementia. Methods: Five hundred twenty (520) patients with Creutzfeldt-Jakob disease (CJD, n = 350), Alzheimer's disease (n = 71) and cerebral small vessel disease (n = 99) were assessed for their ApoE genotype. BBB function was measured in all patients using Q(Alb) and was compared between ApoE genotypes. Dominant and additive genetic models were assumed in order to investigate the potential effect of ApoE on BBB function. Results: We observed no systematic differences in Q(Alb) between ApoE genotypes within the present study. Increased Q(Alb) levels were shown for those without E3 allele in the subgroup of CJD patients when assuming a dominant genetic model (p = 0.035). This could not be confirmed for patients with other forms of dementia (p = 0.234). Discussion: Although there was some evidence for a protective effect of E3 alleles in CJD patients, this study does not support the hypothesis of a systematic role of ApoE genotypes in BBB function in individuals with a diagnosis of dementia. Thus, changes in BBB function do not seem to contribute to the increased risk of cognitive decline associated with certain ApoE genotypes. The interpretation of the results of this study must take into account that BBB function was only assessed by measuring Q(Alb) which has been shown to be a good marker for overall BBB integrity but might not reflect all qualities of the barrier.	[Karch, Andre; Manthey, Henrike; Ponto, Claudia; Hermann, Peter; Heinemann, Uta; Schmidt, Christian; Zerr, Inga] Univ Hosp Gottingen, Clin Dementia Ctr, Dept Neurol, Gottingen, Germany; [Karch, Andre] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany	University of Gottingen; Helmholtz Association; Helmholtz-Center for Infection Research	Karch, A (corresponding author), Univ Hosp Gottingen, Clin Dementia Ctr, Dept Neurol, Gottingen, Germany.	andre.karch@helmholtz-hzi.de	Karch, André/D-6973-2017	Karch, André/0000-0003-3014-8543	Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia [KNDD-2, 01GI1010C]; Robert Koch-Institute through Federal Ministry of Health [1369-341]	Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia; Robert Koch-Institute through Federal Ministry of Health	This work was supported by a Bundesministerium fur Bildung und Forschung grant within the German Network for Degenerative Dementia (KNDD-2, 2012-2015, determinants for disease progression in AD, grant No. 01GI1010C) and by the Robert Koch-Institute through funds of the Federal Ministry of Health (grant no. 1369-341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bickeboller H, 1997, AM J HUM GENET, V60, P439; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Carmeliet P, 2012, NATURE, V485, P451, DOI 10.1038/485451a; Chalbot S, 2011, J ALZHEIMERS DIS, V25, P505, DOI 10.3233/JAD-2011-101959; Chen RL, 2011, NEUROBIOL AGING, V32, P1338, DOI 10.1016/j.neurobiolaging.2008.08.024; Christensen Helen, 2008, BMC Geriatr, V8, P14, DOI 10.1186/1471-2318-8-14; Donahue JE, 2008, J NEUROPATH EXP NEUR, V67, P261, DOI 10.1097/NEN.0b013e31816a0dc8; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Izaks GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027415; Kolovou GD, 2005, ANN CLIN LAB SCI, V35, P391; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; Mollenhauer B, 2006, CLIN CHEM LAB MED, V44, P192, DOI 10.1515/CCLM.2006.035; Okamura T, 2010, ANN THORAC SURG, V89, P187, DOI 10.1016/j.athoracsur.2009.09.030; Pardo LM, 2005, MUTAT RES-FUND MOL M, V592, P89, DOI 10.1016/j.mrfmmm.2005.06.006; Pisani V, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-188; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Romero C, 2009, 6 INT C VASC DEM BAR; Schmidtke K, 2002, J NEUROL SCI, V203, P17, DOI 10.1016/S0022-510X(02)00254-X; Skoog I, 1998, NEUROLOGY, V50, P966, DOI 10.1212/WNL.50.4.966; Wada H, 1998, INTERNAL MED, V37, P509, DOI 10.2169/internalmedicine.37.509; Wierenga CE, 2013, J ALZHEIMERS DIS; Yarchoan M, 2012, BRAIN, V135, P3749, DOI 10.1093/brain/aws271; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84405	10.1371/journal.pone.0084405	http://dx.doi.org/10.1371/journal.pone.0084405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386372	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900091
J	Nettle, D; Monaghan, P; Boner, W; Gillespie, R; Bateson, M				Nettle, Daniel; Monaghan, Pat; Boner, Winnie; Gillespie, Robert; Bateson, Melissa			Bottom of the Heap: Having Heavier Competitors Accelerates Early-Life Telomere Loss in the European Starling, Sturnus vulgaris	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; NEST PARASITISM; LENGTH; STRESS; AGE; MORTALITY; DISEASE; SPAN; RISK; SEX	Early-life adversity is associated with poorer health and survival in adulthood in humans and other animals. One pathway by which early-life environmental stressors could affect the adult phenotype is via effects on telomere dynamics. Several studies have shown that early-life adversity is associated with relatively short telomeres, but these are often cross-sectional and usually correlational in design. Here, we present a novel experimental system for studying the relationship between early-life adversity and telomere dynamics using a wild bird, the European starling (Sturnus vulgaris). We used cross-fostering to experimentally assign sibling chicks to either small or large broods for twelve days of the growth period. We measured telomere length in red blood cells using quantitative PCR near the beginning of the experimental manipulation (4 days old), at the end of the experimental manipulation (15 days old), and once the birds were independent (55 days old). Being in a larger brood slowed growth and retarded wing development and the timing of fledging. We found no evidence that overall brood size affected telomere dynamics. However, the greater the number of competitors above the focal bird in the within-brood size hierarchy, the greater was the telomere loss during the period of the experimental manipulation. The number of competitors below the focal in the hierarchy had no effect. The effect of heavier competitors was still evident when we controlled for the weight of the focal bird at the end of the manipulation, suggesting it was not due to retarded growth per se. Moreover, the impact of early competition on telomeres was still evident at independence, suggesting persistence beyond early life. Our study provides experimental support for the hypothesis that social stress, in this case induced by the presence of a greater number of dominant competitors, accelerates the rate of telomere loss.	[Nettle, Daniel] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nettle, Daniel; Bateson, Melissa] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Monaghan, Pat; Boner, Winnie; Gillespie, Robert] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; University of Glasgow	Nettle, D (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Bateson, Melissa/B-1874-2008; Monaghan, Pat/E-6810-2015; Bateson, Melissa/AAE-7075-2022	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191; Nettle, Daniel/0000-0001-9089-2599	BBSRC (Bateson/Nettle) [BB/J016446/1]; ERC (Monaghan) [ERC AdG 268926]; BBSRC (Monaghan) [BB/J015091/1]; Biotechnology and Biological Sciences Research Council [BB/J015091/1, BB/J016446/1] Funding Source: researchfish; BBSRC [BB/J016446/1, BB/J015091/1] Funding Source: UKRI	BBSRC (Bateson/Nettle); ERC (Monaghan); BBSRC (Monaghan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC under grant numbers BB/J016446/1 (Bateson/Nettle) and BB/J015091/1 (Monaghan), and the ERC under grant number ERC AdG 268926 (Monaghan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A., 2011, NUCLEIC ACIDS RES, V39, P5; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bateson M, 2010, UFAW HDB CARE MANAGE; Bateson M, 2010, ILAR J, V51, P394, DOI 10.1093/ilar.51.4.394; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2012, NATURE, V490, P169, DOI 10.1038/490169a; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Boyce WT, 2012, P NATL ACAD SCI US; Cattan V, 2008, FREE RADICAL BIO MED, V44, P1592, DOI 10.1016/j.freeradbiomed.2008.01.007; Cawthon R.M., 2002, NUCLEIC ACIDS RES, V30; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Cotton PA, 1999, AM NAT, V153, P412, DOI 10.1086/303178; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; delaMora AN, 1996, ETHOLOGY, V102, P748; Drummond H, 2013, J EVOLUTION BIOL, V26, P625, DOI 10.1111/jeb.12087; Dube SR, 2003, PREV MED, V37, P268, DOI 10.1016/S0091-7435(03)00123-3; Epel ES, 2009, CURR DIR PSYCHOL SCI, V18, P6, DOI 10.1111/j.1467-8721.2009.01596.x; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Falkstedt D, 2011, EUR J PUBLIC HEALTH, V21, P713, DOI 10.1093/eurpub/ckq158; Feare C.J., 1984, STARLING; Feenders G., 2011, PLOS ONE, V6; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Foote CG, 2013, MOL ECOL RESOUR, V13, P417, DOI 10.1111/1755-0998.12079; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Geronimus AT, 2010, HUM NATURE-INT BIOS, V21, P19, DOI 10.1007/s12110-010-9078-0; Gomes NMV, 2010, COMPARATIVE BIOLOGY OF AGING, P227, DOI 10.1007/978-90-481-3465-6_11; Hart CL, 2003, J EPIDEMIOL COMMUN H, V57, P385, DOI 10.1136/jech.57.5.385; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Joergensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020795; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kelly-Irving M, 2013, INT J PUBLIC HEALTH, V58, P3, DOI 10.1007/s00038-012-0370-0; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Larson K, 2013, INT J PUBLIC HEALTH, V58, P89, DOI 10.1007/s00038-012-0373-x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; Mock DW, 2009, ANIM BEHAV, V78, P677, DOI 10.1016/j.anbehav.2009.05.032; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2013, J EVOLUTION IN PRESS; Nakagawa S, 2004, MOL ECOL, V13, P2523, DOI 10.1111/j.1365-294X.2004.02291.x; PINXTEN R, 1991, ARDEA, V79, P15; Raberg L, 2005, OECOLOGIA, V145, P496, DOI 10.1007/s00442-005-0133-1; Ramsay SE, 2007, INT J EPIDEMIOL, V36, P560, DOI 10.1093/ije/dym060; Rosivall B, 2010, BEHAV ECOL SOCIOBIOL, V64, P1555, DOI 10.1007/s00265-010-0969-1; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Salomons HM, 2009, FIGHTING FITNESS TEL; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; VAZIRI H, 1993, AM J HUM GENET, V52, P661; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WRIGHT J, 1990, ANIM BEHAV, V40, P462, DOI 10.1016/S0003-3472(05)80526-3; YOMTOV Y, 1974, IBIS, V116, P87, DOI 10.1111/j.1474-919X.1974.tb00226.x; Zafir A, 2009, STRESS, V12, P167, DOI 10.1080/10253890802234168	59	54	54	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83617	10.1371/journal.pone.0083617	http://dx.doi.org/10.1371/journal.pone.0083617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386235	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329117900046
J	Schoville, SD; Widmer, I; Deschamps-Cottin, M; Manel, S				Schoville, Sean D.; Widmer, Ivo; Deschamps-Cottin, Magali; Manel, Stephanie			Morphological Clines and Weak Drift along an Urbanization Gradient in the Butterfly, Pieris rapae	PLOS ONE			English	Article							CRUCIVORA BOISDUVAL LEPIDOPTERA; POPULATION-STRUCTURE; GLOBAL CHANGE; URBAN; SELECTION; DYNAMICS; ECOLOGY	Urban areas are increasing globally, providing opportunities for biodiversity researchers to study the process in which species become established in novel, highly disturbed habitats. This ecological process can be understood through analyses of morphological and genetic variation, which can shed light on patterns of neutral and adaptive evolution. Previous studies have shown that urban populations often diverge genetically from non-urban source populations. This could occur due to neutral genetic drift, but an alternative is that selection could lead to allele frequency changes in urban populations. The development of genome scan methods provides an opportunity to investigate these outcomes from samples of genetic variation taken along an urbanization gradient. Here we examine morphological variation in wing size and diversity at neutral amplified fragment length polymorphisms in the butterfly Pieris rapae L. (Lepidoptera, Pieridae) sampled from the center to the periphery of Marseille. We utilize established and novel environmental correlation approaches to scan genetic variation for evidence of selection. We find significant morphological differences in urban populations, as well as weak genetic structure and decreased genetic diversity in urban versus non-urban sites. However, environmental correlation tests provide little support for selection in our dataset. Our comparison of different methods and allele frequency clines suggests that loci identified as significant are false positives. Although there is some indication that selection may be acting on wing size in urban butterflies, genetic analyses suggest P. rapae are undergoing neutral drift.	[Schoville, Sean D.] Lab Tech Ingn Med & Complexite Informat Math & Ap, UMR 5525, Grenoble, France; [Widmer, Ivo; Deschamps-Cottin, Magali; Manel, Stephanie] Univ Aix Marseille, UMR 151, Inst Rech Dev, Lab Populat Environm & Dev, Marseille, France; [Manel, Stephanie] Lab Bot & BioinforMat Architecture Plantes, UMR 5120, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Schoville, SD (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	schoville2@wisc.edu	Schoville, Sean D./J-8061-2012; Schoville, Sean D./AAY-5324-2020	Schoville, Sean D./0000-0001-7364-434X; Schoville, Sean D./0000-0001-7364-434X	National Science Foundation [OISE-0965038]; Department of Environment Technology and Society, Aix-Marseille University; Institut Universitaire de France; Fondation Francaise pour la Biodiversite (call innovant)	National Science Foundation(National Science Foundation (NSF)); Department of Environment Technology and Society, Aix-Marseille University; Institut Universitaire de France; Fondation Francaise pour la Biodiversite (call innovant)	SDS was supported by the National Science Foundation (OISE-0965038). IW was supported by the Department of Environment Technology and Society, Aix-Marseille University. SM was supported by the Institut Universitaire de France. The project was funded by the Fondation Francaise pour la Biodiversite (call innovant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2012, GLOBAL CHANGE BIOL, V18, P2429, DOI 10.1111/j.1365-2486.2012.02727.x; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; Badyaev AV, 2008, EVOLUTION, V62, P1951, DOI 10.1111/j.1558-5646.2008.00428.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Carreiro MM, 2005, ECOSYSTEMS, V8, P568, DOI 10.1007/s10021-003-0172-6; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; Delaney KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012767; Ducatez S, 2012, OIKOS; Gaggiotti OE, 1996, THEOR POPUL BIOL, V50, P178, DOI 10.1006/tpbi.1996.0028; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KIMURA K, 1986, RES POPUL ECOL, V28, P295, DOI 10.1007/BF02515456; Lizee MH, 2012, LANDSCAPE ECOL, V27, P159, DOI 10.1007/s10980-011-9651-x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; McDonnell Mark J., 1997, Urban Ecosystems, V1, P21, DOI 10.1023/A:1014359024275; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; Pritchard JK, 2000, GENETICS, V155, P945; Schoville SD, 2012, ANNU REV ECOL EVOL S, V43, P23, DOI 10.1146/annurev-ecolsys-110411-160248; Sekar S, 2012, J ANIM ECOL, V81, P174, DOI 10.1111/j.1365-2656.2011.01909.x; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Stracey CM, 2012, J AVIAN BIOL, V43, P50, DOI 10.1111/j.1600-048X.2011.05520.x; TANAKA Y, 1987, APPL ENTOMOL ZOOL, V22, P125, DOI 10.1303/jjaez.31.125; Unfried TM, 2013, CONSERV GENET, V14, P41, DOI 10.1007/s10592-012-0422-2; United Nations, 2012, WORLD URB PROSP 2011; Vekemans X, 2002, AFLP SURV 1 0 PROGRA; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	37	11	12	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83095	10.1371/journal.pone.0083095	http://dx.doi.org/10.1371/journal.pone.0083095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386146	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900021
J	Duursma, DE; Gallagher, RV; Roger, E; Hughes, L; Downey, PO; Leishman, MR				Duursma, Daisy Englert; Gallagher, Rachael V.; Roger, Erin; Hughes, Lesley; Downey, Paul O.; Leishman, Michelle R.			Next-Generation Invaders? Hotspots for Naturalised Sleeper Weeds in Australia under Future Climates	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; ALIEN PLANTS; INVASION; NICHE; PREDICTION; DIVERSITY; ECOLOGY; TRAITS; UPDATE; ZONE	Naturalised, but not yet invasive plants, pose a nascent threat to biodiversity. As climate regimes continue to change, it is likely that a new suite of invaders will emerge from the established pool of naturalised plants. Pre-emptive management of locations that may be most suitable for a large number of potentially invasive plants will help to target monitoring, and is vital for effective control. We used species distribution models (SDM) and invasion-hotspot analysis to determine where in Australia suitable habitat may occur for 292 naturalised plants. SDMs were built in MaxEnt using both climate and soil variables for current baseline conditions. Modelled relationships were projected onto two Representative Concentration Pathways for future climates (RCP 4.5 and 8.5), based on seven global climate models, for two time periods (2035, 2065). Model outputs for each of the 292 species were then aggregated into single 'hotspot' maps at two scales: continental, and for each of Australia's 37 ecoregions. Across Australia, areas in the south-east and south-west corners of the continent were identified as potential hotspots for naturalised plants under current and future climates. These regions provided suitable habitat for 288 and 239 species respectively under baseline climates. The areal extent of the continental hotspot was projected to decrease by 8.8% under climates for 2035, and by a further 5.2% by 2065. A similar pattern of hotspot contraction under future climates was seen for the majority of ecoregions examined. However, two ecoregions - Tasmanian temperate forests and Australian Alps montane grasslands - showed increases in the areal extent of hotspots of >45% under climate scenarios for 2065. The alpine ecoregion also had an increase in the number of naturalised plant species with abiotically suitable habitat under future climate scenarios, indicating that this area may be particularly vulnerable to future incursions by naturalised plants.	[Duursma, Daisy Englert; Gallagher, Rachael V.; Roger, Erin; Hughes, Lesley; Leishman, Michelle R.] Macquarie Univ, Dept Biol Sci, Macquarie PK, Australia; [Downey, Paul O.] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia	Macquarie University; University of Canberra	Gallagher, RV (corresponding author), Macquarie Univ, Dept Biol Sci, Macquarie PK, Australia.	rachael.gallagher@mq.edu.au	Leishman, Michelle/AAU-4102-2020; Leishman, Michelle M/G-9726-2012	Leishman, Michelle/0000-0003-4830-5797; Leishman, Michelle M/0000-0003-4830-5797; Downey, Paul/0000-0002-8867-248X; Gallagher, Rachael/0000-0002-4680-8115; Roger, Erin/0000-0002-9671-132X; Hughes, Lesley/0000-0003-0313-9780	National Climate Change Adaptation Research Facility; Department of Biological Sciences at Macquarie University	National Climate Change Adaptation Research Facility; Department of Biological Sciences at Macquarie University	This work was funded by the National Climate Change Adaptation Research Facility. We thank the Department of Biological Sciences at Macquarie University for financing this open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Cousens Roger D., 2013, Cunninghamia, V13, P275, DOI 10.7751/cunninghamia.2013.005; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Gallagher RV, 2013, BIOL INVASIONS, V15, P961, DOI 10.1007/s10530-012-0342-6; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Groves RH, 2006, EUPHYTICA, V148, P111, DOI 10.1007/s10681-006-5945-5; Groves R. H., 2005, JUMPING GARDEN FENCE; Gurevitch J., 2002, ECOLOGY PLANTS; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hennessy KJ, 2008, CLIM RES, V35, P255, DOI 10.3354/cr00706; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2013, SPECIES DISTRIBUTION; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hughes L, 2011, REG ENVIRON CHANGE, V11, pS189, DOI 10.1007/s10113-010-0158-9; Johnston FM, 2001, MT RES DEV, V21, P284, DOI 10.1659/0276-4741(2001)021[0284:APITAA]2.0.CO;2; Krivanek M, 2006, DIVERS DISTRIB, V12, P319, DOI 10.1111/j.1366-9516.2006.00249.x; Kueffer C, 2013, NEW PHYTOL, V200, P615, DOI 10.1111/nph.12415; Lemke D, 2011, FOREST ECOL MANAG, V262, P139, DOI 10.1016/j.foreco.2011.03.014; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Milbau A, 2008, CONSERV BIOL, V22, P308, DOI 10.1111/j.1523-1739.2007.00877.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pickering C, 2008, BIODIVERS CONSERV, V17, P1627, DOI 10.1007/s10531-008-9371-y; Pielke RA, 1998, GLOBAL CHANGE BIOL, V4, P461, DOI 10.1046/j.1365-2486.1998.t01-1-00176.x; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pyke CR, 2008, CONSERV BIOL, V22, P585, DOI 10.1111/j.1523-1739.2008.00956.x; Pysek Petr, 2007, V193, P97; R Core Team, 2018, R LANG ENV STAT COMP; Randall R. P., 2007, INTRO FLORA AUSTR IT; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Scott J. M., 2002, PREDICTING SPECIES O; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stohlgren Thomas J., 2001, Biological Invasions, V3, P37, DOI 10.1023/A:1011451417418; Stokes KE, 2006, DIVERS DISTRIB, V12, P593, DOI 10.1111/j.1366-9516.2006.00239.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Vanderwal J, 2011, PACKAGE CLIMATES MET; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Venn SE, 2011, PLANT ECOL, V212, P1491, DOI 10.1007/s11258-011-9923-1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	63	29	30	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84222	10.1371/journal.pone.0084222	http://dx.doi.org/10.1371/journal.pone.0084222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386353	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700100
J	Cai, Y; Futcher, B				Cai, Ying; Futcher, Bruce			Effects of the Yeast RNA-Binding Protein Whi3 on the Half-Life and Abundance of CLN3 mRNA and Other Targets	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CYCLIN CLN3; P-BODIES; IN-VIVO; SUBCELLULAR-LOCALIZATION; CLN3-CDC28 KINASE; CELL-DIVISION; LATE G1; GENE	Whi3 is an RNA binding protein known to bind the mRNA of the yeast G1 cyclin gene CLN3. It inhibits CLN3 function, but the mechanism of this inhibition is unclear; in previous studies, Whi3 made no observable difference to CLN3 mRNA levels, translation, or protein abundance. Here, we re-approach this issue using microarrays, RNA-Seq, ribosome profiling, and other methods. By multiple methods, we find that the whi3 mutation causes a small but consistent increase in the abundance of hundreds of mRNAs, including the CLN3 mRNA. The effect on various mRNAs is roughly in proportion to the density of GCAU or UGCAU motifs carried by these mRNAs, which may be a binding site for Whi3. mRNA instability of Whi3 targets may in part depend on a 3' AU rich element (ARE), AUUUUA. In addition, the whi3 mutation causes a small increase in the translational efficiency of CLN3 mRNA. The increase in CLN3 mRNA half-life and abundance together with the increase in translational efficiency is fully sufficient to explain the small-cell phenotype of whi3 mutants. Under stress conditions, Whi3 becomes a component of P-bodies or stress granules, but Whi3 also acts under non-stress condition, when no P-bodies are visible. We suggest that Whi3 may be a very broadly-acting, but mild, modulator of mRNA stability. In CLN3, Whi3 may bind to the 3' GCAU motifs to attract the Ccr4-Not complex to promote RNA deadenylation and turnover, and Whi3 may bind to the 5' GCAU motifs to inhibit translation.	[Cai, Ying; Futcher, Bruce] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Futcher, B (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	bfutcher@gmail.com			National Institutes of Health [RO1 GM039978-25]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants RO1 GM039978-25 Size Control and Commitment to Division in S. cerevisiae (http://http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gari E, 2001, GENE DEV, V15, P2803; GILLIS P, 1991, J BIOL CHEM, V266, P3172; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Haim L, 2007, NAT METHODS, V4, P409, DOI 10.1038/NMETH1040; Hall DD, 1998, EMBO J, V17, P4370, DOI 10.1093/emboj/17.15.4370; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Laabs TL, 2003, P NATL ACAD SCI USA, V100, P10275, DOI 10.1073/pnas.1833999100; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malcher M, 2011, GENETICS, V187, P717, DOI 10.1534/genetics.110.125708; MALTER JS, 1990, ENZYME, V44, P203, DOI 10.1159/000468758; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001; Mizunuma M, 2013, J BIOL CHEM, V288, P10558, DOI 10.1074/jbc.M112.402214; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nash RS, 2001, GENETICS, V157, P1469; Nissan T, 2008, METHOD ENZYMOL, V448, P507, DOI 10.1016/S0076-6879(08)02625-6; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; SALLES FJ, 1995, PCR METH APPL, V4, P317; Salles FJ, 1999, METH MOL B, V118, P441; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Schneider BL, 2004, MOL CELL BIOL, V24, P10802, DOI 10.1128/MCB.24.24.10802-10813.2004; Sengupta DJ, 1999, RNA, V5, P596, DOI 10.1017/S1355838299002113; Shah KH, 2013, GENETICS, V193, P109, DOI 10.1534/genetics.112.146993; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; TYERS M, 1991, COLD SH Q B, V56, P21; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wahle E, 2013, BBA-GENE REGUL MECH, V1829, P561, DOI 10.1016/j.bbagrm.2013.01.003; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Wiederhold K, 2010, BIOCHEM SOC T, V38, P1531, DOI 10.1042/BST0381531	61	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84630	10.1371/journal.pone.0084630	http://dx.doi.org/10.1371/journal.pone.0084630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386402	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700114
J	Casas, L; Szucs, R; Vij, S; Goh, CH; Kathiresan, P; Nemeth, S; Jeney, Z; Bercsenyi, M; Orban, L				Casas, Laura; Szucs, Reka; Vij, Shubha; Goh, Chin Heng; Kathiresan, Purushothaman; Nemeth, Sandor; Jeney, Zsigmond; Bercsenyi, Miklos; Orban, Laszlo			Disappearing Scales in Carps: Re-Visiting Kirpichnikov's Model on the Genetics of Scale Pattern Formation	PLOS ONE			English	Article							COMMON CARP; CYPRINUS-CARPIO; LINKAGE MAP; SADDLEBACK-SYNDROME; COVER PATTERN; ZEBRAFISH; LINE; L.; WILD; MICROSATELLITE	The body of most fishes is fully covered by scales that typically form tight, partially overlapping rows. While some of the genes controlling the formation and growth of fish scales have been studied, very little is known about the genetic mechanisms regulating scale pattern formation. Although the existence of two genes with two pairs of alleles (S&s and N&n) regulating scale coverage in cyprinids has been predicted by Kirpichnikov and colleagues nearly eighty years ago, their identity was unknown until recently. In 2009, the 'S' gene was found to be a paralog of fibroblast growth factor receptor 1, fgfr1a1, while the second gene called 'N' has not yet been identified. We re-visited the original model of Kirpichnikov that proposed four major scale pattern types and observed a high degree of variation within the so-called scattered phenotype due to which this group was divided into two sub-types: classical mirror and irregular. We also analyzed the survival rates of offspring groups and found a distinct difference between Asian and European crosses. Whereas nude 6 nude crosses involving at least one parent of Asian origin or hybrid with Asian parent(s) showed the 25% early lethality predicted by Kirpichnikov (due to the lethality of the NN genotype), those with two Hungarian nude parents did not. We further extended Kirpichnikov's work by correlating changes in phenotype (scale-pattern) to the deformations of fins and losses of pharyngeal teeth. We observed phenotypic changes which were not restricted to nudes, as described by Kirpichnikov, but were also present in mirrors (and presumably in linears as well; not analyzed in detail here). We propose that the gradation of phenotypes observed within the scattered group is caused by a gradually decreasing level of signaling (a dose-dependent effect) probably due to a concerted action of multiple pathways involved in scale formation.	[Casas, Laura; Vij, Shubha; Kathiresan, Purushothaman; Orban, Laszlo] Temasek Life Sci Lab, Strateg Res Program, Reprod Genom Grp, Singapore, Singapore; [Szucs, Reka; Nemeth, Sandor; Bercsenyi, Miklos; Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Anim Husb, Keszthely, Hungary; [Goh, Chin Heng] Temasek Life Sci Lab, Fish Facil, Singapore, Singapore; [Jeney, Zsigmond] Res Inst Fisheries Aquaculture & Irrigat, Szarvas, Hungary; [Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of Pannonia; National University of Singapore	Bercsenyi, M (corresponding author), Univ Pannonia, Georgikon Fac, Dept Anim Sci & Anim Husb, Keszthely, Hungary.	bm@georgikon.hu; laszlo@tll.org.sg	Orbán, László/A-3030-2009; Casas, Laura/G-9347-2015	Orbán, László/0000-0001-5435-5948; Casas, Laura/0000-0001-6617-8731	Galician Government (Xunta de Galicia, Spain); Strategic Research Program of Temasek Life Sciences Laboratory; National Research Foundation of Hungary [OTKA-K-77681]	Galician Government (Xunta de Galicia, Spain)(Xunta de Galicia); Strategic Research Program of Temasek Life Sciences Laboratory(National University of Singapore); National Research Foundation of Hungary	This work was supported by: 1. Galician Government (Xunta de Galicia, Spain), 2. Internal funds from the Strategic Research Program of Temasek Life Sciences Laboratory, 3. National Research Foundation of Hungary (OTKA-K-77681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; Balon EK, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00563.x; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Bercsenyi M., 2011, Allattenyesztes es Takarmanyozas, V60, P267; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Czuczka P, 2002, STUDIES INHERITANCE, P1; Diggles BK, 2013, J FISH DIS, V36, P521, DOI 10.1111/jfd.12021; Drew CF, 2007, DEV BIOL, V305, P232, DOI 10.1016/j.ydbio.2007.02.011; Froufe E, 2002, J FISH BIOL, V61, P301, DOI [10.1006/jfbi.2002.2046, 10.1111/j.1095-8649.2002.tb01756.x]; Gallardo VE, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-120; Gibert Y, 2010, FASEB J, V24, P3298, DOI 10.1096/fj.09-147488; Gomelsky B, 2012, J FISH BIOL, V81, P1201, DOI 10.1111/j.1095-8649.2012.03398.x; GOMELSKY BI, 1992, AQUACULTURE, V106, P233, DOI 10.1016/0044-8486(92)90255-J; Harris MP, 2012, J APPL ICHTHYOL, V28, P306, DOI 10.1111/j.1439-0426.2012.01999.x; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Haworth KE, 2007, DEV BIOL, V303, P244, DOI 10.1016/j.ydbio.2006.11.009; Henkel CV, 2012, ZEBRAFISH, V9, P59, DOI 10.1089/zeb.2012.0773; HORVATH L, 1984, SPECIAL METHODS POND, P1; Houghton L, 2005, DEVELOPMENT, V132, P863, DOI 10.1242/dev.01651; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kirpichnikov V. S., 1936, Biol J Moscow, V5, P327; Kirpichnikov V. S., 1967, GENETIKA, V8, P65; Kirpichnikov VS, 1981, GENETIC BASES FISH S, P1; KIRPICNIKOV V. S., 1935, Zoologicheskii Zhurnal, V14, P45; Kirpitchnikov Valentin S., 1999, P1; Kohlmann K, 2005, AQUACULTURE, V247, P253, DOI 10.1016/j.aquaculture.2005.02.024; Kohlmann K, 2003, AQUAT LIVING RESOUR, V16, P421, DOI 10.1016/S0990-7440(03)00082-2; Komen J, 1990, CLONES COMMON CARP C, P1; Kondo S, 2001, CURR BIOL, V11, P1202, DOI 10.1016/S0960-9822(01)00324-4; Koumoundouros G, 2008, J FISH BIOL, V72, P737, DOI 10.1111/j.1095-8649.2007.01714.x; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; McGraw HF, 2011, DEVELOPMENT, V138, P3921, DOI 10.1242/dev.062554; Memis D, 2006, AQUACULTURE, V258, P257, DOI 10.1016/j.aquaculture.2006.03.041; Michaels VK, 1998, CARP FARMING, P1; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Moav R, 1963, ISR J AQUACULTURE BA, V15, P3; MORRISON C, 1981, J FISH DIS, V4, P243, DOI 10.1111/j.1365-2761.1981.tb01131.x; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nicolescu C, 2004, B U AGR MED VET ZOOT, V60, P78; Orban Laszlo, 2008, V2, P45, DOI 10.1007/978-3-540-73837-4_2; Ortubay S, 2000, ENVIRON BIOL FISH, V58, P144, DOI 10.1023/A:1007694308513; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Prykhozhij SV, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-91; Purdom CE, 1993, GENETICS FISH BREEDI, P1; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Rudzinsky E, 1928, FISCHEREI Z, V31, P613; Rudzinsky E, 1928, FISCH ZTG, V30, P593; Sarrazin AF, 2010, J NEUROSCI, V30, P8234, DOI 10.1523/JNEUROSCI.5137-09.2010; Seritrakul P, 2012, FASEB J, V26, P5014, DOI 10.1096/fj.12-209304; Setiadi E, 2006, J APPL ICHTHYOL, V22, P49, DOI 10.1111/j.1439-0426.2006.00524.x; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; TAVE D, 1983, J FISH DIS, V6, P59, DOI 10.1111/j.1365-2761.1983.tb00051.x; Tave D, 1993, GENETICS FISH HATCHE, P1; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; Wells KL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-257; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Woynarovich E, 1962, ISR J AQUACULT-BAMID, V4, P38; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x; Zhou J, 2004, J ZOOL SYST EVOL RES, V42, P266, DOI 10.1111/j.1439-0469.2004.00266.x; Zhou JF, 2003, CHINESE SCI BULL, V48, P465, DOI 10.1360/03tb9098	65	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83327	10.1371/journal.pone.0083327	http://dx.doi.org/10.1371/journal.pone.0083327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386179	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700033
J	Wang, S; Feng, QH; Han, XD				Wang, Sen; Feng, Qihong; Han, Xiaodong			A Hybrid Analytical/Numerical Model for the Characterization of Preferential Flow Path with Non-Darcy Flow	PLOS ONE			English	Article							FLUID-FLOW; INTERWELL CONNECTIVITY; SANDSTONE; RESERVOIRS; WELL; OPTIMIZATION; IDENTIFICATION; PERMEABILITY; COEFFICIENTS; FRACTURE	Due to the long-term fluid-solid interactions in waterflooding, the tremendous variation of oil reservoir formation parameters will lead to the widespread evolution of preferential flow paths, thereby preventing the further enhancement of recovery efficiency because of unstable fingering and premature breakthrough. To improve oil recovery, the characterization of preferential flow paths is essential and imperative. In efforts that have been previously documented, fluid flow characteristics within preferential paths are assumed to obey Darcy's equation. However, the occurrence of non-Darcy flow behavior has been increasingly suggested. To examine this conjecture, the Forchheimer number with the inertial coefficient estimated from different empirical formulas is applied as the criterion. Considering a 10% non-Darcy effect, the fluid flow in a preferential path may do experience non-Darcy behavior. With the objective of characterizing the preferential path with non-Darcy flow, a hybrid analytical/numerical model has been developed to investigate the pressure transient response, which dynamically couples a numerical model describing the non-Darcy effect of a preferential flow path with an analytical reservoir model. The characteristics of the pressure transient behavior and the sensitivities of corresponding parameters have also been discussed. In addition, an interpretation approach for pressure transient testing is also proposed, in which the Gravitational Search Algorithm is employed as a non-linear regression technology to match measured pressure with this hybrid model. Examples of applications from different oilfields are also presented to illustrate this method. This cost-effective approach provides more accurate characterization of a preferential flow path with non-Darcy flow, which will lay a solid foundation for the design and operation of conformance control treatments, as well as several other Enhanced Oil Recovery projects.	[Wang, Sen; Feng, Qihong; Han, Xiaodong] China Univ Petr East China, Dept Petr Engn, Qingdao, Peoples R China	China University of Petroleum	Wang, S (corresponding author), China Univ Petr East China, Dept Petr Engn, Qingdao, Peoples R China.	fwforest@gmail.com	Wang, Sen/K-8834-2012; han, xiao/HDN-9782-2022	Wang, Sen/0000-0003-2472-6204; 	Fundamental Research Funds for the Central Universities [13CX06028A]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the Fundamental Research Funds for the Central Universities (13CX06028A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL RG, 1970, SOC PETROL ENG J, V10, P279, DOI 10.2118/2466-PA; Ahmed T.H., 2005, ADV RESERVOIR ENG; Al-Gosayir M, 2012, J PETROL SCI ENG, V98-99, P61, DOI 10.1016/j.petrol.2012.09.008; Al-Kobaisi M, 2006, SPE RESERV EVAL ENG, V9, P345, DOI 10.2118/92040-PA; Albertoni A, 2003, SPE RESERV EVAL ENG, V6, P6, DOI 10.2118/83381-PA; Andrade JS, 1999, PHYS REV LETT, V82, P5249, DOI 10.1103/PhysRevLett.82.5249; [Anonymous], 1957, J PETROL TECHNOL, DOI DOI 10.2118/741-G; [Anonymous], RES C FLOW NAT GAS R; Bane RK, 1994, PERML BAS OIL GAS RE; Bear J., 1972, DYNAMICS FLUIDS PORO; Behrang MA, 2011, ENERGY, V36, P5649, DOI 10.1016/j.energy.2011.07.002; Belhaj HA, 2003, SPE LAT AM CAR PETR; BEVC D, 1991, GEOPHYSICS, V56, P769, DOI 10.1190/1.1443094; Blick E.F., 1988, SPE RESERV ENG, V3, P1048, DOI [10.2118/16202-PA, DOI 10.2118/16202-PA]; BRIGHAM WE, 1987, J PETROL TECHNOL, V39, P519, DOI 10.2118/14102-PA; Chai ZH, 2010, COMPUT FLUIDS, V39, P2069, DOI 10.1016/j.compfluid.2010.07.012; Chatterjee A., 2010, Progress In Electromagnetics Research B, V25, P331, DOI 10.2528/PIERB10080405; [陈程 Chen Cheng], 2012, [石油学报, Acta Petrolei Sinica], V33, P257; Chen D, 2011, SPE ENH OIL REC C KU; Chilton TH, 1931, IND ENG CHEM, V23, P913, DOI 10.1021/ie50260a016; Chukwudozie CP, 2012, TRANSPORT POROUS MED, V95, P563, DOI 10.1007/s11242-012-0062-5; CINCOLEY H, 1981, J PETROL TECHNOL, V33, P1749, DOI 10.2118/7490-PA; Coles ME, 1998, SPE GAS TECHN S CALG, DOI 10.2118/39977-MS; Colon CFJ, 2004, GEOCHIM COSMOCHIM AC, V68, P805, DOI 10.1016/j.gca.2003.06.002; Comiti J, 2000, CHEM ENG SCI, V55, P3057, DOI 10.1016/S0009-2509(99)00556-4; Cui C., 2009, J OIL GAS TECHNOL, V31, P122; DATTAGUPTA A, 1995, SPE FORMATION EVAL, V10, P40, DOI 10.2118/24139-PA; Dinges D.D., 1988, SPE FORMATION EVAL, V3, P743, DOI DOI 10.2118/15582-PA; Dorigo M, 1996, IEEE T SYST MAN CY B, V26, P29, DOI 10.1109/3477.484436; Duman S, 2012, ENERG CONVERS MANAGE, V59, P86, DOI 10.1016/j.enconman.2012.02.024; DUPLESSIS JP, 1988, TRANSPORT POROUS MED, V3, P145, DOI 10.1007/BF00820342; Dybbs A., 1984, FUNDAMENTALS TRANSPO, V82, P199, DOI DOI 10.1007/978-94-009-6175-3_4; Ehlig-Economides C. A., 1987, SPE FORM EVAL, V2, P261, DOI DOI 10.2118/14167-PA; Eldos T, 2013, INT J ADV COMPUT SC, V4, P74; Engler TW, 2001, SPE W REG M BAK CAL; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Ezulike O, 2012, J PETROL SCI ENG, V96-97, P120, DOI 10.1016/j.petrol.2012.09.002; Fancher GH, 1933, IND ENG CHEM, V25, P1139, DOI 10.1021/ie50286a020; Fattahpour V, 2012, J PETROL SCI ENG, V86-87, P172, DOI 10.1016/j.petrol.2012.03.023; Feng QH, 2013, J PETROL SCI ENG, V110, P55, DOI 10.1016/j.petrol.2013.08.042; Feng QH, 2010, J PETROL SCI ENG, V75, P13, DOI 10.1016/j.petrol.2010.10.005; Forchheimer P, 1901, Z VER DTSCH ING, V45, P1782; Fourar M, 2004, ADV WATER RESOUR, V27, P669, DOI 10.1016/j.advwatres.2004.02.021; Friedel T, 2006, J PETROL SCI ENG, V54, P112, DOI 10.1016/j.petrol.2006.07.002; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062156; Garrouch AA, 2001, TRANSPORT POROUS MED, V44, P487, DOI 10.1023/A:1010671012287; GEERTSMA J, 1974, SOC PETROL ENG J, V14, P445, DOI 10.2118/4706-PA; Ghahri P, 2012, FUEL, V97, P24, DOI 10.1016/j.fuel.2012.03.030; GREEN L, 1951, J APPL MECH-T ASME, V18, P39; GRINGARTEN AC, 1974, SOC PETROL ENG J, V14, P413, DOI 10.2118/3819-PA; GRINGARTEN AC, 1973, SOC PETROL ENG J, V13, P285, DOI 10.2118/3818-PA; GUPPY KH, 1981, SOC PETROL ENG J, V21, P390, DOI 10.2118/9344-PA; GUPPY KH, 1982, SOC PETROL ENG J, V22, P681, DOI 10.2118/8281-PA; Hajizadeh Y, 2011, J PETROL SCI ENG, V77, P78, DOI 10.1016/j.petrol.2011.02.005; Halliday D., 2013, FUNDAMENTALS PHYS; Hamadneh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066080; Horne RN, 1990, MODERN WELL TEST ANA; Jones S.C., 1987, SPE ANN TECHN C EXH, P10; Kaviani D, 2012, J PETROL SCI ENG, V90-91, P79, DOI 10.1016/j.petrol.2012.04.008; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kuchuk F.J., 2010, PRESSURE TRANSIENT F; Li B, 2008, ANN TECHN C EXH DENV; Li CS, 2011, ENERG CONVERS MANAGE, V52, P374, DOI 10.1016/j.enconman.2010.07.012; Li Shuxia, 1994, J U PETROLEUM CHIN S, V18, P1; Li XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051199; Liu R, 2010, PETROL GEOL OILFIELD, V29, P65; Liu X, 2005, INT THERM OP HEAV OI; Liu YZ, 2010, OIL GAS SCI TECHNOL, V65, P859, DOI 10.2516/ogst/2009057; MA H, 1993, TRANSPORT POROUS MED, V13, P139, DOI 10.1007/BF00654407; MACDONALD IF, 1979, IND ENG CHEM FUND, V18, P199, DOI 10.1021/i160071a001; Macini P, 2011, J PETROL SCI ENG, V77, P365, DOI 10.1016/j.petrol.2011.04.016; Mahdiyar H, 2011, J PETROL SCI ENG, V78, P149, DOI 10.1016/j.petrol.2011.05.013; Newman M.S, 2011, SPE ANN TECHN C EXH SPE ANN TECHN C EXH; Ozkan E., 1989, SPE CAL REG M VENT C, V4, P567, DOI DOI 10.2118/16378-PA; Ozkan E., 1995, SPE ADV TECHNOLOGY, V3, P85, DOI DOI 10.2118/24683-PA; Pascal H., 1980, P SPE ANN TECHN C EX, DOI [10.2118/9348-MS.SPE-9348-MS, DOI 10.2118/9348-MS.SPE-9348-MS]; Perera MSA, 2011, FUEL, V90, P547, DOI 10.1016/j.fuel.2010.09.029; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Samaniego-V F, 1977, SPE ANN TECHN C EXH; Sayarpour M, 2009, J PETROL SCI ENG, V69, P227, DOI 10.1016/j.petrol.2009.09.006; Scheidegger A. E., 1974, PHYS FLOW POROUS MED; Shaw B, 2014, INT J ELEC POWER, V55, P29, DOI 10.1016/j.ijepes.2013.08.010; Smith DH, 1965, FIELD EVALUATION WAT; Stanley HE, 2001, PHYSICA A, V295, P17, DOI 10.1016/S0378-4371(01)00140-6; Szymczak P, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006122; Tang KS, 1996, IEEE SIGNAL PROC MAG, V13, P22, DOI 10.1109/79.543973; Thauvin F, 1998, TRANSPORT POROUS MED, V31, P19, DOI 10.1023/A:1006558926606; Wang SL, 2011, TRANSPORT POROUS MED, V86, P513, DOI 10.1007/s11242-010-9634-4; Wang XZ, 2010, PETROL SCI, V7, P106, DOI 10.1007/s12182-010-0013-0; Wu YS, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000713; Zeng ZW, 2006, TRANSPORT POROUS MED, V63, P57, DOI 10.1007/s11242-005-2720-3; Zhang J, 2012, GEOTHERMICS, V42, P78, DOI 10.1016/j.geothermics.2011.11.002	94	8	8	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83536	10.1371/journal.pone.0083536	http://dx.doi.org/10.1371/journal.pone.0083536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386224	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700048
J	Benedetto, S; Drai-Zerbib, V; Pedrotti, M; Tissier, G; Baccino, T				Benedetto, Simone; Drai-Zerbib, Veronique; Pedrotti, Marco; Tissier, Geoffrey; Baccino, Thierry			E-Readers and Visual Fatigue	PLOS ONE			English	Article							COMPUTER VISION SYNDROME; E-INK DISPLAYS; BLINK RATE; CONFIDENCE-INTERVALS; EYES; SIZE; LCD	The mass digitization of books is changing the way information is created, disseminated and displayed. Electronic book readers (e-readers) generally refer to two main display technologies: the electronic ink (E-ink) and the liquid crystal display (LCD). Both technologies have advantages and disadvantages, but the question whether one or the other triggers less visual fatigue is still open. The aim of the present research was to study the effects of the display technology on visual fatigue. To this end, participants performed a longitudinal study in which two last generation e-readers (LCD, E-ink) and paper book were tested in three different prolonged reading sessions separated by - on average - ten days. Results from both objective (Blinks per second) and subjective (Visual Fatigue Scale) measures suggested that reading on the LCD (Kindle Fire HD) triggers higher visual fatigue with respect to both the E-ink (Kindle Paperwhite) and the paper book. The absence of differences between E-ink and paper suggests that, concerning visual fatigue, the E-ink is indeed very similar to the paper.	[Benedetto, Simone; Tissier, Geoffrey; Baccino, Thierry] Univ Paris 08, CHArt LUTIN, Paris, France; [Drai-Zerbib, Veronique; Pedrotti, Marco] Univ Paris 06, CHArt LUTIN, Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-VIII; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Benedetto, S (corresponding author), Univ Paris 08, CHArt LUTIN, Paris, France.	benedetto.simone@gmail.com	Pedrotti, Marco/AAI-9524-2020	Pedrotti, Marco/0000-0002-3821-5408; Baccino, Thierry/0000-0002-2406-5306; Benedetto, Simone/0000-0002-6053-1052				Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; Baccino T, 2004, LECT EL; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRIDGEMAN B, 1993, P SOC PHOTO-OPT INS, V1913, P134, DOI 10.1117/12.152738; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; Chang PC, 2013, DISPLAYS IN PRESS; Chen H, 1993, PSYCHOL SCI, V4, P237; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; De Leeuw E., 1965, READ BETTER READ FAS; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Fry FB, 1963, TEACHING FASTER READ; Fukuda K, 2005, AVIAT SPACE ENVIR MD, V76, pC75; Garnham A., 1996, MODELS UNDERSTANDING, P313; GERNSBACHER MA, 1991, PSYCHOL LEARN MOTIV, V27, P217, DOI 10.1016/S0079-7421(08)60125-5; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HEUER H, 1989, Z EXP ANGEW PSYCHOL, V36, P538; Hirota M, 2013, OPTOMETRY VISION SCI, V90, P650, DOI 10.1097/OPX.0b013e31829962ec; Kang YY, 2009, DISPLAYS, V30, P49, DOI 10.1016/j.displa.2008.12.002; Kintsch W, 1998, COMPREHENSION PARADI; Kretzschmar F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056178; Kumashiro M, 1995, EVALUATION HUMAN WOR; Lee DS, 2011, DISPLAYS, V32, P1, DOI 10.1016/j.displa.2010.09.001; Liversedge SP, 2006, CURR BIOL, V16, P1726, DOI 10.1016/j.cub.2006.07.051; Loewenfeld I. E., 1993, PUPIL ANATOMY PHYSL, V1; Maupassant GD, 2004, BEL AMI; Menozzi M, 2001, DISPLAYS, V22, P79, DOI 10.1016/S0141-9382(01)00054-3; Michelson Albert A., 1927, STUDIES OPTICS; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; OREGAN JK, 1983, PERCEPT PSYCHOPHYS, V34, P457, DOI 10.3758/BF03203061; PATEL S, 1991, OPTOMETRY VISION SCI, V68, P888, DOI 10.1097/00006324-199111000-00010; Pedrotti M, 2011, BEHAV RES METHODS, V43, P372, DOI 10.3758/s13428-010-0055-7; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; Shen IH, 2009, DISPLAYS, V30, P53, DOI 10.1016/j.displa.2008.12.001; Siegenthaler E, 2012, J EYE MOVEMENT RES, V5; Siegenthaler E, 2012, OPHTHAL PHYSL OPT, V32, P367, DOI 10.1111/j.1475-1313.2012.00928.x; Siegenthaler E, 2011, DISPLAYS, V32, P268, DOI 10.1016/j.displa.2011.05.005; STERN JA, 1994, HUM FACTORS, V36, P285, DOI 10.1177/001872089403600209; TAPTAGAPORN S, 1990, ERGONOMICS, V33, P201, DOI 10.1080/00140139008927110; Tinker MA, 1955, J APPL PSYCHOL, V39, P444, DOI 10.1037/h0041553; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yamada F, 1998, ERGONOMICS, V41, P678, DOI 10.1080/001401398186847; Zambarbieri D, 2012, OPHTHAL PHYSL OPT, V32, P390, DOI 10.1111/j.1475-1313.2012.00930.x	47	90	93	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83676	10.1371/journal.pone.0083676	http://dx.doi.org/10.1371/journal.pone.0083676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386252	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900052
J	Chen, CY; Hofmann, CS; Cottrell, BJ; Strobaugh, TP; Paoli, GC; Nguyen, LH; Yan, XH; Uhlich, GA				Chen, Chin-Yi; Hofmann, Christopher S.; Cottrell, Bryan J.; Strobaugh, Terence P., Jr.; Paoli, George C.; Ly-Huong Nguyen; Yan, Xianghe; Uhlich, Gaylen A.			Phenotypic and Genotypic Characterization of Biofilm Forming Capabilities in Non-O157 Shiga Toxin-Producing Escherichia coli Strains	PLOS ONE			English	Article							IN-GROUND BEEF; CSGD PROMOTER; SALMONELLA-TYPHIMURIUM; EXTRACELLULAR-MATRIX; UNITED-STATES; FOOD; EXPRESSION; MOTILITY; O157-H7; BACTERIOPHAGES	The biofilm life style helps bacteria resist oxidative stress, desiccation, antibiotic treatment, and starvation. Biofilm formation involves a complex regulatory gene network controlled by various environmental signals. It was previously shown that prophage insertions in mlrA and heterogeneous mutations in rpoS constituted major obstacles limiting biofilm formation and the expression of extracellular curli fibers in strains of Escherichia coli serotype O157: H7. The purpose of this study was to test strains from other important serotypes of Shiga toxin-producing E. coli (STEC) (O26, O45, O103, O111, O113, O121, and O145) for similar regulatory restrictions. In a small but diverse collection of biofilm-forming and non-forming strains, mlrA prophage insertions were identified in only 4 of the 19 strains (serotypes O103, O113, and O145). Only the STEC O103 and O113 strains could be complemented by a trans-copy of mlrA to restore curli production and Congo red (CR) dye affinity. RpoS mutations were found in 5 strains (4 serotypes), each with low CR affinity, and the defects were moderately restored by a wild-type copy of rpoS in 2 of the 3 strains attempted. Fourteen strains in this study showed no or weak biofilm formation, of which 9 could be explained by prophage insertions or rpoS mutations. However, each of the remaining five biofilm-deficient strains, as well as the two O145 strains that could not be complemented by mlrA, showed complete or nearly complete lack of motility. This study indicates that mlrA prophage insertions and rpoS mutations do limit biofilm and curli expression in the non-serotype O157: H7 STEC but prophage insertions may not be as common as in serotype O157: H7 strains. The results also suggest that lack of motility provides a third major factor limiting biofilm formation in the non-O157: H7 STEC. Understanding biofilm regulatory mechanisms will prove beneficial in reducing pathogen survival and enhancing food safety.	[Chen, Chin-Yi; Hofmann, Christopher S.; Cottrell, Bryan J.; Strobaugh, Terence P., Jr.; Paoli, George C.; Ly-Huong Nguyen; Yan, Xianghe; Uhlich, Gaylen A.] ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA	United States Department of Agriculture (USDA)	Chen, CY (corresponding author), ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA.	chin-yi.chen@ars.usda.gov		Hofmann, Christopher/0000-0003-4918-6769	National Program 108 Food Safety Project of the United States Department of Agriculture-Agriculture Research Service (USDA-ARS).	National Program 108 Food Safety Project of the United States Department of Agriculture-Agriculture Research Service (USDA-ARS).	This research was funded by the National Program 108 Food Safety Project of the United States Department of Agriculture-Agriculture Research Service (USDA-ARS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutin L, 2007, APPL ENVIRON MICROB, V73, P4769, DOI 10.1128/AEM.00873-07; Biscola FT, 2011, APPL ENVIRON MICROB, V77, P2201, DOI 10.1128/AEM.01920-10; Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x; Burkart M, 1998, P NATL ACAD SCI USA, V95, P2568, DOI 10.1073/pnas.95.5.2568; DebRoy C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/fpd.2010.0769; Fratamico PM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00152; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Gerstel U, 2003, MOL MICROBIOL, V49, P639, DOI 10.1046/j.1365-2958.2003.03594.x; Gerstel U, 2006, FEMS MICROBIOL LETT, V261, P109, DOI 10.1111/j.1574-6968.2006.00332.x; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Medina MB, 2012, J FOOD PROTECT, V75, P819, DOI 10.4315/0362-028X.JFP-11-430; Miller J.H., 1972, EXPT MOL GENETICS; Ogasawara H, 2010, FEMS MICROBIOL LETT, V312, P160, DOI 10.1111/j.1574-6968.2010.02112.x; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pesavento C, 2012, NUCLEIC ACIDS RES, V40, P4783, DOI 10.1093/nar/gks055; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Serra-Moreno R, 2007, J BACTERIOL, V189, P6645, DOI 10.1128/JB.00466-07; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Takkinen J., 2011, SHIGA TOXIN VEROTOXI; Uhlich GA, 2001, APPL ENVIRON MICROB, V67, P2367, DOI 10.1128/AEM.67.5.2367-2370.2001; Uhlich GA, 2013, MICROBIOL-SGM, V159, P1586, DOI 10.1099/mic.0.066118-0; van Hoek AHAM, 2013, FEMS MICROBIOL LETT, V338, P18, DOI 10.1111/1574-6968.12024; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Wang R, 2012, J FOOD PROTECT, V75, P1418, DOI 10.4315/0362-028X.JFP-11-427; Wasilenko JL, 2012, J FOOD PROTECT, V75, P1939, DOI 10.4315/0362-028X.JFP-12-087; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	32	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84863	10.1371/journal.pone.0084863	http://dx.doi.org/10.1371/journal.pone.0084863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386426	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900115
J	Ernst, N; Yay, A; Biro, T; Tiede, S; Humphries, M; Paus, R; Kloepper, JE				Ernst, Nancy; Yay, Arzu; Biro, Tamas; Tiede, Stephan; Humphries, Martin; Paus, Ralf; Kloepper, Jennifer E.			beta 1 Integrin Signaling Maintains Human Epithelial Progenitor Cell Survival In Situ and Controls Proliferation, Apoptosis and Migration of Their Progeny	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; FOLLICLE STEM-CELLS; TRANSIT-AMPLIFYING CELLS; HAIR FOLLICLE; MONOCLONAL-ANTIBODY; BASEMENT-MEMBRANE; DIFFERENTIAL EXPRESSION; INHIBITOR QLT0267; BULGE REGION; ADHESION	beta 1 integrin regulates multiple epithelial cell functions by connecting cells with the extracellular matrix (ECM). While beta 1 integrin-mediated signaling in murine epithelial stem cells is well-studied, its role in human adult epithelial progenitor cells (ePCs) in situ remains to be defined. Using microdissected, organ-cultured human scalp hair follicles (HFs) as a clinically relevant model for studying human ePCs within their natural topobiological habitat, beta 1 integrin-mediated signaling in ePC biology was explored by beta 1 integrin siRNA silencing, specific beta 1 integrin-binding antibodies and pharmacological inhibition of integrin-linked kinase (ILK), a key component of the integrin-induced signaling cascade. beta 1 integrin knock down reduced keratin 15 (K15) expression as well as the proliferation of outer root sheath keratinocytes (ORSKs). Embedding of HF epithelium into an ECM rich in beta 1 integrin ligands that mimic the HF mesenchyme significantly enhanced proliferation and migration of ORSKs, while K15 and CD200 gene and protein expression were inhibited. Employing ECM-embedded beta 1 integrin-activating or -inhibiting antibodies allowed to identify functionally distinct human ePC subpopulations in different compartments of the HF epithelium. The beta 1 integrin-inhibitory antibody reduced beta 1 integrin expression in situ and selectively enhanced proliferation of bulge ePCs, while the beta 1 integrin-stimulating antibody decreased hair matrix keratinocyte apoptosis and enhanced transferrin receptor (CD71) immunoreactivity, a marker of transit amplifying cells, but did not affect bulge ePC proliferation. That the putative ILK inhibitor QLT0267 significantly reduced ORSK migration and proliferation and induced massive ORSK apoptosis suggests a key role for ILK in mediating the beta 1 integrin effects. Taken together, these findings demonstrate that ePCs in human HFs require beta 1 integrin-mediated signaling for survival, adhesion, and migration, and that different human HF ePC subpopulations differ in their response to beta 1 integrin signaling. These insights may be exploited for cell-based regenerative medicine strategies that employ human HF-derived ePCs.	[Ernst, Nancy; Paus, Ralf; Kloepper, Jennifer E.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Yay, Arzu] Erciyes Univ, Dept Histol & Embryol, Kayseri, Turkey; [Biro, Tamas] Univ Debrecen, Dept Physiol, DE MTA Lendulet Cellular Physiol Grp, H-4012 Debrecen, Hungary; [Tiede, Stephan] Euroimmun AG, Inst Expt Immunol, Lubeck, Germany; [Humphries, Martin] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Paus, Ralf] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England	University of Lubeck; Erciyes University; University of Debrecen; EUROIMMUN; University of Manchester; University of Manchester	Paus, R (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	ralf.paus@uksh.de	Hundt, Jennifer/AAU-4504-2020; Kloepper, Jennifer E/B-7403-2015; Yay, Arzu/AAP-4395-2021; Paus, Ralf/B-5279-2015	Paus, Ralf/0000-0002-3492-9358; Tiede, Stephan/0000-0002-6045-3736; Ernst, Nancy/0000-0002-3248-2425; Humphries, Martin/0000-0002-4331-6967	medical faculty of the University of Luebeck [E42-2010]; DFG [PA 345/13-1]	medical faculty of the University of Luebeck; DFG(German Research Foundation (DFG))	This study was supported by a fellowship of the medical faculty of the University of Luebeck to J.K. (E42-2010) and a grant from the DFG (PA 345/13-1) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Assi K, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-42; Attwell S, 2000, ONCOGENE, V19, P3811, DOI 10.1038/sj.onc.1203711; Azimifar SB, 2012, J CELL SCI, V125, P435, DOI 10.1242/jcs.091652; Beck B, 2012, EMBO J, V31, P2067, DOI 10.1038/emboj.2012.67; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Byron A, 2013, INT J EXP PATHOL; Byron A, 2010, CURR BIOL, V20, pR1063, DOI 10.1016/j.cub.2010.10.059; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chen SY, 2013, DEVELOPMENT, V140, P255, DOI 10.1242/dev.083139; Commo S, 1997, CELL MOL LIFE SCI, V53, P466, DOI 10.1007/s000180050057; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Devalliere J, 2012, FASEB J, V26, P2592, DOI 10.1096/fj.11-193383; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Goel HL, 2010, J CELL PHYSIOL, V224, P210, DOI 10.1002/jcp.22116; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Harries MJ, 2010, AM J PATHOL, V177, P2152, DOI 10.2353/ajpath.2010.100454; Harries MJ, 2013, AM J PATHOL; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Humphries MJ, 2002, ARTHRITIS RES THER, V4, pS69, DOI 10.1186/ar563; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inoue K, 2009, LAB INVEST, V89, P844, DOI 10.1038/labinvest.2009.48; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Judah D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036704; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Kaur P, 2004, J INVEST DERM SYMP P, V9, P238, DOI 10.1111/j.1087-0024.2004.09306.x; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Kloepper JE, 2008, EXP CELL RES, V314, P498, DOI 10.1016/j.yexcr.2007.10.030; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Kloepper JE, 2010, EXP DERMATOL, V19, P305, DOI 10.1111/j.1600-0625.2009.00939.x; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Leyme A, 2012, MOL BIOL CELL, V23, P3461, DOI 10.1091/mbc.E11-11-0918; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053702; LINK RE, 1990, J INVEST DERMATOL, V95, P202, DOI 10.1111/1523-1747.ep12478002; Liu ZZ, 2011, CHINESE MED J-PEKING, V124, P2934, DOI 10.3760/cma.j.issn.0366-6999.2011.18.025; Lopez-Rovira T, 2005, J INVEST DERMATOL, V125, P1215, DOI 10.1111/j.0022-202X.2005.23956.x; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lyle S, 1998, J CELL SCI, V111, P3179; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Maydan M, 2010, PLOS ONE, V5, P8, DOI DOI 10.1371/J0URNAL.P0NE.0012356.PUBMED:20827300; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Meves A, 2013, J INVEST DERMATOL; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Morisaki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055947; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Ohyama Manabu, 2012, Methods Mol Biol, V879, P389, DOI 10.1007/978-1-61779-815-3_24; Ohyama M, 2013, J DERMATOL SCI, V70, P78, DOI 10.1016/j.jdermsci.2013.02.004; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002-0109; Philpott M P, 1994, J Dermatol Sci, V7 Suppl, pS55, DOI 10.1016/0923-1811(94)90036-1; Piwko-Czuchra A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005488; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Roh C, 2005, J INVEST DERMATOL, V125, P1099, DOI 10.1111/j.0022-202X.2005.23958.x; Rosenblum MD, 2006, J DERMATOL SCI, V41, P165, DOI 10.1016/j.jdermsci.2005.11.003; Rothnagel JA, 1999, DIFFERENTIATION, V65, P119, DOI 10.1046/j.1432-0436.1999.6520119.x; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Samuelov L, 2012, J INVEST DERMATOL, V132, P2332, DOI 10.1038/jid.2012.171; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; STENN KS, 1989, J INVEST DERMATOL, V93, P287, DOI 10.1111/1523-1747.ep12277593; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129; Sun XY, 2011, BIOL PHARM BULL, V34, P1037, DOI 10.1248/bpb.34.1037; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tiede S, 2007, EUR J CELL BIOL, V86, P355, DOI 10.1016/j.ejcb.2007.03.006; Tiede S, 2009, STEM CELLS, V27, P2793, DOI 10.1002/stem.213; Tuckwell DS, 2000, BIOCHEM J, V350, P485, DOI 10.1042/0264-6021:3500485; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260; Vollmers A, 2012, STEM CELL REV REP, V8, P402, DOI 10.1007/s12015-011-9314-y; Wang Qing-Qing, 2011, Chin J Cancer, V30, P853, DOI 10.5732/cjc.011.10362; Wang XF, 2011, MED ONCOL, V28, P1596, DOI 10.1007/s12032-010-9616-y; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Webb A, 2004, DIFFERENTIATION, V72, P387, DOI 10.1111/j.1432-0436.2004.07208005.x; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wickstrom Sara A, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005116; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Yu YP, 2011, ONCOGENE, V30, P4855, DOI 10.1038/onc.2011.200	108	15	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84356	10.1371/journal.pone.0084356	http://dx.doi.org/10.1371/journal.pone.0084356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386370	gold, Green Accepted, Green Published			2022-12-27	WOS:000329117900089
J	Jamaluddin, MS; Yan, SY; Lu, JM; Liang, ZD; Yao, QZ; Chen, CY				Jamaluddin, Md Saha; Yan, Shaoyu; Lu, Jianming; Liang, Zhengdong; Yao, Qizhi; Chen, Changyi			Resistin Increases Monolayer Permeability of Human Coronary Artery Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASES; TIGHT JUNCTION PROTEINS; P38 MAP KINASE; OXIDATIVE STRESS; BARRIER FUNCTION; NADPH OXIDASE; CARDIOVASCULAR-DISEASES; ACTIN CYTOSKELETON; ADIPOSE-TISSUE	Resistin has been linked to obesity, insulin resistance, atherosclerosis, and the development of cardiovascular disease. Nevertheless, the effects and the molecular mechanisms of resistin on endothelial permeability, a key event in the development of atherosclerosis, inflammation, and vascular disease, are largely unknown. In order to determine the effect of resistin on endothelial permeability, human coronary artery endothelial cells (HCAECs) were treated with clinically relevant concentrations of resistin and the endothelial permeability was measured using the Transwell system with a Texas-Red-labeled dextran tracer. The permeability of HCAEC monolayers treated with resistin (80 ng/mL) was 51% higher than the permeability of control monolayers (P < 0.05). The mRNA levels of tight junction proteins zonula occludens-1 (ZO-1) and occludin in resistin-treated cells were 37% and 42% lower, respectively, than the corresponding levels in untreated cells. The protein levels of these molecules in resistin-treated cells were significantly reduced by 35% and 37%, respectively (P < 0.05), as shown by flow cytometry and Western blot analysis. Superoxide dismutase (SOD) mimetic MnTBAP effectively blocked the resistin-mediated reduction of ZO-1 and occludin levels in HCAECs. In addition, superoxide anion production was increased from 21% (untreated cells) to 55% (cells treated with 40 ng/mL resistin), and 64% (resistin, 80 mg/mL) (P < 0.05). The natural antioxidant Ginkgolide A effectively inhibited resistin-induced increase in permeability and the increase in superoxide anion production in HCAECs. Furthermore, resistin treatment significantly activated p38 MAPK, but not ERK1/2. Pretreatment of HCAECs with a p38 inhibitor effectively blocked resistin-induced permeability. These results provide new evidence that resistin may contribute to the vascular lesion formation via increasing endothelial permeability through the mechanism of oxidative stress and the activation of p38 MAPK.	[Jamaluddin, Md Saha; Yan, Shaoyu; Lu, Jianming; Liang, Zhengdong; Yao, Qizhi; Chen, Changyi] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Mol Surg Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Chen, CY (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Div Surg Res, Mol Surg Res Ctr, Houston, TX 77030 USA.	jchen@bcm.tmc.edu			Baylor College of Medicine, Houston, Texas; National Institutes of Health [T32HL083774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083774] Funding Source: NIH RePORTER	Baylor College of Medicine, Houston, Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Baylor College of Medicine, Houston, Texas. ZL was supported by a grant from National Institutes of Health (T32HL083774). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amerongen GPV, 2002, VASC PHARMACOL, V39, P257, DOI 10.1016/S1537-1891(03)00014-4; Antonetti DA, 2002, J NEUROCHEM, V80, P667, DOI 10.1046/j.0022-3042.2001.00740.x; Baldwin AL, 1998, AM J PHYSIOL-HEART C, V274, pH1776, DOI 10.1152/ajpheart.1998.274.5.H1776; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; Chen CY, 2005, BIOCHEM BIOPH RES CO, V335, P874, DOI 10.1016/j.bbrc.2005.07.155; Chen J, 2008, MOL BIOL CELL, V19, P3701, DOI 10.1091/mbc.E08-02-0175; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Fang C, 2013, CHINESE MED J-PEKING, V126, P646, DOI 10.3760/cma.j.issn.0366-6999.20120970; Force T, 1996, CIRC RES, V78, P947, DOI 10.1161/01.RES.78.6.947; Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hoefen RJ, 2002, VASC PHARMACOL, V38, P271, DOI 10.1016/S1537-1891(02)00251-3; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Huang H, 2004, MOL PHARMACOL, V66, P302, DOI 10.1124/mol.66.2.302; Jamaluddin MS, 2010, ATHEROSCLEROSIS, V208, P104, DOI 10.1016/j.atherosclerosis.2009.07.029; Jamaluddin MS, 2009, ARTERIOSCL THROM VAS, V29, P2146, DOI 10.1161/ATVBAHA.109.194134; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255; Krouwer VJD, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-12; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009; Laudes M, 2010, HORM METAB RES, V42, P268, DOI 10.1055/s-0029-1243638; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald DM, 2002, CANCER RES, V62, P5381; Menzaghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064729; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Ohmori R, 2005, J AM COLL CARDIOL, V46, P379, DOI 10.1016/j.jacc.2005.04.022; Pacquelet S, 2007, BIOCHEM J, V403, P451, DOI 10.1042/BJ20061184; Pai AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049209; Pang L, 2013, INT J MOL SCI, V14, P9751, DOI 10.3390/ijms14059751; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Runkle EA, 2013, CANCER LETT, V337, P41, DOI 10.1016/j.canlet.2013.05.038; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Steinberg D, 1997, ATHEROSCLEROSIS, V131, pS5, DOI 10.1016/S0021-9150(97)06115-7; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Sudo T, 2005, BIOCHEM BIOPH RES CO, V337, P415, DOI 10.1016/j.bbrc.2005.09.063; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tapryal N, 2009, J BIOL CHEM, V284, P1873, DOI 10.1074/jbc.M804079200; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Tsiotra PC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/487081; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Wu TH, 2013, TRANSL RES, V162, P45, DOI 10.1016/j.trsl.2013.03.005; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yan SY, 2006, SURGERY, V140, P243, DOI 10.1016/j.surg.2006.04.001; Yan SY, 2005, SURGERY, V138, P464, DOI 10.1016/j.surg.2005.06.027; Yoshizumi M, 2012, J PHARMACOL SCI, V120, P259, DOI 10.1254/jphs.12R11CP; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105	76	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84576	10.1371/journal.pone.0084576	http://dx.doi.org/10.1371/journal.pone.0084576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386395	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900101
J	Kadlcik, S; Kucera, T; Chalupska, D; Gazak, R; Koberska, M; Ulanova, D; Kopecky, J; Kutejova, E; Najmanova, L; Janata, J				Kadlcik, Stanislav; Kucera, Tomas; Chalupska, Dominika; Gazak, Radek; Koberska, Marketa; Ulanova, Dana; Kopecky, Jan; Kutejova, Eva; Najmanova, Lucie; Janata, Jiri			Adaptation of an L-Proline Adenylation Domain to Use 4-Propyl-L-Proline in the Evolution of Lincosamide Biosynthesis	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; GENE-CLUSTER; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; POLYKETIDE SYNTHASE; THIOESTERASE DOMAIN; NUCLEOTIDE-SEQUENCE; ANATOXIN-A; CLONING	Clinically used lincosamide antibiotic lincomycin incorporates in its structure 4-propyl-L-proline (PPL), an unusual amino acid, while celesticetin, a less efficient related compound, makes use of proteinogenic L-proline. Biochemical characterization, as well as phylogenetic analysis and homology modelling combined with the molecular dynamics simulation were employed for complex comparative analysis of the orthologous protein pair LmbC and CcbC from the biosynthesis of lincomycin and celesticetin, respectively. The analysis proved the compared proteins to be the standalone adenylation domains strictly preferring their own natural substrate, PPL or L-proline. The LmbC substrate binding pocket is adapted to accomodate a rare PPL precursor. When compared with L-proline specific ones, several large amino acid residues were replaced by smaller ones opening a channel which allowed the alkyl side chain of PPL to be accommodated. One of the most important differences, that of the residue corresponding to V306 in CcbC changing to G308 in LmbC, was investigated in vitro and in silico. Moreover, the substrate binding pocket rearrangement also allowed LmbC to effectively adenylate 4-butyl-L-proline and 4-pentyl-L-proline, substrates with even longer alkyl side chains, producing more potent lincosamides. A shift of LmbC substrate specificity appears to be an integral part of biosynthetic pathway adaptation to the PPL acquisition. A set of genes presumably coding for the PPL biosynthesis is present in the lincomycin - but not in the celesticetin cluster; their homologs are found in biosynthetic clusters of some pyrrolobenzodiazepines (PBD) and hormaomycin. Whereas in the PBD and hormaomycin pathways the arising precursors are condensed to another amino acid moiety, the LmbC protein is the first functionally proved part of a unique condensation enzyme connecting PPL to the specialized amino sugar building unit.	[Kadlcik, Stanislav; Kucera, Tomas; Chalupska, Dominika; Gazak, Radek; Koberska, Marketa; Ulanova, Dana; Kopecky, Jan; Kutejova, Eva; Najmanova, Lucie; Janata, Jiri] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Kutejova, Eva] Slovak Acad Sci, Inst Mol Biol, Dept Biochem & Struct Biol, Bratislava, Slovakia	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Slovak Academy of Sciences	Janata, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	janata@biomed.cas.cz	Kutejova, Eva/K-6550-2014; Najmanova, Lucie/H-3663-2014; Kadlčík, Stanislav/K-8851-2014; Janata, Jiri/K-4554-2014; Koběrská, Markéta/AAE-4877-2019; Kopecky, Jan/C-7400-2013; Gažák, Radek/H-2443-2014; Kutejova, Eva/AAI-2544-2021; Chalupska, Dominika/H-1369-2014	Kutejova, Eva/0000-0002-0973-679X; Najmanova, Lucie/0000-0003-0691-7250; Kadlčík, Stanislav/0000-0001-8989-7157; Janata, Jiri/0000-0002-4582-2062; Koběrská, Markéta/0000-0002-9787-4227; Kopecky, Jan/0000-0002-3437-257X; Gažák, Radek/0000-0003-3881-0327; Kutejova, Eva/0000-0002-0973-679X; 	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University [CZ.1.05/1.1.00/02.0109]; European Regional Development Fund in the Czech Republic	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University; European Regional Development Fund in the Czech Republic	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic projects CZ.1.07/2.3.00/20.0055 and CZ.1.07/2.3.00/30.0003 and BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University No. CZ. 1.05/1.1.00/02.0109, from the European Regional Development Fund in the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOUDELIS AD, 1965, BIOCHEMISTRY-US, V4, P698, DOI 10.1021/bi00880a014; Becker JE, 2004, GENE, V325, P35, DOI 10.1016/j.gene.2003.09.034; BRAHME NM, 1984, J AM CHEM SOC, V106, P7873, DOI 10.1021/ja00337a038; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; CHUNG ST, 1997, BIOTECHNOLOGY IND AN, P165; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Crusemann M, 2013, CHEM SCI, V4, P1041, DOI 10.1039/c2sc21722h; deCrecyLagard V, 1997, J BACTERIOL, V179, P705, DOI 10.1128/jb.179.3.705-713.1997; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Garneau S, 2005, BIOCHEMISTRY-US, V44, P2770, DOI 10.1021/bi0476329; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Hoffmann D, 2003, GENE, V311, P171, DOI 10.1016/S0378-1119(03)00587-0; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawasaki T, 2009, J ANTIBIOT, V62, P271, DOI 10.1038/ja.2009.27; Kim D, 2006, J MICROBIOL BIOTECHN, V16, P1912; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; Kopp M, 2011, MOL BIOSYST, V7, P1549, DOI 10.1039/c0mb00240b; Kurmayer R, 2005, MICROBIOL-SGM, V151, P1525, DOI 10.1099/mic.0.27779-0; Kyselkova M, 2010, ARCH MICROBIOL, V192, P195, DOI 10.1007/s00203-010-0545-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lautru S, 2004, MICROBIOL-SGM, V150, P1629, DOI 10.1099/mic.0.26837-0; Li CX, 2009, CHEMBIOCHEM, V10, P1064, DOI 10.1002/cbic.200800822; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Luesch H, 2003, J ORG CHEM, V68, P83, DOI 10.1021/jo026479q; Magerlein BJ, 1971, STRUCTURE ACTIVITY R, P600; Maharjan S, 2012, APPL MICROBIOL BIOT, V93, P687, DOI 10.1007/s00253-011-3567-x; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Meiser P, 2008, CHEM BIOL, V15, P771, DOI 10.1016/j.chembiol.2008.06.005; Mejean A, 2010, BIOCHEMISTRY-US, V49, P103, DOI 10.1021/bi9018785; Mejean A, 2009, J AM CHEM SOC, V131, P7512, DOI 10.1021/ja9024353; Milo R, 2012, SCIENCE, V336, P1663, DOI 10.1126/science.1217665; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Muller C, 2007, ANTIMICROB AGENTS CH, V51, P1028, DOI 10.1128/AAC.00942-06; Najmanova L, 2013, CHEMBIOCHEM, V14, P2259, DOI 10.1002/cbic.201300389; Neusser D, 1998, ARCH MICROBIOL, V169, P322, DOI 10.1007/s002030050578; Novotna J, 2004, EUR J BIOCHEM, V271, P3678, DOI 10.1111/j.1432-1033.2004.04308.x; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; PESCHKE U, 1995, MOL MICROBIOL, V16, P1137, DOI 10.1111/j.1365-2958.1995.tb02338.x; Pfennig F, 1999, J BIOL CHEM, V274, P12508, DOI 10.1074/jbc.274.18.12508; Pohle S, 2011, J AM CHEM SOC, V133, P6194, DOI 10.1021/ja108971p; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Popov AV, 2013, J COMPUT CHEM, V34, P319, DOI 10.1002/jcc.23135; Rantala-Ylinen A, 2011, APPL ENVIRON MICROB, V77, P7271, DOI 10.1128/AEM.06022-11; SAITO F, 1994, J BIOCHEM-TOKYO, V116, P357, DOI 10.1093/oxfordjournals.jbchem.a124532; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Scholz-Schroeder BK, 2003, MOL PLANT MICROBE IN, V16, P271, DOI 10.1094/MPMI.2003.16.4.271; Schrodinger L., 2020, PYMOL; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; Tsuge K, 1999, ANTIMICROB AGENTS CH, V43, P2183, DOI 10.1128/AAC.43.9.2183; Tsuge K, 2001, J BACTERIOL, V183, P6265, DOI 10.1128/JB.183.21.6265-6273.2001; Ulanova D, 2010, ANTIMICROB AGENTS CH, V54, P927, DOI 10.1128/AAC.00918-09; Wang Y, 2011, GENE, V483, P11, DOI 10.1016/j.gene.2011.05.005; Wang ZX, 2000, ANTIMICROB AGENTS CH, V44, P3040, DOI 10.1128/AAC.44.11.3040-3048.2000; Wenzel SC, 2005, CHEMBIOCHEM, V6, P375, DOI 10.1002/cbic.200400282; Wu QL, 2011, ANTIMICROB AGENTS CH, V55, P974, DOI 10.1128/AAC.01130-10; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zhang XJ, 2007, ANTIMICROB AGENTS CH, V51, P946, DOI 10.1128/AAC.01214-06	70	18	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84902	10.1371/journal.pone.0084902	http://dx.doi.org/10.1371/journal.pone.0084902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386435	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900118
J	Meyer, AN; Drafahl, KA; McAndrew, CW; Gilda, JE; Gallo, LH; Haas, M; Brill, LM; Donoghue, DJ				Meyer, April N.; Drafahl, Kristine A.; McAndrew, Christopher W.; Gilda, Jennifer E.; Gallo, Leandro H.; Haas, Martin; Brill, Laurence M.; Donoghue, Daniel J.			Tyrosine Phosphorylation Allows Integration of Multiple Signaling Inputs by IKK beta	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR-2; RHEUMATOID-ARTHRITIS; 2 FGFR2; KINASE; COMPLEX; ACTIVATION; MUTATIONS; ALPHA; CYTOKINE	Signaling regulated by NF kappa B and related transcription factors is centrally important to many inflammatory and autoimmune diseases, cancer, and stress responses. The kinase that directly regulates the canonical NF kappa B transcriptional pathway, Inhibitor of kappa B kinase beta (IKK beta), undergoes activation by Ser phosphorylation mediated by NIK or TAK1 in response to inflammatory signals. Using titanium dioxide-based phosphopeptide enrichment (TiO2)-liquid chromatography (LC)-high mass accuracy tandem mass spectrometry (MS/MS), we analyzed IKK beta phosphorylation in human HEK293 cells expressing IKK beta and FGFR2, a Receptor tyrosine kinase (RTK) essential for embryonic differentiation and dysregulated in several cancers. We attained unusually high coverage of IKK beta, identifying an abundant site of Tyr phosphorylation at Tyr169 within the Activation Loop. The phosphomimic at this site confers a level of kinase activation and NF kappa B nuclear localization exceeding the iconic mutant S177E/S181E, demonstrating that RTK-mediated Tyr phosphorylation of IKK beta has the potential to directly regulate NF kappa B transcriptional activation.	[Meyer, April N.; Drafahl, Kristine A.; McAndrew, Christopher W.; Gilda, Jennifer E.; Gallo, Leandro H.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Haas, Martin; Donoghue, Daniel J.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Brill, Laurence M.] Sanford Burnham Med Res Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Donoghue, DJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			University of California Cancer Research Coordinating Committee; UC San Diego Foundation	University of California Cancer Research Coordinating Committee(University of California System); UC San Diego Foundation	Financial support provided by the University of California Cancer Research Coordinating Committee and the UC San Diego Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2006, ANTICANCER RES, V26, P4235; Andreakos E, 2003, ARTHRITIS RHEUM, V48, P1901, DOI 10.1002/art.11044; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; [Anonymous], J BIOL CHEM, V277, P45129, DOI [10.1074/jbc.M205165200, DOI 10.1074/JBC.M205165200.]; Aupperle KR, 2001, J IMMUNOL, V166, P2705, DOI 10.4049/jimmunol.166.4.2705; Barisic S, 2010, BIOCHEM PHARMACOL, V80, P439, DOI 10.1016/j.bcp.2010.04.028; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drafahl KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014412; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; Henson ES, 2003, J CELL BIOCHEM, V89, P1177, DOI 10.1002/jcb.10597; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jang JH, 2001, CANCER RES, V61, P3541; Kao DD, 2013, MOL CELL BIOCH; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Li ZW, 2008, CURR OPIN HEMATOL, V15, P391, DOI 10.1097/MOH.0b013e328302c7f4; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu SH, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/651901; Locascio LE, 2013, TRENDS BIOCHEM SCI, V38, P75, DOI 10.1016/j.tibs.2012.12.001; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meyer AN, 2008, CANCER RES, V68, P7362, DOI 10.1158/0008-5472.CAN-08-0575; Naimi B, 2002, PROSTATE, V52, P245, DOI 10.1002/pros.10104; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PATI UK, 1992, GENE, V114, P285, DOI 10.1016/0378-1119(92)90589-H; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Ricol D, 1999, ONCOGENE, V18, P7234, DOI 10.1038/sj.onc.1203186; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Rudolph D, 2000, GENE DEV, V14, P854; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; TOBE BTD, 2012, CELL RESEARCH, V8, P16; Wei W, 2012, MOL CELL BIOL; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamaguchi H, 2013, ONCOGENE; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang YH, 2013, CALCIFIED TISSUE INT, V93, P78, DOI 10.1007/s00223-013-9735-5; Zhang YZ, 1999, GENE, V230, P69, DOI 10.1016/S0378-1119(99)00047-5	58	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84497	10.1371/journal.pone.0084497	http://dx.doi.org/10.1371/journal.pone.0084497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386391	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900100
J	Zhu, WQ; Chen, GS; Jiang, N; Liu, JH; Mou, MJ				Zhu, Wenquan; Chen, Guangsheng; Jiang, Nan; Liu, Jianhong; Mou, Minjie			Estimating Carbon Flux Phenology with Satellite-Derived Land Surface Phenology and Climate Drivers for Different Biomes: A Synthesis of AmeriFlux Observations	PLOS ONE			English	Article							GROWING-SEASON LENGTH; NET ECOSYSTEM PRODUCTIVITY; NDVI TIME-SERIES; DECIDUOUS FOREST; SPRING PHENOLOGY; INTERANNUAL VARIABILITY; WATER-VAPOR; VEGETATION; SEQUESTRATION; PHOTOSYNTHESIS	Carbon Flux Phenology (CFP) can affect the interannual variation in Net Ecosystem Exchange (NEE) of carbon between terrestrial ecosystems and the atmosphere. In this study, we proposed a methodology to estimate CFP metrics with satellite-derived Land Surface Phenology (LSP) metrics and climate drivers for 4 biomes (i.e., deciduous broadleaf forest, evergreen needleleaf forest, grasslands and croplands), using 159 site-years of NEE and climate data from 32 AmeriFlux sites and MODIS vegetation index time-series data. LSP metrics combined with optimal climate drivers can explain the variability in Start of Carbon Uptake (SCU) by more than 70% and End of Carbon Uptake (ECU) by more than 60%. The Root Mean Square Error (RMSE) of the estimations was within 8.5 days for both SCU and ECU. The estimation performance for this methodology was primarily dependent on the optimal combination of the LSP retrieval methods, the explanatory climate drivers, the biome types, and the specific CFP metric. This methodology has a potential for allowing extrapolation of CFP metrics for biomes with a distinct and detectable seasonal cycle over large areas, based on synoptic multi-temporal optical satellite data and climate data.	[Zhu, Wenquan] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Zhu, Wenquan; Jiang, Nan; Liu, Jianhong; Mou, Minjie] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Chen, Guangsheng] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	Beijing Normal University; Beijing Normal University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Zhu, WQ (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	zhuwq75@bnu.edu.cn	JIANG, NAN/HHN-3354-2022; Chen, Guangsheng/AAC-4462-2022; Liu, Jianhong/E-6312-2018	JIANG, NAN/0000-0001-5151-5715; Liu, Jianhong/0000-0002-8050-4780	National Natural Science Foundation of China [41371389]; State Key Laboratory of Earth Surface Processes and Resource Ecology [2013-ZY-14]; Fundamental Research Funds for the Central University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Earth Surface Processes and Resource Ecology; Fundamental Research Funds for the Central University	This work was supported by the National Natural Science Foundation of China (Grant No. 41371389), the State Key Laboratory of Earth Surface Processes and Resource Ecology (Grant No. 2013-ZY-14), and the Fundamental Research Funds for the Central University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi DD, 2005, INT J BIOMETEOROL, V49, P377, DOI 10.1007/s00484-005-0256-4; Baldocchi DD, 2001, ECOL MODEL, V142, P155, DOI 10.1016/S0304-3800(01)00287-3; Beck PSA, 2006, REMOTE SENS ENVIRON, V100, P321, DOI 10.1016/j.rse.2005.10.021; Bergeron O, 2007, GLOBAL CHANGE BIOL, V13, P89, DOI 10.1111/j.1365-2486.2006.01281.x; Black TA, 2000, GEOPHYS RES LETT, V27, P1271, DOI 10.1029/1999GL011234; Campbell JB., 2007, INTRO REMOTE SENSING; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Chen WJ, 1999, GLOBAL CHANGE BIOL, V5, P41, DOI 10.1046/j.1365-2486.1998.00201.x; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cong N, 2013, GLOBAL CHANGE BIOL, V19, P881, DOI 10.1111/gcb.12077; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; FISCHER A, 1994, REMOTE SENS ENVIRON, V48, P220, DOI 10.1016/0034-4257(94)90143-0; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Gonsamo A, 2012, AGR FOREST METEOROL, V165, P127, DOI 10.1016/j.agrformet.2012.06.006; Gonsamo A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002070; Hird JN, 2009, REMOTE SENS ENVIRON, V113, P248, DOI 10.1016/j.rse.2008.09.003; HOLBEN B, 1984, INT J REMOTE SENS, V5, P145, DOI 10.1080/01431168408948795; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; Kobayashi H, 2005, REMOTE SENS ENVIRON, V97, P519, DOI 10.1016/j.rse.2005.06.007; KRAMER K, 1995, CLIMATE RES, V5, P119, DOI 10.3354/cr005119; Lindroth A, 2008, TELLUS B, V60, P129, DOI 10.1111/j.1600-0889.2007.00330.x; LLOYD D, 1990, INT J REMOTE SENS, V11, P2269, DOI 10.1080/01431169008955174; Markon Carl J., 1995, Polar Record, V31, P179; MYNENI RB, 1995, REMOTE SENS ENVIRON, V51, P169, DOI 10.1016/0034-4257(94)00073-V; Peng Y, 2011, REMOTE SENS ENVIRON, V115, P978, DOI 10.1016/j.rse.2010.12.001; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Richardson AD, 2009, TREE PHYSIOL, V29, P321, DOI 10.1093/treephys/tpn040; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Tanja S, 2003, GLOBAL CHANGE BIOL, V9, P1410, DOI 10.1046/j.1365-2486.2003.00597.x; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; White MA, 2003, GLOBAL CHANGE BIOL, V9, P967, DOI 10.1046/j.1365-2486.2003.00585.x; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Wu CY, 2013, GLOBAL ECOL BIOGEOGR, V22, P994, DOI 10.1111/geb.12044; Wu CY, 2012, AGR FOREST METEOROL, V164, P29, DOI 10.1016/j.agrformet.2012.05.002; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021; Zhang WJ, 2011, BIOGEOSCIENCES, V8, P1667, DOI 10.5194/bg-8-1667-2011; Zhang XY, 2004, GLOBAL CHANGE BIOL, V10, P1133, DOI 10.1111/j.1529-8817.2003.00784.x; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	48	12	13	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84990	10.1371/journal.pone.0084990	http://dx.doi.org/10.1371/journal.pone.0084990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386441	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900119
J	Leszczynski, M; Wykowska, A; Perez-Osorio, J; Muller, HJ				Leszczynski, Marcin; Wykowska, Agnieszka; Perez-Osorio, Jairo; Mueller, Hermann J.			Deployment of Spatial Attention towards Locations in Memory Representations. An EEG Study	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; ORIENTING ATTENTION; TARGETS; SEARCH; ACCESS	Recalling information from visual short-term memory (VSTM) involves the same neural mechanisms as attending to an actually perceived scene. In particular, retrieval from VSTM has been associated with orienting of visual attention towards a location within a spatially-organized memory representation. However, an open question concerns whether spatial attention is also recruited during VSTM retrieval even when performing the task does not require access to spatial coordinates of items in the memorized scene. The present study combined a visual search task with a modified, delayed central probe protocol, together with EEG analysis, to answer this question. We found a temporal contralateral negativity (TCN) elicited by a centrally presented go-signal which was spatially uninformative and featurally unrelated to the search target and informed participants only about a response key that they had to press to indicate a prepared target-present vs. absent decision. This lateralization during VSTM retrieval (TCN) provides strong evidence of a shift of attention towards the target location in the memory representation, which occurred despite the fact that the present task required no spatial (or featural) information from the search to be encoded, maintained, and retrieved to produce the correct response and that the go-signal did not itself specify any information relating to the location and defining feature of the target.	[Leszczynski, Marcin; Wykowska, Agnieszka; Perez-Osorio, Jairo; Mueller, Hermann J.] Univ Munich, Deptartment Psychol, Munich, Germany; [Leszczynski, Marcin] Univ Bonn, Dept Epileptol, Bonn, Germany; [Wykowska, Agnieszka] Tech Univ Munich, Inst Cognit Syst, D-80290 Munich, Germany; [Perez-Osorio, Jairo] LMU, Grad Sch Syst Neurosci, Munich, Germany; [Mueller, Hermann J.] Univ London Birkbeck Coll, London WC1E 7HX, England	University of Munich; University of Bonn; Technical University of Munich; University of Munich; University of London; Birkbeck University London	Leszczynski, M (corresponding author), Univ Munich, Deptartment Psychol, Munich, Germany.	leszczynski.marcin@gmail.com	Perez-Osorio, Jairo/X-9717-2019	Perez-Osorio, Jairo/0000-0003-0954-5704; Leszczynski, Marcin/0000-0003-3172-4661; Wykowska, Agnieszka/0000-0003-3323-7357				Astle DE, 2010, J NEUROSCI, V30, P3567, DOI 10.1523/JNEUROSCI.5701-09.2010; Awh E, 2000, J COGNITIVE NEUROSCI, V12, P840, DOI 10.1162/089892900562444; Chun MM, 1996, COGNITIVE PSYCHOL, V30, P39, DOI 10.1006/cogp.1996.0002; Dell'Acqua R, 2010, NEUROPSYCHOLOGIA, V48, P419, DOI 10.1016/j.neuropsychologia.2009.09.033; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2010, PSYCHOPHYSIOLOGY, V47, P197, DOI 10.1111/j.1469-8986.2009.00879.x; Fortier-Gauthier U, 2012, NEUROPSYCHOLOGIA, V50, P1748, DOI 10.1016/j.neuropsychologia.2012.03.032; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Kuo BC, 2009, J NEUROSCI, V29, P8032, DOI 10.1523/JNEUROSCI.0952-09.2009; Lepsien J, 2007, CEREB CORTEX, V17, P2072, DOI 10.1093/cercor/bhl116; Leszczynski M, 2012, J COGNITIVE NEUROSCI, V24, P653, DOI 10.1162/jocn_a_00102; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Nobre AC, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.004.2007; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447	20	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83856	10.1371/journal.pone.0083856	http://dx.doi.org/10.1371/journal.pone.0083856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386295	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000329116700083
J	Liu, JL; Zhang, XJ; Zhang, Z; Zhang, AH; Wang, W; Dong, JH				Liu, Jin Long; Zhang, Xue Jun; Zhang, Zhao; Zhang, An Hong; Wang, Wei; Dong, Jia Hong			Meta-Analysis: Prognostic Value of Survivin in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							RISK-FACTORS; EXPRESSION; APOPTOSIS; RESECTION; RECURRENCE; PROLIFERATION; BIOMARKERS	Background: The expression of survivin is a promising prognostic indicator for some carcinomas. However, evidence for the prognostic value of survivin with respect to survival in hepatocellular carcinoma remains controversial. Aim: To conduct a systematic review of studies evaluating survivin expression in hepatocellular carcinoma as a prognostic indicator. Methods: The relevant literature was searched using PubMed, EMBASE, and Chinese biomedicine databases, and two meta-analyses were performed. One studied the association between survivin expression and the overall survival of patients with hepatocellular carcinoma, whereas the other studied the association between survivin expression and disease-free survival. Studies were pooled, and summary hazard ratios (HRs) were calculated. Subgroup analyses were also conducted. Results: Fourteen eligible studies with a total of 890 patients were included in this study. Two meta-analyses were performed according to the different outcomes by which prognosis was valued. The combined HR of the overall survival studies was 2.33 (95% CI: 1.65-3.31). The combined HR of disease-free survival studies was 2.13 (95% CI: 1.65-2.75). These data appeared to be significant when stratified by detection method, the language of publication, and HR estimate. The heterogeneities were highly significant (I-2>50%) when subgroup analyses of overall survival rate were conducted, whereas little heterogeneity was found when subgroup analyses of disease-free survival rate were carried out. The positive expression of survivin in the cytoplasm was significantly correlated with poor prognosis in HCC (HR>1). Conclusions: This study showed that survivin expression was correlated with poor prognosis in patients with hepatocellular carcinoma, regardless whether they were assessed by overall survival or disease-free survival.	[Liu, Jin Long; Zhang, An Hong; Dong, Jia Hong] Chinese Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Liu, Jin Long; Zhang, Xue Jun; Zhang, Zhao] Chengde Med Coll, Affiliated Hosp, Dept Gen Surg 1, Chengde City, Peoples R China; [Wang, Wei] Peoples Liberat Army 252 Hosp, Dept Vasc Surg, Baoding City, Peoples R China	Chinese People's Liberation Army General Hospital; Chengde Medical University	Dong, JH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China.	dongjh301@163.com						Chang CH, 2004, ARCH SURG-CHICAGO, V139, P320, DOI 10.1001/archsurg.139.3.320; Chau GY, 2007, HISTOPATHOLOGY, V51, P204, DOI 10.1111/j.1365-2559.2007.02738.x; Chau Gar-Yang, 2003, Surg Oncol Clin N Am, V12, P25, DOI 10.1016/S1055-3207(02)00077-7; Chau GY, 2003, SURG ONCOL CLIN N AM, V12, pviii; Cho S, 2010, PATHOL INT, V60, P203, DOI 10.1111/j.1440-1827.2009.02507.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding W, 2010, CHIN GER J CLIN ONCO, V9, P628; Fields AC, 2004, MODERN PATHOL, V17, P1378, DOI 10.1038/modpathol.3800203; Guo RH, 2011, CHIN J CANC PREV TRE, V18, P1929; Guo RP, 2006, J CANCER RES CLIN, V132, P547, DOI 10.1007/s00432-006-0097-5; Guo Rong-ping, 2006, Zhonghua Wai Ke Za Zhi, V44, P1626; Hattori M, 2001, CANCER LETT, V169, P155, DOI 10.1016/S0304-3835(01)00499-2; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu W, 2009, MED INFORM MED SURG, V22, P1018; [胡伟 Hu Wei], 2010, [实用肿瘤杂志, Journal of Practical Oncology], V25, P263; Huang YH, 2000, WORLD J SURG, V24, P551, DOI 10.1007/s002689910090; Hui WT, 2008, J NANJING MED U, V22, P255; Ikeguchi M, 2002, DIAGN MOL PATHOL, V11, P33, DOI 10.1097/00019606-200203000-00007; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Jiang CY, 2010, CHINESE CLIN ONCOLOG, V15, P779; Kim BW, 2006, WORLD J GASTROENTERO, V12, P99, DOI 10.3748/wjg.v12.i1.99; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044764; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lin H, 2010, WORLD CHINESE J DIGE, V16, P1676; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071930; Morinaga S, 2004, ONCOL REP, V12, P1189; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Samuel T, 2005, CANCER RES, V65, P210; Srivatanakul Petcharin, 2004, Asian Pac J Cancer Prev, V5, P118; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tamm I, 1998, CANCER RES, V58, P5315; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Yang Y, 2011, MED ONCOL, V28, P796, DOI 10.1007/s12032-010-9519-y; Ye CP, 2007, WORLD J GASTROENTERO, V13, P6264, DOI 10.3748/wjg.13.6264; Zhang JB, 2008, CHINESE J CANCER RES, V20, P133, DOI 10.1007/S11670-008-0133-X; Zhang LQ, 2012, PLOS ONE, V7; [张雁瑞 ZHANG Yanrui], 2007, [中国病理生理杂志, Chinese Journal of Pathophysiology], V23, P2164; Zhu W, 2009, CHIN J CANC PREV TRE, V13, P1009	45	20	22	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83350	10.1371/journal.pone.0083350	http://dx.doi.org/10.1371/journal.pone.0083350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386184	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700044
J	Nicholas, LM; Morrison, JL; Rattanatray, L; Ozanne, SE; Kleemann, DO; Walker, SK; MacLaughlin, SM; Zhang, S; Martin-Gronert, MS; McMillen, IC				Nicholas, Lisa M.; Morrison, Janna L.; Rattanatray, Leewen; Ozanne, Susan E.; Kleemann, Dave O.; Walker, Simon K.; MacLaughlin, Severence M.; Zhang, Song; Martin-Gronert, Malgorzata S.; McMillen, Isabella C.			Differential Effects of Exposure to Maternal Obesity or Maternal Weight Loss during the Periconceptional Period in the Sheep on Insulin Signalling Molecules in Skeletal Muscle of the Offspring at 4 Months of Age	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DIET-INDUCED OBESITY; LOW-BIRTH-WEIGHT; GLUCOSE-TOLERANCE; YOUNG MEN; RESISTANCE; METABOLISM; GROWTH; LEADS; UNDERNUTRITION	Exposure to maternal obesity before and/or throughout pregnancy may increase the risk of obesity and insulin resistance in the offspring in childhood and adult life, therefore, resulting in its transmission into subsequent generations. We have previously shown that exposure to maternal obesity around the time of conception alone resulted in increased adiposity in female lambs. Changes in the abundance of insulin signalling molecules in skeletal muscle and adipose tissue precede the development of insulin resistance and type 2 diabetes. It is not clear, however, whether exposure to maternal obesity results in insulin resistance in her offspring as a consequence of the impact of increased adiposity on skeletal muscle or as a consequence of the programming of specific changes in the abundance of insulin signalling molecules in this tissue. We have used an embryo transfer model in the sheep to investigate the effects of exposure to either maternal obesity or to weight loss in normal and obese mothers preceding and for one week after conception on the expression and abundance of insulin signalling molecules in muscle in the offspring. We found that exposure to maternal obesity resulted in lower muscle GLUT-4 and Ser 9 phospho-GSK3 alpha and higher muscle GSK3 alpha abundance in lambs when compared to lambs conceived in normally nourished ewes. Exposure to maternal weight loss in normal or obese mothers, however, resulted in lower muscle IRS1, PI3K, p110 beta, aPKC zeta, Thr 642 phospho-AS160 and GLUT-4 abundance in the offspring. In conclusion, maternal obesity or weight loss around conception have each programmed specific changes on subsets of molecules in the insulin signalling, glucose transport and glycogen synthesis pathways in offspring. There is a need for a stronger evidence base to ensure that weight loss regimes in obese women seeking to become pregnant minimize the metabolic costs for the next generation.	[Nicholas, Lisa M.; Morrison, Janna L.; Rattanatray, Leewen; MacLaughlin, Severence M.; Zhang, Song; McMillen, Isabella C.] Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Rattanatray, Leewen] Univ Adelaide, Discipline Physiol, Sch Mol & Life Sci, Adelaide, SA, Australia; [Ozanne, Susan E.; Martin-Gronert, Malgorzata S.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 2QQ, England; [Kleemann, Dave O.; Walker, Simon K.] South Australian Res & Dev Inst, Turretfield Res Ctr, Rosedale, SA, Australia	University of South Australia; University of Adelaide; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; South Australian Research & Development Institute (SARDI)	McMillen, IC (corresponding author), Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	caroline.mcmillen@newcastle.edu.au	Morrison, Janna/B-8308-2009; McMillen, Isabella Caroline/N-5540-2019	Morrison, Janna/0000-0002-8602-8519; Ozanne, Susan/0000-0001-8753-5144; Nicholas, Lisa/0000-0003-1976-1953	National Health and Medical Research Council [631928]; South Australian Cardiovascular Research Network Fellowship [CR10A4988]; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); South Australian Cardiovascular Research Network Fellowship; British Heart Foundation(British Heart Foundation)	This work was funded by National Health and Medical Research Council Project, Grant 631928. JLM was funded by a South Australian Cardiovascular Research Network Fellowship (CR10A4988). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alderman G., 1993, ENERGY PROTEIN REQUI; Alkhateeb H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1056, DOI 10.1152/ajpendo.90908.2008; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; CAMPS M, 1992, BIOCHEM J, V282, P765, DOI 10.1042/bj2820765; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; de Rooij SR, 2006, DIABETES CARE, V29, P1897, DOI 10.2337/dc06-0460; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Farese RV, 2005, BIOCHEM SOC T, V33, P350, DOI 10.1042/BST0330350; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Forhead AJ, 2008, J PHYSIOL-LONDON, V586, P2393, DOI 10.1113/jphysiol.2007.149237; Greenfield JR, 2004, CLIN DERMATOL, V22, P289, DOI 10.1016/j.clindermatol.2004.01.011; Greenwood PL, 2000, REPROD FERT DEVELOP, V12, P149, DOI 10.1071/RD00053; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Kakar MA, 2005, THERIOGENOLOGY, V64, P1090, DOI 10.1016/j.theriogenology.2004.12.017; KERN M, 1990, BIOCHEM J, V270, P397, DOI 10.1042/bj2700397; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ozanne SE, 2006, DIABETOLOGIA, V49, P2993, DOI 10.1007/s00125-006-0466-2; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; PETTITT DJ, 1993, DIABETES CARE, V16, P310, DOI 10.2337/diacare.16.1.310; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Rattanatray L, 2010, ENDOCRINOLOGY, V151, P5195, DOI 10.1210/en.2010-0501; RUSSEL AJF, 1981, J AGR SCI, V97, P723, DOI 10.1017/S0021859600037096; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Silverman BL, 1998, DIABETES CARE, V21, pB142; Smith NA, 2010, ANIM REPROD SCI, V121, P94, DOI 10.1016/j.anireprosci.2010.05.001; *STAT ABO, 2007, AUSTR SOC TRENDS; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Todd SE, 2009, PEDIATR RES, V65, P409, DOI 10.1203/PDR.0b013e3181975efa; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Yan X, 2011, BIOL REPROD, V85, P172, DOI 10.1095/biolreprod.110.089649; Zhang S, 2011, PROG BIOPHYS MOL BIO, V106, P307, DOI 10.1016/j.pbiomolbio.2010.12.004; Zhang S, 2011, EXP DIABETES RES, DOI 10.1155/2011/585749; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	55	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84594	10.1371/journal.pone.0084594	http://dx.doi.org/10.1371/journal.pone.0084594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386400	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700111
J	Qu, JL; Li, X; Qu, XJ; Zhu, ZT; Zhou, LZ; Teng, YE; Zhang, JD; Jin, B; Zhao, MF; Yu, P; Liu, YP				Qu, Jing-lei; Li, Xin; Qu, Xiu-juan; Zhu, Zhi-tu; Zhou, Li-zhong; Teng, Yue-e; Zhang, Jing-dong; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Liu, Yun-peng			Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer	PLOS ONE			English	Article							LYMPH-NODE DISSECTION; PHASE-III TRIAL; STAGE-II; SURGERY; CAPECITABINE; OXALIPLATIN; PACLITAXEL; SURVIVAL; BENEFIT; CYCLES	Background: Although several clinical trials have suggested that postoperative adjuvant chemotherapy can improve survival of patients with gastric cancer, the optimal treatment duration has not been studied. This retrospective analysis evaluated the outcomes of patients with gastric cancer treated with six cycles of fluorouracil-based treatment compared with a cohort treated with four or eight cycles. Methods: We retrospectively identified 237 patients with stage IB-IIIC gastric cancer who received four, six, or eight cycles of fluorouracil-based adjuvant chemotherapy administered every 3 weeks after radical gastrectomy. The endpoint was overall survival (OS). Factors associated with prognosis were also analyzed. Results: The estimated 3-year OS rates for the four-, six-, and eight-cycle cohorts were 54.4%, 76.1%, and 68.9%, respectively; and the estimated 5-year OS rates were 41.2%, 74.0%, and 65.8%, respectively. Patients who received six cycles were more likely to have a better OS than those who received four cycles (P = 0.002). Eight cycles failed to show an additional survival benefit (P = 0.454). In the multivariate analysis, the number of chemotherapy cycles was associated with OS independent of clinical covariates (P<0.05). Subgroup analysis suggested that among patients in all age groups examined, male patients, and subgroups of fluorouracil plus oxaliplatin combined chemotherapy, stage III, poor differentiation, and gastrectomy with D2 lymphadenectomy, six cycles of adjuvant chemotherapy were associated with a statistically significant benefit of OS compared with four cycles (P<0.05). Conclusions: Six cycles of adjuvant chemotherapy might lead to a favorable outcome for patients with gastric cancer, and two further cycles could not provide an additional clinical benefit.	[Qu, Jing-lei; Li, Xin; Qu, Xiu-juan; Teng, Yue-e; Zhang, Jing-dong; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Liu, Yun-peng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China; [Zhu, Zhi-tu] Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China; [Zhou, Li-zhong] Fourth Hosp Anshan, Dept Med Oncol, Anshan, Peoples R China	China Medical University; Jinzhou Medical University	Qu, XJ (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China.	qu_xiujuan@hotmail.com; cmuliuyunpeng@hotmail.com	Zhang, Jing/HII-4294-2022; Zhang, Jing/GWZ-7332-2022		National Natural Science Foundation of China [31000607, 81172369]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2013JX09303002]; Program for Liaoning Excellent Talents in University, LNET [LJQ2011082]; Key Laboratory Project of Liaoning Provincial Education Department [LS2010169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Program for Liaoning Excellent Talents in University, LNET; Key Laboratory Project of Liaoning Provincial Education Department	This study was supported by the National Natural Science Foundation of China (No. 31000607, NO. 81172369), National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2013JX09303002), Program for Liaoning Excellent Talents in University, LNET (No. LJQ2011082), and The Key Laboratory Project of Liaoning Provincial Education Department (No. LS2010169). No conflict of interest to be declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2012, GASTRIC CANCER, V15, P76, DOI 10.1007/s10120-011-0068-7; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bennett BK, 2012, SUPPORT CARE CANCER, V20, P2959, DOI 10.1007/s00520-012-1428-5; Chansky K, 2005, CANCER-AM CANCER SOC, V103, P1165, DOI 10.1002/cncr.20878; Chen S, 2011, AM J CLIN ONCOL-CANC, V34, P309, DOI 10.1097/COC.0b013e3181dea94e; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Des Guetz G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007046.pub2; Dikken JL, 2010, J CLIN ONCOL, V28, P2430, DOI 10.1200/JCO.2009.26.9654; Dizon DS, 2006, GYNECOL ONCOL, V100, P417, DOI 10.1016/j.ygyno.2005.10.031; Edge SB, 2009, AM JOINT COMMITTEE C; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053149; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Muratore A, 2009, EJSO-EUR J SURG ONC, V35, P588, DOI 10.1016/j.ejso.2008.12.012; Neugut AI, 2006, J CLIN ONCOL, V24, P2368, DOI 10.1200/JCO.2005.04.5005; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Rougier P, 2011, ANN ONCOL, V22, pv14; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shulman LN, 2012, J CLIN ONCOL, V30, P4071, DOI 10.1200/JCO.2011.40.6405; Socinski MA, 2007, J CLIN ONCOL, V25, P5155, DOI 10.1200/JCO.2007.13.4015; Van Cutsem E, 2011, ANN ONCOL, V22, pv1, DOI 10.1093/annonc/mdr284	21	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83196	10.1371/journal.pone.0083196	http://dx.doi.org/10.1371/journal.pone.0083196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386161	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700035
J	Stenfors, CUD; Marklund, P; Hanson, LLM; Theorell, T; Nilsson, LG				Stenfors, Cecilia U. D.; Marklund, Petter; Hanson, Linda L. Magnusson; Theorell, Tores; Nilsson, Lars-Goran			Subjective Cognitive Complaints and the Role of Executive Cognitive Functioning in the Working Population: A Case-Control Study	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; PROSPECTIVE COHORT; NEURAL EVIDENCE; 3-STATE MODEL; STRESS; SPAN; ASSOCIATION; PERFORMANCE; DEPRESSION	Background: Cognitive functioning is important for managing work and life in general. However, subjective cognitive complaints (SCC), involving perceived difficulties with concentration, memory, decision making, and clear thinking are common in the general and working population and can be coupled with both lowered well-being and work ability. However, the relation between SCC and cognitive functioning across the adult age-span, and in the work force, is not clear as few population-based studies have been conducted on non-elderly adults. Thus, the present study aimed to test the relation between SCC and executive cognitive functioning in a population-based sample of employees. Methods: Participants were 233 employees with either high (cases) or low (controls) levels of SCC. Group differences in neuropsychological test performance on three common executive cognitive tests were analysed through a set of analyses of covariance tests, including relevant covariates. Results & Conclusions: In line with the a priori hypotheses, a high level of SCC was associated with significantly poorer executive cognitive performance on all three executive cognitive tests used, compared to controls with little SCC. Additionally, symptoms of depression, chronic stress and sleeping problems were found to play a role in the relations between SCC and executive cognitive functioning. No significant associations remained after adjusting for all these factors. The current findings contribute to an increased understanding of what characterizes SCC in the work force and may be used at different levels of prevention of-and intervention for SCC and related problems with executive cognitive functioning.	[Stenfors, Cecilia U. D.; Marklund, Petter; Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Stenfors, Cecilia U. D.; Hanson, Linda L. Magnusson; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Theorell, Tores] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Stockholm University; Stockholm University; Karolinska Institutet	Stenfors, CUD (corresponding author), Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.	cecilia.stenfors@psychology.su.se	Hanson, Linda L Magnusson/D-2435-2017	Hanson, Linda L Magnusson/0000-0002-2908-1903; Stenfors, Cecilia/0000-0002-8411-0666; Theorell, Tores/0000-0003-1956-7931	Swedish Council for Working Life and Social Research [2009-0764]; Afa Insurance [090283]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Afa Insurance	This research was supported by grants from the Swedish Council for Working Life and Social Research (LGN, CUDS: Dnr 2009-0764, http://www.fas.se/en/), and Afa Insurance (LGN, CUDS: Dnr 090283, http://www.afaforsakring.se/Andra-sprak/Engelska/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Akerstedt T, 2008, CHRONOBIOL INT, V25, P333, DOI 10.1080/07420520802113922; Andreotti C, 2013, ANXIETY STRESS COPIN, V26, P20, DOI 10.1080/10615806.2011.631526; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Compas BE, 2006, ANN NY ACAD SCI, V1094, P226, DOI 10.1196/annals.1376.024; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Braek DMJMSI, 2011, J ATTEN DISORD, V15, P46, DOI 10.1177/1087054709347260; Ekstedt M, 2005, J ADV NURS, V49, P59, DOI 10.1111/j.1365-2648.2004.03264.x; Elzinga BM, 2005, BEHAV NEUROSCI, V119, P98, DOI 10.1037/0735-7044.119.1.98; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Erk S, 2011, ARCH GEN PSYCHIAT, V68, P845, DOI 10.1001/archgenpsychiatry.2011.80; Forsakringskassan, 2013, SOC INS FIG 2013; Friedman NP, 2005, BEHAV RES METHODS, V37, P581, DOI 10.3758/BF03192728; Grossi G, 2005, J PSYCHOSOM RES, V59, P103, DOI 10.1016/j.jpsychores.2005.02.009; Hanson LLM, 2008, SCAND J PUBLIC HEALT, V36, P737, DOI 10.1177/1403494808090164; HANSON LLM, 2013, SCAND J PUBLIC HEALT, P82463; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jorm AF, 2004, PSYCHOL MED, V34, P1495, DOI 10.1017/S0033291704003162; Jorm AF, 2001, PSYCHOL MED, V31, P441, DOI 10.1017/S0033291701003245; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; KECKLUND G, 1992, J SLEEP RES, V1, P30, DOI 10.1111/j.1365-2869.1992.tb00005.x; Kompier MAJ, 2006, SCAND J WORK ENV HEA, V32, P421, DOI 10.5271/sjweh.1048; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; LEINEWEBER C, 2012, EUR J PUBLIC HLTH; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Murrough JW, 2011, NEUROBIOL LEARN MEM, V96, P553, DOI 10.1016/j.nlm.2011.06.006; Nee DE, 2013, NEUROIMAGE, V74, P1, DOI 10.1016/j.neuroimage.2013.02.019; Nee DE, 2011, NEUROIMAGE, V54, P1540, DOI 10.1016/j.neuroimage.2010.09.002; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Oberauer K., 2007, VARIATION WORKING ME, P49, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0003; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Oztekin I, 2010, PSYCHOL SCI, V21, P1123, DOI 10.1177/0956797610376651; Oztekin I, 2009, J COGNITIVE NEUROSCI, V21, P581, DOI 10.1162/jocn.2008.21016; Ohman L, 2007, SCAND J WORK ENV HEA, V33, P223; Olsen LR, 2003, PSYCHOL MED, V33, P351, DOI 10.1017/S0033291702006724; Oosterholt BG, 2012, SCAND J WORK ENV HEA, V38, P358, DOI 10.5271/sjweh.3256; Osterberg K, 2012, STRESS; Poch C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00036; Podewils LJ, 2003, PSYCHOSOMATICS, V44, P461, DOI 10.1176/appi.psy.44.6.461; Ponds RWHM, 1997, INT J AGING HUM DEV, V45, P207, DOI 10.2190/MVQ1-WB58-875H-Y4X0; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Reid M, 2012, J CLIN EPIDEMIOL, V65, P199, DOI 10.1016/j.jclinepi.2011.06.006; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; de Leon JMRS, 2010, REV NEUROLOGIA, V51, P650, DOI 10.33588/rn.5111.2010270; Sandstrom A, 2005, BIOL PSYCHOL, V69, P271, DOI 10.1016/j.biopsycho.2004.08.003; Sandstrom A, 2011, SCAND J PSYCHOL, V52, P71, DOI 10.1111/j.1467-9450.2010.00844.x; Schaufeli W., 1998, BURNOUT COMPANION ST; Scheef L, 2012, NEUROLOGY, V79, P1332, DOI 10.1212/WNL.0b013e31826c1a8d; Schmidt IW, 2001, PERCEPT MOTOR SKILL, V93, P761, DOI 10.2466/PMS.93.7.761-776; Schmiedek F, 2009, J EXP PSYCHOL LEARN, V35, P1089, DOI 10.1037/a0015730; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schoofs D, 2009, BEHAV NEUROSCI, V123, P1066, DOI 10.1037/a0016980; SETTERLIND S, 1995, STRESS MEDICINE, V11, P85, DOI 10.1002/smi.2460110116; Slebus FG, 2008, OCCUP MED-OXFORD, V58, P475, DOI 10.1093/occmed/kqn091; Stenfors CUD, 2013, PLOS ONE, V8; Stewart R, 2012, CURR OPIN PSYCHIATR, V25, P445, DOI 10.1097/YCO.0b013e3283586fd8; Striepens N, 2010, DEMENT GERIATR COGN, V29, P75, DOI 10.1159/000264630; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Trouton A, 2006, J AM GERIATR SOC, V54, P1108, DOI 10.1111/j.1532-5415.2006.00800.x; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Vestergren P, 2011, APPL COGNITIVE PSYCH, V25, P641, DOI 10.1002/acp.1734; VINGARD E, 2001, HALLBAR ARBETSHALSA; Wild-Wall N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00186; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	76	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83351	10.1371/journal.pone.0083351	http://dx.doi.org/10.1371/journal.pone.0083351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386185	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700045
J	Waller, BM; Peirce, K; Caeiro, CC; Scheider, L; Burrows, AM; McCune, S; Kaminski, J				Waller, Bridget M.; Peirce, Kate; Caeiro, Catia C.; Scheider, Linda; Burrows, Anne M.; McCune, Sandra; Kaminski, Juliane			Paedomorphic Facial Expressions Give Dogs a Selective Advantage	PLOS ONE			English	Article							MOVEMENT CODING SYSTEM; TEDDY BEAR; EVOLUTION; INFANT; DOMESTICATION; PREFERENCES; PERCEPTION; MORPHOLOGY; CUTENESS; FEATURES	How wolves were first domesticated is unknown. One hypothesis suggests that wolves underwent a process of self-domestication by tolerating human presence and taking advantage of scavenging possibilities. The puppy-like physical and behavioural traits seen in dogs are thought to have evolved later, as a byproduct of selection against aggression. Using speed of selection from rehoming shelters as a proxy for artificial selection, we tested whether paedomorphic features give dogs a selective advantage in their current environment. Dogs who exhibited facial expressions that enhance their neonatal appearance were preferentially selected by humans. Thus, early domestication of wolves may have occurred not only as wolf populations became tamer, but also as they exploited human preferences for paedomorphic characteristics. These findings, therefore, add to our understanding of early dog domestication as a complex co-evolutionary process.	[Waller, Bridget M.; Peirce, Kate; Caeiro, Catia C.; Kaminski, Juliane] Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England; [Scheider, Linda] Free Univ Berlin, Dept Psychol, Berlin, Germany; [Burrows, Anne M.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Burrows, Anne M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [McCune, Sandra] WALTHAM, Ctr Pet Nutr, Waltham, Leics, England	University of Portsmouth; Free University of Berlin; Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mars; WALTHAM Petcare Science Institute	Waller, BM (corresponding author), Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England.	bridget.waller@port.ac.uk	Burrows, Anne M/AAP-3577-2021	Burrows, Anne M/0000-0002-9952-8125; Waller, Bridget/0000-0001-6303-7458; Kaminski, Juliane/0000-0002-3437-3484	WALTHAM Foundation	WALTHAM Foundation	The study was funded by a WALTHAM Foundation Research Grant to BMW, JK and AB. The funder had some input during study design, but did not influence study findings, interpretation of results or writing of the manuscript. The funder had some input during study design, but did not influence study findings, interpretation of results or writing of the manuscript.	Archer J, 2011, ETHOLOGY, V117, P217, DOI 10.1111/j.1439-0310.2010.01863.x; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Caeiro CC, 2013, INT J PRIMATOL, V34, P115, DOI 10.1007/s10764-012-9652-x; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Clutton-Brock Juliet, 1995, P7; Coppinger R., 2001, DOGS STARTLING NEW U; Druzhkova AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057754; Ekman P., 2002, MANUAL INVESTIGATORS; Evans H.E., 1993, MILLERS ANATOMY DOG; Feddersen-Petersen D, 1995, AUSDRUCKSVERHALTEN B; Francey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037397; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; HINDE RA, 1985, ANIM BEHAV, V33, P1371, DOI 10.1016/S0003-3472(85)80205-0; King T, 2012, APPL ANIM BEHAV SCI, V137, P1, DOI 10.1016/j.applanim.2011.11.016; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Little AC, 2012, ETHOLOGY, V118, P775, DOI 10.1111/j.1439-0310.2012.02068.x; McComb K, 2009, CURR BIOL, V19, pR507, DOI 10.1016/j.cub.2009.05.033; Morris PH, 1995, ANIM BEHAV, V50, P1697, DOI 10.1016/0003-3472(95)80022-0; Parr LA, 2010, AM J PHYS ANTHROPOL, V143, P625, DOI 10.1002/ajpa.21401; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Trut L. N., 2001, GENETICS DOG; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; Waller BM, 2007, J COMP PSYCHOL, V121, P398, DOI 10.1037/0735-7036.121.4.398; Waller BM, 2012, INT J PRIMATOL, V33, P809, DOI 10.1007/s10764-012-9611-6; Zeuner F. E., 1967, GESCH HAUSTIERE	29	88	90	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82686	10.1371/journal.pone.0082686	http://dx.doi.org/10.1371/journal.pone.0082686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386109	Green Accepted, Green Published, gold			2022-12-27	WOS:000329116700012
J	Fjaer, S; Bo, L; Lundervold, A; Myhr, KM; Pavlin, T; Torkildsen, O; Wergeland, S				Fjaer, Sveinung; Bo, Lars; Lundervold, Arvid; Myhr, Kjell-Morten; Pavlin, Tina; Torkildsen, Oivind; Wergeland, Stig			Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio in the Cuprizone Model	PLOS ONE			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; CORTICAL LESION DETECTION; WHITE-MATTER; TRANSFER MRI; GREY-MATTER; MS; BRAIN; REMYELINATION; PATHOLOGY	In multiple sclerosis (MS), the correlation between lesion load on conventional magnetic resonance imaging (MRI) and clinical disability is weak. This clinico-radiological paradox might partly be due to the low sensitivity of conventional MRI to detect gray matter demyelination. Magnetization transfer ratio (MTR) has previously been shown to detect white matter demyelination in mice. In this study, we investigated whether MTR can detect gray matter demyelination in cuprizone exposed mice. A total of 54 female C57BL/6 mice were split into one control group () and eight cuprizone exposed groups (N-S = 6). The mice were exposed to 0.2% (w/w) cuprizone for up to six weeks. MTR images were obtained at a 7 Tesla Bruker MR-scanner before cuprizone exposure, weekly for six weeks during cuprizone exposure, and once two weeks after termination of cuprizone exposure. Immunohistochemistry staining for myelin (anti-Proteolopid Protein) and oligodendrocytes (anti-Neurite Outgrowth Inhibitor Protein A) was obtained after each weekly scanning. Rates of MTR change and correlations between MTR values and histological findings were calculated in five brain regions. In the corpus callosum and the deep gray matter a significant rate of MTR value decrease was found, 0.96% per week (p<.0001) and 0.39% per week (p<.0001) respectively. The MTR values correlated to myelin loss as evaluated by immunohistochemistry (Corpus callosum: R-2 = (.)43, p<0001. Deep gray matter: R-2 = .21, p<.001), but did not correlate to oligodendrocyte density. Significant results were not found in the cerebellum, the olfactory bulb or the cerebral cortex. This study shows that MTR can be used to detect demyelination in the deep gray matter, which is of particular interest for imaging of patients with MS, as deep gray matter demyelination is common in MS, and is not easily detected on conventional clinical MRI.	[Fjaer, Sveinung; Bo, Lars; Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Fjaer, Sveinung; Bo, Lars; Myhr, Kjell-Morten; Torkildsen, Oivind; Wergeland, Stig] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Lundervold, Arvid] Univ Bergen, Neuroinformat & Image Anal Lab, Dept Biomed, Bergen, Norway; [Pavlin, Tina] Univ Bergen, Mol Imaging Ctr, Dept Biomed, Bergen, Norway; [Lundervold, Arvid; Pavlin, Tina] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Fjaer, S (corresponding author), Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway.	sveinung@fjaer.com	Myhr, Kjell-Morten/H-1528-2018; Torkildsen, Øivind/A-1606-2008	Myhr, Kjell-Morten/0000-0002-0980-510X; Torkildsen, Øivind/0000-0001-5294-2866				Agosta F, 2006, BRAIN, V129, P2620, DOI 10.1093/brain/awl208; Aharoni R, 2012, EXPT NEUROLOGY; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Chen JTH, 2013, NEUROLOGY, V80, P246, DOI 10.1212/WNL.0b013e31827deb99; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Dehmeshki J, 2003, J NEUROL, V250, P67, DOI 10.1007/s00415-003-0955-x; Deloire-Grassin MSA, 2000, J NEUROL SCI, V178, P10, DOI 10.1016/S0022-510X(00)00331-2; Dousset V, 1998, NEUROLOGY, V51, P1150, DOI 10.1212/WNL.51.4.1150; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Filippi M, 1998, J NEUROL SCI, V159, P162, DOI 10.1016/S0022-510X(98)00162-2; FILIPPI M, 1995, NEUROLOGY, V45, P478, DOI 10.1212/WNL.45.3.478; Filippi M, 1999, NEUROLOGY, V52, P588, DOI 10.1212/WNL.52.3.588; Filippi M, 2013, NEUROLOGY; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Geurts JJG, 2008, J NEUROL, V255, P183, DOI 10.1007/s00415-008-0620-5; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Hackmack K, 2012, J NEUROL, V259, P2151, DOI 10.1007/s00415-012-6475-9; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; Nijeholt GJLA, 2001, BRAIN, V124, P154, DOI 10.1093/brain/124.1.154; Rausch M, 2009, MULT SCLER, V15, P16, DOI 10.1177/1352458508096006; Rocca MA, 1999, AM J NEURORADIOL, V20, P821; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Sharma J, 2006, J NEUROIMAGING, V16, P302, DOI 10.1111/j.1552-6569.2006.00054.x; Thiessen JD, 2013, NMR BIOMED, V26, P1562, DOI 10.1002/nbm.2992; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Vrenken H, 2007, MULT SCLER, V13, P708, DOI 10.1177/1352458506075521; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Wergeland S, 2012, APMIS, V120, P648, DOI 10.1111/j.1600-0463.2012.02882.x; Wergeland S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026262; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3	36	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84162	10.1371/journal.pone.0084162	http://dx.doi.org/10.1371/journal.pone.0084162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386344	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700094
J	Gao, RM; Wan, ZY; Wong, SM				Gao, Ruimin; Wan, Zi Yi; Wong, Sek-Man			Plant Growth Retardation and Conserved miRNAs Are Correlated to Hibiscus Chlorotic Ringspot Virus Infection	PLOS ONE			English	Article							SMALL RNAS; MICRORNA; EXPRESSION; CARMOVIRUS; TARGETS; ROLES	Virus infection may cause a multiplicity of symptoms in their host including discoloration, distortion and growth retardation. Hibiscus chlorotic ringspot virus (HCRSV) infection was studied using kenaf (Hibiscus cannabinus L.), a non-wood fiber-producing crop in this study. Infection by HCRSV reduced the fiber yield and concomitant economic value of kenaf. We investigated kenaf growth retardation and fluctuations of four selected miRNAs after HCRSV infection. Vegetative growth (including plant height, leaf size and root development) was severely retarded. From the transverse and radial sections of the mock and HCRSV-infected kenaf stem, the vascular bundles of HCRSV-infected plants were severely disrupted. In addition, four conserved plant developmental and defence related microRNAs (miRNAs) (miR165, miR167, miR168 and miR171) and their respective target genes phabulosa (PHB), auxin response factor 8 (ARF8), argonaute 1 (AGO1) and scarecrow-like protein 1 (SCL1) displayed variation in expression levels after HCRSV infection. Compared with the mock inoculated kenaf plants, miR171 and miR168 and their targets SCL1 and AGO1 showed greater fluctuations after HCRSV infection. As HCRSV upregulates plant SO transcript in kenaf and upregulated AGO1 in HCRSV-infected plants, the expression level of AGO1 transcript was further investigated under sulfite oxidase (SO) overexpression or silencing condition. Interestingly, the four selected miRNAs were also up-or down-regulated upon overexpression or silencing of SO. Plant growth retardation and fluctuation of four conserved miRNAs are correlated to HCRSV infection.	[Gao, Ruimin; Wan, Zi Yi; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wong, Sek-Man] Temasek Life Sci Lab, Singapore, Singapore; [Wong, Sek-Man] Natl Univ Singapore, Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China	National University of Singapore; National University of Singapore	Wong, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg			National University of Singapore [R-154-000-552-112]	National University of Singapore(National University of Singapore)	This work was supported by the National University of Singapore research grant R-154-000-552-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brunt AA, 2000, PLANT PATHOL, V49, P798, DOI 10.1046/j.1365-3059.2000.00501.x; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Gao RM, 2012, MOL PLANT MICROBE IN, V25, P1574, DOI 10.1094/MPMI-08-12-0203-R; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Huang M, 2000, J VIROL, V74, P3149, DOI 10.1128/JVI.74.7.3149-3155.2000; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Li SC, 2002, PLANT PATHOL, V51, P803, DOI 10.1046/j.1365-3059.2002.00775.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu YD, 2008, PLANT CELL REP, V27, P1571, DOI 10.1007/s00299-008-0584-z; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Shimura H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002021; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Tang J, 2008, PLANT DIS, V92, P1367, DOI 10.1094/PDIS-92-9-1367A; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; WATERWORTH HE, 1976, PHYTOPATHOLOGY, V66, P570, DOI 10.1094/Phyto-66-570; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang JG, 2008, GENE, V423, P1, DOI 10.1016/j.gene.2008.05.023; Zhang X, 2009, J GEN VIROL, V90, P3042, DOI 10.1099/vir.0.012112-0; Zhou T, 2006, MOL PLANT MICROBE IN, V19, P948, DOI 10.1094/MPMI-19-0948	32	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85476	10.1371/journal.pone.0085476	http://dx.doi.org/10.1371/journal.pone.0085476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386476	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700137
J	Snowden, JN; Beaver, M; Beenken, K; Smeltzer, M; Horswill, AR; Kielian, T				Snowden, Jessica N.; Beaver, Matt; Beenken, Karen; Smeltzer, Mark; Horswill, Alexander R.; Kielian, Tammy			Staphylococcus aureus sarA Regulates Inflammation and Colonization during Central Nervous System Biofilm Formation	PLOS ONE			English	Article							EXPERIMENTAL BRAIN ABSCESSES; IMMUNE-RESPONSE; RISK-FACTORS; AGR; EPIDERMIDIS; INFECTIONS; STRAIN; ACTIVATION; VIRULENCE; MUTANTS	Infection is a frequent and serious complication following the treatment of hydrocephalus with CSF shunts, with limited therapeutic options because of biofilm formation along the catheter surface. Here we evaluated the possibility that the sarA regulatory locus engenders S. aureus more resistant to immune recognition in the central nervous system (CNS) based on its reported ability to regulate biofilm formation. We utilized our established model of CNS catheter-associated infection, similar to CSF shunt infections seen in humans, to compare the kinetics of bacterial titers, cytokine production and inflammatory cell influx elicited by wild type S. aureus versus an isogenic sarA mutant. The sarA mutant was more rapidly cleared from infected catheters compared to its isogenic wild type strain. Consistent with this finding, several pro-inflammatory cytokines and chemokines, including IL-17, CXCL1, and IL-1 beta were significantly increased in the brain following infection with the sarA mutant versus wild type S. aureus, in agreement with the fact that the sarA mutant displayed impaired biofilm growth and favored a planktonic state. Neutrophil influx into the infected hemisphere was also increased in the animals infected with the sarA mutant compared to wild type bacteria. These changes were not attributable to extracellular protease activity, which is increased in the context of SarA mutation, since similar responses were observed between sarA and a sarA/protease mutant. Overall, these results demonstrate that sarA plays an important role in attenuating the inflammatory response during staphylococcal biofilm infection in the CNS via a mechanism that remains to be determined.	[Snowden, Jessica N.; Beaver, Matt] Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA; [Snowden, Jessica N.; Kielian, Tammy] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Beenken, Karen; Smeltzer, Mark] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Arkansas System; University of Arkansas Medical Sciences; University of Iowa	Snowden, JN (corresponding author), Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA.	jsnowden@unmc.edu	; Smeltzer, Mark/M-2009-2018	Snowden, Jessica/0000-0002-0715-151X; Kielian, Tammy/0000-0001-7624-670X; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Neurological Disorders and Stroke [1K08NS069812-01]; National Institute of Allergy and Infectious Disease [P01 AI083211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS069812] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke to JNS (1K08NS069812-01) and National Institute of Allergy and Infectious Disease P01 AI083211 Project 4 to TK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Blevins JS, 1999, MOL MICROBIOL, V33, P317, DOI 10.1046/j.1365-2958.1999.01475.x; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat James E., 2007, V391, P127; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Forsman H, 2012, INFECT IMMUN, V80, P1987, DOI 10.1128/IAI.05906-11; Fux CA, 2006, CLIN MICROBIOL INFEC, V12, P331, DOI 10.1111/j.1469-0691.2006.01361.x; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Hanke ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042476; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; Kielian T, 2005, INFECT IMMUN, V73, P7428, DOI 10.1128/IAI.73.11.7428-7435.2005; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Kielian T, 2007, J IMMUNOL, V178, P4528, DOI 10.4049/jimmunol.178.7.4528; Kockro RA, 2000, J MED MICROBIOL, V49, P441, DOI 10.1099/0022-1317-49-5-441; Lee JK, 2012, J KOREAN MED SCI, V27, P1563, DOI 10.3346/jkms.2012.27.12.1563; McGirt MJ, 2003, CLIN INFECT DIS, V36, P858, DOI 10.1086/368191; Mootz JM, 2013, INFECT IMMUN, V81, P3227, DOI 10.1128/IAI.00377-13; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; Nichols JR, 2009, J IMMUNOL, V182, P7119, DOI 10.4049/jimmunol.0802656; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10; Snowden JN, 2012, INFECT IMMUN, V80, P3206, DOI 10.1128/IAI.00645-12; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Trotonda MP, 2009, J INFECT DIS, V199, P209, DOI 10.1086/595740; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Wormann ME, 2011, J BACTERIOL, V193, P5279, DOI 10.1128/JB.00369-11; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07; Zielinska AK, 2012, MOL MICROBIOL, V86, P1183, DOI 10.1111/mmi.12048; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	41	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84089	10.1371/journal.pone.0084089	http://dx.doi.org/10.1371/journal.pone.0084089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386336	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700091
J	Barsotti, MC; Losi, P; Briganti, E; Sanguinetti, E; Magera, A; Al Kayal, T; Feriani, R; Di Stefano, R; Soldani, G				Barsotti, Maria Chiara; Losi, Paola; Briganti, Enrica; Sanguinetti, Elena; Magera, Angela; Al Kayal, Tamer; Feriani, Roberto; Di Stefano, Rossella; Soldani, Giorgio			Effect of Platelet Lysate on Human Cells Involved in Different Phases of Wound Healing	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; TISSUE REGENERATION; OXIDATIVE STRESS; ENDOTHELIAL-CELL; RICH PLASMA; IN-VITRO; ANGIOGENESIS; EXPRESSION; EXPANSION; REPAIR	Background: Platelets are rich in mediators able to positively affect cell activity in wound healing. Aim of this study was to characterize the effect of different concentrations of human pooled allogeneic platelet lysate on human cells involved in the different phases of wound healing (inflammatory phase, angiogenesis, extracellular matrix secretion and epithelialization). Methodology/Principal Findings: Platelet lysate effect was studied on endothelial cells, monocytes, fibroblasts and keratinocytes, in terms of viability and proliferation, migration, angiogenesis, tissue repair pathway activation (ERK1/2) and inflammatory response evaluation (NF kappa B). Results were compared both with basal medium and with a positive control containing serum and growth factors. Platelet lysate induced viability and proliferation at the highest concentrations tested (10% and 20% v/v). Whereas both platelet lysate concentrations increased cell migration, only 20% platelet lysate was able to significantly promote angiogenic activity (p<0.05 vs. control), comparably to the positive control. Both platelet lysate concentrations activated important inflammatory pathways such as ERK1/2 and NF kappa B with the same early kinetics, whereas the effect was different for later time-points. Conclusion/Significance: These data suggest the possibility of using allogeneic platelet lysate as both an alternative to growth factors commonly used for cell culture and as a tool for clinical regenerative application for wound healing.	[Barsotti, Maria Chiara; Feriani, Roberto; Di Stefano, Rossella] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy; [Losi, Paola; Briganti, Enrica; Sanguinetti, Elena; Al Kayal, Tamer; Soldani, Giorgio] CNR, Inst Clin Physiol, Massa, Italy; [Magera, Angela] Kedrion SpA, Castelvecchio Pascoli, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Barsotti, MC (corresponding author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy.	mariachiara1970@yahoo.it	Di Stefano, Rossella/C-3880-2009; Barsotti, Maria Chiara/C-5222-2009	Barsotti, Maria Chiara/0000-0002-7957-0131; Al Kayal, Tamer/0000-0002-5700-5326	KEDRION S.p.A (Castelvecchio Pascoli, Lucca, Italy; BANDO UNICO R&D Regional Program; Regione Toscana	KEDRION S.p.A (Castelvecchio Pascoli, Lucca, Italy; BANDO UNICO R&D Regional Program; Regione Toscana(Regione Toscana)	The authors acknowledge the support of KEDRION S.p.A (Castelvecchio Pascoli, Lucca, Italy) by a Research Agreement for the Project of the BANDO UNICO R&D Regional Program 2008 "Nanostructured materials based on fibrin and platelet factors for angiogenesis promotion," funded by Regione Toscana. KEDRION S. p. A had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bernardi M, 2013, CYTOTHERAPY, V15, P920, DOI 10.1016/j.jcyt.2013.01.219; Borzini P, 2005, TRANSFUSION, V45, P1759, DOI 10.1111/j.1537-2995.2005.00600.x; Burnouf T, 2013, TRANSFUSION, V53, P138, DOI 10.1111/j.1537-2995.2012.03668.x; Da Pozzo E, 2012, THROMB RES, V130, pE113, DOI 10.1016/j.thromres.2012.03.013; de la Rosa CM, 2013, J PHARMACOL EXP THER, V345, P15, DOI 10.1124/jpet.112.200881; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Dulmovits BM, 2012, INT J BIOCHEM CELL B, V44, P1800, DOI 10.1016/j.biocel.2012.06.031; El Backly R, 2011, TISSUE ENG PT A, V17, P1787, DOI 10.1089/ten.tea.2010.0729; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Felice F, 2010, MICROVASC RES, V80, P332, DOI 10.1016/j.mvr.2010.05.004; Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.tea.2012.0375, 10.1089/ten.TEA.2012.0375]; Jonsdottir-Buch SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068984; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P444; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; Lan WW, 2012, OCUL SURF, V10, P137, DOI 10.1016/j.jtos.2012.04.001; Lee SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048791; Losi P, 2013, ACTA BIOMATER, V9, P7814, DOI 10.1016/j.actbio.2013.04.019; Mazzucco L, 2004, TRANSFUSION, V44, P1013, DOI 10.1111/j.1537-2995.2004.03366.x; Mazzucco L, 2012, TRANSFUS APHER SCI, V47, P207, DOI 10.1016/j.transci.2012.06.006; Melchionna R, 2012, J INVEST DERMATOL, V132, P1908, DOI 10.1038/jid.2012.51; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Occleston NL, 2011, WOUND REPAIR REGEN, V19, pS38, DOI 10.1111/j.1524-475X.2011.00711.x; Papanas N, 2012, CURR DIABETES REV, V8, P209, DOI 10.2174/157339912800563963; Pawitan JA, 2012, CURR STEM CELL RES T, V7, P329; Radziwon-Balicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059281; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Ranzato E, 2008, BRIT J DERMATOL, V159, P537, DOI 10.1111/j.1365-2133.2008.08699.x; Ranzato E, 2011, EXP DERMATOL, V20, P308, DOI 10.1111/j.1600-0625.2010.01173.x; Ranzato E, 2010, J CELL BIOCHEM, V110, P783, DOI 10.1002/jcb.22591; Ranzato E, 2009, J CELL MOL MED, V13, P2030, DOI 10.1111/j.1582-4934.2008.00467.x; Reinisch A, 2007, REGEN MED, V2, P371, DOI 10.2217/17460751.2.4.371; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rossi S, 2013, INT J PHARMACEUT, V440, P207, DOI 10.1016/j.ijpharm.2012.07.056; Sum R, 2007, TRANSFUSION, V47, P672, DOI 10.1111/j.1537-2995.2007.01170.x; Valacchi G, 2011, CHEM BIOL DRUG DES, V77, P460, DOI 10.1111/j.1747-0285.2011.01121.x; Watson A, 2009, ARCH DERMATOL RES, V301, P307, DOI 10.1007/s00403-009-0945-7; Yang DHA, 2013, INT J BIOCHEM CELL B, V45, P419, DOI 10.1016/j.biocel.2012.11.007	40	71	74	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84753	10.1371/journal.pone.0084753	http://dx.doi.org/10.1371/journal.pone.0084753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386412	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900109
J	Konig, SLB; Hadzic, M; Fiorini, E; Borner, R; Kowerko, D; Blanckenhorn, WU; Sigel, RKO				Koenig, Sebastian L. B.; Hadzic, Melodie; Fiorini, Erica; Boerner, Richard; Kowerko, Danny; Blanckenhorn, Wolf U.; Sigel, Roland K. O.			BOBA FRET: Bootstrap-Based Analysis of Single-Molecule FRET Data	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; STRUCTURAL DYNAMICS; TIME-SERIES; METAL-IONS; RNA; TRAJECTORIES; CATALYSIS; MODEL; SUBPOPULATIONS; SPECTROSCOPY	Time-binned single-molecule Forster resonance energy transfer (smFRET) experiments with surface-tethered nucleic acids or proteins permit to follow folding and catalysis of single molecules in real-time. Due to the intrinsically low signal-to-noise ratio (SNR) in smFRET time traces, research over the past years has focused on the development of new methods to extract discrete states (conformations) from noisy data. However, limited observation time typically leads to pronounced cross-sample variability, i.e., single molecules display differences in the relative population of states and the corresponding conversion rates. Quantification of cross-sample variability is necessary to perform statistical testing in order to assess whether changes observed in response to an experimental parameter (metal ion concentration, the presence of a ligand, etc.) are significant. However, such hypothesis testing has been disregarded to date, precluding robust biological interpretation. Here, we address this problem by a bootstrap-based approach to estimate the experimental variability. Simulated time traces are presented to assess the robustness of the algorithm in conjunction with approaches commonly used in thermodynamic and kinetic analysis of time-binned smFRET data. Furthermore, a pair of functionally important sequences derived from the self-cleaving group II intron Sc.ai5 gamma (d3'EBS1*/IBS1*) is used as a model system. Through statistical hypothesis testing, divalent metal ions are shown to have a statistically significant effect on both thermodynamic and kinetic aspects of their interaction. The Matlab source code used for analysis (bootstrap-based analysis of smFRET data, BOBA FRET), as well as a graphical user interface, is available via http://www.aci.uzh.ch/rna/.	[Koenig, Sebastian L. B.; Hadzic, Melodie; Fiorini, Erica; Boerner, Richard; Kowerko, Danny; Sigel, Roland K. O.] Univ Zurich, Inst Inorgan Chem, CH-8057 Zurich, Switzerland; [Blanckenhorn, Wolf U.] Univ Zurich, Zurich, Switzerland	University of Zurich; University of Zurich	Konig, SLB (corresponding author), Univ Zurich, Inst Inorgan Chem, CH-8057 Zurich, Switzerland.	sebastian.koenig@uzh.ch; roland.sigel@aci.uzh.ch	Sigel, Roland/O-9883-2016; Börner, Richard/AAV-4493-2020; Kowerko, Danny/J-4847-2019	Sigel, Roland/0000-0002-1307-7993; Kowerko, Danny/0000-0002-4538-7814	University of Zurich; Forschungskredit of the University of Zurich [57010302, FK-13-092]; European Research Council [259092]	University of Zurich; Forschungskredit of the University of Zurich; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the University of Zurich, the Forschungskredit of the University of Zurich (57010302, to SLBK, FK-13-092, to MH, http://www.researchers.uzh.ch/promotion/forschungskredit_en.html) and the European Research Council (MIRNA No 259092, to RKOS., http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Blanco M, 2010, METHOD ENZYMOL, V472, P153, DOI 10.1016/S0076-6879(10)72011-5; Borner R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4759108; Bokinsky G, 2003, P NATL ACAD SCI USA, V100, P9302, DOI 10.1073/pnas.1133280100; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Cardo Lucia, 2012, Methods Mol Biol, V848, P227, DOI 10.1007/978-1-61779-545-9_15; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Chung HS, 2010, BIOPHYS J, V98, P696, DOI 10.1016/j.bpj.2009.12.4322; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ennifar E, 2003, NUCLEIC ACIDS RES, V31, P2671, DOI 10.1093/nar/gkg350; Giudici P, 2000, BIOMETRICS, V56, P742, DOI 10.1111/j.0006-341X.2000.00742.x; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gopich IV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2180770; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Haar A, 1910, MATH ANN, V69, P331, DOI 10.1007/BF01456326; Haran G, 2004, CHEM PHYS, V307, P137, DOI 10.1016/j.chemphys.2004.05.017; Hellriegel C, 2004, J PHYS CHEM B, V108, P14699, DOI 10.1021/jp049412a; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019791; Holden SJ, 2010, BIOPHYS J, V99, P3102, DOI 10.1016/j.bpj.2010.09.005; Jung S, 2009, J PHYS CHEM B, V113, P13886, DOI 10.1021/jp907019p; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Kelly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029703; Keough MJ, 2011, EXPT DESIGN DATA ANA; Kim HK, 2007, NAT CHEM BIOL, V3, P763, DOI 10.1038/nchembio.2007.45; Konig SLB, 2013, CHIMIA, V67, P240, DOI 10.2533/chimia.2013.240; Konig SLB, 2013, RNA BIOL, V10, P133, DOI 10.4161/rna.23507; Konig SLB, 2013, CATION DEPENDE UNPUB; Kowerko D, 2013, METAL ION INDU UNPUB; Krause S, 2011, CHEMPHYSCHEM, V12, P303, DOI 10.1002/cphc.201000678; Kruschel D, 2013, RNA IN PRESS; Kruschel D, 2008, J INORG BIOCHEM, V102, P2147, DOI 10.1016/j.jinorgbio.2008.08.006; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee HK, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00017; Lee TH, 2007, BIOPHYS J, V92, P3275, DOI 10.1529/biophysj.106.094623; Lee TH, 2009, J PHYS CHEM B, V113, P11535, DOI 10.1021/jp903831z; Little MA, 2011, P ROY SOC A-MATH PHY, V467, P3088, DOI 10.1098/rspa.2010.0671; Liu Y, 2010, J PHYS CHEM B, V114, P5386, DOI 10.1021/jp9057669; MACQUEEN JT, 1967, J CHEM EDUC, V44, P755, DOI 10.1021/ed044p755; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Okamoto K, 2008, BIOORGAN MED CHEM, V16, P6873, DOI 10.1016/j.bmc.2008.05.053; Okamoto K, 2008, J PHYS CHEM B, V112, P7308, DOI 10.1021/jp712104h; Okamoto K, 2012, BIOPHYS J, V103, P1315, DOI 10.1016/j.bpj.2012.07.047; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pla L, 2004, J AGR BIOL ENVIR ST, V9, P42, DOI 10.1198/1085711043136; Politis DN, 2003, STAT SCI, V18, P219, DOI 10.1214/ss/1063994977; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Rueda D, 2004, P NATL ACAD SCI USA, V101, P10066, DOI 10.1073/pnas.0403575101; Schlegel G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137401; Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008; Selvin P R, 2007, SINGLE MOL TECHNIQUE; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; Steiner M, 2009, ANGEW CHEM INT EDIT, V48, P9739, DOI 10.1002/anie.200903809; Su LHJ, 2001, J MOL BIOL, V306, P655, DOI 10.1006/jmbi.2000.4323; Szoszkiewicz R, 2008, LANGMUIR, V24, P1356, DOI 10.1021/la702368b; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; Uphoff S, 2011, CHEMPHYSCHEM, V12, P571, DOI 10.1002/cphc.201000834; Walter NG, 2001, METHODS, V25, P19, DOI 10.1006/meth.2001.1212; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yang H, 2002, CHEM PHYS, V284, P423, DOI 10.1016/S0301-0104(02)00672-9; Zhao R, 2013, BIOPHYSICS LIFE SCI, P117; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	80	26	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84157	10.1371/journal.pone.0084157	http://dx.doi.org/10.1371/journal.pone.0084157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386343	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900078
J	Wera, E; Velthuis, AGJ; Geong, M; Hogeveen, H				Wera, Ewaldus; Velthuis, Annet G. J.; Geong, Maria; Hogeveen, Henk			Costs of Rabies Control: An Economic Calculation Method Applied to Flores Island	PLOS ONE			English	Article							PARENTERAL VACCINATION CAMPAIGN; OWNED-DOG POPULATION; CANINE RABIES; RURAL AFRICA; COVERAGE; PREVENTION; NDJAMENA; IMPACT	Background: Rabies is a zoonotic disease that, in most human cases, is fatal once clinical signs appear. The disease transmits to humans through an animal bite. Dogs are the main vector of rabies in humans on Flores Island, Indonesia, resulting in about 19 human deaths each year. Currently, rabies control measures on Flores Island include mass vaccination and culling of dogs, laboratory diagnostics of suspected rabid dogs, putting imported dogs in quarantine, and pre-and post-exposure treatment (PET) of humans. The objective of this study was to estimate the costs of the applied rabies control measures on Flores Island. Methodology/principal findings: A deterministic economic model was developed to calculate the costs of the rabies control measures and their individual cost components from 2000 to 2011. The inputs for the economic model were obtained from (i) relevant literature, (ii) available data on Flores Island, and (iii) experts such as responsible policy makers and veterinarians involved in rabies control measures in the past. As a result, the total costs of rabies control measures were estimated to be US$1.12 million (range: US$0.60-1.47 million) per year. The costs of culling roaming dogs were the highest portion, about 39 percent of the total costs, followed by PET (35 percent), mass vaccination (24 percent), pre-exposure treatment (1.4 percent), and others (1.3 percent) (dog-bite investigation, diagnostic of suspected rabid dogs, trace-back investigation of human contact with rabid dogs, and quarantine of imported dogs). Conclusions/significance: This study demonstrates that rabies has a large economic impact on the government and dog owners. Control of rabies by culling dogs is relatively costly for the dog owners in comparison with other measures. Providing PET for humans is an effective way to prevent rabies, but is costly for government and does not provide a permanent solution to rabies in the future.	[Wera, Ewaldus] Kupang State Agr Polytech, Anim Hlth Study Program, West Timor, Indonesia; [Wera, Ewaldus; Velthuis, Annet G. J.; Hogeveen, Henk] Wageningen Univ, Business Econ Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Wera, E (corresponding author), Kupang State Agr Polytech, Anim Hlth Study Program, West Timor, Indonesia.	ewaldus.wera@wur.nl	Wera, Ewaldus/AAS-7146-2021	Wera, Ewaldus/0000-0002-1259-8359; Hogeveen, Henk/0000-0002-9443-1412; Velthuis, Annet/0000-0002-5869-8144	Directorate General of Higher Education, Republic of Indonesia	Directorate General of Higher Education, Republic of Indonesia	The authors would like to acknowledge the Directorate General of Higher Education, Republic of Indonesia for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham J, 2001, RABIES FLORES ISLAND; BPS, 2013, POP IND VILL; Briggs DJ, 2010, INT HEALTH, V2, P161, DOI 10.1016/j.inhe.2010.07.005; Briggs DJ, 2007, RABIES; Childs JE, 2007, PREV VET MED, V78, P246, DOI 10.1016/j.prevetmed.2006.10.014; Chulasugandha P, 2006, VACCINE, V24, P1478, DOI 10.1016/j.vaccine.2005.03.059; Cleaveland S, 2003, VACCINE, V21, P1965, DOI 10.1016/S0264-410X(02)00778-8; Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; FISHBEIN DB, 1991, VACCINE, V9, P581, DOI 10.1016/0264-410X(91)90246-3; GLOSSER JW, 1970, J AM VET MED ASSOC, V157, P820; Gongal G, 2011, ADV PREVENTIVE MED; Goswami A, 2005, VACCINE, V23, P2970, DOI 10.1016/j.vaccine.2004.12.008; Green Alice L, 2011, Vet Clin North Am Exot Anim Pract, V14, P507, DOI 10.1016/j.cvex.2011.05.012; Hutabarat T, 2003, URB AN MAN C P ACIAR; IHM, 2000, PET PER PEN KAS GIG; IQ, 2008, PET TEKN PERS TIND K; Jackson AC, 2003, CLIN INFECT DIS, V36, P60, DOI 10.1086/344905; Jackson AC, 2007, RABIES; Kaare M, 2009, VACCINE, V27, P152, DOI 10.1016/j.vaccine.2008.09.054; Kamoltham T, 2003, B WORLD HEALTH ORGAN, V81, P375; KAPLAN MM, 1962, B WORLD HEALTH ORGAN, V26, P765; Kayali U, 2006, TROP MED INT HEALTH, V11, P1058, DOI 10.1111/j.1365-3156.2006.01663.x; Kayali U, 2003, B WORLD HEALTH ORGAN, V81, P739; KING AA, 1993, J COMP PATHOL, V108, P1, DOI 10.1016/S0021-9975(08)80224-1; Knobel D, 2009, BALI RABIES CONTROL; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Knobel DL, 2005, B WHO, V83; Kongkaew W, 2004, PREV VET MED, V65, P105, DOI 10.1016/j.prevetmed.2004.05.009; Kreindel SM, 1998, PUBLIC HEALTH REP, V113, P247; Linscott A. J., 2012, Clinical Microbiology Newsletter, V34, P177, DOI 10.1016/j.clinmicnews.2012.10.003; Manning S, 2008, HUMAN RABIES PREVENT; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P365, DOI 10.2165/00019053-199814040-00004; Mitchell J, 2003, BEST PRACTICE WILD P; Muir P, 2005, LANCET, V365, P2175, DOI 10.1016/S0140-6736(05)66769-4; Putra AAG, 2013, EMERG INFECT DIS, V19, P648, DOI 10.3201/eid1904.120380; Recuenco S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-47; Scott-Orr H., 2009, P 12 S INT SOC VET E; Shwiff SA, 2011, ZOONOSES PUBLIC HLTH, V58, P169, DOI 10.1111/j.1863-2378.2010.01335.x; Si H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-113; Suzuki K, 2008, ZOONOSES PUBLIC HLTH, V55, P177, DOI 10.1111/j.1863-2378.2008.01114.x; Switzerland World Health Organization, 2010, Weekly Epidemiological Record, V85, P309; Tenzin, 2010, EMERG INFECT DIS, V16, P1925, DOI 10.3201/eid1612.100958; Tierkel ES, 1950, AM J PUBLIC HEALTH N, V40, P1084; Vallat B., 2011, OIE B, V3, P1; Voelker R, 2007, JAMA-J AM MED ASSOC, V298, P1749, DOI 10.1001/jama.298.15.1749; Wera E., 2001, EPIDEMIOLOGI USAHA P; Whitfield SG, 2001, J VIROL METHODS, V95, P145, DOI 10.1016/S0166-0934(01)00304-4; WHO, 2005, WHO TECH REP SER, V931, P1; Wilde H, 1999, J TRAVEL MED, V6, P238, DOI 10.1111/j.1708-8305.1999.tb00525.x; Windiyaningsih Caecilia, 2004, Journal of the Medical Association of Thailand, V87, P1389; WOODRUFF BA, 1991, AM J PUBLIC HEALTH, V81, P1328, DOI 10.2105/AJPH.81.10.1328; Wunner WH, 2005, VIRUS RES, V111, P1, DOI 10.1016/j.virusres.2005.03.005	53	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83654	10.1371/journal.pone.0083654	http://dx.doi.org/10.1371/journal.pone.0083654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386244	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900049
J	Garcia-Murillas, I; Lambros, M; Turner, NC				Garcia-Murillas, Isaac; Lambros, Maryou; Turner, Nicholas C.			Determination of HER2 Amplification Status on Tumour DNA by Digital PCR	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; BREAST-CANCER; IN-SITU; HYBRIDIZATION; RECEPTOR	Determination of the presence of HER2 amplification by quantitative PCR has been challenging, in part due to chromosomal instability and identification of a robust a reference region. We assessed the potential of digital PCR for highly accurate assessment of DNA concentration with EFTUD2 as chromosome 17 reference probe. We assessed a HER2: EFTDU2 ratio by digital PCR assay in the microdissected DNA from 18 HER2 amplified and 58 HER2 non-amplified cancers. The HER2: EFTUD2 ratio had high concordance with conventionally defined HER2 status with a sensitivity of 100% (18/18) and a specificity of 98% (57/58). The HER2: EFTUD2 digital PCR assay has potential to accurately assess HER2 amplification status.	[Garcia-Murillas, Isaac; Lambros, Maryou; Turner, Nicholas C.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Turner, Nicholas C.] Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Turner, NC (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	nicholas.turner@icr.ac.uk		Turner, Nicholas/0000-0001-8937-0873; garcia-murillas, isaac/0000-0001-8183-7969	Breakthrough Breast Cancer; Cancer Research UK [16642] Funding Source: researchfish	Breakthrough Breast Cancer; Cancer Research UK(Cancer Research UK)	Breakthrough Breast Cancer http://www.breakthrough.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehner FL, 2010, J CLIN ONCOL, V28, P4300, DOI 10.1200/JCO.2009.24.8211; Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L; Buerger H, 2001, J CLIN PATHOL, V54, P836, DOI 10.1136/jcp.54.11.836; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Gevensleben H, 2013, CLIN CANCER RES, V19, P3276, DOI 10.1158/1078-0432.CCR-12-3768; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann-Che J, 2011, BRIT J CANCER, V104, P1739, DOI 10.1038/bjc.2011.135; Moelans CB, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-4; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Natrajan R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3154; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	18	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83409	10.1371/journal.pone.0083409	http://dx.doi.org/10.1371/journal.pone.0083409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386193	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700048
J	Levesque, S; Fournier, E; Carrier, N; Frost, E; Arbeit, RD; Michaud, S				Levesque, Simon; Fournier, Eric; Carrier, Nathalie; Frost, Eric; Arbeit, Robert D.; Michaud, Sophie			Campylobacteriosis in Urban versus Rural Areas: A Case-Case Study Integrated with Molecular Typing to Validate Risk Factors and to Attribute Sources of Infection	PLOS ONE			English	Article							MULTILOCUS SEQUENCE TYPES; NEW-ZEALAND; THERMOPHILIC CAMPYLOBACTERS; ENVIRONMENTAL WATER; CLONAL COMPLEXES; PUBLIC-HEALTH; RAW-MILK; JEJUNI; COLI; EPIDEMIOLOGY	Campylobacter infection is a leading cause of bacterial gastroenteritis worldwide, and most clinical cases appear as isolated, sporadic infections for which the source is rarely apparent. From July 2005 to December 2007 we conducted a prospective case-case study of sporadic, domestically-acquired Campylobacter enteritis in rural versus urban areas and a prevalence study of Campylobacter in animal and environmental sources in the Eastern Townships, Quebec. Isolates were typed using Multilocus Sequence Typing (MLST) to reinforce the case-case findings and to assign a source probability estimate for each human isolate. The risk of human campylobacteriosis was 1.89-fold higher in rural than urban areas. Unconditional multivariate logistic regression analysis identified two independent risk factors associated with human Campylobacter infections acquired in rural area: occupational exposure to animals (OR = 10.6, 95% CI: 1.2-91, p = 0.032), and household water coming from a private well (OR = 8.3, 95% CI: 3.4-20.4, p < 0.0001). A total of 851 C. jejuni isolates (178 human, 257 chicken, 87 bovine, 266 water, 63 wild bird) were typed using MLST. Among human isolates, the incidence rates of clonal complexes (CC) CC-21, CC-45, and CC-61 were higher in rural than urban areas. MLST-based source attribution analysis indicated that 64.5% of human C. jejuni isolates were attributable to chicken, followed by cattle (25.8%), water (7.4%), and wild birds (2.3%). Chicken was the attributable source for the majority of cases, independent of residential area, sex and age. The increased incidence in rural compared to urban areas was associated with occupational exposure to animals, particularly cattle among those aged 15-34 years, and with consumption of private well water. Both bovine and water exposure appeared to contribute to the seasonal variation in campylobacteriosis. These results provide a basis for developing public education and preventive programs targeting the risk factors identified.	[Levesque, Simon; Frost, Eric; Michaud, Sophie] Univ Sherbrooke, Fac Med, Dept Microbiol & Infect Dis, Quebec City, PQ, Canada; [Fournier, Eric] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Carrier, Nathalie; Frost, Eric] Ctr Hosp Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ, Canada; [Arbeit, Robert D.] Tufts Univ, Sch Med, Infect Dis Sect, Boston, MA 02111 USA	Laval University; University of Sherbrooke; Institut national de sante publique du Quebec (INSPQ); University of Sherbrooke; Tufts University	Michaud, S (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infect Dis, Quebec City, PQ, Canada.	Sophie.Michaud@USherbrooke.ca		Levesque, Simon/0000-0002-4356-9702; Frost, Eric/0000-0001-8958-4388	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Centre de Recherche Clinique Etienne Le-Bel	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre de Recherche Clinique Etienne Le-Bel	The study was funded by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Centre de Recherche Clinique Etienne Le-Bel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; [Anonymous], 2000, Can Commun Dis Rep, V26, P170; Arsenault J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-32; Buettner S, 2010, EPIDEMIOL INFECT, V138, P1748, DOI 10.1017/S095026881000155X; CARTER AM, 1987, APPL ENVIRON MICROB, V53, P523, DOI 10.1128/AEM.53.3.523-526.1987; Carter PE, 2009, APPL ENVIRON MICROB, V75, P6038, DOI 10.1128/AEM.01039-09; Cawthraw SA, 2000, CLIN EXP IMMUNOL, V122, P55, DOI 10.1046/j.1365-2249.2000.01349.x; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Danis K, 2009, EURO SURVEILL, V14; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Fajo-Pascual M, 2010, EUR J PUBLIC HEALTH, V20, P443, DOI 10.1093/eurpub/ckp206; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzenberger J, 2010, EUROSURVEILL, V15; French NP, 2009, APPL ENVIRON MICROB, V75, P779, DOI 10.1128/AEM.01979-08; Gilpin BJ, 2008, ZOONOSES PUBLIC HLTH, V55, P352, DOI 10.1111/j.1863-2378.2008.01142.x; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Green Chris G, 2006, Int J Health Geogr, V5, P2, DOI 10.1186/1476-072X-5-2; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Habib I, 2010, FOOD MICROBIOL, V27, P829, DOI 10.1016/j.fm.2010.04.009; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Hepworth PJ, 2011, ENVIRON MICROBIOL, P2011; Heuvelink AE, 2009, INT J FOOD MICROBIOL, V134, P70, DOI 10.1016/j.ijfoodmicro.2008.12.026; Kabore H, 2010, ZOONOSES PUBLIC HLTH, V57, pE195, DOI 10.1111/j.1863-2378.2010.01328.x; Koenraad PMFJ, 1997, WATER ENVIRON RES, V69, P52, DOI 10.2175/106143097X125182; Kovats RS, 2005, INT J BIOMETEOROL, V49, P207, DOI 10.1007/s00484-004-0241-3; Levesque S, 2012, APPL ENV MICROBIOL; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Levesque S, 2011, J MICROBIOL METH, V86, P82, DOI 10.1016/j.mimet.2011.04.001; Levesque S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016167; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; McCarthy N, 1999, INT J EPIDEMIOL, V28, P764, DOI 10.1093/ije/28.4.764; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McTavish SM, 2009, FEMS MICROBIOL LETT, V298, P149, DOI 10.1111/j.1574-6968.2009.01712.x; Michaud S, 2004, EMERG INFECT DIS, V10, P1844, DOI 10.3201/eid1010.040228; Michaud S, 2001, J MED MICROBIOL, V50, P1075, DOI 10.1099/0022-1317-50-12-1075; Mickan L, 2007, J APPL MICROBIOL, V102, P144, DOI 10.1111/j.1365-2672.2006.03049.x; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Ministere de l'Agriculture dPedlA Direction regionale de l'Estrie, 2010, AGR AGR ESTR GOUV QU; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Nachamkin I., 2003, MANUAL CLIN MICROBIO, P902; Nylen G, 2002, EPIDEMIOL INFECT, V128, P383, DOI 10.1017/S0950268802006830; Oporto B, 2007, J APPL MICROBIOL, V103, P977, DOI 10.1111/j.1365-2672.2007.03328.x; Peterson MC, 2003, J ENVIRON HEALTH, V65, P20; POPOVICUROIC T, 1989, EPIDEMIOL INFECT, V102, P59, DOI 10.1017/S095026880002968X; Pritchard JK, 2000, GENETICS, V155, P945; Sails AD, 2003, J CLIN MICROBIOL, V41, P4058, DOI 10.1128/JCM.41.9.4058-4067.2003; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SKIRROW MB, 1987, EPIDEMIOL INFECT, V99, P647, DOI 10.1017/S0950268800066504; Slater ER, 1997, LETT APPL MICROBIOL, V25, P274, DOI 10.1046/j.1472-765X.1997.00218.x; Sopwith W, 2008, EMERG INFECT DIS, V14, P1769, DOI 10.3201/eid1411.071678; Sopwith W, 2006, EMERG INFECT DIS, V12, P1500, DOI 10.3201/eid1210.060048; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; St-Pierre K, 2009, APPL ENVIRON MICROB, V75, P6736, DOI 10.1128/AEM.00486-09; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Studahl A, 2000, EPIDEMIOL INFECT, V125, P269, DOI 10.1017/S0950268899004562; Tam CC, 2009, EMERG INFECT DIS, V15, P1402, DOI 10.3201/eid1509.080773; Thomas C, 1999, J APPL MICROBIOL, V85, p168S, DOI 10.1111/j.1365-2672.1998.tb05296.x; THOMPSON JS, 1986, J CLIN MICROBIOL, V24, P876, DOI 10.1128/JCM.24.5.876-878.1986; Weir E, 2005, CAN MED ASSOC J, V172, P1438, DOI 10.1503/cmaj.050377; Williams NJ, 2010, APPL ENVIRON MICROB, V76, P7318, DOI 10.1128/AEM.00511-10; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Young I, 2009, EPIDEMIOL INFECT, V137, P1217, DOI 10.1017/S0950268809002635	71	70	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83731	10.1371/journal.pone.0083731	http://dx.doi.org/10.1371/journal.pone.0083731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386265	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700074
J	Nanjo, S; Yamada, T; Nishihara, H; Takeuchi, S; Sano, T; Nakagawa, T; Ishikawa, D; Zhao, L; Ebi, H; Yasumoto, K; Matsumoto, K; Yano, S				Nanjo, Shigeki; Yamada, Tadaaki; Nishihara, Hiroshi; Takeuchi, Shinji; Sano, Takako; Nakagawa, Takayuki; Ishikawa, Daisuke; Zhao, Lu; Ebi, Hiromichi; Yasumoto, Kazuo; Matsumoto, Kunio; Yano, Seiji			Ability of the Met Kinase Inhibitor Crizotinib and New Generation EGFR Inhibitors to Overcome Resistance to EGFR Inhibitors	PLOS ONE			English	Article							CELL LUNG-CANCER; HEPATOCYTE GROWTH-FACTOR; ACQUIRED-RESISTANCE; GEFITINIB RESISTANCE; T790M MUTATION; PHASE-III; RECEPTOR; ERLOTINIB; AMPLIFICATION; GENE	Purpose: Although EGF receptor tyrosine kinase inhibitors (EGFR-TKI) have shown dramatic effects against EGFR mutant lung cancer, patients ultimately develop resistance by multiple mechanisms. We therefore assessed the ability of combined treatment with the Met inhibitor crizotinib and new generation EGFR-TKIs to overcome resistance to first-generation EGFR-TKIs. Experimental Design: Lung cancer cell lines made resistant to EGFR-TKIs by the gatekeeper EGFR-T790M mutation, Met amplification, and HGF overexpression and mice with tumors induced by these cells were treated with crizotinib and a new generation EGFR-TKI. Results: The new generation EGFR-TKI inhibited the growth of lung cancer cells containing the gatekeeper EGFR-T790M mutation, but did not inhibit the growth of cells with Met amplification or HGF overexpression. In contrast, combined therapy with crizotinib plus afatinib or WZ4002 was effective against all three types of cells, inhibiting EGFR and Met phosphorylation and their downstream molecules. Crizotinib combined with afatinib or WZ4002 potently inhibited the growth of mouse tumors induced by these lung cancer cell lines. However, the combination of high dose crizotinib and afatinib, but not WZ4002, triggered severe adverse events. Conclusions: Our results suggest that the dual blockade of mutant EGFR and Met by crizotinib and a new generation EGFR-TKI may be promising for overcoming resistance to reversible EGFR-TKIs but careful assessment is warranted clinically.	[Nanjo, Shigeki; Yamada, Tadaaki; Takeuchi, Shinji; Sano, Takako; Nakagawa, Takayuki; Ishikawa, Daisuke; Zhao, Lu; Ebi, Hiromichi; Yasumoto, Kazuo; Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan; [Nishihara, Hiroshi] Hokkaido Univ, Grad Sch Med, Lab Translat Pathol, Sapporo, Hokkaido, Japan; [Matsumoto, Kunio] Kanazawa Univ, Canc Res Inst, Div Tumor Dynam & Regulat, Kanazawa, Ishikawa 920, Japan	Kanazawa University; Hokkaido University; Kanazawa University	Yano, S (corresponding author), Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan.	syano@staff.kanazawa-u.ac.jp	Ebi, Hiromichi/AAA-7358-2019; YANO, SEIJI/D-8465-2015; Yamada, Tadaaki/L-5378-2015; Matsumoto, Kunio/D-8441-2015	Ebi, Hiromichi/0000-0003-3155-7576; Yamada, Tadaaki/0000-0002-6945-281X; Matsumoto, Kunio/0000-0002-6532-4482	KAKENHI; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by KAKENHI (Grants-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" (to SY) and Grant-in-Aid for Young Scientists [to TY and ST]), and Grants-in-Aid for Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Ludovini V, 2011, J THORAC ONCOL, V6, P707, DOI 10.1097/JTO.0b013e31820a3a6b; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nishioka Y, 1997, INT J CANCER, V71, P170; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sano T, 2013, INT J CANCER, V133, P505, DOI 10.1002/ijc.28034; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Xu L, 2012, CANCER RES, V72, P3302, DOI 10.1158/0008-5472.CAN-11-3720; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yu Z, 2007, CANCER RES, V67, P10417, DOI 10.1158/0008-5472.CAN-07-1248; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	36	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84700	10.1371/journal.pone.0084700	http://dx.doi.org/10.1371/journal.pone.0084700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386407	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700116
J	Semple-Rowland, S; Madorsky, I; Bolch, S; Berry, J; Smith, WC				Semple-Rowland, Susan; Madorsky, Irina; Bolch, Susan; Berry, Jonathan; Smith, W. Clay			Activation of Phospholipase C Mimics the Phase Shifting Effects of Light on Melatonin Rhythms in Retinal Photoreceptors	PLOS ONE			English	Article							ROD OUTER SEGMENT; CIRCADIAN REGULATION; MEDIATED BREAKDOWN; SIGNALING PATHWAY; CHICKEN RETINA; CLOCK; EXPRESSION; CELLS; RAT; IDENTIFICATION	Many aspects of retinal photoreceptor function and physiology are regulated by the circadian clocks in these cells. It is well established that light is the primary stimulus that entrains these clocks; yet, the biochemical cascade(s) mediating light's effects on these clocks remains unknown. This deficiency represents a significant gap in our fundamental understanding of photoreceptor signaling cascades and their functions. In this study, we utilized re-aggregated spheroid cultures prepared from embryonic chick retina to determine if activation of phospholipase C in photoreceptors in the absence of light can phase shift the melatonin secretion rhythms of these cells in a manner similar to that induced by light. We show that spheroid cultures rhythmically secrete melatonin and that these melatonin rhythms can be dynamically phase shifted by exposing the cultures to an appropriately timed light pulse. Importantly, we show that activation of phospholipase C using m-3M3FBS in the absence of light induces a phase delay in photoreceptor melatonin rhythms that mirrors that induced by light. The implication of this finding is that the light signaling cascade that entrains photoreceptor melatonin rhythms involves activation of phospholipase C.	[Semple-Rowland, Susan; Madorsky, Irina; Berry, Jonathan] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bolch, Susan; Smith, W. Clay] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Semple-Rowland, S (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	rowland@ufl.edu	Smith, W. Clay/AAQ-1589-2021		National Eye Institute [EY014864, EY021721, EY011388]; Research to Prevent Blindness, Inc; University of Florida Faculty Enhancement Opportunity grant; C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL EYE INSTITUTE [R01EY011388, R01EY014864, P30EY021721] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc(Research to Prevent Blindness (RPB)); University of Florida Faculty Enhancement Opportunity grant; C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute (EY014864, EY021721, EY011388); Research to Prevent Blindness, Inc; University of Florida Faculty Enhancement Opportunity grant; C.M. Overstreet Retinal Eye Disease ARMD Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Bernard M, 1999, REPROD NUTR DEV, V39, P325, DOI 10.1051/rnd:19990305; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; BROWN JE, 1987, BIOCHEM BIOPH RES CO, V146, P1392, DOI 10.1016/0006-291X(87)90804-7; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CAHILL GM, 1992, VISUAL NEUROSCI, V8, P487, DOI 10.1017/S0952523800005009; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; Cailleau V, 2005, MOL VIS, V11, P472; Chong NW, 2000, J BIOL CHEM, V275, P32991, DOI 10.1074/jbc.M005671200; Collins B, 2013, NEURON, V78, P580, DOI 10.1016/j.neuron.2013.05.008; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; Contin MA, 2010, INVEST OPHTH VIS SCI, V51, P5491, DOI 10.1167/iovs.10-5643; Dwyer L, 2010, EUR J PHARMACOL, V628, P187, DOI 10.1016/j.ejphar.2009.11.029; FLANNERY JG, 1984, INVEST OPHTH VIS SCI, V25, P229; Frohns F, 2009, EUR J NEUROSCI, V29, P1931, DOI 10.1111/j.1460-9568.2009.06738.x; Garbarino-Pico E, 2004, J BIOL CHEM, V279, P51172, DOI 10.1074/jbc.M309248200; GEHM BD, 1991, BIOCHEMISTRY-US, V30, P11302, DOI 10.1021/bi00111a016; GHALAYINI A, 1984, BIOCHEM BIOPH RES CO, V124, P503, DOI 10.1016/0006-291X(84)91582-1; Ghalayini AJ, 1998, J NEUROCHEM, V70, P171; GHALAYINI AJ, 1991, J NEUROCHEM, V57, P1405, DOI 10.1111/j.1471-4159.1991.tb08307.x; GHALAYINI AJ, 1992, J BIOL CHEM, V267, P17977; GOLDMAN AI, 1980, INVEST OPHTH VIS SCI, V19, P1257; HAMM HE, 1980, P NATL ACAD SCI-BIOL, V77, P4998, DOI 10.1073/pnas.77.8.4998; HAYASHI F, 1985, BIOCHEM BIOPH RES CO, V128, P954, DOI 10.1016/0006-291X(85)90139-1; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hughes S, 2012, PROG BRAIN RES, V199, P19, DOI 10.1016/B978-0-444-59427-3.00002-2; Kasahara T, 2002, J NEUROSCI, V22, P7321; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Krjukova J, 2004, BRIT J PHARMACOL, V143, P3, DOI 10.1038/sj.bjp.0705911; Larkin P, 1999, MOL BRAIN RES, V70, P253, DOI 10.1016/S0169-328X(99)00154-0; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Layer PG, 1997, EUR J NEUROSCI, V9, P1795, DOI 10.1111/j.1460-9568.1997.tb00746.x; Liu SI, 2013, CHINESE J PHYSIOL, V56, P26, DOI 10.4077/CJP.2013.BAA091; MILLAR FA, 1988, BIOCHIM BIOPHYS ACTA, V970, P205, DOI 10.1016/0167-4889(88)90180-2; PANFOLI I, 1990, BIOCHEM BIOPH RES CO, V173, P283, DOI 10.1016/S0006-291X(05)81054-X; Peng YW, 1997, P NATL ACAD SCI USA, V94, P1995, DOI 10.1073/pnas.94.5.1995; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; REPPERT SM, 1983, INVEST OPHTH VIS SCI, V24, P294; Rothermel A, 2005, TISSUE ENG, V11, P1749, DOI 10.1089/ten.2005.11.1749; Rothermel A, 2001, EUR J NEUROSCI, V13, P949, DOI 10.1046/j.1460-9568.2001.01469.x; Rothermel A, 1997, P ROY SOC B-BIOL SCI, V264, P1293, DOI 10.1098/rspb.1997.0179; Sakamoto K, 2006, MOL VIS, V12, P117; Sakamoto K, 2004, J NEUROCHEM, V90, P1019, DOI 10.1111/j.1471-4159.2004.02571.x; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; THOMAS KB, 1993, BRAIN RES, V601, P303; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Verra DM, 2011, INVEST OPHTH VIS SCI, V52, P5111, DOI 10.1167/iovs.11-75301; Voisin P, 2012, CELL TISSUE RES, V348, P417, DOI 10.1007/s00441-012-1374-z; Volpert Katja N, 2009, J Ocul Biol Dis Infor, V2, P1, DOI 10.1007/s12177-009-9014-x; Willbold E, 2002, DEV NEUROSCI-BASEL, V24, P504, DOI 10.1159/000069361; Willbold E, 1998, HISTOL HISTOPATHOL, V13, P531, DOI 10.14670/HH-13.531; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83378	10.1371/journal.pone.0083378	http://dx.doi.org/10.1371/journal.pone.0083378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386190	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700046
J	Bouchet, A; Sakakini, N; El Atifi, M; Le Clec'h, C; Brauer, E; Moisan, A; Deman, P; Rihet, P; Le Duc, G; Pelletier, L				Bouchet, Audrey; Sakakini, Nathalie; El Atifi, Michele; Le Clec'h, Celine; Brauer, Elke; Moisan, Anaick; Deman, Pierre; Rihet, Pascal; Le Duc, Geraldine; Pelletier, Laurent			Early Gene Expression Analysis in 9L Orthotopic Tumor-Bearing Rats Identifies Immune Modulation in Molecular Response to Synchrotron Microbeam Radiation Therapy	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; X-RAY MICROBEAMS; HUMAN TH17 CELLS; IONIZING-RADIATION; IN-VIVO; MOUSE-BRAIN; DENDRITIC CELLS; GROWTH-FACTOR; GLIOSARCOMA; INFILTRATION	Synchrotron Microbeam Radiation Therapy (MRT) relies on the spatial fractionation of the synchrotron photon beam into parallel micro-beams applying several hundred of grays in their paths. Several works have reported the therapeutic interest of the radiotherapy modality at preclinical level, but biological mechanisms responsible for the described efficacy are not fully understood to date. The aim of this study was to identify the early transcriptomic responses of normal brain and glioma tissue in rats after MRT irradiation (400Gy). The transcriptomic analysis of similarly irradiated normal brain and tumor tissues was performed 6 hours after irradiation of 9 L orthotopically tumor-bearing rats. Pangenomic analysis revealed 1012 overexpressed and 497 repressed genes in the irradiated contralateral normal tissue and 344 induced and 210 repressed genes in tumor tissue. These genes were grouped in a total of 135 canonical pathways. More than half were common to both tissues with a predominance for immunity or inflammation (64 and 67% of genes for normal and tumor tissues, respectively). Several pathways involving HMGB1, toll-like receptors, C-type lectins and CD36 may serve as a link between biochemical changes triggered by irradiation and inflammation and immunological challenge. Most immune cell populations were involved: macrophages, dendritic cells, natural killer, T and B lymphocytes. Among them, our results highlighted the involvement of Th17 cell population, recently described in tumor. The immune response was regulated by a large network of mediators comprising growth factors, cytokines, lymphokines. In conclusion, early response to MRT is mainly based on inflammation and immunity which appear therefore as major contributors to MRT efficacy.	[Bouchet, Audrey; El Atifi, Michele; Pelletier, Laurent] INSERM, U836, Team Nanomed & Brain, La Tronche, France; [Bouchet, Audrey; Le Clec'h, Celine; Brauer, Elke; Le Duc, Geraldine] ESRF, Grenoble, France; [El Atifi, Michele; Pelletier, Laurent] Grenoble Univ Hosp, Grenoble, France; [Sakakini, Nathalie; Rihet, Pascal] INSERM, Unite Mixte Rech 1090, Team Technl Adv Genom & Clin TAGC, F-13258 Marseille, France; [Sakakini, Nathalie; Rihet, Pascal] Aix Marseille Univ, Marseille, France; [Moisan, Anaick] INSERM, U836, Team Funct NeuroImaging & Brain Perfus, La Tronche, France; [Deman, Pierre] INSERM, U836, Team Synchrotron Radiat & Med Res, La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); European Synchrotron Radiation Facility (ESRF); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Pelletier, L (corresponding author), INSERM, U836, Team Nanomed & Brain, La Tronche, France.	laurent.pelletier@ujf-grenoble.fr	Rihet, Pascal/GQP-1381-2022; Moisan, Anaïck/P-4838-2014; Brӓuer-Krisch, Elke/O-6026-2017; Audrey, Bouchet/AAR-5929-2021; Rihet, Pascal/L-2173-2016; Rihet, Pascal/AAD-2018-2022	Rihet, Pascal/0000-0002-9459-3905; Moisan, Anaïck/0000-0002-6680-8593; Brӓuer-Krisch, Elke/0000-0003-4587-1160; Audrey, Bouchet/0000-0001-7228-8830; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905	French National Institute of Health and Medical Research INSERM [U836]; European Synchrotron Radiation Facility; Institut National du Cancer (INCa - Bioresis program)	French National Institute of Health and Medical Research INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Synchrotron Radiation Facility; Institut National du Cancer (INCa - Bioresis program)	This work was supported by the French National Institute of Health and Medical Research INSERM (U836), European Synchrotron Radiation Facility and Institut National du Cancer (INCa - Bioresis program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Archer DW, 1998, COLLIMATOR PRODUCING; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BENDA P, 1971, J NEUROSURG, V34, P310, DOI 10.3171/jns.1971.34.3.0310; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boerma M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-6; Bouchet A, 2012, J SYNCHROTRON RADIAT, V19, P478, DOI 10.1107/S0909049512015105; Bouchet A, 2010, INT J RADIAT ONCOL, V78, P1503, DOI 10.1016/j.ijrobp.2010.06.021; Brauer-Krisch E, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3170035; Brauer-Krisch E, 2003, MED PHYS, V30, P583, DOI 10.1118/1.1562169; Crosbie JC, 2010, INT J RADIAT ONCOL, V77, P886, DOI 10.1016/j.ijrobp.2010.01.035; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00153; DeRisi J, 1996, NAT GENET, V14, P457; Desmarais G, 2012, INT J RADIAT BIOL, V88, P565, DOI 10.3109/09553002.2012.692495; Dilmanian F.A., 2003, BIOL MECH UNDERLYING; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; Dilmanian FA, 2001, CELL MOL BIOL, V47, P485; Driessens G, 2004, CANCER RES, V64, P8435, DOI 10.1158/0008-5472.CAN-04-0774; Driessens G, 2008, CANCER IMMUNOL IMMUN, V57, P1745, DOI 10.1007/s00262-008-0500-y; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; KURESHI SA, 1994, NEUROSURGERY, V35, P822, DOI 10.1227/00006123-199411000-00004; Laissue JA, 2001, P SOC PHOTO-OPT INS, V4508, P65, DOI 10.1117/12.450774; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Mahmoud-Ahmed AS, 2006, RADIAT RES, V165, P142, DOI 10.1667/RR3485.1; Miura M, 2006, BRIT J RADIOL, V79, P71, DOI 10.1259/bjr/50464795; Multhoff G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00058; Peterson KE, 2009, IMMUNOL RES, V43, P149, DOI 10.1007/s12026-008-8060-y; Prezado Y, 2011, MED PHYS, V38, P5012, DOI 10.1118/1.3608908; Regnard P, 2008, PHYS MED BIOL, V53, P861, DOI 10.1088/0031-9155/53/4/003; Regnard P, 2008, EUR J RADIOL, V68, pS151, DOI 10.1016/j.ejrad.2008.04.049; Salvat F, 2009, PENELOPE 2008 COD SY; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; Serduc R, 2008, PHYS MED BIOL, V53, P3609, DOI 10.1088/0031-9155/53/13/015; Serduc R, 2008, PHYS MED BIOL, V53, P1153, DOI 10.1088/0031-9155/53/5/001; Serduc R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009028; Shimizu Kenji, 2005, Journal of Nippon Medical School, V72, P335, DOI 10.1272/jnms.72.335; Shin SC, 2011, GENOMICS, V97, P358, DOI 10.1016/j.ygeno.2011.01.005; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Slatkin DN, 1994, METHOD MICROBEAM RAD, V1; Sprung CN, 2012, RADIAT RES, V178, P249, DOI 10.1667/RR2885.1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Witham TF, 2003, J NEURO-ONCOL, V64, P63, DOI 10.1007/BF02700021; Ye J, 2013, AM J PATHOL, V182, P10, DOI 10.1016/j.ajpath.2012.08.041; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; Zhao WL, 2006, CLIN CANCER RES, V12, P3823, DOI 10.1158/1078-0432.CCR-05-2418	55	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81874	10.1371/journal.pone.0081874	http://dx.doi.org/10.1371/journal.pone.0081874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391709	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200006
J	Kimura, S; Sato, M; Okada-Hatakeyama, M				Kimura, Shuhei; Sato, Masanao; Okada-Hatakeyama, Mariko			Inference of Vohradsky's Models of Genetic Networks by Solving Two-Dimensional Function Optimization Problems	PLOS ONE			English	Article							S-SYSTEM MODELS; REGULATORY NETWORKS; TRANSCRIPTIONAL REGULATION; PARAMETER-ESTIMATION; ALGORITHM; IDENTIFICATION; SERIES	The inference of a genetic network is a problem in which mutual interactions among genes are inferred from time-series of gene expression levels. While a number of models have been proposed to describe genetic networks, this study focuses on a mathematical model proposed by Vohradsky. Because of its advantageous features, several researchers have proposed the inference methods based on Vohradsky's model. When trying to analyze large-scale networks consisting of dozens of genes, however, these methods must solve high-dimensional non-linear function optimization problems. In order to resolve the difficulty of estimating the parameters of the Vohradsky's model, this study proposes a new method that defines the problem as several two-dimensional function optimization problems. Through numerical experiments on artificial genetic network inference problems, we showed that, although the computation time of the proposed method is not the shortest, the method has the ability to estimate parameters of Vohradsky's models more effectively with sufficiently short computation times. This study then applied the proposed method to an actual inference problem of the bacterial SOS DNA repair system, and succeeded in finding several reasonable regulations.	[Kimura, Shuhei] Tottori Univ, Grad Sch Engn, Tottori 680, Japan; [Sato, Masanao] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan; [Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Tottori University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); RIKEN	Kimura, S (corresponding author), Tottori Univ, Grad Sch Engn, Tottori 680, Japan.	kimura@ike.tottori-u.ac.jp	Okada, Mariko/N-6933-2015	Sato, Masanao/0000-0003-3790-8218	Ministry of Education, Culture, Sports, Science and Technology of Japan [23700266]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant-in-Aid for Young Scientists (B) No. 23700266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Bansal M, 2007, IET SYST BIOL, V1, P306, DOI 10.1049/iet-syb:20060079; Chemmangattuvalappil N, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-119; Cho DY, 2006, BIOINFORMATICS, V22, P1631, DOI 10.1093/bioinformatics/btl122; Chou IC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-25; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonzalez OR, 2007, BIOINFORMATICS, V23, P480, DOI 10.1093/bioinformatics/btl522; Kabir M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S56; Kikuchi S, 2003, BIOINFORMATICS, V19, P643, DOI 10.1093/bioinformatics/btg027; Kimura S, 2005, BIOINFORMATICS, V21, P1154, DOI 10.1093/bioinformatics/bti071; Kimura S, 2012, MATH BIOSCI, V235, P161, DOI 10.1016/j.mbs.2011.11.008; Kimura S, 2009, BIOINFORMATICS, V25, P918, DOI 10.1093/bioinformatics/btp072; Kimura S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-23; Kobayashi S., 2009, J JPN SOC ARTIF INTE, V24, P147; Liu PK, 2008, BIOINFORMATICS, V24, P1085, DOI 10.1093/bioinformatics/btn075; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mehrotra S, 1992, SIAM J OPTIMIZ, V2, P575, DOI 10.1137/0802028; Nakatsui M, 2008, MATH BIOSCI, V215, P105, DOI 10.1016/j.mbs.2008.06.007; Palafox L., 2012, P 2012 C EV COMP, P1865; Press WH, 1995, NUMERICAL RECIPES C; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tsai KY, 2005, BIOINFORMATICS, V21, P1180, DOI 10.1093/bioinformatics/bti099; Tucker W, 2007, MATH BIOSCI, V208, P607, DOI 10.1016/j.mbs.2006.11.009; Veflingstad Siren R, 2004, Theor Biol Med Model, V1, P8, DOI 10.1186/1742-4682-1-8; Vilela M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-35; Vilela M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-305; Vohradsky J, 2001, FASEB J, V15, P846, DOI 10.1096/fj.00-0361com; Voit E. O., 2000, COMPUTATIONAL ANAL B; Voit EO, 2004, BIOINFORMATICS, V20, P1670, DOI 10.1093/bioinformatics/bth140; Williams RJ, 1990, NEURAL COMPUT, V2, P490, DOI 10.1162/neco.1990.2.4.490; Xu R, 2007, NEURAL NETWORKS, V20, P917, DOI 10.1016/j.neunet.2007.07.002; Xu R, 2007, IEEE ACM T COMPUT BI, V4, P681, DOI 10.1109/TCBB.2007.1057; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83308	10.1371/journal.pone.0083308	http://dx.doi.org/10.1371/journal.pone.0083308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386175	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700032
J	Li, W; Tang, XR; Yi, WX; Li, Q; Ren, LJ; Liu, XH; Chu, CJ; Ozaki, Y; Zhang, J; Zhu, L				Li, Wei; Tang, Xiaorong; Yi, Wenxiu; Li, Qiang; Ren, Lijie; Liu, Xiaohui; Chu, Chunjun; Ozaki, Yukio; Zhang, Jian; Zhu, Li			Glaucocalyxin A Inhibits Platelet Activation and Thrombus Formation Preferentially via GPVI Signaling Pathway	PLOS ONE			English	Article							RECEPTOR GAMMA-CHAIN; ENT-KAURANE DITERPENOIDS; LEUKEMIA HL-60 CELLS; COLLAGEN; AGGREGATION; APOPTOSIS; 3-KINASE; SUPPORT; BINDING; DEATH	Platelets play a pivotal role in atherothrombosis and the antiplatelet agents have been proved to be useful in preventing onset of acute clinical events including myocardial infarction and stroke. Increasing number of natural compounds has been identified to be potential antiplatelet agents. Here we report the antiplatelet effect of glaucocalyxin A (GLA), an ent-diterpenoid that we isolated and purified from the aerial parts of Rabdosia japonica (Burm. f.) var. glaucocalyx (Maxim.) Hara, and investigate the molecular mechanisms by which GLA inhibits platelet activation and thrombus formation. The effect of GLA on platelet activation was measured using platelets freshly isolated from peripheral blood of healthy donors. Results showed that pretreatment of human platelets with lower concentrations of GLA (0.01 mu g/ml, 0.1 mu g/ml) significantly inhibited platelet aggregation induced by collagen (P<0.001) and CRP (P<0.01), a synthetic GPVI ligand, but not by ADP and U46619. Accordingly, GLA inhibited collagen-stimulated tyrosine phosphorylation of Syk, LAT, and phospholipase C gamma 2, the signaling events in collagen receptor GP. pathway. GLA also inhibited platelet p-selectin secretion and integrin activation by convulxin, a GPVI selective ligand. Additionally, GLA was found to inhibit low-dose thrombin-induced platelet activation. Using a flow chamber device, GLA was found to attenuate platelet adhesion on collagen surfaces in high shear condition. In vivo studies showed that GLA administration increased the time for complete occlusion upon vascular injury in mice, but did not extend tail-bleeding time when mice were administered with relatively lower doses of GLA. Therefore, the present results provide the molecular basis for the inhibition effect of GLA on platelet activation and its in vivo effect on thrombus formation, suggesting that GLA could potentially be developed as an antiplatelet and antithrombotic agent.	[Li, Wei; Tang, Xiaorong; Yi, Wenxiu; Li, Qiang; Ren, Lijie; Liu, Xiaohui; Zhu, Li] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China; [Chu, Chunjun; Zhang, Jian] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Peoples R China; [Ozaki, Yukio] Univ Yamanashi, Fac Med, Dept Lab Med, Chuo Ku, Tamaho, Yamanashi, Japan	Soochow University - China; Soochow University - China; University of Yamanashi	Zhang, J (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Suzhou, Peoples R China.	jianzhang@suda.edu.cn; lizhusong@yahoo.com			National Science Foundation of China [NSFC81071410, NSFC81170132]; Jiangsu Province's Key Discipline of Medicine [XK201118]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Discipline of Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	This work was supported in part by grants from the National Science Foundation of China (NSFC81071410, NSFC81170132), Jiangsu Province's Key Discipline of Medicine (XK201118), the Priority Academic Program Development of Jiangsu Higher Education Institutions of China (L.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIN Z, 1992, THROMB HAEMOSTASIS, V67, P458; Brass LF, 2013, PLATELETS, P367, DOI DOI 10.3109/09537104.2013.821602; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Gao LW, 2011, TOXICOL IN VITRO, V25, P51, DOI 10.1016/j.tiv.2010.09.006; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Hong SS, 2008, J NAT PROD, V71, P1055, DOI 10.1021/np0705965; Hong SS, 2011, J NAT PROD, V74, P2382, DOI 10.1021/np200439n; Huang ZS, 2010, J THROMB HAEMOST, V8, P1383, DOI 10.1111/j.1538-7836.2010.03859.x; Hubbard GP, 2004, J THROMB HAEMOST, V2, P2138, DOI 10.1111/j.1538-7836.2004.01067.x; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mou PP, 2013, BLOOD, V121, P4221, DOI 10.1182/blood-2012-11-470609; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Prevost N, 2002, P NATL ACAD SCI USA, V99, P9219, DOI 10.1073/pnas.142053899; SHATTIL SJ, 1987, BLOOD, V70, P307; Shen X, 2011, CHINESE ARCH TRADITI, V29, P2; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Weston C, 2003, INT J CLIN PRACT, V57, P898; Wu Y, 2012, BLOOD, V119, P1737, DOI 10.1182/blood-2011-06-360685; Yang WH, 2013, ANTI-CANCER AGENT ME, V13, P1280, DOI 10.2174/18715206113139990200; ZHANG B, 1993, ACTA PHARM SINIC, V14, P347; Zhang B., 1992, CHIN J PHARM TOXICOL, V6, P52; Zhang WL, 2011, INT J MOL SCI, V12, P2125, DOI 10.3390/ijms12042125; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104	27	25	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85120	10.1371/journal.pone.0085120	http://dx.doi.org/10.1371/journal.pone.0085120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386454	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700128
J	Maheandiran, M; Mylvaganam, S; Wu, CP; El-Hayek, Y; Sugumar, S; Hazrati, L; del Campo, M; Giacca, A; Zhang, L; Carlen, PL				Maheandiran, Margaret; Mylvaganam, Shanthini; Wu, Chiping; El-Hayek, Youssef; Sugumar, Sonia; Hazrati, Lili; del Campo, Martin; Giacca, Adria; Zhang, Liang; Carlen, Peter L.			Severe Hypoglycemia in a Juvenile Diabetic Rat Model: Presence and Severity of Seizures Are Associated with Mortality	PLOS ONE			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; SUBSTANTIA-NIGRA; BRAIN-DAMAGE; TRANSIENT HYPOGLYCEMIA; GLUCOSE-CONCENTRATIONS; FOREBRAIN ISCHEMIA; IMMATURE BRAIN; NEURONAL DEATH; AMINO-ACIDS; IN-VIVO	It is well accepted that insulin-induced hypoglycemia can result in seizures. However, the effects of the seizures, as well as possible treatment strategies, have yet to be elucidated, particularly in juvenile or insulin-dependent diabetes mellitus (IDDM). Here we establish a model of diabetes in young rats, to examine the consequences of severe hypoglycemia in this age group; particularly seizures and mortality. Diabetes was induced in post-weaned 22-day-old Sprague-Dawley rats by streptozotocin (STZ) administered intraperitoneally (IP). Insulin IP (15 U/kg), in rats fasted (14-16 hours), induced hypoglycemia, defined as <3.5 mM blood glucose (BG), in 68% of diabetic (STZ) and 86% of control rats (CON). Seizures occurred in 86% of STZ and all CON rats that reached hypoglycemic levels with mortality only occurring post-seizure. The fasting BG levels were significantly higher in STZ (12.4 +/- 1.3 mM) than in CON rodents (6.3 +/- 0.3 mM), resulting in earlier onset of hypoglycemia and seizures in the CON group. However, the BG at seizure onset was statistically similar between STZ (1.8 +/- 0.2 mM) and CON animals (1.6 +/- 0.1 mM) as well as between those that survived (S+S) and those that died (S+M) post-seizure. Despite this, the S+M group underwent a significantly greater number of seizure events than the S+S group. 25% glucose administered at seizure onset and repeated with recurrent seizures was not sufficient to mitigate these continued convulsions. Combining glucose with diazepam and phenytoin significantly decreased post-treatment seizures, but not mortality. Intracranial electroencephalograms (EEGs) were recorded in 10 CON and 9 STZ animals. Predictive EEG changes were not observed in these animals that underwent seizures. Fluorojade staining revealed damaged cells in non-seizing STZ animals and in STZ and CON animals post-seizure. In summary, this model of hypoglycemia and seizures in juvenile diabetic rats provides a paradigm for further study of underlying mechanisms. Our data demonstrate that severe hypoglycemia (<2.0 mM) is a necessary precondition for seizures, and the increased frequency of these seizures is associated with mortality.	[Maheandiran, Margaret; Mylvaganam, Shanthini; Wu, Chiping; El-Hayek, Youssef; Sugumar, Sonia; Giacca, Adria; Zhang, Liang; Carlen, Peter L.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Maheandiran, Margaret; El-Hayek, Youssef; Sugumar, Sonia; Giacca, Adria; Zhang, Liang; Carlen, Peter L.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Hazrati, Lili] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [del Campo, Martin; Carlen, Peter L.] Toronto Western Hosp, Dept Neurol, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Maheandiran, M (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	m.maheandiran@utoronto.ca	Carlen, Peter Louis/GLN-7260-2022; hazrati, lili-naz/AAE-7785-2020	hazrati, lili-naz/0000-0003-2715-1485; Carlen, Peter/0000-0002-3339-8102	Juvenile Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work is supported by the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalik PA, 2007, NEUROBIOL DIS, V26, P646, DOI 10.1016/j.nbd.2007.03.002; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; AUER RN, 1989, CLIN NEUROPATHOL, V8, P63; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; Becker DJ, 2000, TRENDS ENDOCRIN MET, V11, P198, DOI 10.1016/S1043-2760(00)00259-9; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Blasetti A, 2011, PEDIATR DIABETES, V12, P4, DOI 10.1111/j.1399-5448.2010.00655.x; Bree AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE194, DOI 10.1152/ajpendo.91041.2008; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Cardoso S, 2011, SYNAPSE, V65, P457, DOI 10.1002/syn.20863; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; Cryer PE, 2012, DIABETES CARE, V35, P1814, DOI 10.2337/dc12-0749; Davis EA, 1997, DIABETES CARE, V20, P22, DOI 10.2337/diacare.20.1.22; del Campo M, 2009, EPILEPSY RES, V83, P243, DOI 10.1016/j.eplepsyres.2008.11.012; Ennis K, 2008, BRAIN RES, V1224, P119, DOI 10.1016/j.brainres.2008.06.003; Frier BM, 2011, DIABETOLOGIA, V54, P233, DOI 10.1007/s00125-010-1983-6; Ghasemi M, 2010, SEIZURE-EUR J EPILEP, V19, P53, DOI 10.1016/j.seizure.2009.11.003; Gruetter R, 2003, J NEUROSCI RES, V74, P179, DOI 10.1002/jnr.10785; Han BC, 2004, LIFE SCI, V76, P573, DOI 10.1016/j.lfs.2004.07.016; Hannonen R, 2003, DEV MED CHILD NEUROL, V45, P262, DOI 10.1017/S0012162203000501; Heller SR, 2002, INT J CLIN PRACT, P27; Howorka K, 2000, PSYCHONEUROENDOCRINO, V25, P85, DOI 10.1016/S0306-4530(99)00041-4; Inzucchi SE, 2005, ENDOCRIN METAB CLIN, V34, P199, DOI 10.1016/j.ecl.2004.11.008; Iwai T, 2009, NEUROSCI RES, V64, P67, DOI 10.1016/j.neures.2009.01.013; Katz ML, 2012, DIABETIC MED, V29, P926, DOI 10.1111/j.1464-5491.2012.03646.x; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Kirchner A, 2006, EUR J NEUROSCI, V23, P1512, DOI 10.1111/j.1460-9568.2006.04665.x; Kondo F, 2001, NEUROSCI RES, V39, P339, DOI 10.1016/S0168-0102(00)00233-9; LAHAT E, 1995, CLIN NEUROL NEUROSUR, V97, P314, DOI 10.1016/0303-8467(95)00072-R; Lapenta L, 2010, EPILEPTIC DISORD, V12, P84, DOI 10.1684/epd.2010.0293; LEWIS LD, 1974, J NEUROCHEM, V23, P659, DOI 10.1111/j.1471-4159.1974.tb04389.x; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Lin BW, 1998, ACTA NEUROPATHOL, V96, P610, DOI 10.1007/s004010050942; Marinelli S, 2001, J NEUROPHYSIOL, V85, P1159, DOI 10.1152/jn.2001.85.3.1159; McCall AL, 2004, EUR J PHARMACOL, V490, P147, DOI 10.1016/j.ejphar.2004.02.052; McCrimmon RJ, 2012, J CLIN ENDOCR METAB, V97, P1, DOI 10.1210/jc.2011-1927; McCrimmon RJ, 2010, DIABETES, V59, P2333, DOI 10.2337/db10-0103; Moreira T, 2007, NEUROSCIENCE, V144, P1169, DOI 10.1016/j.neuroscience.2006.10.054; Moseley B, 2013, EPILEPSY BEHAV, V26, P375, DOI 10.1016/j.yebeh.2012.08.020; Moshe SL, 1995, BRAIN DEV-JPN, V17, P61, DOI 10.1016/0387-7604(94)00126-X; Musen G, 2008, DIABETES CARE, V31, P1933, DOI 10.2337/dc08-0607; Perantie DC, 2008, PEDIATR DIABETES, V9, P87, DOI 10.1111/j.1399-5448.2007.00274.x; Puente EC, 2010, DIABETES, V59, P1055, DOI 10.2337/db09-1495; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Sasaki-Hamada S, 2012, NEUROSCIENCE, V227, P293, DOI 10.1016/j.neuroscience.2012.09.081; Schwechter EM, 2003, ANN NEUROL, V53, P91, DOI 10.1002/ana.10415; Seaquist ER, 2001, DIABETES, V50, P2203, DOI 10.2337/diabetes.50.10.2203; Secrest AM, 2010, DIABETES, V59, P3216, DOI 10.2337/db10-0862; Snogdal LS, 2012, DIABETES RES CLIN PR, V98, P91, DOI 10.1016/j.diabres.2012.04.014; Somjen G. G., 2004, IONS BRAIN NORMAL FU; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Svoren BM, 2003, PEDIATRICS, V112, P914, DOI 10.1542/peds.112.4.914; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Timothy WJ, 2009, DIABETES, V32, P1802; Tupola S, 2004, EUR J PEDIATR, V163, P335, DOI 10.1007/s00431-004-1434-9; Velisek L, 2008, J NEUROSCI, V28, P9349, DOI 10.1523/JNEUROSCI.3195-08.2008; Veliskova J, 2004, EPILEPSIA, V45, P6, DOI 10.1111/j.0013-9580.2004.458002.x; Veliskova J, 2007, EPILEPSIA, V48, P106, DOI 10.1111/j.1528-1167.2007.01296.x; Veliskova J, 2006, MODELS OF SEIZURES AND EPILEPSY, P601, DOI 10.1016/B978-012088554-1/50050-5; Verrotti A, 2012, EUR J ENDOCRINOL, V167, P749, DOI 10.1530/EJE-12-0699; Whelan PJ, 1996, PROG NEUROBIOL, V49, P481, DOI 10.1016/0301-0082(96)00028-7; Yamada KA, 2004, PEDIATR RES, V55, P372, DOI 10.1203/01.PDR.0000110523.07240.C1	64	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83168	10.1371/journal.pone.0083168	http://dx.doi.org/10.1371/journal.pone.0083168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386156	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700026
J	Nair, DB; Chung, DKC; Schneider, J; Uchida, K; Aizawa, SI; Jarrell, KF				Nair, Divya B.; Chung, Daniel K. C.; Schneider, James; Uchida, Kaoru; Aizawa, Shin-Ichi; Jarrell, Ken F.			Identification of an Additional Minor Pilin Essential for Piliation in the Archaeon Methanococcus maripaludis	PLOS ONE			English	Article							UNIQUE MOTILITY STRUCTURE; CELL-SURFACE STRUCTURES; III SIGNAL PEPTIDES; IV PILI; PSEUDOMONAS-AERUGINOSA; SULFOLOBUS-ACIDOCALDARIUS; NEISSERIA-MENINGITIDIS; FIMBRIAL BIOGENESIS; PROTEIN-SECRETION; BIOFILM FORMATION	Methanococcus maripaludis is an archaeon with two studied surface appendages, archaella and type IV-like pili. Previously, the major structural pilin was identified as MMP1685 and three additional proteins were designated as minor pilins (EpdA, EpdB and EpdC). All of the proteins are likely processed by the pilin-specific prepilin peptidase EppA. Six other genes were identified earlier as likely encoding pilin proteins processed also by EppA. In this study, each of the six genes (mmp0528, mmp0600, mmp0601, mmp0709, mmp0903 and mmp1283) was deleted and the mutants examined by electron microscopy to determine their essentiality for pili formation. While mRNA transcripts of all genes were detected by RT-PCR, only the deletion of mmp1283 led to nonpiliated cells. This strain could be complemented back to a piliated state by supplying a wildtype copy of the mmp1283 gene in trans. This study adds to the complexity of the type IV pili system in M. maripaludis and raises questions about the functions of the remaining five pilin-like genes and whether M. maripaludis under other growth conditions may be able to assemble additional pili-like structures.	[Nair, Divya B.; Chung, Daniel K. C.; Schneider, James; Jarrell, Ken F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Uchida, Kaoru; Aizawa, Shin-Ichi] Prefectural Univ Hiroshima, Dept Life Sci, Shobara, Hiroshima, Japan	Queens University - Canada	Jarrell, KF (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jarrellk@queensu.ca		Aizawa, Shin-Ichi/0000-0002-9068-0825	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada to KFJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Ajon M, 2011, MOL MICROBIOL, V82, P807, DOI 10.1111/j.1365-2958.2011.07861.x; Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; ALM RA, 1995, MOL MICROBIOL, V16, P485, DOI 10.1111/j.1365-2958.1995.tb02413.x; Alm RA, 1996, MOL MICROBIOL, V22, P161; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Bardy SL, 2003, MOL MICROBIOL, V50, P1339, DOI 10.1046/j.1365-2958.2003.03758.x; Bardy SL, 2002, FEMS MICROBIOL LETT, V208, P53, DOI 10.1016/S0378-1097(01)00579-1; Belete B, 2008, J BACTERIOL, V190, P2023, DOI 10.1128/JB.01623-07; Boesen T, 2013, MBIO, V4, DOI 10.1128/mBio.00270-13; Brown DR, 2010, INFECT IMMUN, V78, P3053, DOI 10.1128/IAI.00099-10; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Burrows LL, 2012, MOL MICROBIOL, V86, P765, DOI 10.1111/mmi.12034; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chaban B, 2007, MOL MICROBIOL, V66, P596, DOI 10.1111/j.1365-2958.2007.05913.x; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Desmond E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-106; Eichler J, 2012, TRENDS MICROBIOL, V20, P512, DOI 10.1016/j.tim.2012.08.007; Esquivel RN, 2013, J BACTERIOL, V195, P3808, DOI 10.1128/JB.00572-13; Froels S, 2008, MOL MICROBIOL, V70, P938, DOI 10.1111/j.1365-2958.2008.06459.x; Ghosh A, 2011, BIOCHEM SOC T, V39, P64, DOI 10.1042/BST0390064; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P3188, DOI 10.1111/j.1462-2920.2012.02898.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P779, DOI 10.1111/j.1462-2920.2011.02638.x; Imam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028919; Ishiwa A, 2004, J MOL BIOL, V343, P615, DOI 10.1016/j.jmb.2004.08.059; Jarrell Ken F., 2013, Life-Basel, V3, P86, DOI 10.3390/life3010086; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Jarrell KF, 2011, FEMS MICROBIOL LETT, V319, P44, DOI 10.1111/j.1574-6968.2011.02264.x; Jarrell KF, 2009, PILI AND FLAGELLA: CURRENT RESEARCH AND FUTURE TRENDS, P215; Jarrell KF, 1996, J BACTERIOL, V178, P5057, DOI 10.1128/jb.178.17.5057-5064.1996; Jarrell KF, 2010, INT J MICROBIOL; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Lassak K, 2012, RES MICROBIOL, V163, P630, DOI 10.1016/j.resmic.2012.10.024; Lassak K, 2012, MOL MICROBIOL, V83, P110, DOI 10.1111/j.1365-2958.2011.07916.x; Lie TJ, 2005, J BIOL CHEM, V280, P5236, DOI 10.1074/jbc.M411778200; Lie TJ, 2003, MOL MICROBIOL, V47, P235, DOI 10.1046/j.1365-2958.2003.03293.x; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Muller DW, 2009, J BACTERIOL, V191, P6465, DOI 10.1128/JB.00858-09; Ng SYM, 2008, J BACTERIOL, V190, P6039, DOI 10.1128/JB.00546-08; Ng SYM, 2007, MICROBIOL-SGM, V153, P305, DOI 10.1099/mic.0.2006/003087-0; Ng SYM, 2006, J MOL MICROB BIOTECH, V11, P167, DOI 10.1159/000094053; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; Ng SYM, 2009, J BACTERIOL, V191, P6732, DOI 10.1128/JB.00673-09; Orell A, 2013, ISME J, V7, P1886, DOI 10.1038/ismej.2013.68; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Pohschroder M, 2005, CURR OPIN MICROBIOL, V8, P713, DOI 10.1016/j.mib.2005.10.006; Reimann J, 2012, MOL MICROBIOL, V86, P24, DOI 10.1111/j.1365-2958.2012.08186.x; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tripepi M, 2010, J BACTERIOL, V192, P3093, DOI 10.1128/JB.00133-10; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; VanDyke DJ, 2008, J BACTERIOL, V190, P5300, DOI 10.1128/JB.00474-08; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Wang YA, 2008, J MOL BIOL, V381, P456, DOI 10.1016/j.jmb.2008.06.017; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wirth R, 2012, TRENDS MICROBIOL, V20, P511, DOI 10.1016/j.tim.2012.07.007; Yu X, 2012, J MOL BIOL, V422, P274, DOI 10.1016/j.jmb.2012.05.031; Zolghadr B, 2007, MOL MICROBIOL, V64, P795, DOI 10.1111/j.1365-2958.2007.05697.x; Zolghadr B, 2011, EXTREMOPHILES, V15, P235, DOI 10.1007/s00792-010-0353-0	71	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83961	10.1371/journal.pone.0083961	http://dx.doi.org/10.1371/journal.pone.0083961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386316	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700082
J	Bellucci, E; Bitocchi, E; Rau, D; Nanni, L; Ferradini, N; Giardini, A; Rodriguez, M; Attene, G; Papa, R				Bellucci, Elisa; Bitocchi, Elena; Rau, Domenico; Nanni, Laura; Ferradini, Nicoletta; Giardini, Alessandro; Rodriguez, Monica; Attene, Giovanna; Papa, Roberto			Population Structure of Barley Landrace Populations and Gene-Flow with Modern Varieties	PLOS ONE			English	Article							HORDEUM-VULGARE L.; LINKAGE DISEQUILIBRIUM; PHASEOLUS-VULGARIS; COMPUTER-PROGRAM; ON-FARM; DIVERSITY; LOCI; SOFTWARE; NUMBER; WILD	Landraces are heterogeneous plant varieties that are reproduced by farmers as populations that are subject to both artificial and natural selection. Landraces are distinguished by farmers due to their specific traits, and different farmers often grow different populations of the same landrace. We used simple sequence repeats (SSRs) to analyse 12 barley landrace populations from Sardinia from two collections spanning 10 years. We analysed the population structure, and compared the population diversity of the landraces that were collected at field level (population). We used a representative pool of barley varieties for diversity comparisons and to analyse the effects of gene flow from modern varieties. We found that the Sardinian landraces are a distinct gene pool from those of both two-row and six-row barley varieties. There is also a low, but significant, mean level and population-dependent level of introgression from the modern varieties into the Sardinian landraces. Moreover, we show that the Sardinian landraces have the same level of gene diversity as the representative sample of modern commercial varieties grown in Italy in the last decades, even within population level. Thus, these populations represent crucial sources of germplasm that will be useful for crop improvement and for population genomics studies and association mapping, to identify genes, loci and genome regions responsible for adaptive variations. Our data also suggest that landraces are a source of valuable germplasm for sustainable agriculture in the context of future climate change, and that in-situ conservation strategies based on farmer use can preserve the genetic identity of landraces while allowing adaptation to local environments.	[Bellucci, Elisa; Bitocchi, Elena; Nanni, Laura; Ferradini, Nicoletta; Giardini, Alessandro; Papa, Roberto] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy; [Rau, Domenico; Rodriguez, Monica; Attene, Giovanna] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Papa, Roberto] Cereal Res Ctr CRA CER, Consiglio Ric & Sperimentaz Agr, Foggia, Italy	Marche Polytechnic University; University of Sassari; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Papa, R (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy.	r.papa@univpm.it	Nanni, Laura/HDN-7936-2022; Rodriguez, Monica/G-6731-2012; Bitocchi, Elena/J-7996-2019; Bellucci, Elisa/AAS-9237-2021; papa, roberto/F-9510-2014	Rodriguez, Monica/0000-0001-8926-2987; Bitocchi, Elena/0000-0002-2152-4634; Rau, Domenico/0000-0002-5294-9053; papa, roberto/0000-0001-9598-3131; Bellucci, Elisa/0000-0002-1636-0719	Universita Politecnica delle Marche; Universita degli Studi di Sassari	Universita Politecnica delle Marche; Universita degli Studi di Sassari	Funded by Universita Politecnica delle Marche and Universita degli Studi di Sassari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; [Anonymous], 1999, POPGENE VERSION 1 3; [Anonymous], 1989, JMP VERS 7; Attene G., 1991, Rivista di Agronomia, V25, P54; Attene G, 1996, GENET RESOUR CROP EV, V43, P385; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BECKER J, 1995, PLANT MOL BIOL, V27, P835, DOI 10.1007/BF00020238; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; Briggs DE., 1978, BARLEY, DOI 10.1007/978-94-009-5715-2; Brown AHD, 2000, GENES IN THE FIELD, P29; BRUSH SB, 1995, CROP SCI, V35, P346, DOI 10.2135/cropsci1995.0011183X003500020009x; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Castillo G. F., 1997, GENE FLOW MAIZE LAND, P67; Ceccarelli S, 2000, GENES IN THE FIELD, P51; Ceccarelli S, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P103, DOI 10.1079/9781845938512.0103; CECCARELLI S, 1987, EUPHYTICA, V36, P389, DOI 10.1007/BF00041482; Cockram J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-16; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Degen B, 2001, J HERED, V92, P447, DOI 10.1093/jhered/92.5.447; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Enjalbert J, 2011, CR BIOL, V334, P458, DOI 10.1016/j.crvi.2011.03.005; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Flowers JM, 2009, MOL BIOL EVOL, V26, P2475, DOI 10.1093/molbev/msp161; Frankel O.H., 1995, CONSERVATION PLANT B; GORHAM J, 1994, J EXP BOT, V45, P895, DOI 10.1093/jxb/45.7.895; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Harlan J. R., 1968, Barley: Origin, Botany, Culture, Winter Hardiness, Genetics, Utilization & Pests., P9; Harlan JR, 1992, CROPS MAN, V2nd; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Jones Huw, 2008, Plant Genetic Resources Characterization and Utilization, V6, P98, DOI 10.1017/S1479262108993138; KIMURA M, 1964, GENETICS, V49, P725; LAW CN, 1978, HEREDITY, V40, P133, DOI 10.1038/hdy.1978.13; LEBOULCH V, 1994, GENET SEL EVOL, V26, pS221, DOI 10.1051/gse:19940715; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Malysheva-Otto L, 2007, MOL BREEDING, V20, P309, DOI 10.1007/s11032-007-9093-y; MANTEL N, 1967, CANCER RES, V27, P209; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Negri V, 2002, GENET RESOUR CROP EV, V49, P511, DOI 10.1023/A:1020902508166; NEI M, 1974, GENETICS, V76, P379; Papa R, 1998, PLANT BREEDING, V117, P523, DOI 10.1111/j.1439-0523.1998.tb02201.x; Papa R, 2005, THEOR APPL GENET, V111, P1147, DOI 10.1007/s00122-005-0045-9; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Papa R, 1993, THESIS U SASSARI ITA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Ramsay L, 2000, GENETICS, V156, P1997; Ritala A, 2002, CROP SCI, V42, P278, DOI 10.2135/cropsci2002.0278; Rodriguez M, 2008, EUPHYTICA, V163, P231, DOI 10.1007/s10681-007-9635-8; Rodriguez M, 2012, THEOR APPL GENET, V125, P171, DOI 10.1007/s00122-012-1824-8; Russell JR, 2003, THEOR APPL GENET, V107, P413, DOI 10.1007/s00122-003-1261-9; SLATKIN M, 1991, GENETICS, V127, P627; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Teshome A., 2001, Plant Breeding Reviews, V21, P221; Vitalis R, 2003, J HERED, V94, P429, DOI 10.1093/jhered/esg083; Vitalis R, 2001, GENETICS, V158, P1811; WAGNER DB, 1991, J HERED, V82, P302, DOI 10.1093/oxfordjournals.jhered.a111090; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1946, GENETICS, V31, P39; Wright S., 1978, EVOLUTION GENETIC PO	75	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83891	10.1371/journal.pone.0083891	http://dx.doi.org/10.1371/journal.pone.0083891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386303	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900067
J	Li, MM; Zhang, XC; Zhen, Q; Han, FP				Li, Mingming; Zhang, Xingchang; Zhen, Qing; Han, Fengpeng			Spatial Analysis of Soil Organic Carbon in Zhifanggou Catchment of the Loess Plateau	PLOS ONE			English	Article							LAND-USE; NITROGEN STOCKS; VARIABILITY; GEOSTATISTICS; LANDSCAPE	Soil organic carbon (SOC) reflects soil quality and plays a critical role in soil protection, food safety, and global climate changes. This study involved grid sampling at different depths (6 layers) between 0 and 100 cm in a catchment. A total of 1282 soil samples were collected from 215 plots over 8.27 km(2). A combination of conventional analytical methods and geostatistical methods were used to analyze the data for spatial variability and soil carbon content patterns. The mean SOC content in the 1282 samples from the study field was 3.08 g.kg(-1). The SOC content of each layer decreased with increasing soil depth by a power function relationship. The SOC content of each layer was moderately variable and followed a lognormal distribution. The semi-variograms of the SOC contents of the six different layers were fit with the following models: exponential, spherical, exponential, Gaussian, exponential, and exponential, respectively. A moderate spatial dependence was observed in the 0-10 and 10-20 cm layers, which resulted from stochastic and structural factors. The spatial distribution of SOC content in the four layers between 20 and 100 cm exhibit were mainly restricted by structural factors. Correlations within each layer were observed between 234 and 562 m. A classical Kriging interpolation was used to directly visualize the spatial distribution of SOC in the catchment. The variability in spatial distribution was related to topography, land use type, and human activity. Finally, the vertical distribution of SOC decreased. Our results suggest that the ordinary Kriging interpolation can directly reveal the spatial distribution of SOC and the sample distance about this study is sufficient for interpolation or plotting. More research is needed, however, to clarify the spatial variability on the bigger scale and better understand the factors controlling spatial variability of soil carbon in the Loess Plateau region.	[Li, Mingming; Zhen, Qing] Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling 712100, Peoples R China; [Li, Mingming; Zhang, Xingchang; Zhen, Qing; Han, Fengpeng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Xingchang; Han, Fengpeng] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Han, FP (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	hanfp@ms.iswc.ac.cn			National Natural Science Foundation [41101528]; China Clean Development Mechanism Fund grant project [2012027-1]; State Key Laboratory of Soil Erosion and Dry-land Farming on the Loess Plateau	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Clean Development Mechanism Fund grant project; State Key Laboratory of Soil Erosion and Dry-land Farming on the Loess Plateau	This study was financially supported by the National Natural Science Foundation (41101528), China Clean Development Mechanism Fund grant project (2012027-1), and the State Key Laboratory of Soil Erosion and Dry-land Farming on the Loess Plateau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batjes NH, 2002, SOIL USE MANAGE, V18, P324, DOI 10.1079/SUM2002138; Batjes NH, 2000, GEODERMA, V97, P135, DOI 10.1016/S0016-7061(00)00031-8; Bhattacharyya T, 2000, CURR SCI INDIA, V79, P655; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Fang X, 2012, CATENA, V88, P6, DOI 10.1016/j.catena.2011.07.012; Fu B.J., 2002, LAND USE STRUCTURE E, P1; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Gregorich E. G, 1994, CAN J SOIL SCI, V74, P885, DOI DOI 10.4141/cjss94-051; Han FP, 2010, ACTA AGR SCAND B-S P, V60, P136, DOI 10.1080/09064710902721354; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; [贾宇平 Jia Yuping], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P31; Journel AG., 1978, MINING GEOSTATISTICS, P600; KERN JS, 1994, SOIL SCI SOC AM J, V58, P439, DOI 10.2136/sssaj1994.03615995005800020029x; Krogh L, 2003, AGR ECOSYST ENVIRON, V96, P19, DOI 10.1016/S0167-8809(03)00016-1; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li JinFen, 2010, Acta Agrestia Sinica, V18, P661; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu ZP, 2012, SOIL RES, V50, P114, DOI 10.1071/SR11183; NELSON D W, 1975, Proceedings of the Indiana Academy of Science, V84, P456; Nielsen D.R., 1984, P WORKSH ISSS SSSA L; Su ZY, 2006, PEDOSPHERE, V16, P10, DOI 10.1016/S1002-0160(06)60020-9; Tan ZX, 2005, AGR ECOSYST ENVIRON, V111, P140, DOI 10.1016/j.agee.2005.05.012; TRANGMAR BB, 1985, ADV AGRON, V38, P45; Walter C, 2003, SOIL SCI SOC AM J, V67, P1477, DOI 10.2136/sssaj2003.1477; [王国梁 Wang Guoliang], 2002, [水土保持通报, Bulletin of Soil and Water Conservation], V22, P1; Wang HQ, 2002, LANDSCAPE ECOL, V17, P671, DOI 10.1023/A:1022962116313; Wang J, 2001, J ARID ENVIRON, V48, P537, DOI 10.1006/jare.2000.0763; [王军 Wang Jun], 2002, [生态学报, Acta Ecologica Sinica], V22, P1173; Wang SQ., 2000, ACTA GEOGRAPHICA SIN, V55, P533; Wang XiaoLi, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P98; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wang YQ, 2009, PEDOSPHERE, V19, P486, DOI 10.1016/S1002-0160(09)60141-7; Wang Z., 1999, GEOSTATISTICS ITS AP; Xie XianLi, 2004, Acta Pedologica Sinica, V41, P35; Yang XiaoMei, 2010, Pratacultural Science, V27, P18; Zhou HuiZhen, 1996, Acta Pedologica Sinica, V33, P232	37	7	7	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83061	10.1371/journal.pone.0083061	http://dx.doi.org/10.1371/journal.pone.0083061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386143	gold, Green Published			2022-12-27	WOS:000329117900019
J	Chiang, EY; Johnston, RJ; Grogan, JL				Chiang, Eugene Y.; Johnston, Robert J.; Grogan, Jane L.			EBI2 Is a Negative Regulator of Type I Interferons in Plasmacytoid and Myeloid Dendritic Cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTORS; RHEUMATOID-ARTHRITIS; MIGRATION; SIGNATURE; ALPHA; RECOGNITION; ACTIVATION; IPC	Epstein-Barr virus induced receptor 2 (EBI2), a G alpha(i)-coupled G protein-coupled receptor, is a chemotactic receptor for B, T and dendritic cells (DC). Genetic studies have also implicated EBI2 as a regulator of an interferon regulatory factor 7 (IRF7)-driven inflammatory network (IDIN) associated with autoimmune diseases, although the corollary in primary type I IFN-producing cells has not been reported. Here we demonstrate that EBI2 negatively regulates type I IFN responses in plasmacytoid DC (pDCs) and CD11b(+) myeloid cells. Activation of EBI2(-/-) pDCs and CD11b(+) cells with various TLR ligands induced elevated type I IFN production compared to wild-type cells. Moreover, in vivo challenge with endosomal TLR agonists or infection with lymphocytic choriomeningitis virus elicited more type I IFNs and proinflammatory cytokines in EBI2(-/-) mice compared to normal mice. Elevated systemic cytokines occurred despite impaired ability of EBI2-deficient pDCs and CD11b(+) cells to migrate from the blood to the spleen and peritoneal cavity under homeostatic conditions. As reported for other immune cells, pDC migration was dependent on the ligand for EBI2, 7 alpha,25-dihydroxycholesterol. Consistent with a cell intrinsic role for EBI2, type I IFN-producing cells from EBI2-deficient mice expressed higher levels of IRF7 and IDIN genes. Together these data suggest a negative regulatory role for EBI2 in balancing TLR-mediated responses to foreign and to self nucleic acids that may precipitate autoimmunity.	[Chiang, Eugene Y.; Johnston, Robert J.; Grogan, Jane L.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Grogan, JL (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	jgrogan@gene.com			Genentech	Genentech(Roche HoldingGenentech)	This work was funded by Genentech, which develops and markets drugs for profit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anwar MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.28; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chiang CY, 2012, CELL HOST MICROBE, V11, P306, DOI 10.1016/j.chom.2012.02.002; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Lafyatis R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2321; Lande R, 2004, J IMMUNOL, V173, P2815, DOI 10.4049/jimmunol.173.4.2815; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Li Q, 2011, CLIN IMMUNOL, V140, P3, DOI 10.1016/j.clim.2011.04.010; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012; McBride JM, 2012, ARTHRITIS RHEUM-US, V64, P3666, DOI 10.1002/art.34632; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Pena JA, 2009, INFLAMM BOWEL DIS, V15, P248, DOI 10.1002/ibd.20744; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Swiecki M, 2011, CURR OPIN VIROL, V1, P463, DOI 10.1016/j.coviro.2011.10.026; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Umemoto E, 2012, J IMMUNOL, V189, P191, DOI 10.4049/jimmunol.1200802; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; Wang Y, 2013, ARCH IMMUNOL THER EX; Wang YM, 2011, IMMUNOL REV, V243, P74, DOI 10.1111/j.1600-065X.2011.01049.x; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	51	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83457	10.1371/journal.pone.0083457	http://dx.doi.org/10.1371/journal.pone.0083457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386204	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700051
J	Leavitt, SD; Lumbsch, HT; Stenroos, S; St Clair, LL				Leavitt, Steven D.; Lumbsch, H. Thorsten; Stenroos, Soili; St Clair, Larry L.			Pleistocene Speciation in North American Lichenized Fungi and the Impact of Alternative Species Circumscriptions and Rates of Molecular Evolution on Divergence Estimates	PLOS ONE			English	Article							GENUS MELANOHALEA PARMELIACEAE; POPULATION-STRUCTURE; XANTHOPARMELIA PARMELIACEAE; PHYLOGENETIC-RELATIONSHIPS; DOMINATED DIVERSIFICATION; MAXIMUM-LIKELIHOOD; CETRARIA-ACULEATA; FORMING FUNGI; DELIMITATION; ASCOMYCOTA	Pleistocene climatic fluctuations influenced patterns of genetic variation and promoted speciation across a wide range of species groups. Lichens are commonly found in habitats that were directly impacted by glacial cycles; however, the role of Pleistocene climate in driving speciation in most lichen symbionts remains unclear. This uncertainty is due in part to limitations in our ability to accurately recognize independently evolving lichen-forming fungal lineages and a lack of relevant fossil calibrations. Using a coalescent-based species tree approach, we estimated divergence times for two sister clades in the genus Xanthoparmelia (Parmeliaceae) restricted to western North America. We assessed the influence of two different species circumscription scenarios and various locus-specific rates of molecular evolution on divergence estimates. Species circumscriptions were validated using the program BP&P. although speciation was generally supported in both scenarios, divergence times differed between traditional species circumscriptions and those based on genetic data, with more recent estimates resulting from the former. Similarly, rates of evolution for different loci resulted in variable divergence time estimates. However, our results unambiguously indicate that diversification in the sampled Xanthoparmelia clades occurred during the Pleistocene. Our study highlights the potential impact of ambiguous species circumscriptions and uncertain rates of molecular evolution on estimating divergence times within a multilocus species tree framework.	[Leavitt, Steven D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Leavitt, Steven D.; Lumbsch, H. Thorsten] Field Museum Nat Hist, Chicago, IL 60605 USA; [Leavitt, Steven D.; St Clair, Larry L.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Leavitt, Steven D.; St Clair, Larry L.] Brigham Young Univ, ML Bean Life Sci Museum, Provo, UT 84602 USA; [Stenroos, Soili] Univ Helsinki, Bot Museum, Finnish Museum Nat Hist, Helsinki, Finland	University of Chicago; Field Museum of Natural History (Chicago); Brigham Young University; Brigham Young University; University of Helsinki	Leavitt, SD (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	sleavitt@fieldmuseum.org	Leavitt, Steven D./AAC-6462-2021	Leavitt, Steven D./0000-0002-5034-9724; Stenroos, Soili/0000-0003-0331-792X	California Lichen Society; Brigham Young University Office of Research and Creative Activities; NSF [DEB-0949147]	California Lichen Society; Brigham Young University Office of Research and Creative Activities; NSF(National Science Foundation (NSF))	This project was supported in part by grants from the California Lichen Society (http://californialichens.org/), the Brigham Young University Office of Research and Creative Activities (http://orca.byu.edu/), and NSF (http://nsf.gov/; "Hidden diversity in parmelioid lichens", DEB-0949147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; de Paz GA, 2010, AUST SYST BOT, V23, P173, DOI 10.1071/SB09055; Asplund J, 2009, BASIC APPL ECOL, V10, P273, DOI 10.1016/j.baae.2008.04.003; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; CAMARGO A, 2013, SPECIES PROBLEM; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Coats LL, 2008, QUATERNARY RES, V70, P322, DOI 10.1016/j.yqres.2008.04.006; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; CULBERSON CF, 1972, J CHROMATOGR, V72, P113, DOI 10.1016/0021-9673(72)80013-X; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DEQUEIROZ K, 1999, GEN LINEAGE CONCEPT, P49; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert AJ, 2008, MOL PHYLOGENET EVOL, V49, P832, DOI 10.1016/j.ympev.2008.09.008; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Edwards SV, 2000, EVOLUTION, V54, P1839; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Graham, 2010, LATE CRETACEOUS CENO; Hale ME, 1990, SYNOPSIS LICHEN GENU; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; HONEGGER R, 1991, ANNU REV PLANT PHYS, V42, P553, DOI 10.1146/annurev.arplant.42.1.553; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Leavitt S. D., 2012, B CALIFORNIA LICHEN, V19, P58; Leavitt S. D., 2008, EVANSIA, V26, P85; Leavitt SD, 2013, J BIOGEOGR, V40, P1792, DOI 10.1111/jbi.12118; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Leavitt SD, 2013, MOL PHYLOGENET EVOL, V66, P138, DOI 10.1016/j.ympev.2012.09.013; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; Leavitt SD, 2012, AM J BOT, V99, P1764, DOI 10.3732/ajb.1200146; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; Lindblom L, 2006, MOL ECOL, V15, P1545, DOI 10.1111/j.1365-294X.2006.02880.x; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Loera I, 2012, MOL PHYLOGENET EVOL, V65, P437, DOI 10.1016/j.ympev.2012.06.025; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch HT, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-257; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Lutzoni F, 1997, P NATL ACAD SCI USA, V94, P11422, DOI 10.1073/pnas.94.21.11422; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Myllys L, 2002, LICHENOLOGIST, V34, P237, DOI 10.1006/lich.2002.0390; NASH III, 2004, 3 NASHBD RYANP DIEDE; NASH TH, 1977, AM J BOT, V64, P664, DOI 10.1002/j.1537-2197.1977.tb11907.x; Nelson MF, 2013, ECOL EVOL, V3, P3455, DOI 10.1002/ece3.725; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Orange A., 2001, MICROCHEMICAL METHOD; Osborn G, 2001, QUATERNARY SCI REV, V20, P1377, DOI 10.1016/S0277-3791(01)00002-6; Palmqvist K, 2000, PLANT CELL ENVIRON, V23, P1, DOI 10.1046/j.1365-3040.2000.00529.x; Perez-Ortega S, 2012, ANN BOT-LONDON, V109, P1133, DOI 10.1093/aob/mcs042; Pinho C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-63; Pino-Bodas R, 2011, ORG DIVERS EVOL, V11, P343, DOI 10.1007/s13127-011-0062-2; Pino-Bodas R, 2012, MYCOL PROG, V11, P269, DOI 10.1007/s11557-011-0746-1; Plata ER, 2008, BIODIVERS CONSERV, V17, P1319, DOI 10.1007/s10531-007-9289-9; Plata ER, 2011, MOL PHYLOGENET EVOL, V61, P45, DOI 10.1016/j.ympev.2011.04.025; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poykko H, 2005, ECOLOGY, V86, P2623, DOI 10.1890/04-1632; Prieto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065576; Printzen C, 2003, MOL ECOL, V12, P1473, DOI 10.1046/j.1365-294X.2003.01812.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2009, TREEANNOTATOR VERSIO; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Rannala B, 2003, GENETICS, V164, P1645; Renhorn KE, 1997, OECOLOGIA, V109, P1, DOI 10.1007/s004420050051; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; ROSENTRETER R, 1993, BRYOLOGIST, V96, P333, DOI 10.2307/3243861; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Ruiz-Sanchez E, 2010, MOL PHYLOGENET EVOL, V54, P344, DOI 10.1016/j.ympev.2009.10.035; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Takamatsu Susumu, 2004, Mycoscience, V45, P340, DOI 10.1007/s10267-004-0187-7; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Thell A., 2009, BIBLIOTHECA LICHENOL, V99, P393; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; Truong C, 2013, MOL PHYLOGENET EVOL, V68, P357, DOI 10.1016/j.ympev.2013.04.005; VANDEVENDER TR, 1979, SCIENCE, V204, P701, DOI 10.1126/science.204.4394.701; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang HY, 2010, SCI CHINA LIFE SCI, V53, P1163, DOI 10.1007/s11427-010-4063-8; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	133	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85240	10.1371/journal.pone.0085240	http://dx.doi.org/10.1371/journal.pone.0085240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386465	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700135
J	McCann, S; Moeri, O; Jones, T; Scott, C; Khaskin, G; Gries, R; O'Donnell, S; Gries, G				McCann, Sean; Moeri, Onour; Jones, Tanya; Scott, Catherine; Khaskin, Grigori; Gries, Regine; O'Donnell, Sean; Gries, Gerhard			Strike Fast, Strike Hard: The Red-Throated Caracara Exploits Absconding Behavior of Social Wasps during Nest Predation	PLOS ONE			English	Article							SWARM-FOUNDING WASP; CHEMICAL DEFENSE; GIANT HONEYBEES; APIS-DORSATA; HYMENOPTERA; MORPHOLOGY; AUKLET; BIRDS; RATES; PREY	Red-throated Caracaras Ibycter americanus (Falconidae) are specialist predators of social wasps in the Neotropics. It had been proposed that these caracaras possess chemical repellents that allow them to take the brood of wasp nests without being attacked by worker wasps. To determine how caracaras exploit nests of social wasps and whether chemical repellents facilitate predation, we: (1) video recorded the birds attacking wasp nests; (2) analyzed surface extracts of the birds' faces, feet, and feathers for potential chemical repellents; and (3) inflicted mechanical damage on wasp nests to determine the defensive behavior of wasps in response to varying levels of disturbance. During caracara predation events, two species of large-bodied wasps mounted stinging attacks on caracaras, whereas three smaller-bodied wasp species did not. The "hit-and-run" predation tactic of caracaras when they attacked nests of large and aggressive wasps reduced the risk of getting stung. Our data reveal that the predation strategy of caracaras is based on mechanical disturbance of, and damage to, target wasp nests. Caracara attacks and severe experimental disturbance of nests invariably caused wasps to abscond (abandon their nests). Two compounds in caracara foot extracts [sulcatone and iridodial] elicited electrophysiological responses from wasp antennae, and were also present in defensive secretions of sympatric arboreal-nesting Azteca ants. These compounds appear not to be wasp repellents but to be acquired coincidentally by caracaras when they perch on trees inhabited with Azteca ants. We conclude that caracara predation success does not depend on wasp repellents but relies on the absconding response that is typical of swarm-founding polistine wasps. Our study highlights the potential importance of vertebrate predators in the ecology and evolution of social wasps.	[McCann, Sean; Moeri, Onour; Jones, Tanya; Scott, Catherine; Khaskin, Grigori; Gries, Regine; Gries, Gerhard] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [O'Donnell, Sean] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Simon Fraser University; Drexel University	McCann, S (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	smmccann@sfu.ca		Scott, Catherine/0000-0003-0860-4805; McCann, Sean/0000-0001-6030-6456	Centre National de la Recherche Scientifique; Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by three Project Amazonie research grants from the Centre National de la Recherche Scientifique to S. M. for travel and accommodation at the Nouragues Station in French Guiana (http://www.cnrs.fr/), and by a Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair to G. G. (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARN H, 1975, Z NATURFORSCH C, V30, P722; Bouwma AM, 2007, BIOTROPICA, V39, P719, DOI 10.1111/j.1744-7429.2007.00321.x; Burger BV, 2004, J CHEM ECOL, V30, P1603, DOI 10.1023/B:JOEC.0000042071.65335.f3; Chadab R., 1979, Psyche (Cambridge), V86, P115, DOI 10.1155/1979/38164; Charles-Dominique P, 2001, MONOG BIOL, V80, P1; Do Nascimento RR, 1998, J CHEM ECOL, V24, P1629, DOI 10.1023/A:1020864427854; Douglas HD, 2004, J CHEM ECOL, V30, P1921, DOI 10.1023/B:JOEC.0000045586.59468.de; Douglas HD, 2001, NATURWISSENSCHAFTEN, V88, P330, DOI 10.1007/s001140100236; DUMBACHER JP, 1992, SCIENCE, V258, P799, DOI 10.1126/science.1439786; Dytham C., 2011, CHOOSING USING STAT, P199; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; Gries R, 2002, J CHEM ECOL, V28, P2283, DOI 10.1023/A:1021005517389; Hagen Y, 1958, FOOD SOME HONEY BUZZ; Hermann H.R., 1981, P77; Hozumi S, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14135; Huang KY, 2004, J RAPTOR RES, V38, P367; ITAMIES J, 1972, Ornis Fennica, V49, P7; Jeanne R.L., 1991, P191; JEANNE RL, 1995, J INSECT BEHAV, V8, P433, DOI 10.1007/BF01995317; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; JEANNE RL, 1975, Q REV BIOL, V50, P267, DOI 10.1086/408564; JEANNE RL, 1978, BIOTROPICA, V10, P234, DOI 10.2307/2387909; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Kastberger G, 2000, APIDOLOGIE, V31, P727, DOI 10.1051/apido:2000157; KING WB, 1970, AUK, V87, P376, DOI 10.2307/4083939; Lee W-J, 2011, ORIENTAL HONEY BUZZA; London KB, 2003, BEHAV ECOL SOCIOBIOL, V54, P539, DOI 10.1007/s00265-003-0662-8; London KB, 2000, ETHOL ECOL EVOL, V12, P13, DOI 10.1080/03949370.2000.9728440; Lowery GH, 1951, BIRDS STATE VERACRUZ, P556; MAYS NM, 1985, WILSON BULL, V97, P231; McCann S, 2010, J RAPTOR RES, V44, P236, DOI 10.3356/JRR-09-75.1; Millar JG, 1998, METHODS CHEM ECOLOGY, P1; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; O'Donnell Sean, 2002, Journal of Insect Science (Tucson), V2, P1; RICHARDS O. W., 1951, TRANS ROY ENT SOC LONDON, V102, P1; Richards O.W., 1978, SOCIAL WASPS AM EXCL; Servigne P, 2003, ASS ENTRE FOURMI AZT; Sievwright H, 2011, ORNITHOL SCI, V10, P131, DOI 10.2326/osj.10.131; Skutch A. F., 1959, Animal Kingdom, V62, P8; Smith AR, 2001, EVOL ECOL RES, V3, P331; STADDON BW, 1980, COMP BIOCHEM PHYS A, V65, P371, DOI 10.1016/0300-9629(80)90046-8; Thapa R, 2003, AM BEE J, V143, P540; THIOLLAY JM, 1991, IBIS, V133, P382, DOI 10.1111/j.1474-919X.1991.tb04586.x; VOOUS KH, 1969, ARDEA, V57, P117; Voss RS, 2012, BIOL REV, V87, P822, DOI 10.1111/j.1469-185X.2012.00222.x; Warham J., 1977, Proceedings of the New Zealand Ecological Society, V24, P84; Weldon PJ, 1997, J CHEM ECOL, V23, P2609, DOI 10.1023/B:JOEC.0000006670.79075.92; Wenzel JW, 1998, AM MUS NOVIT; West-Eberhard M, 1982, NATURE EVOLUTION SWA; YOUNG A M, 1979, Journal of the Kansas Entomological Society, V52, P759	51	8	8	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84114	10.1371/journal.pone.0084114	http://dx.doi.org/10.1371/journal.pone.0084114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386338	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700098
J	Shi, J; Yuan, H; Xu, B				Shi, Jun; Yuan, Hao; Xu, Bing			Treatment of Mandibular Condyle Fractures Using a Modified Transparotid Approach via the Parotid Mini-Incision: Experience with 31 Cases	PLOS ONE			English	Article							RETROMANDIBULAR APPROACH; RIGID FIXATION; NECK	Surgery for mandibular condyle fractures must allow direct vision of the fracture, reduce surgical trauma and achieve reduction and fixation while avoiding facial nerve injury. This prospective study was conducted to introduce a new surgical approach for open reduction and internal fixation of mandibular condyle fractures using a modified transparotid approach via the parotid mini-incision, and surgical outcomes were evaluated. The modified transparotid approach via the parotid mini-incision was applied and rigid internal fixation using a small titanium plate was carried out for 36 mandibular condyle fractures in 31 cases. Postoperative follow-up of patients ranged from 3 to 26 months; in the first 3 months after surgery, outcomes for all patients were analyzed by evaluating the degree of mouth opening, occlusal relationship, facial nerve function and results of imaging studies. The occlusal relationships were excellent in all patients and none had symptoms of intraoperative ipsilateral facial nerve injury. The mean degree of mouth opening was 4.0 (maximum 4.8 cm, minimum 3.0 cm). No mandibular deviations were noted in any patient during mouth opening. CT showed complete anatomical reduction of the mandibular condyle fracture in all patients. The modified transparotid approach via the smaller, easily concealed parotid mini-incision is minimally invasive and achieves anatomical reduction and rigid internal fixation with a simplified procedure that directly exposes the fracture site. Study results showed that this procedure is safe and feasible for treating mandibular condyle fracture, and offers a short operative path, protection of the facial nerve and satisfactory aesthetic outcomes.	[Shi, Jun; Yuan, Hao; Xu, Bing] Shanghai Jiao Tong Univ, Sch Dent, Shanghai Peoples Hosp 9, Dept Craniomaxillofacial Sci, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xu, B (corresponding author), Shanghai Jiao Tong Univ, Sch Dent, Shanghai Peoples Hosp 9, Dept Craniomaxillofacial Sci, Shanghai 200030, Peoples R China.	bingxu568@hotmail.com						Cho BC, 2012, ARCH PLAST SURG-APS, V39, P190, DOI [10.5999/aps.2012.39.3.190, 10.5999/aps.2012.39.4.301]; Croce A, 2010, ACTA OTORHINOLARYNGO, V30, P303; Devlin MF, 2002, BRIT J ORAL MAX SURG, V40, P23, DOI 10.1054/bjom.2001.0748; Downie JJ, 2009, BRIT J ORAL MAX SURG, V47, P370, DOI 10.1016/j.bjoms.2008.11.002; Ebenezer V, 2011, J MAXILLOFAC ORAL SU, V10, P38, DOI 10.1007/s12663-010-0145-1; ELLIS E, 1993, ORAL SURG ORAL MED O, V76, P6, DOI 10.1016/0030-4220(93)90285-C; Guerrissi JO, 2002, J CRANIOFAC SURG, V13, P568; Guven O, 2001, J CRANIO MAXILL SURG, V29, P232, DOI 10.1054/jcms.2001.0228; Kim BK, 2012, J CRANIOFAC SURG, V23, P712, DOI 10.1097/SCS.0b013e31824dbb35; Manisali M, 2003, INT J ORAL MAX SURG, V32, P253, DOI 10.1054/ijom.2002.0270; Schoen R, 2008, INT J ORAL MAX SURG, V37, P111, DOI 10.1016/j.ijom.2007.06.017; Silverman SL, 1925, DENTISUTO COSMOS, V67, P876; Strobl H, 1999, INT J ORAL MAX SURG, V28, P95; Tang W, 2009, J ORAL MAXIL SURG, V67, P552, DOI 10.1016/j.joms.2008.06.066; Villarreal PM, 2004, J ORAL MAXIL SURG, V62, P155, DOI 10.1016/j.joms.2003.08.010; ZACHARIADES N, 1990, J CRANIO MAXILL SURG, V18, P251, DOI 10.1016/S1010-5182(05)80425-1; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854	17	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83525	10.1371/journal.pone.0083525	http://dx.doi.org/10.1371/journal.pone.0083525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386221	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700058
J	Yang, YJ; Li, JY; Liu, XW; Zhang, JY; Liu, YR; Li, B				Yang, Ya-Jun; Li, Jian-Yong; Liu, Xi-Wang; Zhang, Ji-Yu; Liu, Yu-Rong; Li, Bing			A Non-Biological Method for Screening Active Components against Influenza Virus from Traditional Chinese Medicine by Coupling a LC Column with Oseltamivir Molecularly Imprinted Polymers	PLOS ONE			English	Article							MASS-SPECTROMETRY; DRUG DISCOVERY; EXTRACTION; TRANSMISSION; RECOGNITION; TECHNOLOGY; ALKALOIDS; SAMPLES; ACID	To develop a non-biological method for screening active components against influenza virus from traditional Chinese medicine (TCM) extraction, a liquid chromatography (LC) column prepared with oseltamivir molecularly imprinted polymer (OSMIP) was employed with LC-mass spectrometry (LC-MS). From chloroform extracts of compound TCM liquid preparation, we observed an affinitive component m/z 249, which was identified to be matrine following analysis of phytochemical literatures, OSMIP-LC column on-line of control compounds and MS/MS off-line. The results showed that matrine had similar bioactivities with OS against avian influenza virus H9N2 in vitro for both alleviating cytopathic effect and hemagglutination inhibition and that the stereostructures of these two compounds are similar while their two-dimensional structures were different. In addition, our results suggested that the bioactivities of those affinitive compounds were correlated with their chromatographic behaviors, in which less difference of the chromatographic behaviors might have more similar bioactivities. This indicates that matrine is a potential candidate drug to prevent or cure influenza for human or animal. In conclusion, the present study showed that molecularly imprinted polymers can be used as a non-biological method for screening active components against influenza virus from TCM.	[Yang, Ya-Jun; Li, Jian-Yong; Liu, Xi-Wang; Zhang, Ji-Yu; Liu, Yu-Rong; Li, Bing] CAAS, Gansu Prov Engn Res Ctr New Anim Drug, Key Lab New Anim Drug Project,Key Lab Vet Pharmac, Minist Agr,Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Li, JY (corresponding author), CAAS, Gansu Prov Engn Res Ctr New Anim Drug, Key Lab New Anim Drug Project,Key Lab Vet Pharmac, Minist Agr,Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Gansu, Peoples R China.	lijy1971@163.com			National Natural Science Foundation of China [30771590]; Postdoctoral Science Foundation of China [20070420443]; earmarked fund for China Agriculture Research System [cars-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); earmarked fund for China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (No. 30771590), the Postdoctoral Science Foundation of China (No. 20070420443) and the earmarked fund for China Agriculture Research System (cars-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouss M, 2011, J MATER SCI-MATER M, V22, P2273, DOI 10.1007/s10856-011-4395-3; Ansell RJ, 2005, ADV DRUG DELIVER REV, V57, P1809, DOI 10.1016/j.addr.2005.07.014; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HX, 2006, CHINESE J ANAL CHEM, V34, P205; [陈佳娟 CHEN Jia-juan], 2010, [湖北农业科学, Hubei Agricultural Sciences], V49, P635; Chen Q, 2006, ANTIVIRUS, P281; Cirillo G, 2010, J PHARM PHARMACOL, V62, P577, DOI [10.1211/jpp.62.05.0003, 10.1211/jpp/62.05.0003]; Cui Rong, 2012, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V43, P321; Dias ACB, 2008, TALANTA, V76, P988, DOI 10.1016/j.talanta.2008.05.040; Gomez-Caballero A, 2011, BIOSENS BIOELECTRON, V28, P25, DOI 10.1016/j.bios.2011.06.048; Gonzalez-Reiche AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032873, 10.1371/journal.pone.0046852]; Gurtova O, 2013, ANAL BIOANAL CHEM, V405, P287, DOI 10.1007/s00216-012-6493-6; Hayden O, 2006, ADV FUNCT MATER, V16, P1269, DOI 10.1002/adfm.200500626; Huang MX, 2012, J PHARMACEUT BIOMED, V58, P12, DOI 10.1016/j.jpba.2011.09.010; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Karasova G, 2005, J SEP SCI, V28, P2468, DOI 10.1002/jssc.200500190; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Nguyen HT, 2012, ANTIVIR RES, V93, P381, DOI 10.1016/j.antiviral.2012.01.006; O'Connor NA, 2007, J AM CHEM SOC, V129, P1680, DOI 10.1021/ja067276c; PU Q-L, 1987, Yaoxue Xuebao, V22, P438; Puoci F, 2011, EXPERT OPIN DRUG DEL, V8, P1379, DOI 10.1517/17425247.2011.609166; Rathbone DL, 2005, ADV DRUG DELIVER REV, V57, P1854, DOI 10.1016/j.addr.2005.07.017; Ryu YB, 2008, BIOORG MED CHEM LETT, V18, P6046, DOI 10.1016/j.bmcl.2008.10.033; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Seibert CW, 2012, J VIROL, V86, P5386, DOI 10.1128/JVI.00151-12; Szultka M, 2012, ANAL BIOANAL CHEM, V403, P785, DOI 10.1007/s00216-012-5901-2; Tokonami S, 2009, ANAL CHIM ACTA, V641, P7, DOI 10.1016/j.aca.2009.03.035; van Nostrum Cornelus F, 2005, Drug Discov Today Technol, V2, P119, DOI 10.1016/j.ddtec.2005.05.004; Wang SF, 2007, ELECTROPHORESIS, V28, P1399, DOI 10.1002/elps.200600428; Wang Xiao-yan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P2154; Xie JC, 2002, ANAL CHEM, V74, P2352, DOI 10.1021/ac015755i; Xie JC, 2001, ACTA PHYS-CHIM SIN, V17, P582, DOI 10.3866/PKU.WHXB20010702; Xu SY, 2002, EXPT MODELS RES METH, P1729; Xu Xiaojie, 2006, Drug Discov Today Technol, V3, P247, DOI 10.1016/j.ddtec.2006.09.008; Yan HY, 2012, J CHROMATOGR A, V1256, P1, DOI 10.1016/j.chroma.2012.07.037; Yang YJ, 2012, MOLECULES, V17, P10370, DOI 10.3390/molecules170910370; Yang YJ, 2011, ANAL BIOANAL CHEM, V400, P3665, DOI 10.1007/s00216-011-5063-7; Ye L, 2004, ANAL BIOANAL CHEM, V378, P1887, DOI 10.1007/s00216-003-2450-8; Yu TF, 1993, CHIN TRADIT PATENT M, V15, P32; Zhao Qinqin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P762; Zhou L, 2002, ACTA PHYS-CHIM SIN, V18, P808, DOI 10.3866/PKU.WHXB20020908; Zhu LL, 2003, ANAL CHEM, V75, P6381, DOI 10.1021/ac026371a	43	9	9	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84458	10.1371/journal.pone.0084458	http://dx.doi.org/10.1371/journal.pone.0084458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386385	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700108
J	Brummett, BH; Babyak, MA; Jiang, R; Shah, SH; Becker, RC; Haynes, C; Chryst-Ladd, M; Craig, DM; Hauser, ER; Siegler, IC; Kuhn, CM; Singh, A; Williams, RB				Brummett, Beverly H.; Babyak, Michael A.; Jiang, Rong; Shah, Svati H.; Becker, Richard C.; Haynes, Carol; Chryst-Ladd, Megan; Craig, Damian M.; Hauser, Elizabeth R.; Siegler, Ilene C.; Kuhn, Cynthia M.; Singh, Abanish; Williams, Redford B.			A Functional Polymorphism in the 5HTR2C Gene Associated with Stress Responses Also Predicts Incident Cardiovascular Events	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; 5-HT2C RECEPTOR; SALIVARY CORTISOL; MEN; DISEASE; AGOMELATINE; SEROTONIN; SYMPTOMS; CYS23SER; RISK	Previously we have shown that a functional nonsynonymous single nucleotide polymorphism (rs6318) of the 5HTR2C gene located on the X-chromosome is associated with hypothalamic-pituitary-adrenal axis response to a stress recall task, and with endophenotypes associated with cardiovascular disease (CVD). These findings suggest that individuals carrying the rs6318 Ser23 C allele will be at higher risk for CVD compared to Cys23 G allele carriers. The present study examined allelic variation in rs6318 as a predictor of coronary artery disease (CAD) severity and a composite endpoint of all-cause mortality or myocardial infarction (MI) among Caucasian participants consecutively recruited through the cardiac catheterization laboratory at Duke University Hospital (Durham, NC) as part of the CATHGEN biorepository. Study population consisted of 6,126 Caucasian participants (4,036 [65.9%] males and 2,090 [34.1%] females). A total of 1,769 events occurred (1,544 deaths and 225 MIs; median follow-up time = 5.3 years, interquartile range = 3.3-8.2). Unadjusted Cox time-to-event regression models showed, compared to Cys23 G carriers, males hemizygous for Ser23 C and females homozygous for Ser23C were at increased risk for the composite endpoint of all-cause death or MI: Hazard Ratio (HR) = 1.47, 95% confidence interval (CI) = 1.17, 1.84, p = .0008. Adjusting for age, rs6318 genotype was not related to body mass index, diabetes, hypertension, dyslipidemia, smoking history, number of diseased coronary arteries, or left ventricular ejection fraction in either males or females. After adjustment for these covariates the estimate for the two Ser23 C groups was modestly attenuated, but remained statistically significant: HR = 1.38, 95% CI = 1.10, 1.73, p = .005. These findings suggest that this functional polymorphism of the 5HTR2C gene is associated with increased risk for CVD mortality and morbidity, but this association is apparently not explained by the association of rs6318 with traditional risk factors or conventional markers of atherosclerotic disease.	[Brummett, Beverly H.; Babyak, Michael A.; Jiang, Rong; Siegler, Ilene C.; Kuhn, Cynthia M.; Singh, Abanish; Williams, Redford B.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Shah, Svati H.; Becker, Richard C.; Haynes, Carol; Chryst-Ladd, Megan; Craig, Damian M.; Hauser, Elizabeth R.] Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Durham, NC 27710 USA; [Shah, Svati H.; Becker, Richard C.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Kuhn, Cynthia M.] Duke Univ, Med Ctr, Durham, NC USA; [Hauser, Elizabeth R.] Durham VA Med Ctr, Epidemiol Res & Informat Ctr, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Brummett, BH (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA.	brummett@duke.edu		Hauser, Elizabeth/0000-0003-0367-9189	National Heart, Lung, and Blood Institutes [P01 HL036587]; Duke Behavioral Medicine Research Center; NIH [HL095987]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095987, P01HL036587] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Duke Behavioral Medicine Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Heart, Lung, and Blood Institutes grant P01 HL036587 and NIH HL095987; and the Duke Behavioral Medicine Research Center. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni MH, 2009, BRAIN BEHAV IMMUN, V23, P580, DOI 10.1016/j.bbi.2008.09.005; Boyle SH, 2007, DIABETES CARE, V30, P2484, DOI 10.2337/dc07-0258; Brummett BH, 2012, BIOL PSYCHOL, V89, P94, DOI 10.1016/j.biopsycho.2011.09.013; Brummett BH, 2012, ASS CARDIOVASCULAR R; Corbach-Sohle S, 2008, EXP CLIN ENDOCRINOL, V116, pN10; Davey Smith G, 2005, CIRCULATION, V112, P332, DOI DOI 10.1161/CIRCULATIONAHA.104.489088; Dinan TG, 1996, LIFE SCI, V58, P1683, DOI 10.1016/0024-3205(96)00066-5; Hamer M, 2010, EUR HEART J, V31, P424, DOI 10.1093/eurheartj/ehp386; Heisler LK, 2007, J NEUROSCI, V27, P6956, DOI 10.1523/JNEUROSCI.2584-06.2007; Hinkelmann K, 2012, STRESS, V15, P105, DOI 10.3109/10253890.2011.582200; Karlamangla AS, 2005, NEUROBIOL AGING, V26, pS80, DOI 10.1016/j.neurobiolaging.2005.09.037; Kasper S, 2010, J CLIN PSYCHIAT, V71, P109, DOI 10.4088/JCP.09m05347blu; Kuhn KU, 2004, PHARMACOPSYCHIATRY, V37, P286, DOI 10.1055/s-2004-832985; Kuhn KU, 2002, PHARMACOPSYCHIATRY, V35, P226, DOI 10.1055/s-2002-36388; Kumari M, 2010, PSYCHONEUROENDOCRINO, V35, P1091, DOI 10.1016/j.psyneuen.2010.01.010; LAPPALAINEN J, 1995, GENOMICS, V27, P274, DOI 10.1006/geno.1995.1042; Leproult R, 2005, CLIN ENDOCRINOL, V63, P298, DOI 10.1111/j.1365-2265.2005.02341.x; Lerer B, 2001, MOL PSYCHIATR, V6, P579, DOI 10.1038/sj.mp.4000883; Lowry CA, 2002, J NEUROENDOCRINOL, V14, P911, DOI 10.1046/j.1365-2826.2002.00861.x; Minear MA, 2011, HUM GENET, V129, P641, DOI 10.1007/s00439-011-0959-z; Newby AC, 2009, THROMB HAEMOSTASIS, V101, P1006, DOI 10.1160/TH08-07-0469; Nijm J, 2008, INFLAMMATION CORTISO; Okada M, 2004, MOL PSYCHIATR, V9, P55, DOI 10.1038/sj.mp.4001357; Pereg D, 2011, STRESS, V14, P73, DOI 10.3109/10253890.2010.511352; Raff H, 1999, J GERONTOL A-BIOL, V54, pM479, DOI 10.1093/gerona/54.9.M479; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P1602, DOI 10.1210/jc.2009-2112; Rosmond R, 2003, J INTERN MED, V254, P386, DOI 10.1046/j.1365-2796.2003.01205.x; Rosmond R, 2002, OBES RES, V10, P585, DOI 10.1038/oby.2002.79; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shah SH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000318; Suarez EC, 1998, PSYCHOSOM MED, V60, P78, DOI 10.1097/00006842-199801000-00017; Sutton BS, 2008, HUM MOL GENET, V17, P1318, DOI 10.1093/hmg/ddn020; Szymanowski A, 2011, PSYCHONEUROENDOCRINO, V36, P139, DOI 10.1016/j.psyneuen.2010.06.012; Varadhan R, 2008, J GERONTOL A-BIOL, V63, P190, DOI 10.1093/gerona/63.2.190; Williams RB, 2008, ANNU REV CLIN PSYCHO, V4, P349, DOI 10.1146/annurev.clinpsy.4.022007.141237	36	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82781	10.1371/journal.pone.0082781	http://dx.doi.org/10.1371/journal.pone.0082781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24386118	gold, Green Published, Green Submitted			2022-12-27	WOS:000328740300068
J	Zhang, YH; Xu, XL; Zhou, XJ; Chen, RM; Yang, PL; Meng, QC; Meng, K; Luo, HY; Yuan, JH; Bin Yao, B; Zhang, W				Zhang, Yuhong; Xu, Xiaolu; Zhou, Xiaojin; Chen, Rumei; Yang, Peilong; Meng, Qingchang; Meng, Kun; Luo, Huiying; Yuan, Jianhua; Yao, Bin; Zhang, Wei			Overexpression of an Acidic Endo-beta-1,3-1,4-glucanase in Transgenic Maize Seed for Direct Utilization in Animal Feed	PLOS ONE			English	Article							ACIDOTHERMUS-CELLULOLYTICUS ENDOGLUCANASE; THERMOSTABLE BETA-1,3-1,4-GLUCANASE; NUTRIENT DIGESTIBILITY; BROILER-CHICKENS; BARLEY; EXPRESSION; GLUCANASE; XYLANASE; GLUCOSE; BIOMASS	Background: Incorporation of exogenous glucanase into animal feed is common practice to remove glucan, one of the anti-nutritional factors, for efficient nutrition absorption. The acidic endo-beta-1,3-1,4-glucanase (Bgl7A) from Bispora sp. MEY-1 has excellent properties and represents a potential enzyme supplement to animal feed. Methodology/Principal Findings: Here we successfully developed a transgenic maize producing a high level of Bgl7AM (codon modified Bgl7A) by constructing a recombinant vector driven by the embryo-specific promoter ZM-leg1A. Southern and Western blot analysis indicated the stable integration and specific expression of the transgene in maize seeds over four generations. The beta-glucanase activity of the transgenic maize seeds reached up to 779,800 U/kg, about 236-fold higher than that of non-transgenic maize. The beta-glucanase derived from the transgenic maize seeds had an optimal pH of 4.0 and was stable at pH 1.0-8.0, which is in agreement with the normal environment of digestive tract. Conclusion/Significance: Our study offers a transgenic maize line that could be directly used in animal feed without any glucanase production, purification and supplementation, consequently simplifying the feed enzyme processing procedure.	[Zhang, Yuhong; Zhou, Xiaojin; Chen, Rumei; Zhang, Wei] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Xu, Xiaolu; Yang, Peilong; Meng, Kun; Luo, Huiying; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Meng, Qingchang; Yuan, Jianhua] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Jiangsu Academy of Agricultural Sciences	Bin Yao, B (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	binyao@caas.cn; zhangwei02@caas.cn			Key Program of Transgenic Plant Breeding [2013ZX08003-002, 2009ZX08003-020B]; China Modern Agriculture Research System [CARS-42]	Key Program of Transgenic Plant Breeding; China Modern Agriculture Research System	This research was supported by the Key Program of Transgenic Plant Breeding 2013ZX08003-002, 2009ZX08003-020B (http://www.nmp.gov.cn/zxjs/zjy/201012/t20101208_2129.htm) and the China Modern Agriculture Research System CARS-42 (http://english.agri.gov.cn/hottopics/five/201304/t20130421_19483.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; ALMIRALL M, 1995, J NUTR, V125, P947; Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Armstrong JD, 2002, AM J POTATO RES, V79, P39, DOI 10.1007/BF02883522; Biswas GCG, 2006, PLANT SCI, V171, P617, DOI 10.1016/j.plantsci.2006.06.004; BULIGA GS, 1986, CARBOHYD RES, V157, P139, DOI 10.1016/0008-6215(86)85065-0; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Choct M, 2006, WORLD POULTRY SCI J, V62, P5, DOI 10.1079/WPS200480; DENG F, 2009, CHIN AGR SCI B, V25, P7; Flickinger EA, 2000, J NUTR, V130, P1267, DOI 10.1093/jn/130.5.1267; Grishutin SG, 2006, CARBOHYD RES, V341, P218, DOI 10.1016/j.carres.2005.11.011; HOLWERDA BC, 1992, PLANT CELL, V4, P307, DOI 10.1105/tpc.4.3.307; Horvath H, 2000, P NATL ACAD SCI USA, V97, P1914, DOI 10.1073/pnas.030527497; Hua CW, 2010, APPL MICROBIOL BIOT, V88, P509, DOI 10.1007/s00253-010-2759-0; Jensen LG, 1996, P NATL ACAD SCI USA, V93, P3487, DOI 10.1073/pnas.93.8.3487; Jia HY, 2012, J BIOTECHNOL, V159, P50, DOI 10.1016/j.jbiotec.2012.02.007; Jozefiak D, 2010, BRIT POULTRY SCI, V51, P546, DOI 10.1080/00071668.2010.507243; Kiarie E, 2012, LIVEST SCI, V148, P129, DOI 10.1016/j.livsci.2012.05.020; Liu HM, 2010, MOL BIOL REP, V37, P677, DOI 10.1007/s11033-009-9521-7; Luo HY, 2010, APPL MICROBIOL BIOT, V85, P1015, DOI 10.1007/s00253-009-2119-0; Mathlouthi N, 2002, ANIM RES, V51, P395, DOI 10.1051/animres:2002034; McCarthy T, 2003, INT J BIOL MACROMOL, V33, P141, DOI 10.1016/S0141-8130(03)00080-1; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oraby H, 2007, TRANSGENIC RES, V16, P739, DOI 10.1007/s11248-006-9064-9; Ransom C, 2007, APPL BIOCHEM BIOTECH, V137, P207, DOI 10.1007/s12010-007-9053-3; Ribeiro T, 2012, BRIT POULTRY SCI, V53, P224, DOI 10.1080/00071668.2012.674632; Sridevi G, 2008, PLANT SCI, V175, P283, DOI 10.1016/j.plantsci.2008.04.011; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Tomes D. T., 1995, P197; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; von Wettstein D, 2000, P NATL ACAD SCI USA, V97, P13512, DOI 10.1073/pnas.97.25.13512; Wang LL, 2007, J FOOD SCI, V72, pC452, DOI 10.1111/j.1750-3841.2007.00549.x; Woo YM, 2001, PLANT CELL, V13, P2297, DOI 10.1105/tpc.13.10.2297; Yamagata T, 2003, J EXP BOT, V54, P913, DOI 10.1093/jxb/erg090; Zhang Q, 2012, PROTEIN EXPRES PURIF, V82, P279, DOI 10.1016/j.pep.2012.01.011; Ziegler MT, 2000, MOL BREEDING, V6, P37, DOI 10.1023/A:1009667524690	36	4	5	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81993	10.1371/journal.pone.0081993	http://dx.doi.org/10.1371/journal.pone.0081993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391711	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200008
J	Nijmeijer, RM; van Santvoort, HC; Zhernakova, A; Teller, S; Scheiber, JA; de Kovel, CG; Besselink, MGH; Visser, JTJ; Lutgendorff, F; Bollen, TL; Boermeester, MA; Rijkers, GT; Weiss, FU; Mayerle, J; Lerch, MM; Gooszen, HG; Akkermans, LMA; Wijmenga, C				Nijmeijer, Rian M.; van Santvoort, Hjalmar C.; Zhernakova, Alexandra; Teller, Steffen; Scheiber, Jonas A.; de Kovel, Carolien G.; Besselink, Marc G. H.; Visser, Jeroen T. J.; Lutgendorff, Femke; Bollen, Thomas L.; Boermeester, Marja A.; Rijkers, Ger T.; Weiss, Frank U.; Mayerle, Julia; Lerch, Markus M.; Gooszen, Hein G.; Akkermans, Louis M. A.; Wijmenga, Cisca		Dutch Pancreatitis Study Grp	Association Analysis of Genetic Variants in the Myosin IXB Gene in Acute Pancreatitis	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; CELIAC-DISEASE; MY09B GENE; BARRIER DYSFUNCTION; UNITED-STATES; ORGAN FAILURE; SPINK1 GENE; POLYMORPHISMS; MUTATIONS; HAPLOTYPE	Introduction: Impairment of the mucosal barrier plays an important role in the pathophysiology of acute pancreatitis. The myosin IXB (MYO9B) gene and the two tight-junction adaptor genes, PARD3 and MAGI2, have been linked to gastrointestinal permeability. Common variants of these genes are associated with celiac disease and inflammatory bowel disease, two other conditions in which intestinal permeability plays a role. We investigated genetic variation in MYO9B, PARD3 and MAGI2 for association with acute pancreatitis. Methods: Five single nucleotide polymorphisms (SNPs) in MYO9B, two SNPs in PARD3, and three SNPs in MAGI2 were studied in a Dutch cohort of 387 patients with acute pancreatitis and over 800 controls, and in a German cohort of 235 patients and 250 controls. Results: Association to MYO9B and PARD3 was observed in the Dutch cohort, but only one SNP in MYO9B and one in MAGI2 showed association in the German cohort (p < 0.05). Joint analysis of the combined cohorts showed that, after correcting for multiple testing, only two SNPs in MYO9B remained associated (rs7259292, p = 0.0031, odds ratio (OR) 1.94, 95% confidence interval (95% CI) 1.35-2.78; rs1545620, p = 0.0006, OR 1.33, 95% CI 1.16-1.53). SNP rs1545620 is a non-synonymous SNP previously suspected to impact on ulcerative colitis. None of the SNPs showed association to disease severity or etiology. Conclusion: Variants in MYO9B may be involved in acute pancreatitis, but we found no evidence for involvement of PARD3 or MAGI2.	[Nijmeijer, Rian M.; van Santvoort, Hjalmar C.; Besselink, Marc G. H.; Lutgendorff, Femke; Rijkers, Ger T.; Gooszen, Hein G.; Akkermans, Louis M. A.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Zhernakova, Alexandra; de Kovel, Carolien G.; Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Grp, Utrecht, Netherlands; [Zhernakova, Alexandra; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Teller, Steffen; Scheiber, Jonas A.; Weiss, Frank U.; Mayerle, Julia; Lerch, Markus M.] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med A, Greifswald, Germany; [Besselink, Marc G. H.; Boermeester, Marja A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Visser, Jeroen T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Immunol Sect, Groningen, Netherlands; [Bollen, Thomas L.] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands; [Rijkers, Ger T.; Gooszen, Hein G.] Radboud Univ Nijmegen, Med Ctr, Dept Operating Room Evidence Based Surg, NL-6525 ED Nijmegen, Netherlands; [Rijkers, Ger T.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Ernst Moritz Arndt Universitat Greifswald; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; St. Antonius Hospital Utrecht; Radboud University Nijmegen; St. Antonius Hospital Utrecht	Nijmeijer, RM (corresponding author), Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands.	RianNijmeijer@gmail.com	de Kovel, Carolien/AAI-3531-2021; Lerch, Markus M./E-2206-2016; Wijmenga, Cisca/D-2173-2009; Gooszen, H.G./H-8036-2014; Rijkers, Ger/R-7236-2019; Besselink, Marc/H-3294-2019; Mayerle, Julia/W-7907-2019; Rijkers, Ger/AAW-6143-2020; Weiss, Frank Ulrich/A-6386-2009; Besselink, Marc G/R-4268-2019; Zhernakova, Alexandra/ABA-9372-2020; rosman, camiel/F-9059-2016; Wijmenga, Cisca/AAE-7719-2019	de Kovel, Carolien/0000-0002-7818-1396; Lerch, Markus M./0000-0002-9643-8263; Rijkers, Ger/0000-0001-6948-6123; Weiss, Frank Ulrich/0000-0003-3369-6369; Besselink, Marc G/0000-0003-2650-9350; rosman, camiel/0000-0002-9152-3987; Wijmenga, Cisca/0000-0002-5635-1614; Zhernakova, Alexandra/0000-0002-4574-0841; Mayerle, Julia/0000-0002-3666-6459	Senter, an agency of the Dutch Ministry of Economic Affairs [TSGE3109]; Alexandre Suerman stipend from the University Medical Center Utrecht; Dutch Diabetes Foundation [2007.00.069]; VICI grant from the Netherlands Organization for Scientific Research [918.66.620]; Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung [109102]; Deutsche Forschungsgemeinschaft (DFG) [GRK840-E3/E4, MA 4115/1-2/3, NI 1297/1-1]; German Federal Ministry of Education and Research (BMBF) [GANI-MED 03152061A, BMBF 0314107]; European Union	Senter, an agency of the Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Alexandre Suerman stipend from the University Medical Center Utrecht; Dutch Diabetes Foundation; VICI grant from the Netherlands Organization for Scientific Research; Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This study was supported by Senter, an agency of the Dutch Ministry of Economic Affairs (grant. no. TSGE3109). RMN was supported by an Alexandre Suerman stipend from the University Medical Center Utrecht. JTJV was supported by a grant from the Dutch Diabetes Foundation (2007.00.069). CW was supported by a VICI grant (918.66.620) from the Netherlands Organization for Scientific Research. The study was further supported by the Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung (109102), the Deutsche Forschungsgemeinschaft (DFG GRK840-E3/E4, MA 4115/1-2/3, NI 1297/1-1), the German Federal Ministry of Education and Research (BMBF GANI-MED 03152061A and BMBF 0314107) and the European Union (EU-FP-7: EPC-TM and EU-FP7-REGPOT-2010-1). All funding was independent of the work described in this article. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ammori BJ, 1999, J GASTROINTEST SURG, V3, P252, DOI 10.1016/S1091-255X(99)80067-5; Aoun E, 2010, AM J GASTROENTEROL, V105, P446, DOI 10.1038/ajg.2009.630; Bagul Anil, 2009, Eur J Gastroenterol Hepatol, V21, P485, DOI 10.1097/MEG.0b013e3283218645; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beger HG, 1997, WORLD J SURG, V21, P130, DOI 10.1007/s002689900204; Besselink MG, 2009, BRIT J SURG, V96, P267, DOI 10.1002/bjs.6447; Besselink MG, 2009, ANN SURG, V250, P712, DOI 10.1097/SLA.0b013e3181bce5bd; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Carratu R, 1999, J PEDIATR GASTR NUTR, V28, P264, DOI 10.1097/00005176-199903000-00010; Cooney R, 2009, INFLAMM BOWEL DIS, V15, P1014, DOI 10.1002/ibd.20885; Damci T, 2003, EUR J CLIN INVEST, V33, P397, DOI 10.1046/j.1365-2362.2003.01161.x; DEITCH EA, 1990, ARCH SURG-CHICAGO, V125, P403; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; FALLON MB, 1995, GASTROENTEROLOGY, V108, P1863, DOI 10.1016/0016-5085(95)90151-5; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Guenther A, 2010, GUT, V59, P1154, DOI 10.1136/gut.2009.192492; Kume K, 2005, PANCREATOLOGY, V5, P354, DOI 10.1159/000086535; Latiano A, 2008, ALIMENT PHARM THER, V27, P241, DOI 10.1111/j.1365-2036.2007.03551.x; Santiago J, 2008, HUM IMMUNOL, V69, P112, DOI 10.1016/j.humimm.2008.01.003; Lutgendorff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004512; Meddings JB, 1999, AM J PHYSIOL-GASTR L, V276, pG951, DOI 10.1152/ajpgi.1999.276.4.G951; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Nunez C, 2007, GUT, V56, P1321, DOI 10.1136/gut.2007.121905; O'Reilly DA, 2008, EUR J GASTROEN HEPAT, V20, P726, DOI 10.1097/MEG.0b013e3282f5728c; Post PL, 1998, J CELL SCI, V111, P941; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanchez E, 2007, HUM IMMUNOL, V68, P610, DOI 10.1016/j.humimm.2007.03.006; Schmitt M, 2004, PANCREAS, V28, P181, DOI 10.1097/00006676-200403000-00010; Schnekenburger J, 2005, GUT, V54, P1445, DOI 10.1136/gut.2004.063164; Secondulfo M, 2004, DIGEST LIVER DIS, V36, P35, DOI 10.1016/j.dld.2003.09.016; Tukiainen E, 2005, PANCREAS, V30, P239, DOI 10.1097/01.mpa.0000157479.84036.ed; Van Bodegraven AA, 2006, GASTROENTEROLOGY, V131, P1768, DOI 10.1053/j.gastro.2006.09.011; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Whitcomb DC, 2010, AM J GASTROENTEROL, V105, P2287, DOI 10.1038/ajg.2010.183; Whitcomb DC, 2010, ANNU REV MED, V61, P413, DOI 10.1146/annurev.med.041608.121416; Whitcomb DC, 2004, GUT, V53, P1710, DOI 10.1136/gut.2003.015511; Wolters VM, 2007, CLIN GASTROENTEROL H, V5, P1399, DOI 10.1016/j.cgh.2007.08.018; Wolters VM, 2011, HUM IMMUNOL, V72, P592, DOI 10.1016/j.humimm.2011.03.025; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233	44	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85870	10.1371/journal.pone.0085870	http://dx.doi.org/10.1371/journal.pone.0085870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386489	Green Published, gold			2022-12-27	WOS:000329194700146
J	Santamaria, CA; Mateos, M; Taiti, S; DeWitt, TJ; Hurtado, LA				Santamaria, Carlos A.; Mateos, Mariana; Taiti, Stefano; DeWitt, Thomas J.; Hurtado, Luis A.			A Complex Evolutionary History in a Remote Archipelago: Phylogeography and Morphometrics of the Hawaiian Endemic Ligia Isopods	PLOS ONE			English	Article							HALOCARIDINA-RUBRA; DIVERSIFICATION; BIOGEOGRAPHY; CONFIDENCE; PHYLOGENY; CRUSTACEA; LIGIIDAE; DIPTERA; ORIGIN; OCCIDENTALIS	Compared to the striking diversification and levels of endemism observed in many terrestrial groups within the Hawaiian Archipelago, marine invertebrates exhibit remarkably lower rates of endemism and diversification. Supralittoral invertebrates restricted to specific coastal patchy habitats, however, have the potential for high levels of allopatric diversification. This is the case of Ligia isopods endemic to the Hawaiian Archipelago, which most likely arose from a rocky supralittoral ancestor that colonized the archipelago via rafting, and diversified into rocky supralittoral and inland lineages. A previous study on populations of this isopod from O. ahu and Kaua. i revealed high levels of allopatric differentiation, and suggested inter-island historical dispersal events have been rare. To gain a better understanding on the diversity and evolution of this group, we expanded prior phylogeographic work by incorporating populations from unsampled main Hawaiian Islands (Maui, Moloka. i, Lana. i, and Hawai. i), increasing the number of gene markers (four mitochondrial and two nuclear genes), and conducting Maximum likelihood and Bayesian phylogenetic analyses. Our study revealed new lineages and expanded the distribution range of several lineages. The phylogeographic patterns of Ligia in the study area are complex, with Hawai. i, O. ahu, and the Maui-Nui islands sharing major lineages, implying multiple inter-island historical dispersal events. In contrast, the oldest and most geographically distant of the major islands (Kaua. i) shares no lineages with the other islands. Our results did not support the monophyly of all the supralittoral lineages (currently grouped into L. hawaiensis), or the monophyly of the terrestrial lineages (currently grouped into L. perkinsi), implying more than one evolutionary transition between coastal and inland forms. Geometric-morphometric analyses of three supralittoral clades revealed significant body shape differences among them. A taxonomic revision of Hawaiian Ligia is warranted. Our results are relevant for the protection of biodiversity found in an environment subject to high pressure from disturbances.	[Santamaria, Carlos A.; Mateos, Mariana; DeWitt, Thomas J.; Hurtado, Luis A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Santamaria, Carlos A.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Taiti, Stefano] CNR, Ist Studio Ecosistemi, Florence, Italy	Texas A&M University System; Texas A&M University College Station; Texas State University System; Sam Houston State University; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR)	Hurtado, LA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lhurtado@tamu.edu	Hurtado, Luis A/B-5953-2008; Santamaria, Carlos A/T-9447-2017; Taiti, Stefano/O-2202-2019; Mateos, Mariana/B-5235-2008	Hurtado, Luis A/0000-0002-9773-4996; Santamaria, Carlos A/0000-0001-8576-463X; Mateos, Mariana/0000-0001-5738-0145; DeWitt, Thomas/0000-0001-7405-3904	Alfred P. Sloan Foundation Minority Ph. D. Program in Mathematics, Science and Engineering Fellowship; National Science Foundation (NSF) [DEB 0743782]; Texas A&M Hispanics Leaders in Agriculture and the Environment Fellowship; Tom Slick Senior Graduate Fellowship; Division Of Environmental Biology [0743782] Funding Source: National Science Foundation	Alfred P. Sloan Foundation Minority Ph. D. Program in Mathematics, Science and Engineering Fellowship; National Science Foundation (NSF)(National Science Foundation (NSF)); Texas A&M Hispanics Leaders in Agriculture and the Environment Fellowship; Tom Slick Senior Graduate Fellowship; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Fieldwork was partially supported by funds from an Alfred P. Sloan Foundation Minority Ph. D. Program in Mathematics, Science and Engineering Fellowship to CAS. Reagents and laboratory expenses were supported by National Science Foundation (NSF) grant DEB 0743782 to LAH and MM. This grant also provided partial support for CAS. Additional support for CAS was provided by a Texas A&M Hispanics Leaders in Agriculture and the Environment Fellowship, and by the Tom Slick Senior Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli A., 1954, Atti Accad Torino Cl Sci fiz mat e nat, V88, P147; Baldwin Bruce G., 1995, P259; Bertocchi S, 2008, J NAT HIST, V42, P2063, DOI 10.1080/00222930802254664; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Carefoot T. H., 1995, TERRESTRIAL ISOPOD B, P47; Carefoot TH, 2000, CAN J ZOOL, V78, P588, DOI 10.1139/cjz-78-4-588; CAREFOOT TH, 1973, MAR BIOL, V18, P302; Carson Hampton L., 1995, P14; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; CARSON HL, 1982, HEREDITY, V48, P3, DOI 10.1038/hdy.1982.2; Carvajal-Rodriguez Antonio, 2006, Iberus, V24, P81; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Eberl R, 2013, J BIOGEOGR, V40, P2361, DOI 10.1111/jbi.12168; Eberl R, 2012, J NAT HIST, V46, P1779, DOI 10.1080/00222933.2012.700334; Eroukhmanoff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006173; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francuski L, 2009, ZOOL SCI, V26, P301, DOI 10.2108/zsj.26.301; GILLESPIE RG, 1994, P NATL ACAD SCI USA, V91, P2290, DOI 10.1073/pnas.91.6.2290; Holland BS, 2004, MOL PHYLOGENET EVOL, V32, P588, DOI 10.1016/j.ympev.2004.01.003; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurtado LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067827; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Jackson HG, 1922, P ZOOL SOC LOND, V1922, P683; Jordan S, 2005, MOL ECOL, V14, P3457, DOI 10.1111/j.1365-294X.2005.02669.x; Jung J, 2008, MOL CELLS, V25, P523; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khalaji-Pirbalouty V, 2010, ORG DIVERS EVOL, V10, P135, DOI 10.1007/s13127-010-0003-5; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; LEE JD, 1994, CRUSTACEANA, V66, P110, DOI 10.1163/156854094X00198; Lewis P, 2008, PHYCAS SOFTWARE PHYL; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Lichtwardt R.W., 1986, TRICHOMYCETES FUNGAL; Magnacca KN, 2006, CLADISTICS, V22, P393, DOI 10.1111/j.1096-0031.2006.00119.x; Mateos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032066; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Milankov V, 2009, ZOOL J LINN SOC-LOND, V155, P819, DOI 10.1111/j.1096-3642.2008.00462.x; Mitrovski-Bogdanovic A, 2013, ANN ENTOMOL SOC AM, V106, P170, DOI 10.1603/AN12100; Nunomura Noboru, 2011, Bulletin of the Toyama Science Museum, V34, P73; Nunomura Noboru, 2001, Bulletin of the Toyama Science Museum, V24, P1; Nunomura Noburo, 2009, Bulletin of the Toyama Science Museum, V32, P75; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Podsiadlowski L, 2005, MAR BIOTECHNOL, V7, P618, DOI 10.1007/s10126-005-0017-8; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Rambaut A, 2009, TRACER V1 5; Rohlf F. J., 2004, TPSDIG VERSION 1 40; Rohlf FJ, 2005, TPSREGR VERSION 1 31; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2008, PHILOS T R SOC B, V363, P3459, DOI 10.1098/rstb.2008.0115; Rundell RJ, 2004, MOL PHYLOGENET EVOL, V31, P246, DOI 10.1016/j.ympev.2003.07.014; Santos SR, 2006, MOL ECOL, V15, P2699, DOI 10.1111/j.1365-294X.2006.02965.x; Schmalfuss Helmut, 2003, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V654, P1; Schultz G. A, 1974, STUD FAUNA CURACAO, V45, P162; SCHULTZ GA, 1984, J CRUSTACEAN BIOL, V4, P154, DOI 10.2307/1547904; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taiti S, 2003, CRUSTACEANA MONOGR, V2, P85; Taiti S., 1991, Bishop Museum Occasional Papers, V31, P202; Taiti Stefano, 2004, V20, P211; Taiti Stefano, 1996, Bishop Museum Occasional Papers, V45, P59; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarr Cheryl L., 1995, P147; TEMPLETON AR, 1992, GENETICS, V132, P619; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; Tsuge Maki, 2008, Bulletin of the Toyama Science Museum, V31, P51; VANDEL ALBERT, 1960, FAUNE DE FRANCE, V64, P1; Wagner WL, 1995, HAWAIIAN BIOGEOGRAPH; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Yang, 2006, COMPUTATIONAL MOL EV, P357; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zuykova EI, 2013, HYDROBIOLOGIA, V715, P135, DOI 10.1007/s10750-012-1423-3; Zwickl DJ., 2006, THESIS; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	94	23	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85199	10.1371/journal.pone.0085199	http://dx.doi.org/10.1371/journal.pone.0085199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386463	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700131
J	van Wijk, E; Kobayashi, M; van Wijk, R; van der Greef, J				van Wijk, Eduard; Kobayashi, Masaki; van Wijk, Roeland; van der Greef, Jan			Imaging of Ultra-Weak Photon Emission in a Rheumatoid Arthritis Mouse Model	PLOS ONE			English	Article							OXIDATIVE STRESS; CHEMILUMINESCENCE; OXYGEN; CELLS; ACIDS	Ultra-weak photon emission (UPE) of a living system received scientific attention because of its potential for monitoring increased levels of reactive oxygen species (ROS) in the pathogenesis of rheumatoid arthritis (RA). In this study, a highly sensitive cryogenic charge-coupled device (CCD) camera was used to monitor in a RA mouse model the photon emission both without and with luminol. For that purpose, arthritis was induced in mice utilizing a repeated co-administration of type II collagen with lipopolysaccharide. Quantitative imaging of ultra-weak photon emission of the front and back paws of the animals was initiated 70 days after the first injection. All of the animals were measured once without luminol and once again immediately after luminol injection. Data illustrated a higher UPE intensity after initiating arthritis by CII-injection of the animals. The increase in UPE intensity was measured with and without using luminol indicating that this imaging technology may be useful for the future study of human RA.	[van Wijk, Eduard; van Wijk, Roeland; van der Greef, Jan] Leiden Univ, Sino Dutch Ctr Prevent & Personalized Med, Ctr Photon Living Syst, Leiden, Netherlands; [Kobayashi, Masaki] Tohoku Inst Technol, Dept Elect & Intelligent Syst, Sendai, Miyagi 982, Japan; [van Wijk, Eduard; van der Greef, Jan] Leiden Univ, LACDR, Netherlands Metabol Ctr, Div Analyt Biosci, Leiden, Netherlands; [van der Greef, Jan] TNO Netherlands Org Appl Sci Res, Zeist, Netherlands; [van Wijk, Eduard; van Wijk, Roeland] Meluna Res, Geldermalsen, Netherlands; [van Wijk, Eduard] Samueli Inst, Alexandria, VA USA	Leiden University; Leiden University - Excl LUMC; Tohoku Institute Technology; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	van Wijk, E (corresponding author), Leiden Univ, Sino Dutch Ctr Prevent & Personalized Med, Ctr Photon Living Syst, Leiden, Netherlands.	epa.vanwijk@lacdr.leidenuniv.nl			Samueli Institute of Information Biology; Rockefeller-Samueli Center for Research in Mind-Body Energy	Samueli Institute of Information Biology; Rockefeller-Samueli Center for Research in Mind-Body Energy	This work was supported by an independent research grant from the Samueli Institute of Information Biology and the Rockefeller-Samueli Center for Research in Mind-Body Energy (www.siib.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO T, 1995, UROL RES, V23, P315, DOI 10.1007/BF00300020; BOVERIS A, 1980, P NATL ACAD SCI-BIOL, V77, P347, DOI 10.1073/pnas.77.1.347; CADENAS E, 1980, BIOCHEM J, V186, P659, DOI 10.1042/bj1860659; Chen Wei-Tsung, 2004, Mol Imaging, V3, P159, DOI 10.1162/1535350042380290; CILENTO G, 1988, EXPERIENTIA, V44, P572, DOI 10.1007/bf01953304; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Darlington LG, 2001, BRIT J NUTR, V85, P251, DOI 10.1079/BJN2000239; FAULKNER K, 1993, FREE RADICAL BIO MED, V15, P447, DOI 10.1016/0891-5849(93)90044-U; GRASSO F, 1992, EXPERIENTIA, V48, P10, DOI 10.1007/BF01923595; Hadjigogos K, 2003, PANMINERVA MED, V45, P7; IRIE S, 1960, Curr Ther Res Clin Exp, V2, P107; Ishibashi T, 2013, CURR PHARM DESIGN, V19, P6375; Kobayashi M, 2005, Biophotonics: Optical Science and Engineering for the 21st Century, P155, DOI 10.1007/0-387-24996-6_12; Kobayashi M, 2003, ENERGY AND INFORMATION TRANSFER BIOLOGICAL SYSTEMS, PROCEEDINGS, P157, DOI 10.1142/9789812705181_0008; Kobayashi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006256; KRUK I, 1989, Z NATURFORSCH C, V44, P895; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; Musumeci F, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1900317; Nakano M., 2005, J BIOLUMIN CHEMILUM, V4, P231, DOI DOI 10.1002/BI0.1170040133; NIGGLI HJ, 1992, J PHOTOCH PHOTOBIO B, V14, P144, DOI 10.1016/1011-1344(92)85090-H; Prasad A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.085004; Prasad A, 2011, J BIOPHOTONICS, V4, P840, DOI 10.1002/jbio.201100073; Prasad A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022345; SCHOLZ W, 1988, CELL BIOPHYS, V13, P55, DOI 10.1007/BF02797365; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V83, P69, DOI 10.1016/j.jphotobiol.2005.12.005; Van Wijk R, 2007, BIOPHOTONICS AND COHERENT SYSTEMS IN BIOLOGY, P177; VANWIJK R, 1993, J PHOTOCH PHOTOBIO B, V18, P75, DOI 10.1016/1011-1344(93)80042-8; VANWIJK R, 1991, CELL BIOPHYS, V18, P15, DOI 10.1007/BF02990513; VANWIJK R, 1988, EXPERIENTIA, V44, P586; WATTS BP, 1995, ARCH BIOCHEM BIOPHYS, V317, P324, DOI 10.1006/abbi.1995.1170; Winyard PG, 2011, BIOCHEM SOC T, V39, P1226, DOI 10.1042/BST0391226; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yoshino S, 2000, IMMUNOLOGY, V99, P607, DOI 10.1046/j.1365-2567.2000.00015.x	36	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84579	10.1371/journal.pone.0084579	http://dx.doi.org/10.1371/journal.pone.0084579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386396	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700112
J	Chang, DK; Li, PC; Lu, RM; Jane, WN; Wu, HC				Chang, De-Kuan; Li, Pi-Chun; Lu, Ruei-Min; Jane, Wann-Neng; Wu, Han-Chung			Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models	PLOS ONE			English	Article							TUMOR VASCULATURE; ANTI-HER2 IMMUNOLIPOSOMES; CANCER-CELLS; ENDOCYTOSIS; MECHANISM; NANOPARTICLES; CHEMOTHERAPY; EXOCYTOSIS; CARCINOMA; MEMBRANE	Lung cancer ranks among the most common malignancies, and is the leading cause of cancer-related mortality worldwide. Chemotherapy for lung cancer can be made more specific to tumor cells, and less toxic to normal tissues, through the use of ligand-mediated drug delivery systems. In this study, we investigated the targeting mechanism of the ligand-mediated drug delivery system using a peptide, SP5-2, which specifically binds to non-small cell lung cancer (NSCLC) cells. Conjugation of SP5-2 to liposomes enhanced the amount of drug delivered directly into NSCLC cells, through receptor-mediated endocytosis. Functional SP5-2 improved the therapeutic index of Lipo-Dox by enhancing therapeutic efficacy, reducing side effects, and increasing the survival rate of tumor-bearing mice in syngenic, metastatic and orthotopic animal models. Accumulation of SP5-2-conjugated liposomal doxorubicin (SP5-2-LD) in tumor tissues was 11.2-fold higher than that of free doxorubicin, and the area under the concentration-time curve (AUC(0-72) (hours)) was increased 159.2-fold. Furthermore, the experiment of bioavailability was assessed to confirm that SP5-2 elevates the uptake of the liposomal drugs by the tumor cells in vivo. In conclusion, the use of SP5-2-conjugated liposomes enhances pharmacokinetic properties, improves efficacy and safety profiles, and allows for controlled biodistribution and drug release.	[Chang, De-Kuan; Li, Pi-Chun; Lu, Ruei-Min; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Jane, Wann-Neng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011; Lu, Ruei-Min/ABF-4388-2021	Wu, Han-Chung/0000-0002-5185-1169; Lu, Ruei-Min/0000-0003-3792-5499	Academia Sinica; National Science Council, Taiwan [NSC-100-2325-B-001-011, NSC-100-2321-B-001-038]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and the National Science Council (NSC-100-2325-B-001-011 and NSC-100-2321-B-001-038), Taiwan (to HC Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Andreopoulou E, 2007, ANN ONCOL, V18, P716, DOI 10.1093/annonc/mdl484; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; Bosslet K, 1998, CANCER RES, V58, P1195; Cai WB, 2008, NAT PROTOC, V3, P89, DOI 10.1038/nprot.2007.478; Camus P, 2004, BRIT J CANCER, V91, pS18, DOI 10.1038/sj.bjc.6602063; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chinn P, 2003, CANCER IMMUNOL IMMUN, V52, P257, DOI 10.1007/s00262-002-0347-6; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Dharap SS, 2005, P NATL ACAD SCI USA, V102, P12962, DOI 10.1073/pnas.0504274102; Falciani C, 2011, CHEMMEDCHEM, V6, P678, DOI 10.1002/cmdc.201000463; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; FREI E, 1980, AM J MED, V69, P585, DOI 10.1016/0002-9343(80)90472-6; Frei E, 1998, CLIN CANCER RES, V4, P2027; Frenkel V, 2006, ACAD RADIOL, V13, P469, DOI 10.1016/j.acra.2005.08.024; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; GAZIT Y, 1995, PHYS REV LETT, V75, P2428, DOI 10.1103/PhysRevLett.75.2428; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kim ES, 2001, LUNG CANCER-J IASLC, V34, P427, DOI 10.1016/S0169-5002(01)00278-1; Kirpotin D, 1997, BIOCHEMISTRY-US, V36, P66, DOI 10.1021/bi962148u; Kok MB, 2009, MAGN RESON MED, V61, P1022, DOI 10.1002/mrm.21910; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lee RJ, 1998, BIOSCIENCE REP, V18, P69, DOI 10.1023/A:1020132226113; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Li TH, 2010, LUNG CANCER, V68, P89, DOI 10.1016/j.lungcan.2009.05.009; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Lu RM, 2011, BIOMATERIALS, V32, P3265, DOI 10.1016/j.biomaterials.2010.12.061; Maule M, 2007, JNCI-J NATL CANCER I, V99, P790, DOI 10.1093/jnci/djk180; Mayer LD, 1997, J PHARMACOL EXP THER, V280, P1406; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miller AD, 2003, CURR MED CHEM, V10, P1195, DOI 10.2174/0929867033457485; Miller Andrew D, 2004, Methods Mol Med, V90, P107; Muggia F, 2001, EUR J CANCER, V37, pS15; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Novello Silvia, 2003, Oncology (Williston Park), V17, P357; Park JW, 2002, CLIN CANCER RES, V8, P1172; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Ross JS, 2004, AM J CLIN PATHOL, V122, P598, DOI 10.1309/5CWPU41AFR1VYM3F; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; Tseng YL, 2002, MOL PHARMACOL, V62, P864, DOI 10.1124/mol.62.4.864; Voigt W, 2005, METH MOLEC MED, V110, P39; Wu HC, 2010, J ONCOL, V2010, DOI 10.1155/2010/723798; Zuhorn IS, 2002, J MEMBRANE BIOL, V189, P167, DOI 10.1007/s00232-002-1015-7	55	35	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83239	10.1371/journal.pone.0083239	http://dx.doi.org/10.1371/journal.pone.0083239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386166	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900027
J	Davidich, M; Koster, G				Davidich, Maria; Koester, Gerta			Predicting Pedestrian Flow: A Methodology and a Proof of Concept Based on Real-Life Data	PLOS ONE			English	Article							SOCIAL FORCE MODEL; SIMULATION; DYNAMICS; EVACUATION; CROWDS	Building a reliable predictive model of pedestrian motion is very challenging: Ideally, such models should be based on observations made in both controlled experiments and in real-world environments. De facto, models are rarely based on real-world observations due to the lack of available data; instead, they are largely based on intuition and, at best, literature values and laboratory experiments. Such an approach is insufficient for reliable simulations of complex real-life scenarios: For instance, our analysis of pedestrian motion under natural conditions at a major German railway station reveals that the values for free-flow velocities and the flow-density relationship differ significantly from widely used literature values. It is thus necessary to calibrate and validate the model against relevant real-life data to make it capable of reproducing and predicting real-life scenarios. In this work we aim at constructing such realistic pedestrian stream simulation. Based on the analysis of real-life data, we present a methodology that identifies key parameters and interdependencies that enable us to properly calibrate the model. The success of the approach is demonstrated for a benchmark model, a cellular automaton. We show that the proposed approach significantly improves the reliability of the simulation and hence the potential prediction accuracy. The simulation is validated by comparing the local density evolution of the measured data to that of the simulated data. We find that for our model the most sensitive parameters are: the source-target distribution of the pedestrian trajectories, the schedule of pedestrian appearances in the scenario and the mean free-flow velocity. Our results emphasize the need for real-life data extraction and analysis to enable predictive simulations.	[Davidich, Maria] Siemens AG, Corp Technol, Munich, Bavaria, Germany; [Koester, Gerta] Munich Univ Appl Sci, Dept Comp Sci, Munich, Bavaria, Germany	Siemens AG; Siemens Germany; University of Munich	Davidich, M (corresponding author), Siemens AG, Corp Technol, Otto Hahn Ring 6, Munich, Bavaria, Germany.	maria.davidich@siemens.com		Koester, Gerta/0000-0002-3369-6206	German Federal Ministry of Education and Research [13N10094]; MEPKA [17PNT028]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MEPKA	This work was partially funded by the German Federal Ministry of Education and Research through the projects SinoVE, on protection of critical infrastructures (Grant No. 13N10094), and MEPKA on mathematical characteristics of pedestrian stream models (Grant No. 17PNT028) (http://www.bmbf.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini G, 2006, TRANSPORT RES B-METH, V40, P667, DOI 10.1016/j.trb.2005.09.006; Asano M, 2007, TRANSP RES RECORD, P42, DOI 10.3141/2039-05; Asano M, 2010, TRANSPORT RES C-EMER, V18, P842, DOI 10.1016/j.trc.2010.01.005; Batty M, 2003, URBAN STUD, V40, P1573, DOI 10.1080/0042098032000094432; Berrou J.L., 2007, PEDESTRIAN EVACUATIO, P167, DOI DOI 10.1007/978-3-540-47064-9_15; Blue VJ, 2001, TRANSPORT RES B-METH, V35, P293, DOI 10.1016/S0191-2615(99)00052-1; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; Butenuth M., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P150, DOI 10.1109/ICCVW.2011.6130237; Carsten OMJ, 1998, TRANSPORT RES C-EMER, V6, P213, DOI 10.1016/S0968-090X(98)00016-3; Chraibi M, 2011, NETW HETEROG MEDIA, V6, P425, DOI 10.3934/nhm.2011.6.425; Davidich M, 2012, SAFETY SCI, V50, P1253, DOI 10.1016/j.ssci.2011.12.024; Davidich M, 2010, PEDESTRIAN EVACUATIO, V2010, P537; Davidich M, 2013, TRANSP RE C IN PRESS; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Funge J., 1999, Reliable Computing, V5, P35, DOI 10.1023/A:1026441624550; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guo RY, 1999, TRANSPORT RES C-EMER, V24, P50; Gwynne S, 1999, BUILD ENVIRON, V34, P842; Haklay M, 2001, ENVIRON PLANN B, V28, P343, DOI 10.1068/b2758t; Hamacher HW, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P227; Hartmann D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043032; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2001, ENVIRON PLANN B, V28, P361, DOI 10.1068/b2697; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; HENDERSON LF, 1971, NATURE, V229, P381, DOI 10.1038/229381a0; Hoogendoorn S, 2005, TRAFFIC AND GRANULAR FLOW '03, P373, DOI 10.1007/3-540-28091-X_36; Hoogendoorn SP, 2004, ADV TRANSPORT, V15, P135; Hoogendoorn SP, 2000, ESTIMATORS TRAVEL TI, P107; Jiang YQ, 2012, APPL MATH COMPUT, V218, P6135, DOI 10.1016/j.amc.2011.11.099; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kinkeldey C, 2003, FORUM BAUINFORMATIK, P77; Klugl F, 2007, LECT NOTES COMPUT SC, V4687, P145; Klupfel H. L., 2003, THESIS U DUISBURG ES; Koester G, 2012, PEDESTRIAN IN PRESS, V2012; Koster G, 2011, CONTEMP SOC SCI, V6, P397, DOI 10.1080/21582041.2011.619867; Kretz T, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03012; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10001; Lachapelle A, 2011, TRANSPORT RES B-METH, V45, P1572, DOI 10.1016/j.trb.2011.07.011; Lakoba TI, 2005, SIMUL-T SOC MOD SIM, V81, P339, DOI 10.1177/0037549705052772; Lammel G, 2008, 5 WORKSH AG TRAF TRA; Langston PA, 2006, SAFETY SCI, V44, P395, DOI 10.1016/j.ssci.2005.11.007; Lerner A, 2007, COMPUT GRAPH FORUM, V26, P655, DOI 10.1111/j.1467-8659.2007.01089.x; Lovas GG, 1998, EUR J OPER RES, V105, P371, DOI 10.1016/S0377-2217(97)00084-2; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; NAGEL K, 1992, J PHYS I, V2, P2221, DOI 10.1051/jp1:1992277; Pelechano N, 2008, AUTOMAT CONSTR, V17, P377, DOI 10.1016/j.autcon.2007.06.005; Rahman K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063503; Robin T, 2009, TRANSPORT RES B-METH, V43, P36, DOI 10.1016/j.trb.2008.06.010; Rogsch C, 2012, PEDESTRIAN IN PRESS, V2012; Rudloff C, 2011, TRANSPORT RES REC, P101, DOI 10.3141/2264-12; Schadschneider A., 2011, PEDESTRIAN EVACUATIO, P557; Schadschneider A., 2010, PEDESTRIAN EVACUATIO, P557; Schadschneider A., 2011, ENCY COMPLEXITY SYST, P517, DOI [DOI 10.1007/978-0-387-30440-3_187, 10.1007/978-1-4419-7695-6_29, 10.1007/978-0-387-30440-3_187]; Schadschneider A, 2011, NETW HETEROG MEDIA, V6, P545, DOI 10.3934/nhm.2011.6.545; Seitz MJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046108; Shiwakoti N, 2011, TRANSPORT RES REC, P97, DOI 10.3141/2234-11; Shiwakoti N, 2010, TRANSPORT RES REC, P176, DOI 10.3141/2196-19; Singh H, 2009, APPL MATH MODEL, V33, P4408, DOI 10.1016/j.apm.2009.03.020; Sud A, 2008, IEEE T VIS COMPUT GR, V14, P526, DOI 10.1109/TVCG.2008.27; Teknomo K, 2006, TRANSPORT RES F-TRAF, V9, P15, DOI 10.1016/j.trf.2005.08.006; Weidmann U., 1993, TRANSPORTTECHNIK FUS, V90, DOI [10.3929/ethz-a-000687810, DOI 10.3929/ETHZ-A-000687810]; Xia YH, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066113; Xiong T, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/10/108901; Yamamoto K, 2007, PHYSICA A, V379, P654, DOI 10.1016/j.physa.2007.02.040; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105; Zanlungo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050720; Zheng XP, 2009, BUILD ENVIRON, V44, P437, DOI 10.1016/j.buildenv.2008.04.002	68	20	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83355	10.1371/journal.pone.0083355	http://dx.doi.org/10.1371/journal.pone.0083355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386186	gold, Green Published			2022-12-27	WOS:000329117900032
J	Paintain, LS; Kolaczinski, J; Renshaw, M; Filler, S; Kilian, A; Webster, J; Lokko, K; Lynch, M				Paintain, Lucy Smith; Kolaczinski, Jan; Renshaw, Melanie; Filler, Scott; Kilian, Albert; Webster, Jayne; Lokko, Kojo; Lynch, Matthew			Sustaining Fragile Gains: The Need to Maintain Coverage with Long-Lasting Insecticidal Nets for Malaria Control and Likely Implications of Not Doing So	PLOS ONE			English	Article							TREATED NETS; PROTECTIVE EFFICACY; UNIVERSAL COVERAGE; CHILD-MORTALITY; MOSQUITO NETS; IMPACT; SURVIVAL; TANZANIA; AFRICA; MODEL	Global commitment to malaria control has greatly increased over the last decade. Long-lasting insecticidal nets (LLINs) have become a core intervention of national malaria control strategies and over 450 million nets were distributed in sub-Saharan Africa between 2008 and 2012. Despite the impressive gains made as a result of increased investment in to malaria control, such gains remain fragile. Existing funding commitments for LLINs in the pipeline to 2016 were collated for 40 sub-Saharan African countries. The population-based model NetCALC was used to estimate the potential LLIN coverage achievable with these commitments and identify remaining gaps, and the Lives Saved Tool (LiST) was used to estimate likely consequences for mortality impact if these gaps remain unfilled. Overall, countries calculated a total need of 806 million LLINs for 2013-16. Current funding commitments meet just over half of this need, leaving approximately 374 million LLINs unfunded, most of which are needed to maintain coverage in 2015 and 2016. An estimated additional 938,500 child lives (uncertainty range: 559,400-1,364,200) could be saved from 2013 through 2016 with existing funding (relative to 2009 LLIN coverage taken as the 'baseline' for this analysis); if the funding gap were closed this would increase to 1,180,500 lives saved (uncertainty range: 707,000-1,718,900). Overall, the funding gap equates to approximately 242,000 avoidable malaria-attributable deaths amongst under-fives. Substantial additional resources will need to be mobilized to meet the full LLIN need of sub-Saharan countries to maintain universal coverage. Unless these resources are mobilized, the impressive gains made to date will not be sustained and tens of thousands of avoidable child deaths will occur.	[Paintain, Lucy Smith; Webster, Jayne] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Kolaczinski, Jan; Filler, Scott] Global Fund Fight AIDS TB & Malaria, Strategy Investment & Impact Div, Geneva, Switzerland; [Renshaw, Melanie] African Leaders Malaria Alliance, Geneva, Switzerland; [Kilian, Albert] Trop Hlth LLP, Montagut, Girona, Spain; [Lokko, Kojo; Lynch, Matthew] Johns Hopkins Univ, Ctr Commun Programs, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Paintain, LS (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Lucy.Paintain@lshtm.ac.uk		Webster, Jayne/0000-0002-0498-8883	United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement [GHS-A-00-09-00014-00]	United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement No. GHS-A-00-09-00014-00 for the NetWorks Project. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; [Anonymous], GLOB MAL ACT PLAN; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], RES MOB STRAT 2012 2; Briet OJT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-20; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Kilian A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-330; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Koenker HM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-150; Korenromp EL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-94; Larsen DA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S34; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okell LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-327; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Thwing J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S14; UN General Assembly, 2012, GEN ASS CALLS ACC EF; UNPOP, 2006, WORLD POP PROSP 2006; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Willey BA, 2012, B WORLD HEALTH ORGAN, V90, P672, DOI 10.2471/BLT.11.094771; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; Yukich J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-174	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83816	10.1371/journal.pone.0083816	http://dx.doi.org/10.1371/journal.pone.0083816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386283	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000329117900060
J	Tsang, TM; Wiese, JS; Felek, S; Kronshage, M; Krukonis, ES				Tsang, Tiffany M.; Wiese, Jeffrey S.; Felek, Suleyman; Kronshage, Malte; Krukonis, Eric S.			Ail Proteins of Yersinia pestis and Y-pseudotuberculosis Have Different Cell Binding and Invasion Activities	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; EPITHELIAL-CELLS; YOP DELIVERY; BACTERIAL ATTACHMENT; MEDIATES BINDING; PLAGUE VIRULENCE; HOST-CELLS; O-ANTIGEN; FACTOR-H	The Yersinia pestis adhesin Ail mediates host cell binding and facilitates delivery of cytotoxic Yop proteins. Ail from Y. pestis and Y. pseudotuberculosis is identical except for one or two amino acids at positions 43 and 126 depending on the Y. pseudotuberculosis strain. Ail from Y. pseudotuberculosis strain YPIII has been reported to lack host cell binding ability, thus we sought to determine which amino acid difference(s) are responsible for the difference in cell adhesion. Y. pseudotuberculosis YPIII Ail expressed in Escherichia coli bound host cells, albeit at -50% the capacity of Y. pestis Ail. Y. pestis Ail single mutants, Ail-E43D and Ail-F126V, both have decreased adhesion and invasion in E. coli when compared to wildtype Y. pestis Ail. Y. pseudotuberculosis YPIII Ail also had decreased binding to the Ail substrate fibronectin, relative to Y. pestis Ail in E. coli. When expressed in Y. pestis, there was a 30-50% decrease in adhesion and invasion depending on the substitution. Ail-mediated Yop delivery by both Y. pestis Ail and Y. pseudotuberculosis Ail were similar when expressed in Y. pestis, with only Ail-F126V giving a statistically significant reduction in Yop delivery of 25%. In contrast to results in E. coli and Y. pestis, expression of Ail in Y. pseudotuberculosis led to no measurable adhesion or invasion, suggesting the longer LPS of Y. pseudotuberculosis interferes with Ail cell-binding activity. Thus, host context affects the binding activities of Ail and both Y. pestis and Y. pseudotuberculosis Ail can mediate cell binding, cell invasion and facilitate Yop delivery.	[Tsang, Tiffany M.; Krukonis, Eric S.] Univ Michigan, Sch Med Ann Arbor, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Wiese, Jeffrey S.; Krukonis, Eric S.] Univ Detroit, Dept Biomed & Diagnost Sci, Mercy Sch Dent, Detroit, MI 48221 USA; [Felek, Suleyman; Kronshage, Malte] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Detroit Mercy; University of Michigan System; University of Michigan	Krukonis, ES (corresponding author), Univ Michigan, Sch Med Ann Arbor, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	krukones@udmercy.edu			NIH [R03 AI092318, R21 AI090194]; University of Michigan Department of Microbiology and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090194, R03AI092318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Department of Microbiology and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R03 AI092318 and R21 AI090194 to ESK and the Dr. Frances Wang Chin Fellowship to TMT from the University of Michigan Department of Microbiology and Immunology. The funders of the work had no role in study design, data collection or the decision to publish.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P5016, DOI 10.1128/IAI.00314-08; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; BLISKA JB, 1992, P NATL ACAD SCI USA, V89, P3561, DOI 10.1073/pnas.89.8.3561; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Boyd A.P., 2001, PRINCIPLES BACTERIAL, P227; Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Felek S, 2010, INFECT IMMUN, V78, P4134, DOI 10.1128/IAI.00167-10; Felek S, 2009, INFECT IMMUN, V77, P825, DOI 10.1128/IAI.00913-08; Fernandez C, 2001, FEBS LETT, V504, P173, DOI 10.1016/S0014-5793(01)02742-9; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; HEESEMANN J, 1987, FEMS MICROBIOL LETT, V40, P37, DOI 10.1016/0378-1097(87)90512-X; Ho DK, 2012, J IMMUNOL, V189, P3593, DOI 10.4049/jimmunol.1201145; Ho DK, 2012, J IMMUNOL, V188, P4450, DOI 10.4049/jimmunol.1103149; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kolodziejek AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00103; Kolodziejek AM, 2010, INFECT IMMUN, V78, P5233, DOI 10.1128/IAI.00783-10; Krasikova IN, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1272; Kukkonen M, 2004, MOL MICROBIOL, V51, P215, DOI 10.1046/j.1365-2958.2003.03817.x; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; LINDLER LE, 1990, INFECT IMMUN, V58, P2569, DOI 10.1128/IAI.58.8.2569-2577.1990; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; MILLER VL, 1990, J BACTERIOL, V172, P1062, DOI 10.1128/jb.172.2.1062-1069.1990; MILLER VL, 1988, INFECT IMMUN, V56, P1242, DOI 10.1128/IAI.56.5.1242-1248.1988; Miller VL, 2001, MOL MICROBIOL, V41, P1053, DOI 10.1046/j.1365-2958.2001.02575.x; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PIERSON DE, 1993, INFECT IMMUN, V61, P1846, DOI 10.1128/IAI.61.5.1846-1852.1993; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; TERTTI R, 1992, INFECT IMMUN, V60, P3021, DOI 10.1128/IAI.60.7.3021-3024.1992; Tsang TM, 2012, J BIOL CHEM, V287, P16759, DOI 10.1074/jbc.M112.358978; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; WACHTEL MR, 1995, INFECT IMMUN, V63, P2541, DOI 10.1128/IAI.63.7.2541-2548.1995; Yamashita S, 2011, STRUCTURE, V19, P1672, DOI 10.1016/j.str.2011.08.010; YANG YX, 1993, INFECT IMMUN, V61, P3907, DOI 10.1128/IAI.61.9.3907-3913.1993; Yang YX, 1996, INFECT IMMUN, V64, P2483, DOI 10.1128/IAI.64.7.2483-2489.1996	48	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83621	10.1371/journal.pone.0083621	http://dx.doi.org/10.1371/journal.pone.0083621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386237	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900047
J	Xiang, J; deGrauw, X; Korman, AM; Allen, JR; O'Brien, HL; Kabbouche, MA; Powers, SW; Hershey, AD				Xiang, Jing; deGrauw, Xinyao; Korman, Abraham M.; Allen, Janelle R.; O'Brien, Hope L.; Kabbouche, Marielle A.; Powers, Scott W.; Hershey, Andrew D.			Neuromagnetic Abnormality of Motor Cortical Activation and Phases of Headache Attacks in Childhood Migraine	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HIGH-FREQUENCY OSCILLATIONS; VISUAL-CORTEX EXCITABILITY; HEMIPLEGIC MIGRAINE; EVOKED POTENTIALS; EPILEPSY; AURA; HYPEREXCITABILITY; DIAGNOSIS; SIGNALS	The cerebral cortex serves a primary role in the pathogenesis of migraine. This aberrant brain activation in migraine can be noninvasively detected with magnetoencephalography (MEG). The objective of this study was to investigate the differences in motor cortical activation between attacks (ictal) and pain free intervals (interictal) in children and adolescents with migraine using both low-and high-frequency neuromagnetic signals. Thirty subjects with an acute migraine and 30 subjects with a history of migraine, while pain free, were compared to age-and gender-matched controls using MEG. Motor cortical activation was elicited by a standardized, validated finger-tapping task. Low-frequency brain activation (1 similar to 50 Hz) was analyzed with waveform measurements and high-frequency oscillations (65-150 Hz) were analyzed with wavelet-based beamforming. MEG waveforms showed that the ictal latency of low-frequency brain activation was significantly delayed as compared with controls, while the interictal latency of brain activation was similar to that of controls. The ictal amplitude of low-frequency brain activation was significantly increased as compared with controls, while the interictal amplitude of brain activation was similar to that of controls. The ictal source power of high-frequency oscillations was significantly stronger than that of the controls, while the interictal source power of high-frequency oscillations was significantly weaker than that of controls. The results suggest that aberrant low-frequency brain activation in migraine during a headache attack returned to normal interictally. However, high-frequency oscillations changed from ictal hyper-activation to interictal hypo-activation. Noninvasive assessment of cortical abnormality in migraine with MEG opens a new window for developing novel therapeutic strategies for childhood migraine by maintaining a balanced cortical excitability.	[Xiang, Jing; deGrauw, Xinyao; Korman, Abraham M.; O'Brien, Hope L.; Kabbouche, Marielle A.; Hershey, Andrew D.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Xiang, Jing; O'Brien, Hope L.; Kabbouche, Marielle A.; Hershey, Andrew D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Allen, Janelle R.; Powers, Scott W.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Xiang, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA.	jing.xiang@cchmc.org	O'Brien, Hope Lorraine/AHB-9810-2022; Hershey, Andrew D./K-1245-2019; O'Brien, Hope/AAZ-9717-2020	Hershey, Andrew D./0000-0002-1598-7536; Powers, Scott/0000-0002-5348-9650; Xiang, Jing/0000-0003-0242-5590	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health [R21NS072817]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072817] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Grant Number R21NS072817 from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora SK, 1999, CEPHALALGIA, V19, P708, DOI 10.1046/j.1468-2982.1999.019008708.x; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bianchin MM, 2010, CURR PAIN HEADACHE R, V14, P276, DOI 10.1007/s11916-010-0121-y; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Bigal ME, 2003, EPILEPSY BEHAV, V4, pS13, DOI 10.1016/j.yebeh.2003.07.003; Bohotin V, 2003, CEPHALALGIA, V23, P264, DOI 10.1046/j.1468-2982.2003.00475.x; Bowyer SM, 2005, J CLIN NEUROPHYSIOL, V22, P65, DOI 10.1097/01.WNP.0000150928.23523.A9; Bowyer SM, 1999, BRAIN RES, V843, P79, DOI 10.1016/S0006-8993(99)01893-4; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Bramanti P, 2005, FUNCT NEUROL, V20, P29; Brighina F, 2010, CEPHALALGIA, V30, P46, DOI 10.1111/j.1468-2982.2009.01870.x; Brigo F, 2012, J HEADACHE PAIN, V13, P339, DOI 10.1007/s10194-012-0445-6; Caraballo R, 2009, J CHILD NEUROL, V24, P1536, DOI 10.1177/0883073809332395; Chen WT, 2009, CEPHALALGIA, V29, P1202, DOI 10.1111/j.1468-2982.2009.01857.x; Chen WT, 2012, CEPHALALGIA, V32, P537, DOI 10.1177/0333102412443337; Chen WT, 2011, BRAIN, V134, P2387, DOI 10.1093/brain/awr157; Clarke T, 2009, EPILEPSIA, V50, P2428, DOI 10.1111/j.1528-1167.2009.02240.x; Conforto AB, 2012, J HEADACHE PAIN, V13, P29, DOI 10.1007/s10194-011-0379-4; Conte A, 2010, PAIN, V148, P43, DOI 10.1016/j.pain.2009.09.031; Coppola G, 2007, CEPHALALGIA, V27, P803, DOI 10.1111/j.1468-2982.2007.01323.x; Coppola G, 2012, CEPHALALGIA, V32, P700, DOI 10.1177/0333102412446313; Coppola G, 2012, CURR PAIN HEADACHE R, V16, P93, DOI 10.1007/s11916-011-0231-1; de Tommaso M, 2010, J HEADACHE PAIN, V11, P505, DOI 10.1007/s10194-010-0247-7; DENOORDHOUT AM, 1992, ELECTROEN CLIN NEURO, V85, P110, DOI 10.1016/0168-5597(92)90076-N; Esposito M, 2012, EUR J PEDIATR, V171, P1599, DOI 10.1007/s00431-012-1759-8; FRIBERG L, 1987, BRAIN, V110, P917, DOI 10.1093/brain/110.4.917; Fumal A, 2003, ACTA NEUROL BELG, V103, P144; Guo XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050095; Hall SD, 2004, HEADACHE, V44, P204, DOI 10.1111/j.1526-4610.2004.04048.x; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; Hershey AD, 2005, PEDIATR ANN, V34, P426, DOI 10.3928/0090-4481-20050601-04; Hershey AD, 2005, HEADACHE, V45, P1288, DOI 10.1111/j.1526-4610.2005.00260.x; Hershey AD, 2010, PEDIATR ANN, V39, P416, DOI 10.3928/00904481-20100623-06; Hershey AD, 2010, CURR OPIN NEUROL, V23, P249, DOI 10.1097/WCO.0b013e3283391888; Hershey AD, 2010, LANCET NEUROL, V9, P190, DOI 10.1016/S1474-4422(09)70303-5; Huo XL, 2011, BRAIN TOPOGR, V23, P375, DOI 10.1007/s10548-010-0151-0; Huo XL, 2010, BRAIN DEV-JPN, V32, P619, DOI 10.1016/j.braindev.2009.09.021; Jen JC, 1993, FAMILIAL HEMIPLEGIC; Kedia S, 2012, HEADACHE, V52, P674, DOI 10.1111/j.1526-4610.2012.02116.x; Khedr EM, 2006, NEUROPHYSIOL CLIN, V36, P13, DOI 10.1016/j.neucli.2006.01.007; Korostenskaja M, 2011, INT J NEUROSCI, V121, P355, DOI 10.3109/00207454.2011.560312; Korostenskaja M, 2010, EPILEPSY RES, V92, P63, DOI 10.1016/j.eplepsyres.2010.08.008; Lewis DW, 2009, NEUROL CLIN, V27, P481, DOI 10.1016/j.ncl.2008.11.003; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Lipton RB, 2010, NEUROTHERAPEUTICS, V7, P204, DOI 10.1016/j.nurt.2010.03.002; Lo YL, 2010, NAT REV NEUROL, V6, P425, DOI 10.1038/nrneurol.2010.109; Mackert B M, 2004, Neurol Clin Neurophysiol, V2004, P41; Magis D, 2011, CURR OPIN NEUROL, V24, P203, DOI 10.1097/WCO.0b013e3283462c3f; Minks E, 2010, BIOMED PAP, V154, P133, DOI 10.5507/bp.2010.020; Papadelis C, 2011, NEUROIMAGE, V54, P60, DOI 10.1016/j.neuroimage.2010.07.054; Papadelis C, 2009, CLIN NEUROPHYSIOL, V120, P1958, DOI 10.1016/j.clinph.2009.08.018; Piccinelli P, 2006, HEADACHE, V46, P413, DOI 10.1111/j.1526-4610.2006.00373.x; Rapoport A, 2011, NEUROL SCI, V32, pS105, DOI 10.1007/s10072-011-0542-3; Restuccia D, 2012, CLIN NEUROPHYSIOL, V123, P2050, DOI 10.1016/j.clinph.2012.03.009; Sakai Y, 2008, NEUROLOGY, V70, P431, DOI 10.1212/01.wnl.0000299095.65331.6f; Sand T, 2003, CEPHALALGIA, V23, P5, DOI 10.1046/j.1468-2982.2003.00570.x; Sankar R, 2004, NEUROLOGY, V63, pS30, DOI 10.1212/WNL.63.10_suppl_4.S30; Scherer P, 1997, ACTA NEUROL SCAND, V96, P392; Siniatchkin M, 2012, CEREB CORTEX, V22, P2207, DOI 10.1093/cercor/bhr248; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Teepker M, 2010, CEPHALALGIA, V30, P137, DOI 10.1111/j.1468-2982.2009.01911.x; Toldo I, 2011, CEPHALALGIA, V31, P751, DOI 10.1177/0333102410392068; Turk W R, 2000, Adv Pediatr, V47, P161; Vincent MB, 2011, CEPHALALGIA, V31, P13, DOI 10.1177/0333102410372424; Wang XS, 2010, HEADACHE, V50, P1005, DOI 10.1111/j.1526-4610.2010.01674.x; Wang YY, 2011, CLIN NEUROPHYSIOL, V122, P1706, DOI 10.1016/j.clinph.2011.02.008; Ward TN, 2010, HEADACHE, V50, P1629, DOI 10.1111/j.1526-4610.2010.01786.x; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Xiang J, 2013, J PAIN; Xiang J, 2010, J NEUROS-PEDIATR, V5, P113, DOI 10.3171/2009.8.PEDS09345; Yoshino A, 2012, J PAIN, V13, P628, DOI 10.1016/j.jpain.2011.12.005; Young WB, 2007, J NEUROL NEUROSUR PS, V78, P600, DOI 10.1136/jnnp.2006.100214; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Zach V, 2010, J HEADACHE PAIN, V11, P79, DOI 10.1007/s10194-009-0181-8	74	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83669	10.1371/journal.pone.0083669	http://dx.doi.org/10.1371/journal.pone.0083669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386250	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900051
J	Destici, E; Jacobs, EH; Tamanini, F; Loos, M; van der Horst, GTJ; Oklejewicz, M				Destici, Eugin; Jacobs, Edwin H.; Tamanini, Filippo; Loos, Maarten; van der Horst, Gijsbertus T. J.; Oklejewicz, Malgorzata			Altered Phase-Relationship between Peripheral Oscillators and Environmental Time in Cry1 or Cry2 Deficient Mouse Models for Early and Late Chronotypes	PLOS ONE			English	Article							INTRINSIC CIRCADIAN CLOCK; GENE-EXPRESSION; IN-VITRO; RHYTHMS; TRANSCRIPTION; LIVER; PACEMAKER; MUTATION; DBP; CORTICOSTERONE	The mammalian circadian system is composed of a light-entrainable central clock in the suprachiasmatic nuclei (SCN) of the brain and peripheral clocks in virtually any other tissue. It allows the organism to optimally adjust metabolic, physiological and behavioral functions to the physiological needs it will have at specific time of the day. According to the resonance theory, such rhythms are only advantageous to an organism when in tune with the environment, which is illustrated by the adverse health effects originating from chronic circadian disruption by jetlag and shift work. Using short-period Cry1 and long-period Cry2 deficient mice as models for morningness and eveningness, respectively, we explored the effect of chronotype on the phase relationship between the central SCN clock and peripheral clocks in other organs. Whereas the behavioral activity patterns and circadian gene expression in the SCN of light-entrained Cry1(-/-) and Cry2(-/-) mice largely overlapped with that of wild type mice, expression of clock and clock controlled genes in liver, kidney, small intestine, and skin was shown to be markedly phase-advanced or phase-delayed, respectively. Likewise, circadian rhythms in urinary corticosterone were shown to display a significantly altered phase relationship similar to that of gene expression in peripheral tissues. We show that the daily dissonance between peripheral clocks and the environment did not affect the lifespan of Cry1(-/-) or Cry2(-/-) mice. Nonetheless, the phase-shifted peripheral clocks in light-entrained mice with morningness and eveningness-like phenotypes may have implications for personalized preventive and therapeutic (i.e. chronomodulation-based) health care for people with early and late chronotypes.	[Destici, Eugin; Jacobs, Edwin H.; Tamanini, Filippo; van der Horst, Gijsbertus T. J.; Oklejewicz, Malgorzata] Erasmus MC, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands; [Loos, Maarten] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	van der Horst, GTJ (corresponding author), Erasmus MC, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands.	g.vanderhorst@erasmusmc.nl; m.oklejewicz@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Loos, Maarten/A-2768-2012	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Loos, Maarten/0000-0003-1629-2928; Destici, Eugin/0000-0002-8472-1766	ZonMW Vici grant [918.36.619]; Neuro-Bsik [BSIK03053]; "EUCLOCK" [LSHG-CT-2006-018741]	ZonMW Vici grant; Neuro-Bsik; "EUCLOCK"(European Commission)	This work was supported by ZonMW Vici grant no. 918.36.619; Neuro-Bsik BSIK03053; and "EUCLOCK" LSHG-CT-2006-018741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brown S, 2005, AM POETRY REV, V34, P3; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hurd MW, 1998, J BIOL RHYTHM, V13, P430, DOI 10.1177/074873098129000255; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; MEIER AH, 1976, ENDOCRINOLOGY, V98, P1475, DOI 10.1210/endo-98-6-1475; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Novakova M, 2013, CHRONOBIOL INT, V30, P607, DOI 10.3109/07420528.2012.754455; OTTENWELLER JE, 1982, ENDOCRINOLOGY, V111, P1334, DOI 10.1210/endo-111-4-1334; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Pan XY, 2009, J LIPID RES, V50, P1800, DOI 10.1194/jlr.M900085-JLR200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; PITTENDR.CS, 1972, P NATL ACAD SCI USA, V69, P1537, DOI 10.1073/pnas.69.6.1537; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Ptacek LJ, 2007, COLD SPRING HARB SYM, V72, P273; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Sewlall Seshni, 2010, Current Drug Delivery, V7, P370, DOI 10.2174/156720110793566236; Sosniyenko S, 2010, AM J PHYSIOL-REG I, V298, pR959, DOI 10.1152/ajpregu.00561.2009; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; Spoelstra K, 2004, J BIOL RHYTHM, V19, P518, DOI 10.1177/0748730404268122; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Sumova A, 2003, J BIOL RHYTHM, V18, P134, DOI 10.1177/0748730403251801; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thorpe JB, 2012, HORM METAB RES, V44, P429, DOI 10.1055/s-0032-1306307; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; UEDA HR, 2007, COLD SPRING HARB SYM, V72, P365; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	63	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83602	10.1371/journal.pone.0083602	http://dx.doi.org/10.1371/journal.pone.0083602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386234	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700063
J	Djawe, K; Daly, KR; Levin, L; Zar, HJ; Walzer, PD				Djawe, Kpandja; Daly, Kieran R.; Levin, Linda; Zar, Heather J.; Walzer, Peter D.			Humoral Immune Responses to Pneumocystis jirovecii Antigens in HIV-Infected and Uninfected Young Children with Pneumocystis Pneumonia	PLOS ONE			English	Article							MAJOR SURFACE GLYCOPROTEIN; REAL-TIME PCR; BRONCHOALVEOLAR LAVAGE FLUID; SOUTH-AFRICAN CHILDREN; SEROLOGIC RESPONSES; CARINII-PNEUMONIA; DIRECT IMMUNOFLUORESCENCE; HIV-1-INFECTED CHILDREN; ETIOLOGY RESEARCH; ASSAY	Background: Humoral immune responses in human immunodeficiency virus (HIV)-infected and uninfected children with Pneumocystis pneumonia (PcP) are poorly understood. Methods: Consecutive children hospitalized with acute pneumonia, tachypnea, and hypoxia in South Africa were investigated for PcP, which was diagnosed by real-time polymerase chain reaction on lower respiratory tract specimens. Serum antibody responses to recombinant fragments of the carboxyl terminus of Pneumocystis jirovecii major surface glycoprotein (MsgC) were analyzed. Results: 149 children were enrolled of whom 96 (64%) were HIV-infected. PcP occurred in 69 (72%) of HIV-infected and 14 (26%) of HIV-uninfected children. HIV-infected children with PcP had significantly decreased IgG antibodies to MsgC compared to HIV-infected patients without PcP, but had similar IgM antibodies. In contrast, HIV-uninfected children with PcP showed no change in IgG antibodies to MsgC, but had significantly increased IgM antibodies compared to HIV-uninfected children without PCP. Age was an independent predictor of high IgG antibodies, whereas PcP was a predictor of low IgG antibodies and high IgM antibodies. IgG and IgM antibody levels to the most closely related MsgC fragments were predictors of survival from PcP. Conclusions: Young HIV-infected children with PcP have significantly impaired humoral immune responses to MsgC, whereas HIV-uninfected children with PcP can develop active humoral immune responses. The children also exhibit a complex relationship between specific host factors and antibody levels to MsgC fragments that may be related to survival from PcP.	[Djawe, Kpandja; Levin, Linda; Walzer, Peter D.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Daly, Kieran R.; Walzer, Peter D.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA; [Daly, Kieran R.; Walzer, Peter D.] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Zar, Heather J.] Univ Cape Town, Dept Pediat & Child Hlth, ZA-7925 Cape Town, South Africa	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University of Cape Town	Walzer, PD (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	peter.walzer@uc.edu	Zar, Heather/GZL-5350-2022	Zar, Heather/0000-0002-9046-759X	National Institutes of Health [R01 HL090335]; Department of Veterans Affairs, the National Research Foundation, South Africa; ASTRA-Zeneca Respiratory Award from the South African Thoracic Society; Medical Research Council of South Africa; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, the National Research Foundation, South Africa; ASTRA-Zeneca Respiratory Award from the South African Thoracic Society; Medical Research Council of South Africa(South African Medical Research Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grant R01 HL090335 and the Department of Veterans Affairs, the National Research Foundation, South Africa; an ASTRA-Zeneca Respiratory Award from the South African Thoracic Society and the Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, CLIN MICROBIOL INFEC, V17, P1531, DOI 10.1111/j.1469-0691.2010.03400.x; BERNSTEIN LJ, 1985, J PEDIATR-US, V107, P352, DOI 10.1016/S0022-3476(85)80505-9; Bhat N, 2012, CLIN INFECT DIS, V54, pS153, DOI 10.1093/cid/cir1060; BLANCHE S, 1989, NEW ENGL J MED, V320, P1643, DOI 10.1056/NEJM198906223202502; Blount RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051545; Botterel F, 2012, J CLIN MICROBIOL, V50, P227, DOI 10.1128/JCM.06036-11; Bunders M, 2010, AIDS RES HUM RETROV, V26, P967, DOI 10.1089/aid.2009.0241; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Crothers K, 2011, CLIN VACCINE IMMUNOL, V18, P380, DOI 10.1128/CVI.00421-10; Daly K, 2009, CLIN MICROBIOL INFEC, V15, P937, DOI 10.1111/j.1469-0691.2009.02716.x; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; DEMARTINO M, 1991, J PEDIATR-US, V119, P702, DOI 10.1016/S0022-3476(05)80283-5; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Djawe K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014259; Djawe K, 2010, INT J INFECT DIS, V14, pE1060, DOI 10.1016/j.ijid.2010.07.003; Eilers PHC, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-37; Eley BS, 1999, ANN TROP PAEDIATR, V19, P3, DOI 10.1080/02724939992572; Fillaux Judith, 2013, Methods Mol Biol, V943, P159, DOI 10.1007/978-1-60327-353-4_11; Gigliotti F, 1998, INFECT IMMUN, V66, P3179, DOI 10.1128/IAI.66.7.3179-3182.1998; GIGLIOTTI F, 1988, J CLIN INVEST, V81, P1666, DOI 10.1172/JCI113503; Gingo MR, 2011, JAIDS-J ACQ IMM DEF, V57, P190, DOI 10.1097/QAI.0b013e3182167516; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; Italian Register for HIV Infection in Children, 2004, AIDS, V18; Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100; KOVACS JA, 1993, J BIOL CHEM, V268, P6034; Larsen HH, 2007, EMERG INFECT DIS, V13, P66, DOI 10.3201/eid1301.060315; Lyamuya EF, 1999, E AFR MED J, V76, P370; Madhi SA, 2002, CLIN INFECT DIS, V35, P1120, DOI 10.1086/343049; McNally LM, 2005, AIDS, V19, P1548, DOI 10.1097/01.aids.0000183941.67730.3a; McTaggart LR, 2012, J CLIN MICROBIOL, V50, P1856, DOI 10.1128/JCM.05880-11; MEUWISSEN JHET, 1977, J INFECT DIS, V136, P43, DOI 10.1093/infdis/136.1.43; Morrow BM, 2010, PEDIATR INFECT DIS J, V29, P535, DOI 10.1097/INF.0b013e3181ce871e; Nair N, 2009, J INFECT DIS, V200, P1031, DOI 10.1086/605648; PEGLOW SL, 1990, J INFECT DIS, V161, P296, DOI 10.1093/infdis/161.2.296; PIFER LL, 1978, PEDIATRICS, V61, P35; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; Samuel CM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-329; Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065; Seah C, 2012, MED MYCOL, V50, P324, DOI 10.3109/13693786.2011.598878; Seymour J, 2010, HEALTH ECON, V19, P683, DOI 10.1002/hec.1505; Stringer JR, 2007, J EUKARYOT MICROBIOL, V54, P8, DOI 10.1111/j.1550-7408.2006.00225.x; THEUS SA, 1995, J CLIN INVEST, V95, P2587, DOI 10.1172/JCI117960; Theus SA, 1998, VACCINE, V16, P1149, DOI 10.1016/S0264-410X(98)80113-8; Tia T, 2012, CLIN MICROBIOL INFEC, V18, P598, DOI 10.1111/j.1469-0691.2011.03656.x; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; Walzer PD, 1999, CLIN DIAGN LAB IMMUN, V6, P149, DOI 10.1128/CDLI.6.2.149-155.1999; Walzer PD, 2009, J INFECT DIS, V199, P1335, DOI 10.1086/597803; Wonodi CB, 2012, CLIN INFECT DIS, V54, pS124, DOI 10.1093/cid/cir1067; Zar HJ, 2012, CLIN INFECT DIS, V55, P1088, DOI 10.1093/cid/cis598; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004	55	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82783	10.1371/journal.pone.0082783	http://dx.doi.org/10.1371/journal.pone.0082783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386119	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700017
J	Ikeda, D; Ono, Y; Hirano, S; Kan-no, N; Watabe, S				Ikeda, Daisuke; Ono, Yosuke; Hirano, Shigeki; Kan-no, Nobuhiro; Watabe, Shugo			Lampreys Have a Single Gene Cluster for the Fast Skeletal Myosin Heavy Chain Gene Family	PLOS ONE			English	Article							EXPRESSION PATTERNS; MUSCLE; ZEBRAFISH; EVOLUTION; SEQUENCE; ELEMENTS; SLOW; PERSPECTIVES; ACTIVATION; DIVERSITY	Muscle tissues contain the most classic sarcomeric myosin, called myosin II, which consists of 2 heavy chains (MYHs) and 4 light chains. In the case of humans (tetrapod), a total of 6 fast skeletal-type MYH genes (MYHs) are clustered on a single chromosome. In contrast, torafugu (teleost) contains at least 13 fast skeletal MYHs, which are distributed in 5 genomic regions; the MYHs are clustered in 3 of these regions. In the present study, the evolutionary relationship among fast skeletal MYHs is elucidated by comparing the MYHs of teleosts and tetrapods with those of cyclostome lampreys, one of two groups of extant jawless vertebrates (agnathans). We found that lampreys contain at least 3 fast skeletal MYHs, which are clustered in a head-to-tail manner in a single genomic region. Although there was apparent synteny in the corresponding MYH cluster regions between lampreys and tetrapods, phylogenetic analysis indicated that lamprey and tetrapod MYHs have independently duplicated and diversified. Subsequent transgenic approaches showed that the 5'-flanking sequences of Japanese lamprey fast skeletal MYHs function as a regulatory sequence to drive specific reporter gene expression in the fast skeletal muscle of zebrafish embryos. Although zebrafish MYH promoters showed apparent activity to direct reporter gene expression in myogenic cells derived from mice, promoters from Japanese lamprey MYHs had no activity. These results suggest that the muscle-specific regulatory mechanisms are partially conserved between teleosts and tetrapods but not between cyclostomes and tetrapods, despite the conserved synteny.	[Ikeda, Daisuke; Kan-no, Nobuhiro; Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 228, Japan; [Ono, Yosuke; Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan; [Hirano, Shigeki] Niigata Univ, Fac Med, Sch Hlth Sci, Dept Med Technol, Niigata, Japan	Kitasato University; University of Tokyo; Niigata University	Ikeda, D (corresponding author), Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 228, Japan.	adikeda@kitasato-u.ac.jp		Ono, Yosuke/0000-0002-7257-0120; Ikeda, Daisuke/0000-0002-5666-7387	Japan Society for the Promotion of Science KAKENHI [23780214]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant Number 23780214 (https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolkar DB, 2010, J EXP BIOL, V213, P137, DOI 10.1242/jeb.030759; Allen DL, 2005, J BIOL CHEM, V280, P17126, DOI 10.1074/jbc.M501207200; Asaduzzaman M, 2011, GENE, V489, P41, DOI 10.1016/j.gene.2011.08.005; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hunter MP, 2002, DEV BIOL, V247, P367, DOI 10.1006/dbio.2002.0701; IKEDA D, 2004, MAR BIOTECHNOL, V6, pS462; Ikeda D, 2007, PHYSIOL GENOMICS, V32, P1, DOI 10.1152/physiolgenomics.00278.2006; Ikeda D, 2010, MAR GENOM, V3, P1, DOI 10.1016/j.margen.2009.12.001; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kikuchi K, 1999, GENE, V228, P189, DOI 10.1016/S0378-1119(99)00005-0; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; Kusakabe R, 2005, DEV DYNAM, V234, P824, DOI 10.1002/dvdy.20587; Kusakabe R, 2004, J EXP ZOOL PART B, V302B, P121, DOI 10.1002/jez.b.20009; Kusakabe R, 2003, J EXP ZOOL PART B, V296B, P87, DOI 10.1002/jez.b.00011; Kusakabe R, 2007, DEV DYNAM, V236, P2410, DOI 10.1002/dvdy.21177; Lakich MM, 1998, J BIOL CHEM, V273, P15217, DOI 10.1074/jbc.273.24.15217; Lee HC, 2006, DEV BIOL, V290, P359, DOI 10.1016/j.ydbio.2005.11.032; Liang CS, 2007, PHYSIOL GENOMICS, V29, P201, DOI 10.1152/physiolgenomics.00078.2006; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Maccatrozzo L, 2007, GENOMICS, V89, P224, DOI 10.1016/j.ygeno.2006.08.004; McGuigan K, 2004, MOL BIOL EVOL, V21, P1042, DOI 10.1093/molbev/msh103; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Muramatsu-Uno M, 2005, GENE, V349, P143, DOI 10.1016/j.gene.2004.11.040; Nihei Y, 2006, J EXP BIOL, V209, P188, DOI 10.1242/jeb.01978; Ono Y, 2006, DEV DYNAM, V235, P3092, DOI 10.1002/dvdy.20942; Ono Y, 2010, DEV DYNAM, V239, P1807, DOI 10.1002/dvdy.22298; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Peng MY, 2002, MOL REPROD DEV, V63, P422, DOI 10.1002/mrd.10201; Schachat F, 2002, J EXP BIOL, V205, P2189; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Shrager JB, 2000, J MUSCLE RES CELL M, V21, P345, DOI 10.1023/A:1005635030494; TAHARA Y, 1988, ZOOL SCI, V5, P109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watabe S, 2006, COMP BIOCHEM PHYS D, V1, P28, DOI 10.1016/j.cbd.2005.12.001; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Xu YF, 2000, DEV DYNAM, V219, P201, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1043>3.3.CO;2-9; Yasmin L, 2011, COMP BIOCHEM PHYS D, V6, P76, DOI 10.1016/j.cbd.2010.05.002; Zhang YQ, 2011, IN VITRO CELL DEV-AN, V47, P399, DOI 10.1007/s11626-011-9406-7	48	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85500	10.1371/journal.pone.0085500	http://dx.doi.org/10.1371/journal.pone.0085500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376886	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100206
J	Hovakimyan, M; Meyer, A; Lukas, J; Luo, JK; Gudziol, V; Hummel, T; Rolfs, A; Wree, A; Witt, M				Hovakimyan, Marina; Meyer, Anja; Lukas, Jan; Luo, Jiankai; Gudziol, Volker; Hummel, Thomas; Rolfs, Arndt; Wree, Andreas; Witt, Martin			Olfactory Deficits in Niemann-Pick Type C1 (NPC1) Disease	PLOS ONE			English	Article							MURINE MODEL; LYSOSOMAL DYSFUNCTION; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; GLIAL-CELLS; MOUSE MODEL; CHOLESTEROL; EXPRESSION; NEURODEGENERATION; PROTEIN	Background: Niemann-Pick type C disease (NPC) is a rare autosomal recessive lipid storage disease characterized by progressive neurodegeneration. As only a few studies have been conducted on the impact of NPC on sensory systems, we used a mutant mouse model (NPC1(-/-)) to examine the effects of this disorder to morphologically distinct regions of the olfactory system, namely the olfactory epithelium (OE) and olfactory bulb (OB). Methodology/Principal findings: For structural and functional analysis immunohistochemistry, electron microscopy, western blotting, and electrophysiology have been applied. For histochemistry and western blotting, we used antibodies against a series of neuronal and glia marker proteins, as well as macrophage markers. NPC1(-/-) animals present myelin-like lysosomal deposits in virtually all types of cells of the peripheral and central olfactory system. Especially supporting cells of the OE and central glia cells are affected, resulting in pronounced astrocytosis and microgliosis in the OB and other olfactory cortices. Up-regulation of Galectin-3, Cathepsin D and GFAP in the cortical layers of the OB underlines the critical role and location of the OB as a possible entrance gate for noxious substances. Unmyelinated olfactory afferents of the lamina propria seem less affected than ensheathing cells. Supporting the structural findings, electro-olfactometry of the olfactory mucosa suggests that NPC1(-/-) animals exhibit olfactory and trigeminal deficits. Conclusions/Significance: Our data demonstrate a pronounced neurodegeneration and glia activation in the olfactory system of NPC1(-/-), which is accompanied by sensory deficits.	[Hovakimyan, Marina; Meyer, Anja; Wree, Andreas; Witt, Martin] Univ Rostock, Inst Anat, Med Ctr, D-18055 Rostock, Germany; [Lukas, Jan; Luo, Jiankai; Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Med Ctr, D-18055 Rostock, Germany; [Gudziol, Volker; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Dresden, Germany	University of Rostock; University of Rostock; Technische Universitat Dresden	Witt, M (corresponding author), Univ Rostock, Inst Anat, Med Ctr, D-18055 Rostock, Germany.	martin.witt@uni-rostock.de	Witt, Martin/AAU-7529-2020	Witt, Martin/0000-0002-4538-877X				Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; Bahar-Fuchs A, 2010, J ALZHEIMERS DIS, V22, P1081, DOI 10.3233/JAD-2010-100696; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; BARNETT EM, 1993, NEUROSCIENCE, V57, P1007, DOI 10.1016/0306-4522(93)90045-H; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Bejarano-Escobar R, 2011, DEV DYNAM, V240, P1841, DOI 10.1002/dvdy.22673; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; Bi XN, 2007, AUTOPHAGY, V3, P646, DOI 10.4161/auto.5074; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen G, 2007, GLIA, V55, P1509, DOI 10.1002/glia.20563; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Dahm R, 2003, HISTOCHEM CELL BIOL, V119, P219, DOI 10.1007/s00418-003-0508-5; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Duda JE, 1999, EXP NEUROL, V160, P515, DOI 10.1006/exnr.1999.7228; Erickson RP, 2005, AM J PHYSIOL-GASTR L, V289, pG300, DOI 10.1152/ajpgi.00568.2004; Frasnelli J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00288; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Getchell ML, 2002, BRAIN RES, V945, P232, DOI 10.1016/S0006-8993(02)02805-6; Gudziol V, 2010, EUR ARCH OTO-RHINO-L, V267, P239, DOI 10.1007/s00405-009-1076-7; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Hovakimyan M, 2013, NEUROSCIENC IN PRESS; Hovakimyan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028418; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Hummel T, 2010, J NEUROL SCI, V289, P119, DOI 10.1016/j.jns.2009.08.026; Kaltner H, 2002, CELL TISSUE RES, V307, P35, DOI 10.1007/s004410100457; Karasinska JM, 2013, NEUROBIOL DIS; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; Loftus SK, 2002, HUM MOL GENET, V11, P3107, DOI 10.1093/hmg/11.24.3107; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Mackay-Sim A, 2000, PROG NEUROBIOL, V62, P527, DOI 10.1016/S0301-0082(00)00009-5; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; McNeill A, 2012, MOVEMENT DISORD, V27, P526, DOI 10.1002/mds.24945; Mellon S, 2004, ENDOCR RES, V30, P727, DOI 10.1081/ERC-200044016; Morris JA, 1999, BIOCHEM BIOPH RES CO, V261, P493, DOI 10.1006/bbrc.1999.1070; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ostalska-Nowicka D, 2007, HISTOPATHOLOGY, V51, P468, DOI 10.1111/j.1365-2559.2007.02818.x; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Patterson M., 2001, METABOLIC MOL BASES, VII, P3611; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Reid PC, 2003, J LIPID RES, V44, P1010, DOI 10.1194/jlr.M300009-JLR200; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Saunders-Pullman R, 2010, MOVEMENT DISORD, V25, P1364, DOI 10.1002/mds.23046; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Spiegel R, 2009, AM J MED GENET A, V149A, P446, DOI 10.1002/ajmg.a.32642; Suzuki H, 2003, PEDIATR INT, V45, P1, DOI 10.1046/j.1442-200X.2003.01651.x; Suzuki M, 2007, J NEUROSCI, V27, P1879, DOI 10.1523/JNEUROSCI.5282-06.2007; TAYLOR CR, 1994, HUM PATHOL, V25, P263, DOI 10.1016/0046-8177(94)90198-8; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Weiler E, 2005, J NEUROCYTOL, V34, P217, DOI 10.1007/s11068-005-8355-z; Wesson DW, 2010, EXPERT REV NEUROTHER, V10, P633, DOI [10.1586/ern.10.33, 10.1586/ERN.10.33]; Witt M, 2009, MOVEMENT DISORD, V24, P906, DOI 10.1002/mds.22464; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Yamada A, 2001, BRAIN DEV-JPN, V23, P288, DOI 10.1016/S0387-7604(01)00209-1; Yan X, 2011, METAB BRAIN DIS, V26, P299, DOI 10.1007/s11011-011-9263-9; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Zervas M, 2001, J NEUROPATH EXP NEUR, V60, P49, DOI 10.1093/jnen/60.1.49	80	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82216	10.1371/journal.pone.0082216	http://dx.doi.org/10.1371/journal.pone.0082216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391715	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200012
J	Hampton, M; Melvin, RG; Andrews, MT				Hampton, Marshall; Melvin, Richard G.; Andrews, Matthew T.			Transcriptomic Analysis of Brown Adipose Tissue across the Physiological Extremes of Natural Hibernation	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADENYLATE-CYCLASE; MICE LACKING; PROTEIN; FAT; EXPRESSION; RECEPTOR; MOUSE; IDENTIFICATION; PGC-1-ALPHA	We used RNAseq to generate a comprehensive transcriptome of Brown Adipose Tissue (BAT) over the course of a year in the naturally hibernating thirteen-lined ground squirrel, Ictidomys tridecemlineatus. During hibernation ground squirrels do not feed and use fat stored in White Adipose Tissue (WAT) as their primary source of fuel. Stored lipid is consumed at high rates by BAT to generate heat at specific points during the hibernation season. The highest rate of BAT activity occurs during periodic arousals from hypothermic torpor bouts, referred to as Interbout Arousals (IBAs). IBAs are characterized by whole body re-warming (from 5 to 37 degrees C) in 2-3 hours, and provide a unique opportunity to determine the genes responsible for the highly efficient lipid oxidation and heat generation that drives the arousal process. Illumina HighSeq sequencing identified 14,573 distinct BAT mRNAs and quantified their levels at four points: active ground squirrels in April and October, and hibernating animals during both torpor and IBA. Based on significant changes in mRNA levels across the four collection points, 2,083 genes were shown to be differentially expressed. In addition to providing detail on the expression of nuclear genes encoding mitochondrial proteins, and genes involved in beta-adrenergic and lipolytic pathways, we identified differentially expressed genes encoding various transcription factors and other regulatory proteins which may play critical roles in high efficiency fat catabolism, non-shivering thermogenesis, and transitions into and out of the torpid state.	[Hampton, Marshall] Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA; [Melvin, Richard G.; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Andrews, MT (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.	mandrews@d.umn.edu		Hampton, Marshall/0000-0002-9725-3316; Melvin, Richard George/0000-0001-6428-6763	National Institutes of Health [1RC2HL101625-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grant 1RC2HL101625-01 to MTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 1998, P NATL ACAD SCI USA, V95, P8392, DOI 10.1073/pnas.95.14.8392; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Barger JL, 2006, J APPL PHYSIOL, V101, P339, DOI 10.1152/japplphysiol.01260.2005; Bauer VW, 2001, AM J PHYSIOL-REG I, V281, pR1186, DOI 10.1152/ajpregu.2001.281.4.R1186; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bourova L, 2000, MOL CELL ENDOCRINOL, V167, P23, DOI 10.1016/S0303-7207(00)00303-8; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burmeister R, 2001, J BIOL CHEM, V276, P13295, DOI 10.1074/jbc.M010679200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen M, 2004, ENDOCRINOLOGY, V145, P4094, DOI 10.1210/en.2004-0038; Cinti S, 2007, ADIPOSE TISSUE ADIPO, P3, DOI [10.1007/978-1-59745-370-7_1, DOI 10.1007/978-1-59745-370-7_1]; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FAIN JN, 1972, J BIOL CHEM, V247, P6866; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIBBINS JM, 1985, BIOCHEM J, V228, P751, DOI 10.1042/bj2280751; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Kozyraki R, 1999, NAT MED, V5, P656, DOI 10.1038/9504; Kramarova LI, 2007, COMP BIOCHEM PHYS A, V146, P408, DOI 10.1016/j.cbpa.2006.11.017; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Lassi G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002706; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; MCMAHON KK, 1982, LIFE SCI, V30, P1185, DOI 10.1016/0024-3205(82)90661-0; Millman EE, 2008, TRAFFIC, V9, P1958, DOI 10.1111/j.1600-0854.2008.00813.x; Mount MP, 2013, J BIOL CHEM, V288, P14362, DOI 10.1074/jbc.M112.439216; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Rodriguez A, 2011, CELL CYCLE, V10, P1548, DOI 10.4161/cc.10.10.15672; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Schwartz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058427; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; SHERIDAN JD, 1971, J CELL BIOL, V50, P795, DOI 10.1083/jcb.50.3.795; Singh H, 2007, FEBS J, V274, P6306, DOI 10.1111/j.1742-4658.2007.06145.x; Squire TL, 2003, PHYSIOL GENOMICS, V16, P131, DOI 10.1152/physiolgenomics.00168.2002; Takemori H, 2007, FEBS J, V274, P3202, DOI 10.1111/j.1742-4658.2007.05889.x; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Yamashita A, 2009, BBA-MOL CELL BIOL L, V1791, P1011, DOI 10.1016/j.bbalip.2009.05.008; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437	69	57	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85157	10.1371/journal.pone.0085157	http://dx.doi.org/10.1371/journal.pone.0085157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386461	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700130
J	Lacey, RJ; Jordan, KP; Croft, PR				Lacey, Rosie J.; Jordan, Kelvin P.; Croft, Peter R.			Does Attrition during Follow-Up of a Population Cohort Study Inevitably Lead to Biased Estimates of Health Status?	PLOS ONE			English	Article							GENERAL-POPULATION; PRIMARY-CARE; OLDER-ADULTS; PAIN INTERFERENCE; OSTEOARTHRITIS; PREVALENCE; PARTICIPATION; NONRESPONSE; RECORDS; RECRUITMENT	Attrition is a potential source of bias in cohort studies. Although attrition may be inevitable in cohort studies of older people, there is little empirical evidence as to whether bias due to such attrition is also inevitable. Anonymised primary care data, routinely collected in clinical practice and independent of any cohort research study, represents an ideal unselected comparison dataset with which to compare primary care data from consenting responders to a cohort study. Our objective was to use this method as a novel means to assess if (i) responders at follow-up stages in a cohort study remain representative of responders at baseline and (ii) attrition biases estimates of longitudinal associations. We compared primary care consultation morbidities and prescription prevalences among circa 32,000 patients aged 50+ who contribute to an anonymised general practice database (Consultations in Primary Care Archive (CiPCA)) with those from patients aged 50+ in the North Staffordshire Osteoarthritis Project (NorStOP) cohort, United Kingdom (2002-2008; n = 16,159). 8,197 (51%) persons responded to the NorStOP baseline survey and consented to medical record review. 5,121 and 3,311 responded at 3- and 6-year follow-ups. Differences in consulting prevalence of non-musculoskeletal morbidities between NorStOP responders and CiPCA comparison population did not increase over the two follow-up points except for ischaemic heart disease. Differences observed at baseline for osteoarthritis-related consultations were generally unchanged at the two follow-ups (standardised prevalence ratios for osteoarthritis (1.09-1.13) and joint pain (1.12-1.23)). Age and gender adjusted associations between baseline consultation for chronic morbidity and future new osteoarthritis and related consultations were similar in CiPCA (adjusted Hazard Ratio: 1.40; 95% Confidence Interval: 1.34,1.47) and NorStOP 6-year responders (1.32; 1.15,1.51). There was little evidence that responders at follow-ups represented any further selection bias to that present at baseline. Attrition in cohort studies of older people does not inevitably indicate bias.	[Lacey, Rosie J.; Jordan, Kelvin P.; Croft, Peter R.] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England	Keele University	Lacey, RJ (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England.	r.lacey@keele.ac.uk	Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; Jordan, Kelvin/0000-0003-4748-5335	Medical Research Council [G9900220, G0501798]; Primary Care Research West Midlands North; North Staffordshire Primary Care Research Consortium; Keele University Research Institute for Primary Care and Health Sciences; Medical Research Council [MR/K006584/1, MC_PC_13041, G0902393] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10183] Funding Source: researchfish; MRC [G0501798, G0902393] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Primary Care Research West Midlands North; North Staffordshire Primary Care Research Consortium; Keele University Research Institute for Primary Care and Health Sciences; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work presented in this paper was funded by the Medical Research Council (http://www.mrc.ac.uk/index.htm) grants G9900220 and G0501798; and Primary Care Research West Midlands North (http://www.crncc.nihr.ac.uk/about_us/ccrn/wmids-north/corporate/pcrn_westmids_north). CiPCA is funded by the North Staffordshire Primary Care Research Consortium and Keele University Research Institute for Primary Care and Health Sciences (http://www.keele.ac.uk/pchs/). PRC is a UK National Institute for Health Research (NIHR) Senior Investigator and partner in the MRC PROGnosis RESearch Strategy (PROGRESS) Partnership. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedson J, 2013, EUR J PAIN, V17, P434, DOI 10.1002/j.1532-2149.2012.00189.x; Bhamra S, 2008, QUAL AGEING OLDER AD, V9, P27, DOI 10.1108/14717794200800025; Bowling A., 1997, RES METHODS HLTH; Brilleman SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-71; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Dunn KM, 2004, AM J EPIDEMIOL, V159, P1087, DOI 10.1093/aje/kwh141; Freudenstein U, 2001, AGE AGEING, V30, P517, DOI 10.1093/ageing/30.6.517; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Green DJ, 2013, EUR J PAIN, V17, P234, DOI 10.1002/j.1532-2149.2012.00185.x; Haring R, 2009, J CLIN EPIDEMIOL, V62, P252, DOI 10.1016/j.jclinepi.2008.06.010; Harris T, 2005, J EPIDEMIOL COMMUN H, V59, P336, DOI 10.1136/jech.2004.025296; Hoeymans N, 1998, AGE AGEING, V27, P35, DOI 10.1093/ageing/27.1.35; Jacobsen SJ, 2004, ANN EPIDEMIOL, V14, P579, DOI 10.1016/j.annepidem.2003.11.001; Jeffery A, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-101; Jordan K, 2006, RHEUMATOLOGY, V45, P126, DOI 10.1093/rheumatology/kei265; Jordan KP, 2008, PAIN, V137, P469, DOI 10.1016/j.pain.2008.04.015; Jordan KP, 2012, EUR J PAIN, V16, P1185, DOI 10.1002/j.1532-2149.2012.00118.x; Jordan K, 2007, BRIT J GEN PRACT, V57, P7; Jordan KP, 2008, PAIN, V137, P652, DOI 10.1016/j.pain.2008.02.030; Kempen GIJM, 2002, J CLIN EPIDEMIOL, V55, P224, DOI 10.1016/S0895-4356(01)00474-7; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kristman VL, 2005, EUR J EPIDEMIOL, V20, P657, DOI 10.1007/s10654-005-7919-7; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; Mein G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-164; Menz HB, 2011, ARTHRIT CARE RES, V63, P396, DOI 10.1002/acr.20396; NHS Information Authority, 2000, CLIN TERMS VERS 3 RE; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nummela O, 2011, J CLIN EPIDEMIOL, V64, P1418, DOI 10.1016/j.jclinepi.2011.04.003; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; Peat G, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-30; Petty DR, 2001, PHARM WORLD SCI, V23, P22, DOI 10.1023/A:1011276924820; Pizzi C, 2011, J EPIDEMIOL COMMUN H, V65, P407, DOI 10.1136/jech.2009.107185; Porcheret M, 2004, J AM MED INFORM ASSN, V11, P78, DOI 10.1197/jamia.M1362; Rahman MM, 2013, ARTHRITIS CARE RES H, DOI [10.1002/acr.22092, DOI 10.1002/ACR.22092.[]; ROCKWOOD K, 1989, AGE AGEING, V18, P177, DOI 10.1093/ageing/18.3.177; Schmidt CO, 2011, EUR J PAIN, V15, P84, DOI 10.1016/j.ejpain.2010.05.007; Thomas E, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-2; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Thomas E, 2007, PAIN, V129, P21, DOI 10.1016/j.pain.2006.09.027; Van Beijsterveldt CEM, 2002, J CLIN EPIDEMIOL, V55, P216, DOI 10.1016/S0895-4356(01)00473-5; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Vega S, 2010, J CLIN EPIDEMIOL, V63, P215, DOI 10.1016/j.jclinepi.2009.03.005; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WALSH K, 1994, BRIT J GEN PRACT, V44, P118; Wells TS, 2008, EUR J EPIDEMIOL, V23, P79, DOI 10.1007/s10654-007-9216-0; Young AF, 2006, AUST NZ J PUBL HEAL, V30, P353, DOI 10.1111/j.1467-842X.2006.tb00849.x	49	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83948	10.1371/journal.pone.0083948	http://dx.doi.org/10.1371/journal.pone.0083948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386313	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700080
J	Moroz, A; Delella, FK; Almeida, R; Lacorte, LM; Favaro, WJ; Deffune, E; Felisbino, SL				Moroz, Andrei; Delella, Flavia K.; Almeida, Rodrigo; Lacorte, Livia Maria; Favaro, Wagner Jose; Deffune, Elenice; Felisbino, Sergio L.			Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ANDROGEN RECEPTOR; TISSUE INHIBITORS; DIFFERENTIAL EXPRESSION; CHEMOPREVENTION; TESTOSTERONE; OVEREXPRESSION; RESISTANCE; APOPTOSIS; SURVIVAL	Introduction: The use of the 5-alpha reductase inhibitors (5-ARIs) finasteride and dutasteride for prostate cancer prevention is still under debate. The FDA recently concluded that the increased prevalence of high-grade tumors among 5-ARI-treated patients must not be neglected, and they decided to disallow the use of 5-ARIs for prostate cancer prevention. This study was conducted to verify the effects of finasteride on prostate cell migration and invasion and the related enzymes/proteins in normal human and tumoral prostatic cell lines. Materials and Methods: RWPE-1, LNCaP, PC3 and DU145 cells were cultivated to 60% confluence and exposed for different periods to either 10 mu M or 50 mu M finasteride that was diluted in culture medium. The conditioned media were collected and concentrated, and MMP2 and MMP9 activities and TIMP-1 and TIMP-2 protein expression were determined. Cell viability, migration and invasion were analyzed, and the remaining cell extracts were submitted to androgen receptor (AR) detection by western blotting techniques. Experiments were carried out in triplicate. Results: Cell viability was not significantly affected by finasteride exposure. Finasteride significantly downregulated MMP2 and MMP9 activities in RWPE-1 and PC3 cells and MMP2 in DU145 cells. TIMP-2 expression in RWPE-1 cells was upregulated after exposure. The cell invasion of all four tested cell lines was inhibited by exposure to 50 mM of finasteride, and migration inhibition only occurred for RWPE-1 and LNCaP cells. AR was expressed by LNCaP, RWPE-1 and PC3 cells. Conclusions: Although the debate on the higher incidence of high-grade prostate cancer among 5-ARI-treated patients remains, our findings indicate that finasteride may attenuate tumor aggressiveness and invasion, which could vary depending on the androgen responsiveness of a patient's prostate cells.	[Moroz, Andrei; Delella, Flavia K.; Almeida, Rodrigo; Lacorte, Livia Maria; Felisbino, Sergio L.] Univ Estadual Paulista, UNESP, Inst Biosci, Dept Morphol,Extracellular Matrix Lab, Sao Paulo, Brazil; [Moroz, Andrei; Deffune, Elenice] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Blood Transfus Ctr,Cell Engn Lab, Sao Paulo, Brazil; [Lacorte, Livia Maria; Favaro, Wagner Jose] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Deffune, Elenice] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Dept Urol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista	Felisbino, SL (corresponding author), Univ Estadual Paulista, UNESP, Inst Biosci, Dept Morphol,Extracellular Matrix Lab, Sao Paulo, Brazil.	felisbin@ibb.unesp.br	Fávaro, Wagner José/AAS-7463-2020; Deffune, Elenice/K-6263-2012; de Almeida, Rodrigo/E-6189-2014; Felisbino, Sergio L/K-7641-2012; Delella, Flavia K/C-7731-2012; Moroz, Andrei/K-7767-2012	Fávaro, Wagner José/0000-0001-5830-8938; Deffune, Elenice/0000-0002-0533-3248; Delella, Flavia K/0000-0001-6362-5882; Moroz, Andrei/0000-0002-4498-9784	FAPESP (the Research Council for the State of Sao Paulo) [2010/16671-3]; CAPES	FAPESP (the Research Council for the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a FAPESP (the Research Council for the State of Sao Paulo) funding (process n. 2010/16671-3) and a CAPES Ph.D. scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Andriole G, 2005, J UROLOGY, V174, P2098, DOI 10.1097/01.ju.0000181216.71605.38; [Anonymous], 5 ALPH RED INH 5 ARI; Bass R, 2009, J UROLOGY, V181, P615, DOI 10.1016/j.juro.2008.10.029; Benbrahim-Tallaa L, 2005, ENVIRON HEALTH PERSP, V113, P1134, DOI 10.1289/ehp.7832; Bonaccorsi L, 2003, INT J ANDROL, V26, P21, DOI 10.1046/j.1365-2605.2003.00375.x; Boxler S, 2010, AM J PATHOL, V177, P2216, DOI 10.2353/ajpath.2010.091190; Buchanan G, 2004, PROSTATE, V60, P352, DOI 10.1002/pros.20079; Byrns MC, 2012, J STEROID BIOCHEM, V130, P7, DOI 10.1016/j.jsbmb.2011.12.012; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; Chatterjee B, 2003, MOL CELL BIOCHEM, V253, P89, DOI 10.1023/A:1026057402945; Chignalia AZ, 2012, HYPERTENSION, V59, P1263, DOI 10.1161/HYPERTENSIONAHA.111.180620; Cussenot O, 2007, EUR UROL, V52, P1082, DOI 10.1016/j.eururo.2007.04.008; Daja MM, 2003, PROSTATE CANCER P D, V6, P15, DOI 10.1038/sj.pcan.4500609; Das K, 2010, ENDOCR-RELAT CANCER, V17, P757, DOI 10.1677/ERC-10-0022; Delella FK, 2010, INT J ANDROL, V33, pE114, DOI 10.1111/j.1365-2605.2009.00970.x; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Golbano JM, 2008, INT J ONCOL, V32, P919; Higgins AZ, 2011, J NEUROSCI METH, V201, P9, DOI 10.1016/j.jneumeth.2011.06.033; Justulin LA, 2010, INT J ANDROL, V33, P489, DOI 10.1111/j.1365-2605.2009.00963.x; Klein EA, 2012, WORLD J UROL, V30, P189, DOI 10.1007/s00345-011-0822-9; Kobayashi N, 2012, ONCOTARGET, V3, P1455; Lokeshwar BL, 1991, ANN NY ACAD SCI, V878, P271; Ludwig S, 2011, TOXICOL SCI, V122, P52, DOI 10.1093/toxsci/kfr099; Moroz A, 2013, BIOCHEM BIOPH RES CO, V430, P1319, DOI 10.1016/j.bbrc.2012.12.031; Opoku-Acheampong AB, 2012, PLOS ONE, DOI [10.1371/journal.pone.0029068, DOI 10.1371/J0URNAL.P0NE.0029068]; Opoku-Acheampong AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077738; PAJOUH MS, 1991, J CANCER RES CLIN, V117, P144, DOI 10.1007/BF01613138; Racioppi Marco, 2012, Arch Ital Urol Androl, V84, P47; Rittmaster RS, 2011, ACTA ONCOL, V50, P127, DOI 10.3109/0284186X.2010.527367; Sawaya ME, 2002, J CUTAN MED SURG, V6, P1, DOI 10.1007/s10227-001-0024-y; Thompson IM, 2003, EUR UROL, V44, P650, DOI 10.1016/j.eururo.2003.11.001; TILLEY WD, 1995, STEROIDS, V60, P180, DOI 10.1016/0039-128X(94)00031-7; Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x; Tsui KH, 2008, ANTICANCER RES, V28, P1977; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2007, ASIAN J ANDROL, V9, P353, DOI 10.1111/j.1745-7262.2007.00278.x; Zhang J, 2002, PROSTATE, V50, P38, DOI 10.1002/pros.10030	39	32	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84757	10.1371/journal.pone.0084757	http://dx.doi.org/10.1371/journal.pone.0084757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386413	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700116
J	Moussaid, M				Moussaid, Mehdi			Opinion Formation and the Collective Dynamics of Risk Perception	PLOS ONE			English	Article							SOCIAL-INFLUENCE; BOUNDED CONFIDENCE; IMPACT; AMPLIFICATION; INFORMATION; CULTURE; BENEFITS; SPREAD; MODEL	The formation of collective opinion is a complex phenomenon that results from the combined effects of mass media exposure and social influence between individuals. The present work introduces a model of opinion formation specifically designed to address risk judgments, such as attitudes towards climate change, terrorist threats, or children vaccination. The model assumes that people collect risk information from the media environment and exchange them locally with other individuals. Even though individuals are initially exposed to the same sample of information, the model predicts the emergence of opinion polarization and clustering. In particular, numerical simulations highlight two crucial factors that determine the collective outcome: the propensity of individuals to search for independent information, and the strength of social influence. This work provides a quantitative framework to anticipate and manage how the public responds to a given risk, and could help understanding the systemic amplification of fears and worries, or the underestimation of real dangers.	[Moussaid, Mehdi] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Moussaid, Mehdi] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany	Max Planck Society; Max Planck Society	Moussaid, M (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	mehdi.moussaid@gmail.com			Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The author is funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EUROBAROMETER SURVEY; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Binder AR, 2011, RISK ANAL, V31, P324, DOI 10.1111/j.1539-6924.2010.01516.x; Caldarelli Guido, 2013, INFLUENCE MEDIA COLL; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Deffuant G, 2002, JASSS-J ARTIF SOC S, V5; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gonzalez-Avella JC, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/013010; Gonzalez-Avella JC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.065102; Gonzalez-Avella JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046119; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; ISENBERG DJ, 1986, J PERS SOC PSYCHOL, V50, P1141, DOI 10.1037/0022-3514.50.6.1141; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2009, NAT NANOTECHNOL, V4, P87, DOI [10.1038/nnano.2008.341, 10.1038/NNANO.2008.341]; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Latane B, 1996, J COMMUN, V46, P13, DOI 10.1111/j.1460-2466.1996.tb01501.x; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; Mason WA, 2007, PERS SOC PSYCHOL REV, V11, P279, DOI 10.1177/1088868307301032; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Moussaid M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002442; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; MYERS DG, 1970, SCIENCE, V169, P778, DOI 10.1126/science.169.3947.778; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; RENN O, 1992, J SOC ISSUES, V48, P137, DOI 10.1111/j.1540-4560.1992.tb01949.x; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schelling T., 1978, MICROMOTIVES MACROBE; Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306; Shibanai Y, 2001, J CONFLICT RESOLUT, V45, P80, DOI 10.1177/0022002701045001004; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P, 2000, PERCEPTION RISK; STASSER G, 1985, J PERS SOC PSYCHOL, V48, P1467, DOI 10.1037/0022-3514.48.6.1467; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	51	60	61	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84592	10.1371/journal.pone.0084592	http://dx.doi.org/10.1371/journal.pone.0084592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386398	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700113
J	Reynaud, Y; Pitchford, S; De Decker, S; Wikfors, GH; Brown, CL				Reynaud, Yann; Pitchford, Steven; De Decker, Sophie; Wikfors, Gary H.; Brown, Christopher L.			Molecular Typing of Environmental and Clinical Strains of Vibrio vulnificus Isolated in the Northeastern USA	PLOS ONE			English	Article							ESCHERICHIA-COLI; SIALIC-ACID; PCR ASSAY; IDENTIFICATION; PATHOGENESIS; POLYMORPHISM; EVOLUTION; OYSTERS; SEROVAR; CLADE	Vibrio vulnificus is a ubiquitous marine bacterium that is responsible for infections and some seafood-related illnesses and deaths in the United States, mainly in individuals with compromised health status in the Gulf of Mexico region. Most phylogenetic studies focus on V. vulnificus strains isolated in the southern United States, but almost no genetic data are available on northeastern bacterial isolates of clinical or environmental origin. Our goal in this study was to examine the genetic diversity of environmental strains isolated from commercially-produced oysters and in clinical strains of known pathogenicity in northeastern United States. We conducted analyses of a total of eighty-three strains of V. vulnificus, including 18 clinical strains known to be pathogenic. A polyphasic, molecular-typing approach was carried out, based upon established biotypes, vcg, CPS, 16S rRNA types and three other genes possibly associated with virulence (arylsulfatase A, mtlABC, and nanA). An established Multi Locus Sequence Typing (MLST) method was also performed. Phylogenetic analyses of these markers and MLST results produced similar patterns of clustering of strains into two main lineages (we categorized as 'LI' and 'LII'), with clinical and environmental strains clustering together in both lineages. Lineage LII was comprised primarily but not entirely of clinical bacterial isolates. Putative virulence markers were present in both clinical and environmental strains. These results suggest that some northeastern environmental strains of V. vulnificus are phylogenetically close to clinical strains and probably are capable of virulence. Further studies are necessary to assess the risk of human illness from consuming raw oysters harvested in the northeastern US.	[Reynaud, Yann; Pitchford, Steven; De Decker, Sophie; Wikfors, Gary H.; Brown, Christopher L.] NOAA, NEFSC, Milford Lab, Milford, CT 06460 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Brown, CL (corresponding author), NOAA, NEFSC, Milford Lab, Milford, CT 06460 USA.	Christopher.L.Brown@noaa.gov	Reynaud, Yann/ABD-7936-2021	Reynaud, Yann/0000-0002-1966-7249	National Academy of Science [P102628]	National Academy of Science	Funding by the National Academy of Science as part of the Research Associate Program (No P102628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZNAR R, 1994, INT J SYST BACTERIOL, V44, P330, DOI 10.1099/00207713-44-2-330; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 2007, INFECT GENET EVOL, V7, P685, DOI 10.1016/j.meegid.2007.07.007; Canigral I, 2010, MICROBIOL RES, V165, P657, DOI 10.1016/j.micres.2009.11.012; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Chatzidaki-Livanis M, 2006, APPL ENVIRON MICROB, V72, P6136, DOI 10.1128/AEM.00341-06; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Drake SL, 2010, FOODBORNE PATHOG DIS, V7, P97, DOI 10.1089/fpd.2009.0362; Fouz B, 2007, MICROBIOL-SGM, V153, P1926, DOI 10.1099/mic.0.2006/005405-0; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gordon KV, 2008, APPL ENVIRON MICROB, V74, P1704, DOI 10.1128/AEM.01100-07; Gulig PA, 2005, J MICROBIOL, V43, P118; Gulig PA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-512; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kaysner CA., 2004, BACTERIOLOGICAL ANAL; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lubin JB, 2012, APPL ENVIRON MICROB, V78, P3407, DOI 10.1128/AEM.07395-11; MILKMAN R, 1990, GENETICS, V126, P505; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oliver JD, 2006, BIOLOGY OF VIBRIOS, P349; ONEILL KR, 1990, FEMS MICROBIOL LETT, V72, P163, DOI 10.1111/j.1574-6968.1990.tb03882.x; ONEILL KR, 1992, APPL ENVIRON MICROB, V58, P3257, DOI 10.1128/AEM.58.10.3257-3262.1992; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sanjuan E, 2007, APPL ENVIRON MICROB, V73, P2029, DOI 10.1128/AEM.02320-06; Sanjuan E, 2011, APPL ENVIRON MICROB, V77, P688, DOI 10.1128/AEM.01263-10; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Thiaville PC, 2011, INFECT IMMUN, V79, P1194, DOI 10.1128/IAI.01031-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TILTON RC, 1987, DIAGN MICR INFEC DIS, V6, P109, DOI 10.1016/0732-8893(87)90094-0; Vickery MCL, 2007, J MICROBIOL METH, V68, P376, DOI 10.1016/j.mimet.2006.02.018; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Warner E, 2007, APPL ENVIRON MICROB, V73, P3098, DOI 10.1128/AEM.02245-06; Warner JM, 1999, APPL ENVIRON MICROB, V65, P1141	45	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83357	10.1371/journal.pone.0083357	http://dx.doi.org/10.1371/journal.pone.0083357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386187	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700036
J	Adukpo, S; Kusi, KA; Ofori, MF; Tetteh, JKA; Amoako-Sakyi, D; Goka, BQ; Adjei, GO; Edoh, DA; Akanmori, BD; Gyan, BA; Dodoo, D				Adukpo, Selorme; Kusi, Kwadwo A.; Ofori, Michael F.; Tetteh, John K. A.; Amoako-Sakyi, Daniel; Goka, Bamenla Q.; Adjei, George O.; Edoh, Dominic A.; Akanmori, Bartholomew D.; Gyan, Ben A.; Dodoo, Daniel			High Plasma Levels of Soluble Intercellular Adhesion Molecule (ICAM)-1 Are Associated with Cerebral Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; MICROVESSEL ENDOTHELIAL-CELLS; VARIANT SURFACE-ANTIGENS; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; HUMAN BRAIN; PARASITIZED ERYTHROCYTES; AFRICAN CHILDREN; DISEASE SEVERITY; FLOW CONDITIONS	Background: Cerebral malaria (CM) is responsible for most of the malaria-related deaths in children in sub-Saharan Africa. Although, not well understood, the pathogenesis of CM involves parasite and host factors which contribute to parasite sequestration through cytoadherence to the vascular endothelium. Cytoadherence to brain microvasculature is believed to involve host endothelial receptor, CD54 or intercellular adhesion molecule (ICAM)-1, while other receptors such as CD36 are generally involved in cytoadherence of parasites in other organs. We therefore investigated the contributions of host ICAM-1 expression and levels of antibodies against ICAM-1 binding variant surface antigen (VSA) on parasites to the development of CM. Methodology/Principal Findings: Paediatric malaria patients, 0.5 to 13 years were recruited and grouped into CM and uncomplicated malaria (UM) patients, based on well defined criteria. Standardized ELISA protocol was used to measure soluble ICAM-1 (sICAM-1) levels from acute plasma samples. Levels of IgG to CD36- or ICAM-1-binding VSA were measured by flow cytometry during acute and convalescent states. Wilcoxon sign rank-test analysis to compare groups revealed association between sICAM-1 levels and CM (p<0.0037). Median levels of antibodies to CD36-binding VSA were comparable in the two groups at the time of admission and 7 days after treatment was initiated (p>0.05). Median levels of antibodies to CD36-binding VSAs were also comparable between acute and convalescent samples within any patient group. Median levels of antibodies to ICAM-1-binding VSAs were however significantly lower at admission time than during recovery in both groups. Conclusions/Significance: High levels of sICAM-1 were associated with CM, and the sICAM-1 levels may reflect expression levels of the membrane bound form. Anti-VSA antibody levels to ICAM-binding parasites was more strongly associated with both UM and CM than antibodies to CD36 binding parasites. Thus, increasing host sICAM-1 levels were associated with CM whilst antibodies to parasite expressing non-ICAM-1-binding VSAs were not.	[Adukpo, Selorme; Kusi, Kwadwo A.; Ofori, Michael F.; Tetteh, John K. A.; Amoako-Sakyi, Daniel; Akanmori, Bartholomew D.; Gyan, Ben A.; Dodoo, Daniel] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana; [Adukpo, Selorme; Edoh, Dominic A.] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Accra, Ghana; [Goka, Bamenla Q.; Adjei, George O.] Univ Ghana, Coll Hlth Sci, Sch Med, Dept Child Hlth, Legon, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana	Adukpo, S (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Accra, Ghana.	sadukpo812@gmail.com	Kusi, Kwadwo Asamoah/J-5941-2019; Ofori, Michael F/H-9072-2013	Kusi, Kwadwo Asamoah/0000-0001-5483-9985; Ofori, Michael F/0000-0003-2341-7514	Multinational Initiative on Malaria-Training in Tropical Diseases (MIM-TDR) [A11034]	Multinational Initiative on Malaria-Training in Tropical Diseases (MIM-TDR)	The study was funded by Multinational Initiative on Malaria-Training in Tropical Diseases (MIM-TDR grant A11034). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Armah Henry, 2005, Int J Environ Res Public Health, V2, P123, DOI 10.3390/ijerph2005010123; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Budnik A, 1996, EXP HEMATOL, V24, P352; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cooke BM, 1996, BLOOD, V88, P4040, DOI 10.1182/blood.V88.10.4040.bloodjournal88104040; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Cserti-Gazdewich CM, 2012, BRIT J HAEMATOL, V159, P223, DOI 10.1111/bjh.12014; Cserti-Gazdewich CM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-233; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; GRAU GE, 1990, IMMUNOL LETT, V25, P189, DOI 10.1016/0165-2478(90)90113-5; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; HVIID L, 1993, IMMUNOL LETT, V36, P51, DOI 10.1016/0165-2478(93)90068-D; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kampfl A, 1997, AM J TROP MED HYG, V56, P585, DOI 10.4269/ajtmh.1997.56.585; KAUL DK, 1991, BLOOD, V78, P812; KERN P, 1992, J INFECT DIS, V166, P930, DOI 10.1093/infdis/166.4.930; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Mayengue PI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-276; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; McGuire W, 1996, T ROY SOC TROP MED H, V90, P274, DOI 10.1016/S0035-9203(96)90244-8; Mendez MP, 2008, AM J PHYSIOL-LUNG C, V294, pL807, DOI 10.1152/ajplung.00398.2007; MOLYNEUX ME, 1989, Q J MED, V71, P441; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; PAUL F, 1981, LANCET, V2, P70; Ponsford MJ, 2012, J INFECT DIS, V205, P663, DOI 10.1093/infdis/jir812; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Staalsoe T, 2003, PARASITE IMMUNOL, V25, P421, DOI 10.1111/j.1365-3024.2003.00652.x; Tang THT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-219; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Vastag M, 1999, MICROVASC RES, V57, P52, DOI 10.1006/mvre.1998.2115; WARRELL DA, 1987, PARASITOLOGY, V94, pS53, DOI 10.1017/S0031182000085826; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P	52	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84181	10.1371/journal.pone.0084181	http://dx.doi.org/10.1371/journal.pone.0084181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386348	Green Published, gold			2022-12-27	WOS:000329117900081
J	Inayathullah, M; Satheeshkumar, KS; Malkovskiy, AV; Carre, AL; Sivanesan, S; Hardesty, JO; Rajadas, J				Inayathullah, Mohammed; Satheeshkumar, K. S.; Malkovskiy, Andrey V.; Carre, Antoine L.; Sivanesan, Senthilkumar; Hardesty, Jasper O.; Rajadas, Jayakumar			Solvent Microenvironments and Copper Binding Alters the Conformation and Toxicity of a Prion Fragment	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM; ALZHEIMERS-DISEASE; OCTAREPEAT DOMAIN; NEUROTOXICITY; PEPTIDES; POLYMORPHISM; AGGREGATION; CONVERSION; NEURONS	The secondary structures of amyloidogenic proteins are largely influenced by various intra and extra cellular microenvironments and metal ions that govern cytotoxicity. The secondary structure of a prion fragment, PrP(111-126), was determined using circular dichroism (CD) spectroscopy in various microenvironments. The conformational preferences of the prion peptide fragment were examined by changing solvent conditions and pH, and by introducing external stress (sonication). These physical and chemical environments simulate various cellular components at the water-membrane interface, namely differing aqueous environments and metal chelating ions. The results show that PrP(111-126) adopts different conformations in assembled and non-assembled forms. Aging studies on the PrP(111-126) peptide fragment in aqueous buffer demonstrated a structural transition from random coil to a stable beta-sheet structure. A similar, but significantly accelerated structural transition was observed upon sonication in aqueous environment. With increasing TFE concentrations, the helical content of PrP(111-126) increased persistently during the structural transition process from random coil. In aqueous SDS solution, PrP(111-126) exhibited beta-sheet conformation with greater a-helical content. No significant conformational changes were observed under various pH conditions. Addition of Cu2+ ions inhibited the structural transition and fibril formation of the peptide in a cell free in vitro system. The fact that Cu2+ supplementation attenuates the fibrillar assemblies and cytotoxicity of PrP(111-126) was witnessed through structural morphology studies using AFM as well as cytotoxicity using MTT measurements. We observed negligible effects during both physical and chemical stimulation on conformation of the prion fragment in the presence of Cu2+ ions. The toxicity of PrP(111-126) to cultured astrocytes was reduced following the addition of Cu2+ ions, owing to binding affinity of copper towards histidine moiety present in the peptide.	[Inayathullah, Mohammed; Malkovskiy, Andrey V.; Sivanesan, Senthilkumar; Rajadas, Jayakumar] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA; [Satheeshkumar, K. S.] Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India; [Carre, Antoine L.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Hardesty, Jasper O.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Rajadas, Jayakumar] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rajadas, Jayakumar] Stanford Univ, Sch Med, Cardiovasc Pharmacol Div, Cardiovasc Inst, Stanford, CA 94305 USA	Stanford University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI); Stanford University; Stanford University; Stanford University; Stanford University	Rajadas, J (corresponding author), Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.	jayraja@stanford.edu	Inayathullah, Mohammed/C-6953-2015; Rajadas, Jayakumar/AHC-0630-2022	Inayathullah, Mohammed/0000-0001-7646-1709; Rajadas, Jayakumar/0000-0001-6520-3923; Sivanesan, Senthilkumar/0000-0001-5133-7090				Abe K, 1996, JPN J PHARMACOL, V72, P299, DOI 10.1254/jjp.72.299; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Andrews ME, 2009, J STRUCT BIOL, V166, P116, DOI 10.1016/j.jsb.2008.12.011; Ashe KH, 2013, PRION, V7, P55, DOI 10.4161/pri.23061; BALDWIN MA, 1995, J BIOL CHEM, V270, P19197, DOI 10.1074/jbc.270.33.19197; Bate C, 2002, NEUROREPORT, V13, P1695, DOI 10.1097/00001756-200209160-00025; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Bodanszky M, 1984, PRACTICE PEPTIDE SYN, Vxvii; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1998, J NEUROCHEM, V70, P1686; Brown DR, 1999, J NEUROCHEM, V73, P1105, DOI 10.1046/j.1471-4159.1999.0731105.x; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Caughey B, 1997, TRENDS CELL BIOL, V7, P56, DOI 10.1016/S0962-8924(96)10054-4; Chacon MA, 2003, MOL PSYCHIATR, V8, P853, DOI [10.1038/sj.mp.4001400, 10.1038/sj.mp.4001414]; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chen H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S14; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chun YS, 2002, CHEM COMMUN, P1846, DOI 10.1039/b205046c; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Das D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011420; De Armond S J, 1989, Prog Clin Biol Res, V317, P601; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Ferreiro E, 2008, J NEUROCHEM, V104, P766, DOI 10.1111/j.1471-4159.2007.05048.x; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Forloni G, 1996, PROG NEUROBIOL, V49, P287, DOI 10.1016/0301-0082(96)00013-5; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Huang Z, 1996, CURR TOP MICROBIOL, V207, P49; Inayathullah M, 2011, AMYLOID, V18, P98, DOI 10.3109/13506129.2011.580399; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kawahara M, 2011, METALLOMICS, V3, P726, DOI 10.1039/c1mt00015b; Klewpatinond M, 2007, BIOCHEM J, V404, P393, DOI 10.1042/BJ20061893; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Levy Y, 2002, PROTEINS, V47, P458, DOI 10.1002/prot.10095; Luidens MK, 1996, BIOPOLYMERS, V39, P367, DOI 10.1002/(SICI)1097-0282(199609)39:3<367::AID-BIP8>3.3.CO;2-C; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Moses JP, 2003, LANGMUIR, V19, P3413, DOI 10.1021/la026661m; Murali J, 2005, J STRUCT BIOL, V150, P180, DOI 10.1016/j.jsb.2005.02.009; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Petchanikow C, 2001, FEBS LETT, V509, P451, DOI 10.1016/S0014-5793(01)03147-7; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Ragg E, 1999, EUR J BIOCHEM, V266, P1192, DOI 10.1046/j.1432-1327.1999.00985.x; RAPOPORT TA, 1986, CRC CR REV BIOCH MOL, V20, P73, DOI 10.3109/10409238609115901; REDDY GL, 1989, J BIOL CHEM, V264, P16591; Rivillas-Acevedo L, 2011, INORG CHEM, V50, P1956, DOI 10.1021/ic102381j; Ronga L, 2007, BIOINORG CHEM APPL, V2017, DOI 10.1155/2007/10720; Satheeshkumar KS, 2004, J STRUCT BIOL, V148, P176, DOI 10.1016/j.jsb.2004.05.006; Satheeshkumar KS, 2003, BIOPHYS J, V85, P473, DOI 10.1016/S0006-3495(03)74492-0; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Shanmugam G, 2004, BIOPOLYMERS, V76, P421, DOI 10.1002/bip.20131; Simon D., 2013, NEUROPATHOL APPL NEU; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart JM, 1984, SOLID PHASE PEPTIDE, Vxvi; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Sureshbabu N, 2009, EUR BIOPHYS J BIOPHY, V38, P355, DOI 10.1007/s00249-008-0379-8; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; Tcherkasskaya O, 2003, J BIOMOL STRUCT DYN, V21, P353, DOI 10.1080/07391102.2003.10506931; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Tizzano B, 2005, PROTEINS, V59, P72, DOI 10.1002/prot.20395; Viles JH, 2008, BIOCHEM SOC T, V36, P1288, DOI 10.1042/BST0361288; Whittal RM, 2000, PROTEIN SCI, V9, P332; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zhou GP, 2013, CURR TOP MED CHEM, V13, P1152, DOI 10.2174/15680266113139990003	87	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85160	10.1371/journal.pone.0085160	http://dx.doi.org/10.1371/journal.pone.0085160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386462	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900128
J	LeBoldus, JM; Isabel, N; Floate, KD; Blenis, P; Thomas, BR				LeBoldus, Jared M.; Isabel, Nathalie; Floate, Kevin D.; Blenis, Peter; Thomas, Barb R.			Testing the 'Hybrid Susceptibility' and 'Phenological Sink' Hypotheses Using the P. balsamifera - P. deltoides Hybrid Zone and Septoria Leaf Spot [Septoria musiva]	PLOS ONE			English	Article							STEM CANKER; POPULUS; RESISTANCE; POPLAR; HYBRIDIZATION; POPULICOLA	Hybrid genotypes that arise between plant species frequently have increased susceptibility to arthropod pests and fungal pathogens. This pattern has been attributed to the breakdown of plant defenses ('Hybrid susceptibility' hypothesis) and (or) to extended periods of susceptibility attributed to plant phenologies in zones of species overlap and (or) hybridization ('phenological sink' hypothesis). We examined these hypotheses by assessing the susceptibility of parental and hybrid Populus host genotypes to a leaf spot disease caused by the fungal pathogen Septoria musiva. For this purpose, 214 genotypes were obtained from morphologically pure zones of P. balsamifera and P. deltoides, and from an intervening zone of overlap and hybridization on the drainage of the Red Deer River, Alberta, Canada. Genotypes were identified as P. balsamifera, P. deltoides, or hybrid using a suite of 27 species-specific SNP markers. Initially the genetic structure of the hybrid zone was characterized with 27.7% of trees classified as admixed individuals. To test the hybrid susceptibility hypothesis, a subset of 52 genotypes was inoculated with four isolates of S. musiva. Levels of susceptibility were P. balsamifera > F-1 hybrid > P. deltoides. A further 53 genotypes were grown in a common garden to assess the effect of genotype on variation in leaf phenology. Leaf phenology was more variable within the category of hybrid genotypes than within categories of either parental species. Leaf phenology was also more variable for the category of trees originating in the hybrid (P. balsamifera - P. deltoides [hybrid and parental genotypes combined]) zone than in adjacent pure zones of the parental species. The results from the inoculation experiment support the hybrid intermediacy hypothesis. The results from the common garden experiment support the 'phenological sink' hypothesis. These findings have greatly increased our understanding of the epidemiology and ecology of fungal pathogens in plant hybrid zones.	[LeBoldus, Jared M.] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; [Isabel, Nathalie] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Ste Foy, PQ, Canada; [Floate, Kevin D.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Blenis, Peter; Thomas, Barb R.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Thomas, Barb R.] Alberta Pacific Forest Ind Inc, Boyle, AB, Canada	North Dakota State University Fargo; Natural Resources Canada; Canadian Forest Service; Agriculture & Agri Food Canada; University of Alberta	LeBoldus, JM (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	jared.leboldus@ndsu.edu	Floate, Kevin/AAD-9856-2019	Floate, Kevin/0000-0002-7485-5170; Isabel, Nathalie/0000-0001-8621-9801; Thomas, Barb R./0000-0002-9718-9297	CFS-NSERC-Industry Forest Research Partnership; NSERC-IPS-2; Alberta-pacific Forest Industries Inc.; West Fraser Timber Company; University of Alberta's Queen Elizabeth II	CFS-NSERC-Industry Forest Research Partnership(Natural Resources CanadaCanadian Forest Service); NSERC-IPS-2; Alberta-pacific Forest Industries Inc.; West Fraser Timber Company; University of Alberta's Queen Elizabeth II	CFS-NSERC-Industry Forest Research Partnership to PB. NSERC-IPS-2, Alberta-pacific Forest Industries Inc., West Fraser Timber Company for the West Fraser Scholarship in Enhanced Forest Management, and The University of Alberta's Queen Elizabeth II scholarship to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOL POPULUS ITS IMP; BIER J. E., 1939, CANADIAN JOUR RES SECT C BOT SCI, V17, P195; CEULEMANS R, 1992, CAN J FOREST RES, V22, P1937, DOI 10.1139/x92-253; Desrochers A, 2003, NEW FOREST, V26, P17, DOI 10.1023/A:1024492103150; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feau N, 2005, MYCOL RES, V109, P1015, DOI 10.1017/S0953756205003242; Feau N, 2010, CAN J PLANT PATHOL, V32, P122, DOI 10.1080/07060661003740009; Floate KD, 2004, CAN J BOT, V82, P253, DOI [10.1139/B03-135, 10.1139/b03-135]; FLOATE KD, 1993, ECOLOGY, V74, P2056, DOI 10.2307/1940851; Fritz RS, 1999, ANNU REV ECOL SYST, V30, P565, DOI 10.1146/annurev.ecolsys.30.1.565; Hamzeh M, 2007, CAN J BOT, V85, P1227, DOI 10.1139/B07-105; Isabel N, 2013, TREE GENET GENOMES, V9, P621, DOI 10.1007/s11295-012-0569-5; KAHN RP, 1958, PHYTOPATHOLOGY, V48, P25; Lamari L, 2008, ASSESS 20 IMAGE ANAL; LeBoldus JM, 2010, PLANT DIS, V94, P1238, DOI 10.1094/PDIS-02-10-0094; Littell RC, 2006, SAS MIXED MODELS, V2nd; Luley CJ, 1989, PHYTOPATHOLOGY, V87, P381; McIntire EJB, 2002, AM J BOT, V89, P642, DOI 10.3732/ajb.89.4.642; Meirmans PG, 2007, CAN J BOT, V85, P1082, DOI 10.1139/B07-069; Newcombe G, 1998, PHYTOPATHOLOGY, V88, P114, DOI 10.1094/PHYTO.1998.88.2.114; Newcombe G, 1996, CAN J FOREST RES, V26, P1943, DOI 10.1139/x26-219; Newcombe G, 2001, PHYTOPATHOLOGY, V91, P1081, DOI 10.1094/PHYTO.2001.91.11.1081; OSTRY ME, 1987, EUR J FOREST PATHOL, V17, P158; OSTRY ME, 1985, PLANT DIS, V69, P755, DOI 10.1094/PD-69-755; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; Pritchard JK, 2000, GENETICS, V155, P945; Stanosz JC, 2002, FOREST PATHOL, V32, P145, DOI 10.1046/j.1439-0329.2002.00278.x; STRAUSS SY, 1994, TRENDS ECOL EVOL, V9, P209, DOI 10.1016/0169-5347(94)90245-3; Talbot P, 2012, FOREST ECOL MANAG, V285, P142, DOI 10.1016/j.foreco.2012.07.036; Thompson SL, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04442.x; WATERMAN A. M., 1954, Circular. United States Department of Agriculture; WHITHAM TG, 1989, SCIENCE, V244, P1490, DOI 10.1126/science.244.4911.1490; Whitham TG, 1999, ECOLOGY, V80, P416	33	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84437	10.1371/journal.pone.0084437	http://dx.doi.org/10.1371/journal.pone.0084437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386379	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900093
J	Neider, MB; Ang, CW; Voss, MW; Carbonari, R; Kramer, AF				Neider, Mark B.; Ang, Cher Wee; Voss, Michelle W.; Carbonari, Ronald; Kramer, Arthur F.			Training and Transfer of Training in Rapid Visual Search for Camouflaged Targets	PLOS ONE			English	Article							EYE-MOVEMENTS; SPECIFICITIES; ATTENTION	Previous examinations of search under camouflage conditions have reported that performance improves with training and that training can engender near perfect transfer to similar, but novel camouflage-type displays [1]. What remains unclear, however, are the cognitive mechanisms underlying these training improvements and transfer benefits. On the one hand, improvements and transfer benefits might be associated with higher-level overt strategy shifts, such as through the restriction of eye movements to target-likely (background) display regions. On the other hand, improvements and benefits might be related to the tuning of lower-level perceptual processes, such as figure-ground segregation. To decouple these competing possibilities we had one group of participants train on camouflage search displays and a control group train on non-camouflage displays. Critically, search displays were rapidly presented, precluding eye movements. Before and following training, all participants completed transfer sessions in which they searched novel displays. We found that search performance on camouflage displays improved with training. Furthermore, participants who trained on camouflage displays suffered no performance costs when searching novel displays following training. Our findings suggest that training to break camouflage is related to the tuning of perceptual mechanisms and not strategic shifts in overt attention.	[Neider, Mark B.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA; [Ang, Cher Wee; Carbonari, Ronald; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	State University System of Florida; University of Central Florida; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa	Neider, MB (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	mark.neider@ucf.edu	Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	Office of Naval Research [N00014-07-1-1913]	Office of Naval Research(Office of Naval Research)	This work was supported by a grant from the Office of Naval Research (N00014-07-1-1913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Boot WR, 2009, ATTEN PERCEPT PSYCHO, V71, P950, DOI 10.3758/APP.71.4.950; Chen X, 2012, PSYCHOL SCI, V23, P1395, DOI 10.1177/0956797612445315; Cott H. B., 1948, Advancement of Science London, V4, P300; Ellison A, 1998, VISION RES, V38, P333, DOI 10.1016/S0042-6989(97)00195-8; FIORENTINI A, 1981, VISION RES, V21, P1149, DOI 10.1016/0042-6989(81)90017-1; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Neider MB, 2006, VISION RES, V46, P2217, DOI 10.1016/j.visres.2006.01.006; Neider MB, 2010, ACTA PSYCHOL, V134, P29, DOI 10.1016/j.actpsy.2009.12.001; Peterson MS, 2004, PERCEPT PSYCHOPHYS, V66, P398, DOI 10.3758/BF03194888; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Wolfe JM, 2002, VISION RES, V42, P2985, DOI 10.1016/S0042-6989(02)00388-7; Yi DJ, 2006, VISION RES, V46, P914, DOI 10.1016/j.visres.2005.09.009	15	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83885	10.1371/journal.pone.0083885	http://dx.doi.org/10.1371/journal.pone.0083885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386301	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900065
J	Jenkins, R; Kerr, C				Jenkins, Rob; Kerr, Christie			Identifiable Images of Bystanders Extracted from Corneal Reflections	PLOS ONE			English	Article							UNFAMILIAR FACES; MATCHING TASK; RECOGNITION; FAMILIARITY; EYE	Criminal investigations often use photographic evidence to identify suspects. Here we combined robust face perception and high-resolution photography to mine face photographs for hidden information. By zooming in on high-resolution face photographs, we were able to recover images of unseen bystanders from reflections in the subjects' eyes. To establish whether these bystanders could be identified from the reflection images, we presented them as stimuli in a face matching task (Experiment 1). Accuracy in the face matching task was well above chance (50%), despite the unpromising source of the stimuli. Participants who were unfamiliar with the bystanders' faces (n = 16) performed at 71% accuracy [t(15) = 7.64, p<.0001, d = 1.91], and participants who were familiar with the faces (n = 16) performed at 84% accuracy [t(15) = 11.15, p<.0001, d = 2.79]. In a test of spontaneous recognition (Experiment 2), observers could reliably name a familiar face from an eye reflection image. For crimes in which the victims are photographed (e. g., hostage taking, child sex abuse), reflections in the eyes of the photographic subject could help to identify perpetrators.	[Jenkins, Rob] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Kerr, Christie] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of York - UK; University of Glasgow	Jenkins, R (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	rob.jenkins@york.ac.uk	Jenkins, Rob/C-5289-2008		Economic and Social Research Council, UK	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the Economic and Social Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Calder AJ, 2002, NEUROPSYCHOLOGIA, V40, P1129, DOI 10.1016/S0028-3932(02)00008-8; Clutterbuck R, 2005, EUR J COGN PSYCHOL, V17, P97, DOI 10.1080/09541440340000439; Clutterbuck R, 2004, VIS COGN, V11, P857, DOI 10.1080/13506280444000021; Clutterbuck R, 2002, PERCEPTION, V31, P985, DOI 10.1068/p3335; CREER KE, 1984, FORENSIC SCI INT, V24, P263, DOI 10.1016/0379-0738(84)90160-9; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; HARMON LD, 1973, SCI AM, V229, P70, DOI 10.1038/scientificamerican1173-70; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; Hendy B, 1998, PMA DIMA C SYDN AUST; Jenkins R, 2011, PHILOS T R SOC B, V366, P1671, DOI 10.1098/rstb.2010.0379; Johnson MK, 2007, LECT NOTES COMPUT SC, V4567, P311, DOI 10.1007/978-3-540-77370-2_21; Laustsen CB, 2008, J CULT RES, V12, P123, DOI 10.1080/14797580802390848; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Moore G. E., 1965, ELECTRONICS, V38, P1, DOI DOI 10.1109/JPROC.1998.658762; Nishino K, 2006, INT J COMPUT VISION, V70, P23, DOI 10.1007/s11263-006-6274-9; Ricci LR, 2006, PHOTODOCUMENTATION I; Torralba A, 2012, PROC CVPR IEEE, P374, DOI 10.1109/CVPR.2012.6247698; Trevisa J, 1975, PROPERTIES THINGS J, P184; Trucco E., 1998, INTRO TECHNIQUES 3 D; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376	23	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83325	10.1371/journal.pone.0083325	http://dx.doi.org/10.1371/journal.pone.0083325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386177	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700040
J	Joyee, AG; Yang, X				Joyee, Antony George; Yang, Xi			Plasmacytoid Dendritic Cells Mediate the Regulation of Inflammatory Type T Cell Response for Optimal Immunity against Respiratory Chlamydia Pneumoniae Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; IFN-GAMMA; PROTECTIVE IMMUNITY; TOXOPLASMA-GONDII; ADAPTIVE IMMUNITY; TNF-ALPHA; IN-VIVO; MICE; IL-10; ANTIGEN	Chlamydia pneumoniae (Cpn) infection is a leading cause for a variety of respiratory diseases and has been implicated in the pathogenesis of chronic inflammatory diseases. The regulatory mechanisms in host defense against Cpn infection are less understood. In this study, we investigated the role of plasmacytoid dendritic cells (pDCs) in immune regulation in Cpn respiratory tract infection. We found that in vivo depletion of pDCs increased the severity of infection and lung pathology. Mice depleted of pDC had greater body weight loss, higher lung bacterial burden and excessive tissue inflammation compared to the control mice. Analysis of specific T cell cytokine production pattern in the lung following Cpn infection revealed that pDC depleted mice produced significantly higher amounts of inflammatory cytokines, especially TNF-alpha, but lower IL-10 compared to the controls. In particular, pDC depleted mice showed pathogenic T cell responses characterized by inflammatory type-1 (CD8 and CD4) and inflammatory Th2 cell responses. Moreover, pDC depletion dramatically reduced CD4 regulatory T cells (Tregs) in the lungs and draining lymph nodes. Furthermore, pDC-T cell co-culture experiments showed that pDCs isolated from Cpn infected mice were potent in inducing IL-10 producing CD4 Tregs. Together, these findings provide in vivo evidence for a critical role of pDCs in homeostatic regulation of immunity during Cpn infection. Our findings highlight the importance of a 'balanced' immune response for host protective immunity and preventing detrimental immunopathology during microbial infections.	[Yang, Xi] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada; Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada	University of Manitoba; University of Manitoba	Yang, X (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada.	Xi.Yang@med.umanitoba.ca		Yang, Xi/0000-0002-8831-7488	Canadian Institutes for Health Research (CIHR); Manitoba Health Research Council (MHRC); International Centre for Infectious Diseases/CIHR National Training Program; MHRC	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC); International Centre for Infectious Diseases/CIHR National Training Program; MHRC	This work was supported by operating grants from the Canadian Institutes for Health Research (CIHR) and the Manitoba Health Research Council (MHRC) to X.Y. A.G.J. was a recipient of Postdoctoral Fellowship Awards from the International Centre for Infectious Diseases/CIHR National Training Program and the MHRC. X.Y. is Canada Research Chair in Infection and Immunity. The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang DKY, 2010, J IMMUNOL, V184, P5429, DOI 10.4049/jimmunol.1000128; Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Crother TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048655; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Droemann D, 2007, AM J RESP CRIT CARE, V175, P791, DOI 10.1164/rccm.200607-926OC; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gencay Mesut, 2003, Am J Respir Med, V2, P31; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Grimaldi LME, 2003, MULT SCLER, V9, P467, DOI 10.1191/1352458503ms944oa; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Jewell NA, 2007, J VIROL, V81, P9790, DOI 10.1128/JVI.00530-07; Johnston SC, 2001, STROKE, V32, P2748, DOI 10.1161/hs1201.099631; Joyee AG, 2008, AM J RESP CRIT CARE, V178, P745, DOI 10.1164/rccm.200804-517OC; Joyee AG, 2007, J IMMUNOL, V178, P1048, DOI 10.4049/jimmunol.178.2.1048; Joyee AG, 2010, J IMMUNOL, V184, P2095, DOI 10.4049/jimmunol.0901348; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Penttila JM, 1999, IMMUNOLOGY, V97, P490, DOI 10.1046/j.1365-2567.1999.00809.x; Penttila T, 2008, MICROB PATHOGENESIS, V45, P25, DOI 10.1016/j.micpath.2008.02.004; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Srikiatkhachorn A, 2010, VIRAL IMMUNOL, V23, P639, DOI 10.1089/vim.2010.0076; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Wantia N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026101; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wizel B, 2002, J IMMUNOL, V169, P2524, DOI 10.4049/jimmunol.169.5.2524; Yang X, 1999, J IMMUNOL, V162, P1010; Yang X, 2003, CURR PHARM DESIGN, V9, P67, DOI 10.2174/1381612033392486; Yang X, 1996, J IMMUNOL, V156, P4338	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83463	10.1371/journal.pone.0083463	http://dx.doi.org/10.1371/journal.pone.0083463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386207	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700053
J	Tian, MM; Feng, D; Chen, X; Chen, YC; Sun, X; Xiang, YX; Yuan, F; Feng, ZC				Tian, Miaomiao; Feng, Da; Chen, Xi; Chen, Yingchun; Sun, Xi; Xiang, Yuanxi; Yuan, Fang; Feng, Zhanchun			China's Rural Public Health System Performance: A Cross-Sectional Study	PLOS ONE			English	Article							REFORM; STANDARDS; VALIDITY	Background: In the past three years, the Government of China initiated health reform with rural public health system construction to achieve equal access to public health services for rural residents. The study assessed trends of public health services accessibility in rural China from 2008 to 2010, as well as the current situation about the China's rural public health system performance. Methods: The data were collected from a cross-sectional survey conducted in 2011, which used a multistage stratified random sampling method to select 12 counties and 118 villages from China. Three sets of indicators were chosen to measure the trends in access to coverage, equality and effectiveness of rural public health services. Data were disaggregated by provinces and by participants: hypertension patients, children, elderly and women. We examined the changes in equality across and within region. Results: China's rural public health system did well in safe drinking water, children vaccinations and women hospital delivery. But more hypertension patients with low income could not receive regular healthcare from primary health institutions than those with middle and high income. In 2010, hypertension treatment rate of Qinghai in Western China was just 53.22% which was much lower than that of Zhejiang in Eastern China (97.27%). Meanwhile, low performance was showed in effectiveness of rural public health services. The rate of effective treatment for controlling their blood pressure within normal range was just 39.7%. Conclusions: The implementation of health reform since 2009 has led the public health development towards the right direction. Physical access to public health services had increased from 2008 to 2010. But, inter-and intra-regional inequalities in public health system coverage still exist. Strategies to improve the quality and equality of public health services in rural China need to be considered.	[Tian, Miaomiao; Feng, Da; Chen, Xi; Chen, Yingchun; Sun, Xi; Xiang, Yuanxi; Yuan, Fang; Feng, Zhanchun] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Wuhan 430074, Hubei, Peoples R China; [Tian, Miaomiao] Chinese Acad Med Sci, Inst Med Informat, Ctr Hlth Policy & Management, Beijing 100730, Peoples R China; [Chen, Xi] Jiangsu Univ, Sch Management, Zhanjiang, Jiangsu, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Information - CAMS; Jiangsu University	Feng, ZC (corresponding author), Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Wuhan 430074, Hubei, Peoples R China.	zcfeng@mails.tjmu.edu.com			National Natural Science Foundation of China [70973042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by the National Natural Science Foundation of China (Program No: 70973042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET, V378, P457, DOI 10.1016/S0140-6736(11)61232-4; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Beaulieu J, 2003, PUBLIC HEALTH REP, V118, P508, DOI 10.1016/S0033-3549(04)50287-X; Beaulieu J, 2002, PUBLIC HEALTH REP, V117, P28, DOI 10.1016/S0033-3549(04)50105-X; Center for Health Statistics and Information, 2004, REP NAT HLTH SERV SU; Chinese center for disease control and prevention, 2011, ENL NAT IMM PROGR IM; Communist Party of China Central Committee, 2009, IMPL PLAN REC PRIOR; Diderichsen F, 2004, RESOURCE ALLOCATION, P20; Feng ZC, 2011, RURAL PUBLIC HLTH PE, P141; General Office of the State Council (GOSC), 1998, ZHONG ZHENG JIJ ORG; Handler A, 2001, AM J PUBLIC HEALTH, V91, P1235, DOI 10.2105/AJPH.91.8.1235; Jia ZB, 2010, QUAL LIFE RES, V19, P775, DOI 10.1007/s11136-010-9638-0; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Lu Z, 2012, BMC HEALTH SERV RES, V24, P212; Mays GP, 2006, AM J PUBLIC HEALTH, V96, P523, DOI 10.2105/AJPH.2005.064253; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Health of the People's Republic of China, 2008, BAS NORMS INT CONTR, P5; Ministry of Health PRC, 2011, GUID ENH PERF APPR B; Ministry of Health PRC, 2010, CHIN HLTH STAT YB 20; Ministry of Health PRC, 2012, CHIN HLTH STAT DIG 2; Ministry of Health PRC, 2009, OP PROM BAS PUBL HLT; Ministry of Health PRC, 2011, NAT BAS PUBL HLTH SE; Ministry of Health PRC, 2004, CHIN HLTH STAT DIG 2; National Bureau of Statistics of China, 2011, CHIN STAT YB 2011; Qian G, 2011, CHINESE J PUBLIC HLT, V28, P986; Scutchfield FD, 2009, AM J PREV MED, V36, P266, DOI 10.1016/j.amepre.2008.11.007; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tang Z, 2004, CHIN J HOSP ADM, V8, P464; Teng L, 2011, CHINESE J NEW CLIN M, V4, P909; The Central People's Government of the People's Republic of China, 2009, CENTR FIN FUND 10 4; UNDP, 2010, CHIN HUM DEV REP 200; United National Development Program, 2010, 200910 UN DEV PROGR, P13; Weir E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-127; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	36	29	29	11	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83822	10.1371/journal.pone.0083822	http://dx.doi.org/10.1371/journal.pone.0083822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386284	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700080
J	Tiburzy, B; Szyska, M; Iwata, H; Chrobok, N; Kulkarni, U; Hirose, M; Ludwig, RJ; Kalies, K; Westermann, J; Wong, D; Manz, RA				Tiburzy, Benjamin; Szyska, Martin; Iwata, Hiroaki; Chrobok, Navina; Kulkarni, Upasana; Hirose, Misa; Ludwig, Ralf J.; Kalies, Kathrin; Westermann, Juergen; Wong, David; Manz, Rudolf Armin			Persistent Autoantibody-Production by Intermediates between Short- and Long-Lived Plasma Cells in Inflamed Lymph Nodes of Experimental Epidermolysis Bullosa Acquisita	PLOS ONE			English	Article							DERMAL-EPIDERMAL SEPARATION; MEMORY B-CELLS; VII COLLAGEN; T-CELLS; BONE-MARROW; NZB/W MICE; CD154 EXPRESSION; HUMORAL IMMUNITY; PASSIVE TRANSFER; MAJOR SITE	Autoantibodies are believed to be maintained by either the continuous generation of short-lived plasma cells in secondary lymphoid tissues or by long-lived plasma cells localized in bone marrow and spleen. Here, we show in a mouse model for the autoimmune blistering skin disease epidermolysis bullosa acquisita (EBA) that chronic autoantibody production can also be maintained in inflamed lymph nodes, by plasma cells exhibiting intermediate lifetimes. After EBA induction by immunization with a mCOL7c-GST-fusion protein, antigen-specific plasma cells and CD4 T cells were analyzed. Plasma cells were maintained for months in stable numbers in the draining lymph nodes, but not in spleen and bone marrow. In contrast, localization of mCOL7c-GST -specific CD4 T cells was not restricted to lymph nodes, indicating that availability of T cell help does not limit plasma cell localization to this site. BrdU-incorporation studies indicated that pathogenic mCOL7c- and non-pathogenic GST-specific plasma cells resemble intermediates between short-and long-lived plasma cells with half-lives of about 7 weeks. Immunization with mCOL7c-GST also yielded considerable numbers of plasma cells neither specific for mCOL7c- nor GST. These bystander-activated plasma cells exhibited much shorter half-lives and higher population turnover, suggesting that plasma cell lifetimes were only partly determined by the lymph node environment but also by the mode of activation. These results indicate that inflamed lymph nodes can harbor pathogenic plasma cells exhibiting distinct properties and hence may resemble a so far neglected site for chronic autoantibody production.	[Tiburzy, Benjamin; Szyska, Martin; Kulkarni, Upasana; Wong, David; Manz, Rudolf Armin] Univ Lubeck, Inst Syst Inflammat Res ISEF, Lubeck, Germany; [Iwata, Hiroaki; Hirose, Misa; Ludwig, Ralf J.] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Chrobok, Navina; Kalies, Kathrin; Westermann, Juergen] Univ Lubeck, Inst Anat, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Lubeck	Manz, RA (corresponding author), Univ Lubeck, Inst Syst Inflammat Res ISEF, Lubeck, Germany.	Rudolf.Manz@uksh.de	Ludwig, Ralf/F-3996-2018; Manz, Rudolf A/C-8340-2011; Kalies, Kathrin/A-8114-2014; Hirose, Misa/A-2858-2014; Ludwig, Ralf J/A-2629-2008	Ludwig, Ralf/0000-0002-1394-1737; Ludwig, Ralf J/0000-0002-1394-1737; Kalies, Kathrin/0000-0002-8929-4249	Deutsche Forschungsgemeinschaft DFG [GRK1727/1]; University of Luebeck	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); University of Luebeck	This work was supported by the Deutsche Forschungsgemeinschaft DFG via GRK1727/1. David Wong and Upasana Kulkarni were supported by an internal grant of the University of Luebeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Chen M, 2007, AM J PATHOL, V170, P2009, DOI 10.2353/ajpath.2007.061212; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Frey O, 2011, J AUTOIMMUN, V36, P161, DOI 10.1016/j.jaut.2010.12.006; Gupta R, 2012, CLIN DERMATOL, V30, P60, DOI 10.1016/j.clindermatol.2011.03.011; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Kasperkiewicz M, 2011, J AM ACAD DERMATOL, V65, P552, DOI 10.1016/j.jaad.2010.07.032; Kirchhoff D, 2007, EUR J IMMUNOL, V37, P2370, DOI 10.1002/eji.200737322; Le Roux-Villet C, 2011, ARCH DERMATOL, V147, P843, DOI 10.1001/archdermatol.2011.54; Ludwig RJ, 2012, AUTOIMMUNITY, V45, P102, DOI 10.3109/08916934.2011.606451; Ludwig RJ, 2011, DERMATOL CLIN, V29, P493, DOI 10.1016/j.det.2011.03.003; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; Moser K, 2006, CURR OPIN IMMUNOL, V18, P265, DOI 10.1016/j.coi.2006.03.004; Moser K, 2012, ARTHRITIS RHEUM-US, V64, P1237, DOI 10.1002/art.33424; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Mumtaz IM, 2012, J AUTOIMMUN, V39, P180, DOI 10.1016/j.jaut.2012.05.010; Nagel A, 2009, J INVEST DERMATOL, V129, P289, DOI 10.1038/jid.2008.192; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Ryan KR, 2007, J AUTOIMMUN, V29, P262, DOI 10.1016/j.jaut.2007.07.014; Schmidt E, 2006, ARCH DERMATOL, V142, P147, DOI 10.1001/archderm.142.2.147; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Sitaru AG, 2010, J IMMUNOL, V184, P1596, DOI 10.4049/jimmunol.0901412; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Starke C, 2011, EUR J IMMUNOL, V41, P2107, DOI 10.1002/eji.201041315; TESCH H, 1984, EUR J IMMUNOL, V14, P188, DOI 10.1002/eji.1830140215; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Woodley DT, 2006, J INVEST DERMATOL, V126, P1323, DOI 10.1038/sj.jid.5700254	41	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83631	10.1371/journal.pone.0083631	http://dx.doi.org/10.1371/journal.pone.0083631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386241	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700066
J	Anderson, AC; Al-Ahmad, A; Elamin, F; Jonas, D; Mirghani, Y; Schilhabel, M; Karygianni, L; Hellwig, E; Rehman, A				Anderson, Annette Carola; Al-Ahmad, Ali; Elamin, Fadil; Jonas, Daniel; Mirghani, Yousra; Schilhabel, Markus; Karygianni, Lamprini; Hellwig, Elmar; Rehman, Ateequr			Comparison of the Bacterial Composition and Structure in Symptomatic and Asymptomatic Endodontic Infections Associated with Root-Filled Teeth Using Pyrosequencing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CANAL-TREATED TEETH; MOLECULAR ANALYSIS; ENTEROCOCCUS-FAECALIS; INTESTINAL MICROBIOTA; PERIRADICULAR LESIONS; ORAL MICROBIOTA; DENTAL PLAQUE; DIVISION TM7; DIVERSITY	Residual microorganisms and/or re-infections are a major cause for root canal therapy failure. Understanding of the bacterial content could improve treatment protocols. Fifty samples from 25 symptomatic and 25 asymptomatic previously root-filled teeth were collected from Sudanese patients with periradicular lesions. Amplified 16S rRNA gene (V1-V2) variable regions were subjected to pyrosequencing (FLX 454) to determine the bacterial profile. Obtained quality-controlled sequences from forty samples were classified into 741 operational taxonomic units (OTUs) at 3% dissimilarity, 525 at 5% dissimilarity and 297 at 10% dissimilarity, approximately corresponding to species-, genus-and class levels. The most abundant phyla were: Firmicutes (29.9%), Proteobacteria (26.1%), Actinobacteria (22.72%), Bacteroidetes (13.31%) and Fusobacteria (4.55%). Symptomatic patients had more Firmicutes and Fusobacteria than asymptomatic patients, while asymptomatic patients showed more Proteobacteria and Actinobacteria. Interaction of disease status and age was observed by two-way ANOSIM. Canonical correspondence analysis for age, tooth restoration and disease status showed a correlation of disease status with the composition and prevalence of different members of the microbial community. The pyrosequencing analysis revealed a distinctly higher diversity of the microbiota compared to earlier reports. The comparison of symptomatic and asymptomatic patients showed a clear association of the composition of the bacterial community with the presence and absence of symptoms in conjunction with the patients' age.	[Anderson, Annette Carola; Al-Ahmad, Ali; Karygianni, Lamprini; Hellwig, Elmar] Univ Freiburg, Dept Operat Dent & Periodontol, D-79106 Freiburg, Germany; [Elamin, Fadil; Mirghani, Yousra] Khartoum Ctr Res & Med Training, Khartoum, Sudan; [Jonas, Daniel; Rehman, Ateequr] Univ Freiburg, Inst Environm Med & Hosp Hyg, D-79106 Freiburg, Germany; [Schilhabel, Markus] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of Freiburg; University of Freiburg; University of Kiel	Al-Ahmad, A (corresponding author), Univ Freiburg, Dept Operat Dent & Periodontol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ali.al-ahmad@uniklinik-freiburg.de	Rehman, Ateequr/O-3727-2016	Rehman, Ateequr/0000-0002-5664-4628	German Research foundation (DFG) [AL 1179/1-1]	German Research foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research foundation (DFG, AL 1179/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Britton E, 2013, P NUTR SOC, V72, P173, DOI 10.1017/S0029665112002807; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Case PD, 2012, J ENDODONT, V38, P523, DOI 10.1016/j.joen.2011.12.020; Cheung GSP, 2001, ORAL MICROBIOL IMMUN, V16, P332, DOI 10.1034/j.1399-302X.2001.160603.x; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Davis JP, 2009, APPL ENVIRON MICROB, V75, P4139, DOI 10.1128/AEM.00137-09; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Figdor D, 2007, AUST DENT J, V52, pS38, DOI 10.1111/j.1834-7819.2007.tb00524.x; Gomes BPFA, 2005, ORAL MICROBIOL IMMUN, V20, P211, DOI 10.1111/j.1399-302X.2005.00214.x; Gomes BPFA, 2004, ORAL MICROBIOL IMMUN, V19, P71, DOI 10.1046/j.0902-0055.2003.00116.x; Gomes BPFA, 1996, J DENT, V24, P47, DOI 10.1016/0300-5712(95)00042-9; Gomes BPFA, 2008, J ENDODONT, V34, P537, DOI 10.1016/j.joen.2008.01.016; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Haapasalo M, 2003, ENDODONTIC TOPICS, V6, P29, DOI DOI 10.1111/J.1601-1546.2003.00041.X; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hancock HH, 2001, ORAL SURG ORAL MED O, V91, P579, DOI 10.1067/moe.2001.113587; HARPER DAT, 2001, PALAEONTOLOGIA ELECT, V4; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; HASHIOKA K, 1992, J ENDODONT, V18, P558, DOI 10.1016/S0099-2399(06)81214-8; Hsiao WWL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-345; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jung IY, 2000, J ENDODONT, V26, P599, DOI 10.1097/00004770-200010000-00006; Katzenberger RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045009; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marsh PD, 2005, J CLIN PERIODONTOL, V32, P7, DOI 10.1111/j.1600-051X.2005.00790.x; Martins MR, 2013, LASER MED SCI, V28, P1049, DOI 10.1007/s10103-012-1172-6; Molander A, 1998, INT ENDOD J, V31, P1, DOI 10.1046/j.1365-2591.1998.t01-1-00111.x; O'Toole PW, 2012, CLIN MICROBIOL INFEC, V18, P44, DOI 10.1111/j.1469-0691.2012.03867.x; Ozok AR, 2012, INT ENDOD J, V45, P530, DOI 10.1111/j.1365-2591.2011.02006.x; Pawar R, 2012, J ENDODONT, V38, P1177, DOI 10.1016/j.joen.2012.06.013; Peciuliene V, 2001, INT ENDOD J, V34, P429, DOI 10.1046/j.1365-2591.2001.00411.x; Peciuliene V, 2000, J ENDODONT, V26, P593, DOI 10.1097/00004770-200010000-00004; Pinheiro ET, 2003, INT ENDOD J, V36, P1, DOI 10.1046/j.1365-2591.2003.00603.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Rocas IN, 2004, J ENDODONT, V30, P504, DOI 10.1097/00004770-200407000-00011; Rocas IN, 2008, J ENDODONT, V34, P926, DOI 10.1016/j.joen.2008.05.008; Rocas IN, 2012, J CLIN MICROBIOL, V50, P1721, DOI 10.1128/JCM.00531-12; Rolph HJ, 2001, J CLIN MICROBIOL, V39, P3282, DOI 10.1128/JCM.39.9.3282-3289.2001; Sakamoto M, 2008, ORAL MICROBIOL IMMUN, V23, P275, DOI 10.1111/j.1399-302X.2007.00423.x; Santos AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028088; Schirrmeister JF, 2007, J ENDODONT, V33, P536, DOI 10.1016/j.joen.2007.01.012; Schirrmeister JF, 2009, J ENDODONT, V35, P169, DOI 10.1016/j.joen.2008.10.024; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Sedgley C, 2006, J ENDODONT, V32, P173, DOI 10.1016/j.joen.2005.10.037; Shrestha A, 2012, J ENDODONT, V38, P1275, DOI 10.1016/j.joen.2012.05.006; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P85, DOI 10.1016/S1079-2104(03)00353-6; Siqueira JF, 2005, J CLIN MICROBIOL, V43, P3314, DOI 10.1128/JCM.43.7.3314-3319.2005; Siqueira Jose F Jr, 2009, J Oral Microbiol, V1, DOI 10.3402/jom.v1i0.2009; Siqueira JF, 2013, CLIN MICROBIOL REV, V26, P255, DOI 10.1128/CMR.00082-12; Siqueira JF, 2011, J ENDODONT, V37, P1499, DOI 10.1016/j.joen.2011.08.012; Siqueira JF, 2009, ORAL SURG ORAL MED O, V107, P870, DOI 10.1016/j.tripleo.2009.01.044; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stahringer SS, 2012, GENOME RES, V22, P2146, DOI 10.1101/gr.140608.112; Subramanian K, 2009, J ENDODONT, V35, P950, DOI 10.1016/j.joen.2009.04.010; Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8; SYED SA, 1972, APPL MICROBIOL, V24, P638, DOI 10.1128/AEM.24.4.638-644.1972; Whelan K, 2013, CURR OPIN GASTROEN, V29, P184, DOI 10.1097/MOG.0b013e32835d7bba	75	35	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84960	10.1371/journal.pone.0084960	http://dx.doi.org/10.1371/journal.pone.0084960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386438	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700123
J	Chuchuen, O; Henderson, MH; Sykes, C; Kim, MS; Kashuba, ADM; Katz, DF				Chuchuen, Oranat; Henderson, Marcus H.; Sykes, Craig; Kim, Min Sung; Kashuba, Angela D. M.; Katz, David F.			Quantitative Analysis of Microbicide Concentrations in Fluids, Gels and Tissues Using Confocal Raman Spectroscopy	PLOS ONE			English	Article							EXCISED HUMAN SKIN; IN-VITRO; BUCCAL MUCOSA; COMPARATIVE PERMEABILITY; PERCUTANEOUS-ABSORPTION; TOPICAL MICROBICIDES; DEPTH RESOLUTION; EX-VIVO; SPECTRA; DAPIVIRINE	Topical vaginal anti-HIV microbicides are an important focus in female-based strategies to prevent the sexual transmission of HIV. Understanding microbicide pharmacokinetics is essential to development, characterization and implementation of efficacious microbicide drug delivery formulations. Current methods to measure drug concentrations in tissue (e. g., LC-MS/MS, liquid chromatography coupled with tandem mass spectrometry) are highly sensitive, but destructive and complex. This project explored the use of confocal Raman spectroscopy to detect microbicide drugs and to measure their local concentrations in fluids, drug delivery gels, and tissues. We evaluated three candidate microbicide drugs: tenofovir, Dapivirine and IQP-0528. Measurements were performed in freshly excised porcine buccal tissue specimens, gel vehicles and fluids using two Horiba Raman microscopes, one of which is confocal. Characteristic spectral peak calibrations for each drug were obtained using serial dilutions in the three matrices. These specific Raman bands demonstrated strong linear concentration dependences in the matrices and were characterized with respect to their unique vibrational signatures. At least one specific Raman feature was identified for each drug as a marker band for detection in tissue. Sensitivity of detection was evaluated in the three matrices. A specific peak was also identified for tenofovir diphosphate, the anti-HIV bioactive product of tenofovir after phosphorylation in host cells. Z-scans of drug concentrations vs. depth in excised tissue specimens, incubated under layers of tenofovir solution in a Transwell assay, showed decreasing concentration with depth from the surface into the tissue. Time-dependent concentration profiles were obtained from tissue samples incubated in the Transwell assay, for times ranging 30 minutes - 6 hours. Calibrations and measurements from tissue permeation studies for tenofovir showed good correlation with gold standard LC-MS/MS data. These results demonstrate that confocal Raman spectroscopy holds promise as a tool for practical, minimally invasive, label-free measurement of microbicide drug concentrations in fluids, gels and tissues.	[Chuchuen, Oranat; Henderson, Marcus H.; Kim, Min Sung; Katz, David F.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Sykes, Craig; Kashuba, Angela D. M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Sykes, Craig; Kashuba, Angela D. M.] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA; [Kashuba, Angela D. M.] Univ N Carolina, Sch Med, Dept Infect Dis, Chapel Hill, NC USA; [Katz, David F.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Katz, DF (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	dkatz@duke.edu	Chuchuen, Oranat/GQA-4250-2022	Chuchuen, Oranat/0000-0002-4152-683X	National Institutes of Health [RO1 HD072702, P30 AI50410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health RO1 HD072702 and P30 AI50410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; ARMSTRONG RS, 1990, APPL ORGANOMET CHEM, V4, P569, DOI 10.1002/aoc.590040519; Baldwin KJ, 2001, APPL SPECTROSC, V55, P517, DOI 10.1366/0003702011952190; Bell SEJ, 2007, J PHARM PHARMACOL, V59, P203, DOI 10.1211/jpp.59.2.0007; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRONAUGH RL, 1986, J PHARM SCI, V75, P1094, DOI 10.1002/jps.2600751115; Bruneel JL, 2002, J RAMAN SPECTROSC, V33, P815, DOI 10.1002/jrs.915; Buckheit KW, 2011, ANTIMICROB AGENTS CH, V55, P5243, DOI 10.1128/AAC.05237-11; Centre for the AIDS Programme of Research in South Africa, 2007, SAF EFF STUD CAND VA; Chernenko T, 2009, ACS NANO, V3, P3552, DOI 10.1021/nn9010973; Choi SO, 2010, J CHROMATOGR SCI, V48, P219, DOI 10.1093/chromsci/48.3.219; Chrit L, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003747; Conrad, 2011, SAF EFF TEN GEL PREV; Cost M, 2012, ANTIMICROB AGENTS CH, V56, P3058, DOI 10.1128/AAC.06284-11; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; das Neves J, 2012, J CHROMATOGR B, V911, P76, DOI 10.1016/j.jchromb.2012.10.034; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; Dezzutti CS, 2012, ANTIVIR RES, V96, P221, DOI 10.1016/j.antiviral.2012.08.004; Doncel GF, 2010, ANTIVIR RES, V88, pS10, DOI 10.1016/j.antiviral.2010.09.018; Dong J, 2000, BIOCHEMISTRY-US, V39, P13241, DOI 10.1021/bi001437m; Erckens RJ, 2001, J CATARACT REFR SURG, V27, P1065, DOI 10.1016/S0886-3350(00)00828-2; Everall NJ, 2000, APPL SPECTROSC, V54, P1515, DOI 10.1366/0003702001948439; Everall NJ, 2000, APPL SPECTROSC, V54, P773, DOI 10.1366/0003702001950382; FDA, 2018, BIOANALYTICAL METHOD; FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356; Franzen L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061210; Gao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074404; GRASS GM, 1988, PHARMACEUT RES, V5, P372, DOI 10.1023/A:1015911712079; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; HERSHEY FB, 1958, J HISTOCHEM CYTOCHEM, V6, P191, DOI 10.1177/6.3.191; Holtz M, 1999, ANAL CHEM, V71, P2934, DOI 10.1021/ac981261i; Imbert D, 1999, J CONTROL RELEASE, V58, P39, DOI 10.1016/S0168-3659(98)00143-6; International Partnership for Microbicides, 2012, SAF EFF TRIAL DAP VA; International Partnership for Microbicides, 2012, PHAS 3 SAF EFF TRIAL; Johnson TJ, 2010, EUR J PHARM SCI, V41, P736, DOI 10.1016/j.ejps.2010.09.010; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kashuba AD, 2010, 18 INT AIDS C VIENN; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; Khan KM, 2013, J BIOPHOTONICS; Kiser PF, 2012, AIDS REV, V14, P62; KUWAE A, 1979, SPECTROCHIM ACTA A, V35, P841, DOI 10.1016/0584-8539(79)80043-4; Lai BE, 2010, ANTIVIR RES, V88, P143, DOI 10.1016/j.antiviral.2010.08.006; Lambert J.B., 1987, INTRO ORGANIC SPECTR; LANIR A, 1979, J BIOL CHEM, V254, P5882; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; MATHLOUTHI M, 1984, CARBOHYD RES, V131, P1, DOI 10.1016/0008-6215(84)85398-7; Microbicide Trials Network, 2010, PHAS 2B SAF EFF STUD; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Nel AM, 2010, AIDS RES HUM RETROV, V26, P1181, DOI 10.1089/aid.2009.0227; Nel AM, 2010, JAIDS-J ACQ IMM DEF, V55, P161, DOI 10.1097/QAI.0b013e3181e3293a; Ng SF, 2010, AAPS PHARMSCITECH, V11, P1432, DOI 10.1208/s12249-010-9522-9; NIAID, 2008, SAF EFF TEN 1 GEL TE; Nicolazzo JA, 2003, J PHARM SCI-US, V92, P2399, DOI 10.1002/jps.10505; Plosker GL, 2013, DRUGS, V73, P1; Ramkumaar GR, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/126502; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Romano J, 2009, AIDS RES HUM RETROV, V25, P483, DOI 10.1089/aid.2008.0184; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15; Singh JS, 2008, J MOL STRUCT, V876, P127, DOI 10.1016/j.molstruc.2007.06.014; Skoog D.A., 1992, PRINCIPLES INSTRUMEN; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Supino Rosa, 1995, V43, P137; Surmacki J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-48; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tfayli A, 2008, J BIOPHOTONICS, V1, P140, DOI 10.1002/jbio.200710004; Tfayli A, 2007, EUR BIOPHYS J BIOPHY, V36, P1049, DOI 10.1007/s00249-007-0191-x; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; van der Bijl P, 1997, EUR J ORAL SCI, V105, P571; van Eyk AD, 2004, ARCH ORAL BIOL, V49, P387, DOI 10.1016/j.archoralbio.2003.12.002; WERTZ PW, 1993, ADV DRUG DELIVER REV, V12, P1, DOI 10.1016/0169-409X(93)90037-5; WILLIAMS AC, 1994, ANALYST, V119, P563, DOI 10.1039/an9941900563; Xiao CH, 2004, APPL SPECTROSC, V58, P382, DOI 10.1366/000370204773580202; Zeng HS, 2008, J INNOV OPT HEAL SCI, V1, P95, DOI 10.1142/S1793545808000054; Zhang GJ, 2007, J INVEST DERMATOL, V127, P1205, DOI 10.1038/sj.jid.5700690; Zhang Y, 2010, CURR PHARM BIOTECHNO, V11, P654, DOI 10.2174/138920110792246483; ZHELYASKOV V, 1992, BIOCHEM J, V287, P561, DOI 10.1042/bj2870561	82	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85124	10.1371/journal.pone.0085124	http://dx.doi.org/10.1371/journal.pone.0085124			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386455	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700129
J	Moon, TD; Silva, WP; Buene, M; Morais, L; Valverde, E; Vermund, SH; Brentlinger, PE				Moon, Troy D.; Silva, Wilson P.; Buene, Manuel; Morais, Luis; Valverde, Emilio; Vermund, Sten H.; Brentlinger, Paula E.			Bacteremia as a Cause of Fever in Ambulatory, HIV-Infected Mozambican Adults: Results and Policy Implications from a Prospective Observational Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ANTIRETROVIRAL THERAPY HAART; SEVERE FEBRILE ILLNESS; SALMONELLA; RESISTANCE; CHILDREN; MALARIA; TRENDS; PREDICTORS; TANZANIA	Fever is typically treated empirically in rural Mozambique. We examined the distribution and antimicrobial susceptibility patterns of bacterial pathogens isolated from blood-culture specimens, and clinical characteristics of ambulatory HIV-infected febrile patients with and without bacteremia. This analysis was nested within a larger prospective observational study to evaluate the performance of new Mozambican guidelines for fever and anemia in HIV-infected adults (clinical trial registration NCT01681914, www.clinicaltrials.gov); the guidelines were designed to be used by non-physician clinicians who attended ambulatory HIV-infected patients in very resource-constrained peripheral health units. In 2012 (April-September), we recruited 258 HIV-infected adults with documented fever or history of recent fever in three sites within Zambezia Province, Mozambique. Although febrile patients were routinely tested for malaria, blood culture capacity was unavailable in Zambezia prior to study initiation. We confirmed bacteremia in 39 (15.1%) of 258 patients. The predominant organisms were non-typhoid Salmonella, nearly all resistant to multiple first-line antibiotics (ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole). Features most associated with bacteremia included higher temperature, lower CD4+ T-lymphocyte count, lower hemoglobin, and headache. Introduction of blood cultures allowed us to: 1) confirm bacteremia in a substantial proportion of patients; 2) tailor specific antimicrobial therapy for confirmed bacteremia based on known susceptibilities; 3) make informed choices of presumptive antibiotics for patients with suspected bacteremia; and 4) construct a preliminary clinical profile to help clinicians determine who would most likely benefit from presumptive bacteremia treatment. Our findings demonstrate that in resource-limited settings, there is urgent need to expand local microbiologic capacity to better identify and treat cases of bacteremia in HIV-infected and other patients, and to support surveillance. Data on the prevalence and susceptibility patterns of important pathogens can guide national formulary and prescribing practices.	[Moon, Troy D.; Vermund, Sten H.] Vanderbilt Inst Global Hlth, Nashville, TN USA; [Moon, Troy D.; Silva, Wilson P.; Buene, Manuel; Morais, Luis; Valverde, Emilio; Vermund, Sten H.; Brentlinger, Paula E.] Friends Global Hlth, Maputo, Mozambique	Vanderbilt University	Moon, TD (corresponding author), Vanderbilt Inst Global Hlth, Nashville, TN USA.	troy.moon@vanderbilt.edu	Vermund, Sten/AAD-3592-2020; Valverde, Emilio/ABD-2715-2021	Vermund, Sten/0000-0001-7289-8698; Valverde, Emilio/0000-0002-0437-1816; Brentlinger, Paula/0000-0002-4865-8915; Moon, Troy/0000-0002-1637-829X	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GPS000631]; NCATS/NIH [UL1 TR000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR), through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement U2GPS000631 to Vanderbilt University. The REDCap (Research Electronic Data Capture) on-line database that were used for initial data entry and management was supported by grant number UL1 TR000445 from NCATS/NIH. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi AI, 2010, J HEALTH POPUL NUTR, V28, P318; Ali Jemal, 2008, Ethiop Med J, V46, P155; [Anonymous], 2011, WORLD HLTH STAT; [Anonymous], COUNTR HLTH PROF; [Anonymous], 2009, KIRBY BAUER DISK DIF; Arthur G, 2001, CLIN INFECT DIS, V33, P248, DOI 10.1086/321820; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Bedell RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039347; Bell M, 2001, Int J Infect Dis, V5, P63, DOI 10.1016/S1201-9712(01)90027-X; Brentlinger PE, 2013, 20 C RETR OPP INF CR; CELUM CL, 1987, J INFECT DIS, V156, P998, DOI 10.1093/infdis/156.6.998; Chen HM, 2013, PEDIATR NEONATOL, V54, P147, DOI 10.1016/j.pedneo.2013.01.010; CLSI Publishes, 2012, ANT SUSC TEST STAND; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Daxboeck F, 2004, DIAGN MICR INFEC DIS, V48, P1, DOI 10.1016/j.diagmicrobio.2003.08.001; Donati KD, 2003, J CHEMOTHERAPY, V15, P60, DOI 10.1179/joc.2003.15.1.60; Dougle ML, 1997, E AFR MED J, V74, P353; Elzi L, 2012, CLIN MICROBIOL INFEC, V18, pE355, DOI 10.1111/j.1469-0691.2012.03964.x; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; GLASER JB, 1985, ANN INTERN MED, V102, P189, DOI 10.7326/0003-4819-102-2-189; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Guerrini V, 2013, TUBERCULOSIS, V93, P405, DOI 10.1016/j.tube.2013.02.017; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; INSIDA, 2009, INQ NAC PREV RISC CO; Lahuerta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037125; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Malik M, 2012, ANTIMICROB AGENTS CH, V56, P3879, DOI 10.1128/AAC.00474-12; Mandomando I, 2010, AM J TROP MED HYG, V83, P152, DOI 10.4269/ajtmh.2010.09-0578; Meynard J-L, 2003, HIV Med, V4, P127, DOI 10.1046/j.1468-1293.2003.00146.x; Ministerio da Saude Republica de Mocambique, 2008, PLAN DES REC HUM 200; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; Mootsikapun P, 2007, INT J INFECT DIS, V11, P226, DOI 10.1016/j.ijid.2006.02.010; Murray P.R., 1995, MANUAL CLIN MICROBIO; Muyanja SZ, 2011, TROP MED INT HEALTH, V16, P756, DOI 10.1111/j.1365-3156.2011.02754.x; Mzileni Mogiyana Olga, 2008, Pol Arch Med Wewn, V118, P548; Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006; Ogunsola F T, 2009, Niger Postgrad Med J, V16, P186; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Republica de Mocambique Ministerio da Saude Direccao Nacional de Assistencia Medica Seccao dos Laboratorios Clinicos, 2013, PLAN OP REV LAB MIC; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Ruiz J, 2008, AM J TROP MED HYG, V79, P918, DOI 10.4269/ajtmh.2008.79.918; Sajadi MM, 2012, CLIN INFECT DIS, V55, P976, DOI 10.1093/cid/cis596; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Tacconelli E, 1998, CLIN INFECT DIS, V27, P901, DOI 10.1086/517165; Tayler-Smith K, 2011, TROP MED INT HEALTH, V16, P579, DOI 10.1111/j.1365-3156.2011.02740.x; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Tran VTN, 2012, T ROY SOC TROP MED H, V106, P26, DOI 10.1016/j.trstmh.2011.10.004; Tumbarello M, 2000, J ACQ IMMUN DEF SYND, V23, P145; van der Meeren BT, 2013, SAMJ S AFR MED J, V103, P382, DOI [10.7196/SAMJ.5941, 10.7196/samj.5941, 10.7196/sam]; van Lettow M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048856; Varma JK, 2010, EMERG INFECT DIS, V16, P1569, DOI 10.3201/eid1610.091686; Vigilancia Epidemiologica do HIV e seu Impacto Demografico em Mocambique Atualizacao Ronda, 2009, VIG EP HIV E SEU IMP; Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933; World Health Organization, 2004, INT MAN AD AD ILLN; World Health Organization, 2008, TASK SHIFT RAT RED; World Health Organization, WHO CAS DEF HIV SURV	59	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83591	10.1371/journal.pone.0083591	http://dx.doi.org/10.1371/journal.pone.0083591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386229	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700050
J	Ponten, A; Walsh, S; Malan, D; Xian, XJ; Scheele, S; Tarnawski, L; Fleischmann, BK; Jovinge, S				Ponten, Annica; Walsh, Stuart; Malan, Daniela; Xian, Xiaojie; Scheele, Susanne; Tarnawski, Laura; Fleischmann, Bernd K.; Jovinge, Stefan			FACS-Based Isolation, Propagation and Characterization of Mouse Embryonic Cardiomyocytes Based on VCAM-1 Surface Marker Expression	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; MAMMALIAN HEART; STEM-CELLS; ENGRAFTMENT; MOLECULE; ORIGIN; MICE	Purification of cardiomyocytes from the embryonic mouse heart, embryonic stem (ES) or induced pluripotent stem cells (iPS) is a challenging task and will require specific isolation procedures. Lately the significance of surface markers for the isolation of cardiac cell populations with fluorescence activated cell sorting (FACS) has been acknowledged, and the hunt for cardiac specific markers has intensified. As cardiomyocytes have traditionally been characterized by their expression of specific transcription factors and structural proteins, and not by specific surface markers, this constitutes a significant bottleneck. Lately, Flk-1, c-kit and the cellular prion protein have been reported to specify cardiac progenitors, however, no surface markers have so far been reported to specify a committed cardiomyocyte. Herein show for the first time, that embryonic cardiomyocytes can be isolated with 98% purity, based on their expression of vascular cell adhesion molecule-1 (VCAM-1). The FACS-isolated cells express phenotypic markers for embryonic committed cardiomyocytes but not cardiac progenitors. An important aspect of FACS is to provide viable cells with retention of functionality. We show that VCAM-1 positive cardiomyocytes can be isolated with 95% viability suitable for in vitro culture, functional assays or expression analysis. In patch-clamp experiments we provide evidence of functionally intact cardiomyocytes of both atrial and ventricular subtypes. This work establishes that cardiomyocytes can be isolated with a high degree of purity and viability through FACS, based on specific surface marker expression as has been done in the hematopoietic field for decades. Our FACS protocol represents a significant advance in which purified populations of cardiomyocytes may be isolated and utilized for downstream applications, such as purification of ES-cell derived cardiomyocytes.	[Ponten, Annica; Walsh, Stuart; Xian, Xiaojie; Scheele, Susanne; Tarnawski, Laura; Jovinge, Stefan] Lund Univ, Lund Strateg Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Malan, Daniela; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53115 Bonn, Germany; [Jovinge, Stefan] Scania Univ Hosp, Dept Cardiol, Lund, Sweden	Lund University; University of Bonn	Jovinge, S (corresponding author), Lund Univ, Lund Strateg Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden.	Stefan.Jovinge@med.lu.se	Tarnawski, Laura/ABB-1979-2020; Tarnawski, Laura/AAA-2254-2022	Tarnawski, Laura/0000-0001-7993-0232; 	Swedish Heart-Lung Foundation; Swedish Research Council [90423301]; AFA; Crafoord Foundation; Deutsche Forschungsgemeinschaft [FL276/3-3]; EU (CardioCell consortium) [223372]	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA; Crafoord Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU (CardioCell consortium)	This study was supported by grants from the Swedish Heart-Lung Foundation, the Swedish Research Council, (No 90423301), AFA grants, the Crafoord Foundation, the Deutsche Forschungsgemeinschaft (FL276/3-3) and the EU (CardioCell consortium, No 223372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin HE, 2012, DERMATOLOGIST S, P1; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hirata H, 2006, CELLS TISSUES ORGANS, V184, P172, DOI 10.1159/000099624; Hordijk PL, 2006, FEBS J, V273, P4408, DOI 10.1111/j.1742-4658.2006.05440.x; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; KWEE L, 1995, DEVELOPMENT, V121, P489; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Malan D, 2009, STEM CELLS, V27, P88, DOI 10.1634/stemcells.2008-0335; Morales MO, 2005, MICROSC MICROANAL, V11, P260, DOI 10.1017/S1431927605050518; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rubart M, 2006, ANN NY ACAD SCI, V1080, P34, DOI 10.1196/annals.1380.004; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Shiraishi I, 1997, VINCULIN IS ESSENTIA, P1; Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wang Q, 2001, ANAT RECORD, V263, P72, DOI 10.1002/ar.1078; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; WOODCOCKMITCHELL J, 1988, DIFFERENTIATION, V39, P161, DOI 10.1111/j.1432-0436.1988.tb00091.x; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	31	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82403	10.1371/journal.pone.0082403	http://dx.doi.org/10.1371/journal.pone.0082403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386094	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700005
J	Sensi, L; Tedesco, D; Mimmi, S; Rucci, P; Pisano, E; Pedrini, L; McDonald, KM; Fantini, MP				Sensi, Luigi; Tedesco, Dario; Mimmi, Stefano; Rucci, Paola; Pisano, Emilio; Pedrini, Luciano; McDonald, Kathryn M.; Fantini, Maria Pia		AAA-Working Grp	Hospitalization Rates and Post-Operative Mortality for Abdominal Aortic Aneurysm in Italy over the Period 2000-2011	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OPEN REPAIR; INCREASING INCIDENCE; ENDOVASCULAR REPAIR; ADMINISTRATIVE DATA; SMOKING BAN; EPIDEMIOLOGY; ENGLAND; WALES; RISK	Background: Recent studies have reported declines in incidence, prevalence and mortality for abdominal aortic aneurysms (AAAs) in various countries, but evidence from Mediterranean countries is lacking. The aim of this study is to examine the trend of hospitalization and post-operative mortality rates for AAAs in Italy during the period 2000-2011, taking into account the introduction of endovascular aneurysm repair (EVAR) in 1990s. Methods: This retrospective cohort study was carried out in Emilia-Romagna, an Italian region with 4.5 million inhabitants. A total of 19,673 patients hospitalized for AAAs between 2000 and 2011, were identified from the hospital discharge records (HDR) database. Hospitalization rates, percentage of OSR and EVAR and 30-day mortality rates were calculated for unruptured (uAAAs) and ruptured AAAs (rAAAs). Results: Adjusted hospitalization rates decreased on average by 2.9% per year for uAAAs and 3.2% for rAAAs (p<0.001). The temporal trend of 30-day mortality rates remained stable for both groups. The percentage of EVAR for uAAAs increased significantly from 2006 to 2011 (42.7 versus 60.9% respectively, mean change of 3.9% per year, p<0.001). No significant difference in mortality was found between OSR and EVAR for uAAAs and rAAAs. Conclusions: The incidence and trend of hospitalization rates for rAAAs and uAAAs decreased significantly in the last decade, while 30-day mortality rates in operated patients remained stable. OSR continued to be the most common surgery in rAAAs, although the gap between OSR and EVAR recently declined. The EVAR technique became the preferred surgery for uAAAs since 2008.	[Sensi, Luigi; Pisano, Emilio; Pedrini, Luciano] Maggiore Hosp, Dept Surg, Vasc Surg Unit, Bologna, Italy; [Tedesco, Dario; Mimmi, Stefano; Rucci, Paola; Fantini, Maria Pia] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [McDonald, Kathryn M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford Ctr Hlth Policy, Stanford, CA 94305 USA; Maggiore Hosp, Vasc Surg Unit, Bologna, Italy	AUSL di Bologna; University of Bologna; Stanford University; AUSL di Bologna	Fantini, MP (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	mariapia.fantini@unibo.it	Tedesco, Dario/AAD-8342-2022; Tedesco, Dario/AAC-1848-2019	Tedesco, Dario/0000-0002-5027-5446; Rucci, Paola/0000-0002-7704-0831				Anjum A, 2012, EUR J VASC ENDOVASC, V43, P161, DOI 10.1016/j.ejvs.2011.11.014; [Anonymous], 2013, NHS ABD AORT AN SCRE; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Barone-Adesi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017419; Blanchard JF, 1999, EPIDEMIOL REV, V21, P207, DOI 10.1093/oxfordjournals.epirev.a017997; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Buonanno P, 2013, HEALTH POLICY, V109, P192, DOI 10.1016/j.healthpol.2012.10.009; Burns H., 2010, SCOTTISH ABDOMINAL A; Casey K, 2013, J VASC SURG, V57, P89, DOI 10.1016/j.jvs.2012.07.005; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Cheng SWK, 2003, WORLD J SURG, V27, P241, DOI 10.1007/s00268-002-6470-x; Choke E, 2012, EUR J VASC ENDOVASC, V44, P549, DOI 10.1016/j.ejvs.2012.08.011; Choke E, 2012, CIRCULATION, V125, P1617, DOI 10.1161/CIRCULATIONAHA.111.077503; FOWKES FGR, 1989, BRIT MED J, V298, P33, DOI 10.1136/bmj.298.6665.33; Giardina S, 2011, J VASC SURG, V54, P938, DOI 10.1016/j.jvs.2011.03.264; Greenblatt DY, 2012, ANN SURG, V256, P595, DOI 10.1097/SLA.0b013e31826b4bfe; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Gretarsdottir S, 2010, NAT GENET, V42, P692, DOI 10.1038/ng.622; Gupta PK, 2012, EUR J VASC ENDOVASC, V43, P506, DOI 10.1016/j.ejvs.2012.02.006; Hernandez-Boussard T, 2012, J AM COLL SURGEONS, V214, P788, DOI 10.1016/j.jamcollsurg.2012.01.045; Hultgren R, 2012, BRIT J SURG, V99, P647, DOI 10.1002/bjs.8685; Istituto Superiore di Sanita, 2010, RAPP ANN FUM IT ANN; Kuivaniemi H, 2012, ANN VASC SURG, V26, P862, DOI 10.1016/j.avsg.2012.02.005; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Min SI, 2012, J KOREAN MED SCI, V27, P416, DOI 10.3346/jkms.2012.27.4.416; Ministero della Salute, 2011, DOC TECN IND RID CAR; Mofidi R, 2008, BRIT J SURG, V95, P1475, DOI 10.1002/bjs.6432; Norman PE, 2007, CONNECT TISSUE RES, V48, P125, DOI 10.1080/03008200701331524; Norman PE, 2011, J VASC SURG, V53, P274, DOI 10.1016/j.jvs.2010.08.087; Palombo D, 2010, J CARDIOVASC SURG, V51, P777; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Pieroni L, 2013, HEALTH POLICY, V111, P116, DOI 10.1016/j.healthpol.2013.04.001; Reitsma JB, 1996, EUR J VASC ENDOVASC, V12, P446, DOI 10.1016/S1078-5884(96)80012-8; Sandiford P, 2011, BRIT J SURG, V98, P645, DOI 10.1002/bjs.7461; Schermerhorn ML, 2011, J AM COLL SURGEONS, V212, P349, DOI 10.1016/j.jamcollsurg.2010.12.003; Schwarze ML, 2009, J VASC SURG, V50, P722, DOI 10.1016/j.jvs.2009.05.010; Shteinberg D, 2000, EUR J VASC ENDOVASC, V20, P462, DOI 10.1053/ejvs.2000.1210; Sternbergh WC, 2000, J VASC SURG, V31, P237, DOI 10.1016/S0741-5214(00)90154-X; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; Yuen E, 2011, TUMORI, V97, P428, DOI 10.1700/950.10393; 1998, LANCET, V352, P1649	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83855	10.1371/journal.pone.0083855	http://dx.doi.org/10.1371/journal.pone.0083855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386294	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700075
J	Thong, JYJ; Qiu, AQ; Sum, MY; Kuswanto, CN; Tuan, TA; Donohoe, G; Sitoh, YY; Sim, K				Thong, Jamie Yu Jin; Qiu, Anqi; Sum, Min Yi; Kuswanto, Carissa Nadia; Ta Ahn Tuan; Donohoe, Gary; Sitoh, Yih Yian; Sim, Kang			Effects of the Neurogranin Variant rs12807809 on Thalamocortical Morphology in Schizophrenia	PLOS ONE			English	Article							REDUCED CORTICAL THICKNESS; LONG-TERM POTENTIATION; PROTEIN-KINASE-II; RISK VARIANT; THALAMIC PATHOLOGY; CEREBRAL-CORTEX; BASAL GANGLIA; SHAPE; VOLUMES; ASSOCIATION	Although the genome wide supported psychosis susceptibility neurogranin (NRGN) gene is expressed in human brains, it is unclear how it impacts brain morphology in schizophrenia. We investigated the influence of NRGN rs12807809 on cortical thickness, subcortical volumes and shapes in patients with schizophrenia. One hundred and fifty six subjects (91 patients with schizophrenia and 65 healthy controls) underwent structural MRI scans and their blood samples were genotyped. A brain mapping algorithm, large deformation diffeomorphic metric mapping, was used to perform group analysis of subcortical shapes and cortical thickness. Patients with risk TT genotype were associated with widespread cortical thinning involving frontal, parietal and temporal cortices compared with controls with TT genotype. No volumetric difference in subcortical structures (hippocampus, thalamus, amygdala, basal ganglia) was observed between risk TT genotype in patients and controls. However, patients with risk TT genotype were associated with thalamic shape abnormalities involving regions related to pulvinar and medial dorsal nuclei. Our results revealed the influence of the NRGN gene on thalamocortical morphology in schizophrenia involving widespread cortical thinning and thalamic shape abnormalities. These findings help to clarify underlying NRGN mediated pathophysiological mechanisms involving cortical-subcortical brain networks in schizophrenia.	[Thong, Jamie Yu Jin; Qiu, Anqi; Ta Ahn Tuan] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res, Singapore 117548, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Sum, Min Yi; Kuswanto, Carissa Nadia; Sim, Kang] Inst Mental Hlth, Div Res, Singapore, Singapore; [Donohoe, Gary] Univ Dublin Trinity Coll, Dept Psychiat, Sch Med, Dublin 2, Ireland; [Donohoe, Gary] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Sitoh, Yih Yian] Natl Neurosci Inst, Dept Neuroradiol, Singapore, Singapore; [Sim, Kang] Inst Mental Hlth, Dept Gen Psychiat, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Trinity College Dublin; Trinity College Dublin; National Neuroscience Institute (NNI)	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011; Donohoe, Gary/J-6481-2013; Kuswanto, Carissa/AAR-6230-2021	Qiu, Anqi/0000-0002-0215-6338; Donohoe, Gary/0000-0003-3037-7426; Sim, Kang/0000-0003-3209-9626	Young Investigator Award at National University of Singapore (NUSYIA) [FY10 P07]; National University of Singapore MOE AcRF Tier 1; National Healthcare Group SIG Grant [NHG-SIG/05004]; ASTAR/Singapore Biomedical Imaging Consortium [SBIC RP C-009/2006]	Young Investigator Award at National University of Singapore (NUSYIA)(National University of Singapore); National University of Singapore MOE AcRF Tier 1(Ministry of Education, SingaporeNational University of Singapore); National Healthcare Group SIG Grant; ASTAR/Singapore Biomedical Imaging Consortium(Agency for Science Technology & Research (A*STAR))	This work is supported by the Young Investigator Award at National University of Singapore (NUSYIA FY10 P07, AQ), National University of Singapore MOE AcRF Tier 1 (AQ), National Healthcare Group SIG Grant NHG-SIG/05004 (KS) and ASTAR/Singapore Biomedical Imaging Consortium Grant SBIC RP C-009/2006 (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ananth H, 2002, AM J PSYCHIAT, V159, P1497, DOI 10.1176/appi.ajp.159.9.1497; Arendt T, 2004, INT J DEV NEUROSCI, V22, P507, DOI 10.1016/j.ijdevneu.2004.07.007; Bagary MS, 2002, J NEUROPSYCH CLIN N, V14, P443, DOI 10.1176/appi.neuropsych.14.4.443; Bridle N, 2002, AUST NZ J PSYCHIAT, V36, P347, DOI 10.1046/j.1440-1614.2001.01022.x; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Byne W, 2002, AM J PSYCHIAT, V159, P59, DOI 10.1176/appi.ajp.159.1.59; Chance SA, 2006, ACTA NEUROPATHOL, V111, P459, DOI 10.1007/s00401-005-0014-z; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Chung MK, 2010, NEUROIMAGE, V53, P491, DOI 10.1016/j.neuroimage.2010.06.032; Cobia DJ, 2012, SCHIZOPHR RES, V139, P1, DOI 10.1016/j.schres.2012.05.002; Coscia DM, 2009, HUM BRAIN MAPP, V30, P1236, DOI 10.1002/hbm.20595; Crespo-Facorro B, 2011, PSYCHOL MED, V41, P1449, DOI 10.1017/S003329171000200X; Cronenwett WJ, 2010, CURR TOP BEHAV NEURO, V4, P509, DOI 10.1007/7854_2010_55; Csernansky JG, 2004, AM J PSYCHIAT, V161, P896, DOI 10.1176/appi.ajp.161.5.896; deArrieta CM, 1997, GENOMICS, V41, P243, DOI 10.1006/geno.1997.4622; Donohoe G, 2011, SCHIZOPHR RES, V125, P304, DOI 10.1016/j.schres.2010.10.019; Eyjolfsson EM, 2011, J CEREBR BLOOD F MET, V31, P976, DOI 10.1038/jcbfm.2010.193; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Gilbert AR, 2001, AM J PSYCHIAT, V158, P618, DOI 10.1176/appi.ajp.158.4.618; Gutierrez-Galve L, 2010, BIOL PSYCHIAT, V68, P51, DOI 10.1016/j.biopsych.2010.03.019; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hayashi Y, 2009, EMBO J, V28, P2859, DOI 10.1038/emboj.2009.273; Heckers S, 1997, SCHIZOPHRENIA BULL, V23, P403, DOI 10.1093/schbul/23.3.403; Huang FL, 2007, LEARN MEMORY, V14, P512, DOI 10.1101/lm.636107; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jones EG, 1997, SCHIZOPHRENIA BULL, V23, P483, DOI 10.1093/schbul/23.3.483; Kang DH, 2008, NEUROREPORT, V19, P609, DOI 10.1097/WNR.0b013e3282fa6db9; Kemether EM, 2003, ARCH GEN PSYCHIAT, V60, P983, DOI 10.1001/archpsyc.60.9.983; Krug A, 2013, SCHIZOPHRENIA BULL, V39, P141, DOI 10.1093/schbul/sbr076; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lee KW, 2012, NEUROSCI BIOBEHAV R, V36, P556, DOI 10.1016/j.neubiorev.2011.09.001; Li JF, 1999, J BIOL CHEM, V274, P1294, DOI 10.1074/jbc.274.3.1294; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Narr KL, 2009, HUM BRAIN MAPP, V30, P3783, DOI 10.1002/hbm.20806; Oertel-Knochel V, 2013, CEREB CORTEX, V23, P61, DOI 10.1093/cercor/bhr380; Ohi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029780; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; PAKKENBERG B, 1990, ARCH GEN PSYCHIAT, V47, P1023; Pohlack ST, 2011, MOL PSYCHIATR, V16, P1072, DOI 10.1038/mp.2011.66; Qiu AQ, 2010, NEUROIMAGE, V52, P1181, DOI 10.1016/j.neuroimage.2010.05.046; Qiu AQ, 2010, IEEE T IMAGE PROCESS, V19, P1539, DOI 10.1109/TIP.2010.2042099; Qiu AQ, 2009, NEUROIMAGE, V47, P1163, DOI 10.1016/j.neuroimage.2009.04.027; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Raznahan A, 2011, NEUROIMAGE, V57, P1517, DOI 10.1016/j.neuroimage.2011.05.032; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rose EJ, 2012, TWIN RES HUM GENET, V15, P296, DOI 10.1017/thg.2012.7; Rose EJ, 2013, SCHIZOPHRENIA BULL, V39, P518, DOI 10.1093/schbul/sbs056; Salgado-Pineda P, 2003, NEUROIMAGE, V19, P365, DOI 10.1016/S1053-8119(03)00094-6; Schultz CC, 2011, NEUROPSYCHOPHARMACOL, V36, P1747, DOI 10.1038/npp.2011.56; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sim K, 2006, J NEURAL TRANSM, V113, P907, DOI 10.1007/s00702-005-0363-8; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith MJ, 2011, J PSYCHIATR RES, V45, P378, DOI 10.1016/j.jpsychires.2010.08.003; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; SWERDLOW NR, 2010, PREFACE CURR TOP BEH, V4, pR5; Takayanagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021047; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; van Haren NEM, 2011, ARCH GEN PSYCHIAT, V68, P871, DOI 10.1001/archgenpsychiatry.2011.88; Volk DW, 2010, CURR TOP BEHAV NEURO, V4, P485, DOI 10.1007/7854_2010_44; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yang YL, 2010, SCHIZOPHR RES, V123, P116, DOI 10.1016/j.schres.2010.08.005; Young KA, 2000, BIOL PSYCHIAT, V47, P944, DOI 10.1016/S0006-3223(00)00826-X; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zhong JD, 2010, NEUROIMAGE, V49, P355, DOI 10.1016/j.neuroimage.2009.08.026	70	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85603	10.1371/journal.pone.0085603	http://dx.doi.org/10.1371/journal.pone.0085603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386483	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700143
J	Vidick, S; Leroy, B; Palmeira, L; Machiels, B; Mast, J; Francois, S; Wattiez, R; Vanderplasschen, A; Gillet, L				Vidick, Sarah; Leroy, Baptiste; Palmeira, Leonor; Machiels, Benedicte; Mast, Jan; Francois, Sylvie; Wattiez, Ruddy; Vanderplasschen, Alain; Gillet, Laurent			Proteomic Characterization of Murid Herpesvirus 4 Extracellular Virions	PLOS ONE			English	Article							CHEMOKINE-BINDING-PROTEIN; SARCOMA-ASSOCIATED HERPESVIRUS; GAMMAHERPESVIRUS-68 GLYCOPROTEIN-B; CELLULAR ANNEXIN-II; SIMPLEX-VIRUS; HUMAN CYTOMEGALOVIRUS; KAPOSIS-SARCOMA; IN-VIVO; STRUCTURAL PROTEINS; VIRAL SPREAD	Gammaherpesvirinae, such as the human Epstein-Barr virus (EBV) and the Kaposi's sarcoma associated herpesvirus (KSHV) are highly prevalent pathogens that have been associated with several neoplastic diseases. As EBV and KSHV are host-range specific and replicate poorly in vitro, animal counterparts such as Murid herpesvirus-4 (MuHV-4) have been widely used as models. In this study, we used MuHV-4 in order to improve the knowledge about proteins that compose gammaherpesviruses virions. To this end, MuHV-4 extracellular virions were isolated and structural proteins were identified using liquid chromatography tandem mass spectrometry-based proteomic approaches. These analyses allowed the identification of 31 structural proteins encoded by the MuHV-4 genome which were classified as capsid (8), envelope (9), tegument (13) and unclassified (1) structural proteins. In addition, we estimated the relative abundance of the identified proteins in MuHV-4 virions by using exponentially modified protein abundance index analyses. In parallel, several host proteins were found in purified MuHV-4 virions including Annexin A2. Although Annexin A2 has previously been detected in different virions from various families, its role in the virion remains controversial. Interestingly, despite its relatively high abundance in virions, Annexin A2 was not essential for the growth of MuHV-4 in vitro. Altogether, these results extend previous work aimed at determining the composition of gammaherpesvirus virions and provide novel insights for understanding MuHV-4 biology.	[Vidick, Sarah; Palmeira, Leonor; Machiels, Benedicte; Francois, Sylvie; Vanderplasschen, Alain; Gillet, Laurent] Univ Liege, Dept Infect Dis, Fac Vet Med, Liege, Belgium; [Leroy, Baptiste; Wattiez, Ruddy] Univ Mons, Dept Prote & Microbiol, Res Inst Biosci Interdisciplinary Mass Spectromet, B-7000 Mons, Belgium; [Mast, Jan] Vet & Agrochem Res Ctr, Electron Microscopy Unit, Brussels, Belgium	University of Liege; University of Mons	Gillet, L (corresponding author), Univ Liege, Dept Infect Dis, Fac Vet Med, Liege, Belgium.	L.gillet@ulg.ac.be		Leroy, Baptiste/0000-0001-7166-4478; Gillet, Laurent/0000-0002-1047-2525; Machiels, Benedicte/0000-0003-1326-3865; wattiez, ruddy/0000-0003-2071-4310; Mast, Jan/0000-0002-4879-3367	GLYVIR ARC of the University of Liege [F.4510.10]; FRFC of the F.R.S. - FNRS [2.4622.10]; belgian federal BELVIR Interuniversity attraction pole;  [C-11/57]	GLYVIR ARC of the University of Liege; FRFC of the F.R.S. - FNRS(Fonds de la Recherche Scientifique - FNRS); belgian federal BELVIR Interuniversity attraction pole; 	This work was supported by the following grants: starting grant (C-11/57) and GLYVIR ARC of the University of Liege (http://www.ulg.ac.be), Scientific impulse grant (no F.4510.10) and FRFC grant (2.4622.10) of the F.R.S. - FNRS (http://www.frs-fnrs.be), and the belgian federal BELVIR Interuniversity attraction pole. S. V. is a Research Fellow of the "Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique" (F.R.S. - FNRS). P.G.S. is a Wellcome Trust Senior Clinical Fellow (GR076956MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak B, 2007, J VIROL, V81, P13424, DOI 10.1128/JVI.01528-07; Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BAINES JD, 1992, J VIROL, V66, P5168, DOI 10.1128/JVI.66.8.5168-5174.1992; Baines JD, 2011, TRENDS MICROBIOL, V19, P606, DOI 10.1016/j.tim.2011.09.001; BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005; Benach J, 2007, J BIOL CHEM, V282, P31534, DOI 10.1074/jbc.M705637200; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Bohannon KP, 2013, P NATL ACAD SCI USA, V110, pE1613, DOI 10.1073/pnas.1221896110; Bold S, 1996, J GEN VIROL, V77, P2297, DOI 10.1099/0022-1317-77-9-2297; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Bortz E, 2007, J VIROL, V81, P10137, DOI 10.1128/JVI.01233-06; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Brown JC, 2011, CURR OPIN VIROL, V1, P142, DOI 10.1016/j.coviro.2011.06.003; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Charif D, 2007, SEQINR 1 0 2 CONTRIB; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Costes B, 2005, J GEN VIROL, V86, P3209, DOI 10.1099/vir.0.81388-0; Dai W, 2008, J STRUCT BIOL, V161, P428, DOI 10.1016/j.jsb.2007.10.010; DAVISON AJ, 1995, VIROLOGY, V206, P1035, DOI 10.1006/viro.1995.1026; Derry MEC, 2007, J GEN VIROL, V88, P19, DOI 10.1099/vir.0.82294-0; Dry I, 2008, J VIROL, V82, P5390, DOI 10.1128/JVI.00094-08; Francois S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003292; Francois S, 2010, J GEN VIROL, V91, P2553, DOI 10.1099/vir.0.023481-0; Gaspar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002781; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002811; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; Guo HT, 2009, J VIROL, V83, P10582, DOI 10.1128/JVI.00497-09; Guo HD, 2010, INT J DIGIT EARTH, V3, P1, DOI 10.1080/17538941003650702; Han J, 2011, J VIROL, V85, P9437, DOI 10.1128/JVI.05207-11; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Hughes DJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001321; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jons A, 1998, J VIROL, V72, P550; Kattenhorn LM, 2004, J VIROL, V78, P11187, DOI 10.1128/JVI.78.20.11187-11197.2004; Koyano S, 2003, J GEN VIROL, V84, P1485, DOI 10.1099/vir.0.18941-0; Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10; Le Sage V, 2013, J VIROL, V87, P5904, DOI 10.1128/JVI.03489-12; Lete C, 2012, J VIROL, V86, P11567, DOI 10.1128/JVI.00456-12; Lete C, 2012, J VIROL, V86, P2653, DOI 10.1128/JVI.06238-11; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Mastroleo F, 2009, J PROTEOME RES, V8, P2530, DOI 10.1021/pr900007d; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166; Mounce BC, 2013, J VIROL, V87, P7314, DOI 10.1128/JVI.02713-12; Nozawa N, 2005, J VIROL, V79, P6947, DOI 10.1128/JVI.79.11.6947-6956.2005; O'Connor CM, 2006, J VIROL, V80, P1574, DOI 10.1128/JVI.80.3.1574-1583.2006; Ohno S, 2012, J GEN VIROL, V93, P1076, DOI 10.1099/vir.0.041129-0; Palmeira L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-406; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Peng L, 2010, STRUCTURE, V18, P47, DOI 10.1016/j.str.2009.10.017; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Pietropaolo R, 1999, J GEN VIROL, V80, P1807, DOI 10.1099/0022-1317-80-7-1807; Pietropaolo RL, 1997, J VIROL, V71, P9803, DOI 10.1128/JVI.71.12.9803-9807.1997; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Rai T, 2010, J VIROL, V84, P9783, DOI 10.1128/JVI.01584-09; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Raynor CM, 1999, BIOCHEMISTRY-US, V38, P5089, DOI 10.1021/bi982095b; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Sathish N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00098; Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Stewart JP, 1996, J VIROL, V70, P3528, DOI 10.1128/JVI.70.6.3528-3535.1996; Team RDC, 2010, R LANG ENV STAT COMP; Tran LC, 2000, P NATL ACAD SCI USA, V97, P1818, DOI 10.1073/pnas.020510297; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; van Berkel V, 1999, J VIROL, V73, P4524, DOI 10.1128/JVI.73.5.4524-4529.1999; van Beurden SJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-105; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang LL, 2012, J VIROL, V86, P1348, DOI 10.1128/JVI.05497-11; Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519; WRIGHT JF, 1995, J VIROL, V69, P4784, DOI 10.1128/JVI.69.8.4784-4791.1995; WRIGHT JF, 1994, BIOCHEM BIOPH RES CO, V198, P983, DOI 10.1006/bbrc.1994.1140; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	96	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83842	10.1371/journal.pone.0083842	http://dx.doi.org/10.1371/journal.pone.0083842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386290	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700073
J	Zhou, L; He, MA; Mo, ZN; Wu, C; Yang, HD; Yu, DK; Yang, XB; Zhang, XM; Wang, YQ; Sun, JL; Gao, Y; Tan, AH; He, YF; Zhang, HY; Qin, X; Zhu, JW; Li, HX; Lin, X; Zhu, J; Min, XW; Lang, MJ; Li, DF; Zhai, K; Chang, J; Tan, W; Yuan, J; Chen, WH; Wang, YJ; Wei, S; Miao, XP; Wang, F; Fang, WM; Liang, Y; Deng, QF; Dai, XY; Lin, DF; Huang, SL; Guo, H; Zheng, SL; Xu, JF; Lin, DX; Hu, FB; Wu, TC				Zhou, Li; He, Meian; Mo, Zengnan; Wu, Chen; Yang, Handong; Yu, Dianke; Yang, Xiaobo; Zhang, Xiaomin; Wang, Yiqin; Sun, Jielin; Gao, Yong; Tan, Aihua; He, Yunfeng; Zhang, Haiying; Qin, Xue; Zhu, Jingwen; Li, Huaixing; Lin, Xu; Zhu, Jiang; Min, Xinwen; Lang, Mingjian; Li, Dongfeng; Zhai, Kan; Chang, Jiang; Tan, Wen; Yuan, Jing; Chen, Weihong; Wang, Youjie; Wei, Sheng; Miao, Xiaoping; Wang, Feng; Fang, Weimin; Liang, Yuan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Guo, Huan; Zheng, S. Lilly; Xu, Jianfeng; Lin, Dongxin; Hu, Frank B.; Wu, Tangchun			A Genome Wide Association Study Identifies Common Variants Associated with Lipid Levels in the Chinese Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; RISK; LOCI; CHOLESTEROL; TRIGLYCERIDES; VISUALIZATION	Plasma lipid levels are important risk factors for cardiovascular disease and are influenced by genetic and environmental factors. Recent genome wide association studies (GWAS) have identified several lipid-associated loci, but these loci have been identified primarily in European populations. In order to identify genetic markers for lipid levels in a Chinese population and analyze the heterogeneity between Europeans and Asians, especially Chinese, we performed a meta-analysis of two genome wide association studies on four common lipid traits including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL) and high-density lipoprotein cholesterol (HDL) in a Han Chinese population totaling 3,451 healthy subjects. Replication was performed in an additional 8,830 subjects of Han Chinese ethnicity. We replicated eight loci associated with lipid levels previously reported in a European population. The loci genome wide significantly associated with TC were near DOCK7, HMGCR and ABO; those genome wide significantly associated with TG were near APOA1/C3/A4/A5 and LPL; those genome wide significantly associated with LDL were near HMGCR, ABO and TOMM40; and those genome wide significantly associated with HDL were near LPL, LIPC and CETP. In addition, an additive genotype score of eight SNPs representing the eight loci that were found to be associated with lipid levels was associated with higher TC, TG and LDL levels (P = 5.52x10(-16), 1.38x10(-6) and 5.59x10(-9), respectively). These findings suggest the cumulative effects of multiple genetic loci on plasma lipid levels. Comparisons with previous GWAS of lipids highlight heterogeneity in allele frequency and in effect size for some loci between Chinese and European populations. The results from our GWAS provided comprehensive and convincing evidence of the genetic determinants of plasma lipid levels in a Chinese population.	[Zhou, Li; He, Meian; Zhang, Xiaomin; He, Yunfeng; Yuan, Jing; Chen, Weihong; Wang, Youjie; Wei, Sheng; Miao, Xiaoping; Wang, Feng; Fang, Weimin; Liang, Yuan; Deng, Qifei; Dai, Xiayun; Lin, Dafeng; Huang, Suli; Guo, Huan; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Zhou, Li] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Epidemiol, Chongqing, Peoples R China; [Mo, Zengnan; Yang, Xiaobo; Gao, Yong; Tan, Aihua; Zhang, Haiying; Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China; [Mo, Zengnan; Yang, Xiaobo; Gao, Yong; Tan, Aihua; Zhang, Haiying; Qin, Xue] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China; [Wu, Chen; Yu, Dianke; Zhai, Kan; Chang, Jiang; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Yu, Dianke; Zhai, Kan; Chang, Jiang; Tan, Wen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Handong; Zhu, Jiang; Min, Xinwen; Lang, Mingjian; Li, Dongfeng] Dongfeng Motor Corp, Dongfeng Cent Hosp, Shiyan, Hubei, Peoples R China; [Yang, Handong; Zhu, Jiang; Min, Xinwen; Lang, Mingjian; Li, Dongfeng] Hubei Univ Med, Shiyan, Hubei, Peoples R China; [Zhang, Xiaomin; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Zhang, Xiaomin; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Yiqin; Zhu, Jingwen; Li, Huaixing; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Sun, Jielin; Zheng, S. Lilly; Xu, Jianfeng] Fudan Univ, Huashan Hosp, Inst Urol, Shanghai 200433, Peoples R China; [Sun, Jielin; Zheng, S. Lilly; Xu, Jianfeng] Fudan Univ, Sch Life Sci, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China	Huazhong University of Science & Technology; Chongqing Medical University; Guangxi Medical University; Guangxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Dongfeng Motor; Hubei University of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University	Mo, ZN (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China.	zengnanmo@hotmail.com; wut@mails.tjmu.edu.cn	Zhang, Xiaomin/GVT-8927-2022; Lin, Dafeng/J-1015-2014; miao, xiaoping/C-4336-2011; Zhang, Xiaomin/F-3206-2018; Yang, Xiaobo/G-3854-2016	miao, xiaoping/0000-0002-6818-9722; Wang, Yiqin/0000-0003-4714-774X; Lin, Dongxin/0000-0002-8723-8868; mo, zengnan/0000-0002-3047-3138; Li, Dongfeng/0000-0003-2583-1727; Wu, Chen/0000-0003-4954-1011	National Basic Research Program [2011CB503806]; Program of Introducing Talents of Discipline to Universities and Yangze Scholarship; National Natural Science Foundation of China [30945204, 30360124, 30260110, 81172751, 81202274]; Guangxi Provincial Department of Finance and Education [2009GJCJ150]; Fudan-VARI (Van Andel Institute, United States of America) Center for Genetic Epidemiology; Fudan University Institute of Urology; Program for New Century Excellent Talents in University	National Basic Research Program(National Basic Research Program of China); Program of Introducing Talents of Discipline to Universities and Yangze Scholarship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Provincial Department of Finance and Education; Fudan-VARI (Van Andel Institute, United States of America) Center for Genetic Epidemiology; Fudan University Institute of Urology; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Basic Research Program grant (2011CB503806), the Program of Introducing Talents of Discipline to Universities and Yangze Scholarship to TW, the General Program of the National Natural Science Foundation of China (30945204, 30360124, 30260110, 81172751 and 81202274), the Guangxi Provincial Department of Finance and Education (2009GJCJ150), intramural funding from Fudan-VARI (Van Andel Institute, United States of America) Center for Genetic Epidemiology and Intramural Funding from Fudan University Institute of Urology to ZM and Program for New Century Excellent Talents in University to MH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; ENDO A, 1992, J LIPID RES, V33, P1569; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang F, 2013, INT J EPIDEMIOL; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027481	23	50	51	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82420	10.1371/journal.pone.0082420	http://dx.doi.org/10.1371/journal.pone.0082420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386095	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700006
J	Cranmer, M; Cranmer, SJ				Cranmer, Mirjam; Cranmer, Skyler J.			The Impact of Hispanic and White Group Cues on Attitudes Towards the Violation of Generic Norms	PLOS ONE			English	Article							SUBJECTIVE GROUP-DYNAMICS; LOCAL TELEVISION-NEWS; RACIAL-ATTITUDES; IN-GROUP; RACE; PERCEPTIONS; OPPOSITION; EMOTIONS; VOTERS; ANXIETY	While much work in political science has examined the impact of racial cues on individual perceptions, we know little about how individuals evaluate members of minority outgroups on issues that are not linked to stereotypes. We measure the impacts of Hispanic and White cues on individual assessments related to a stereotype-independent norm violation: alcoholism. We test three competing theories - cognition, intergroup emotions, and social identity - using a population-based vignette experiment included in the General Social Survey. Our results contradict much of the literature, but keep with social identity theory's predictions. Hispanic alcoholics, when Hispanics constitute the outgroup, are assessed less negatively than White alcoholics in the ingroup, the latter experiencing what is called the black sheep effect. The black sheep effect occurs when ingroup members are more punitive towards members of the ingroup than the outgroup. However, the black sheep effect does not extend to measures that are more consistent with outgroup stereotypes, such as violence or money mismanagement; Hispanic alcoholics are evaluated more negatively than Whites on these measures. The implication is that the effect of racial cues depends strongly on issue linkages to group stereotypes.	[Cranmer, Mirjam] Duke Univ, Social Sci Res Inst, Durham, NC USA; [Cranmer, Skyler J.] Univ N Carolina, Dept Polit Sci, Chapel Hill, NC 27515 USA; [Cranmer, Skyler J.] Univ Konstanz, Constance, Germany	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Konstanz	Cranmer, SJ (corresponding author), Univ N Carolina, Dept Polit Sci, Chapel Hill, NC 27515 USA.	skyler@unc.edu	Cranmer, Skyler/D-9414-2016	Cranmer, Skyler/0000-0002-6213-6400	Swiss National Science Foundation (SNF); Social Science Research Institute (SSRI) at Duke University; Alexander von Humboldt foundation	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Social Science Research Institute (SSRI) at Duke University; Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	Mirjam Cranmer gratefully acknowledges the support of the Swiss National Science Foundation's (SNF) post-doctoral research fellowship and the Social Science Research Institute (SSRI) at Duke University. Skyler Cranmer gratefully acknowledges the support of the Alexander von Humboldt foundation's fellowship for experienced researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2008, CHILD DEV, V79, P444, DOI 10.1111/j.1467-8624.2007.01135.x; Brader T, 2008, AM J POLIT SCI, V52, P959, DOI 10.1111/j.1540-5907.2008.00353.x; BRANSCOMBE NR, 1993, PERS SOC PSYCHOL B, V19, P381, DOI 10.1177/0146167293194003; Civettini AJW, 2009, POLIT PSYCHOL, V30, P125, DOI 10.1111/j.1467-9221.2008.00683.x; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Federico CM, 2005, POLIT PSYCHOL, V26, P683, DOI 10.1111/j.1467-9221.2005.00439.x; Gilens M, 1996, AM POLIT SCI REV, V90, P593, DOI 10.2307/2082611; Gilliam FD, 2000, AM J POLIT SCI, V44, P560, DOI 10.2307/2669264; Gilliam FD, 2002, POLIT RES QUART, V55, P755, DOI 10.1177/106591290205500402; Glaser JM, 2002, AM J POLIT SCI, V46, P35, DOI 10.2307/3088413; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Huber GA, 2006, AM J POLIT SCI, V50, P421, DOI 10.1111/j.1540-5907.2006.00192.x; Huddy L., 2007, AFFECT EFFECT DYNAMI, P202, DOI DOI 10.7208/CHICAGO/9780226574431.003.0009; Hurwitz J, 1997, AM J POLIT SCI, V41, P375, DOI 10.2307/2111769; Kaufman Kantor G, 1997, RECENT DEV ALCOHOLIS, V13; Marques JM, 2001, J PERS SOC PSYCHOL, V81, P436, DOI 10.1037//0022-3514.81.3.436; Matthews D, 1998, J APPL SOC PSYCHOL, V28, P1903, DOI 10.1111/j.1559-1816.1998.tb01352.x; Mendelberg T, 2008, PERSPECT POLIT, V6, P135, DOI 10.1017/S1537592708080110; Mendelberg T, 2008, PERSPECT POLIT, V6, P109, DOI 10.1017/S1537592708080092; Mendelberg Tali, 2001, RACE CARD CAMPAIGN S; Mutz DC, 2011, POPULATION-BASED SURVEY EXPERIMENTS, P1; Newman BJ, 2012, POLIT PSYCHOL, V33, P635, DOI 10.1111/j.1467-9221.2012.00904.x; Peffley M, 2002, POLIT PSYCHOL, V23, P59, DOI 10.1111/0162-895X.00270; Pescosolido BA, 1996, TECHNICAL REPORT; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Petersen MB, 2010, J POLIT, V72, P357, DOI 10.1017/S002238160999079X; Pratto, 1999, SOCIAL DOMINANCE THE; Short Jr James F., 1997, POVERTY ETHNICITY VI; Singer E, 2010, PUBLIC OPIN QUART, V74, P460, DOI 10.1093/poq/nfq009; Tajfel H., 1979, SOCIAL PSYCHOL INTER; Tapias MP, 2007, GROUP PROCESS INTERG, V10, P27, DOI 10.1177/1368430207071338; Valentino NA, 2002, AM POLIT SCI REV, V96, P75, DOI 10.1017/S0003055402004240	32	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83154	10.1371/journal.pone.0083154	http://dx.doi.org/10.1371/journal.pone.0083154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386153	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900023
J	Geurden, I; Borchert, P; Balasubramanian, MN; Schrama, JW; Dupont-Nivet, M; Quillet, E; Kaushik, SJ; Panserat, S; Medale, F				Geurden, Inge; Borchert, Peter; Balasubramanian, Mukundh N.; Schrama, Johan W.; Dupont-Nivet, Mathilde; Quillet, Edwige; Kaushik, Sadasivam J.; Panserat, Stephane; Medale, Francoise			The Positive Impact of the Early-Feeding of a Plant-Based Diet on Its Future Acceptance and Utilisation in Rainbow Trout	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; ATLANTIC SALMON; AMINO-ACIDS; EPIGENETIC MODIFICATIONS; GROWTH-PERFORMANCE; BODY-COMPOSITION; OIL REPLACEMENT; RATION LEVEL; FISH-MEAL; PRODUCTS	Sustainable aquaculture, which entails proportional replacement of fish-based feed sources by plant-based ingredients, is impeded by the poor growth response frequently seen in fish fed high levels of plant ingredients. This study explores the potential to improve, by means of early nutritional exposure, the growth of fish fed plant-based feed. Rainbow trout swim-up fry were fed for 3 weeks either a plant-based diet (diet V, V-fish) or a diet containing fishmeal and fish oil as protein and fat source (diet M, M-fish). After this 3-wk nutritional history period, all V- or M-fish received diet M for a 7-month intermediate growth phase. Both groups were then challenged by feeding diet V for 25 days during which voluntary feed intake, growth, and nutrient utilisation were monitored (V-challenge). Three isogenic rainbow trout lines were used for evaluating possible family effects. The results of the V-challenge showed a 42% higher growth rate (P = 0.002) and 30% higher feed intake (P = 0.005) in fish of nutritional history V compared to M (averaged over the three families). Besides the effects on feed intake, V-fish utilized diet V more efficiently than M-fish, as reflected by the on average 18% higher feed efficiency (P = 0.003). We noted a significant family effect for the above parameters (P<0.001), but the nutritional history effect was consistent for all three families (no interaction effect, P>0.05). In summary, our study shows that an early short-term exposure of rainbow trout fry to a plant-based diet improves acceptance and utilization of the same diet when given at later life stages. This positive response is encouraging as a potential strategy to improve the use of plant-based feed in fish, of interest in the field of fish farming and animal nutrition in general. Future work needs to determine the persistency of this positive early feeding effect and the underlying mechanisms.	[Geurden, Inge; Borchert, Peter; Balasubramanian, Mukundh N.; Schrama, Johan W.; Kaushik, Sadasivam J.; Panserat, Stephane; Medale, Francoise] Aquapole INRA, NUMEA Nutr Metab & Aquaculture UR1067, INRA, St Pee Sur Nivelle, France; [Borchert, Peter] Wageningen Univ, WIAS, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands; [Dupont-Nivet, Mathilde; Quillet, Edwige] INRA, GABI Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France	INRAE; Universite de Pau et des Pays de l'Adour; Wageningen University & Research; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Geurden, I (corresponding author), Aquapole INRA, NUMEA Nutr Metab & Aquaculture UR1067, INRA, St Pee Sur Nivelle, France.	geurden@st-pee.inra.fr	, Dupont-Nivet/J-2850-2019	Dupont-Nivet, Mathilde/0000-0002-9299-0560; Medale, Francoise/0000-0002-8083-1298; Schrama, Johan/0000-0001-7156-8806; Panserat, Stephane/0000-0002-4479-9868	VEGE-AQUA project (FUI funding of French government); institutional INRA funds; INRA/MRI (INRA-WUR Aquaculture Platform)	VEGE-AQUA project (FUI funding of French government); institutional INRA funds; INRA/MRI (INRA-WUR Aquaculture Platform)	This study was financed by the VEGE-AQUA project (FUI funding of French government), by institutional INRA funds, and by INRA/MRI (INRA-WUR Aquaculture Platform, post-doc grant MNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrows FT, 2008, REV FISH SCI, V16, P449, DOI 10.1080/10641260802046734; Breier BH, 2001, MOL CELL ENDOCRINOL, V185, P73, DOI 10.1016/S0303-7207(01)00634-7; Bureau DP, 1998, AQUACULTURE, V161, P27, DOI 10.1016/S0044-8486(97)00254-8; Cleveland BM, 2011, AQUACULTURE, V319, P194, DOI 10.1016/j.aquaculture.2011.06.043; COOPER JC, 1976, J FISH RES BOARD CAN, V33, P703, DOI 10.1139/f76-087; Dittman AH, 1996, CAN J FISH AQUAT SCI, V53, P434, DOI 10.1139/cjfas-53-2-434; Dupont-Nivet M, 2009, AQUACULTURE, V295, P15, DOI 10.1016/j.aquaculture.2009.06.031; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Geurden I, 2007, AM J PHYSIOL-REG I, V292, pR2275, DOI 10.1152/ajpregu.00444.2006; Geurden I, 2005, PHYSIOL BEHAV, V85, P107, DOI 10.1016/j.physbeh.2005.03.010; Glencross B, 2006, AQUACULTURE, V253, P512, DOI 10.1016/j.aquaculture.2005.07.009; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Hara TJ, 2006, J FISH BIOL, V68, P810, DOI 10.1111/j.1095.8649.2006.00967.x; HARA TJ, 1989, T AM FISH SOC, V118, P183, DOI 10.1577/1548-8659(1989)118<0183:SAFDOT>2.3.CO;2; Hepper PG, 2012, CHEM SENSES, V37, P755, DOI 10.1093/chemse/bjs062; Hua K, 2012, AQUACULTURE, V356, P284, DOI 10.1016/j.aquaculture.2012.05.003; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; Johnstone KA, 2011, MOL ECOL, V20, P4059, DOI 10.1111/j.1365-294X.2011.05251.x; Kasumyan AO, 2003, FISH FISH, V4, P289, DOI 10.1046/j.1467-2979.2003.00121.x; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Kyriazakis I, 1998, BRIT J NUTR, V79, P55, DOI 10.1079/BJN19980009; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Le Boucher R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044898; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; LONDON RM, 1979, PHYSIOL BEHAV, V22, P1149, DOI 10.1016/0031-9384(79)90270-1; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Manteifel YB, 1996, COMP BIOCHEM PHYS A, V115, P31, DOI 10.1016/0300-9629(95)02135-3; Martin I, 2011, NEUROBIOL LEARN MEM, V96, P297, DOI 10.1016/j.nlm.2011.06.003; Milagro FI, 2013, MOL ASPECTS MED, V34, P782, DOI 10.1016/j.mam.2012.06.010; National Research Council, 2011, NUTR REQ FISH SHRIMP; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Overturf K, 2013, AQUAC RES, V44, P604, DOI 10.1111/j.1365-2109.2011.03065.x; Petry CJ, 2001, MOL CELL ENDOCRINOL, V185, P81, DOI 10.1016/S0303-7207(01)00627-X; Pettersson A, 2009, AQUACULT NUTR, V15, P577, DOI 10.1111/j.1365-2095.2008.00625.x; Pierce LR, 2008, AQUACULTURE, V278, P37, DOI 10.1016/j.aquaculture.2008.03.017; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; Serrano E, 2011, AQUACULTURE, V318, P122, DOI 10.1016/j.aquaculture.2011.05.004; Shoji T, 2003, FISH PHYSIOL BIOCHEM, V28, P249, DOI 10.1023/B:FISH.0000030544.64774.f6; Simoes PMV, 2012, J EXP BIOL, V215, P1711, DOI 10.1242/jeb.068106; STOREBAKKEN T, 1987, AQUACULTURE, V60, P207, DOI 10.1016/0044-8486(87)90288-2; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Ueda H, 2012, J FISH BIOL, V81, P543, DOI 10.1111/j.1095-8649.2012.03354.x; Ueji K, 2012, PHYSIOL BEHAV, V106, P417, DOI 10.1016/j.physbeh.2012.02.021; Vagner M, 2007, AQUACULTURE, V267, P165, DOI 10.1016/j.aquaculture.2007.01.031; Vagner M, 2009, BRIT J NUTR, V101, P1452, DOI 10.1017/S0007114508088053; vandenIngh TSGAM, 1996, J FISH DIS, V19, P47; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wacyk J, 2012, AQUACULTURE, V356, P223, DOI 10.1016/j.aquaculture.2012.05.013; Wang Y, 2007, AQUACULTURE, V271, P350, DOI 10.1016/j.aquaculture.2007.03.022; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Welch KD, 2012, EAAP PUBLIC, P33; WISBY WARREN J., 1954, JOUR FISH RES BD CANADA, V11, P472; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008633; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106; Yuan YC, 2010, AQUAC RES, V41, P1030, DOI 10.1111/j.1365-2109.2009.02387.x	59	71	71	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83162	10.1371/journal.pone.0083162	http://dx.doi.org/10.1371/journal.pone.0083162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386155	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900024
J	Montenegro-Miranda, PS; Paneda, A; ten Bloemendaal, L; Duijst, S; de Waart, DR; Aseguinolaza, GG; Bosma, PJ				Montenegro-Miranda, Paula S.; Paneda, Astrid; ten Bloemendaal, Lysbeth; Duijst, Suzanne; de Waart, Dirk R.; Gonzalez Aseguinolaza, Gloria; Bosma, Piter J.			Adeno-Associated Viral Vector Serotype 5 Poorly Transduces Liver in Rat Models	PLOS ONE			English	Article							EFFICIENT TRANSDUCTION; GENE-TRANSFER; SKELETAL-MUSCLE; FACTOR-IX; VIRUS; EXPRESSION; PURIFICATION; HEMOPHILIA; THERAPY; SAFE	Preclinical studies in mice and non-human primates showed that AAV serotype 5 provides efficient liver transduction and as such seems a promising vector for liver directed gene therapy. An advantage of AAV5 compared to serotype 8 already shown to provide efficient correction in a phase 1 trial in patients suffering from hemophilia B, is its lower seroprevalence in the general population. Our goal is liver directed gene therapy for Crigler-Najjar syndrome type I, inherited severe unconjugated hyperbilirubinemia caused by UGT1A1 deficiency. In a relevant animal model, the Gunn rat, we compared the efficacy of AAV 5 and 8 to that of AAV1 previously shown to be effective. Ferrying a construct driving hepatocyte specific expression of UGT1A1, both AAV8 and AAV1 provided an efficient correction of hyperbilirubinemia. In contrast to these two and to other animal models AAV5 failed to provide any correction. To clarify whether this unexpected finding was due to the rat model used or due to a problem with AAV5, the efficacy of this serotype was compared in a mouse and two additional rat strains. Administration of an AAV5 vector expressing luciferase under the control of a liver specific promoter confirmed that this serotype poorly performed in rat liver, rendering it not suitable for proof of concept studies in this species.	[Montenegro-Miranda, Paula S.; ten Bloemendaal, Lysbeth; Duijst, Suzanne; de Waart, Dirk R.; Bosma, Piter J.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Paneda, Astrid; Gonzalez Aseguinolaza, Gloria] CIMA, Navarra, Spain	University of Amsterdam; Academic Medical Center Amsterdam; University of Navarra	Montenegro-Miranda, PS (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	psmm82@gmail.com	Gonzalez-Aseguinolaza, Gloria/H-9928-2015	Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562	Netherlands Organization for Health Research and Development (ZonMw); UTE project CIMA; Spanish Department of Science [SAF2009-08524]; EU [FP7 261506]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); UTE project CIMA; Spanish Department of Science(Spanish Government); EU(European Commission)	This work was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw) to PJ Bosma. This work was funded in part by grants from the UTE project CIMA, SAF2009-08524 from the Spanish Department of Science and the EU-funded project AIPGENE (FP7 261506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD J, 1957, NATURE, V180, P1426, DOI 10.1038/1801426a0; Bantel-Schaal U, 2002, J VIROL, V76, P2340, DOI 10.1128/JVI.76.5.2340-2349.2002; Bantel-Schaal U, 2009, J GEN VIROL, V90, P317, DOI 10.1099/vir.0.005595-0; BOOM R, 1991, J CLIN MICROBIOL, V29, P1804, DOI 10.1128/JCM.29.9.1804-1811.1991; BOSMA PJ, 1992, HEPATOLOGY, V15, P941, DOI 10.1002/hep.1840150531; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Favaro P, 2011, HUM GENE THER, V22, P843, DOI 10.1089/hum.2010.155; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Lochrie MA, 2006, VIROLOGY, V353, P68, DOI 10.1016/j.virol.2006.05.023; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2007, BLOOD, V109, P1414, DOI 10.1182/blood-2006-03-010181; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Peden CS, 2009, MOL THER, V17, P524, DOI 10.1038/mt.2008.284; Riviere C, 2006, GENE THER, V13, P1300, DOI 10.1038/sj.gt.3302766; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Seppen J, 2006, MOL THER, V13, P1085, DOI 10.1016/j.ymthe.2006.01.014; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Stroes ES, 2008, ARTERIOSCL THROM VAS, V28, P2303, DOI 10.1161/ATVBAHA.108.175620; Unzu C, 2011, MOL THER, V19, P243, DOI 10.1038/mt.2010.210; Vanrell L, 2011, MOL THER, V19, P1245, DOI 10.1038/mt.2011.37	26	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82597	10.1371/journal.pone.0082597	http://dx.doi.org/10.1371/journal.pone.0082597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386104	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900011
J	Pohlon, E; Fandino, AO; Marxsen, J				Pohlon, Elisabeth; Fandino, Adriana Ochoa; Marxsen, Juergen			Bacterial Community Composition and Extracellular Enzyme Activity in Temperate Streambed Sediment during Drying and Rewetting	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; CLIMATE-CHANGE; DROUGHT; SOIL; IMPACT; WATER; DESICCATION; CARBON; RECOLONIZATION; BREITENBACH	Droughts are among the most important disturbance events for stream ecosystems; they not only affect stream hydrology but also the stream biota. Although desiccation of streams is common in Mediterranean regions, phases of dryness in headwaters have been observed more often and for longer periods in extended temperate regions, including Central Europe, reflecting global climate change and enhanced water withdrawal. The effects of desiccation and rewetting on the bacterial community composition and extracellular enzyme activity, a key process in the carbon flow of streams and rivers, were investigated in a typical Central European stream, the Breitenbach (Hesse, Germany). Wet streambed sediment is an important habitat in streams. It was sampled and exposed in the laboratory to different drying scenarios (fast, intermediate, slow) for 13 weeks, followed by rewetting of the sediment from the fast drying scenario via a sediment core perfusion technique for 2 weeks. Bacterial community structure was analyzed using CARD-FISH and TGGE, and extracellular enzyme activity was assessed using fluorogenic model substrates. During desiccation the bacterial community composition shifted toward composition in soil, exhibiting increasing proportions of Actinobacteria and Alphaproteobacteria and decreasing proportions of Bacteroidetes and Betaproteobacteria. Simultaneously the activities of extracellular enzymes decreased, most pronounced with aminopeptidases and less pronounced with enzymes involved in the degradation of polymeric carbohydrates. After rewetting, the general ecosystem functioning, with respect to extracellular enzyme activity, recovered after 10 to 14 days. However, the bacterial community composition had not yet achieved its original composition as in unaffected sediments within this time. Thus, whether the bacterial community eventually recovers completely after these events remains unknown. Perhaps this community undergoes permanent changes, especially after harsh desiccation, followed by loss of the specialized functions of specific groups of bacteria.	[Pohlon, Elisabeth; Fandino, Adriana Ochoa; Marxsen, Juergen] Univ Giessen, Inst Allgemeine & Spezielle Zool, Giessen, Germany; [Marxsen, Juergen] Max Planck Inst Limnol, Limnol Flussstn, Schlitz, Germany	Justus Liebig University Giessen; Max Planck Society	Pohlon, E (corresponding author), Univ Giessen, Inst Allgemeine & Spezielle Zool, Heinrich Buff Ring 29, Giessen, Germany.	Elisabeth.Pohlon@allzool.bio.uni-giessen.de	Marxsen, Juergen/AAE-5939-2020; Marxsen, Juergen/D-9628-2011	Marxsen, Juergen/0000-0003-3954-0998; Marxsen, Juergen/0000-0003-3954-0998	Deutsche Forschungsgemeinschaft (German Research Foundation) [PO 1505/1-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This research was supported by a grant (PO 1505/1-1) from Deutsche Forschungsgemeinschaft (German Research Foundation; www.dfg.de) to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Amalfitano S, 2008, MICROB ECOL, V55, P270, DOI 10.1007/s00248-007-9274-6; [Anonymous], 1996, ISO10694 NORM DIN; [Anonymous], 1998, 13878 NORM DIN ISO; Arnell NW, 1998, CLIMATIC CHANGE, V39, P83, DOI 10.1023/A:1005339412565; Austin BJ, 2011, HYDROBIOLOGIA, V658, P183, DOI 10.1007/s10750-010-0462-x; Baldwin DS, 2000, REGUL RIVER, V16, P457, DOI 10.1002/1099-1646(200009/10)16:5&lt;457::AID-RRR597&gt;3.0.CO;2-B; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Blagodatskaya E, 2013, SOIL BIOL BIOCHEM, V67, P192, DOI 10.1016/j.soilbio.2013.08.024; Buesing N, 2005, LIMNOL OCEANOGR-METH, V3, P101, DOI 10.4319/lom.2005.3.101; Dahm CN, 2003, FRESHWATER BIOL, V48, P1219, DOI 10.1046/j.1365-2427.2003.01082.x; Dodds WK, 2004, OECOLOGIA, V140, P458, DOI 10.1007/s00442-004-1599-y; Fazi S, 2008, ENVIRON MICROBIOL, V10, P2760, DOI 10.1111/j.1462-2920.2008.01695.x; Fiebig DM, 1997, LIMNOL OCEANOGR, V42, P763, DOI 10.4319/lo.1997.42.4.0763; FIEBIG DM, 1995, ARCH HYDROBIOL, V134, P129; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; FREEMAN C, 1994, FRESHWATER BIOL, V32, P223, DOI 10.1111/j.1365-2427.1994.tb00878.x; Fromin N, 2010, ECOHYDROLOGY, V3, P339, DOI 10.1002/eco.115; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; Gao XQ, 2005, AQUAT MICROB ECOL, V40, P51, DOI 10.3354/ame040051; Gomez R, 2012, HYDROBIOLOGIA, V679, P43, DOI 10.1007/s10750-011-0854-6; Halverson LJ, 2000, SOIL SCI SOC AM J, V64, P1630, DOI 10.2136/sssaj2000.6451630x; HLUG - Hessisches Landesamt fur Umwelt und Geologie, 2012, KLIM SEIN FOLG HESS; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Krysanova V, 2008, HYDROLOG SCI J, V53, P519, DOI 10.1623/hysj.53.3.519; Labat D, 2004, ADV WATER RESOUR, V27, P631, DOI 10.1016/j.advwatres.2004.02.020; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Ledger ME, 2001, ARCH HYDROBIOL, V152, P1; Lehner B, 2006, CLIMATIC CHANGE, V75, P273, DOI 10.1007/s10584-006-6338-4; Manz W, 1999, MICROB ECOL, V37, P225, DOI 10.1007/s002489900148; Marxsen J, 1997, J N AM BENTHOL SOC, V16, P28, DOI 10.2307/1468227; MARXSEN J, 1993, HYDROBIOLOGIA, V253, P207, DOI 10.1007/BF00050739; MARXSEN J, 1993, FEMS MICROBIOL ECOL, V13, P1; Marxsen J, 2001, ARCH HYDROBIOL, V152, P543; Marxsen J, 1996, FEMS MICROBIOL ECOL, V21, P313, DOI 10.1016/S0168-6496(96)00067-0; MARXSEN J, 1980, Archiv fuer Hydrobiologie Supplement, V57, P461; MARXSEN J, 1991, BROCK SPR S, P270; Marxsen J, 2011, CENTRAL EUROPEAN STR, P131; Marxsen J, 2011, CENTRAL EUROPEAN STR, P5; Marxsen J, 2006, FRESHWATER BIOL, V51, P1838, DOI 10.1111/j.1365-2427.2006.01620.x; Marxsen J, 2010, FEMS MICROBIOL ECOL, V71, P374, DOI 10.1111/j.1574-6941.2009.00819.x; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Mosisch TD, 2001, NEW ZEAL J MAR FRESH, V35, P173, DOI 10.1080/00288330.2001.9516987; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; PEREZMATEOS M, 1991, J SCI FOOD AGR, V55, P229, DOI 10.1002/jsfa.2740550208; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Pesaro M, 2004, APPL ENVIRON MICROB, V70, P2577, DOI 10.1128/AEM.70.5.2577-2587.2004; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Pohlon E, 2013, FUND APPL LIMNOL, V182, P123, DOI 10.1127/1863-9135/2013/0465; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prudhomme C, 2012, HYDROL PROCESS, V26, P1115, DOI 10.1002/hyp.8434; Rees GN, 2006, J N AM BENTHOL SOC, V25, P370, DOI 10.1899/0887-3593(2006)25[370:VISMCI]2.0.CO;2; Robson BJ, 2008, FRESHWATER BIOL, V53, P2385, DOI 10.1111/j.1365-2427.2008.02061.x; Romani AM, 1997, ARCH HYDROBIOL, V140, P261; Sabater Sergi, 2008, Freshwater Reviews, V1, P75, DOI 10.1608/FRJ-1.1.5; SCHIMEL J, 1995, ECOL STU AN, V113, P239; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schlief J, 2011, INT REV HYDROBIOL, V96, P633, DOI 10.1002/iroh.201111322; Sirova D, 2006, AQUAT MICROB ECOL, V44, P11, DOI 10.3354/ame044011; Sutherland WJ, 2008, J APPL ECOL, V45, P821, DOI 10.1111/j.1365-2664.2008.01474.x; Toberman H, 2008, FEMS MICROBIOL ECOL, V66, P426, DOI 10.1111/j.1574-6941.2008.00560.x; VDLUFA, 1991, UNT BOD; Wagner R., 2011, CENTRAL EUROPEAN STR; Ylla I, 2011, AQUAT SCI, V73, P523, DOI 10.1007/s00027-011-0211-x; Zoppini A, 2011, SOIL BIOL, V22, P103, DOI 10.1007/978-3-642-14225-3_6; Zoppini A, 2010, HYDROBIOLOGIA, V657, P37, DOI 10.1007/s10750-010-0199-6	68	48	49	7	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83365	10.1371/journal.pone.0083365	http://dx.doi.org/10.1371/journal.pone.0083365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386188	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900033
J	Tsuji, S; Yamashita, M; Kageyama, T; Ohtsu, T; Suzuki, K; Kato, S; Akitomi, J; Furuichi, M; Waga, I				Tsuji, Shoutaro; Yamashita, Makiko; Kageyama, Taihei; Ohtsu, Takashi; Suzuki, Katsuo; Kato, Shintaro; Akitomi, Joe; Furuichi, Makio; Waga, Iwao			Hishot Display-A New Combinatorial Display for Obtaining Target-Recognizing Peptides	PLOS ONE			English	Article							ESCHERICHIA-COLI; AFFINITY ANTIBODIES; LAC REPRESSOR; LIBRARIES; LIGANDS; TECHNOLOGY; EXPRESSION; PROTEINS; SURFACE; PHAGE	Display technologies are procedures used for isolating target-recognizing peptides without using immunized animals. In this study, we describe a new display method, named Hishot display, that uses Escherichia coli and an expression plasmid to isolate target-recognizing peptides. This display method is based on the formation, in bacteria, of complexes between a polyhistidine (His)-tagged peptide including random sequences and the peptide-encoding mRNA including an RNA aptamer against the His-tag. When this system was tested using a sequence encoding His-tagged green fluorescent protein that included an RNA aptamer against the His-tag, the collection of mRNA encoding the protein was dependent on the RNA aptamer. Using this display method and a synthetic library of surrogate single-chain variable fragments consisting of VpreB and Ig heavy-chain variable domains, it was possible to isolate clones that could specifically recognize a particular target (intelectin-1 or tumor necrosis factor-a). These clones were obtained as soluble proteins produced by E. coli, and the purified peptide clones recognizing intelectin-1 could be used as detectors for sandwich enzyme-linked immunosorbent assays. The Hishot display will be a useful method to add to the repertoire of display technologies.	[Tsuji, Shoutaro; Yamashita, Makiko; Kageyama, Taihei; Suzuki, Katsuo] Kanagawa Canc Ctr, Res Inst, Mol Diagnost Project, Yokohama, Kanagawa 2410815, Japan; [Ohtsu, Takashi] Kanagawa Canc Ctr, Res Inst, Anticanc Drug Project, Yokohama, Kanagawa 2410815, Japan; [Kato, Shintaro; Akitomi, Joe; Furuichi, Makio; Waga, Iwao] NEC Soft Ltd, VALWAY Technol Ctr, Tokyo, Japan	Kanagawa Prefectural Cancer Center; Kanagawa Prefectural Cancer Center	Tsuji, S (corresponding author), Kanagawa Canc Ctr, Res Inst, Mol Diagnost Project, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	stsuji@gancen.asahi.yokohama.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [22590544]; Yokohama Foundation for Advancement of Medical Science	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yokohama Foundation for Advancement of Medical Science	This research was supported in part by the following grants: Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (JSPS KAKENHI) (22590544) and Yokohama Foundation for Advancement of Medical Science (to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CULL MG, 1992, P NATL ACAD SCI USA, V89, P1865, DOI 10.1073/pnas.89.5.1865; Gates CM, 1996, J MOL BIOL, V255, P373, DOI 10.1006/jmbi.1996.0031; Hagihara Y, 2005, J BIOL CHEM, V280, P24752, DOI 10.1074/jbc.M503963200; Hanes J, 2000, NAT BIOTECHNOL, V18, P1287, DOI 10.1038/82407; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Naimuddin M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-2; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Roth R, 1997, J EXP BIOL, V200, P2057; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Speight RE, 2001, CHEM BIOL, V8, P951, DOI 10.1016/S1074-5521(01)00066-7; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Xu L, 2008, P NATL ACAD SCI USA, V105, P10756, DOI 10.1073/pnas.0805293105	21	1	1	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83108	10.1371/journal.pone.0083108	http://dx.doi.org/10.1371/journal.pone.0083108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386149	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900022
J	Xiong, HZ; Maraver, A; Latkowski, JA; Henderson, T; Schlessinger, K; Ding, Y; Shen, J; Tadokoro, CE; Lafaille, JJ				Xiong, Huizhong; Maraver, Antonio; Latkowski, Jo-Ann; Henderson, Tanya; Schlessinger, Karni; Ding, Yi; Shen, Jie; Tadokoro, Carlos E.; Lafaille, Juan J.			Characterization of Two Distinct Lymphoproliferative Diseases Caused by Ectopic Expression of the Notch Ligand DLL4 on T Cells	PLOS ONE			English	Article							DELTA-LIKE 4; TUMOR-SUPPRESSOR; LINEAGE COMMITMENT; DONOR CELLS; ALPHA; INACTIVATION; ACTIVATION; LEUKEMIA; GENE; THYMOCYTES	Notch signaling is essential for the development of T cell progenitors through the interaction of NOTCH1 receptor on their surface with the ligand, Delta-like 4 (DLL4), which is expressed by the thymic epithelial cells. Notch signaling is quickly shut down once the cells pass beta-selection, and CD4/CD8 double positive (DP) cells are unresponsive to Notch. Over the past two decades a number of papers reported that over-activation of Notch signaling causes T cell acute lymphoblastic leukemia (T-ALL), a cancer that prominently features circulating monoclonal CD4/CD8 double positive T cells in different mouse models. However, the possible outcomes of Notch over-activation at different stages of T cell development are unknown, and the fine timing of Notch signaling that results in T-ALL is poorly understood. Here we report, by using a murine model that ectopically expresses DLL4 on developing T cells, that the T-ALL onset is highly dependent on a sustained Notch activity throughout the DP stage, which induces additional mutations to further boost the signaling. In contrast, a shorter period of Notch activation that terminates at the DP stage causes a polyclonal, non-transmissible lymphoproliferative disorder that is also lethal. These observations resolved the discrepancy of previous papers on DLL4 driven hematological diseases in mice, and show the critical importance of the timing and duration of Notch activity.	[Xiong, Huizhong; Maraver, Antonio; Latkowski, Jo-Ann; Henderson, Tanya; Schlessinger, Karni; Ding, Yi; Tadokoro, Carlos E.; Lafaille, Juan J.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA; [Xiong, Huizhong] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA; [Latkowski, Jo-Ann] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Ding, Yi; Lafaille, Juan J.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Shen, Jie] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	New York University; New York University; New York University; NYU Langone Medical Center; New York University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Maraver, A (corresponding author), Spanish Natl Canc Res Ctr, Tumor Suppress Grp, Madrid, Spain.	amaraver@cnio.es; juan.lafaille@med.nyu.edu	Tadokoro, Carlos E/D-5111-2011; Shen, Jie/GXH-9449-2022; Maraver, Antonio/G-2666-2015	Maraver, Antonio/0000-0002-5527-5680; Tadokoro, Carlos Eduardo/0000-0002-7874-5657; Xiong, Huizhong/0000-0002-1043-1627	Spanish Ministry of Science; NYU Cancer Institute Center; NIH/NCI [5 P30CA16087-31]; NIH/NIAID; National Multiple Sclerosis Society; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NYU Cancer Institute Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	A.M. is the recipient of a postdoctoral contract of the "Miguel Servet" Program of the Spanish Ministry of Science. The NYU Cancer Institute Center Support Grant partially funds this core through grant NIH/NCI 5 P30CA16087-31. Work in JJL lab is supported by the NIH/NIAID, National Multiple Sclerosis Society, and the Helmsley Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; BOYD CN, 1982, LEUKEMIA RES, V6, P833, DOI 10.1016/0145-2126(82)90067-4; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Curtis DJ, 2010, CLIN CANCER RES, V16, P5618, DOI 10.1158/1078-0432.CCR-10-0440; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Hertenstein B, 2005, HAEMATOLOGICA, V90, P969; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Maraver A, 2007, BLOOD, V110, P3218, DOI 10.1182/blood-2007-01-070359; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2013, THER ADV HEMATOL, V4, P199, DOI 10.1177/2040620712471368; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84841	10.1371/journal.pone.0084841	http://dx.doi.org/10.1371/journal.pone.0084841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386421	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900112
J	Yin, LT; Hao, HX; Wang, HL; Zhang, JH; Meng, XL; Yin, GR				Yin, Li-Tian; Hao, Hai-Xia; Wang, Hai-Long; Zhang, Jian-Hong; Meng, Xiao-Li; Yin, Guo-Rong			Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis	PLOS ONE			English	Article							IMMUNE-RESPONSES; VACCINE CANDIDATE; IMMUNOGLOBULIN-A; DNA VACCINE; MUCOSAL; SAG1; MOTILITY; PARASITE; IDENTIFICATION; PROTEINS	Toxoplasma gondii is a ubiquitous protozoan intracellular parasite, the causative agent of toxoplasmosis, and a worldwide zoonosis for which an effective vaccine is needed. Actin is a highly conserved microfilament protein that plays an important role in the invasion of host cells by T. gondii. This study investigated the immune responses elicited by BALB/c mice after nasal immunisation with a recombinant T. gondii actin (rTgACT) and the subsequent protection against chronic and lethal T. gondii infections. We evaluated the systemic response by proliferation, cytokine and antibody measurements, and we assessed the mucosal response by examining the levels of TgACT-specific secretory IgA (SIgA) in nasal, vaginal and intestinal washes. Parasite load was assessed in the liver and brain, and the survival of mice challenged with a virulent strain was determined. The results showed that the mice immunised with rTgACT developed high levels of specific anti-rTgACT IgG titres and a mixed IgG1/IgG2a response with a predominance of IgG2a. The systemic immune response was associated with increased production of Th1 (IFN-gamma and IL-2), Th2 (IL-4) and Treg (IL-10) cytokines, indicating that not only Th1-type response was induced, but also Th2- and Treg-types responses were induced, and the splenocyte stimulation index (SI) was increased in the mice immunised with rTgACT. Nasal immunisation with rTgACT led to strong mucosal immune responses, as seen by the increased secretion of SIgA in nasal, vaginal and intestinal washes. The vaccinated mice displayed significant protection against lethal infection with the virulent RH strain (survival increased by 50%), while the mice chronically infected with RH exhibited lower liver and brain parasite loads (60.05% and 49.75%, respectively) than the controls. Our data demonstrate, for the first time, that actin triggers a strong systemic and mucosal response against T. gondii. Therefore, actin may be a promising vaccine candidate against toxoplasmosis.	[Yin, Li-Tian] Shanxi Med Univ, Dept Physiol, Key Lab Cellular Physiol Coconstructed Prov, Taiyuan, NC, Peoples R China; [Yin, Li-Tian] Shanxi Med Univ, Minist Educ, Taiyuan, NC, Peoples R China; [Hao, Hai-Xia; Wang, Hai-Long; Zhang, Jian-Hong; Meng, Xiao-Li; Yin, Guo-Rong] Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China; [Hao, Hai-Xia] Datong Coal Mine Co Ltd, Gen Hosp, Datong, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Yin, GR (corresponding author), Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China.	guorongyin@163.com			National Natural Science Foundation of China [81071374]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi Seyed Hossein, 2013, Oman Med J, V28, P112, DOI 10.5001/omj.2013.29; Ambroise-Thomas P, 2001, PARASITOLOGY, V122, pS65, DOI 10.1017/S0031182000017339; Arababadi MK, 2010, BIOMARK MED, V4, P755, DOI 10.2217/BMM.10.81; Asahi-Ozaki Y, 2006, MICROBES INFECT, V8, P2706, DOI 10.1016/j.micinf.2006.07.018; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; BRINKMANN V, 1993, MOL IMMUNOL, V30, P353, DOI 10.1016/0161-5890(93)90064-I; BUXTON D, 1995, PARASITOLOGY, V110, pS11, DOI 10.1017/S003118200000144X; Buxton D, 2007, VET PARASITOL, V149, P25, DOI 10.1016/j.vetpar.2007.07.003; Cenci-Goga BT, 2011, FOODBORNE PATHOG DIS, V8, P751, DOI 10.1089/fpd.2010.0795; Cui X, 2012, VACCINE, V30, P2282, DOI 10.1016/j.vaccine.2012.01.073; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Debard N, 1996, INFECT IMMUN, V64, P2158, DOI 10.1128/IAI.64.6.2158-2166.1996; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Doskaya M, 2007, VACCINE, V25, P1824, DOI 10.1016/j.vaccine.2006.10.060; Dziadek B, 2011, VACCINE, V29, P821, DOI 10.1016/j.vaccine.2010.11.002; Dziadek B, 2009, EXP PARASITOL, V123, P81, DOI 10.1016/j.exppara.2009.06.002; Fatoohi AF, 2002, CLIN DIAGN LAB IMMUN, V9, P704, DOI 10.1128/CDLI.9.3.704-707.2002; Garcia JL, 2009, EXPERT REV VACCINES, V8, P215, DOI 10.1586/14760584.8.2.215; Golkar M, 2007, VACCINE, V25, P4301, DOI 10.1016/j.vaccine.2007.02.057; Gordon JL, 2008, EUKARYOT CELL, V7, P1500, DOI 10.1128/EC.00064-08; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Huang XS, 2012, EXP PARASITOL, V130, P218, DOI 10.1016/j.exppara.2012.01.001; Igarashi M, 2008, EXP PARASITOL, V118, P386, DOI 10.1016/j.exppara.2007.10.002; Igarashi M, 2010, REV BRAS PARASITOL V, V19, P210, DOI 10.1590/S1984-29612010000400004; Iijima H, 2001, REV MED VIROL, V11, P117, DOI 10.1002/rmv.307; Innes EA, 2009, MEM I OSWALDO CRUZ, V104, P246, DOI 10.1590/S0074-02762009000200018; Jabbal-Gill I, 2010, J DRUG TARGET, V18, P771, DOI 10.3109/1061186X.2010.523790; Jongert E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000200019; Kasper L, 2004, INT J PARASITOL, V34, P401, DOI 10.1016/j.ijpara.2003.11.023; Kieffer F, 2013, HAND CLINIC, V112, P1099, DOI 10.1016/B978-0-444-52910-7.00028-3; KING CA, 1988, PARASITOL TODAY, V4, P315, DOI 10.1016/0169-4758(88)90113-5; Li Run-hua, 2013, Chinese Journal of Parasitology and Parasitic Diseases, V31, P352; Mantis NJ, 2010, IMMUNOL INVEST, V39, P383, DOI 10.3109/08820131003622635; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Min J, 2012, VACCINE, V30, P5631, DOI 10.1016/j.vaccine.2012.06.081; MONDRAGON R, 1994, J EUKARYOT MICROBIOL, V41, P330, DOI 10.1111/j.1550-7408.1994.tb06086.x; Patron SA, 2005, INT J PARASITOL, V35, P883, DOI 10.1016/j.ijpara.2005.03.016; Peng GH, 2009, VACCINE, V27, P6570, DOI 10.1016/j.vaccine.2009.08.043; Sanchez VR, 2011, EXP PARASITOL, V128, P448, DOI 10.1016/j.exppara.2011.04.004; Shang LM, 2009, VACCINE, V27, P2741, DOI 10.1016/j.vaccine.2009.03.013; Shen Jin-yan, 2010, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V28, P21; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Tan F, 2011, VACCINE, V29, P2742, DOI 10.1016/j.vaccine.2011.01.089; Velge-Roussel F, 2000, INFECT IMMUN, V68, P969, DOI 10.1128/IAI.68.2.969-972.2000; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070884; Wang HX, 2009, EXP PARASITOL, V122, P226, DOI 10.1016/j.exppara.2009.04.002; WINNER L, 1991, INFECT IMMUN, V59, P977, DOI 10.1128/IAI.59.3.977-982.1991; Wu HY, 1998, VACCINE, V16, P286, DOI 10.1016/S0264-410X(97)00168-0; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Yin Guo-rong, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P290; Yu HJ, 2013, VET PARASITOL, V197, P670, DOI 10.1016/j.vetpar.2013.06.013; Yuan ZG, 2011, CLIN VACCINE IMMUNOL, V18, P119, DOI 10.1128/CVI.00312-10; Zaman M, 2013, DRUG DELIV TRANSL RE, V3, P100, DOI 10.1007/s13346-012-0085-z; Zhao GH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-175; Zheng B, 2013, VACCINE, V31, P4578, DOI 10.1016/j.vaccine.2013.07.058; Zhou HY, 2012, VACCINE, V30, P1800, DOI 10.1016/j.vaccine.2012.01.004	56	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82765	10.1371/journal.pone.0082765	http://dx.doi.org/10.1371/journal.pone.0082765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386114	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900014
J	Zhang, S; Yang, Y; Liang, ZX; Duan, WX; Yang, J; Yan, JJ; Wang, N; Feng, WQ; Ding, ML; Nie, YZ; Jin, ZX				Zhang, Song; Yang, Yang; Liang, Zhenxing; Duan, Weixun; Yang, Jian; Yan, Juanjuan; Wang, Ning; Feng, Wenqiang; Ding, Meiling; Nie, Yongzhan; Jin, Zhenxiao			Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HUMAN OSTEOSARCOMA CELLS; CANCER CELLS; HEPATOMA-CELLS; IN-VITRO; SILIBININ; PATHWAY; APOPTOSIS; ACTIVATION; INVASION; GROWTH	Hepatocellular carcinoma (HCC) is a global health burden that is associated with limited treatment options and poor patient prognoses. Silybin (SIL), an antioxidant derived from the milk thistle plant (Silybum marianum), has been reported to exert hepatoprotective and antitumorigenic effects both in vitro and in vivo. While SIL has been shown to have potent antitumor activity against various types of cancer, including HCC, the molecular mechanisms underlying the effects of SIL remain largely unknown. The Notch signaling pathway plays crucial roles in tumorigenesis and immune development. In the present study, we assessed the antitumor activity of SIL in human HCC HepG2 cells in vitro and in vivo and explored the roles of the Notch pathway and of the apoptosis-related signaling pathway on the activity of SIL. SIL treatment resulted in a dose-and time-dependent inhibition of HCC cell viability. Additionally, SIL exhibited strong antitumor activity, as evidenced not only by reductions in tumor cell adhesion, migration, intracellular glutathione (GSH) levels and total antioxidant capability (T-AOC) but also by increases in the apoptotic index, caspase3 activity, and reactive oxygen species (ROS). Furthermore, SIL treatment decreased the expression of the Notch1 intracellular domain (NICD), RBP-J kappa, and Hes1 proteins, upregulated the apoptosis pathway-related protein Bax, and downregulated Bcl2, survivin, and cyclin D1. Notch1 siRNA (in vitro) or DAPT (a known Notch1 inhibitor, in vivo) further enhanced the antitumor activity of SIL, and recombinant Jagged1 protein (a known Notch ligand in vitro) attenuated the antitumor activity of SIL. Taken together, these data indicate that SIL is a potent inhibitor of HCC cell growth that targets the Notch signaling pathway and suggest that the inhibition of Notch signaling may be a novel therapeutic intervention for HCC.	[Zhang, Song; Feng, Wenqiang; Ding, Meiling; Nie, Yongzhan] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China; [Yang, Yang; Liang, Zhenxing; Duan, Weixun; Yang, Jian; Wang, Ning; Jin, Zhenxiao] Fourth Mil Med Univ, Dept Cardiovasc Surg, Xijing Hosp, Xian 710032, Peoples R China; [Yan, Juanjuan] Fourth Mil Med Univ, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Nie, YZ (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China.	nieyongzhan210@126.com; zhenxiaojin210@126.com	Jin, Zhenxiao/AAJ-5777-2020		12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81120108005, 81225003, 81102687, 81270170, 81070198, 81000938]; Social Development Project of Shaanxi Province [2012JQ4001, 2012K15-02-01, 2012SF2-21-1]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Project of Shaanxi Province	This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81120108005, 81225003, 81102687, 81270170, 81070198, and 81000938), and the Social Development Project of Shaanxi Province (2012JQ4001, 2012K15-02-01, and 2012SF2-21-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, HEPATOB PANCREAT DIS, V12, P286, DOI 10.1016/S1499-3872(13)60046-6; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chang HR, 2011, MOL CARCINOGEN, V50, P812, DOI 10.1002/mc.20756; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cheng YD, 2013, EUR J PHARMACOL, V715, P219, DOI 10.1016/j.ejphar.2013.05.017; Cho H.J., 2013, J AGR FOOD CHEM; Deep G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034630; Deep G, 2010, CANCER METAST REV, V29, P447, DOI 10.1007/s10555-010-9237-0; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Dizaji MZ, 2012, NEUROCHEM RES, V37, P370, DOI 10.1007/s11064-011-0620-1; Angeli JPF, 2010, MUTAGENESIS, V25, P223, DOI 10.1093/mutage/gep064; Gao J, 2010, EXP CELL RES, V316, P149, DOI 10.1016/j.yexcr.2009.09.025; Ghasemi R, 2013, NUTR CANCER, V65, P590, DOI 10.1080/01635581.2013.770043; Guo WJ, 2011, CANCER LETT, V312, P55, DOI 10.1016/j.canlet.2011.07.024; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kauntz H, 2012, INT J ONCOL, V41, P849, DOI 10.3892/ijo.2012.1526; Khan M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/719858; Liu YW, 2013, TOXICOLOGY, V304, P120, DOI 10.1016/j.tox.2012.12.018; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Naganuma S, 2012, AM J CANCER RES, V2, P459; Nguyen KC, 2013, TOXICOLOGY, V306, P114, DOI 10.1016/j.tox.2013.02.010; Post-White J, 2007, INTEGR CANCER THER, V6, P104, DOI 10.1177/1534735407301632; Raina K, 2013, MOL CARCINOGEN, V52, P195, DOI 10.1002/mc.21843; Ristorcelli E, 2009, INT J CANCER, V125, P1016, DOI 10.1002/ijc.24375; Singh RR, 2009, CLIN CANCER RES, V15, P613, DOI 10.1158/1078-0432.CCR-08-1846; Yang LL, 2013, MAR DRUGS, V11, P1961, DOI 10.3390/md11061961; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062652; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7	30	27	30	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83699	10.1371/journal.pone.0083699	http://dx.doi.org/10.1371/journal.pone.0083699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386256	gold, Green Submitted, Green Published			2022-12-27	WOS:000329117900054
J	Fung, J; Lee, CK; Chan, M; Seto, WK; Wong, DKH; Lai, CL; Yuen, MF				Fung, James; Lee, Cheuk-kwong; Chan, Monica; Seto, Wai-kay; Wong, Danny Ka-ho; Lai, Ching-lung; Yuen, Man-fung			Defining Normal Liver Stiffness Range in a Normal Healthy Chinese Population without Liver Disease	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; FIBROSIS; BIOPSY; VALUES; COMPLICATIONS	Background: For patients with chronic liver disease, different optimal liver stiffness cut-off values correspond to different stages of fibrosis, which are specific for the underlying liver disease and population. Aims: To establish the normal ranges of liver stiffness in the healthy Chinese population without underlying liver disease. Methods: This is a prospective cross sectional study of 2,528 healthy volunteers recruited from the general population and the Red Cross Transfusion Center in Hong Kong. All participants underwent a comprehensive questionnaire survey, measurement of weight, height, and blood pressure. Fasting liver function tests, glucose and cholesterol was performed. Abdominal ultrasound and transient elastography were performed on all participants. Results: Of the 2,528 subjects, 1,998 were excluded with either abnormal liver parenchyma on ultrasound, chronic medical condition, abnormal blood tests including liver enzymes, fasting glucose, fasting cholesterol, high body mass index, high blood pressure, or invalid liver stiffness scan. The reference range for the 530 subjects without known liver disease was 2.3 to 5.9 kPa (mean 4.1, SD 0.89). The median liver stiffness was higher in males compared with females (4.3 vs 4.0 kPa respectively, p<0.001). There was also a decline in median Lliver stiffness in the older age group, from 4.2 kPa in those <25 years to 3.4 kPa for those >55 years (p=0.001). Conclusions: The healthy reference range for liver stiffness in the Chinese population is 2.3 to 5.9 kPa. Female gender and older age group was associated with a lower median liver stiffness.	[Fung, James; Seto, Wai-kay; Wong, Danny Ka-ho; Lai, Ching-lung; Yuen, Man-fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Fung, James; Wong, Danny Ka-ho; Lai, Ching-lung; Yuen, Man-fung] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Fung, James; Seto, Wai-kay; Yuen, Man-fung] Hong Kong Liver Fdn, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-kwong] Hong Kong Red Cross Blood Transfus Serv, Hong Kong, Hong Kong, Peoples R China; [Chan, Monica] Access Med Diagnost & Lab Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Wong, Danny/S-6230-2019; LEE, Cheuk Kwong/F-3950-2017; Wong, Danny/H-6819-2016; Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012	LEE, Cheuk Kwong/0000-0002-3939-564X; SETO, Wai-Kay/0000-0002-9012-313X; /0000-0001-9078-5005; Lai, Ching-Lung/0000-0002-5927-2436; Fung, James/0000-0002-1286-8902	Bristol-Myers-Squibbs (Hong Kong); Chong Lap (Hong Kong); GlaxoSmithKline, (Hong Kong); Novartis Pharmaceuticals (Hong Kong)	Bristol-Myers-Squibbs (Hong Kong); Chong Lap (Hong Kong); GlaxoSmithKline, (Hong Kong)(GlaxoSmithKline); Novartis Pharmaceuticals (Hong Kong)	The Hong Kong Liver Health Census was an investigator-initiated, not-for-profit study, in conjunction with the Hong Kong Liver Foundation. Financial support was provided by unrestricted grants from Bristol-Myers-Squibbs (Hong Kong), Chong Lap (Hong Kong), GlaxoSmithKline,(Hong Kong) and Novartis Pharmaceuticals (Hong Kong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; Das K, 2012, HEPATOLOGY, V55, P584, DOI 10.1002/hep.24694; Foucher J, 2006, EUR J GASTROEN HEPAT, V18, P411, DOI 10.1097/00042737-200604000-00015; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; FROEHLICH F, 1993, DIGEST DIS SCI, V38, P1480, DOI 10.1007/BF01308607; Fung J, 2011, J VIRAL HEPATITIS, V18, P738, DOI 10.1111/j.1365-2893.2010.01355.x; Fung J, 2010, HEPATOL INT; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Fung J, 2010, AM J GASTROENTEROL, V105, P1116, DOI 10.1038/ajg.2009.665; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Kumar M, 2011, J GASTROEN HEPATOL, V26, P1318, DOI 10.1111/j.1440-1746.2011.06736.x; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Mayfield J, 1998, AM FAM PHYSICIAN, V58, P1355; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020	22	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85067	10.1371/journal.pone.0085067	http://dx.doi.org/10.1371/journal.pone.0085067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386446	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700129
J	Sant'Anna, RTP; Monteiro, EV; Pereira, JRT; Faria, RB				Sant'Anna, Rafaela T. P.; Monteiro, Emily V.; Pereira, Juliano R. T.; Faria, Roberto B.			The Ozone-Iodine-Chlorate Clock Reaction	PLOS ONE			English	Article							CHLORINE DIOXIDE; MECHANISM; KINETICS; ION	This work presents a new clock reaction based on ozone, iodine, and chlorate that differs from the known chlorate-iodine clock reaction because it does not require UV light. The induction period for this new clock reaction depends inversely on the initial concentrations of ozone, chlorate, and perchloric acid but is independent of the initial iodine concentration. The proposed mechanism considers the reaction of ozone and iodide to form HOI, which is a key species for producing nonlinear autocatalytic behavior. The novelty of this system lies in the presence of ozone, whose participation has never been observed in complex systems such as clock or oscillating reactions. Thus, the autocatalysis demonstrated in this new clock reaction should open the possibility for a new family of oscillating reactions.	[Sant'Anna, Rafaela T. P.; Monteiro, Emily V.; Pereira, Juliano R. T.; Faria, Roberto B.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Faria, RB (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil.	faria@iq.ufrj.br	Faria, Roberto B./B-5455-2013	FARIA, ROBERTO/0000-0001-9337-4324	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303988/2009-6]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/110-107/2007]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 303988/2009-6 (www.cnpq.br); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, E-26/110-107/2007 (www.faperj.br); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chance B., 1973, BIOL BIOCH OSCILLATO; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; de Violet PF, 1973, J CHIM PHYS PCB, V70, P1404; EDBLOM EC, 1986, J AM CHEM SOC, V108, P2826, DOI 10.1021/ja00271a007; Epstein I.R., 1998, INTRO NONLINEAR CHEM; Galajda M, 2007, J AM CHEM SOC, V129, P7738, DOI 10.1021/ja072361l; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Jowza M, 2005, J PHYS CHEM A, V109, P1873, DOI 10.1021/jp0457895; KAPS P, 1979, NUMER MATH, V33, P55, DOI 10.1007/BF01396495; Landolt H., 1886, BER DTSCH CHEM GES, V19, P1317; Lengyel I, 1996, J AM CHEM SOC, V118, P3708, DOI 10.1021/ja953938e; Lente G, 2007, NEW J CHEM, V31, P1707, DOI 10.1039/b708846a; Liu Q, 2001, INORG CHEM, V40, P4436, DOI 10.1021/ic000919j; Neuenschwander U, 2013, J PHYS CHEM A, V117, P4343, DOI 10.1021/jp400879d; Oliveira AP, 2005, J AM CHEM SOC, V127, P18022, DOI 10.1021/ja0570537; Rabai G, 2001, J PHYS CHEM A, V105, P6167, DOI 10.1021/jp010370p; RABAI G, 1987, INORG CHEM, V26, P1195, DOI 10.1021/ic00255a004; Shakhashiri BZ, 1985, CLOCK REACTIONS CHEM, V2, P3	18	8	8	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83706	10.1371/journal.pone.0083706	http://dx.doi.org/10.1371/journal.pone.0083706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386257	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700071
J	Trebicka, J; Krag, A; Gansweid, S; Schiedermaier, P; Strunk, HM; Fimmers, R; Strassburg, CP; Bendtsen, F; Moller, S; Sauerbruch, T; Spengler, U				Trebicka, Jonel; Krag, Aleksander; Gansweid, Stefan; Schiedermaier, Peter; Strunk, Holger M.; Fimmers, Rolf; Strassburg, Christian P.; Bendtsen, Fleming; Moller, Soren; Sauerbruch, Tilman; Spengler, Ulrich			Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; NECROSIS-FACTOR RECEPTORS; BACTERIAL TRANSLOCATION; LIVER-CIRRHOSIS; SERUM-LEVELS; P55; P75; CIRRHOTICS; EXPRESSION; RESISTANCE	Background: TNF alpha levels are increased in liver cirrhosis even in the absence of infection, most likely owing to a continuous endotoxin influx into the portal blood. Soluble TNF alpha receptors (sTNFR type I and II) reflect release of the short-lived TNF alpha, because they are cleaved from the cells after binding of TNF alpha. The aims were to investigate the circulating levels of soluble TNFR-I and -II in cirrhotic patients receiving TIPS. Methods: Forty-nine patients with liver cirrhosis and portal hypertension (12 viral, 37 alcoholic) received TIPS for prevention of re-bleeding (n = 14), therapy-refractory ascites (n = 20), or both (n = 15). Portal and hepatic venous blood was drawn in these patients during the TIPS procedure and during the control catheterization two weeks later. sTNFR-I and sTNFR-II were measured by ELISA, correlated to clinical and biochemical characteristics. Results: Before TIPS insertion, sTNFR-II levels were lower in portal venous blood than in the hepatic venous blood, as well as in portal venous blood after TIPS insertion. No significant differences were measured in sTNFR-I levels. Hepatic venous levels of sTNFR-I above 4.5 ng/mL (p = 0.036) and sTNFR-II above 7 ng/mL (p = 0.05) after TIPS insertion were associated with decreased survival. A multivariate Cox-regression survival analysis identified the hepatic venous levels of sTNFR-I (p = 0.004) two weeks after TIPS, and Child score (p = 0.002) as independent predictors of mortality, while MELD-score was not. Conclusion: Hepatic venous levels of sTNFR-I after TIPS insertion may predict mortality in patients with severe portal hypertension.	[Trebicka, Jonel; Gansweid, Stefan; Schiedermaier, Peter; Strassburg, Christian P.; Sauerbruch, Tilman; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Trebicka, Jonel; Krag, Aleksander; Bendtsen, Fleming] Univ Copenhagen, Hvidovre Hosp, Div Med, Gastrounit, Copenhagen, Denmark; [Krag, Aleksander] Univ Southern Denmark, Odense Univ Hosp, Dept Gastroenterol, Odense, Denmark; [Strunk, Holger M.] Univ Bonn, Dept Radiol, Bonn, Germany; [Fimmers, Rolf] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Moller, Soren] Univ Copenhagen, Hvidovre Hosp, Dept Clin Physiol & Nucl Med, Ctr Funct Imaging & Res, Copenhagen, Denmark	University of Bonn; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Bonn; University of Bonn; University of Copenhagen	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Krag, Aleksander/ABH-9649-2020	Krag, Aleksander/0000-0002-9598-4932; Moller, Soren/0000-0001-9684-7764; Trebicka, Jonel/0000-0002-7028-3881	Deutsche Forschungsgemeinschaft [SFB TRR57]; H.J. & W. Hector Stiftung; Capital Region of Denmark Foundation of Health Research; Hvidovre Hospital Foundation for Liver Diseases; Novo Nordisk Fonden [NNF11OC1015075, NNF13OC0006329, NNF11OC1014467] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H.J. & W. Hector Stiftung; Capital Region of Denmark Foundation of Health Research; Hvidovre Hospital Foundation for Liver Diseases; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by grants of Deutsche Forschungsgemeinschaft (SFB TRR57 to P12 and P18), by grants of H.J. & W. Hector Stiftung, as well as by the Capital Region of Denmark Foundation of Health Research and Hvidovre Hospital Foundation for Liver Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari K, 2012, WORLD J GASTROENTERO, V18, P1166, DOI 10.3748/wjg.v18.i11.1166; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; Brensing KA, 2000, GUT, V47, P288, DOI 10.1136/gut.47.2.288; Brensing KA, 2002, SCAND J GASTROENTERO, V37, P1070, DOI 10.1080/003655202320378284; Garcia-Pagan JC, 2010, NEW ENGL J MED, V362, P2370, DOI 10.1056/NEJMoa0910102; Cubillas R, 2010, HEPAT RES TREAT, V2010; DIEZRUIZ A, 1995, HEPATOLOGY, V21, P976; Fickert P, 2010, LAB INVEST, V90, P844, DOI 10.1038/labinvest.2010.61; Fidelman N, 2012, AM J ROENTGENOL, V199, P746, DOI 10.2214/AJR.12.9101; Gonzalez-Calvin JL, 2004, J CLIN ENDOCR METAB, V89, P4325, DOI 10.1210/jc.2004-0077; Grunhage F, 2008, CLIN GASTROENTEROL H, V6, P1255, DOI 10.1016/j.cgh.2008.06.018; Hanck C, 2000, J HEPATOL, V32, P51, DOI 10.1016/S0168-8278(00)80189-0; Ingaramo PI, 2011, MOL IMMUNOL, V48, P1397, DOI 10.1016/j.molimm.2011.03.015; Itoh Y, 1999, AM J GASTROENTEROL, V94, P1332, DOI 10.1111/j.1572-0241.1999.01083.x; Jalan R, 2011, J HEPATOL; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Kallinowski B, 1998, CLIN EXP IMMUNOL, V111, P269; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Lin SY, 2004, METABOLISM, V53, P922, DOI 10.1016/j.metabol.2004.01.016; Machado MV, 2009, EUR J GASTROEN HEPAT, V21, P201, DOI 10.1097/MEG.0b013e32831016e0; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Moreland LW, 2001, ISR MED ASSOC J, V3, P686; Moura AS, 2010, EUR J CLIN MICROBIOL, V29, P1153, DOI 10.1007/s10096-010-0981-4; Naveau S, 2001, AM J GASTROENTEROL, V96, P3361; Naveau S, 1998, J HEPATOL, V28, P778, DOI 10.1016/S0168-8278(98)80227-4; Pandey M, 2003, AM J PATHOL, V162, P933, DOI 10.1016/S0002-9440(10)63888-6; Riordan SM, 2003, HEPATOLOGY, V37, P1154, DOI 10.1053/jhep.2003.50180; Salerno F, 2007, GASTROENTEROLOGY, V133, P825, DOI 10.1053/j.gastro.2007.06.020; Schlatter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018646; Shiraki M, 2010, NUTRITION, V26, P269, DOI 10.1016/j.nut.2009.04.016; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Toda K, 2010, BBA-MOL CELL BIOL L, V1801, P655, DOI 10.1016/j.bbalip.2010.03.002; Trebicka J, 2011, EUR J GASTROEN HEPAT, V23, P1218, DOI 10.1097/MEG.0b013e32834a75dc; Wiest R, 1999, J CLIN INVEST, V104, P1223, DOI 10.1172/JCI7458; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Yang YY, 2009, LIVER INT, V29, P678, DOI 10.1111/j.1478-3231.2009.01983.x; Yang YY, 2009, BIOCHEM BIOPH RES CO, V380, P666, DOI 10.1016/j.bbrc.2009.01.160; Zekri Abdel-Rahman N, 2010, Comp Hepatol, V9, P1, DOI 10.1186/1476-5926-9-1; Zimmerer JM, 2012, TRANSPLANTATION, V94, P1103, DOI 10.1097/TP.0b013e318270f3c0	39	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83341	10.1371/journal.pone.0083341	http://dx.doi.org/10.1371/journal.pone.0083341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386183	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700043
J	Chen, WH; Cheng, SJ; Tzen, JTC; Cheng, CM; Lin, YW				Chen, Wei-Hsin; Cheng, Sin-Jhong; Tzen, Jason T. C.; Cheng, Chao-Min; Lin, Yi-Wen			Probing Relevant Molecules in Modulating the Neurite Outgrowth of Hippocampal Neurons on Substrates of Different Stiffness	PLOS ONE			English	Article							CELL-ADHESION; IN-VITRO; EXTRACELLULAR-MATRIX; PYRAMIDAL NEURONS; MECHANOTRANSDUCTION; FIBRONECTIN; ACTIVATION; LAMININ; REGENERATION; INITIATION	Hippocampal neurons play a critical role in learning and memory; however, the effects of environmental mechanical forces on neurite extension and associated underlying mechanisms are largely unexplored, possibly due to difficulties in maintaining central nervous system neurons. Neuron adhesion, neurite length, and mechanotransduction are mainly influenced by the extracellular matrix (ECM), which is often associated with structural scaffolding. In this study, we investigated the relationship between substrate stiffness and hippocampal neurite outgrowth by controlling the ratios of polydimethylsiloxane (PDMS) base to curing agent to create substrates of varying stiffness. Immunostaining results demonstrated that hippocampal neurons have longer neurite elongation in 35: 1 PDMS substrate compared those grown on 15: 1 PDMS, indicating that soft substrates provide a more optimal stiffness for hippocampal neurons. Additionally, we discovered that pPKC alpha expression was higher in the 15: 1 and 35: 1 PDMS groups than in the poly-L-lysine-coated glass group. However, when we used a fibronectin (FN) coating, we found that pFAKy397 and pFAKy925 expression were higher in glass group than in the 15:1 or 35:1 PDMS groups, but pPKC alpha and pERK1/2 expression were higher in the 35: 1 PDMS group than in the glass group. These results support the hypothesis that environmental stiffness influences hippocampal neurite outgrowth and underlying signaling pathways.	[Chen, Wei-Hsin; Tzen, Jason T. C.] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Cheng, Sin-Jhong] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Cheng, Sin-Jhong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Cheng, Chao-Min] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu, Taiwan; [Lin, Yi-Wen] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Lin, Yi-Wen] China Med Univ, Acupuncture Res Ctr, Taichung, Taiwan	National Chung Hsing University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan	Lin, YW (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.	yiwenlin@mail.cmu.edu.tw	Lin, Yi-Wen/O-3541-2015; Chang, Sin-Jhong/AAL-4118-2020	Lin, Yi-Wen/0000-0001-7204-8837; 	NSC [101-2320-B-039-014-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	NSC(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence	This work was supported by NSC 101-2320-B-039-014-MY3 and in part by the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Chen ZL, 2003, MOL BIOL CELL, V14, P2665, DOI 10.1091/mbc.E02-12-0832; Cheng CM, 2011, J BIOMECH, V44, P856, DOI 10.1016/j.jbiomech.2010.12.006; Cheng CM, 2010, NAT PROTOC, V5, P714, DOI 10.1038/nprot.2010.15; Choi KM, 2003, J AM CHEM SOC, V125, P4060, DOI 10.1021/ja029973k; Chou SY, 2011, SOFT MATTER, V7, P9871, DOI 10.1039/c1sm06336g; Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Elston GN, 2003, CEREB CORTEX, V13, P1124, DOI 10.1093/cercor/bhg093; Evans ND, 2009, EUR CELLS MATER, V18, P1; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; FLETCHER TL, 1989, DEV BIOL, V136, P446, DOI 10.1016/0012-1606(89)90269-8; Garcia-Lopez P, 2006, J NEUROSCI, V26, P11249, DOI 10.1523/JNEUROSCI.3543-06.2006; Hattori N, 2007, BIOMED RES-TOKYO, V28, P139, DOI 10.2220/biomedres.28.139; Hinsby AM, 2004, J NEUROCHEM, V91, P694, DOI 10.1111/j.1471-4159.2004.02772.x; Hodgkinson GN, 2007, BIOMATERIALS, V28, P2590, DOI 10.1016/j.biomaterials.2007.01.038; HORACEK MJ, 1993, ACTA ANAT, V147, P69; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293; Lobato RD, 2008, NEUROCIRUGIA, V19, P456; Lydolph MC, 2009, EXP CELL RES, V315, P3312, DOI 10.1016/j.yexcr.2009.09.022; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Previtera ML, 2010, ANN BIOMED ENG, V38, P3733, DOI 10.1007/s10439-010-0112-5; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Ramon y Cajal S, 1991, CAJALS DEGENERATION, Vxvi; Santama N, 1996, EUR J NEUROSCI, V8, P892, DOI 10.1111/j.1460-9568.1996.tb01576.x; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tonge DA, 2012, BRAIN RES, V1453, P8, DOI 10.1016/j.brainres.2012.03.024; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; WOODS A, 1992, J CELL SCI, V101, P277	43	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83394	10.1371/journal.pone.0083394	http://dx.doi.org/10.1371/journal.pone.0083394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386192	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700038
J	Degauque, N; Ngono, AE; Akl, A; Lepetit, M; Crochette, R; Giral, M; Lepourry, J; Pallier, A; Castagnet, S; Dugast, E; Guillot-Gueguen, C; Jacq-Foucher, M; Saulquin, X; Cesbron, A; Laplaud, D; Nicot, A; Brouard, S; Soulillou, JP				Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Guillot-Gueguen, Cecile; Jacq-Foucher, Marylene; Saulquin, Xavier; Cesbron, Anne; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul			Characterization of Antigen-Specific B Cells Using Nominal Antigen-Coated Flow-Beads	PLOS ONE			English	Article							T-CELLS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; SELF-ANTIGEN; GRANZYME-B; FOLLOW-UP; B10 CELLS; MOUSE; INDIVIDUALS; TOLERANCE	In order to characterize the reactivity of B cells against nominal antigens, a method based on the coupling of antigens onto the surface of fluorescent core polystyrene beads was developed. We first demonstrate that murine B cells with a human MOG-specific BCR are able to interact with MOG-coated beads and do not recognize beads coated with human albumin or pp65. B cells purified from human healthy volunteer blood or immunized individuals were tested for their ability to interact with various nominal antigens, including viral, vaccine, self and alloantigens, chosen for their usefulness in studying a variety of pathological processes. A substantial amount of B cells binding self-antigen MOG-coated beads can be detected in normal blood. Furthermore, greater frequencies of B cell against anti-Tetanic Toxin or anti-EBNA1 were observed in primed individuals. This method can reveal increased frequencies of anti-HLA committed B cells in patients with circulating anti-HLA antibodies compared to unsensitized patients and normal individuals. Of interest, those specific CD19 cells were preferentially identified within CD27(-)IgD(+) (i-e naive) subset. These observations suggest that a broad range of medical situations could benefit from a tool that allows the detection, the quantification and the characterization of antigen-specific blood B cells.	[Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul] INSERM, UMR 1064, Nantes, France; [Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Guillot-Gueguen, Cecile; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Degauque, Nicolas; Ngono, Annie Elong; Akl, Ahmed; Lepetit, Maud; Crochette, Romain; Giral, Magali; Lepourry, Julie; Pallier, Annaick; Castagnet, Stephanie; Dugast, Emilie; Saulquin, Xavier; Laplaud, David; Nicot, Arnaud; Brouard, Sophie; Soulillou, Jean-Paul] Univ Nantes, Fac Med, Nantes, France; [Jacq-Foucher, Marylene; Laplaud, David] INSERM, CIC 004, Nantes, France; [Saulquin, Xavier] INSERM, UMR892, Nantes, France; [Cesbron, Anne] Lab HLA, Etab Francais Sang, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Soulillou, JP (corresponding author), INSERM, UMR 1064, Nantes, France.	jean-paul.soulillou@univ-nantes.fr	Nicot, Arnaud/L-8898-2016; LAPLAUD, David/AAG-4367-2020; brouard, sophie c/Q-1285-2016; SAULQUIN, Xavier/L-2886-2015; Degauque, Nicolas/R-4944-2017; akl, ahmed/X-2562-2018	Nicot, Arnaud/0000-0003-2695-3304; Degauque, Nicolas/0000-0003-2990-3513; Dugast, Emilie/0000-0001-7439-1903; Saulquin, Xavier/0000-0002-5209-7030; Laplaud, David/0000-0001-6113-6938; akl, ahmed/0000-0002-7447-5530	ITERT Transplantation Sciences post doctorate grant; Region Pays de la Loire; DGOS FCB-REC (DIRECTION GENERALE DE L'ORGANISATION DES SOINS - "Frequence des cellules B dans le rejet chronique")	ITERT Transplantation Sciences post doctorate grant; Region Pays de la Loire(Region Pays de la Loire); DGOS FCB-REC (DIRECTION GENERALE DE L'ORGANISATION DES SOINS - "Frequence des cellules B dans le rejet chronique")	A.A was supported by the ITERT Transplantation Sciences post doctorate grant. A.N. is supported by Region Pays de la Loire. A DGOS FCB-REC (DIRECTION GENERALE DE L'ORGANISATION DES SOINS - "Frequence des cellules B dans le rejet chronique") supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Bahbouhi B, 2009, J LEUKOCYTE BIOL, V86, P1049, DOI 10.1189/jlb.1008666; Berthelot L, 2008, EUR J IMMUNOL, V38, P1889, DOI 10.1002/eji.200838023; Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; Bromage E, 2009, J IMMUNOL METHODS, V346, P75, DOI 10.1016/j.jim.2009.05.005; Brulhart L, 2006, ANN RHEUM DIS, V65, P1255, DOI 10.1136/ard.2005.051169; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Damoiseaux J, 2007, ANN NY ACAD SCI, V1109, P454, DOI 10.1196/annals.1398.051; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Hagn M, 2010, EUR J IMMUNOL, V40, P2060, DOI 10.1002/eji.200940113; Hagn M, 2009, J IMMUNOL, V183, P1838, DOI 10.4049/jimmunol.0901066; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Hippen BE, 2005, AM J TRANSPLANT, V5, P2248, DOI 10.1111/j.1600-6143.2005.01009.x; Hwang HS, 2010, TRANSPLANTATION, V89, P1489, DOI 10.1097/TP.0b013e3181dd35b8; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Klinman Dennis, 2008, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0619s83; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Lycke N Y, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0714s17; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Ngono AE, 2012, CLIN IMMUNOL, V144, P117, DOI 10.1016/j.clim.2012.05.009; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Pei R, 2003, TRANSPLANTATION, V75, P43, DOI 10.1097/00007890-200301150-00008; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; RUDOLPHI U, 1993, CLIN EXP IMMUNOL, V92, P404, DOI 10.1111/j.1365-2249.1993.tb03412.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Taylor JJ, 2012, J EXP MED, V209, P2065, DOI 10.1084/jem.20112272; Terasaki PI, 2007, AM J TRANSPLANT, V7, P408, DOI 10.1111/j.1600-6143.2006.01644.x; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Zarkhin V, 2008, KIDNEY INT, V74, P664, DOI 10.1038/ki.2008.249; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	34	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84273	10.1371/journal.pone.0084273	http://dx.doi.org/10.1371/journal.pone.0084273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386360	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700099
J	Melis, RJF; Marengoni, A; Rizzuto, D; Teerenstra, S; Kivipelto, M; Angleman, SB; Fratiglioni, L				Melis, Rene J. F.; Marengoni, Alessandra; Rizzuto, Debora; Teerenstra, Steven; Kivipelto, Miia; Angleman, Sara B.; Fratiglioni, Laura			The Influence of Multimorbidity on Clinical Progression of Dementia in a Population-Based Cohort	PLOS ONE			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; MEDICAL COMORBIDITY; COGNITIVE DECLINE; PREVALENCE; AGE; ASSOCIATION; PATTERNS; ILLNESS; HEALTH	Introduction: Co-occurrence with other chronic diseases may influence the progression of dementia, especially in case of multiple chronic diseases. We aimed to verify whether multimorbidity influenced cognitive and daily functioning during nine years after dementia diagnosis compared with the influence in persons without dementia. Methods: In the Kungsholmen Project, a population-based cohort study, we followed 310 persons with incident dementia longitudinally. We compared their trajectories with those of 679 persons without dementia. Progression was studied for cognition and activities of daily life (ADLs), measured by MMSE and Katz Index respectively. The effect of multimorbidity and its interaction with dementia status was studied using individual growth models. Results: The mean (SD) follow-up time was 4.7 (2.3) years. As expected, dementia related to both the decline in cognitive and daily functioning. Irrespective of dementia status, persons with more diseases had significantly worse baseline daily functioning. In dementia patients having more diseases also related to a significantly faster decline in daily functioning. Due to the combination of lower functioning in ADLs at baseline and faster decline, dementia patients with multimorbidity were about one to two years ahead of the decline of dementia patients without any co-morbidity. In persons without dementia, no significant decline in ADLs over time was present, nor was multimorbidity related to the decline rate. Cognitive decline measured with MMSE remained unrelated to the number of diseases present at baseline. Conclusion: Multimorbidity was related to baseline daily function in both persons with and without dementia, and with accelerated decline in people with dementia but not in non-demented individuals. No relationship of multimorbidity with cognitive functioning was established. These findings imply a strong interconnection between physical and mental health, where the greatest disablement occurs when both somatic and mental disorders are present.	[Melis, Rene J. F.] Radboud Univ Nijmegen Med Ctr, Radboud Alzheimer Ctr, Dept Geriatr Med, Nijmegen, Netherlands; [Marengoni, Alessandra] Univ Brescia, Dept Med & Surg Sci, Brescia, Italy; [Rizzuto, Debora; Kivipelto, Miia; Angleman, Sara B.; Fratiglioni, Laura] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Rizzuto, Debora; Kivipelto, Miia; Angleman, Sara B.; Fratiglioni, Laura] Stockholm Univ, S-10691 Stockholm, Sweden; [Teerenstra, Steven] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands	Radboud University Nijmegen; University of Brescia; Karolinska Institutet; Stockholm University; Radboud University Nijmegen	Melis, RJF (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Alzheimer Ctr, Dept Geriatr Med, Nijmegen, Netherlands.	rene.melis@radboudumc.nl	Rizzuto, Debora/V-1890-2018; Kivipelto, Miia/AAS-3557-2021; Melis, René/J-5943-2012; Teerenstra, Steven/C-2870-2018; Rizzuto, Debora/X-7065-2019	Melis, René/0000-0002-7863-4738; Teerenstra, Steven/0000-0003-4103-7451; Rizzuto, Debora/0000-0001-6199-9629; Angleman, Sara/0000-0002-9520-5716; Kivipelto, Miia/0000-0003-0992-3875; marengoni, alessandra/0000-0002-4851-1825	Rubicon Travel grant, Netherlands Organisation for Scientific Research [825.08.008]	Rubicon Travel grant, Netherlands Organisation for Scientific Research	This work was supported by a Rubicon Travel grant, Netherlands Organisation for Scientific Research (825.08.008) to Rene Melis (http://www.nwo.nl/nwohome.nsf/pages/NWOP_6H2G7R_Eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S, 2011, INT J GERIATR PSYCH, V26, P1046, DOI 10.1002/gps.2642; Aarts S, 2011, INT PSYCHOGERIATR, V23, P616, DOI 10.1017/S1041610210002024; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Backman L, 2003, J GERONTOL B-PSYCHOL, V58, pP228, DOI 10.1093/geronb/58.4.P228; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Clark CM, 1999, ARCH NEUROL-CHICAGO, V56, P857, DOI 10.1001/archneur.56.7.857; Doraiswamy PM, 2002, J GERONTOL A-BIOL, V57, pM173, DOI 10.1093/gerona/57.3.M173; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; FRATIGLIONI L, 1992, ARCH NEUROL-CHICAGO, V49, P927, DOI 10.1001/archneur.1992.00530330049015; FRATIGLIONI L, 1992, NEUROEPIDEMIOLOGY, V11, P29, DOI 10.1159/000110958; Fratiglioni L, 2007, PHYSIOL BEHAV, V92, P98, DOI 10.1016/j.physbeh.2007.05.059; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Leoutsakos JMS, 2012, INT PSYCHOGERIATR, V24, P1561, DOI 10.1017/S104161021200049X; Lyketsos CG, 2005, AM J GERIAT PSYCHIAT, V13, P656, DOI 10.1176/appi.ajgp.13.8.656; MacDonald SWS, 2011, DEMENT GERIATR COGN, V31, P202, DOI 10.1159/000325666; Marengoni A, 2011, AGEING RES REV; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; MCCORMICK WC, 1994, J AM GERIATR SOC, V42, P517, DOI 10.1111/j.1532-5415.1994.tb04974.x; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Solomon A, 2011, INT J GERIATR PSYCHI; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; Wang L, 2006, ARCH INTERN MED, V166, P1115, DOI 10.1001/archinte.166.10.1115; World Health Organization. WHO, 1987, INT CLASS DIS INJ CA	33	55	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84014	10.1371/journal.pone.0084014	http://dx.doi.org/10.1371/journal.pone.0084014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386324	Green Published, gold			2022-12-27	WOS:000329194700085
J	Permenter, MG; Dennis, WE; Sutto, TE; Jackson, DA; Lewis, JA; Stallings, JD				Permenter, Matthew G.; Dennis, William E.; Sutto, Thomas E.; Jackson, David A.; Lewis, John A.; Stallings, Jonathan D.			Exposure to Cobalt Causes Transcriptomic and Proteomic Changes in Two Rat Liver Derived Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; OXIDATIVE STRESS; HYPOXIC STRESS; PROTEINS; MECHANISM; TUNGSTEN; OXYGEN; PROGRESSION; TOXICOLOGY	Cobalt is a transition group metal present in trace amounts in the human diet, but in larger doses it can be acutely toxic or cause adverse health effects in chronic exposures. Its use in many industrial processes and alloys worldwide presents opportunities for occupational exposures, including military personnel. While the toxic effects of cobalt have been widely studied, the exact mechanisms of toxicity remain unclear. In order to further elucidate these mechanisms and identify potential biomarkers of exposure or effect, we exposed two rat liver-derived cell lines, H4-II-E-C3 and MH1C1, to two concentrations of cobalt chloride. We examined changes in gene expression using DNA microarrays in both cell lines and examined changes in cytoplasmic protein abundance in MH1C1 cells using mass spectrometry. We chose to closely examine differentially expressed genes and proteins changing in abundance in both cell lines in order to remove cell line specific effects. We identified enriched pathways, networks, and biological functions using commercial bioinformatic tools and manual annotation. Many of the genes, proteins, and pathways modulated by exposure to cobalt appear to be due to an induction of a hypoxic-like response and oxidative stress. Genes that may be differentially expressed due to a hypoxic-like response are involved in Hif-1 alpha signaling, glycolysis, gluconeogenesis, and other energy metabolism related processes. Gene expression changes linked to oxidative stress are also known to be involved in the NRF2-mediated response, protein degradation, and glutathione production. Using microarray and mass spectrometry analysis, we were able to identify modulated genes and proteins, further elucidate the mechanisms of toxicity of cobalt, and identify biomarkers of exposure and effect in vitro, thus providing targets for focused in vivo studies.	[Permenter, Matthew G.] Excet Inc, Ft Detrick, MD USA; [Dennis, William E.; Jackson, David A.; Lewis, John A.; Stallings, Jonathan D.] US Army Ctr Environm Hlth Res, Ft Detrick, MD USA; [Sutto, Thomas E.] Naval Res Lab, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Stallings, JD (corresponding author), US Army Ctr Environm Hlth Res, Ft Detrick, MD USA.	jonathan.d.stallings.mil@mail.mil	Jackson, David/E-9984-2014; Stallings, Jonathan D/H-7779-2013	Stallings, Jonathan D/0000-0002-6430-5888	U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program	U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The research described herein was sponsored by the U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WWW DOC; Archer KJ, 2010, BRIEF BIOINFORM, V11, P244, DOI 10.1093/bib/bbp055; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P201, DOI 10.1081/CLT-100102420; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Bianchet MA, 2004, METHOD ENZYMOL, V382, P144; BRAHMACHARI HD, 1973, AEROSPACE MED, V44, P636; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; DEMATTEIS F, 1977, BIOCHEM J, V162, P213, DOI 10.1042/bj1620213; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; EATON RP, 1973, AM J PHYSIOL, V225, P67, DOI 10.1152/ajplegacy.1973.225.1.67; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finley BL, 2012, REGUL TOXICOL PHARM, V64, P491, DOI 10.1016/j.yrtph.2012.08.022; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GROSS RT, 1955, PEDIATRICS, V15, P284; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartwig A, 2001, ANTIOXID REDOX SIGN, V3, P625, DOI 10.1089/15230860152542970; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoet PMH, 2002, ARCH TOXICOL, V76, P1, DOI 10.1007/s00204-001-0300-z; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalinich JF, 2005, ENVIRON HEALTH PERSP, V113, P729, DOI 10.1289/ehp.7791; Kocher T, 2009, J PROTEOME RES, V8, P4743, DOI 10.1021/pr900451u; KUSAKA Y, 1986, BRIT J IND MED, V43, P486; KUSAKA Y, 1986, BRIT J IND MED, V43, P474; Leggett RW, 2008, SCI TOTAL ENVIRON, V389, P259, DOI 10.1016/j.scitotenv.2007.08.054; Lewis JA, 2010, J PROTEOME RES, V9, P5794, DOI 10.1021/pr1005668; Lison D, 1996, EUR RESPIR J, V9, P1024, DOI 10.1183/09031936.96.09051024; Liu Ya-ke, 2010, Orthop Surg, V2, P134, DOI 10.1111/j.1757-7861.2010.00076.x; LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MATHESON NR, 1979, BIOCHEM BIOPH RES CO, V88, P402, DOI 10.1016/0006-291X(79)92062-X; Miller Alexandra C., 2007, Reviews on Environmental Health, V22, P75; MOGER WH, 1983, BIOL REPROD, V28, P528, DOI 10.1095/biolreprod28.3.528; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Ostergaard L, 2009, PROTEOMICS, V9, P4457, DOI 10.1002/pmic.200800130; Pawan K, 2007, BBA-GENE STRUCT EXPR, V1769, P117, DOI 10.1016/j.bbaexp.2006.12.005; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Rutledge AC, 2010, BIOCHEM CELL BIOL, V88, P251, DOI [10.1139/O09-168, 10.1139/o09-168]; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Schmechel DE, 2007, NEUROTOXICOLOGY, V28, P899, DOI 10.1016/j.neuro.2007.05.011; Schmitt J, 2012, BIOCHEM BIOPH RES CO, V418, P445, DOI 10.1016/j.bbrc.2012.01.036; Schuster BE, 2012, TOXICOL APPL PHARM, V265, P128, DOI 10.1016/j.taap.2012.08.025; SCHWARTZ L, 1945, J ALLERGY, V16, P51, DOI 10.1016/0021-8707(45)90040-2; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Simonsen LO, 2012, SCI TOTAL ENVIRON, V432, P210, DOI 10.1016/j.scitotenv.2012.06.009; STOKINGER H E, 1958, AMA Arch Ind Health, V17, P273; Sutto T. E., 2011, PRIORITIZATION ORAL; Takahara Y, 2006, WORLD J GASTROENTERO, V12, P6473, DOI 10.3748/wjg.v12.i40.6473; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; van der Voet GB, 2007, MIL MED, V172, P1002, DOI 10.7205/MILMED.172.9.1002; WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6	59	36	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83751	10.1371/journal.pone.0083751	http://dx.doi.org/10.1371/journal.pone.0083751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386269	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700063
J	Santini, D; Procopio, G; Porta, C; Ibrahim, T; Barni, S; Mazzara, C; Fontana, A; Berruti, A; Berardi, R; Vincenzi, B; Ortega, C; Ottaviani, D; Carteni, G; Lanzetta, G; Virzi, V; Santoni, M; Silvestris, N; Satolli, MA; Collova, E; Russo, A; Badalamenti, G; Fedeli, SL; Tanca, FM; Adamo, V; Maiello, E; Sabbatini, R; Felici, A; Cinieri, S; Tonini, G; Bracarda, S				Santini, Daniele; Procopio, Giuseppe; Porta, Camillo; Ibrahim, Toni; Barni, Sandro; Mazzara, Calogero; Fontana, Andrea; Berruti, Alfredo; Berardi, Rossana; Vincenzi, Bruno; Ortega, Cinzia; Ottaviani, Davide; Carteni, Giacomo; Lanzetta, Gaetano; Virzi, Vladimir; Santoni, Matteo; Silvestris, Nicola; Satolli, Maria Antonietta; Collova, Elena; Russo, Antonio; Badalamenti, Giuseppe; Fedeli, Stefano Luzi; Tanca, Francesca Maria; Adamo, Vincenzo; Maiello, Evaristo; Sabbatini, Roberto; Felici, Alessandra; Cinieri, Saverio; Tonini, Giuseppe; Bracarda, Sergio			Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey	PLOS ONE			English	Article							PROGRESSION-FREE SURVIVAL; CELL CARCINOMA; ZOLEDRONIC ACID; SKELETAL COMPLICATIONS; PAMIDRONATE; EFFICACY; EVENTS	Background: Bone metastasis represents an increasing clinical problem in advanced renal cell carcinoma (RCC) as disease-related survival improves. There are few data on the natural history of bone disease in RCC. Patients and methods: Data on clinicopathology, survival, skeletal-related events (SREs), and bone-directed therapies for 398 deceased RCC patients (286 male, 112 female) with evidence of bone metastasis were statistically analyzed. Results: Median time to bone metastasis was 25 months for patients without bone metastasis at diagnosis. Median time to diagnosis of bone metastasis by MSKCC risk was 24 months for good, 5 months for intermediate, and 0 months for poor risk. Median number of SREs/patient was one, and 71% of patients experienced at least one SRE. Median times to first, second, and third SRE were 2, 5, and 12 months, respectively. Median survival was 12 months after bone metastasis diagnosis and 10 months after first SRE. Among 181 patients who received zoledronic acid (ZOL), median time to first SRE was significantly prolonged versus control (n = 186) (3 months vs 1 month for control; P<0.05). Conclusions: RCC patients with bone metastasis are at continuous risk of SREs, and in this survey ZOL effectively reduced this risk.	[Santini, Daniele; Mazzara, Calogero; Vincenzi, Bruno; Virzi, Vladimir; Tonini, Giuseppe] Univ Campus Biomed, Dept Med Oncol, Rome, Italy; [Procopio, Giuseppe] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Porta, Camillo] Fdn IRCCS Policlin S Matteo, Pavia, Italy; [Ibrahim, Toni] Osteoncol & Rare Tumors Ctr, Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy; [Barni, Sandro] Treviglio & Caravaggio Hosp, Div Med Oncol, Treviglio, Italy; [Fontana, Andrea] Azienda Osped Univ Pisana, Ist Toscano Tumori, Div Med Oncol 2, Pisa, Italy; [Berruti, Alfredo] AOU San Luigi Gonzaga, Dept Clin & Biol Sci, Orbassano, Italy; [Berardi, Rossana] Univ Politecn Marche, AO Osped Riuniti, Clin Oncol Med, Ancona, Italy; [Ortega, Cinzia] Osped Mauriziano Umberto I Torino, Turin, Italy; [Ortega, Cinzia] Ist La Ric & La Cura Canc Candiolo, Turin, Italy; [Ottaviani, Davide] Presidio Sanit Gradenigo, Dept Med Oncol, Turin, Italy; [Carteni, Giacomo] Azienda Osped Rilievo Nazl A Cardarelli, Naples, Italy; [Lanzetta, Gaetano] INI, Grottaferrata, Italy; [Santoni, Matteo] Univ Ancona, Med Oncol Unit, Ancona, Italy; [Silvestris, Nicola] IRCCS Natl Canc Inst Giovanni Paolo II, Med Oncol Unit, Bari, Italy; [Satolli, Maria Antonietta] Azienda Osped Univ San Giovanni Battista Torino, COES, SC Oncol Med 1, Molinette, Italy; [Collova, Elena] Hosp Legnano, Div Med Oncol, Milan, Italy; [Russo, Antonio; Badalamenti, Giuseppe] Univ Palermo, Dept Surg & Oncol, Sect Med Oncol, Palermo, Italy; [Fedeli, Stefano Luzi] Azienda Osped Osped Riuniti Marche Nord, UOC Oncol, Presidio San Salvatore, Pesaro, Italy; [Tanca, Francesca Maria] Univ Cagliari, Dept Med Oncol, Cagliari, Italy; [Adamo, Vincenzo] Univ Messina, Unit Integrated Therapies Oncol, Dept Human Pathol, Messina, Italy; [Maiello, Evaristo] IRCCS Casa Sollievo Sofferenza, Oncol Unit, San Giovanni Rotondo, FG, Italy; [Sabbatini, Roberto] Univ Modena & Reggio Emilia, Div Oncol, Dipartimento Integrato Oncol & Ematol, Modena, Italy; [Felici, Alessandra] Regina Elena Inst Canc Res, Dept Med Oncol, Rome, Italy; [Cinieri, Saverio] Hosp Brindisi, Dept Med Oncol, Milan, Italy; [Cinieri, Saverio] Hosp Brindisi, Breast Unit, Milan, Italy; [Cinieri, Saverio] European Inst Oncol, Dept Med Oncol, Milan, Italy; [Bracarda, Sergio] Osped San Donato, Dept Oncol, USL 8, Arezzo, Italy	University Campus Bio-Medico - Rome Italy; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione San Matteo; IRCCS Meldola (IRST); Ospedale di Treviglio-Caravaggio; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Marche Polytechnic University; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Mauritian Umberto I Hospital; IRCCS Fondazione del Piemonte per l'Oncologia; Humanitas Hospital Gradenigo; Antonio Cardarelli Hospital; Marche Polytechnic University; IRCCS Istituto Tumori Bari Giovanni Paolo II; University of Palermo; University of Cagliari; University of Messina; IRCCS Casa Sollievo Della Sofferenza; Universita di Modena e Reggio Emilia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS European Institute of Oncology (IEO); IRCCS Policlinico San Donato	Silvestris, N (corresponding author), IRCCS Natl Canc Inst Giovanni Paolo II, Med Oncol Unit, Bari, Italy.	n.silvestris@oncologico.bari.it	Sabbatini, Roberto/AAC-5398-2022; Procopio, Giuseppe/K-2072-2016; Berardi, Rossana/AAC-5216-2022; Berardi, Rossana/AAC-5758-2022; SATOLLI, MARIA ANTONIETTA/AHE-0053-2022; Maiello, Evaristo/C-5224-2017; Silvestris, Nicola/K-5889-2012; Sabbatini, Roberto/AAC-5739-2022; Berruti, Alfredo/AAC-2069-2019; Porta, Camillo/AAB-9482-2020; GIACOMO, CARTENI/K-5810-2016	Sabbatini, Roberto/0000-0002-8943-7545; Procopio, Giuseppe/0000-0002-2498-402X; Berardi, Rossana/0000-0002-9529-2960; Maiello, Evaristo/0000-0003-3890-3435; Silvestris, Nicola/0000-0001-7814-7318; GIACOMO, CARTENI/0000-0003-1441-6376; FONTANA, ANDREA/0000-0003-2496-2506; Santoni, Matteo/0000-0001-7340-6173; CINIERI, Saverio/0000-0002-5555-0814; Vincenzi, Bruno/0000-0001-8222-9025; Porta, Camillo/0000-0003-2412-1563; Bracarda, Sergio/0000-0002-0703-2959; Tonini, Giuseppe/0000-0003-4442-8677; Santini, Daniele/0000-0002-9118-3337; Ibrahim, Toni/0000-0003-0259-4167	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	The authors thank Mithu Majumder, PhD, ProEd Communications, Inc., for medical editorial assistance with this manuscript. Funding for medical editorial assistance was provided by Novartis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Athar U, 2008, CAN J UROL, V15, P3954; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; Brown JE, 2009, ASCO 2009 GEN CANC S; European Medicines Agency, VOTR PAZ AUTH DET; FORBES GS, 1977, AM J ROENTGENOL, V129, P61, DOI 10.2214/ajr.129.1.61; Heng DYC, 2011, CANCER-AM CANCER SOC, V117, P2637, DOI 10.1002/cncr.25750; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Hutson TE, 2011, ONCOLOGIST, V16, P14, DOI 10.1634/theoncologist.2011-S2-14; Kankuri M, 2001, CANCER-AM CANCER SOC, V92, P761, DOI 10.1002/1097-0142(20010815)92:4<761::AID-CNCR1380>3.0.CO;2-#; Keizman D, 2012, EUR J CANCER, V48, P1031, DOI 10.1016/j.ejca.2012.02.050; Kinnane N, 2007, EUR J ONCOL NURS, V11, pS28, DOI 10.1016/j.ejon.2007.07.002; Lipton A, 2004, CLIN CANCER RES, V10, p6397S, DOI 10.1158/1078-0432.CCR-040030; Lipton A, 2003, CANCER, V98, P962, DOI 10.1002/cncr.11571; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Major P, 2001, J CLIN ONCOL, V19, P558, DOI 10.1200/JCO.2001.19.2.558; Major Pierre P, 2009, BMC Cancer, V9, P272, DOI 10.1186/1471-2407-9-272; Mortimer JE, 2010, SEMIN ONCOL, V37, pS66, DOI 10.1053/j.seminoncol.2010.06.006; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Mulders P, 2009, BJU INT, V104, P1585, DOI 10.1111/j.1464-410X.2009.08987.x; Rosen LS, 2003, J CLIN ONCOL, V21, P3150, DOI 10.1200/JCO.2003.04.105; Saad F, 2010, SEMIN ONCOL, V37, pS38, DOI 10.1053/j.seminoncol.2010.06.001; Smith Matthew R, 2005, Cancer Treat Rev, V31 Suppl 3, P19, DOI 10.1016/j.ctrv.2005.09.004; Szendroi A, 2010, PATHOL ONCOL RES, V16, P29, DOI 10.1007/s12253-009-9184-7; Woodward E, 2011, BONE, V48, P160, DOI 10.1016/j.bone.2010.09.008; Zekri J, 2001, INT J ONCOL, V19, P379	26	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83026	10.1371/journal.pone.0083026	http://dx.doi.org/10.1371/journal.pone.0083026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386138	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700023
J	Sastre, C; Rubio-Navarro, A; Buendia, I; Gomez-Guerrero, C; Blanco, J; Mas, S; Egido, J; Blanco-Colio, LM; Ortiz, A; Moreno, JA				Sastre, Cristina; Rubio-Navarro, Alfonso; Buendia, Irene; Gomez-Guerrero, Carmen; Blanco, Julia; Mas, Sebastian; Egido, Jesus; Miguel Blanco-Colio, Luis; Ortiz, Alberto; Antonio Moreno, Juan			Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; OXIDIZED LDL; DOWN-REGULATION; LIPOPROTEIN ABNORMALITIES; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; APOLIPOPROTEIN-E; HORMONE KLOTHO	Background: Klotho is a renal protein with anti-aging properties that is downregulated in conditions related to kidney injury. Hyperlipidemia accelerates the progression of renal damage, but the mechanisms of the deleterious effects of hyperlipidemia remain unclear. Methods: We evaluated whether hyperlipidemia modulates Klotho expression in kidneys from C57BL/6 and hyperlipidemic apolipoprotein E knockout (ApoE KO) mice fed with a normal chow diet (ND) or a Western-type high cholesterol-fat diet (HC) for 5 to 10 weeks, respectively. Results: In ApoE KO mice, the HC diet increased serum and renal cholesterol levels, kidney injury severity, kidney macrophage infiltration and inflammatory chemokine expression. A significant reduction in Klotho mRNA and protein expression was observed in kidneys from hypercholesteromic ApoE KO mice fed a HC diet as compared with controls, both at 5 and 10 weeks. In order to study the mechanism involved in Klotho down-regulation, murine tubular epithelial cells were treated with ox-LDL. Oxidized-LDL were effectively uptaken by tubular cells and decreased both Klotho mRNA and protein expression in a time-and dose-dependent manner in these cells. Finally, NF-kappa B and ERK inhibitors prevented ox-LDL induced Klotho downregulation. Conclusion: Our results suggest that hyperlipidemia-associated kidney injury decreases renal expression of Klotho. Therefore, Klotho could be a key element explaining the relationship between hyperlipidemia and aging with renal disease.	[Sastre, Cristina; Rubio-Navarro, Alfonso; Buendia, Irene; Gomez-Guerrero, Carmen; Mas, Sebastian; Egido, Jesus; Miguel Blanco-Colio, Luis; Ortiz, Alberto; Antonio Moreno, Juan] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Vasc & Renal Res Lab, Madrid, Spain; [Blanco, Julia] Hosp Clin San Carlos, Madrid, Spain; [Egido, Jesus] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital Clinico San Carlos	Moreno, JA (corresponding author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Vasc & Renal Res Lab, Madrid, Spain.	jamoreno@fjd.es	Mas, S/T-1489-2018; Blanco-Colio, Luis M./Z-2390-2019; Rubio, Alfonso/ABH-5028-2020; ortiz, alberto/Y-7582-2018; Moreno, Juan Antonio/B-3487-2018	Mas, S/0000-0001-6604-3327; Rubio, Alfonso/0000-0001-5677-3123; ortiz, alberto/0000-0002-9805-9523; Moreno, Juan Antonio/0000-0002-7468-2871; BUENDIA, IRENE/0000-0003-0593-1368; Blanco-Colio, Luis Miguel/0000-0002-1560-6609	FIS (Programa Miguel Servet) [CP10/00479]; ISCIII (Programa de Estabilizacion); PI10/00234; Fundacion Conchita Rabago; Ministry of Science [SAF2012/38830]; Sociedad Espanola de Nefrologia; ISCIII; FEDER [PS09/00447]; ISCIII-RETIC [REDinREN/RD06/0016]; Comunidad de Madrid [CIFRA/S2010/BMD-2378]; ISCIII-Redes RECAVA [RD06/0014/0035]; REDINREN [RD12/0021/]; European Network [HEALTH F2-2008-200647]; Euro Salud [EUS2005-03565]; cvREMOD; Fundacion Lilly; FRIAT; ISCIII fund [PI10/00072]	FIS (Programa Miguel Servet); ISCIII (Programa de Estabilizacion); PI10/00234; Fundacion Conchita Rabago; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Sociedad Espanola de Nefrologia; ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); ISCIII-Redes RECAVA; REDINREN; European Network; Euro Salud; cvREMOD; Fundacion Lilly; FRIAT; ISCIII fund	This work has been supported by grants from FIS (Programa Miguel Servet: CP10/00479) to JAM and ISCIII (Programa de Estabilizacion) and PI10/00234 to LMBC. Fundacion Conchita Rabago to CS and ARN. Ministry of Science (SAF2012/38830) and Sociedad Espanola de Nefrologia to CGG. ISCIII and FEDER funds PS09/00447, Sociedad Espanola de Nefrologia, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/CIFRA/S2010/BMD-2378 to AO, and ISCIII-Redes RECAVA (RD06/0014/0035) REDINREN (RD12/0021/), European Network (HEALTH F2-2008-200647), Euro Salud EUS2005-03565, cvREMOD, Fundacion Lilly, FRIAT and ISCIII fund PI10/00072 to JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 1996, AM J PHYSIOL-RENAL, V271, pF814, DOI 10.1152/ajprenal.1996.271.4.F814; Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Attman PO, 1999, KIDNEY INT, V56, pS14, DOI 10.1046/j.1523-1755.1999.07104.x; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Bentley MD, 2002, KIDNEY INT, V61, P1056, DOI 10.1046/j.1523-1755.2002.00211.x; Bosmans JL, 2001, KIDNEY INT, V59, P2346, DOI 10.1046/j.1523-1755.2001.00752.x; Catalan MPE, 2005, KIDNEY INT, V68, P1303; Chade AR, 2002, CIRCULATION, V106, P1165, DOI 10.1161/01.CIR.0000027105.02327.48; Chai YC, 1996, J BIOL CHEM, V271, P17791, DOI 10.1074/jbc.271.30.17791; Chien MW, 2003, J LIPID RES, V44, P1667, DOI 10.1194/jlr.M300006-JLR200; Choi BH, 2010, GENE, V450, P121, DOI 10.1016/j.gene.2009.11.004; Collins AJ, 2003, KIDNEY INT, V64, pS24, DOI 10.1046/j.1523-1755.64.s87.5.x; Drueke TB, 2001, KIDNEY INT, V59, pS114, DOI 10.1046/j.1523-1755.2001.59780114.x; Ha H, 2005, NEPHROLOGY, V10, pS7, DOI 10.1111/j.1440-1797.2005.00448.x; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Jing Q, 1999, CIRC RES, V84, P831; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Kuwahara N, 2008, INT J CARDIOL, V123, P84, DOI 10.1016/j.ijcard.2007.02.029; Lanske B, 2007, AGEING RES REV, V6, P73, DOI 10.1016/j.arr.2007.02.002; Lee HS, 1999, DIABETES RES CLIN PR, V45, P117, DOI 10.1016/S0168-8227(99)00040-6; Lopez-Franco O, 2006, ARTERIOSCL THROM VAS, V26, P1864, DOI 10.1161/01.ATV.0000229659.94020.53; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Malle E, 1997, AM J PATHOL, V150, P603; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Mas S, 2007, ANALYST, V132, P24, DOI 10.1039/b614619h; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Narumiya H, 2004, CARDIOVASC RES, V64, P331, DOI 10.1016/j.cardiores.2004.07.011; Oda H, 1997, KIDNEY INT, V52, pS36; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Prie D, 2005, CURR OPIN NEPHROL HY, V14, P318, DOI 10.1097/01.mnh.0000172716.41853.1e; Robbesyn F, 2004, FREE RADICAL RES, V38, P541, DOI 10.1080/10715760410001665244; Saito K, 2003, FEBS LETT, V551, P58, DOI 10.1016/S0014-5793(03)00894-9; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Samuelsson O, 1997, NEPHROL DIAL TRANSPL, V12, P1908, DOI 10.1093/ndt/12.9.1908; Scheuer H, 2000, AM J PHYSIOL-RENAL, V278, pF63, DOI 10.1152/ajprenal.2000.278.1.F63; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Stevens LA, 2010, ADV CHRONIC KIDNEY D, V17, P293, DOI 10.1053/j.ackd.2010.03.010; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P261, DOI 10.1016/j.bbrc.2009.11.046; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	53	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83713	10.1371/journal.pone.0083713	http://dx.doi.org/10.1371/journal.pone.0083713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386260	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700058
J	Danjon, F; Khuder, H; Stokes, A				Danjon, Frederic; Khuder, Hayfa; Stokes, Alexia			Deep Phenotyping of Coarse Root Architecture in R. pseudoacacia Reveals That Tree Root System Plasticity Is Confined within Its Architectural Model	PLOS ONE			English	Article							SHALLOW-SLOPE STABILITY; RESOURCE ACQUISITION; FRACTAL DIMENSIONS; PLANT ARCHITECTURE; YOUNG TREES; GROWTH; ANCHORAGE; SEEDLINGS; SIMULATION; ALLOCATION	This study aims at assessing the influence of slope angle and multi-directional flexing and their interaction on the root architecture of Robinia pseudoacacia seedlings, with a particular focus on architectural model and trait plasticity. 36 trees were grown from seed in containers inclined at 0 degrees (control) or 45 degrees (slope) in a glasshouse. The shoots of half the plants were gently flexed for 5 minutes a day. After 6 months, root systems were excavated and digitized in 3D, and biomass measured. Over 100 root architectural traits were determined. Both slope and flexing increased significantly plant size. Non-flexed trees on 45 degrees slopes developed shallow roots which were largely aligned perpendicular to the slope. Compared to the controls, flexed trees on 0 degrees slopes possessed a shorter and thicker taproot held in place by regularly distributed long and thin lateral roots. Flexed trees on the 45 degrees slope also developed a thick vertically aligned taproot, with more volume allocated to upslope surface lateral roots, due to the greater soil volume uphill. We show that there is an inherent root system architectural model, but that a certain number of traits are highly plastic. This plasticity will permit root architectural design to be modified depending on external mechanical signals perceived by young trees.	[Danjon, Frederic] INRA, BIOGECO UMR1202, Cestas, France; [Danjon, Frederic] Univ Bordeaux, BIOGECO UMR1202, Cestas, France; [Khuder, Hayfa] Univ Bordeaux, UMR 5295, Inst Mecan & Ingn Bordeaux I2M, Dept Genie Civil & Environm GCE, Bordeaux, France; [Stokes, Alexia] INRA, UMR AMAP Bot & Bioinformat Architecture Plantes, F-34060 Montpellier, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite de Bordeaux; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE	Danjon, F (corresponding author), INRA, BIOGECO UMR1202, Cestas, France.	frederic.danjon@pierroton.inra.fr		stokes, alexia/0000-0002-2276-0911	Syrian government	Syrian government	The PhD grant of H.Khuder was financed by the Syrian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBY WC, 1979, FOREST SCI, V25, P212; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Basu P, 2011, PLANT PHYSIOL, V155, P2056, DOI 10.1104/pp.110.168229; BERTHIER S, 2001, THESIS U BORDEAUX 1; BIDDINGTON NL, 1986, PLANT GROWTH REGUL, V4, P103, DOI 10.1007/BF00025193; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; Collet C, 2006, PLANT SOIL, V279, P367, DOI 10.1007/s11104-005-2419-9; COUTTS MP, 1991, NEW PHYTOL, V119, P227, DOI 10.1111/j.1469-8137.1991.tb01025.x; COUTTS MP, 1983, PLANT SOIL, V71, P171, DOI 10.1007/BF02182653; COUTTS MP, 1983, FORESTRY, V56, P1, DOI 10.1093/forestry/56.1.1; Danjon F, 1999, PLANT SOIL, V211, P241, DOI 10.1023/A:1004680824612; Danjon F, 1999, PLANT SOIL, V217, P49, DOI 10.1023/A:1004686119796; Danjon F, 2008, ANN BOT-LONDON, V101, P1281, DOI 10.1093/aob/mcm199; Danjon F, 2008, PLANT SOIL, V303, P1, DOI 10.1007/s11104-007-9470-7; Drexhage M, 1999, CAN J FOREST RES, V29, P600, DOI 10.1139/cjfr-29-5-600; Eis S., 1974, Canadian Journal of Forest Research, V4, P28, DOI 10.1139/x74-005; ENNOS AR, 1993, J THEOR BIOL, V161, P61, DOI 10.1006/jtbi.1993.1040; Eshel A, 1998, PLANT CELL ENVIRON, V21, P247, DOI 10.1046/j.1365-3040.1998.00252.x; Ferrari AE, 2007, BIOL FERT SOILS, V43, P471, DOI 10.1007/s00374-006-0125-2; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Fourcaud T, 2003, TREES-STRUCT FUNCT, V17, P31, DOI 10.1007/s00468-002-0203-5; Genet M, 2005, PLANT SOIL, V278, P1, DOI 10.1007/s11104-005-8768-6; Ghestem M, 2014, PLANT SOIL, V377, P43, DOI 10.1007/s11104-012-1572-1; Godin C, 1999, ANN BOT-LONDON, V84, P343, DOI 10.1006/anbo.1999.0923; Godin C, 1997, SILVA FENNICA, V31, P355, DOI DOI 10.14214/sf.a8533; Izumi Y, 1996, JPN J CROP SCI, V65, P303, DOI 10.1626/jcs.65.303; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; Jourdan C, 1995, PLANT SOIL, V177, P63, DOI 10.1007/BF00010338; KHUDER H, 2007, THESIS U BORDEAUX 1; Khuder H., 2006, P 5 PLANT BIOM C STO, P299; Khuder H, 2007, PLANT SOIL, V294, P87, DOI 10.1007/s11104-007-9232-6; Korndorfer CL, 2008, TREES-STRUCT FUNCT, V22, P835, DOI 10.1007/s00468-008-0244-5; Larjavaara M, 2012, AM J BOT, V99, P165, DOI 10.3732/ajb.1100324; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; Nicoll B, 1999, DEV PLANT SOIL SCI, V87, P61; Nicoll BC, 2006, TREES-STRUCT FUNCT, V20, P701, DOI 10.1007/s00468-006-0085-z; Nicoll BC, 2005, CAN J FOREST RES, V35, P2360, DOI [10.1139/x05-157, 10.1139/X05-157]; NICOLL BC, 1997, WIND WIND RELATED DA, P276; Oppelt AL, 2000, ANN FOREST SCI, V57, P463; Pages L, 2000, ANN FOR SCI, V57, P513; Perez FL, 2012, GEOMORPHOLOGY, V138, P29, DOI 10.1016/j.geomorph.2011.08.021; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; REES DJ, 1980, FORESTRY, V53, P155, DOI 10.1093/forestry/53.2.155; Reubens B, 2007, TREES-STRUCT FUNCT, V21, P385, DOI 10.1007/s00468-007-0132-4; Reubens B, 2009, TREES-STRUCT FUNCT, V23, P1213, DOI 10.1007/s00468-009-0360-x; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Scippa GS, 2006, ANN BOT-LONDON, V97, P857, DOI 10.1093/aob/mcj603; Smith VC, 2003, J EXP BOT, V54, P845, DOI 10.1093/jxb/erg068; Soethe N, 2007, ECOL MODEL, V207, P363, DOI 10.1016/j.ecolmodel.2007.05.007; Soethe N, 2006, PLANT SOIL, V279, P173, DOI 10.1007/s11104-005-1005-5; SPEK LY, 1994, PLANT SOIL, V164, P119, DOI 10.1007/BF00010117; STOKES A, 1995, J EXP BOT, V46, P1139, DOI 10.1093/jxb/46.9.1139; Stokes A, 1996, ANN BOT-LONDON, V78, P415, DOI 10.1006/anbo.1996.0137; Stokes A, 2012, J VEG SCI, V23, P325, DOI 10.1111/j.1654-1103.2011.01349.x; Tamasi E, 2005, TREES-STRUCT FUNCT, V19, P374, DOI 10.1007/s00468-004-0396-x; Telewski F. W., 1995, P237, DOI 10.1017/CBO9780511600425.015; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Tokgoz N, 2005, GEOTECH GEOL ENG, V23, P519, DOI 10.1007/s10706-004-8679-y; Tracy SR, 2012, ANN BOT-LONDON, V110, P511, DOI 10.1093/aob/mcs031	62	23	25	7	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83548	10.1371/journal.pone.0083548	http://dx.doi.org/10.1371/journal.pone.0083548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386227	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900045
J	Fichna, J; Wood, JT; Papanastasiou, M; Vadivel, SK; Oprocha, P; Salaga, M; Sobczak, M; Mokrowiecka, A; Cygankiewicz, AI; Zakrzewski, PK; Malecka-Panas, E; Krajewska, WM; Koscielniak, P; Makriyannis, A; Storr, MA				Fichna, Jakub; Wood, JodiAnne T.; Papanastasiou, Malvina; Vadivel, Subramanian K.; Oprocha, Piotr; Salaga, Maciej; Sobczak, Marta; Mokrowiecka, Anna; Cygankiewicz, Adam I.; Zakrzewski, Piotr K.; Malecka-Panas, Ewa; Krajewska, Wanda M.; Koscielniak, Piotr; Makriyannis, Alexandros; Storr, Martin A.			Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL MOTILITY; RECEPTOR IMMUNOREACTIVITY; PHARMACOGENETIC TRIAL; COLONIC MOTILITY; CB1 RECEPTORS; GUINEA-PIG; BLOCKADE; LOCALIZATION; ANANDAMIDE	Aims: Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder, associated with alterations of bowel function, abdominal pain and other symptoms related to the GI tract. Recently the endogenous cannabinoid system (ECS) was shown to be involved in the physiological and pathophysiological control of the GI function. The aim of this pilot study was to investigate whether IBS defining symptoms correlate with changes in endocannabinoids or cannabinoid like fatty acid levels in IBS patients. Methods: AEA, 2-AG, OEA and PEA plasma levels were determined in diarrhoea-predominant (IBS-D) and constipation-predominant (IBS-C) patients and were compared to healthy subjects, following the establishment of correlations between biolipid contents and disease symptoms. FAAH mRNA levels were evaluated in colonic biopsies from IBS-D and IBS-C patients and matched controls. Results: Patients with IBS-D had higher levels of 2AG and lower levels of OEA and PEA. In contrast, patients with IBS-C had higher levels of OEA. Multivariate analysis found that lower PEA levels are associated with cramping abdominal pain. FAAH mRNA levels were lower in patients with IBS-C. Conclusion: IBS subtypes and their symptoms show distinct alterations of endocannabinoid and endocannabinoid-like fatty acid levels. These changes may partially result from reduced FAAH expression. The here reported changes support the notion that the ECS is involved in the pathophysiology of IBS and the development of IBS symptoms.	[Fichna, Jakub; Storr, Martin A.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Fichna, Jakub; Storr, Martin A.] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB, Canada; [Fichna, Jakub; Salaga, Maciej; Sobczak, Marta] Med Univ Lodz, Fac Med, Dept Biomol Chem, Lodz, Poland; [Mokrowiecka, Anna; Malecka-Panas, Ewa] Med Univ Lodz, Fac Med, Dept Digest Tract Dis, Lodz, Poland; [Wood, JodiAnne T.; Papanastasiou, Malvina; Vadivel, Subramanian K.; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Oprocha, Piotr] AGH Univ Sci & Technol, Fac Appl Math, Krakow, Poland; [Cygankiewicz, Adam I.; Zakrzewski, Piotr K.; Krajewska, Wanda M.] Univ Lodz, Fac Biol & Environm Protect, Dept Cytobiochem, PL-90131 Lodz, Poland; [Koscielniak, Piotr] Jagiellonian Univ, Fac Math & Comp Sci, Krakow, Poland; [Storr, Martin A.] Univ Munich, Div Gastroenterol, Dept Med, Munich, Germany	University of Calgary; University of Calgary; Medical University Lodz; Medical University Lodz; Northeastern University; AGH University of Science & Technology; University of Lodz; Jagiellonian University; University of Munich	Storr, MA (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada.	Martin.Storr@med.uni-muenchen.de	Cygankiewicz, Adam/G-2776-2013; Mokrowiecka, Anna/S-9226-2016; Oprocha, Piotr/A-2099-2009; Koscielniak, Piotr/M-5190-2014; Krajewska, Wanda/AAD-6039-2021; Fichna, Jakub/S-6641-2016; Malecka-Panas, Ewa/AAV-8022-2021; Makriyannis, Alexandros/GRF-1518-2022	Cygankiewicz, Adam/0000-0001-5807-2654; Oprocha, Piotr/0000-0002-0261-7229; Krajewska, Wanda/0000-0002-1450-3712; Fichna, Jakub/0000-0002-8443-4417; Makriyannis, Alexandros/0000-0003-3272-3687; Zakrzewski, Piotr K./0000-0002-7205-8901; ZIELINSKA, MARTA/0000-0001-5939-791X; Malecka-Wojciesko, Ewa/0000-0002-1825-1807; Papanastasiou, Malvina/0000-0003-3378-6612; Mokrowiecka, Anna/0000-0001-9332-8088	University of Calgary Research Grant Committee; Iuventus Plus program of the Polish Ministry of Science and Higher Education [0119/IP1/2011/71, 0107/IP1/2013/72]; Deutsche Forschungsgemeinschaft [STO 645/6-1]	University of Calgary Research Grant Committee; Iuventus Plus program of the Polish Ministry of Science and Higher Education; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the University of Calgary Research Grant Committee (to MS), the Iuventus Plus program of the Polish Ministry of Science and Higher Education (0119/IP1/2011/71 and 0107/IP1/2013/72 to JF), and the Deutsche Forschungsgemeinschaft (STO 645/6-1 to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar A, 2009, ALIMENT PHARM THER, V30, P423, DOI 10.1111/j.1365-2036.2009.04056.x; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Brocato B, 2013, PLACENTA, V34, P983, DOI 10.1016/j.placenta.2013.08.007; Brusberg M, 2009, J NEUROSCI, V29, P1554, DOI 10.1523/JNEUROSCI.5166-08.2009; Camilleri M, 2008, AM J PHYSIOL-GASTR L, V294, pG13, DOI 10.1152/ajpgi.00371.2007; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Casu MA, 2003, EUR J PHARMACOL, V459, P97, DOI 10.1016/S0014-2999(02)02830-3; Cluny NL, 2009, NEUROGASTROENT MOTIL, V21, P420, DOI 10.1111/j.1365-2982.2008.01248.x; Coutts AA, 2002, J COMP NEUROL, V448, P410, DOI 10.1002/cne.10270; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Croxford JL, 2003, CNS DRUGS, V17, P179, DOI 10.2165/00023210-200317030-00004; Di Marzo V, 2001, Expert Opin Ther Targets, V5, P241; Esfandyari T, 2007, AM J PHYSIOL-GASTR L, V293, pG137, DOI 10.1152/ajpgi.00565.2006; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox A, 2005, EXPERT OPIN INV DRUG, V14, P695, DOI 10.1517/13543784.14.6.695; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; JONES R, 1992, BRIT MED J, V304, P87, DOI 10.1136/bmj.304.6819.87; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kulkarni-Narla A, 2000, CELL TISSUE RES, V302, P73, DOI 10.1007/s004410000261; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Li K, 2013, NEUROPHARMACOLOGY, V71, P255, DOI 10.1016/j.neuropharm.2013.03.029; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; MacNaughton WK, 2004, AM J PHYSIOL-GASTR L, V286, pG863, DOI 10.1152/ajpgi.00482.2003; Obata T, 2003, J CHROMATOGR B, V792, P131, DOI 10.1016/S1570-0232(03)00311-8; Pinto L, 2002, GASTROENTEROLOGY, V123, P227, DOI 10.1053/gast.2002.34242; Ramesh D, 2011, J PHARMACOL EXP THER, V339, P173, DOI 10.1124/jpet.111.181370; SANDLER RS, 1984, GASTROENTEROLOGY, V87, P314; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schlosburg JE, 2009, AAPS J, V11, P342, DOI 10.1208/s12248-009-9110-7; Slominski A. T., 2012, ADV ANATOMY EMBRYOLO, V212, P115, DOI DOI 10.1007/978-3-642-19683-6_1; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, pvii, Patent No. 22894052; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; TALLEY NJ, 1991, GASTROENTEROLOGY, V101, P927, DOI 10.1016/0016-5085(91)90717-Y; Ueda N, 2000, PROSTAG OTH LIPID M, V61, P19, DOI 10.1016/S0090-6980(00)00052-6; Williams J, 2007, ANAL CHEM, V79, P5582, DOI 10.1021/ac0624086; Wong BS, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01874.x; Wong BS, 2011, GASTROENTEROLOGY, V141, P1638, DOI 10.1053/j.gastro.2011.07.036; Wood JT, 2008, CLIN CHEM LAB MED, V46, P1289, DOI 10.1515/CCLM.2008.242	42	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85073	10.1371/journal.pone.0085073	http://dx.doi.org/10.1371/journal.pone.0085073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386448	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900122
J	Choi, J; Jeong, B; Lee, SW; Go, HJ				Choi, Jeewook; Jeong, Bumseok; Lee, Sang Won; Go, Hyo-Jin			Aberrant Development of Functional Connectivity among Resting State-Related Functional Networks in Medication-Naive ADHD Children	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; DEFAULT-MODE NETWORK; HUMAN BRAIN; ATTENTION; CHILDHOOD; ADOLESCENCE; DYSFUNCTION; COMPONENTS; CINGULATE; SYSTEMS	Objective: The aim of this study was to investigate the compromised developmental trajectory of the functional connectivity among resting-state-related functional networks (RSFNs) in medication-naive children with attention-deficit/hyperactivity disorder (ADHD). Subjects and Methods: Using both independent component analysis and dual regression, subject-specific time courses of 12 RSFNs were extracted from both 20 medication-naive children with ADHD, and 20 age and gender-matched control children showing typical development (TDC). Both partial correlation coefficients among the 12 RSFNs and a resting-state resource allocation index (rsRAI) of the salience network (SN) were entered into multiple linear regression analysis to investigate the compromised, age-related change in medication-naive ADHD children. Finally, correlation analyses were performed between the compromised RSFN connections showing significant group-by-age interaction and rsRAI of SN or clinical variables. Results: Medication-naive ADHD subjects failed to show age-related increment of functional connectivity in both rsRAI of SN and two RSFN connections, SN-Sensory/motor and posterior default mode/precuneus network (pDMN/prec) - anterior DMN. Lower SN-Sensory/motor connectivity was related with higher scores on the ADHD Rating Scale, and with poor scores on the continuous performance test. The pDMN/prec-aDMN connectivity was positively related with rsRAI of SN. Conclusions: Our results suggest that medication-naive ADHD subjects may have delayed maturation of the two functional connections, SN-Sensory/Motor and aDMN-pDMN/prec. Interventions that enhance the functional connectivity of these two connections may merit attention as potential therapeutic or preventive options in both ADHD and TDC.	[Choi, Jeewook; Go, Hyo-Jin] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Psychiat, Taejon, South Korea; [Jeong, Bumseok; Lee, Sang Won] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Clin Neurosci & Dev, Taejon 305701, South Korea	Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST)	Jeong, B (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Clin Neurosci & Dev, Taejon 305701, South Korea.	bs.jeong@kaist.ac.kr	Jeong, Bumseok/G-2722-2011	Jeong, Bumseok/0000-0001-6805-6535	National Research Foundation [NRF-2012R1A1A2001, NRF-2006-2005372]; Ministry of Education, Science and Technology [N01130009, N01130010, G04110085]	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants NRF-2012R1A1A2001 and NRF-2006-2005372 (to B. Jeong) from National Research Foundation, and in part by grant for KAIST Future Systems Healthcare Project from the Ministry of Education, Science and Technology (N01130009, N01130010, G04110085 to B. Jeong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Cho S-Z, 2000, J KOREAN ACAD CHILD, V11, P91; Cho SC, 2006, J KOREAN ACAD CHILD, V18, P138; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cortese S, 2013, BIOL PSYCHIAT; De Pisapia N, 2012, CEREB CORTEX, V22, P639, DOI 10.1093/cercor/bhr146; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; DuPaul G. J., 1998, ADHD RATING SCALE 4; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jeong B, 2012, KOREAN J RADIOL, V13, P265, DOI 10.3348/kjr.2012.13.3.265; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Makris N, 2008, CEREB CORTEX, V18, P1210, DOI 10.1093/cercor/bhm156; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Park K., 1996, DEV KEDI WISC INDIVI; Pavuluri MN, 2009, BIOL PSYCHIAT, V65, P586, DOI 10.1016/j.biopsych.2008.10.015; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Sato JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045671; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Shaw P, 2013, BIOL PSYCHIAT; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sun L, 2012, PSYCHIAT RES-NEUROIM, V201, P120, DOI 10.1016/j.pscychresns.2011.07.001; Supekar K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002374; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Wang X, 2013, EUR J RADIOL; 소유경, 2002, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V41, P283	54	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83516	10.1371/journal.pone.0083516	http://dx.doi.org/10.1371/journal.pone.0083516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386219	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700057
J	Eichel, JA; Wong, A; Fieguth, P; Clausi, DA				Eichel, Justin A.; Wong, Alexander; Fieguth, Paul; Clausi, David A.			Robust Spectral Clustering Using Statistical Sub-Graph Affinity Model	PLOS ONE			English	Article								Spectral clustering methods have been shown to be effective for image segmentation. Unfortunately, the presence of image noise as well as textural characteristics can have a significant negative effect on the segmentation performance. To accommodate for image noise and textural characteristics, this study introduces the concept of sub-graph affinity, where each node in the primary graph is modeled as a sub-graph characterizing the neighborhood surrounding the node. The statistical sub-graph affinity matrix is then constructed based on the statistical relationships between sub-graphs of connected nodes in the primary graph, thus counteracting the uncertainty associated with the image noise and textural characteristics by utilizing more information than traditional spectral clustering methods. Experiments using both synthetic and natural images under various levels of noise contamination demonstrate that the proposed approach can achieve improved segmentation performance when compared to existing spectral clustering methods.	[Eichel, Justin A.; Wong, Alexander; Fieguth, Paul; Clausi, David A.] U Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada		Eichel, JA (corresponding author), U Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada.	jaeichel@uwaterloo.ca	Wong, Alexander/GZM-2929-2022; Clausi, David A/J-4613-2013	Wong, Alexander/0000-0002-5295-2797; 	Natural Sciences and Engineering Research Council (NSERC) of Canada; Ontario Ministry of Research and Innovation; Canada Research Chairs program	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canada Research Chairs program(Canada Research Chairs)	The study was funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Ontario Ministry of Research and Innovation. This research was undertaken, in part, thanks to funding from the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingxiang Liu, 2011, 2011 Proceedings of IEEE International Conference on Computer Science and Automation Engineering (CSAE), P550, DOI 10.1109/CSAE.2011.5953280; Carcassoni M, 2003, IEEE T PATTERN ANAL, V25, P1609, DOI 10.1109/TPAMI.2003.1251153; Carcassoni M, 2003, PATTERN RECOGN, V36, P193, DOI 10.1016/S0031-3203(02)00054-7; Chung F., 1997, SPECTRAL GRAPH THEOR; Ge B, 2010, SPIE MED IMAGING; Luo B, 2003, PATTERN RECOGN, V36, P2213, DOI 10.1016/S0031-3203(03)00084-0; Malik J, 2001, INT J COMPUT VISION, V43, P7, DOI 10.1023/A:1011174803800; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mohar B, 1997, NATO ADV SCI I C-MAT, V497, P225; Mohar B., 1991, GRAPH THEORY COMBINA, V2, P871898; Ng AY, 2002, ADV NEUR IN, V14, P849; Pardo A, 2011, PATTERN RECOGN LETT, V32, P2145, DOI 10.1016/j.patrec.2011.06.022; Perona P., 1998, Computer Vision - ECCV'98. 5th European Conference on Computer Vision. Proceedings, P655, DOI 10.1007/BFb0055696; Schoenmakers R.P.H.M., 1995, INTEGRATED METHODOLO; Scott G. L., 1990, BMVC90 Proceedings of the British Machine Vision Conference, P103; Shi Hong, 2010, 2010 5th International Conference on Computer Science & Education (ICCSE 2010), P1760, DOI 10.1109/ICCSE.2010.5593834; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Sundaram N., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P475, DOI 10.1109/ICCVW.2011.6130281; Tilton JC, 1998, INT GEOSCI REMOTE SE, P1766, DOI 10.1109/IGARSS.1998.703645; von Luxburg U, 2006, TECHNICAL REPORT; Xiang T, 2008, PATTERN RECOGN, V41, P1012, DOI 10.1016/j.patcog.2007.07.023; Zelnik-Manor L., 2004, ADV NEURAL INFORM PR, V17; Zhang XR, 2008, IEEE T GEOSCI REMOTE, V46, P2126, DOI 10.1109/TGRS.2008.918647	23	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82722	10.1371/journal.pone.0082722	http://dx.doi.org/10.1371/journal.pone.0082722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386111	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700014
J	Johnstone, JF; Henkelman, J; Allen, K; Helgason, W; Bedard-Haughn, A				Johnstone, Jill F.; Henkelman, Jonathan; Allen, Kirsten; Helgason, Warren; Bedard-Haughn, Angela			Controlled Soil Warming Powered by Alternative Energy for Remote Field Sites	PLOS ONE			English	Article							OPEN-TOP CHAMBERS; CLIMATE-CHANGE; NITROGEN MINERALIZATION; TERRESTRIAL ECOSYSTEMS; PLANT PERFORMANCE; RESPONSES; TEMPERATURE; TUNDRA; GROWTH; COMMUNITY	Experiments using controlled manipulation of climate variables in the field are critical for developing and testing mechanistic models of ecosystem responses to climate change. Despite rapid changes in climate observed in many high latitude and high altitude environments, controlled manipulations in these remote regions have largely been limited to passive experimental methods with variable effects on environmental factors. In this study, we tested a method of controlled soil warming suitable for remote field locations that can be powered using alternative energy sources. The design was tested in high latitude, alpine tundra of southern Yukon Territory, Canada, in 2010 and 2011. Electrical warming probes were inserted vertically in the near-surface soil and powered with photovoltaics attached to a monitoring and control system. The warming manipulation achieved a stable target warming of 1.3 to 2 degrees C in 1 m(2) plots while minimizing disturbance to soil and vegetation. Active control of power output in the warming plots allowed the treatment to closely match spatial and temporal variations in soil temperature while optimizing system performance during periods of low power supply. Active soil heating with vertical electric probes powered by alternative energy is a viable option for remote sites and presents a low-disturbance option for soil warming experiments. This active heating design provides a valuable tool for examining the impacts of soil warming on ecosystem processes.	[Johnstone, Jill F.; Henkelman, Jonathan; Allen, Kirsten] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Henkelman, Jonathan; Bedard-Haughn, Angela] Univ Saskatchewan, Dept Soil Sci, Saskatoon, SK S7N 0W0, Canada; [Helgason, Warren] Univ Saskatchewan, Dept Chem & Biol Engn, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Johnstone, JF (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	jill.johnstone@usask.ca	Johnstone, Jill F./C-9204-2009	Johnstone, Jill F./0000-0001-6131-9339; Helgason, Warren/0000-0002-7068-5717; Bedard-Haughn, Angela/0000-0002-3971-8509	Natural Science and Engineering Research Council; Canadian Foundation for Innovation	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	Research activities were supported by grants from the Natural Science and Engineering Research Council and Canadian Foundation for Innovation to JFJ. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aerts R, 2006, PLANT ECOL, V182, P65, DOI 10.1007/s11258-005-9031-1; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Bergh J, 1999, GLOB CHANGE BIOL, V5, P245, DOI 10.1046/j.1365-2486.1999.00205.x; Bokhorst S, 2013, GLOBAL CHANGE BIOL, V19, P64, DOI 10.1111/gcb.12028; Callaghan TV, 2011, AMBIO, V40, P705, DOI 10.1007/s13280-011-0179-8; Canadian Agricultural Services Coordinating Committee, 1998, CAN SYST SOIL CLASS; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Dabros A, 2010, PLANT SOIL, V333, P203, DOI 10.1007/s11104-010-0336-z; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Emmett BA, 2004, ECOSYSTEMS, V7, P625, DOI 10.1007/s10021-004-0220-x; Grogan P, 2004, SOIL BIOL BIOCHEM, V36, P641, DOI 10.1016/j.soilbio.2003.12.007; Gugerli F, 2001, BOT HELV, V111, P169; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Hartley AE, 1999, OIKOS, V86, P331, DOI 10.2307/3546450; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hofgaard A, 2010, PLANT ECOL DIVERS, V3, P19, DOI 10.1080/17550871003717016; Hollister RD, 2006, ARCT ANTARCT ALP RES, V38, P206, DOI 10.1657/1523-0430(2006)38[206:STATRT]2.0.CO;2; Ibanez I, 2006, ECOLOGY, V87, P1896, DOI 10.1890/0012-9658(2006)87[1896:PBCOTC]2.0.CO;2; Ineson P, 1998, GLOB CHANGE BIOL, V4, P153, DOI 10.1046/j.1365-2486.1998.00119.x; Janowicz JR., 1999, WATER RESOUR DIV IND, V1, P121; Jonasson S, 1999, ECOLOGY, V80, P1828, DOI 10.1890/0012-9658(1999)080[1828:RIMAPT]2.0.CO;2; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Li JW, 2013, SOIL BIOL BIOCHEM, V66, P204, DOI 10.1016/j.soilbio.2013.07.018; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Michelsen A, 2012, AMBIO, V41, P218, DOI 10.1007/s13280-012-0303-4; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Pieper SJ, 2011, ARCT ANTARCT ALP RES, V43, P442, DOI 10.1657/1938-4246-43.3.442; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; R Development Core Team, 2012, R LANG ENV STAT COMP; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Rustad LE, 2006, PLANT ECOL, V182, P43, DOI 10.1007/s11258-005-9030-2; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Solomon S., 2007, PHYS SCI BASIS WORKI; Stenstrom A, 2004, NORD J BOT, V24, P355, DOI 10.1111/j.1756-1051.2004.tb00850.x; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Zuur Alain F., 2009, P1	38	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82903	10.1371/journal.pone.0082903	http://dx.doi.org/10.1371/journal.pone.0082903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386125	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700019
J	Lonskaya, I; Desforges, NM; Hebron, ML; Moussa, CEH				Lonskaya, Irina; Desforges, Nicole M.; Hebron, Michaeline L.; Moussa, Charbel E-H.			Ubiquitination Increases Parkin Activity to Promote Autophagic alpha-Synuclein Clearance	PLOS ONE			English	Article							DISEASE INSIGHTS; PROTEIN LIGASE; LEWY BODIES; MUTATIONS; PHOSPHORYLATION; MITOCHONDRIA; BETA; ACCUMULATION; DEGRADATION; ASSOCIATION	Parkinson's disease (PD) is a movement disorder associated with genetic and age related causes. Although autosomal recessive early onset PD linked to parkin mutations does not exhibit alpha-Synuclein accumulation, while autosomal dominant and sporadic PD manifest with alpha-Synuclein inclusions, loss of dopaminergic substantia nigra neurons is a common denominator in PD. Here we show that decreased parkin ubiquitination and loss of parkin stability impair interaction with Beclin-1 and alter alpha-Synuclein degradation, leading to death of dopaminergic neurons. Tyrosine kinase inhibition increases parkin ubiquitination and interaction with Beclin-1, promoting autophagic alpha-Synuclein clearance and nigral neuron survival. However, loss of parkin via deletion increases alpha-Synuclein in the blood compared to the brain, suggesting that functional parkin prevents alpha-Synuclein release into the blood. These studies demonstrate that parkin ubiquitination affects its protein stability and E3 ligase activity, possibly leading to alpha-Synuclein sequestration and subsequent clearance.	[Lonskaya, Irina; Desforges, Nicole M.; Hebron, Michaeline L.; Moussa, Charbel E-H.] Georgetown Univ, Med Ctr, Lab Dementia & Parkinsonism, Dept Neurosci, Washington, DC 20007 USA	Georgetown University	Moussa, CEH (corresponding author), Georgetown Univ, Med Ctr, Lab Dementia & Parkinsonism, Dept Neurosci, Washington, DC 20007 USA.	cem46@georgetown.edu			NIH [NIA 30378]; Georgetown University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown University	These studies were supported by NIH grant NIA 30378 and Georgetown University funding to Charbel E-H Moussa. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Hebron ML, 2013, J BIOL CHEM, V288, P4103, DOI 10.1074/jbc.M112.419945; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Herman AM, 2011, AUTOPHAGY, V7, P919, DOI 10.4161/auto.7.8.15814; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Khandelwal PJ, 2011, HUM MOL GENET, V20, P2091, DOI 10.1093/hmg/ddr091; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2009, J NEUROCHEM, V110, P613, DOI 10.1111/j.1471-4159.2009.06152.x; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lonskaya I, 2013, NEUROSCIENCE, V232, P90, DOI 10.1016/j.neuroscience.2012.12.018; Lonskaya I, 2013, EMBO MOL MED; Lonskaya I, 2012, J ALZHEIMERS DIS; Lonskaya I, 2013, EMBO MOL MED, V5, P1247, DOI 10.1002/emmm.201302771; Lonskaya I, 2013, J ALZHEIMERS DIS, V33, P231, DOI 10.3233/JAD-2012-121141; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Mollenhauer B, 2012, J NEURAL TRANSM, V119, P739, DOI 10.1007/s00702-012-0784-0; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587; Reynolds AD, 2008, J NEUROIMMUNE PHARM, V3, P59, DOI 10.1007/s11481-008-9100-z; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rodriguez-Navarro JA, 2008, HUM MOL GENET, V17, P3128, DOI 10.1093/hmg/ddn210; Rosen KM, 2010, J NEUROSCI RES, V88, P167, DOI 10.1002/jnr.22178; Sasaki S, 2004, NEUROLOGY, V63, P678, DOI 10.1212/01.WNL.0000134657.25904.0B; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winslow AR, 2011, AUTOPHAGY, V7, P429, DOI 10.4161/auto.7.4.14393; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66	61	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83914	10.1371/journal.pone.0083914	http://dx.doi.org/10.1371/journal.pone.0083914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386307	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700087
J	Nettersheim, D; Heukamp, LC; Fronhoffs, F; Grewe, MJ; Haas, N; Waha, A; Honecker, F; Waha, A; Kristiansen, G; Schorle, H				Nettersheim, Daniel; Heukamp, Lukas C.; Fronhoffs, Florian; Grewe, Marc J.; Haas, Natalie; Waha, Anke; Honecker, Friedemann; Waha, Andreas; Kristiansen, Glen; Schorle, Hubert			Analysis of TET Expression/Activity and 5mC Oxidation during Normal and Malignant Germ Cell Development	PLOS ONE			English	Article							MOUSE PREIMPLANTATION DEVELOPMENT; ACTIVE DNA DEMETHYLATION; CARCINOMA-IN-SITU; MAMMALIAN DNA; STEM-CELLS; 5-HYDROXYMETHYLCYTOSINE; LINE; TUMORS; DIFFERENTIATION; METHYLATION	During mammalian development the fertilized zygote and primordial germ cells lose their DNA methylation within one cell cycle leading to the concept of active DNA demethylation. Recent studies identified the TET hydroxylases as key enzymes responsible for active DNA demethylation, catalyzing the oxidation of 5-methylcytosine to 5-hydroxymethylcytosine. Further oxidation and activation of the base excision repair mechanism leads to replacement of a modified cytosine by an unmodified one. In this study, we analyzed the expression/activity of TET1-3 and screened for the presence of 5-mC oxidation products in adult human testis and in germ cell cancers. By analyzing human testis sections, we show that levels of 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine are decreasing as spermatogenesis proceeds, while 5-methylcytosine levels remain constant. These data indicate that during spermatogenesis active DNA demethylation becomes downregulated leading to a conservation of the methylation marks in mature sperm. We demonstrate that all carcinoma in situ and the majority of seminomas are hypomethylated and hypohydroxymethylated compared to non-seminomas. Interestingly, 5-formylcytosine and 5-carboxylcytosine were detectable in all germ cell cancer entities analyzed, but levels did not correlate to the 5-methylcytosine or 5-hydroxymethylcytosine status. A meta-analysis of gene expression data of germ cell cancer tissues and corresponding cell lines demonstrates high expression of TET1 and the DNA glycosylase TDG, suggesting that germ cell cancers utilize the oxidation pathway for active DNA demethylation. During xenograft experiments, where seminoma-like TCam-2 cells transit to an embryonal carcinoma-like state DNMT3B and DNMT3L where strongly upregulated, which correlated to increasing 5-methylcytosine levels. Additionally, 5-hydroxymethylcytosine levels were elevated, demonstrating that de novo methylation and active demethylation accompanies this transition process. Finally, mutations of IDH1 (IDH1(R132)) and IDH2 (IDH2(R172)) leading to production of the TET inhibiting oncometabolite 2-hydroxyglutarate in germ cell cancer cell lines were not detected.	[Nettersheim, Daniel; Haas, Natalie; Schorle, Hubert] Univ Hosp, Dept Dev Pathol, Inst Pathol, Bonn, Germany; [Heukamp, Lukas C.; Fronhoffs, Florian; Grewe, Marc J.; Kristiansen, Glen] Univ Hosp, Inst Pathol, Bonn, Germany; [Waha, Anke; Waha, Andreas] Univ Hosp, Inst Neuropathol, Bonn, Germany; [Honecker, Friedemann] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Sect Pneumol, Dept Oncol Haematol & Bone Marrow Transplantat, Hamburg, Germany	University of Bonn; University of Bonn; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schorle, H (corresponding author), Univ Hosp, Dept Dev Pathol, Inst Pathol, Bonn, Germany.	Hubert.Schorle@ukb.uni-bonn.de	Nettersheim, Daniel/M-9249-2013; Schorle, Hubert/M-5001-2016; Schorle, Hubert/S-1713-2019; Heukamp, Lukas/G-9967-2012	Nettersheim, Daniel/0000-0002-4483-845X; Schorle, Hubert/0000-0001-8272-0076; Heukamp, Lukas/0000-0002-3388-3482	DFG [Scho-503/9]; Deutsche Krebshilfe [108249]; National Genome Research Network, "NGFNplus", Brain Tumor Network [01GS08187]	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); National Genome Research Network, "NGFNplus", Brain Tumor Network	This work was supported by DFG grant Scho-503/9 and Deutsche Krebshilfe # 108249 to HS and the National Genome Research Network, "NGFNplus", Brain Tumor Network plus grant 01GS08187 to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2005, BRIT J CANCER, V92, P1934, DOI 10.1038/sj.bjc.6602560; ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; ANDREWS PW, 1984, LAB INVEST, V50, P147; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; Biermann Katharina, 2007, Cancer Genomics & Proteomics, V4, P359; Biermann K, 2007, ANTICANCER RES, V27, P3091; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; BRONSON DL, 1980, CANCER RES, V40, P2500; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Gong ZZ, 2011, CELL RES, V21, P1649, DOI 10.1038/cr.2011.140; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; HIRAOKA A, 1988, CANCER INVEST, V6, P393, DOI 10.3109/07357908809080067; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Manning M, 2001, UROL INT, V67, P151, DOI 10.1159/000050972; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; Mochizuki K, 2010, DEV GROWTH DIFFER, V52, P517, DOI 10.1111/j.1440-169X.2010.01190.x; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Mueller T, 2006, TUMOR BIOL, V27, P71, DOI 10.1159/000092324; Muller T, 2012, AM J PATHOL, V181, P675, DOI 10.1016/j.ajpath.2012.04.017; Muller T, 2012, AM J PATHOL; Nettersheim D, 2011, INT J ANDROL, V34, pE189, DOI 10.1111/j.1365-2605.2011.01172.x; Nettersheim D, 2012, GENE CHROMOSOME CANC, V51, P717, DOI 10.1002/gcc.21958; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; PATTILLO RA, 1972, J CLIN ENDOCR METAB, V34, P59, DOI 10.1210/jcem-34-1-59; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHLAPPACK OK, 1988, EUR J CANCER CLIN ON, V24, P777, DOI 10.1016/0277-5379(88)90314-8; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; VOGELZANG NJ, 1985, CANCER, V55, P2584, DOI 10.1002/1097-0142(19850601)55:11<2584::AID-CNCR2820551110>3.0.CO;2-B; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang H, 2012, ONCOGENE; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	59	59	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82881	10.1371/journal.pone.0082881	http://dx.doi.org/10.1371/journal.pone.0082881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386123	Green Published, gold			2022-12-27	WOS:000329116700018
J	Ni, F; Long, X; Wan, H; Gao, XP				Ni, Fan; Long, Xiang; Wan, Han; Gao, Xiaopeng			Combining Instruction Prefetching with Partial Cache Locking to Improve WCET in Real-Time Systems	PLOS ONE			English	Article								Caches play an important role in embedded systems to bridge the performance gap between fast processor and slow memory. And prefetching mechanisms are proposed to further improve the cache performance. While in real-time systems, the application of caches complicates the Worst-Case Execution Time (WCET) analysis due to its unpredictable behavior. Modern embedded processors often equip locking mechanism to improve timing predictability of the instruction cache. However, locking the whole cache may degrade the cache performance and increase the WCET of the real-time application. In this paper, we proposed an instruction-prefetching combined partial cache locking mechanism, which combines an instruction prefetching mechanism (termed as BBIP) with partial cache locking to improve the WCET estimates of real-time applications. BBIP is an instruction prefetching mechanism we have already proposed to improve the worst-case cache performance and in turn the worst-case execution time. The estimations on typical real-time applications show that the partial cache locking mechanism shows remarkable WCET improvement over static analysis and full cache locking.	[Ni, Fan; Long, Xiang; Wan, Han; Gao, Xiaopeng] Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China	Beihang University	Wan, H (corresponding author), Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China.	wanhan@buaa.edu.cn	Ni, Fan/AAD-8379-2019		State Key Laboratory of Software Development Environment in BUAA grant [SKLSDE-2009ZX-02]; Chinese National 863 program [2007AA01Z183]; fundamental research funds for the Central Universities [YWF-13-B04-002]	State Key Laboratory of Software Development Environment in BUAA grant; Chinese National 863 program; fundamental research funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the fund of the State Key Laboratory of Software Development Environment in BUAA grant SKLSDE-2009ZX-02 and the Chinese National 863 program grant 2007AA01Z183. This research was supported by the fundamental research funds for the Central Universities (Project No. YWF-13-B04-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio LC, 2011, J SYST ARCHITECT, V57, P695, DOI 10.1016/j.sysarc.2010.08.008; Aparicio LC, 2010, IEEE INT CONF EMBED, P319, DOI 10.1109/RTCSA.2010.8; Arnaud A., 2006, P 14 INT C REAL TIM; ARNOLD R, 1994, REAL TIM SYST SYMP P, P172, DOI 10.1109/REAL.1994.342718; Buck B, 2000, INT J HIGH PERFORM C, V14, P317, DOI 10.1177/109434200001400404; Burger D, 1997, 1342 U WISC MAD COMP; Campoy AM, 2005, EUROMICRO, P49; Ding HP, 2012, DES AUT CON, P412; Ding Huping, 2013, DES AUT C, P147; Ding Y, 2009, J COMPUTING SCI ENG, V3, P59; Falk H., 2007, 2007 5th IEEE/ACM/IFIP International Conference on Hardware/Software Codesign and System Synthesis (CODES+ISSS), P143; LEE M, 1994, MICROPROC MICROPROG, V40, P681, DOI 10.1016/0165-6074(94)90017-5; Li X, 2007, SCI COMPUT PROGRAM, V69, P56, DOI 10.1016/j.scico.2007.01.014; Li XF, 2006, REAL-TIME SYST, V34, P195, DOI 10.1007/s11241-006-9205-5; Liang Y, 2010, DES AUT CON, P344; Liu TT, 2012, REAL-TIME SYST, V48, P166, DOI 10.1007/s11241-011-9139-4; Liu TT, 2009, 15TH IEEE REAL-TIME AND EMBEDDED TECHNOLOGY AND APPLICATION SYMPOSIUM: RTAS 2009, PROCEEDINGS, P35, DOI 10.1109/RTAS.2009.11; Ni F, 2012, 13 INT C PAR DISTR C, P459; OriginLab, 2012, DAT AN GRAPH SOFTW; Puaut I, 2002, REAL TIM SYST SYMP P, P114, DOI 10.1109/REAL.2002.1181567; Puaut I., 2006, P ECRTS; Robertson J, 2006, APPL NOTE; Sascha Plazar J. C. K., 2012, P 10 INT S COD GEN O, P44, DOI DOI 10.1145/2259016.2259023; Yan J, 2007, ACM SIGPLAN NOTICES, V42, P175, DOI 10.1145/1273444.1254801	24	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82975	10.1371/journal.pone.0082975	http://dx.doi.org/10.1371/journal.pone.0082975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386133	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700023
J	Zhuang, ZH; Yang, DB; Huang, YL; Wang, SH				Zhuang, Zhenhong; Yang, Daibin; Huang, Yaling; Wang, Shihua			Study on the Apoptosis Mechanism Induced by T-2 Toxin	PLOS ONE			English	Article							CELL-DEATH; TOPICAL APPLICATION; EXPRESSION; CANCER; P53; DNA; MYCOTOXIN; PROTEINS; KINETICS; PATHWAY	T-2 toxin is known to induce apoptosis in mammalian cells. The mechanism of apoptosis induced by T-2 toxin has been proposed to be linked with oxidative stress and mitochondrial pathway. In the current study, the toxic effect of T-2 on Hela, Bel-7402, and Chang liver cells was examined in dose-dependent and time-dependent manner by MTT assay. Caspase-3 was found to be up-regulated under T-2 toxin stress, which suggested that T-2 toxin induced cell apoptosis. Endogenous GSH and MDA levels in all three cell lines were found down-and up-regulated respectively, which indicated the link between toxic effect of T-2 toxin and intracellular oxidative stress. It was also found by MTT assay that NAC, which maintained the level of GSH in cells, could protect cells from death. Western-blot result showed that the level of both activated Caspase-8 and Caspase-9 increased when cells were treated by T-2 toxin. Caspase-9 was found to be activated earlier than Caspase-8. It was also found that p53 was up-regulated under T-2 toxin stress in the study. These results implied that the effect of T-2 toxin on cells was apoptosis rather than necrosis, and it was probably induced through mitochondrial pathway. To the best of our knowledge, the present study is the first to show that JunD is down-regulated in T-2 toxin induced apoptosis. By construction of an over-expression vector for the JunD gene, we observed that the survival ratio of JunD over-expressed cells obviously increased under T-2 toxin stress. These results suggested that the mechanism of T-2 induced cell death was closely connected with oxidative stress, and that JunD plays an important role in the defensive process against T-2 toxin stress.	[Wang, Shihua] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Key Lab Pathogen Fungi & Mycotoxins Fujian Prov, Fuzhou, Peoples R China; Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Key Lab Pathogen Fungi & Mycotoxins Fujian Prov, Fuzhou, Peoples R China.	wshyyl@sina.com			National Natural Science Fund [31000961, 31172297]; Nature Science Foundation of Fujian Province [2010J01068, 2009J06008]; Subsidizing Program for Provincial Universities of Department of Education of Fujian Province [JK2010022]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Subsidizing Program for Provincial Universities of Department of Education of Fujian Province	This work was supported by the National Natural Science Fund Project (31000961, 31172297)(http://isis.nsfc.gov.cn/); the Nature Science Foundation of Fujian Province (2010J01068, 2009J06008) (http://xmgl.fjkjt.gov.cn/); Subsidizing Program for Provincial Universities of Department of Education of Fujian Province (JK2010022) (http://kj.fjedu.gov.cn/html/NewsView-433.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarenque SM, 2001, EXP TOXICOL PATHOL, V52, P553, DOI 10.1016/S0940-2993(01)80016-6; BAMBURG JR, 1968, TETRAHEDRON, V24, P3329, DOI 10.1016/S0040-4020(01)92631-6; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; BOS JL, 1989, CANCER RES, V49, P4682; Bouaziz C, 2006, TOXICON, V48, P343, DOI 10.1016/j.toxicon.2006.06.004; Canady RA, 2001, WHO FOOD ADDITIVE SE, V47; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; CHANG IM, 1988, TOXICOL LETT, V40, P275, DOI 10.1016/0378-4274(88)90051-3; Chaudhari M, 2009, TOXICOLOGY, V262, P153, DOI 10.1016/j.tox.2009.06.002; Chen JH, 2008, J ZHEJIANG UNIV-SC B, V9, P455, DOI 10.1631/jzus.B0820013; Coureuil M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012134; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; Fandrey J, 2000, ADV EXP MED BIOL, V475, P153; Fang HQ, 2012, APOPTOSIS, V17, P895, DOI 10.1007/s10495-012-0724-3; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073004; Frank AK, 2011, CANCER BIOL THER, V11, P740, DOI 10.4161/cbt.11.8.14906; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; He SJ, 2012, J APPL TOXICOL, V32, P980, DOI 10.1002/jat.1697; Islam Z, 1998, TOXICOL APPL PHARM, V148, P205, DOI 10.1006/taap.1997.8338; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Ji Y, 2012, CURR ONCOL, V19, pES1, DOI 10.3747/co.19.1139; Knowles HJ, 2003, CANCER RES, V63, P1764; Lallemand D, 1997, ONCOGENE, V14, P819, DOI 10.1038/sj.onc.1200901; LUTSKY I, 1981, LAB ANIM SCI, V31, P43; MAGNUSON BA, 1987, CAN J PHYSIOL PHARM, V65, P799, DOI 10.1139/y87-128; Martinez-Palacian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053108; Mendivil-Perez M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/313275; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; Shinozuka J, 1997, EXP TOXICOL PATHOL, V49, P387, DOI 10.1016/S0940-2993(97)80124-8; Souza CO, 2012, BBA-GEN SUBJECTS, V1820, P1867, DOI 10.1016/j.bbagen.2012.08.013; STANFORD GK, 1975, RES COMMUN CHEM PATH, V10, P743; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tang X, 2011, ACTA BIOCH BIOPH SIN, V43, P779, DOI 10.1093/abbs/gmr073; THOMPSON WL, 1990, TOXICOL APPL PHARM, V105, P483, DOI 10.1016/0041-008X(90)90151-J; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Wang X, 2012, TOXICOL SCI, V127, P412, DOI 10.1093/toxsci/kfs106; WILLIAMS PP, 1989, ARCH ENVIRON CON TOX, V18, P374, DOI 10.1007/BF01062362; Wu J, 2011, TOXICOL LETT, V202, P168, DOI 10.1016/j.toxlet.2011.01.029; YAGEN B, 1993, DRUG METAB REV, V25, P281, DOI 10.3109/03602539308993978; Zhuang ZH, 2011, FISH SHELLFISH IMMUN, V31, P217, DOI 10.1016/j.fsi.2011.05.004	41	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83105	10.1371/journal.pone.0083105	http://dx.doi.org/10.1371/journal.pone.0083105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386148	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700029
J	Bruel, A; Roze, JC; Flamant, C; Simeoni, U; Roussey-Kesler, G; Allain-Launay, E				Bruel, Alexandra; Roze, Jean-Christophe; Flamant, Cyril; Simeoni, Umberto; Roussey-Kesler, Gwenaelle; Allain-Launay, Emma			Critical Serum Creatinine Values in Very Preterm Newborns	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BIRTH-WEIGHT INFANTS; ACUTE-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; RIFLE CRITERIA; MORTALITY; LABORATORIES; MANAGEMENT; CHILDREN	Background: Renal failure in neonates is associated with an increased risk of mortality and morbidity. But critical values are not known. Objective: To define critical values for serum creatinine levels by gestational age in preterm infants, as a predictive factor for mortality and morbidity. Study Design: This was a retrospective study of all preterm infants born before 33 weeks of gestational age, hospitalized in Nantes University Hospital NICU between 2003 and 2009, with serum creatinine levels measured between postnatal days 3 to 30. Children were retrospectively randomized into either training or validation set. Critical creatinine values were defined within the training set as the 90th percentile values of highest serum creatinine (HSCr) in infants with optimal neurodevelopmental at two years of age. The relationship between these critical creatinine values and neonatal mortality, and non-optimal neural development at two years, was then assessed in the validation set. Results and Conclusion: The analysis involved a total of 1,461 infants (gestational ages of 24-27 weeks (n=322), 28-29 weeks (n=336), and 30-32 weeks (803)), and 14,721 creatinine assessments. The critical values determined in the training set (n=485) were 1.6, 1.1 and 1.0 mg/dL for each gestational age group, respectively. In the validation set (n=976), a serum creatinine level above the critical value was significantly associated with neonatal mortality (Odds ratio: 8.55 (95% confidence interval: 4.23-17.28); p<0.01) after adjusting for known renal failure risk factors, and with non-optimal neurodevelopmental outcome at two years (odds ratio: 2.06 (95% confidence interval: 1.26-3.36); p=0.004) before adjustment. Creatinine values greater than 1.6, 1.1 and 1.0 mg/dL respectively at 24-27, 28-29, 30-32 weeks of gestation were associated with mortality before and after adjustment for risk factors, and with non-optimal neurodevelopmental outcome, before adjustment.	[Bruel, Alexandra; Roussey-Kesler, Gwenaelle; Allain-Launay, Emma] Univ Nantes, Nantes Univ Hosp, Dept Pediat, Nantes, France; [Roze, Jean-Christophe; Flamant, Cyril] Univ Nantes, Nantes Univ Hosp, Dept Neonatal, Nantes, France; [Roze, Jean-Christophe; Flamant, Cyril] Nantes Univ Hosp, INSERM, CIC 004, Nantes, France; [Roze, Jean-Christophe; Flamant, Cyril] Nantes Univ Hosp, INRA, UMR Physiol Adaptat Nutr 1280, Nantes, France; [Simeoni, Umberto] AP HM, Dept Neonatal, Marseille, France; [Simeoni, Umberto] Aix Marseille Univ, Marseille, France	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; INRAE; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Roze, JC (corresponding author), Univ Nantes, Nantes Univ Hosp, Dept Neonatal, Nantes, France.	jcroze@chu-nantes.fr	Rozé, Jean-Christophe/AAS-1314-2021; Simeoni, Umberto/GRO-6971-2022; SIMEONI, Umberto/AAQ-1870-2021	Simeoni, Umberto/0000-0003-0730-9337; SIMEONI, Umberto/0000-0003-0730-9337; Roze, Jean-Christophe/0000-0003-3367-512X	Regional Health Agency of Pays de la Loire	Regional Health Agency of Pays de la Loire	The LIFT cohort is supported by grants from the Regional Health Agency of Pays de la Loire. The sponsor has no role in this manuscript.	Abitbol CL, 2003, PEDIATR NEPHROL, V18, P887, DOI 10.1007/s00467-003-1186-1; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Askenazi DJ, 2011, J PEDIATR-US, V159, P907, DOI 10.1016/j.jpeds.2011.05.045; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Auron A, 2006, J PERINATOL, V26, P755, DOI 10.1038/sj.jp.7211604; Baraton L, 2009, PEDIATRICS, V124, pE655, DOI 10.1542/peds.2008-3415; Bargnoux AS, 2011, ANN BIOL CLIN-PARIS, V69, P9, DOI 10.1684/abc.2010.0510; Boussicault G, 2013, J PEDIATR-US, V163, P460, DOI 10.1016/j.jpeds.2013.01.052; Cataldi L, 2005, ARCH DIS CHILD-FETAL, V90, pF514, DOI 10.1136/adc.2004.060434; Choker G, 2004, BIOL NEONATE, V86, P212, DOI 10.1159/000079619; Cobbaert CM, 2009, CLIN CHEM, V55, P549, DOI 10.1373/clinchem.2008.116863; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Csaicsich D, 2008, WIEN KLIN WOCHENSCHR, V120, P153, DOI 10.1007/s00508-008-0941-5; Drion I, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-133; Fily A, 2006, PEDIATRICS, V117, P357, DOI 10.1542/peds.2005-0236; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Gallini F, 2000, PEDIATR NEPHROL, V15, P119, DOI 10.1007/s004670000356; Gong Y, 2009, CLIN BIOCHEM, V42, P1610, DOI 10.1016/j.clinbiochem.2009.08.004; GORDJANI N, 1988, EUR J PEDIATR, V148, P143, DOI 10.1007/BF00445923; Gouyon JB, 2000, PEDIATR NEPHROL, V14, P1037, DOI 10.1007/s004670050068; GUIGNARD JP, 1975, J PEDIATR-US, V87, P268, DOI 10.1016/S0022-3476(75)80600-7; Iacobelli S, 2009, J PERINATOL, V29, P232, DOI 10.1038/jp.2008.203; Koralkar R, 2011, PEDIATR RES, V69, P354, DOI 10.1203/PDR.0b013e31820b95ca; LUNDBERG GD, 1990, JAMA-J AM MED ASSOC, V263, P709, DOI 10.1001/jama.263.5.709; Lunn AJF, 2006, ARCH DIS CHILD-FETAL, V91, P388, DOI 10.1136/adc.2005.092023; McCoy L, 1999, ARCH DIS CHILD-FETAL, V80, pF38; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Ostermann M, 2011, QJM-INT J MED, V104, P237, DOI 10.1093/qjmed/hcq185; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Seronie-Vivien S, 2004, ANN BIOL CLIN-PARIS, V62, P165; Toth-Heyn P, 2000, PEDIATR NEPHROL, V14, P227, DOI 10.1007/s004670050048; Vieux R, 2010, PEDIATRICS, V125, pE1186, DOI 10.1542/peds.2009-1426; Walker MW, 2011, J PERINATOL, V31, P199, DOI 10.1038/jp.2010.82	34	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84892	10.1371/journal.pone.0084892	http://dx.doi.org/10.1371/journal.pone.0084892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386431	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700121
J	Choi, JY; Jang, HM; Park, J; Kim, YS; Kang, SW; Yang, CW; Kim, NH; Cho, JH; Park, SH; Kim, CD; Kim, YL				Choi, Ji-Young; Jang, Hye Min; Park, Jongha; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Cho, Jang-Hee; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim		Clinical Res Ctr End Stage Renal	Survival Advantage of Peritoneal Dialysis Relative to Hemodialysis in the Early Period of Incident Dialysis Patients: A Nationwide Prospective Propensity-Matched Study in Korea	PLOS ONE			English	Article							VASCULAR ACCESS; COMPARING MORTALITY; MODALITY; AUSTRALIA; THERAPY; DEATH; US; SELECTION; TRENDS; IMPACT	Background: The impact of dialysis modality on survival is still somewhat controversial. Given possible differences in patients' characteristics and the cause and rate of death in different countries, the issue needs to be evaluated in Korean cohorts. Methods: A nationwide prospective observational cohort study (NCT00931970) was performed to compare survival between peritoneal dialysis (PD) and hemodialysis (HD). A total of 1,060 end-stage renal disease patients in Korea who began dialysis between September 1, 2008 and June 30, 2011 were followed through December 31, 2011. Results: The patients (PD, 30.6%; HD, 69.4%) were followed up for 16.3+/-7.9 months. PD patients were significantly younger, less likely to be diabetic, with lower body mass index, and larger urinary volume than HD patients. Infection was the most common cause of death. Multivariate Cox regression with the entire cohort revealed that PD tended to be associated with a lower risk of death compared to HD [hazard ratio (HR) 0.63, 95% confidence interval (CI) 0.36-1.08]. In propensity score matched pairs (n = 278 in each modality), cumulative survival probabilities for PD and HD patients were 96.9% and 94.1% at 12 months (P = 0.152) and 94.3% and 87.6% at 24 months (P = 0.022), respectively. Patients on PD had a 51% lower risk of death compared to those on HD (HR 0.49, 95% CI 0.25-0.97). Conclusions: PD exhibits superior survival to HD in the early period of dialysis, even after adjusting for differences in the patients' characteristics between the two modalities. Notably, the most common cause of death was infection in this Korean cohort.	[Choi, Ji-Young; Cho, Jang-Hee; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Park, Jongha] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Div Nephrol, Ulsan 680749, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Choi, Ji-Young; Jang, Hye Min; Park, Jongha; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Cho, Jang-Hee; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim] Clin Res Ctr End Stage Renal Dis Korea, Daegu, South Korea	Kyungpook National University; Kyungpook National University; University of Ulsan; Ulsan University Hospital; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University	Kim, YL (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea.	ylkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020	Cho, Jang-hee/0000-0002-7031-5214; Ryu, Dong-Ryeol/0000-0002-5309-7606; Park, Jung Tak/0000-0002-2325-8982	Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea [HI10C2020, A111345]; National Research Foundation; Korea Government (MEST) [20100019392]	Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea; National Research Foundation; Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI10C2020 and A111345) and a National Research Foundation grant funded by the Korea Government (MEST) (No. 20100019392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bruns FJ, 1998, J AM SOC NEPHROL, V9, P884; Carrero JJ, 2011, NEPHROL DIAL TRANSPL, V26, P270, DOI 10.1093/ndt/gfq386; Collins AJ, 1999, AM J KIDNEY DIS, V34, P1065, DOI 10.1016/S0272-6386(99)70012-0; Dhingra RK, 2001, KIDNEY INT, V60, P1443, DOI 10.1046/j.1523-1755.2001.00947.x; Fenton SSA, 1997, AM J KIDNEY DIS, V30, P334, DOI 10.1016/S0272-6386(97)90276-6; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; Grace BS, 2012, NEPHROLOGY, V17, P76, DOI 10.1111/j.1440-1797.2011.01512.x; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Jaar BG, 2005, ANN INTERN MED, V143, P174, DOI 10.7326/0003-4819-143-3-200508020-00003; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Johnson DW, 2009, AM J KIDNEY DIS, V53, P290, DOI 10.1053/j.ajkd.2008.06.032; JOHNSON DW, 2010, ANZDATA REGISTRY REP; Korevaar JC, 2003, KIDNEY INT, V64, P2222, DOI 10.1046/j.1523-1755.2003.00321.x; Liem YS, 2007, KIDNEY INT, V71, P153, DOI 10.1038/sj.ki.5002014; Lukowsky LR, 2013, CLIN J AM SOC NEPHRO, V8, P619, DOI 10.2215/CJN.04810512; McDonald SP, 2009, J AM SOC NEPHROL, V20, P155, DOI 10.1681/ASN.2007111188; Mehrotra R, 2007, J AM SOC NEPHROL, V18, P2781, DOI 10.1681/ASN.2006101130; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Moist LM, 2007, AM J KIDNEY DIS, V50, P612, DOI 10.1053/j.ajkd.2007.07.016; MORDUCHOWICZ G, 1992, ISRAEL J MED SCI, V28, P776; PARK JY, 2010, J AM SOC NEPHROL KID; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Quinn RR, 2011, J AM SOC NEPHROL, V22, P1534, DOI 10.1681/ASN.2010121232; Sanabria M, 2008, KIDNEY INT, V73, pS165, DOI 10.1038/sj.ki.5002619; Soucie JM, 1996, J AM SOC NEPHROL, V7, P2169; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Suzuki K, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/231018; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; van de Luijtgaarden MWM, 2011, NEPHROL DIAL TRANSPL, V26, P2940, DOI 10.1093/ndt/gfq845; Weinhandl ED, 2010, J AM SOC NEPHROL, V21, P499, DOI 10.1681/ASN.2009060635; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76	33	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84257	10.1371/journal.pone.0084257	http://dx.doi.org/10.1371/journal.pone.0084257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386357	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700098
J	Jackson, SA; Flemer, B; McCann, A; Kennedy, J; Morrissey, JP; O'Gara, F; Dobson, ADW				Jackson, Stephen A.; Flemer, Burkhardt; McCann, Angela; Kennedy, Jonathan; Morrissey, John P.; O'Gara, Fergal; Dobson, Alan D. W.			Archaea Appear to Dominate the Microbiome of Inflatella pellicula Deep Sea Sponges	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; 16S RIBOSOMAL-RNA; MARINE SPONGE; PHYLOGENETIC DIVERSITY; TRANSMISSION; COMMUNITIES; BACTERIAL; POPULATIONS; SYMBIONTS; ECOLOGY	Microbes associated with marine sponges play significant roles in host physiology. Remarkable levels of microbial diversity have been observed in sponges worldwide through both culture-dependent and culture-independent studies. Most studies have focused on the structure of the bacterial communities in sponges and have involved sponges sampled from shallow waters. Here, we used pyrosequencing of 16S rRNA genes to compare the bacterial and archaeal communities associated with two individuals of the marine sponge Inflatella pellicula from the deep-sea, sampled from a depth of 2,900 m, a depth which far exceeds any previous sequence-based report of sponge-associated microbial communities. Sponge-microbial communities were also compared to the microbial community in the surrounding seawater. Sponge-associated microbial communities were dominated by archaeal sequencing reads with a single archaeal OTU, comprising similar to 60% and similar to 72% of sequences, being observed from Inflatella pellicula. Archaeal sequencing reads were less abundant in seawater (similar to 11% of sequences). Sponge-associated microbial communities were less diverse and less even than any other sponge-microbial community investigated to date with just 210 and 273 OTUs (97% sequence identity) identified in sponges, with 4 and 6 dominant OTUs comprising similar to 88% and similar to 89% of sequences, respectively. Members of the candidate phyla, SAR406, NC10 and ZB3 are reported here from sponges for the first time, increasing the number of bacterial phyla or candidate divisions associated with sponges to 43. A minor cohort from both sponge samples (similar to 0.2% and similar to 0.3% of sequences) were not classified to phylum level. A single OTU, common to both sponge individuals, dominates these unclassified reads and shares sequence homology with a sponge associated clone which itself has no known close relative and may represent a novel taxon.	[Jackson, Stephen A.; Flemer, Burkhardt; McCann, Angela; Kennedy, Jonathan; Morrissey, John P.; O'Gara, Fergal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Ctr Marine Biotechnol, Environm Res Inst, Cork, Ireland; [Morrissey, John P.; O'Gara, Fergal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, BIOMERIT Res Ctr, Cork, Ireland	University College Cork; University College Cork; University College Cork	Dobson, ADW (corresponding author), Natl Univ Ireland Univ Coll Cork, Ctr Marine Biotechnol, Environm Res Inst, Cork, Ireland.	a.dobson@ucc.ie	Morrissey, John/AAD-2255-2019; Dobson, Alan D W/M-7844-2017; Jackson, Stephen/J-4368-2019	Dobson, Alan D W/0000-0002-7713-5574; Jackson, Stephen/0000-0001-7869-9032; Flemer, Burkhardt/0000-0003-4614-4432; O'Gara, Fergal/0000-0002-2659-0673; Morrissey, John/0000-0001-7960-2001	Department of Agriculture, Fisheries and Food [FIRM08/RDC/629]; Beaufort Marine Biodiscovery Research award; Irish Government under the National Development Plan	Department of Agriculture, Fisheries and Food; Beaufort Marine Biodiscovery Research award; Irish Government under the National Development Plan	This research was supported in part by grants awarded by the Department of Agriculture, Fisheries and Food (FIRM08/RDC/629) and the Beaufort Marine Biodiscovery Research award funded by the Irish Government under the National Development Plan (2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker PW, 2009, MAR BIOTECHNOL, V11, P540, DOI 10.1007/s10126-008-9169-7; Bavestrello G, 2000, BIOL BULL, V198, P29, DOI 10.2307/1542801; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerrano C, 2004, CHEM ECOL, V20, pS57, DOI 10.1080/02757540310001629198; Dupont S, 2013, FEMS MICROBIOL ECOL, V2013, P1; Flemer B., 2013, THESIS U COLL CORK I; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Han MQ, 2013, MICROB ECOL, V66, P427, DOI 10.1007/s00248-013-0197-0; Han MQ, 2012, MAR BIOTECHNOL, V14, P701, DOI 10.1007/s10126-012-9436-5; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Kennedy J, 2008, ENVIRON MICROBIOL, V10, P1888, DOI 10.1111/j.1462-2920.2008.01614.x; Kennedy J, 2010, MAR DRUGS, V8, P608, DOI 10.3390/md8030608; Kennedy J, 2009, MAR BIOTECHNOL, V11, P384, DOI 10.1007/s10126-008-9154-1; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lee OO, 2011, ISME J, V2010, P1; Liu F, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/723696; Margot H, 2002, MAR BIOL, V140, P739, DOI 10.1007/s00227-001-0740-2; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; Pape T, 2006, POLAR BIOL, V29, P662, DOI 10.1007/s00300-005-0103-4; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; REISWIG HM, 1975, CAN J ZOOL, V53, P582, DOI 10.1139/z75-072; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sipkema D, 2009, MICROB ECOL, V58, P903, DOI 10.1007/s00248-009-9534-8; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1978, MAR BIOL, V49, P161, DOI 10.1007/BF00387115; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	48	38	38	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84438	10.1371/journal.pone.0084438	http://dx.doi.org/10.1371/journal.pone.0084438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386380	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700107
J	Nelson, TM; Rogers, TL; Brown, MV				Nelson, Tiffanie M.; Rogers, Tracey L.; Brown, Mark V.			The Gut Bacterial Community of Mammals from Marine and Terrestrial Habitats	PLOS ONE			English	Article							CHEMICAL ECOLOGY; ZOSTERA-MARINA; MICROBIOTA; DIET; INVERTEBRATES; PHYLOGENY; TAXONOMY; DEFENSE; GROWTH; LEAVES	After birth, mammals acquire a community of bacteria in their gastro-intestinal tract, which harvests energy and provides nutrients for the host. Comparative studies of numerous terrestrial mammal hosts have identified host phylogeny, diet and gut morphology as primary drivers of the gut bacterial community composition. To date, marine mammals have been excluded from these comparative studies, yet they represent distinct examples of evolutionary history, diet and lifestyle traits. To provide an updated understanding of the gut bacterial community of mammals, we compared bacterial 16S rRNA gene sequence data generated from faecal material of 151 marine and terrestrial mammal hosts. This included 42 hosts from a marine habitat. When compared to terrestrial mammals, marine mammals clustered separately and displayed a significantly greater average relative abundance of the phylum Fusobacteria. The marine carnivores (Antarctic and Arctic seals) and the marine herbivore (dugong) possessed significantly richer gut bacterial community than terrestrial carnivores and terrestrial herbivores, respectively. This suggests that evolutionary history and dietary items specific to the marine environment may have resulted in a gut bacterial community distinct to that identified in terrestrial mammals. Finally we hypothesize that reduced marine trophic webs, whereby marine carnivores (and herbivores) feed directly on lower trophic levels, may expose this group to high levels of secondary metabolites and influence gut microbial community richness.	[Nelson, Tiffanie M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, POB 1, Kensington, NSW 2033, Australia; [Nelson, Tiffanie M.; Rogers, Tracey L.] Australian Inst Marine Sci, Arafura Timor Res Facil, Casuarina, Australia; [Brown, Mark V.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Evolut & Ecol Res Ctr, Kensington, NSW 2033, Australia	University of New South Wales Sydney; Australian Institute of Marine Science; University of New South Wales Sydney	Nelson, TM (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, POB 1, Kensington, NSW 2033, Australia.	t.nelson@aims.gov.au	Rogers, Tracey L/C-3419-2008; Nelson, Tiffanie/A-9907-2013	Nelson, Tiffanie/0000-0002-5341-312X; Rogers, Tracey/0000-0002-7141-4177	Secretaria de Ciencia y Tecnologia; Direccion Nacional del Antartico (PICTO) [36054]; Australian Research Council; Winifred Scott Foundation; Evolution and Ecology Research Centre, University of New South Wales, Sydney, Australia	Secretaria de Ciencia y Tecnologia(Secretaria de Ciencia y Tecnologia (SECYT)); Direccion Nacional del Antartico (PICTO); Australian Research Council(Australian Research Council); Winifred Scott Foundation; Evolution and Ecology Research Centre, University of New South Wales, Sydney, Australia	Funding for the field support was provided by the Secretaria de Ciencia y Tecnologia and the Direccion Nacional del Antartico (PICTO No. 36054), the Australian Research Council, Winifred Scott Foundation, and the Evolution and Ecology Research Centre, University of New South Wales, Sydney, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; BENNETT KW, 1993, J MED MICROBIOL, V39, P246, DOI 10.1099/00222615-39-4-246; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CHAO A, 1984, SCAND J STAT, V11, P265; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Clarke KR, 2006, PRIMER V 6 USER MANU; COLLINSON ME, 1991, PHILOS T ROY SOC B, V333, P197, DOI 10.1098/rstb.1991.0068; Colwell R.K, 1997, ESTIMATES STAT ESTIM; Davis CS, 2004, MOL PHYLOGENET EVOL, V33, P363, DOI 10.1016/j.ympev.2004.06.006; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Glad T, 2010, MICROB ECOL, V60, P320, DOI 10.1007/s00248-010-9690-x; GUTTMAN L, 1968, PSYCHOMETRIKA, V33, P469, DOI 10.1007/BF02290164; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HAY ME, 1988, ANNU REV ECOL SYST, V19, P111, DOI 10.1146/annurev.es.19.110188.000551; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lippert H, 2003, POLAR BIOL, V26, P591, DOI 10.1007/s00300-003-0525-9; Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9; Marsh H, 1992, J WILDL RES, V9, P55; McClintock JB, 1997, AM ZOOL, V37, P329; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nagaraja TG, 2005, ANAEROBE, V11, P239, DOI 10.1016/j.anaerobe.2005.01.007; Nelson T, 2012, DRYAD DIGIT REPOS; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Potrykus J, 2007, PROTEOMICS, V7, P1839, DOI 10.1002/pmic.200600464; PREEN A, 1995, J MAMMAL, V76, P163, DOI 10.2307/1382325; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schreiber A, 1998, EXP CLIN IMMUNOGENET, V15, P154, DOI 10.1159/000019067; Staley J. T., 2005, BERGEYS MANUAL SYSTE, P747; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96; Tsukinowa E, 2008, J GEN APPL MICROBIOL, V54, P25, DOI 10.2323/jgam.54.25; Vergeer LHT, 1997, AQUAT BOT, V58, P65, DOI 10.1016/S0304-3770(96)01115-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963	45	48	51	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83655	10.1371/journal.pone.0083655	http://dx.doi.org/10.1371/journal.pone.0083655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386245	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700055
J	Parola, C; Salogni, L; Vaira, X; Scutera, S; Somma, P; Salvi, V; Musso, T; Tabbia, G; Bardessono, M; Pasquali, C; Mantovani, A; Sozzani, S; Bosisio, D				Parola, Carmen; Salogni, Laura; Vaira, Xenia; Scutera, Sara; Somma, Paolo; Salvi, Valentina; Musso, Tiziana; Tabbia, Giuseppe; Bardessono, Marco; Pasquali, Christian; Mantovani, Alberto; Sozzani, Silvano; Bosisio, Daniela			Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PURIFIED BACTERIAL EXTRACTS; DIFFERENTIATION; INTERLEUKIN-10; LYMPHOCYTES; INTERFERON; CHILDHOOD; IMMUNITY; GROWTH; CCL20	OM-85 (Broncho-Vaxom(R), Broncho-Munal(R), Ommunal(R), Paxoral(R), Vaxoral(R)), a product made of the water soluble fractions of 21 inactivated bacterial strain patterns responsible for respiratory tract infections, is used for the prevention of recurrent upper respiratory tract infections and acute exacerbations in chronic obstructive pulmonary disease patients. OM-85 is able to potentiate both innate and adaptive immune responses. However, the molecular mechanisms responsible for OM-85 activation are still largely unknown. Purpose of this study was to investigate the impact of OM-85 stimulation on human dendritic cell functions. We show that OM-85 selectively induced NF-kB and MAPK activation in human DC with no detectable action on the interferon regulatory factor (IRF) pathway. As a consequence, chemokines (i.e. CXCL8, CXCL6, CCL3, CCL20, CCL22) and B-cell activating cytokines (i.e. IL-6, BAFF and IL-10) were strongly upregulated. OM-85 also synergized with the action of classical pro-inflammatory stimuli used at suboptimal concentrations. Peripheral blood mononuclear cells from patients with COPD, a pathological condition often associated with altered PRR expression pattern, fully retained the capability to respond to OM-85. These results provide new insights on the molecular mechanisms of OM-85 activation of the immune response and strengthen the rational for its use in clinical settings.	[Parola, Carmen; Salogni, Laura; Vaira, Xenia; Somma, Paolo; Salvi, Valentina; Sozzani, Silvano; Bosisio, Daniela] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Scutera, Sara; Musso, Tiziana] Univ Turin, Dept Publ Hlth & Pediat Sci, Turin, Italy; [Tabbia, Giuseppe; Bardessono, Marco] Osped San Giovanni Battista, Div Pulm, Turin, Italy; [Pasquali, Christian] OM Pharma SA, Preclin Res, Geneva 2, Switzerland; [Mantovani, Alberto; Sozzani, Silvano] Humanitas Clin & Res Ctr, Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dept Biotechnol & Translat Med, Milan, Italy	University of Brescia; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Humanitas Research Hospital; University of Milan	Bosisio, D (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	bosisio@med.unibs.it	SCUTERA, SARA AGATA CATERINA/AAU-6455-2020; Salvi, Valentina/Y-8757-2019; Mantovani, Alberto/HCI-7449-2022; Sozzani, Silvano/C-1447-2009	SCUTERA, SARA AGATA CATERINA/0000-0002-7431-0875; Salvi, Valentina/0000-0003-4802-1524; Mantovani, Alberto/0000-0001-5578-236X; Sozzani, Silvano/0000-0002-3144-8743; BOSISIO, Daniela/0000-0001-6276-5365; MUSSO, Tiziana/0000-0002-7487-6078	FIRC (Fondazione Italiana Ricerca sul Cancro); Viforpharma; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	FIRC (Fondazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Viforpharma; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by academic funds and fellowships. VS receives a three year fellowship from FIRC (Fondazione Italiana Ricerca sul Cancro). This work was also partially funded by Viforpharma, who initially took part in general research planning. The funders had no role in experiment design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; BALADI S, 1994, MEDIAT INFLAMM, V3, P143, DOI 10.1155/S0962935194000189; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Caramori G, 2013, CELL COMMUN ADHES, V20, P21, DOI 10.3109/15419061.2013.775257; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Collet JP, 1997, AM J RESP CRIT CARE, V156, P1719, DOI 10.1164/ajrccm.156.6.9612096; Del-Rio-Navarro BE, 2008, EUR J PEDIATR, V167, P121, DOI 10.1007/s00431-007-0420-4; Diebold Sandra S, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-71029-5_1; EMMERICH B, 1990, RESPIRATION, V57, P90; FLUCKIGER AC, 1993, J EXP MED, V178, P1473, DOI 10.1084/jem.178.5.1473; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Macpherson AJ, 2012, IMMUNOL REV, V245, P132, DOI 10.1111/j.1600-065X.2011.01072.x; MAUEL J, 1994, RESPIRATION, V61, P8; Muzio M, 2000, BIOCHEM SOC T, V28, P563, DOI 10.1042/bst0280563; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Salogni L, 2009, BLOOD, V113, P5848, DOI 10.1182/blood-2008-12-194597; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Sozzani S, 2005, CYTOKINE GROWTH F R, V16, P581, DOI 10.1016/j.cytogfr.2005.04.008; Steinman RM, 2010, EUR J IMMUNOL, V40, P2085, DOI 10.1002/eji.201040733; Steurer-Stey C, 2007, EUR J PEDIATR, V166, P365, DOI 10.1007/s00431-006-0248-3; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Yamashita U, 2002, CRIT REV IMMUNOL, V22, P105; Zelle-Rieser C, 2001, IMMUNOL LETT, V76, P63, DOI 10.1016/S0165-2478(00)00326-6	27	32	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82867	10.1371/journal.pone.0082867	http://dx.doi.org/10.1371/journal.pone.0082867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386121	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700014
J	Rai, RK; Barbhuyan, T; Singh, C; Mittal, M; Khan, MP; Sinha, N; Chattopadhyay, N				Rai, Ratan Kumar; Barbhuyan, Tarun; Singh, Chandan; Mittal, Monika; Khan, Mohd Parvez; Sinha, Neeraj; Chattopadhyay, Naibedya			Total Water, Phosphorus Relaxation and Inter-Atomic Organic to Inorganic Interface Are New Determinants of Trabecular Bone Integrity	PLOS ONE			English	Article							SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; MECHANICAL-PROPERTIES; COMPUTED-TOMOGRAPHY; CANCELLOUS BONE; SPECTROSCOPY; LACTATION; DEHYDRATION; COLLAGEN; MICE	Bone is the living composite biomaterial having unique structural property. Presently, there is a considerable gap in our understanding of bone structure and composition in the native state, particularly with respect to the trabecular bone, which is metabolically more active than cortical bones, and is readily lost in post-menopausal osteoporosis. We used solid-state nuclear magnetic resonance (NMR) to compare trabecular bone structure and composition in the native state between normal, bone loss and bone restoration conditions in rat. Trabecular osteopenia was induced by lactation as well as prolonged estrogen deficiency (bilateral ovariectomy, Ovx). Ovx rats with established osteopenia were administered with PTH (parathyroid hormone, trabecular restoration group), and restoration was allowed to become comparable to sham Ovx (control) group using bone mineral density (BMD) and mu CT determinants. We used a technique combining H-1 NMR spectroscopy with P-31 and C-13 to measure various NMR parameters described below. Our results revealed that trabecular bones had diminished total water content, inorganic phosphorus NMR relaxation time (T-1) and space between the collagen and inorganic phosphorus in the osteopenic groups compared to control, and these changes were significantly reversed in the bone restoration group. Remarkably, bound water was decreased in both osteopenic and bone restoration groups compared to control. Total water and T-1 correlated strongly with trabecular bone density, volume, thickness, connectivity, spacing and resistance to compression. Bound water did not correlate with any of the microarchitectural and compression parameters. We conclude that total water, T-1 and atomic space between the crystal and organic surface are altered in the trabecular bones of osteopenic rats, and PTH reverses these parameters. Furthermore, from these data, it appears that total water and T-1 could serve as trabecular surrogates of micro-architecture and compression strength.	[Rai, Ratan Kumar; Singh, Chandan; Sinha, Neeraj] Ctr Biomed Res, Lucknow, Uttar Pradesh, India; [Barbhuyan, Tarun; Mittal, Monika; Khan, Mohd Parvez; Chattopadhyay, Naibedya] Cent Drug Res Inst, Div Endocrinol, CSIR, Lucknow, Uttar Pradesh, India; [Barbhuyan, Tarun; Mittal, Monika; Khan, Mohd Parvez; Chattopadhyay, Naibedya] Cent Drug Res Inst, CSIR, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sinha, N (corresponding author), Ctr Biomed Res, SGPGIMS Campus, Lucknow, Uttar Pradesh, India.	neeraj.sinha@cbmr.res.in; n_chattopadhyay@cdri.res.in	Chattopadhyay, Naibedya/AAF-2058-2019; Chattopadhyay, Naibedya/AAQ-3213-2021; Rai, Ratan K/N-6344-2018; Rai, Ratan/L-9787-2019	Chattopadhyay, Naibedya/0000-0003-2473-0246; Rai, Ratan K/0000-0001-6015-5539; Rai, Ratan/0000-0001-6015-5539; Sinha, Neeraj/0000-0003-3235-6127; Mittal, Monika/0000-0002-3328-7787; Singh, Dr. Chandan/0000-0001-8006-1329	Council of Scientific and Industrial Research, Government of India [BSC0201]; University Grants Commission, Government of India; Indian Council of Medical Research, Government of India; Department of Biotechnology, Government of India [BT/PR12700/BRB/10/719/2009]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Council of Scientific and Industrial Research (BSC0201, ASTHI), Government of India. Fellowship grants from the Council of Scientific and Industrial Research (RKR, TB, CS), University Grants Commission (MM), Indian Council of Medical Research (MPK), Department of Biotechnology (BT/PR12700/BRB/10/719/2009), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467; BAUD CA, 1978, CLIN ORTHOP RELAT R, P270; BELANGER LF, 1969, CALC TISS RES, V4, P1, DOI 10.1007/BF02279101; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Compston J, 2011, J OSTEOPOROSIS, V2011, P4; Fernandez-Seara MA, 2004, J BONE MINER RES, V19, P289, DOI 10.1359/JBMR.0301227; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Iida-Klein A, 2007, BONE, V40, P391, DOI 10.1016/j.bone.2006.09.010; Jerome CP, 2001, BONE, V28, P150, DOI 10.1016/S8756-3282(00)00430-0; Kaflak A, 2007, SOLID STATE NUCL MAG, V31, P174, DOI 10.1016/j.ssnmr.2007.04.005; Kalkwarf HJ, 1999, J MAMMARY GLAND BIOL, V4, P319, DOI 10.1023/A:1018780425600; Khan K, 2013, OSTEOPOROSIS INT, V24, P1455, DOI 10.1007/s00198-012-2121-8; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; MEIER DE, 1984, ANN INTERN MED, V101, P605, DOI 10.7326/0003-4819-101-5-605; Mroue KH, 2012, J PHYS CHEM B, V116, P11656, DOI 10.1021/jp307935g; Nikel O, 2012, J PHYS CHEM C, V116, P6320, DOI 10.1021/jp2125312; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768; Recker RR, 2009, BONE, V44, P113, DOI 10.1016/j.bone.2008.09.019; Reichert D, 2004, MAGN RESON CHEM, V42, P276, DOI 10.1002/mrc.1334; ROBINSON RA, 1975, CLIN ORTHOP RELAT R, P263; SAITO H, 1992, J BIOCHEM-TOKYO, V111, P376, DOI 10.1093/oxfordjournals.jbchem.a123765; Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434; Sharan K, 2010, MENOPAUSE, V17, P577, DOI [10.1097/gme.0b013e3181bfae38, 10.1097/gme.0b013e3181d2ce7f]; Siddiqui JA, 2011, MENOPAUSE, V18, P198, DOI 10.1097/gme.0b013e3181e84e67; Singh C, 2013, SOLID STATE NUCL MAG, V54, P18, DOI 10.1016/j.ssnmr.2013.05.003; Srivastava K, 2013, EVID-BASED COMPL ALT, V2013, P12; Takata Shinjiro, 2004, J Med Invest, V51, P133, DOI 10.2152/jmi.51.133; Trivedi R, 2009, MOL CELL ENDOCRINOL, V302, P86, DOI 10.1016/j.mce.2009.01.011; Tyagi AM, 2012, MENOPAUSE, V19, P856, DOI 10.1097/gme.0b013e31824f9306; Vinogradov E, 1999, CHEM PHYS LETT, V314, P443, DOI 10.1016/S0009-2614(99)01174-4; Wehrli FW, 2005, ANN BIOMED ENG, V33, P79, DOI 10.1007/s10439-005-8965-8; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243; Wilson EE, 2005, J BONE MINER RES, V20, P625, DOI 10.1359/JBMR.041217; Xu JD, 2011, J PHYS CHEM B, V115, P9948, DOI 10.1021/jp205663z; Zhang G, 2005, CLIN BIOMECH, V20, P729, DOI 10.1016/j.clinbiomech.2005.03.016; Zhang QB, 2009, RADIAT RES, V172, P607, DOI 10.1667/RR1715.1; Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83478	10.1371/journal.pone.0083478	http://dx.doi.org/10.1371/journal.pone.0083478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386209	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700043
J	Srisen, K; Rohrl, C; Meisslitzer-Ruppitsch, C; Ranftler, C; Ellinger, A; Pavelka, M; Neumuller, J				Srisen, Kaemisa; Roehrl, Clemens; Meisslitzer-Ruppitsch, Claudia; Ranftler, Carmen; Ellinger, Adolf; Pavelka, Margit; Neumueller, Josef			Human Endothelial Progenitor Cells Internalize High-Density Lipoprotein	PLOS ONE			English	Article							SMOOTH-MUSCLE CELLS; RECEPTOR SR-BI; MEDIATED ENDOCYTOSIS; CHOLESTEROL; EFFLUX; TRANSPORT; BINDING; VISUALIZATION; TRANSCYTOSIS; METABOLISM	Endothelial progenitor cells (EPCs) originate either directly from hematopoietic stem cells or from a subpopulation of monocytes. Controversial views about intracellular lipid traffic prompted us to analyze the uptake of human high density lipoprotein (HDL), and HDL-cholesterol in human monocytic EPCs. Fluorescence and electron microscopy were used to investigate distribution and intracellular trafficking of HDL and its associated cholesterol using fluorescent surrogates (bodipy-cholesterol and bodipy-cholesteryl oleate), cytochemical labels and fluorochromes including horseradish peroxidase and Alexa Fluor (R) 568. Uptake and intracellular transport of HDL were demonstrated after internalization periods from 0.5 to 4 hours. In case of HDL-Alexa Fluor (R) 568, bodipy-cholesterol and bodipy-cholesteryl oleate, a photooxidation method was carried out. HDL-specific reaction products were present in invaginations of the plasma membrane at each time of treatment within endocytic vesicles, in multivesicular bodies and at longer periods of uptake, also in lysosomes. Some HDL-positive endosomes were arranged in form of "strings of pearl"-like structures. HDL-positive multivesicular bodies exhibited intensive staining of limiting and vesicular membranes. Multivesicular bodies of HDL-Alexa Fluor (R) 568-treated EPCs showed multilamellar intra-vacuolar membranes. At all periods of treatment, labeled endocytic vesicles and organelles were apparent close to the cell surface and in perinuclear areas around the Golgi apparatus. No HDL-related particles could be demonstrated close to its cisterns. Electron tomographic reconstructions showed an accumulation of HDL-containing endosomes close to the trans-Golgi-network. HDL-derived bodipy-cholesterol was localized in endosomal vesicles, multivesicular bodies, lysosomes and in many of the stacked Golgi cisternae and the trans-Golgi-network Internalized HDL-derived bodipy-cholesteryl oleate was channeled into the lysosomal intraellular pathway and accumulated prominently in all parts of the Golgi apparatus and in lipid droplets. Subsequently, also the RER and mitochondria were involved. These studies demonstrated the different intracellular pathway of HDL-derived bodipy-cholesterol and HDL-derived bodipy-cholesteryl oleate by EPCs, with concomitant.	[Srisen, Kaemisa; Meisslitzer-Ruppitsch, Claudia; Ranftler, Carmen; Ellinger, Adolf; Pavelka, Margit; Neumueller, Josef] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell Biol & Ultrastruct Res, Vienna, Austria; [Roehrl, Clemens] Med Univ Vienna, Inst Med Chem, Ctr Pathobiochem & Genet, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Neumuller, J (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell Biol & Ultrastruct Res, Vienna, Austria.	josef.neumueller@meduniwien.ac.at		Rohrl, Clemens/0000-0002-1192-0748	Austrian Science Fund (FWF) [P22838]; Thailand Government	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Thailand Government	This project is supported by the Austrian Science Fund (FWF) grant P22838 and Thailand Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Balazs Z, 2004, J NEUROCHEM, V89, P939, DOI 10.1111/j.1471-4159.2004.02373.x; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Chao WT, 2002, HISTOCHEM J, V34, P233, DOI 10.1023/A:1021789429893; DANIELS RJ, 1981, J BIOL CHEM, V256, P4978; DELAMATRE JG, 1990, J LIPID RES, V31, P191; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Gonzalez-Pecchi V, 2002, J CELL SCI THER, V3, P8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; INNERARITY TL, 1982, ARTERIOSCLEROSIS, V2, P114, DOI 10.1161/01.ATV.2.2.114; Ishida T, 2004, CELL TISSUE RES, V318, P533, DOI 10.1007/s00441-004-0962-y; JOHNSON WJ, 1990, J BIOL CHEM, V265, P5546; KAMBOURIS AM, 1990, ARTERIOSCLEROSIS, V10, P582, DOI 10.1161/01.ATV.10.4.582; Kuzmenko ES, 2004, INT J BIOCHEM CELL B, V36, P519, DOI 10.1016/j.biocel.2003.09.010; Li D, 2010, ARTERIOSCL THROM VAS, V30, P1354, DOI 10.1161/ATVBAHA.110.204230; Li ZG, 2006, J ORG CHEM, V71, P1718, DOI 10.1021/jo052029x; Meisslitzer-Ruppitsch C, HISTOCHEM CELL BIOL, V135, P159; Meisslitzer-Ruppitsch C, 2008, HISTOCHEM CELL BIOL, V130, P407, DOI 10.1007/s00418-008-0429-4; Noor R, 2007, ATHEROSCLEROSIS, V192, P92, DOI 10.1016/j.atherosclerosis.2006.06.023; O'Connell BJ, 2004, CIRCULATION, V110, P2881, DOI 10.1161/01.CIR.0000146333.20727.2B; Pagler TA, 2006, J BIOL CHEM, V281, P38159, DOI 10.1074/jbc.M603334200; PALADE GE, 1952, J EXP MED, V95, P285, DOI 10.1084/jem.95.3.285; Phillips MC, 1998, ATHEROSCLEROSIS, V137, pS13, DOI 10.1016/S0021-9150(97)00312-2; RAJAN VP, 1987, BIOCHIM BIOPHYS ACTA, V921, P25, DOI 10.1016/0005-2760(87)90166-4; Reaven E, 1996, J BIOL CHEM, V271, P16208, DOI 10.1074/jbc.271.27.16208; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rohrl C, 2012, CURR PHARM BIOTECHNO, V13, P331, DOI 10.2174/138920112799095338; Rohrl C, 2010, HISTOCHEM CELL BIOL, V133, P261, DOI 10.1007/s00418-009-0672-3; ROGLER G, 1992, GASTROENTEROLOGY, V103, P469, DOI 10.1016/0016-5085(92)90836-N; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Rosengren BI, 2002, J VASC RES, V39, P230, DOI 10.1159/000063688; RUTLEDGE JC, 1995, AM J PHYSIOL-HEART C, V268, pH1982, DOI 10.1152/ajpheart.1995.268.5.H1982; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tso C, 2006, ARTERIOSCL THROM VAS, V26, P1144, DOI 10.1161/01.ATV.0000216600.37436.cf; Vantourout P, 2010, WORLD J GASTROENTERO, V16, P5925, DOI 10.3748/wjg.v16.i47.5925; VASILE E, 1983, J CELL BIOL, V96, P1677, DOI 10.1083/jcb.96.6.1677; Wadsack C, 2003, PLACENTA, V24, P131, DOI 10.1053/plac.2002.0912; Yeh YC, 2002, ATHEROSCLEROSIS, V161, P95, DOI 10.1016/S0021-9150(01)00642-6	47	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83189	10.1371/journal.pone.0083189	http://dx.doi.org/10.1371/journal.pone.0083189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386159	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700027
J	Zech, M; Nubling, G; Castrop, F; Jochim, A; Schulte, EC; Mollenhauer, B; Lichtner, P; Peters, A; Gieger, C; Marquardt, T; Vanier, MT; Latour, P; Klunemann, H; Trenkwalder, C; Diehlschmid, J; Perneczky, R; Meitinger, T; Oexle, K; Haslinger, B; Lorenzl, S; Winkelmann, J				Zech, Michael; Nuebling, Georg; Castrop, Florian; Jochim, Angela; Schulte, Eva C.; Mollenhauer, Brit; Lichtner, Peter; Peters, Annette; Gieger, Christian; Marquardt, Thorsten; Vanier, Marie T.; Latour, Philippe; Kluenemann, Hans; Trenkwalder, Claudia; Diehlschmid, Janine; Perneczky, Robert; Meitinger, Thomas; Oexle, Konrad; Haslinger, Bernhard; Lorenzl, Stefan; Winkelmann, Juliane			Niemann-Pick C Disease Gene Mutations and Age-Related Neurodegenerative Disorders	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GLUCOCEREBROSIDASE MUTATIONS; PARKINSONS-DISEASE; NPC1 MUTATIONS; RISK-FACTOR; DIAGNOSIS; TRAFFICKING; IDENTIFICATION; DISRUPTION; AUTOPHAGY	Niemann-Pick type C (NPC) disease is a rare autosomal-recessively inherited lysosomal storage disorder caused by mutations in NPC1 (95%) or NPC2. Given the highly variable phenotype, diagnosis is challenging and particularly late-onset forms with predominantly neuropsychiatric presentations are likely underdiagnosed. Pathophysiologically, genetic alterations compromising the endosomal/lysosomal system are linked with age-related neurodegenerative disorders. We sought to examine a possible association of rare sequence variants in NPC1 and NPC2 with Parkinson's disease (PD), frontotemporal lobar degeneration (FTLD) and progressive supranuclear palsy (PSP), and to genetically determine the proportion of potentially misdiagnosed NPC patients in these neurodegenerative conditions. By means of high-resolution melting, we screened the coding regions of NPC1 and NPC2 for rare genetic variation in a homogenous German sample of patients clinically diagnosed with PD (n = 563), FTLD (n = 133) and PSP (n = 94), and 846 population-based controls. The frequencies of rare sequence variants in NPC1/2 did not differ significantly between patients and controls. Disease-associated NPC1/2 mutations were found in six PD patients (1.1%) and seven control subjects (0.8%), but not in FTLD or PSP. All rare variation was detected in the heterozygous state and no compound heterozygotes were observed. Our data do not support the hypothesis that rare NPC1/2 variants confer susceptibility for PD, FTLD, or PSP in the German population. Misdiagnosed NPC patients were not present in our samples. However, further assessment of NPC disease genes in age-related neurodegeneration is warranted.	[Zech, Michael; Castrop, Florian; Jochim, Angela; Schulte, Eva C.; Haslinger, Bernhard; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany; [Zech, Michael; Schulte, Eva C.; Lichtner, Peter; Meitinger, Thomas; Oexle, Konrad; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Munich, Germany; [Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Munich, Germany; [Lichtner, Peter; Meitinger, Thomas; Oexle, Konrad; Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-80290 Munich, Germany; [Nuebling, Georg] Univ Munich, Neurol Klin & Poliklin, Klinikum Univ Munchen, Munich, Germany; [Mollenhauer, Brit; Trenkwalder, Claudia] Paracelsus Elena Klin, Kassel, Germany; [Diehlschmid, Janine; Perneczky, Robert] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany; [Perneczky, Robert] Univ London Imperial Coll Sci Technol & Med, Neuroepidemiol & Ageing Res Unit,Sch, Sch Publ Hlth, Fac Med, London, England; [Perneczky, Robert] West London Mental Hlth Trust, West London Cognit Disorders Treatment & Res Unit, London, England; [Kluenemann, Hans] Univ Regensburg, Klin Psychiat & Psychotherapie, D-93053 Regensburg, Germany; [Mollenhauer, Brit; Trenkwalder, Claudia] Univ Gottingen, Neurochirurg Klin, D-37073 Gottingen, Germany; [Marquardt, Thorsten] Univ Klinikum Munster, Klin Kinder & Jugendmed, Munster, Germany; [Vanier, Marie T.; Latour, Philippe] Hosp Civils Lyon, CBPE, Lab Gillet Merieux, Lyon, France; [Latour, Philippe] Hosp Civils Lyon, CBPE, UF Neurogenet, Lyon, France; [Meitinger, Thomas; Winkelmann, Juliane] SyNergy, Munich Cluster Syst Neurol, Munich, Germany; [Winkelmann, Juliane] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Winkelmann, Juliane] Stanford Univ, Sch Med, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Technical University of Munich; University of Munich; Imperial College London; University of Regensburg; University of Gottingen; University of Munster; CHU Lyon; CHU Lyon; Stanford University; Stanford University	Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany.	winkelmann@lrz.tum.de	Meitinger, Thomas/O-1318-2015; Perneczky, Robert/AAJ-2550-2020; Trenkwalder, Claudia/ABD-6559-2021; Peters, Annette/A-6117-2011; Mollenhauer, Brit/F-8863-2010; Schulte, Eva C./AAT-2410-2021; Trenkwalder, Claudia/AHD-1232-2022	Peters, Annette/0000-0001-6645-0985; Trenkwalder, Claudia/0000-0001-6407-1199; Gieger, Christian/0000-0001-6986-9554; Winkelmann, Juliane/0000-0003-2667-9691; Oexle, Konrad/0000-0001-7447-2252; Meitinger, Thomas/0000-0002-8838-8403; Schulte, Eva Christina/0000-0003-3105-5672; Perneczky, Robert/0000-0003-1981-7435; Diehl-Schmid, Janine/0000-0002-7745-1382; Nubling, Georg/0000-0003-4492-7302	Actelion Pharmaceuticals Ltd; Technische Universitat Munchen; Helmholtz Zentrum Munchen, Munich, Germany; Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	Actelion Pharmaceuticals Ltd; Technische Universitat Munchen; Helmholtz Zentrum Munchen, Munich, Germany; Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	Recruitment and analysis of 94 patients with progressive supranuclear palsy was funded by Actelion Pharmaceuticals Ltd (www.actelion.com). The remaining study as well as the recruitment of patients with Parkinson's disease and frontotemporal lobar degeneration was funded by in-house institutional funding from Technische Universitat Munchen and Helmholtz Zentrum Munchen, Munich, Germany. Controls belong to the KORA research platform (KORA, Cooperative Research in the Region of Augsburg), which was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Bauer P, 2013, HUM MOL GENET; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Brown DE, 1996, J INHERIT METAB DIS, V19, P319, DOI 10.1007/BF01799262; Chikh K, 2005, HUM MUTAT, V26, P20, DOI 10.1002/humu.20173; Dehay B, 2013, MOV DISORD; Eblan MJ, 2006, MOVEMENT DISORD, V21, P282, DOI 10.1002/mds.20766; Gan-Or Z, 2013, NEUROLOGY, V80, P1606, DOI 10.1212/WNL.0b013e31828f180e; Greer WL, 1999, AM J HUM GENET, V65, P1252, DOI 10.1086/302620; Harzer K, 2013, NIEMANN PICK DIS TYP; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Josephs KA, 2003, J NEUROL NEUROSUR PS, V74, P528, DOI 10.1136/jnnp.74.4.528; Josephs KA, 2004, NEUROLOGY, V63, P2189, DOI 10.1212/01.WNL.0000145710.25588.2F; Kluenemann HH, 2013, J NEUROL SCI; Klunemann HH, 2002, ANN NEUROL, V52, P743, DOI 10.1002/ana.10366; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Ribeiro I, 2001, HUM GENET, V109, P24, DOI 10.1007/s004390100531; Rodriguez-Pascau L, 2012, MOL GENET METAB, V107, P716, DOI 10.1016/j.ymgme.2012.10.004; Rodriguez-Pascau L, 2009, HUM MUTAT, V30, pE993, DOI 10.1002/humu.21119; Sato C, 2005, MOVEMENT DISORD, V20, P367, DOI 10.1002/mds.20319; Schicks J, 2013, NEUROLOGY, V80, P1169, DOI 10.1212/WNL.0b013e31828869f9; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; Shachar T, 2011, MOVEMENT DISORD, V26, P1593, DOI 10.1002/mds.23774; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Spitz M, 2008, PARKINSONISM RELAT D, V14, P58, DOI 10.1016/j.parkreldis.2007.06.010; Sun XF, 2001, AM J HUM GENET, V68, P1361, DOI 10.1086/320599; Sztolsztener ME, 2010, ARCH BIOCHEM BIOPHYS, V493, P221, DOI 10.1016/j.abb.2009.11.001; Tangemo C, 2011, J LIPID RES, V52, P813, DOI 10.1194/jlr.P013524; Tan EK, 2007, ARCH NEUROL-CHICAGO, V64, P1056, DOI 10.1001/archneur.64.7.1056; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Trendelenburg G, 2006, J NEUROL NEUROSUR PS, V77, P997, DOI 10.1136/jnnp.2005.086785; Urwin H, 2010, HUM MOL GENET, V19, P2228, DOI 10.1093/hmg/ddq100; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1988, CLIN GENET, V33, P331; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Walterfang M, 2006, J NEUROPSYCH CLIN N, V18, P158, DOI 10.1176/appi.neuropsych.18.2.158; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wraith JE, 2009, MOL GENET METAB, V98, P152, DOI 10.1016/j.ymgme.2009.06.008; Xiao J, 2010, NEUROLOGY, V74, P229, DOI 10.1212/WNL.0b013e3181ca00ca; Yu WX, 2005, J BIOL CHEM, V280, P27296, DOI 10.1074/jbc.M503922200; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031	58	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82879	10.1371/journal.pone.0082879	http://dx.doi.org/10.1371/journal.pone.0082879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386122	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700015
J	Lieberman-Lazarovich, M; Melamed-Bessudo, C; de Pater, S; Levy, AA				Lieberman-Lazarovich, Michal; Melamed-Bessudo, Cathy; de Pater, Sylvia; Levy, Avraham A.			Epigenetic Alterations at Genomic Loci Modified by Gene Targeting in Arabidopsis thaliana	PLOS ONE			English	Article							DNA METHYLATION; HOMOLOGOUS RECOMBINATION; RNA; MUTAGENESIS; EFFICIENT; STRAND; MODEL; MULTIPLEX; REVEALS; CELLS	Gene Targeting (GT) is the integration of an introduced vector into a specific chromosomal site, via homologous recombination. It is considered an effective tool for precise genome editing, with far-reaching implications in biological research and biotechnology, and is widely used in mice, with the potential of becoming routine in many species. Nevertheless, the epigenetic status of the targeted allele remains largely unexplored. Using GT-modified lines of the model plant Arabidopsis thaliana, we show that the DNA methylation profile of the targeted locus is changed following GT. This effect is non-directional as methylation can be either completely lost, maintained with minor alterations or show instability in the generations subsequent to GT. As DNA methylation is known to be involved in several cellular processes, GT-related alterations may result in unexpected or even unnoticed perturbations. Our analysis shows that GT may be used as a new tool for generating epialleles, for example, to study the role of gene body methylation. In addition, the analysis of DNA methylation at the targeted locus may be utilized to investigate the mechanism of GT, many aspects of which are still unknown.	[Lieberman-Lazarovich, Michal] Univ Geneva, Dept Plant Biol, Geneva, Switzerland; [Lieberman-Lazarovich, Michal; Melamed-Bessudo, Cathy; Levy, Avraham A.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [de Pater, Sylvia] Leiden Univ, Dept Mol & Dev Genet, Inst Biol, Leiden, Netherlands	University of Geneva; Weizmann Institute of Science; Leiden University; Leiden University - Excl LUMC	Lieberman-Lazarovich, M (corresponding author), Univ Geneva, Dept Plant Biol, Geneva, Switzerland.	michal.lieberman@unige.ch			European Union [LSHG-CT-2005-018785, KBBE-2008-227190]	European Union(European Commission)	This work was supported by the European Union FP6 TAGIP (LSHG-CT-2005-018785) and FP7 RECBREED (KBBE-2008-227190) grants (URL: http://cordis.europa.eu/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bogue CW, 2003, J APPL PHYSIOL, V94, P2502, DOI 10.1152/japplphysiol.00209.2003; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040; Deleris A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003062; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Even-Faitelson L, 2011, PLANT J, V68, P929, DOI 10.1111/j.1365-313X.2011.04741.x; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Hanin M, 2003, CURR OPIN PLANT BIOL, V6, P157, DOI 10.1016/S1369-5266(03)00016-5; Hanin M, 2001, PLANT J, V28, P671, DOI 10.1046/j.1365-313x.2001.01183.x; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Leung WY, 1997, P NATL ACAD SCI USA, V94, P6851, DOI 10.1073/pnas.94.13.6851; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Mak TW, 2007, CELL, V131, P1027, DOI 10.1016/j.cell.2007.11.033; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Melamed-Bessudo C, 2012, P NATL ACAD SCI USA, V109, pE981, DOI 10.1073/pnas.1120742109; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Shaked H, 2005, P NATL ACAD SCI USA, V102, P12265, DOI 10.1073/pnas.0502601102; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Yelina NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002844; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	55	7	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85383	10.1371/journal.pone.0085383	http://dx.doi.org/10.1371/journal.pone.0085383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386472	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700137
J	Liu, DL; Zhao, XL				Liu, Dinglin; Zhao, Xianglian			Method and Application for Dynamic Comprehensive Evaluation with Subjective and Objective Information	PLOS ONE			English	Article								In an effort to deal with more complicated evaluation situations, scientists have focused their efforts on dynamic comprehensive evaluation research. How to make full use of the subjective and objective information has become one of the noteworthy content. In this paper, a dynamic comprehensive evaluation method with subjective and objective information is proposed. We use the combination weighting method to determine the index weight. Analysis hierarchy process method is applied to dispose the subjective information, and criteria importance through intercriteria correlation method is used to handle the objective information. And for the time weight determination, we consider both time distance and information size to embody the principle of esteeming the present over the past. And then the linear weighted average model is constructed to make the evaluation process more practicable. Finally, an example is presented to illustrate the effectiveness of this method. Overall, the results suggest that the proposed method is reasonable and effective.	[Liu, Dinglin; Zhao, Xianglian] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics	Liu, DL (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing, Jiangsu, Peoples R China.	liudinglinjiayou@163.com			key project of Jiangsu Social Science Research [2013ZDIXM015]; Fundamental Research Funds for the Central Universities Funding of Jiangsu Innovation Program for Graduate Education [CXLX12_0181]; Production and Research Open Fund Project of Nanjing University of Aeronautics and Astronautics [56XZA12074]	key project of Jiangsu Social Science Research; Fundamental Research Funds for the Central Universities Funding of Jiangsu Innovation Program for Graduate Education; Production and Research Open Fund Project of Nanjing University of Aeronautics and Astronautics	This work was partially supported by the key project of Jiangsu Social Science Research (Grant NO. 2013ZDIXM015), the Fundamental Research Funds for the Central Universities Funding of Jiangsu Innovation Program for Graduate Education (Grant NO. CXLX12_0181) and the Production and Research Open Fund Project of Nanjing University of Aeronautics and Astronautics (Grant NO. 56XZA12074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett LM, 2005, QUAL RELIAB ENG INT, V21, P413, DOI 10.1002/qre.674; Chen H, 2011, SCI SCI MANAGEMENT S, V32, P129; DIAKOULAKI D, 1995, COMPUT OPER RES, V22, P763, DOI 10.1016/0305-0548(94)00059-H; Du D., 2001, SYST ENG ELECT, V5, P36; Duval D, 1996, MATH COMPUT SIMULAT, V42, P551, DOI 10.1016/S0378-4754(96)00032-8; Grammatikopoulos V., 2004, STUDIES ED EVALUATIO, V30, P255, DOI DOI 10.1016/J.STUEDUC.2004.09.005; [郭善瑞 Guo Shanrui], 2012, [东北大学学报. 自然科学版, Journal of Northeastern University. Natural Science], V33, P296; Guo Y, 2001, J NE U NATURAL SCI, V22, P465; Guo Y, 2012, COMPRENHENSIVE EVALU; Guo Y., 2007, THEORY METHOD APPL C; Guo Y, 1995, J NE U NATURAL SCI, V16, P547; Guo Ya-jun, 2010, Systems Engineering and Electronics, V32, P1225, DOI 10.3969/j.issn.1001-506X.2010.06.025; [郭亚军 Guo Yajun], 2011, [系统工程学报, Journal of Systems Engineering], V26, P546; [郭亚军 GUO Yajun], 2007, [系统工程理论与实践, Systems Engineering-Theory & Practice], V27, P154, DOI 10.1016/S1874-8651(08)60060-5; [郭亚军 Guo Yajun], 2002, [管理科学学报, Journal of management sciences in china], V5, P49; Guo Yajun, 2011, J MANAGEMENT SCI CHI, V14, P19; [黄玮强 HUANG Weiqiang], 2011, [东北大学学报. 自然科学版, Journal of Northeastern University. Natural Science], V32, P891; JOHNSTON J, 1972, EC METHODS; [刘微微 Liu Weiwei], 2013, [系统工程理论与实践, Systems Engineering-Theory & Practice], V33, P705; Ma Zan-fu, 2009, Journal of Systems Engineering, V24, P243; Otero MC, 2004, INFORM SOFTWARE TECH, V46, P35, DOI 10.1016/S0950-5849(03)00108-3; Parra-Lopez C, 2008, ECOL ECON, V64, P820, DOI 10.1016/j.ecolecon.2007.05.004; [曲常胜 Qu Changsheng], 2010, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V46, P477; Vidal LA, 2011, EXPERT SYST APPL, V38, P5388, DOI 10.1016/j.eswa.2010.10.016; Wang X, 2005, MANAGE REV, V17, P41; Yi P, 2009, J NE U NATURAL SCI, V30, P891; Yue C., 2003, DECISION THEORY METH; Zhao H, 1986, ANAL HIERARCHY PROCE; Zhou JY, 2008, J SW FORESTRY, V28, P9	29	10	11	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83323	10.1371/journal.pone.0083323	http://dx.doi.org/10.1371/journal.pone.0083323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386176	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700039
J	Martin, TA; Lane, J; Harrison, GM; Jiang, WG				Martin, Tracey A.; Lane, Jane; Harrison, Gregory M.; Jiang, Wen G.			The Expression of the Nectin Complex in Human Breast Cancer and the Role of Nectin-3 in the Control of Tight Junctions during Metastasis	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE LOOP; CELL-ADHESION MOLECULES; POLIOVIRUS RECEPTOR; ORGANIZATION; CADHERIN; MARKER; AFADIN; MEMBER; LOCALIZATION; INVOLVEMENT	Introduction: Nectins are a family of integral protein molecules involved in the formation of functioning Adherens and Tight Junctions (TJ). Aberrant expression is associated with cancer progression but little is known how this effects changes in cell behaviour. This study aimed to ascertain the distribution of Nectins-1 to -4 in human breast cancer and the effect on junctional integrity of Nectin-3 modulation in human endothelial and breast cancer cells. Methods: A human breast tissue cohort was processed for Q-PCR and immunohistochemistry for analysis of Nectin-1/-2/-3/-4. Nectin-3 over-expression was induced in the human breast cancer cell line MDA-MB-231 and the human endothelial cell line HECV. Functional testing was carried out to ascertain changes in cell behaviour. Results: Q-PCR revealed a distinct reduction in node positive tumours and in patients with poor outcome. There was increased expression of Nectin-1/-2 in patients with metastatic disease, Nectin-3/-4 was reduced. IHC revealed that Nectin-3 expression showed clear changes in distribution between normal and cancerous cells. Nectin-3 over-expression in MDA-MB-231 cells showed reduced invasion and migration even when treated with HGF. Changes in barrier function resulted in MDAN3 cells showing less change in resistance after 2h treatment with HGF (p<0.001). Nectin-3 transformed endothelial cells were significantly more adhesive, irrespective of treatment with HGF (p<0.05) and had reduced growth. Barrier function revealed that transformed HECV cells had significantly tighter junctions that wildtype cells when treated with HGF (p<0.0001). HGF-induced changes in permeability were also reduced. Overexpression of Nectin-3 produced endothelial cells with significantly reduced ability to form tubules (p<0.0001). Immunoprecipitation studies discovered hitherto novel associations for Nectin-3. Moreover, HGF appeared to exert an effect on Nectin-3 via tyrosine and threonine phosphorylation. Conclusions: Nectin-3 may be a key component in the formation of cell junctions and be a putative suppressor molecule to the invasion of breast cancer cells.	[Martin, Tracey A.; Lane, Jane; Harrison, Gregory M.; Jiang, Wen G.] Cardiff Univ, Cardiff Sch Med, Cardiff Univ Peking Univ Canc Res Inst, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Martin, TA (corresponding author), Cardiff Univ, Cardiff Sch Med, Cardiff Univ Peking Univ Canc Res Inst, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	martinta1@cf.ac.uk	Jiang, Wen G./AAF-1876-2020; jiang, wen/GYI-9662-2022; Jiang, Wen G/B-1293-2010	Jiang, Wen G./0000-0002-3283-1111; Jiang, Wen G/0000-0002-3283-1111	Cancer Research Wales [WGJ2007]	Cancer Research Wales	Cancer Research Wales provided funding for this work (grant number WGJ2007; http://crw.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; Cocchi F, 1998, J VIROL, V72, P9992, DOI 10.1128/JVI.72.12.9992-10002.1998; DeRycke MS, 2010, AM J CLIN PATHOL, V134, P835, DOI 10.1309/AJCPGXK0FR4MHIHB; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Fournier G, 2010, M S-MED SCI, V26, P273, DOI 10.1051/medsci/2010263273; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Halon A, 2012, POSTEP HIG MED DOSW, V66, P158, DOI 10.5604/17322693.987628; Huang YY, 2007, J CLIN ENDOCR METAB, V92, P1965, DOI 10.1210/jc.2007-0040; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Inagaki M, 2003, J COMP NEUROL, V460, P514, DOI 10.1002/cne.10653; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kikyo M, 2000, ONCOGENE, V19, P4022, DOI 10.1038/sj.onc.1203744; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; Maniwa Y, 2012, THORAC CANCER, V3, P175, DOI 10.1111/j.1759-7714.2011.00104.x; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Martin TA, 2004, CELL BIOL INT, V28, P361, DOI 10.1016/j.cellbi.2004.03.003; Martin TA, 2011, FRONT BIOSCI-LANDMRK, V16, P898, DOI 10.2741/3726; Miao XY, 2013, INT J CLIN EXP PATHO, V6, P179; Momose Y, 2002, BIOCHEM BIOPH RES CO, V293, P45, DOI 10.1016/S0006-291X(02)00183-3; Oshima T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-60; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; Sainio M, 1997, J CELL SCI, V110, P2249; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yasumi M, 2003, BIOCHEM BIOPH RES CO, V302, P61, DOI 10.1016/S0006-291X(03)00106-2; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Yu ZK, 2007, MOL THER, V15, P103, DOI 10.1038/sj.mt.6300009	34	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82696	10.1371/journal.pone.0082696	http://dx.doi.org/10.1371/journal.pone.0082696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386110	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000329116700013
J	Nanni, L; Brahnam, S; Ghidoni, S; Menegatti, E; Barrier, T				Nanni, Loris; Brahnam, Sheryl; Ghidoni, Stefano; Menegatti, Emanuele; Barrier, Tonya			Different Approaches for Extracting Information from the Co-Occurrence Matrix	PLOS ONE			English	Article							TEXTURE DESCRIPTORS; IMAGE; CLASSIFICATION; FEATURES; SEGMENTATION; RECOGNITION; MULTIPLE; SCALE	In 1979 Haralick famously introduced a method for analyzing the texture of an image: a set of statistics extracted from the co-occurrence matrix. In this paper we investigate novel sets of texture descriptors extracted from the co-occurrence matrix; in addition, we compare and combine different strategies for extending these descriptors. The following approaches are compared: the standard approach proposed by Haralick, two methods that consider the co-occurrence matrix as a three-dimensional shape, a gray-level run-length set of features and the direct use of the co-occurrence matrix projected onto a lower dimensional subspace by principal component analysis. Texture descriptors are extracted from the co-occurrence matrix evaluated at multiple scales. Moreover, the descriptors are extracted not only from the entire co-occurrence matrix but also from subwindows. The resulting texture descriptors are used to train a support vector machine and ensembles. Results show that our novel extraction methods improve the performance of standard methods. We validate our approach across six medical datasets representing different image classification problems using the Wilcoxon signed rank test. The source code used for the approaches tested in this paper will be available at: http://www.dei.unipd.it/wdyn/?IDsezione = 3314&IDgruppo_pass = 124&preview=.	[Nanni, Loris; Ghidoni, Stefano; Menegatti, Emanuele] Univ Padua, Dept Informat Engn, Padua, Italy; [Brahnam, Sheryl; Barrier, Tonya] Missouri State Univ, Dept Comp Informat Syst, Springfield, MO 65897 USA	University of Padua; Missouri State University	Brahnam, S (corresponding author), Missouri State Univ, Dept Comp Informat Syst, Springfield, MO 65897 USA.	sbrahnam@facescience.org	Ghidoni, Stefano/AAC-4100-2022	Menegatti, Emanuele/0000-0001-5794-9979				Akono A., 2005, TELEDETECTION, V5, P227; Ameling S., 2009, BILDVERARBEITUNG MED, P346, DOI DOI 10.1007/978-3-540-93860-6_70; [Anonymous], 2013, INT C BIOIN COMP BIO; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Benco M, 2007, RADIOENGINEERING, V16, P64; Boland MV, 1998, CYTOMETRY, V33, P366; Braz G, 2009, COMPUT BIOL MED, V39, P1063, DOI 10.1016/j.compbiomed.2009.08.009; Chen S, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND INTELLIGENT SYSTEMS, PROCEEDINGS, VOL 4, P482, DOI 10.1109/ICICISYS.2009.5357627; Coggins J.M., 1982, THESIS; Cruz-Roa A, 2011, ARTIF INTELL MED, V52, P91, DOI 10.1016/j.artmed.2011.04.010; Dalal N, 2005, 9 EUR C COMP VIS SAN; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dominio F, 2013, PATTERN REC IN PRESS; Eaton C., 2012, UNDERSTANDING BIG DA; Fawcett T., 2004, ROC GRAPHS NOTES PRA; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Gelzinis A, 2007, PATTERN RECOGN, V40, P2367, DOI 10.1016/j.patcog.2006.12.004; Ghidoni S, 2012, INT C INT AUT SYST I; Gong R, 2012, OPT COMMUN, V285, P4961, DOI 10.1016/j.optcom.2012.07.121; Hamilton NA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-94; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoang ND, 2010, 2010 THIRD INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND ELECTRONICS (ICCE), P169, DOI 10.1109/ICCE.2010.5670704; Hu Y., 2009, P IEEE IND APPL SOC, P1, DOI DOI 10.1109/IAS.2009.5324874; Huang J, 1997, PROC CVPR IEEE, P762, DOI 10.1109/CVPR.1997.609412; JAIN AK, 1991, PATTERN RECOGN, V24, P1167, DOI 10.1016/0031-3203(91)90143-S; Jantzen J., 2005, P NISIS, P1; Karkanis SA, 2003, IEEE T INF TECHNOL B, V7, P141, DOI 10.1109/TITB.2003.813794; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Kylberg G, 2011, LECT NOTES COMPUT SC, V7042, P573, DOI 10.1007/978-3-642-25085-9_68; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mitrea D, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/348135; Murphy RF, 2006, NAT BIOTECHNOL, V24, P1223, DOI 10.1038/nbt1006-1223; Nanni L, 2013, COMPUTER CO IN PRESS; Nanni L, 2008, ARTIF INTELL MED, V43, P87, DOI 10.1016/j.artmed.2008.03.005; Nanni L, 2010, J THEOR BIOL, V264, P1024, DOI 10.1016/j.jtbi.2010.03.020; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Oliver A, 2007, LECT NOTES COMPUT SC, V4791, P286; Paci M, 2013, CURR BIOINFORM, V8, P208, DOI 10.2174/1574893611308020009; Pacifici F., 2008, 2008 IEEE International Geoscience and Remote Sensing Symposium, IGARSS 2008, P342, DOI 10.1109/IGARSS.2008.4780098; Pass G, 1996, P ACM INT C MULT, P65, DOI DOI 10.1145/244130.244148; Qian XM, 2011, PATTERN RECOGN, V44, P2502, DOI 10.1016/j.patcog.2011.03.029; Rakwatin P, 2010, INT GEOSCI REMOTE SE, P1234, DOI 10.1109/IGARSS.2010.5651347; Ren XM, 2012, LECT NOTES ARTIF INT, V7390, P237, DOI 10.1007/978-3-642-31576-3_31; Samant A, 2000, COMPUT-AIDED CIV INF, V15, P241, DOI 10.1111/0885-9507.00188; Sastry S. S., 2012, ADV CONDENSED MATTER, V2012, P1; Shen L, 2007, IMAGE VISION COMPUT, V25, P553, DOI 10.1016/j.imavis.2006.05.002; SKLANSKY J, 1978, IEEE T SYST MAN CYB, V8, P237, DOI 10.1109/TSMC.1978.4309944; Sun X, 2012, IEEE WORLD C COMP IN; SWAIN MJ, 1991, INT J COMPUT VISION, V7, P11, DOI 10.1007/BF00130487; Tan XY, 2007, LECT NOTES COMPUT SC, V4778, P168; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Tuzel O, 2006, LECT NOTES COMPUT SC, V3952, P589; Unay D, 2008, I S BIOMED IMAGING, P241, DOI 10.1109/ISBI.2008.4540977; Vapnik V., 1964, AUTOMATION REMOTE CO, V25; Vapnik V., 1963, AUTOM REMOTE, V24, P774; Vecsei A, 2011, COMPUT BIOL MED, V41, P313, DOI 10.1016/j.compbiomed.2011.03.009; Walker RF, 2003, INT J PATTERN RECOGN, V17, P17, DOI 10.1142/S0218001403002228; Wolpert DH, 2002, SOFT COMPUTING AND INDUSTRY, P25; Wu B, 2005, IEEE I CONF COMP VIS, P90; Zhang R, 2010, IEEE IMAGE PROC, P1073, DOI 10.1109/ICIP.2010.5651261; Zucker SW., 1976, COMPUTER GRAPHICS IM, V5, P190, DOI [10.1016/0146-664X(76)90027-7, DOI 10.1016/0146-664X(76)90027-7]	64	63	64	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83554	10.1371/journal.pone.0083554	http://dx.doi.org/10.1371/journal.pone.0083554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386228	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700059
J	Bakhoum, MT; Fall, M; Fall, AG; Bellis, GA; Gottlieb, Y; Labuschagne, K; Venter, GJ; Diop, M; Mall, I; Seck, MT; Allene, X; Diarra, M; Gardes, L; Bouyer, J; Delecolle, JC; Balenghien, T; Garros, C				Bakhoum, Mame T.; Fall, Moussa; Fall, Assane G.; Bellis, Glenn A.; Gottlieb, Yuval; Labuschagne, Karien; Venter, Gert J.; Diop, Mariame; Mall, Iba; Seck, Momar T.; Allene, Xavier; Diarra, Maryam; Gardes, Laetitia; Bouyer, Jeremy; Delecolle, Jean-Claude; Balenghien, Thomas; Garros, Claire			First Record of Culicoides oxystoma Kieffer and Diversity of Species within the Schultzei Group of Culicoides Latreille (Diptera: Ceratopogonidae) Biting Midges in Senegal	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BLUETONGUE VIRUS; CLIMATE-CHANGE; TRANSMISSION; REGION; GENE	The Schultzei group of Culicoides Latreille (Diptera: Ceratopogonidae) is distributed throughout Africa to northern Asia and Australasia and includes several potential vector species of livestock pathogens. The taxonomy of the species belonging to this species group is confounded by the wide geographical distribution and morphological variation exhibited by many species. In this work, morphological and molecular approaches were combined to assess the taxonomic validity of the species and morphological variants of the Schultzei group found in Senegal by comparing their genetic diversity with that of specimens from other geographical regions. The species list for Senegal was updated with four species: Culicoides kingi, C. oxystoma, C. enderleini and C. nevilli being recorded. This is the first record of C. oxystoma from Africa south of Sahara, and its genetic relationship with samples from Israel, Japan and Australia is presented. This work provides a basis for ecological studies of the seasonal and spatial dynamics of species of this species group that will contribute to better understanding of the epidemiology of the viruses they transmit.	[Bakhoum, Mame T.; Fall, Moussa; Fall, Assane G.; Diop, Mariame; Mall, Iba; Seck, Momar T.; Diarra, Maryam; Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal; [Bellis, Glenn A.] Dept Agr, Winnellie, Australia; [Gottlieb, Yuval] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Labuschagne, Karien; Venter, Gert J.] Onderstepoort Vet Inst, Agr Res Council, Onderstepoort, South Africa; [Labuschagne, Karien] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Venter, Gert J.] Univ Pretoria, Dept Vet Trop Dis, Onderstepoort, South Africa; [Allene, Xavier; Gardes, Laetitia; Bouyer, Jeremy; Balenghien, Thomas; Garros, Claire] INRA, Cirad, Controle Malad UMR15, Controle Malad UMR1309, Montpellier, France; [Delecolle, Jean-Claude] Inst Parasitol & Pathol Trop Strasbourg, Fac Med, Strasbourg, France	Hebrew University of Jerusalem; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Pretoria; CIRAD; INRAE	Bakhoum, MT (corresponding author), Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal.	thierbakhoum2@yahoo.fr; claire.garros@cirad.fr	Bouyer, Jérémy/AAK-7370-2020; Garros, Claire/C-2715-2011; Labuschagne, Karien/J-9084-2019; Gottlieb, Yuval/H-6461-2013	Bouyer, Jérémy/0000-0002-1913-416X; Diarra, Maryam/0000-0001-9110-4435; Bakhoum, Mame Thierno/0000-0001-6794-4426; Labuschagne, Karien/0000-0002-8352-0313	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (Cirad); EU [261504 EDENext]	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (Cirad); EU(European Commission)	This study was funded partly by the Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (Cirad), and by the EU FP7-HEALTH-2010-single-stage grant 261504 EDENext. This paper is catalogued by the EDENext Steering Committee as EDENext177 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Akakpo A. J., 2011, Bulletin of Animal Health and Production in Africa, V59, P1; Alahmed A. M., 2010, Journal of Entomology, V7, P227; Augot D, 2013, B SOC PATHOL EXOT; Barnard BJH, 1998, ONDERSTEPOORT J VET, V65, P145; Bellis GA, 2013, ZOOTAXA, V3680, P15, DOI 10.11646/zootaxa.3680.1.4; Boorman J., 1989, Fauna of Saudi Arabia, V10, P160; Borkent A, 2012, CATALOG CERATOPOGONI; Borkent A, 2012, SUBGENERIC CLASSIFIC; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Cornet Michel, 1994, Bulletin de la Societe Entomologique de France, V99, P149; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Meillon B, 1961, REV ENTOMOL MOCAMBAI, V4, P34; Dik B, 2006, J NAT HIST, V40, P1947, DOI 10.1080/00222930601046634; Diouf ND, 2013, VET REC, V172, P152, DOI 10.1136/vr.101083; Dyce A.L., 2007, PICTORIAL ATLAS AUST, V1st; Gerdes GH, 2004, VETER ITAL SER, V40, P39; GLICK JI, 1990, J MED ENTOMOL, V27, P85, DOI 10.1093/jmedent/27.2.85; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hilali Musaad, 2003, Veterinarski Arhiv, V73, P285; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; KHAMALA CPM, 1971, T ROY ENT SOC LONDON, V123, P1; Labuschagne K, 2007, ONDERSTEPOORT J VET, V74, P343; Mardulyn P, 2013, MOL ECOL, V22, P2456, DOI 10.1111/mec.12264; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Meiswinkel R, 2004, INFECT DIS LIVESTOCK; Mellor PS, 2009, BIOL ANIM INFECT, P1; MELLOR PS, 1993, VET RES, V24, P199; MELLOR PS, 1984, J HYG-CAMBRIDGE, V93, P621, DOI 10.1017/S0022172400065190; Morag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033610; Oem JK, 2013, J VET SCI, V14, P91, DOI 10.4142/jvs.2013.14.1.91; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rambaut A., 2007, TRACER V1 4; Rawlings P, 1998, MED VET ENTOMOL, V12, P155, DOI 10.1046/j.1365-2915.1998.00094.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SEN PURNENDU., 1959, ANN ENT SOC AMER, V52, P617; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Solano P, 1997, ACTA TROP, V65, P175, DOI 10.1016/S0001-706X(97)00663-3; Standfast H.A., 1985, Progress in Clinical and Biological Research, V178, P177; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsutsui T, 2011, PARASITOL RES, V108, P1575, DOI 10.1007/s00436-010-2048-y; Venail R., 2012, P77; Venter GJ, 2007, MED VET ENTOMOL, V21, P239, DOI 10.1111/j.1365-2915.2007.00687.x; Venter GJ, 2009, MED VET ENTOMOL, V23, P367, DOI 10.1111/j.1365-2915.2009.00829.x; Viennet E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-119; Wirth W.W., 1985, Progress in Clinical and Biological Research, V178, P151; Wirth W.W., 1989, MEM AM ENTOMOL INST, V44, P1; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2; Yu YX, 2005, CERATOPOGONIDAE CHIN	49	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84316	10.1371/journal.pone.0084316	http://dx.doi.org/10.1371/journal.pone.0084316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386366	Green Published, gold			2022-12-27	WOS:000329194700103
J	Chen, ZX; Li, FL; Yang, SN; Dong, YB; Yuan, QH; Wang, F; Li, WM; Jiang, Y; Jia, SR; Pei, XW				Chen, Zongxiang; Li, FuLi; Yang, Songnan; Dong, Yibo; Yuan, Qianhua; Wang, Feng; Li, Weimin; Jiang, Ying; Jia, Shirong; Pei, XinWu			Identification and Functional Analysis of Flowering Related microRNAs in Common Wild Rice (Oryza rufipogon Griff.)	PLOS ONE			English	Article							SMALL RNAS; GENETIC-CONTROL; PHOTOPERIODIC CONTROL; HAINAN ISLAND; TIME; EXPRESSION; ARABIDOPSIS; BIOGENESIS; ANNOTATION; DIVERSITY	Background: MicroRNAs (miRNAs) is a class of non-coding RNAs involved in post-transcriptional control of gene expression, via degradation and/or translational inhibition. Six-hundred sixty-one rice miRNAs are known that are important in plant development. However, flowering-related miRNAs have not been characterized in Oryza rufipogon Griff. It was approved by supervision department of Guangdong wild rice protection. We analyzed flowering-related miRNAs in O. rufipogon using high-throughput sequencing (deep sequencing) to understand the changes that occurred during rice domestication, and to elucidate their functions in flowering. Results: Three O. rufipogon sRNA libraries, two vegetative stage (CWR-V1 and CWR-V2) and one flowering stage (CWR-F2) were sequenced using Illumina deep sequencing. A total of 20,156,098, 21,531,511 and 20,995,942 high quality sRNA reads were obtained from CWR-V1, CWR-V2 and CWR-F2, respectively, of which 3,448,185, 4,265,048 and 2,833,527 reads matched known miRNAs. We identified 512 known rice miRNAs in 214 miRNA families and predicted 290 new miRNAs. Targeted functional annotation, GO and KEGG pathway analyses predicted that 187 miRNAs regulate expression of flowering-related genes. Differential expression analysis of flowering-related miRNAs showed that: expression of 95 miRNAs varied significantly between the libraries, 66 are flowering-related miRNAs, such as oru-miR97, oru-miR117, oru-miR135, oru-miR137, et al. 17 are early-flowering -related miRNAs, including osa-miR160f, osa-miR164d, osa-miR167d, osa-miR169a, osa-miR172b, oru-miR4, et al., induced during the floral transition. Real-time PCR revealed the same expression patterns as deep sequencing. miRNAs targets were confirmed for cleavage by 59-RACE in vivo, and were negatively regulated by miRNAs. Conclusions: This is the first investigation of flowering miRNAs in wild rice. The result indicates that variation in miRNAs occurred during rice domestication and lays a foundation for further study of phase change and flowering in O. rufipogon. Complicated regulatory networks mediated by multiple miRNAs regulate the expression of flowering genes that control the induction of flowering.	[Chen, Zongxiang; Li, FuLi; Dong, Yibo; Li, Weimin; Jia, Shirong; Pei, XinWu] Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100193, Peoples R China; [Yang, Songnan; Yuan, Qianhua] Hainan Univ, Coll Agr Sci, MOE Key Lab Trop Biol Resources, Haikou, Peoples R China; [Wang, Feng] Guangdong Acad Agr Sci, Rice Res Inst, Guangzhou, Guangdong, Peoples R China; [Jiang, Ying] Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Hainan University; Guangdong Academy of Agricultural Sciences; Capital Medical University	Jiang, Y (corresponding author), Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China.	jiangy@ccmu.edu.cn; peixinwu@caas.cn	Pei, Xinwu/AAI-1736-2019; pei, xinwu/O-7083-2019; Yuan, Qianhua/A-3336-2015; Jia, Shirong/L-8788-2019	Pei, Xinwu/0000-0001-7828-3037; Yuan, Qianhua/0000-0002-0443-1567; dong, yibo/0000-0002-5264-1382	National Special Program of Transgenic Research [2013ZX08011-001]	National Special Program of Transgenic Research	This work was supported by grants from the National Special Program of Transgenic Research (Nos. 2013ZX08011-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARD P, 2004, SCI SIGNAL, V131, P3357; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Dong YB, 2013, GENETICS MO IN PRESS; Dong YB, 2012, BIOCHEM SYST ECOL, V45, P224, DOI 10.1016/j.bse.2012.07.007; Dong YB, 2010, GENET RESOUR CROP EV, V57, P915, DOI 10.1007/s10722-009-9523-2; [董轶博 DONG Yibo], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P218; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Glazinska P, 2009, J PLANT PHYSIOL, V166, P1801, DOI 10.1016/j.jplph.2009.05.011; Guleria P, 2012, MICRORNAS THEIR ROLE, P265; Hagiwara WE, 2009, MOL ECOL, V18, P1537, DOI 10.1111/j.1365-294X.2009.04119.x; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Jarillo JA, 2008, SPAN J AGRIC RES, V6, P221, DOI 10.5424/sjar/200806S1-391; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Oikawa T, 2004, PLANT MOL BIOL, V55, P687, DOI 10.1007/s11103-004-1692-y; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Quesada V, 2005, INT J DEV BIOL, V49, P773, DOI 10.1387/ijdb.051995vq; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sun LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043760; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang Y, 2012, NEW PHYTOL, V196, P914, DOI 10.1111/j.1469-8137.2012.04304.x; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Westholm JO, 2011, BIOCHIMIE, V93, P1897, DOI 10.1016/j.biochi.2011.06.017; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xiao JH, 1996, NATURE, V384, P223, DOI 10.1038/384223a0; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yano M, 2001, PLANT PHYSIOL, V127, P1425, DOI 10.1104/pp.010710; Yu CH, 2011, FLOWERING HABITS FER, p39 21; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383; Zhu Q-H, 2012, MICRORNAS PLANT DEV, P149; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	66	25	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82844	10.1371/journal.pone.0082844	http://dx.doi.org/10.1371/journal.pone.0082844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386120	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700013
J	Gustafsson, JK; Navabi, N; Rodriguez-Pineiro, AM; Alomran, AHA; Premaratne, P; Fernandez, HR; Banerjee, D; Sjovall, H; Hansson, GC; Linden, SK				Gustafsson, Jenny K.; Navabi, Nazanin; Rodriguez-Pineiro, Ana M.; Alomran, Ala H. A.; Premaratne, Pushpa; Fernandez, Harvey R.; Banerjee, Debashish; Sjovall, Henrik; Hansson, Gunnar C.; Linden, Sara K.			Dynamic Changes in Mucus Thickness and Ion Secretion during Citrobacter rodentium Infection and Clearance	PLOS ONE			English	Article							CYSTIC-FIBROSIS; INTESTINAL MUCUS; MUCOSAL BARRIER; MUCIN DYNAMICS; MOUSE SMALL; BICARBONATE; CFTR; CELLS; COLON; IDENTIFICATION	Citrobacter rodentium is an attaching and effacing pathogen used as a murine model for enteropathogenic Escherichia coli. The mucus layers are a complex matrix of molecules, and mucus swelling, hydration and permeability are affected by many factors, including ion composition. Here, we used the C. rodentium model to investigate mucus dynamics during infection. By measuring the mucus layer thickness in tissue explants during infection, we demonstrated that the thickness changes dynamically during the course of infection and that its thickest stage coincides with the start of a decrease of bacterial density at day 14 after infection. Although quantitative PCR analysis demonstrated that mucin mRNA increases during early infection, the increased mucus layer thickness late in infection was not explained by increased mRNA levels. Proteomic analysis of mucus did not demonstrate the appearance of additional mucins, but revealed an increased number of proteins involved in defense responses. Ussing chamber-based electrical measurements demonstrated that ion secretion was dynamically altered during the infection phases. Furthermore, the bicarbonate ion channel Bestrophin-2 mRNA nominally increased, whereas the Cftr mRNA decreased during the late infection clearance phase. Microscopy of Muc2 immunostained tissues suggested that the inner striated mucus layer present in the healthy colon was scarce during the time point of most severe infection (10 days post infection), but then expanded, albeit with a less structured appearance, during the expulsion phase. Together with previously published literature, the data implies a model for clearance where a change in secretion allows reformation of the mucus layer, displacing the pathogen to the outer mucus layer, where it is then outcompeted by the returning commensal flora. In conclusion, mucus and ion secretion are dynamically altered during the C. rodentium infection cycle.	[Gustafsson, Jenny K.; Navabi, Nazanin; Rodriguez-Pineiro, Ana M.; Alomran, Ala H. A.; Premaratne, Pushpa; Fernandez, Harvey R.; Banerjee, Debashish; Hansson, Gunnar C.; Linden, Sara K.] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Sjovall, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Linden, SK (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	sara.linden@gu.se	Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019; Rodriguez-Pineiro, Ana M./AAF-6353-2020; Linden, Sara/A-3271-2011	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Fernandez, Harvey/0000-0003-0878-5570; Linden, Sara/0000-0002-7751-9586	Swedish Research Council [7461, 21027, 21372, 21955]; Swedish Research Council Formas [221-2011-1036]; Swedish Cancer Foundation; Ake Wibergs Foundation; Knut and Alice Wallenberg Foundation; Inga Britt and Arne Lundberg Foundation; Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Jeansson Foundation; Ake Wiberg Foundation; Wilhelm och Martina Lundgrens Vetenskapsfond; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Cancer Foundation; Ake Wibergs Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga Britt and Arne Lundberg Foundation; Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; Jeansson Foundation; Ake Wiberg Foundation; Wilhelm och Martina Lundgrens Vetenskapsfond; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 7461, 21027, 21372 and 21955, http://www.vr.se/), the Swedish Research Council Formas (221-2011-1036, http://www.formas.se/), The Swedish Cancer Foundation, Ake Wibergs Foundation, The Knut and Alice Wallenberg Foundation, Inga Britt and Arne Lundberg Foundation, Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser (http://www.ragnarsoderbergsstiftelse.se/), The Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program, (www.cancerfonden.se), the Jeansson Foundation (www.jeanssonsstiftelser.se/), the Ake Wiberg Foundation (www.ake-wiberg.com/) and Wilhelm och Martina Lundgrens Vetenskapsfond (http://www.wmlundgren.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Gustafsson JK, 2012, METHODS MOL BIOL, V842, P237, DOI 10.1007/978-1-61779-513-8_14; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Joo N S, 2001, JOP, V2, P280; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; KHAN WI, 1995, PARASITE IMMUNOL, V17, P485, DOI 10.1111/j.1365-3024.1995.tb00919.x; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Malmberg EK, 2006, AM J PHYSIOL-GASTR L, V291, pG203, DOI 10.1152/ajpgi.00491.2005; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Muchekehu RW, 2010, J PHYSIOL-LONDON, V588, P2329, DOI 10.1113/jphysiol.2010.187237; Navabi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068761; Navabi N, 2013, INFECT IMMUN, V81, P829, DOI 10.1128/IAI.01000-12; Parmley RR, 1998, J CLIN INVEST, V102, P1798, DOI 10.1172/JCI3820; Philips MA, 2009, BIOL CELL, V101, P361, DOI 10.1042/BC20080086; Rodriguez-Pineiro AM, 2012, J PROTEOME RES, V11, P1879, DOI 10.1021/pr2010988; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Shiomi H, 2010, INFECT IMMUN, V78, P2653, DOI 10.1128/IAI.01343-09; Singh AK, 2013, J PHYSIOL-LONDON, V591, P2189, DOI 10.1113/jphysiol.2012.247874; Skinn AC, 2006, CAN J PHYSIOL PHARM, V84, P1301, DOI 10.1139/Y06-086; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Stefanovic B, 2004, MOL CELL BIOL, V24, P1758, DOI 10.1128/MCB.24.4.1758-1768.2004; Sterling D, 2002, AM J PHYSIOL-CELL PH, V283, pC1522, DOI 10.1152/ajpcell.00115.2002; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07; Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG753, DOI 10.1152/ajpgi.2000.278.5.G753; VERDUGO P, 1991, AM REV RESPIR DIS, V144, pS33, DOI 10.1164/ajrccm/144.3_pt_2.S33; Verdugo P, 1991, MUCIN EXOCYTOSIS, V144, pS33; Vidyasagar S, 2004, AM J PHYSIOL-CELL PH, V287, pC612, DOI 10.1152/ajpcell.00474.2003; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129	53	36	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84430	10.1371/journal.pone.0084430	http://dx.doi.org/10.1371/journal.pone.0084430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386378	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700106
J	Liu, QH; He, SH; Groysman, L; Shaked, D; Russin, J; Cen, S; Mack, WJ				Liu, Qinghai; He, Shuhan; Groysman, Leonid; Shaked, David; Russin, Jonathan; Cen, Steven; Mack, William J.			White Matter Injury Due to Experimental Chronic Cerebral Hypoperfusion Is Associated with C5 Deposition	PLOS ONE			English	Article							COMPLEMENT COMPONENT; ALZHEIMERS-DISEASE; GLIAL ACTIVATION; MURINE MODELS; MOUSE MODEL; LESIONS; EXPRESSION; C3A; DYSFUNCTION; IMPAIRMENT	The C5 complement protein is a potent inflammatory mediator that has been implicated in the pathogenesis of both stroke and neurodegenerative disease. Microvascular failure is proposed as a potential mechanism of injury. Along these lines, this investigation examines the role of C5 in the setting of chronic cerebral hypoperfusion. Following experimental bilateral carotid artery stenosis, C5 protein deposition increases in the corpus callosum over thirty days (p<0.05). The time course is temporally consistent with the appearance of white matter injury. Concurrently, systemic serum C5 levels do not appear to differ between bilateral carotid artery stenosis and sham-operated mice, implicating a local cerebral process. Following bilateral carotid artery stenosis, C5 deficient mice demonstrate decreased white matter ischemia in the corpus callosum when compared to C5 sufficient controls (p<0.05). Further, the C5 deficient mice exhibit fewer reactive astrocytes and microglia (p<0.01). This study reveals that the C5 complement protein may play a critical role in mediating white matter injury through inflammation in the setting of chronic cerebral hypoperfusion.	[Liu, Qinghai; Mack, William J.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [He, Shuhan; Groysman, Leonid; Shaked, David; Russin, Jonathan; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Cen, Steven] Univ So Calif, Keck Sch Med, Dept Preventat Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	He, SH (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA.	Shuhanhe@usc.edu	He, Shuhan/AAF-1764-2020	He, Shuhan/0000-0002-9902-5077	NIH KL2 grant through the Southern California CTSI; SC CTSI (NIH/NCRR/NCATS) [KL2RR031991]; Wright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031991] Funding Source: NIH RePORTER	NIH KL2 grant through the Southern California CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Wright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	WJM is supported by an NIH KL2 grant through the Southern California CTSI. This publication/project was supported by SC CTSI (NIH/NCRR/NCATS) through Grant KL2RR031991, http://www.nih.gov/. SH is supported by the Wright Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Ager RR, 2010, J NEUROCHEM, V113, P389, DOI 10.1111/j.1471-4159.2010.06595.x; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; del Zoppo Gregory J, 2008, Rev Neurol Dis, V5 Suppl 1, pS12; Duan W, 2009, J NEUROL SCI, V285, P39, DOI 10.1016/j.jns.2009.05.010; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; Ducruet AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038664; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Foreman KE, 1996, INFLAMMATION, V20, P1, DOI 10.1007/BF01487740; HAVILAND DL, 1991, J BIOL CHEM, V266, P11818; Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Kim GH, 2008, NEUROSURGERY, V63, P122, DOI 10.1227/01.NEU.0000335079.70222.8D; Mack WJ, 2008, ACTA NEUROCHIR, V150, P779, DOI 10.1007/s00701-008-1618-6; Mack WJ, 2006, J NEUROSCI RES, V83, P883, DOI 10.1002/jnr.20775; Masumura M, 2001, NEUROSCI RES, V39, P401, DOI 10.1016/S0168-0102(01)00195-X; Miki K, 2009, J NEUROSCI RES, V87, P1270, DOI 10.1002/jnr.21925; Minkner K, 2005, NEURORADIOLOGY, V47, P425, DOI 10.1007/s00234-005-1358-8; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; Mulligan MS, 1997, J IMMUNOL, V158, P1857; Pavlovski D, 2012, FASEB J, V26, P3680, DOI 10.1096/fj.11-202382; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Rosenberg GA, 2001, STROKE, V32, P1162, DOI 10.1161/01.STR.32.5.1162; Sahu A, 1998, IMMUNOL RES, V17, P109, DOI 10.1007/BF02786436; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Suemoto CK, 2011, STROKE, V42, P3614, DOI 10.1161/STROKEAHA.111.628156; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Tomimoto H, 1996, STROKE, V27, P2069, DOI 10.1161/01.STR.27.11.2069; WAKITA H, 1994, ACTA NEUROPATHOL, V87, P484; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; WHEAT WH, 1987, J EXP MED, V165, P1442, DOI 10.1084/jem.165.5.1442; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94	38	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84802	10.1371/journal.pone.0084802	http://dx.doi.org/10.1371/journal.pone.0084802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386419	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700119
J	Liu, YH; El-Serag, HB; Jiao, L; Lee, J; Moore, D; Franco, LM; Tavakoli-Tabasi, S; Tsavachidis, S; Kuzniarek, J; Ramsey, DJ; White, DL				Liu, Yanhong; El-Serag, Hashem B.; Jiao, Li; Lee, JuSeog; Moore, David; Franco, Luis M.; Tavakoli-Tabasi, Shahriar; Tsavachidis, Spiridon; Kuzniarek, Jill; Ramsey, David J.; White, Donna L.			WNT Signaling Pathway Gene Polymorphisms and Risk of Hepatic Fibrosis and Inflammation in HCV-Infected Patients	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-2; BETA-CATENIN; LIVER FIBROSIS; BIOCHEMICAL MARKERS; C VIRUS; VALIDATION; EXPRESSION; FIBROTEST; THERAPY; CELLS	Background: Chronic hepatitis C infection is the leading cause of hepatocellular carcinoma (HCC), a highly lethal malignancy with rapidly increasing prevalence in the United States. Little is known about genetic variations and HCC risk. This study aimed to determine if genetic variation in Wnt signaling pathway genes are associated with advanced hepatic fibrosis and inflammation risk in a hepatitis C virus (HCV) infected population. Methods: We performed a genetic association cross-sectional study evaluating single nucleotide polymorphisms (SNPs) in 58 candidate genes and risk of FibroSURE-Acti Test determined advanced fibrosis (F3/F4-F4 advanced cases vs. F0-F3 mild controls) and inflammation (A2/A3-A3 advanced cases vs. A0-A2 mild controls). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) employing multivariate logistic regression. Haplotypes were inferred by the HAPLO. STAT program, interactions were evaluated using multifactor dimensionality reduction (MDR) analysis. Results: Among 425 chronically HCV-infected male veterans, 155 (37%) had advanced fibrosis and 180 (42%) had advanced inflammation. Of 3016 SNPs evaluated, eight were significantly associated with fibrosis risk (e. g., SFRP2 rs11937424: OR = 2.19, 95% CI 1.48-3.23, P = 0.00004), and seven were significantly associated with inflammation risk (e. g., SFRP1 rs16890282: OR = 2.15, 95% CI 1.39-3.16, P = 0.0004). MDR analysis identified overweight/obese, SOST rs1405952, SFRP2 rs11937424, and FZD4 rs11234870 as the best interaction model for predicting risk of fibrosis; whereas race/ethnicity, FZD1 rs1346665, and TBX3 rs1520177 as the best interaction model for predicting risk of inflammation. Conclusions: Polymorphisms in several genes involved in the Wnt signaling pathway were associated with hepatic fibrosis or inflammation risk in HCV-infected males. Additional studies in other multi-ethnic HCV cohorts are needed to validate our findings in males and to assess if similar associations exist in chronically HCV-infected females.	[Liu, Yanhong] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [El-Serag, Hashem B.; Jiao, Li; White, Donna L.] Michael E DeBakey VA Med Ctr, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA; [El-Serag, Hashem B.; Jiao, Li; Tavakoli-Tabasi, Shahriar; Kuzniarek, Jill; Ramsey, David J.; White, Donna L.] Baylor Coll Med, Houston, TX 77030 USA; [El-Serag, Hashem B.; Jiao, Li; Kuzniarek, Jill; Ramsey, David J.; White, Donna L.] Michael E DeBakey VA Med Ctr, Clin Epidemiol & Comparat Effectiveness Program, Sect Hlth Serv Res IQuEST, Houston, TX USA; [Liu, Yanhong; El-Serag, Hashem B.; Jiao, Li; Tsavachidis, Spiridon; White, Donna L.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [El-Serag, Hashem B.; Jiao, Li; White, Donna L.] Texas Med Ctr, Ctr Digest Dis, Houston, TX USA; [Jiao, Li; White, Donna L.] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX USA; [Lee, JuSeog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Moore, David] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Moore, David] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Franco, Luis M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tavakoli-Tabasi, Shahriar] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	White, DL (corresponding author), Michael E DeBakey VA Med Ctr, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA.	dwhite1@bcm.edu	White, Donna/AAZ-9349-2021; liu, yan/HCI-5542-2022	White, Donna/0000-0003-0297-2949; Ramsey, David/0000-0002-5504-812X	VA Clinical Research and Development Merit Review Award [H-22934]; Diana Helis Henry Medical Research Foundation; National Institute of Diabetes Digestive and Kidney Diseases [R03 DK095082, K24 DK04-107, K01 DK081736]; Texas Medical Center Digestive Disease Center [P30 DK56338]; Houston Veterans Affairs Health Services Research and Development Center of Excellence [HFP90-020]; National Institute of Allergy and Infectious Diseases [K23 AI 087821]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI087821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095082, K01DK081736, P30DK056338] Funding Source: NIH RePORTER	VA Clinical Research and Development Merit Review Award; Diana Helis Henry Medical Research Foundation; National Institute of Diabetes Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Texas Medical Center Digestive Disease Center; Houston Veterans Affairs Health Services Research and Development Center of Excellence; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded in part by a VA Clinical Research and Development Merit Review Award H-22934 (PI: El-Serag), a Diana Helis Henry Medical Research Foundation grant (PI: Moore), the National Institute of Diabetes Digestive and Kidney Diseases (R03 DK095082, PI: White), and a Texas Medical Center Digestive Disease Center (P30 DK56338) pilot grant (PI: White). Drs. White's and El-Serag's effort was supported in part by the National Institute of Diabetes Digestive and Kidney Diseases (K24 DK04-107 and K01 DK081736, respectively) and the Houston Veterans Affairs Health Services Research and Development Center of Excellence (HFP90-020). Dr. Franco receives support from the National Institute of Allergy and Infectious Diseases (K23 AI 087821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; Gonzalez-Reimers E, 2013, ALCOHOL ALCOHOLISM, V48, P278, DOI 10.1093/alcalc/ags136; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Halfon P, 2006, AM J GASTROENTEROL, V101, P547, DOI 10.1111/j.1572-0241.2006.00411.x; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Huang CK, 2013, HEPATOLOGY, V57, P1550, DOI 10.1002/hep.26135; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; LEWONTIN RC, 1988, GENETICS, V120, P849; Li Y, 2013, ENDOCR-RELAT CANCER, V20, P293, DOI 10.1530/ERC-12-0328; Merle P, 2005, J HEPATOL, V43, P854, DOI 10.1016/j.jhep.2005.05.018; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Patel K, 2009, J VIRAL HEPATITIS, V16, P178, DOI 10.1111/j.1365-2893.2008.01062.x; Poynard T, 2010, GASTROEN CLIN BIOL, V34, P388, DOI 10.1016/j.gcb.2010.05.001; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Poynard T, 2012, J HEPATOL, V56, P541, DOI 10.1016/j.jhep.2011.08.007; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Takahara Y, 2008, WORLD J GASTROENTERO, V14, P2010, DOI 10.3748/wjg.14.2010; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; White DL, 2012, HEPATOLOGY, V55, P759, DOI 10.1002/hep.24618	32	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84407	10.1371/journal.pone.0084407	http://dx.doi.org/10.1371/journal.pone.0084407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386373	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700105
J	Terris-Prestholt, F; Hanson, K; MacPhail, C; Vickerman, P; Rees, H; Watts, C				Terris-Prestholt, Fern; Hanson, Kara; MacPhail, Catherine; Vickerman, Peter; Rees, Helen; Watts, Charlotte			How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa	PLOS ONE			English	Article							VACCINE ACCEPTABILITY; PREEXPOSURE PROPHYLAXIS; EPIDEMIOLOGIC IMPACT; VAGINAL MICROBICIDES; COST-EFFECTIVENESS; MEN; INFECTION; DIAPHRAGM; GEL; SEX	Background: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experiment (DCE) to: understand the relative strength of women's preferences for product characteristics, understand the implications for substitution away from male condoms, and inform realistic modelling of their potential impact and cost-effectiveness. Methods: A DCE was conducted among 1017 women in urban South Africa. Women were presented with choices between potential women's NPTs (microbicides, diaphragm, female condom) and 'what I did last time' (use or not use a condom) with different HIV and pregnancy prevention effectiveness' and prices. Choice probabilities are estimated using the nested logit model and used to predict uptake. Results: In this high HIV prevalence setting, HIV prevention effectiveness is the main driver of uptake followed by pregnancy prevention effectiveness. For example a microbicide with poor effectiveness would have niche appeal at just 11% predicted uptake, while a highly effective microbicide (95% effective against HIV and pregnancy) would have far wider appeal (56% predicted uptake). Though women who reported not using condoms were more likely to choose the NPTs, at current very high rates of male condom use in South Africa (60%), about half of microbicide uptake is projected to be among those currently not using condoms. Conclusions: Women are very interested in NPTs, especially if highly effective in preventing HIV and pregnancy. Women in greatest need were also most likely to switch to the new products. Where products are not yet available for distribution, proxy data, such as that generated by DCEs, can bring realism to overly optimistic uptake scenarios found in many current impact models.	[Terris-Prestholt, Fern; Hanson, Kara; Vickerman, Peter; Watts, Charlotte] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [MacPhail, Catherine; Rees, Helen] Wits Reprod Hlth & HIV Inst, Johannesburg, Gauteng, South Africa; [MacPhail, Catherine] Univ New England, Collaborat Res Network Mental Hlth & Wellbeing Ru, Armidale, NSW, Australia	University of London; London School of Hygiene & Tropical Medicine; University of New England	Terris-Prestholt, F (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Fern.Terris-Prestholt@lshtm.ac.uk	MacPhail, Catherine/N-4234-2014	MacPhail, Catherine/0000-0002-0614-0157; Rees, Helen/0000-0003-1442-6734; Vickerman, Peter/0000-0002-8291-5890; Terris-Prestholt, Fern/0000-0003-1693-5196	Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine; Microbicide Development Programme (MDP); British Department for International Development (DfID); UK Medical Research Council	Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine; Microbicide Development Programme (MDP); British Department for International Development (DfID); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a fellowship supported by the Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine and the Microbicide Development Programme (MDP). MDP is a partnership of African UK and Spanish academic/government institutions and commercial organisations. MDP was funded by the British Department for International Development (DfID) and the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsallaq RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054575; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Brau R, 2008, HEALTH ECON, V17, P411, DOI 10.1002/hec.1271; Cameron MP, 2013, VACCINE, V31, P3712, DOI 10.1016/j.vaccine.2013.05.089; ChoiceMetrics Pty Ltd, 2010, NGEN 1 1, V1; Clark MR, 2011, INFECT DIS OBSTET GY, V2011; Cohen J., 2003, APPL MULTIPLE REGRES; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Dimitrov DT, 2011, J THEOR BIOL, V288, P9, DOI 10.1016/j.jtbi.2011.08.001; FACTS consortium, 2012, FACTS 001 STUD; Friend DR, 2010, ANTIVIR RES, V88, pS47, DOI 10.1016/j.antiviral.2010.09.005; Gafos M, 2013, AIDS CARE, V25, P573, DOI 10.1080/09540121.2012.722604; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Gray RT, 2011, VACCINE, V29, P6125, DOI 10.1016/j.vaccine.2011.06.061; Greene W.H., 2007, ECONOMETRIC ANAL; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Harrison PF, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/790154; Henscher D, 2005, APPL CHOICE ANAL PRI; Hensher DA, 2010, TRANSPORT RES B-METH, V44, P735, DOI 10.1016/j.trb.2009.12.012; Holt BY, 2010, CONTRACEPTION, V81, P177, DOI 10.1016/j.contraception.2009.11.009; Holt K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002208; KARIM QA, 2010, SCIENCE; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; Lee SJ, 2012, INT J STD AIDS, V23, P235, DOI 10.1258/ijsa.2011.011189; Lee SJ, 2008, AIDS CARE, V20, P1161, DOI 10.1080/09540120701855375; Luchters S, 2007, EUR J CONTRACEP REPR, V12, P345, DOI 10.1080/13625180701516989; MacPhail C, 2008, MICROBICIDES 2008; MacPhail C, 2009, CULT HEALTH SEX, V11, P485, DOI 10.1080/13691050902803537; Marrazzo J, 2013, PREEXPOSURE PROPHYLA; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Mensch BS, 2012, CURR OPIN HIV AIDS, V7, P534, DOI 10.1097/COH.0b013e3283590632; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Newman PA, 2010, VACCINE, V28, P958, DOI 10.1016/j.vaccine.2009.10.142; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; OANDA, 2013, OANDA CURR CONV; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Schwartz JL, 2008, CONTRACEPTION, V78, P237, DOI 10.1016/j.contraception.2008.04.118; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC STUDY; Terris-Prestholt F., 2010, DETERMINANTS WOMENS; Terris-Prestholt F, 2009, VARIATION WOMENS PRE; Underhill K, 2013, SOC SCI MED; Verguet S, 2010, SEX TRANSM INFECT, V86, P212, DOI 10.1136/sti.2009.037176; Verguet S, 2013, SEXUALLY TRANSMITTED; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; Williams BG, 2011, JAIDS-J ACQ IMM DEF, V58, P207, DOI 10.1097/QAI.0b013e3182253c19	54	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83193	10.1371/journal.pone.0083193	http://dx.doi.org/10.1371/journal.pone.0083193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386160	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000329194700028
J	Yang, MX; Li, XM; Li, ZB; Ou, ZM; Liu, M; Liu, SH; Li, XJ; Yang, SY				Yang, Mingxing; Li, Xiumin; Li, Zhibin; Ou, Zhimin; Liu, Ming; Liu, Suhuan; Li, Xuejun; Yang, Shuyu			Gene Features Selection for Three-Class Disease Classification via Multiple Orthogonal Partial Least Square Discriminant Analysis and S-Plot Using Microarray Data	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; MOLECULAR CLASSIFICATION; MATRIX FACTORIZATION; TUMOR CLASSIFICATION; PLS-DA; CANCER; MULTICLASS; PREDICTION; REGRESSION; MODELS	Motivation: DNA microarray analysis is characterized by obtaining a large number of gene variables from a small number of observations. Cluster analysis is widely used to analyze DNA microarray data to make classification and diagnosis of disease. Because there are so many irrelevant and insignificant genes in a dataset, a feature selection approach must be employed in data analysis. The performance of cluster analysis of this high-throughput data depends on whether the feature selection approach chooses the most relevant genes associated with disease classes. Results: Here we proposed a new method using multiple Orthogonal Partial Least Squares-Discriminant Analysis (mOPLS-DA) models and S-plots to select the most relevant genes to conduct three-class disease classification and prediction. We tested our method using Golub's leukemia microarray data. For three classes with subtypes, we proposed hierarchical orthogonal partial least squares-discriminant analysis (OPLS-DA) models and S-plots to select features for two main classes and their subtypes. For three classes in parallel, we employed three OPLS-DA models and S-plots to choose marker genes for each class. The power of feature selection to classify and predict three-class disease was evaluated using cluster analysis. Further, the general performance of our method was tested using four public datasets and compared with those of four other feature selection methods. The results revealed that our method effectively selected the most relevant features for disease classification and prediction, and its performance was better than that of the other methods.	[Yang, Mingxing; Li, Xiumin; Li, Zhibin; Ou, Zhimin; Liu, Ming; Liu, Suhuan; Li, Xuejun; Yang, Shuyu] Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Xiamen, Peoples R China; [Li, Xuejun] Xiamen Univ, Affiliated Hosp 1, Dept Endocrinol & Diabet, Xiamen, Peoples R China; [Yang, Mingxing] Xiamen Univ, Sch Phys & Mech & Elect Engn, Dept Elect Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Li, XJ (corresponding author), Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Xiamen, Peoples R China.	lixuejun99@aliyun.com; xmyangshuyu@126.com	li, xiu/GXV-1745-2022		Xiamen Science and Technology Bureau [3502Z20100001]; National Natural Science Foundation [30973912, 81073113, 81270901]	Xiamen Science and Technology Bureau; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Xiamen Science and Technology Bureau (Xiamen Research Platform for Systems Biology of Metabolic Disease,3502Z20100001), National Natural Science Foundation to Shuyu Yang (30973912), Xuejun Li (81073113) and Suhuan Liu (81270901). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the menuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bicciato S, 2003, BIOINFORMATICS, V19, P571, DOI 10.1093/bioinformatics/btg051; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Devore J., 1997, STAT EXPLORATION ANA; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Eriksson L., 2006, MULTI MEGAVARIATE 1; Eriksson L., 2008, DESIGN EXPT PRINCIPL, V3rd ed.; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Huang CY, 2013, J PROTEOME RES, V12, P537, DOI 10.1021/pr301033a; Jenssen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042947; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee KR, 2003, PROTEOMICS, V3, P1680, DOI 10.1002/pmic.200300515; Lee Y, 2003, BIOINFORMATICS, V19, P1132, DOI 10.1093/bioinformatics/btg102; Li LP, 2001, BIOINFORMATICS, V17, P1131, DOI 10.1093/bioinformatics/17.12.1131; Liao W, 2012, J PROTEOME RES, V11, P3436, DOI 10.1021/pr300284h; Molteni CG, 2009, QSAR COMB SCI, V28, P822, DOI 10.1002/qsar.200860195; Nguyen DV, 2002, BIOINFORMATICS, V18, P1625, DOI 10.1093/bioinformatics/18.12.1625; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Porto-Pazos AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019109; Purohit PV, 2003, PROTEOMICS, V3, P1699, DOI 10.1002/pmic.200300518; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Shi XH, 2013, J PROTEOME RES; Skupin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058779; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Stephanopoulos G, 2002, BIOINFORMATICS, V18, P1054, DOI 10.1093/bioinformatics/18.8.1054; Su AI, 2001, CANCER RES, V61, P7388; Tan YX, 2004, COMPUT BIOL CHEM, V28, P235, DOI 10.1016/j.compbiolchem.2004.05.002; Thomas JG, 2001, GENOME RES, V11, P1227, DOI 10.1101/gr.165101; Tian Y, 2012, J PROTEOME RES, V11, P1397, DOI 10.1021/pr2011507; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wang J, 2012, 21 INT C PATT REC IC; Wang JJY, 2013, PATTERN RECOGN, V46, P2840, DOI 10.1016/j.patcog.2013.03.007; Wang JJY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-107; Whelehan OP, 2006, CHEMOMETR INTELL LAB, V84, P82, DOI 10.1016/j.chemolab.2006.03.008; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wold H., 1975, PERSPECTIVES PROBABI, V12, P117, DOI [10.1017/s0021900200047604, DOI 10.1017/S0021900200047604, 10.1017/S0021900200047604]; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Xie GX, 2012, J PROTEOME RES, V11, P3449, DOI 10.1021/pr300318m; Yang MX, 2012, TALANTA, V88, P136, DOI 10.1016/j.talanta.2011.10.022; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	57	31	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84253	10.1371/journal.pone.0084253	http://dx.doi.org/10.1371/journal.pone.0084253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386356	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700097
J	Zeng, J; Chen, XX; Dai, JP; Zhao, XF; Xin, G; Su, Y; Wang, GF; Li, R; Yan, YX; Su, JH; Deng, YX; Li, KS				Zeng, Jun; Chen, Xiao Xuan; Dai, Jian Ping; Zhao, Xiang Feng; Xin, Gang; Su, Yun; Wang, Ge Fei; Li, Rui; Yan, Yin Xia; Su, Jing Hua; Deng, Yu Xue; Li, Kang Sheng			An Attenuated Coxsackievirus B3 Vector: A Potential Tool for Viral Tracking Study and Gene Delivery	PLOS ONE			English	Article							HEART-FAILURE; EXPRESSION; CARDIOVIRULENT; TRANSDUCTION; GENERATION; THERAPY; GENOME; MICE	Cardiomyocytes are quite resistant to gene transfer using standard techniques. We developed an expression vector carrying an attenuated but infectious and replicative coxsackievirus B3 (CVB3) genome, and unique ClaI-StuI cloning sites for an exogenous gene, whose product can be released from the nascent viral polyprotein by 2A(pro) cleavage. This vector was tested as an expression vehicle for green fluorescent protein (GFP). The vector transiently expressed GFP in cell cultures for at least ten passages and delivered functional GFP to the infected cardiomyocytes for at least 6 days. Moreover, the recombinant viruses showed virulence attenuation in vitro and in vivo. The findings suggest that the recombinant CVB3 vector could be a useful tool for viral tracking study and delivering exogenous proteins to cardiomyocytes.	[Zeng, Jun; Chen, Xiao Xuan; Dai, Jian Ping; Zhao, Xiang Feng; Xin, Gang; Su, Yun; Wang, Ge Fei; Li, Rui; Yan, Yin Xia; Su, Jing Hua; Deng, Yu Xue; Li, Kang Sheng] Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou, Guangdong, Peoples R China; [Zeng, Jun] Three Gorges Univ, Coll Med, Dept Endocrinol, Hosp Yichang 1, Yichang, Hubei, Peoples R China	Shantou University; China Three Gorges University	Wang, GF (corresponding author), Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou, Guangdong, Peoples R China.	gfwangcn@gmail.com; ksli@stu.edu.cn		Li, Kangsheng/0000-0002-6981-9263; Zeng, Jun/0000-0002-4317-2182	National Natural Science Foundation of China [81001322, 30972766, 31170852, 31300761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81001322, 30972766 and 31170852). This study was also supported in part by National Natural Science Foundation of China (31300761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2007, J VIROL, V81, P650, DOI 10.1128/JVI.01327-06; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Chaanine AH, 2010, SEMIN THORAC CARDIOV, V22, P127, DOI 10.1053/j.semtcvs.2010.09.009; Chapman NM, 2000, J VIROL, V74, P7952, DOI 10.1128/JVI.74.17.7952-7962.2000; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Djurovic S, 2004, MOL BIOTECHNOL, V28, P21, DOI 10.1385/MB:28:1:21; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Harvala H, 2005, J GEN VIROL, V86, P1897, DOI 10.1099/vir.0.80603-0; Hofling K, 2000, J VIROL, V74, P4570, DOI 10.1128/JVI.74.10.4570-4578.2000; Kim DS, 2010, EXPERT OPIN BIOL TH, V10, P179, DOI 10.1517/14712590903379502; Ly HQ, 2008, J CARDIOVASC TRANSL, V1, P127, DOI 10.1007/s12265-008-9022-4; Meyer RG, 2004, VIRUS RES, V104, P17, DOI 10.1016/j.virusres.2004.02.037; Molin Y, 2009, MICROBES INFECT, V11, P493, DOI 10.1016/j.micinf.2009.02.002; Mueller S, 1998, J VIROL, V72, P20, DOI 10.1128/JVI.72.1.20-31.1998; Pan JY, 2011, J VIROL, V85, P7436, DOI 10.1128/JVI.00503-11; Tilemann L, 2012, CIRC RES, V110, P777, DOI 10.1161/CIRCRESAHA.111.252981; Toivonen R, 2010, HISTOCHEM CELL BIOL, V133, P349, DOI 10.1007/s00418-009-0666-1; TRACY S, 1992, ARCH VIROL, V122, P399, DOI 10.1007/BF01317202; TU ZG, 1995, J VIROL, V69, P4607, DOI 10.1128/JVI.69.8.4607-4618.1995	19	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83753	10.1371/journal.pone.0083753	http://dx.doi.org/10.1371/journal.pone.0083753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386270	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700064
J	Akhmedov, K; Rizzo, V; Kadakkuzha, BM; Carter, CJ; Magoski, NS; Capo, TR; Puthanveettil, SV				Akhmedov, Komolitdin; Rizzo, Valerio; Kadakkuzha, Beena M.; Carter, Christopher J.; Magoski, Neil S.; Capo, Thomas R.; Puthanveettil, Sathyanarayanan V.			Decreased Response to Acetylcholine during Aging of Aplysia Neuron R15	PLOS ONE			English	Article							AGE-RELATED-CHANGES; CHOLINERGIC SYNAPTIC-TRANSMISSION; MESSENGER-RNA EXPRESSION; CALCIUM-CHANNELS; ELECTROPHYSIOLOGICAL PROPERTIES; ABDOMINAL-GANGLION; IDENTIFIED NEURONS; BEHAVIORAL-CHANGES; PYRAMIDAL CELLS; HUMAN BRAIN	How aging affects the communication between neurons is poorly understood. To address this question, we have studied the electrophysiological properties of identified neuron R15 of the marine mollusk Aplysia californica. R15 is a bursting neuron in the abdominal ganglia of the central nervous system and is implicated in reproduction, water balance, and heart function. Exposure to acetylcholine (ACh) causes an increase in R15 burst firing. Whole-cell recordings of R15 in the intact ganglia dissected from mature and old Aplysia showed specific changes in burst firing and properties of action potentials induced by ACh. We found that while there were no significant changes in resting membrane potential and latency in response to ACh, the burst number and burst duration is altered during aging. The action potential waveform analysis showed that unlike mature neurons, the duration of depolarization and the repolarization amplitude and duration did not change in old neurons in response to ACh. Furthermore, single neuron quantitative analysis of acetylcholine receptors (AChRs) suggested alteration of expression of specific AChRs in R15 neurons during aging. These results suggest a defect in cholinergic transmission during aging of the R15 neuron.	[Akhmedov, Komolitdin; Rizzo, Valerio; Kadakkuzha, Beena M.; Puthanveettil, Sathyanarayanan V.] Scripps Florida, Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Carter, Christopher J.; Magoski, Neil S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Capo, Thomas R.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA	Scripps Research Institute; State University System of Florida; University of Florida; Queens University - Canada; University of Miami	Puthanveettil, SV (corresponding author), Scripps Florida, Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	sputhanv@scripps.edu	Kadakkuzha, Beena/B-8344-2014	Kadakkuzha, Beena/0000-0001-8225-5231; Rizzo, Valerio/0000-0002-6610-7324	Landenberger Foundation; Whitehall foundation; Scripps Research Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010952] Funding Source: NIH RePORTER	Landenberger Foundation; Whitehall foundation; Scripps Research Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge funding support from Landenberger Foundation, Whitehall foundation, and start up funds from The Scripps Research Institute to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WB, 1985, J PHYSIOL-LONDON, V360, P51, DOI 10.1113/jphysiol.1985.sp015603; ADAMS WB, 1985, PROG BIOPHYS MOL BIO, V46, P1, DOI 10.1016/0079-6107(85)90011-2; Akhmedov K, 2014, JOVE-J VIS EXP, DOI 10.3791/51075; ALEVIZOS A, 1991, J NEUROSCI, V11, P1275; ALEVIZOS A, 1991, J NEUROSCI, V11, P1263; ALEVIZOS A, 1991, J NEUROSCI, V11, P1282; Almaguer W, 2002, NEUROBIOL AGING, V23, P319, DOI 10.1016/S0197-4580(01)00278-0; BAILEY CH, 1983, BEHAV NEURAL BIOL, V38, P70, DOI 10.1016/S0163-1047(83)90399-0; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bertoni-Freddari C, 2007, ANN NY ACAD SCI, V1096, P128, DOI 10.1196/annals.1397.078; BLANKENSHIP JE, 1971, J NEUROPHYSIOL, V34, P76, DOI 10.1152/jn.1971.34.1.76; BUTERA RJ, 1995, J COMPUT NEUROSCI, V2, P19, DOI 10.1007/BF00962706; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; CANAVIER CC, 1991, J NEUROPHYSIOL, V66, P2107, DOI 10.1152/jn.1991.66.6.2107; CARPENTER DO, 1978, ABNORMAL NEURONAL DI, P189; CEPEDA C, 1992, NEUROSCIENCE, V51, P411, DOI 10.1016/0306-4522(92)90325-V; Charpantier E, 1999, DEV BRAIN RES, V118, P153, DOI 10.1016/S0165-3806(99)00157-1; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; Ferrari R, 1999, NEUROBIOL AGING, V20, P37, DOI 10.1016/S0197-4580(99)00015-9; Fieber LA, 2010, BRAIN RES, V1343, P28, DOI 10.1016/j.brainres.2010.05.001; Flinn Jane M., 1997, Invertebrate Neuroscience, V2, P253, DOI 10.1007/BF02211938; FRAZIER WT, 1967, J NEUROPHYSIOL, V30, P1288, DOI 10.1152/jn.1967.30.6.1288; Gerdes R, 2006, J AM ASSOC LAB ANIM, V45, P40; HERMANN A, 1981, J GEN PHYSIOL, V78, P63, DOI 10.1085/jgp.78.1.63; Jung DK, 2005, NEUROL RES, V27, P436, DOI 10.1179/016164105X22011; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelly KM, 2003, EPILEPSY RES, V57, P15, DOI 10.1016/j.eplepsyres.2003.10.007; KINDY MS, 1991, NEUROREPORT, V2, P465, DOI 10.1097/00001756-199108000-00014; LANDFIELD PW, 1978, BRAIN RES, V150, P85, DOI 10.1016/0006-8993(78)90655-8; Leal SL, 2013, AGEING RES REV, V12, P823, DOI 10.1016/j.arr.2013.01.006; LEVITAN ES, 1987, P NATL ACAD SCI USA, V84, P6307, DOI 10.1073/pnas.84.17.6307; Luebke JI, 2007, NEUROSCIENCE, V150, P556, DOI 10.1016/j.neuroscience.2007.09.042; Luebke JI, 2004, NEUROSCIENCE, V125, P277, DOI 10.1016/j.neuroscience.2004.01.035; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; Martella G, 2008, NEUROSCIENCE, V152, P469, DOI 10.1016/j.neuroscience.2007.12.040; Marutle A, 1998, BRAIN RES, V801, P143, DOI 10.1016/S0006-8993(98)00558-7; MEYER EM, 1984, NEUROBIOL AGING, V5, P315, DOI 10.1016/0197-4580(84)90008-3; Moroz LL, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.006.2010; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Murphy GG, 2004, CURR BIOL, V14, P1907, DOI 10.1016/j.cub.2004.10.021; Nygard M, 2005, BRAIN RES BULL, V65, P149, DOI 10.1016/j.brainresbull.2004.12.006; PAPKA R, 1981, J NEUROBIOL, V12, P455, DOI 10.1002/neu.480120505; PERETZ B, 1984, P NATL ACAD SCI-BIOL, V81, P4232; PERETZ B, 1982, J NEUROBIOL, V13, P141, DOI 10.1002/neu.480130206; Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RATTAN KS, 1981, J NEUROBIOL, V12, P469, DOI 10.1002/neu.480120506; Rex CS, 2005, J NEUROSCI, V25, P5956, DOI 10.1523/JNEUROSCI.0880-05.2005; Rogers SW, 1998, J NEUROSCI, V18, P4825; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Shen JM, 1996, NEUROBIOL AGING, V17, P439, DOI 10.1016/0197-4580(96)00020-6; Sibille Etienne, 2013, Dialogues Clin Neurosci, V15, P53; Sloan MA, 1999, J BIOL RHYTHM, V14, P151, DOI 10.1177/074873099129000542; SMITH DO, 1987, J NEUROCHEM, V48, P1834, DOI 10.1111/j.1471-4159.1987.tb05744.x; Southall MD, 1997, COMP BIOCHEM PHYS C, V118, P137, DOI 10.1016/S0742-8413(97)00109-6; Srivatsan M, 1996, BEHAV BRAIN RES, V77, P115, DOI 10.1016/0166-4328(95)00207-3; Stanley EM, 2012, SYNAPSE, V66, P445, DOI 10.1002/syn.21533; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Stommes D, 2005, CONTEMP TOP LAB ANIM, V44, P31; Tanaka Y, 1996, J NEUROSCI RES, V43, P63, DOI 10.1002/jnr.490430108; Tanaka Y, 2001, NEUROSCI RES, V39, P213, DOI 10.1016/S0168-0102(00)00212-1; TAYLOR L, 1993, NEUROBIOL AGING, V14, P509, DOI 10.1016/0197-4580(93)90110-W; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Tombaugh GC, 2002, J NEUROSCI, V22, P9932; TREMBLAY JP, 1976, BRAIN RES, V109, P61, DOI 10.1016/0006-8993(76)90380-2; Utsugisawa K, 1999, NEUROSCI LETT, V270, P145, DOI 10.1016/S0304-3940(99)00473-5; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; Woodruff-Pak DS, 2010, P NATL ACAD SCI USA, V107, P1624, DOI 10.1073/pnas.0914207107; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu XT, 2004, J NEUROPHYSIOL, V91, P2297, DOI 10.1152/jn.00787.2003; ZOLMAN JF, 1987, BEHAV NEUROSCI, V101, P524, DOI 10.1037/0735-7044.101.4.524	72	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84793	10.1371/journal.pone.0084793	http://dx.doi.org/10.1371/journal.pone.0084793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386417	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900111
J	Menon, R; Boldogh, I; Urrabaz-Garza, R; Polettini, J; Syed, TA; Saade, GR; Papaconstantinou, J; Taylor, RN				Menon, Ramkumar; Boldogh, Istvan; Urrabaz-Garza, Rheanna; Polettini, Jossimara; Syed, Tariq Ali; Saade, George R.; Papaconstantinou, John; Taylor, Robert N.			Senescence of Primary Amniotic Cells via Oxidative DNA Damage	PLOS ONE			English	Article							PRETERM PREMATURE RUPTURE; FACTOR-KAPPA-B; CIGARETTE-SMOKE; EPITHELIAL-CELLS; IN-VIVO; STRESS; ACTIVATION; MEMBRANES; OXYGEN; APOPTOSIS	Objective: Oxidative stress is a postulated etiology of spontaneous preterm birth (PTB) and preterm prelabor rupture of the membranes (pPROM); however, the precise mechanistic role of reactive oxygen species (ROS) in these complications is unclear. The objective of this study is to examine impact of a water soluble cigarette smoke extract (wsCSE), a predicted cause of pregnancy complications, on human amnion epithelial cells. Methods: Amnion cells isolated from fetal membranes were exposed to wsCSE prepared in cell culture medium and changes in ROS levels, DNA base and strand damage was determined by using 2 ' 7 '-dichlorodihydro-fluorescein and comet assays as well as Fragment Length Analysis using Repair Enzymes (FLARE) assays, respectively. Western blot analyses were used to determine the changes in mass and post-translational modification of apoptosis signal-regulating kinase (ASK1), phospho-p38 (P-p38 MAPK), and p19(arf). Expression of senescence-associated beta-galectosidase (SA beta-gal) was used to confirm cell ageing in situ. Results: ROS levels in wsCSE-exposed amnion cells increased rapidly (within 2 min) and significantly (p < 0.01) at all-time points, and DNA strand and base damage was evidenced by comet and FLARE assays. Activation of ASK1, P-p38 MAPK and p19(Arf) correlated with percentage of SA beta-gal expressing cells after wsCSE treatment. The antioxidant N-acetyl-L-cysteine (NAC) prevented ROS-induced DNA damage and phosphorylation of p38 MAPK, whereas activation of ASK1 and increased expression of p19(Arf) were not significantly affected by NAC. Conclusions: The findings support the hypothesis that compounds in wsCSE induces amnion cell senescence via a mechanism involving ROS and DNA damage. Both pathways may contribute to PTB and pPROM. Our results imply that antioxidant interventions that control ROS may interrupt pathways leading to pPROM and other causes of PTB.	[Menon, Ramkumar; Urrabaz-Garza, Rheanna; Polettini, Jossimara; Syed, Tariq Ali; Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med Perinatal Res, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Papaconstantinou, John] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Taylor, Robert N.] Wake Forest Sch Med, Dept Obstet & Gynecol, Winston Salem, NC USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Wake Forest University	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med Perinatal Res, Galveston, TX 77555 USA.	Ram.menon@utmb.edu	Polettini, Jossimara/K-9437-2014; Polettini, Jossimara/M-8562-2019; Polettini, Jossimara/C-5814-2012	Polettini, Jossimara/0000-0002-6719-8715; Polettini, Jossimara/0000-0002-6719-8715; Polettini, Jossimara/0000-0002-6719-8715	UTMB development funds	UTMB development funds	This work was supported by UTMB development funds provided to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; BENNETT PR, 1987, AM J OBSTET GYNECOL, V156, P649, DOI 10.1016/0002-9378(87)90070-6; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Cha J, 2012, CELL CYCLE, V11, P205, DOI 10.4161/cc.11.2.18781; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Colombo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029930; Colombo G, 2010, ANTIOXID REDOX SIGN, V12, P349, DOI 10.1089/ars.2009.2806; Coughlan MT, 2004, J CLIN ENDOCR METAB, V89, P3585, DOI 10.1210/jc.2003-031953; Cukusic A, 2008, CYTOGENET GENOME RES, V122, P263, DOI 10.1159/000167812; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; De Boeck M, 2000, MUTAT RES-GEN TOX EN, V469, P181, DOI 10.1016/S1383-5718(00)00075-9; Dennery PA, 2010, FREE RADICAL BIO MED, V49, P1147, DOI 10.1016/j.freeradbiomed.2010.07.011; Dietrich M, 2003, AM J CLIN NUTR, V77, P160, DOI 10.1093/ajcn/77.1.160; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194; Hsieh CC, 2009, AGING-US, V1, P784, DOI 10.18632/aging.100077; Kniss DA, 2002, PLACENTA, V23, P32, DOI 10.1053/plac.2001.0749; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; LEANDERSON P, 1993, ANN NY ACAD SCI, V686, P249, DOI 10.1111/j.1749-6632.1993.tb39183.x; Lim R, 2013, REPROD SCI, V20, P957, DOI 10.1177/1933719112472741; Longini M, 2007, CLIN BIOCHEM, V40, P793, DOI 10.1016/j.clinbiochem.2007.03.004; Menon R, 2004, J PERINAT MED, V32, P391, DOI 10.1515/JPM.2004.134; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Mercer BM, 1997, INFECT DIS CLIN N AM, V11, P177, DOI 10.1016/S0891-5520(05)70348-2; Milyavsky M, 2001, NUCLEIC ACIDS RES, V29, P5207, DOI 10.1093/nar/29.24.5207; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; MOORE JJ, 1991, J CLIN ENDOCR METAB, V72, P1073, DOI 10.1210/jcem-72-5-1073; Moore RM, 2003, PLACENTA, V24, P173, DOI 10.1053/plac.2002.0886; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Papaconstantinou J, 2010, CELL CYCLE, V9, P3831, DOI 10.4161/cc.9.19.13324; Passos JF, 2006, FREE RADICAL RES, V40, P1277, DOI 10.1080/10715760600917151; Reaper PM, 2004, CELL CYCLE, V3, P543; Rodgman A, 2000, HUM EXP TOXICOL, V19, P573, DOI 10.1191/096032700701546514; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saquib Q, 2012, MUTAT RES-GEN TOX EN, V744, P125, DOI 10.1016/j.mrgentox.2012.01.001; Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SPENCER JPE, 1995, FEBS LETT, V375, P179, DOI 10.1016/0014-5793(95)01199-O; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Vande Loock K, 2012, MUTAGENESIS, V27, P573, DOI 10.1093/mutage/ges022; Wall PD, 2002, J PERINAT MED, V30, P447, DOI 10.1515/JPM.2002.071; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; WISDOM SJ, 1991, AM J OBSTET GYNECOL, V165, P1701, DOI 10.1016/0002-9378(91)90018-M; Woods JR, 2001, PLACENTA, V22, pS38, DOI 10.1053/plac.2001.0638	59	82	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83416	10.1371/journal.pone.0083416	http://dx.doi.org/10.1371/journal.pone.0083416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386195	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900034
J	Snyder, JC; Rochelle, LK; Barak, LS; Caron, MG				Snyder, Joshua C.; Rochelle, Lauren K.; Barak, Larry S.; Caron, Marc G.			The Stem Cell-Expressed Receptor Lgr5 Possesses Canonical and Functionally Active Molecular Determinants Critical to beta-arrestin-2 Recruitment	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; CYSTINE KNOT PROTEIN; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; STIMULATING-HORMONE; WNT/BETA-CATENIN; STRUCTURAL BASIS; WNT RECEPTORS; DESENSITIZATION; PHOSPHORYLATION	Lgr5 is a membrane protein related to G protein-coupled receptors (GPCR)s whose expression identifies stem cells in multiple tissues and is strongly correlated with cancer. Despite the recent identification of endogenous ligands for Lgr5, its mode of signaling remains enigmatic. The ability to couple to G proteins and beta arrestins are classical molecular behaviors of GPCRs that have yet to be observed for Lgr5. Therefore, the goal of this study was to determine if Lgr5 can engage a classical GPCR behavior and elucidate the molecular determinants of this process. Structural analysis of Lgr5 revealed several motifs consistent with its ability to recruit beta arr2. Among them, a "SSS" serine cluster located at amino acid position 873-875 within the C-terminal tail (C-tail), is in a region consistent with other GPCRs that bind beta arr2 with high-affinity. To test its functionality, a ligand-independent beta arr2 translocation assay was implemented. We show that Lgr5 recruits beta arr2 and that the "SSS" amino acids (873-875) are absolutely critical to this process. We also demonstrate that for full efficacy, this cluster requires other Lgr5 C-tail serines that were previously shown to be important for constitutive and beta arr2 independent internalization of Lgr5. These data are proof of principle that a classical GPCR behavior can be manifested by Lgr5. The existence of alternative ligands or missing effectors of Lgr5 that scaffold this classical GPCR behavior and the downstream signaling pathways engaged should be considered. Characterizing Lgr5 signaling will be invaluable for assessing its role in tissue maintenance, repair, and disease.	[Snyder, Joshua C.; Rochelle, Lauren K.; Barak, Larry S.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	marc.caron@dm.duke.edu		Snyder, Joshua/0000-0002-9787-3371	Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; NIDA [P30 5P30DA29925]; NIMH [F32 NRSA 5F32MH092013-03]; NATIONAL CANCER INSTITUTE [R21CA173245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH092013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA029925] Funding Source: NIH RePORTER	Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Duke Cancer Center Stewart Trust and Duke Cancer Center Cancer and the Environment to JCS, LKR, LSB, and MGC; and NIDA P30 5P30DA29925 to LSB and MGC, and an NIMH F32 NRSA 5F32MH092013-03 to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak LS, 2013, BIOCHEMISTRY-US, V52, P5403, DOI 10.1021/bi400217r; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Evron T, 2012, TRENDS PHARMACOL SCI, V33, P154, DOI 10.1016/j.tips.2011.12.003; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Frenzel R, 2006, ENDOCRINOLOGY, V147, P3114, DOI 10.1210/en.2005-0687; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harwood BN, 2013, MOL PHARMACOL, V83, P814, DOI 10.1124/mol.112.081570; Hearn MTW, 2000, J MOL RECOGNIT, V13, P223, DOI 10.1002/1099-1352(200009/10)13:5<223::AID-JMR501>3.3.CO;2-C; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kingston R.E., 2001, CURRENT PROTOCOLS IM; Kwon MS, 2013, MOL CELLS, V36, P267, DOI 10.1007/s10059-013-0173-z; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Menard L, 1996, BIOCHEMISTRY-US, V35, P4155, DOI 10.1021/bi952961+; Nakamura K, 2000, J BIOL CHEM, V275, P241, DOI 10.1074/jbc.275.1.241; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oakley RH, 2006, METHOD ENZYMOL, V414, P50, DOI 10.1016/S0076-6879(06)14004-5; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schubert RL, 2003, ENDOCRINOLOGY, V144, P129, DOI 10.1210/en.2002-220829; Sharman JL, 2013, NUCLEIC ACIDS RES, V41, pD1083, DOI 10.1093/nar/gks960; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snyder JC, 2013, J BIOL CHEM; Troispoux C, 1999, MOL ENDOCRINOL, V13, P1599, DOI 10.1210/me.13.9.1599; Verkaar F, 2008, BIOTECHNOL ANN REV, V14, P253, DOI 10.1016/S1387-2656(08)00010-0; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilbanks AM, 2002, BIOCHEMISTRY-US, V41, P11981, DOI 10.1021/bi020275m; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	60	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84476	10.1371/journal.pone.0084476	http://dx.doi.org/10.1371/journal.pone.0084476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386388	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900098
J	Thorpe, AS; Perakis, S; Catricala, C; Kaye, TN				Thorpe, Andrea S.; Perakis, Steven; Catricala, Christina; Kaye, Thomas N.			Nutrient Limitation of Native and Invasive N-2-Fixing Plants in Northwest Prairies	PLOS ONE			English	Article							N-15 ISOTOPE-DILUTION; NITROGEN-FIXATION; NATURAL-ABUNDANCE; CRITICAL LOADS; ROOT-NODULES; N-2 FIXATION; PHOSPHORUS; SOIL; AVAILABILITY; ECOSYSTEMS	Nutrient rich conditions often promote plant invasions, yet additions of non-nitrogen (N) nutrients may provide a novel approach for conserving native symbiotic N-fixing plants in otherwise N-limited ecosystems. Lupinus oreganus is a threatened N-fixing plant endemic to prairies in western Oregon and southwest Washington (USA). We tested the effect of non-N fertilizers on the growth, reproduction, tissue N content, and stable isotope delta(15) N composition of Lupinus at three sites that differed in soil phosphorus (P) and N availability. We also examined changes in other Fabaceae (primarily Vicia sativa and V. hirsuta) and cover of all plant species. Variation in background soil P and N availability shaped patterns of nutrient limitation across sites. Where soil P and N were low, P additions increased Lupinus tissue N and altered foliar d delta N-15, suggesting P limitation of N fixation. Where soil P was low but N was high, P addition stimulated growth and reproduction in Lupinus. At a third site, with higher soil P, only micro-and macronutrient fertilization without N and P increased Lupinus growth and tissue N. Lupinus foliar delta(15) N averaged 20.010% across all treatments and varied little with tissue N, suggesting consistent use of fixed N. In contrast, foliar delta(15) N of Vicia spp. shifted towards 0% as tissue N increased, suggesting that conditions fostering N fixation may benefit these exotic species. Fertilization increased cover, N fixation, and tissue N of nontarget, exotic Fabaceae, but overall plant community structure shifted at only one site, and only after the dominant Lupinus was excluded from analyses. Our finding that non-N fertilization increased the performance of Lupinus with few community effects suggests a potential strategy to aid populations of threatened legume species. The increase in exotic Fabaceae species that occurred with fertilization further suggests that monitoring and adaptive management should accompany any large scale applications.	[Thorpe, Andrea S.; Kaye, Thomas N.] Inst Appl Ecol, Corvallis, OR USA; [Perakis, Steven; Catricala, Christina] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA	United States Department of the Interior; United States Geological Survey	Thorpe, AS (corresponding author), Natl Ecol Observ Network Inc, Boulder, CO 80301 USA.	athorpe@neoninc.org	Thorpe, Andrea/AAH-2684-2020	Thorpe, Andrea/0000-0002-0670-4135	US Geological Survey; Forest and Rangeland Ecosystem Science Center	US Geological Survey(United States Geological Survey); Forest and Rangeland Ecosystem Science Center	Funding for this project was provided by the US Geological Survey, Forest and Rangeland Ecosystem Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JPF, 2000, J EXP BOT, V51, P1289, DOI 10.1093/jexbot/51.348.1289; Barron AR, 2009, NAT GEOSCI, V2, P42, DOI 10.1038/NGEO366; BERGERSEN FJ, 1986, SOIL BIOL BIOCHEM, V18, P97, DOI 10.1016/0038-0717(86)90109-4; Boyd R., 1999, INDIANS FIRE LAND PA; Brown JR, 1996, P S 7 8 MAR COL MISS; CHARTER RA, 1995, COMMUN SOIL SCI PLAN, V26, P3051, DOI 10.1080/00103629509369508; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; EVANS J, 1987, FIELD CROP RES, V17, P109, DOI 10.1016/0378-4290(87)90086-4; Finzi AC, 2009, BIOGEOCHEMISTRY, V95, P309, DOI 10.1007/s10533-009-9338-4; Fisher K., 2002, Nitrogen fixation at the millennium, P1, DOI 10.1016/B978-044450965-9/50001-X; FRANKLIN JF, 1993, ECOL APPL, V3, P202, DOI 10.2307/1941820; Geiser LH, 2010, ENVIRON POLLUT, V158, P2412, DOI 10.1016/j.envpol.2010.04.001; Goergen E, 2009, APPL SOIL ECOL, V42, P200, DOI 10.1016/j.apsoil.2009.04.001; Gosling P, 2005, PLANT ECOL, V178, P141, DOI 10.1007/s11258-004-2782-2; HARDARSON G, 1991, PLANT SOIL, V131, P161, DOI 10.1007/BF00009445; Harpole WS., 2007, CALIFORNIA GRASSLAND; Haubensak K. A., 2001, THESIS U CALIFORNIA; Haubensak KA, 2011, BIOL INVASIONS, V13, P1275, DOI 10.1007/s10530-010-9904-7; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; HOWARTH RW, 1985, SCIENCE, V229, P653, DOI 10.1126/science.229.4714.653; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Johansen C., 1997, Molybdenum in agriculture., P202, DOI 10.1017/CBO9780511574689.014; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Leidi EO, 2000, NEW PHYTOL, V147, P337, DOI 10.1046/j.1469-8137.2000.00703.x; LONSDALE WM, 1993, J ENVIRON MANAGE, V39, P77, DOI 10.1006/jema.1993.1055; Lotscher M, 1997, J ECOL, V85, P341, DOI 10.2307/2960506; Maron JL, 1999, ECOLOGY, V80, P443, DOI 10.1890/0012-9658(1999)080[0443:BLMARA]2.0.CO;2; McCune B., 2005, MULTIVARIATE ANAL PC; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Myrold DD, 2003, PLANT SOIL, V254, P47, DOI 10.1023/A:1024951115548; Oregon State College Experiment Station, 1958, MOL PROBL OR; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Perakis SS, 2011, ECOSPHERE, V3, P1; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Roscher C, 2011, PLANT SOIL, V341, P333, DOI 10.1007/s11104-010-0647-0; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Sheley RL, 2003, WEED SCI, V51, P260, DOI 10.1614/0043-1745(2003)051[0260:PFRIPI]2.0.CO;2; SMITH VH, 1992, BIOGEOCHEMISTRY, V18, P19, DOI 10.1007/BF00000424; Stanley AG, 2008, NATIVE PLANTS J, V9, P255; Stanley AG, 2011, NORTHWEST SCI, V85, P233, DOI 10.3955/046.085.0212; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tang C, 1998, AUST J AGR RES, V49, P657, DOI 10.1071/A97145; TURNER GL, 1983, SOIL BIOL BIOCHEM, V15, P525, DOI 10.1016/0038-0717(83)90045-7; U.S. Fish and Wildlife Service, 2010, REC PLAN PRAIR SPEC, pxi; Unkovich M, 2001, CURR PLANT SCI BIOT, V40, P103; USDA NRCS, 2012, PLANTS DAT; VanAuken OW, 1997, INT J PLANT SCI, V158, P325, DOI 10.1086/297444; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Vitousek PM, 2013, PHILOS T RS B; Wall LG, 2000, SYMBIOSIS, V29, P91; Walsh MK, 2010, QUATERNARY SCI REV, V29, P1093, DOI 10.1016/j.quascirev.2010.02.011; West JB, 2005, NEW PHYTOL, V167, P523, DOI 10.1111/j.1469-8137.2005.01444.x; WITKOWSKI ETF, 1991, J APPL ECOL, V28, P1, DOI 10.2307/2404109; Wurzburger N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033710; Yelenik SG, 2007, BIOL INVASIONS, V9, P117, DOI 10.1007/s10530-006-0008-3	57	5	5	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84593	10.1371/journal.pone.0084593	http://dx.doi.org/10.1371/journal.pone.0084593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386399	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900103
J	Fecteau, S; Levasseur-Moreau, J; Garcia-Molina, A; Kumru, H; Vergara, RP; Bernabeu, M; Roig, T; Pascual-Leone, A; Tormos, JM				Fecteau, Shirley; Levasseur-Moreau, Jean; Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose			Risk Taking in Hospitalized Patients with Acute and Severe Traumatic Brain Injury	PLOS ONE			English	Article							DECISION-MAKING PROCESSES; COGNITIVE REHABILITATION; EXECUTIVE FUNCTION; HEAD-INJURY; TASK BART; ATTENTION; DYSFUNCTION; PROPENSITY; MORTALITY; BEHAVIOR	Rehabilitation can improve cognitive deficits observed in patients with traumatic brain injury (TBI). However, despite rehabilitation, the ability of making a choice often remains impaired. Risk taking is a daily activity involving numerous cognitive processes subserved by a complex neural network. In this work we investigated risk taking using the Balloon Analogue Risk Task (BART) in patients with acute TBI and healthy controls. We hypothesized that individuals with TBI will take less risk at the BART as compared to healthy individuals. We also predicted that within the TBI group factors such as the number of days since the injury, severity of the injury, and sites of the lesion will play a role in risk taking as assessed with the BART. Main findings revealed that participants with TBI displayed abnormally cautious risk taking at the BART as compared to healthy subjects. Moreover, healthy individuals showed increased risk taking throughout the task which is in line with previous work. However, individuals with TBI did not show this increased risk taking during the task. We also investigated the influence of three patients' characteristics on their performance at the BART: Number of days post injury, Severity of the head injury, and Status of the frontal lobe. Results indicate that performance at the BART was influenced by the number of days post injury and the status of the frontal lobe, but not by the severity of the head injury. Reported findings are encouraging for risk taking seems to naturally improve with time postinjury. They support the need of conducting longitudinal prospective studies to ultimately identify impaired and intact cognitive skills that should be trained postinjury.	[Fecteau, Shirley; Levasseur-Moreau, Jean] Univ Laval, Ctr Rech Univ Sante Mentale Quebec, Ctr Interdisciplinaire Rech Readaptat & Integrat, Sch Med, Quebec City, PQ, Canada; [Fecteau, Shirley; Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Sch Med, Boston, MA 02215 USA; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Inst Univ Neurorehabil Adscrit UAB, Inst Guttmann, Barcelona, Spain; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Garcia-Molina, Alberto; Kumru, Hatiche; Pelayo Vergara, Raul; Bernabeu, Monste; Roig, Teresa; Pascual-Leone, Alvaro; Maria Tormos, Jose] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain	Laval University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP)	Fecteau, S (corresponding author), Univ Laval, Ctr Rech Univ Sante Mentale Quebec, Ctr Interdisciplinaire Rech Readaptat & Integrat, Sch Med, Quebec City, PQ, Canada.	shirley.fecteau@fmed.ulaval.ca	Kumru, Hatice/ABB-1109-2021; Pascual-Leone, Alvaro/AAC-5101-2019; Fecteau, Shirley/N-3017-2016	Pascual-Leone, Alvaro/0000-0001-8975-0382; Fecteau, Shirley/0000-0002-9781-4451; Garcia-Molina, Alberto/0000-0002-5014-7591; Kumru, Hatice/0000-0002-0501-1660; Tormos Munoz, Jose Maria/0000-0002-8764-2289	Canada Research Chair in Cognitive Neuroplasticity; National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMC [NCRR MO1 RR01032]; Harvard Clinical and Translational Science Center [UL1 RR025758]; NIH [K24 RR018875]; Foundation La Marato TV3 [071931]; Instituto de Salud Carlos III [PI082004]; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, UL1RR025758, M01RR001032] Funding Source: NIH RePORTER	Canada Research Chair in Cognitive Neuroplasticity; National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard Clinical and Translational Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation La Marato TV3; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Canada Research Chair in Cognitive Neuroplasticity to SF, from the National Center for Research Resources: Harvard-Thorndike General Clinical Research Center at BIDMC (NCRR MO1 RR01032) and Harvard Clinical and Translational Science Center (UL1 RR025758), NIH grant K24 RR018875 to APL, and by the Foundation La Marato TV3 (071931) and grant PI082004 from the Instituto de Salud Carlos III to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Baguley I, 2000, BRAIN INJURY, V14, P505; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Boyle PA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-53; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chiu CYP, 2012, DEV NEUROPSYCHOL, V37, P176, DOI 10.1080/87565641.2011.632796; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Dams-O'Connor K, 2010, PSYCHIAT CLIN N AM, V33, P893, DOI 10.1016/j.psc.2010.08.002; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Drechsler R, 2008, J NEURAL TRANSM, V115, P201, DOI 10.1007/s00702-007-0814-5; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Garcia-Molina A, 2007, NEUROLOGIA, V22, P206; Gentleman D, 2001, TRAUMA, V3, P193, DOI DOI 10.1177/146040860100300401; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Gordon W.A., 2005, TXB TRAUMATIC BRAIN, P655; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Krishnan M, 2012, CLIN NEUROPSYCHOL, V26, P951, DOI 10.1080/13854046.2012.708166; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Leigh BC, 1999, ADDICTION, V94, P371, DOI 10.1046/j.1360-0443.1999.9433717.x; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lu J, 2005, ACT NEUR S, V95, P281; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2000, BRAIN INJURY, V14, P987; Nybo T, 1999, BRAIN INJURY, V13, P759; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544	62	5	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83598	10.1371/journal.pone.0083598	http://dx.doi.org/10.1371/journal.pone.0083598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386232	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700061
J	Zhou, Y; Li, Y; Xu, L; Xu, J; Wang, AX; Gao, X; Wu, SL; Wei, WB; Zhao, XQ; Jonas, JB				Zhou, Yong; Li, Yang; Xu, Liang; Xu, Jie; Wang, Anxing; Gao, Xiang; Wu, Shouling; Wei, Wen Bin; Zhao, Xingquan; Jonas, Jost B.			Asymptomatic Polyvascular Abnormalities in Community (APAC) Study in China: Objectives, Design and Baseline Characteristics	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; FIBER LAYER DEFECTS; OPTICAL COHERENCE TOMOGRAPHY; CAROTID-ARTERY STENOSIS; ATHEROSCLEROSIS RISK; INTRACRANIAL ATHEROSCLEROSIS; CEREBRAL INFARCTION; OCCLUSIVE DISEASE; BLOOD-PRESSURE; LIFETIME RISK	Objective: The population-based "Asymptomatic Polyvascular Abnormalities in Community (APAC) Study was designed to examine prevalence and associations of asymptomatic polyvascular abnormalities (APA) in a general population. In this report, the objectives, design and baseline data of the APAC study are described. Methods: The study included 5,440 participants (40.1% women) with an age of 40+ years who were randomly selected from the population of the Kailuan Study which included 101,510 employees and retirees of the Kailuan Co. Ltd, a large coal mine industry located in Tangshan, Hebei, China. Exclusion criteria were previous cerebral stroke, transient ischemic attacks and coronary heart disease. In 2010 and 2011, information on potential cardiovascular risk factors was collected and all participants underwent transcranial Doppler sonography, measurement of the ankle brachial index, and bilateral carotid duplex sonography. In a first follow-up examination in 2012/2013, retinal photography and spectral-domain optical coherence tomography were additionally performed. In a planned long-term follow-up, data from clinical examinations and laboratory tests and the occurrence of cardiovascular or cerebrovascular events will be collected to build up a predicting model for the risk of ischemic events. Results: At baseline, mean age of the participants was 55.2 +/- 11.8 years, and men showed a significantly (P<0.001) higher prevalence of arterial hypertension (55.5% vs. 36.5%) and hyperlipidemia (50.7% vs. 46.0%) and a higher blood homocysteine concentration (18.68 +/- 10.28 mu mol/L versus 11.69 +/- 6.40 mu mol/L). Conclusions: The APAC is the first study to prospectively evaluate the relationship between intracranial arterial stenosis, retinal nerve fiber layer changes, retinal microvascular signs, and the eventual development of cerebrovascular or cardiovascular events.	[Zhou, Yong; Wang, Anxing; Zhao, Xingquan] Capital Med Univ, BeijingTianTan Hosp, Dept Neurol, Beijing, Peoples R China; [Li, Yang; Xu, Jie; Wei, Wen Bin] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Gao, Xiang] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; North China University of Science & Technology; Ruprecht Karls University Heidelberg	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; weiwenbintr@163.com; zxq@vip.163.com	Xu, Jie/AIE-0524-2022; wei, wei/HHR-8613-2022; xu, jie/GQR-1913-2022	xu, jie/0000-0002-2039-7055; , Xiang/0000-0003-2617-6509	National Natural Science Foundation of China [81202279]; advanced health care professional development project of Beijing Municipal Health Bureau [2009-3-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); advanced health care professional development project of Beijing Municipal Health Bureau	This research was supported by a grant from the National Natural Science Foundation of China (Grant No. 81202279), and by a grant from advanced health care professional development project of Beijing Municipal Health Bureau (Grant No. 2009-3-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; [Anonymous], 1989, STROKE, V20, P1407; Arenillas JF, 2005, STROKE, V36, P1201, DOI 10.1161/01.STR.0000166045.12976.af; Bae HJ, 2007, CEREBROVASC DIS, V24, P355, DOI 10.1159/000106982; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; DOZONO K, 1991, STROKE, V22, P993, DOI 10.1161/01.STR.22.8.993; Elmore EM, 2003, J NEUROIMAGING, V13, P224, DOI 10.1177/1051228403013003004; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Greenland P, 2000, CIRCULATION, V101, P723; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P458; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hoshino A, 2008, CIRC J, V72, P404, DOI 10.1253/circj.72.404; Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Hwang JM, 2006, J GLAUCOMA, V15, P223, DOI 10.1097/01.ijg.0000212218.96932.f7; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020; Lopez-Cancio E, 2012, STROKE, V43, P2712, DOI 10.1161/STROKEAHA.112.661702; Mitchell P, 1997, STROKE, V28, P63, DOI 10.1161/01.STR.28.1.63; Mitchell P, 2000, CLIN EXP OPHTHALMOL, V28, P13, DOI 10.1046/j.1442-9071.2000.00218.x; Mitchell P, 2005, NEUROLOGY, V65, P1005, DOI 10.1212/01.wnl.0000179177.15900.ca; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Park Kwang-Yeol, 2006, J Clin Neurol, V2, P29, DOI 10.3988/jcn.2006.2.1.29; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; SCHNEIDER R, 1993, STROKE, V24, P1874, DOI 10.1161/01.STR.24.12.1874; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Suri MFK, 2011, NEUROEPIDEMIOLOGY, V37, P64, DOI 10.1159/000327757; Uehara T, 2005, EUR J NEUROL, V12, P218, DOI 10.1111/j.1468-1331.2004.00959.x; Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89; Wong KS, 2007, NEUROLOGY, V68, P2031, DOI 10.1212/01.wnl.0000264426.63544.ee; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007; Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Xu L, 2013, AM J HYPERTENS, V26, P511, DOI 10.1093/ajh/hps081; Ye C, 2011, OPHTHALMOLOGY, V118, P2196, DOI 10.1016/j.ophtha.2011.03.035; Zhang S, 2013, EUR J NEUROL, V20, P1479, DOI 10.1111/ene.12210; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068998	52	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84685	10.1371/journal.pone.0084685	http://dx.doi.org/10.1371/journal.pone.0084685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386406	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700115
J	Seto, S; Tsujimura, K; Horii, T; Koide, Y				Seto, Shintaro; Tsujimura, Kunio; Horii, Toshinobu; Koide, Yukio			Autophagy Adaptor Protein p62/SQSTM1 and Autophagy-Related Gene Atg5 Mediate Autophagosome Formation in Response to Mycobacterium tuberculosis Infection in Dendritic Cells	PLOS ONE			English	Article							T-CELLS; IN-VITRO; PHAGOSOMES; SURVIVAL; BCG; UBIQUITIN; BIOLOGY; INNATE; LC3; PHAGOLYSOSOME	Mycobacterium tuberculosis is an intracellular pathogen that can survive within phagocytic cells by inhibiting phagolysosome biogenesis. However, host cells can control the intracellular M. tuberculosis burden by the induction of autophagy. The mechanism of autophagosome formation to M. tuberculosis has been well studied in macrophages, but remains unclear in dendritic cells. We therefore characterized autophagosome formation in response to M. tuberculosis infection in dendritic cells. Autophagy marker protein LC3, autophagy adaptor protein p62/SQSTM1 (p62) and ubiquitin co-localized to M. tuberculosis in dendritic cells. Mycobacterial autophagosomes fused with lysosomes during infection, and major histcompatibility complex class II molecules (MHC II) also localized to mycobacterial autophagosomes. The proteins p62 and Atg5 function in the initiation and progression of autophagosome formation to M. tuberculosis, respectively; p62 mediates ubiquitination of M. tuberculosis and Atg5 is involved in the trafficking of degradative vesicles and MHC II to mycobacterial autophagosomes. These results imply that the autophagosome formation to M. tuberculosis in dendritic cells promotes the antigen presentation of mycobacterial peptides to CD4(+) T lymphocytes via MHC II.	[Seto, Shintaro; Tsujimura, Kunio; Horii, Toshinobu; Koide, Yukio] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Seto, S (corresponding author), Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan.	s-seto@hama-med.ac.jp			Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan; United States-Japan Cooperative Medical Science Committee	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); United States-Japan Cooperative Medical Science Committee	This work was supported in part by Grants-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science; the Health and Labour Science Research Grants for Research into Emerging and Reemerging Infectious Diseases from the Ministry of Health, Labour and Welfare of Japan; and the United States-Japan Cooperative Medical Science Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Giri PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002461; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jo EK, 2010, CELL MICROBIOL, V12, P1026, DOI 10.1111/j.1462-5822.2010.01491.x; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Li QB, 2011, J PROTEOME RES, V10, P2425, DOI 10.1021/pr101245u; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Petruccioli E, 2012, J INFECT DIS, V205, P1425, DOI 10.1093/infdis/jis226; Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465; Pieters Jean, 2008, V48, P116, DOI 10.1007/978-0-387-09595-0_11; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Seto S, 2010, MICROBIOL IMMUNOL, V54, P170, DOI 10.1111/j.1348-0421.2010.00199.x; Seto S, 2009, BIOCHEM BIOPH RES CO, V387, P272, DOI 10.1016/j.bbrc.2009.06.152; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Sugaya K, 2011, BIOCHEM BIOPH RES CO, V410, P371, DOI 10.1016/j.bbrc.2011.06.023; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Weischenfeldt J, 2008, CSH PROTOC, V2008; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	56	43	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e86017	10.1371/journal.pone.0086017	http://dx.doi.org/10.1371/journal.pone.0086017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376899	Green Submitted, gold, Green Published			2022-12-27	WOS:000328882000194
J	Li, G; Hu, HH; Dong, Z; Arao, T				Li, Gang; Hu, Huanhuan; Dong, Zhong; Arao, Takashi			Development of the Chinese Family Support Scale in a Sample of Chinese Patients with Hypertension	PLOS ONE			English	Article							SOCIAL SUPPORT; DEPRESSIVE SYMPTOMS; HOSPITAL ANXIETY; CHRONIC DISEASE; MANAGEMENT; VERSION; GENDER; HEALTH	Background: Despite strong recommendations to involve family social support in hypertension control, few questionnaires have been designed to measure family support in Chinese patients. The Chinese Family Support Scale is a self-rated questionnaire that assesses family support over a 6-month period. Methods: A total of 282 patients with hypertension participated in this study and 136 of them completed the questionnaire twice within an interval of two to three weeks. Exploratory factor analysis was conducted to assess the structural validity of the scale. Concurrent validity was determined by measuring the correlation between the Chinese Family Support Scale, and Hospital Anxiety and Depression Scale using the Sperman's Correlation Coefficient. Cronbach's alpha and intraclass correlation coefficients were employed to evaluate the internal and test-retest reliability of the scale. Results: Exploratory factor analysis revealed a three-factor solution accounting for 62% of the total variance. The three underlying sub-scale dimensions were kinship, nuclear family, and social resources. Significant correlation (r=-0.266; p<0.01) was found between the depression subscales of the Hospital Anxiety and Depression Scale and the extent of support perceived by the patients as measured by the Chinese Family Support Scale. The Chinese Family Support Scale had an acceptable internal consistency (Cronbach's alpha = 0.84) and test-retest reliability (intraclass correlation coefficient = 0.82). Conclusion: The study provides preliminary evidence that the 12-item Chinese Family Support Scale is acceptable, valid and reliable for measuring the perceived family support in hypertension patients. It is a promising tool which can be easily incorporated into epidemiological surveys.	[Li, Gang; Dong, Zhong] Beijing Ctr Dis Control & Prevent, Inst Chron Dis Control & Prevent, Beijing, Peoples R China; [Hu, Huanhuan] Waseda Univ, Grad Sch Sport Sci, Lab Exercise Epidemiol, Tokorozawa, Saitama, Japan; [Arao, Takashi] Waseda Univ, Fac Sport Sci, Lab Exercise Epidemiol, Tokorozawa, Saitama, Japan	Waseda University; Waseda University	Arao, T (corresponding author), Waseda Univ, Fac Sport Sci, Lab Exercise Epidemiol, Tokorozawa, Saitama, Japan.	tarao@waseda.jp			GCOE in Waseda University	GCOE in Waseda University	This research was supported by grant of GCOE in Waseda University (http://www.sport-sciences-gcoe-waseda.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman MG., 1998, J CHILD FAM STUD, V7, P69, DOI DOI 10.1023/A:1022912130180; Bailey JJ, 2010, INTENS CRIT CARE NUR, V26, P114, DOI 10.1016/j.iccn.2009.12.006; Baumann Linda C, 2012, Nurse Pract, V37, P32, DOI 10.1097/01.NPR.0000411104.12617.64; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Capitao CG, 2012, INT J CURRENT RES, V4, P255; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi NG, 2011, AGING MENT HEALTH, V15, P307, DOI 10.1080/13607863.2010.513042; Cornwell EY, 2012, J HEALTH SOC BEHAV, V53, P215, DOI 10.1177/0022146512446832; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; Costa RD, 2008, REV LAT-AM ENFERM, V16, P871, DOI 10.1590/S0104-11692008000500012; DeVellis R., 2011, SCALE DEV THEORY APP, VXXVI; DiNicola G, 2013, J PSYCHOSOM RES, V74, P110, DOI 10.1016/j.jpsychores.2012.09.022; Fisher L, 2000, J FAM PRACTICE, V49, P561; Friedmann E, 2014, J CARDIOVASC NURS, V29, P20, DOI 10.1097/JCN.0b013e318276fa07; Gorman BK, 2007, SOC SCI MED, V65, P958, DOI 10.1016/j.socscimed.2007.04.017; Hamer M, 2010, HYPERTENSION, V56, P547, DOI 10.1161/HYPERTENSIONAHA.110.153775; Hanley J, 2012, INT J INTEGR CARE S1, V12, pe64; Hogan BE, 2002, CLIN PSYCHOL REV, V22, P381, DOI 10.1016/S0272-7358(01)00102-7; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Jenkins CR, 1997, WILEY SER PROB STAT, P165; Johansen A, 2012, EUR J EPIDEMIOL, V27, P63, DOI [10.1007/s10654-011-9641-y, 10.1007/s10654-011-9639-5]; Kamen C, 2011, J CLIN PSYCHOL, V67, P215, DOI 10.1002/jclp.20765; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Leung CM, 1999, ACTA PSYCHIAT SCAND, V100, P456, DOI 10.1111/j.1600-0447.1999.tb10897.x; Lu ZX, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-216; Marin-Reyes F, 2001, SALUD PUBLICA MEXICO, V43, P336, DOI 10.1590/S0036-36342001000400010; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; Mollaoglu M, 2006, DIALYSIS TRANSPLANT, V35, P144, DOI 10.1002/dat.20002; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Raikkonen K, 2001, HYPERTENSION, V38, P798, DOI 10.1161/hyp.38.4.798; Rosland AM, 2010, CHRONIC ILLN, V6, P7, DOI 10.1177/1742395309352254; Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Tselebis Athanasios, 2011, Asia Pac Fam Med, V10, P3, DOI 10.1186/1447-056X-10-3; Verma R., 2012, ADV ALZHEIMERS DIS, V1, P17, DOI [10.4236/aad.2012.13003, DOI 10.4236/AAD.2012.13003]; Wang WR, 2009, J CLIN NURS, V18, P2436, DOI 10.1111/j.1365-2702.2009.02807.x; Wilson DK, 2001, ANN BEHAV MED, V23, P59, DOI 10.1207/S15324796ABM2301_9; Wilson KA, 2000, QUAL LIFE RES, V9, P1041, DOI 10.1023/A:1016647407161; Xiaolian Jiang, 2002, Nurs Health Sci, V4, P41, DOI 10.1046/j.1442-2018.2002.00100.x; Zheng L, 2006, SHANGHAI ARCH PSYCHI, V15, P264	42	7	7	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85682	10.1371/journal.pone.0085682	http://dx.doi.org/10.1371/journal.pone.0085682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276IX	24376892	Green Submitted, Green Published, gold			2022-12-27	WOS:000328745100208
J	Miyata, M; Suzuki, S; Misaka, T; Shishido, T; Saitoh, S; Ishigami, A; Kubota, I; Takeishi, Y				Miyata, Makiko; Suzuki, Satoshi; Misaka, Tomofumi; Shishido, Tetsuro; Saitoh, Shu-ichi; Ishigami, Akihito; Kubota, Isao; Takeishi, Yasuchika			Senescence Marker Protein 30 Has a Cardio-Protective Role in Doxorubicin-Induced Cardiac Dysfunction	PLOS ONE			English	Article							OXIDATIVE STRESS; SMP30 DEFICIENCY; TRANSGENIC MICE; KNOCKOUT MICE; CARDIOTOXICITY; CARDIOMYOPATHY; MODULATION; LIVER; PATHOGENESIS; ANGIOTENSIN	Background: Senescence marker protein 30 (SMP30), which was originally identified as an aging marker protein, is assumed to act as a novel anti-aging factor in the liver, lungs and brain. We hypothesized that SMP30 has cardio-protective function due to its anti-aging and anti-oxidant effects on doxorubicin (DOX)-induced cardiac dysfunction. Methods and Results: SMP30 knockout (SMP30 KO) mice, SMP30 transgenic (SMP30 TG) mice with cardiac-specific overexpression of SMP30 gene and wild-type (WT) littermate mice at 12-14 weeks of age were given intra-peritoneal injection of DOX (20 mg/kg) or saline. Five days after DOX injection, echocardiography revealed that left ventricular ejection fraction was more severely reduced in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but was preserved in the DOX-treated SMP30 TG mice. Generation of reactive oxygen species and oxidative DNA damage in the myocardium were greater in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but much less in the SMP30 TG mice. The numbers of deoxynucleotidyltransferase-mediated dUTP nick end-labeling positive nuclei in the myocardium, apoptotic signaling pathways such as caspase-3 activity, Bax/Bcl-2 ratio and phosphorylation activity of c-Jun N-terminal kinase were increased in SMP30 KO mice and decreased in SMP30 TG mice compared with WT mice after DOX injection. Conclusions: SMP30 has a cardio-protective role by anti-oxidative and anti-apoptotic effects in DOX-induced cardiotoxicity, and can be a new therapeutic target to prevent DOX-induced heart failure.	[Miyata, Makiko; Suzuki, Satoshi; Misaka, Tomofumi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Shishido, Tetsuro; Kubota, Isao] Yamagata Univ, Sch Med, Dept Internal Med 1, Yamagata 99023, Japan; [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan	Fukushima Medical University; Yamagata University; Tokyo Metropolitan Institute of Gerontology	Takeishi, Y (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.	takeishi@fmu.ac.jp		Ishigami, Akihito/0000-0001-7875-7482	Japan Society for the Promotion of Science [21590935, 24591100]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by grants-in-aid for Scientific Research (Nos. 21590935 and 24591100) from Japan Society for the Promotion of Science. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771; Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007; Ewer MS, 2005, J CLIN ONCOL, V23, P2900, DOI 10.1200/JCO.2005.05.827; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6; Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163; Ichiseki T, 2005, RHEUMATOLOGY, V44, P456, DOI 10.1093/rheumatology/keh518; Iliskovic N, 1998, MOL CELL BIOCHEM, V188, P161, DOI 10.1023/A:1006845120287; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Machii H, 2010, MECH AGEING DEV, V131, P710, DOI 10.1016/j.mad.2010.09.009; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Menna P, 2007, CELL BIOL TOXICOL, V23, P49, DOI 10.1007/s10565-006-0143-8; Misaka T, 2011, CIRCULATION, V124; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Pai VB, 2000, DRUG SAFETY, V22, P263, DOI 10.2165/00002018-200022040-00002; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; TSAO CS, 1987, J NUTR, V117, P291, DOI 10.1093/jn/117.2.291; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wang MY, 2010, J MOL CELL CARDIOL, V48, P765, DOI 10.1016/j.yjmcc.2010.01.006; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151	36	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e79093	10.1371/journal.pone.0079093	http://dx.doi.org/10.1371/journal.pone.0079093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391705	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200002
J	Fraix, V; Bastin, J; David, O; Goetz, L; Ferraye, M; Benabid, AL; Chabardes, S; Pollak, P; Debu, B				Fraix, Valerie; Bastin, Julien; David, Olivier; Goetz, Laurent; Ferraye, Murielle; Benabid, Alim-Louis; Chabardes, Stephan; Pollak, Pierre; Debu, Bettina			Pedunculopontine Nucleus Area Oscillations during Stance, Stepping and Freezing in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; LOCAL-FIELD POTENTIALS; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; GAIT; RECORDINGS; PATHOPHYSIOLOGY; CONNECTIVITY; RELEVANT; TARGET	The pedunculopontine area (PPNa) including the pedunculopontine and cuneiform nuclei, belongs to the mesencephalic locomotor region. Little is known about the oscillatory mechanisms underlying the function of this region in postural and gait control. We examined the modulations of the oscillatory activity of the PPNa and cortex during stepping, a surrogate of gait, and stance in seven Parkinson's disease patients who received bilateral PPNa implantation for disabling freezing of gait (FOG). In the days following the surgery, we recorded behavioural data together with the local field potentials of the PPNa during sitting, standing and stepping-in-place, under two dopaminergic medication conditions (OFF and ON levodopa). Our results showed that OFF levodopa, all subjects had FOG during step-in-place trials, while ON levodopa, stepping was effective (mean duration of FOG decreasing from 61.7+/-36.1% to 7.3+/-10.1% of trial duration). ON levodopa, there was an increase in PPNa alpha (5-12 Hz) oscillatory activity and a decrease in beta (13-35 Hz) and gamma (65-90 Hz) bands activity. PPNa activity was not modulated during quiet standing and sitting. Our results confirm the role of the PPNa in the regulation of gait and suggest that, in Parkinson disease, gait difficulties could be related to an imbalance between low and higher frequencies.	[Fraix, Valerie; Pollak, Pierre] Univ Hosp, Dept Neurol, Grenoble, France; [Fraix, Valerie; Bastin, Julien; Goetz, Laurent; Chabardes, Stephan; Pollak, Pierre; Debu, Bettina] Univ Grenoble 1, Grenoble, France; [Fraix, Valerie; Bastin, Julien; David, Olivier; Goetz, Laurent; Chabardes, Stephan; Pollak, Pierre; Debu, Bettina] INSERM, U836, Grenoble Inst Neurosci, Grenoble, France; [Ferraye, Murielle] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Chabardes, Stephan] Univ Hosp, Dept Neurosurg, Grenoble, France; [Benabid, Alim-Louis] Clinatec CEA Leti, Grenoble, France; [Pollak, Pierre] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Radboud University Nijmegen; CHU Grenoble Alpes; CEA; University of Geneva	Fraix, V (corresponding author), Univ Hosp, Dept Neurol, Grenoble, France.	Valerie.Fraix@ujf-grenoble.fr	David, Olivier/A-6068-2009; David, Olivier/S-9463-2019; Benabid, Alim L/Q-3506-2017; Debû, Bettina/AAB-9935-2019; FRAIX, VALERIE/AAC-3616-2019; bastin, julien JDP/H-8785-2017; Goetz, Laurent/L-9954-2018	David, Olivier/0000-0003-0776-0216; David, Olivier/0000-0003-0776-0216; Debû, Bettina/0000-0002-2195-8846; bastin, julien JDP/0000-0002-0533-7564; Goetz, Laurent/0000-0001-5807-131X	University Hospital of Grenoble, France,; Michael J. Fox Foundation; Fondation de France, Paris, France	University Hospital of Grenoble, France,; Michael J. Fox Foundation; Fondation de France, Paris, France(Fondation de France)	This work was supported by the University Hospital of Grenoble, France, the Michael J. Fox Foundation and Fondation de France, Paris, France. Medtronic provided the implantable pulse generators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2012, NEUROSURGERY, V71, P804, DOI 10.1227/NEU.0b013e3182676b91; Alam M, 2011, BRAIN, V134, P11, DOI 10.1093/brain/awq322; Androulidakis AG, 2008, EXP NEUROL, V211, P59, DOI 10.1016/j.expneurol.2008.01.002; Androulidakis AG, 2008, NEUROREPORT, V19, P59, DOI 10.1097/WNR.0b013e3282f2e2d1; Arnulf I, 2010, ANN NEUROL, V67, P546, DOI 10.1002/ana.21912; Aziz TZ, 2008, EXP NEUROL, V212, P247, DOI 10.1016/j.expneurol.2008.04.029; Ballanger B, 2009, HUM BRAIN MAPP, V30, P3901, DOI 10.1002/hbm.20815; Bonneville F, 2005, NEUROLOGY, V64, P1598, DOI 10.1212/01.WNL.0000160401.24880.83; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brown P, 2005, CLIN NEUROPHYSIOL, V116, P2510, DOI 10.1016/j.clinph.2005.05.009; Castrioto A, 2011, ARCH NEUROL-CHICAGO, V68, P1550, DOI 10.1001/archneurol.2011.182; Faist M, 2001, BRAIN, V124, P1590, DOI 10.1093/brain/124.8.1590; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Ferraye M, 2010, THESIS J FOURIER U G; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Fling BW, 2013, BRAIN, V136, P2405, DOI 10.1093/brain/awt172; GARCIARILL E, 1987, BRAIN RES BULL, V18, P731, DOI 10.1016/0361-9230(87)90208-5; Giannicola G, 2012, EXP NEUROL, V237, P312, DOI 10.1016/j.expneurol.2012.06.012; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Grabli D, 2012, J NEUROL NEUROSUR PS, V83, P979, DOI 10.1136/jnnp-2012-302263; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jenkinson N, 2009, MOVEMENT DISORD, V24, P319, DOI 10.1002/mds.22189; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lempka SF, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046001; Marani E, 2008, ADV ANAT EMBRYOL CEL, V198, P1, DOI 10.1007/978-3-540-79460-8; Marsden JF, 2001, BRAIN, V124, P378, DOI 10.1093/brain/124.2.378; Mazzone P, 2007, NEUROREPORT, V18, P1407, DOI 10.1097/WNR.0b013e3282638614; Mena-Segovia J, 2004, TRENDS NEUROSCI, V27, P585, DOI 10.1016/j.tins.2004.07.009; Moro E, 2010, BRAIN, V133, P215, DOI 10.1093/brain/awp261; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Neagu B, 2013, EXP NEUROL, V250, P221, DOI 10.1016/j.expneurol.2013.09.018; Piallat B, 2009, NEUROSCIENCE, V158, P1201, DOI 10.1016/j.neuroscience.2008.10.046; Plaha P, 2005, NEUROREPORT, V16, P1883, DOI 10.1097/01.wnr.0000187637.20771.a0; Rosa M, 2011, NEUROSIGNALS, V19, P151, DOI 10.1159/000328508; Rosa M, 2010, EXP NEUROL, V222, P184, DOI 10.1016/j.expneurol.2009.12.013; Schweder PM, 2010, NEUROREPORT, V21, P1065, DOI 10.1097/WNR.0b013e32833ce607; Shimamoto SA, 2010, J NEUROL NEUROSUR PS, V81, P80, DOI 10.1136/jnnp.2009.179069; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346; Takakusaki K, 2008, BRAIN RES REV, V57, P192, DOI 10.1016/j.brainresrev.2007.06.024; Thevathasan W, 2012, BRAIN; Thevathasan W, 2012, BRAIN, V135, P148, DOI 10.1093/brain/awr315; Tsang EW, 2010, NEUROLOGY, V75, P950, DOI 10.1212/WNL.0b013e3181f25b35; Weinberger M, 2008, EXP BRAIN RES, V188, P165, DOI 10.1007/s00221-008-1349-1; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Yelnik J, 2007, BRAIN, V130, DOI 10.1093/brain/awm138; Yeo SS, 2011, STEREOT FUNCT NEUROS, V89, P152, DOI 10.1159/000324890; Zrinzo L, 2008, Br J Neurosurg, V22 Suppl 1, pS19, DOI 10.1080/02688690802448426; Zrinzo L, 2008, BRAIN, V131, P1588, DOI 10.1093/brain/awn075; Zrinzo L, 2007, BRAIN, V130, DOI 10.1093/brain/awm079	54	57	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83919	10.1371/journal.pone.0083919	http://dx.doi.org/10.1371/journal.pone.0083919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386308	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700078
J	Ko, JH; Llopis, PM; Heinritz, J; Jacobs-Wagner, C; Soll, D				Ko, Jae-hyeong; Llopis, Paula Montero; Heinritz, Jennifer; Jacobs-Wagner, Christine; Soell, Dieter			Suppression of Amber Codons in Caulobacter crescentus by the Orthogonal Escherichia coli Histidyl-tRNA Synthetase/tRNA(His) Pair	PLOS ONE			English	Article							HOST STRAINS; GENE; EXPRESSION; SEQUENCE; TRANSLATION; DECAY; CYCLE; UAG	While translational read-through of stop codons by suppressor tRNAs is common in many bacteria, archaea and eukaryotes, this phenomenon has not yet been observed in the alpha-proteobacterium Caulobacter crescentus. Based on a previous report that C. crescentus and Escherichia coli tRNA(His) have distinctive identity elements, we constructed E. coli tRNA(CUA)(His), a UAG suppressor tRNA for C. crescentus. By examining the expression of three UAG codon-containing reporter genes (encoding a beta-lactamase, the fluorescent mCherry protein, or the C. crescentus xylonate dehydratase), we demonstrated that the E. coli histidyl-tRNA synthetase/tRNA(CUA)(His) pair enables in vivo UAG suppression in C. crescentus. E. coli histidyl-tRNA synthetase (HisRS) or tRNA(CUA)(His) alone did not achieve suppression; this indicates that the E. coli HisRS/tRNA(CUA)(His) pair is orthogonal in C. crescentus. These results illustrate that UAG suppression can be achieved in C. crescentus with an orthogonal aminoacyl-tRNA synthetase/suppressor tRNA pair.	[Ko, Jae-hyeong; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Llopis, Paula Montero; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Heinritz, Jennifer; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	dieter.soll@yale.edu	Llopis, Paula Montero/AAG-2853-2019	Jacobs-Wagner, Christine/0000-0003-0980-5334	National Institutes of Health [GM022854, GM065835]; DARPA [N66001-12-C-4211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM065835, R01GM022854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM022854, D. S. and GM065835, C.J-W.), and by DARPA contract (N66001-12-C-4211; D. S.). C.J.-W. is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardell DH, 2006, NUCLEIC ACIDS RES, V34, P893, DOI 10.1093/nar/gkj449; Avedissian M, 1996, MOL MICROBIOL, V19, P79, DOI 10.1046/j.1365-2958.1996.347879.x; BOLTEN SL, 1984, P NATL ACAD SCI-BIOL, V81, P6784, DOI 10.1073/pnas.81.21.6784; BOSSI L, 1983, J MOL BIOL, V164, P73, DOI 10.1016/0022-2836(83)90088-8; Bunjun S, 2000, P NATL ACAD SCI USA, V97, P12997, DOI 10.1073/pnas.230444397; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GILCHRIST A, 1992, CAN J MICROBIOL, V38, P193, DOI 10.1139/m92-033; GORINI L, 1970, ANNU REV GENET, V4, P107, DOI 10.1146/annurev.ge.04.120170.000543; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; HIMENO H, 1989, NUCLEIC ACIDS RES, V17, P7855, DOI 10.1093/nar/17.19.7855; HOESL MG, 2012, CURR OPIN BIOTECHNOL; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MILLER JH, 1983, J MOL BIOL, V164, P59, DOI 10.1016/0022-2836(83)90087-6; ONEILL VA, 1985, J BIOL CHEM, V260, P2501; Ozawa Y, 2003, J MOL EVOL, V56, P665, DOI 10.1007/s00239-002-2435-9; PALZKILL T, 1992, PROTEINS, V14, P29, DOI 10.1002/prot.340140106; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHERMAN F, 1982, MOL BIOL YEAST SACCH, P463; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Wang CX, 2007, J BACTERIOL, V189, P1954, DOI 10.1128/JB.01203-06; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; West L, 2002, J BACTERIOL, V184, P2155, DOI 10.1128/JB.184.8.2155-2166.2002; WILLS N, 1983, CELL, V33, P575, DOI 10.1016/0092-8674(83)90438-5; Winzeler E, 1997, J MOL BIOL, V272, P665, DOI 10.1006/jmbi.1997.1261; Xie JM, 2005, CURR OPIN CHEM BIOL, V9, P548, DOI 10.1016/j.cbpa.2005.10.011; Yan W, 1996, BIOCHEMISTRY-US, V35, P6559, DOI 10.1021/bi952889f; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yuan J, 2011, NUCLEIC ACIDS RES, V39, P2286, DOI 10.1093/nar/gkq1176	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83630	10.1371/journal.pone.0083630	http://dx.doi.org/10.1371/journal.pone.0083630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386240	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700053
J	Liu, ZN; Kong, LJ; Zhang, M; Lv, YX; Liu, YP; Zou, MH; Lu, G; Cao, JS; Yu, XL				Liu, Zhenning; Kong, Lijun; Zhang, Mei; Lv, Yanxia; Liu, Yapei; Zou, Minghau; Lu, Gang; Cao, Jiashu; Yu, Xiaolin			Genome-Wide Identification, Phylogeny, Evolution and Expression Patterns of AP2/ERF Genes and Cytokinin Response Factors in Brassica rapa ssp pekinensis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; DNA-BINDING DOMAIN; SIGNALING PATHWAY; DUPLICATED GENES; ARABIDOPSIS; PROTEIN; ERF; DIVERGENCE; ETHYLENE; DATABASE	The AP2/ERF transcription factor family is one of the largest families involved in growth and development, hormone responses, and biotic or abiotic stress responses in plants. In this study, 281 AP2/ERF transcription factor unigenes were identified in Chinese cabbage. These superfamily members were classified into three families (AP2, ERF, and RAV). The ERF family was subdivided into the DREB subfamily and the ERF subfamily with 13 groups (I-XI) based on sequence similarity. Duplication, evolution and divergence of the AP2/ERF genes in B. rapa and Arabidopsis thaliana were investigated and estimated. Cytokinin response factors (CRFs), as a subclade of the AP2/ERF family, are important transcription factors that define a branch point in the cytokinin two-component signal (TCS) transduction pathway. Up to 21 CRFs with a conserved CRF domain were retrieved and designated as BrCRFs. The amino acid sequences, conserved regions and motifs, phylogenetic relationships, and promoter regions of the 21 BrCRFs were analyzed in detail. The BrCRFs broadly expressed in various tissues and organs. The transcripts of BrCRFs were regulated by factors such as drought, high salinity, and exogenous 6-BA, NAA, and ABA, suggesting their involvement in abiotic stress conditions and regulatory mechanisms of plant hormone homeostasis. These results provide new insight into the divergence, variation, and evolution of AP2/ERF genes at the genome-level in Chinese cabbage.	[Liu, Zhenning; Kong, Lijun; Zhang, Mei; Lv, Yanxia; Liu, Yapei; Zou, Minghau; Lu, Gang; Cao, Jiashu; Yu, Xiaolin] Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Zhenning; Kong, Lijun; Zhang, Mei; Lv, Yanxia; Liu, Yapei; Zou, Minghau; Lu, Gang; Cao, Jiashu; Yu, Xiaolin] Minist Agr, Lab Hort Plant Growth & Qual Regulat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	Yu, XL (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China.	xlyu@zju.edu.cn			National Program on Key Basic Research Projects [2012CB113900]; Hi-Tech Research and Development Program of China [2012AA100104-4]; Zhejiang Provincial Natural Science Foundation of China [Y13C150001]; Breeding Project of the Sci-tech Foundation of Zhejiang Province [2012C12903]; Department of Education of Zhejiang Province [Y200909433]	National Program on Key Basic Research Projects(National Basic Research Program of China); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Breeding Project of the Sci-tech Foundation of Zhejiang Province; Department of Education of Zhejiang Province	This work was partially supported by the National Program on Key Basic Research Projects (2012CB113900), the Hi-Tech Research and Development Program of China (2012AA100104-4), Zhejiang Provincial Natural Science Foundation of China (Y13C150001), the Breeding Project of the Sci-tech Foundation of Zhejiang Province (2012C12903), and the Program of Department of Education of Zhejiang Province (Y200909433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Brenner WG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00008; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cheng F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00198; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Chu ZX, 2011, GENET MOL RES, V10, P3316, DOI 10.4238/2011.December.8.3; Cutcliffe JW, 2011, J EXP BOT, V62, P4995, DOI 10.1093/jxb/err199; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Du DL, 2013, PLANT MOL BIOL REP, V31, P741, DOI 10.1007/s11105-012-0531-6; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu LF, 2011, GENET MOL BIOL, V34, P624, DOI 10.1590/S1415-47572011005000054; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Lai Y, 2013, PLANT PHYSIOL BIOCH, V62, P70, DOI 10.1016/j.plaphy.2012.10.010; Lee JM, 2012, PLANT J, V70, P191, DOI 10.1111/j.1365-313X.2011.04863.x; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li MY, 2013, PLANT MOL BIOL REP, V31, P1002, DOI 10.1007/s11105-013-0570-7; Liang HX, 2008, J EXP BOT, V59, P3111, DOI 10.1093/jxb/ern165; Liang YS, 2010, J KOREAN SOC APPL BI, V53, P142, DOI 10.3839/jksabc.2010.024; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu ZN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-594; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mine T, 2003, PLANT CELL PHYSIOL, V44, P10, DOI 10.1093/pcp/pcg004; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rashotte AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-74; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shan HY, 2007, MOL PHYLOGENET EVOL, V44, P26, DOI 10.1016/j.ympev.2007.02.016; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shi XL, 2012, J EXP BOT, V63, P973, DOI 10.1093/jxb/err325; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-573; Sun S, 2008, J BIOL CHEM, V283, P6261, DOI 10.1074/jbc.M706800200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Wagner A, 2002, GENOME BIOL, V3; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wellmer F, 2005, INT J DEV BIOL, V49, P745, DOI 10.1387/ijdb.051991fw; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Wessler SR, 2005, TRENDS PLANT SCI, V10, P54, DOI 10.1016/j.tplants.2004.12.007; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Yang HJ, 2002, PLANT MOL BIOL, V50, P379, DOI 10.1023/A:1019859612791; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2010, PLANT GROWTH REGUL, V62, P51, DOI 10.1007/s10725-010-9484-7; Zhuang J, 2010, MOL BIOL REP, V37, P2485, DOI 10.1007/s11033-009-9763-4; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002; Ziolkowski PA, 2006, PLANT J, V47, P63, DOI 10.1111/j.1365-313X.2006.02762.x; Zwack PJ, 2012, PLANT CELL PHYSIOL, V53, P1683, DOI 10.1093/pcp/pcs110	98	81	88	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83444	10.1371/journal.pone.0083444	http://dx.doi.org/10.1371/journal.pone.0083444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386201	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700042
J	Maddocks, M; Halliday, V; Chauhan, A; Taylor, V; Nelson, A; Sampson, C; Byrne, A; Griffiths, G; Wilcock, A				Maddocks, Matthew; Halliday, Vanessa; Chauhan, Alpna; Taylor, Victoria; Nelson, Annmarie; Sampson, Cathy; Byrne, Anthony; Griffiths, Gareth; Wilcock, Andrew			Neuromuscular Electrical Stimulation of the Quadriceps in Patients with Non-Small Cell Lung Cancer Receiving Palliative Chemotherapy: A Randomized Phase II Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; EXERCISE; THERAPY; MUSCLE; INTERVENTION; WEIGHT; MASS	Background: A reduced exercise capacity is associated with increased morbidity and mortality in patients with advanced non-small cell lung cancer (NSCLC). Therapeutic exercise can be beneficial and neuromuscular electrical stimulation (NMES) of the quadriceps muscles may represent a practical approach. The primary aim of this study was to determine the acceptability of NMES of the quadriceps to patients with NSCLC used alongside palliative chemotherapy. Secondary aims explored aspects of safety and efficacy of NMES in this setting. Methods: Patients with advanced NSCLC due to receive first-line palliative chemotherapy were randomized to usual care with or without NMES. They were asked to undertake 30 minute sessions of NMES, ideally daily, but as a minimum, three times weekly. For NMES to be considered acceptable, it was predetermined that >= 80% of patients should achieve this minimum level of adherence. Qualitative interviews were held with a subset of patients to explore factors influencing adherence. Safety was assessed according to the Common Terminology Criteria for Adverse Events. Quadriceps muscle strength, thigh lean mass, and physical activity level were assessed at baseline and after three cycles of chemotherapy. Results: 49 patients (28 male, median (IQR) age 69 (64-75) years) participated. Of 30 randomized to NMES, 18 were eligible for the primary endpoint, of whom 9 (50% [90% CI, 29 to 71]) met the minimum level of adherence. Adherence was enhanced by incorporating sessions into a daily routine and hindered by undesirable effects of chemotherapy. There were no serious adverse events related to NMES, nor significant differences in quadriceps muscle strength, thigh lean mass or physical activity level between groups. Conclusions: NMES is not acceptable in this setting, nor was there a suggestion of benefit. The need remains to explore NMES in patients with cancer in other settings.	[Maddocks, Matthew] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Maddocks, Matthew; Taylor, Victoria; Wilcock, Andrew] Nottingham Univ Hosp Natl Hlth Serv Trust, Dept Palliat Med, Nottingham, England; [Halliday, Vanessa] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England; [Chauhan, Alpna] Sherwood Forest Hosp Natl Hlth Serv Fdn Trust, Kings Mill Hosp, Sutton In Ashfield, Notts, England; [Nelson, Annmarie; Sampson, Cathy; Byrne, Anthony; Griffiths, Gareth] Cardiff Univ, Marie Curie Res Ctr, Cardiff CF10 3AX, S Glam, Wales; [Nelson, Annmarie; Sampson, Cathy; Byrne, Anthony; Griffiths, Gareth] Cardiff Univ, Wales Canc Trials Unit, Cardiff CF10 3AX, S Glam, Wales	University of London; King's College London; Nottingham University Hospital NHS Trust; University of Nottingham; Cardiff University; Cardiff University	Wilcock, A (corresponding author), Nottingham Univ Hosp Natl Hlth Serv Trust, Dept Palliat Med, Nottingham, England.	andrew.wilcock@nottingham.ac.uk	Nelson, Annmarie/AAD-2193-2020	Nelson, Annmarie/0000-0002-6075-8425; Wilcock, Andrew/0000-0002-3214-1188; Griffiths, Gareth/0000-0002-9579-8021; Maddocks, Matthew/0000-0002-0189-0952	National Cancer Research Institute Lung Cancer Supportive and Palliative Care Award [LCSuPaC35]; Cancer Research United Kingdom Wales Cancer Trial Unit programme grant; AN the Marie Curie Palliative Care Research Centre programme grant; National Institute for Health Research (NIHR) Post-Doctoral Fellowship award; Cancer Research UK [15954] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-048] Funding Source: researchfish	National Cancer Research Institute Lung Cancer Supportive and Palliative Care Award; Cancer Research United Kingdom Wales Cancer Trial Unit programme grant; AN the Marie Curie Palliative Care Research Centre programme grant; National Institute for Health Research (NIHR) Post-Doctoral Fellowship award(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by a National Cancer Research Institute Lung Cancer Supportive and Palliative Care Award (LCSuPaC35) who had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. GG and AB are funded by the Cancer Research United Kingdom Wales Cancer Trial Unit programme grant and AN the Marie Curie Palliative Care Research Centre programme grant. MM is funded by an National Institute for Health Research (NIHR) Post-Doctoral Fellowship award. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; Gray C, 2011, CLIN NUTR, V30, P106, DOI 10.1016/j.clnu.2010.07.012; Hwang CL, 2012, SUPPORT CARE CANCER, V20, P3169, DOI 10.1007/s00520-012-1452-5; Jones LW, 2008, J THORAC ONCOL, V3, P194, DOI 10.1097/JTO.0b013e318160f36b; Jones LW, 2012, LUNG CANCER, V76, P248, DOI 10.1016/j.lungcan.2011.10.009; Jones LW, 2009, LANCET ONCOL, V10, P598, DOI 10.1016/S1470-2045(09)70031-2; Jones LW, 2012, CANCER, V116, P4825; Kasymjanova G, 2009, J THORAC ONCOL, V4, P602, DOI 10.1097/JTO.0b013e31819e77e8; Lakoski SG, 2012, NAT REV CLIN ONCOL, V9, P288, DOI 10.1038/nrclinonc.2012.27; Levine JA, 2000, J APPL PHYSIOL, V88, P452, DOI 10.1152/jappl.2000.88.2.452; Maddocks M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009419.pub2; Maddocks M, 2011, PSYCHO-ONCOLOGY, V20, P173, DOI 10.1002/pon.1720; Maddocks M, 2010, SUPPORT CARE CANCER, V18, P1539, DOI 10.1007/s00520-009-0776-2; Maddocks M, 2010, BRIT J SPORT MED, V44, P606, DOI 10.1136/bjsm.2008.051128; Maddocks M, 2009, J PAIN SYMPTOM MANAG, V38, P950, DOI 10.1016/j.jpainsymman.2009.05.011; Maddocks M, 2009, CANCER TREAT REV, V35, P383, DOI 10.1016/j.ctrv.2008.11.008; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Murphy RA, 2011, CANCER-AM CANCER SOC, V117, P1775, DOI 10.1002/cncr.25709; National Cancer Institute, 2009, NIH PUBLICATION; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Purcell A, 2010, SUPPORT CARE CANCER, V18, P307, DOI 10.1007/s00520-009-0653-z; Quist M, 2012, LUNG CANCER, V75, P203, DOI 10.1016/j.lungcan.2011.07.006; Scott HR, 2002, BRIT J CANCER, V87, P264, DOI 10.1038/sj.bjc.6600466; Sillen MJH, 2009, CHEST, V136, P44, DOI 10.1378/chest.08-2481; Skipworth RJE, 2011, CLIN NUTR, V30, P812, DOI 10.1016/j.clnu.2011.05.010; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smets EMA, 1996, BRIT J CANCER, V73, P241, DOI 10.1038/bjc.1996.42; Temel JS, 2009, J THORAC ONCOL, V4, P595, DOI 10.1097/JTO.0b013e31819d18e5; Wilcock Andrew, 2008, BMC Palliat Care, V7, P3, DOI 10.1186/1472-684X-7-3	36	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e86059	10.1371/journal.pone.0086059	http://dx.doi.org/10.1371/journal.pone.0086059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386491	Green Published, Green Accepted, gold			2022-12-27	WOS:000329194700148
J	Soora, M; Cypionka, H				Soora, Maya; Cypionka, Heribert			Light Enhances Survival of Dinoroseobacter shibae during Long-Term Starvation	PLOS ONE			English	Article							ANOXYGENIC PHOTOTROPHIC BACTERIA; MARINE ROSEOBACTER LINEAGE; PHOTOSYNTHETIC BACTERIA; HIGH ABUNDANCES; AEROBIC GROWTH; BALTIC SEA; GEN. NOV.; BACTERIOCHLOROPHYLL; DIVERSITY; OCEAN	Aerobic anoxygenic phototrophs (AAPs) as being photoheterotrophs require organic substrates for growth and use light as a supplementary energy source under oxic conditions. We hypothesized that AAPs benefit from light particularly under carbon and electron donor limitation. The effect of light was determined in long-term starvation experiments with Dinoroseobacter shibae DFL 12(T) in both complex marine broth and defined minimal medium with succinate as the sole carbon source. The cells were starved over six months under three conditions: continuous darkness (DD), continuous light (LL), and light/dark cycle (LD, 12 h/12 h, 12 mu mol photons m(-2) s(-1)). LD starvation at low light intensity resulted in 10-fold higher total cell and viable counts, and higher bacteriochlorophyll a and polyhydroxyalkanoate contents. This coincided with better physiological fitness as determined by respiration rates, proton translocation and ATP concentrations. In contrast, LD starvation at high light intensity (>22 mu mol photons m(-2) s(-1), LD conditions) resulted in decreasing cell survival rates but increasing carotenoid concentrations, indicating a photo-protective response. Cells grown in complex medium survived longer starvation (more than 20 weeks) than those grown in minimal medium. Our experiments show that D. shibae benefits from the light and dark cycle, particularly during starvation.	[Soora, Maya; Cypionka, Heribert] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Cypionka, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany.	heribert.cypionka@uni-oldenburg.de			German Science Foundation within the Collaborative Research Centre [SFB-TRR51]	German Science Foundation within the Collaborative Research Centre	This study has been funded by the German Science Foundation within the Collaborative Research Centre SFB-TRR51 (Roseobacter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Biebl H, 2006, PROCESS BIOCHEM, V41, P2153, DOI 10.1016/j.procbio.2006.06.029; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Clayton RK, 1963, BACTERIAL PHOTOSYNTH, P95; Cottrell MT, 2010, ISME J, V4, P945, DOI 10.1038/ismej.2010.13; Cottrell MT, 2006, APPL ENVIRON MICROB, V72, P557, DOI 10.1128/AEM.72.1.557-564.2006; Csotonyi JT, 2010, ENV MICROBIOL REP, V2, P651, DOI 10.1111/j.1758-2229.2010.00151.x; Cuperova Z, 2013, APPL ENV MICROBIOL; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Goericke R, 2002, LIMNOL OCEANOGR, V47, P290, DOI 10.4319/lo.2002.47.1.0290; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; HARASHIMA K, 1980, PLANT CELL PHYSIOL, V21, P1283, DOI 10.1093/oxfordjournals.pcp.a076127; HARASHIMA K, 1987, PLANT CELL PHYSIOL, V28, P365; Hauruseu D, 2012, APPL ENVIRON MICROB, V78, P7414, DOI 10.1128/AEM.01747-12; Hiraishi A, 2000, INT J SYST EVOL MICR, V50, P1539, DOI 10.1099/00207713-50-4-1539; Holert J, 2011, ENV MICROBIOL REP, V3, P136, DOI 10.1111/j.1758-2229.2010.00199.x; IBA K, 1989, PLANT CELL PHYSIOL, V30, P471, DOI 10.1093/oxfordjournals.pcp.a077765; Jiang HC, 2009, FEMS MICROBIOL ECOL, V67, P268, DOI 10.1111/j.1574-6941.2008.00616.x; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Lami R, 2007, APPL ENVIRON MICROB, V73, P4198, DOI 10.1128/AEM.02652-06; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masin M, 2008, ENVIRON MICROBIOL, V10, P1988, DOI 10.1111/j.1462-2920.2008.01615.x; Masin M, 2006, AQUAT MICROB ECOL, V45, P247, DOI 10.3354/ame045247; Medova H, 2011, FEMS MICROBIOL ECOL, V76, P393, DOI 10.1111/j.1574-6941.2011.01059.x; OKAMURA K, 1986, J BACTERIOL, V168, P1142, DOI 10.1128/jb.168.3.1142-1146.1986; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238, DOI 10.1128/AEM.44.1.238-241.1982; Pfennig N, 1982, FAMILY CHROMATIACEAE, P3584; Salka I, 2008, APPL ENVIRON MICROB, V74, P4398, DOI 10.1128/AEM.02447-07; Schwalbach MS, 2005, LIMNOL OCEANOGR, P50; SHIBA T, 1984, J GEN APPL MICROBIOL, V30, P239, DOI 10.2323/jgam.30.239; SHNEOUR EA, 1962, BIOCHIM BIOPHYS ACTA, V62, P534, DOI 10.1016/0006-3002(62)90235-4; Sieracki ME, 2006, LIMNOL OCEANOGR, P51; Spring S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-117; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Waidner LA, 2008, APPL ENVIRON MICROB, V74, P4012, DOI 10.1128/AEM.02324-07; YURKOV VV, 1993, ARCH MICROBIOL, V159, P84, DOI 10.1007/BF00244268; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Zong R, 2012, MICROBES ENVIRON, V27, P430, DOI 10.1264/jsme2.ME12029	46	14	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83960	10.1371/journal.pone.0083960	http://dx.doi.org/10.1371/journal.pone.0083960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386315	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700081
J	Wu, TF; Jia, J; Xiong, XP; He, HJ; Bu, LL; Zhao, ZL; Huang, CF; Zhang, WF				Wu, Tianfu; Jia, Jun; Xiong, Xuepeng; He, Haijun; Bu, Linlin; Zhao, Zhili; Huang, Congfa; Zhang, Wenfeng			Increased Expression of Lin28B Associates with Poor Prognosis in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							BINDING PROTEIN LIN28; MICRORNA BIOGENESIS; CANCER PROGRESSION; HEAD; SURVIVAL; MARKER	Recent studies showed that incomplete cell reprogramming can transform cells into tumour-like cells. Lin28A is associated with fibroblast and sarcoma cell reprogramming, whereas its homologue Lin28B is associated with hematopoietic cell reprogramming. This study aimed to investigate the expression and prognostic difference between Lin28A and Lin28B in oral squamous cell carcinoma (OSCC). Expression level was assessed by immunohistochemistry and staining location was confirmed by immunofluorescence. Prognostic values were analysed and compared by the Kaplan-Meier analysis and uni and multivariate Cox regression models. Besides, in vitro cell assays and in vivo nude mice xenograft were used to demonstrate the influence of increased Lin28B expression in OSCC. Lin28A and Lin28B expression increased in OSCC, and co-expression of Lin28A and Lin28B showed no significant association with patient prognosis. Kaplan-Meier analysis showed that patients with high Lin28B but not Lin28A expression had lower overall survival (OS) rates than those with low Lin28B expression. Further Univariate analysis showed that patients with increased Lin28B expression had shorter disease-free survival (DFS) and shorter OS, while multivariate analysis showed Lin28B overexpression with TNM stage predicted poor prognosis in patients with OSCC. Besides, stable expressing Lin28B in oral cancer cells promoted cell migration, invasion, colony formation, in vivo proliferation and increased the expression of cancer suppressor miRNA let-7 targeted genes IL-6, HMGA2, the EMT markers Snail and Twist, the angiogenesis inducer VEGF, and the apoptosis inhibitor Survivin. These combined results indicate that Lin28B is a novel marker for predicting prognosis in patients with OSCC and may be a therapeutic target.	[Wu, Tianfu; Jia, Jun; Zhao, Zhili] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Wu, Tianfu; Jia, Jun; Zhao, Zhili] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Peoples R China; [Xiong, Xuepeng; He, Haijun; Bu, Linlin; Huang, Congfa; Zhang, Wenfeng] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zhang, WF (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China.	zhangwf59@163.com	Bu, Lin-Lin/AAK-8357-2020; zhao, zhili/F-4137-2016; Wu, Tianfu/AAB-4992-2021	zhao, zhili/0000-0002-9030-1979; Wu, Tianfu/0000-0003-4705-2687	Fundamental Research Funds from the Central Universities of Wuhan University [2012304020209]; National Natural Science Foundation of China [81272964]	Fundamental Research Funds from the Central Universities of Wuhan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Fundamental Research Funds from the Central Universities of Wuhan University in 2012 (No.2012304020209) and the National Natural Science Foundation of China (No. 81272964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alajez NM, 2012, ONCOTARGET, V3, P1641; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Andric M, 2010, ORAL DIS, V16, P156, DOI 10.1111/j.1601-0825.2009.01612.x; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Cao DF, 2011, MODERN PATHOL, V24, P288, DOI 10.1038/modpathol.2010.195; Chen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050104; Childs AJ, 2012, STEM CELLS DEV; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Hayashi S, 2013, EXP CELL RES, V319, P1220, DOI 10.1016/j.yexcr.2013.03.004; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huang Y, 2012, WILEY INTERDISCIP RE; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Lei XX, 2012, NUCLEIC ACIDS RES, V40, P3574, DOI 10.1093/nar/gkr1279; Leonardi R, 2010, ORAL DIS, V16, P795, DOI 10.1111/j.1601-0825.2010.01690.x; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Liu YH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0426-2; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Qu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068724; Shinriki S, 2011, J PATHOL, V225, P142, DOI 10.1002/path.2935; Shkeir O, 2013, HEAD NECK; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun ZJ, 2010, J PHARMACOL EXP THER, V334, P500, DOI 10.1124/jpet.110.167692; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang AX, 2008, ONCOL RES, V17, P175, DOI 10.3727/096504008785114129; Wang Q, 2013, TUMOUR BIOL; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061640; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wu TF, 2013, CELLS TISSUES ORGANS, V197, P239, DOI 10.1159/000342926; Xu CY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0382-x; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu SY, 2011, ORAL SURG ORAL MED O, V112, P616, DOI 10.1016/j.tripleo.2011.02.053; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; ZHANG X, 2012, ONCOGENE	41	44	47	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83869	10.1371/journal.pone.0083869	http://dx.doi.org/10.1371/journal.pone.0083869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386298	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700076
J	Yukalov, VI; Yukalova, EP; Sornette, D				Yukalov, Vyacheslav I.; Yukalova, Elizaveta P.; Sornette, Didier			Utility Rate Equations of Group Population Dynamics in Biological and Social Systems	PLOS ONE			English	Article							DIVISION-OF-LABOR; ALTRUISTIC PUNISHMENT; WORLD-POPULATION; GROUP SELECTION; EVOLUTION; CASTE; COOPERATION; FITNESS; GROWTH; RECIPROCITY	We present a novel system of equations to describe the evolution of self-organized structured societies (biological or human) composed of several trait groups. The suggested approach is based on the combination of ideas employed in the theory of biological populations, system theory, and utility theory. The evolution equations are defined as utility rate equations, whose parameters are characterized by the utility of each group with respect to the society as a whole and by the mutual utilities of groups with respect to each other. We analyze in detail the cases of two groups (cooperators and defectors) and of three groups (cooperators, defectors, and regulators) and find that, in a self-organized society, neither defectors nor regulators can overpass the maximal fractions of about 10% each. This is in agreement with the data for bee and ant colonies. The classification of societies by their distance from equilibrium is proposed. We apply the formalism to rank the countries according to the introduced metric quantifying their relative stability, which depends on the cost of defectors and regulators as well as their respective population fractions. We find a remarkable concordance with more standard economic ranking based, for instance, on GDP per capita.	[Yukalov, Vyacheslav I.; Yukalova, Elizaveta P.; Sornette, Didier] Swiss Fed Inst Technol, ETH Zurich, Dept Management Technol & Econ, Zurich, Switzerland; [Yukalov, Vyacheslav I.] Joint Inst Nucl Res, Bogolubov Lab Theoret Phys, Dubna, Russia; [Yukalova, Elizaveta P.] Joint Inst Nucl Res, Informat Technol Lab, Dubna, Russia; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Joint Institute for Nuclear Research - Russia; Joint Institute for Nuclear Research - Russia; University of Geneva	Yukalov, VI (corresponding author), Swiss Fed Inst Technol, ETH Zurich, Dept Management Technol & Econ, Zurich, Switzerland.	yukalov@theor.jinr.ru			ETH Zurich Competence Center "Coping with Crises in Complex Socio-Economic Systems"	ETH Zurich Competence Center "Coping with Crises in Complex Socio-Economic Systems"	Partial financial support from the ETH Zurich Competence Center "Coping with Crises in Complex Socio-Economic Systems" is acknowledged. No additional external funding was received for this study.	Acocella N, 2000, FDN EC POLICY; Akin E., 1979, GEOMETRY POPULATION; [Anonymous], 1877, DIFFERENT FORMS FLOW; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bailey K., 1994, SOCIOLOGY NEW SYSTEM; Balding D.J., 2007, HDB STAT GENETICS; Banathy B.H., 1996, CONT SYSTEMS THINKIN, DOI [10.1007/978-1-4757-9981-1, DOI 10.1007/978-1-4757-9981-1]; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Bausch K. C, 2001, EMERGING CONSENSUS S; Beissinger S. R., 2002, POPULATION VIABILITY; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Bowles S, 2004, ROUNDTABLE SER BEHAV, P1; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Cai DH, 2010, INT J BIFURCAT CHAOS, V20, P3461, DOI 10.1142/S0218127410027817; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; COHEN JE, 1995, SCIENCE, V269, P341, DOI 10.1126/science.7618100; Combes Claude, 2005, ART BEING PARASITE; Crothers C, 1996, SOCIAL STRUCTURE; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Darcet D, 2008, J ECON INTERACT COOR, V3, P137, DOI 10.1007/s11403-007-0027-x; Darwin C., 1871, P423; Dawkins Richard, 1976, SELFISH GENE; DOBZHANSKY T., 1951, Genetics and the origin of species.; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Evens WJ, 1979, MATH POPULATION GENE; Favre M, 2012, J THEOR BIOL, V310, P43, DOI 10.1016/j.jtbi.2012.06.026; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Fraser VS, 2000, BEHAV ECOL SOCIOBIOL, V47, P188, DOI 10.1007/s002650050010; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; Gigerenzer G., 2002, BOUNDED RATIONALITY; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Haldane JB., 1990, CAUSES EVOLUTION; HAMMOND D, 2003, SCI SYNTHESIS; HANNAN MT, 1977, AM J SOCIOL, V82, P929, DOI 10.1086/226424; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hetzer M, 2011, THEORY EVOLUTION FAI; Hetzer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054308; Hinrichsen D., 2005, MATH SYSTEMS THEORY; Hofbauer J., 1988, THEORY EVOLUTION DYN; Jackson M.C., 2000, SYSTEMS APPROACHES M; Jain K, 2011, J NONLINEAR MATH PHY, V18, P321, DOI 10.1142/S1402925111001556; Johansen A, 2001, PHYSICA A, V294, P465, DOI 10.1016/S0378-4371(01)00105-4; Kapitza SP, 1996, USP FIZ NAUK+, V166, P63, DOI 10.3367/UFNr.0166.199601c.0063; KASPARI M, 1995, BEHAV ECOL SOCIOBIOL, V37, P255, DOI 10.1007/s002650050189; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; KIMBROUGH SO, 1980, J SOC BIOL STRUCT, V3, P149, DOI 10.1016/0140-1750(80)90007-X; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LAW R, 1979, AM NAT, V114, P399, DOI 10.1086/283488; LEWONTIN RC, 1961, J THEOR BIOL, V1, P382, DOI 10.1016/0022-5193(61)90038-8; Liu XS, 2010, J THEOR BIOL, V267, P647, DOI 10.1016/j.jtbi.2010.09.034; Luhmann N., 1996, SOCIAL SYSTEMS; Marcoux M, 2013, J THEOR BIOL, V324, P103, DOI 10.1016/j.jtbi.2012.12.012; Maynard Smith J., 1982, pi; MICHAELS JW, 1978, AM SOCIOL, V13, P23; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Morris WF, 2012, QUANTITATIVE CONSERV; Moulin HJ, 2003, FAIR DIVISION AND COLLECTIVE WELFARE, P1; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; Oster G.F., 1978, Monographs in Population Biology, pi; Page KM, 2002, J THEOR BIOL, V219, P93, DOI 10.1006/yjtbi.3112; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1; Parsons T., 1951, SOCIAL SYSTEM; Parsons T., 1970, SOCIAL STRUCTURE PER; Porpora D., 1987, CONCEPT SOCIAL STRUC; Rapaport A, 1965, PRISONERS DILEMMA; REIJNDERS L, 1978, J THEOR BIOL, V75, P245, DOI 10.1016/0022-5193(78)90234-5; Requejo RJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066112; Requejo RJ, 2011, J THEOR BIOL, V272, P35, DOI 10.1016/j.jtbi.2010.12.005; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Scott J, 2000, SOCIAL STRUCTURE; Simmel G, 1976, STRANGER; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Sober E., 1998, OTHERS EVOLUTION PSY; Sornette D, 2009, J BIOL SYST, V17, P225, DOI 10.1142/S0218339009002880; Sornette D, 2009, CONCEPTS PHYS, V6, P179; Stinchcombe JR, 2008, EVOLUTION, V62, P2435, DOI 10.1111/j.1558-5646.2008.00449.x; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; von Bertalanffy L., 1976, GEN SYSTEM THEORY FD; WALKER J, 1986, ECOLOGY, V67, P1052, DOI 10.2307/1939828; Weidlich W., 2000, SOCIODYNAMICS SYSTEM; Weidlich W, 2008, J ECON BEHAV ORGAN, V67, P1, DOI 10.1016/j.jebo.2007.02.002; WILBUR HM, 1974, AM NAT, V108, P805, DOI 10.1086/282956; Wilson DS, 2008, CURR DIR PSYCHOL SCI, V17, P6, DOI 10.1111/j.1467-8721.2008.00538.x; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; WILSON DS, 1994, BEHAV BRAIN SCI, V17, P585, DOI 10.1017/S0140525X00036104; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; Wilson EO, 1978, BEHAV ECOL SOCIOBIOL, V1, P141; Wilson EO, 1967, THEORY ISLAND BIOGEO; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Yukalov VI, 2012, PHYSICA D, V241, P1270, DOI 10.1016/j.physd.2012.04.005; Yukalov VI, 2012, EUR PHYS J-SPEC TOP, V205, P313, DOI 10.1140/epjst/e2012-01577-3; Yukalov VI, 2011, PHYS LETT A, V375, P2797, DOI 10.1016/j.physleta.2011.06.026; Yukalov VI, 2009, PHYSICA D, V238, P1752, DOI 10.1016/j.physd.2009.05.011; Yukalov VI, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052117; Yukalov VI, 1998, PHYS ATOM NUCL, V61, P252	111	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83225	10.1371/journal.pone.0083225	http://dx.doi.org/10.1371/journal.pone.0083225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386163	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700029
J	Zhang, L; Yan, J; Ojcius, DM; Lv, HK; Miao, ZP; Chen, Y; Zhang, YJ; Yan, JY				Zhang, Lei; Yan, Jie; Ojcius, David M.; Lv, Huakun; Miao, Ziping; Chen, Yin; Zhang, Yanjun; Yan, Jvying			Novel and Predominant Pathogen Responsible for the Enterovirus-Associated Encephalitis in Eastern China	PLOS ONE			English	Article							PROVINCE; CHILDREN; INDIA	Enteroviruses (EV) have been increasingly identified as the causative agent for unknown etiological encephalitis in many parts of the world, but the long period surveillance for enterovirus-associated encephalitis (EAE) was not reported in China. From 2002-2012 in Zhejiang, Coxsackieviruses A9, B1, B2, B3, B4, B5; and echoviruses 3, 4, 6, 9, 14, 25, 30 were detected from the unknown etiological encephalitis cases, with coxsackievirus B4 been identified here for the first time. From 2002-2004 and 2010-2012, echovirus 30 was found to be the periodically predominant serotype for in the EAE. The molecular typing results showed that all the EV isolates from this study belonged to the human EV B (HEV B) family and were distributed in three clusters.	[Zhang, Lei; Lv, Huakun; Miao, Ziping; Chen, Yin; Zhang, Yanjun; Yan, Jvying] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Yan, Jie] Zhejiang Univ, Sch Med, State Key Lab Diag & Treatment Infect Dis, Div Basic Med Microbiol,Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang University; University of California System; University of California Merced; University of California System; University of California Merced	Zhang, YJ (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	zhangyjtt@126.com; jyyan@cdc.zj.cn	Ojcius, David/ABE-6557-2020		Science and Technology department of Zhejiang, China [2012C33063]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents and Monitor Technology Platform of Infectious Diseases of the State Major Science and Technology Special Projects during the 12th five-year plan of China [2012ZX10004-210]	Science and Technology department of Zhejiang, China; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents and Monitor Technology Platform of Infectious Diseases of the State Major Science and Technology Special Projects during the 12th five-year plan of China	This work was supported by grants from Science and Technology department of Zhejiang, China (2012C33063), Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents and Monitor Technology Platform of Infectious Diseases of the State Major Science and Technology Special Projects during the 12th five-year plan of China (2012ZX10004-210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fowlkes AL, 2008, J INFECT DIS, V198, P1685, DOI 10.1086/592988; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Kumar A, 2012, J CLIN MICROBIOL, V50, P3509, DOI 10.1128/JCM.01483-12; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Muir P, 1998, CLIN MICROBIOL REV, V11, P202, DOI 10.1128/CMR.11.1.202; Sapkal GN, 2009, EMERG INFECT DIS, V15, P295, DOI 10.3201/eid1502.080865; Tao ZX, 2012, EMERG INFECT DIS, V18, P1865, DOI 10.3201/eid1811.120090; Zhao YN, 2005, EMERG INFECT DIS, V11, P562, DOI 10.3201/eid1104.040995	8	21	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85023	10.1371/journal.pone.0085023	http://dx.doi.org/10.1371/journal.pone.0085023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386442	Green Published, gold			2022-12-27	WOS:000329194700126
J	Hasegawa, D; Tamura, S; Nakamoto, Y; Matsuki, N; Takahashi, K; Fujita, M; Uchida, K; Yamato, O				Hasegawa, Daisuke; Tamura, Shinji; Nakamoto, Yuya; Matsuki, Naoaki; Takahashi, Kimimasa; Fujita, Michio; Uchida, Kazuyuki; Yamato, Osamu			Magnetic Resonance Findings of the Corpus Callosum in Canine and Feline Lysosomal Storage Diseases	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; JAPANESE DOMESTIC CAT; SANDHOFF-LIKE DISEASE; GM2 GANGLIOSIDOSIS; TOY POODLES; VARIANT; MUTATION; GENE; MRI	Several reports have described magnetic resonance (MR) findings in canine and feline lysosomal storage diseases such as gangliosidoses and neuronal ceroid lipofuscinosis. Although most of those studies described the signal intensities of white matter in the cerebrum, findings of the corpus callosum were not described in detail. A retrospective study was conducted on MR findings of the corpus callosum as well as the rostral commissure and the fornix in 18 cases of canine and feline lysosomal storage diseases. This included 6 Shiba Inu dogs and 2 domestic shorthair cats with GM1 gangliosidosis; 2 domestic shorthair cats, 2 familial toy poodles, and a golden retriever with GM2 gangliosidosis; and 2 border collies and 3 chihuahuas with neuronal ceroid lipofuscinoses, to determine whether changes of the corpus callosum is an imaging indicator of those diseases. The corpus callosum and the rostral commissure were difficult to recognize in all cases of juvenile-onset gangliosidoses (GM1 gangliosidosis in Shiba Inu dogs and domestic shorthair cats and GM2 gangliosidosis in domestic shorthair cats) and GM2 gangliosidosis in toy poodles with late juvenile-onset. In contrast, the corpus callosum and the rostral commissure were confirmed in cases of GM2 gangliosidosis in a golden retriever and canine neuronal ceroid lipofuscinoses with late juvenile-to early adult-onset, but were extremely thin. Abnormal findings of the corpus callosum on midline sagittal images may be a useful imaging indicator for suspecting lysosomal storage diseases, especially hypoplasia (underdevelopment) of the corpus callosum in juvenile-onset gangliosidoses.	[Hasegawa, Daisuke; Fujita, Michio] Nippon Vet & Life Sci Univ, Div Vet Radiol, Dept Vet Sci, Tokyo, Japan; [Tamura, Shinji] Tamura Anim Clin, Hiroshima, Japan; [Nakamoto, Yuya] Kyoto Anim Referral Med Ctr, Kyoto, Japan; [Matsuki, Naoaki] Univ Tokyo, Dept Vet Clin Pathobiol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Takahashi, Kimimasa] Nippon Vet & Life Sci Univ, Div Vet Pathol, Dept Vet Sci, Tokyo, Japan; [Uchida, Kazuyuki] Univ Tokyo, Dept Vet Pathol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yamato, Osamu] Kagoshima Univ, Dept Vet Med, Clin Pathol Lab, Kagoshima 890, Japan	Nippon Veterinary & Life Science University; University of Tokyo; Nippon Veterinary & Life Science University; University of Tokyo; Kagoshima University	Hasegawa, D (corresponding author), Nippon Vet & Life Sci Univ, Div Vet Radiol, Dept Vet Sci, Tokyo, Japan.	disk-hsgw@nvlu.ac.jp	Hasegawa, Daisuke/H-7510-2019; Tamura, Shinji/AAC-6783-2019	Hasegawa, Daisuke/0000-0002-7554-9108; Tamura, Shinji/0000-0002-1005-2598; Yamato, Osamu/0000-0002-4430-5645				Arrol LP, 2011, J FELINE MED SURG, V13, P120, DOI 10.1016/j.jfms.2010.09.001; Freeman AC, 2013, J VET INTERN MED, V27, P771, DOI 10.1111/jvim.12118; Gross B, 2010, VET RADIOL ULTRASOUN, V51, P361, DOI 10.1111/j.1740-8261.2010.01681.x; Hasegawa D, 2007, J FELINE MED SURG, V9, P232, DOI 10.1016/j.jfms.2006.11.003; Hasegawa D, 2012, SCI WORLD J, DOI 10.1100/2012/250197; Koie H, 2004, J VET MED SCI, V66, P1453, DOI 10.1292/jvms.66.1453; Matsuki N, 2005, CAN VET J, V46, P275; Mizukami K, 2012, SCI WORLD J, DOI 10.1100/2012/383174; Nakamoto Y, 2011, J AM ANIM HOSP ASSOC, V47, pE64, DOI 10.5326/JAAHA-MS-5564; Rahman MM, 2012, VET J, V194, P412, DOI 10.1016/j.tvjl.2012.05.021; SHULL RM, 1982, AM J PATHOL, V109, P244; Takahashi E, 2011, CEREB CORTEX, V21, P200, DOI 10.1093/cercor/bhq084; Tamura S, 2010, J VET INTERN MED, V24, P1013, DOI 10.1111/j.1939-1676.2010.0564.x; Uddin MM, 2013, J VET MED SCI, V75, P395, DOI 10.1292/jvms.12-0307; Vite CH, 2013, COMPARATIVE MED, V63, P163; Yamato O, 2008, J VET MED SCI, V70, P813, DOI 10.1292/jvms.70.813	16	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83455	10.1371/journal.pone.0083455	http://dx.doi.org/10.1371/journal.pone.0083455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386203	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900037
J	Tautzenberger, A; Fortsch, C; Zwerger, C; Dmochewitz, L; Kreja, L; Ignatius, A; Barth, H				Tautzenberger, Andrea; Foertsch, Christina; Zwerger, Christian; Dmochewitz, Lydia; Kreja, Ludwika; Ignatius, Anita; Barth, Holger			C3 Rho-Inhibitor for Targeted Pharmacological Manipulation of Osteoclast-Like Cells	PLOS ONE			English	Article							ADP-RIBOSYLATING TOXINS; BOTULINUM C2 TOXIN; CYTOSKELETAL ORGANIZATION; DELIVERY; RIBOSYLTRANSFERASE; MACROPHAGES; EXOENZYMES; INSIGHTS; PROTEIN	The C3 toxins from Clostridium botulinum (C3bot) and Clostridium limosum (C3lim) as well as C3-derived fusion proteins are selectively taken up into the cytosol of monocytes/macrophages where the C3-catalyzed ADP-ribosylation of Rho results in inhibition of Rho-signalling and characteristic morphological changes. Since the fusion toxin C2IN-C3lim was efficiently taken up into and inhibited proliferation of murine macrophage-like RAW 264.7 cells, its effects on RAW 264.7-derived osteoclasts were investigated. C2IN-C3lim was taken up into differentiated osteoclasts and decreased their resorption activity. In undifferentiated RAW 264.7 cells, C2IN-C3lim-treatment significantly decreased their differentiation into osteoclasts as determined by counting the multi-nucleated, TRAP-positive cells. This inhibitory effect was concentration-and time-dependent and most efficient when C2IN-C3lim was applied in the early stage of osteoclast-formation. A single-dose application of C2IN-C3lim at day 0 and its subsequent removal at day 1 reduced the number of osteoclasts in a comparable manner while C2IN-C3lim-application at later time points did not reduce the number of osteoclasts to a comparable degree. Control experiments with an enzymatically inactive C3 protein revealed that the ADP-ribosylation of Rho was essential for the observed effects. In conclusion, the results indicate that Rho-activity is crucial during the early phase of osteoclast-differentiation. Other bone cell types such as pre-osteoblastic cells were not affected by C2IN-C3lim. Due to their cell-type selective and specific mode of action, C3 proteins and C3-fusions might be valuable tools for targeted pharmacological manipulation of osteoclast formation and activity, which could lead to development of novel therapeutic strategies against osteoclast-associated diseases.	[Tautzenberger, Andrea; Kreja, Ludwika; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany; [Foertsch, Christina; Zwerger, Christian; Dmochewitz, Lydia; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89069 Ulm, Germany	Ulm University; Ulm University	Ignatius, A (corresponding author), Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany.	anita.ignatius@uni-ulm.de; holger.barth@uni-ulm.de	Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979	Medical Faculty of the University of Ulm; International Graduate School in Molecular Medicine Ulm (IGradU)	Medical Faculty of the University of Ulm; International Graduate School in Molecular Medicine Ulm (IGradU)	The work was supported by the Medical Faculty of the University of Ulm and the International Graduate School in Molecular Medicine Ulm (IGradU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme F, 2012, J MATER SCI-MATER M, V23, P743, DOI 10.1007/s10856-011-4539-5; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; AKTORIES K, 1995, BIOCHIMIE, V77, P326, DOI 10.1016/0300-9084(96)88142-9; ALLEY MC, 1988, CANCER RES, V48, P589; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Barth H, 2008, CURR MED CHEM, V15, P459, DOI 10.2174/092986708783503195; Barth H, 2011, EUR J CELL BIOL, V90, P944, DOI 10.1016/j.ejcb.2010.11.007; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Christow H, 2013, TOXICON, V75, P144, DOI 10.1016/j.toxicon.2013.02.002; Dmochewitz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054517; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Itzstein Cecile, 2011, Small GTPases, V2, P117; JUST I, 1992, J BIOL CHEM, V267, P10274; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lillich M, 2012, BIOCONJUGATE CHEM, V23, P1426, DOI 10.1021/bc300041z; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wang YW, 2012, BIOMATERIALS, V33, P8540, DOI 10.1016/j.biomaterials.2012.07.039; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204; ZHANG D, 1995, J CELL SCI, V108, P2285	24	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85695	10.1371/journal.pone.0085695	http://dx.doi.org/10.1371/journal.pone.0085695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386487	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900133
J	Fan, SF; Yu, D; Liu, CH				Fan, Shufeng; Yu, Dan; Liu, Chunhua			The Invasive Plant Alternanthera philoxeroides Was Suppressed More Intensively than Its Native Congener by a Native Generalist: Implications for the Biotic Resistance Hypothesis	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; INSECT HERBIVORES; NATURAL ENEMIES; EXOTIC PLANTS; PHOTOSYNTHESIS; RESPONSES; VEGETATION; SUCCESS; GROWTH; LEAVES	Prior studies on preferences of native herbivores for native or exotic plants have tested both the enemy release hypothesis and the biotic resistance hypothesis and have reported inconsistent results. The different levels of resistance of native and exotic plants to native herbivores could resolve this controversy, but little attention has been paid to this issue. In this study, we investigated population performance, photosynthesis, leaf nitrogen concentration, and the constitutive and induced resistances of the successful invasive plant, Alternanthera philoxeroides, and its native congener, Alternanthera sessilis, in the presence of three population densities of the grasshopper, Atractomorpha sinensis. When the grasshopper was absent, leaf biomass, total biomass, photosynthesis, and leaf nitrogen concentration of A. philoxeroides were higher than those of A. sessilis. However, the morphological and physiological performances of A. philoxeroides were all decreased more intensively than A. sessilis after herbivory by grasshoppers. Especially as the concentrations of constitutive lignin and cellulose in leaf of A. philoxeroides were higher than A. sessilis, A. philoxeroides exhibited increased leaf lignin concentration to reduce its palatability only at severe herbivore load, whereas, leaf lignin, cellulose, and polyphenolic concentrations of A. sessilis all increased with increasing herbivory pressure, and cellulose and polyphenolic concentrations were higher in A. sessilis than in A. philoxeroides after herbivory. Our study indicated that the capability of the invasive plant to respond to native insect damage was lower than the native plant, and the invasive plant was suppressed more intensively than its native congener by the native insect. Our results support the biotic resistance hypothesis and suggest that native herbivores can constrain the abundance and reduce the adverse effects of invasive species.	[Fan, Shufeng; Yu, Dan; Liu, Chunhua] Wuhan Univ, Coll Life Sci, Natl Field Stn Freshwater Ecosyst Liangzi Lake, Wuhan 430072, Peoples R China	Wuhan University	Yu, D (corresponding author), Wuhan Univ, Coll Life Sci, Natl Field Stn Freshwater Ecosyst Liangzi Lake, Wuhan 430072, Peoples R China.	yudan01@public.wh.hb.cn		Fan, Shufeng/0000-0002-5930-2631	National Natural Science Foundation of China [30930011, 31170339]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (30930011 and 31170339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; BERENBAUM M, 1981, ECOLOGY, V62, P1254, DOI 10.2307/1937290; BERNAYS EA, 1981, ECOL ENTOMOL, V6, P353, DOI 10.1111/j.1365-2311.1981.tb00625.x; Biqinluoke X.H., 1987, ANAL METHODS PLANT B; BOX JD, 1983, WATER RES, V17, P511, DOI 10.1016/0043-1354(83)90111-2; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; Coulson JR, 1977, USDA TECHNICAL B, V1547; Dietz H, 2004, BIOL INVASIONS, V6, P511, DOI 10.1023/B:BINV.0000041566.23330.60; Dini J., 1995, African Journal of Range and Forage Science, V12, P49, DOI 10.1080/10220119.1995.9647863; Elton C. S., 1958, ECOLOGY INVASIONS AN; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Geng YP, 2006, ACTA OECOL, V30, P380, DOI 10.1016/j.actao.2006.07.002; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Han XM, 2008, PLANT ECOL, V198, P197, DOI 10.1007/s11258-008-9395-0; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; Hu, 1990, J JIANGSU AGR COLL, V11, P57; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Jogesh T, 2008, BIOL INVASIONS, V10, P797, DOI 10.1007/s10530-008-9236-z; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; KARBAN R, 1987, OECOLOGIA, V73, P414, DOI 10.1007/BF00385258; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Li HS, 2000, PRINCIPLES TECHNIQUE, P274; Li Z., 2002, INVADING ALIEN SPECI; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Marlin D, 2013, AQUAT BOT, V104, P60, DOI 10.1016/j.aquabot.2012.09.005; Morrison WE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017227; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Nnuez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541; Pan X., 2008, SHAANXI FOREST SCI T, V4, P6; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Parker JD, 2005, ECOL LETT, V8, P959, DOI 10.1111/j.1461-0248.2005.00799.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; Sainty G., 1997, WETLANDS ECOLOGY MAN, V5, P195, DOI DOI 10.1023/A:1008248921849; Schooler SS, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P25; Siemann E, 2003, ECOLOGY, V84, P1489, DOI 10.1890/0012-9658(2003)084[1489:HDRLAS]2.0.CO;2; Sosa AJ, 2003, CANB P 11 INT S BIOL, P180; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Vogt GB, 1979, USDA TECHNICAL B; Wardle DA, 2002, FUNCT ECOL, V16, P585, DOI 10.1046/j.1365-2435.2002.00659.x; Wu ZY, 2003, FLORA CHINA, V5; Xiong W, 2008, FRESHWATER BIOL, V53, P2256, DOI 10.1111/j.1365-2427.2008.02058.x; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; Zas R, 2011, J ECOL, V99, P1316, DOI 10.1111/j.1365-2745.2011.01872.x	48	23	24	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83619	10.1371/journal.pone.0083619	http://dx.doi.org/10.1371/journal.pone.0083619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386236	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700064
J	Narayanan, R; Yepuru, M; Coss, CC; Wu, ZZ; Bauler, MN; Barrett, CM; Mohler, ML; Wang, Y; Kim, J; Snyder, LM; He, YL; Levy, N; Miller, DD; Dalton, JT				Narayanan, Ramesh; Yepuru, Muralimohan; Coss, Christopher C.; Wu, Zhongzhi; Bauler, Matthew N.; Barrett, Christina M.; Mohler, Michael L.; Wang, Yun; Kim, Juhyun; Snyder, Linda M.; He, Yali; Levy, Nelson; Miller, Duane D.; Dalton, James T.			Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NGF; MOUSE; GLIOBLASTOMA; EXPRESSION; PSORIASIS; CELLS; AIR	Receptor tyrosine kinases (RTKs), in response to their growth factor ligands, phosphorylate and activate downstream signals important for physiological development and pathological transformation. Increased expression, activating mutations and rearrangement fusions of RTKs lead to cancer, inflammation, pain, neurodegenerative diseases, and other disorders. Activation or over-expression of ALK, ROS1, TRK (A, B, and C), and RET are associated with oncogenic phenotypes of their respective tissues, making them attractive therapeutic targets. Cancer cDNA array studies demonstrated over-expression of TRK-A and ROS1 in a variety of cancers, compared to their respective normal tissue controls. We synthesized a library of small molecules that inhibit the above indicated RTKs with picomolar to nanomolar potency. The lead molecule GTx-186 inhibited RTK-dependent cancer cell and tumor growth. In vitro and in vivo growth of TRK-A-dependent IMR-32 neuroblastoma cells and ROS1-overexpressing NIH3T3 cells were inhibited by GTx-186. GTx-186 also inhibited inflammatory signals mediated by NF kappa B, AP-1, and TRK-A and potently reduced atopic dermatitis and air-pouch inflammation in mice and rats. Moreover, GTx-186 effectively inhibited ALK phosphorylation and ALK-dependent cancer cell growth. Collectively, the RTK inhibitor GTx-186 has a unique kinase profile with potential to treat cancer, inflammation, and neuropathic pain.	[Narayanan, Ramesh; Yepuru, Muralimohan; Coss, Christopher C.; Wu, Zhongzhi; Bauler, Matthew N.; Barrett, Christina M.; Mohler, Michael L.; Wang, Yun; Kim, Juhyun; Snyder, Linda M.; He, Yali; Miller, Duane D.; Dalton, James T.] GTx Inc, Preclin Res & Dev, Memphis, TN USA; [Levy, Nelson] Chembridge Res Lab, San Diego, CA USA		Narayanan, R (corresponding author), GTx Inc, Preclin Res & Dev, Memphis, TN USA.	rnarayanan@gtxinc.com; jdalton@gtxinc.com	Wang, Yun/G-3203-2015	Dalton, James T/0000-0002-3915-7326; Coss, Christopher/0000-0002-8184-9190				Albert L, 2003, J CELL PHYSIOL, V195, P168, DOI 10.1002/jcp.10252; Barouch R, 2001, J LEUKOCYTE BIOL, V69, P1019; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; Bonini S, 1999, INT ARCH ALLERGY IMM, V118, P159, DOI 10.1159/000024055; BOYLE MDP, 1985, J IMMUNOL, V134, P564; BURCHILL SA, 1995, J NEUROL SCI, V133, P3, DOI 10.1016/0022-510X(95)00163-V; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Cattaneo A, 2010, CURR OPIN MOL THER, V12, P94; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Eggert A, 2000, MED PEDIATR ONCOL, V35, P623, DOI 10.1002/1096-911X(20001201)35:6<623::AID-MPO29>3.0.CO;2-H; El-Deeb IM, 2010, MED RES REV; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jardi F, 2012, NEUROGASTROENT MOTIL, V24, pe580, DOI 10.1111/nmo.12027; JEPSEN S, 1992, CRIT CARE MED, V20, P918, DOI 10.1097/00003246-199207000-00004; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KIMATA H, 1994, ARCH DIS CHILD, V70, P119, DOI 10.1136/adc.70.2.119; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Lee J, 2013, CANCER; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liang SB, 2011, CLIN CANCER RES, V17, P4693, DOI 10.1158/1078-0432.CCR-10-3097; McKelvey L, 2013, J NEUROCHEM, V124, P276, DOI 10.1111/jnc.12093; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Narayanan R, 2010, CANCER RES, V70, P842, DOI 10.1158/0008-5472.CAN-09-3206; Nelson V, 2013, ONCOTARGETS THER, V6, P135, DOI 10.2147/OTT.S23165; Oddiah D, 1998, NEUROREPORT, V9, P1455, DOI 10.1097/00001756-199805110-00038; Raychaudhuri SK, 2009, ANN NY ACAD SCI, V1173, P470, DOI 10.1111/j.1749-6632.2009.04652.x; REYNOLDS CP, 1981, J NEUROSCI RES, V6, P319, DOI 10.1002/jnr.490060307; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rohn TA, 2011, J IMMUNOL, V186, P1769, DOI 10.4049/jimmunol.1000030; Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901; Sachs M, 1996, J CELL BIOL, V133, P1095, DOI 10.1083/jcb.133.5.1095; Sammons MJ, 2000, BRAIN RES, V876, P48, DOI 10.1016/S0006-8993(00)02596-8; Shin S, 2010, J VET SCI, V11, P43, DOI 10.4142/jvs.2010.11.1.43; TUBARO A, 1986, AGENTS ACTIONS, V17, P347, DOI 10.1007/BF01982641; Wang F, 2013, ENV TOXICOL; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Yamaguchi J, 2009, J DERMATOL SCI, V53, P48, DOI 10.1016/j.jdermsci.2008.08.011; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; ZHAO JF, 1995, CANCER GENET CYTOGEN, V83, P148, DOI 10.1016/0165-4608(95)00043-O	51	18	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83380	10.1371/journal.pone.0083380	http://dx.doi.org/10.1371/journal.pone.0083380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386191	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700047
J	Shi, JH; Feng, HX; Lee, J; Chen, WN				Shi, Jiahua; Feng, Huixing; Lee, Jaslyn; Chen, Wei Ning			Comparative Proteomics Profile of Lipid-Cumulating Oleaginous Yeast: An iTRAQ-Coupled 2-D LC-MS/MS Analysis	PLOS ONE			English	Article							RHODOSPORIDIUM-TORULOIDES; GLUTAMATE-DEHYDROGENASE; CUNNINGHAMELLA-ECHINULATA; SACCHAROMYCES-CEREVISIAE; BIODIESEL PRODUCTION; ACCUMULATION; ELECTROPHORESIS; MICROORGANISMS; MITOCHONDRIA; BIOCHEMISTRY	Accumulation of intracellular lipid in oleaginous yeast cells has been studied for providing an alternative supply for energy, biofuel. Numerous studies have been conducted on increasing lipid content in oleaginous yeasts. However, few explore the mechanism of the high lipid accumulation ability of oleaginous yeast strains at the proteomics level. In this study, a time-course comparative proteomics analysis was introduced to compare the non-oleaginous yeast Saccharomyces cerevisiae, with two oleaginous yeast strains, Cryptococcus albidus and Rhodosporidium toruloides at different lipid accumulation stages. Two dimensional LC-MS/MS approach has been applied for protein profiling together with isobaric tag for relative and absolute quantitation (iTRAQ) labelling method. 132 proteins were identified when three yeast strains were all at early lipid accumulation stage; 122 and 116 proteins were found respectively within cells of three strains collected at middle and late lipid accumulation stages. Significantly up-regulation or downregulation of proteins were experienced among comparison. Essential proteins correlated to lipid synthesis and regulation were detected. Our approach provides valuable indication and better understanding for lipid accumulation mechanism from proteomics level and would further contribute to genetic engineering of oleaginous yeasts.	[Shi, Jiahua; Feng, Huixing; Lee, Jaslyn; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, WN (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	WNChen@ntu.edu.sg		Shi, Jiahua/0000-0002-4933-0081; , Yang/0000-0002-6620-8897	Competitive Research Programme Funding, National Research Foundation of Singapore	Competitive Research Programme Funding, National Research Foundation of Singapore	This work was supported by Competitive Research Programme Funding, National Research Foundation of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah C, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-37; Azocar L, 2010, APPL MICROBIOL BIOT, V88, P621, DOI 10.1007/s00253-010-2804-z; Bellou S, 2013, J BIOTECHNOL, V164, P318, DOI 10.1016/j.jbiotec.2013.01.010; Bellou S, 2012, APPL BIOCHEM BIOTECH, V166, P146, DOI 10.1007/s12010-011-9411-z; BENACHENHOULAHFA N, 1993, J MOL EVOL, V36, P335; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branyikova I, 2011, BIOTECHNOL BIOENG, V108, P766, DOI 10.1002/bit.23016; Chatterjee MT, 2000, MICROBIOL-UK, V146, P877, DOI 10.1099/00221287-146-4-877; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Dyer JM, 2002, APPL MICROBIOL BIOT, V59, P224, DOI 10.1007/s00253-002-0997-5; Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214; EVANS CT, 1985, CAN J MICROBIOL, V31, P845, DOI 10.1139/m85-157; EVANS CT, 1983, EUR J BIOCHEM, V130, P195; Fakas S, 2007, ENZYME MICROB TECH, V40, P1321, DOI 10.1016/j.enzmictec.2006.10.005; Fei Q, 2011, BIORESOURCE TECHNOL, V102, P2695, DOI 10.1016/j.biortech.2010.10.141; Galiotou-Panayotou M, 1998, ANTON LEEUW INT J G, V73, P155, DOI 10.1023/A:1000657403593; HANSSON L, 1986, APPL MICROBIOL BIOT, V24, P12; Huang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046975; Li Q, 2008, APPL MICROBIOL BIOT, V80, P749, DOI 10.1007/s00253-008-1625-9; Li YH, 2007, ENZYME MICROB TECH, V41, P312, DOI 10.1016/j.enzmictec.2007.02.008; Lin JT, 2011, J BIOTECHNOL, V152, P184, DOI 10.1016/j.jbiotec.2011.02.010; Liu HW, 2009, YEAST, V26, P553, DOI 10.1002/yea.1706; Lotero E, 2005, IND ENG CHEM RES, V44, P5353, DOI 10.1021/ie049157g; Makri A, 2010, BIORESOURCE TECHNOL, V101, P2351, DOI 10.1016/j.biortech.2009.11.024; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Michely S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063356; Pagadala V, 2011, J BIOENERG BIOMEMBR, V43, P333, DOI 10.1007/s10863-011-9364-5; Pagliarulo C, 2004, MOL MICROBIOL, V51, P1757, DOI 10.1111/j.1365-2958.2003.03947.x; Papanikolaou S, 2004, J APPL MICROBIOL, V97, P867, DOI 10.1111/j.1365-2672.2004.02376.x; Papanikolaou S, 2002, BIORESOURCE TECHNOL, V82, P43, DOI 10.1016/S0960-8524(01)00149-3; Papanikolaou S, 2012, FERMENTAT TECHNOL, P1; Papanikolaou S., 2009, LIPID TECHNOL, V21, P83, DOI DOI 10.1002/LITE.200900017; Papanikolaou S, 2011, EUR J LIPID SCI TECH, V113, P1031, DOI 10.1002/ejlt.201100014; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C, 1994, TECHNOLOGICAL ADV IM, P235, DOI DOI 10.1007/978-1-4615-2109-9_9; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; TURCOTTE G, 1988, J BIOTECHNOL, V8, P221, DOI 10.1016/0168-1656(88)90004-1; Wang W, 2004, ANAL BIOCHEM, V329, P139, DOI 10.1016/j.ab.2004.02.044; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Xu JL, 2008, PROTEOMICS, V8, P4249, DOI 10.1002/pmic.200800103; Zhou YS, 2011, J PROTEOMICS, V75, P511, DOI 10.1016/j.jprot.2011.08.015	44	23	26	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85532	10.1371/journal.pone.0085532	http://dx.doi.org/10.1371/journal.pone.0085532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386479	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700140
J	Yu, Y; Walia, V; Elble, RC				Yu, Yang; Walia, Vijay; Elble, Randolph C.			Loss of CLCA4 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer Cells	PLOS ONE			English	Article							CYSTIC-FIBROSIS; EXPRESSION; PROTEIN; METALLOPROTEASE; PROGRESSION; METASTASIS; PROGNOSIS; CLEAVAGE; FAMILY; MCLCA3	The epithelial to mesenchymal transition (EMT) is a developmental program in which epithelial cells downregulate their cell-cell junctions, acquire spindle cell morphology and exhibit cellular motility. In breast cancer, EMT facilitates invasion of surrounding tissues and correlates closely with cancer metastasis and relapse. We found previously that the candidate tumor suppressor CLCA2 is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and EMT. We further demonstrated that CLCA2 is a p53-inducible proliferation-inhibitor whose loss indicates an increased risk of metastasis. We show here that another member of the CLCA gene family, CLCA4, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines. Like CLCA2, the gene is stress-inducible, and ectopic expression inhibits colony formation. Transcriptional profiling studies revealed that CLCA4 and CLCA2 together are markers for mammary epithelial differentiation, and both are downregulated by TGF beta. Moreover, knockdown of CLCA4 in immortalized cells by shRNAs caused downregulation of epithelial marker E-cadherin and CLCA2, while mesenchymal markers N-cadherin, vimentin, and fibronectin were upregulated. Double knockdown of CLCA2 and CLCA4 enhanced the mesenchymal profile. These findings suggest that CLCA4 and CLCA2 play complementary but distinct roles in epithelial differentiation. Clinically, low expression of CLCA4 signaled lower relapse-free survival in basal and luminal B breast cancers.	[Walia, Vijay; Elble, Randolph C.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Yu, Yang; Walia, Vijay; Elble, Randolph C.] So Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL USA; [Walia, Vijay] NCI, Lab Cell & Dev Signaling, Ctr Canc Res, Frederick, MD 21701 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Elble, RC (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	relble2@siumed.edu			NIH [R15CA151094]; Department of Defense [W81XWH-10-1-0402]; NATIONAL CANCER INSTITUTE [R15CA151094] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R15CA151094 and Department of Defense grant number W81XWH-10-1-0402 to RCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Bustin SA, 2001, DNA CELL BIOL, V20, P331, DOI 10.1089/10445490152122442; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Derichs N, 2013, EUR RESPIR REV, V22, P58, DOI 10.1183/09059180.00008412; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Fuller CM, 2001, PFLUG ARCH EUR J PHY, V443, pS107, DOI 10.1007/s004240100655; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hsu YM, 2007, J CELL PHYSIOL, V210, P626, DOI 10.1002/jcp.20859; Kolbe EW, 2013, EUR J HUM GENET, V21, P691, DOI 10.1038/ejhg.2012.234; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marshall A, 2009, CELL TISSUE RES, V335, P383, DOI 10.1007/s00441-008-0719-0; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porter DA, 2001, CANCER RES, V61, P5697; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Xie C, 2013, ONCOGENE, V32, P2282, DOI 10.1038/onc.2012.251; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060861; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282; Zhang JT, 2013, BBA-MOL CELL RES, V1833, P2961, DOI 10.1016/j.bbamcr.2013.07.021	38	40	41	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83943	10.1371/journal.pone.0083943	http://dx.doi.org/10.1371/journal.pone.0083943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386311	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700090
J	Zulkowski, PR; Sivak, DA; DeWeese, MR				Zulkowski, Patrick R.; Sivak, David A.; DeWeese, Michael R.			Optimal Control of Transitions between Nonequilibrium Steady States	PLOS ONE			English	Article								Biological systems fundamentally exist out of equilibrium in order to preserve organized structures and processes. Many changing cellular conditions can be represented as transitions between nonequilibrium steady states, and organisms have an interest in optimizing such transitions. Using the Hatano-Sasa Y-value, we extend a recently developed geometrical framework for determining optimal protocols so that it can be applied to systems driven from nonequilibrium steady states. We calculate and numerically verify optimal protocols for a colloidal particle dragged through solution by a translating optical trap with two controllable parameters. We offer experimental predictions, specifically that optimal protocols are significantly less costly than naive ones. Optimal protocols similar to these may ultimately point to design principles for biological energy transduction systems and guide the design of artificial molecular machines.	[Zulkowski, Patrick R.; DeWeese, Michael R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Zulkowski, Patrick R.; DeWeese, Michael R.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Sivak, David A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA; [DeWeese, Michael R.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Zulkowski, PR (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	pzulkowski@berkeley.edu	Sivak, David/A-1605-2012	Sivak, David/0000-0003-4815-4722	McKnight Foundation; Hellman Family Faculty Fund; McDonnell Foundation; Mary Elizabeth Rennie Endowment for Epilepsy Research; National Science Foundation [IIS-1219199]; NIGMS Systems Biology Center [P50 GM081879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER	McKnight Foundation; Hellman Family Faculty Fund; McDonnell Foundation; Mary Elizabeth Rennie Endowment for Epilepsy Research; National Science Foundation(National Science Foundation (NSF)); NIGMS Systems Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.R.D. acknowledges support from the McKnight Foundation, the Hellman Family Faculty Fund, the McDonnell Foundation, and the Mary Elizabeth Rennie Endowment for Epilepsy Research. M. R. D. and P.R.Z. were partly supported by the National Science Foundation through Grant No. IIS-1219199. D. A. S. was supported by NIGMS Systems Biology Center grant P50 GM081879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, STAT PHYS PARTICLES; Aurell E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.250601; Brody DC, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/2/023001; Bruce A., 2002, MOL BIOL CELL, V4th ed.; do Carmo M., 1992, RIEMANNIAN GEOMETRY, Vfirst; Hatano T, 2001, PHYS REV LETT, V86, P3463, DOI 10.1103/PhysRevLett.86.3463; Howard J, 2001, MECH MOTOR PROTEINS; Joykutty J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.193902; Mazonka O, 1999, EXACTLY SOLVABLE MOD; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; Risken H., 1989, FOKKER PLANCK EQUATI, DOI [10.1007/978-3-642-61544-3, DOI 10.1007/978-3-642-61544-3, 10.1007/978-3-642-61544-3_4]; Schmiedl T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108301; Schrodinger E., 1992, WHAT IS LIFE; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001; Shenfeld DK, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046705; Sivak DA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.190602; Trepagnier EH, 2004, P NATL ACAD SCI USA, V101, P15038, DOI 10.1073/pnas.0406405101; Zwanzig R., 2001, NONEQUILIBRIUM STAT	21	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82754	10.1371/journal.pone.0082754	http://dx.doi.org/10.1371/journal.pone.0082754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386112	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700015
J	Simoens, S				Simoens, Steven			Assessment of Methodological Quality of Economic Evaluations in Belgian Drug Reimbursement Applications	PLOS ONE			English	Article								Objectives: This paper aims to assess the methodological quality of economic evaluations included in Belgian reimbursement applications for Class 1 drugs. Materials and Methods: For 19 reimbursement applications submitted during 2011 and Spring 2012, a descriptive analysis assessed the methodological quality of the economic evaluation, evaluated the assessment of that economic evaluation by the Drug Reimbursement Committee and the response to that assessment by the company. Compliance with methodological guidelines issued by the Belgian Healthcare Knowledge Centre was assessed using a detailed checklist of 23 methodological items. The rate of compliance was calculated based on the number of economic evaluations for which the item was applicable. Results: Economic evaluations tended to comply with guidelines regarding perspective, target population, subgroup analyses, comparator, use of comparative clinical data and final outcome measures, calculation of costs, incremental analysis, discounting and time horizon. However, more attention needs to be paid to the description of limitations of indirect comparisons, the choice of an appropriate analytic technique, the expression of unit costs in values for the current year, the estimation and valuation of outcomes, the presentation of results of sensitivity analyses, and testing the face validity of model inputs and outputs. Also, a large variation was observed in the scope and depth of the quality assessment by the Drug Reimbursement Committee. Conclusions: Although general guidelines exist, pharmaceutical companies and the Drug Reimbursement Committee would benefit from the existence of a more detailed checklist of methodological items that need to be reported in an economic evaluation.	Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium	KU Leuven	Simoens, S (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium.	steven.simoens@pharm.kuleuven.be		Simoens, Steven/0000-0002-9512-2005	Pharma.be, the Belgian association of the innovative pharmaceutical industry	Pharma.be, the Belgian association of the innovative pharmaceutical industry	Financial support for this research was received from Pharma.be, the Belgian association of the innovative pharmaceutical industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleemput I, 2008, GUIDELINES PHARMACOE; De Rijdt T, 2010, PHARMACOECONOMICS EU, P60; Denis A, 2011, PHARMACOECONOMICS, V29, P883, DOI 10.2165/11585980-000000000-00000; Hoomans T, 2012, PHARMACOECONOMICS, V30, P219, DOI 10.2165/11539850-000000000-00000; Simoens S, 2012, J CLIN PHARM THER, V37, P182, DOI 10.1111/j.1365-2710.2011.01277.x; Simoens S, 2010, INT J ENV RES PUB HE, V7, P1835, DOI 10.3390/ijerph7041835; Yong JHE, 2013, PHARMACOECONOMICS, V31, P229, DOI 10.1007/s40273-012-0022-5	7	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85411	10.1371/journal.pone.0085411	http://dx.doi.org/10.1371/journal.pone.0085411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386474	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700136
J	Aadland, E; Andersen, JR; Anderssen, SA; Kvalheim, OM				Aadland, Eivind; Andersen, John Roger; Anderssen, Sigmund Alfred; Kvalheim, Olav Martin			Physical Activity versus Sedentary Behavior: Associations with Lipoprotein Particle Subclass Concentrations in Healthy Adults	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; INACTIVITY PHYSIOLOGY; METABOLIC SYNDROME; ENERGY-INTAKE; EXERCISE; RISK; TIME; INTENSITY; MORTALITY	Background: Physical activity (PA) and sedentary behavior (SED) may have independent effects on health and disease. This might be due to PA and SED having distinct effects on lipoprotein metabolism. The aim of this study was to determine associations between lipoprotein subclass particle concentrations (-P) and accelerometer-measured SED and moderate-to-vigorous PA (MVPA) in a sample of healthy adult subjects. Methods: Lipoprotein subclass particle concentrations were determined by proton nuclear magnetic resonance spectroscopy, whereas SED and MVPA were measured using Agtigraph GT1M and GT3X+ accelerometers. We obtained valid data in 73 subjects (30 men and 43 women, age 40.5 +/- 10.6 years; body mass index 24.0 +/- 2.8). Multiple regression analysis was used to determine associations (partial correlations) with lipoproteins. Results: Positive associations were detected between SED and small VLDL-P, large LDL-P and TG (partial r = 0.24 to 0.25, p < .047). Corresponding associations were non-significant for MVPA (partial r = -0.12 to 0.04, p > .355). On the contrary, MVPA was positively associated with large HDL-P, average HDL size, Apo A1 and HDL-cholesterol (partial r = 0.28 to 0.50, p < .027), whereas SED was not (partial r = -0.06 to 0.07, p > .607). Conclusion: There might be a specific effect of SED versus MVPA on lipoprotein metabolism. However, our results must be interpreted carefully due to possible effect-modification by gender and a low sample size. Thus, our findings should be viewed as preliminary.	[Aadland, Eivind; Andersen, John Roger; Kvalheim, Olav Martin] Sogn Og Fjordane Univ Coll, Fac Hlth Studies, Forde, Norway; [Andersen, John Roger] Forde Cent Hosp, Dept Surg, Forde, Norway; [Anderssen, Sigmund Alfred] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Anderssen, Sigmund Alfred] Sogn Og Fjordane Univ Coll, Fac Teacher Educ & Sports, Sogndal, Norway; [Kvalheim, Olav Martin] Univ Bergen, Dept Chem, Bergen, Norway	Western Norway University of Applied Sciences; Norwegian School of Sport Sciences; Western Norway University of Applied Sciences; University of Bergen	Aadland, E (corresponding author), Sogn Og Fjordane Univ Coll, Fac Hlth Studies, Forde, Norway.	eivind.aadland@hisf.no		Andersen, John Roger/0000-0001-6300-9086				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Andersen LF, 2005, BRIT J NUTR, V93, P519, DOI 10.1079/BJN20041381; Andersen LF, 1999, AM J EPIDEMIOL, V150, P75, DOI 10.1093/oxfordjournals.aje.a009921; Archer E, 2011, PROG CARDIOVASC DIS, V53, P387, DOI 10.1016/j.pcad.2011.02.006; Atienza AA, 2011, MED SCI SPORT EXER, V43, P815, DOI 10.1249/MSS.0b013e3181fdfc32; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2007, DIABETES CARE, V30, P337, DOI 10.2337/dc06-1883; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Freedman DS, 1998, ARTERIOSCL THROM VAS, V18, P1046, DOI 10.1161/01.ATV.18.7.1046; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Holme I, 2007, J INTERN MED, V262, P235, DOI 10.1111/j.1365-2796.2007.01806.x; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI [DOI 10.1056/NEJMoa020194, DOI 10.1056/NEJMOA020194, 10.1056/NEJMoa020194]; Magkos F, 2009, OBSTET GYN CLIN N AM, V36, P245, DOI 10.1016/j.ogc.2009.03.001; McGuire KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020503; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Pedersen BK, 2007, SCAND J MED SCI SPOR, V17, P196, DOI 10.1111/j.1600-0838.2006.00626.x; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ried-Larsen M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-113; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Sirard JR, 2011, J PHYS ACT HEALTH, V8, P668, DOI 10.1123/jpah.8.5.668; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	41	21	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85223	10.1371/journal.pone.0085223	http://dx.doi.org/10.1371/journal.pone.0085223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386464	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000329117900129
J	Juurlink, DN; Dormuth, CR; Huang, AJ; Hellings, C; Paterson, JM; Raymond, C; Kozyrskyj, A; Moride, Y; Macdonald, EM; Mamdani, MM				Juurlink, David N.; Dormuth, Colin R.; Huang, Anjie; Hellings, Chelsea; Paterson, J. Michael; Raymond, Colette; Kozyrskyj, Anita; Moride, Yola; Macdonald, Erin M.; Mamdani, Muhammad M.			Proton Pump Inhibitors and the Risk of Adverse Cardiac Events	PLOS ONE			English	Article							HEART-FAILURE; NEGATIVE INOTROPY; PANTOPRAZOLE; CLOPIDOGREL; OUTCOMES; COMORBIDITIES	Background: Recent evidence suggests that proton pump inhibitors (PPIs) might be linked with adverse cardiac events, but a causal relationship is unproven. Methods: We applied the self-matched case series method to two studies using population-based health care data from Ontario, Canada between 1996 and 2008. The first included subjects aged 66 years or older hospitalized for acute myocardial infarction within 12 weeks following initiation of PPI, while the second included subjects hospitalized for heart failure. In both studies we designated the primary risk interval as the initial 4 weeks of therapy and the control interval as the final 4 weeks. To test the specificity of our findings we examined use of histamine H2 receptor antagonists and benzodiazepines, drugs with no plausible causal link to adverse cardiac events. Results: During the 13-year study period, we identified 5550 hospital admissions for acute myocardial infarction and 6003 admissions for heart failure within 12 weeks of commencing PPI therapy. In the main analyses, we found that initiation of a PPI was associated with a higher risk of acute myocardial infarction (odds ratio 1.8; 95% confidence interval 1.7 to 1.9) and heart failure (odds ratio 1.8; 95% confidence interval 1.7 to 1.9). However, secondary analyses revealed similar risk estimates histamine H2 receptor antagonists and benzodiazepines, drugs with no known or suspected association with adverse cardiac events. Conclusion: PPIs are associated with a short-term risk of adverse cardiac events, but similar associations are seen with other drugs exhibiting no known cardiac toxicity. Collectively these observations suggest that the association between PPIs and adverse cardiac events does not represent reflect cause-and-effect.	[Juurlink, David N.; Huang, Anjie; Hellings, Chelsea; Paterson, J. Michael; Macdonald, Erin M.; Mamdani, Muhammad M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada; [Dormuth, Colin R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.; Mamdani, Muhammad M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juurlink, David N.; Paterson, J. Michael; Mamdani, Muhammad M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mamdani, Muhammad M.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Paterson, J. Michael] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Paterson, J. Michael] St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON, Canada; [Raymond, Colette; Kozyrskyj, Anita] Univ Manitoba, Fac Med, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Raymond, Colette; Kozyrskyj, Anita] Winnipeg Reg Hlth Author, Winnipeg, MB, Canada; [Kozyrskyj, Anita] Univ Alberta, Women & Childrens Res Inst, Calgary, AB, Canada; [Kozyrskyj, Anita] Univ Alberta, Fac Med & Dent, Dept Pediat, Calgary, AB, Canada; [Moride, Yola] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; McMaster University; University of Manitoba; University of Alberta; University of Alberta; Universite de Montreal	Juurlink, DN (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	dnj@ices.on.ca		Dormuth, Colin/0000-0001-8577-8783	Canadian Institutes of Health Research to the Canadian Drug Safety and Effectiveness Research Network (CDSERN); Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research to the Canadian Drug Safety and Effectiveness Research Network (CDSERN)(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a grant from the Canadian Institutes of Health Research to the Canadian Drug Safety and Effectiveness Research Network (CDSERN) and by the Institute for Clinical Evaluative Sciences (ICES), a non-profit research institute funded by the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2011, CLIN PHARMACOL THER, V89, P65, DOI 10.1038/clpt.2010.219; Antoniou T, 2010, ARCH INTERN MED, V170, P1045, DOI 10.1001/archinternmed.2010.142; Charlot M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2690; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; Goodman SG, 2012, CIRCULATION, V125, P978, DOI 10.1161/CIRCULATIONAHA.111.032912; Hungin APS, 1999, BRIT J GEN PRACT, V49, P451; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Schillinger W, 2007, CIRCULATION, V116, P57, DOI 10.1161/CIRCULATIONAHA.106.666008; Schillinger W, 2009, CLIN RES CARDIOL, V98, P391, DOI 10.1007/s00392-009-0012-6; Sibbing D, 2009, THROMB HAEMOSTASIS, V101, P714, DOI 10.1160/TH08-12-0808; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; van Vliet EPM, 2008, EUR J GASTROEN HEPAT, V20, P608, DOI 10.1097/MEG.0b013e3282f52f95; Wright AJ, 2011, CAN MED ASSOC J, V183, P303, DOI 10.1503/cmaj.100702; Zinman L, 2009, MUSCLE NERVE, V40, P947, DOI 10.1002/mus.21440	18	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84890	10.1371/journal.pone.0084890	http://dx.doi.org/10.1371/journal.pone.0084890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386430	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900116
J	Niu, JP; Liberda, EN; Qu, S; Guo, XB; Li, XM; Zhang, JJ; Meng, JL; Yan, B; Li, NR; Zhong, MH; Ito, K; Wildman, R; Liu, H; Chen, LC; Qu, QS				Niu, Jingping; Liberda, Eric N.; Qu, Song; Guo, Xinbiao; Li, Xiaomei; Zhang, Jingjing; Meng, Junliang; Yan, Bing; Li, Nairong; Zhong, Mianhua; Ito, Kazuhiko; Wildman, Rachel; Liu, Hong; Chen, Lung Chi; Qu, Qingshan			The Role of Metal Components in the Cardiovascular Effects of PM2.5	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PARTICULATE AIR-POLLUTION; INHALATION EXPOSURE; VASCULAR FUNCTION; OXIDATIVE STRESS; ARSENIC EXPOSURE; CARDIAC-FUNCTION; EXPERT PANEL; NICKEL; HEALTH	Exposure to ambient fine particulate matter (PM2.5) increases risks for cardiovascular disorders (CVD). However, the mechanisms and components responsible for the effects are poorly understood. Based on our previous murine exposure studies, a translational pilot study was conducted in female residents of Jinchang and Zhangye, China, to test the hypothesis that specific chemical component of PM2.5 is responsible for PM2.5 associated CVD. Daily ambient and personal exposures to PM2.5 and 35 elements were measured in the two cities. A total of 60 healthy nonsmoking adult women residents were recruited for measurements of inflammation biomarkers. In addition, circulating endothelial progenitor cells (CEPCs) were also measured in 20 subjects. The ambient levels of PM2.5 were comparable between Jinchang and Zhangye (47.4 and 54.5 mu g/m(3), respectively). However, the levels of nickel, copper, arsenic, and selenium in Jinchang were 82, 26, 12, and 6 fold higher than Zhangye, respectively. The levels of C-reactive protein (3.44 +/- 3.46 vs. 1.55 +/- 1.13), interleukin-6 (1.65 +/- 1.17 vs. 1.09 +/- 0.60), and vascular endothelial growth factor (117.6 +/- 217.0 vs. 22.7 +/- 21.3) were significantly higher in Jinchang. Furthermore, all phenotypes of CEPCs were significantly lower in subjects recruited from Jinchang than those from Zhangye. These results suggest that specific metals may be important components responsible for PM2.5-induced cardiovascular effects and that the reduced capacity of endothelial repair may play a critical role.	[Niu, Jingping; Zhang, Jingjing; Meng, Junliang; Yan, Bing; Li, Nairong] Lanzhou Univ, Sch Publ Hlth, Lanzhou 730000, Peoples R China; [Liberda, Eric N.; Li, Xiaomei; Zhong, Mianhua; Ito, Kazuhiko; Chen, Lung Chi; Qu, Qingshan] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA; [Qu, Song] NYU, Coll Arts & Sci, New York, NY USA; [Guo, Xinbiao; Liu, Hong] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China; [Wildman, Rachel] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Lanzhou University; New York University; New York University; Peking University; Yeshiva University; Albert Einstein College of Medicine	Chen, LC (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA.	lung-chi.chen@nyumc.org; qingshan.qu@nyumc.org	Zhang, Jing/HII-4294-2022	Chen, Lung Chi/0000-0003-1154-2107	NIEHS [R21ES016570, R01ES015495, P30 ES00260]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015495, R21ES016570, P30ES000260] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work supported by NIEHS R21ES016570, R01ES015495, and P30 ES00260. Personnel support by CIHR-DRA to E.N. Liberda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (Work supported by the National Institute of Environmental Health Sciences R21ES016570, 385 R01ES015495, and P30 ES00260. Personnel support by Canadian Institutes of Health Research 386 to E.N. Liberda.)	ARIEL SC, 2011, ENV HLTH PERSPECT, V119, P559, DOI DOI 10.1289/EHP.1002653.PUBMED:21216722; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; AXELSON O, 1978, BRIT J IND MED, V35, P8; Balakumar P, 2009, CARDIOVASC TOXICOL, V9, P169, DOI 10.1007/s12012-009-9050-6; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Bonello L, 2006, ARCH MAL COEUR VAISS, V99, P607; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; CAHILL TA, 2010, AAAR, P201; Chakrabarti SK, 1999, BIOCHEM PHARMACOL, V58, P1501, DOI 10.1016/S0006-2952(99)00232-4; Chen CY, 2003, ARCH TOXICOL, V77, P123, DOI 10.1007/s00204-002-0427-6; CHEN L, 2005, INHAL TOXICOL, P4; CHEN LC, 2005, INHAL TOXICOL, V17, P4; Chen LC, 2010, INHAL TOXICOL, V22, P580, DOI 10.3109/08958371003596579; Cuevas AK, 2010, INHAL TOXICOL, V22, P100, DOI 10.3109/08958378.2010.521206; Das KK, 2008, INDIAN J MED RES, V128, P412; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hoenig MR, 2008, CURR DRUG TARGETS, V9, P422, DOI 10.2174/138945008784221215; Jevon M, 2008, CELL PROLIFERAT, V41, P146, DOI 10.1111/j.1365-2184.2008.00488.x; Joshi S, 2005, HUM EXP TOXICOL, V24, P13, DOI 10.1191/0960327105ht493oa; Kang GS, 2011, ENVIRON HEALTH PERSP, V119, P176, DOI 10.1289/ehp.1002508; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Liberda EN, 2010, INHAL TOXICOL, V22, P95, DOI 10.3109/08958378.2010.515269; Lippmann M, 2005, ENVIRON HEALTH PERSP, V113, P1575, DOI 10.1289/ehp.8091; Lippmann M, 2006, ENVIRON HEALTH PERSP, V114, P1662, DOI 10.1289/ehp.9150; Meyers Melissa R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P365, DOI 10.1097/MED.0b013e3282be90a8; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; O'Toole TE, 2010, CIRC RES, V107, P200, DOI 10.1161/CIRCRESAHA.110.222679; Pearson TA, 2003, CIRCULATION, V107, P645, DOI 10.1161/01.CIR.0000054482.38437.13; Peltier RE, 2009, J EXPO SCI ENV EPID, V19, P603, DOI 10.1038/jes.2008.60; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Povsic Thomas J, 2008, Ther Adv Cardiovasc Dis, V2, P199, DOI 10.1177/1753944708093412; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; *US EPA, 2008, INT SCI ASS PART MAT; Wang CH, 2007, TOXICOL APPL PHARM, V222, P315, DOI 10.1016/j.taap.2006.12.022; Wang CH, 2010, CARDIOVASC TOXICOL, V10, P17, DOI 10.1007/s12012-009-9059-x; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2007, ANN MED, V39, P82, DOI 10.1080/07853890601073429; Xun PC, 2010, ATHEROSCLEROSIS, V210, P662, DOI 10.1016/j.atherosclerosis.2010.01.021; Ying ZK, 2013, TOXICOL SCI, V135, P72, DOI 10.1093/toxsci/kft136	48	53	59	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83782	10.1371/journal.pone.0083782	http://dx.doi.org/10.1371/journal.pone.0083782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386277	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900058
J	Shi, S; Gao, SN; Cao, TC; Liu, J; Gao, X; Hao, J; Lv, CY; Huang, HL; Xu, J; Yao, TM				Shi, Shuo; Gao, Shane; Cao, Tongcheng; Liu, Jie; Gao, Xing; Hao, Jian; Lv, Chunyan; Huang, Hailiang; Xu, Jun; Yao, Tianming			Targeting Human Telomeric G-Quadruplex DNA and Inhibition of Telomerase Activity With [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+)	PLOS ONE			English	Article							MOLECULAR LIGHT SWITCH; RNA G-QUADRUPLEXES; 2 DIFFERENT FORMS; CIRCULAR-DICHROISM; METAL-COMPLEXES; RUTHENIUM COMPLEXES; CRYSTAL-STRUCTURE; BINDING; LIGAND; DESIGN	Inhibition of telomerase by inducing/stabilizing G-quadruplex formation is a promising strategy to design new anticancer drugs. We synthesized and characterized a new dinuclear complex [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+) (dmb = 4,4'-dimethyl-2,2'-bipyridine, obip = (2-(2-pyridyl)imidazo[4,5-f][1,10] phenanthroline) with high affinity for both antiparallel and mixed parallel /antiparallel G-quadruplex DNA. This complex can promote the formation and stabilize G-quadruplex DNA. Dialysis and TRAP experiments indicated that [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+) acted as an excellent telomerase inhibitor due to its obvious selectivity for G-quadruplex DNA rather than double stranded DNA. In vitro co-culture experiments implied that [(dmb)(2)Ru(obip)Ru(dmb)(2)](4+) inhibited telomerase activity and hindered cancer cell proliferation without side effects to normal fibroblast cells. TUNEL assay indicated that inhibition of telomerase activity induced DNA cleavage further apoptosis in cancer cells. Therefore, Ru-II complex represents an exciting opportunity for anticancer drug design by specifically targeting cancer cell G-quadruplexes DNA.	[Shi, Shuo; Cao, Tongcheng; Gao, Xing; Hao, Jian; Lv, Chunyan; Huang, Hailiang; Yao, Tianming] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China; [Gao, Shane; Xu, Jun] Tongji Univ, Sch Med, East Hosp, Shanghai 200092, Peoples R China; [Liu, Jie] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China	Tongji University; Tongji University; Jinan University	Shi, S (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	shishuo@tongji.edu.cn; xunymc2000@yahoo.com; tmyao@tongji.edu.cn	Shi, Shuo/S-8717-2019; Shi, Shuo/H-5025-2013	Shi, Shuo/0000-0003-4387-3445; Gao, Shane/0000-0002-7871-1537	National Programme on Key Basic Research Project (973 Program) [2010CB945200, 2011CB966200]; National Natural Science Foundation of China [20901060, 31170776, 20871094, 81171646, 20707015, 81070910]; New Century Excellent Talents in University [NCET-10-0606]; Shanghai Rising-Star program [11QA1407100]; Projects of International Cooperation and Exchanges NSFC [81261130318]; Fundamental Research Funds for the Central Universities	National Programme on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star program; Projects of International Cooperation and Exchanges NSFC; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Programme on Key Basic Research Project (973 Program) (2010CB945200, 2011CB966200); the National Natural Science Foundation of China (20901060, 31170776, 20871094, 81171646, 20707015, 81070910); New Century Excellent Talents in University (NCET-10-0606); Shanghai Rising-Star program (11QA1407100); Projects of International Cooperation and Exchanges NSFC (81261130318) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti P, 2003, MINI-REV MED CHEM, V3, P23, DOI 10.2174/1389557033405485; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Bailey SM, 2004, DNA REPAIR, V3, P349, DOI 10.1016/j.dnarep.2003.11.007; Baker ES, 2006, J AM CHEM SOC, V128, P2641, DOI 10.1021/ja0564968; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bertrand H, 2007, ORG BIOMOL CHEM, V5, P2555, DOI 10.1039/b708635k; Bertrand H, 2007, J BIOL INORG CHEM, V12, P1003, DOI 10.1007/s00775-007-0273-3; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Blackburn EH, 1995, TELOMERES; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Campbell NH, 2012, J MED CHEM, V55, P209, DOI 10.1021/jm201140v; Chen WZ, 2011, CHEM-EUR J, V17, P5595, DOI 10.1002/chem.201002168; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Cuesta J, 2003, MINI-REV MED CHEM, V3, P11, DOI 10.2174/1389557033405502; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Giri P, 2008, J PHOTOCH PHOTOBIO A, V194, P111, DOI 10.1016/j.jphotochem.2007.07.022; Granotier C, 2005, NUCLEIC ACIDS RES, V33, P4182, DOI 10.1093/nar/gki722; Huppert JL, 2007, PHILOS T R SOC A, V365, P2969, DOI 10.1098/rsta.2007.0011; Incles CM, 2004, MOL CANCER THER, V3, P1201; Jiang YL, 2010, MINI-REV MED CHEM, V10, P726, DOI 10.2174/138955710791572433; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Kieltyka R, 2008, J AM CHEM SOC, V130, P10040, DOI 10.1021/ja8014023; KUMAR CV, 1985, J AM CHEM SOC, V107, P5518, DOI 10.1021/ja00305a032; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Leonetti C, 2004, MOL PHARMACOL, V66, P1138, DOI 10.1124/mol.104.001537; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Ma DL, 2009, J AM CHEM SOC, V131, P1835, DOI 10.1021/ja806045x; MABROUK PA, 1986, INORG CHEM, V25, P526, DOI 10.1021/ic00224a027; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Qi HY, 2006, CANCER RES, V66, P11808, DOI 10.1158/0008-5472.CAN-06-1225; Ragazzon P, 2007, METHODS, V43, P313, DOI 10.1016/j.ymeth.2007.08.003; Read M, 2001, P NATL ACAD SCI USA, V98, P4844, DOI 10.1073/pnas.081560598; Reed J, 2008, ANAL BIOCHEM, V380, P99, DOI 10.1016/j.ab.2008.05.013; Reed JE, 2006, J AM CHEM SOC, V128, P5992, DOI 10.1021/ja058509n; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Rezler EM, 2005, J AM CHEM SOC, V127, P9439, DOI 10.1021/ja0505088; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sahoo D, 2010, J PHYS CHEM B, V114, P2044, DOI 10.1021/jp910766q; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Shi S, 2008, INORG CHEM, V47, P2910, DOI 10.1021/ic7021209; Shi S, 2013, J INORG BIOCHEM, V121, P19, DOI 10.1016/j.jinorgbio.2012.12.011; Shi S, 2012, INORG CHEM COMMUN, V24, P212, DOI 10.1016/j.inoche.2012.07.015; Shi S, 2012, DALTON T, V41, P5789, DOI 10.1039/c2dt30076a; Shi S, 2010, BIOCHIMIE, V92, P370, DOI 10.1016/j.biochi.2010.01.003; Shi S, 2010, DALTON T, V39, P2490, DOI 10.1039/b916094a; Sparapani S, 2010, J AM CHEM SOC, V132, P12263, DOI 10.1021/ja1003944; Suntharalingam K, 2010, INORG CHEM, V49, P8371, DOI 10.1021/ic100884p; Teulade-Fichou MP, 2003, J AM CHEM SOC, V125, P4732, DOI 10.1021/ja021299j; Vorlickova M, 2012, CHIRALITY, V24, P691, DOI 10.1002/chir.22064; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xu Y, 2010, J AM CHEM SOC, V130, P11579; Xu Y, 2006, BIOORGAN MED CHEM, V14, P5584, DOI 10.1016/j.bmc.2006.04.033; Yao JL, 2013, DALTON T, V42, P5661, DOI 10.1039/c3dt32640c; Yao JL, 2012, INORG CHEM, V51, P12591, DOI 10.1021/ic301305q; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; Zou XH, 2001, INORG CHEM, V40, P7091, DOI 10.1021/ic001429u	65	14	14	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84419	10.1371/journal.pone.0084419	http://dx.doi.org/10.1371/journal.pone.0084419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386376	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900092
J	Hirasaki, M; Hiraki-Kamon, K; Kamon, M; Suzuki, A; Katano, M; Nishimoto, M; Okuda, A				Hirasaki, Masataka; Hiraki-Kamon, Keiko; Kamon, Masayoshi; Suzuki, Ayumu; Katano, Miyuki; Nishimoto, Masazumi; Okuda, Akihiko			Striking Similarity in the Gene Expression Levels of Individual Myc Module Members among ESCs, EpiSCs, and Partial iPSCs	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; TRANSCRIPTIONAL NETWORK; SOMATIC-CELLS; PLURIPOTENCY; MOUSE; LINEAGE; DIFFERENTIATION; INDUCTION	Predominant transcriptional subnetworks called Core, Myc, and PRC modules have been shown to participate in preservation of the pluripotency and self-renewality of embryonic stem cells (ESCs). Epiblast stem cells (EpiSCs) are another cell type that possesses pluripotency and self-renewality. However, the roles of these modules in EpiSCs have not been systematically examined to date. Here, we compared the average expression levels of Core, Myc, and PRC module genes between ESCs and EpiSCs. EpiSCs showed substantially higher and lower expression levels of PRC and Core module genes, respectively, compared with those in ESCs, while Myc module members showed almost equivalent levels of average gene expression. Subsequent analyses revealed that the similarity in gene expression levels of the Myc module between these two cell types was not just overall, but striking similarities were evident even when comparing the expression of individual genes. We also observed equivalent levels of similarity in the expression of individual Myc module genes between induced pluripotent stem cells (iPSCs) and partial iPSCs that are an unwanted byproduct generated during iPSC induction. Moreover, our data demonstrate that partial iPSCs depend on a high level of c-Myc expression for their self-renewal properties.	[Hirasaki, Masataka; Hiraki-Kamon, Keiko; Kamon, Masayoshi; Suzuki, Ayumu; Katano, Miyuki; Nishimoto, Masazumi; Okuda, Akihiko] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Hidaka, Saitama, Japan; [Okuda, Akihiko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Saitama Medical University; Japan Science & Technology Agency (JST)	Okuda, A (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Hidaka, Saitama, Japan.	akiokuda@saitama-med.ac.jp		Hiraki-kamon, Keiko/0000-0002-0901-9619	Ministry of Education, Culture, Sports, Science and Technology, Japan;  [25293082];  [25670147]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	Grant numbers: 25293082, 25670147. The funders (Ministry of Education, Culture, Sports, Science and Technology, Japan) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hishida T, 2012, STEM CELLS, V30, P1634, DOI 10.1002/stem.1147; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jia JL, 2012, CELL, V151, P576, DOI 10.1016/j.cell.2012.09.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pardo FN, 2012, DIABETOLOGIA, V55, P3331, DOI 10.1007/s00125-012-2696-9; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Walker MR, 2010, J BIOL CHEM, V285, P5026, DOI 10.1074/jbc.M109.032672; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	52	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83769	10.1371/journal.pone.0083769	http://dx.doi.org/10.1371/journal.pone.0083769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386274	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700076
J	Toffolo, MB; Fantalkin, A; Lemos, IS; Felsch, RCS; Niemeier, WD; Sanders, GDR; Finkelstein, I; Boaretto, E				Toffolo, Michael B.; Fantalkin, Alexander; Lemos, Irene S.; Felsch, Rainer C. S.; Niemeier, Wolf-Dietrich; Sanders, Guy D. R.; Finkelstein, Israel; Boaretto, Elisabetta			Towards an Absolute Chronology for the Aegean Iron Age: New Radiocarbon Dates from Lefkandi, Kalapodi and Corinth	PLOS ONE			English	Article							MEDITERRANEAN CHRONOLOGY; LATE BRONZE; CALIBRATION; CONTEXTS; CHARCOAL; ISRAEL; DEBATE	The relative chronology of the Aegean Iron Age is robust. It is based on minute stylistic changes in the Submycenaean, Protogeometric and Geometric styles and their sub-phases. Yet, the absolute chronology of the time-span between the final stages of Late Helladic IIIC in the late second millennium BCE and the archaic colonization of Italy and Sicily toward the end of the 8th century BCE lacks archaeological contexts that can be directly related to events carrying absolute dates mentioned in Egyptian/Near Eastern historical sources, or to well-dated Egyptian/Near Eastern rulers. The small number of radiocarbon dates available for this time span is not sufficient to establish an absolute chronological sequence. Here we present a new set of short-lived radiocarbon dates from the sites of Lefkandi, Kalapodi and Corinth in Greece. We focus on the crucial transition from the Submycenaean to the Protogeometric periods. This transition is placed in the late 11th century BCE according to the Conventional Aegean Chronology and in the late 12th century BCE according to the High Aegean Chronology. Our results place it in the second half of the 11th century BCE.	[Toffolo, Michael B.; Boaretto, Elisabetta] Weizmann Inst Sci, Kimmel Ctr Archaeol Sci, IL-76100 Rehovot, Israel; [Toffolo, Michael B.; Fantalkin, Alexander; Finkelstein, Israel] Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, IL-69978 Tel Aviv, Israel; [Lemos, Irene S.] Univ Oxford Merton Coll, Oxford OX1 4JD, England; [Felsch, Rainer C. S.] Haferkamp 3C, Isernhagen, Germany; [Niemeier, Wolf-Dietrich] German Archaeol Inst, Athens 10678, Greece; [Sanders, Guy D. R.] Amer Sch Class Studies Athens, Corinth Excavations, Ancient Corinth, Greece; [Boaretto, Elisabetta] Weizmann Inst Sci, D REAMS Radiocarbon Lab, Weizmann Inst, Max Planck Ctr Integrat Archaeol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Tel Aviv University; University of Oxford; Max Planck Society; Weizmann Institute of Science	Toffolo, MB (corresponding author), Weizmann Inst Sci, Kimmel Ctr Archaeol Sci, IL-76100 Rehovot, Israel.	michael.toffolo@weizmann.ac.il	Toffolo, Michael B./M-7754-2016	Toffolo, Michael B./0000-0001-5894-4301; Fantalkin, Alexander/0000-0001-5996-6465	European Research Council under the European Community [229418]	European Research Council under the European Community(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement number 229418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascough P, 2005, PROG PHYS GEOG, V29, P532, DOI 10.1191/0309133305pp461ra; Bartoloni G., 2005, ATT INC STUD ROM 30; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Berna F, 2007, J ARCHAEOL SCI, V34, P358, DOI 10.1016/j.jas.2006.05.011; Boaretto E., 2007, Israel Journal of Earth Sciences, V56, P207, DOI 10.1560/IJES.56.2-4.207; Boaretto E, 2009, RADIOCARBON, V51, P275, DOI 10.1017/S0033822200033804; Brandherm Dirk, 2008, NEW DAWN DARK AGE SH; Bruins HJ, 2011, RADIOCARBON, V53, P199, DOI 10.1017/S0033822200034470; CASKEY JL, 1974, HESPERIA, V43, P1; Coldstream J. N., 2003, TEL AVIV, V30, P247; Coldstream N, 1968, GREEK GEOMETRIC POTT; Craig OE, 2013, AM J PHYS ANTHR; D Lancy, 2015, PROTOGEOMETRIC AEGEA; Desborough V. R. d'A, 1957, J HELLENIC STUD, V77, P212; Dickinson O, 2006, AEGEAN BRONZE AGE IR, DOI DOI 10.4324/9780203968369; Fantalkin A., 2001, LEVANT, V33, P117; Fantalkin A, 2011, RADIOCARBON, V53, P179, DOI 10.1017/S0033822200034469; Felsch R, 1996, KALAPODI 1 ERGEBNISS; Felsch R, 2007, KALAPODI 2 ERGEBNISS; Finkelstein I, 2011, NEAR EAST ARCHAEOL, V74, P50, DOI 10.5615/neareastarch.74.1.0050; Finkelstein I, 2010, ANTIQUITY, V84, P374, DOI 10.1017/S0003598X00066643; Finkelstein Israel, 1996, LEVANT, V28, P177, DOI DOI 10.1179/LEV.1996.28.1.177; French E. B., 2007, SYNCHRONISATION CIVI, P525; Gjerstad E., 1944, OPARCH, V3, P73; Luce J.-M., 1993, B CORRESP HELLENIQUE, V117, P619; Maeir A.M., 2009, ANC WEST EAST, V8, P57; MANNING SW, 1992, ANTIQUITY, V66, P636, DOI 10.1017/S0003598X00039351; Mazar A., 2005, BIBLE RADIOCARBON DA, P15; Mazar A, 2008, RADIOCARBON, V50, P159, DOI 10.1017/S0033822200033506; Mazar A, 2011, NEAR EAST ARCHAEOL, V74, P105, DOI 10.5615/neareastarch.74.2.0105; Miller J. Maxwell, 1997, AGE SOLOMON SCHOLARS, V11, P1; Mountjoy P.A., 1988, JB DTSCH ARCHAOLOGIS, V103, P1; Newton M.W., 2005, BIBLE RADIOCARBON DA, P104; Newton MW, 2007, STRUMA STRYMON RIVER, P481; Niemann H. M., 1997, AGE SOLOMON SCHOLARS, P252; Nijboer AJ, 2005, ANCIENT W E, V4, P254; Papadopoulos J.K., 2011, OUR CUPS ARE FULL PO, V2227, P187; Popham M., 1996, LEFKANDI 3 TOUMBA CE; Ramsey CB, 2010, RADIOCARBON, V52, P953, DOI 10.1017/S0033822200046063; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rebollo NR, 2008, RADIOCARBON, V50, P289, DOI 10.1017/S0033822200033592; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Ruppenstein F, 2007, SUBMYKENISCHE NEKROP; Rutter JB, 1978, TUAS, V3, P58; Sharon I, 2001, RADIOCARBON, V43, P345; Sharon I, 2007, RADIOCARBON, V49, P1, DOI 10.1017/S0033822200041886; Sherratt S, 2006, I WILL SPEAK RIDDLES, P261; Snodgrass A.M., 1971, DARK AGE GREECE ARCH; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Toffolo MB, RADIOCARBON IN PRESS; Toffolo M, 2012, RADIOCARBON, V54, P371, DOI 10.1017/S0033822200047159; van der Plicht J, 2009, RADIOCARBON, V51, P213, DOI 10.1017/S0033822200033786; Van Seters John, 1983, SEARCH HIST; VRdA Desborough, 1972, GREEK DARK AGES; VRdA Desborough, 1952, PROTOGEOMETRIC POTTE; Warren Peter, 1989, AEGEAN BRONZE AGE CH; Wells B, 1983, ASINE 2 RESULTS EX 2, V4; Weninger B., 2009, LH 3 C CHRONOLOGY SY, V30, P373; Whitley J, 1991, STYLE SOC DARK AGE G; WILLIAMS CK, 1970, HESPERIA, V39, P1; WILLIAMS CK, 1972, HESPERIA, V41, P143; Williams CK, 2003, CORINTH CENTENNARY 1; Yasur-Landau A, 1993, LH 3C CHRON SYNCHR P, P235; Yizhaq M, 2005, RADIOCARBON, V47, P193, DOI 10.1017/S003382220001969X	65	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83117	10.1371/journal.pone.0083117	http://dx.doi.org/10.1371/journal.pone.0083117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	281QS	24386150	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700030
J	Karok, S; Witney, AG				Karok, Sophia; Witney, Alice G.			Enhanced Motor Learning Following Task-Concurrent Dual Transcranial Direct Current Stimulation	PLOS ONE			English	Article							HEMISPHERIC-ASYMMETRY; CORTEX; EXCITABILITY; TDCS; MODULATION; PERFORMANCE; INHIBITION; PLASTICITY; POLARIZATION; FACILITATION	Objective: Transcranial direct current stimulation (tDCS) of the primary motor cortex (M1) has beneficial effects on motor performance and motor learning in healthy subjects and is emerging as a promising tool for motor neurorehabilitation. Applying tDCS concurrently with a motor task has recently been found to be more effective than applying stimulation before the motor task. This study extends this finding to examine whether such task-concurrent stimulation further enhances motor learning on a dual M1 montage. Method: Twenty healthy, right-handed subjects received anodal tDCS to the right M1, dual tDCS (anodal current over right M1 and cathodal over left M1) and sham tDCS in a repeated-measures design. Stimulation was applied for 10 mins at 1.5 mA during an explicit motor learning task. Response times (RT) and accuracy were measured at baseline, during, directly after and 15 mins after stimulation. Motor cortical excitability was recorded from both hemispheres before and after stimulation using single-pulse transcranial magnetic stimulation. Results: Task-concurrent stimulation with a dual M1 montage significantly reduced RTs by 23% as early as with the onset of stimulation (p<0.01) with this effect increasing to 30% at the final measurement. Polarity-specific changes in cortical excitability were observed with MEPs significantly reduced by 12% in the left M1 and increased by 69% in the right M1. Conclusion: Performance improvement occurred earliest in the dual M1 condition with a stable and lasting effect. Unilateral anodal stimulation resulted only in trendwise improvement when compared to sham. Therefore, task-concurrent dual M1 stimulation is most suited for obtaining the desired neuromodulatory effects of tDCS in explicit motor learning.	[Karok, Sophia; Witney, Alice G.] Trinity Coll Dublin, Inst Biomed Sci, Sch Med, Dept Physiol, Dublin, Ireland	Trinity College Dublin	Karok, S (corresponding author), Trinity Coll Dublin, Inst Biomed Sci, Sch Med, Dept Physiol, Dublin, Ireland.	karoks@tcd.ie	Witney, Alice G./AAH-3107-2021	Witney, Alice G./0000-0002-3726-8479	Irish Research Council EMBARK Initiative [409.G30568]	Irish Research Council EMBARK Initiative(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Irish Research Council EMBARK Initiative (409.G30568); www.research.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastani A, 2013, BRAIN STIMUL, V6, P932, DOI 10.1016/j.brs.2013.04.005; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Kang Eun Kyoung, 2011, Exp Transl Stroke Med, V3, P4, DOI 10.1186/2040-7378-3-4; Kidgell DJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-64; Kim GW, 2013, NEUROSCI LETT, V548, P181, DOI 10.1016/j.neulet.2013.05.037; Kuo MF, 2008, NEUROPSYCHOLOGIA, V46, P2122, DOI 10.1016/j.neuropsychologia.2008.02.023; Kwon JW, 2013, NEUROREHABILITATION, V32, P191, DOI 10.3233/NRE-130836; Kwon YH, 2012, NEURAL REGEN RES, V7, P1889, DOI 10.3969/j.issn.1673-5374.2012.24.007; Kwon YH, 2011, NEUROSCI LETT, V492, P105, DOI 10.1016/j.neulet.2011.01.066; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lefebvre S, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00343; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lindenberg R, 2010, NEUROLOGY, V75, P2176, DOI 10.1212/WNL.0b013e318202013a; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Mahmoudi H, 2011, DISABIL REHABIL, V33, P1383, DOI 10.3109/09638288.2010.532283; Marquez CMS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00333; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; MORDILLOMATEOS L, 2012, EUR J NEUROL, V19, P227; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; NETZ J, 1995, EXP BRAIN RES, V104, P527; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Perez MA, 2009, J PHYSIOL-LONDON, V587, P725, DOI 10.1113/jphysiol.2008.166926; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Reis J, 2011, CURR OPIN NEUROL, V24, P590, DOI 10.1097/WCO.0b013e32834c3db0; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Schade S, 2012, RESTOR NEUROL NEUROS, V30, P191, DOI 10.3233/RNN-2012-110175; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Sehm B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00183; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Teasell Robert, 2005, Top Stroke Rehabil, V12, P11; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	50	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85693	10.1371/journal.pone.0085693	http://dx.doi.org/10.1371/journal.pone.0085693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376893	Green Published, Green Submitted, gold			2022-12-27	WOS:000328882000191
J	Al-Janabi, S; van Slooten, HJ; Visser, M; van der Ploeg, T; van Diest, PJ; Jiwa, M				Al-Janabi, Shaimaa; van Slooten, Henk-Jan; Visser, Mike; van der Ploeg, Tjeerd; van Diest, Paul J.; Jiwa, Mehdi			Evaluation of Mitotic Activity Index in Breast Cancer Using Whole Slide Digital Images	PLOS ONE			English	Article							INTEROBSERVER AGREEMENT; PROGNOSTIC VALUE; PRIMARY DIAGNOSTICS; SURGICAL PATHOLOGY; VIRTUAL MICROSCOPY; CARCINOMA; PROLIFERATION; FEASIBILITY; SPECIMENS; ROUTINE	Introduction: Mitotic Activity Index (MAI) is an important independent prognostic factor and an integral part of the breast cancer grading system. Thus, correct estimation of this prognostically relevant feature is essential for guiding treatment decision and assessing patient prognosis. The aim of this study was to validate the use of high resolution Whole Slide Images (WSI) in estimating MAI in breast cancer specimens. Methods: MAI was evaluated in 100 consecutive breast cancer specimens by three observers on two occasions, microscopically and on WSI with a wash out period of 4 months. MAI was also translated to mitotic scores as in grading. Inter-and intra-observer agreement between microscopic and digital MAI counts and scores was measured. Results: Almost perfect inter-observer agreements were obtained from counting MAI using a conventional microscope (intra-class correlation coefficient (ICCC) 0.879) as well as on WSI (ICCC 0.924). K coefficients reflected good inter-observer agreements among observers' microscopic mitotic scores (average kappa 0.642). Comparable results were also observed among digital mitotic scores (average kappa 0.635). There was strong to perfect intra-observer agreements between MAI counts and mitotic scores for the two diagnostic modalities (ICCC 0.716-0.863, kappa 0.506-0.617). There were no significant differences in mitotic scores using both diagnostic modalities. Conclusion: Scoring mitoses using WSI in breast cancer seems to be just as reliable and reproducible as when using a microscope. Further development of software and image quality will definitely encourage the use of WSI in routine pathology practice.	[Al-Janabi, Shaimaa; van Slooten, Henk-Jan; Jiwa, Mehdi] Symbiant Pathol Expert Ctr, Alkmaar, Netherlands; [Visser, Mike] Symbiant Pathol Expert Ctr, Zaandam, Netherlands; [van der Ploeg, Tjeerd] Med Ctr Alkmaar, Alkmaar, Netherlands; [van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Nokia Corporation; Nokia Corporation; Medical Center Of Alkmaar; Utrecht University; Utrecht University Medical Center	Jiwa, M (corresponding author), Symbiant Pathol Expert Ctr, Alkmaar, Netherlands.	m.jiwa@symbiant.nl		van der Ploeg, Tjeerd/0000-0003-0429-6753				Al-Janabi S, 2012, HUM PATHOL, V43, P2318, DOI 10.1016/j.humpath.2012.03.027; Al-Janabi S, 2013, J CLIN PATHOL, V66, P218, DOI 10.1136/jclinpath-2012-201104; Al-Janabi S, 2012, J CLIN PATHOL, V65, P1107, DOI 10.1136/jclinpath-2012-200878; Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Al-Janabi S, 2012, HUM PATHOL, V43, P702, DOI 10.1016/j.humpath.2011.06.017; Al-Janabi S, 2012, J CLIN PATHOL, V65, P152, DOI 10.1136/jclinpath-2011-200277; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; BAAK JPA, 1993, J CELL BIOCHEM, P220; BECK JS, 1985, J CLIN PATHOL, V38, P1358, DOI 10.1136/jcp.38.12.1358; Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618; CLAYTON F, 1991, CANCER, V68, P1309, DOI 10.1002/1097-0142(19910915)68:6<1309::AID-CNCR2820680621>3.0.CO;2-I; Cornish TC, 2012, ADV ANAT PATHOL, V19, P152, DOI 10.1097/PAP.0b013e318253459e; Dee FR, 2009, HUM PATHOL, V40, P1112, DOI 10.1016/j.humpath.2009.04.010; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Gilbertson JR, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-4; Ho J, 2006, HUM PATHOL, V37, P322, DOI 10.1016/j.humpath.2005.11.005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange H, 2011, LABMEDICINE, V42, P587, DOI 10.1309/LMA2M9NQQF0ZCVHC; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P1515, DOI 10.1043/1543-2165-133.10.1515; Li XX, 2007, HUM PATHOL, V38, P1842, DOI 10.1016/j.humpath.2007.04.019; Longacre TA, 2006, MODERN PATHOL, V19, P195, DOI 10.1038/modpathol.3800496; Martin DT, 2011, ACTA CYTOL, V55, P271, DOI 10.1159/000324029; Medri L, 2003, MODERN PATHOL, V16, P1067, DOI 10.1097/01.MP.0000093625.20366.9D; Meyer JS, 2005, MODERN PATHOL, V18, P1067, DOI 10.1038/modpathol.3800388; Molnar B, 2003, J CLIN PATHOL, V56, P433, DOI 10.1136/jcp.56.6.433; Nielsen PS, 2010, HUM PATHOL, V41, P1770, DOI 10.1016/j.humpath.2010.05.015; Pantanowitz Liron, 2011, J Pathol Inform, V2, P36, DOI 10.4103/2153-3539.83746; Pietilainen T, 1996, J CANCER RES CLIN, V122, P687, DOI 10.1007/BF01209033; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Rocha R, 2009, PATHOL RES PRACT, V205, P735, DOI 10.1016/j.prp.2009.05.004; Tsuda H, 2000, JPN J CANCER RES, V91, P451, DOI 10.1111/j.1349-7006.2000.tb00966.x; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Veta M, 2012, MODERN PATHOL, V25, P1559, DOI 10.1038/modpathol.2012.126; Viera AJ, 2005, FAM MED, V37, P360	36	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82576	10.1371/journal.pone.0082576	http://dx.doi.org/10.1371/journal.pone.0082576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386102	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700010
J	Chiang, CC; Lin, CL; Tsai, YY; Peng, CL; Liao, YT; Sung, FC				Chiang, Chun-Chi; Lin, Cheng-Li; Tsai, Yi-Yu; Peng, Chiao-Ling; Liao, Ya-Tang; Sung, Fung-Chang			Patients with Blepharitis Are at Elevated Risk of Anxiety and Depression	PLOS ONE			English	Article							FILM LIPID LAYER; MEIBOMIAN GLAND; DRY EYE; ANDROGEN DEFICIENCY; GENDER-DIFFERENCES; SEX STEROIDS; INFLAMMATION; PREVALENCE; EPIDEMIOLOGY; PROFILES	Purpose: Population-based cohort study on the risk of anxiety and depression in patients with blepharitis is limited. This study evaluated whether blepharitis patients are at a higher risk of anxiety and depression. Design: A retrospective cohort study. Methods: We used the universal insurance claims data from 1997 to 2010 in Taiwan to identify annually patients with newly diagnosed blepharitis (N = 9764) and without the disease (N = 39056). Incidences, rate ratios (IRR) and hazard ratios (HR) of anxiety and depression were measured for both cohorts by baseline demographic characteristics and comorbidities until the end of 2010. Results: Compared with the non-blepharitis cohort, the blepharitis cohort had higher incidence of anxiety (15.9 vs. 9.5 per 1000 person-years), with an adjusted HR of 1.58 (95% confidence interval (CI) = 1.46-1.70). The incidence of depression was also higher in the blepharitis cohort (7.66 vs. 5.05 per 1000 person-years), with an adjusted HR of 1.42 (95% CI = 1.28-1.58). The blepharitis cohort to the non-blepharitis cohort IRR decreased from 1.73 in the first quartile to 1.32 in the 4th quartile for anxiety, and from 1.67 to 1.29 for depression. Conclusions: Patients with blepharitis are at elevated risks of anxiety and depression. The risk is higher in earlier period after the diagnosis of blepharitis, and declines by time, but remains significantly higher for those with blepharitis than those without blepharitis.	[Chiang, Chun-Chi; Tsai, Yi-Yu] China Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan; [Chiang, Chun-Chi; Tsai, Yi-Yu] China Med Univ, Sch Med, Taichung, Taiwan; [Lin, Cheng-Li; Peng, Chiao-Ling; Liao, Ya-Tang; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	fcsung@mail.cmu.edu.tw			Executive Yuan National Sciences Council [NSC 100-2621-M-039-001]; China Medical University Hospital [1MS1, DMR-101-075]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH101-TD-B-111-004]; Cancer Research Center of Excellence [DOH101-TD-C-111-005]	Executive Yuan National Sciences Council; China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center for Excellence; Cancer Research Center of Excellence	This study was supported in part by the Executive Yuan National Sciences Council (grant numbers NSC 100-2621-M-039-001), China Medical University Hospital (grant number 1MS1 and DMR-101-075), and Taiwan Department of Health Clinical Trial and Research Center for Excellence (grant number DOH101-TD-B-111-004) and Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAO 2008 American Academy of Ophthalmology Retina Panel, 2008, PREF PRACT PATT GUID; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; Cohen CI, 2006, PSYCHIAT SERV, V57, P1719, DOI 10.1176/appi.ps.57.12.1719; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Foulks Gary N, 2003, Ocul Surf, V1, P107; Henderson AS, 1998, PSYCHOL MED, V28, P1321, DOI 10.1017/S0033291798007570; Hybels CF, 2003, CLIN GERIATR MED, V19, P663, DOI 10.1016/S0749-0690(03)00042-9; Jeste DV, 2005, BIOL PSYCHIAT, V58, P265, DOI 10.1016/j.biopsych.2005.02.004; Kessler R.C., 2006, WOMEN DEPRESSION HDB, P22, DOI DOI 10.1017/CBO9780511841262.004; Korb DR, 2005, OPTOMETRY VISION SCI, V82, P594, DOI 10.1097/01.opx.0000171818.01353.8c; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lemp MA, 2009, OCUL SURF, V7, pS1, DOI 10.1016/S1542-0124(12)70620-1; MCCULLEY JP, 1982, OPHTHALMOLOGY, V89, P1173; McDonald MB, 2009, OCUL SURF, V7, pS17, DOI 10.1016/S1542-0124(12)70622-5; Mehta KM, 2003, J AM GERIATR SOC, V51, P499, DOI 10.1046/j.1532-5415.2003.51158.x; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nemet AY, 2011, OPHTHALMOLOGY, V118, P1062, DOI 10.1016/j.ophtha.2010.10.015; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Pflugfelder SC, 2000, CORNEA, V19, P644, DOI 10.1097/00003226-200009000-00009; Pigott TA, 1999, J CLIN PSYCHIAT, V60, P4; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ridker PM, 2007, NUTR REV, V65, pS253, DOI [10.1111/j.1753-4887.2007.tb00372.x, 10.1301/nr.2007.dec.S253-S259]; Rubin M, 2006, J OCUL PHARMACOL TH, V22, P47, DOI 10.1089/jop.2006.22.47; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Sullivan BD, 2002, ADV EXP MED BIOL, V506, P449; Sullivan BD, 2002, ARCH OPHTHALMOL-CHIC, V120, P1689; Sullivan BD, 2000, J CLIN ENDOCR METAB, V85, P4866, DOI 10.1210/jc.85.12.4866; Sullivan DA, 2000, INVEST OPHTH VIS SCI, V41, P3732; Sullivan DA, 1999, INVEST OPHTH VIS SCI, V40, P1261; Sullivan DA, 1998, ADV EXP MED BIOL, V438, P327; Sullivan DA, 2002, ADV EXP MED BIOL, V506, P389; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Sullivan DA, 2009, MOL VIS, V15, P1553; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Warrington TP, 2006, MAYO CLIN PROC, V81, P1361, DOI 10.4065/81.10.1361; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	44	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83335	10.1371/journal.pone.0083335	http://dx.doi.org/10.1371/journal.pone.0083335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386181	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700034
J	Fort, H; Inchausti, P				Fort, Hugo; Inchausti, Pablo			Tropical Forests Are Non-Equilibrium Ecosystems Governed by Interspecific Competition Based on Universal 1/6 Niche Width	PLOS ONE			English	Article							NEUTRAL-THEORY; SPECIES ABUNDANCE; DIVERSITY; MODELS; COMMUNITIES; SIMILARITY; STATISTICS; PATTERNS	Tropical forests are mega-diverse ecosystems that display complex and non-equilibrium dynamics. However, theoretical approaches have largely focused on explaining steady-state behaviour and fitting snapshots of data. Here we show that local and niche interspecific competition can realistically and parsimoniously explain the observed non-equilibrium regime of permanent plots of nine tropical forests, in eight different countries. Our spatially-explicit model, besides predicting with accuracy the main biodiversity metrics for these plots, can also reproduce their dynamics. A central finding is that tropical tree species have a universal niche width of approximately 1/6 of the niche axis that echoes the observed widespread convergence in their functional traits enabling them to exploit similar resources and to coexist despite of having large niche overlap. This niche width yields an average ratio of 0.25 between interspecific and intraspecific competition that corresponds to an intermediate value between the extreme claims of the neutral model and the classical niche-based model of community assembly (where interspecific competition is dominant). In addition, our model can explain and yield observed spatial patterns that classical niche-based and neutral theories cannot.	[Fort, Hugo] Univ Republica, Fac Ciencias, Inst Phys, Complex Syst Grp, Montevideo, Uruguay; [Inchausti, Pablo] Univ Republ, Ctr Univ Reg Este, Maldonado, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Inchausti, P (corresponding author), Univ Republ, Ctr Univ Reg Este, Maldonado, Uruguay.	pablo.inchausti.f@gmail.com			PEDECIBA; SNI of Uruguay; National Science Foundation [DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197]; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund	PEDECIBA; SNI of Uruguay; National Science Foundation(National Science Foundation (NSF)); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund	This work was partly supported by PEDECIBA and SNI of Uruguay. The authors are grateful to the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute. The BCI forest dynamics research project was made possible by National Science Foundation grants to Stephen P. Hubbell: DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, support from the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation, the Small World Institute Fund, and numerous private individuals, and through the hard work of over 100 people from 10 countries over the past two decades. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We duly requested and formally obtained authorization form the Smithsonian Tropical Research Institute to access and use the information on the permanent tropical forest plots available in the web site. We had also contacted researchers of the STRI regarding authorship on this paper but we never received a response. We included the sentences acknowledging the funding to gather the BCI data as requested by STRI. In sum, we have fully complied with what was requested by the owners of the data that we used in this manuscript.	CHASE JM, 2004, ECOLOGICAL NICHES LI; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; Garrod C, 1994, STAT MECH THERMODYNA; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Grimm V, 2002, AGENT BASED INDIVIDU; Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001; Holyoak M, 2006, ECOLOGY, V87, P1368; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell S.P., 2001, MG POP BIOL, V32; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HUBBELL SP, 2001, ECOLOGICAL RES, V16, pS45; Hubbell SP., 2008, TROPICAL FOREST COMM, P143; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell SP, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P264; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Krapivsky P., 2010, KINETIC VIEW STAT PH; Leimar O, J THEOR BIO IN PRESS; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Seri E, 2012, AM NAT, V180, pE161, DOI 10.1086/668125; SILVERTOWN J, 1992, J ECOL, V80, P527, DOI 10.2307/2260696; Terborgh J, 1996, ECOLOGY, V77, P561, DOI 10.2307/2265630; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Wolfram S, 1996, CELLULAR AUTOMATA CO; Zillio T., 2005, PHYS REV E, V71, P1507; Zillio T, 2007, OIKOS, V116, P931, DOI 10.1111/j.2007.0030-1299.15662.x	39	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82768	10.1371/journal.pone.0082768	http://dx.doi.org/10.1371/journal.pone.0082768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386115	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700012
J	Ma, ZG; Li, CF; Pan, GQ; Li, ZH; Han, B; Xu, JS; Lan, XQ; Chen, J; Yang, DL; Chen, QM; Sang, Q; Ji, XC; Li, T; Long, MX; Zhou, ZY				Ma, Zhengang; Li, Chunfeng; Pan, Guoqing; Li, Zhihong; Han, Bing; Xu, Jinshan; Lan, Xiqian; Chen, Jie; Yang, Donglin; Chen, Quanmei; Sang, Qi; Ji, Xiaocun; Li, Tian; Long, Mengxian; Zhou, Zeyang			Genome-Wide Transcriptional Response of Silkworm (Bombyx mori) to Infection by the Microsporidian Nosema bombycis	PLOS ONE			English	Article							SPORE WALL PROTEIN; JUVENILE-HORMONE; GENE-EXPRESSION; IMMUNE-RESPONSE; DROSOPHILA-MELANOGASTER; DOMESTICATED SILKWORM; MOLECULAR ACTIONS; POLAR TUBE; IDENTIFICATION; INVASION	Microsporidia have attracted much attention because they infect a variety of species ranging from protists to mammals, including immunocompromised patients with AIDS or cancer. Aside from the study on Nosema ceranae, few works have focused on elucidating the mechanism in host response to microsporidia infection. Nosema bombycis is a pathogen of silkworm pebrine that causes great economic losses to the silkworm industry. Detailed understanding of the host (Bombyx mori) response to infection by N. bombycis is helpful for prevention of this disease. A genome-wide survey of the gene expression profile at 2, 4, 6 and 8 days post-infection by N. bombycis was performed and results showed that 64, 244, 1,328, 1,887 genes were induced, respectively. Up to 124 genes, which are involved in basal metabolism pathways, were modulated. Notably, B. mori genes that play a role in juvenile hormone synthesis and metabolism pathways were induced, suggesting that the host may accumulate JH as a response to infection. Interestingly, N. bombycis can inhibit the silkworm serine protease cascade melanization pathway in hemolymph, which may be due to the secretion of serpins in the microsporidia. N. bombycis also induced up-regulation of several cellular immune factors, in which CTL11 has been suggested to be involved in both spore recognition and immune signal transduction. Microarray and real-time PCR analysis indicated the activation of silkworm Toll and JAK/STAT pathways. The notable up-regulation of antimicrobial peptides, including gloverins, lebocins and moricins, strongly indicated that antimicrobial peptide defense mechanisms were triggered to resist the invasive microsporidia. An analysis of N. bombycis-specific response factors suggested their important roles in anti-microsporidia defense. Overall, this study primarily provides insight into the potential molecular mechanisms for the host-parasite interaction between B. mori and N. bombycis and may provide a foundation for further work on host-parasite interaction between insects and microsporidia.	[Ma, Zhengang; Li, Chunfeng; Pan, Guoqing; Li, Zhihong; Han, Bing; Lan, Xiqian; Chen, Jie; Yang, Donglin; Chen, Quanmei; Sang, Qi; Ji, Xiaocun; Li, Tian; Long, Mengxian; Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Xu, Jinshan; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China; [Ma, Zhengang; Li, Chunfeng; Pan, Guoqing; Li, Zhihong; Han, Bing; Chen, Jie; Yang, Donglin; Chen, Quanmei; Sang, Qi; Ji, Xiaocun; Li, Tian; Long, Mengxian; Zhou, Zeyang] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing, Peoples R China	Southwest University - China; Chongqing Normal University; Ministry of Agriculture & Rural Affairs; Southwest University - China	Zhou, ZY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zyzhou@swu.edu.cn			National Basic Research Program of China (973 Program) [2012CB114604]; Natural Science Foundation of China [30930067, 31072089, 31001036]; National High-Tech R&D Program (863 Program) [2012AA101301, 2013AA102507]; Doctorial Innovation Fund of Southwest University [KB2010004]; Natural Science Foundation Program of Chongqing [CSTC2011jjA0533]; Natural Science Foundation Project of China SWU [SWUB2008008]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program (863 Program)(National High Technology Research and Development Program of China); Doctorial Innovation Fund of Southwest University; Natural Science Foundation Program of Chongqing; Natural Science Foundation Project of China SWU(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, No. 2012CB114604, http://www.most.gov.cn/eng/), the Natural Science Foundation of China (No. 30930067, No. 31072089 and No. 31001036, http://www.nsfc.gov.cn/Portal0/default166.htm), the National High-Tech R&D Program (863 Program, No. 2012AA101301 and No. 2013AA102507, http://www.most.gov.cn/eng/), the Doctorial Innovation Fund of Southwest University (No. KB2010004 for ZM, http://www.swu.edu.cn/english/), the Natural Science Foundation Program of Chongqing (No. CSTC2011jjA0533, http://www.ctin.ac.cn/Index.aspx), the Natural Science Foundation Project of China SWU (SWUB2008008 for XL, http://www.swu.edu.cn/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; ASHIDA M, 1990, RES IMMUNOL, V141, P908, DOI 10.1016/0923-2494(90)90191-Z; Bao YY, 2011, INSECT BIOCHEM MOLEC, V41, P696, DOI 10.1016/j.ibmb.2011.05.001; Bede JC, 2001, PLANT PHYSIOL, V127, P584, DOI 10.1104/pp.010264; Bigliardi E, 2001, MICROBES INFECT, V3, P373, DOI 10.1016/S1286-4579(01)01393-4; BLALOCK JE, 1984, J IMMUNOL, V132, P1067; Borghetti P, 2009, VET IMMUNOL IMMUNOP, V130, P141, DOI 10.1016/j.vetimm.2009.01.013; Bouzahzah B, 2010, INFECT IMMUN, V78, P2745, DOI 10.1128/IAI.01205-09; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Dang XQ, 2013, J INVERTEBR PATHOL, V112, P166, DOI 10.1016/j.jip.2012.10.009; Didier ES, 1998, ADV PARASIT, V40, P283, DOI 10.1016/S0065-308X(08)60125-6; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Ellis J, 2010, MOL BIOCHEM PARASIT, V174, P117, DOI 10.1016/j.molbiopara.2010.08.007; FINLAYSON LH, 1957, NATURE, V180, P713, DOI 10.1038/180713b0; FISHER FM, 1964, BIOL BULL, V126, P235, DOI 10.2307/1539522; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Freitak D, 2003, P ROY SOC B-BIOL SCI, V270, pS220, DOI 10.1098/rsbl.2003.0069; Frixione E, 1997, J EUKARYOT MICROBIOL, V44, P109, DOI 10.1111/j.1550-7408.1997.tb05946.x; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Glinski Zdzislaw, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P149; Grace Michael J., 2004, Antiviral Chemistry & Chemotherapy, V15, P287; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Herve C, 1996, J MOL BIOL, V258, P778, DOI 10.1006/jmbi.1996.0286; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Huang L, 2009, INSECT MOL BIOL, V18, P517, DOI 10.1111/j.1365-2583.2009.00896.x; HUANG L, 2010, THESIS SW U CHONGQIN, P43; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Li Z, 2012, EUKARYOT CELL, V11, P229, DOI 10.1128/EC.05127-11; Liu HD, 2008, J INVERTEBR PATHOL, V99, P235, DOI 10.1016/j.jip.2008.06.012; Luo H, 2001, BIOESSAYS, V23, P1138, DOI 10.1002/bies.10016; Muniz CA, 2007, CELL MICROBIOL, V9, P106, DOI 10.1111/j.1462-5822.2006.00771.x; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Neill JD, 2003, BIOLOGICALS, V31, P97, DOI 10.1016/S1045-1056(03)00022-8; Nishiguchi M, 2002, MOL GENET GENOMICS, V267, P506, DOI 10.1007/s00438-002-0683-4; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Seleznev K.V., 2003, Parazitologiya (St. Petersburg), V37, P428; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Takase H, 2009, DEV COMP IMMUNOL, V33, P789, DOI 10.1016/j.dci.2009.01.005; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vieira CU, 2008, ARCH INSECT BIOCHEM, V67, P97, DOI 10.1002/arch.20224; Wang F, 2006, VIRUS GENES, V33, P351, DOI 10.1007/s11262-006-0075-7; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; WEIDNER E, 1982, J CELL BIOL, V93, P970, DOI 10.1083/jcb.93.3.970; WITTNER M, 1999, MICROSPORIDIA MICROS, P447; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Xu YJ, 2006, INFECT IMMUN, V74, P239, DOI 10.1128/IAI.74.1.239-247.2006; Yang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018109; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YL, 2010, INFECT IMMUN, V78, P1040, DOI 10.1128/IAI.01009-09; Zhang QR, 2005, INSECT BIOCHEM MOLEC, V35, P153, DOI 10.1016/j.ibmb.2004.10.010; Zhou YJ, 2002, BIOSCI BIOTECH BIOCH, V66, P1488, DOI 10.1271/bbb.66.1488; Zouali M, 2001, ARCH IMMUNOL THER EX, V49, P361	71	47	58	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84137	10.1371/journal.pone.0084137	http://dx.doi.org/10.1371/journal.pone.0084137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386341	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700093
J	Gibbons, CH; Bonyhay, I; Benson, A; Wang, NS; Freeman, R				Gibbons, Christopher H.; Bonyhay, Istvan; Benson, Adam; Wang, Ningshan; Freeman, Roy			Structural and Functional Small Fiber Abnormalities in the Neuropathic Postural Tachycardia Syndrome	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; POSTGANGLIONIC CHOLINERGIC DYSAUTONOMIA; BLOOD-PRESSURE; AUTONOMIC NEUROPATHY; ORTHOSTATIC INTOLERANCE; VALSALVA MANEUVER; SKIN BIOPSY; GENDER; HYPOTENSION	Objective: To define the neuropathology, clinical phenotype, autonomic physiology and differentiating features in individuals with neuropathic and non-neuropathic postural tachycardia syndrome (POTS). Methods: Twenty-four subjects with POTS and 10 healthy control subjects had skin biopsy analysis of intraepidermal nerve fiber density (IENFD), quantitative sensory testing (QST) and autonomic testing. Subjects completed quality of life, fatigue and disability questionnaires. Subjects were divided into neuropathic and non-neuropathic POTS, defined by abnormal IENFD and abnormal small fiber and sudomotor function. Results: Nine of 24 subjects had neuropathic POTS and had significantly lower resting and tilted heart rates; reduced parasympathetic function; and lower phase 4 valsalva maneuver overshoot compared with those with non-neuropathic POTS (P<0.05). Neuropathic POTS subjects also had less anxiety and depression and greater overall self-perceived health-related quality of life scores than non-neuropathic POTS subjects. A sub-group of POTS patients (cholinergic POTS) had abnormal proximal sudomotor function and symptoms that suggest gastrointestinal and genitourinary parasympathetic nervous system dysfunction. Conclusions and Relevance: POTS subtypes may be distinguished using small fiber and autonomic structural and functional criteria. Patients with non-neuropathic POTS have greater anxiety, greater depression and lower health-related quality of life scores compared to those with neuropathic POTS. These findings suggest different pathophysiological processes underlie the postural tachycardia in neuropathic and non-neuropathic POTS patients. The findings have implications for the therapeutic interventions to treat this disorder.	[Gibbons, Christopher H.; Bonyhay, Istvan; Benson, Adam; Wang, Ningshan; Freeman, Roy] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Freeman, R (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA.	rfreeman@bidmc.harvard.edu			NIH NINDS [K23NS050209]; NIH [NIH RO1 HL059459]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS050209] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH NINDS K23NS050209 (CHG) and NIH RO1 HL059459 (RF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shekhlee A, 2005, CLIN AUTON RES, V15, P219, DOI 10.1007/s10286-005-0282-7; Barnett SR, 1999, HYPERTENSION, V33, P1195, DOI 10.1161/01.HYP.33.5.1195; Baron R, 1996, J NEUROL, V243, P18; Bonyhay I, 2007, ANN NEUROL, V61, P332, DOI 10.1002/ana.21090; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Christou DD, 2005, CIRCULATION, V111, P494, DOI 10.1161/01.CIR.0000153864.24034.A6; Convertino VA, 1998, AM J PHYSIOL-REG I, V275, pR1909, DOI 10.1152/ajpregu.1998.275.6.R1909; Freeman R, 1997, AM J MED, V102, P357, DOI 10.1016/S0002-9343(97)00087-9; Freeman R, 2011, AUTON NEUROSCIENCE; Fu Q, 2005, AM J PHYSIOL-REG I, V289, pR109, DOI 10.1152/ajpregu.00013.2005; Fu Q, 2004, AM J PHYSIOL-HEART C, V286, pH449, DOI 10.1152/ajpheart.00735.2002; Gibbons C, 2004, NEUROL CLIN, V22, P683, DOI 10.1016/j.ncl.2004.03.002; Gibbons CH, 2006, NEUROLOGY, V66, P256, DOI 10.1212/01.wnl.0000194314.86486.a2; Gibbons CH, 2008, NEUROLOGY, V70, P2299, DOI 10.1212/01.wnl.0000314646.49565.c0; Gibbons CH, 2011, NEUROLOGY, V76, pA264; Gibbons CH, 2010, ANN NEUROL, V67, P534, DOI 10.1002/ana.21952; Goldstein David S., 2002, Annals of Internal Medicine, V137, P753; HARIK SI, 1977, ANN NEUROL, V1, P393, DOI 10.1002/ana.410010411; HART RG, 1990, ARCH INTERN MED, V150, P2373, DOI 10.1001/archinte.150.11.2373; HOELDTKE RD, 1989, NEUROLOGY, V39, P34, DOI 10.1212/WNL.39.1.34; INAMDAR S, 1982, PEDIATRICS, V70, P976; Jacob G, 2000, NEW ENGL J MED, V343, P1008, DOI 10.1056/NEJM200010053431404; Kaufmann H, 2012, CLIN AUTON RES, V22, P79, DOI 10.1007/s10286-011-0146-2; Khurana R K, 1995, Clin Auton Res, V5, P12, DOI 10.1007/BF01845493; KIRBY RS, 1985, J NEUROL NEUROSUR PS, V48, P762, DOI 10.1136/jnnp.48.8.762; Komaroff AL, 1998, ANNU REV MED, V49, P1; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Parsaik A, 2012, NEUROLOGY, V79, P1435, DOI 10.1212/WNL.0b013e31826d5f95; Peltier AC, 2010, CLIN AUTON RES, V20, P93, DOI 10.1007/s10286-009-0045-y; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rage M, 2011, J NEUROL, V258, P1852, DOI 10.1007/s00415-011-6031-z; SANDRONI P, 1991, J APPL PHYSIOL, V71, P1563, DOI 10.1152/jappl.1991.71.4.1563; Sandroni P, 2000, CLIN AUTON RES, V10, P1, DOI 10.1007/BF02291382; Shoemaker JK, 2001, AM J PHYSIOL-HEART C, V281, pH2028, DOI 10.1152/ajpheart.2001.281.5.H2028; Singer W, 2004, NEUROLOGY, V62, P612, DOI 10.1212/01.WNL.0000110313.39239.82; Soetekouw PMMB, 1999, CLIN AUTON RES, V9, P334, DOI 10.1007/BF02318380; Stouten B, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-37; STREETEN DHP, 1990, J CLIN INVEST, V86, P1582, DOI 10.1172/JCI114878; SUAREZ GA, 1994, NEUROLOGY, V44, P1675, DOI 10.1212/WNL.44.9.1675; Thieben MJ, 2007, MAYO CLIN PROC, V82, P308; Wang NS, 2011, J HISTOCHEM CYTOCHEM, V59, P382, DOI 10.1369/0022155410396931; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84716	10.1371/journal.pone.0084716	http://dx.doi.org/10.1371/journal.pone.0084716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386408	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900107
J	Hufnagel, TC; Vempati, UK; Almer, JD				Hufnagel, Todd C.; Vempati, Uday K.; Almer, Jonathan D.			Crack-Tip Strain Field Mapping and the Toughness of Metallic Glasses	PLOS ONE			English	Article							FRACTURE MORPHOLOGY; BEHAVIOR; DUCTILE; DEFORMATION; BRITTLENESS; PLASTICITY; MECHANISM	We have used high-energy x-ray scattering to map the strain fields around crack tips in fracture specimens of a bulk metallic glass under load at room temperature and below. From the measured strain fields we can calculate the components of the stress tensor as a function of position and determine the size and shape of the plastic process zone around the crack tip. Specimens tested at room temperature develop substantial plastic zones and achieve high stress intensities ((K) over bar (If) = 76MPam(1/2)) prior to fracture. Specimens tested at cryogenic temperatures fail at reduced but still substantial stress intensities ((K) over bar (If) = 39MPam(1/2)) and show only limited evidence of crack-tip plasticity. We propose that the difference in behavior is associated with changes in the flow stress and elastic constants, which influence the number density of shear bands in the plastic zone and thus the strain required to initiate fracture on an individual band. A secondary effect is a change in the triaxial state of stress around the crack tip due to the temperature dependence of Poisson's ratio. It is likely that this ability to map elastic strains on the microscale will be useful in other contexts, although interpreting shifts in the position of the scattering peaks in amorphous materials in terms of elastic strains must be done with caution.	[Hufnagel, Todd C.; Vempati, Uday K.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Almer, Jonathan D.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Johns Hopkins University; United States Department of Energy (DOE); Argonne National Laboratory	Hufnagel, TC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	hufnagel@jhu.edu	Hufnagel, Todd C/A-3309-2010	Hufnagel, Todd C/0000-0002-6373-9377	National Science Foundation [0705517, 1107838, 1066293]; hospitality of the Aspen Center for Physics; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH1135]; Division Of Materials Research [1107838] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); hospitality of the Aspen Center for Physics; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding from the National Science Foundation under grants 0705517, 1107838, 1066293 and the hospitality of the Aspen Center for Physics. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH1135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand L, 2005, J MECH PHYS SOLIDS, V53, P1362, DOI 10.1016/j.jmps.2004.12.006; Anderson T.L., 1995, FRACTURE MECH FUNDAM; ARGON AS, 1976, MATER SCI ENG, V23, P219, DOI 10.1016/0025-5416(76)90198-1; Choi-Yim H, 2002, ACTA MATER, V50, P2737, DOI 10.1016/S1359-6454(02)00113-1; Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]; Fitzpatrick M., 2003, ANAL RESIDUAL STRESS; Flores KM, 1999, SCRIPTA MATER, V41, P937, DOI 10.1016/S1359-6462(99)00243-2; Gilbert CJ, 1999, METALL MATER TRANS A, V30, P1739, DOI 10.1007/s11661-999-0173-y; Gu X, 2002, J NON-CRYST SOLIDS, V311, P77, DOI 10.1016/S0022-3093(02)01193-6; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Hufnagel TC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064204; Hufnagel TC, 2002, J MATER RES, V17, P1441, DOI 10.1557/JMR.2002.0214; Kawashima A, 2005, MATER TRANS, V46, P1725, DOI 10.2320/matertrans.46.1725; KELLY A, 1967, PHILOS MAG, V15, P567, DOI 10.1080/14786436708220903; Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474; Li HQ, 2006, ADV MATER, V18, P752, DOI 10.1002/adma.200501990; Liu XF, 2010, SCRIPTA MATER, V62, P254, DOI 10.1016/j.scriptamat.2009.11.010; Mear FO, 2008, PHIL MAG LETT, V88, P757, DOI 10.1080/09500830802235776; Nye J.F., 1984, PHYS PROPERTIES CRYS; PICK M, 1979, NATURE, V281, P658, DOI 10.1038/281658a0; Poulsen HF, 2005, NAT MATER, V4, P33, DOI 10.1038/nmat1266; Ravichandran G, 2005, ACTA MATER, V53, P4087, DOI 10.1016/j.actamat.2005.05.011; Rice J.R., 1967, ASTM STP, P247, DOI DOI 10.1520/STP47234S; Schneibel JH, 2001, METALL MATER TRANS A, V32, P2819, DOI 10.1007/s11661-001-1032-7; Schroers J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255506; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; SPAEPEN F, 1975, ACTA METALL MATER, V23, P615, DOI 10.1016/0001-6160(75)90102-9; STEIF PS, 1983, J MECH PHYS SOLIDS, V31, P359, DOI 10.1016/0022-5096(83)90005-4; Suh JY, 2010, J MATER RES, V25, P982, DOI 10.1557/JMR.2010.0112; Suresh S., 1998, FATIGUE MAT; SUZUKI Y, 1987, PHYS REV B, V35, P2162, DOI 10.1103/PhysRevB.35.2162; Tandaiya P, 2013, ACTA MATER, V61, P1558, DOI 10.1016/j.actamat.2012.11.033; Tandaiya P, 2008, ACTA MATER, V56, P6077, DOI 10.1016/j.actamat.2008.08.018; Vempati UK, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.214201; Wang WH, 2012, PROG MATER SCI, V57, P487, DOI 10.1016/j.pmatsci.2011.07.001; WU TW, 1990, PHILOS MAG B, V61, P739, DOI 10.1080/13642819008219307; Xi XK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.125510	37	17	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83289	10.1371/journal.pone.0083289	http://dx.doi.org/10.1371/journal.pone.0083289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386172	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900031
J	Yu, Y; Gao, MX; Li, HT; Zhang, F; Gu, CX				Yu, Yang; Gao, Mingxin; Li, Haitao; Zhang, Fan; Gu, Chengxiong			Pulmonary Artery Perfusion with Anti-Tumor Necrosis Factor Alpha Antibody Reduces Cardiopulmonary Bypass-Induced Inflammatory Lung Injury in a Rabbit Model	PLOS ONE			English	Article							APOPTOSIS; EXPRESSION; CYTOKINE; RECEPTOR; BLOOD	Inflammatory lung injury is one of the main complications associated with cardiopulmonary bypass (CPB). Tumor necrosis factor-a (TNF-alpha) is one of the key factors mediating the CPB-induced inflammatory reactions. Our previous studies have shown that endotracheal administration of anti-tumor necrosis factor-alpha antibody (TNF-alpha Ab) produces some beneficial effects on lung in a rabbit CPB model. In this study, we further examined the effects of pulmonary artery perfusion with TNF-alpha Ab (27 ng/ kg) on lung tissue integrity and pulmonary inflammation during CPB and investigated the mechanism underlying the TNF-alpha Ab-mediated effects in a rabbit model of CPB. Our results from transmission electron microscopy showed that the perfusion with TNF-alpha Ab alleviated CPB-induced histopathological changes in lung tissue. The perfusion with TNF-alpha Ab also prevented CPB-induced pulmonary edema and improved oxygenation index. Parameters indicating pulmonary inflammation, including neutrophil count and plasma TNF-alpha and malondialdehyde (MDA) levels, were significantly reduced during CPB by pulmonary artery perfusion with TNF-alpha Ab, suggesting that the perfusion with TNF-alpha Ab reduces CPB-induced pulmonary inflammation. We further investigated the molecular mechanism underlying the protective effects of TNF-alpha Ab on lung. Our quantitative RT-PCR analysis revealed that pulmonary artery perfusion with TNFa Ab significantly decreased TNF-alpha expression in lung tissue during CPB. The apoptotic index in lung tissue and the expression of proteins that play stimulatory roles in apoptosis pathways including the fas ligand (FasL) and Bax were markedly reduced during CPB by the perfusion with TNF-alpha Ab. In contrast, the expression of Bcl-2, which plays an inhibitory role in apoptosis pathways, was significantly increased during CPB by the perfusion with TNF-alpha Ab, indicating that the perfusion with TNF-alpha Ab significantly reduces CPB-induced apoptosis in lung. Thus, our study suggests that pulmonary artery perfusion with TNF-alpha Ab might be a promising approach for attenuating CPB-induced inflammatory lung injury.	[Yu, Yang; Gao, Mingxin; Li, Haitao; Zhang, Fan; Gu, Chengxiong] Capital Med Univ, Dept Cardiac Surg, Beijing An Zhen Hosp, Beijing, Peoples R China	Capital Medical University	Gu, CX (corresponding author), Capital Med Univ, Dept Cardiac Surg, Beijing An Zhen Hosp, Beijing, Peoples R China.	anzhengu@sina.com	yu, yang/HGC-6679-2022	Yu, Yang/0000-0002-8482-4626	National Natural Science Foundation of China [81070204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binns OAR, 1996, J THORAC CARDIOV SUR, V112, P1515, DOI 10.1016/S0022-5223(96)70010-7; Delmotte P, 2012, AM J PHYSIOL-CELL PH, V303, pC244, DOI 10.1152/ajpcell.00414.2011; Goebel U, 2008, EUR J CARDIO-THORAC, V34, P1165, DOI 10.1016/j.ejcts.2008.07.031; Kakishita T, 2010, ANN THORAC SURG, V89, P1773, DOI 10.1016/j.athoracsur.2010.02.077; Kearney CJ, 2013, J BIOL CHEM, V288, P4878, DOI 10.1074/jbc.M112.422410; Klass O, 2007, J INVEST SURG, V20, P349, DOI 10.1080/08941930701772165; Kroon A, 2012, ARCH DIS CHILD, V97, pA67; Li Tao, 2012, Front Med, V6, P296, DOI 10.1007/s11684-012-0219-1; Lisby S, 2007, BIOCHEM PHARMACOL, V73, P526, DOI 10.1016/j.bcp.2006.11.006; Luan ZG, 2013, CLIN EXP IMMUNOL, V172, P417, DOI 10.1111/cei.12062; Qi DN, 2013, ARTIF ORGANS, V37, P142, DOI 10.1111/j.1525-1594.2012.01542.x; Radovits T, 2012, EUR J CARDIO-THORAC, V41, P391, DOI 10.1016/j.ejcts.2011.05.056; Rong J, 2013, ASAIO J, V59, P302, DOI 10.1097/MAT.0b013e318290504e; Santini F, 2012, EUR J CARDIO-THORAC, V42, P942, DOI 10.1093/ejcts/ezs199; Sewing ACP, 2012, AM J PHYSIOL-LUNG C, V303, pL75, DOI 10.1152/ajplung.00072.2012; Sugimoto R, 2012, EUR J CARDIO-THORAC, V42, P1035, DOI 10.1093/ejcts/ezs298; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Veltkamp C, 2011, GUT, V60, P1345, DOI 10.1136/gut.2010.217117; Wang CT, 2012, LAB INVEST, V92, P910, DOI 10.1038/labinvest.2012.50; Yan XC, 2010, EXP BIOL MED, V235, P623, DOI 10.1258/ebm.2009.009293; Yu Y, 2003, CHINESE J CLIN THORA, V10, P151; Yu Y, 2004, CHINESE J CLIN THORA, V11, P35	22	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83236	10.1371/journal.pone.0083236	http://dx.doi.org/10.1371/journal.pone.0083236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386164	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900026
J	Zhang, L; Fan, YX; Zheng, HY; Du, FG; Zhang, KQ; Huang, XW; Wang, LF; Zhang, M; Niu, QH				Zhang, Lin; Fan, Yongxin; Zheng, Haoying; Du, Fengguang; Zhang, Ke-qin; Huang, Xiaowei; Wang, Linfeng; Zhang, Man; Niu, Qiuhong			Isolation and Characterization of a Novel Endoglucanase from a Bursaphelenchus xylophilus Metagenomic Library	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; TRICHODERMA-REESEI; CELLULASE; GENE; IDENTIFICATION; BETA-1,4-ENDOGLUCANASE; PROTEINS; SYSTEM; CONSTRUCTION; PRETREATMENT	A novel gene (designated as cen219) encoding endoglucanase was isolated from a Bursaphelenchus xylophilus metagenomic library by functional screening. Sequence analysis revealed that cen219 encoded a protein of 367 amino acids. SDS-PAGE analysis of purified endoglucanase suggested that Cen219 was a monomeric enzyme with a molecular mass of 40 kDa. The optimum temperature and pH for endoglucanase activity of Cen219 was separately 50 degrees C and 6.0. It was stable from 30 to 50 degrees C, and from pH 4.0 to 7.0. The activity was significantly enhanced by Mn2+ and dramatically reduced by detergent SDS and metals Fe3+, Cu2+ or Hg2+. The enzyme hydrolyzed a wide range of beta-1, 3-, and beta-1, 4-linked polysaccharides, with varying activities. Activities towards microcrystalline cellulose and filter paper were relatively high, while the highest activity was towards oat gum. The K-m and V-max of Cen219 towards CMC was 17.37 mg/ml and 333.33 U/mg, respectively. The findings have an insight into understanding the molecular basis of host-parasite interactions in B. xylophilus species. The properties also make Cen219 an interesting enzyme for biotechnological application.	[Zhang, Lin; Fan, Yongxin; Zheng, Haoying; Niu, Qiuhong] Nanyang Normal Univ, Dept Life Sci & Biotechnol, Nanyang, Peoples R China; [Du, Fengguang; Wang, Linfeng; Zhang, Man] Henan Tianguan Grp Co Ltd, State Key Lab Motor Biofuel Technol, Nanyang, Peoples R China; [Zhang, Ke-qin; Huang, Xiaowei] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Zhang, Ke-qin; Huang, Xiaowei] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China	Nanyang Normal College; Yunnan University; Yunnan University	Niu, QH (corresponding author), Nanyang Normal Univ, Dept Life Sci & Biotechnol, Nanyang, Peoples R China.	qiuhongniu@gmail.com	wang, lin/GSE-3040-2022; zhang, ke/AAH-8217-2019		Major State Basic Research Development Program of China (973 Program) [2013CB127504]; National Natural Science Foundation Program of the People's Republic of China [31100104]; State Key Laboratory of Motor Vehicle Biofuel Technology, Henan Tianguan Enterprise Group Co., Ltd. [2013014]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation Program of the People's Republic of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Motor Vehicle Biofuel Technology, Henan Tianguan Enterprise Group Co., Ltd.	This work was supported by a grant from the Major State Basic Research Development Program of China (973 Program) (No. 2013CB127504), by the projects from the National Natural Science Foundation Program of the People's Republic of China (31100104) and by the State Key Laboratory of Motor Vehicle Biofuel Technology (2013014), Henan Tianguan Enterprise Group Co., Ltd. but this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha N, 2011, APPL ENVIRON MICROB, V77, P4859, DOI 10.1128/AEM.02808-10; Aikawa T, 2006, FOREST PATHOL, V36, P1, DOI 10.1111/j.1439-0329.2006.00428.x; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amore A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-164; Bauer MW, 1999, J BACTERIOL, V181, P284, DOI 10.1128/JB.181.1.284-290.1999; Bera-Maillet C, 2000, EUR J BIOCHEM, V267, P3255, DOI 10.1046/j.1432-1327.2000.01356.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; CHANG WTH, 1977, CAN J MICROBIOL, V23, P1285, DOI 10.1139/m77-192; CHAUVAUX S, 1990, BIOCHEM J, V265, P261, DOI 10.1042/bj2650261; Cho KM, 2006, APPL MICROBIOL BIOT, V73, P618, DOI 10.1007/s00253-006-0523-2; Chu XM, 2008, APPL MICROBIOL BIOT, V80, P615, DOI 10.1007/s00253-008-1566-3; Curtis Rosane H. C., 2007, Briefings in Functional Genomics & Proteomics, V6, P50, DOI 10.1093/bfgp/elm006; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Feng Y, 2007, APPL MICROBIOL BIOT, V75, P319, DOI 10.1007/s00253-006-0820-9; Fontes CMGA, 1997, APPL MICROBIOL BIOT, V48, P473, DOI 10.1007/s002530051082; Girfoglio M, 2012, J BACTERIOL, V194, P5091, DOI 10.1128/JB.00672-12; Gong Xia, 2012, BMC Res Notes, V5, P566, DOI 10.1186/1756-0500-5-566; HAN SJ, 1995, J BIOL CHEM, V270, P26012, DOI 10.1074/jbc.270.43.26012; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; HUSSEY RS, 2002, BRAZ J PLANT PHYSIOL, V14, P123; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kim TH, 2009, METHODS MOL BIOL, V581, P79, DOI 10.1007/978-1-60761-214-8_6; Kim YJ, 2006, PROTEIN EXPRES PURIF, V45, P315, DOI 10.1016/j.pep.2005.06.008; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLUEPFEL D, 1988, METHOD ENZYMOL, V160, P180; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Lee SW, 2004, APPL MICROBIOL BIOT, V65, P720, DOI 10.1007/s00253-004-1722-3; Lima AOS, 2005, APPL MICROBIOL BIOT, V68, P57, DOI 10.1007/s00253-004-1740-1; Matsuoka S, 2007, J BACTERIOL, V189, P7190, DOI 10.1128/JB.00842-07; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Pang H, 2009, CURR MICROBIOL, V58, P404, DOI 10.1007/s00284-008-9346-y; Rondon MR, 1999, TRENDS BIOTECHNOL, V17, P403, DOI 10.1016/S0167-7799(99)01352-9; Rosso MN, 1999, MOL PLANT MICROBE IN, V12, P585, DOI 10.1094/MPMI.1999.12.7.585; Rubini MR, 2010, J APPL MICROBIOL, V108, P1187, DOI 10.1111/j.1365-2672.2009.04528.x; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sadhu S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-10; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Uzbas F, 2012, APPL MICROBIOL BIOT, V93, P1601, DOI 10.1007/s00253-011-3674-8; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Voget S, 2006, J BIOTECHNOL, V126, P26, DOI 10.1016/j.jbiotec.2006.02.011; WANG WY, 1993, J GEN MICROBIOL, V139, P1219, DOI 10.1099/00221287-139-6-1219; Waschkowitz T, 2009, APPL ENVIRON MICROB, V75, P2506, DOI 10.1128/AEM.02136-08; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; WOOD PJ, 1988, METHOD ENZYMOL, V160, P59; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353; Yao J, 2011, J AGR FOOD CHEM, V59, P3812, DOI 10.1021/jf104394m; Yun J, 2004, APPL ENVIRON MICROB, V70, P7229, DOI 10.1128/AEM.70.12.7229-7235.2004; Zhao BG., 2008, PINE WILT DIS; Zhao XB, 2009, APPL MICROBIOL BIOT, V82, P815, DOI 10.1007/s00253-009-1883-1; Zou G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-21	55	21	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82437	10.1371/journal.pone.0082437	http://dx.doi.org/10.1371/journal.pone.0082437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386096	gold, Green Submitted, Green Published			2022-12-27	WOS:000329117900009
J	Alexander, LEC; Marsh, BJ; Timmer, AM; Lin, AE; Zainabadi, K; Czopik, A; Guarente, L; Nizet, V				Alexander, Laura E. Crotty; Marsh, Brenda J.; Timmer, Anjuli M.; Lin, Ann E.; Zainabadi, Kayvan; Czopik, Agnieszka; Guarente, Leonard; Nizet, Victor			Myeloid Cell Sirtuin-1 Expression Does Not Alter Host Immune Responses to Gram-Negative Endotoxemia or Gram-Positive Bacterial Infection	PLOS ONE			English	Article							LEUKEMIA-CELLS; LIFE-SPAN; IN-VITRO; KAPPA-B; SIRT1; MACROPHAGES; RESVERATROL; ACTIVATION; PROTEIN; OXYGEN	The role of sirtuin-1 (SIRT1) in innate immunity, and in particular the influence of SIRT1 on antimicrobial defense against infection, has yet to be reported but is important to define since SIRT1 inhibitors are being investigated as therapeutic agents in the treatment of cancer, Huntington's disease, and autoimmune diseases. Given the therapeutic potential of SIRT1 suppression, we sought to characterize the role of SIRT1 in host defense. Utilizing both pharmacologic methods and a genetic knockout, we demonstrate that SIRT1 expression has little influence on macrophage and neutrophil antimicrobial functions. Myeloid SIRT1 expression does not change mortality in gram-negative toxin-induced shock or gram-positive bacteremia, suggesting that therapeutic suppression of SIRT1 may be done safely without suppression of myeloid cell-specific immune responses to severe bacterial infections.	[Alexander, Laura E. Crotty; Marsh, Brenda J.] Vet Affairs San Diego Healthcare Syst, Pulm Crit Care Sect, San Diego, CA USA; [Alexander, Laura E. Crotty; Marsh, Brenda J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Timmer, Anjuli M.; Lin, Ann E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Zainabadi, Kayvan; Czopik, Agnieszka; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Alexander, LEC (corresponding author), Vet Affairs San Diego Healthcare Syst, Pulm Crit Care Sect, San Diego, CA USA.	lcrotty@ucsd.edu	Nizet, Victor/AAF-3190-2019; Alexander, Laura Crotty/AIC-1001-2022	Alexander, Laura Crotty/0000-0002-5091-2660; marsh, brenda/0000-0003-1481-9036; Nizet, Victor/0000-0003-3847-0422	American Asthma Foundation; Veterans Affairs Career Development Award-2 [1154866]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	American Asthma Foundation; Veterans Affairs Career Development Award-2; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by two Stephen Silberstein Senior Fellowship Awards from the American Asthma Foundation (PI Victor Nizet and PI Leonard Guarente; http://www.americanasthmafoundation.org) and a Veterans Affairs Career Development Award-2 (PI Laura E. Crotty Alexander; Project Number 1154866; http://www.research.va.gov/funding/CDP.cfm#.UbpFS-C2vlI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Briceno JC, 2004, AM J PHYSIOL-HEART C, V286, pH1223, DOI 10.1152/ajpheart.00666.2003; Caballero B, 2003, AM J CLIN NUTR, V78, P308; Cabana VG, 2004, J LIPID RES, V45, P317, DOI 10.1194/jlr.M300414-JLR200; Cabell CH, 2003, CIRCULATION, V107, pE185, DOI 10.1161/01.CIR.0000071082.36561.F1; Cakir Z, 2011, J CANCER RES CLIN, V137, P279, DOI 10.1007/s00432-010-0884-x; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choi SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032378; Clement MV, 1998, BLOOD, V92, P996; Fernandes CA, 2012, BIOCHEM BIOPH RES CO, V420, P857, DOI 10.1016/j.bbrc.2012.03.088; Fregosi RF, 2003, J APPL PHYSIOL, V95, P2030, DOI 10.1152/japplphysiol.00293.2003; Hangai-Hoger N, 2004, AM J PHYSIOL-HEART C, V286, pH878, DOI 10.1152/ajpheart.00913.2003; HOESS RH, 1982, P NATL ACAD SCI-BIOL, V79, P3398, DOI 10.1073/pnas.79.11.3398; Hu N, 2009, SCAND J RHEUMATOL, V38, P464, DOI 10.3109/03009740902895750; Kassotis J, 2003, J CARDIOVASC ELECTR, V14, P1233, DOI 10.1046/j.1540-8167.2003.02413.x; Kozako T, 2012, INT J CANCER, V131, P2044, DOI 10.1002/ijc.27481; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lee SM, 2011, DIABETOLOGIA, V54, P1136, DOI 10.1007/s00125-011-2064-1; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Mbaruku Godfrey, 2003, Afr J Reprod Health, V7, P84, DOI 10.2307/3583293; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mwangangi JM, 2003, J AM MOSQUITO CONTR, V19, P371; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Radhakrishnan K, 2003, ADV EXP MED BIOL, V530, P547; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Stervbo U, 2006, CELL PROLIFERAT, V39, P479, DOI 10.1111/j.1365-2184.2006.00406.x; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wampfler J, 2009, BRIT J HAEMATOL, V146, P337, DOI 10.1111/j.1365-2141.2009.07749.x; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	38	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84481	10.1371/journal.pone.0084481	http://dx.doi.org/10.1371/journal.pone.0084481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386389	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700110
J	Boon, E; Zimmerman, E; St-Arnaud, M; Hijri, M				Boon, Eva; Zimmerman, Erin; St-Arnaud, Marc; Hijri, Mohamed			Allelic Differences within and among Sister Spores of the Arbuscular Mycorrhizal Fungus iSuggest Segregation at Sporulation	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; ANASTOMOSIS FORMATION; RARE BIOSPHERE; HYPHAL FUSION; DIVERSITY; EVOLUTION; GLOMEROMYCOTA; EXCHANGE; POLYMORPHISMS; COMMUNITIES	Arbuscular mycorrhizal fungi (AMF) are root-inhabiting fungi that form mutualistic symbioses with their host plants. AMF are made up of coenocytic networks of hyphae through which nuclei and organelles can freely migrate. In this study, we investigated the possibility of a genetic bottleneck and segregation of allelic variation at sporulation for a low-copy Polymerase1-like gene, PLS. Specifically, our objectives were (1) to estimate what allelic diversity is passed on to a single spore (2) to determine whether this diversity is less than the total amount of variation found in all spores (3) to investigate whether there is any differential segregation of allelic variation. We inoculated three tomato plants with a single spore of Glomus etunicatum each and after six months sampled between two and three daughter spores per tomato plant. Pyrosequencing PLS amplicons in eight spores revealed high levels of allelic diversity; between 43 and 152 alleles per spore. We corroborated the spore pyrosequencing results with Sanger- and pyrosequenced allele distributions from the original parent isolate. Both sequencing methods retrieved the most abundant alleles from the offspring spore allele distributions. Our results indicate that individual spores contain only a subset of the total allelic variation from the pooled spores and parent isolate. Patterns of allele diversity between spores suggest the possibility for segregation of PLS alleles among spores. We conclude that a genetic bottleneck could potentially occur during sporulation in AMF, with resulting differences in genetic variation among sister spores. We suggest that the effects of this bottleneck may be countered by anastomosis (hyphal fusion) between related hyphae.	[Boon, Eva; Zimmerman, Erin; St-Arnaud, Marc; Hijri, Mohamed] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	St-Arnaud, M (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	marc.st-arnaud@umontreal.ca	Hijri, Mohamed/ABC-5969-2021; Boon, Eva/Y-3884-2019; St-Arnaud, Marc/D-1184-2017; Hijri, Mohamed/AAL-5737-2021	Hijri, Mohamed/0000-0001-6112-8372; Boon, Eva/0000-0002-3398-8946; St-Arnaud, Marc/0000-0002-7181-9895; 	NSERC; Alexander Graham Bell and Vanier Canada Graduate Scholarships from NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alexander Graham Bell and Vanier Canada Graduate Scholarships from NSERC	This work was supported jointly by two NSERC discovery grants allocated to M. St-Arnaud and M. Hijri. E. Zimmerman and E. Boon received Alexander Graham Bell and Vanier Canada Graduate Scholarships from NSERC, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelard C, 2014, ISME J, V8, P284, DOI 10.1038/ismej.2013.154; Angelard C, 2011, NEW PHYTOL, V189, P652, DOI 10.1111/j.1469-8137.2010.03602.x; Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bever J. D., 2008, MYCORRHIZA, P135, DOI [DOI 10.1007/978-3-540-78826-3_7, 10.1007/978-3-540-78826-3_7]; Bever JD, 2005, NATURE, V433, pE3, DOI 10.1038/nature03294; Boon E, 2010, J EVOLUTION BIOL, V23, P1519, DOI 10.1111/j.1420-9101.2010.02019.x; Buss L., 1987, EVOLUTION INDIVIDUAL; Cardenas-Flores A, 2010, MYCORRHIZA, V20, P415, DOI 10.1007/s00572-009-0295-5; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2010, SPADE SPECIES PREDIC; Corradi N, 2004, FUNGAL GENET BIOL, V41, P1037, DOI 10.1016/j.fgb.2004.08.005; Corradi N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-21; Corradi N, 2007, APPL ENVIRON MICROB, V73, P366, DOI 10.1128/AEM.01574-06; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; de la Providencia IE, 2005, NEW PHYTOL, V165, P261, DOI 10.1111/j.1469-8137.2004.01236.x; de la Providencia IE, 2013, NEW PHYTOL, V200, P211, DOI 10.1111/nph.12372; Ehinger MO, 2012, NEW PHYTOL, V196, P853, DOI 10.1111/j.1469-8137.2012.04278.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hijri M, 2005, NATURE, V433, P160, DOI 10.1038/nature03069; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jany JL, 2010, AM NAT, V175, P424, DOI 10.1086/650725; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; KUHN G, 2003, ORG GENETIC VARIATIO; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marleau J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-51; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Meissner R, 1997, PLANT J, V12, P1465, DOI 10.1046/j.1365-313x.1997.12061465.x; Michod RE, 2001, HEREDITY, V86, P1, DOI 10.1046/j.1365-2540.2001.00808.x; Pawlowska TE, 2005, NATURE, V433, pE4, DOI 10.1038/nature03295; Pawlowska TE, 2004, NATURE, V427, P733, DOI 10.1038/nature02290; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1192, DOI 10.1111/j.1420-9101.2004.00815.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Queller DC, 2009, PHILOS T R SOC B, V364, P3143, DOI 10.1098/rstb.2009.0095; Rodriguez A, 2004, J ECOL, V92, P986, DOI 10.1111/j.1365-2745.2004.00935.x; Rodriguez A, 2001, NEW PHYTOL, V152, P159, DOI 10.1046/j.0028-646X.2001.00237.x; Sanders IR, 2010, ANNU REV GENET, V44, P271, DOI 10.1146/annurev-genet-102108-134239; SANDERS IR, 1995, NEW PHYTOL, V130, P419, DOI 10.1111/j.1469-8137.1995.tb01836.x; Sanders IR, 2002, AM NAT, V160, pS128, DOI 10.1086/342085; Santelices B, 2004, J EVOLUTION BIOL, V17, P1187, DOI 10.1111/j.1420-9101.2004.00813.x; Santelices B, 1999, TRENDS ECOL EVOL, V14, P152, DOI 10.1016/S0169-5347(98)01519-5; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2013, ISME J, V7, P457, DOI 10.1038/ismej.2012.102; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; St-Arnaud M., 2007, MYCORRHIZAE CROP PRO, P67; Stewart CN, 1996, J EVOLUTION BIOL, V9, P153, DOI 10.1046/j.1420-9101.1996.9020153.x; Subramanian KS, 1999, MYCORRHIZA, V9, P69, DOI 10.1007/s005720050002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiery O, 2012, SYMBIOSIS, V58, P135, DOI 10.1007/s13199-012-0212-0; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997	68	17	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83301	10.1371/journal.pone.0083301	http://dx.doi.org/10.1371/journal.pone.0083301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386173	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700038
J	Clark, J; Grznarova, P; Stansell, E; Diehl, W; Lipov, J; Spearman, P; Ruml, T; Hunter, E				Clark, Jasmine; Grznarova, Petra; Stansell, Elizabeth; Diehl, William; Lipov, Jan; Spearman, Paul; Ruml, Tomas; Hunter, Eric			A Mason-Pfizer Monkey Virus Gag-GFP Fusion Vector Allows Visualization of Capsid Transport in Live Cells and Demonstrates a Role for Microtubules	PLOS ONE			English	Article							TARGETING-RETENTION SIGNAL; GREEN FLUORESCENT PROTEIN; DEPENDENT MOVEMENT; CYTOPLASMIC DOMAIN; MATRIX PROTEIN; IDENTIFICATION; GLYCOPROTEIN; POLYPEPTIDES; REPLICATION; INFECTIVITY	Immature capsids of the Betaretrovirus, Mason-Pfizer Monkey virus (M-PMV), are assembled in the pericentriolar region of the cell, and are then transported to the plasma membrane for budding. Although several studies, utilizing mutagenesis, biochemistry, and immunofluorescence, have defined the role of some viral and host cells factors involved in these processes, they have the disadvantage of population analysis, rather than analyzing individual capsid movement in real time. In this study, we created an M-PMV vector in which the enhanced green fluorescent protein, eGFP, was fused to the carboxyl-terminus of the M-PMV Gag polyprotein, to create a Gag-GFP fusion that could be visualized in live cells. In order to express this fusion protein in the context of an M-PMV proviral backbone, it was necessary to codon-optimize gag, optimize the Kozak sequence preceding the initiating methionine, and mutate an internal methionine codon to one for alanine (M100A) to prevent internal initiation of translation. Co-expression of this pSARM-Gag-GFP-M100A vector with a WT M-PMV provirus resulted in efficient assembly and release of capsids. Results from fixed-cell immunofluorescence and pulse-chase analyses of wild type and mutant Gag-GFP constructs demonstrated comparable intracellular localization and release of capsids to untagged counterparts. Real-time, live-cell visualization and analysis of the GFP-tagged capsids provided strong evidence for a role for microtubules in the intracellular transport of M-PMV capsids. Thus, this M-PMV Gag-GFP vector is a useful tool for identifying novel virus-cell interactions involved in intracellular M-PMV capsid transport in a dynamic, real-time system.	[Clark, Jasmine; Stansell, Elizabeth; Diehl, William; Hunter, Eric] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Grznarova, Petra; Lipov, Jan; Ruml, Tomas] Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Spearman, Paul] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Hunter, Eric] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; University of Chemistry & Technology, Prague; Emory University; Emory University	Hunter, E (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ehunte4@emory.edu	Prokšová, Petra Grznarova/AAE-3231-2022; Lipov, Jan/AAF-6232-2019; Ruml, Tomas/R-2543-2017; Lipov, Jan/Q-5880-2017; Lipov, Jan/Y-2414-2019	Lipov, Jan/0000-0002-3244-5827; Ruml, Tomas/0000-0002-5698-4366; Lipov, Jan/0000-0002-3244-5827; Diehl, William/0000-0001-7943-1214	NIH from the National Cancer Institute [R01-CA-27834]; Czech Science Foundation [P302/12/1895]; Czech and Ministry of Education [LH12011]; American Society for Microbiology Robert D. Watkins fellowship; NATIONAL CANCER INSTITUTE [R01CA027834] Funding Source: NIH RePORTER	NIH from the National Cancer Institute; Czech Science Foundation(Grant Agency of the Czech Republic); Czech and Ministry of Education; American Society for Microbiology Robert D. Watkins fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by NIH grant R01-CA-27834 from the National Cancer Institute, and by a Czech Science Foundation grant P302/12/1895. International travel for Petra Grznarova was supported by the Czech and Ministry of Education grant LH12011. Jasmine Clark was also the recipient of the American Society for Microbiology Robert D. Watkins fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; BRADAC J, 1984, VIROLOGY, V138, P260, DOI 10.1016/0042-6822(84)90350-7; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; CHATTERJEE S, 1985, VIROLOGY, V141, P65, DOI 10.1016/0042-6822(85)90183-7; Choi G, 1999, J VIROL, V73, P5431, DOI 10.1128/JVI.73.7.5431-5437.1999; CHOPRA HC, 1970, CANCER RES, V30, P2081; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; JENSEN EM, 1970, CANCER RES, V30, P2388; KESSLER SW, 1975, J IMMUNOL, V115, P1617; Kohoutova Z, 2009, VIROLOGY, V384, P59, DOI 10.1016/j.virol.2008.10.048; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; MASON MM, 1972, J NATL CANCER I, V48, P1323; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; Prchal J, 2011, PROTEIN EXPRES PURIF, V79, P122, DOI 10.1016/j.pep.2011.05.010; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; RHEE SS, 1987, J VIROL, V61, P1045, DOI 10.1128/JVI.61.4.1045-1053.1987; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Sakalian M, 1999, J VIROL, V73, P8073, DOI 10.1128/JVI.73.10.8073-8082.1999; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sfakianos JN, 2003, TRAFFIC, V4, P660, DOI 10.1034/j.1600-0854.2003.00125.x; Sfakianos JN, 2003, TRAFFIC, V4, P671, DOI 10.1034/j.1600-0854.2003.00126.x; Song C, 2003, J VIROL, V77, P5192, DOI 10.1128/JVI.77.9.5192-5200.2003; Song CS, 2005, J VIROL, V79, P11559, DOI 10.1128/JVI.79.18.11559-11568.2005; Stansell E, 2004, J VIROL, V78, P5023, DOI 10.1128/JVI.78.10.5023-5031.2004; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07	35	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83863	10.1371/journal.pone.0083863	http://dx.doi.org/10.1371/journal.pone.0083863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386297	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700084
J	Goldingay, RL; Harrisson, KA; Taylor, AC; Ball, TM; Sharpe, DJ; Taylor, BD				Goldingay, Ross L.; Harrisson, Katherine A.; Taylor, Andrea C.; Ball, Tina M.; Sharpe, David J.; Taylor, Brendan D.			Fine-Scale Genetic Response to Landscape Change in a Gliding Mammal	PLOS ONE			English	Article							GLIDER PETAURUS-NORFOLCENSIS; HABITAT FRAGMENTATION; WOODEN POLES; POPULATION ECOLOGY; SQUIRREL; FLOW; DISPERSAL; MATRIX; FOREST; DIFFERENTIATION	Understanding how populations respond to habitat loss is central to conserving biodiversity. Population genetic approaches enable the identification of the symptoms of population disruption in advance of population collapse. However, the spatio-temporal scales at which population disruption occurs are still too poorly known to effectively conserve biodiversity in the face of human-induced landscape change. We employed microsatellite analysis to examine genetic structure and diversity over small spatial (mostly 1-50 km) and temporal scales (20-50 years) in the squirrel glider (Petaurus norfolcensis), a gliding mammal that is commonly subjected to a loss of habitat connectivity. We identified genetically differentiated local populations over distances as little as 3 km and within 30 years of landscape change. Genetically isolated local populations experienced the loss of genetic diversity, and significantly increased mean relatedness, which suggests increased inbreeding. Where tree cover remained, genetic differentiation was less evident. This pattern was repeated in two landscapes located 750 km apart. These results lend support to other recent studies that suggest the loss of habitat connectivity can produce fine-scale population genetic change in a range of taxa. This gives rise to the prediction that many other vertebrates will experience similar genetic changes. Our results suggest the future collapse of local populations of this gliding mammal is likely unless habitat connectivity is maintained or restored. Landscape management must occur on a fine-scale to avert the erosion of biodiversity.	[Goldingay, Ross L.; Sharpe, David J.; Taylor, Brendan D.] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Harrisson, Katherine A.; Taylor, Andrea C.] Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Clayton, Vic 3800, Australia; [Ball, Tina M.] Cent Queensland Univ, Mackay, Qld, Australia; [Ball, Tina M.] Queensland Pk & Wildlife Serv, Mackay, Qld, Australia	Southern Cross University; Monash University; Central Queensland University	Goldingay, RL (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	ross.goldingay@scu.edu.au	Harrisson, Katherine/AFA-8905-2022	Harrisson, Katherine/0000-0002-8070-8070; Goldingay, Ross/0000-0002-6684-9299	Brisbane City Council	Brisbane City Council	Some research funding was provided by Brisbane City Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agudo R, 2013, P ROY SOC LOND B BIO, V279, P3241; Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; Bakker VJ, 2004, CONSERV BIOL, V18, P689, DOI 10.1111/j.1523-1739.2004.00149.x; Ball T, 2007, THESIS CENTRAL QUEEN; Ball TM, 2008, LANDSCAPE URBAN PLAN, V87, P140, DOI 10.1016/j.landurbplan.2008.05.007; Berry O, 2005, CONSERV BIOL, V19, P855, DOI 10.1111/j.1523-1739.2005.00161.x; Bolger DT, 1997, ECOL APPL, V7, P552, DOI 10.1890/1051-0761(1997)007[0552:RORTHF]2.0.CO;2; Brekke P, 2010, P ROY SOC B-BIOL SCI, V277, P3677, DOI 10.1098/rspb.2010.1144; Brown M, 2004, MOL ECOL NOTES, V4, P704, DOI 10.1111/j.1471-8286.2004.00769.x; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Centeno-Cuadros A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024613; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clark RW, 2010, CONSERV BIOL, V24, P1059, DOI 10.1111/j.1523-1739.2009.01439.x; Coulon A, 2010, CONSERV BIOL, V24, P1080, DOI 10.1111/j.1523-1739.2009.01438.x; Crooks KR, 2001, CONSERV BIOL, V15, P159, DOI 10.1046/j.1523-1739.2001.99379.x; Delaney KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012767; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Goldingay RL, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P663; Goldingay Ross L., 2004, P376; Goldingay RL, 2013, AUST MAMMAL, V35, P30, DOI 10.1071/AM12006; Goldingay Ross L., 2011, Australian Mammalogy, V33, P36, DOI 10.1071/AM10023; Goldingay RL, 2009, AUST J ZOOL, V57, P99, DOI 10.1071/ZO09003; Gottelli D, 2013, ANIM CONSERV, V16, P234, DOI 10.1111/j.1469-1795.2012.00591.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johansson M, 2007, MOL ECOL, V16, P2693, DOI 10.1111/j.1365-294X.2007.03357.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Keyghobadi N, 2005, MOL ECOL, V14, P1897, DOI 10.1111/j.1365-294X.2005.02563.x; KITCHENER DJ, 1980, BIOL CONSERV, V18, P179, DOI 10.1016/0006-3207(80)90033-6; Lancaster ML, 2011, MOL ECOL, V20, P2258, DOI 10.1111/j.1365-294X.2011.05072.x; LAURANCE WF, 1990, J MAMMAL, V71, P641, DOI 10.2307/1381805; Lee KE, 2010, CONSERV GENET, V11, P2091, DOI 10.1007/s10592-009-9987-9; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Mikulicek P, 2012, EUR J WILDLIFE RES, V58, P833, DOI 10.1007/s10344-012-0631-5; Millis AL, 2000, MOL ECOL, V9, P1681, DOI 10.1046/j.1365-294x.2000.01060-14.x; Moore JA, 2008, MOL ECOL, V17, P4630, DOI 10.1111/j.1365-294X.2008.03951.x; Munguia-Vega A, 2013, BIOL CONSERV, V157, P11, DOI 10.1016/j.biocon.2012.06.026; Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Postma E, 2009, BIOL J LINN SOC, V97, P867, DOI 10.1111/j.1095-8312.2009.01252.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rizkalla CE, 2007, BIOL CONSERV, V140, P339, DOI 10.1016/j.biocon.2007.08.019; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Selonen V, 2003, ECOGRAPHY, V26, P641, DOI 10.1034/j.1600-0587.2003.03548.x; Sharpe DJ, 2010, WILDLIFE RES, V37, P77, DOI 10.1071/WR09051; Simmons JM, 2010, ECOL SOC, V15; Soanes K, 2013, BIOL CONSERV, V159, P434, DOI 10.1016/j.biocon.2012.10.016; Sotiropoulos K, 2013, CONSERV GENET, V14, P385, DOI 10.1007/s10592-013-0452-4; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Taylor AC, 2007, MOL ECOL, V16, P2655, DOI 10.1111/j.1365-294X.2007.03331.x; Taylor AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026651; Taylor B. D., 2010, THESIS GRIFFITH U BR; Taylor BD, 2013, AUST MAMMAL, V35, P119, DOI 10.1071/AM12013; Taylor BD, 2012, RESTOR ECOL, V20, P671, DOI 10.1111/j.1526-100X.2011.00847.x; Taylor BD, 2009, ECOL SOC, V14; van der Ree R, 2004, BIOL CONSERV, V115, P241, DOI 10.1016/S0006-3207(03)00142-3; van der Ree R, 2002, WILDLIFE RES, V29, P329, DOI 10.1071/WR01095; van der Ree Rodney, 2006, Ecological Management & Restoration, V7, P226, DOI 10.1111/j.1442-8903.2006.312_3.x; van der Ree R, 2010, ECOL SOC, V15; Weston Nigel, 2011, Australian Mammalogy, V33, P93, DOI 10.1071/AM11003; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Willi Y, 2007, J EVOLUTION BIOL, V20, P534, DOI 10.1111/j.1420-9101.2006.01263.x; Wilson GA, 2003, GENETICS, V163, P1177	83	23	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e80383	10.1371/journal.pone.0080383	http://dx.doi.org/10.1371/journal.pone.0080383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386079	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700001
J	Hennis, MR; Seamans, KW; Marvin, MA; Casey, BH; Goldberg, MS				Hennis, Meghan R.; Seamans, Katherine W.; Marvin, Marian A.; Casey, Bradford H.; Goldberg, Matthew S.			Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; RECESSIVE JUVENILE PARKINSONISM; CYSTEINE-SULFINIC ACID; OXIDATIVE STRESS; DJ-1-DEFICIENT MICE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; TRANSGENIC MICE; NULL MICE; RETROGRADE DEGENERATION	Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by loss of neurons in the substantia nigra that project to the striatum and release dopamine. The cause of PD remains uncertain, however, evidence implicates mitochondrial dysfunction and oxidative stress. Although most cases of PD are sporadic, 5-10% of cases are caused by inherited mutations. Loss-of-function mutations in Parkin and DJ-1 were the first to be linked to recessively inherited Parkinsonism. Surprisingly, mice bearing similar loss-of-function mutations in Parkin and DJ-1 do not show age-dependent loss of nigral dopaminergic neurons or depletion of dopamine in the striatum. Although the normal cellular functions of Parkin and DJ-1 are not fully understood, we hypothesized that loss-of-function mutations in Parkin and DJ-1 render cells more sensitive to mitochondrial dysfunction and oxidative stress. To test this hypothesis, we crossed mice deficient for Parkin and DJ-1 with mice deficient for the mitochondrial antioxidant protein Mn-superoxide dismutase (SOD2) or the cytosolic antioxidant protein Cu-Zn-superoxide dismutase (SOD1). Aged Parkin(-/-)DJ-1(-/-) and Mn-superoxide dismutase triple deficient mice have enhanced performance on the rotorod behavior test. Cu/Zn-superoxide dismutase triple deficient mice have elevated levels of dopamine in the striatum in the absence of nigral cell loss. Our studies demonstrate that on a Parkin/DJ-1 null background, mice that are also deficient for major antioxidant proteins do not have progressive loss of dopaminergic neurons but have behavioral and striatal dopamine abnormalities.	[Hennis, Meghan R.; Seamans, Katherine W.; Marvin, Marian A.; Casey, Bradford H.; Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Goldberg, Matthew S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldberg, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	Matthew.Goldberg@UTSouthwestern.edu	Goldberg, Matthew/T-7827-2019	Goldberg, Matthew/0000-0002-5172-9841	Parkinson's Disease Foundation; NIH from the National Institute of General Medical Sciences [5T32GM00820322]; David M. Crowley Foundation; Parkinson's Benefactors	Parkinson's Disease Foundation; NIH from the National Institute of General Medical Sciences(General Electric); David M. Crowley Foundation; Parkinson's Benefactors(Parkinson's UK)	The following sources of funding supported this work: Parkinson's Disease Foundation, NIH Training Grant 5T32GM00820322 from the National Institute of General Medical Sciences, the David M. Crowley Foundation and Parkinson's Benefactors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Andreassen OA, 2001, EXP NEUROL, V167, P189, DOI 10.1006/exnr.2000.7525; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Andrews AM, 1996, MOL PHARMACOL, V50, P1511; Asanuma M, 1998, NEUROSCIENCE, V85, P907, DOI 10.1016/S0306-4522(97)00665-9; Barkats M, 2006, J NEUROSCI RES, V83, P233, DOI 10.1002/jnr.20696; Belluzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038026; Ben-Shachar D, 2004, BIOCHEM PHARMACOL, V67, P1965, DOI 10.1016/j.bcp.2004.02.015; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bian MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039953; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Boll MC, 2008, NEUROCHEM RES, V33, P1717, DOI 10.1007/s11064-008-9610-3; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brooks SP, 2012, BRAIN RES BULL, V88, P81, DOI 10.1016/j.brainresbull.2011.10.002; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Fleming SM, 2006, BEHAV PHARMACOL, V17, P383, DOI 10.1097/00008877-200609000-00004; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; Floor E, 1998, J NEUROCHEM, V70, P268; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Hattori Nobutaka, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS1, DOI 10.1016/S1353-8020(11)70003-7; Hattori N, 2009, PARKINSONISM RELAT D, V15, pS35, DOI 10.1016/S1353-8020(09)70010-0; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Hennis MR, 2014, NEUROBIOL DIS, V62, P113, DOI 10.1016/j.nbd.2013.09.009; Hirata H, 1998, MOL BRAIN RES, V58, P209, DOI 10.1016/S0169-328X(98)00055-2; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Ihara Y, 1999, J NEUROL SCI, V170, P90, DOI 10.1016/S0022-510X(99)00192-6; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jiang HB, 2004, J BIOL CHEM, V279, P54380, DOI 10.1074/jbc.M409282200; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Kondo T, 1997, J NEUROSCI, V17, P4180; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Kuhn K, 2004, DEV BRAIN RES, V149, P131, DOI 10.1016/j.devbrainres.2004.02.001; Kunikowska G, 2003, BRAIN RES, V968, P206, DOI 10.1016/S0006-8993(03)02240-6; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liang LP, 2004, J NEUROCHEM, V90, P1076, DOI 10.1111/j.1471-4159.2004.02567.x; Liddell JR, 2010, GLIA, V58, P1500, DOI 10.1002/glia.21024; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lopez G, 2010, BIOMARK MED, V4, P713, DOI 10.2217/bmm.10.96; Manning-Bog AB, 2007, NEUROBIOL DIS, V27, P141, DOI 10.1016/j.nbd.2007.03.014; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Mullett SJ, 2011, J NEUROCHEM, V117, P375, DOI 10.1111/j.1471-4159.2011.07175.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Oliveras-Salva M, 2011, J PARKINSON DIS, V1, P229, DOI 10.3233/JPD-2011-11041; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Perez FA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-71; Perucho J, 2010, EXP NEUROL, V221, P54, DOI 10.1016/j.expneurol.2009.09.029; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Pham TT, 2010, GENES BRAIN BEHAV, V9, P305, DOI 10.1111/j.1601-183X.2009.00559.x; Raman AV, 2013, FEBS LETT, V587, P1562, DOI 10.1016/j.febslet.2013.04.001; Ramaswamy S, 2009, NEUROBIOL DIS, V34, P40, DOI 10.1016/j.nbd.2008.12.005; Rodriguez-Navarro JA, 2007, J NEUROCHEM, V103, P98, DOI 10.1111/j.1471-4159.2007.04762.x; Rousseaux MWC, 2012, P NATL ACAD SCI USA, V109, P15918, DOI 10.1073/pnas.1205102109; Sato S, 2006, J NEUROSCI RES, V84, P1350, DOI 10.1002/jnr.21032; Shang H, 2004, NEUROSCI LETT, V367, P273, DOI 10.1016/j.neulet.2004.06.002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1111/j.1460-9568.2000.01314.x; Sun SY, 2012, BRAIN RES BULL, V88, P609, DOI 10.1016/j.brainresbull.2012.05.013; Nguyen T, 2013, J COAT TECHNOL RES, V10, P1, DOI 10.1007/s11998-012-9455-1; Tripanichkul W, 2007, BRAIN RES, V1164, P24, DOI 10.1016/j.brainres.2007.05.076; Usami Y, 2011, NEUROBIOL DIS, V43, P651, DOI 10.1016/j.nbd.2011.05.014; Van Remmen H, 1999, ARCH BIOCHEM BIOPHYS, V363, P91, DOI 10.1006/abbi.1998.1060; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Vercammen L, 2006, MOL THER, V14, P716, DOI 10.1016/j.ymthe.2006.06.009; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vinish M, 2011, ACTA BIOCHIM POL, V58, P165; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Xie ZG, 2009, NEUROSCI LETT, V465, P214, DOI 10.1016/j.neulet.2009.09.024; Yang W, 2007, HUM MOL GENET, V16, P2900, DOI 10.1093/hmg/ddm249; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5; Zhang J, 2000, J NEUROPATH EXP NEUR, V59, P53, DOI 10.1093/jnen/59.1.53; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhu XR, 2007, EUR J NEUROSCI, V26, P1902, DOI 10.1111/j.1460-9568.2007.05812.x	99	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84894	10.1371/journal.pone.0084894	http://dx.doi.org/10.1371/journal.pone.0084894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386432	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700124
J	Zhao, K; Li, W; Huang, TT; Luo, XM; Chen, G; Zhang, Y; Guo, C; Dai, CX; Jin, Z; Zhao, Y; Cui, HY; Wang, YF				Zhao, Kai; Li, Wei; Huang, Tingting; Luo, Xiaomei; Chen, Gang; Zhang, Yang; Guo, Chen; Dai, Chunxiao; Jin, Zheng; Zhao, Yan; Cui, Hongyu; Wang, Yunfeng			Preparation and Efficacy of Newcastle Disease Virus DNA Vaccine Encapsulated in PLGA Nanoparticles	PLOS ONE			English	Article							IMMUNOLOGICAL EFFECTIVENESS; PLASMID DNA; IN-VITRO; M CELLS; GENE; DRUG; DELIVERY; CARRIERS; POLY(DL-LACTIDE-CO-GLYCOLIDE); MICROPARTICLES	Background: Although the Newcastle disease virus (NDV) inactivated vaccines and attenuated live vaccines have been used to prevent and control Newcastle disease (ND) for years, there are some disadvantages. Recently, newly developed DNA vaccines have the potential to overcome these disadvantages. The low delivery efficiency, however, hindered the application of DNA vaccines for ND in practice. Methodology/Principal Findings: The eukaryotic expression plasmid pVAX1-F (o) DNA that expressed the F gene of NDV encapsulated in PLGA nanoparticles (pFNDV-PLGA-NPs) were prepared by a double emulsion-solvent evaporation method and optimal preparation conditions of the pFNDV-PLGA-NPs were determined. Under the optimal conditions, the pFNDV-PLGA-NPs were produced in good morphology and had high stability with a mean diameter of 433.5 +/- 7.5 nm, with encapsulation efficiency of 91.8 +/- 0.3% and a Zeta potential of +2.7 mV. Release assay in vitro showed that the fusion gene plasmid DNA could be sustainably released from the pFNDV-PLGA-NPs up to 93.14% of the total amount. Cell transfection test indicated that the vaccine expressed and maintained its bioactivity. Immunization results showed that better immune responses of SPF chickens immunized with the pFNDV-PLGA-NPs were induced compared to the chickens immunized with the DNA vaccine alone. In addition, the safety of mucosal immunity delivery system of the pFNDV-PLGA-NPs was also tested in an in vitro cytotoxicity assay. Conclusions/Significance: The pFNDV-PLGA-NPs could induce stronger cellular, humoral, and mucosal immune responses and reached the sustained release effect. These results laid a foundation for further development of vaccines and drugs in PLGA nanoparticles.	[Zhao, Kai; Li, Wei; Huang, Tingting; Luo, Xiaomei; Chen, Gang; Zhang, Yang; Guo, Chen] Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China; [Zhao, Kai; Li, Wei; Huang, Tingting; Zhang, Yang; Zhao, Yan; Cui, Hongyu; Wang, Yunfeng] CAAS, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Dai, Chunxiao; Jin, Zheng] Heilongjiang Univ, Key Lab Chem Engn Proc & Technol High Efficiency, Harbin, Peoples R China	Heilongjiang University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Heilongjiang University	Zhao, K (corresponding author), Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China.	zybin395@126.com; yfwang@hvri.ac.cn		Zhao, Kai/0000-0001-6139-1912; Jin, Zheng/0000-0003-2537-6664	National Natural Science Foundation of China [31072119]; Program for International Science and Technology Cooperation Projects of China [2012DFA30250]; Key Project of Chinese Ministry of Education [212048]; Program for New Century Excellent Talents in University [NCET-12-0707]; Chang Jiang Scholar Candidates Program for Provincial Universities in Heilongjiang; Scientific and Technological Key Project of Heilongjiang Province [GC13B403]; Early Research and Development Cultivation Project of Scientific and Technological Achievements Industrialization for Provincial Universities in Heilongjiang [1253CGZH10]; Program for New Century Excellent Talents in Heilongjiang Provincial University [1251-NCET-005]; Innovation Foundation of Harbin [2013RFQXJ030, 2011RFQXN039]; Education Committee Science and Technology Research General Projects of Heilongjiang Province [12521408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for International Science and Technology Cooperation Projects of China; Key Project of Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chang Jiang Scholar Candidates Program for Provincial Universities in Heilongjiang; Scientific and Technological Key Project of Heilongjiang Province; Early Research and Development Cultivation Project of Scientific and Technological Achievements Industrialization for Provincial Universities in Heilongjiang; Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); Innovation Foundation of Harbin; Education Committee Science and Technology Research General Projects of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (31072119), Program for International Science and Technology Cooperation Projects of China (2012DFA30250), Key Project of Chinese Ministry of Education (212048), Program for New Century Excellent Talents in University (NCET-12-0707), Chang Jiang Scholar Candidates Program for Provincial Universities in Heilongjiang, Scientific and Technological Key Project of Heilongjiang Province (GC13B403), Early Research and Development Cultivation Project of Scientific and Technological Achievements Industrialization for Provincial Universities in Heilongjiang (1253CGZH10), Program for New Century Excellent Talents in Heilongjiang Provincial University (1251-NCET-005), Innovation Foundation of Harbin (2013RFQXJ030 and 2011RFQXN039) and Education Committee Science and Technology Research General Projects of Heilongjiang Province (12521408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AO, 2008, J PHARM SCI-US, V97, P2448, DOI 10.1002/jps.21215; Basarkar A, 2007, INT J PHARM, V343, P247, DOI 10.1016/j.ijpharm.2007.05.023; Conese M, 2011, J CYST FIBROS, V10, pS114, DOI 10.1016/S1569-1993(11)60017-9; Costantino L, 2006, BIOMATERIALS, V27, P4635, DOI 10.1016/j.biomaterials.2006.04.026; Csaba N, 2006, J CONTROL RELEASE, V113, P164, DOI 10.1016/j.jconrel.2006.03.017; Csaba Noemi, 2006, Expert Opin Drug Deliv, V3, P463, DOI 10.1517/17425247.3.4.463; Dillen K, 2004, EUR J PHARM BIOPHARM, V58, P539, DOI 10.1016/j.ejpb.2004.03.035; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Elkharraz K, 2006, INT J PHARMACEUT, V314, P127, DOI 10.1016/j.ijpharm.2005.07.028; Fievez V, 2009, EUR J PHARM BIOPHARM, V73, P16, DOI 10.1016/j.ejpb.2009.04.009; Fowler V, 2012, ANTIVIR RES, V94, P25, DOI 10.1016/j.antiviral.2012.02.002; Hallengard D, 2011, VACCINE, V29, P839, DOI 10.1016/j.vaccine.2010.10.083; Ho J, 2008, BIOTECHNOL BIOENG, V101, P172, DOI 10.1002/bit.21876; Intra J, 2010, J PHARM SCI-US, V99, P368, DOI 10.1002/jps.21840; Kim YC, 2012, EUR J PHARM BIOPHARM, V81, P239, DOI 10.1016/j.ejpb.2012.03.010; Liang Ming Tao, 2006, Current Drug Delivery, V3, P379; Malhotra M, 2011, INT J NANOMED, V6, P485, DOI 10.2147/IJN.S17190; Mann JFS, 2009, VACCINE, V27, P3643, DOI 10.1016/j.vaccine.2009.03.040; Marazuela EG, 2008, CLIN EXP ALLERGY, V38, P520, DOI 10.1111/j.1365-2222.2007.02922.x; Mast J, 2006, VACCINE, V24, P1756, DOI 10.1016/j.vaccine.2005.10.020; MEULEMANS G, 1986, AVIAN PATHOL, V15, P761, DOI 10.1080/03079458608436338; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Mishra N, 2011, J DRUG TARGET, V19, P67, DOI 10.3109/10611861003733946; Moghimi SM, 2006, ADV DRUG DELIVER REV, V58, P1451, DOI 10.1016/j.addr.2006.09.010; Mollenkopf HJ, 2004, VACCINE, V22, P2690, DOI 10.1016/j.vaccine.2004.05.005; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Panyam J, 2012, ADV DRUG DELIVER REV, V64, P61, DOI 10.1016/j.addr.2012.09.023; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Ribeiro S, 2005, INT J PHARMACEUT, V298, P354, DOI 10.1016/j.ijpharm.2005.03.036; Shakweh M, 2005, EUR J PHARM BIOPHARM, V61, P1, DOI 10.1016/j.ejpb.2005.04.006; Shi ZK, 1999, VACCINE, V17, P2136, DOI 10.1016/S0264-410X(98)00488-5; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Sinkovics JG, 2000, J CLIN VIROL, V16, P1, DOI 10.1016/S1386-6532(99)00072-4; Slutter B, 2009, J CONTROL RELEASE, V138, P113, DOI 10.1016/j.jconrel.2009.05.011; Stern M, 2003, GENE THER, V10, P1282, DOI 10.1038/sj.gt.3301994; Tseng LP, 2009, J BIOMED MATER RES B, V91B, P621, DOI 10.1002/jbm.b.31437; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; Wang T, 2012, INT J PHARMACEUT, V427, P3, DOI 10.1016/j.ijpharm.2011.07.013; Wu HZ, 2009, VIRUS RES, V145, P39, DOI 10.1016/j.virusres.2009.06.012; Xu K, 2011, VIRAL IMMUNOL, V24, P45, DOI 10.1089/vim.2010.0056; Zhao K, 2011, VACCINE, V29, P8549, DOI 10.1016/j.vaccine.2011.09.029; Zhao K, 2010, J MICROENCAPSUL, V27, P178, DOI 10.3109/02652040903059239	43	40	40	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82648	10.1371/journal.pone.0082648	http://dx.doi.org/10.1371/journal.pone.0082648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386106	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700010
J	Bosson, JA; Blomberg, A; Stenfors, N; Helleday, R; Kelly, FJ; Behndig, AF; Mudway, IS				Bosson, Jenny A.; Blomberg, Anders; Stenfors, Nikolai; Helleday, Ragnberth; Kelly, Frank J.; Behndig, Annelie F.; Mudway, Ian S.			Peripheral Blood Neutrophilia as a Biomarker of Ozone-Induced Pulmonary Inflammation	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; BRONCHOALVEOLAR LAVAGE FLUID; TIME-DEPENDENT CHANGES; AIR-POLLUTION; INHALED OZONE; HUMAN EXPOSURE; MARKERS; MEDIATORS; MORTALITY; CHILDREN	Background: Ozone concentrations are predicted to increase over the next 50 years due to global warming and the increased release of precursor chemicals. It is therefore urgent that good, reliable biomarkers are available to quantify the toxicity of this pollutant gas at the population level. Such a biomarker would need to be easily performed, reproducible, economically viable, and reflective of ongoing pathological processes occurring within the lung. Methodology: We examined whether blood neutrophilia occurred following a controlled ozone challenge and addressed whether this could serve as a biomarker for ozone-induced airway inflammation. Three separate groups of healthy subjects were exposed to ozone (0.2 ppm, 2h) and filtered air (FA) on two separate occasions. Peripheral blood samples were collected and bronchoscopy with biopsy sampling and lavages was performed at 1.5h post exposures in group 1 (n=13), at 6h in group 2 (n=15) and at 18h in group 3 (n=15). Total and differential cell counts were assessed in blood, bronchial tissue and airway lavages. Results: In peripheral blood, we observed fewer neutrophils 1.5h after ozone compared with the parallel air exposure (-1.1 +/- 1.0x10(9) cells/L, p<0.01), at 6h neutrophil numbers were increased compared to FA (+1.2 +/- 1.3x10(9) cells/L, p<0.01), and at 18h this response had fully attenuated. Ozone induced a peak in neutrophil numbers at 6h post exposure in all compartments examined, with a positive correlation between the response in blood and bronchial biopsies. Conclusions: These data demonstrate a systemic neutrophilia in healthy subjects following an acute ozone exposure, which mirrors the inflammatory response in the lung mucosa and lumen. This relationship suggests that blood neutrophilia could be used as a relatively simple functional biomarker for the effect of ozone on the lung.	[Bosson, Jenny A.; Blomberg, Anders; Stenfors, Nikolai; Helleday, Ragnberth; Behndig, Annelie F.] Umea Univ, Dept Publ Hlth & Clin Med, Div Med Resp Med & Allergy, Umea, Sweden; [Stenfors, Nikolai] Dept Med, Div Resp Med & Allergy, Ostersund, Sweden; [Kelly, Frank J.; Mudway, Ian S.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Sch Biomed Sci, London WC2R 2LS, England	Umea University; University of London; King's College London	Mudway, IS (corresponding author), Kings Coll London, MRC PHE Ctr Environm & Hlth, Sch Biomed Sci, London WC2R 2LS, England.	ian.mudway@kcl.ac.uk	Kelly, Frank J/C-6125-2009; Kelly, Frank/ABG-3411-2021; Stenfors, Nikolai/AAK-5334-2020	Kelly, Frank J/0000-0003-2558-8392; Kelly, Frank/0000-0003-2558-8392; Stenfors, Nikolai/0000-0002-1684-1301; Bosson Damewood, Jenny/0000-0003-2380-2607; Blomberg, Anders/0000-0002-2452-7347; Mudway, Ian/0000-0003-1239-5014	Swedish Heart and Lung Foundation; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G1000758, G0801056] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The study was generously supported by the Swedish Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alexis NE, 2004, CLIN IMMUNOL, V111, P126, DOI 10.1016/j.clim.2003.12.002; ARIS RM, 1993, AM REV RESPIR DIS, V148, P1363, DOI 10.1164/ajrccm/148.5.1363; Arjomandi M, 2005, CHEST, V128, P416, DOI 10.1378/chest.128.1.416; BATES DV, 1970, CAN MED ASSOC J, V103, P833; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Blomberg A, 1999, EUR RESPIR J, V13, P1418, DOI 10.1034/j.1399-3003.1999.13f31.x; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Christian DL, 1998, AM J RESP CRIT CARE, V158, P532, DOI 10.1164/ajrccm.158.2.9709023; Corradi M, 2002, TOXICOL LETT, V134, P219, DOI 10.1016/S0378-4274(02)00169-8; Devlin RB, 1996, TOXICOL APPL PHARM, V138, P176, DOI 10.1006/taap.1996.0111; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Halonen JI, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-42; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Hunt J, 2007, IMMUNOL ALLERGY CLIN, V27, P587, DOI 10.1016/j.iac.2007.09.001; Jorres RA, 2000, AM J RESP CRIT CARE, V161, P1855; KEHRL HR, 1987, AM REV RESPIR DIS, V135, P1124; Kharitonov SA, 2000, EUR RESPIR J, V16, P781, DOI 10.1183/09031936.00.16478100; KOREN HS, 1991, TOXICOL PATHOL, V19, P406, DOI 10.1177/0192623391019004-109; KOREN HS, 1989, AM REV RESPIR DIS, V139, P407, DOI 10.1164/ajrccm/139.2.407; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; MCDONNELL WF, 1991, ARCH ENVIRON HEALTH, V46, P145, DOI 10.1080/00039896.1991.9937441; Miller MD, 2010, ENVIRON HEALTH PERSP, V118, P1155, DOI 10.1289/ehp.0901856; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Montuschi Paolo, 2007, Ther Adv Respir Dis, V1, P5, DOI 10.1177/1753465807082373; Mudway I. S., 2000, Molecular Aspects of Medicine, V21, P1, DOI 10.1016/S0098-2997(00)00003-0; Mudway IS, 2006, FREE RADICAL BIO MED, V40, P1702, DOI 10.1016/j.freeradbiomed.2005.10.050; Mudway IS, 1999, EUR RESPIR J, V13, P1429, DOI 10.1183/09031936.99.13614399; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Nightingale JA, 1999, THORAX, V54, P1061, DOI 10.1136/thx.54.12.1061; PEDEN DB, 1995, AM J RESP CRIT CARE, V151, P1336, DOI 10.1164/ajrccm.151.5.7735583; Plopper CG, 1998, AM J RESP CELL MOL, V19, P387, DOI 10.1165/ajrcmb.19.3.3183; Ratto J, 2006, ENVIRON HEALTH PERSP, V114, P209, DOI 10.1289/ehp.8341; Robroeks CMHHT, 2010, CLIN EXP ALLERGY, V40, P77, DOI 10.1111/j.1365-2222.2009.03397.x; Rosias PP, 2008, EUR RESPIR J, V31, P934, DOI 10.1183/09031936.00073207; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; SCHELEGLE ES, 1991, AM REV RESPIR DIS, V143, P1353, DOI 10.1164/ajrccm/143.6.1353; Stenfors N, 2002, RESP MED, V96, P352, DOI 10.1053/rmed.2001.1265; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Tan WC, 2000, AM J RESP CRIT CARE, V161, P1213, DOI 10.1164/ajrccm.161.4.9904084; Thompson AMS, 2010, ENVIRON HEALTH PERSP, V118, P120, DOI 10.1289/ehp.0900550; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; WHO, 2006, AIR QUAL GUID; Zanobetti A, 2008, AM J RESP CRIT CARE, V177, P184, DOI 10.1164/rccm.200706-823OC	44	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81816	10.1371/journal.pone.0081816	http://dx.doi.org/10.1371/journal.pone.0081816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391708	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200005
J	Molden, S; Moldestad, O; Storm, JF				Molden, Sturla; Moldestad, Olve; Storm, Johan F.			Estimating Extracellular Spike Waveforms from CA1 Pyramidal Cells with Multichannel Electrodes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SINGLE NEURONS; PLACE FIELDS; HIPPOCAMPUS; RECORDINGS; REPRESENTATION; OSCILLATIONS; SEPARATION; FREQUENCY; LIMULUS	Extracellular (EC) recordings of action potentials from the intact brain are embedded in background voltage fluctuations known as the "local field potential" (LFP). In order to use EC spike recordings for studying biophysical properties of neurons, the spike waveforms must be separated from the LFP. Linear low-pass and high-pass filters are usually insufficient to separate spike waveforms from LFP, because they have overlapping frequency bands. Broad-band recordings of LFP and spikes were obtained with a 16-channel laminar electrode array (silicone probe). We developed an algorithm whereby local LFP signals from spike-containing channel were modeled using locally weighted polynomial regression analysis of adjoining channels without spikes. The modeled LFP signal was subtracted from the recording to estimate the embedded spike waveforms. We tested the method both on defined spike waveforms added to LFP recordings, and on in vivo-recorded extracellular spikes from hippocampal CA1 pyramidal cells in anaesthetized mice. We show that the algorithm can correctly extract the spike waveforms embedded in the LFP. In contrast, traditional high-pass filters failed to recover correct spike shapes, albeit produceing smaller standard errors. We found that high-pass RC or 2-pole Butterworth filters with cut-off frequencies below 12.5 Hz, are required to retrieve waveforms comparable to our method. The method was also compared to spike-triggered averages of the broad-band signal, and yielded waveforms with smaller standard errors and less distortion before and after the spike.	[Molden, Sturla; Moldestad, Olve; Storm, Johan F.] Univ Oslo, Dept Physiol, Insitute Basic Med Sci, Oslo 3, Norway	University of Oslo	Molden, S (corresponding author), Univ Oslo, Dept Physiol, Insitute Basic Med Sci, Oslo 3, Norway.	sturla.molden@medisin.uio.no			Norwegian Research Council [178872, 214079]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Funding from the Norwegian Research Council, grant no. 178872 and 214079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian E.D., 1928, BASIS SENSATION ACTI; Anderson E., 1999, LAPACK USERS GUIDE; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bialek W., 1996, SPIKES EXPLORING NEU; Bierer SM, 1999, NEUROCOMPUTING, V26-7, P947, DOI 10.1016/S0925-2312(99)00090-9; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Golub G.H, 1996, J HOPKINS STUDIES MA; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hartline HK, 1930, J GEN PHYSIOL, V13, P379, DOI 10.1085/jgp.13.3.379; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Horowitz P., 2015, ART ELECT; James CJ, 1997, IEEE T BIO-MED ENG, V44, P775, DOI 10.1109/10.605438; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lin YS, 2005, P ANN INT IEEE EMBS, P7345; Liu JS, 2011, J BIOL RHYTHM, V26, P335, DOI 10.1177/0748730411409712; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Moldestad O, 2009, J NEUROSCI METH, V176, P57, DOI 10.1016/j.jneumeth.2008.08.015; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Musial PG, 2002, J NEUROSCI METH, V115, P29, DOI 10.1016/S0165-0270(01)00516-7; Neuralynx Inc, 2000, LYNX 8 AMPL US MAN; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Oweiss KG, 2001, NEUROCOMPUTING, V38, P1687, DOI 10.1016/S0925-2312(01)00533-1; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Press W. H., 2007, NUMERICAL RECEIPES A; Quiroga RQ, 2009, J NEUROSCI METH, V177, P194, DOI 10.1016/j.jneumeth.2008.09.033; Quiroga RQ, 2013, SCI AM, V308, P30, DOI 10.1038/scientificamerican0213-30; Quiroga RQ, 2012, CURR BIOL, V22, pR45, DOI 10.1016/j.cub.2011.11.005; Quiroga RQ, 2009, CURR BIOL, V19, P1308, DOI 10.1016/j.cub.2009.06.060; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Renshaw B, 1940, J NEUROPHYSIOL, V3, P74, DOI 10.1152/jn.1940.3.1.74; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Smith SW, 1997, SCI ENG GUIDE DIGITA; STORM JF, 1990, PROG BRAIN RES, V83, P161; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Van Drongelen W., 2018, SIGNAL PROCESSING NE, DOI 10.1016/B978-0-12-370867-0.X5000-1; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VanDrongelen W, 2010, SIGNAL PROCESSING FOR NEUROSCIENTISTS, A COMPANION VOLUME: ADVANCED TOPICS, NONLINEAR TECHNIQUES AND MULTI-CHANNEL ANALYSIS, P1; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; YLINEN A, 1995, J NEUROSCI, V15, P30	56	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82141	10.1371/journal.pone.0082141	http://dx.doi.org/10.1371/journal.pone.0082141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391714	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200011
J	Caffrey, E; Ingoldsby, H; Wall, D; Webber, M; Dinneen, K; Murillo, LS; Inderhaug, C; Newell, J; Gupta, S; Callagy, G				Caffrey, Emer; Ingoldsby, Helen; Wall, Deirdre; Webber, Mark; Dinneen, Kate; Murillo, Laura S.; Inderhaug, Celine; Newell, John; Gupta, Sanjeev; Callagy, Grace			Prognostic Significance of Deregulated Dicer Expression in Breast Cancer	PLOS ONE			English	Article							CENTRALLY REVIEWED EXPRESSION; IMMUNOHISTOCHEMICAL ANALYSIS; PROGESTERONE-RECEPTORS; PROLIFERATION MARKERS; ADJUVANT THERAPY; PREDICTIVE-VALUE; BCL-2 PROTEIN; DROSHA; MICRORNAS; ESTROGEN	Background: Dicer, an RNase III-type endonuclease, is the key enzyme involved in RNA interference and microRNA pathways. Aberrant expression of Dicer is reported in several human cancers. Our aim was to assess the prognostic role of Dicer in breast cancer. Methods: The entire series comprised 666 invasive breast cancers (IBCs), 480 DCIS cases (397 associated with IBC and 83 pure DCIS) and 305 lymph node metastases. Cytoplasmic Dicer expression by immunohistochemistry was scored as negative (no staining) and positive (weak, moderate or strong staining). Results: Dicer staining was assessable in 446 IBC, 128 DCIS and 101 lymph node metastases. Expression of Dicer was observed in 33% (145/446) of IBCs, 34% (44/128) of DCIS and 57% (58/101) of lymph node metastases. Dicer expression was increased in nodal metastases compared to primary tumours (p< 0.001); and was associated with ER negativity (p<0.001), HER2 positivity (p<0.001), high Ki67 labeling index (p<0.001) and expression of basal-like biomarkers (p = 0.002). Dicer positivity was more frequent in the HER2 overexpressing (p<0.001) and basal-like (p = 0.002) subtypes compared to luminal A subtype. Dicer expression was associated with reduced overall survival (OS) on univariate analysis (p = 0.058) and remained an independent predictor of OS on multivariate analysis (HR 2.84, 95% CI 1.43-5.62, p = 0.003), with nodal status (HR 2.61, 95% CI 1.18-5.80, p = 0.018) and PR (HR 0.28, 95% CI 0.13-0.59, p = 0.001). Further, moderate or strong expression of Dicer was associated with improved disease-free survival in the HER2-overexpressing subtype compared to negative or weak expression (p = 0.038). Conclusion: Deregulated Dicer expression is associated with aggressive tumour characteristics and is an independent prognostic factor for OS. Our findings suggest that Dicer is an important prognostic marker in breast cancer and that its prognostic role may be subtype specific.	[Caffrey, Emer; Ingoldsby, Helen; Webber, Mark; Dinneen, Kate; Murillo, Laura S.; Inderhaug, Celine; Gupta, Sanjeev; Callagy, Grace] Natl Univ Ireland, Inst Clin Sci, Sch Med, Galway, Ireland; [Wall, Deirdre] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland; [Newell, John] Natl Univ Ireland, HRB Clin Res Facil, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway	Callagy, G (corresponding author), Natl Univ Ireland, Inst Clin Sci, Sch Med, Galway, Ireland.	grace.callagy@nuigalway.ie	Gupta, Sanjeev/AAG-9749-2020; gupta, sanjeev/B-2824-2008	Gupta, Sanjeev/0000-0002-4691-6853; gupta, sanjeev/0000-0002-4691-6853; Newell, John/0000-0001-7685-6655; Wall, Deirdre/0000-0001-6510-6082; Murillo, Laura/0000-0002-2493-8584	Health Research Board [HRA_HSR/2010/24]; National University of Ireland, Galway; Breast Cancer Campaign [2011PR26]	Health Research Board; National University of Ireland, Galway; Breast Cancer Campaign	This publication has emanated from research conducted with the financial support of the Health Research Board [grant number HRA_HSR/2010/24], Millennium Fund from National University of Ireland, Galway to S. G. and Breast Cancer Campaign [grant number 2011PR26 (to G.C.)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NHSBSP PUBL, V58; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beezhold KJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-134; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brown RW, 1996, CLIN CANCER RES, V2, P585; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cancer IUA, 2009, TNM CLASSIFICATION M; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chiosea SI, 2008, VIRCHOWS ARCH, V452, P629, DOI 10.1007/s00428-007-0574-5; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cochrane Dawn R., 2010, Hormones & Cancer, V1, P306, DOI 10.1007/s12672-010-0043-5; Dedes KJ, 2011, EUR J CANCER, V47, P138, DOI 10.1016/j.ejca.2010.08.007; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Elledge RM, 1997, J CLIN ONCOL, V15, P1916, DOI 10.1200/JCO.1997.15.5.1916; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Faggad A, 2012, HISTOPATHOLOGY; Faggad A, 2010, J PATHOL, V220, P382, DOI 10.1002/path.2658; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Flavin RJ, 2008, MODERN PATHOL, V21, P676, DOI 10.1038/modpathol.2008.33; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo XF, 2012, J CANCER RES CLIN, V138, P49, DOI 10.1007/s00432-011-1058-1; Harbeck N, 1999, BRIT J CANCER, V80, P419, DOI 10.1038/sj.bjc.6690373; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hinkal GW, 2011, BRIT J CANCER, V104, P387, DOI 10.1038/sj.bjc.6606022; Jansen RLH, 1998, BRIT J CANCER, V78, P460, DOI 10.1038/bjc.1998.515; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Le MG, 1999, INT J CANCER, V84, P562, DOI 10.1002/(SICI)1097-0215(19991222)84:6<562::AID-IJC4>3.0.CO;2-0; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Menard S, 1999, BREAST CANCER RES TR, V55, P169; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Moran MS, 2009, BREAST J, V15, P571, DOI 10.1111/j.1524-4741.2009.00833.x; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Osanai T, 2005, JPN J CLIN ONCOL, V35, P121, DOI 10.1093/jjco/hyi036; Papachristou DJ, 2012, HISTOPATHOLOGY, V60, pE28, DOI 10.1111/j.1365-2559.2012.04192.x; Papachristou DJ, 2012, CANCER INVEST, V30, P172, DOI 10.3109/07357907.2011.633293; Passon N, 2012, J CLIN PATHOL, V65, P320, DOI 10.1136/jclinpath-2011-200496; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Regan MM, 2006, JNCI-J NATL CANCER I, V98, P1571, DOI 10.1093/jnci/djj415; Shu GS, 2012, PATHOL RES PRACT, V208, P392, DOI 10.1016/j.prp.2012.05.001; SILVESTRINI R, 1994, J NATL CANCER I, V86, P499, DOI 10.1093/jnci/86.7.499; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Spyratos F, 2002, CANCER-AM CANCER SOC, V94, P2151, DOI 10.1002/cncr.10458; Stratmann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-345; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tan P, 1997, CANCER RES, V57, P1259; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Vaksman O, 2012, HUMAN PATHOLOGY; VERONESE SM, 1993, CANCER, V71, P3926, DOI 10.1002/1097-0142(19930615)71:12<3926::AID-CNCR2820711221>3.0.CO;2-2; Viale G, 2008, J CLIN ONCOL, V26, P1404, DOI 10.1200/JCO.2007.10.6393; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yan M, 2012, PATHOL ONCOL RES, V18, P343, DOI 10.1007/s12253-011-9450-3; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	68	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83724	10.1371/journal.pone.0083724	http://dx.doi.org/10.1371/journal.pone.0083724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386264	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700060
J	Curtis, DE; Hlady, CS; Kanade, G; Pemmaraju, SV; Polgreen, PM; Segre, AM				Curtis, Donald E.; Hlady, Christopher S.; Kanade, Gaurav; Pemmaraju, Sriram V.; Polgreen, Philip M.; Segre, Alberto M.			Healthcare Worker Contact Networks and the Prevention of Hospital-Acquired Infections	PLOS ONE			English	Article							ISOLATION PRECAUTIONS; COMMUNITY STRUCTURE; SOCIAL NETWORK; DISEASE; TRANSMISSION; GUIDELINE; EVOLUTION	We present a comprehensive approach to using electronic medical records (EMR) for constructing contact networks of healthcare workers in a hospital. This approach is applied at the University of Iowa Hospitals and Clinics (UIHC) - a 3.2 million square foot facility with 700 beds and about 8,000 healthcare workers - by obtaining 19.8 million EMR data points, spread over more than 21 months. We use these data to construct 9,000 different healthcare worker contact networks, which serve as proxies for patterns of actual healthcare worker contacts. Unlike earlier approaches, our methods are based on large-scale data and do not make any a priori assumptions about edges (contacts) between healthcare workers, degree distributions of healthcare workers, their assignment to wards, etc. Preliminary validation using data gathered from a 10-day long deployment of a wireless sensor network in the Medical Intensive Care Unit suggests that EMR logins can serve as realistic proxies for hospital-wide healthcare worker movement and contact patterns. Despite spatial and job-related constraints on healthcare worker movement and interactions, analysis reveals a strong structural similarity between the healthcare worker contact networks we generate and social networks that arise in other (e. g., online) settings. Furthermore, our analysis shows that disease can spread much more rapidly within the constructed contact networks as compared to random networks of similar size and density. Using the generated contact networks, we evaluate several alternate vaccination policies and conclude that a simple policy that vaccinates the most mobile healthcare workers first, is robust and quite effective relative to a random vaccination policy.	[Curtis, Donald E.; Hlady, Christopher S.; Kanade, Gaurav; Pemmaraju, Sriram V.; Segre, Alberto M.] Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA; [Polgreen, Philip M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Pemmaraju, SV (corresponding author), Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA.	sriram-pemmaraju@uiowa.edu	Segre, Alberto M/B-1734-2009	Polgreen, Philip/0000-0002-0630-5898	University of Iowa College of Medicine Translational Research Pilot Grant; National Institutes of Health Young Investigator Award [NIHK01AI075089]; National Institutes of Health [NIHR21AI081164]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081164, K01AI075089] Funding Source: NIH RePORTER	University of Iowa College of Medicine Translational Research Pilot Grant; National Institutes of Health Young Investigator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research was provided by a University of Iowa College of Medicine Translational Research Pilot Grant (to PMP, SVP, and AMS), by a National Institutes of Health Young Investigator Award NIHK01AI075089 (to PMP), and by the National Institutes of Health grant NIHR21AI081164 (to AMS, SVP, and PMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; BarabuYSi A., 2003, LINKED EVERYTHING IS; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Curtis D, 2010, 3 BIENN C AM SOC HLT; Curtis D, 2010, 5 DEC INT C HEALTHC; Curtis D, 2010, IHI 2010 IN PRESS; Donker T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000715; Edmond M, 2005, PRINCIPLES PRACTICE, P3323; GARNER JS, 1983, INFECT CONT HOSP EP, V4, P245; Garner JS, 1996, AM J INFECT CONTROL, V24, P24; Garner JS, 1996, INFECT CONT HOSP EP, V17, P54, DOI 10.1017/S0195941700006123; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Haas JP, 2007, J HOSP INFECT, V66, P6, DOI 10.1016/j.jhin.2006.11.013; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Herman T, 2012, Proceedings of 2012 ASE/IEEE International Conference on Privacy, Security, Risk and Trust and 2012 ASE/IEEE International Conference on Social Computing (SocialCom/PASSAT 2012), P572, DOI 10.1109/SocialCom-PASSAT.2012.113; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Kampf G, 2009, DTSCH ARZTEBL INT, V106, P649, DOI 10.3238/arztebl.2009.0649; Kazandjieva M., 2010, ACM WORKSH HOT TOP E; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kleinberg J, 2008, COMMUN ACM, V51, P66, DOI 10.1145/1400214.1400232; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Lesosky M, 2011, INFECT CONT HOSP EP, V32, P136, DOI 10.1086/657945; Liljeros F, 2007, MATH POPUL STUD, V14, P269, DOI 10.1080/08898480701612899; Meyers LA, 2003, EMERG INFECT DIS, V9, P204, DOI 10.3201/eid0902.020188; Meyers LA, 2007, B AM MATH SOC, V44, P63; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Mitzenmacher M, 2003, INTERNET MATH, P1; Molloy M, 1998, COMB PROBAB COMPUT, V7, P295, DOI 10.1017/S0963548398003526; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Olguin D. O., 2009, P 2009 3 INT C PERVA, P1; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P893, DOI 10.1086/655466; Stehle J, 2011, BMC MED, P9; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Ueno T, 2008, J THEOR BIOL, V254, P655, DOI 10.1016/j.jtbi.2008.07.001; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	50	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e79906	10.1371/journal.pone.0079906	http://dx.doi.org/10.1371/journal.pone.0079906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	282SX	24386075	Green Submitted, gold, Green Published			2022-12-27	WOS:000329194700002
J	Donders, GGG; Depuydt, CE; Bogers, JP; Vereecken, AJ				Donders, Gilbert G. G.; Depuydt, Christophe E.; Bogers, John-Paul; Vereecken, Annie J.			Association of Trichomonas vaginalis and Cytological Abnormalities of the Cervix in Low Risk Women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA CIN; NATURAL-HISTORY; DIAGNOSIS; PCR; DNA	Objective: Is Trichomonas vaginalis (TV) an inducing factor for the development of (pre-)cancerous lesions of the cervix? Design: Cross sectional study. Setting: Screening healthy Belgian women with low infection risk. Sample: 63,251 consecutive liquid based cervical samples. Methods: Real time quantitative PCR for presence of TV, 18 HPV types and Pap smear analysis of cytologic abnormalities. Main Outcome Measures: Association of TV and HPV with cervix dysplasia Results: The overall prevalence of TV DNA was 0.37%, of low risk HPV 2%, of high risk HPV 13.2%, and 8.8 % had cytological abnormalities. Both LR-HPV and HR-HPV were significantly associated with all cytological abnormalities. Presence of TV was associated with LR- and HR-HPV, ASC-US and HSIL, but not with other abnormalities. All women with TV and HSIL also had HR-HPV, while the latter was present in only 59% of women with TV and ASCUS. Amongst HPV negative women, TV was found in 1.3% of women with ASC-US, but only in 0.03% of women with normal cytology (OR 4.2, CL95% 2.1-8.6). In HR-HPV positive women, presence of TV increased the likelihood of cytological abnormalities somewhat (P=0.05), mainly due to an increase in ASC-US and LSIL, but not HSIL. Conclusions: We conclude that TV infection is associated with both LR and HR-HPV infection of the cervix, as well as with ASC-US and HSIL. TV is a concomitant STI, but is not thought to be a co-factor in the causation of HSIL and cervical cancer. However, TV may cause false positive diagnoses of ASC-US.	[Donders, Gilbert G. G.] Univ Antwerp Hosp, Dept Obstet, Antwerp, Belgium; [Donders, Gilbert G. G.] Univ Antwerp Hosp, Dept Gynecol, Antwerp, Belgium; [Donders, Gilbert G. G.] Heilig Hart Reg Hosp, Dept Obstet & Gynecol, Tienen, Belgium; [Donders, Gilbert G. G.] Dept Clin Res Women, Tienen, Belgium; [Depuydt, Christophe E.; Bogers, John-Paul; Vereecken, Annie J.] AML Lab Son Healthcare Benelux, Lab Mol & Clin Pathol RIATOL, Antwerp, Belgium	University of Antwerp; University of Antwerp	Donders, GGG (corresponding author), Univ Antwerp Hosp, Dept Obstet, Antwerp, Belgium.	Gilbert.Donders@femicare.net	Depuydt, Christophe/H-8592-2019; Donders, Gilbert/AAA-9004-2021; Bogers, John-Paul/E-2596-2017	Depuydt, Christophe/0000-0003-3462-6557; Bogers, John-Paul/0000-0001-9107-132X; Donders, Gilbert/0000-0001-9890-6254				[Anonymous], 2001, WHOHIVAIDS200102; Aslan DL, 2005, DIAGN CYTOPATHOL, V32, P341, DOI 10.1002/dc.20256; Audisio T, 2001, J Low Genit Tract Dis, V5, P223, DOI 10.1046/j.1526-0976.2001.54007.x; Boyle DCM, 1999, INT J GYNECOL CANCER, V9, P177; Caliendo A M, 2005, Infect Dis Obstet Gynecol, V13, P145, DOI 10.1080/10647440500068248; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Depuydt CE, 2006, CYTOPATHOLOGY, V17, P374, DOI 10.1111/j.1365-2303.2006.00386.x; Depuydt CE, 2003, BRIT J CANCER, V88, P560, DOI 10.1038/sj.bjc.6600756; Depuydt CE, 2010, GYNECOL OBSTET INVES, V70, P273, DOI 10.1159/000314017; Donders GGG, 2013, J LOW GENIT TRACT DI, V17, pE31, DOI 10.1097/LGT.0b013e318284dbc3; El-Gayar Eman K., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P623; Erbelding Emily J, 2002, Hopkins HIV Rep, V14, P1; Fitzhugh VA, 2008, J LOW GENIT TRACT DI, V12, P40, DOI 10.1097/lgt.0b013e31813e07ff; GRAM IT, 1992, CANCER CAUSE CONTROL, V3, P231, DOI 10.1007/BF00124256; Herbert A, 2007, CYTOPATHOLOGY, V18, P213, DOI 10.1111/j.1365-2303.2007.00469.x; KENGNE P, 1994, CELL MOL BIOL, V40, P819; Lara-Torre E, 2003, AM J OBSTET GYNECOL, V188, P354, DOI 10.1067/mob.2003.8; Micalessi IM, 2012, CLIN CHEM LAB MED, V50, P655, DOI [10.1515/CCLM.2011.835, 10.1515/cclm.2011.835]; Moodley P, 2002, CLIN INFECT DIS, V34, P519, DOI 10.1086/338399; Renshaw AA, 2004, ARCH PATHOL LAB MED, V128, P403; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stemmer SM, 2012, J LOW GENIT TRACT DI, V16, P352, DOI 10.1097/LGT.0b013e31824b9be2; Tirone NR, 2008, EUR J GYNAECOL ONCOL, V29, P144; Van Der Pol B, 2005, J INFECT DIS, V192, P2039, DOI 10.1086/498217; Van der Pol B, 2007, CLIN INFECT DIS, V44, P23, DOI 10.1086/509934; Vassilakos P, 1998, ACTA CYTOL, V42, P198, DOI 10.1159/000331546; Vassilakos P, 1999, ACTA CYTOL, V43, P65, DOI 10.1159/000330870; Viikki M, 2000, ACTA ONCOL, V39, P71, DOI 10.1080/028418600431003; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; Wiese W, 2000, AM J MED, V108, P301, DOI 10.1016/S0002-9343(99)00466-0	31	35	42	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e86266	10.1371/journal.pone.0086266	http://dx.doi.org/10.1371/journal.pone.0086266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386492	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700149
J	Ramakrishnan, VR; Feazel, LM; Gitomer, SA; Ir, D; Robertson, CE; Frank, DN				Ramakrishnan, Vijay R.; Feazel, Leah M.; Gitomer, Sarah A.; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.			The Microbiome of the Middle Meatus in Healthy Adults	PLOS ONE			English	Article							MAXILLARY SINUS ASPIRATE; CHRONIC RHINOSINUSITIS; DIAGNOSIS; RESPONSES; CULTURES; PRIMERS; SYSTEM; ASTHMA; AIRWAY; CELLS	Rhinitis and rhinosinusitis are multifactorial disease processes in which bacteria may play a role either in infection or stimulation of the inflammatory process. Rhinosinusitis has been historically studied with culture-based techniques, which have implicated several common pathogens in disease states. More recently, the NIH Human Microbiome Project has examined the microbiome at a number of accessible body sites, and demonstrated differences among healthy and diseased patients. Recent DNA-based sinus studies have suggested that healthy sinuses are not sterile, as was previously believed, but the normal sinonasal microbiome has yet to be thoroughly examined. Middle meatus swab specimens were collected from 28 consecutive patients presenting with no signs or symptoms of rhinosinusitis. Bacterial colonization was assessed in these specimens using quantitative PCR and 16S rRNA pyrosequencing. All subjects were positive for bacterial colonization of the middle meatus. Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acnes were the most prevalent and abundant microorganisms detected. Rich and diverse bacterial assemblages are present in the sinonasal cavity in the normal state, including opportunistic pathogens typically found in the nasopharynx. This work helps establish a baseline for understanding how the sinonasal microbiome may impact diseases of the upper airways.	[Ramakrishnan, Vijay R.; Gitomer, Sarah A.] Univ Colorado, Dept Otolaryngol Head & Neck Surg, Aurora, CO 80045 USA; [Feazel, Leah M.; Ir, Diana; Frank, Daniel N.] Univ Colorado, Div Infect Dis, Aurora, CO USA; [Frank, Daniel N.] Univ Colorado, Microbiome Res Consortium, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Ramakrishnan, VR (corresponding author), Univ Colorado, Dept Otolaryngol Head & Neck Surg, Aurora, CO 80045 USA.	vijay.ramakrishnan@ucdenver.edu		Ramakrishnan, Vijay/0000-0003-2748-0705; ROBERTSON, CHARLES/0000-0002-4136-4121	NIH [HG005964]; University of Colorado Department of Otolaryngology and Division of Infectious Diseases; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Department of Otolaryngology and Division of Infectious Diseases; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by NIH grant HG005964 (DNF). Additional funding was received from the University of Colorado Department of Otolaryngology and Division of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bhattacharyya N, 2011, ANN OTO RHINOL LARYN, V120, P423, DOI 10.1177/000348941112000701; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Boyd EL, 2002, ALLERGY IMMUNOLOGY O, P81; Brook Itzhak, 2011, Proc Am Thorac Soc, V8, P90, DOI 10.1513/pats.201006-038RN; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Chandra RK, 2010, J OTOLARYNGOL-HEAD N, V39, P171, DOI 10.2310/7070.2009.090044; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; *DEV COR TEAM, 2008, R LANG ENV STAT COMP; Dubin MG, 2005, AM J RHINOL, V19, P462, DOI 10.1177/194589240501900508; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Feazel LM, 2011, INT FORUM ALLERGY RH, V1, P451, DOI 10.1002/alr.20071; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frank DN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-420; Frank DN, 2007, ENCY INFECT DIS MODE, P4, DOI [10.1002/9780470114209.ch, DOI 10.1002/9780470114209.CH]; GLIKLICH RE, 1995, OTOLARYNG HEAD NECK, V113, P104, DOI 10.1016/S0194-5998(95)70152-4; Gold SM, 1997, LARYNGOSCOPE, V107, P1586, DOI 10.1097/00005537-199712000-00002; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Joniau S, 2005, AM J RHINOL, V19, P135, DOI 10.1177/194589240501900205; Kennedy DW, 2004, ANN OTO RHINOL LARYN, V113, P6, DOI 10.1177/00034894041130S503; Kingdom TT, 2004, AM J OTOLARYNG, V25, P323, DOI 10.1016/j.amjoto.2004.03.003; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Nadel DM, 1998, AM J RHINOL, V12, P233, DOI 10.2500/105065898781390000; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Orlandi RR, 2004, ANN OTO RHINOL LARYN, V113, P24, DOI 10.1177/00034894041130S507; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Relman DA, 2012, NATURE, V486, P194, DOI 10.1038/486194a; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Sistek D, 2001, EUR RESPIR J, V17, P214, DOI 10.1183/09031936.01.17202140; Soler ZM, 2011, LARYNGOSCOPE, V121, P2672, DOI 10.1002/lary.21847; Stephenson MF, 2010, J OTOLARYNGOL-HEAD N, V39, P182, DOI 10.2310/7070.2009.090060; Sudo N, 1997, J IMMUNOL, V159, P1739; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Talbot GH, 2001, CLIN INFECT DIS, V33, P1668, DOI 10.1086/323813; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vogan JC, 2000, OTOLARYNG HEAD NECK, V122, P370, DOI 10.1016/S0194-5998(00)70051-9; WAGENMANN M, 1992, J ALLERGY CLIN IMMUN, V90, P419, DOI 10.1016/0091-6749(92)90161-T; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; YOUSEM DM, 1991, J OTOLARYNGOL, V20, P419	56	118	122	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85507	10.1371/journal.pone.0085507	http://dx.doi.org/10.1371/journal.pone.0085507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386477	gold, Green Published, Green Submitted			2022-12-27	WOS:000329194700138
J	Tsai, LY; Chang, YW; Lin, PY; Chou, HJ; Liu, TJ; Lee, PT; Huang, WH; Tsou, YL; Huang, YS				Tsai, Li-Yun; Chang, Yu-Wei; Lin, Pei-Yi; Chou, Hsin-Jung; Liu, Ta-Jen; Lee, Ping-Tao; Huang, Wen-Hsuan; Tsou, Yueh-Liang; Huang, Yi-Shuian			CPEB4 Knockout Mice Exhibit Normal Hippocampus-Related Synaptic Plasticity and Memory	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; CELLULAR SENESCENCE; RNA TRANSLATION; MESSENGER-RNA; NEURONS; FORMS; CYCLE; GENE	Regulated RNA translation is critical to provide proteins needed to maintain persistent modification of synaptic strength, which underlies the molecular basis of long-term memory (LTM). Cytoplasmic polyadenylation element-binding proteins (CPEBs) are sequence-specific RNA-binding proteins and regulate translation in various tissues. All four CPEBs in vertebrates are expressed in the brain, including the hippocampal neurons, suggesting their potential roles in translation-dependent plasticity and memory. Although CPEB1 and CPEB3 have been shown to control specific kinds of hippocampus-related LTM, the role of CPEB2 and CPEB4 in learning and memory remains elusive. Thus, we generated CPEB4 knockout (KO) mice and analyzed them using several behavioral tests. No difference was found in the anxiety level, motor coordination, hippocampus-dependent learning and memory between the KO mice and their wild-type (WT) littermates. Electrophysiological recordings of multiple forms of synaptic plasticity in the Schaffer collateral pathway-CA1 neurons also showed normal responses in the KO hippocampal slices. Morphological analyses revealed that the CPEB4-lacking pyramidal neurons possessed slightly elongated dendritic spines. Unlike its related family members, CPEB1 and CPEB3, CPEB4 seems to be dispensable for hippocampus-dependent plasticity, learning and memory.	[Tsai, Li-Yun; Chang, Yu-Wei; Lin, Pei-Yi; Chou, Hsin-Jung; Liu, Ta-Jen; Lee, Ping-Tao; Huang, Wen-Hsuan; Tsou, Yueh-Liang; Huang, Yi-Shuian] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Yu-Wei; Huang, Yi-Shuian] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, Ta-Jen; Huang, Yi-Shuian] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University	Huang, YS (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	yishuian@ibms.sinica.edu.tw	Huang, Yi-Shuian/P-2824-2018	Huang, Yi-Shuian/0000-0001-9000-7748; Lin, Pei-Yi/0000-0001-7447-3212	National Science Council [NSC 102-2628-B-001-007-MY3]; Academia Sinica in Taiwan [AS-100-TP-B09]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council [NSC 102-2628-B-001-007-MY3] and Academia Sinica [AS-100-TP-B09] in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chao HW, 2013, J NEUROSCI, V 33, P17008, DOI 10.1523/JNEUROSCI.3043-13.2013; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; LeFur N, 1996, GENOMICS, V37, P245; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023	23	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84978	10.1371/journal.pone.0084978	http://dx.doi.org/10.1371/journal.pone.0084978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386439	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700124
J	Yatsuda, J; Irie, A; Harada, K; Michibata, Y; Tsukamoto, H; Senju, S; Tomita, Y; Yuno, A; Hirayama, M; Abu Sayem, M; Takeda, N; Shibuya, I; Sogo, S; Fujiki, F; Sugiyama, H; Eto, M; Nishimura, Y				Yatsuda, Junji; Irie, Atsushi; Harada, Kumiko; Michibata, Yayoi; Tsukamoto, Hirotake; Senju, Satoru; Tomita, Yusuke; Yuno, Akira; Hirayama, Masatoshi; Abu Sayem, Mohammad; Takeda, Naoki; Shibuya, Isao; Sogo, Shinji; Fujiki, Fumihiro; Sugiyama, Haruo; Eto, Masatoshi; Nishimura, Yasuharu			Establishment of HLA-DR4 Transgenic Mice for the Identification of CD4(+) T Cell Epitopes of Tumor-Associated Antigens	PLOS ONE			English	Article							DENDRITIC CELLS; MELANOMA; HELPER; VACCINATION; GENERATION; PEPTIDES; SURVIVAL; IMMUNITY; COMPLEX; MEMORY	Reports have shown that activation of tumor-specific CD4(+) helper T (Th) cells is crucial for effective anti-tumor immunity and identification of Th-cell epitopes is critical for peptide vaccine-based cancer immunotherapy. Although computer algorithms are available to predict peptides with high binding affinity to a specific HLA class II molecule, the ability of those peptides to induce Th-cell responses must be evaluated. We have established HLA-DR4 (HLA-DRA*01:01/HLA-DRB1*04:05) transgenic mice (Tgm), since this HLA-DR allele is most frequent (13.6%) in Japanese population, to evaluate HLA-DR4-restricted Th-cell responses to tumor-associated antigen (TAA)-derived peptides predicted to bind to HLA-DR4. To avoid weak binding between mouse CD4 and HLA-DR4, Tgm were designed to express chimeric HLA-DR4/I-E-d, where I-E-d alpha 1 and beta 1 domains were replaced with those from HLA-DR4. Th cells isolated from Tgm immunized with adjuvant and HLA-DR4-binding cytomegalovirus-derived peptide proliferated when stimulated with peptide-pulsed HLA-DR4-transduced mouse L cells, indicating chimeric HLA-DR4/I-E-d has equivalent antigen presenting capacity to HLA-DR4. Immunization with CDCA1(55-78) peptide, a computer algorithm-predicted HLA-DR4-binding peptide derived from TAA CDCA1, successfully induced Th-cell responses in Tgm, while immunization of HLA-DR4-binding Wilms' tumor 1 antigen-derived peptide with identical amino acid sequence to mouse ortholog failed. This was overcome by using peptide-pulsed syngeneic bone marrow-derived dendritic cells (BM-DC) followed by immunization with peptide/CFA booster. BM-DC-based immunization of KIF20A(494-517) peptide from another TAA KIF20A, with an almost identical HLA-binding core amino acid sequence to mouse ortholog, successfully induced Th-cell responses in Tgm. Notably, both CDCA1(55-78) and KIF20A(494-517) peptides induced human Th-cell responses in PBMCs from HLA-DR4-positive donors. Finally, an HLA-DR4 binding DEPDC1(191-213) peptide from a new TAA DEPDC1 overexpressed in bladder cancer induced strong Th-cell responses both in Tgm and in PBMCs from an HLA-DR4-positive donor. Thus, the HLA-DR4 Tgm combined with computer algorithm was useful for preliminary screening of candidate peptides for vaccination.	[Yatsuda, Junji; Irie, Atsushi; Harada, Kumiko; Michibata, Yayoi; Tsukamoto, Hirotake; Senju, Satoru; Tomita, Yusuke; Yuno, Akira; Hirayama, Masatoshi; Abu Sayem, Mohammad; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan; [Yatsuda, Junji; Eto, Masatoshi] Kumamoto Univ, Grad Sch Med Sci, Dept Urol, Kumamoto, Japan; [Abu Sayem, Mohammad] Mawlana Bhashani Sci & Technol Univ, Dept Biotechnol & Genet Engn, Tangail, Bangladesh; [Takeda, Naoki] Kumamoto Univ, Inst Resource Dev & Anal, Div Transgen Technol, Kumamoto, Japan; [Shibuya, Isao; Sogo, Shinji] Otsuka Pharmaceut Co Ltd, Microbiol Res Inst, Tokushima 77101, Japan; [Fujiki, Fumihiro] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Osaka, Japan; [Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan	Kumamoto University; Kumamoto University; Mawlana Bhashani Science & Technology University; Kumamoto University; Otsuka Pharmaceutical; Osaka University; Osaka University	Nishimura, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan.	mxnishim@gpo.kumamoto-u.ac.jp	Tsukamoto, Hirotake/GRJ-7436-2022; Tsukamoto, Hirotake/S-2448-2019	Tsukamoto, Hirotake/0000-0003-3214-1652; Sayem, Mohammad Abu/0000-0001-9903-6959	Ministry of Education, Culture, Sports, Science, and Technology, Japan [22133005, 24300334]; Otsuka Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [24700991, 23510243] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid Nos. 22133005 and 24300334 to YN from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.mext.go.jp/) and a collaborative research funding from Otsuka Pharmaceutical Co., Ltd. (http://www.otsuka.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Claerhout S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024662; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Fujiki F, 2007, J IMMUNOTHER, V30, P282, DOI 10.1097/01.cji.0000211337.91513.94; Giuntoli RL, 2002, CLIN CANCER RES, V8, P922; Gritzapis AD, 2010, CANCER RES, V70, P2686, DOI 10.1158/0008-5472.CAN-09-2517; Harada Y, 2010, CANCER RES, V70, P5829, DOI 10.1158/0008-5472.CAN-10-0255; Harao M, 2008, INT J CANCER, V123, P2616, DOI 10.1002/ijc.23823; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kanehira M, 2007, ONCOGENE, V26, P6448, DOI 10.1038/sj.onc.1210466; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Labeur MS, 1999, J IMMUNOL, V162, P168; Obara W, 2012, JPN J CLIN ONCOL, V42, P591, DOI 10.1093/jjco/hys069; Osawa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/848042; Osen W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014137; Patel SD, 1997, P NATL ACAD SCI USA, V94, P8082, DOI 10.1073/pnas.94.15.8082; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Slingluff CL, 2013, CLIN CANCER RES, V19, P4228, DOI 10.1158/1078-0432.CCR-13-0002; Sugita S, 2006, INVEST OPHTH VIS SCI, V47, P2547, DOI 10.1167/iovs.05-1547; Taniuchi K, 2005, CANCER RES, V65, P105; TOMITA Y, 2013, INT J CANC IN PRESS; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; WOODS A, 1994, J EXP MED, V180, P173, DOI 10.1084/jem.180.1.173; Woods K, 2013, CLIN CANCER RES, V19, P4021, DOI 10.1158/1078-0432.CCR-13-1349; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84908	10.1371/journal.pone.0084908	http://dx.doi.org/10.1371/journal.pone.0084908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386437	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700122
J	Grammes, F; Reveco, FE; Romarheim, OH; Landsverk, T; Mydland, LT; Overland, M				Grammes, Fabian; Reveco, Felipe Eduardo; Romarheim, Odd Helge; Landsverk, Thor; Mydland, Liv Torunn; Overland, Margareth			Candida utilis and Chlorella vulgaris Counteract Intestinal Inflammation in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; MEAL-INDUCED ENTERITIS; SOYBEAN-MEAL; DISTAL INTESTINE; ANTIMICROBIAL PEPTIDES; ULCERATIVE-COLITIS; CROHNS-DISEASE; PROTEIN; MAINTENANCE; ENTEROPATHY	Intestinal inflammation, caused by impaired intestinal homeostasis, is a serious condition in both animals and humans. The use of conventional extracted soybean meal (SBM) in diets for Atlantic salmon and several other fish species is known to induce enteropathy in the distal intestine, a condition often referred to as SBM induced enteropathy (SBMIE). In the present study, we investigated the potential of different microbial ingredients to alleviate SBMIE in Atlantic salmon, as a model of feed-induced inflammation. The dietary treatments consisted of a negative control based on fish meal (FM), a positive control based on 20% SBM, and four experimental diets combining 20% SBM with either one of the three yeasts Candida utilis (CU), Kluyveromyces marxianus (KM), Saccharomyces cerevisiae (SC) or the microalgae Chlorella vulgaris (CV). Histopathological examination of the distal intestine showed that all fish fed the SC or SBM diets developed characteristic signs of SBMIE, while those fed the FM, CV or CU diets showed a healthy intestine. Fish fed the KM diet showed intermediate signs of SBMIE. Corroborating results were obtained when measuring the relative length of PCNA positive cells in the crypts of the distal intestine. Gene set enrichment analysis revealed decreased expression of amino acid, fat and drug metabolism pathways as well as increased expression of the pathways for NOD-like receptor signalling and chemokine signalling in both the SC and SBM groups while CV and CU were similar to FM and KM was intermediate. Gene expression of antimicrobial peptides was reduced in the groups showing SBMIE. The characterisation of microbial communities using PCR-DGGE showed a relative increased abundance of Firmicutes bacteria in fish fed the SC or SBM diets. Overall, our results show that both CU and CV were highly effective to counteract SBMIE, while KM had less effect and SC had no functional effects.	[Grammes, Fabian; Reveco, Felipe Eduardo; Romarheim, Odd Helge; Mydland, Liv Torunn; Overland, Margareth] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, CoE, Aquaculture Prot Ctr, As, Norway; [Landsverk, Thor] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Overland, M (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, CoE, Aquaculture Prot Ctr, As, Norway.	margareth.overland@umb.no	Mydland, Liv Torunn/AAO-2783-2020	Grammes, Fabian/0000-0002-9551-9280	Research Council of Norway [417091]	Research Council of Norway(Research Council of Norway)	The research was financed by the Research Council of Norway (www.forskningsradet.no), grant no. 417091. The yeast was provided by Borregaard ASA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burrells C, 1999, VET IMMUNOL IMMUNOP, V72, P277, DOI 10.1016/S0165-2427(99)00143-9; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Escaffre AM, 2007, AQUACULTURE, V273, P127, DOI 10.1016/j.aquaculture.2007.09.028; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Janczyk P, 2007, ANIM FEED SCI TECH, V132, P163, DOI 10.1016/j.anifeedsci.2006.03.007; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Kleiveland CR, 2013, APPL ENVIRON MICROB, V79, P48, DOI 10.1128/AEM.02464-12; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kortner T. M., 2012, BR J NUTR, V30, P1; Kortner TM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-101; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; Manocha M, 2012, CLIN TRANSL GASTROEN, V3, pe13, DOI [10.1038/ctg.2012.8, DOI 10.1038/CTG.2012.8]; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Nordrum S, 2000, COMP BIOCHEM PHYS B, V125, P317, DOI 10.1016/S0305-0491(99)00190-X; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Overland M, 2009, AQUACULTURE, V288, P305, DOI 10.1016/j.aquaculture.2008.12.012; Overland M, 2013, AQUACULTURE, V402, P1, DOI 10.1016/j.aquaculture.2013.03.016; Overland M, 2010, ARCH ANIM NUTR, V64, P171, DOI 10.1080/17450391003691534; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Refstie S, 2006, AQUACULTURE, V261, P392, DOI 10.1016/j.aquaculture.2006.08.005; Romarheim O.H., 2012, BR J NUTR, P1, DOI [10.1017/S0007114512002899, DOI 10.1017/S0007114512002899]; Romarheim OH, 2013, AQUACULTURE, V402, P13, DOI 10.1016/j.aquaculture.2013.03.011; Romarheim OH, 2011, J NUTR, V141, P124, DOI 10.3945/jn.110.128900; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Samarakoon K, 2012, FOOD RES INT, V48, P948, DOI 10.1016/j.foodres.2012.03.013; Samiec PS, 2000, TOXICOL SCI, V54, P52, DOI 10.1093/toxsci/54.1.52; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sveinbjornsson B, 1996, J FISH DIS, V19, P349, DOI 10.1111/j.1365-2761.1996.tb00373.x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; vandenIngh TSGAM, 1996, J FISH DIS, V19, P47; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zar JH, 1996, BIOSTAT ANAL, P211	65	57	58	6	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83213	10.1371/journal.pone.0083213	http://dx.doi.org/10.1371/journal.pone.0083213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386162	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900025
J	Liu, WH; Chen, CH; Yeh, KH; Li, CL; Wu, YJ; Chen, DS; Chen, PJ; Yeh, SH				Liu, Wan-Hsin; Chen, Chao-Hung; Yeh, Kun-Huei; Li, Chiao-Ling; Wu, Yi-Jinn; Chen, Ding-Shinn; Chen, Pei-Jer; Yeh, Shiou-Hwei			ADAR2-Mediated Editing of miR-214 and miR-122 Precursor and Antisense RNA Transcripts in Liver Cancers	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ADAR DEAMINASES; EXPRESSION; MICRORNAS; MODULATION; CLEAVAGE; PROTEIN; CELLS; PCR	A growing list of microRNAs (miRNAs) show aberrant expression patterns in hepatocellular carcinoma (HCC), but the regulatory mechanisms largely remain unclear. RNA editing catalyzed by members of the adenosine deaminase acting on the RNA (ADAR) family could target the miRNA precursors and affect the biogenesis process. Therefore, we investigate whether RNA editing could be one mechanism contributing to the deregulation of specific miRNAs in HCC. By overexpression of individual ADARs in hepatoma cells, RNA editing on the precursors of 16 miRNAs frequently deregulated in HCC was screened by a sensitive high-resolution melting platform. The results identified RNA precursors of miR-214 and miR-122 as potential targets edited by ADAR2. A subset of HCC showing elevated ADAR2 verified the major editings identified in ARAR2 overexpressed hepatoma cells, either with A-to-I or U-to-C changes. The unusual U-to-C editing at specific residues was demonstrated as being attributed to the A-to-I editing on the RNA transcripts complementary to the pri-miRNAs. The editing event caused a decrease of the RNA transcript complementary to pri-miR-214, which led to the decrease of pri-miR-214 and miR-214 and resulted in the increased protein level of its novel target gene Rab15. In conclusion, the current study discovered ADAR2-mediated editing of the complementary antisense transcripts as a novel mechanism for regulating the biogenesis of specific miRNAs during hepatocarcinogenesis.	[Liu, Wan-Hsin; Chen, Chao-Hung; Li, Chiao-Ling; Wu, Yi-Jinn; Yeh, Shiou-Hwei] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Liu, Wan-Hsin; Yeh, Shiou-Hwei] Natl Taiwan Univ, Coll Med, Ctr Genom Med, Taipei 10764, Taiwan; [Yeh, Kun-Huei] Natl Taiwan Univ, Coll Med, Dept Oncol, Taipei 10764, Taiwan; [Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chen, Ding-Shinn; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, Shiou-Hwei] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Yeh, SH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	shyeh@ntu.edu.tw	Yeh, Kun-Huei/HGD-3316-2022; CHEN, DING-SHINN/T-4395-2019	YEH, Kun-Huei/0000-0002-7306-174X; Chen, Pei-Jer/0000-0001-8316-3785; CHEN, DING-SHINN/0000-0001-7791-6154; /0000-0003-4509-180X	National Research Program for Biopharmaceuticals, National Science Council, Taiwan [NSC102-2325-B-002-032-]; National Health Research Institutes, Taiwan [NHRI-EX100-9832BI]	National Research Program for Biopharmaceuticals, National Science Council, Taiwan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Research Program for Biopharmaceuticals, National Science Council, Taiwan (NSC102-2325-B-002-032-), and the National Health Research Institutes, Taiwan (NHRI-EX100-9832BI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Braconi C, 2011, SEMIN ONCOL, V38, P752, DOI 10.1053/j.seminoncol.2011.08.001; Chan T.H., 2013, GUT; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Ho ECH, 2010, METHODS MOL BIOL, V630, P125, DOI 10.1007/978-1-60761-629-0_9; Hsiao CC, 2012, ANTIVIR THER, V17, P291, DOI 10.3851/IMP2022; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Loebel DAF, 2005, GENOMICS, V85, P782, DOI 10.1016/j.ygeno.2005.02.001; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Nishimura N, 2011, ONCOL REP, V26, P145, DOI 10.3892/or.2011.1255; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Strick DJ, 2005, MOL BIOL CELL, V16, P5699, DOI 10.1091/mbc.E05-03-0204; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wulff BE, 2012, CURR TOP MICROBIOL, V353, P91, DOI 10.1007/82_2011_151; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875	29	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e81922	10.1371/journal.pone.0081922	http://dx.doi.org/10.1371/journal.pone.0081922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386085	gold, Green Submitted, Green Published			2022-12-27	WOS:000329117900006
J	White, JR; McCormick, MI; Meekan, MG				White, James R.; McCormick, Mark I.; Meekan, Mark G.			Syndromes or Flexibility: Behavior during a Life History Transition of a Coral Reef Fish	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PERSONALITY-TRAITS; GASTEROSTEUS-ACULEATUS; PUMPKINSEED SUNFISH; ANIMAL PERSONALITY; BOLDNESS; MORTALITY; ECOLOGY; SELECTION; SHYNESS	The theory of behavioral syndromes focuses on quantifying variation in behavior within and among individual organisms and attempts to account for the maintenance of differences in behavior that occur in a consistent manner among individuals. Behavioral syndromes have potentially important ecological consequences (e.g. survivorship tradeoffs) and can be shaped by population dynamics through selective mortality. Here, we search for any evidence for consistency of behavior across situations in juveniles of a common damselfish, Pomacentrus amboinensis (Pomacentridae) at the transition between larval habitats in the plankton and juvenile habitats on the reef. Naive fish leaving the pelagic phase to settle on reefs were caught by light traps and their behaviors observed using similar methods across three different situations (small aquaria, large aquaria, field setting); all of which represent low risk and well-sheltered environments. Seven behavioral traits were compared within and among individuals across situations to determine if consistent behavioral syndromes existed. No consistency was found in any single or combination of behavioral traits for individuals across all situations. We suggest that high behavioral flexibility is likely beneficial for newly-settled fish at this ontogenetic transition and it is possible that consistent behavioral syndromes are unlikely to emerge in juveniles until environmental experience is gained or certain combinations of behaviors are favored by selective mortality.	[White, James R.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Meekan, Mark G.] Univ Western Australia, Australian Inst Marine Sci, Crawley, WA, Australia	James Cook University; Australian Institute of Marine Science; University of Western Australia	White, JR (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	james.ryan.white@gmail.com	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645; White, James/0000-0001-7977-1956; Meekan, Mark/0000-0002-3067-9427	ARC Centre of Excellence for Coral Reef Studies	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	This work was supported by the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Ambrose R, 2006, ANIM BEHAV, V72, P1135, DOI [10.1016/j.anbehav.2006.04.001., DOI 10.1016/J.ANBEHAV.2006.04.001]; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Dugatkin LA, 2003, ETHOL ECOL EVOL, V15, P43; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Fuiman LA, 2010, OECOLOGIA, V164, P99, DOI 10.1007/s00442-010-1712-3; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Houston AI, 1999, MODELS ADAPTIVE BEHA; IBM Corp, 2016, IBM SPSS STAT WINDOW; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lonnstedt OM, 2012, P R SOC B, DOI [10.1098/rspb.2001.2516., DOI 10.1098/RSPB.2001.2516]; Marks C, 2005, COPEIA, P901, DOI 10.1643/0045-8511(2005)005[0901:DEACAI]2.0.CO;2; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; McCormick MI, 2002, MAR BIOL, V141, P841, DOI 10.1007/s00227-002-0883-9; Meekan MG, 2010, ANIM BEHAV, V79, P803, DOI 10.1016/j.anbehav.2009.12.002; Meekan MG, 2001, MAR BIOL, V139, P373; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; PITCHER CR, 1988, CORAL REEFS, V7, P105, DOI 10.1007/BF00300969; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; STAMPS JA, 1991, AM ZOOL, V31, P338; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; White JR, 2013, PLOS ONE, P8; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	52	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84262	10.1371/journal.pone.0084262	http://dx.doi.org/10.1371/journal.pone.0084262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386358	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900087
J	Liu, Q; Liu, SL; Zhao, HD; Deng, L; Wang, C; Zhao, QH; Dong, SK				Liu, Qi; Liu, Shiliang; Zhao, Haidi; Deng, Li; Wang, Cong; Zhao, Qinghe; Dong, Shikui			Longitudinal Variability of Phosphorus Fractions in Sediments of a Canyon Reservoir Due to Cascade Dam Construction: A Case Study in Lancang River, China	PLOS ONE			English	Article							MANWAN RESERVOIR; LAKE-SEDIMENTS; TRACE-ELEMENTS; DALIAO RIVER; HEAVY-METALS; HAIHE RIVER; GRAIN-SIZE; RELEASE; WATER; SORPTION	Dam construction causes the accumulation of phosphorus in the sediments of reservoirs and increases the release rate of internal phosphorus (P) loading. This study investigated the longitudinal variability of phosphorus fractions in sediments and the relationship between the contents of phosphorus fractions and its influencing factors of the Manwan Reservoir, Lancang River, Yunnan Province, China. Five sedimentary phosphorus fractions were quantified separately: loosely bound P (ex-P); reductant soluble P (BD-P); metal oxide-bound P (NaOH-P); calcium-bound P (HCl-P), and residual-P. The results showed that the total phosphorus contents ranged from 623 to 899 mu g/g and were correlated positively with iron content in the sediments of the reservoir. The rank order of P fractions in sediments of the mainstream was HCl-P. NaOHP. residual-P. BD-P. ex-P, while it was residual-P. HCl-P. NaOH-P. BD-P. ex-P in those of the tributaries. The contents of bio-available phosphorus in the tributaries, including ex-P, BD-P and NaOH-P, were significantly lower than those in the mainstream. The contents of ex-P, BD-P, NaOH-P showed a similar increasing trend from the tail to the head of the Manwan Reservoir, which contributed to the relatively higher content of bio-available phosphorus, and represents a high bio-available phosphorus releasing risk within a distance of 10 km from Manwan Dam. Correlation and redundancy analyses showed that distance to Manwan Dam and the silt/clay fraction of sediments were related closely to the spatial variation of bio-available phosphorus.	[Liu, Qi; Liu, Shiliang; Zhao, Haidi; Deng, Li; Wang, Cong; Zhao, Qinghe; Dong, Shikui] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China	Beijing Normal University	Liu, SL (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	shiliangliu@bnu.edu.cn	Liu, Shiliang/N-1885-2019		Non-profit Environment Protection Specific Project of China [201209029-4]; National Natural Sciences Foundation of China [50939001]	Non-profit Environment Protection Specific Project of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Non-profit Environment Protection Specific Project of China (No. 201209029-4) and the National Natural Sciences Foundation of China (No. 50939001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux-Loyer F, 2001, ESTUAR COAST SHELF S, V52, P617, DOI 10.1006/ecss.2001.0766; [Anonymous], [No title captured]; Birks H.J.B., 1995, STAT MODELING QUATER, P116, DOI DOI 10.1002/JQS.3390010111; BOSTROM B, 1988, HYDROBIOLOGIA, V170, P229, DOI 10.1007/BF00024907; Christophoridis C, 2006, J ENVIRON QUAL, V35, P1181, DOI 10.2134/jeq2005.0213; COOKE GD, 1977, HYDROBIOLOGIA, V56, P129, DOI 10.1007/BF00023351; DANENLOUWERSE H, 1993, HYDROBIOLOGIA, V253, P311, DOI 10.1007/BF00050751; de Vicente I, 2010, HYDROBIOLOGIA, V651, P253, DOI 10.1007/s10750-010-0304-x; Dittrich M, 2013, WATER RES, V47, P1433, DOI 10.1016/j.watres.2012.12.006; FARMER JG, 1994, AQUAT CONSERV, V4, P45, DOI 10.1002/aqc.3270040105; Fu KD, 2008, QUATERN INT, V186, P91, DOI 10.1016/j.quaint.2007.09.041; Fytianos K, 2005, ENVIRON MONIT ASSESS, V100, P191, DOI 10.1007/s10661-005-4770-y; GOLTERMAN HL, 1988, HYDROBIOLOGIA, V159, P149, DOI 10.1007/BF00014722; Gong GC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025800; Gonzalez CM, 1998, J ENVIRON MANAGE, V53, P73, DOI 10.1006/jema.1998.0194; Han L, 2011, SOIL SEDIMENT CONTAM, V20, P30, DOI 10.1080/15320383.2011.528469; [He Daming 何大明], 2004, [云南大学学报. 自然科学版, Journal of Yunnan University (Natural Science)], V26, P220; [何大明 He Daming], 2005, [地球科学进展, Advance in Earth Sciences], V20, P338; Heath SK, 2010, WATER RES, V44, P4226, DOI 10.1016/j.watres.2010.05.026; Hong YN, 2010, J HAZARD MATER, V181, P556, DOI 10.1016/j.jhazmat.2010.05.049; Huang KM, 2003, CHEMOSPHERE, V53, P1113, DOI 10.1016/S0045-6535(03)00592-7; Hupfer M, 1995, AQUAT SCI, V57, P305, DOI 10.1007/BF00878395; Jacobs JW, 2002, GEOGR J, V168, P354, DOI 10.1111/j.0016-7398.2002.00061.x; JACOBY JM, 1982, WATER RES, V16, P911, DOI 10.1016/0043-1354(82)90022-7; Jin XC, 2006, ENVIRON POLLUT, V139, P288, DOI 10.1016/j.envpol.2005.05.010; Kaiserli A, 2002, CHEMOSPHERE, V46, P1147, DOI 10.1016/S0045-6535(01)00242-9; Kim LH, 2003, CHEMOSPHERE, V50, P53, DOI 10.1016/S0045-6535(02)00310-7; Kopacek J, 2005, ENVIRON SCI TECHNOL, V39, P8784, DOI 10.1021/es050916b; Kozerski HP, 2007, INT REV HYDROBIOL, V83, P77; Lanza GR, 2011, EUTROPHICATION: CAUSES, CONSEQUENCES AND CONTROL, P373, DOI 10.1007/978-90-481-9625-8_19; Lin CY, 2009, J HAZARD MATER, V170, P278, DOI 10.1016/j.jhazmat.2009.04.102; Liu H., 1998, ADV WATER SCI, V9, P70; Liu SL, 2008, ECOL ENG, V34, P91, DOI 10.1016/j.ecoleng.2008.07.006; Luo XX, 2012, GEOMORPHOLOGY, V179, P126, DOI 10.1016/j.geomorph.2012.05.034; Maazouzi C, 2013, J SOIL SEDIMENT, V13, P207, DOI 10.1007/s11368-012-0622-x; MORSE JW, 1978, LIMNOL OCEANOGR, V23, P825, DOI 10.4319/lo.1978.23.4.0825; Onema JMK, 2006, PHYS CHEM EARTH, V31, P870, DOI 10.1016/j.pce.2006.08.022; Ouyang W, 2011, WATER RESOUR MANAG, V25, P913, DOI 10.1007/s11269-010-9733-6; Pan K, 2012, SCI TOTAL ENVIRON, V421, P3, DOI 10.1016/j.scitotenv.2011.03.013; Pettersson K, 2001, SCI TOTAL ENVIRON, V266, P79, DOI 10.1016/S0048-9697(00)00737-3; Psenner R., 1988, ADV LIMNOLOGY, V30, P43; Psenner R, 1984, ARCH HYDROBIOL, V1; Ramm K, 1997, HYDROBIOLOGIA, V342, P43, DOI 10.1023/A:1017092618517; Ribeiro DC, 2008, CHEMOSPHERE, V70, P1256, DOI 10.1016/j.chemosphere.2007.07.064; Rubio B, 2000, MAR POLLUT BULL, V40, P968, DOI 10.1016/S0025-326X(00)00039-4; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; SanClements MD, 2009, FOREST ECOL MANAG, V258, P2318, DOI 10.1016/j.foreco.2009.03.016; Spears BM, 2006, WATER RES, V40, P383, DOI 10.1016/j.watres.2005.11.013; STONE M, 1993, HYDROBIOLOGIA, V253, P17, DOI 10.1007/BF00050719; Sun SJ, 2009, J ENVIRON SCI-CHINA, V21, P291, DOI 10.1016/S1001-0742(08)62266-4; Topping DJ, 2000, WATER RESOUR RES, V36, P515, DOI 10.1029/1999WR900285; van Dobben HF, 2001, ENVIRON POLLUT, V112, P163, DOI 10.1016/S0269-7491(00)00121-4; Vollenweider R. A., 1982, EUTROPHICATION WATER; Wang C, 2012, ECOTOX ENVIRON SAFE, V82, P32, DOI 10.1016/j.ecoenv.2012.05.006; Wang P, 2009, ESTUAR COAST SHELF S, V84, P246, DOI 10.1016/j.ecss.2009.06.020; Wang SR, 2006, COLLOID SURFACE A, V273, P109, DOI 10.1016/j.colsurfa.2005.08.015; Warner RF, 2012, J ENVIRON MANAGE, V104, P35, DOI 10.1016/j.jenvman.2012.03.011; Wei GL, 2009, WATER RESOUR MANAG, V23, P1763, DOI 10.1007/s11269-008-9351-8; Williams GP., 1984, DOWNSTREAM EFFECTS D; Xiang SL, 2011, INT J SEDIMENT RES, V26, P230, DOI 10.1016/S1001-6279(11)60089-9; Zhang B, 2012, ECOL ENG, V40, P153, DOI 10.1016/j.ecoleng.2011.12.024; Zhang CS, 2002, APPL GEOCHEM, V17, P59, DOI 10.1016/S0883-2927(01)00079-8; Zhang ZJ, 2012, HYDROL PROCESS, V26, P15, DOI 10.1002/hyp.8105; Zhao Q, 2012, ENVIRON MONIT ASSESS, P1; Zhao QH, 2012, ENVIRON MONIT ASSESS, V184, P4253, DOI 10.1007/s10661-011-2260-y; Zhao QH, 2012, INT J APPL EARTH OBS, V16, P17, DOI 10.1016/j.jag.2011.11.009; Zhou AM, 2005, J ENVIRON SCI-CHINA, V17, P384; Zhou QX, 2001, CHEMOSPHERE, V42, P221, DOI 10.1016/S0045-6535(00)00129-6	68	12	16	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83329	10.1371/journal.pone.0083329	http://dx.doi.org/10.1371/journal.pone.0083329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386180	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700042
J	Pollmann, MMH; van Beest, I				Pollmann, Monique M. H.; van Beest, Ilja			Women Are Better at Selecting Gifts than Men	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; FUNCTIONING AUTISM; CHRISTMAS GIFT; EMPATHY; PERSPECTIVE; COMPETENCE; STRATEGIES; EXCHANGE; BENEFITS; LOVE	There is a widespread belief that women are better at selecting gifts than men; however, this claim has not been assessed on the basis of objective criteria. The current studies do exactly that and show that women do indeed make better gift selections for others, regardless of the gender of the receiver and the type of relationship between the giver and receiver. We investigate the mediating role of different aspects of interpersonal sensitivity and reveal that differences in interpersonal interest (measured with an autism questionnaire), but not differences in interpersonal reactivity, explain gender differences in gift selection quality. The current studies thus present the first objective evidence for the claim that women are better in selecting gifts for others and also give an indication of why this is the case.	[Pollmann, Monique M. H.] Tilburg Univ, Dept Commun & Informat Sci, NL-5000 LE Tilburg, Netherlands; [van Beest, Ilja] Tilburg Univ, Dept Social Psychol, NL-5000 LE Tilburg, Netherlands	Tilburg University; Tilburg University	Pollmann, MMH (corresponding author), Tilburg Univ, Dept Commun & Informat Sci, NL-5000 LE Tilburg, Netherlands.	m.m.h.pollmann@uvt.nl	van Beest, Ilja/M-3708-2019; Pollmann, Monique Maria Henriette/C-6508-2011	van Beest, Ilja/0000-0003-2855-3638; Pollmann, Monique Maria Henriette/0000-0003-3918-0646	Tilburg Institute for Behavioral Economics research (TIBER)	Tilburg Institute for Behavioral Economics research (TIBER)	This research was funded by the Tilburg Institute for Behavioral Economics research (TIBER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DR, 2004, J NONVERBAL BEHAV, V28, P187, DOI 10.1023/B:JONB.0000039649.20015.0e; Association of Universities, 2005, GEDR GEBR PERS WET O; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; BELK RW, 1976, J CONSUM RES, V3, P155, DOI 10.1086/208662; Camerer C, 1988, AM J SOCIOL, V94, P180; CAPLOW T, 1982, AM SOCIOL REV, V47, P383, DOI 10.2307/2094994; CHEAL D, 1987, SOCIOL REV, V35, P150, DOI 10.1111/j.1467-954X.1987.tb00007.x; Ciarrochi J, 2005, COGNITION EMOTION, V19, P133, DOI 10.1080/02699930441000102; Davis M. H, 1980, MULTIDIMENSIONAL APP; Davis M.H, 1983, J PERS SOC PSYCHOL, V44, P14; Dunn EW, 2008, SOC COGNITION, V26, P469, DOI 10.1521/soco.2008.26.4.469; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; FISCHER E, 1990, J CONSUM RES, V17, P333, DOI 10.1086/208561; Flynn FJ, 2009, J EXP SOC PSYCHOL, V45, P404, DOI 10.1016/j.jesp.2008.11.003; General Board of the Association of Universities, 2004, NETH COD COND SCI PR; Gino F, 2011, J EXP SOC PSYCHOL, V47, P915, DOI 10.1016/j.jesp.2011.03.015; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Hoekstra RA, 2011, J AUTISM DEV DISORD, V41, P589, DOI 10.1007/s10803-010-1073-0; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Laroche M, 2000, J CONSUM MARK, V17, P500, DOI 10.1108/07363760010349920; Lerouge D, 2006, J CONSUM RES, V33, P393, DOI 10.1086/508523; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Pollmann MMH, 2009, PERS SOC PSYCHOL B, V35, P1512, DOI 10.1177/0146167209342754; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Ruffle BJ, 1999, J ECON BEHAV ORGAN, V39, P399, DOI 10.1016/S0167-2681(99)00048-7; Ruth JA, 1999, J CONSUM RES, V25, P385, DOI 10.1086/209546; SHERRY JF, 1983, J CONSUM RES, V10, P157, DOI 10.1086/208956; Steffel M, 2011, SOCIAL COMP DECISION; Waldfogel J, 2002, ECON INQ, V40, P415, DOI 10.1093/ei/40.3.415; Wing L., 1988, DIAGNOSIS ASSESSMENT, P91, DOI 10.1007/978-1-4899-0792-9_7; Zhang Y, 2009, J PERS SOC PSYCHOL, V97, P796, DOI 10.1037/a0016233	35	3	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e81643	10.1371/journal.pone.0081643	http://dx.doi.org/10.1371/journal.pone.0081643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386082	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700002
J	Shu, J; Xing, LL; Ding, GL; Luo, Q; Liu, XM; Yan, QF; Sheng, JZ; Huang, HF				Shu, Jing; Xing, Lili; Ding, Guolian; Luo, Qiong; Liu, Xinmei; Yan, Qingfeng; Sheng, Jianzhong; Huang, Hefeng			The Effect of Peritoneal Fluid from Patients with Endometriosis on Mitochondrial Function and Development of Early Mouse Embryos	PLOS ONE			English	Article							NITRIC-OXIDE; INFERTILE WOMEN; OOCYTES; FERTILIZATION; OVULATION	Background: Peritoneal fluid (PF) from patients with endometriosis can inhibit early embryo development via probable functional changes of embryo mitochondria in the early stage of embryo development. The purpose of this study was to determine the effect of PF from patients with endometriosis on mitochondrial function and development of early mouse embryos. Methodology/Principal Findings: PF was collected from patients with infertility and endometriosis, infertility due to tubal factors, and normal control subjects, and the level of NO was measured. Early murine embryos were then cultured with PF from normal control subjects, those with endometriosis, and with human tubal fluid (HTF), respectively. Cleavage and blastulation rates, mitochondrial DNA (mtDNA) copy numbers, adenosine triphosphate (ATP) level, and mitochondrial membrane potential (Delta Psi m) of the different groups were compared. The NO level in the PF of patients with endometriosis was significantly greater than in those without endometriosis and control patients. The embryos cultures with PF from patients with endometriosis had a lower cleavage rate and blastulation rate, and higher ATP and Delta Psi m level at the 2- and 4-cell stages. No significant difference was found in mtDNA copies among the 3 groups. Conclusions/Significance: PF from patients with endometriosis can inhibit early embryo development via probable functional changes of embryo mitochondria in the early stage of embryo development. Understanding the effects of PF on embryo development may assist in developing new methods of treatment for infertility.	[Shu, Jing; Xing, Lili] Zhejiang Prov Peoples Hosp, Dept Reprod Endocrinol, Hangzhou, Zhejiang, Peoples R China; [Ding, Guolian; Luo, Qiong; Liu, Xinmei; Huang, Hefeng] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Sheng, Jianzhong] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang University; Zhejiang University; Zhejiang University	Huang, HF (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	huanghefg@hotmail.com	Huang, He-Feng/AAN-7985-2020; yan, qing/GZN-2287-2022; Ding, Guolian/GXG-7578-2022; Huang, Hefeng/ABF-1117-2020; Huang, Hefeng/AAR-7184-2021	Huang, He-Feng/0000-0003-4344-8019; Ding, Guolian/0000-0002-0099-9980; 	Natural Science Foundation of China [81200251]; Medicine and Health Care Projects of Zhejiang Province [2011KYA085]; Natural Science Foundation of Zhejiang Province [LY12H04008]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medicine and Health Care Projects of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by the Natural Science Foundation of China (81200251), Medicine and Health Care Projects of Zhejiang Province (2011KYA085) and Natural Science Foundation of Zhejiang Province (LY12H04008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045; Blashkiv TV, 2001, B EXP BIOL MED+, V132, P1034; Butt FS, 2007, QUAL HEALTH RES, V17, P571, DOI 10.1177/1049732307299907; Cho S, 2012, DNA CELL BIOL, V31, P316, DOI 10.1089/dna.2011.1279; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Ding GL, 2010, FERTIL STERIL, V93, P2538, DOI 10.1016/j.fertnstert.2009.11.011; Dong MY, 2001, J REPROD MED, V46, P887; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Esfandiari N, 2005, REPROD BIOMED ONLINE, V11, P615, DOI 10.1016/S1472-6483(10)61170-4; Gomez-Torres MJ, 2002, HUM REPROD, V17, P777, DOI 10.1093/humrep/17.3.777; Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093; Guzick DS, 1997, FERTIL STERIL, V67, P822, DOI 10.1016/S0015-0282(97)81392-1; Hefler LA, 2002, FERTIL STERIL, V77, P147, DOI 10.1016/S0015-0282(01)02952-1; Ho HN, 1997, HUM REPROD, V12, P2810, DOI 10.1093/humrep/12.12.2810; Kalu E, 2007, J OBSTET GYNAECOL RE, V33, P490, DOI 10.1111/j.1447-0756.2007.00569.x; Khamsi F, 2001, J ASSIST REPROD GEN, V18, P106, DOI 10.1023/A:1026586709554; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Luo QO, 2010, CELL PHYSIOL BIOCHEM, V26, P1023, DOI 10.1159/000323977; Luo Qiong, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P424; Mansour G, 2010, FERTIL STERIL, V94, P1894, DOI 10.1016/j.fertnstert.2009.09.043; Mansour G, 2009, FERTIL STERIL, V92, P61, DOI 10.1016/j.fertnstert.2008.05.048; Missmer SA, 2003, OBSTET GYN CLIN N AM, V30, P3; MORCOS RN, 1985, FERTIL STERIL, V44, P678; OOSTERLYNCK DJ, 1993, OBSTET GYNECOL, V82, P206; Ozkan S, 2008, ANN NY ACAD SCI, V1127, P92, DOI 10.1196/annals.1434.007; Polak G, 2013, EUR J OBSTET GYN R B, V168, P187, DOI 10.1016/j.ejogrb.2012.12.043; Practice Committee of the American Society for Reproductive Medicine, 2004, Fertil Steril, V82 Suppl 1, pS40; Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Trimarchi JR, 2000, BIOL REPROD, V62, P1866, DOI 10.1095/biolreprod62.6.1866; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wu MY, 2003, HUM REPROD, V18, P2668, DOI 10.1093/humrep/deg484	32	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82334	10.1371/journal.pone.0082334	http://dx.doi.org/10.1371/journal.pone.0082334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386092	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700009
J	Song, SJ; Zhou, L; Si, SY; Liu, JL; Zhou, JL; Feng, K; Wu, J; Zhang, WY				Song, Shu Jun; Zhou, Ling; Si, Shaoyan; Liu, Junli; Zhou, Jinlian; Feng, Kai; Wu, Jie; Zhang, Wenying			The High Prevalence of Vitamin D Deficiency and Its Related Maternal Factors in Pregnant Women in Beijing	PLOS ONE			English	Article							D SUPPLEMENTATION; POSTMENOPAUSAL WOMEN; CUTANEOUS SYNTHESIS; HEALTH; EXPOSURE; SUNLIGHT; INFANTS; IMPACT; POLLUTION; CHILDREN	Maternal vitamin D deficiency has been suggested to influence fetal and neonatal health. Little is known about vitamin D status in Chinese pregnant women. The purpose of this study was to assess the vitamin D status of pregnant women residing in Beijing in winter and evaluate the impact of maternal factors on serum 25-hydroxyvitamin D [25(OH)D] levels. The study was conducted on 125 healthy pregnant women. For each individual, data concerning pre-pregnancy weight, educational status, use of multivitamins and behavioral factors such as daily duration of computer use, walking and sun exposure were obtained. Serum concentrations of 25(OH)D were measured by enzyme-linked immunosorbent assay. The prevalence of vitamin D deficiency (25(OH)D < 50 nmol/L) was 96.8% and almost half (44.8%) of women were severely vitamin D deficiency (25(OH)D < 25 nmol/L). The concentration of 25(OH) D was lower in women with shorter duration of sun exposure (<= 0.5 h/day, 25.3 +/- 8.9 nmol/L) than that in women with longer duration of sun exposure (> 0.5 h/day; 30.3 +/- 9.5 nmol/L; P = 0.003). Thirty six women (28.8%) had sun exposure duration >= 1.5h/day. The 25(OH)D concentration in these women was 31.5 +/- 9.4 nmol/L which was also much lower than the normal level. Women who reported taking a multivitamin supplement had significantly higher 25(OH)D concentrations (32.3 +/- 9.5 nmol/L) when compared with non-users (24.9 +/- 8.2 nmol/L; P < 0.001). Pregnant women in Beijing are at very high risk of vitamin D deficiency in winter. Duration of Sun exposure and the use of multivitamin were the most important determinants for vitamin D status. However, neither prolonging the time of sunlight exposure nor multivitamin supplements can effectively prevent pregnant women from vitamin D deficiency. Other measures might have to be taken for pregnant women to improve their vitamin D status in winter.	[Song, Shu Jun; Si, Shaoyan; Liu, Junli; Zhou, Jinlian; Feng, Kai] PLA, Hosp 306, Dept Pathol & Expt Med, Beijing, Peoples R China; [Zhou, Ling; Zhang, Wenying] PLA, Hosp 306, Dept Obstet & Gynecol, Beijing, Peoples R China; [Wu, Jie] PLA, Hosp 306, Dept Outpatient, Beijing, Peoples R China		Zhang, WY (corresponding author), PLA, Hosp 306, Dept Obstet & Gynecol, Beijing, Peoples R China.	zh1365440@163.com			The Medical Research Grant of 306 Hospital of PLA	The Medical Research Grant of 306 Hospital of PLA	This work was supported by "The Medical Research Grant of 306 Hospital of PLA". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Aly YF, 2013, PEDIATRIC REP, V5, P24, DOI 10.4081/pr.2013.e6; Arantes HP, 2013, OSTEOPOROSIS INT, V24, P2707, DOI 10.1007/s00198-013-2366-x; ARONSSON CA, 2013, PUBLIC HEALTH NUTR, V16, P1390, DOI DOI 10.1017/S1368980013000293.PUBMED:23452986; Barnard WF, 2003, J AIR WASTE MANAGE, V53, P237, DOI 10.1080/10473289.2003.10466134; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Bodnar LM, 2007, J NUTR, V137, P2437, DOI 10.1093/jn/137.11.2437; Borradale D, 2009, NUTR RES REV, V22, P118, DOI 10.1017/S0954422409990102; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Food and Nutrition Board IOM, 1997, DIET REF INT CALC MA; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Hatun S, 2005, J NUTR, V135, P279, DOI 10.1093/jn/135.2.279; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; HOLLIS BW, 1984, J CLIN ENDOCR METAB, V59, P652, DOI 10.1210/jcem-59-4-652; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Kung AWC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-226; Looker AC, 2005, J CLIN ENDOCR METAB, V90, P635, DOI 10.1210/jc.2004-1765; Madar AA, 2009, BRIT J NUTR, V101, P1052, DOI 10.1017/S0007114508055712; MALLET E, 1986, OBSTET GYNECOL, V68, P300, DOI 10.1097/00006250-198609000-00002; Manicourt DH, 2008, J CLIN ENDOCR METAB, V93, P3893, DOI 10.1210/jc.2007-2663; MATSUOKA LY, 1990, J AM ACAD DERMATOL, V22, P772, DOI 10.1016/0190-9622(90)70107-S; MATSUOKA LY, 1989, J LAB CLIN MED, V114, P301; Mulligan ML, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.002; NHS, 2013, VIT MIN VIT D WHAT D; Nicolaidou P, 2006, CALCIFIED TISSUE INT, V78, P337, DOI 10.1007/s00223-006-0007-5; Paxton GA, 2013, MED J AUSTRALIA, V198, P142, DOI 10.5694/mja11.11592; Pope SJ, 2008, PHOTOCHEM PHOTOBIOL, V84, P1277, DOI 10.1111/j.1751-1097.2008.00373.x; Sahu M, 2009, CLIN ENDOCRINOL, V70, P680, DOI 10.1111/j.1365-2265.2008.03360.x; Salek M, 2008, EXP CLIN ENDOCR DIAB, V116, P352, DOI 10.1055/s-2008-1042403; Samanek AJ, 2006, MED J AUSTRALIA, V184, P338, DOI 10.5694/j.1326-5377.2006.tb00267.x; Song SJ, 2013, PUBLIC HEALTH NUTR, V16, P687, DOI 10.1017/S1368980012003084; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; van Oort RVA, 2004, PREV MED, V39, P1126, DOI 10.1016/j.ypmed.2004.04.025; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wagner CL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.888; Wang J, 2010, WORLD J PEDIATR, V6, P265, DOI 10.1007/s12519-010-0224-x; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wicherts IS, 2011, OSTEOPOROSIS INT, V22, P873, DOI 10.1007/s00198-010-1343-x; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x	47	37	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85081	10.1371/journal.pone.0085081	http://dx.doi.org/10.1371/journal.pone.0085081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386450	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700131
J	Tavares, AF; Parente, MR; Justino, MC; Oleastro, M; Nobre, LS; Saraiva, LM				Tavares, Ana F.; Parente, Margarida R.; Justino, Marta C.; Oleastro, Monica; Nobre, Ligia S.; Saraiva, Ligia M.			The Bactericidal Activity of Carbon Monoxide-Releasing Molecules against Helicobacter pylori	PLOS ONE			English	Article							ANTIMICROBIAL ACTION; UREASE INHIBITOR; RU(CO)(3)CL(GLYCINATE); SUSCEPTIBILITY; RESPIRATION; MECHANISMS; VIRULENCE; THERAPY	Helicobacter pylori is a pathogen that establishes long life infections responsible for chronic gastric ulcer diseases and a proved risk factor for gastric carcinoma. The therapeutic properties of carbon-monoxide releasing molecules (CORMs) led us to investigate their effect on H. pylori. We show that H. pylori 26695 is susceptible to two widely used CORMs, namely CORM-2 and CORM-3. Also, several H. pylori clinical isolates were killed by CORM-2, including those resistant to metronidazole. Moreover, sub-lethal doses of CORM-2 combined with metronidazole, amoxicillin and clarithromycin was found to potentiate the effect of the antibiotics. We further demonstrate that the mechanisms underpinning the antimicrobial effect of CORMs involve the inhibition of H. pylori respiration and urease activity. In vivo studies done in key cells of the innate immune system, such as macrophages, showed that CORM-2, either alone or when combined with metronidazole, strongly reduces the ability of H. pylori to infect animal cells. Hence, CORMs have the potential to kill antibiotic resistant strains of H. pylori.	[Tavares, Ana F.; Parente, Margarida R.; Justino, Marta C.; Nobre, Ligia S.; Saraiva, Ligia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Dept Biol Chem, Oeiras, Portugal; [Oleastro, Monica] Inst Nacl Saude Dr Ricardo Jorge, Dept Infect Dis, Lisbon, Portugal	Universidade Nova de Lisboa; Instituto Nacional de Saude Dr. Ricardo Jorge	Saraiva, LM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Dept Biol Chem, Oeiras, Portugal.	lst@itqb.unl.pt	Saraiva, Ligia M/H-8537-2012	Saraiva, Ligia M/0000-0002-0675-129X; Justino, Marta/0000-0002-9310-9456; Nobre, Ligia/0000-0002-3060-2593; Oleastro, Monica/0000-0001-6360-2576				Albertson N, 1998, J CLIN MICROBIOL, V36, P1232, DOI 10.1128/JCM.36.5.1232-1235.1998; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Graham David Y., 2000, Journal of Gastroenterology, V35, P90; Gu Q, 2004, ALIMENT PHARM THER, V20, P675, DOI 10.1111/j.1365-2036.2004.02168.x; Johnson TR, 2007, DALTON T, P1500, DOI 10.1039/b613629j; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Mann BE, 2010, TOP ORGANOMETAL CHEM, V32, P247, DOI 10.1007/978-3-642-13185-1_10; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Murray TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035499; Nagata K, 1996, MICROBIOL-UK, V142, P1757, DOI 10.1099/13500872-142-7-1757; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Pena AC, 2012, ANTIMICROB AGENTS CH, V56, P1281, DOI 10.1128/AAC.05571-11; PHILLIPS K, 1993, J CLIN PATHOL, V46, P372, DOI 10.1136/jcp.46.4.372; Pope AJ, 1998, DIGEST DIS SCI, V43, P109, DOI 10.1023/A:1018884322973; Rimbara E, 2011, NAT REV GASTRO HEPAT, V8, P79, DOI 10.1038/nrgastro.2010.210; Rodrigues SS, 2008, ALFAMA INVESTIGACAO; Romao CC, 2012, CHEM SOC REV, V41, P3571, DOI 10.1039/c2cs15317c; She FF, 2001, WORLD J GASTROENTERO, V7, P254; Sheikh SZ, 2011, J IMMUNOL, V186, P5506, DOI 10.4049/jimmunol.1002433; Smith H, 2011, IUBMB LIFE, V63, P363, DOI 10.1002/iub.476; Stingl K, 2005, INT J MED MICROBIOL, V295, P307, DOI 10.1016/j.ijmm.2005.06.006; Tavares AFN, 2011, J BIOL CHEM, V286, P26708, DOI 10.1074/jbc.M111.255752; Wegiel B, 2013, TRENDS MOL MED, V19, P3, DOI 10.1016/j.molmed.2012.10.001; Zacharia VM, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-30; Zanotti G, 2010, IUBMB LIFE, V62, P715, DOI 10.1002/iub.382	35	27	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83157	10.1371/journal.pone.0083157	http://dx.doi.org/10.1371/journal.pone.0083157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386154	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700032
J	Tseng, WY; Hsu, SH; Huang, CH; Tu, YC; Tseng, SC; Chen, HL; Chen, MH; Su, WF; Lin, LD				Tseng, Wan-Yu; Hsu, Sheng-Hao; Huang, Chieh-Hsiun; Tu, Yu-Chieh; Tseng, Shao-Chin; Chen, Hsuen-Li; Chen, Min-Huey; Su, Wei-Fang; Lin, Li-Deh			Low Pressure Radio-Frequency Oxygen Plasma Induced Oxidation of Titanium - Surface Characteristics and Biological Effects	PLOS ONE			English	Article							OXIDE; ROUGHNESS; WETTABILITY; TOPOGRAPHY; IMMERSION; TIO2	Objective: This research was designed to investigate the effects of low pressure radio-frequency (RF) oxygen plasma treatment (OPT) on the surface of commercially pure titanium (CP-Ti) and Ti6Al4V. Surface topography, elemental composition, water contact angle, cell viability, and cell morphology were surveyed to evaluate the biocompatibility of titanium samples with different lengths of OP treating time. Materials and Methods: CP-Ti and Ti6Al4V discs were both classified into 4 groups: untreated, treated with OP generated by using oxygen (99.98%) for 5, 10, and 30 min, respectively. After OPT on CP-Ti and Ti6Al4V samples, scanning probe microscopy, X-ray photoelectron spectrometry (XPS), and contact angle tests were conducted to determine the surface topography, elemental composition and hydrophilicity, respectively. The change of surface morphology was further studied using sputtered titanium on silicon wafers. 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay and F-actin immunofluorescence stain were performed to investigate the viability and spreading behavior of cultivated MG-63 cells on the samples. Results: The surface roughness was most prominent after 5 min OPT in both CP-Ti and Ti6Al4V, and the surface morphology of sputtered Ti sharpened after the 5 min treatment. From the XPS results, the intensity of Ti degrees, Ti2+, and Ti3+ of the samples' surface decreased indicating the oxidation of titanium after OPT. The water contact angles of both CP-Ti and Ti6Al4V were increased after 5 min OPT. The results of MTT assay demonstrated MG-63 cells proliferated best on the 5 min OP treated titanium sample. The F-actin immunofluorescence stain revealed the cultivated cell number of 5 min treated CP-Ti/Ti6Al4V was greater than other groups and most of the cultivated cells were spindle-shaped. Conclusions: Low pressure RF oxygen plasma modified both the composition and the morphology of titanium samples' surface. The CP-Ti/Ti6Al4V treated with 5 min OPT displayed the roughest surface, sharpest surface profile and best biocompatibility.	[Tseng, Wan-Yu; Huang, Chieh-Hsiun; Chen, Min-Huey; Lin, Li-Deh] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan; [Tseng, Wan-Yu; Chen, Min-Huey; Lin, Li-Deh] Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan; [Hsu, Sheng-Hao; Su, Wei-Fang] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Tu, Yu-Chieh; Tseng, Shao-Chin; Chen, Hsuen-Li; Su, Wei-Fang] Natl Taiwan Univ, Dept Mat Sci & Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Lin, LD (corresponding author), Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.	lidehlin@ntu.edu.tw	su, wei/GZM-3986-2022; Su, Wei-Fang/C-2646-2009; Su, Wei-Fang/AHB-8796-2022; Tseng, Wan-Yu/V-4444-2019	Su, Wei-Fang/0000-0002-3375-4664; TSENG, WAN-YU/0000-0002-9012-3703; CHEN, MIN-HUEY/0000-0002-4853-1906; LIN, LI-DEH/0000-0002-6050-7394	NSC (National Science Council, Taiwan); National Taiwan University Hospital [NSC-100-2314-B-002-154-, NTUH.100-N1753]	NSC (National Science Council, Taiwan)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the NSC (National Science Council, Taiwan) and the National Taiwan University Hospital (NSC-100-2314-B-002-154- and NTUH.100-N1753). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell R, 1985, Swed Dent J Suppl, V28, P175; Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Boyan B. D., 2003, European Cells & Materials, V6, P22; Brandt ES, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.3666026; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8; Cho YH, 2010, MICROFLUID NANOFLUID, V9, P163, DOI 10.1007/s10404-009-0509-3; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264; Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x; Fridman A, 2004, PLASMA PHYS ENG; Gentsch R, 2011, MACROMOLECULES, V44, P453, DOI 10.1021/ma102847a; Giljean S, 2012, SCANNING, P1; Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x; Hara Toshihiro, 2012, Bull Tokyo Dent Coll, V53, P45; Harmankaya N, 2013, ACTA BIOMATER, V9, P7064, DOI 10.1016/j.actbio.2013.02.040; Hsu SH, 2013, ACS APPL MATER INTER, V5, P2991, DOI 10.1021/am302446t; Kawasaki A, 2012, J DENT SCI, V7, P94, DOI 10.1016/j.jds.2012.03.002; Langmuir I, 1928, P NATL ACAD SCI USA, V14, P627, DOI 10.1073/pnas.14.8.627; Mandl S, 2002, BIOMOL ENG, V19, P129, DOI 10.1016/S1389-0344(02)00025-4; Marino CEB, 2004, THIN SOLID FILMS, V468, P109, DOI 10.1016/j.tsf.2004.05.006; Martin IT, 2007, PLASMA PROCESS POLYM, V4, P414, DOI 10.1002/ppap.200600197; Meffert R M, 1987, Int J Periodontics Restorative Dent, V7, P9; Mejia MI, 2009, APPL CATAL B-ENVIRON, V91, P481, DOI 10.1016/j.apcatb.2009.06.017; Nakamura T, 2009, APPL SURF SCI, V256, P1096, DOI 10.1016/j.apsusc.2009.05.121; Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X; Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3; RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702; Rotenberg S, 2006, DENT MATER, V22, P759, DOI 10.1016/j.dental.2005.11.003; Rupf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025893; Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509; Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y; SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902; Sugita Y, 2011, BIOMATERIALS, V32, P8374, DOI 10.1016/j.biomaterials.2011.07.077; Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4; Uzumaki ET, 2006, KEY ENG MATER, V309-311, P367, DOI 10.4028/www.scientific.net/KEM.309-311.367; Vesel A, 2006, PLASMA CHEM PLASMA P, V26, P577, DOI 10.1007/s11090-006-9025-3; Wataha JC, 2003, DENT MATER, V19, P25, DOI 10.1016/S0109-5641(02)00012-X; Yang CH, 2011, CLIN ORAL IMPLAN RES, V22, P1426, DOI 10.1111/j.1600-0501.2010.02132.x; Youngblood T, 2003, Implant Dent, V12, P54; Zuo J, 2013, J BIOMED MATER RES A, V101, P3278, DOI 10.1002/jbm.a.34612	42	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84898	10.1371/journal.pone.0084898	http://dx.doi.org/10.1371/journal.pone.0084898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386433	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700125
J	Das, M; Banerjee, B; Choudhury, MG; Saha, N				Das, Manas; Banerjee, Bodhisattwa; Choudhury, Mahua G.; Saha, Nirmalendu			Environmental Hypertonicity Causes Induction of Gluconeogenesis in the Air-Breathing Singhi Catfish, Heteropneustes fossilis	PLOS ONE			English	Article							CELL-VOLUME REGULATION; GLUCOSE-6-PHOSPHATASE GENE-EXPRESSION; HEPATIC GLUCOSE-METABOLISM; TROUT ONCORHYNCHUS-MYKISS; MESSENGER-RNA LEVELS; FRESH-WATER TELEOST; PERFUSED LIVER; PHOSPHOENOLPYRUVATE CARBOXYKINASE; NUTRITIONAL REGULATION; HEPATOCELLULAR HYDRATION	The air-breathing singhi catfish (Heteropneustes fossilis) is frequently being challenged by different environmental insults such as hyper-ammonia, dehydration and osmotic stresses in their natural habitats throughout the year. The present study investigated the effect of hyperosmotic stress, due to exposure to hypertonic environment (300 mM mannitol) for 14 days, on gluconeogenesis in this catfish. In situ exposure to hypertonic environment led to significant stimulation of gluconeogenic fluxes from the perfused liver after 7 days of exposure, followed by further increase after 14 days in presence of three different potential gluconeogenic substrates (lactate, pyruvate and glutamate). Environmental hypertonicity also caused a significant increase of activities of key gluconeogenic enzymes, namely phosphoenolpyruvate carboxykinase, fructose 1, 6-bisphosphatase and glucose 6-phosphatase by about 2-6 fold in liver, and 3-6 fold in kidney tissues. This was accompanied by more abundance of enzyme proteins by about 1.8-3.7 fold and mRNAs by about 2.2-5.2 fold in both the tissues with a maximum increase after 14 days of exposure. Hence, the increase in activities of key gluconeogenic enzymes under hypertonic stress appeared to be as a result of transcriptional regulation of genes. Immunocytochemical analysis further confirmed the tissue specific localized expression of these enzymes in both the tissues with the possibility of expressing more in the same localized places. The induction of gluconeogenesis during exposure to environmental hypertonicity possibly occurs as a consequence of changes in hydration status/cell volume of different cell types. Thus, these adaptational strategies related to gluconeogenesis that are observed in this catfish under hypertonic stress probably help in maintaining glucose homeostasis and also for a proper energy supply to support metabolic demands mainly for ion transport and other altered metabolic processes under various environmental hypertonic stress-related insults.	[Das, Manas; Banerjee, Bodhisattwa; Choudhury, Mahua G.; Saha, Nirmalendu] NE Hill Univ, Dept Zool, Biochem Adaptat Lab, Shillong 793014, Meghalaya, India	North Eastern Hill University	Saha, N (corresponding author), NE Hill Univ, Dept Zool, Biochem Adaptat Lab, Shillong 793014, Meghalaya, India.	nsaha@nehu.ac.in	Saha, Nirmalendu/J-8100-2014; Saha, Nirmalendu/AAH-7792-2021; Banerjee, Bodhisattwa/I-6945-2013	Saha, Nirmalendu/0000-0002-9635-3024; Saha, Nirmalendu/0000-0002-9635-3024; Banerjee, Bodhisattwa/0000-0001-9358-6976; Gupta Choudhury, Mahua/0000-0002-4586-8060	DSA programme by the University Grants Commission, New Delhi; UPE-Biosciences project by the University Grants Commission, New Delhi; University Grant Commission, New Delhi	DSA programme by the University Grants Commission, New Delhi; UPE-Biosciences project by the University Grants Commission, New Delhi; University Grant Commission, New Delhi(University Grants Commission, India)	This study was supported by the DSA programme to the Department of Zoology and the UPE-Biosciences project to the North-Eastern Hill University, Shillong by the University Grants Commission, New Delhi. The financial support as meritorious research fellowship to M.D. from the University Grant Commission, New Delhi, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; BEVER K, 1981, AM J PHYSIOL, V240, pR246, DOI 10.1152/ajpregu.1981.240.3.R246; Biswas K, 2010, FISH PHYSIOL BIOCHEM, V36, P17, DOI 10.1007/s10695-008-9275-5; Biswas K, 2009, J EXP ZOOL PART A, V311A, P115, DOI 10.1002/jez.508; Botini FF, 2005, LIVER INT, V25, P861, DOI 10.1111/j.1478-3231.2005.01093.x; CARNEIRO NM, 1983, GEN COMP ENDOCR, V49, P115, DOI 10.1016/0016-6480(83)90014-X; Caseras A, 2002, BRIT J NUTR, V88, P607, DOI 10.1079/BJN2002701; Chandramouli V, 1997, AM J PHYSIOL-ENDOC M, V273, pE1209, DOI 10.1152/ajpendo.1997.273.6.E1209; Choudhury MG, 2012, AQUAT TOXICOL, V116, P43, DOI 10.1016/j.aquatox.2012.03.006; CHRISTIANSEN DC, 1987, COMP BIOCHEM PHYS B, V88, P701, DOI 10.1016/0305-0491(87)90232-X; DELAHIGUERA M, 1986, COMP BIOCHEM PHYS B, V85, P517, DOI 10.1016/0305-0491(86)90040-4; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; FISKE CH, 1957, METHOD ENZYMOL, P843; FUGELLI K, 1995, ACTA PHYSIOL SCAND, V155, P223, DOI 10.1111/j.1748-1716.1995.tb09967.x; Goswami C, 2004, J BIOSCIENCES, V29, P337, DOI 10.1007/BF02702616; Goswami C, 1998, COMP BIOCHEM PHYS A, V119, P999, DOI 10.1016/S1095-6433(98)00017-8; Goswami C, 2006, J BIOSCIENCES, V31, P589, DOI 10.1007/BF02708411; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hallgren NK, 2003, J COMP PHYSIOL B, V173, P591, DOI 10.1007/s00360-003-0369-1; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Haussinger D, 1996, BIOCHEM J, V313, P697; HAYASHI S, 1979, J COMP PHYSIOL, V132, P343; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Kaiser S, 1998, AM J PHYSIOL-GASTR L, V274, pG509, DOI 10.1152/ajpgi.1998.274.3.G509; Kirchner S, 2003, J NUTR, V133, P2561; Kirchner S, 2008, J COMP PHYSIOL B, V178, P429, DOI 10.1007/s00360-007-0235-7; Kultz D, 2007, J EXP BIOL, V210, P1593, DOI 10.1242/jeb.000141; Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367; Lansard M, 2009, BRIT J NUTR, V102, P1564, DOI 10.1017/S000711450999095X; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meton I, 2004, COMP BIOCHEM PHYS B, V138, P145, DOI 10.1016/j.cbpc.2004.03.004; MICHEL F, 1994, EXP PHYSIOL, V79, P983, DOI 10.1113/expphysiol.1994.sp003823; Minassian C, 1999, BBA-MOL CELL RES, V1452, P172, DOI 10.1016/S0167-4889(99)00130-5; MOMMSEN TP, 1985, MOL PHYSIOL, V8, P89; MOMMSEN TP, 1986, CAN J ZOOL, V64, P1110, DOI 10.1139/z86-166; Moon T.W., 1995, BIOCH MOL BIOL FISHE, V4, P65, DOI [10.1016/S1873-0140(06)80007-X, DOI 10.1016/S1873-0140(06)80007-X]; MOON TW, 1988, CAN J ZOOL, V66, P1059, DOI 10.1139/z88-156; MOON TW, 1985, CAN J FISH AQUAT SCI, V42, P1772, DOI 10.1139/f85-222; MOON TW, 1980, J COMP PHYSIOL, V136, P31, DOI 10.1007/BF00688619; MUNSHI JSD, 1994, ADV FISH BIOL, V1, P70; NEWSOME WP, 1994, BIOCHEM J, V304, P555, DOI 10.1042/bj3040555; NORDLIE RC, 1966, METHOD ENZYMOL, V9, P619; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Panserat S, 2002, BBA-GENE STRUCT EXPR, V1579, P35, DOI 10.1016/S0167-4781(02)00501-8; Panserat S, 2001, J EXP BIOL, V204, P2351; Panserat S, 2001, COMP BIOCHEM PHYS B, V128, P275, DOI 10.1016/S1096-4959(00)00322-5; Perlman DF, 1999, J EXP ZOOL, V283, P725, DOI 10.1002/(SICI)1097-010X(19990601)283:7<725::AID-JEZ10>3.3.CO;2-R; Petersen KF, 2004, J CLIN ENDOCR METAB, V89, P4656, DOI 10.1210/jc.2004-0408; Plagnes-Juan E, 2008, J EXP BIOL, V211, P2510, DOI 10.1242/jeb.018374; Polakof S, 2008, J EXP BIOL, V211, P1075, DOI 10.1242/jeb.014050; Polakof S, 2006, J COMP PHYSIOL B, V176, P441, DOI 10.1007/s00360-006-0065-z; RENAUD JM, 1980, J COMP PHYSIOL, V135, P127, DOI 10.1007/BF00691202; RENAUD JM, 1980, J COMP PHYSIOL, V135, P115, DOI 10.1007/BF00691201; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Saez DE, 2000, J CELL BIOCHEM, V78, P62, DOI 10.1002/(SICI)1097-4644(20000701)78:1<62::AID-JCB6>3.3.CO;2-N; Saha N, 2007, FISH PHYSIOL BIOCHEM, V33, P283, DOI 10.1007/s10695-007-9172-3; Saha N, 2004, J BIOSCIENCES, V29, P179, DOI 10.1007/BF02703416; SAHA N, 1992, EUR J BIOCHEM, V209, P437, DOI 10.1111/j.1432-1033.1992.tb17307.x; Saha N, 1995, COMP BIOCHEM PHYS B, V112, P733, DOI 10.1016/0305-0491(95)00115-8; Saha N, 1998, COMP BIOCHEM PHYS A, V120, P195, DOI 10.1016/S1095-6433(98)00026-9; Saha N, 2011, FISH PHYSIOL BIOCHEM, V37, P681, DOI 10.1007/s10695-011-9468-1; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Sangiao-Alvarellos S, 2003, AM J PHYSIOL-REG I, V285, pR897, DOI 10.1152/ajpregu.00161.2003; SEN TK, 1985, RECORDS ZOOLOGICAL S, P217; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Somero G. N., 1997, HDB PHYSIOL 14, P441; SUAREZ RK, 1987, CAN J ZOOL, V65, P1869, DOI 10.1139/z87-287; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vijayan MM, 1996, J EXP BIOL, V199, P1509; Weiergraber O, 2000, CELL PHYSIOL BIOCHEM, V10, P409, DOI 10.1159/000016373; WELDON SL, 1990, J BIOL CHEM, V265, P7308	78	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85535	10.1371/journal.pone.0085535	http://dx.doi.org/10.1371/journal.pone.0085535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376888	gold, Green Submitted, Green Published			2022-12-27	WOS:000328745100207
J	Boechat, AL; Kaihami, GH; Politi, MJ; Lepine, F; Baldini, RL				Boechat, Ana Laura; Kaihami, Gilberto Hideo; Politi, Mario Jose; Lepine, Francois; Baldini, Regina L.			A Novel Role for an ECF Sigma Factor in Fatty Acid Biosynthesis and Membrane Fluidity in Pseudomonas aeruginosa	PLOS ONE			English	Article							VIRULENCE FACTOR PRODUCTION; ESCHERICHIA-COLI; OUTER-MEMBRANE; GENE-EXPRESSION; MUTANT LIBRARY; LIPOIC ACID; PROTEIN-F; PATHWAYS; IRON; SYNTHASE	Extracytoplasmic function (ECF) sigma factors are members of cell-surface signaling systems, abundant in the opportunistic pathogen Pseudomonas aeruginosa. Twenty genes coding for ECF sigma factors are present in P. aeruginosa sequenced genomes, most of them being part of TonB systems related to iron uptake. In this work, poorly characterized sigma factors were overexpressed in strain PA14, in an attempt to understand their role in the bacterium's physiology. Cultures overexpressing SigX displayed a biphasic growth curve, reaching stationary phase earlier than the control strain, followed by subsequent growth resumption. During the first stationary phase, most cells swell and die, but the remaining cells return to the wild type morphology and proceed to a second exponential growth. This is not due to compensatory mutations, since cells recovered from late time points and diluted into fresh medium repeated this behavior. Swollen cells have a more fluid membrane and contain higher amounts of shorter chain fatty acids. A proteomic analysis was performed to identify differentially expressed proteins due to overexpression of sigX, revealing the induction of several fatty acid synthesis (FAS) enzymes. Using qRT-PCR, we showed that at least one isoform from each of the FAS pathway enzymes were upregulated at the mRNA level in the SigX overexpressing strain thus pointing to a role for this ECF sigma factor in the FAS regulation in P. aeruginosa.	[Boechat, Ana Laura; Kaihami, Gilberto Hideo; Politi, Mario Jose; Baldini, Regina L.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Lepine, Francois] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada	Universidade de Sao Paulo; University of Quebec; Institut national de la recherche scientifique (INRS)	Baldini, RL (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	baldini@iq.usp.br	Borges, Ana Laura/AAQ-4158-2020; Baldini, Regina L/C-4035-2012; Politi, Mario J/F-2605-2016; Kaihami, Gilberto/E-9542-2014	Baldini, Regina L/0000-0003-4349-6352; Kaihami, Gilberto/0000-0002-8161-0403	Sao Paulo Research Foundation (FAPESP) [2009/09211-2, 2008/03528-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304349/2010-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants 2009/09211-2 for RLB and 2008/03528-0 for ALB, Sao Paulo Research Foundation (FAPESP, www.fapesp.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, www.capes.gov.br). RLB was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 304349/2010-0, www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Baysse C, 2005, MICROBIOL-SGM, V151, P2529, DOI 10.1099/mic.0.28185-0; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; BOUFFARTIGUES E, 2012, J BACTERIOL; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; Brinkman FSL, 1999, J BACTERIOL, V181, P4746, DOI 10.1128/JB.181.16.4746-4754.1999; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Cronan JE, 2006, MOL MICROBIOL, V60, P256, DOI 10.1111/j.1365-2958.2006.05107.x; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; Dubois-Brissonnet F, 2000, INT J FOOD MICROBIOL, V55, P79, DOI 10.1016/S0168-1605(00)00198-7; FAURE L, 2013, MICROBIOLOGY; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; GOTOH N, 1989, J BACTERIOL, V171, P983, DOI 10.1128/jb.171.2.983-990.1989; HANCOCK REW, 1981, J BACTERIOL, V145, P628, DOI 10.1128/JB.145.1.628-631.1981; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; HAYDEN MA, 1992, J BIOL CHEM, V267, P9512; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Inoue K, 1997, J BACTERIOL, V179, P2872, DOI 10.1128/jb.179.9.2872-2878.1997; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kingston AW, 2011, MOL MICROBIOL, V81, P69, DOI 10.1111/j.1365-2958.2011.07679.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kutchma AJ, 1999, J BACTERIOL, V181, P5498, DOI 10.1128/JB.181.17.5498-5504.1999; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Leoni L, 2000, J BACTERIOL, V182, P1481, DOI 10.1128/JB.182.6.1481-1491.2000; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LITMAN BJ, 1982, METHOD ENZYMOL, V81, P678; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llamas MA, 2006, J BACTERIOL, V188, P1882, DOI 10.1128/JB.188.5.1882-1891.2006; Llamas MA, 2008, MOL MICROBIOL, V67, P458; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; Los DA, 2004, BBA-BIOMEMBRANES, V1666, P142, DOI 10.1016/j.bbamem.2004.08.002; Lu YJ, 2004, BIOCHEM CELL BIOL, V82, P145, DOI 10.1139/o03-076; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Marrakchi H, 2002, BIOCHEM SOC T, V30, P1050, DOI 10.1042/bst0301050; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; Micevski Dimce, 2013, Subcell Biochem, V66, P105, DOI 10.1007/978-94-007-5940-4_5; Najjar MB, 2007, APPL ENVIRON MICROB, V73, P6429, DOI 10.1128/AEM.00980-07; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; NICAS TI, 1983, J BACTERIOL, V153, P281, DOI 10.1128/JB.153.1.281-285.1983; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Ravel J, 2003, TRENDS MICROBIOL, V11, P195, DOI 10.1016/S0966-842X(03)00076-3; Redly GA, 2003, J BACTERIOL, V185, P1261, DOI 10.1128/JB.185.4.1261-1265.2003; Redly GA, 2005, J BACTERIOL, V187, P5648, DOI 10.1128/JB.187.16.5648-5657.2005; RICK PD, 1977, J BIOL CHEM, V252, P4895; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Schweizer HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045646; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Subramanian C, 2010, J BACTERIOL, V192, P280, DOI 10.1128/JB.00404-09; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tiburzi F, 2008, MOL MICROBIOL, V67, P213, DOI 10.1111/j.1365-2958.2007.06051.x; TSAY JT, 1992, J BIOL CHEM, V267, P6807; VANDENBOOM TJ, 1991, J BACTERIOL, V173, P6411, DOI 10.1128/jb.173.20.6411-6420.1991; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Walsh AG, 1999, FEMS MICROBIOL LETT, V173, P27, DOI 10.1111/j.1574-6968.1999.tb13480.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yuan YQ, 2012, J BACTERIOL, V194, P5171, DOI 10.1128/JB.00792-12; Yuan YQ, 2012, J BACTERIOL, V194, P5185, DOI 10.1128/JB.00860-12; Zhang YM, 2012, J BACTERIOL, V194, P5159, DOI 10.1128/JB.01198-12; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	82	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84775	10.1371/journal.pone.0084775	http://dx.doi.org/10.1371/journal.pone.0084775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386415	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000329194700117
J	Lambers, FM; Bouman, AR; Rimnac, CM; Hernandez, CJ				Lambers, Floor M.; Bouman, Amanda R.; Rimnac, Clare M.; Hernandez, Christopher J.			Microdamage Caused by Fatigue Loading in Human Cancellous Bone: Relationship to Reductions in Bone Biomechanical Performance	PLOS ONE			English	Article							VERTEBRAL TRABECULAR BONE; CORTICAL BONE; MINERAL DENSITY; YIELD STRAIN; COMPACT-BONE; ACCUMULATION; BEHAVIOR; DAMAGE; FAILURE; CREEP	Vertebral fractures associated with osteoporosis are often the result of tissue damage accumulated over time. Microscopic tissue damage (microdamage) generated in vivo is believed to be a mechanically relevant aspect of bone quality that may contribute to fracture risk. Although the presence of microdamage in bone tissue has been documented, the relationship between loading, microdamage accumulation and mechanical failure is not well understood. The aim of the current study was to determine how microdamage accumulates in human vertebral cancellous bone subjected to cyclic fatigue loading. Cancellous bone cores (n = 32) from the third lumbar vertebra of 16 donors (10 male, 6 female, age 76 +/- 8.8, mean +/- SD) were subjected to compressive cyclic loading at sigma/E-0 = 0.0035 (where sigma is stress and E-0 is the initial Young's modulus). Cyclic loading was suspended before failure at one of seven different amounts of loading and specimens were stained for microdamage using lead uranyl acetate. Damage volume fraction (DV/BV) varied from 0.8 +/- 0.5% (no loading) to 3.4 +/- 2.1% (fatigue-loaded to complete failure) and was linearly related to the reductions in Young's modulus caused by fatigue loading (r(2) = 0.60, p<0.01). The relationship between reductions in Young's modulus and proportion of fatigue life was nonlinear and suggests that most microdamage generation occurs late in fatigue loading, during the tertiary phase. Our results indicate that human vertebral cancellous bone tissue with a DV/BV of 1.5% is expected to have, on average, a Young's modulus 31% lower than the same tissue without microdamage and is able to withstand 92% fewer cycles before failure than the same tissue without microdamage. Hence, even small amounts of microscopic tissue damage in human vertebral cancellous bone may have large effects on subsequent biomechanical performance.	[Lambers, Floor M.; Bouman, Amanda R.; Hernandez, Christopher J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Hernandez, Christopher J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Rimnac, Clare M.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Hernandez, Christopher J.] Hosp Special Surg, New York, NY 10021 USA	Cornell University; Cornell University; Case Western Reserve University	Hernandez, CJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	cjh275@cornell.edu	Hernandez, Christopher J/B-5290-2009	Hernandez, Christopher J/0000-0002-0712-6533; Rimnac, Clare/0000-0001-9981-8723	NIAMS/NIH [R01 AR057362]; NIH [8U42OD011158-22]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057362] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012287, U42OD011158] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This publication was made possible by Grant Number R01 AR057362 from NIAMS/NIH (PI CJH). The authors acknowledge use of human vertebral bodies provided by the National Disease Research Interchange (NDRI, Philadelphia, PA), with support from NIH grant 8U42OD011158-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus O, 2001, J BIOMECH, V34, P757, DOI 10.1016/S0021-9290(01)00025-2; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; Bevill G, 2006, BONE, V39, P1218, DOI 10.1016/j.bone.2006.06.016; Bowman SM, 1998, J BIOMECH ENG-T ASME, V120, P647, DOI 10.1115/1.2834757; BRINCKMANN P, 1983, SPINE, V8, P851, DOI 10.1097/00007632-198311000-00007; Brock GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057942; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; CARTER DR, 1976, J BIOMECH, V9, P27, DOI 10.1016/0021-9290(76)90136-6; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Diab T, 2005, BONE, V37, P96, DOI 10.1016/j.bone.2005.03.014; Fazzalari NL, 1998, BONE, V22, P381, DOI 10.1016/S8756-3282(97)00298-6; FORWOOD MR, 1989, CALCIFIED TISSUE INT, V45, P47, DOI 10.1007/BF02556660; Giambini H, 2013, CLIN BIOMECH, V28, P10, DOI 10.1016/j.clinbiomech.2012.10.005; Gong H, 2007, ANN BIOMED ENG, V35, P1622, DOI 10.1007/s10439-007-9332-8; Green JO, 2011, J BIOMECH, V44, P2659, DOI 10.1016/j.jbiomech.2011.08.006; Haddock SM, 2004, J BIOMECH, V37, P181, DOI 10.1016/S0021-9290(03)00245-8; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Hernandez CJ, 2011, STAT POWER MEASURES; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Karim L, 2011, J ORTHOP RES, V29, P1739, DOI 10.1002/jor.21448; Keaveny TM, 1999, J ORTHOPAED RES, V17, P346, DOI 10.1002/jor.1100170308; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; Kopperdahl DL, 1998, J BIOMECH, V31, P601, DOI 10.1016/S0021-9290(98)00057-8; Kopperdahl DL, 2000, J ORTHOPAED RES, V18, P685, DOI 10.1002/jor.1100180502; Kummari SR, 2009, CALCIFIED TISSUE INT, V85, P127, DOI 10.1007/s00223-009-9257-3; Landrigan MD, 2011, BONE, V48, P443, DOI 10.1016/j.bone.2010.10.160; Lee TC, 2000, J ORTHOPAED RES, V18, P322, DOI 10.1002/jor.1100180222; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Lynch JA, 2008, BONE, V42, P942, DOI 10.1016/j.bone.2008.01.004; MICHEL MC, 1993, J BIOMECH, V26, P453, DOI 10.1016/0021-9290(93)90009-4; Moore TLA, 2004, J BIOMECH ENG-T ASME, V126, P321, DOI 10.1115/1.1762892; Moore TLA, 2003, J BIOMECH ENG-T ASME, V125, P769, DOI 10.1115/1.1631584; Moore TLA, 2003, J BIOMECH ENG-T ASME, V125, P761, DOI 10.1115/1.1631583; Moore TLA, 2002, J BIOMECH ENG-T ASME, V124, P63, DOI 10.1115/1.1428745; Morgan EF, 2001, J BIOMECH, V34, P569, DOI 10.1016/S0021-9290(01)00011-2; Morgan EF, 2001, J BIOMECH ENG-T ASME, V123, P1, DOI 10.1115/1.1338122; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; RIMNAC CM, 1993, J BIOMECH, V26, P219, DOI 10.1016/0021-9290(93)90360-Q; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0; SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2; Seref-Ferlengez Z, 2012, DIFFUSE MICRODAMAGE, P1348; Shi XT, 2010, J BIOMECH, V43, P2460, DOI 10.1016/j.jbiomech.2010.05.032; Sobelman OS, 2004, J BIOMECH, V37, P1295, DOI 10.1016/j.jbiomech.2003.12.034; Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116; Sun XH, 2010, J BIOMECH, V43, P1989, DOI 10.1016/j.jbiomech.2010.03.011; Tang SY, 2007, BONE, V40, P1259, DOI 10.1016/j.bone.2006.10.031; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Uthgenannt BA, 2007, J BIOMECH, V40, P317, DOI 10.1016/j.jbiomech.2006.01.005; Vashishth D, 2000, BONE, V26, P147, DOI 10.1016/S8756-3282(99)00253-7; Vashishth D, 2007, INT J FATIGUE, V29, P1024, DOI 10.1016/j.ijfatigue.2006.09.010; Wachtel EF, 1997, J ORTHOPAED RES, V15, P781, DOI 10.1002/jor.1100150522; Wang XA, 2006, J BIOMECH, V39, P781, DOI 10.1016/j.jbiomech.2005.02.007; Wang X, 2007, J BIOMECH, V40, P3397, DOI 10.1016/j.jbiomech.2007.05.009; Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5; Wu ZH, 2013, BONE, V55, P208, DOI 10.1016/j.bone.2013.02.019; Xu ZB, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3514633; Yamamoto E, 2006, J BIOMECH, V39, P1812, DOI 10.1016/j.jbiomech.2005.05.017; Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108	67	42	45	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83662	10.1371/journal.pone.0083662	http://dx.doi.org/10.1371/journal.pone.0083662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386247	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700056
J	Liu, C; Gotz, J				Liu, Chang; Goetz, Juergen			Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; NEUROBLASTOMA-CELLS; FILAMENT FORMATION; AXONAL-TRANSPORT; BETA TOXICITY; MOUSE-BRAIN; P301L TAU; PHOSPHORYLATION	In the adult murine brain, the microtubule-associated protein tau exists as three major isoforms, which have four microtubule-binding repeats (4R), with either no (0N), one (1N) or two (2N) amino-terminal inserts. The human brain expresses three additional isoforms with three microtubule-binding repeats (3R) each. However, little is known about the role of the amino-terminal inserts and how the 0N, 1N and 2N tau species differ. In order to investigate this, we generated a series of isoform-specific antibodies and performed a profiling by Western blotting and immunohistochemical analyses using wild-type mice in three age groups: two months, two weeks and postnatal day 0 (P0). This revealed that the brain is the only organ to express tau at significant levels, with 0N4R being the predominant isoform in the two month-old adult. Subcellular fractionation of the brain showed that the 1N isoform is over-represented in the soluble nuclear fraction. This is in agreement with the immunohistochemical analysis as the 1N isoform strongly localizes to the neuronal nucleus, although it is also found in cell bodies and dendrites, but not axons. The 0N isoform is mainly found in cell bodies and axons, whereas nuclei and dendrites are only slightly stained with the 0N antibody. The 2N isoform is highly expressed in axons and in cell bodies, with a detectable expression in dendrites and a very slight expression in nuclei. The 2N isoform that was undetectable at P0, in adult brain was mainly found localized to cell bodies and dendrites. Together these findings reveal significant differences between the three murine tau isoforms that are likely to reflect different neuronal functions.	[Liu, Chang; Goetz, Juergen] Univ Sydney, Sydney Med Sch, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Goetz, Juergen] Univ Queensland, Queensland Brain Inst, CJCADR, Brisbane, Qld, Australia	University of Sydney; University of Queensland	Gotz, J (corresponding author), Univ Queensland, Queensland Brain Inst, CJCADR, St Lucia Campus, Brisbane, Qld, Australia.	j.goetz@uq.edu.au	Götz, Jürgen/C-2448-2014	Götz, Jürgen/0000-0001-8501-7896	Estate of Dr Clem Jones AO; Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC)	Estate of Dr Clem Jones AO; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Estate of Dr Clem Jones AO, and grants from the Australian Research Council (ARC) and the National Health and Medical Research Council of Australia (NHMRC) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN JB, 1992, BIOL REPROD, V46, P120, DOI 10.1095/biolreprod46.1.120; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Hanger DP, 2002, FEBS LETT, V531, P538, DOI 10.1016/S0014-5793(02)03611-6; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Ingelsson M, 2007, ACTA NEUROPATHOL, V114, P471, DOI 10.1007/s00401-007-0280-z; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Ke YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035678; Lee G, 1998, J CELL SCI, V111, P3167; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lim YA, 2012, BBA-MOL BASIS DIS, V1822, P1247, DOI 10.1016/j.bbadis.2012.04.007; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Monroy-Ramirez HC, 2013, J ALZHEIMERS DIS, V36, P503, DOI 10.3233/JAD-122401; MULOT SFC, 1994, FEBS LETT, V349, P359, DOI 10.1016/0014-5793(94)00702-0; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067	43	77	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84849	10.1371/journal.pone.0084849	http://dx.doi.org/10.1371/journal.pone.0084849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386422	gold, Green Submitted, Green Published			2022-12-27	WOS:000329194700120
J	Shamis, Y; Silva, EA; Hewitt, KJ; Brudno, Y; Levenberg, S; Mooney, DJ; Garlick, JA				Shamis, Yulia; Silva, Eduardo A.; Hewitt, Kyle J.; Brudno, Yevgeny; Levenberg, Shulamit; Mooney, David J.; Garlick, Jonathan A.			Fibroblasts Derived from Human Pluripotent Stem Cells Activate Angiogenic Responses In Vitro and In Vivo	PLOS ONE			English	Article							MESENCHYMAL CELLS; VESSEL FORMATION; STROMAL CELLS; NEURAL CREST; HUMAN ORGANS; PERICYTES; DIFFERENTIATION; FUNCTIONALITY; MECHANISMS; NETWORKS	Human embryonic and induced pluripotent stem cells (hESC/hiPSC) are promising cell sources for the derivation of large numbers of specific cell types for tissue engineering and cell therapy applications. We have describe a directed differentiation protocol that generates fibroblasts from both hESC and hiPSC (EDK/iPDK) that support the repair and regeneration of epithelial tissue in engineered, 3D skin equivalents. In the current study, we analyzed the secretory profiles of EDK and iPDK cells to investigate the production of factors that activate and promote angiogenesis. Analysis of in vitro secretion profiles from EDK and iPDK cells demonstrated the elevated secretion of pro-angiogenic soluble mediators, including VEGF, HGF, IL-8, PDGF-AA, and Ang-1, that stimulated endothelial cell sprouting in a 3D model of angiogenesis in vitro. Phenotypic analysis of EDK and iPDK cells during the course of differentiation from hESCs and iPSCs revealed that both cell types progressively acquired pericyte lineage markers NG2, PDGFR beta, CD105, and CD73 and demonstrated transient induction of pericyte progenitor markers CD31, CD34, and Flk1/VEGFR2. Furthermore, when co-cultured with endothelial cells in 3D fibrin-based constructs, EDK and iPDK cells promoted self-assembly of vascular networks and vascular basement membrane deposition. Finally, transplantation of EDK cells into mice with hindlimb ischemia significantly reduced tissue necrosis and improved blood perfusion, demonstrating the potential of these cells to stimulate angiogenic responses in vivo. These findings demonstrate that stable populations of pericyte-like angiogenic cells can be generated with high efficiency from hESC and hiPSC using a directed differentiation approach. This provides new cell sources and opportunities for vascular tissue engineering and for the development of novel strategies in regenerative medicine.	[Shamis, Yulia; Hewitt, Kyle J.; Garlick, Jonathan A.] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Silva, Eduardo A.; Brudno, Yevgeny; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Silva, Eduardo A.; Brudno, Yevgeny] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Levenberg, Shulamit; Mooney, David J.] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel	Tufts University; Harvard University; Harvard University; Technion Israel Institute of Technology	Garlick, JA (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.	Jonathan.Garlick@tufts.edu	Silva, Eduardo A./M-2711-2015; Hewitt, Kyle/S-6512-2019	Silva, Eduardo A./0000-0003-3173-7622; Levenberg, Shulamit/0000-0001-5471-7339; Mooney, David/0000-0001-6299-1194; Brudno, Yevgeny/0000-0003-2963-3293	National Institute for Dental Research (NIDCR) [DE017413];  [HL069957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098055] Funding Source: NIH RePORTER	National Institute for Dental Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant #DE017413 to Dr. Jonathan A. Garlick from National Institute for Dental Research (NIDCR) and grant #HL069957 to Dr. David Mooney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Boyd NL, 2011, TISSUE ENG PT A, V17, P1537, DOI [10.1089/ten.tea.2010.0397, 10.1089/ten.TEA.2010.0397]; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cassiman D, 2006, J HEPATOL, V44, P1098, DOI 10.1016/j.jhep.2005.09.023; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2009, ANN NY ACAD SCI, V1176, P118, DOI 10.1111/j.1749-6632.2009.04967.x; Dar A, 2012, CIRCULATION, V125, P87, DOI 10.1161/CIRCULATIONAHA.111.048264; Etchevers HC, 2002, TRENDS CARDIOVAS MED, V12, P299, DOI 10.1016/S1050-1738(02)00178-0; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Grainger SJ, 2013, TISSUE ENG PT A, V19, P1209, DOI [10.1089/ten.TEA.2012.0281, 10.1089/ten.tea.2012.0281]; Gruenloh W, 2011, TISSUE ENG PT A, V17, P1517, DOI [10.1089/ten.tea.2010.0460, 10.1089/ten.TEA.2010.0460]; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hewitt KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017128; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Shamis Y, 2012, IN VITRO CELL DEV-AN, V48, P112, DOI 10.1007/s11626-011-9478-4; Shamis Y, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt51; Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; Vo E, 2010, STEM CELL REV REP, V6, P237, DOI 10.1007/s12015-010-9144-3; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	34	20	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83755	10.1371/journal.pone.0083755	http://dx.doi.org/10.1371/journal.pone.0083755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386271	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700065
J	Boucas, AP; Brondani, LA; Souza, BM; Lemos, NE; de Oliveira, FS; Canani, LH; Crispim, D				Boucas, Ana P.; Brondani, Leticia A.; Souza, Bianca M.; Lemos, Natalia E.; de Oliveira, Fernanda S.; Canani, Luis H.; Crispim, Daisy			The A Allele of the rs1990760 Polymorphism in the IFIH1 Gene Is Associated with Protection for Arterial Hypertension in Type 1 Diabetic Patients and with Expression of This Gene in Human Mononuclear Cells	PLOS ONE			English	Article							ANTIVIRAL RESPONSES; IMMUNE-MECHANISMS; VIRUS; INFLAMMATION; METAANALYSIS; INSULITIS; LOCUS	Background: The rs1990760 polymorphism of interferon induced with helicase C domain 1 (IFIH1) has been associated with type 1 diabetes mellitus (T1DM). Here, we investigated whether this polymorphism is associated with T1DM or its clinical characteristics in a Brazilian population, and if IFIH1 gene expression in mononuclear cells from T1DM patients differs according to the genotypes of this polymorphism. A meta-analysis was also conducted to evaluate if the rs1990760 polymorphism is associated with T1DM. Methods: Frequencies of the rs1990760 polymorphism were analyzed in 527 T1DM patients and in 517 healthy subjects. IFIH1 gene expressions according to genotypes were measured in a sub-sample of 26 T1DM patients by quantitative real-time PCR. Results: Our data show the association of the A allele with risk to T1DM under a dominant model of inheritance [odds ratio (OR) = 1.421, P = 0.037], adjusting for ethnicity. The meta-analysis revealed significant association between the rs199760A allele and risk for T1DM for all analyzed inheritance models. Surprisingly, T1DM patients carrying the A allele showed lower levels of systolic (P = 0.001) and diastolic (P = 1 x10(-10)) blood pressures as compared to G/G carriers. Furthermore, the A/A genotype seems to be associated with protection to arterial hypertension (AH) after adjustment for covariates (OR = 0.339, P = 0.019). IFIH1 gene expression in mononuclear cells from 26 T1DM patients did not differ among genotypes (P = 0.274). Nevertheless, IFIH1 gene expression was increased in mononuclear cells from T1DM patients with AH as compared with T1DM patients without AH [6.7 (1.7-2.0) vs. 1.8 (1.3-7.1) arbitrary units; P = 0.036]. The association with blood pressures and AH was not observed in patients with type 2 diabetes mellitus. Conclusions: Our results indicate that the rs1990760 polymorphism is associated with T1DM. Interestingly, the rs1990760 A allele seems to be associated with protection for AH in T1DM patients. Further studies are needed to confirm the association with AH.	[Boucas, Ana P.; Brondani, Leticia A.; Souza, Bianca M.; de Oliveira, Fernanda S.; Crispim, Daisy] Univ Fed Rio Grande do Sul, Lab Biol Human Pancreat Islet, Div Endocrinol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Boucas, Ana P.; Brondani, Leticia A.; Souza, Bianca M.; Lemos, Natalia E.; Canani, Luis H.; Crispim, Daisy] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Crispim, D (corresponding author), Univ Fed Rio Grande do Sul, Lab Biol Human Pancreat Islet, Div Endocrinol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	dcmoreira@hcpa.ufrgs.br	Canani, Luis H/G-9686-2012; Crispim, Daisy/R-5170-2019; de Oliveira, Fernanda/W-2819-2019; Lemos, NE/AAL-7763-2020	Canani, Luis H/0000-0002-1813-4491; Crispim, Daisy/0000-0001-5095-9269; Lemos, NE/0000-0002-0096-5801; Boucas, Ana Paula/0000-0002-1563-1513	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre	This study was partially supported by grants from the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Applied Biosystems, 2004, REL QUANT GEN EXPR E; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Camargo JL, 1998, SCAND J CLIN LAB INV, V58, P521, DOI 10.1080/00365519850186337; Camargo JL, 2008, CLIN CHEM, V54, P925, DOI 10.1373/clinchem.2007.096628; Canani LH, 2005, DIABETIC MED, V22, P1167, DOI 10.1111/j.1464-5491.2005.01622.x; Cen H, 2013, AUTOIMMUNITY, V46, P455, DOI 10.3109/08916934.2013.796937; Chatterjee P, 2011, PLACENTA, V32, P201, DOI 10.1016/j.placenta.2010.12.026; Chatterjee P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041884; Chistiakov DA, 2010, VIRAL IMMUNOL, V23, P3, DOI 10.1089/vim.2009.0071; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; De Ciuceis C, 2005, ARTERIOSCL THROM VAS, V25, P2106, DOI 10.1161/01.ATV.0000181743.28028.57; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Elshebani A, 2007, VIRUS RES, V124; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hober D, 2012, CLIN EXP IMMUNOL, V168, P47, DOI 10.1111/j.1365-2249.2011.04559.x; Jaidane H, 2010, REV MED VIROL, V20, P265, DOI 10.1002/rmv.647; Jermendy A, 2010, DIABETOLOGIA, V53, P98, DOI 10.1007/s00125-009-1561-y; Knip M, 2005, PEDIAT ADOL, V10, P1; Ko EA, 2007, AM J PHYSIOL-HEART C, V292, pH1789, DOI 10.1152/ajpheart.01118.2006; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Leibowitz A, 2011, CURR HYPERTENS REP, V13, P465, DOI 10.1007/s11906-011-0224-9; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Luft FC, 2012, ANN MED, V44, pS49, DOI 10.3109/07853890.2011.653396; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Molitch ME., 2004, DIABETES CARE, V27, pS79, DOI [10.2337/diacare.27.2007.S79, DOI 10.2337/DIACARE.27.2007.S79]; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pirot P, 2008, ARQ BRAS ENDOCRINOL, V52, P156, DOI 10.1590/S0004-27302008000200003; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Schiffrin EL, 2010, CURR OPIN NEPHROL HY, V19, P181, DOI 10.1097/MNH.0b013e3283360a2e; Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Verlohren S, 2009, HYPERTENSION, V54, P439, DOI 10.1161/HYPERTENSIONAHA.108.120253; Wells G.A., NEWCASTLE OTTAWA SCA; WHITE FN, 1964, NEPHRON, V1, P93, DOI 10.1159/000179322; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Yang H, 2012, AUTOIMMUNITY, V45, P226, DOI 10.3109/08916934.2011.633134; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	51	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83451	10.1371/journal.pone.0083451	http://dx.doi.org/10.1371/journal.pone.0083451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386202	Green Published, gold			2022-12-27	WOS:000329117900036
J	Chapnick, DA; Jacobsen, J; Liu, XD				Chapnick, Douglas A.; Jacobsen, Jeremy; Liu, Xuedong			The Development of a Novel High Throughput Computational Tool for Studying Individual and Collective Cellular Migration	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIN STRESS FIBERS; PHOSPHOINOSITIDE 3-KINASE; DIRECTIONAL PERSISTENCE; EXTRACELLULAR-MATRIX; BINDING PROTEINS; MOTILITY DRIVEN; GROWTH-FACTOR; N-WASP; CDC42	Understanding how cells migrate individually and collectively during development and cancer metastasis can be significantly aided by a computation tool to accurately measure not only cellular migration speed, but also migration direction and changes in migration direction in a temporal and spatial manner. We have developed such a tool for cell migration researchers, named Pathfinder, which is capable of simultaneously measuring the migration speed, migration direction, and changes in migration directions of thousands of cells both instantaneously and over long periods of time from fluorescence microscopy data. Additionally, we demonstrate how the Pathfinder software can be used to quantify collective cell migration. The novel capability of the Pathfinder software to measure the changes in migration direction of large populations of cells in a spatiotemporal manner will aid cellular migration research by providing a robust method for determining the mechanisms of cellular guidance during individual and collective cell migration.	[Chapnick, Douglas A.; Jacobsen, Jeremy; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	liux@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	Chapnick, Douglas/0000-0003-3317-5432; LIU, XUEDONG/0000-0001-7209-4964	NIGMS [T32GM08759]; US Army [W81XWH-10-1-0989]; National Institutes of Health [R01GM083172, R01CA107098]; NCRR from NIH [S10 RR026680]; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM083172] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Army(United States Department of DefenseUnited States Army); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR from NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.A.C. was supported by a predoctoral training grant from NIGMS (T32GM08759). This work was supported by grants by US Army grant no. W81XWH-10-1-0989 and the National Institutes of Health (R01GM083172 and R01CA107098) to X. L. The ImageXpress MicroXL was supported by a NCRR grant S10 RR026680 from NIH.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; ABERCROMBIE M, 1954, NATURE, V174, P697, DOI 10.1038/174697a0; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bray Kristi, 2011, Small GTPases, V2, P247; Bronner-Fraser Marianne, 1993, Trends in Cell Biology, V3, P392, DOI 10.1016/0962-8924(93)90089-J; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01879; Condeelis JS, 2001, SEMIN CANCER BIOL, V11, P119, DOI 10.1006/scbi.2000.0363; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Huth J, 2011, COMPUT METH PROG BIO, V104, P227, DOI 10.1016/j.cmpb.2011.06.002; Huth J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-24; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Murase S, 2004, CURR TOP DEV BIOL, V61, P135, DOI 10.1016/S0070-2153(04)61006-4; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Platek A, 2004, J CELL SCI, V117, P4849, DOI 10.1242/jcs.01359; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Ren XD, 2000, J CELL SCI, V113, P3673; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Rosello C, 2004, ACTA BIOTHEOR, V52, P343, DOI 10.1023/B:ACBI.0000046602.58202.5e; Sawyer C, 2003, CANCER RES, V63, P1667; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Slater B, 2013, BIOTECHNIQUES, V54, P87, DOI 10.2144/000113990; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Sturge J, 2002, J CELL SCI, V115, P699; Tang HR, 2013, CURR BIOL, V23, P107, DOI 10.1016/j.cub.2012.11.059; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vitorino P, 2011, MOL CELL BIOL, V31, P342, DOI 10.1128/MCB.00800-10; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Ware MF, 1998, J CELL SCI, V111, P2423; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Xie H, 1998, J CELL SCI, V111, P615; Zamir E, 2001, J CELL SCI, V114, P3583; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	85	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e82444	10.1371/journal.pone.0082444	http://dx.doi.org/10.1371/journal.pone.0082444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386097	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900010
J	Dasmeh, P; Kepp, KP				Dasmeh, Pouria; Kepp, Kasper P.			Unfolding Simulations of Holomyoglobin from Four Mammals: Identification of Intermediates and beta-Sheet Formation from Partially Unfolded States	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SPERM-WHALE MYOGLOBIN; APOMYOGLOBIN FOLDING INTERMEDIATE; MOLTEN GLOBULE INTERMEDIATE; X-RAY-SCATTERING; CIRCULAR-DICHROISM; STRUCTURAL-CHARACTERIZATION; CONFORMATIONAL STATES; THERMAL-DENATURATION; SECONDARY STRUCTURE	Myoglobin (Mb) is a centrally important, widely studied mammalian protein. While much work has investigated multi-step unfolding of apoMb using acid or denaturant, holomyoglobin unfolding is poorly understood despite its biological relevance. We present here the first systematic unfolding simulations of holoMb and the first comparative study of unfolding of protein orthologs from different species (sperm whale, pig, horse, and harbor seal). We also provide new interpretations of experimental mean molecular ellipticities of myoglobin intermediates, notably correcting for random coil and number of helices in intermediates. The simulated holoproteins at 310 K displayed structures and dynamics in agreement with crystal structures (R-g similar to 1.48-1.51 nm, helicity similar to 75%). At 400 K, heme was not lost, but some helix loss was observed in pig and horse, suggesting that these helices are less stable in terrestrial species. At 500 K, heme was lost within 1.0-3.7 ns. All four proteins displayed exponentially decaying helix structure within 20 ns. The C-and F-helices were lost quickly in all cases. Heme delayed helix loss, and sperm whale myoglobin exhibited highest retention of heme and D/E helices. Persistence of conformation (RMSD), secondary structure, and ellipticity between 2-11 ns was interpreted as intermediates of holoMb unfolding in all four species. The intermediates resemble those of apoMb notably in A and H helices, but differ substantially in the D-, E- and F-helices, which interact with heme. The identified mechanisms cast light on the role of metal/cofactor in poorly understood holoMb unfolding. We also observed beta-sheet formation of several myoglobins at 500 K as seen experimentally, occurring after disruption of helices to a partially unfolded, globally disordered state; heme reduced this tendency and sperm-whale did not display any sheet propensity during the simulations.	[Dasmeh, Pouria; Kepp, Kasper P.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Dasmeh, Pouria] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Technical University of Denmark; Max Planck Society	Kepp, KP (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper Planeta/G-1748-2013; Kepp, Kasper P./AAA-4626-2021	Kepp, Kasper Planeta/0000-0002-6754-7348; Kepp, Kasper P./0000-0002-6754-7348	Danish Center for Scientific Computing [2012-02-23]	Danish Center for Scientific Computing	The authors wish to thank the Danish Center for Scientific Computing (grant # 2012-02-23) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALESTRIERI C, 1976, FEBS LETT, V66, P60, DOI 10.1016/0014-5793(76)80585-6; BARRICK D, 1993, BIOCHEMISTRY-US, V32, P3790, DOI 10.1021/bi00065a035; BARRICK D, 1993, PROTEIN SCI, V2, P869, DOI 10.1002/pro.5560020601; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Best RB, 2008, BIOPHYS J, V95, P4494, DOI 10.1529/biophysj.108.0900187; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Bhatt D, 2011, J CHEM THEORY COMPUT, V7, P2520, DOI 10.1021/ct200086k; Billeter S.R., 1996, GROMOS96 MANUAL USER; BRESLOW E, 1962, J BIOL CHEM, V237, P3308; CAFLISCH A, 1995, J MOL BIOL, V252, P672, DOI 10.1006/jmbi.1995.0528; Cavagnero S, 1999, J MOL BIOL, V285, P269, DOI 10.1006/jmbi.1998.2273; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Christensen NJ, 2013, J CHEM THEORY COMPUT, V9, P3210, DOI 10.1021/ct4002152; Christensen NJ, 2012, J CHEM INF MODEL, V52, P3028, DOI 10.1021/ci300398z; Cino EA, 2012, J CHEM THEORY COMPUT, V8, P2725, DOI 10.1021/ct300323g; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; DAGGETT V, 1992, J MOL BIOL, V223, P1121, DOI 10.1016/0022-2836(92)90264-K; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; DAGGETT V, 1993, J MOL BIOL, V232, P600, DOI 10.1006/jmbi.1993.1414; Dametto M, 2008, J PHYS CHEM B, V112, P9501, DOI 10.1021/jp804300w; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dasmeh P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002929; Dasmeh P, 2012, COMP BIOCHEM PHYS A, V161, P9, DOI 10.1016/j.cbpa.2011.07.027; Day R, 2005, PROTEIN SCI, V14, P1242, DOI 10.1110/ps.041226005; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113; ELIEZER D, 1995, SCIENCE, V270, P487, DOI 10.1126/science.270.5235.487; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; EVANS SV, 1990, J MOL BIOL, V213, P885, DOI 10.1016/S0022-2836(05)80270-0; Fabiani E, 2009, EUR BIOPHYS J BIOPHY, V38, P237, DOI 10.1007/s00249-008-0375-z; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; FLANAGAN MA, 1983, BIOCHEMISTRY-US, V22, P6027, DOI 10.1021/bi00294a051; GARCIAMORENO B, 1985, J BIOL CHEM, V260, P4070; GAST K, 1994, EUR BIOPHYS J BIOPHY, V23, P297, DOI 10.1007/BF00213579; GOTO Y, 1990, J MOL BIOL, V214, P803, DOI 10.1016/0022-2836(90)90334-I; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Gu W, 1996, BASIC LIFE SCI, V64, P289; GU W, 1995, PROTEINS, V22, P20, DOI 10.1002/prot.340220104; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIRST JD, 1995, BIOCHEMISTRY-US, V34, P7614, DOI 10.1021/bi00023a007; HIRST JD, 1994, J MOL BIOL, V243, P173, DOI 10.1006/jmbi.1994.1644; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Jamin M, 2005, PROTEIN PEPTIDE LETT, V12, P229, DOI 10.2174/0929866053587174; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; KATAOKA M, 1995, J MOL BIOL, V249, P215, DOI 10.1006/jmbi.1995.0290; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Khandogin J, 2006, P NATL ACAD SCI USA, V103, P18546, DOI 10.1073/pnas.0605216103; Kondrashov DA, 2008, PROTEINS, V70, P353, DOI 10.1002/prot.21499; LEVY RM, 1985, BIOPHYS J, V48, P509, DOI 10.1016/S0006-3495(85)83806-6; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Luo YZ, 2001, BIOCHEMISTRY-US, V40, P5283, DOI 10.1021/bi010122j; MARK AE, 1992, BIOCHEMISTRY-US, V31, P7745, DOI 10.1021/bi00149a001; Marracino P, 2013, J PHYS CHEM B, V117, P2273, DOI 10.1021/jp309857b; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Mehl AF, 2009, J CHEM EDUC, V86, P600, DOI 10.1021/ed086p600; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moczygemba C, 2000, FEBS LETT, V470, P203, DOI 10.1016/S0014-5793(00)01319-3; Mulligan VK, 2013, PROTEINS, V81, P1285, DOI 10.1002/prot.24285; Myers JK, 1997, P NATL ACAD SCI USA, V94, P2833, DOI 10.1073/pnas.94.7.2833; Nishimura C, 2006, J MOL BIOL, V355, P139, DOI 10.1016/j.jmb.2005.10.047; Nishimura C, 2003, J MOL BIOL, V334, P293, DOI 10.1016/j.jmb.2003.09.042; Nishimura C, 2011, J MOL BIOL, V411, P248, DOI 10.1016/j.jmb.2011.05.028; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oliveberg M, 2001, CURR OPIN STRUC BIOL, V11, P94, DOI 10.1016/S0959-440X(00)00171-8; Onufriev A, 2003, J MOL BIOL, V325, P555, DOI 10.1016/S0022-2836(02)01207-X; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; Ozdemir A, 2002, BIOCHEMISTRY-US, V41, P1893, DOI 10.1021/bi010970e; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; PHILLIPS GN, 1995, PROTEIN SCI, V4, P149; PHILLIPS SEV, 1980, J MOL BIOL, V142, P531, DOI 10.1016/0022-2836(80)90262-4; Picotti P, 2004, PROTEIN SCI, V13, P1572, DOI 10.1110/ps.04635304; PUETT D, 1973, J BIOL CHEM, V248, P4623; Ramos CHI, 2009, AFR J BIOCH RES, V3, P164; Reymond MT, 1997, PROTEIN SCI, V6, P706; Rizzuti B, 2013, ARCH BIOCHEM BIOPHYS, V531, P128, DOI 10.1016/j.abb.2012.12.015; Scott EE, 2000, J BIOL CHEM, V275, P27129; SCOULOUDI H, 1978, J MOL BIOL, V126, P637, DOI 10.1016/0022-2836(78)90013-X; Seki Y, 2007, BIOCHEMISTRY-US, V46, P234, DOI 10.1021/bi061578+; SMERDON SJ, 1990, ACTA CRYSTALLOGR B, V46, P370, DOI 10.1107/S0108768189012450; Stadler AM, 2012, BIOPHYS J, V102, P351, DOI 10.1016/j.bpj.2011.12.031; STEINBACH PJ, 1991, CHEM PHYS, V158, P383, DOI 10.1016/0301-0104(91)87078-A; TIRADORIVES J, 1993, BIOCHEMISTRY-US, V32, P4175, DOI 10.1021/bi00067a004; Tsytlonok M, 2013, ARCH BIOCHEM BIOPHYS, V531, P14, DOI 10.1016/j.abb.2012.10.006; Uzawa T, 2008, P NATL ACAD SCI USA, V105, P13859, DOI 10.1073/pnas.0804033105; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WHITAKER TL, 1995, BIOCHEMISTRY-US, V34, P8221, DOI 10.1021/bi00026a002; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; YANG AS, 1994, J MOL BIOL, V237, P602, DOI 10.1006/jmbi.1994.1258; Zhou YQ, 1998, J PHYS CHEM B, V102, P10615, DOI 10.1021/jp982542x	101	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e80308	10.1371/journal.pone.0080308	http://dx.doi.org/10.1371/journal.pone.0080308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386077	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900002
J	Kirchner, M; AbuOun, M; Mafura, M; Bagnall, M; Hunt, T; Thomas, C; Weile, J; Anjum, MF				Kirchner, Miranda; AbuOun, Manal; Mafura, Muriel; Bagnall, Mary; Hunt, Theresa; Thomas, Christopher; Weile, Jan; Anjum, Muna F.			Cefotaxime Resistant Escherichia coli Collected from a Healthy Volunteer; Characterisation and the Effect of Plasmid Loss	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; MOLECULAR CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; EFFLUX PUMP; SALMONELLA; STRAINS; GENES; IDENTIFICATION; MICROARRAY; MUTATIONS	In this study 6 CTX-M positive E. coli isolates collected during a clinical study examining the effect of antibiotic use in a human trial were analysed. The aim of the study was to analyse these isolates and assess the effect of full or partial loss of plasmid genes on bacterial fitness and pathogenicity. A DNA array was utilised to assess resistance and virulence gene carriage. Plasmids were characterised by PCR-based replicon typing and addiction system multiplex PCR. A phenotypic array and insect virulence model were utilised to assess the effect of plasmid-loss in E. coli of a large multi-resistance plasmid. All six E. coli carrying blaCTX-M-14 were detected from a single participant and were identical by pulse field gel electrophoresis and MLST. Plasmid profiling and arrays indicated absence of a large multi-drug resistance (MDR) F-replicon plasmid carrying blaTEM, aadA4, strA, strB, dfrA17/19, sul1, and tetB from one isolate. Although this isolate partially retained the plasmid it showed altered fitness characteristics e. g. inability to respire in presence of antiseptics, similar to a plasmid-cured strain. However, unlike the plasmid-cured or plasmid harbouring strains, the survival rate for Galleria mellonella infected by the former strain was approximately 5-times lower, indicating other possible changes accompanying partial plasmid loss. In conclusion, our results demonstrated that an apparently healthy individual can harbour blaCTX-M-14 E. coli strains. In one such strain, isolated from the same individual, partial absence of a large MDR plasmid resulted in altered fitness and virulence characteristics, which may have implications in the ability of this strain to infect and any subsequent treatment.	[Kirchner, Miranda; AbuOun, Manal; Mafura, Muriel; Bagnall, Mary; Hunt, Theresa; Anjum, Muna F.] Anim Hlth & Vet Labs, Dept Bacteriol & Food Safety, Addlestone, Surrey, England; [Thomas, Christopher] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Weile, Jan] Ruhr Univ Bochum, Univ Hosp, Heart & Diabet Ctr, Inst Lab & Transfus Med, Bochum, Germany	University of Birmingham; Ruhr University Bochum	Anjum, MF (corresponding author), Anim Hlth & Vet Labs, Dept Bacteriol & Food Safety, Addlestone, Surrey, England.	Muna.Anjum@ahvla.gsi.gov.uk	Thomas, Christopher M/J-8258-2017; anjum, muna/C-5213-2011	Thomas, Christopher M/0000-0002-2810-0455; 	EU [241446]	EU(European Commission)	This work was supported by an EU FP7 project "Antiresdev" (Grant number 241446) of which MFA was a work package leader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Anjum MF, 2011, J ANTIMICROB CHEMOTH, V66, P550, DOI 10.1093/jac/dkq498; Batchelor M, 2005, MICROB DRUG RESIST, V11, P58, DOI 10.1089/mdr.2005.11.58; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Card R, 2013, ANTIMICROB AGENTS CH, V57, P458, DOI 10.1128/AAC.01223-12; Dhanji H, 2012, ANTIMICROB AGENTS CH, V56, P3376, DOI 10.1128/AAC.00313-12; ESCANDE F, 1991, VET MICROBIOL, V26, P107, DOI 10.1016/0378-1135(91)90047-J; Fang CT, 2002, ANTIMICROB AGENTS CH, V46, P2024, DOI 10.1128/AAC.46.6.2024-2028.2002; Hale L, 2010, BIOTECHNIQUES, V48, P223, DOI 10.2144/000113366; Held KG, 2007, APPL ENVIRON MICROB, V73, P7622, DOI 10.1128/AEM.01000-07; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Karisik E, 2006, J ANTIMICROB CHEMOTH, V58, P665, DOI 10.1093/jac/dkl309; Kirchner M, 2011, MICROB DRUG RESIST, V17, P463, DOI 10.1089/mdr.2010.0151; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Leuko S, 2012, INFECT IMMUN, V80, P3077, DOI 10.1128/IAI.00081-12; Liebana E, 2006, J CLIN MICROBIOL, V44, P1630, DOI 10.1128/JCM.44.5.1630-1634.2006; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Morita Y, 2003, J ANTIMICROB CHEMOTH, V51, P991, DOI 10.1093/jac/dkg173; Pitout JDD, 2004, CLIN LAB MED, V24, P605, DOI 10.1016/j.cll.2004.05.006; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Senior NJ, 2011, J MED MICROBIOL, V60, P661, DOI 10.1099/jmm.0.026658-0; Simarro E, 2000, J CLIN MICROBIOL, V38, P4676, DOI 10.1128/JCM.38.12.4676-4678.2000; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; Wickramasinghe NH, 2012, J ANTIMICROB CHEMOTH, V67, P1108, DOI 10.1093/jac/dks018; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zorzet A, 2010, MOL MICROBIOL, V75, P1299, DOI 10.1111/j.1365-2958.2010.07057.x	33	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84142	10.1371/journal.pone.0084142	http://dx.doi.org/10.1371/journal.pone.0084142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386342	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900077
J	Xu, B; Lin, HF; Chen, Y; Yang, ZH; Liu, HF				Xu, Bo; Lin, Hongfei; Chen, Yang; Yang, Zhihao; Liu, Hongfang			Protein Complex Identification by Integrating Protein-Protein Interaction Evidence from Multiple Sources	PLOS ONE			English	Article							GENE-EXPRESSION; INTERACTION NETWORKS; PREDICTION; ONTOLOGY; ALGORITHM; DATABASE; TOOL	Background: Understanding protein complexes is important for understanding the science of cellular organization and function. Many computational methods have been developed to identify protein complexes from experimentally obtained protein-protein interaction (PPI) networks. However, interaction information obtained experimentally can be unreliable and incomplete. Reconstructing these PPI networks with PPI evidences from other sources can improve protein complex identification. Results: We combined PPI information from 6 different sources and obtained a reconstructed PPI network for yeast through machine learning. Some popular protein complex identification methods were then applied to detect yeast protein complexes using the new PPI networks. Our evaluation indicates that protein complex identification algorithms using the reconstructed PPI network significantly outperform ones on experimentally verified PPI networks. Conclusions: We conclude that incorporating PPI information from other sources can improve the effectiveness of protein complex identification.	[Xu, Bo; Lin, Hongfei; Yang, Zhihao] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China; [Xu, Bo; Liu, Hongfang] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Chen, Yang] Virginia Tech, Dept Comp Sci, Falls Church, VA USA	Dalian University of Technology; Mayo Clinic; Virginia Polytechnic Institute & State University	Xu, B (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China.	xubofm@gmail.com			China Scholarship Council; National Science Foundation [ABI: 0845523]; National Institute of Health [R01LM009959A1]; Natural Science Foundation of China [60673039, 61070098, 61272373]; National High Tech Research and Development Plan of China [2006AA01Z151]; Fundamental Research Funds for the Central Universities [DUT10JS09, DUT13JB09]; Liaoning Province Doctor Startup Fund [20091015]; Ministry of Education	China Scholarship Council(China Scholarship Council); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund; Ministry of Education	This study was supported by an award from China Scholarship Council, Ministry of Education, grants from National Science Foundation ABI: 0845523, National Institute of Health R01LM009959A1, the Natural Science Foundation of China (numbers 60673039, 61070098 and 61272373), the National High Tech Research and Development Plan of China (number 2006AA01Z151), the Fundamental Research Funds for the Central Universities (numbers DUT10JS09, DUT13JB09) and Liaoning Province Doctor Startup Fund (number 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baudot A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r76; Bhardwaj N, 2005, BIOINFORMATICS, V21, P2730, DOI 10.1093/bioinformatics/bti398; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Chen Jin, 2006, Genome Inform, V17, P284; Chen Y, 2011, LEARNING POSITIVE UN, P530; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Coppock DS, 2002, INFORM MANAGEMENT ON, P5329; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng JX, 2011, IEEE ACM T COMPUT BI, V8, P621, DOI 10.1109/TCBB.2010.78; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Geva G, 2011, BIOINFORMATICS, V27, P111, DOI 10.1093/bioinformatics/btq652; Gilchrist MA, 2004, BIOINFORMATICS, V20, P689, DOI 10.1093/bioinformatics/btg469; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jung SH, 2010, BIOINFORMATICS, V26, P385, DOI 10.1093/bioinformatics/btp668; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-398; Li XL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S23; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu HF, 2010, LECT N BIOINFORMAT, V6004, P62, DOI 10.1007/978-3-642-13131-8_8; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Ng SK, 2003, NUCLEIC ACIDS RES, V31, P251, DOI 10.1093/nar/gkg079; Ozawa Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-350; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; van Dongen S, 2000, THESIS U UTRECHT; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wu M, 2011, J COMPUT BIOL; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xu B, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S7	43	8	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83841	10.1371/journal.pone.0083841	http://dx.doi.org/10.1371/journal.pone.0083841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386289	gold, Green Published			2022-12-27	WOS:000329117900061
J	Xu, XY; Tian, Y; Li, SY; Li, YZ; Wang, GL; Tian, X				Xu, Xinyu; Tian, Yu; Li, Shuangyan; Li, Yize; Wang, Guolin; Tian, Xin			Inhibition of Propofol Anesthesia on Functional Connectivity between LFPs in PFC during Rat Working Memory Task	PLOS ONE			English	Article							DIRECTED TRANSFER-FUNCTION; SCALE CORTICAL NETWORKS; LOCAL-FIELD POTENTIALS; BRAIN NETWORKS; GRANGER CAUSALITY; INFORMATION-FLOW; EEG; SYNCHRONIZATION; OSCILLATIONS; CORTEX	Working memory (WM) refers to the temporary storage and manipulation of information necessary for performance of complex cognitive tasks. There is a growing interest in whether and how propofol anesthesia inhibits WM function. The aim of this study is to investigate the possible inhibition mechanism of propofol anesthesia based on the functional connections of multi-local field potentials (LFPs) and behavior during WM tasks. Adult SD rats were randomly divided into 3 groups: pro group (0.5 mg.kg(-1).min(-1),2 h), PRO group (0.9 mg.kg(-1).min(-1), 2 h) and control group. The experimental data were 16-channel LFPs obtained at prefrontal cortex with implanted microelectrode array in SD rats during WM tasks in Y-maze at 24, 48, 72, 96, 120 hours (day 1-day 5) after propofol anesthesia, and the behavior results of WM were recoded at the same time. Directed transfer function (DTF) method was applied to analyze the connections among LFPs directly. Furthermore, the causal networks were identified by DTF. The clustering coefficient (C), network density (D) and global efficiency (E-global) were selected to describe the functional connectivity quantitatively. The results show that: comparing with the control group, the LFPs functional connectivity in pro group were no significantly difference (p > 0.05); the connectivity in PRO group were significantly decreased (p < 0.05 at 24 hours, p < 0.05 at 48 hours), while no significant difference at 72, 96 and 120 hours for rats (p > 0.05), which were consistent with the behavior results. These findings could lead to improved understanding the mechanism of inhibition of anesthesia on WM functions from the view of connections among LFPs.	[Xu, Xinyu; Tian, Yu; Li, Shuangyan; Tian, Xin] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China; [Li, Yize; Wang, Guolin] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Tian, X (corresponding author), Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China.	tianx@tmu.edu.cn			National Natural Science Foundation of China (NSFC) [91132722, 61375113, 61301252]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC 91132722, 61375113 and 61301252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Astolfi L, 2004, MAGN RESON IMAGING, V22, P1457, DOI 10.1016/j.mri.2004.10.006; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Barr G, 2001, ACTA ANAESTH SCAND, V45, P834, DOI 10.1034/j.1399-6576.2001.045007834.x; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bercker S, 2009, NEUROTOX RES, V16, P140, DOI 10.1007/s12640-009-9063-8; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brzezicka A, 2011, BRAIN TOPOGR, V24, P1, DOI 10.1007/s10548-010-0158-6; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Dejean C, 2008, J NEUROPHYSIOL, V100, P385, DOI 10.1152/jn.90466.2008; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dressler I, 2007, EUR J ANAESTH, V24, P347, DOI 10.1017/S0265021506001530; Eichler M, 2006, BIOL CYBERN, V94, P469, DOI 10.1007/s00422-006-0062-z; Erasso DM, 2012, BRAIN RES, V1441, P38, DOI 10.1016/j.brainres.2011.11.025; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; FRANASZCZUK PJ, 1994, ELECTROEN CLIN NEURO, V91, P413, DOI 10.1016/0013-4694(94)90163-5; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; He H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038195; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Jones RH, 2011, STAT MED, V30, P3050, DOI 10.1002/sim.4323; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kawasaki M, 2007, NEUROSCI LETT, V422, P141, DOI 10.1016/j.neulet.2007.04.079; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Korzeniewska A, 2003, J NEUROSCI METH, V125, P195, DOI 10.1016/S0165-0270(03)00052-9; LeBeau FEN, 2002, J PHYSIOL-LONDON, V542, P167, DOI 10.1113/jphysiol.2002.015933; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Marceglia S, 2007, EXPERT REV MED DEVIC, V4, P605, DOI 10.1586/17434440.4.5.605; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milner B, 2005, PSYCHIAT CLIN N AM, V28, P599, DOI 10.1016/j.psc.2005.06.002; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; N'Kaoua B, 2002, J CLIN EXP NEUROPSYC, V24, P713, DOI 10.1076/jcen.24.6.713.8401; Nagashima K, 2005, ANESTHESIOLOGY, V103, P318, DOI 10.1097/00000542-200508000-00015; Price CC, 2008, ANESTHESIOLOGY, V108, P8, DOI 10.1097/01.anes.0000296072.02527.18; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanou J, 1996, NEUROREPORT, V7, P1130, DOI 10.1097/00001756-199604260-00005; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Schlogl A, 2006, PROG BRAIN RES, V159, P135, DOI 10.1016/S0079-6123(06)59009-0; Semba K, 2005, ANESTHESIOLOGY, V102, P616, DOI 10.1097/00000542-200503000-00021; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	69	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83653	10.1371/journal.pone.0083653	http://dx.doi.org/10.1371/journal.pone.0083653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386243	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900048
J	Bertier, L; Leus, L; D'hondt, L; de Cock, AWAM; Hofte, M				Bertier, Lien; Leus, Leen; D'hondt, Liesbet; de Cock, Arthur W. A. M.; Hofte, Monica			Host Adaptation and Speciation through Hybridization and Polyploidy in Phytophthora	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; PATHOGEN PHYTOPHTHORA; MITOCHONDRIAL GENOME; CONCERTED EVOLUTION; NATURAL HYBRIDS; DNA; NUCLEAR; ALLOPOLYPLOIDS; NICOTIANAE; ALNI	It is becoming increasingly evident that interspecific hybridization is a common event in phytophthora evolution. Yet, the fundamental processes underlying interspecific hybridization and the consequences for its ecological fitness and distribution are not well understood. We studied hybridization events in phytophthora clade 8b. This is a cold-tolerant group of plant pathogenic oomycetes in which six host-specific species have been described that mostly attack winter-grown vegetables. Hybrid characterization was done by sequencing and cloning of two nuclear (ITS and Ypt1) and two mitochondrial loci (Cox1 and Nadh1) combined with DNA content estimation using flow cytometry. Three different mtDNA haplotypes were recovered among the presumed hybrid isolates, dividing the hybrids into three types, with different parental species involved. In the nuclear genes, additivity, i.e. the presence of two alleles coming from different parents, was detected. Hybrid isolates showed large variations in DNA content, which was positively correlated with the additivity in nuclear loci, indicating allopolyploid hybridization followed by a process of diploidization. Moreover, indications of homeologous recombination were found in the hybrids by cloning ITS products. The hybrid isolates have been isolated from a range of hosts that have not been reported previously for clade 8b species, indicating that they have novel pathogenic potential. Next to this, DNA content measurements of the non-hybrid clade 8b species suggest that polyploidy is a common feature of this clade. We hypothesize that interspecific hybridization and polyploidy are two linked phenomena in phytophthora, and that these processes might play an important and ongoing role in the evolution of this genus.	[Bertier, Lien; Hofte, Monica] Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium; [Leus, Leen; D'hondt, Liesbet] Inst Agr Fisheries Res ILVO, Plant Sci Unit, Melle, Belgium; [de Cock, Arthur W. A. M.] Fungal Biodivers Ctr CBS KNAW, Utrecht, Netherlands	Ghent University; Institute For Agricultural & Fisheries Research; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Hofte, M (corresponding author), Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium.	monica.hofte@ugent.be	Hofte, Monica MR/A-6154-2008; LEUS, LEEN/GPW-8377-2022	Hofte, Monica/0000-0002-0850-3249	Agency for Innovation by Science and Technology in Flanders (IWT)	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was funded by a PhD grant of the Agency for Innovation by Science and Technology in Flanders (IWT; http://www.iwt.be/) given to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL ET, 2004, BIOL J LINN SOC, V82, P615, DOI DOI 10.1111/J.1095-8312.2004.00345.X; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Bertier L, 2013, PERSOONIA, V31, P63, DOI 10.3767/003158513X668554; Bonants PJM, 2000, PHYTOPATHOLOGY, V90, P867, DOI 10.1094/PHYTO.2000.90.8.867; Boutet X, 2010, FUNGAL BIOL-UK, V114, P369, DOI 10.1016/j.funbio.2010.02.009; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 2004, MYCOL RES, V108, P1172, DOI 10.1017/S0953756204001005; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Catal M, 2010, CYTOM PART A, V77A, P769, DOI 10.1002/cyto.a.20888; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Declercq B, 2010, EUR J PLANT PATHOL, V127, P341, DOI 10.1007/s10658-010-9601-5; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Donahoo RS, 2008, MYCOLOGIA, V100, P911, DOI 10.3852/08-028; ERSEK T, 1995, PHYTOPATHOLOGY, V85, P1343, DOI 10.1094/Phyto-85-1343; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Gaeta RT, 2010, NEW PHYTOL, V186, P18, DOI 10.1111/j.1469-8137.2009.03089.x; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; GOODWIN SB, 1994, EXP MYCOL, V18, P20, DOI 10.1006/emyc.1994.1003; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Greilhuber J, 2009, CHROMOSOMA, V118, P391, DOI 10.1007/s00412-009-0205-9; Grunwald NJ, 2012, PLANT PATHOL, V61, P610, DOI 10.1111/j.1365-3059.2011.02538.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hurtado-Gonzales OP, 2009, MYCOLOGIA, V101, P496, DOI 10.3852/08-079; Ioos R, 2006, FUNGAL GENET BIOL, V43, P511, DOI 10.1016/j.fgb.2006.02.006; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; LaFave MC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000411; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; Martin FN, 2007, CURR GENET, V51, P285, DOI 10.1007/s00294-007-0121-6; Nagel JH, 2013, FUNGAL BIOL-UK, V117, P329, DOI 10.1016/j.funbio.2013.03.004; Nirenberg HI, 2009, MYCOLOGIA, V101, P220, DOI 10.3852/06-157; Renny-Byfield S, 2013, PLANT J, V74, P829, DOI 10.1111/tpj.12168; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; SANSOME E, 1991, MYCOL RES, V95, P273, DOI 10.1016/S0953-7562(09)81232-X; SANSOME E, 1977, J GEN MICROBIOL, V99, P311, DOI 10.1099/00221287-99-2-311; SANSOME E, 1974, T BRIT MYCOL SOC, V63, P461, DOI 10.1016/S0007-1536(74)80093-8; Schena L, 2006, J MICROBIOL METH, V67, P70, DOI 10.1016/j.mimet.2006.03.003; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOOLEY PW, 1989, PHYT RECT S BRIT MYC, pCH13; VELD WAM, 2006, EUR J PLANT PATHOL, V117, DOI DOI 10.1007/S10658-006-9065-9.AVAILABLE; VELD WAM, 1998, PHYTOPATHOLOGY, V88, P922, DOI DOI 10.1094/PHYTO.1998.88.9.922; Vercauteren A, 2011, FUNGAL GENET BIOL, V48, P537, DOI 10.1016/j.fgb.2011.01.008; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	50	54	58	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85385	10.1371/journal.pone.0085385	http://dx.doi.org/10.1371/journal.pone.0085385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386473	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700138
J	Pushpakumar, SB; Kundu, S; Metreveli, N; Sen, U				Pushpakumar, Sathnur B.; Kundu, Sourav; Metreveli, Naira; Sen, Utpal			Folic Acid Mitigates Angiotensin-II-Induced Blood Pressure and Renal Remodeling	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; FOLATE INTAKE; HYPERHOMOCYSTEINAEMIC SUBJECTS; ASYMMETRIC DIMETHYLARGININE; ESSENTIAL-HYPERTENSION; DIABETIC-NEPHROPATHY; GLOMERULAR INJURY; DOWN-REGULATION	Clinical data suggests an association between systolic hypertension, renal function and hyperhomocysteinemia (HHcy). HHcy is a state of elevated plasma homocysteine (Hcy) levels and is known to cause vascular complications. In this study, we tested the hypothesis whether Ang II-induced hypertension increases plasma Hcy levels and contributes to renovascular remodeling. We also tested whether folic acid (FA) treatment reduces plasma Hcy levels by enhancing Hcy remethylation and thus mitigating renal remodeling. Hypertension was induced in WT mice by infusing Ang II using Alzet mini osmotic pumps. Blood pressure, Hcy level, renal vascular density, oxidative stress, inflammation and fibrosis markers, and angiogenic-and anti-angiogenic factors were measured. Ang II hypertension increased plasma Hcy levels and reduced renal cortical blood flow and microvascular density. Elevated Hcy in Ang II hypertension was associated with decreased 4, 5-Diaminofluorescein (DAF-2DA) staining suggesting impaired endothelial function. Increased expression of Nox-2, -4 and dihydroethidium stain revealed oxidative stress. Excess collagen IV deposition in the peri-glomerular area and increased MMP-2, and -9 expression and activity indicated renal remodeling. The mRNA and protein expression of asymmetric dimethylarginine (ADMA) was increased and eNOS protein was decreased suggesting the involvement of this pathway in Hcy mediated hypertension. Decreased expressions of VEGF and increased anti-angiogenic factors, angiostatin and endostatin indicated impaired vasculogenesis. FA treatment partially reduced hypertension by mitigating HHcy in Ang II-treated animals and alleviated pro-inflammatory, pro-fibrotic and anti-angiogenic factors. These results suggest that renovascular remodeling in Ang II-induced hypertension is, in part, due to HHcy.	[Pushpakumar, Sathnur B.; Kundu, Sourav; Metreveli, Naira; Sen, Utpal] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40292 USA	University of Louisville	Sen, U (corresponding author), Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40292 USA.	u0sen001@louisville.edu	Kundu, Sourav/J-1531-2015	KUNDU, SOURAV/0000-0001-9027-5734	National Institutes of Health [HL-104103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in part, by National Institutes of Health grant HL-104103 to US. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; AK A, 2009, J HLTH SCI, V55, P473; Arendshorst WJ, 1999, J AM SOC NEPHROL, V10, pS149; Bellamy MF, 1999, EUR J CLIN INVEST, V29, P659, DOI 10.1046/j.1365-2362.1999.00527.x; Boini KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045020; Chang PY, 2008, CIRC RES, V102, P933, DOI 10.1161/CIRCRESAHA.108.171082; Chen LH, 2012, ARTERIOSCL THROM VAS, V32, P3024, DOI 10.1161/ATVBAHA.112.254052; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Christen WG, 2009, ARCH INTERN MED, V169, P335, DOI 10.1001/archinternmed.2008.574; Cichocka E, 1995, Pediatr Pol, V70, P171; Clarke ZL, 2006, EUR J PHARMACOL, V551, P92, DOI 10.1016/j.ejphar.2006.08.085; Doshi SN, 2001, ARTERIOSCL THROM VAS, V21, P1196, DOI 10.1161/hq0701.092000; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; Feng WG, 2012, HYPERTENSION, V60, P1226, DOI 10.1161/HYPERTENSIONAHA.112.197871; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiedler L, 2008, CELL ADHES MIGR, V2, P149, DOI 10.4161/cam.2.3.6819; Geisel J, 2001, CLIN CHEM LAB MED, V39, P698, DOI 10.1515/CCLM.2001.115; Granger JP, 2009, HYPERTENSION, V54, P465, DOI 10.1161/HYPERTENSIONAHA.109.132274; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; Harding P, 2011, AM J PHYSIOL-HEART C, V300, pH1053, DOI 10.1152/ajpheart.00772.2010; Hayden MR, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-4; Holven KB, 2003, BRIT J NUTR, V89, P359, DOI 10.1079/BJN2002779; Horvath B, 2012, FREE RADICAL BIO MED, V52, P1325, DOI 10.1016/j.freeradbiomed.2012.01.014; Joseph J, 2008, J HEART LUNG TRANSPL, V27, P1237, DOI 10.1016/j.healun.2008.07.024; Kahleova R, 2002, AM J HYPERTENS, V15, P857, DOI 10.1016/S0895-7061(02)02984-9; Kennedy BP, 2003, J HYPERTENS, V21, P1307, DOI 10.1097/00004872-200307000-00018; Kitayama H, 2006, AM J HYPERTENS, V19, P718, DOI 10.1016/j.amjhyper.2005.09.022; Kumagai H, 2002, KIDNEY INT, V62, P1219, DOI 10.1046/j.1523-1755.2002.00558.x; Lim U, 2002, AM J EPIDEMIOL, V156, P1105, DOI 10.1093/aje/kwf157; Loscalzo J, 2009, J CLIN INVEST, V119, P3203, DOI 10.1172/JCI40924; McLennan SV, 2002, DIABETOLOGIA, V45, P268, DOI 10.1007/s00125-001-0730-4; McNulty M, 2006, J HUM HYPERTENS, V20, P867, DOI 10.1038/sj.jhh.1002015; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Moens AL, 2008, CIRCULATION, V117, P1810, DOI 10.1161/CIRCULATIONAHA.107.725481; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakano E, 2001, BRIT J NUTR, V86, P637, DOI 10.1079/BJN2001478; Neves MF, 2004, J HYPERTENS, V22, P959, DOI 10.1097/00004872-200405000-00018; Papandreou D, 2010, INT J FOOD SCI NUTR, V61, P11, DOI 10.3109/09637480903286371; Persson EC, 2013, CANCER EPIDEM BIOMAR, V22, P415, DOI 10.1158/1055-9965.EPI-12-1169; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; POUSSE H, 1990, ANN PEDIATR-PARIS, V37, P189; Qipshidze N, 2012, AM J PHYSIOL-HEART C, V302, pH688, DOI 10.1152/ajpheart.00777.2011; Rodrigo R, 2003, J CARDIOVASC PHARM, V42, P453, DOI 10.1097/00005344-200310000-00001; Sen U, 2008, AM J PHYSIOL-ENDOC M, V295, pE1205, DOI 10.1152/ajpendo.90534.2008; Sen U, 2007, CLIN CHEM LAB MED, V45, P1771, DOI 10.1515/CCLM.2007.354; Sen U, 2007, AM J PHYSIOL-CELL PH, V293, pC1779, DOI 10.1152/ajpcell.00207.2007; Sen U, 2006, J CELL PHYSIOL, V209, P767, DOI 10.1002/jcp.20752; Sen U, 2010, PPAR RES, V2010, DOI 10.1155/2010/806538; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Sodha NR, 2009, AM J PHYSIOL-HEART C, V296, pH428, DOI 10.1152/ajpheart.00283.2008; Soetikno V, 2012, MOL NUTR FOOD RES; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Solini A, 2006, DIABETOLOGIA, V49, P2499, DOI 10.1007/s00125-006-0377-2; Stopper H, 2008, NEPHROL DIAL TRANSPL, V23, P3272, DOI 10.1093/ndt/gfn254; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; SuttonTyrrell K, 1997, CIRCULATION, V96, P1745, DOI 10.1161/01.CIR.96.6.1745; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Tanaka T, 2013, NAT REV NEPHROL, V9, P211, DOI 10.1038/nrneph.2013.35; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Tummalapalli CM, 1999, J CELL BIOCHEM, V75, P515, DOI 10.1002/(SICI)1097-4644(19991201)75:3<515::AID-JCB15>3.0.CO;2-C; Tyagi Neetu, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P210; Varga EA, 2005, CIRCULATION, V111, pE289, DOI 10.1161/01.CIR.0000165142.37711.E7; Verhaar MC, 1999, CIRCULATION, V100, P335, DOI 10.1161/01.CIR.100.4.335; Virdis A, 2003, ARTERIOSCL THROM VAS, V23, P1352, DOI 10.1161/01.ATV.0000083297.47245.DA; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wentzel P, 2005, DIABETES, V54, P546, DOI 10.2337/diabetes.54.2.546; Wilmink HW, 2000, ARTERIOSCL THROM VAS, V20, P185, DOI 10.1161/01.ATV.20.1.185; Wollesen F, 1999, KIDNEY INT, V55, P1028, DOI 10.1046/j.1523-1755.1999.0550031028.x; Woo KS, 1999, J AM COLL CARDIOL, V34, P2002, DOI 10.1016/S0735-1097(99)00469-6; Xun P, 2012, AM J CLIN NUTR, V95, P1023, DOI 10.3945/ajcn.111.027250; Yang ZZ, 2003, KIDNEY INT, V63, P1012, DOI 10.1046/j.1523-1755.2003.00825.x; Yi F, 2006, KIDNEY INT, V70, P88, DOI 10.1038/sj.ki.5001517; Yi F, 2009, HYPERTENSION, V53, P90, DOI 10.1161/HYPERTENSIONAHA.108.115675; Zhu XY, 2011, J HYPERTENS, V29, P1972, DOI 10.1097/HJH.0b013e32834ae611	76	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83813	10.1371/journal.pone.0083813	http://dx.doi.org/10.1371/journal.pone.0083813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386282	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700079
J	Safavian, D; Goring, DR				Safavian, Darya; Goring, Daphne R.			Secretory Activity Is Rapidly Induced in Stigmatic Papillae by Compatible Pollen, but Inhibited for Self-Incompatible Pollen in the Brassicaceae	PLOS ONE			English	Article							S-LOCUS GLYCOPROTEIN; EXOCYST COMPLEX; PISTIL INTERACTIONS; ARABIDOPSIS-LYRATA; PLASMA-MEMBRANE; TUBE GROWTH; DRY STIGMAS; PROTEIN; CELL; POLLINATION	In the Brassicaceae, targeted exocytosis to the stigmatic papillar plasma membrane under the compatible pollen grain is hypothesized to be essential for pollen hydration and pollen tube penetration. In contrast, polarized secretion is proposed to be inhibited in the stigmatic papillae during the rejection of self-incompatible pollen. Using transmission electron microscopy (TEM), we performed a detailed time-course of post-pollination events to view the cytological responses of the stigmatic papillae to compatible and self-incompatible pollinations. For compatible pollinations in Arabidopsis thaliana and Arabidopsis lyrata, vesicle secretion was observed at the stigmatic papillar plasma membrane under the pollen grain while Brassica napus stigmatic papillae appeared to use multivesicular bodies (MVBs) for secretion. Exo70A1, a component of the exocyst complex, has been previously implicated in the compatible pollen responses, and disruption of Exo70A1 in both A. thaliana and B. napus resulted in a loss of secretory vesicles/MVBs at the stigmatic papillar plasma membrane. Similarly, for self-incompatible pollinations, secretory vesicles/MVBs were absent from the stigmatic papillar plasma membrane in A. lyrata and B. napus; and furthermore, autophagy appeared to be induced to direct vesicles/MVBs to the vacuole for degradation. Thus, these findings support a model where the basal pollen recognition pathway in the stigmatic papilla promotes exocytosis to accept compatible pollen, and the basal pollen recognition pathway is overridden by the self-incompatibility pathway to prevent exocytosis and reject self-pollen.	[Safavian, Darya; Goring, Daphne R.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Goring, Daphne R.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Goring, DR (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	d.goring@utoronto.ca		Goring, Daphne/0000-0001-5295-4744	Ontario Graduate Scholarship (OGS); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair (CRC)	Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair (CRC)(Canada Research Chairs)	DS is supported by an Ontario Graduate Scholarship (OGS https://osap.gov.on.ca/OSAPPortal). This research was supported by grants from Natural Sciences and Engineering Research Council of Canada (NSERC www.nserc-crsng.gc.ca) and a Canada Research Chair (CRC www.chairs-chaires.gc.ca) to DRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An QL, 2006, CELL MICROBIOL, V8, P1009, DOI 10.1111/j.1462-5822.2006.00683.x; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Bohlenius H, 2010, PLANT CELL, V22, P3831, DOI 10.1105/tpc.110.078063; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; CARTER AL, 1976, EUPHYTICA, V25, P531, DOI 10.1007/BF00041588; Chapman LA, 2010, J EXP BOT, V61, P1987, DOI 10.1093/jxb/erq021; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Chong YT, 2010, NEW PHYTOL, V185, P401, DOI 10.1111/j.1469-8137.2009.03070.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Dearnaley JDW, 1999, NEW PHYTOL, V141, P199, DOI 10.1046/j.1469-8137.1999.00334.x; Dearnaley JDW, 1997, PLANT CELL PHYSIOL, V38, P985, DOI 10.1093/oxfordjournals.pcp.a029278; Dearnaley JDW, 2001, SEX PLANT REPROD, V13, P265, DOI 10.1007/s004970000062; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; DICKINSON H, 1995, SEX PLANT REPROD, V8, P1, DOI 10.1007/BF00228756; DICKINSON HG, 1985, MICRON MICROSC ACTA, V16, P255, DOI 10.1016/0739-6260(85)90050-4; Ding Y, 2012, TRENDS PLANT SCI, V17, P606, DOI 10.1016/j.tplants.2012.06.004; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Drdova EJ, 2013, PLANT J, V73, P709, DOI 10.1111/tpj.12074; ELLEMAN CJ, 1988, NEW PHYTOL, V109, P111, DOI 10.1111/j.1469-8137.1988.tb00225.x; ELLEMAN CJ, 1990, NEW PHYTOL, V114, P511, DOI 10.1111/j.1469-8137.1990.tb00419.x; Elleman CJ, 1996, NEW PHYTOL, V133, P197, DOI 10.1111/j.1469-8137.1996.tb01886.x; ELLEMAN CJ, 1986, J CELL SCI, V80, P141; ELLEMAN CJ, 1992, NEW PHYTOL, V121, P413, DOI 10.1111/j.1469-8137.1992.tb02941.x; Fendrych M, 2010, PLANT CELL, V22, P3053, DOI 10.1105/tpc.110.074351; Fobis-Loisy I, 2007, PLANT CELL REP, V26, P745, DOI 10.1007/s00299-006-0282-7; Foster E, 2005, SEX PLANT REPROD, V17, P261, DOI 10.1007/s00497-004-0236-6; Franklin TM, 1996, SEX PLANT REPROD, V9, P203, DOI 10.1007/BF02173099; GORING DR, 1992, MOL GEN GENET, V234, P185, DOI 10.1007/BF00283838; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; HISCOCK SJ, 1994, PLANTA, V193, P377, DOI 10.1007/BF00201816; Hiscock SJ, 2002, SEX PLANT REPROD, V15, P65, DOI 10.1007/s00497-002-0143-7; Indriolo E, 2012, PLANT CELL, V24, P4607, DOI 10.1105/tpc.112.104943; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; Ivanov R, 2010, TRENDS PLANT SCI, V15, P387, DOI 10.1016/j.tplants.2010.04.010; Iwano M, 2004, PLANT PHYSIOL, V136, P3562, DOI 10.1104/pp.104.046961; Iwano M, 2007, PLANT PHYSIOL, V144, P72, DOI 10.1104/pp.106.095273; Iwano M, 2012, CURR OPIN PLANT BIOL, V15, P78, DOI 10.1016/j.pbi.2011.09.003; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; Kivimaki M, 2007, MOL ECOL, V16, P453, DOI 10.1111/j.1365-294X.2007.03109.x; Kulich I, 2013, TRAFFIC, V14, P1155, DOI 10.1111/tra.12101; Kulich I, 2010, NEW PHYTOL, V188, P615, DOI 10.1111/j.1469-8137.2010.03372.x; Li FQ, 2012, TRENDS PLANT SCI, V17, P526, DOI 10.1016/j.tplants.2012.05.006; Li SP, 2013, PLANT CELL, V25, P1774, DOI 10.1105/tpc.113.112144; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Luu DT, 1997, SEX PLANT REPROD, V10, P227, DOI 10.1007/s004970050091; Luu DT, 1999, PLANT CELL, V11, P251; MATTSON O, 1974, NATURE, V247, P298, DOI 10.1038/247298a0; Meyer D, 2009, PLANT J, V57, P986, DOI 10.1111/j.1365-313X.2008.03743.x; Micali CO, 2011, CELL MICROBIOL, V13, P210, DOI 10.1111/j.1462-5822.2010.01530.x; Murase K, 2004, SCIENCE, V303, P1516, DOI 10.1126/science.1093586; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OCKENDON DJ, 1978, THEOR APPL GENET, V52, P113, DOI 10.1007/BF00264743; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; ROBERTS IN, 1980, THEOR APPL GENET, V58, P241, DOI 10.1007/BF00265173; Samuel M. A., 2008, P173, DOI 10.1007/978-3-540-68486-2_8; Samuel MA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011338; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; SARKER RH, 1988, P NATL ACAD SCI USA, V85, P4340, DOI 10.1073/pnas.85.12.4340; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; STEAD AD, 1980, J CELL SCI, V42, P417; STEAD AD, 1979, PLANTA, V146, P211, DOI 10.1007/BF00388234; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Synek L, 2006, PLANT J, V48, P54, DOI 10.1111/j.1365-313X.2006.02854.x; Takayama S, 2000, P NATL ACAD SCI USA, V97, P3765, DOI 10.1073/pnas.040580797; Tantikanjana T, 2010, CURR OPIN PLANT BIOL, V13, P520, DOI 10.1016/j.pbi.2010.06.004; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; ZUBERI MI, 1985, J CELL SCI, V76, P321	81	56	60	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84286	10.1371/journal.pone.0084286	http://dx.doi.org/10.1371/journal.pone.0084286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386363	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700102
J	Tarrade, A; Rousseau-Ralliard, D; Aubriere, MC; Peynot, N; Dahirel, M; Bertrand-Michel, J; Aguirre-Lavin, T; Morel, O; Beaujean, N; Duranthon, V; Chavatte-Palmer, P				Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Peynot, Nathalie; Dahirel, Michele; Bertrand-Michel, Justine; Aguirre-Lavin, Tiphaine; Morel, Olivier; Beaujean, Nathalie; Duranthon, Veronique; Chavatte-Palmer, Pascale			Sexual Dimorphism of the Feto-Placental Phenotype in Response to a High Fat and Control Maternal Diets in a Rabbit Model	PLOS ONE			English	Article							INDUCED HYPERLIPIDEMIA; DENSITY-LIPOPROTEIN; EXPRESSION PROFILES; ADAPTIVE RESPONSES; ACID TRANSPORTER; GENE-EXPRESSION; FETAL-GROWTH; CHOLESTEROL; RECEPTOR; HYPERCHOLESTEROLEMIA	Maternal environment during early developmental stages plays a seminal role in the establishment of adult phenotype. Using a rabbit model, we previously showed that feeding dams with a diet supplemented with 8% fat and 0.2% cholesterol (HH diet) from the prepubertal period and throughout gestation induced metabolic syndrome in adult offspring. Here, we examined the effects of the HH diet on feto-placental phenotype at 28 days post-coitum (term = 31days) in relation to earlier effects in the blastocyst (Day 6). At 28 days, both male and female HH fetuses were intrauterine growth retarded and dyslipidemic, with males more affected than females. Lipid droplets accumulated in the HH placentas' trophoblast, consistent with the increased concentrations in cholesteryl esters (3.2-fold), triacylglycerol (2.5-fold) and stored FA (2.12-fold). Stored FA concentrations were significantly higher in female compared to male HH placentas (2.18-fold, p < 0.01), whereas triacylglycerol was increased only in HH males. Trophoblastic lipid droplet accumulation was also observed at the blastocyst stage. The expression of numerous genes involved in lipid pathways differed significantly according to diet both in term placenta and at the blastocyst stage. Among them, the expression of LXR-alpha in HH placentas was reduced in HH males but not females. These data demonstrate that maternal HH diet affects the blastocyst and induces sex-dependent metabolic adaptations in the placenta, which appears to protect female fetuses from developing severe dyslipidemia.	[Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Peynot, Nathalie; Dahirel, Michele; Aguirre-Lavin, Tiphaine; Morel, Olivier; Beaujean, Nathalie; Duranthon, Veronique; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Peynot, Nathalie; Dahirel, Michele; Aguirre-Lavin, Tiphaine; Morel, Olivier; Beaujean, Nathalie; Duranthon, Veronique; Chavatte-Palmer, Pascale] ENVA, Maisons Alfort, France; [Tarrade, Anne; Rousseau-Ralliard, Delphine; Aubriere, Marie-Christine; Dahirel, Michele; Morel, Olivier; Chavatte-Palmer, Pascale] PremUp Fdn, Paris, France; [Bertrand-Michel, Justine] Fac Med Toulouse, INSERM, Inst Malad Metab & Cardiovasc, UMR 1048, F-31073 Toulouse, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chavatte-Palmer, P (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	Pascale.Chavatte-Palmer@jouy.inra.fr	ROUSSEAU-RALLIARD, Delphine/AAA-4035-2020; Beaujean, Nathalie/C-9883-2011; Chavatte-Palmer, Pascale/K-7349-2012; Duranthon, Véronique/D-8855-2019	Beaujean, Nathalie/0000-0003-0188-9190; Chavatte-Palmer, Pascale/0000-0002-4581-6092; Duranthon, Véronique/0000-0001-8120-7481; Couturier-Tarrade, Anne/0000-0003-1559-5476; Rousseau (Rousseau-Ralliard), Delphine/0000-0003-2684-1791	INRA	INRA	This work was supported by INRA with dedicated help from the INRA PhASE and AlimH departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amusquivar E, 2003, BIOL NEONATE, V83, P136, DOI 10.1159/000067963; Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Aye ILMH, 2010, BBA-MOL CELL BIOL L, V1801, P1013, DOI 10.1016/j.bbalip.2010.05.015; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; BARKER DJP, 1992, EUR J CLIN NUTR, V46, pS3; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Bausenwein J, 2010, MOL HUM REPROD, V16, P117, DOI 10.1093/molehr/gap078; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burke KT, 2009, J LIPID RES, V50, P1146, DOI 10.1194/jlr.M800538-JLR200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; Diaz-Hernandez V, 2008, SEX DEV, V2, P152, DOI 10.1159/000143433; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Enders AC, 2009, PLACENTA, V30, pS15, DOI 10.1016/j.placenta.2008.09.018; Ethier-Chiasson M, 2007, BIOCHEM BIOPH RES CO, V359, P8, DOI 10.1016/j.bbrc.2007.05.002; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Jansson T, 2002, PLACENTA, V23, P392, DOI 10.1053/plac.2002.0826; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kevorkova O, 2007, BIOL REPROD, V76, P487, DOI 10.1095/biolreprod.106.055285; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Leroy JLMR, 2010, HUM REPROD, V25, P768, DOI 10.1093/humrep/dep420; Mamo S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-67; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; McArdle AM, 2009, PLACENTA, V30, P590, DOI 10.1016/j.placenta.2009.04.006; Montoudis A, 1999, LIFE SCI, V64, P2439, DOI 10.1016/S0024-3205(99)00201-5; MORRISON WR, 1964, J LIPID RES, V5, P600; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Napoli C, 2000, CIRC RES, V87, P946, DOI 10.1161/01.RES.87.10.946; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Picone O, 2011, THERIOGENOLOGY, V75, P287, DOI 10.1016/j.theriogenology.2010.08.015; Plosch T, 2007, PLACENTA, V28, P604, DOI 10.1016/j.placenta.2006.10.009; Ramin N, 2010, ENDOCRINOLOGY, V151, P4158, DOI 10.1210/en.2010-0187; Silva ARRE, 2012, EPIGENETICS-US, V7, P440, DOI 10.4161/epi.19563; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Rousseau D, 2003, AM J PHYSIOL-HEART C, V285, pH1294, DOI 10.1152/ajpheart.00651.2002; Santos AN, 2004, REPRODUCTION, V128, P503, DOI 10.1530/rep.1.00203; Springer MS, 2007, BIOL REV, V82, P375, DOI 10.1111/j.1469-185X.2007.00016.x; Tobin KAR, 2006, J LIPID RES, V47, P815, DOI 10.1194/jlr.M500527-JLR200; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Weedon-Fekjaer MS, 2010, PLACENTA, V31, P818, DOI 10.1016/j.placenta.2010.06.015; WEHRMAN ME, 1991, BIOL REPROD, V45, P514, DOI 10.1095/biolreprod45.3.514; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	57	55	56	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83458	10.1371/journal.pone.0083458	http://dx.doi.org/10.1371/journal.pone.0083458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386205	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700052
J	Wang, HF; Jiang, L; Liu, X; Yang, J; Wei, JL; Xu, JG; Zhang, Q; Liu, JF				Wang, Haifei; Jiang, Li; Liu, Xuan; Yang, Jie; Wei, Julong; Xu, Jingen; Zhang, Qin; Liu, Jian-Feng			A Post-GWAS Replication Study Confirming the PTK2 Gene Associated with Milk Production Traits in Chinese Holstein	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FOCAL ADHESION KINASE; MESSENGER-RNA STABILITY; DAIRY-CATTLE BREEDS; SOMATIC-CELL SCORE; LINKAGE DISEQUILIBRIUM; BOVINE CHROMOSOME-14; SECONDARY STRUCTURE; ATOPIC-DERMATITIS; ALZHEIMER-DISEASE	Our initial genome-wide association study (GWAS) demonstrated that two SNPs (ARS-BFGL-NGS-33248, UA-IFASA-9288) within the protein tyrosine kinase 2 (PTK2) gene were significantly associated with milk production traits in Chinese Holstein dairy cattle. To further validate if the statistical evidence provided in GWAS were true-positive findings, a replication study was performed herein through genotype-phenotype associations. The two tested SNPs were found to show significant associations with milk production traits, which confirmed the associations observed in the original study. Specifically, SNPs lying in the PTK2 gene were also detected by sequencing 14 unrelated sires in Chinese Holsteins and a total of thirty-three novel SNPs were identified. Thirteen out of these identified SNPs were genotyped and tested for association with milk production traits in an independent resource population. After Bonferroni correction for multiple testing, twelve SNPs were statistically significant for more than two milk production traits. Analyses of pairwise D' measures of linkage disequilibrium (LD) between all SNPs were also explored. Two haplotype blocks were inferred and the association study at haplotype level revealed similar effects on milk production traits. In addition, the RNA expression analyses revealed that a non-synonymous coding SNP (g.4061098T>G) was involved in the regulation of gene expression. Thus the findings presented here provide strong evidence for associations of PTK2 variants with dairy production traits and may be applied in Chinese Holstein breeding program.	[Wang, Haifei; Jiang, Li; Liu, Xuan; Yang, Jie; Wei, Julong; Xu, Jingen; Zhang, Qin; Liu, Jian-Feng] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, JF (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding,Minist Agr, Beijing 100094, Peoples R China.	liujf@cau.edu.cn		Liu, Jian-Feng/0000-0002-5766-7864; Jiang, Li/0000-0002-0648-2173	National High Technology Research and Development Program of China (863 Program) [2011AA100302, 2013AA102503]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; National Natural Science Foundations of China [31272419]; New-Century Training Program Foundation for the Talents by the State Education Commission of China [NETC-10-0783]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program for Changjiang Scholar and Innovation Research Team in University; National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); New-Century Training Program Foundation for the Talents by the State Education Commission of China	This work was financially supported by the National High Technology Research and Development Program of China (863 Program 2011AA100302, 2013AA102503), Program for Changjiang Scholar and Innovation Research Team in University (IRT1191), the National Natural Science Foundations of China (31272419) and the New-Century Training Program Foundation for the Talents by the State Education Commission of China (NETC-10-0783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennewitz J, 2004, J DAIRY SCI, V87, P431, DOI 10.3168/jds.S0022-0302(04)73182-3; Blott S, 2003, GENETICS, V163, P253; Boichard D, 2003, GENET SEL EVOL, V35, P77, DOI 10.1051/gse:2002037; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Capasso M, 2009, J CANCER RES CLIN, V135, P1799, DOI 10.1007/s00432-009-0628-y; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Faraldo MM, 2005, J MAMMARY GLAND BIOL, V10, P211, DOI 10.1007/s10911-005-9582-8; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Farnir F, 2002, GENETICS, V161, P275; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Ganguly KK, 2012, J CANC THER, V03, P7, DOI DOI 10.4236/JCT.2012.31002; Garcia-Gamez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047782; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hayes BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006676; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Israel C, 1998, J DAIRY SCI, V81, P1653, DOI 10.3168/jds.S0022-0302(98)75733-9; Jairath L, 1998, J DAIRY SCI, V81, P550, DOI 10.3168/jds.S0022-0302(98)75607-3; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looft C, 2001, MAMM GENOME, V12, P646, DOI 10.1007/s003350020003; Magwire MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003057; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nagy T, 2007, J BIOL CHEM, V282, P31766, DOI 10.1074/jbc.M705403200; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Pei YF, 2009, ANN HUM GENET, V73, P456, DOI 10.1111/j.1469-1809.2009.00527.x; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Riquet J, 1999, P NATL ACAD SCI USA, V96, P9252, DOI 10.1073/pnas.96.16.9252; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schroder W, 2012, ANIM GENET, V43, P392, DOI 10.1111/j.1365-2052.2011.02265.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Thomsen H, 2001, J ANIM BREED GENET, V118, P357, DOI 10.1046/j.1439-0388.2001.00302.x; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Turner LB, 2010, ANIM PROD SCI, V50, P235, DOI 10.1071/AN09135; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Vasilopoulos Y, 2007, ALLERGY, V62, P514, DOI 10.1111/j.1398-9995.2007.01350.x; Viitala SM, 2003, J DAIRY SCI, V86, P1828, DOI 10.3168/jds.S0022-0302(03)73769-2; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	70	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83625	10.1371/journal.pone.0083625	http://dx.doi.org/10.1371/journal.pone.0083625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386238	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700065
J	Yang, C; Wang, J; Fang, Y; Sun, YH				Yang, Chen; Wang, Jie; Fang, Yun; Sun, Yue-Hua			Is Sexual Ornamentation an Honest Signal of Male Quality in the Chinese Grouse (Tetrastes sewerzowi)?	PLOS ONE			English	Article							AUTUMN TERRITORIAL BEHAVIOR; RED GROUSE; OXIDATIVE STRESS; TRICHOSTRONGYLUS-TENUIS; PHYSIOLOGICAL-STATE; IMMUNE FUNCTION; TESTOSTERONE; CAROTENOIDS; PARASITES; SELECTION	We examined the variation in sexual ornamentation of male Chinese grouse (Tetrastes sewerzowi) in the Gansu Province, China, seeking to identify factors involved in whether ornament size and brightness are honest signals of male quality. Compared to unmated males, mated males had significantly larger and redder combs and, although they did not have significantly larger territories, they defended them more vigorously. Mated males had significantly higher blood carotenoid and testosterone levels, significantly better body condition, and significantly lower parasite loads than unmated males. Our findings are thus consistent with the hypothesis that comb size and color are honest signals of better male quality in the grouse, mediated through lower parasite loads and/or higher testosterone levels.	[Yang, Chen; Wang, Jie; Fang, Yun; Sun, Yue-Hua] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Yang, Chen; Wang, Jie] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Sun, YH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	sunyh@ioz.ac.cn		yang, chen/0000-0001-5186-9847	National Natural Sciences Foundation of China [31071931, 30620130110]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the National Natural Sciences Foundation of China (Project 31071931, 30620130110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; Alatalo RV, 1996, P ROY SOC B-BIOL SCI, V263, P1697, DOI 10.1098/rspb.1996.0248; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Bergmann HH, 1996, DIE HASELHUHNER BONA; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; COLLINS WP, 1972, J STEROID BIOCHEMIST, V3, P333, DOI 10.1016/0022-4731(72)90080-5; Delahay RJ, 1996, CONDOR, V98, P501, DOI 10.2307/1369564; Endrulat EG, 2005, NORTHEAST NAT, V12, P411, DOI 10.1656/1092-6194(2005)012[0411:HSAHRS]2.0.CO;2; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Furlow B, 1998, AUK, V115, P763, DOI 10.2307/4089425; FURUYAMA S, 1970, STEROIDS, V16, P415, DOI 10.1016/S0039-128X(70)80124-6; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; HILL GE, 1990, ANIM BEHAV, V40, P563, DOI 10.1016/S0003-3472(05)80537-8; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; JAMIESON IG, 1983, AUK, V100, P653, DOI 10.1093/auk/100.3.653; Ji Ting, 2005, Chinese Journal of Zoology, V40, P49; Kenward RE, 2006, RANGES7EXTRA ANAL TR; Klaus S, 1998, J ORNITHOL, V139, P185, DOI 10.1007/BF01651228; Klaus Siegfried, 2009, International Journal of Galliformes Conservation, V1, P44; Kotiaho JS, 2007, FUNCT ECOL, V21, P638, DOI 10.1111/j.1365-2435.2007.01286.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Martinez-Padilla J, 2007, BIOL LETTERS, V3, P161, DOI 10.1098/rsbl.2006.0593; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; MOSS R, 1979, AGGRESSIVE BEHAV, V5, P59, DOI 10.1002/1098-2337(1979)5:1<59::AID-AB2480050108>3.0.CO;2-S; MOSS R, 1994, P ROY SOC B-BIOL SCI, V258, P175, DOI 10.1098/rspb.1994.0159; Mougeot F, 2007, FUNCT ECOL, V21, P886, DOI 10.1111/j.1365-2435.2007.01302.x; Mougeot F, 2007, BEHAV ECOL SOCIOBIOL, V61, P741, DOI 10.1007/s00265-006-0304-z; Mougeot F, 2005, OECOLOGIA, V144, P289, DOI 10.1007/s00442-005-0080-x; Mougeot F, 2005, HORM BEHAV, V47, P576, DOI 10.1016/j.yhbeh.2004.11.021; Mougeot F, 2004, J AVIAN BIOL, V35, P425, DOI 10.1111/j.0908-8857.2004.03256.x; Mougeot F, 2004, BEHAV ECOL, V15, P930, DOI 10.1093/beheco/arh087; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Mougeot F, 2009, J AVIAN BIOL, V40, P67, DOI 10.1111/j.1600-048X.2008.04439.x; Navara KJ, 2012, BEHAV ECOL, V23, P1036, DOI 10.1093/beheco/ars068; Newborn D, 2002, J APPL ECOL, V39, P909, DOI 10.1046/j.1365-2664.2002.00771.x; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Perez-Rodriguez L, 2008, J EXP BIOL, V211, P2155, DOI 10.1242/jeb.017178; Perez-Rodriguez L, 2007, PHYSIOL BIOCHEM ZOOL, V80, P250, DOI 10.1086/510638; Perez-Rodriguez L, 2006, ANIM BEHAV, V72, P97, DOI 10.1016/j.anbehav.2005.09.021; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Qi W, 2007, CHINA FOOD ADDITIVES, V6; Rintamaki PT, 2000, BEHAV ECOL, V11, P465, DOI 10.1093/beheco/11.5.465; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rubenstein DR, 2008, TRENDS ECOL EVOL, V23, P655, DOI 10.1016/j.tree.2008.07.010; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Saks L, 2003, FUNCT ECOL, V17, P555, DOI 10.1046/j.1365-2435.2003.00765.x; SAVORY CJ, 1983, ORNIS SCAND, V14, P135, DOI 10.2307/3676017; Seivwright LJ, 2004, J HELMINTHOL, V78, P69, DOI 10.1079/JOH2003220; Shaw JL, 1988, THESIS; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Sun YH, 2003, BIOL CONSERV, V110, P177, DOI 10.1016/S0006-3207(02)00187-8; Sun YH, 2000, WILDLIFE BIOL, V6, P271, DOI 10.2981/wlb.2000.026; Swenson JE, 1996, J ORNITHOL, V137, P253, DOI 10.1007/BF01653640; Van Oort H, 2005, FUNCT ECOL, V19, P822, DOI 10.1111/j.1365-2435.2005.01035.x; Villafuerte R, 1998, ECOL LETT, V1, P151; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Whitworth Darell, 2007, FAO ANIMAL PRODUCTIO; WINGFIELD JC, 1987, AM SCI, V75, P602; WITTENBERGER JF, 1978, CONDOR, V80, P126, DOI 10.2307/1367912; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; Zheng GM, 1995, ORNITHOLOGY; Zheng GM, 1998, CHINA RED DATA BOOK, P104	71	10	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e82972	10.1371/journal.pone.0082972	http://dx.doi.org/10.1371/journal.pone.0082972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386132	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700022
J	Kelly, R; Davey, SK				Kelly, Ryan; Davey, Scott K.			Tousled-Like Kinase-Dependent Phosphorylation of Rad9 Plays a Role in Cell Cycle Progression and G2/M Checkpoint Exit	PLOS ONE			English	Article							REPLICATION PROTEIN-A; DNA-DAMAGE; FACTOR-C; ATM; HRAD9; RAD9-HUS1-RAD1; COMPLEXES; RECOVERY; REGION; REPAIR	Genomic integrity is preserved by checkpoints, which act to delay cell cycle progression in the presence of DNA damage or replication stress. The heterotrimeric Rad9-Rad1-Hus1 (9-1-1) complex is a PCNA-like clamp that is loaded onto DNA at structures resulting from damage and is important for initiating and maintaining the checkpoint response. Rad9 possesses a C-terminal tail that is phosphorylated constitutively and in response to cell cycle position and DNA damage. Previous studies have identified tousled-like kinase 1 (TLK1) as a kinase that may modify Rad9. Here we show that Rad9 is phosphorylated in a TLK-dependent manner in vitro and in vivo, and that T355 within the C-terminal tail is the primary targeted residue. Phosphorylation of Rad9 at T355 is quickly reduced upon exposure to ionizing radiation before returning to baseline later in the damage response. We also show that TLK1 and Rad9 interact constitutively, and that this interaction is enhanced in chromatin-bound Rad9 at later stages of the damage response. Furthermore, we demonstrate via siRNA-mediated depletion that TLK1 is required for progression through S-phase in normally cycling cells, and that cells lacking TLK1 display a prolonged G2/M arrest upon exposure to ionizing radiation, a phenotype that is mimicked by over-expression of a Rad9-T355A mutant. Given that TLK1 has previously been shown to be transiently inactivated upon phosphorylation by Chk1 in response to DNA damage, we propose that TLK1 and Chk1 act in concert to modulate the phosphorylation status of Rad9, which in turn serves to regulate the DNA damage response.	[Kelly, Ryan; Davey, Scott K.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON, Canada; [Kelly, Ryan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Davey, Scott K.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; McMaster University; Queens University - Canada	Davey, SK (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON, Canada.	scott.davey@queensu.ca			National Cancer Institute of Canada, through Canadian Cancer Society [016390]; Ontario Chapter of the Canadian Breast Cancer Foundation; Canadian Foundation for Innovation Leaders Opportunity Fund [12598]; Ontario Research Fund	National Cancer Institute of Canada, through Canadian Cancer Society; Ontario Chapter of the Canadian Breast Cancer Foundation; Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Ontario Research Fund	This work was supported by the National Cancer Institute of Canada, through funds from the Canadian Cancer Society (grant 016390), and by the Ontario Chapter of the Canadian Breast Cancer Foundation (grant name "BRCA1 Status"). Infrastructure used in the course of this work was purchased with funds from the Canadian Foundation for Innovation Leaders Opportunity Fund (grant 12598) and the Ontario Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Battu A, 2011, NUCLEIC ACIDS RES, V39, P7931, DOI 10.1093/nar/gkr523; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Canfield C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-110; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Dutta B, 2012, J PROTEOMICS, V75, P5493, DOI 10.1016/j.jprot.2012.06.030; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Galvani A, 2008, MOL CELL BIOL, V28, P3672, DOI 10.1128/MCB.00510-07; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Greer DA, 2003, CANCER RES, V63, P4829; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; KASTAN MB, 1991, CANCER RES, V51, P6304; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kleiner HE, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-5; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lieberman HB, 1996, P NATL ACAD SCI USA, V93, P13890, DOI 10.1073/pnas.93.24.13890; Macurek L, 2013, CELL CYCLE, V12, P251, DOI 10.4161/cc.23057; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Naryzhny SN, 2005, J BIOL CHEM, V280, P13888, DOI 10.1074/jbc.M500304200; Pilyugin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008328; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Riva F, 2004, EXP CELL RES, V293, P357, DOI 10.1016/j.yexcr.2003.10.025; Roe JL, 1997, J BIOL CHEM, V272, P5838, DOI 10.1074/jbc.272.9.5838; Ronald S, 2011, PROSTATE, V71, P1367, DOI 10.1002/pros.21358; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shabbeer S, 2013, ONCOGENE, V32, P5005, DOI 10.1038/onc.2012.522; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; St Onge RP, 2001, J BIOL CHEM, V276, P41898, DOI 10.1074/jbc.M105152200; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; Sunauala-Dossabhoy G, 2009, DNA REPAIR, V8, P87, DOI 10.1016/j.dnarep.2008.09.005; Ueda S, 2012, GENES CELLS, V17, P807, DOI 10.1111/j.1365-2443.2012.01630.x; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Zhan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044923; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	64	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85859	10.1371/journal.pone.0085859	http://dx.doi.org/10.1371/journal.pone.0085859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376897	Green Published, gold, Green Submitted			2022-12-27	WOS:000328745100211
J	Alonso-Gonzalez, IJ; Aristegui, J; Lee, C; Sanchez-Vidal, A; Calafat, A; Fabres, J; Sangra, P; Mason, E				Alonso-Gonzalez, Ivan J.; Aristegui, Javier; Lee, Cindy; Sanchez-Vidal, Anna; Calafat, Antoni; Fabres, Joan; Sangra, Pablo; Mason, Evan			Carbon Dynamics within Cyclonic Eddies: Insights from a Biomarker Study	PLOS ONE			English	Article							NORTHEAST ATLANTIC-OCEAN; TIME-SERIES; ORGANIC-MATTER; SEDIMENT TRAPS; AMINO-ACIDS; MESOSCALE EDDIES; SOUTHERN-OCEAN; EDDY; ISLAND; EXPORT	It is generally assumed that episodic nutrient pulses by cyclonic eddies into surface waters support a significant fraction of the primary production in subtropical low-nutrient environments in the northern hemisphere. However, contradictory results related to the influence of eddies on particulate organic carbon (POC) export have been reported. As a step toward understanding the complex mechanisms that control export of material within eddies, we present here results from a sediment trap mooring deployed within the path of cyclonic eddies generated near the Canary Islands over a 1.5-year period. We find that, during summer and autumn (when surface stratification is stronger, eddies are more intense, and a relative enrichment in CaCO3 forming organisms occurs), POC export to the deep ocean was 2-4 times higher than observed for the rest of the year. On the contrary, during winter and spring (when mixing is strongest and the seasonal phytoplankton bloom occurs), no significant enhancement of POC export associated with eddies was observed. Our biomarker results suggest that a large fraction of the material exported from surface waters during the late-winter bloom is either recycled in the mesopelagic zone or bypassed by migrant zooplankton to the deep scattering layer, where it would disaggregate to smaller particles or be excreted as dissolved organic carbon. Cyclonic eddies, however, would enhance carbon export below 1000 m depth during the summer stratification period, when eddies are more intense and frequent, highlighting the important role of eddies and their different biological communities on the regional carbon cycle.	[Alonso-Gonzalez, Ivan J.; Aristegui, Javier; Sangra, Pablo] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global IOCAG, Las Palmas Gran Canaria, Spain; [Alonso-Gonzalez, Ivan J.] Spanish Bank Algae BEA, Telde, Spain; [Lee, Cindy] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Sanchez-Vidal, Anna; Calafat, Antoni] Univ Barcelona, Fac Geol, GRC Geociencies Marines, Barcelona, Spain; [Fabres, Joan] UNEP GRID Arendal, UNEP Shelf Programme Facil, Arendal, Norway; [Mason, Evan] CMIMA CSIC, Inst Ciencies Mar, Grp Oceanog Fis, Barcelona, Spain; [Mason, Evan] Mediterranean Inst Adv Studies IMEDEA, Esporles, Spain	Universidad de Las Palmas de Gran Canaria; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Alonso-Gonzalez, IJ (corresponding author), Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global IOCAG, Las Palmas Gran Canaria, Spain.	ialonso@oceomic.com	Calafat, Antoni/J-5848-2017; Mason, Evan/A-5101-2019; Arístegui, Javier/D-5833-2013; Lee, Cindy/B-1456-2009; Sanchez-Vidal, Anna/B-6919-2016; Sangra, Pablo/I-1350-2015	Calafat, Antoni/0000-0001-7927-3105; Mason, Evan/0000-0002-2283-6285; Arístegui, Javier/0000-0002-7526-7741; Lee, Cindy/0000-0002-7608-6213; Sanchez-Vidal, Anna/0000-0002-8209-1959; Alonso-Gonzalez, Ivan/0000-0003-4593-0482; Sangra, Pablo/0000-0002-6600-2194	Spanish "Plan Nacional de I+D'' under the RODA project [CTM2004-06842-C03-03/MAR]; Spanish "Plan Nacional de I+D'' under the PUMP project [CMT2012-33355]; Spanish "Plan Nacional de I+D'' under the HOTMIX project [CTM2011-30010-C02-01]; Generalitat de Catalunya "Grups de Recerca Consolidats'' grant [2009 SGR-1305]; Office of Naval Research [N00014-08-1-0597]; National Center for Supercomputing Applications [OCE030007]	Spanish "Plan Nacional de I+D'' under the RODA project; Spanish "Plan Nacional de I+D'' under the PUMP project; Spanish "Plan Nacional de I+D'' under the HOTMIX project; Generalitat de Catalunya "Grups de Recerca Consolidats'' grant(Generalitat de Catalunya); Office of Naval Research(Office of Naval Research); National Center for Supercomputing Applications	This work was funded through the Spanish "Plan Nacional de I+D'' under the RODA (CTM2004-06842-C03-03/MAR), PUMP (CMT2012-33355) and HOTMIX (CTM2011-30010-C02-01) projects. A. S-V. and A. C. acknowledge a Generalitat de Catalunya "Grups de Recerca Consolidats'' grant (2009 SGR-1305). The ROMS model configuration was developed at UCLA, where ROMS development is supported by the Office of Naval Research (currently grant N00014-08-1-0597). The ROMS work was partially supported by the National Center for Supercomputing Applications under the grant number OCE030007 and utilized the abe system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Gonzalez IJ, 2010, BIOGEOSCIENCES, V7, P2101, DOI 10.5194/bg-7-2101-2010; Alonso-Gonzalez IJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003185; Alonso-Gonzalez IJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043827; Aristegui J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021863; Aristegui J, 1997, DEEP-SEA RES PT I, V44, P71, DOI 10.1016/S0967-0637(96)00093-3; ARISTEGUI J, 1994, DEEP-SEA RES PT I, V41, P1509, DOI 10.1016/0967-0637(94)90058-2; Aristegui J, 2003, AQUAT MICROB ECOL, V33, P289, DOI 10.3354/ame033289; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Baltar F, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043105; Baltar F, 2009, LIMNOL OCEANOGR, V54, P182, DOI 10.4319/lo.2009.54.1.0182; Barton ED, 1998, PROG OCEANOGR, V41, P455, DOI 10.1016/S0079-6611(98)00023-8; Basterretxea G, 2000, MAR ECOL PROG SER, V197, P27, DOI 10.3354/meps197027; Benitez-Nelson CR, 2008, DEEP-SEA RES PT II, V55, P1133, DOI 10.1016/j.dsr2.2008.03.001; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; Buesseler KO, 2008, DEEP-SEA RES PT II, V55, P1426, DOI 10.1016/j.dsr2.2008.02.007; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; BUTMAN CA, 1986, J MAR RES, V44, P645, DOI 10.1357/002224086788403051; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Dauwe B, 1998, LIMNOL OCEANOGR, V43, P782, DOI 10.4319/lo.1998.43.5.0782; Goni MA, 2000, MAR CHEM, V71, P23, DOI 10.1016/S0304-4203(00)00037-2; Goutx M, 2007, LIMNOL OCEANOGR, V52, P1645, DOI 10.4319/lo.2007.52.4.1645; Gruber N, 2011, NAT GEOSCI, V4, P787, DOI [10.1038/NGEO1273, 10.1038/ngeo1273]; Gust G, 1996, AQUAT SCI, V58, P297, DOI 10.1007/BF00877473; Hernandez-Leon S, 2001, DEEP-SEA RES PT I, V48, P1071, DOI 10.1016/S0967-0637(00)00074-1; Hernandez-Leon S, 2010, LIMNOL OCEANOGR, V55, P2503, DOI 10.4319/lo.2010.55.6.2503; HEUSSNER S, 1990, CONT SHELF RES, V10, P943, DOI 10.1016/0278-4343(90)90069-X; Ingalls AE, 2003, DEEP-SEA RES PT II, V50, P713, DOI 10.1016/S0967-0645(02)00592-1; Ingalls AE, 2006, DEEP-SEA RES PT I, V53, P836, DOI 10.1016/j.dsr.2006.01.004; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Jimenez B, 2008, OCEAN MODEL, V22, P146, DOI 10.1016/j.ocemod.2008.02.004; Lee C, 2000, DEEP-SEA RES PT I, V47, P1535, DOI 10.1016/S0967-0637(99)00116-8; Maiti K, 2008, DEEP-SEA RES PT II, V55, P1445, DOI 10.1016/j.dsr2.2008.02.008; Mason E, 2009, THESIS U LAS PALMAS; Mason E, 2013, J ATMOS OCEANI UNPUB; Mason E, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006665; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Neuer S, 2007, PROG OCEANOGR, V72, P1, DOI 10.1016/j.pocean.2006.08.001; Piedeleu M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037010; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; Sangra P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002526; Sangra P, 2007, DEEP-SEA RES PT I, V54, P687, DOI 10.1016/j.dsr.2007.02.004; Sangra P, 2009, DEEP-SEA RES PT I, V56, P2100, DOI 10.1016/j.dsr.2009.08.008; Scholten JC, 2001, DEEP-SEA RES PT II, V48, P2383, DOI 10.1016/S0967-0645(00)00176-4; Shchepetkin AF, 2009, J COMPUT PHYS, V228, P8985, DOI 10.1016/j.jcp.2009.09.002; Sheridan CC, 2002, DEEP-SEA RES PT I, V49, P1983, DOI 10.1016/S0967-0637(02)00118-8; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; Turnewitsch R, 2007, MAR CHEM, V105, P208, DOI 10.1016/j.marchem.2007.01.017; UNESCO, 1994, MANUAL GUIDES, V29, P169; Wakeham SG, 2009, DEEP-SEA RES PT II, V56, P1437, DOI 10.1016/j.dsr2.2008.11.030; Williams RG, 2011, NAT GEOSCI, V4, P739, DOI 10.1038/ngeo1307; Yu EF, 2001, DEEP-SEA RES PT I, V48, P865, DOI 10.1016/S0967-0637(00)00067-4	55	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e82447	10.1371/journal.pone.0082447	http://dx.doi.org/10.1371/journal.pone.0082447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386098	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700007
J	Renand, A; Milpied, P; Rossignol, J; Bruneau, J; Lemonnier, F; Dussiot, M; Coulon, S; Hermine, O				Renand, Amedee; Milpied, Pierre; Rossignol, Julien; Bruneau, Julie; Lemonnier, Francois; Dussiot, Michael; Coulon, Severine; Hermine, Olivier			Neuropilin-1 Expression Characterizes T Follicular Helper (Tfh) Cells Activated during B Cell Differentiation in Human Secondary Lymphoid Organs	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; DENDRITIC CELLS; IN-VIVO; GROWTH; CANCER; SUBSET; BCL-6; DYNAMICS; MARKERS; BCI6	T follicular helper (Tfh) cells play an essential role in the development of antigen-specific B cell immunity. Tfh cells regulate the differentiation and survival of activated B cells outside and inside germinal centers (GC) of secondary lymphoid organs. They act through cognate contacts with antigen-presenting B cells, but there is no current marker to specifically identify those Tfh cells which productively interact with B cells. Here we show that neuropilin 1 (Nrp1), a cell surface receptor, is selectively expressed by a subset of Tfh cells in human secondary lymphoid organs. Nrp1 expression on Tfh cells correlates with B cell differentiation in vivo and in vitro, is transient, and can be induced upon co-culture with autologous memory B cells in a cell contact-dependent manner. Comparative analysis of ex vivo Nrp1(+) and Nrp1(-) Tfh cells reveals gene expression modulation during activation. Finally, Nrp1 is expressed by malignant Tfh-like cells in a severe case of angioimmunoblastic T-cell lymphoma (AITL) associated with elevated terminal B cell differentiation. Thus, Nrp1 is a specific marker of Tfh cells cognate activation in humans, which may prove useful as a prognostic factor and a therapeutic target in neoplastic diseases associated with Tfh cells activity.	[Renand, Amedee; Milpied, Pierre; Rossignol, Julien; Bruneau, Julie; Dussiot, Michael; Coulon, Severine; Hermine, Olivier] Univ Paris 05, Sorbonne Paris Cite, Hop Necker, CNRS,UMR 8147, Paris, France; [Lemonnier, Francois; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol Adulte, Paris, France; [Bruneau, Julie] Hop Necker Enfants Malad, AP HP, Serv Anatomopathol, Paris, France; [Rossignol, Julien; Bruneau, Julie; Dussiot, Michael; Coulon, Severine; Hermine, Olivier] Inst Imagine, Paris, France; [Rossignol, Julien; Bruneau, Julie; Dussiot, Michael; Coulon, Severine; Hermine, Olivier] Univ Paris 04, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Hermine, O (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Hop Necker, CNRS,UMR 8147, Paris, France.	ohermine@gmail.com	Hermine, Olivier/Q-7072-2018; Milpied, Pierre J/Q-1380-2015; Renand, Amedee/A-9884-2018	Milpied, Pierre J/0000-0003-1873-5358; Renand, Amedee/0000-0003-2265-549X; Bruneau, Julie/0000-0001-5519-8489; Lemonnier, Francois/0000-0001-6205-5419; Hermine, Olivier/0000-0003-2574-3874	Ligue Nationale contre le Cancer (LNCC, France); Fondation pour la Recherche Medicale (FRM, France); Ministere de la Recherche, Association pour la Recherche contre le Cancer (ARC, France); INCa (France); ANR (France); Canceropole (France); Fondation de France (France)	Ligue Nationale contre le Cancer (LNCC, France); Fondation pour la Recherche Medicale (FRM, France)(Fondation pour la Recherche Medicale); Ministere de la Recherche, Association pour la Recherche contre le Cancer (ARC, France); INCa (France)(Institut National du Cancer (INCA) France); ANR (France)(French National Research Agency (ANR)); Canceropole (France); Fondation de France (France)(Fondation de France)	This work was supported by grants from Ligue Nationale contre le Cancer (LNCC, France), Fondation pour la Recherche Medicale (FRM, France), Ministere de la Recherche, Association pour la Recherche contre le Cancer (ARC, France), INCa (France), ANR (France), Canceropole (France) and the Fondation de France (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Tato A, 2012, IMMUNITY; Battaglia A, 2008, IMMUNOLOGY, V123, P129, DOI 10.1111/j.1365-2567.2007.02737.x; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Ellyard JI, 2012, BLOOD, V120, P812, DOI 10.1182/blood-2011-07-365130; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Jackson SM, 2009, BLOOD, V113, P3999, DOI 10.1182/blood-2008-03-145979; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Karjalainen K, 2011, BLOOD, V117, P920, DOI 10.1182/blood-2010-05-282921; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim JR, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-3; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lemonnier F, 2012, BLOOD; Lepelletier Y, 2007, P NATL ACAD SCI USA, V104, P5545, DOI 10.1073/pnas.0700705104; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Mendes-da-Cruz DA, 2009, PUBMED, V1153, P20, DOI [10.1111/j.1749-6632.2008.03980.x, DOI 10.1111/J.1749-6632.2008.03980.X.PUBMED:19236324]; Milpied P, 2011, BLOOD, V118, P2993, DOI 10.1182/blood-2011-01-329268; Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nasarre C, 2010, ONCOGENE, V29, P2381, DOI 10.1038/onc.2010.9; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	51	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e85589	10.1371/journal.pone.0085589	http://dx.doi.org/10.1371/journal.pone.0085589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386482	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700142
J	Xin, YH; Bian, BSJ; Yang, XJ; Cui, W; Cui, HJ; Cui, YH; Zhang, X; Xu, C; Bian, XW				Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, Hong-juan; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu			POU5F1 Enhances the Invasiveness of Cancer Stem-Like Cells in Lung Adenocarcinoma by Upregulation of MMP-2 Expression	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; POOR-PROGNOSIS; INVASION; MIGRATION; PROLIFERATION; PROGRESSION; SURVIVAL; OCT4	Lung cancer is the leading cause of cancer-related human deaths. Exploration of the mechanisms underlying the metastasis of cancer stem-like cells (CSLCs) will open new avenues in lung cancer diagnosis and therapy. Here, we demonstrated that CSLCs-derived from lung adenocarcinoma (LAC) cells displayed highly invasive and migratory capabilities via expressing high levels of POU5F1 and MMP-2. We found that POU5F1 directly regulated MMP-2 transcription via interaction with the promoter of MMP-2. POU5F1 knockdown in LACSLCs reduced MMP-2 protein abundance, leading to inhibition of the cell invasion, migration and tumorigenesis potentials of LAC cells. Clinically, aberrantly high expressions of POU5F1 and MMP-2 were inversely correlated with the survival of LAC patients, and the double-positive POU5F1 and MMP-2 showed the worst prediction for the patient's poor survival. These results indicate that POU5F1 can bind to the MMP-2 promoter for the degradation of surrounding extracellular matrix, and therefore promote invasive and migratory capabilities of LACSLCs. Moreover, our data implicate that the pathological detection of the double-positive expressions for POU5F1 and MMP-2 will be useful as diagnostic and prognostic biomarkers in LAC to advance anti-metastasis therapy.	[Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Xin, Yan-hong; Bian, Bai-shi-jiao; Yang, Xiao-jun; Cui, Wei; Cui, You-hong; Zhang, Xia; Xu, Chuan; Bian, Xiu-wu] Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Xu, Chuan] Gen Hosp PLA Chengdu Mil Area Command, Dept Oncol, Chengdu, Peoples R China; [Cui, Hong-juan] Southwest Univ, Inst Sericulture & Syst Biol, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Bian, Bai-shi-jiao] Chongqing Med Univ, Yongchuan Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Ministry of Education, China; Southwest University - China; Chongqing Medical University	Xu, C (corresponding author), Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China.	xuchuan100@163.com; bianxiuwu@263.net	Bian, Xiu-Wu/D-4736-2017; Zhang, Xia/B-8152-2008	Bian, Xiu-Wu/0000-0003-4383-0197; Zhang, Xia/0000-0002-9040-1486; XU, CHUAN/0000-0002-5320-2277	National Basic Research Program of China (973 Program) [2010CB529403]; National Natural Science Foundations of China [81272598]; China Postdoctoral Science Foundation [2012T50852]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Basic Research Program of China (973 Program, Grant No.2010CB529403), National Natural Science Foundations of China (Grant No.81272598) and China Postdoctoral Science Foundation (Grant No.2012T50852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chien MH, 2013, EXPERT OPIN THER TAR, V17, P203, DOI 10.1517/14728222.2013.740012; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Duan JJ, 2013, STEM CELLS DEV, V22, P2221, DOI 10.1089/scd.2012.0613; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; He LR, 2010, ANN ONCOL, V21, P1675, DOI 10.1093/annonc/mdp592; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kim Y, 2009, BMB REP, V42, P758, DOI 10.5483/BMBRep.2009.42.11.758; Kobayashi K, 2012, J CELL BIOCHEM, V113, P508, DOI 10.1002/jcb.23374; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Marsden CG, 2009, METHODS MOL BIOL, V590, P363, DOI 10.1007/978-1-60327-378-7_23; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Qian QA, 2010, CANCER INVEST, V28, P661, DOI 10.3109/07357901003735634; Rivera C, 2011, J ONCOL, V2011, DOI 10.1155/2011/549181; Shi MM, 2013, MOL BIOL REP, V40, P617, DOI 10.1007/s11033-012-2100-3; Sobin, 2009, UICC TNM CLASSIFICAT; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Sullivan JP, 2010, CELL STEM CELL, V7, P2, DOI 10.1016/j.stem.2010.06.005; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Wang CK, 2010, CANCER LETT, V292, P261, DOI 10.1016/j.canlet.2009.12.010; Wang J, 2013, MOL CANCER THER, V12, P925, DOI 10.1158/1535-7163.MCT-12-1045; Wu KC, 2012, ANTICANCER RES, V32, P4833; Xu C, 2013, CANCER RES, V73, P3181, DOI 10.1158/0008-5472.CAN-12-4403; Xu XF, 2013, INT J BIOCHEM CELL B, V45, P536, DOI 10.1016/j.biocel.2012.12.010; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Yu SC, 2012, STEM CELLS, V30, P108, DOI 10.1002/stem.1685; Zhang XY, 2010, JPN J CLIN ONCOL, V40, P961, DOI 10.1093/jjco/hyq066	33	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83373	10.1371/journal.pone.0083373	http://dx.doi.org/10.1371/journal.pone.0083373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386189	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700037
J	Biot, FV; Lopez, MM; Poyot, T; Neulat-Ripoll, F; Lignon, S; Caclard, A; Thibault, FM; Peinnequin, A; Pages, JM; Valade, E				Biot, Fabrice Vincent; Lopez, Melanie Monique; Poyot, Thomas; Neulat-Ripoll, Fabienne; Lignon, Sabrina; Caclard, Arnaud; Thibault, Francois Michel; Peinnequin, Andre; Pages, Jean-Marie; Valade, Eric			Interplay between Three RND Efflux Pumps in Doxycycline-Selected Strains of Burkholderia thailandensis	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; GENE-EXPRESSION DATA; MEXA-MEXB-OPRM; BPEAB-OPRB; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; MULTIDRUG-RESISTANCE; PSEUDOMALLEI; CHLORAMPHENICOL; STANDARDIZATION	Background: Efflux systems are involved in multidrug resistance in most Gram-negative non-fermentative bacteria. We have chosen Burkholderia thailandensis to dissect the development of multidrug resistance phenotypes under antibiotic pressure. Methodology/Principal Findings: We used doxycycline selection to obtain several resistant B. thailandensis variants. The minimal inhibitory concentrations of a large panel of structurally unrelated antibiotics were determined 6 the efflux pump inhibitor phenylalanine-arginine SS-naphthylamide (PASSN). Membrane proteins were identified by proteomic method and the expressions of major efflux pumps in the doxycycline selected variants were compared to those of the parental strains by a quantitative RT-PCR analysis. Doxycycline selected variants showed a multidrug resistance in two major levels corresponding to the overproduction of two efflux pumps depending on its concentration: AmrAB-OprA and BpeEF-OprC. The study of two mutants, each lacking one of these pumps, indicated that a third pump, BpeAB-OprB, could substitute for the defective pump. Surprisingly, we observed antagonistic effects between PASSN and aminoglycosides or some ss-lactams. PA beta N induced the overexpression of AmrAB-OprA and BpeAB-OprB pump genes, generating this unexpected effect. Conclusions/Significance: These results may account for the weak activity of PASSN in some Gram-negative species. We clearly demonstrated two antagonistic effects of this molecule on bacterial cells: the blocking of antibiotic efflux and an increase in efflux pump gene expression. Thus, doxycycline is a very efficient RND efflux pump inducer and PASSN may promote the production of some efflux pumps. These results should be taken into account when considering antibiotic treatments and in future studies on efflux pump inhibitors.	[Biot, Fabrice Vincent; Lopez, Melanie Monique; Neulat-Ripoll, Fabienne; Caclard, Arnaud; Thibault, Francois Michel; Valade, Eric] Inst Rech Biomed Armees, Unite Bacteriol UMR MD 1, Bretigny Sur Orge, France; [Biot, Fabrice Vincent; Neulat-Ripoll, Fabienne; Caclard, Arnaud; Thibault, Francois Michel; Pages, Jean-Marie; Valade, Eric] Aix Marseille Univ, UMR MD 1, IRBA, Fac Med & Pharm, Marseille, France; [Poyot, Thomas; Peinnequin, Andre] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Lignon, Sabrina] Aix Marseille Univ, FR Plate Forme Proteom 3479, CNRS, Marseille, France; [Valade, Eric] Ecole Val de Grace, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Biot, FV (corresponding author), Inst Rech Biomed Armees, Unite Bacteriol UMR MD 1, Bretigny Sur Orge, France.	fabrice.biot@irba.fr	PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977; BIOT, Fabrice/0000-0002-3632-2146; neulat-ripoll, fabienne/0000-0001-5387-0382	French Ministry of Defense [PDH-2-NRBC-4-B-201]; Aix Marseille Universite	French Ministry of Defense; Aix Marseille Universite	This work was supported by the French Ministry of Defense (grant number PDH-2-NRBC-4-B-201) and by the Aix Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biot FV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016892; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Bolla JM, 2011, FEBS LETT, V585, P1682, DOI 10.1016/j.febslet.2011.04.054; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Carr G, 2011, ORG LETT, V13, P3048, DOI 10.1021/ol200922s; Chan YY, 2005, J BACTERIOL, V187, P4707, DOI 10.1128/JB.187.14.4707-4719.2005; Chan YY, 2004, ANTIMICROB AGENTS CH, V48, P1128, DOI 10.1128/AAC.48.4.1128-1135.2004; Chevalier J, 2004, ANTIMICROB AGENTS CH, V48, P1043, DOI 10.1128/AAC.48.3.1043-1046.2004; Cortez-Cordova J, 2011, INT J ANTIMICROB AG, V37, P420, DOI 10.1016/j.ijantimicag.2011.01.006; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Gelhaus HC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01146; Ghisalberti D, 2005, BIOCHEM BIOPH RES CO, V328, P1113, DOI 10.1016/j.bbrc.2005.01.069; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Gotoh N, 1998, ANTIMICROB AGENTS CH, V42, P1938, DOI 10.1128/AAC.42.8.1938; Griffin MO, 2010, AM J PHYSIOL-CELL PH, V299, pC539, DOI 10.1152/ajpcell.00047.2010; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kumar Ayush, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS145, DOI 10.1016/S0035-9203(08)70032-4; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Lister IM, 2012, ANTIMICROB AGENTS CH, V56, P1120, DOI 10.1128/AAC.05338-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mima T, 2011, J ANTIMICROB CHEMOTH, V66, P73, DOI 10.1093/jac/dkq391; Mima T, 2010, ANTIMICROB AGENTS CH, V54, P3113, DOI 10.1128/AAC.01803-09; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Pannek S, 2006, J ANTIMICROB CHEMOTH, V57, P970, DOI 10.1093/jac/dkl081; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Pugniere P, 2011, ANAL BIOCHEM, V415, P151, DOI 10.1016/j.ab.2011.04.008; Rajendran R, 2010, INT J ANTIMICROB AG, V36, P151, DOI 10.1016/j.ijantimicag.2010.03.009; Sarkar-Tyson M, 2011, FUTURE MICROBIOL, V6, P667, DOI [10.2217/FMB.11.50, 10.2217/fmb.11.50]; Schweizer HP, 2012, FUTURE MICROBIOL, V7, P1389, DOI [10.2217/fmb.12.116, 10.2217/FMB.12.116]; Simpson AJH, 1999, ANTIMICROB AGENTS CH, V43, P2332, DOI 10.1128/AAC.43.9.2332; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Trunck LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000519; Udani RA, 2006, ANTIMICROB AGENTS CH, V50, P2971, DOI 10.1128/AAC.00015-06; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	42	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84068	10.1371/journal.pone.0084068	http://dx.doi.org/10.1371/journal.pone.0084068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386333	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900074
J	Dietrich, D; Jung, M; Puetzer, S; Leisse, A; Holmes, EE; Meller, S; Uhl, B; Schatz, P; Ivascu, C; Kristiansen, G				Dietrich, Dimo; Jung, Maria; Puetzer, Svenja; Leisse, Annette; Holmes, Emily Eva; Meller, Sebastian; Uhl, Barbara; Schatz, Philipp; Ivascu, Claudia; Kristiansen, Glen			Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions	PLOS ONE			English	Article							COLORECTAL-CANCER; TUMOR-MARKERS; BIOMARKERS; MANAGEMENT; FLUID; ASSAY; MESOTHELIOMA; PERFORMANCE; EXPERIENCE; EPIGENOME	Pleural effusions (PE) are a common clinical problem. The discrimination between benign (BPE), malignant (MPE) and paramalignant (PPE) pleural effusions is highly important to ensure appropriate patient treatment. Today, cytology is the gold standard for diagnosing malignant pleural effusions. However, its sensitivity is limited due to the sometimes low abundance of tumor cells and the challenging assessment of cell morphology in cytological samples. This study aimed to develop and validate a diagnostic test, which allows for the highly specific detection of malignant cells in pleural effusions based on the DNA methylation biomarkers SHOX2 and SEPT9. A quantitative real-time PCR assay was developed which enabled the accurate and sensitive detection of SHOX2 and SEPT9 in PEs. Cytological and DNA methylation analyses were conducted in a case control study comprised of PEs from 114 patients (58 cases, 56 controls). Cytological analysis as well as SHOX2 and SEPT9 methylation resulted in 100% specificity. 21% of the cases were cytologically positive and 26% were SHOX2 or SEPT9 methylation positive. The combined analysis of cytology and DNA methylation resulted in an increase of 71% positively classified PEs from cancer patients as compared to cytological analysis alone. The absolute sensitivity of cytology and DNA methylation was not determinable due to the lack of an appropriate gold standard diagnostic for distinguishing between MPEs and PPEs. Therefore, it was unclear which PEs from cancer patients were malignant (containing tumor cells) and which PEs were paramalignant and resulted from benign conditions in cancer patients, respectively. Furthermore, DNA methylation analysis in PEs allowed the prognosis of the overall survival in cancer patients (Kaplan-Meier analysis, log rank test, p = 0.02 (SHOX2), p = 0.02 (SEPT9)). The developed test may be used as a diagnostic and prognostic adjunct to existing clinical and cytopathological investigations in patients with PEs of unclear etiology.	[Dietrich, Dimo; Jung, Maria; Puetzer, Svenja; Leisse, Annette; Holmes, Emily Eva; Meller, Sebastian; Uhl, Barbara; Kristiansen, Glen] Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany; [Schatz, Philipp] Metan Hlth GmbH, Berlin, Germany; [Ivascu, Claudia] Roche Pharma AG, Hematol Oncol, Grenzach Wyhlen, Germany	University of Bonn; Roche Holding	Dietrich, D (corresponding author), Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany.	dimo.dietrich@gmail.com						Alatas F, 2001, LUNG CANCER, V31, P9, DOI 10.1016/S0169-5002(00)00153-7; [Anonymous], ONCOLOGIST, V10, P501; Antony VB, 2001, EUR RESPIR J, V18, P402, DOI 10.1183/09031936.01.00225601; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Bhatnagar R, 2013, CLIN CHEST MED, V34, P47, DOI 10.1016/j.ccm.2012.11.004; Brock MV, 2005, ANN THORAC SURG, V80, P1241, DOI 10.1016/j.athoracsur.2005.05.088; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; DIBONITO L, 1992, ACTA CYTOL, V36, P329; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Gonzalez AV, 2010, CHEST, V137, P1375, DOI 10.1378/chest.09-2020; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Heffner JE, 2000, CHEST, V117, P79, DOI 10.1378/chest.117.1.79; Heffner JE, 2008, RESPIROLOGY, V13, P5, DOI 10.1111/j.1440-1843.2007.01154.x; Heichman KA, 2012, CLIN CHEM LAB MED, V50, P1707, DOI 10.1515/cclm-2011-0935; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; JAY SJ, 1985, CLIN CHEST MED, V6, P33; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kneip C, 2009, BIOTECHNIQUES, V47, P737, DOI 10.2144/000113208; LEUALLEN EC, 1955, NEW ENGL J MED, V252, P79, DOI 10.1056/NEJM195501202520301; Lewin J., 2011, United States Patent Application, Patent No. 20110027789; Liang QL, 2008, THORAX, V63, P35, DOI 10.1136/thx.2007.077958; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; MAREL M, 1995, CHEST, V107, P1598, DOI 10.1378/chest.107.6.1598; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; Mitrouska I, 2005, CAN RESPIR J, V11, P499; Park DS, 2012, CLIN EXP METASTAS, V29, P83, DOI 10.1007/s10585-011-9431-7; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; Porcel JM, 2004, CHEST, V126, P1757, DOI 10.1378/chest.126.6.1757; Porcel JM, 2013, DM-DIS MON, V59, P29, DOI 10.1016/j.disamonth.2012.11.002; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Rodriguez-Panadero F, 2008, RESPIRATION, V76, P363, DOI 10.1159/000158545; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Schmidt B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-600; Schneider KU, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-102; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Woenckhaus M, 2005, J MOL DIAGN, V7, P517, DOI 10.1016/S1525-1578(10)60583-1	42	48	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84225	10.1371/journal.pone.0084225	http://dx.doi.org/10.1371/journal.pone.0084225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386354	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900086
J	Gomez-Laplaza, LM; Gerlai, R				Gomez-Laplaza, Luis M.; Gerlai, Robert			The Role of Body Surface Area in Quantity Discrimination in Angelfish (Pterophyllum scalare)	PLOS ONE			English	Article							CONTOUR LENGTH; INFANTS DISCRIMINATION; NUMERICAL COMPETENCE; SHOALING DECISIONS; NUMBER; SIZE; JUDGMENTS; CHOICE; ZEBRAFISH; FISH	Although some fish species have been shown to be able to discriminate between two groups (shoals) of conspecifics differing in the number of members, most studies have not controlled for continuous variables that covary with number. Previously, using angelfish (Pterophyllum scalare) we started the systematic analysis of the potential influence of such continuous variables, and found that they play different roles in shoal discrimination depending on whether large (>= 4 fish) or small (< 4 fish) shoals were contrasted. Here, we examine the potential role of the overall body surface area of stimulus fish in shoal preference, a prominent variable not yet examined in angelfish. We report that both when numerically large (5 versus 10 fish) and when small (2 versus 3 fish) shoals were contrasted, angelfish were unable to discriminate the numerically different shoals as long as the surface area of the contrasted shoals was equated. Thus, we conclude that body surface may be an important continuous variable in shoal discrimination. This conclusion was further supported by the analysis of preference when shoals of the same numerical size but different body surface area were contrasted. We found subjects to spend significantly more time close to the shoals with the greater overall surface area. Last, we conducted an experiment in which we simultaneously controlled a set of continuous variables, including overall surface area, and found angelfish to use the number of shoal members as a cue only in large shoal contrasts but not in small shoal contrasts. This result suggests the potential existence of different processing systems for large and small numbers in fish.	[Gomez-Laplaza, Luis M.] Univ Oviedo, Dept Psychol, Oviedo, Spain; [Gerlai, Robert] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Oviedo; University of Toronto; University Toronto Mississauga	Gomez-Laplaza, LM (corresponding author), Univ Oviedo, Dept Psychol, Oviedo, Spain.	lmgomez@uniovi.es; robert_gerlai@yahoo.com	Laplaza, Luis M. Gómez/ABF-6852-2021	Laplaza, Luis M. Gómez/0000-0003-1572-0580	Ministerio de Ciencia e Innovacion (Spain) [MICINN-10-PSI2010-16487]; NSERC (Canada) Discovery grant	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NSERC (Canada) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grant MICINN-10-PSI2010-16487 from the Ministerio de Ciencia e Innovacion (Spain) to LMG-L, and an NSERC (Canada) Discovery grant to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, DEV PSYCHOBIOL, DOI 10-1002/dev.21122; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2006, ETHOLOGY, V112, P592, DOI 10.1111/j.1439-0310.2006.01188.x; Agrillo C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00483; Agrillo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031923; Agrillo C, 2012, BEHAV BRAIN RES, V230, P343, DOI 10.1016/j.bbr.2012.02.025; Agrillo C, 2011, COGNITION, V119, P281, DOI 10.1016/j.cognition.2010.10.022; Agrillo C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015232; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Armstrong N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00584; Benson-Amram S, 2011, ANIM BEHAV, V82, P743, DOI 10.1016/j.anbehav.2011.07.004; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Beran MJ, 2007, J EXP PSYCHOL-ANIM B, V33, P42, DOI 10.1037/0097-7403.33.1.42; Bisazza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015516; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Booksmythe I, 2013, ANIM BEHAV, V85, P371, DOI 10.1016/j.anbehav.2012.11.009; Brannon EM, 2006, DEVELOPMENTAL SCI, V9, pF59, DOI 10.1111/j.1467-7687.2006.00530.x; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Clearfield MW, 2001, J COGN DEV, V2, P243, DOI 10.1207/S15327647JCD0203_1; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; Emmerton J, 1998, ANIM LEARN BEHAV, V26, P243, DOI 10.3758/BF03199218; Emmerton J, 2009, ANIM COGN, V12, P511, DOI 10.1007/s10071-009-0212-5; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; Frommen JG, 2009, BEHAV ECOL SOCIOBIOL, V63, P1141, DOI 10.1007/s00265-009-0767-9; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gomez-Laplaza LM, 2013, ANIM COGN, V16, P373, DOI 10.1007/s10071-012-0578-7; Gomez-Laplaza LM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00484; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P565, DOI 10.1007/s10071-011-0392-7; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; Jones KA, 2010, ETHOLOGY, V116, P147, DOI 10.1111/j.1439-0310.2009.01727.x; Jones Sarah M, 2012, Front Psychol, V3, P550, DOI 10.3389/fpsyg.2012.00550; Kilian A, 2003, LEARN BEHAV, V31, P133; Krause J, 2002, LIVING GROUPS; Krusche P, 2010, J EXP BIOL, V213, P1822, DOI 10.1242/jeb.039297; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Low J, 2009, IBIS, V151, P775, DOI 10.1111/j.1474-919X.2009.00951.x; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Pahl M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00162; Perdue BM, 2012, ANIM COGN, V15, P955, DOI 10.1007/s10071-012-0521-y; Peuhkuri N, 1997, ANIM BEHAV, V54, P271, DOI 10.1006/anbe.1996.0453; Piffer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062466; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; RANTA E, 1992, ANIM BEHAV, V43, P160, DOI 10.1016/S0003-3472(05)80082-X; Reznikova Z, 2011, BEHAVIOUR, V148, P405, DOI 10.1163/000579511X568562; Rohlf F. J., 2004, TPSDIG VERSION 1 40; Rugani R, 2008, J EXP PSYCHOL-ANIM B, V34, P388, DOI 10.1037/0097-7403.34.3.388; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Scerbina T, 2012, AMINO ACIDS, V43, P2059, DOI 10.1007/s00726-012-1284-0; Stancher G, 2013, ANIM COGN, V16, P307, DOI 10.1007/s10071-012-0590-y; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Svensson PA, 2000, J FISH BIOL, V56, P1477, DOI 10.1111/j.1095-8649.2000.tb02158.x; Utrata Ewelina, 2012, Front Psychol, V3, P505, DOI 10.3389/fpsyg.2012.00505; Vonk J, 2012, ANIM BEHAV, V84, P231, DOI 10.1016/j.anbehav.2012.05.001; Ward AJW, 2001, ANIM BEHAV, V62, P617, DOI 10.1006/anbe.2001.1785; Ward C, 2007, ANIM COGN, V10, P71, DOI 10.1007/s10071-006-0042-7; Wilson ML, 2012, ANIM BEHAV, V83, P277, DOI 10.1016/j.anbehav.2011.11.004; Wood JN, 2005, DEVELOPMENTAL SCI, V8, P173, DOI 10.1111/j.1467-7687.2005.00404.x	66	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83880	10.1371/journal.pone.0083880	http://dx.doi.org/10.1371/journal.pone.0083880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386299	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900064
J	Steuerwald, NM; Foureau, DM; Norton, HJ; Zhou, J; Parsons, JC; Chalasani, N; Fontana, RJ; Watkins, PB; Lee, WM; Reddy, KR; Stolz, A; Talwalkar, J; Davern, T; Saha, D; Bell, LN; Barnhart, H; Gu, JZ; Serrano, J; Bonkovsky, HL				Steuerwald, Nury M.; Foureau, David M.; Norton, H. James; Zhou, Jie; Parsons, Judith C.; Chalasani, Naga; Fontana, Robert J.; Watkins, Paul B.; Lee, William M.; Reddy, K. Rajender; Stolz, Andrew; Talwalkar, Jayant; Davern, Timothy; Saha, Dhanonjoy; Bell, Lauren N.; Barnhart, Huiman; Gu, Jiezhun; Serrano, Jose; Bonkovsky, Herbert L.			Profiles of Serum Cytokines in Acute Drug-Induced Liver Injury and Their Prognostic Significance	PLOS ONE			English	Article							THERAPY; INTERLEUKIN-10; HEPATITIS; IL-10; POLYMORPHISMS; BIOMARKERS; FEATURES; FAILURE; CELLS	Drug-induced liver injury (DILI) is the most common cause of acute liver failure in the United-States. The aim of the study was to describe serum immune profiles associated with acute DILI, to investigate whether there are profiles associated with clinical features or types of DILI and/or with prognosis, and to assess temporal changes in levels. Twenty-seven immune analytes were measured in the sera of 78 DILI subjects in the Drug-Induced Liver Injury Network (DILIN) and compared with 40 healthy controls. Immune analytes (14 cytokines, 7 chemokines and 6 growth factors) were measured by BioPlex multiplex ELISA at DILI onset and after 6 months. A modeling process utilizing immune principles was used to select a final set of variables among 27 immune analytes and several additional clinical lab values for prediction of early death (within 6 months of DILI onset). Nineteen of the 27 immune analytes were differentially expressed among healthy control, DILI onset and 6-month cohorts. Disparate patterns of immune responses, especially innate and adaptive cellular (mostly TH17) immunity were evident. Low values of four immune analytes (IL-9, IL-17, PDGF-bb and RANTES) and serum albumin are predictive of early death [PPV = 88% (95% CI, 65%-100%), NPV = 97% (95% CI, 93%-100%), accuracy = 96% (95% CI, 92%-100%)]. Conclusions: Acute DILI is associated with robust and varying immune responses. High levels of expression of cytokines associated with innate immunity are associated with a poor prognosis, whereas high levels of expression of adaptive cytokines are associated with good long-term prognosis and eventual recovery. Serum immune analyte profiles at DILI onset appear to be of prognostic, and perhaps, diagnostic significance.	[Steuerwald, Nury M.; Foureau, David M.; Norton, H. James; Zhou, Jie; Parsons, Judith C.; Saha, Dhanonjoy; Bonkovsky, Herbert L.] Carolinas Med Ctr, Liver Biliary Pancreat Ctr, Charlotte, NC 28203 USA; [Steuerwald, Nury M.; Foureau, David M.; Norton, H. James; Zhou, Jie; Parsons, Judith C.; Saha, Dhanonjoy; Bonkovsky, Herbert L.] Carolinas Med Ctr, Dept Internal Med, Charlotte, NC 28203 USA; [Steuerwald, Nury M.; Foureau, David M.; Norton, H. James; Zhou, Jie; Parsons, Judith C.; Saha, Dhanonjoy; Bonkovsky, Herbert L.] Carolinas Med Ctr, Dept Gen Surg, Charlotte, NC 28203 USA; [Steuerwald, Nury M.; Foureau, David M.; Norton, H. James; Zhou, Jie; Parsons, Judith C.; Saha, Dhanonjoy; Bonkovsky, Herbert L.] Carolinas Med Ctr, Dept Res, Charlotte, NC 28203 USA; [Steuerwald, Nury M.; Foureau, David M.; Norton, H. James; Zhou, Jie; Parsons, Judith C.; Saha, Dhanonjoy; Bonkovsky, Herbert L.] Carolinas Med Ctr, Dept Dickson Adv Analyt, Charlotte, NC 28203 USA; [Chalasani, Naga; Bell, Lauren N.] IUPUI, Dept Internal Med, Indianapolis, IN USA; [Fontana, Robert J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Watkins, Paul B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Watkins, Paul B.] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Lee, William M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Reddy, K. Rajender] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA; [Stolz, Andrew] Univ So Calif, Dept Internal Med, Los Angeles, CA USA; [Talwalkar, Jayant] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Davern, Timothy] Pacific Med Ctr, Dept Internal Med, San Francisco, CA USA; [Barnhart, Huiman; Gu, Jiezhun] Duke Clin Res Inst, Durham, NC USA; [Serrano, Jose] NIDDK, NIH, Bethesda, MD 20892 USA	Carolinas Medical Center; Carolinas Medical Center; Carolinas Medical Center; Carolinas Medical Center; Carolinas Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; University of Southern California; Mayo Clinic; California Pacific Medical Center; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Steuerwald, NM (corresponding author), Carolinas Med Ctr, Liver Biliary Pancreat Ctr, Charlotte, NC 28203 USA.	nury.steuerwald@carolinas.org	Bonkovsky, Herbert L./AAH-1892-2021; , wife/ABH-2499-2020	Bonkovsky, Herbert L./0000-0001-7387-3230; 	National Institute of Diabetes and Digestive and Kidney Diseases [1U01DK065193, U01DK065211, U01DK065238, U01DK065184, U01DK065201, U01DK83023, U01DK083020, U01DK08992, U01DK083027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK065201, U01DK065193, U01DK083023, U01DK065211, F32DK008992, U01DK065238, U01DK083020, U01DK082992, U01DK065184, U01DK065176, U01DK083027] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by The DILIN (Drug Induced Liver Injury Network) is supported by the National Institute of Diabetes and Digestive and Kidney Diseases. Numbers of the cooperative agreements are as follows: 1U01DK065193, U01DK065211, U01DK065238, U01DK065184, U01DK065201, U01DK83023, U01DK083020, U01DK08992, U01DK083027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 2004, HEPATOLOGY, V39, P1430, DOI 10.1002/hep.20205; Au JS, 2011, ALIMENT PHARM THER, V34, P11, DOI 10.1111/j.1365-2036.2011.04674.x; Bell LN, 2012, ALIMENT PHARM THER, V35, P600, DOI 10.1111/j.1365-2036.2011.04982.x; Bjornsson E, 2010, ALIMENT PHARM THER, V32, P3, DOI 10.1111/j.1365-2036.2010.04320.x; BONKOVSKY HL, 2012, ZAKIM BOYERS HEPATOL, P417; BONKOWSKY HL, 1976, JAMA-J AM MED ASSOC, V236, P1602, DOI 10.1001/jama.236.14.1602; Cacoub P, 2011, AM J MED, V124, P588, DOI 10.1016/j.amjmed.2011.01.017; Callan HE, 2009, CHEM RES TOXICOL, V22, P937, DOI 10.1021/tx900034r; CHALASANI N, 2012, ANN INTERN IN PRESS; Chalasani N, 2010, GASTROENTEROLOGY, V138, P2246, DOI 10.1053/j.gastro.2010.04.001; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Egwuagu CE, 2009, CYTOKINE, V47, P149, DOI 10.1016/j.cyto.2009.07.003; Feng DC, 2009, BIOCHEM PHARMACOL, V77, P277, DOI 10.1016/j.bcp.2008.09.028; Fontana RJ, 2009, DRUG SAFETY, V32, P55, DOI 10.2165/00002018-200932010-00005; GHABRIL M, 2013, CLIN GASTROENTEROL H; Higuchi S, 2012, J APPL TOXICOL, V32, P815, DOI 10.1002/jat.1706; Higuchi S, 2011, TOXICOL LETT, V200, P139, DOI 10.1016/j.toxlet.2010.11.006; Hill DB, 2004, AM J GASTROENTEROL, V99, P261, DOI 10.1111/j.1572-0241.2004.04033.x; Hirayama S, 2013, AM J TRANSPLANT, V13, P1586, DOI 10.1111/ajt.12230; Jutel M, 2011, CURR ALLERGY ASTHM R, V11, P139, DOI 10.1007/s11882-011-0178-7; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kobayashi E, 2009, TOXICOL SCI, V111, P302, DOI 10.1093/toxsci/kfp165; Kobayashi M, 2010, TOXICOLOGY, V275, P50, DOI 10.1016/j.tox.2010.05.011; Laverty HG, 2010, EUR J CLIN PHARMACOL, V66, P961, DOI 10.1007/s00228-010-0862-x; Levy O, 2013, BLOOD, V122, pE23, DOI 10.1182/blood-2013-04-495119; Li JZ, 2010, J IMMUNOTOXICOL, V7, P157, DOI 10.3109/15476910903501748; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mandal P, 2010, WORLD J GASTROENTERO, V16, P1330, DOI 10.3748/wjg.v16.i11.1330; Meng XL, 2011, J PHARMACOL EXP THER, V338, P841, DOI 10.1124/jpet.111.183871; Monshi MM, 2013, HEPATOLOGY, V57, P727, DOI 10.1002/hep.26077; Mumm JB, 2011, CURR TOP MICROBIOL, V344, P25, DOI 10.1007/82_2010_47; Nakashima Hitoshi, 2006, Rinsho Byori, V54, P706; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; Orman ES, 2011, CLIN GASTROENTEROL H, V9, P517, DOI 10.1016/j.cgh.2011.02.019; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pachkoria K, 2008, J HEPATOL, V49, P107, DOI 10.1016/j.jhep.2008.03.017; Poynard T, 2003, J HEPATOL, V38, P518, DOI 10.1016/S0168-8278(03)00045-X; Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937; Rockey DC, 2010, HEPATOLOGY, V51, P2117, DOI 10.1002/hep.23577; Shi Q, 2010, EXPERT REV GASTROENT, V4, P225, DOI [10.1586/egh.10.8, 10.1586/EGH.10.8]; STEUERWALD N, 2011, HEPATOLOGY, V54, DOI DOI 10.1016/S0168-8278(11)60904-5; Takayama H, 2011, J GASTROEN HEPATOL, V26, P116, DOI 10.1111/j.1440-1746.2010.06441.x; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; Uetrecht J, 2009, SEMIN LIVER DIS, V29, P383, DOI 10.1055/s-0029-1240007; Vuppalanchi R, 2010, ALIMENT PHARM THER, V32, P1174, DOI 10.1111/j.1365-2036.2010.04449.x; Wai CT, 2007, LIVER INT, V27, P465, DOI 10.1111/j.1478-3231.2007.01461.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Zimmerman HJ., 1999, HEPATOTOXICITY ADVER, V2nd ed	50	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e81974	10.1371/journal.pone.0081974	http://dx.doi.org/10.1371/journal.pone.0081974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386086	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900007
J	Woelfle, R; Grahn, JA				Woelfle, Rebecca; Grahn, Jessica A.			Auditory and Visual Interhemispheric Communication in Musicians and Non-Musicians	PLOS ONE			English	Article							HUMAN CORPUS-CALLOSUM; HUMAN BRAIN-STEM; VISUOMOTOR INFORMATION; LATERAL LEMNISCUS; TRANSMISSION TIME; WHITE-MATTER; HUMANS; ACTIVATION; CORTEX; FMRI	The corpus callosum (CC) is a brain structure composed of axon fibres linking the right and left hemispheres. Musical training is associated with larger midsagittal cross-sectional area of the CC, suggesting that interhemispheric communication may be faster in musicians. Here we compared interhemispheric transmission times (ITTs) for musicians and non-musicians. ITT was measured by comparing simple reaction times to stimuli presented to the same hemisphere that controlled a button-press response (uncrossed reaction time), or to the contralateral hemisphere (crossed reaction time). Both visual and auditory stimuli were tested. We predicted that the crossed-uncrossed difference (CUD) for musicians would be smaller than for non-musicians as a result of faster interhemispheric transfer times. We did not expect a difference in CUDs between the visual and auditory modalities for either musicians or non-musicians, as previous work indicates that interhemispheric transfer may happen through the genu of the CC, which contains motor fibres rather than sensory fibres. There were no significant differences in CUDs between musicians and non-musicians. However, auditory CUDs were significantly smaller than visual CUDs. Although this auditory-visual difference was larger in musicians than non-musicians, the interaction between modality and musical training was not significant. Therefore, although musical training does not significantly affect ITT, the crossing of auditory information between hemispheres appears to be faster than visual information, perhaps because subcortical pathways play a greater role for auditory interhemispheric transfer.	[Woelfle, Rebecca] Univ Western Ontario, Dept Biol, London, ON, Canada; [Grahn, Jessica A.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Grahn, Jessica A.] Univ Western Ontario, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Grahn, JA (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	jgrahn@uwo.ca	Grahn, Jessica/A-1371-2010	Grahn, Jessica/0000-0001-7270-2114	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); NSERC [145629217]; CFI [29607]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation)	The sources of funding that have supported the work are: the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Canadian Foundation for Innovation (CFI). For NSERC, the URL is: www.nserc-crsng.gc.ca, and the grant number is: 145629217. For CFI, the URL is: www.innovation.ca, and the grant number is: 29607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; [Anonymous], E PRIM VERS 2 0 COMP; Barnett KJ, 2005, NEUROSCI LETT, V380, P88, DOI 10.1016/j.neulet.2005.01.025; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; BERLUCCHI G, 1968, SCIENCE, V159, P308, DOI 10.1126/science.159.3812.308; BJORKLUND RA, 1993, SCAND J PSYCHOL, V34, P174, DOI 10.1111/j.1467-9450.1993.tb01112.x; Bohr S, 2007, BRAIN RES, V1186, P194, DOI 10.1016/j.brainres.2007.10.013; Brochard R, 2004, BRAIN COGNITION, V54, P103, DOI 10.1016/S0278-2626(03)00264-1; Campos ML, 2001, NEUROSCIENCE, V102, P625, DOI 10.1016/S0306-4522(00)00525-X; COWELL PE, 1992, DEV BRAIN RES, V66, P187, DOI 10.1016/0165-3806(92)90079-C; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Fagard J, 2001, J EXP CHILD PSYCHOL, V80, P1, DOI 10.1006/jecp.2000.2623; Fraser LM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-91; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; HARVEY LO, 1978, NEUROPSYCHOLOGIA, V16, P601, DOI 10.1016/0028-3932(78)90088-X; Iacoboni M, 2004, NEUROPSYCHOLOGIA, V42, P419, DOI 10.1016/j.neuropsychologia.2003.10.007; Iacoboni M, 1999, EXP BRAIN RES, V128, P421, DOI 10.1007/s002210050864; IBM Corp, IBM SPSS STAT WIND V; Lee DJ, 2003, NEUROREPORT, V14, P205, DOI 10.1097/00001756-200302100-00009; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Luce RD, 1986, RESPONSE TIMES THEIR; Marzi CA, 1999, BRAIN RES BULL, V50, P421, DOI 10.1016/S0361-9230(99)00174-4; MARZI CA, 1991, NEUROPSYCHOLOGIA, V29, P1163, DOI 10.1016/0028-3932(91)90031-3; Mazerolle EL, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-84; Microsoft Corp, 2008, MICR EXC VERS 12 0 C; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; MUSIEK FE, 1986, EAR HEARING, V7, P349, DOI 10.1097/00003446-198612000-00001; Omura K, 2004, NEUROREPORT, V15, P2707; Patston LLM, 2007, NEUROPSYCHOLOGIA, V45, P2059, DOI 10.1016/j.neuropsychologia.2007.02.001; Poffenberger AT., 1912, ARCH PSYCHOL, V23, P1; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; Ridding MC, 2000, EXP BRAIN RES, V133, P249, DOI 10.1007/s002210000428; ROSENZWEIG MR, 1951, AM J PHYSIOL, V167, P147, DOI 10.1152/ajplegacy.1951.167.1.147; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; SHNEIDERMAN A, 1988, J COMP NEUROL, V276, P188, DOI 10.1002/cne.902760204; Sloboda J., 1974, PSYCHOL MUSIC, V2, P4, DOI [10.1177/030573567422001, DOI 10.1177/030573567422001]; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Weber B, 2005, J COGNITIVE NEUROSCI, V17, P113, DOI 10.1162/0898929052880002; Westerhausen R, 2006, NEUROSCI LETT, V409, P140, DOI 10.1016/j.neulet.2006.09.028; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Yetkin FZ, 2004, LARYNGOSCOPE, V114, P96, DOI 10.1097/00005537-200401000-00017	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84446	10.1371/journal.pone.0084446	http://dx.doi.org/10.1371/journal.pone.0084446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386382	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900094
J	Costa, MA; Marques, JV; Dalisay, DS; Herman, B; Bedgar, DL; Davin, LB; Lewis, NG				Costa, Michael A.; Marques, Joaquim V.; Dalisay, Doralyn S.; Herman, Barrington; Bedgar, Diana L.; Davin, Laurence B.; Lewis, Norman G.			Transgenic Hybrid Poplar for Sustainable and Scalable Production of the Commodity/Specialty Chemical, 2-Phenylethanol	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASES; BIOTECHNOLOGICAL PRODUCTION; PHENYLPROPANOID METABOLISM; MEDIATED TRANSFORMATION; POPULUS; BIOSYNTHESIS; SALICYLATE; ENZYME; ASPEN	Fast growing hybrid poplar offers the means for sustainable production of specialty and commodity chemicals, in addition to rapid biomass production for lignocellulosic deconstruction. Herein we describe transformation of fast-growing transgenic hybrid poplar lines to produce 2-phenylethanol, this being an important fragrance, flavor, aroma, and commodity chemical. It is also readily converted into styrene or ethyl benzene, the latter being an important commodity aviation fuel component. Introducing this biochemical pathway into hybrid poplars marks the beginnings of developing a platform for a sustainable chemical delivery system to afford this and other valuable specialty/commodity chemicals at the scale and cost needed. These modified plant lines mainly sequester 2-phenylethanol via carbohydrate and other covalently linked derivatives, thereby providing an additional advantage of effective storage until needed. The future potential of this technology is discussed. MALDI metabolite tissue imaging also established localization of these metabolites in the leaf vasculature.	[Costa, Michael A.; Marques, Joaquim V.; Dalisay, Doralyn S.; Herman, Barrington; Bedgar, Diana L.; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Lewis, Norman G.] Ealasid Inc, Pullman, WA USA	Washington State University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu	Dalisay, Doralyn S/I-7558-2016	Davin, Laurence/0000-0002-3248-6485; Lewis, Norman/0000-0001-5742-032X; Dalisay, Doralyn/0000-0003-2850-7797	Washington State University Agricultural Research Center federal special grant [WNP00768]; U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA-NIFA); USDA-NIFA [683A757612]; G. Thomas and Anita Hargrove Center for Plant Genomic Research; Div Of Biological Infrastructure [1229749] Funding Source: National Science Foundation	Washington State University Agricultural Research Center federal special grant; U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA-NIFA); USDA-NIFA(United States Department of Agriculture (USDA)); G. Thomas and Anita Hargrove Center for Plant Genomic Research; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by Washington State University Agricultural Research Center federal special grant Project No. WNP00768 "Aegilops Cylindrica, WA," one of whose various objectives focused on transgenic poplar development with funding received from the U.S. Department of Agriculture National Institutes for Food and Agriculture (USDA-NIFA). Additionally, the authors thank USDA-NIFA (#683A757612), and the G. Thomas and Anita Hargrove Center for Plant Genomic Research for generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Alouisius RN, 2008, European Patent, Patent No. [EP2231559, 2231559]; [Anonymous], 2010, CHEM ENG NEWS, V88, P33; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Chen CS, 2004, APPL CATAL A-GEN, V260, P207, DOI 10.1016/j.apcata.2003.10.022; Chen XM, 2011, J PLANT PHYSIOL, V168, P88, DOI 10.1016/j.jplph.2010.06.011; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRAWFORD DJ, 1974, BRITTONIA, V26, P74, DOI 10.2307/2805923; DEBLOCK M, 1990, PLANT PHYSIOL, V93, P1110, DOI 10.1104/pp.93.3.1110; Ehrlich F, 1907, BER DTSCH CHEM GES, V40, P1027, DOI 10.1002/cber.190704001156; Etschmann MMW, 2002, APPL MICROBIOL BIOT, V59, P1, DOI 10.1007/s00253-002-0992-x; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Farhi M, 2010, PLANT MOL BIOL, V72, P235, DOI 10.1007/s11103-009-9564-0; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Han X, 2013, INT J MOL SCI, V14, P2515, DOI 10.3390/ijms14022515; Harding SA, 2009, J EXP BOT, V60, P3443, DOI 10.1093/jxb/erp180; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hua DL, 2011, BIOTECHNOL ADV, V29, P654, DOI 10.1016/j.biotechadv.2011.05.001; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lindroth RL, 1996, BIOCHEM SYST ECOL, V24, P357, DOI 10.1016/0305-1978(96)00043-9; Ma C. P., 2004, Plant Molecular Biology Reporter, V22, P311, DOI 10.1007/BF02773145; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Patten AM, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P1173; Reineccius G. A., 2007, FLAVOURS FRAGRANCES; SHU CK, 1994, J AGR FOOD CHEM, V42, P1732, DOI 10.1021/jf00044a029; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Tieman DM, 2007, PHYTOCHEMISTRY, V68, P2660, DOI 10.1016/j.phytochem.2007.06.005; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Warren JM, 2003, TREE PHYSIOL, V23, P527, DOI 10.1093/treephys/23.8.527	31	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83169	10.1371/journal.pone.0083169	http://dx.doi.org/10.1371/journal.pone.0083169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386157	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700033
J	Harada, T; Ozaki, S; Oda, A; Tsuji, D; Ikegame, A; Iwasa, M; Udaka, K; Fujii, S; Nakamura, S; Miki, H; Kagawa, K; Kuroda, Y; Kawai, S; Itoh, K; Yamada-Okabe, H; Matsumoto, T; Abe, M				Harada, Takeshi; Ozaki, Shuji; Oda, Asuka; Tsuji, Daisuke; Ikegame, Akishige; Iwasa, Masami; Udaka, Kengo; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Kagawa, Kumiko; Kuroda, Yoshiaki; Kawai, Shigeto; Itoh, Kohji; Yamada-Okabe, Hisafumi; Matsumoto, Toshio; Abe, Masahiro			Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; FC-GAMMA-RIIIA; MULTIPLE-MYELOMA; STEM-CELLS; STAGING SYSTEM; DEXAMETHASONE; ANTIGEN; IMMUNOTHERAPY; CHEMOTHERAPY; POLYMORPHISM	The immunomodulatory drug lenalidomide (Len) has drawn attention to potentiate antibody-dependent cellular cytotoxicity (ADCC)-mediated immunotherapies. We developed the defucosylated version (YB-AHM) of humanized monoclonal antibody against HM1.24 (CD317) overexpressed in multiple myeloma (MM) cells. In this study, we evaluated ADCC by YB-AHM and Len in combination against MM cells and their progenitors. YB-AHM was able to selectively kill via ADCC MM cells in bone marrow samples from patients with MM with low effector/target ratios, which was further enhanced by treatment with Len. Interestingly, Len also up-regulated HM1.24 expression on MM cells in an effector-dependent manner. HM1.24 was found to be highly expressed in a drug-resistant clonogenic "side population" in MM cells; and this combinatory treatment successfully reduced SP fractions in RPMI 8226 and KMS-11 cells in the presence of effector cells, and suppressed a clonogenic potential of MM cells in colony-forming assays. Collectively, the present study suggests that YB-AHM and Len in combination may become an effective therapeutic strategy in MM, warranting further study to target drug-resistant MM clonogenic cells.	[Harada, Takeshi; Oda, Asuka; Iwasa, Masami; Udaka, Kengo; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Kagawa, Kumiko; Matsumoto, Toshio; Abe, Masahiro] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Ozaki, Shuji] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Japan; [Tsuji, Daisuke; Itoh, Kohji] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Med Biotechnol, Tokushima 770, Japan; [Ikegame, Akishige] Tokushima Univ Hosp, Div Med Technol, Tokushima, Japan; [Kuroda, Yoshiaki] Hiroshima Univ, Dept Hematol & Oncol, RIRBM, Hiroshima, Japan; [Kawai, Shigeto] Forerunner Pharma Res Co Ltd, Div Res, Tokyo, Japan; [Yamada-Okabe, Hisafumi] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa, Japan	Tokushima University; Tokushima University; Tokushima University; Hiroshima University; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Ozaki, S (corresponding author), Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Japan.	ozaki@tph.gr.jp	Tsuji, Daisuke/F-7085-2013	Tsuji, Daisuke/0000-0002-1528-7820; Kawai, Shigeto/0000-0002-3746-0794	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25460389] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (C) for S.O. and M. A. and (A) for T. M. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; ELLIS JH, 1995, J IMMUNOL, V155, P925; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GOTO T, 1994, BLOOD, V84, P1922; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; HAMBURGER A, 1977, J CLIN INVEST, V60, P846, DOI 10.1172/JCI108839; Harada T, 2013, INT J HEMATOL, V97, P743, DOI 10.1007/s12185-013-1321-0; Hsi ED, 2008, CLIN CANCER RES, V14, P2775, DOI 10.1158/1078-0432.CCR-07-4246; Ikegame A, 2012, LEUKEMIA, V26, P2124, DOI 10.1038/leu.2012.78; Ishiguro T, 2010, CANCER SCI, V101, P2227, DOI 10.1111/j.1349-7006.2010.01663.x; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Kawai S, 2006, LEUKEMIA RES, V30, P949, DOI 10.1016/j.leukres.2005.11.023; Kawai S, 2008, CANCER SCI, V99, P2461, DOI 10.1111/j.1349-7006.2008.00968.x; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lapalombella R, 2008, BLOOD, V112, P5180, DOI 10.1182/blood-2008-01-133108; Nowakowski GS, 2011, LEUKEMIA, V25, P1877, DOI 10.1038/leu.2011.165; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono K, 1999, MOL IMMUNOL, V36, P387, DOI 10.1016/S0161-5890(99)00029-2; Ozaki S, 1997, BLOOD, V90, P3179, DOI 10.1182/blood.V90.8.3179; Ozaki S, 1999, BLOOD, V93, P3922, DOI 10.1182/blood.V93.11.3922.411a32_3922_3930; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Plesner T, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.73.73; Powles R, 2001, BLOOD, V98, p165A; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Raje N, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.202.202; Tai YT, 2005, CANCER RES, V65, P11712, DOI 10.1158/0008-5472.CAN-05-1657; Tai YT, 2008, BLOOD, V112, P1329, DOI 10.1182/blood-2007-08-107292; Tai YT, 2012, BLOOD, V119, P2074, DOI 10.1182/blood-2011-06-364521; van der Veer MS, 2011, HAEMATOL-HEMATOL J, V96, P284, DOI 10.3324/haematol.2010.030759; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Zonder JA, 2012, BLOOD, V120, P552, DOI 10.1182/blood-2011-06-360552	44	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83905	10.1371/journal.pone.0083905	http://dx.doi.org/10.1371/journal.pone.0083905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386306	Green Submitted, Green Published, gold			2022-12-27	WOS:000329116700086
J	Ma, J; Hu, YT; Guo, MX; Huang, Z; Li, WX; Wu, YL				Ma, Jian; Hu, Youtian; Guo, Mingxiong; Huang, Zan; Li, Wenxin; Wu, Yingliang			hERG Potassium Channel Blockage by Scorpion Toxin BmKKx2 Enhances Erythroid Differentiation of Human Leukemia Cells K562	PLOS ONE			English	Article							K+ CHANNEL; HEMATOPOIETIC PROGENITORS; AUTOIMMUNE-DISEASES; REGULATES LINEAGE; MYELOID-LEUKEMIA; STRUCTURAL BASIS; KV1.3 CHANNEL; ION CHANNELS; PEPTIDE; RECOGNITION	Background: The hERG potassium channel can modulate the proliferation of the chronic myelogenous leukemic K562 cells, and its role in the erythroid differentiation of K562 cells still remains unclear. Principal Findings: The hERG potassium channel blockage by a new 36-residue scorpion toxin BmKKx2, a potent hERG channel blocker with IC50 of 6.7 +/- 1.7 nM, enhanced the erythroid differentiation of K562 cells. The mean values of GPA (CD235a) fluorescence intensity in the group of K562 cells pretreated by the toxin for 24 h and followed by cytosine arabinoside (Ara-C) treatment for 72 h were about 2-fold stronger than those of K562 cells induced by Ara-C alone. Such unique role of hERG potassium channel was also supported by the evidence that the effect of the toxin BmKKx2 on cell differentiation was nullified in hERG-deficient cell lines. During the K562 cell differentiation, BmKKx2 could also suppress the expression of hERG channels at both mRNA and protein levels. Besides the function of differentiation enhancement, BmKKx2 was also found to promote the differentiation-dependent apoptosis during the differentiation process of K562 cells. In addition, the blockage of hERG potassium channel by toxin BmKKx2 was able to decrease the intracellular Ca2+ concentration during the K562 cell differentiation, providing an insight into the mechanism of hERG potassium channel regulating this cellular process. Conclusions/Significance: Our results revealed scorpion toxin BmKKx2 could enhance the erythroid differentiation of leukemic K562 cells via inhibiting hERG potassium channel currents. These findings would not only accelerate the functional research of hERG channel in different leukemic cells, but also present the prospects of natural scorpion toxins as anti-leukemic drugs.	[Ma, Jian; Hu, Youtian; Guo, Mingxiong; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Huang, Zan] Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liwxlab@whu.edu.cn; ylwu@whu.edu.cn	Hu, Youtian/G-5408-2014	Huang, Zan/0000-0001-5623-6950	National Basic Research Program of China [2010CB529800]; National High Technology Research and Development Program of China [2012AA020304]; National Natural Sciences Foundation of China [31170789]; New Century Excellent Talents in Wuhan University by the Ministry of Education of China [NCET-10-0651]; Wuhan City Science and Technology Foundation of China [2013070204020046]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in Wuhan University by the Ministry of Education of China; Wuhan City Science and Technology Foundation of China	This work was supported by grants from the National Basic Research Program of China (2010CB529800), National High Technology Research and Development Program of China (2012AA020304), and National Natural Sciences Foundation of China (number 31170789). New Century Excellent Talents in Wuhan University by the Ministry of Education of China (No. NCET-10-0651), and Wuhan City Science and Technology Foundation of China (No. 2013070204020046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Bellantuono H, 2004, INT J BIOCHEM CELL B, V36, P607, DOI 10.1016/j.biocel.2003.10.008; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cavarra MS, 2007, J MEMBRANE BIOL, V219, P49, DOI 10.1007/s00232-007-9060-x; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Huang M, 2004, LEUKEMIA, V18, P1857, DOI 10.1038/sj.leu.2403490; Jimenez-Vargas JM, 2012, TOXICON, V60, P492, DOI 10.1016/j.toxicon.2012.03.024; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Korolkova YV, 2001, J BIOL CHEM, V276, P9868, DOI 10.1074/jbc.M005973200; Li HY, 2008, INT J HEMATOL, V87, P387, DOI 10.1007/s12185-008-0056-9; Li Z, 2012, J BIOL CHEM, V287, P29479, DOI 10.1074/jbc.M112.379594; Manabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052592; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Park KS, 2011, MOL CELLS, V32, P181, DOI 10.1007/s10059-011-0068-9; Pillozzi S, 2002, LEUKEMIA, V16, P1791, DOI 10.1038/sj.leu.2402572; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Shieh CC, 2000, PHARMACOL REV, V52, P557; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Walters MJ, 2002, DEVELOPMENT, V129, P1455; Wayman GA, 2000, J CELL BIOL, V151, P811, DOI 10.1083/jcb.151.4.811; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Yao XQ, 2000, J BIOL CHEM, V275, P10859, DOI 10.1074/jbc.275.15.10859; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Zeng XC, 2006, PEPTIDES, V27, P1745, DOI 10.1016/j.peptides.2006.01.012; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518	39	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84903	10.1371/journal.pone.0084903	http://dx.doi.org/10.1371/journal.pone.0084903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386436	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700126
J	Modgil, A; Guo, LR; O'Rourke, ST; Sun, CW				Modgil, Amit; Guo, Lirong; O'Rourke, Stephen T.; Sun, Chengwen			Apelin-13 Inhibits Large-Conductance Ca2+-Activated K+ Channels in Cerebral Artery Smooth Muscle Cells via a PI3-Kinase Dependent Mechanism	PLOS ONE			English	Article							ORPHAN RECEPTOR APJ; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS; BLOOD-PRESSURE; IMMUNOCYTOCHEMICAL LOCALIZATION; ENDOGENOUS LIGAND; PEPTIDE APELIN; PROTEIN; ROLES; GENE	Apelin-13 causes vasoconstriction by acting directly on APJ receptors in vascular smooth muscle (VSM) cells; however, the ionic mechanisms underlying this action at the cellular level remain unclear. Large-conductance Ca2+-activated K+ (BKCa) channels in VSM cells are critical regulators of membrane potential and vascular tone. In the present study, we examined the effect of apelin-13 on BKCa channel activity in VSM cells, freshly isolated from rat middle cerebral arteries. In whole-cell patch clamp mode, apelin-13 (0.001-1 mu M) caused concentration-dependent inhibition of BKCa in VSM cells. Apelin-13 (0.1 mu M) significantly decreased BKCa current density from 71.25 +/- 8.14 pA/pF to 44.52 +/- 7.10 pA/pF (n=14 cells, P<0.05). This inhibitory effect of apelin-13 was confirmed by single channel recording in cell-attached patches, in which extracellular application of apelin-13 (0.1 mu M) decreased the open-state probability (NPo) of BKCa channels in freshly isolated VSM cells. However, in inside-out patches, extracellular application of apelin-13 (0.1 mu M) did not alter the NPo of BKCa channels, suggesting that the inhibitory effect of apelin-13 on BKCa is not mediated by a direct action on BKCa. In whole cell patches, pretreatment of VSM cells with LY-294002, a PI3-kinase inhibitor, markedly attenuated the apelin-13-induced decrease in BKCa current density. In addition, treatment of arteries with apelin-13 (0.1 mu M) significantly increased the ratio of phosphorylated-Akt/total Akt, indicating that apelin-13 significantly increases PI3-kinase activity. Taken together, the data suggest that apelin-13 inhibits BKCa channel via a PI3-kinase-dependent signaling pathway in cerebral artery VSM cells, which may contribute to its regulatory action in the control of vascular tone.	[Guo, Lirong] Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun 130023, Jilin, Peoples R China; [Modgil, Amit; Guo, Lirong; O'Rourke, Stephen T.; Sun, Chengwen] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	Jilin University; North Dakota State University Fargo	Guo, LR (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun 130023, Jilin, Peoples R China.	Guolr@jlu.edu.cn; chengwen.sun@ndsu.edu	Sun, Chengwen/AAC-4522-2019; guo, lirong/K-3942-2019	Sun, Chengwen/0000-0001-5889-8448; 	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [2P20-RR-015566]; American Heart Association [10GRNT3170012]; National Natural Scientific Foundation of China [81000271]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103332] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Grant 2P20-RR-015566 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The project described was also supported by the American Heart Association (10GRNT3170012) and National Natural Scientific Foundation of China (Grant#, 81000271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Gebremedhin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068498; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; KITAZONO T, 1995, STROKE, V26, P1713, DOI 10.1161/01.STR.26.9.1713; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Liu B, 2002, CHANNELS FREE RADIC, V44, P1004; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Shan PF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017938; Sun CW, 1998, CIRC RES, V83, P1069, DOI 10.1161/01.RES.83.11.1069; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Yao FR, 2011, J PHARMACOL EXP THER, V336, P372, DOI 10.1124/jpet.110.174102; Zhang Q, 2009, AM J PHYSIOL-HEART C, V297, pH1837, DOI 10.1152/ajpheart.00354.2009; Zhang Q, 2009, CIRC RES, V104, P1421, DOI 10.1161/CIRCRESAHA.108.192302	28	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83051	10.1371/journal.pone.0083051	http://dx.doi.org/10.1371/journal.pone.0083051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386141	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700025
J	Zschorlich, VR; Kohling, R				Zschorlich, Volker R.; Koehling, Ruediger			How Thoughts Give Rise to Action - Conscious Motor Intention Increases the Excitability of Target-Specific Motor Circuits	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EVOKED-POTENTIALS; CORTICOSPINAL EXCITABILITY; CORTEX EXCITABILITY; MOVEMENT PREPARATION; MENTAL-IMAGERY; H-REFLEXES; MUSCLE; FACILITATION; AWARENESS	The present study shows evidence for conscious motor intention in motor preparation prior to movement execution. We demonstrate that conscious motor intention of directed movement, combined with minimally supra-threshold transcranial magnetic stimulation (TMS) of the motor cortex, determines the direction and the force of resulting movements, whilst a lack of intention results in weak and omni-directed muscle activation. We investigated changes of consciously intended goal directed movements by analyzing amplitudes of motor-evoked potentials of the forearm muscle, flexor carpi radialis (FCR), and extensor carpi radialis (ECR), induced by transcranial magnetic stimulation over the right motor cortex and their motor outcome. Right-handed subjects were asked to develop a strong intention to move their left wrist (flexion or extension), without any overt motor output at the wrist, prior to brain stimulation. Our analyses of hand acceleration and electromyography showed that during the strong motor intention of wrist flexion movement, it evoked motor potential responses that were significantly larger in the FCR muscle than in the ECR, whilst the opposite was true for an extension movement. The acceleration data on flexion/extension corresponded to this finding. Under no-intention conditions again, which served as a reference for motor evoked potentials, brain stimulation resulted in undirected and minimally simultaneous extension/flexion innervation and virtually no movement. These results indicate that conscious intentions govern motor function, which in turn shows that a neuronal activation representing an "intention network" in the human brain pre-exists, and that it functionally represents target specific motor circuits. Until today, it was unclear whether conscious motor intention exists prior to movement, or whether the brain constructs such an intention after movement initiation. Our study gives evidence that motor intentions become aware before any motor execution.	[Zschorlich, Volker R.] Univ Rostock, Dept Movement Sci, D-18055 Rostock, Germany; [Zschorlich, Volker R.; Koehling, Ruediger] Univ Rostock, Dept Aging Sci, Interdisciplinary Fac, D-18055 Rostock, Germany; [Zschorlich, Volker R.; Koehling, Ruediger] Univ Rostock, Fac Med, D-18055 Rostock, Germany; [Zschorlich, Volker R.] Univ Rostock, Fac Philosophy, D-18055 Rostock, Germany; [Koehling, Ruediger] Univ Rostock, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock	Zschorlich, VR (corresponding author), Univ Rostock, Dept Movement Sci, D-18055 Rostock, Germany.	volker.zschorlich@uni-rostock.de; ruediger.koehling@uni-rostock.de	, volker.zschorlich@uni-rostock.de/ABH-8796-2020; Köhling, Rüdiger/K-8647-2013	, volker.zschorlich@uni-rostock.de/0000-0001-8158-6223; Köhling, Rüdiger/0000-0003-3330-4898				AMMON K, 1990, J NEUROL NEUROSUR PS, V53, P705, DOI 10.1136/jnnp.53.8.705; Aranyi Z, 1998, MUSCLE NERVE, V21, P1309, DOI 10.1002/(SICI)1097-4598(199810)21:10<1309::AID-MUS10>3.0.CO;2-X; Auksztulewicz R, 2012, J NEUROSCI, V32, P799, DOI 10.1523/JNEUROSCI.3974-11.2012; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Bonnard M, 2009, EUR J NEUROSCI, V30, P913, DOI 10.1111/j.1460-9568.2009.06864.x; Boussaoud D, 2001, NEUROIMAGE, V14, pS40, DOI 10.1006/nimg.2001.0816; BRASILNETO JP, 1992, J NEUROL NEUROSUR PS, V55, P964, DOI 10.1136/jnnp.55.10.964; Brooke JD, 2000, J ELECTROMYOGR KINES, V10, P211, DOI 10.1016/S1050-6411(00)00005-5; CASTIELLO U, 1991, BRAIN, V114, P2639, DOI 10.1093/brain/114.6.2639; CASTIELLO U, 1991, NEUROREPORT, V2, P797, DOI 10.1097/00001756-199112000-00017; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Cros D, 2007, BRAIN RES, V1185, P103, DOI 10.1016/j.brainres.2007.09.003; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Desmurget M, 2013, J COGNITIVE NEUROSCI, V25, P830, DOI 10.1162/jocn_a_00368; Desmurget M, 2012, CURR OPIN NEUROBIOL, V22, P1004, DOI 10.1016/j.conb.2012.06.006; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Facchini S, 2002, ACTA NEUROL SCAND, V105, P146, DOI 10.1034/j.1600-0404.2002.1o004.x; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; Filippi MM, 2001, NEUROLOGY, V57, P55, DOI 10.1212/WNL.57.1.55; FRIED I, 1991, J NEUROSCI, V11, P3656; Fried I, 2011, NEURON, V69, P548, DOI 10.1016/j.neuron.2010.11.045; Gabbard C, 2009, CONSCIOUS COGN, V18, P300, DOI 10.1016/j.concog.2008.07.003; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; GANDEVIA SC, 1987, BRAIN, V110, P1117, DOI 10.1093/brain/110.5.1117; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Hasegawa Y, 2001, EXP BRAIN RES, V140, P387, DOI 10.1007/s002210100842; Herrmann CS, 2008, INT J PSYCHOPHYSIOL, V67, P151, DOI 10.1016/j.ijpsycho.2007.10.013; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Holl N, 2011, EXP BRAIN RES, V210, P229, DOI 10.1007/s00221-011-2618-y; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Kaufman MT, 2013, J NEUROPHYS IN PRESS, DOI [10.1152/jn.00892.2011, DOI 10.1152/JN.00892.2011)]; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Li S, 2004, J NEUROSCI, V24, P9674, DOI 10.1523/JNEUROSCI.2781-04.2004; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; MacKinnon CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063417; Merletti R., 2004, ELECTROMYOGRAPHY PHY, DOI [10.1002/0471678384, DOI 10.1002/0471678384.CH5]; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overduin SA, 2012, NEURON, V76, P1071, DOI 10.1016/j.neuron.2012.10.018; Park WH, 2011, NEUROSCI LETT, V494, P255, DOI 10.1016/j.neulet.2011.03.027; PASCUALLEONE A, 1992, BRAIN, V115, P1045, DOI 10.1093/brain/115.4.1045; Patuzzo S, 2003, NEUROPSYCHOLOGIA, V41, P1272, DOI 10.1016/S0028-3932(02)00293-2; Ramos-Estebanez C, 2007, J NEUROSCI, V27, P4178, DOI 10.1523/JNEUROSCI.5468-06.2007; Ricciardi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058632; Schlegel A, 2013, EXPT BRAIN RES, V229, P1; Schneider L, 2013, J COGNITIVE NEUROSCI, V25, P822, DOI 10.1162/jocn_a_00360; Searle John, 1983, INTENTIONALITY; Senot P, 2011, EXP BRAIN RES, V211, P161, DOI 10.1007/s00221-011-2635-x; Sohn YH, 2003, J NEUROPHYSIOL, V90, P2303, DOI 10.1152/jn.00206.2003; Sparing R, 2002, BRAIN RES, V938, P92, DOI 10.1016/S0006-8993(02)02478-2; Stinear CM, 2003, CLIN NEUROPHYSIOL, V114, P909, DOI 10.1016/S1388-2457(02)00373-5; Sugawara K, 2002, HUM MOVEMENT SCI, V21, P203, DOI 10.1016/S0167-9457(02)00099-4; Trevena JA, 2002, CONSCIOUS COGN, V11, P162, DOI 10.1006/ccog.2002.0548; Trevena J, 2010, CONSCIOUS COGN, V19, P447, DOI 10.1016/j.concog.2009.08.006; Urbach D, 2002, EXP BRAIN RES, V142, P25, DOI 10.1007/s00221-001-0911-x; van Elswijk G, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-51; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Yahagi S, 1999, NEUROSCI LETT, V276, P185, DOI 10.1016/S0304-3940(99)00823-X; Yahagi S, 1996, PERCEPT MOTOR SKILL, V83, P288, DOI 10.2466/pms.1996.83.1.288; Yoo SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060410; ZSCHORLICH V R, 1989, Electromyography and Clinical Neurophysiology, V29, P81	75	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83845	10.1371/journal.pone.0083845	http://dx.doi.org/10.1371/journal.pone.0083845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386291	gold, Green Published, Green Submitted			2022-12-27	WOS:000329116700082
J	Li, AY; Liang, H; Li, W; Wang, ZZ; Pang, T; Li, J; Shi, H; Zhang, CQ				Li, Aiyin; Liang, Hui; Li, Wei; Wang, Zhongzhou; Pang, Tao; Li, Jun; Shi, Hao; Zhang, Chengqi			Spectral CT Imaging of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma: Evaluation of Image Quality and Status of Lymph Nodes	PLOS ONE			English	Article							DUAL-ENERGY CT; COMPUTED-TOMOGRAPHY; LOCAL-CONTROL; TUMOR VOLUME; FDG PET; NECK; HEAD; CANCER; METASTASES; PREDICTOR	Purpose: The purpose of this study was to evaluate image quality and status of lymph nodes in laryngeal and hypopharyngeal squamous cell carcinoma (SCC) patients using spectral CT imaging. Materials and Methods: Thirty-eight patients with laryngeal and hypopharyngeal SCCs were scanned with spectral CT mode in venous phase. The conventional 140-kVp polychromatic images and one hundred and one sets of monochromatic images were generated ranging from 40 keV to 140 keV. The mean optimal keV was calculated on the monochromatic images. The image quality of the mean optimal keV monochromatic images and polychromatic images was compared with two different methods including a quantitative analysis method and a qualitative analysis method. The HU curve slope (lambda(HU)) in the target lymph nodes and the primary lesion was calculated respectively. The ratio of lambda(HU) was studied between metastatic and non-metastatic lymph nodes group. Results: A total of 38 primary lesions were included. The mean optimal keV was obtained at 55 +/- 1.77 keV on the monochromatic images. The image quality evaluated by two different methods including a quantitative analysis method and a qualitative analysis method was obviously increased on monochromatic images than polychromatic images (p<0.05). The ratio of lambda(HU) between metastatic and non-metastatic lymph nodes was significantly different in the venous phase images (p<0.05). Conclusion: The monochromatic images obtained with spectral CT can be used to improve the image quality of laryngeal and hypopharyngeal SCC and the N-staging accuracy. The quantitative ratio of lambda(HU) may be helpful for differentiating between metastatic and non-metastatic cervical lymph nodes.	[Li, Aiyin; Li, Wei; Wang, Zhongzhou; Pang, Tao; Li, Jun; Shi, Hao; Zhang, Chengqi] Shandong Univ, Qianfoshan Hosp, Dept Radiol, Jinan 250100, Shandong, Peoples R China; [Liang, Hui] Shandong Univ, Qianfoshan Hosp, Dept Otolaryngol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhang, CQ (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Radiol, Jinan 250100, Shandong, Peoples R China.	zhangchengqi@sdhospital.com.cn	zhang, chi/GRX-3610-2022					Boll DT, 2010, RADIOLOGY, V254, P270, DOI 10.1148/radiol.09090068; Chu MMAY, 2010, RADIOGRAPHICS, V30, P1353, DOI 10.1148/rg.305095764; Coursey CA, 2010, RADIOGRAPHICS, V30, P1037, DOI 10.1148/rg.304095175; Daisne JF, 2004, RADIOLOGY, V233, P93, DOI 10.1148/radiol.2331030660; Dietz A, 2000, OTOLARYNG HEAD NECK, V122, P596, DOI 10.1067/mhn.2000.98175; DON DM, 1995, LARYNGOSCOPE, V105, P669, DOI 10.1288/00005537-199507000-00001; Guimaraes LS, 2010, RADIOLOGY, V257, P732, DOI 10.1148/radiol.10092016; Hermans R, 1999, INT J RADIAT ONCOL, V44, P755, DOI 10.1016/S0360-3016(99)00039-5; Hoorweg JJ, 2006, OTOLARYNG HEAD NECK, V135, P129, DOI 10.1016/j.otohns.2006.01.024; Unzurrunzaga EI, 2011, ACTA OTORRINOLAR ESP, V62, P443, DOI 10.1016/j.otorri.2011.06.004; JOHNSON JT, 1990, RADIOLOGY, V175, P607, DOI 10.1148/radiology.175.3.2188292; Keberle M, 2004, EUR RADIOL, V14, P286, DOI 10.1007/s00330-003-1994-5; Kraas JR, 2001, HEAD NECK-J SCI SPEC, V23, P1031, DOI 10.1002/hed.10030; Krestan C, 2006, EUR J RADIOL, V58, P360, DOI 10.1016/j.ejrad.2005.12.040; Kuno H, 2012, RADIOLOGY, V265, P488, DOI 10.1148/radiol.12111719; Li M, 2012, INVEST RADIOL, V47, P58, DOI 10.1097/RLI.0b013e318229fef3; Lyshchik A, 2007, RADIOLOGY, V243, P258, DOI 10.1148/radiol.2431052032; Mancuso AA, 1999, J CLIN ONCOL, V17, P631, DOI 10.1200/JCO.1999.17.2.631; MANCUSO AA, 1983, RADIOLOGY, V148, P715, DOI 10.1148/radiology.148.3.6878692; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Mukherji SK, 2000, HEAD NECK-J SCI SPEC, V22, P282, DOI 10.1002/(SICI)1097-0347(200005)22:3<282::AID-HED11>3.0.CO;2-K; Pan ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053651; Park SR, 2010, ANN SURG, V251, P428, DOI 10.1097/SLA.0b013e3181ca69a7; Silverman Paul M, 2005, Cancer Imaging, V5 Spec No A, pS57, DOI 10.1102/1470-7330.2005.0031; SOM PM, 1987, RADIOLOGY, V165, P593, DOI 10.1148/radiology.165.3.3317494; SOM PM, 1992, AM J ROENTGENOL, V158, P961, DOI 10.2214/ajr.158.5.1566697; Sumi M, 2006, AM J ROENTGENOL, V186, P749, DOI 10.2214/AJR.04.1832	27	12	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83492	10.1371/journal.pone.0083492	http://dx.doi.org/10.1371/journal.pone.0083492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386214	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700045
J	Trabucchi, A; Iacono, RF; Guerra, LL; Faccinetti, NI; Krochik, AG; Arriazu, MC; Poskus, E; Valdez, SN				Trabucchi, Aldana; Iacono, Ruben F.; Guerra, Luciano L.; Faccinetti, Natalia I.; Krochik, Andrea G.; Arriazu, Maria C.; Poskus, Edgardo; Valdez, Silvina N.			Characterization of Insulin Antibodies by Surface Plasmon Resonance in Two Clinical Cases: Brittle Diabetes and Insulin Autoimmune Syndrome	PLOS ONE			English	Article							AUTOANTIBODY MEASUREMENT; HYPOGLYCEMIA; RADIOIMMUNOASSAY; STANDARDIZATION; PROINSULIN; RESISTANCE; MELLITUS; CHILDREN; DISEASE; ASSAY	In this study, the characterization of insulin (auto) antibodies has been described, mainly in terms of concentration (q), affinity (K-a) and Ig (sub) isotypes by Surface Plasmon Resonance (SPR) in two particular clinical cases of individuals with severe episodes of impaired glycemia. Subject 1 suffers from brittle diabetes associated with circulating insulin antibodies (IA) due to insulin treatment. Subject 2 has insulin autoantibodies (IAA) associated with hypoglycemia in spite of not being diabetic and not having ever received exogenous insulin therapy. After conventional screening for IA/IAA by radioligand binding assay (RBA), we further characterized IA/IAA in sera of both patients in terms of concentration (q), affinity (K-a) and Ig (sub) isotypes by means of SPR technology. In both cases, q values were higher and K-a values were lower than those obtained in type 1 diabetic patients, suggesting that IA/IAA: insulin immunocomplexes could be responsible for the uncontrolled glycemia. Moreover, subject 1 had a predominat IgG(1) response and subject 2 had an IgG(3) response. In conclusion, SPR technology is useful for the complete characterization of IA/IAA which can be used in special cases where the simple positive/negative determination is not enough to achieve a detailed description of the disease fisiopathology.	[Trabucchi, Aldana; Iacono, Ruben F.; Guerra, Luciano L.; Faccinetti, Natalia I.; Poskus, Edgardo; Valdez, Silvina N.] Univ Buenos Aires, Sch Pharm & Biochem, Buenos Aires, DF, Argentina; [Trabucchi, Aldana; Iacono, Ruben F.; Guerra, Luciano L.; Faccinetti, Natalia I.; Poskus, Edgardo; Valdez, Silvina N.] Natl Res Council CONICET UBA, Prof Ricardo A Margni Humoral Immun Inst IDEHU, Buenos Aires, DF, Argentina; [Krochik, Andrea G.] JP Garrahan Natl Pediat Hosp, Nutr Serv, Buenos Aires, DF, Argentina; [Arriazu, Maria C.] Private Community Hosp, Pedriatr Serv, Mar Del Plata, Buenos Aires, Argentina	University of Buenos Aires; Hospital de Pediatria Doctor Juan Garrahan	Valdez, SN (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Buenos Aires, DF, Argentina.	silval@ffyb.uba.ar			FONCYT Programme of the Agency for Science and Technology Promotion (ANPCyT) [PICT-2008-0998]; National Research Council (CONICET) [PIP-0697]; University of Buenos Aires, Buenos Aires, Argentina [UBA 200 200 902 003 95]	FONCYT Programme of the Agency for Science and Technology Promotion (ANPCyT); National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires, Buenos Aires, Argentina(University of Buenos Aires)	This work was supported in part by grants from FONCYT Programme of the Agency for Science and Technology Promotion (ANPCyT) PICT-2008-0998, National Research Council (CONICET) PIP-0697, and the University of Buenos Aires, Buenos Aires, Argentina (UBA 200 200 902 003 95). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Achenbach P, 2007, CLIN IMMUNOL, V122, P85, DOI 10.1016/j.clim.2006.09.004; ALBERT SG, 1984, DIABETES CARE, V7, P285, DOI 10.2337/diacare.7.3.285; [Anonymous], 1985, WHO TECH REP SER, V727, P1; Berzofsky Jay A., 1993, P421; DAVIDSON JK, 1978, DIABETES, V27, P307, DOI 10.2337/diabetes.27.3.307; FELDMAN H, 1972, ANAL BIOCHEM, V45, P530, DOI 10.1016/0003-2697(72)90216-3; GILL GV, 1992, DIABETIC MED, V9, P667, DOI 10.1111/j.1464-5491.1992.tb01864.x; GREENBAUM CJ, 1992, J CLIN ENDOCR METAB, V74, P1040, DOI 10.1210/jc.74.5.1040; HIRATA Y, 1983, LANCET, V2, P1037; HIRATA Y, 1974, ANN INTERN MED, V81, P214, DOI 10.7326/0003-4819-81-2-214; Hirata Y, 1970, J JPN DIABET SOC, V13, P312; Hoppu S, 2004, PEDIATR RES, V55, P236, DOI 10.1203/01.PDR.0000100905.41131.3F; Ishizuka Tsuneo, 2009, Diabetes Res Clin Pract, V84, pe21, DOI 10.1016/j.diabres.2009.02.007; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KURTZ AB, 1980, DIABETOLOGIA, V18, P147, DOI 10.1007/BF00290492; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Petersen JS, 1999, CLIN IMMUNOL, V90, P276, DOI 10.1006/clim.1998.4641; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Potter KN, 2000, DIABETES-METAB RES, V16, P338, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR145>3.0.CO;2-L; Raile K, 2001, EXP CLIN ENDOCR DIAB, V109, P393, DOI 10.1055/s-2001-18991; REDMON B, 1992, NEW ENGL J MED, V326, P994, DOI 10.1056/NEJM199204093261505; TATTERSALL R, 1977, CLIN ENDOCRINOL META, V6, P403, DOI 10.1016/S0300-595X(77)80045-5; Trabucchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033574; UCHIGATA Y, 1992, LANCET, V339, P393, DOI 10.1016/0140-6736(92)90080-M; Uchigata Y, 1999, ANN MED INTERNE, V150, P245; Valdez SN, 2003, J IMMUNOL METHODS, V279, P173, DOI 10.1016/S0022-1759(03)00197-2; WASADA T, 1989, DIABETES CARE, V12, P147, DOI 10.2337/diacare.12.2.147	28	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e84099	10.1371/journal.pone.0084099	http://dx.doi.org/10.1371/journal.pone.0084099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386337	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700092
J	Garcia-Caballero, L; Quintas, V; Prada-Lopez, I; Seoane, J; Donos, N; Tomas, I				Garcia-Caballero, Lucia; Quintas, Victor; Prada-Lopez, Isabel; Seoane, Juan; Donos, Nikos; Tomas, Inmaculada			Chlorhexidine Substantivity on Salivary Flora and Plaque-Like Biofilm: An In Situ Model	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; DENTAL BIOFILMS; BACTERIAL BIOFILMS; ANTIMICROBIAL AGENTS; ORAL HYGIENE; VIVO; MICROORGANISMS; HYBRIDIZATION; COLONIZATION; STREPTOCOCCI	Objective: To evaluate the in situ antibacterial activity of a mouthrinse with 0.2% Chlorhexidine (M-0.2% CHX) on undisturbed de novo plaque-like biofilm (PL-biofilm) and on salivary flora up to 7 hours after its application. Methods: A special acrylic appliance was designed, with 3 inserted glass disks on each buccal side, allowing for PL-biofilm growth. Fifteen healthy volunteers wore the appliance for 48 hours and then performed an M-0.2% CHX; disks were removed at 30 seconds and 1, 3, 5 and 7 hours after the mouth-rinsing. Applying a washout period, saliva samples were collected from each volunteer at 30 seconds and 1, 3, 5 and 7 hours after performing an M-0.2% CHX. The PL-biofilm and saliva samples were analysed by confocal laser scanning and epifluorescence microscopes, respectively. Results: At 30 seconds after M-0.2% CHX, the levels of viable bacteria detected in saliva were significantly lower than those observed in PL-biofilm. The difference in the percentage of live bacteria detected in saliva was significantly higher than that observed in PL-biofilm at 5 and 7 hours after M-0.2% CHX. Conclusion: After a single mouthrinse of the 0.2% CHX formulation tested in the present study, the 2-day PL-biofilm presented a significantly higher resistance to this antiseptic in situ than that observed in salivary flora. However, this 0.2% CHX formulation showed a higher substantivity on PL-biofilm than on salivary flora at 5 and 7 hours after mouth-rinsing, which could be related to the slower growth rate of PL-biofilm and the possible reservoir function for antimicrobial agents associated with the undisturbed de novo PL-biofilm.	[Garcia-Caballero, Lucia; Quintas, Victor; Prada-Lopez, Isabel; Seoane, Juan; Tomas, Inmaculada] Univ Santiago de Compostela, Oral Sci Res Grp, Sch Med & Dent, Santiago De Compostela, Spain; [Donos, Nikos] UCL Eastman Dent Inst, Periodontol Unit, London, England	Universidade de Santiago de Compostela; University of London; University College London	Tomas, I (corresponding author), Univ Santiago de Compostela, Oral Sci Res Grp, Sch Med & Dent, Santiago De Compostela, Spain.	inmaculada.tomas@usc.es	TOMAS-CARMONA, INMACULADA/M-1135-2014	TOMAS-CARMONA, INMACULADA/0000-0002-3317-0853; seoane, Juan/0000-0003-4751-591X	Carlos III Institute of Health (Ministry of Economy and Competitiveness, Madrid, Spain) [FIS PI11/01383]	Carlos III Institute of Health (Ministry of Economy and Competitiveness, Madrid, Spain)	This work was supported by project FIS PI11/01383 from Carlos III Institute of Health (Ministry of Economy and Competitiveness, Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Al-Ahmad A, 2010, CLIN ORAL INVEST, V14, P391, DOI 10.1007/s00784-009-0318-9; Aparna MSPBD, 2008, BRAZ J INFECT DIS, V12, P526, DOI 10.1590/S1413-86702008000600016; Arweiler NB, 2006, J CLIN PERIODONTOL, V33, P334, DOI 10.1111/j.1600-051X.2006.00917.x; Arweiler NB, 2004, CARIES RES, V38, P442, DOI 10.1159/000079625; Arweiler NB, 2008, CLIN ORAL INVEST, V12, P203, DOI 10.1007/s00784-008-0188-6; Auschill T M, 2004, Clin Oral Investig, V8, P97; Auschill TM, 2005, J CLIN PERIODONTOL, V32, P147, DOI 10.1111/j.1600-051X.2005.00650.x; Auschill TM, 2002, EUR J ORAL SCI, V110, P48, DOI 10.1046/j.0909-8836.2001.101160.x; Auschill TM, 2001, ARCH ORAL BIOL, V46, P471, DOI 10.1016/S0003-9969(00)00136-9; Balbuena L, 1998, OTOLARYNG HEAD NECK, V118, P625, DOI 10.1016/S0194-5998(98)70231-1; Chalmers NI, 2007, APPL ENVIRON MICROB, V73, P630, DOI 10.1128/AEM.02164-06; Cousido MC, 2010, CLIN ORAL INVEST, V14, P397, DOI 10.1007/s00784-009-0320-2; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Daneshmand N, 2002, J PERIODONTAL RES, V37, P375, DOI 10.1034/j.1600-0765.2002.01003.x; Diaz J., 2010, MICROSCOPY SCI TECHN, P597; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, ORAL MICROBIOL IMMUN, V24, P69, DOI 10.1111/j.1399-302X.2008.00482.x; Dige I, 2007, EUR J ORAL SCI, V115, P459, DOI 10.1111/j.1600-0722.2007.00494.x; Elworthy A, 1996, J PERIODONTOL, V67, P572, DOI 10.1902/jop.1996.67.6.572; Gu F, 2005, J MICROBIOL METH, V62, P145, DOI 10.1016/j.mimet.2005.02.013; Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3; JENKINS S, 1994, J CLIN PERIODONTOL, V21, P397, DOI 10.1111/j.1600-051X.1994.tb00736.x; Jung DJ, 2010, J MICROBIOL METH, V81, P166, DOI 10.1016/j.mimet.2010.03.002; Loivukene Krista, 2005, Stomatologija, V7, P45; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; NETUSCHIL L, 1983, DEUT ZAHNAERZTL Z, V38, P914; Netuschil L, 1998, ARCH ORAL BIOL, V43, P277, DOI 10.1016/S0003-9969(97)00121-0; Palmer Jr R. J., 2010, COMPEND CONTIN ED DE, V31, P108; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P138; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P124; Palmer Jr RJ, 2010, COMPEND CONTIN ED DE, V31, P110; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2001, METHOD ENZYMOL, V337, P393, DOI 10.1016/S0076-6879(01)37028-3; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Palmer Robert J Jr, 2010, Compend Contin Educ Dent, V31, P104; Roberts SK, 1999, DENT PLAQUE REVISITE, P1; Robinson C, 2006, ARCH ORAL BIOL, V51, P1006, DOI 10.1016/j.archoralbio.2006.04.010; Robinson C, 1997, CARIES RES, V31, P194, DOI 10.1159/000262398; Sreenivasan PK, 2004, ORAL MICROBIOL IMMUN, V19, P297, DOI 10.1111/j.1399-302x.2004.00158.x; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Tomas I, 2010, J DENT, V38, P541, DOI 10.1016/j.jdent.2010.03.012; Tomas I, 2009, ORAL DIS, V15, P428, DOI 10.1111/j.1601-0825.2009.01570.x; van der Mei HC, 2006, J CLIN PERIODONTOL, V33, P14, DOI 10.1111/j.1600-051X.2005.00859.x; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; Watson PS, 2005, J DENT RES, V84, P451, DOI 10.1177/154405910508400510; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1; Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79; Wood S, 1999, J PHOTOCH PHOTOBIO B, V50, P1, DOI 10.1016/S1011-1344(99)00056-1; Wood SR, 2000, J DENT RES, V79, P21, DOI 10.1177/00220345000790010201; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001	53	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83522	10.1371/journal.pone.0083522	http://dx.doi.org/10.1371/journal.pone.0083522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386220	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900042
J	Mareri, A; Adler, SP; Nigro, G				Mareri, Arianna; Adler, Stuart P.; Nigro, Giovanni			Herpesvirus-Associated Acute Urticaria: An Age Matched Case-Control Study	PLOS ONE			English	Article							VIRUS; HHV-6; CHILDREN; RELEASE	Background: Acute and recurrent acute urticaria are often associated with multiple factors including infections and recent data suggest a role for herpesviruses. Objective: To test the null hypothesis, that is, there is no association of herpesvirus infections with urticaria. Methods: Thirty-seven patients between one month and 15 years of age were age matched to 37 controls who were healthy or had mild acute respiratory infections but without urticaria. Patients and controls were followed for 1 to 6 years. Diagnostic studies included DNA detection by real-time PCR for herpes simplex virus (HSV) types 1 and 2, Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human herpesvirus-6 (HHV-6). Tests for other infections included adenovirus, parvovirus B 19, respiratory syncytial virus, influenza A, Group A streptococci, rotavirus, and parasites. Results: Specific infections were diagnosed in 26 of 37 cases and among 9 of 37 control children (P=0.0002). Single or concomitant herpesvirus infections occurred in 24 cases and in 4 controls (65% vs 11 %, p=0.0003). Cases had 10 HHV-6 infections, 8 CMV infections, 5 EBV infections, and 4 HSV-1 infections. Conclusion: Herpesvirus infections are associated with acute or recurrent acute urticaria.	[Mareri, Arianna; Nigro, Giovanni] Univ Aquila, Pediat Unit & Sch, San Salvatore Hosp, I-67100 Laquila, Italy; [Adler, Stuart P.] Virginia Commonwealth Univ, Dept Microbiol, Richmond, VA USA	University of L'Aquila; Virginia Commonwealth University	Nigro, G (corresponding author), Univ Aquila, Pediat Unit & Sch, San Salvatore Hosp, I-67100 Laquila, Italy.	nigrogio@libero.it						ABLASHI DV, 1987, NATURE, V329, P207, DOI 10.1038/329207a0; Arena A, 1996, MICROBIOLOGICA, V19, P183; Caubet JC, 2011, J ALLERGY CLIN IMMUN, V127, P218, DOI 10.1016/j.jaci.2010.08.025; CHERRY JD, 1963, PEDIATRICS, V31, P819; Corne JM, 1997, THORAX, V52, P380, DOI 10.1136/thx.52.4.380; DIENSTAG JL, 1978, ANN INTERN MED, V89, P34, DOI 10.7326/0003-4819-89-1-34; Dreyfus DH, 2013, J ALLERGY CLIN IMMUN, V132, P1278, DOI 10.1016/j.jaci.2013.02.039; FRICK OL, 1979, J ALLERGY CLIN IMMUN, V63, P228, DOI 10.1016/0091-6749(79)90106-4; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Kanwar AJ, 1996, HOSP PRACT, V31, P175; Kulthanan K, 2008, ASIAN PAC J ALLERGY, V26, P1; Kumar A, 2009, ANN ALLERG ASTHMA IM, V103, P181, DOI 10.1016/S1081-1206(10)60178-0; LEVY JA, 1990, LANCET, V335, P1047, DOI 10.1016/0140-6736(90)92628-U; Lipsker D, 2006, CLIN EXP DERMATOL, V31, P473, DOI 10.1111/j.1365-2230.2006.02087.x; Liu Tzu-Hsuan, 2008, Pediatrics and Neonatology, V49, P58, DOI 10.1016/S1875-9572(08)60014-5; McAlpine SM, 2011, J INNATE IMMUN, V3, P120, DOI 10.1159/000323350; McMahon AW, 2008, VACCINE, V26, P427, DOI 10.1016/j.vaccine.2007.10.071; Mortureux P, 1998, ARCH DERMATOL, V134, P319, DOI 10.1001/archderm.134.3.319; Nilsson C, 2009, CLIN EXP ALLERGY, V39, P509, DOI 10.1111/j.1365-2222.2008.03147.x; Sackesen C, 2004, PEDIATR DERMATOL, V21, P102, DOI 10.1111/j.0736-8046.2004.21202.x; SCHULLER DE, 1980, PEDIATRICS, V65, P592; SCULLY LJ, 1993, AM J GASTROENTEROL, V88, P277; Smith C, 2013, AM J TRANSPLANT, V13, P9, DOI 10.1111/ajt.12005; Wedi B, 2008, ALLERGY PRACTICAL DI, P84; Wedi B, 2004, CURR OPIN ALLERGY CL, V4, P387, DOI 10.1097/00130832-200410000-00010; Wu CC, 2009, ANN ALLERG ASTHMA IM, V103, P134, DOI 10.1016/S1081-1206(10)60166-4; Zuberbier T, 2003, ALLERGY, V58, P1224, DOI 10.1046/j.1398-9995.2003.00327.x; Zuberbier T, 1995, ACTA DERM-VENEREOL, V75, P484	28	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85378	10.1371/journal.pone.0085378	http://dx.doi.org/10.1371/journal.pone.0085378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386470	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900130
J	Suvorov, A; Nolte, V; Pandey, RV; Franssen, SU; Futschik, A; Schlotterer, C				Suvorov, Anton; Nolte, Viola; Pandey, Ram Vinay; Franssen, Susanne U.; Futschik, Andreas; Schloetterer, Christian			Intra-Specific Regulatory Variation in Drosophila pseudoobscura	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; RNA-SEQ DATA; GENE-EXPRESSION; CIS; TRANS; DIVERGENCE; MELANOGASTER; EVOLUTION; SIMULANS; YEAST	It is generally accepted that gene regulation serves an important role in determining the phenotype. To shed light on the evolutionary forces operating on gene regulation, previous studies mainly focused on the expression differences between species and their inter-specific hybrids. Here, we use RNA-Seq to study the intra-specific distribution of cis- and trans-regulatory variation in Drosophila pseudoobscura. Consistent with previous results, we find almost twice as many genes (26%) with significant trans-effects than genes with significant cis- effects (18%). While this result supports the previous suggestion of a larger mutational target of trans-effects, we also show that trans-effects may be subjected to purifying selection. Our results underline the importance of intra-specific analyses for the understanding of the evolution of gene expression.	[Suvorov, Anton; Nolte, Viola; Pandey, Ram Vinay; Franssen, Susanne U.; Futschik, Andreas; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria; [Suvorov, Anton] Vienna Grad Sch Populat Genet, Vienna, Austria; [Futschik, Andreas] Univ Linz, Dept Appl Stat, A-4040 Linz, Austria	University of Veterinary Medicine Vienna; Johannes Kepler University Linz	Schlotterer, C (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vetmeduni.ac.at	Schlötterer, Christian/G-6326-2010; Suvorov, Anton/AAB-1774-2019; Schlötterer, Christian/Q-5264-2019; Pandey, Ram Vinay/AAA-3544-2022; Pandey, Ram Vinay/AAL-1701-2021; Futschik, Andreas/G-3697-2010	Schlötterer, Christian/0000-0003-4710-6526; Suvorov, Anton/0000-0003-3898-9195; Schlötterer, Christian/0000-0003-4710-6526; Futschik, Andreas/0000-0002-7980-0304; Pandey, Ram Vinay/0000-0002-2533-8687; Franssen, Susanne U./0000-0002-4725-1793	Austrian Science Fund (FWF) [P22834, W1225]; European Research Council (ERC, ArchAdapt); Austrian Science Fund (FWF) [P 22834] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC, ArchAdapt); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The laboratory of CS is supported by Austrian Science Fund (FWF, P22834, W1225) and the European Research Council (ERC, ArchAdapt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford T, 2009, P NATL ACAD SCI USA, V106, P1133, DOI 10.1073/pnas.0812009106; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Emerson JJ, 2010, GENOME RES, V20, P826, DOI 10.1101/gr.101576.109; Genissel A, 2008, MOL BIOL EVOL, V25, P101, DOI 10.1093/molbev/msm247; Graze RM, 2009, GENETICS, V183, P547, DOI 10.1534/genetics.109.105957; Kiekens R, 2006, NUCLEIC ACIDS RES, V34, P3677, DOI 10.1093/nar/gkl510; Kliman RM, 2000, GENETICS, V156, P1913; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Legrand D, 2009, GENETICS, V182, P1197, DOI 10.1534/genetics.108.092080; Lemos B, 2008, P NATL ACAD SCI USA, V105, P14471, DOI 10.1073/pnas.0805160105; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Palmieri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046415; Pandey RV, 2013, MOL ECOL RESOUR, V13, P740, DOI 10.1111/1755-0998.12110; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schaefke B, 2013, MOL BIOL EVOL, V30, P2121, DOI 10.1093/molbev/mst114; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Wayne ML, 2004, GENETICS, V168, P1413, DOI 10.1534/genetics.104.030973; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wittkopp PJ, 2005, CELL MOL LIFE SCI, V62, P1779, DOI 10.1007/s00018-005-5064-9; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499	31	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83547	10.1371/journal.pone.0083547	http://dx.doi.org/10.1371/journal.pone.0083547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386226	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900044
J	Wang, J; Hui, DF; Ren, H; Liu, ZF; Yang, L				Wang, Jun; Hui, Dafeng; Ren, Hai; Liu, Zhanfeng; Yang, Long			Effects of Understory Vegetation and Litter on Plant Nitrogen (N), Phosphorus (P), N:P Ratio and Their Relationships with Growth Rate of Indigenous Seedlings in Subtropical Plantations	PLOS ONE			English	Article							SOIL; NUTRITION; FERTILIZATION; STOICHIOMETRY; NUTRIENTS; REMOVAL; FOREST; CHINA; WATER	Establishing seedlings in subtropical plantations is very important for forest health, succession and management. Information on seedling nutrient concentrations is essential for both the selection of suitable indigenous tree species to accelerate succession of the established plantation and sustainable forest management. In this study, we investigated the concentrations of nitrogen ([N]), phosphorus ([P]), and N: P ratio in leaves, stems and roots of seedlings of three indigenous tree species (Castanopsis chinensis, Michelia chapensis and Psychotria rubra) transplanted with removing or retaining understory vegetation and litter at two typical subtropical forest plantations (Eucalyptus plantation and native species plantation). We also measured the relative growth rate (RGR) of seedling height, and developed the relationships between RGR and leaf [N], [P] and N: P ratio. Results showed that treatments of understory vegetation and associated litter (i.e. removal or retained) generally had no significant effects on leaf [N], [P], N: P ratio and RGR of the transplanted tree seedlings for the experimental period. But among different species, there were significant differences in nutrient concentrations. M. chapensis and P. rubra had higher [N] and [P] compared to C. chinensis. [N] and [P] also varied among different plant tissues with much higher values in leaves than in roots for all indigenous species. RGR of indigenous tree seedlings was mostly positively correlated with leaf [N] and [P], but negatively correlated with leaf N: P ratio. Considering the low [P] and high N: P ratio observed in the introduced indigenous tree seedlings, we propose that the current experimental plantations might be P limited for plant growth.	[Wang, Jun; Ren, Hai; Liu, Zhanfeng] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Yang, Long] Guangzhou Inst Geog, Ctr Resource & Environm, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Tennessee State University; Guangdong Academy of Sciences; Guangzhou Institute of Geography, Guangdong Academy of Sciences	Ren, H (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	renhai@scbg.ac.cn	Liu, Zhanfeng/ABD-3933-2021	Liu, Zhanfeng/0000-0002-6602-6196; Wang, Jun/0000-0003-4492-4953; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [31100469]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31100469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen Y, 2011, ECOGRAPHY, V34; Crous JW, 2008, FOREST ECOL MANAG, V256, P712, DOI 10.1016/j.foreco.2008.05.024; Davis MR, 2007, FOREST ECOL MANAG, V240, P122, DOI 10.1016/j.foreco.2006.12.023; dos Santos UM, 2006, FOREST ECOL MANAG, V226, P299, DOI 10.1016/j.foreco.2006.01.042; Du YJ, 2008, FOREST ECOL MANAG, V255, P2495, DOI 10.1016/j.foreco.2008.01.013; Duan WJ, 2010, RESTOR ECOL, V18, P206, DOI 10.1111/j.1526-100X.2008.00444.x; Graciano C, 2006, FOREST ECOL MANAG, V236, P202, DOI 10.1016/j.foreco.2006.09.005; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Heiskanen J, 2006, FOREST ECOL MANAG, V222, P410, DOI 10.1016/j.foreco.2005.10.047; Ibanez I, 2002, J ARID ENVIRON, V52, P209, DOI 10.1006/jare.2002.0988; Institute of soil science, 1978, SOIL PHYS CHEM AN; Kazda M, 2004, PLANT SOIL, V264, P25, DOI 10.1023/B:PLSO.0000047715.95176.63; Kranabetter JM, 2010, PLANT SOIL, V327, P389, DOI 10.1007/s11104-009-0062-6; Liu Y. H., 1996, FLORA OF CHINA; Matsushima M, 2006, FOREST ECOL MANAG, V236, P332, DOI 10.1016/j.foreco.2006.09.018; Olsen S., 1954, ESTIMATION AVAILABLE; Oskarsson H, 2006, FOREST ECOL MANAG, V229, P88, DOI 10.1016/j.foreco.2006.03.018; Park BB, 2009, FOREST ECOL MANAG, V258, P1153, DOI 10.1016/j.foreco.2009.06.003; Parker WC, 2012, FOREST ECOL MANAG, V271, P104, DOI 10.1016/j.foreco.2012.01.042; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Peng YH, 2011, J PLANT ECOL-UK, V4, P147, DOI 10.1093/jpe/rtq026; Ren H, 2002, FOREST RESOURCES ITS; REN H, 1997, ACTA PHYTOECOLOGICA, V21, P386; Ribeiro C, 2002, FOREST ECOL MANAG, V171, P31, DOI 10.1016/S0378-1127(02)00459-0; Sardans J, 2006, ACTA OECOL, V29, P221, DOI 10.1016/j.actao.2005.10.006; Schuler JL, 2010, NEW FOREST, V40, P119, DOI 10.1007/s11056-009-9187-y; STANFORD S, 1949, AGRON J, V41, P446, DOI DOI 10.2134/AGRONJ1949.00021962004100090012X; Wang GG, 1997, FOREST ECOL MANAG, V98, P89, DOI 10.1016/S0378-1127(97)00048-0; Wang J, 2011, NEW FOREST, V42, P19, DOI 10.1007/s11056-010-9234-8; Wang J, 2010, FOREST ECOL MANAG, V259, P2390, DOI 10.1016/j.foreco.2010.03.015; Wu CC, 2007, FOREST ECOL MANAG, V239, P81, DOI 10.1016/j.foreco.2006.11.008; Yu Z., 1996, ECOLOGICAL STUDIES V	34	6	7	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84130	10.1371/journal.pone.0084130	http://dx.doi.org/10.1371/journal.pone.0084130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386340	Green Submitted, Green Published, gold			2022-12-27	WOS:000329117900076
J	Zhang, YH; Yan, WS; Chen, XB				Zhang, Yanhong; Yan, Wensheng; Chen, Xinbin			Mutant p53 Cooperates with Knockdown of Endogenous Wild-Type p53 to Disrupt Tubulogenesis in Madin-Darby Canine Kidney Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; LI-FRAUMENI-SYNDROME; GAIN-OF-FUNCTION; SCATTER FACTOR; E6 ONCOPROTEIN; MUTATIONS; PROTEIN; CANCER; CARCINOMA	Mutation of the p53 gene is the most common genetic alteration in human malignances and associated clinically with tumor progression and metastasis. To determine the effect of mutant p53 on epithelial differentiation, we developed three-dimensional culture (3-D) of Madin-Darby canine kidney (MDCK) cells. We found that parental MDCK cells undergo a series of morphological changes and form polarized and growth-arrested cysts with hollow lumen, which resembles branching tubules in vitro. We also found that upon knockdown of endogenous wild-type p53 (p53-KD), MDCK cells still form normal cysts in 3-D culture, indicating that p53-KD alone is not sufficient to disrupt cysts formation. However, we found that ectopic expression of mutant R163H (human equivalent R175H) or R261H (human equivalent R273H) in MDCK cells leads to disruption of cyst polarity and formation of invasive aggregates, which is further compounded by knockdown of endogenous wild-type p53. Consistently, we found that expression of E-cadherin, beta-catenin, and epithelial-to-mesenchymal transition (EMT) transcription factors (Snail-1, Slug and Twist) is altered by mutant p53, which is also compounded by knockdown of wild-type p53. Moreover, the expression level of c-Met, the hepatocyte growth factor receptor and a key regulator of kidney cell tubulogenesis, is enhanced by combined knockdown of endogenous wild-type p53 and ectopic expression of mutant R163H or R261H but not by each individually. Together, our data suggest that upon inactivating mutation of the p53 gene, mutant p53 acquires its gain of function by altering morphogenesis and promoting cell migration and invasion in part by upregulating EMT and c-Met.	[Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health Grant [CA 121137, CA 076069]; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA121137, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA 121137 and CA 076069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; CLARK P, 1994, J CELL SCI, V107, P1265; Comoglio PM, 2001, SEMIN CANCER BIOL, V11, P153, DOI 10.1006/scbi.2000.0366; Conant JL, 2011, J CLIN PATHOL, V64, P1088, DOI 10.1136/jclinpath-2011-200216; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; El-Hizawi S, 2002, CANCER RES, V62, P3264; Engelberg JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002030; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Girgin C, 2001, UROL INT, V66, P78, DOI 10.1159/000056575; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Keleti J, 1996, AM J PATHOL, V149, P143; Kirpensteijn J, 2008, VET SURG, V37, P454, DOI 10.1111/j.1532-950X.2008.00407.x; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lim SO, 2010, FEBS LETT, V584, P2231, DOI 10.1016/j.febslet.2010.04.006; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; MCATEER JA, 1987, ANAT REC, V217, P229, DOI 10.1002/ar.1092170303; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pisters LL, 1997, J UROLOGY, V158, P724, DOI 10.1016/S0022-5347(01)64301-5; Prives C, 1999, J PATHOL, V187, P112; REITER RE, 1993, CANCER RES, V53, P3092; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Saifudeen Z, 2002, AM J PHYSIOL-RENAL, V283, pF727, DOI 10.1152/ajprenal.00114.2002; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang XW, 1997, J CELL PHYSIOL, V173, P247, DOI 10.1002/(SICI)1097-4652(199711)173:2<247::AID-JCP30>3.0.CO;2-A; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang Y, 2013, ONCOGENE; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585; Zigeuner R, 2004, UROLOGY, V63, P651, DOI 10.1016/j.urology.2003.11.011	56	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85624	10.1371/journal.pone.0085624	http://dx.doi.org/10.1371/journal.pone.0085624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386484	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900131
J	Berry, M; Jaquiery, A; Oliver, M; Harding, J; Bloomfield, F				Berry, Mary; Jaquiery, Anne; Oliver, Mark; Harding, Jane; Bloomfield, Frank			Preterm Birth Has Sex-Specific Effects on Autonomic Modulation of Heart Rate Variability in Adult Sheep	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; GESTATIONAL-AGE; BLOOD-PRESSURE; RISK-FACTORS; YOUNG; HYPERTENSION; CONTRIBUTES; STRESS; SYSTEM; FETAL	Introduction: Globally, 11% of infants are born preterm. In adulthood, individuals born preterm are at increased risk of cardiovascular morbidity and mortality, but the mechanistic basis of this remains unknown. Clinically overt cardiovascular disease may be preceded by altered cardiac autonomic activity characterised by increased sympathetic activity and/or reduced parasympathetic activity. Thus, altered cardiac autonomic activity in survivors of preterm birth may underlie later cardiovascular risk. Objective: To investigate the impact of gestational age on cardiac autonomic activity in juvenile and adult sheep. Methods and Results: Singleton-bearing ewes were randomised antenatally to spontaneous term birth (TC; n=73) or corticosteroid induced preterm birth (PT; n=60). Cardiac autonomic modulation was assessed using heart rate variability analysis in juvenile and adult offspring. Preterm birth in adult males was associated with altered sympathovagal modulation (LFnu: PT 64 +/- 4 vs. TC 49 +/- 4, p<0.05; LogLF/HF: PT 1.8 +/- 0.1 vs. TC 1.5 +/- 0.1, p<0.05) and reduced parasympathetic modulation (LogRMSSD: PT 2.9 +/- 0.2 vs. TC 3.4 +/- 0.1, p<0.05; LogNN50: PT 0.3 +/- 0.4 vs. TC 1.6 +/- 0.4, p<0.05). Within the range of term birth, each one-day increment in gestational age was associated with a decrement in LFnu in juvenile females and with a decrement in LFnu and LF/HF ratio, but an increment in RMSSD and NN50 in adult females. Conclusions: Cardiac autonomic function in adult sheep is affected in a sex-specific manner by gestational age at birth, even within the term range. Altered cardiac autonomic function may contribute to increased later cardiovascular morbidity in those born preterm.	[Berry, Mary; Jaquiery, Anne; Oliver, Mark; Harding, Jane; Bloomfield, Frank] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Jaquiery, Anne; Oliver, Mark; Bloomfield, Frank] Univ Auckland, Natl Ctr Growth & Dev, Auckland 1, New Zealand; [Jaquiery, Anne; Bloomfield, Frank] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Berry, M (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	max.berry@otago.ac.nz	Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Oliver, Mark/0000-0002-0359-2297; Bloomfield, Frank/0000-0001-6424-6577	Health Research Council, New Zealand; National Research Centre for Growth and Development, New Zealand	Health Research Council, New Zealand(Health Research Council of New Zealand); National Research Centre for Growth and Development, New Zealand	Funding provided by Health Research Council, New Zealand, National Research Centre for Growth and Development, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANZNN (Australian and New Zealand Neonatal Network), 2011, REP AUSTR NZ NEON NE; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Bonamy AKE, 2008, ACTA PAEDIATR, V97, P1080, DOI 10.1111/j.1651-2227.2008.00890.x; Bonamy AKE, 2008, ACTA PAEDIATR, V97, P434, DOI 10.1111/j.1651-2227.2008.00723.x; Boudreau P, 2012, CHRONOBIOL INT, V29, P757, DOI 10.3109/07420528.2012.674592; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Burns J, 2007, CIRCULATION, V115, P1999, DOI 10.1161/CIRCULATIONAHA.106.668863; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Dart AM, 2002, CARDIOVASC RES, V53, P678, DOI 10.1016/S0008-6363(01)00508-9; Davrath LR, 2003, AM J PHYSIOL-HEART C, V285, pH1697, DOI 10.1152/ajpheart.00208.2003; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; Erami C, 2005, AM J PHYSIOL-HEART C, V289, pH744, DOI 10.1152/ajpheart.00129.2005; Feldt K, 2007, J HUM HYPERTENS, V21, P401, DOI 10.1038/sj.jhh.1002176; Fisher JP, 2012, J HUM HYPERTENS, V26, P463, DOI 10.1038/jhh.2011.66; Frasch MG, 2007, J PHYSIOL-LONDON, V579, P893, DOI 10.1113/jphysiol.2006.124800; Giuffre M, 2012, J MATERN-FETAL NEO M, V25, P6, DOI 10.3109/14767058.2012.712350; Hernandez CE, 2009, BEHAV BRAIN RES, V204, P82, DOI 10.1016/j.bbr.2009.05.019; Kuo TBJ, 2010, ENDOCRINOLOGY, V151, P2613, DOI 10.1210/en.2009-1410; Lewandowski AJ, 2013, CIRCULATION, V127, P197, DOI 10.1161/CIRCULATIONAHA.112.126920; Lucini D, 2002, CIRCULATION, V106, P2673, DOI 10.1161/01.CIR.0000039106.89299.AB; Masuo K, 1997, AM J HYPERTENS, V10, P77, DOI 10.1016/S0895-7061(96)00303-2; Mitoff PR, 2011, HEART, V97, P382, DOI 10.1136/hrt.2010.199760; Patural H, 2008, EARLY HUM DEV, V84, P681, DOI 10.1016/j.earlhumdev.2008.04.010; Patural H, 2010, RES VET SCI, V89, P242, DOI 10.1016/j.rvsc.2010.01.019; Reefmann N, 2009, PHYSIOL BEHAV, V98, P235, DOI 10.1016/j.physbeh.2009.05.017; Ribatti D, 2007, PHARMACOL REV, V59, P185, DOI 10.1124/pr.59.2.3; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Segar JL, 1998, AM J PHYSIOL-REG I, V274, pR160, DOI 10.1152/ajpregu.1998.274.1.R160; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; WALKER AM, 1978, BIOL NEONATE, V33, P135, DOI 10.1159/000241063; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	38	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e85468	10.1371/journal.pone.0085468	http://dx.doi.org/10.1371/journal.pone.0085468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386475	Green Submitted, gold, Green Published			2022-12-27	WOS:000329116700139
J	Franciotti, R; D'Ascenzo, S; Di Domenico, A; Onofrj, M; Tommasi, L; Laeng, B				Franciotti, Raffaella; D'Ascenzo, Stefania; Di Domenico, Alberto; Onofrj, Marco; Tommasi, Luca; Laeng, Bruno			Focusing Narrowly or Broadly Attention When Judging Categorical and Coordinate Spatial Relations: A MEG Study	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; VISUAL-ATTENTION; UNILATERAL STROKE; PARIETAL CORTEX; TASK-DIFFICULTY; TIME-COURSE; STIMULI; RESOLUTION; VOLUNTARY; OBJECTS	We measured activity in the dorsal system of the human cortex with magnetoencephalography (MEG) during a matching-to-sample plus cueing paradigm, where participants judged the occurrence of changes in either categorical or coordinate spatial relations (e. g., exchanges of left versus right positions or changes in the relative distances) between images of pairs of animals. The attention window was primed in each trial to be either small or large by using cues that immediately preceded the matching image. In this manner, we could assess the modulatory effects of the scope of attention on the activity of the dorsal system of the human cortex during spatial relations processing. The MEG measurements revealed that large spatial cues yielded greater activations and longer peak latencies in the right inferior parietal lobe for coordinate trials, whereas small cues yielded greater activations and longer peak latencies in the left inferior parietal lobe for categorical trials. The activity in the superior parietal lobe, middle frontal gyrus, and visual cortex, was also modulated by the size of the spatial cues and by the type of spatial relation change. The present results support the theory that the lateralization of each kind of spatial processing hinges on differences in the sizes of regions of space attended to by the two hemispheres. In addition, the present findings are inconsistent with the idea of a right-hemispheric dominance for all kinds of challenging spatial tasks, since response times and accuracy rates showed that the categorical spatial relation task was more difficult than the coordinate task and the cortical activations were overall greater in the left hemisphere than in the right hemisphere.	[Franciotti, Raffaella; D'Ascenzo, Stefania; Di Domenico, Alberto; Onofrj, Marco] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Franciotti, Raffaella] Univ G dAnnunzio, ITAB, Chieti, Italy; [Tommasi, Luca] Univ G DAnnunzio, Dept Psychol Humanities & Terr, Chieti, Italy; [Laeng, Bruno] Univ Oslo, Dept Psychol, Oslo, Norway	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Oslo	Franciotti, R (corresponding author), Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy.	raffaella.franciotti@itab.unich.it	onofrj, marco/K-7710-2016; Di Domenico, Alberto/AIB-7965-2022; Franciotti, Raffaella/AAC-2664-2022; Di Domenico, Alberto/O-2111-2015	onofrj, marco/0000-0002-0480-2495; Di Domenico, Alberto/0000-0002-9962-2891; Di Domenico, Alberto/0000-0002-9962-2891; Tommasi, Luca/0000-0003-0664-714X				Amorapanth PX, 2010, J COGNITIVE NEUROSCI, V22, P1739, DOI 10.1162/jocn.2009.21322; Baciu M, 1999, NEUROREPORT, V10, P1373, DOI 10.1097/00001756-199904260-00040; Ballard BH, 1986, BEHAV BRAIN SCI, V9, P67; Baumann O, 2012, NEUROIMAGE, V60, P1630, DOI 10.1016/j.neuroimage.2012.01.089; Borst G, 2010, NEUROPSYCHOLOGIA, V48, P2769, DOI 10.1016/j.neuropsychologia.2010.04.027; Brancucci A, 2011, J NEUROSCI, V31, P16611, DOI 10.1523/JNEUROSCI.3949-11.2011; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Carpenter PS, 1999, J COGNITIVE NEUROSCI, V31, P16611; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Della Penna S, 2004, NEUROIMAGE, V22, P1438, DOI 10.1016/j.neuroimage.2004.03.045; Della Penna S, 2000, PHILOS MAG B, V80, P937, DOI 10.1080/01418630008221960; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Eurich CW, 1997, BIOL CYBERN, V76, P357, DOI 10.1007/s004220050349; FAHLE M, 1981, PROC R SOC SER B-BIO, V213, P451, DOI 10.1098/rspb.1981.0075; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Franciotti R, 2009, NEUROIMAGE, V46, P1082, DOI 10.1016/j.neuroimage.2009.03.034; Franconeri SL, 2012, COGNITION, V122, P210, DOI 10.1016/j.cognition.2011.11.002; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; HAYWARD WG, 1995, COGNITION, V55, P39, DOI 10.1016/0010-0277(94)00643-Y; Hellige JB., 2010, 2 HALVES BRAIN, V2002, P379, DOI [10.7551/mitpress/9780262014137.003.0279, DOI 10.7551/MITPRESS/9780262014137.003.0279]; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Hinton G. E., 1986, FOUNDATIONS, V1, P77; Hubner R, 2002, PERCEPT PSYCHOPHYS, V64, P1290, DOI 10.3758/BF03194772; HUMPHREYS GW, 1981, Q J EXP PSYCHOL-A, V33, P17, DOI 10.1080/14640748108400765; JACOBS RA, 1994, COGNITIVE SCI, V18, P361, DOI 10.1207/s15516709cog1803_1; Jager G, 2003, NEUROPSYCHOLOGIA, V41, P504, DOI 10.1016/S0028-3932(02)00086-6; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI, P516; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; KOSSLYN SM, 1992, J EXP PSYCHOL HUMAN, V18, P562, DOI 10.1037/0096-1523.18.2.562; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Kosslyn SM, 1998, PSYCHOBIOLOGY, V26, P333; Laeng B, 2003, ASYMMETRICAL BRAIN, P303; Laeng B, 2002, COGN NEUROPSYCHOL, V19, P697, DOI 10.1080/02643290244000121; Laeng B, 1999, COGNITION, V70, P53, DOI 10.1016/S0010-0277(98)00077-8; LAENG B, 1994, J COGNITIVE NEUROSCI, V6, P189, DOI 10.1162/jocn.1994.6.3.189; Laeng B, 2006, NEUROPSYCHOLOGIA, V44, P1595, DOI 10.1016/j.neuropsychologia.2006.01.023; Laeng B, 2011, COGNITIVE SCI, V35, P297, DOI 10.1111/j.1551-6709.2010.01139.x; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; LURIA AR, 1973, WORKING BRAIN INTRO, P398; Maringelli F, 1998, EUR J COGN PSYCHOL, V10, P225; Martin R, 2008, NEUROPSYCHOLOGIA, V46, P576, DOI 10.1016/j.neuropsychologia.2007.10.010; Michimata C, 2011, BRAIN COGNITION, V77, P292, DOI 10.1016/j.bandc.2011.07.008; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Okubo M, 2010, ACTA PSYCHOL, V135, P1, DOI 10.1016/j.actpsy.2010.04.004; Palermo L, 2008, NEUROPSYCHOLOGIA, V46, P2802, DOI 10.1016/j.neuropsychologia.2008.05.020; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Prinzmetal W, 2005, PERCEPT PSYCHOPHYS, V67, P48, DOI 10.3758/BF03195012; Robertson LC, 1999, PSYCHOL SCI, V10, P76, DOI 10.1111/1467-9280.00110; Samonas M, 1997, IEEE T BIO-MED ENG, V44, P386, DOI 10.1109/10.568914; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P1560, DOI 10.1016/j.neuropsychologia.2006.01.018; Slotnick SD, 2001, J COGNITIVE NEUROSCI, V13, P1088, DOI 10.1162/089892901753294383; Steger J, 2001, PSYCHOPHYSIOLOGY, V38, P243; STOFFER TH, 1993, PSYCHOL RES-PSYCH FO, V56, P14, DOI 10.1007/BF00572129; THEEUWES J, 1994, PERCEPTION, V23, P429, DOI 10.1068/p230429; Trojano L, 2002, NEUROPSYCHOLOGIA, V40, P1666, DOI 10.1016/S0028-3932(02)00021-0; Trojano L, 2006, NEUROPSYCHOLOGIA, V44, P1569, DOI 10.1016/j.neuropsychologia.2006.01.017; Turatto M, 2000, PERCEPT PSYCHOPHYS, V62, P935, DOI 10.3758/BF03212079; van der Ham IJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038644; VANKLEECK MH, 1989, NEUROPSYCHOLOGIA, V27, P1165, DOI 10.1016/0028-3932(89)90099-7; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Volberg G, 2007, EXP PSYCHOL, V54, P83, DOI 10.1027/1618-3169.54.1.83; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; WARD LM, 1982, J EXP PSYCHOL HUMAN, V8, P562, DOI 10.1037/0096-1523.8.4.562; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; Yeshurun Y, 2008, PERCEPT PSYCHOPHYS, V70, P104, DOI 10.3758/PP.70.1.104	72	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83434	10.1371/journal.pone.0083434	http://dx.doi.org/10.1371/journal.pone.0083434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281QS	24386197	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700049
J	Sun, JJ; Wang, ZY; Teo, M; Li, ZD; Wu, HB; Yen, RY; Zheng, M; Chang, Q; Liu, IY				Sun, Jian-jun; Wang, Zhen-yu; Teo, Mario; Li, Zhen-dong; Wu, Hai-bo; Yen, Ru-yu; Zheng, Mei; Chang, Qing; Liu, Isabelle Yisha			Comparative Outcomes of the Two Types of Sacral Extradural Spinal Meningeal Cysts Using Different Operation Methods: A Prospective Clinical Study	PLOS ONE			English	Article							TARLOV CYSTS; PERINEURAL CYSTS; THERAPY	This prospective study compares different clinical characteristics and outcomes of patients with two types of sacral extradural spinal meningeal cysts (SESMC) undergoing different means of surgical excision. Using the relationship between the cysts and spinal nerve roots fibers (SNRF) as seen under microscope, SESMCs were divided into two types: cysts with SNRF known as Tarlov cysts and cysts without. The surgical methods were tailored to the different types of SESMCs. The improved Japanese Orthopedic Association (IJOA) scoring system was used to evaluate preoperative and postoperative neurological function of the patients. Preoperative IJOA scores were 18.5 +/- 1.73, and postoperative IJOA scores were 19.6 +/- 0.78. The difference between preoperative and postoperative IJOA scores was statistically significant (t = -4.52, p = 0.0001), with a significant improvement in neurological function after surgery. Among the improvements in neurological functions, the most significant was sensation (z=-2.74, p=0.006), followed by bowel/bladder function (z=-2.50, p=0.01). There was a statistically significant association between the types of SESMC and the number (F=12.57, p=0.001) and maximum diameter (F=8.08, p=0.006) of the cysts. SESMC with SNRF are often multiple and small, while cysts without SNRF tend to be solitary and large. We advocate early surgical intervention for symptomatic SESMCs in view of significant clinical improvement postoperatively.	[Sun, Jian-jun; Wang, Zhen-yu; Li, Zhen-dong] Peking Univ, Hosp 3, Dept Neurosurg, Beijing 100871, Peoples R China; [Teo, Mario] So Gen Hosp, Inst Neurol Sci, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland; [Wu, Hai-bo] Peking Univ, Hosp 3, Dept Neuroradiol, Beijing 100871, Peoples R China; [Yen, Ru-yu] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100871, Peoples R China; [Zheng, Mei] Peking Univ, Hosp 3, Dept Neurol, Beijing 100871, Peoples R China; [Chang, Qing] Peking Univ, Hosp 3, Dept Pathol, Beijing 100871, Peoples R China; [Liu, Isabelle Yisha] UCLA Med Ctr, Dept Head & Neck Surg, Los Angeles, CA USA	Peking University; University of Glasgow; Peking University; Peking University; Peking University; Peking University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Sun, JJ (corresponding author), Peking Univ, Hosp 3, Dept Neurosurg, Beijing 100871, Peoples R China.	sunjj2008@gmail.com; wzyu502@hotmail.com	Teo, Mario/AAE-5804-2020	Teo, Mario/0000-0002-0051-3303	Science Foundation for The Excellent Youth Scholars of Ministry of Education of China [200800011035]	Science Foundation for The Excellent Youth Scholars of Ministry of Education of China	Data collection and analysis was supported by grants from Science Foundation for The Excellent Youth Scholars of Ministry of Education of China (200800011035). Preparation and English language editing was supported by National Natural Science Foundation of China (81200969/H0912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta FL, 2003, NEU ROSURGICAL FOCUS, P15, DOI 10.3171/foc.2003.15.2.15; Duja CM, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-18; Fernandes C, 2012, TECH COLOPROCTOL, V16, P319, DOI 10.1007/s10151-012-0826-5; Freidenstein J, 2012, PAIN PHYSICIAN, V15, P141; Ju CI, 2009, J KOREAN NEUROSURG S, V45, P185, DOI 10.3340/jkns.2009.45.3.185; Jung KT, 2012, J PAIN, V25, P191; Landers J, 2002, BRIT J NEUROSURG, V16, P182, DOI 10.1080/026886902317384535; NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366; Oh JK, 2012, ACTA NEUROCHIR, V154, P341, DOI 10.1007/s00701-011-1110-6; ORAHILLY R, 1990, J ANAT, V168, P95; Park HJ, 2008, J KOREAN NEUROSURG S, V44, P174, DOI 10.3340/jkns.2008.44.3.174; Patel MR, 1997, AM J ROENTGENOL, V168, P367, DOI 10.2214/ajr.168.2.9016209; Pena E, 2011, PARKINSONISM RELAT D, V17, P645, DOI 10.1016/j.parkreldis.2011.05.001; Singh PK, 2009, J SPINAL CORD MED, V32, P191, DOI 10.1080/10790268.2009.11760771; Slipman Curtis W, 2003, Spine J, V3, P317, DOI 10.1016/S1529-9430(03)00027-5; Smith ZA, 2013, WORLD NEUROSURG, V79, P285, DOI 10.1016/j.wneu.2012.07.016; Sun JJ, 2013, SCI CHINA LIFE SCI, V56, P1007, DOI 10.1007/s11427-013-4536-7; Tanaka M, 2006, ACTA MED OKAYAMA, V60, P65; TARLOV IM, 1970, J NEUROL NEUROSUR PS, V33, P833, DOI 10.1136/jnnp.33.6.833; Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025; Xu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039958	21	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83964	10.1371/journal.pone.0083964	http://dx.doi.org/10.1371/journal.pone.0083964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386317	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700091
J	You, JS; Lee, HJ; Chung, YE; Lee, HS; Kim, MJ; Chung, SP; Kim, MJ; Park, I; Kim, KW				You, Je Sung; Lee, Hye-Jeong; Chung, Yong Eun; Lee, Hye Sun; Kim, Myo Jeong; Chung, Sung Phil; Kim, Myeong-Jin; Park, Incheol; Kim, Ki Whang			Diagnostic Radiation Exposure of Injury Patients in the Emergency Department: A Cross-Sectional Large Scaled Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; TRAUMA PATIENTS; CT; TRENDS; RISK	In contrast to patients with underlying cancer or chronic disease, injury patients are relatively young, and can be expected to live their natural lifespan if injuries are appropriately treated. Multiple and repeated diagnostic scans might be performed in these patients during admission. Nevertheless, radiation exposure in injury patients has been overlooked and underestimated because of the emergent nature of such situations. Therefore, we tried to assess the cumulative effective dose (cED) of injury patients in the emergency department. We included patients who visited the emergency department (ED) of a single tertiary hospital due to injury between February 2010 and February 2011. The cED for each patient was calculated and compared across age, sex and injury mechanism. A total of 11,676 visits (mean age: 28.0 years, M: F = 6,677: 4,999) were identified. Although CT consisted of only 7.8% of total radiologic examinations (n=78,025), it accounted for 87.1% of the total cED. The mean cED per visit was 2.6 mSv. A significant difference in the cED among injury mechanisms was seen (p<0.001) and patients with traffic accidents and fall down injuries showed relatively high cED values. Hence, to reduce the cED of injury patients, an age-, sex- and injury mechanism-specific dose reduction strategy should be considered.	[You, Je Sung; Chung, Sung Phil; Park, Incheol] Yonsei Univ, Coll Med, Dept Emergency Med, Severance Hosp, Seoul, South Korea; [Lee, Hye-Jeong; Chung, Yong Eun; Kim, Myeong-Jin; Kim, Ki Whang] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea; [Lee, Hye Sun; Kim, Myo Jeong] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea.	yelv@yuhs.ac	; Kim, Myeong-Jin/E-1623-2011; Lee, Hye Sun/J-2154-2015; Chung, Sung Phil/F-8344-2016	Lee, Hye-Jeong/0000-0003-4349-9174; Chung, Yong Eun/0000-0003-0811-9578; Park, Incheol/0000-0001-7033-766X; You, Je Sung/0000-0002-2074-6745; Kim, Myeong-Jin/0000-0001-7949-5402; Lee, Hye Sun/0000-0001-6328-6948; Chung, Sung Phil/0000-0002-3074-011X				American College of Surgeons - Committee on Trauma, 2008, ADV TRAUM LIF SUPP D; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Bleyer A, 2002, PEDIATR RADIOL, V32, P242, DOI 10.1007/s00247-002-0674-y; Brenner D, 2008, RADIAT PROT DOSIM, V128, P503, DOI 10.1093/rpd/ncn056; Brunetti MA, 2011, J TRAUMA, V70, pE24, DOI 10.1097/TA.0b013e3181e80d8d; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Desmond AN, 2012, CLIN GASTROENTEROL H, V10, P259, DOI 10.1016/j.cgh.2011.11.007; Donnelly LF, 2005, AM J ROENTGENOL, V184, P655, DOI 10.2214/ajr.184.2.01840655; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Griffey RT, 2009, AM J ROENTGENOL, V192, P887, DOI 10.2214/AJR.08.1351; Hadley JL, 2006, AM J ROENTGENOL, V186, P937, DOI 10.2214/AJR.05.0041; Hart D., 2002, NRPBW4; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Kim PK, 2004, J TRAUMA, V57, P510, DOI 10.1097/01.TA.0000141028.97753.67; Kinsella SM, 2010, KIDNEY INT, V78, P789, DOI 10.1038/ki.2010.196; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lee YJ, 2012, KOREAN J RADIOL, V13, P144, DOI 10.3348/kjr.2012.13.2.144; McCollough CH, 2012, RADIOLOGY, V264, P567, DOI 10.1148/radiol.12112265; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; National Council on Radiation Protection and Measurements. National Council on Radiation Protection and Measurements. Scientific Committee-2 on Radiation Exposure of the U.S. Population, 2009, ION RAD EXP POP US, Vxv, P3; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Sharma OP, 2011, J EMERG MED, V41, P640, DOI 10.1016/j.jemermed.2011.03.004; Sharma OP, 2011, AM SURGEON, V77, P193; SHRIMPTON PC, 2004, NRPBPE12004; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Valentin Jack, 2007, Annals of the ICRP, V37, P3	28	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84870	10.1371/journal.pone.0084870	http://dx.doi.org/10.1371/journal.pone.0084870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386427	Green Published, gold, Green Submitted			2022-12-27	WOS:000329116700121
J	Shuryak, I; Smilenov, LB; Kleiman, NJ; Brenner, DJ				Shuryak, Igor; Smilenov, Lubomir B.; Kleiman, Norman J.; Brenner, David J.			Potential Reduction of Contralateral Second Breast-Cancer Risks by Prophylactic Mammary Irradiation: Validation in a Breast-Cancer-Prone Mouse Model	PLOS ONE			English	Article							LOCAL RECURRENCE; RADIOTHERAPY; RADIATION; INDUCTION; TAMOXIFEN; TUMORS	Background: Long-term breast-cancer survivors have a highly elevated risk (1 in 6 at 20 years) of contralateral second breast cancer. This high risk is associated with the presence of multiple pre-malignant cell clones in the contralateral breast at the time of primary breast cancer diagnosis. Mechanistic analyses suggest that a moderate dose of X-rays to the contralateral breast can kill these pre-malignant clones such that, at an appropriate Prophylactic Mammary Irradiation (PMI) dose, the long-term contralateral breast cancer risk in breast cancer survivors would be considerably decreased. Aims: To test the predicted relationship between PMI dose and cancer risk in mammary glands that have a high risk of developing malignancies. Methods: We tested the PMI concept using MMTV-PyVT mammary-tumor-prone mice. Mammary glands on one side of each mouse were irradiated with X-rays, while those on the other side were shielded from radiation. The unshielded mammary glands received doses of 0, 4, 8, 12 and 16 Gy in 4-Gy fractions. Results: In high-risk mammary glands exposed to radiation doses designed for PMI (12 and 16 Gy), tumor incidence rates were respectively decreased by a factor of 2.2 (95% CI, 1.1-5.0) at 12 Gy, and a factor of 3.1 (95% CI, 1.3-8.3) at 16 Gy, compared to those in the shielded glands that were exposed to very low radiation doses. The same pattern was seen for PMI-exposed mammary glands relative to zero-dose controls. Conclusions: The pattern of cancer risk reduction by PMI was consistent with mechanistic predictions. Contralateral breast PMI may thus have promise as a spatially targeted breast-conserving option for reducing the current high risk of contralateral second breast cancers. For estrogen-receptor positive primary tumors, PMI might optimally be used concomitantly with systemically delivered chemopreventive drugs such as tamoxifen or aromatase inhibitors, while for estrogen-receptor negative tumors, PMI might be used alone.	[Shuryak, Igor; Smilenov, Lubomir B.; Kleiman, Norman J.; Brenner, David J.] Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10027 USA	Columbia University	Shuryak, I (corresponding author), Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10027 USA.	is144@columbia.edu	Kleiman, Norman/B-9745-2008	Kleiman, Norman/0000-0002-4725-998X	Irving Institute for Clinical and Translational Research, Columbia University; NIAID [U19 AI67773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	Irving Institute for Clinical and Translational Research, Columbia University; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a Pilot Study Award Grant from the Irving Institute for Clinical and Translational Research, Columbia University, and by NIAID grant U19 AI67773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; American Cancer Society Inc, 2011, BREAST CANC FACTS FI; Anastasiadis Panagiotis G., 2000, Breast J, V6, P178, DOI 10.1046/j.1524-4741.2000.99081.x; Arrington AK, 2009, ANN SURG ONCOL, V16, P2697, DOI 10.1245/s10434-009-0641-z; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bartstra RW, 1998, RADIAT RES, V150, P442, DOI 10.2307/3579664; Bhatnagar AK, 2006, BREAST CANCER RES TR, V96, P41, DOI 10.1007/s10549-005-9032-8; BOICE JD, 1992, NEW ENGL J MED, V326, P781, DOI 10.1056/NEJM199203193261201; Boice JD, 2001, MED PEDIATR ONCOL, V36, P508, DOI 10.1002/mpo.1122; Brenner DJ, 2007, J CLIN ONCOL, V25, P4868, DOI 10.1200/JCO.2007.11.0379; Breslow NE, 1987, DESIGN ANAL COHORT S, P1; Chai Yunfei, 2009, Acta Medica Nagasakiensia, V53, P65; Chiang HC, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-31; Curtis RE, 2006, NIH PUBLICATION, P1973; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Freedman GM, 2005, INT J RADIAT ONCOL, V61, P1328, DOI 10.1016/j.ijrobp.2004.08.026; Gao X, 2003, INT J RADIAT ONCOL, V56, P1038, DOI 10.1016/S0360-3016(03)00203-7; Gujral DM, 2011, INT J RADIAT ONCOL, V79, P19, DOI 10.1016/j.ijrobp.2009.10.074; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; International Agency for Research on Cancer, 1980, STAT METHODS CANC RE; King TA, 2011, J CLIN ONCOL, V29, P2158, DOI 10.1200/JCO.2010.29.4041; Lam JBB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004968; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Ramaseshan R, 2004, PHYS MED BIOL, V49, P4031, DOI 10.1088/0031-9155/49/17/014; Sandberg MEC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046535; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stucky CCH, 2010, ANN SURG ONCOL, V17, pS330, DOI 10.1245/s10434-010-1259-x; Taggart F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-238; Uray IP, 2011, RECENT RESULTS CANC, V188, P147, DOI 10.1007/978-3-642-10858-7_13; Veronesi U, 2013, LANCET ONCOL, V14, P1269, DOI 10.1016/S1470-2045(13)70497-2; William WN, 2009, NAT REV DRUG DISCOV, V8, P213, DOI 10.1038/nrd2663; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Yi M, 2011, ANN SURG, V253, P572, DOI 10.1097/SLA.0b013e318208fc2a	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2013	8	12							e85795	10.1371/journal.pone.0085795	http://dx.doi.org/10.1371/journal.pone.0085795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276IX	24376895	Green Published, Green Submitted, gold			2022-12-27	WOS:000328745100209
J	Eyben, F; Weninger, F; Lehment, N; Schuller, B; Rigoll, G				Eyben, Florian; Weninger, Felix; Lehment, Nicolas; Schuller, Bjoern; Rigoll, Gerhard			Affective Video Retrieval: Violence Detection in Hollywood Movies by Large-Scale Segmental Feature Extraction	PLOS ONE			English	Article							RECOGNITION; SCENES; AUDIO	Without doubt general video and sound, as found in large multimedia archives, carry emotional information. Thus, audio and video retrieval by certain emotional categories or dimensions could play a central role for tomorrow's intelligent systems, enabling search for movies with a particular mood, computer aided scene and sound design in order to elicit certain emotions in the audience, etc. Yet, the lion's share of research in affective computing is exclusively focusing on signals conveyed by humans, such as affective speech. Uniting the fields of multimedia retrieval and affective computing is believed to lend to a multiplicity of interesting retrieval applications, and at the same time to benefit affective computing research, by moving its methodology "out of the lab" to real-world, diverse data. In this contribution, we address the problem of finding "disturbing" scenes in movies, a scenario that is highly relevant for computer-aided parental guidance. We apply large-scale segmental feature extraction combined with audio-visual classification to the particular task of detecting violence. Our system performs fully data-driven analysis including automatic segmentation. We evaluate the system in terms of mean average precision (MAP) on the official data set of the MediaEval 2012 evaluation campaign's Affect Task, which consists of 18 original Hollywood movies, achieving up to .398 MAP on unseen test data in full realism. An in-depth analysis of the worth of individual features with respect to the target class and the system errors is carried out and reveals the importance of peak-related audio feature extraction and low-level histogram-based video analysis.	[Eyben, Florian; Weninger, Felix; Lehment, Nicolas; Schuller, Bjoern; Rigoll, Gerhard] Tech Univ Munich, Inst Human Machine Commun, D-80290 Munich, Germany; [Schuller, Bjoern] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Technical University of Munich; Imperial College London	Eyben, F (corresponding author), Tech Univ Munich, Inst Human Machine Commun, D-80290 Munich, Germany.	eyben@tum.de		Schuller, Bjorn/0000-0002-6478-8699	European Community [289021]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007- 2013) under grant agreement No. 289021 (ASC-Inclusion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nievas EB, 2011, LECT NOTES COMPUT SC, V6855, P332, DOI 10.1007/978-3-642-23678-5_39; Bogdan I, 2013, P 3 ACM C INT C MULT, P215, DOI DOI 10.1145/2461466.2461502; Datta A, 2002, INT C PATT RECOG, P433, DOI 10.1109/ICPR.2002.1044748; de Souza F. D. M., 2010, Proceedings of the 23rd SIBGRAPI Conference on Graphics, Patterns and Images (SIBGRAPI 2010), P224, DOI 10.1109/SIBGRAPI.2010.38; Demarty C. H., 2012, P MEDIAEVAL 2012 WOR; Demarty CH, 2012, LECT NOTES COMPUT SC, V7585, P416, DOI 10.1007/978-3-642-33885-4_42; Deng J, 2012, P INTERSPEECH, P4; Eyben F., 2012, P MEDIAEVAL 2012 WOR; Eyben F., 2010, ACM MULTIMEDIA MM, P1459, DOI DOI 10.1145/1873951.1874246; Giannakopoulos T., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3244, DOI 10.1109/ICPR.2010.793; Giannakopoulos T, 2010, LECT NOTES ARTIF INT, V6040, P91, DOI 10.1007/978-3-642-12842-4_13; Gong Y, 2008, LECT NOTES COMPUT SC, V5353, P317, DOI 10.1007/978-3-540-89796-5_33; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hanjalic  Alan, 2005, IEEE T MULTIMEDIA, V7; Lee CM, 2005, IEEE T SPEECH AUDI P, V13, P293, DOI 10.1109/TSA.2004.838534; Liang-Hua Chen, 2011, Proceedings of the 2011 Eighth International Conference on Computer Graphics, Imaging and Visualization (CGIV 2011), P119, DOI 10.1109/CGIV.2011.14; Lin JA, 2009, LECT NOTES COMPUT SC, V5879, P930; Nam J, 1998, 1998 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL 1, P353, DOI 10.1109/ICIP.1998.723496; Schuller B, 2012, INT CONF ACOUST SPEE, P341, DOI 10.1109/ICASSP.2012.6287886; Schuller BW, 2012, IEEE SIGNAL PROC MAG, V29, P97, DOI 10.1109/MSP.2012.2192211; Sundaram S, 2010, IEEE INT CON MULTI, P573, DOI 10.1109/ICME.2010.5583001; Wang KY, 2012, COMM COM INF SC, V321, P137; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52	24	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e78506	10.1371/journal.pone.0078506	http://dx.doi.org/10.1371/journal.pone.0078506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391704	Green Published, gold			2022-12-27	WOS:000329325200001
J	Haukoos, JS; Campbell, JD; Conroy, AA; Hopkins, E; Bucossi, MM; Sasson, C; Al-Tayyib, AA; Thrun, MW				Haukoos, Jason S.; Campbell, Jonathan D.; Conroy, Amy A.; Hopkins, Emily; Bucossi, Meggan M.; Sasson, Comilla; Al-Tayyib, Alia A.; Thrun, Mark W.		Denver ED HIV Opt-Out Study Grp	Programmatic Cost Evaluation of Nontargeted Opt-Out Rapid HIV Screening in the Emergency Department	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; UNITED-STATES; CARE; PREVENTION; RECOMMENDATIONS; INFECTION; HEALTH; MODEL	Background: The Centers for Disease Control and Prevention recommends nontargeted opt-out HIV screening in healthcare settings. Cost effectiveness is critical when considering potential screening methods. Our goal was to compare programmatic costs of nontargeted opt-out rapid HIV screening with physician-directed diagnostic rapid HIV testing in an urban emergency department (ED) as part of the Denver ED HIV Opt-Out Trial. Methods: This was a prospective cohort study nested in a larger quasi-experiment. Over 16 months, nontargeted rapid HIV screening (intervention) and diagnostic rapid HIV testing (control) were alternated in 4-month time blocks. During the intervention phase, patients were offered HIV testing using an opt-out approach during registration; during the control phase, physicians used a diagnostic approach to offer HIV testing to patients. Each method was fully integrated into ED operations. Direct program costs were determined using the perspective of the ED. Time-motion methodology was used to estimate personnel activity costs. Costs per patient newly-diagnosed with HIV infection by intervention phase, and incremental cost effectiveness ratios were calculated. Results: During the intervention phase, 28,043 eligible patients were included, 6,933 (25%) completed testing, and 15 (0.2%, 95% CI: 0.1%-0.4%) were newly-diagnosed with HIV infection. During the control phase, 29,925 eligible patients were included, 243 (0.8%) completed testing, and 4 (1.7%, 95% CI: 0.4%-4.2%) were newly-diagnosed with HIV infection. Total annualized costs for nontargeted screening were $148,997, whereas total annualized costs for diagnostic HIV testing were $31,355. The average costs per HIV diagnosis were $9,932 and $7,839, respectively. Nontargeted HIV screening identified 11 more HIV infections at an incremental cost of $10,693 per additional infection. Conclusions: Compared to diagnostic testing, nontargeted HIV screening was more costly but identified more HIV infections. More effective and less costly testing strategies may be required to improve the identification of patients with undiagnosed HIV infection in the ED.	[Haukoos, Jason S.; Hopkins, Emily; Bucossi, Meggan M.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; [Haukoos, Jason S.; Sasson, Comilla] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Haukoos, Jason S.; Al-Tayyib, Alia A.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Campbell, Jonathan D.] Skaggs Sch Pharm & Pharmaceut Sci, Dept Clin Pharm, Aurora, CO USA; [Conroy, Amy A.] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Conroy, Amy A.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Al-Tayyib, Alia A.; Thrun, Mark W.] Denver Publ Hlth, Denver, CO USA	Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; University of California System; University of California San Francisco	Haukoos, JS (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA.	Jason.Haukoos@dhha.org	Campbell, Jonathan/C-1279-2015	Al-Tayyib, Alia/0000-0002-5909-6719	Centers for Disease Control and Prevention [U18PS000314]; Agency for Healthcare Research and Quality [K02HS017526]; National Institute of Allergy and Infectious Diseases [R01AI106057]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017526] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U18PS000314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI106057] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by U18PS000314 from the Centers for Disease Control and Prevention (Haukoos), and supported, in part, by K02HS017526 from the Agency for Healthcare Research and Quality (Haukoos) and R01AI106057 from the National Institute of Allergy and Infectious Diseases (Haukoos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Emergency Physicians, 2007, Ann Emerg Med, V50, P209; [Anonymous], 2010, NAT HIV AIDS STRAT U; Bayer R, 2011, NEW ENGL J MED, V365, P1265, DOI 10.1056/NEJMp1108657; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Drummond MF, 2015, METHODS EC EVALUATIO; Gabow P, 2003, ANN INTERN MED, V138, P143, DOI 10.7326/0003-4819-138-2-200301210-00016; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gold MR, 1996, COST EFFECTIVENESS H; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI 10.1111/j.1553-2712.2007.tb02335.x; Haukoos Jason S, 2011, Ann Emerg Med, V58, pS10, DOI 10.1016/j.annemergmed.2011.03.033; Haukoos JS, 2013, ANN EMERG MED, V61, P353, DOI 10.1016/j.annemergmed.2012.10.031; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Hutchinson AB, 2011, AIDS EDUC PREV, V23, P58, DOI 10.1521/aeap.2011.23.3_supp.58; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026; Pitts Stephen R, 2008, Natl Health Stat Report, P1; Prabhu VS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019936; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Walensky RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025575	29	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e81565	10.1371/journal.pone.0081565	http://dx.doi.org/10.1371/journal.pone.0081565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391706	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200003
J	D'Anselmi, F; Masiello, MG; Cucina, A; Proietti, S; Dinicola, S; Pasqualato, A; Ricci, G; Dobrowolny, G; Catizone, A; Palombo, A; Bizzarri, M				D'Anselmi, Fabrizio; Masiello, Maria Grazia; Cucina, Alessandra; Proietti, Sara; Dinicola, Simona; Pasqualato, Alessia; Ricci, Giulia; Dobrowolny, Gabriella; Catizone, Angela; Palombo, Alessandro; Bizzarri, Mariano			Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							MESENCHYMAL TRANSITION; PHENOTYPE; TARGET; DIFFERENTIATION; TRANSPLANTATION; CARCINOGENESIS; ORGANIZATION; APOPTOSIS; MIGRATION; REVERSION	The microenvironment drives mammary gland development and function, and may influence significantly both malignant behavior and cell growth of mammary cancer cells. By restoring context, and forcing cells to properly interpret native signals from the microenvironment, the cancer cell aberrant behavior can be quelled, and organization re-established. In order to restore functional and morphological differentiation, human mammary MCF-7 and MDA-MB-231 cancer cells were allowed to grow in a culture medium filled with a 10% of the albumen (EW, Egg White) from unfertilized chicken egg. That unique microenvironment behaves akin a 3D culture and induces MCF-7 cells to produce acini and branching duct-like structures, distinctive of mammary gland differentiation. EW-treated MDA-MB-231 cells developed buds of acini and duct-like structures. Both MCF-7 and MDA-MB-231 cells produced beta-casein, a key milk component. Furthermore, E-cadherin expression was reactivated in MDA-MB-231 cells, as a consequence of the increased cdh1 expression; meanwhile beta-catenin - a key cytoskeleton component - was displaced behind the inner cell membrane. Such modification hinders the epithelial-mesenchymal transition in MDA-MB-231 cells. This differentiating pathway is supported by the contemporary down-regulation of canonical pluripotency markers (Klf4, Nanog). Given that egg-conditioned medium behaves as a 3D-medium, it is likely that cancer phenotype reversion could be ascribed to the changed interactions between cells and their microenvironment.	[D'Anselmi, Fabrizio; Bizzarri, Mariano] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [D'Anselmi, Fabrizio; Cucina, Alessandra] Univ Roma La Sapienza, Dept Surg Pietro Valdoni, I-00185 Rome, Italy; [Masiello, Maria Grazia; Proietti, Sara; Dinicola, Simona] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy; [Pasqualato, Alessia] Univ G DAnnunzio, Dept Basic & Appl Med Sci, Chieti, Italy; [Ricci, Giulia] Univ Naples 2, Dept Expt Med, Naples, Italy; [Dobrowolny, Gabriella; Catizone, Angela] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, I-00185 Rome, Italy; [Palombo, Alessandro] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Bizzarri, Mariano] ASI, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; Universita della Campania Vanvitelli; Sapienza University Rome; University of Rome Tor Vergata; Agenzia Spaziale Italiana (ASI)	Bizzarri, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	mariano.bizzarri@uniroma1.it	Ricci, Giulia/AAO-1856-2020; Bizzarri, Mariano/U-8300-2017	Ricci, Giulia/0000-0002-2199-170X; Bizzarri, Mariano/0000-0003-0408-4136; catizone, angela/0000-0002-7836-9495; Dobrowolny, Gabriella/0000-0001-8693-0724; Cucina, Alessandra/0000-0001-5469-6419; Masiello, Maria Grazia/0000-0002-7474-5553	Fondazione Roma Terzo Settore [8.1.3.3.19.1]	Fondazione Roma Terzo Settore(Fondazione Roma)	The present study was partially supported by the Fondazione Roma Terzo Settore (grant no. 8.1.3.3.19.1; URL: http://www.fondazioneroma-terzosettore.it/it/index.html). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Alberio R, 2006, REPRODUCTION, V132, P709, DOI 10.1530/rep.1.01077; Allegrucci C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-7; Baker SG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-151; Berlutti F, 2010, INT J IMMUNOPATH PH, V23, P1253, DOI 10.1177/039463201002300430; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Biskind MS, 1944, P SOC EXP BIOL MED, V55, P176; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bizzarri M, 2008, ACTA BIOTHEOR, V56, P173, DOI 10.1007/s10441-008-9047-8; Bizzarri M, 2013, HISTOL HISTOPATHOL, V28, P155, DOI 10.14670/HH-28.155; Bizzarri M, 2011, CURR PHARM BIOTECHNO, V12, P243, DOI 10.2174/138920111794295701; Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3; BOVERI T, 1929, ORIGIN MALIGNANT TUM, P62; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Catizone A, 2008, J CELL PHYSIOL, V216, P253, DOI 10.1002/jcp.21400; Christofori G, 2010, EMBO J, V29, P1787, DOI 10.1038/emboj.2010.92; Cooper, 2009, MED STUD, V1, P55, DOI [10.1007/s12376-008-0002-4, DOI 10.1007/S12376-008-0002-4]; Cucina A, 2006, APOPTOSIS, V11, P1617, DOI 10.1007/s10495-006-8895-4; D'Anselmi F, 2011, CURR PHARM BIOTECHNO, V12, P261, DOI 10.2174/138920111794295864; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; Dhimolea E, 2012, J BIOMED MATER RES A, V100A, P2905, DOI 10.1002/jbm.a.34227; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Ferranti F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076192; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Inoue T, 2001, J INVEST DERMATOL, V117, P244, DOI 10.1046/j.0022-202x.2001.01431.x; Kasemeier-Kulesa JC, 2008, DEV DYNAM, V237, P2657, DOI 10.1002/dvdy.21613; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Lee JT, 2006, NAT MED, V12, P882, DOI 10.1038/nm0806-882; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Li-Chan EC., 1995, EGG SCI TECHNOL, P105; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; McCullough KD, 1997, CANCER RES, V57, P1807; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; PIERCE GB, 1983, AM J PATHOL, V113, P115; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Sonnenschein C, 1996, J STEROID BIOCHEM, V59, P147, DOI 10.1016/S0960-0760(96)00112-4; Sonnenschein C, 2008, SEMIN CANCER BIOL, V18, P372, DOI 10.1016/j.semcancer.2008.03.012; Soto AM, 2011, BIOESSAYS, V33, P332, DOI 10.1002/bies.201100025; Tafani M, 2012, J CANC SCI THER, V4; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231	50	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83770	10.1371/journal.pone.0083770	http://dx.doi.org/10.1371/journal.pone.0083770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386275	Green Submitted, Green Published, gold			2022-12-27	WOS:000329194700067
J	Kagawa, Y; Matsumoto, S; Kamioka, Y; Mimori, K; Naito, Y; Ishii, T; Okuzaki, D; Nishida, N; Maeda, S; Naito, A; Kikuta, J; Nishikawa, K; Nishimura, J; Haraguchi, N; Takemasa, I; Mizushima, T; Ikeda, M; Yamamoto, H; Sekimoto, M; Ishii, H; Doki, Y; Matsuda, M; Kikuchi, A; Mori, M; Ishii, M				Kagawa, Yoshinori; Matsumoto, Shinji; Kamioka, Yuji; Mimori, Koshi; Naito, Yoko; Ishii, Taeko; Okuzaki, Daisuke; Nishida, Naohiro; Maeda, Sakae; Naito, Atsushi; Kikuta, Junichi; Nishikawa, Keizo; Nishimura, Junichi; Haraguchi, Naotsugu; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Ishii, Hideshi; Doki, Yuichiro; Matsuda, Michiyuki; Kikuchi, Akira; Mori, Masaki; Ishii, Masaru			Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo	PLOS ONE			English	Article							IMMUNE-SYSTEM; MOUSE MODEL; KINASE; MIGRATION; ROCK; PROLIFERATION; ACTIVATION; EXPRESSION; INHIBITOR; PROTEINS	The mechanism behind the spatiotemporal control of cancer cell dynamics and its possible association with cell proliferation has not been well established. By exploiting the intravital imaging technique, we found that cancer cell motility and invasive properties were closely associated with the cell cycle. In vivo inoculation of human colon cancer cells bearing fluorescence ubiquitination-based cell cycle indicator (Fucci) demonstrated an unexpected phenomenon: S/G2/M cells were more motile and invasive than G1 cells. Microarray analyses showed that Arhgap11a, an uncharacterized Rho GTPase-activating protein (RhoGAP), was expressed in a cell-cycle-dependent fashion. Expression of ARHGAP11A in cancer cells suppressed RhoA-dependent mechanisms, such as stress fiber formation and focal adhesion, which made the cells more prone to migrate. We also demonstrated that RhoA suppression by ARHGAP11A induced augmentation of relative Rac1 activity, leading to an increase in the invasive properties. RNAi-based inhibition of Arhgap11a reduced the invasion and in vivo expansion of cancers. Additionally, analysis of human specimens showed the significant up-regulation of Arhgap11a in colon cancers, which was correlated with clinical invasion status. The present study suggests that ARHGAP11A, a cell cycle-dependent RhoGAP, is a critical regulator of cancer cell mobility and is thus a promising therapeutic target in invasive cancers.	[Kagawa, Yoshinori; Naito, Yoko; Ishii, Taeko; Maeda, Sakae; Naito, Atsushi; Kikuta, Junichi; Ishii, Masaru] Osaka Univ, Grad Sch Med, Dept Immunol & Cell Biol, Suita, Osaka, Japan; [Kagawa, Yoshinori; Naito, Yoko; Ishii, Taeko; Maeda, Sakae; Naito, Atsushi; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] Osaka Univ, Lab Cellular Dynam, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kagawa, Yoshinori; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] CREST, JST, Chiyoda Ku, Tokyo, Japan; [Kagawa, Yoshinori; Nishida, Naohiro; Maeda, Sakae; Naito, Atsushi; Nishimura, Junichi; Haraguchi, Naotsugu; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Matsumoto, Shinji; Kikuchi, Akira] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Suita, Osaka, Japan; [Kamioka, Yuji; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan; [Mimori, Koshi; Nishida, Naohiro] Kyushu Univ, Dept Surg, Med Inst Bioregulat, Beppu, Oita, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 565, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Kyoto University; Kyushu University; Osaka University	Mori, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan.	mmori@gesurg.med.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; Sekimoto, Mitsugu/T-2217-2019; Kikuta, Junichi/HHS-8875-2022; Ishii, Hideshi/AAV-5317-2020; Nishimura, Junichi/K-8390-2015; Sekimoto, MItsugu/AAE-5878-2019	Okuzaki, Daisuke/0000-0002-4552-783X; Nishimura, Junichi/0000-0001-8220-3423; Matsuda, Michiyuki/0000-0002-5876-9969; Mimori, Koshi/0000-0003-3897-9974	Ministry of Education, Science, Sports and Culture of Japan; International Human Frontier Science Program [RGY0077/2011]; Takeda Science Foundation; Cell Science Research Foundation; Kanae Foundation for the Promotion of Medical Science; Nakajima Foundation;  [22113007]; Grants-in-Aid for Scientific Research [22113007] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Human Frontier Science Program(Human Frontier Science Program); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Kanae Foundation for the Promotion of Medical Science; Nakajima Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grants-in-Aid for Scientific Research on Innovative Areas (22113007), by the FIRST Program from the Ministry of Education, Science, Sports and Culture of Japan, by grants from the International Human Frontier Science Program (RGY0077/2011); and by grants from the Takeda Science Foundation, the Cell Science Research Foundation, the Kanae Foundation for the Promotion of Medical Science, and the Nakajima Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bravou V, 2005, INT J ONCOL, V27, P1511; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Cance WG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004021; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kostourou V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3020; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Martinelli R, 2009, MOL BIOL CELL, V20, P995, DOI 10.1091/mbc.E08-06-0636; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mori M, 2002, SURGERY, V131, pS39, DOI 10.1067/msy.2002.119292; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Rashidi B, 2000, CLIN CANCER RES, V6, P2556; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Sobin, 2009, UICC TNM CLASSIFICAT; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Walmod PS, 2004, EXP CELL RES, V295, P407, DOI 10.1016/j.yexcr.2004.01.011; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xu J, 2013, CELL REP, V3, P1526, DOI 10.1016/j.celrep.2013.04.017; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yoshida K, 2004, ONCOGENE, V23, P58, DOI 10.1038/sj.onc.1206987	55	48	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83629	10.1371/journal.pone.0083629	http://dx.doi.org/10.1371/journal.pone.0083629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386239	Green Published, Green Submitted, gold			2022-12-27	WOS:000329194700052
J	Li, ZP; Zhang, XS; Wang, RS; Liu, HW; Zhang, SH				Li, Zhenping; Zhang, Xiang-Sun; Wang, Rui-Sheng; Liu, Hongwei; Zhang, Shihua			Discovering Link Communities in Complex Networks by an Integer Programming Model and a Genetic Algorithm	PLOS ONE			English	Article							FUNCTIONAL MODULES	Identification of communities in complex networks is an important topic and issue in many fields such as sociology, biology, and computer science. Communities are often defined as groups of related nodes or links that correspond to functional subunits in the corresponding complex systems. While most conventional approaches have focused on discovering communities of nodes, some recent studies start partitioning links to find overlapping communities straightforwardly. In this paper, we propose a new quantity function for link community identification in complex networks. Based on this quantity function we formulate the link community partition problem into an integer programming model which allows us to partition a complex network into overlapping communities. We further propose a genetic algorithm for link community detection which can partition a network into overlapping communities without knowing the number of communities. We test our model and algorithm on both artificial networks and real-world networks. The results demonstrate that the model and algorithm are efficient in detecting overlapping community structure in complex networks.	[Li, Zhenping; Liu, Hongwei] Beijing Wuzi Univ, Sch Informat, Beijing, Peoples R China; [Zhang, Xiang-Sun; Zhang, Shihua] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Wang, Rui-Sheng] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Beijing Wuzi University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, SH (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	zsh@amss.ac.cn		Wang, Ruisheng/0000-0003-4920-4357	National Natural Science Foundation of China [11131009]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201006217, CITTCD20130327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality	This work is supported by National Natural Science Foundation of China under grant number 11131009. It is also partially supported by the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (No.PHR201006217, CIT&TCD20130327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Esquivel AV, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021025; Evans TS, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12037; Evans TS, 2010, EUR PHYS J B, V77, P265, DOI 10.1140/epjb/e2010-00261-8; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gregory S, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02017; He DX, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/10/P10015; Holland JH., 1975, Q REV BIOL; Hu YQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026121; Knuth DE., 1993, STANFORD GRAPH BASE; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Lee JG, 2013, SCI REP-UK, V3, DOI [10.1038/srep01034, 10.1038/srep02197]; Li K, 2012, PHYSICA A, V391, P1788, DOI 10.1016/j.physa.2011.09.027; Li ZP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036109; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicosia V, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03024; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Shen HW, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07042; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Szalay-Beko M, 2012, BIOINFORMATICS, V28, P2202, DOI 10.1093/bioinformatics/bts352; Tasgin M., 2006, COMMUNITY DETECTION; Vicsek T, 2007, PHYSICA A, V378, P20, DOI 10.1016/j.physa.2006.11.075; Wang RS, 2007, LECT NOTES ARTIF INT, V4682, P1090; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhan WH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066120; Zhang S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046103; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhang SH, 2009, INT J DATA MIN BIOIN, V3, P68, DOI 10.1504/IJDMB.2009.023885; Zhang XS, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/38002	37	13	14	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2013	8	12							e83739	10.1371/journal.pone.0083739	http://dx.doi.org/10.1371/journal.pone.0083739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282SX	24386268	Green Published, gold, Green Submitted			2022-12-27	WOS:000329194700062
J	Decraene, J; Monterola, C; Lee, GKK; Hung, TGG; Batty, M				Decraene, James; Monterola, Christopher; Lee, Gary Kee Khoon; Hung, Terence Gih Guang; Batty, Michael			The Emergence of Urban Land Use Patterns Driven by Dispersion and Aggregation Mechanisms	PLOS ONE			English	Article								We employ a cellular-automata to reconstruct the land use patterns of cities that we characterize by two measures of spatial heterogeneity: (a) a variant of spatial entropy, which measures the spread of residential, business, and industrial activity sectors, and (b) an index of dissimilarity, which quantifies the degree of spatial mixing of these land use activity parcels. A minimalist and bottom-up approach is adopted that utilizes a limited set of three parameters which represent the forces which determine the extent to which each of these sectors spatially aggregate into clusters. The dispersion degrees of the land uses are governed by a fixed pre-specified power-law distribution based on empirical observations in other cities. Our method is then used to reconstruct land use patterns for the city state of Singapore and a selection of North American cities. We demonstrate the emergence of land use patterns that exhibit comparable visual features to the actual city maps defining our case studies whilst sharing similar spatial characteristics. Our work provides a complementary approach to other measures of urban spatial structure that differentiate cities by their land use patterns resulting from bottom-up dispersion and aggregation processes.	[Decraene, James; Monterola, Christopher; Lee, Gary Kee Khoon; Hung, Terence Gih Guang] Agcy Sci Technol & Res, Inst High Performance Comp, Dept Comp Sci, Complex Syst Grp, Singapore, Singapore; [Batty, Michael] UCL, Ctr Adv Spatial Anal, London, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); University of London; University College London	Monterola, C (corresponding author), Agcy Sci Technol & Res, Inst High Performance Comp, Dept Comp Sci, Complex Syst Grp, Singapore, Singapore.	monterolac@ihpc.a-star.edu.sg	Batty, Michael/D-4422-2011; Batty, Michael/I-5638-2014	Batty, Michael/0000-0002-9931-1305; 	Singapore A*STAR SERC Complex Systems Programme' research grant [1224504056]; EPSRC [EP/G060983/1, EP/G057737/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G057737/1, EP/G060983/1] Funding Source: researchfish	Singapore A*STAR SERC Complex Systems Programme' research grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by Singapore A*STAR SERC Complex Systems Programme' research grant (1224504056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso W., 1964, LOCATION LAND USE; Anas A, 1998, J ECON LIT, V36, P1426; Batty M, 1974, GEOGR ANAL, P1; Batty M., 1994, FRACTAL CITIES; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Cervero R, 1997, TRANSPORT RES D-TR E, V2, P199, DOI 10.1016/S1361-9209(97)00009-6; Cervero R., 1989, AM SUBURBAN CTR LAND; CURRY L, 1972, REG STUD, V6, P131, DOI 10.1080/09595237200185141; Decraene J, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183112500921; Valenzuela JF, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02038; Lau KH, 2005, ENVIRON PLANN B, V32, P247, DOI 10.1068/b31110; Leibovici DG, 2009, LECT NOTES COMPUT SC, V5756, P392, DOI 10.1007/978-3-642-03832-7_24; Makse HA, 1998, PHYS REV E, V58, P7054, DOI 10.1103/PhysRevE.58.7054; Thunen J.H. von, 1966, ISOLATED STATE; Wang B, 2009, INT J NUMERICAL ANAL, V9	15	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e80309	10.1371/journal.pone.0080309	http://dx.doi.org/10.1371/journal.pone.0080309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24386078	gold, Green Published, Green Submitted			2022-12-27	WOS:000329117900003
J	Harmon, QE; Laughlin, SK; Baird, DD				Harmon, Quaker E.; Laughlin, Shannon K.; Baird, Donna D.			Keloids and Ultrasound Detected Fibroids in Young African American Women	PLOS ONE			English	Article							UTERINE LEIOMYOMAS; PATHOGENESIS; PREVALENCE; EXPRESSION; SCARS; RISK	Objective: Keloids and fibroids share a number of biologic and demographic similarities however there are no published reports of the association between them. The objective of this study was to investigate the association between self-reported keloids and ultrasound detected fibroids in a population of young African American women. Study Design: The Study of Environment, Life-style & Fibroids (SELF), is a volunteer cohort of over 1600 African American women aged 23-34 years recruited in Detroit, Michigan. Enrollment occurred between December 2010 and December 2012. Data are available for the first 1196 participants. Participants self-reported a history of raised (hypertrophic) scars or scars extending beyond the limits of the original injury (keloid) and had an enrollment pelvic ultrasound examination to detect prevalent fibroids. Log linear regression was used to model the association between abnormal scars and prevalent fibroids controlling for possible covariates. Among women with fibroids, associations between particular fibroid characteristics (tumor location, size or number) and scarring were assessed using chi-square and Mann Whitney U-tests. Results: Both abnormal scarring (keloids, 9.0%; hypertrophic scars, 28.3%) and fibroids (23.3%) were common in this cohort. There was no indication [ adjusted Risk Ratio (95% Confidence Interval): 0.7 (0.5-1.1)] of an association between self-reported keloids and prevalent fibroids. Nor was there any association with hypertrophic scars. Specific characteristics of the prevalent fibroids were not associated with abnormal scarring. Conclusion: Despite similarly dysregulated extracellular matrices in keloids and fibroids, these conditions did not tend to co-occur in this young African American population.	[Harmon, Quaker E.; Baird, Donna D.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Laughlin, Shannon K.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Mayo Clinic	Harmon, QE (corresponding author), NIEHS, Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	quaker.harmon@nih.gov	Harmon, Quaker/ABG-1109-2021; Baird, Donna D/D-5214-2017	Baird, Donna D/0000-0002-5544-2653; Harmon, Quaker/0000-0002-5866-848X	Intramural Research Program of the NIH; National Institute of Environmental Health Sciences; American Recovery and Reinvestment Act funds designated for National Institute of Health research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049013] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Recovery and Reinvestment Act funds designated for National Institute of Health research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. Funding also came from the American Recovery and Reinvestment Act funds designated for National Institute of Health research. SELF website: detroitself.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar A, 2006, PLAST RECONSTR SURG, V117, P286, DOI 10.1097/01.prs.0000195073.73580.46; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bran GM, 2009, INT J MOL MED, V24, P283, DOI 10.3892/ijmm_00000231; Carrino DA, 2012, BIOCHEM J, V443, P361, DOI 10.1042/BJ20111996; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; COSMAN B, 1961, PLAST RECONSTR SURG, V27, P335, DOI 10.1097/00006534-196104000-00001; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Huang C, 2012, INT WOUND J; Laughlin SK, 2010, SEMIN REPROD MED, V28, P203, DOI 10.1055/s-0030-1251477; Laughlin SK, 2009, OBSTET GYNECOL, V113, P630, DOI 10.1097/AOG.0b013e318197bbaf; Leppert PC, 2006, AM J OBSTET GYNECOL, V195, P415, DOI 10.1016/j.ajog.2005.12.059; Luo X, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-35; Marsh EE, 2013, FERTIL STERIL, V99, P1951, DOI 10.1016/j.fertnstert.2013.02.017; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P141; Seifert O, 2009, ARCH DERMATOL RES, V301, P259, DOI 10.1007/s00403-009-0952-8; Shih B, 2010, ARCH DERMATOL RES, V302, P319, DOI 10.1007/s00403-009-1014-y; Slemp AE, 2006, CURR OPIN PEDIATR, V18, P396, DOI 10.1097/01.mop.0000236389.41462.ef; United States Census Bureau,, 2010, 2 US CENS BUR	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84737	10.1371/journal.pone.0084737	http://dx.doi.org/10.1371/journal.pone.0084737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386410	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900108
J	Liu, F; Gao, MQ; Zhang, X; Du, FJ; Jia, HY; Yang, XT; Wang, ZT; Zhang, LQ; Ma, LP; Wu, XG; Xie, L; Zhang, ZD				Liu, Fei; Gao, Mengqiu; Zhang, Xia; Du, Fengjiao; Jia, Hongyan; Yang, Xinting; Wang, Zitong; Zhang, Liqun; Ma, Liping; Wu, Xiaoguang; Xie, Li; Zhang, Zongde			Interferon-Gamma Release Assay Performance of Pleural Fluid and Peripheral Blood in Pleural Tuberculosis	PLOS ONE			English	Article							ENZYME-LINKED IMMUNOSPOT; POLYMERASE-CHAIN-REACTION; ADENOSINE-DEAMINASE; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; T-CELLS; DIAGNOSIS; INFECTION; EFFUSIONS	Background: The diagnosis of pleural tuberculosis (TB) remains to be difficult. Interferon-gamma release assay (IGRA) is a promising method for diagnosing TB in low TB burden countries. The release of interferon-gamma (IFN-gamma) y T lymphocytes increases at a localized site of infection with Mycobacterium tuberculosis antigen. This study aimed to examine the clinical accuracy of T-SPOT.TB on pleural fluid and peripheral blood for the diagnosis of pleural TB in high TB burden country. Methods: 168 subjects with pleural effusion were enrolled prospectively and examined with T-SPOT.TB on pleural fluid and peripheral blood samples simultaneously. Results: The receiver operating characteristic (ROC) curve and cut-off value of pleural fluid T-SPOT.TB was established according to spot forming cells (SFC) between culture/biopsy-confirmed pleural TB group and no pleural TB group. The sensitivity of pleural fluid T-SPOT. TB and peripheral blood T-SPOT.TB was similar (96.3% and 92.7%, respectively) (P= 0.691). In contrast, the specificity of pleural fluid T-SPOT.TB (94.5%) was significantly higher than that of peripheral blood T-SPOT.TB (76.1%) (P=0.002). 2% (2/98) of pleural fluid T-SPOT.TB results were indeterminate. Conclusion: The diagnostic accuracy of peripheral blood T-SPOT.TB is low in high TB burden countries due to latent tuberculosis infection. Pleural fluid T-SPOT.TB is a relatively useful and supplementary test to explore pleural TB in high TB burden countries, but its diagnostic accuracy needs to be validated in further large scale research.	[Liu, Fei; Zhang, Xia; Du, Fengjiao; Jia, Hongyan; Zhang, Zongde] Capital Med Univ, Beijing Key Lab Drug Resistant TB Res, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Gao, Mengqiu; Yang, Xinting; Zhang, Liqun; Ma, Liping; Wu, Xiaoguang; Xie, Li] Capital Med Univ, TB Dept, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Wang, Zitong] Capital Med Univ, Dept Thorac Surg, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Key Lab Drug Resistant TB Res, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China.	zzd417@163.com	Zhang, Li/GWM-7501-2022		National Major Project [2012ZX10003002-003]; Beijing health systems of high-level health and technical personnel training plan [2009-3-51]; Capital Science &Development fund [2009-3146]	National Major Project; Beijing health systems of high-level health and technical personnel training plan; Capital Science &Development fund	This work was supported by grants of the National Major Project (2012ZX10003002-003), Beijing health systems of high-level health and technical personnel training plan (2009-3-51). It was also supported by Capital Science &Development fund (2009-3146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUENO CE, 1990, ARCH INTERN MED, V150, P1190, DOI 10.1001/archinte.1990.00390180034005; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Duanmu Hongjin, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P3; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Greco S, 2003, INT J TUBERC LUNG D, V7, P777; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Kang JY, 2012, TUBERC RESPIR DIS, V73, P143, DOI 10.4046/trd.2012.73.3.143; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lee LN, 2009, CLIN MICROBIOL INFEC, V15, P173, DOI 10.1111/j.1469-0691.2008.02655.x; Li H, 2012, INT J TUBERC LUNG D, V16, P1668, DOI 10.5588/ijtld.12.0292; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Lima DM, 2003, CHEST, V124, P909, DOI 10.1378/chest.124.3.909; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nagesh BS, 2001, CHEST, V119, P1737, DOI 10.1378/chest.119.6.1737; Nemeth J, 2009, J INTERN MED, V265, P163, DOI 10.1111/j.1365-2796.2008.02012.x; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Perez-Rodriguez E, 2000, Curr Opin Pulm Med, V6, P259, DOI 10.1097/00063198-200007000-00002; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Valdes L, 1996, EUR RESPIR J, V9, P747, DOI 10.1183/09031936.96.09040747; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Valdes L, 1996, CHEST, V109, P158, DOI 10.1378/chest.109.1.158; Wang SM, 2006, PROTOCOL BACTERIOLOG; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Wu X, 2008, CLIN EXP IMMUNOL, V152, P81, DOI 10.1111/j.1365-2249.2008.03605.x	28	23	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83857	10.1371/journal.pone.0083857	http://dx.doi.org/10.1371/journal.pone.0083857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386296	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900063
J	Mordini, S; Osera, C; Marini, S; Scavone, F; Bellazzi, R; Galizzi, A; Calvio, C				Mordini, Serena; Osera, Cecilia; Marini, Simone; Scavone, Francesco; Bellazzi, Riccardo; Galizzi, Alessandro; Calvio, Cinzia			The Role of SwrA, DegU and P-D3 in fla/che Expression in B. subtilis	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; BACILLUS-SUBTILIS; SWARMING MOTILITY; GENES; MUTATIONS; OPERON; PHOSPHORYLATION; PROMOTERS; ENZYMES; SIGD	In B. subtilis swarming and robust swimming motility require the positive trigger of SwrA on fla/che operon expression. Despite having an essential and specific activity, how SwrA executes this task has remained elusive thus far. We demonstrate here that SwrA acts at the main sA-dependent fla/che promoter P-A(fla/che) through DegU. Electrophoretic mobility shift assays (EMSA) reveal that SwrA forms a complex with the phosphorylated form of DegU (DegU similar to P) at P-A(fla/che) while it is unable to do so with either unphosphorylated DegU or the DegU32(Hy) mutant protein. Motility assays show that a highly phosphorylated DegU is not detrimental for flagellar motility provided that SwrA is present; however, DegU similar to P represses P-A(fla/che) in the absence of SwrA. Overall, our data support a model in which DegU similar to P is a dual regulator, acting either as a repressor when alone or as a positive regulator of PA(fla/che) when combined with SwrA. Finally, we demonstrate that the sD-dependent P-D3(fla/che) promoter plays an important role in motility, representing a contingent feedback loop necessary to maintain basal motility when swrA is switched to the non-functional swrA-status.	[Mordini, Serena; Osera, Cecilia; Scavone, Francesco; Galizzi, Alessandro; Calvio, Cinzia] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Marini, Simone; Bellazzi, Riccardo] Univ Pavia, Dept Elect Comp & Biomed Engn, I-27100 Pavia, Italy	University of Pavia; University of Pavia	Calvio, C (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, Italy.	cinzia.calvio@unipv.it	Cinzia, Calvio/E-1353-2011; Bellazzi, Riccardo/J-6432-2018; Osera, Cecilia/K-3677-2016	Cinzia, Calvio/0000-0003-1631-0452; Bellazzi, Riccardo/0000-0002-6974-9808; Osera, Cecilia/0000-0002-7406-7166; Marini, Simone/0000-0002-5704-3533	Ministero dell'Universita e della Ricerca; PRIN [2008KY8WN9]; Alma Mater Ticinensis Foundation	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Alma Mater Ticinensis Foundation	This work was supported by grants from Ministero dell'Universita e della Ricerca to CC and AG, PRIN # 2008KY8WN9 (http://prin.miur.it/), and from the Alma Mater Ticinensis Foundation (www.almamaterticinensis.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati G, 2004, J BACTERIOL, V186, P6003, DOI 10.1128/jb.186.18.6003-6014.2004; AMORY A, 1987, J BACTERIOL, V169, P324, DOI 10.1128/jb.169.1.324-333.1987; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Cairns LS, 2013, MOL MICROBIOL, V90, P6, DOI 10.1111/mmi.12342; Calvio C, 2005, J BACTERIOL, V187, P5356, DOI 10.1128/JB.187.15.5356-5366.2005; Calvio C, 2008, J BACTERIOL, V190, P5720, DOI 10.1128/JB.00455-08; Carey Michael F, 2012, Cold Spring Harb Protoc, V2012, P18, DOI 10.1101/pdb.top067470; DAHL MK, 1992, J BIOL CHEM, V267, P14509; Estacio W, 1998, J BACTERIOL, V180, P3548, DOI 10.1128/JB.180.14.3548-3555.1998; Gordon AJE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003595; HENNER DJ, 1988, J BACTERIOL, V170, P5102, DOI 10.1128/jb.170.11.5102-5109.1988; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; KUNST F, 1974, BIOCHIMIE, V56, P1481; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; MSADEK T, 1991, J BACTERIOL, V173, P2366, DOI 10.1128/JB.173.7.2366-2377.1991; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; MUKAI K, 1992, J BACTERIOL, V174, P7954, DOI 10.1128/JB.174.24.7954-7962.1992; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; NAGAMI Y, 1986, J BACTERIOL, V166, P20, DOI 10.1128/jb.166.1.20-28.1986; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Ogura M, 2012, J BIOCHEM, V151, P643, DOI 10.1093/jb/mvs036; Osera C, 2009, MICROBIOL-SGM, V155, P2282, DOI 10.1099/mic.0.026435-0; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Patrick JE, 2009, J BACTERIOL, V191, P7129, DOI 10.1128/JB.00905-09; TANAKA T, 1991, J BACTERIOL, V173, P5507, DOI 10.1128/jb.173.17.5507-5515.1991; TOKUNAGA T, 1994, J BACTERIOL, V176, P5177, DOI 10.1128/jb.176.16.5177-5180.1994; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; West JT, 2000, J BACTERIOL, V182, P4841, DOI 10.1128/JB.182.17.4841-4848.2000; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	33	27	29	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e85065	10.1371/journal.pone.0085065	http://dx.doi.org/10.1371/journal.pone.0085065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386445	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900121
J	Peng, Y; Zhang, F; Gui, SL; Qiao, HP; Hose, GC				Peng, Yu; Zhang, Fan; Gui, Shaolan; Qiao, Huping; Hose, Grant C.			Comparative Growth and Development of Spiders Reared on Live and Dead Prey	PLOS ONE			English	Article							ARANEAE; PREDATORS	Scavenging (feeding on dead prey) has been demonstrated across a number of spider families, yet the implications of feeding on dead prey for the growth and development of individuals and population is unknown. In this study we compare the growth, development, and predatory activity of two species of spiders that were fed on live and dead prey. Pardosa astrigera (Lycosidae) and Hylyphantes graminicola (Lyniphiidae) were fed live or dead fruit flies, Drosophila melanogaster. The survival of P. astrigera and H. graminicola was not affected by prey type. The duration of late instars of P. astrigera fed dead prey were longer and mature spiders had less protein content than those fed live prey, whereas there were no differences in the rate of H. graminicola development, but the mass of mature spiders fed dead prey was greater than those fed live prey. Predation rates by P. astrigera did not differ between the two prey types, but H. graminicola had a higher rate of predation on dead than alive prey, presumably because the dead flies were easier to catch and handle. Overall, the growth, development and reproduction of H. graminicola reared with dead flies was better than those reared on live flies, yet for the larger P. astrigera, dead prey may suit smaller instars but mature spiders may be best maintained with live prey. We have clearly demonstrated that dead prey may be suitable for rearing spiders, although the success of the spiders fed such prey appears size-and species specific.	[Peng, Yu; Zhang, Fan; Gui, Shaolan; Qiao, Huping] Hubei Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Hose, Grant C.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Hubei University; Macquarie University	Hose, GC (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	grant.hose@mq.edu.au		Hose, Grant/0000-0003-2106-5543	National Natural Science Fund of China [31071895]; Natural Science Fund of Hubei Province [2011CDB071]; Key Scientific and Technological Projects of Wuhan [201120722216-3]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Hubei Province; Key Scientific and Technological Projects of Wuhan	This work was supported by the National Natural Science Fund of China [31071895]; the Natural Science Fund of Hubei Province [2011CDB071], and the Key Scientific and Technological Projects of Wuhan [201120722216-3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XQ, 2012, B ENVIRON CONTAM TOX, V88, P654, DOI 10.1007/s00128-012-0584-0; Chen XQ, 2011, B ENVIRON CONTAM TOX, V86, P203, DOI 10.1007/s00128-011-0194-2; Chen XQ, 2010, B INSECTOL, V63, P203; Cross FR, 2009, NEW ZEAL J ZOOL, V36, P75, DOI 10.1080/03014220909510142; Deng LL, 2006, ENVIRON TOXICOL CHEM, V25, P3073, DOI 10.1897/06-194R.1; Foelix R., 2011, BIOL SPIDERS, V3; Holling C. S., 1959, Canadian Entomologist, V91, P385; MANSOUR F, 1993, ENTOMOPHAGA, V38, P79, DOI 10.1007/BF02373142; Marc P, 1999, AGR ECOSYST ENVIRON, V74, P229, DOI 10.1016/S0167-8809(99)00038-9; Meehan CJ, 2009, CURR BIOL, V19, pR892, DOI 10.1016/j.cub.2009.08.049; Miliczky ER, 2002, PAN-PAC ENTOMOL, V78, P140; NYFFELER M, 1990, J APPL ENTOMOL, V109, P490, DOI 10.1111/j.1439-0418.1990.tb00080.x; Peng Y, 2010, AGR FOREST ENTOMOL, V12, P343, DOI 10.1111/j.1461-9563.2010.00481.x; PFANNENSTIEL RS, 2004, P BELTW COTT C NAT C, P1594; Riechert S.E., 1987, P645; SAMU F, 1993, OECOLOGIA, V94, P139, DOI 10.1007/BF00317315; Sandidge JS, 2003, NATURE, V426, P30, DOI 10.1038/426030a; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; Taylor RM, 2000, ENVIRON ENTOMOL, V37, P996; UETZ GW, 1992, J ARACHNOL, V20, P207; Vetter RS, 2011, J ECON ENTOMOL, V104, P986, DOI 10.1603/EC10428; Wang M, 2007, KOREAN ARACHNOL, V23, P107; Xiao XQ, 2003, HUNAN GUIDING J TCMP, V8, P563; Xu HJ, 2013, KOREAN ARACHNOL, V29, P168; Zhao ZJ, 1993, COTTON SPIDERS CHINA	26	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e83663	10.1371/journal.pone.0083663	http://dx.doi.org/10.1371/journal.pone.0083663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386248	Green Submitted, gold, Green Published			2022-12-27	WOS:000329117900050
J	Symes, AJ; Eilertsen, M; Millar, M; Nariculam, J; Freeman, A; Notara, M; Feneley, MR; Patel, HRH; Masters, JRW; Ahmed, A				Symes, Andrew J.; Eilertsen, Marte; Millar, Michael; Nariculam, Joseph; Freeman, Alex; Notara, Maria; Feneley, Mark R.; Patel, Hitenedra R. H.; Masters, John R. W.; Ahmed, Aamir			Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue	PLOS ONE			English	Article							IMMUNOHISTOCHEMISTRY; TRANSCRIPTION; BIOMARKERS; UTILITY; BCL-2; P53	Prostate carcinoma is the most common cancer in men with few, quantifiable, biomarkers. Prostate cancer biomarker discovery has been hampered due to subjective analysis of protein expression in tissue sections. An unbiased, quantitative immunohistochemical approach provided here, for the diagnosis and stratification of prostate cancer could overcome this problem. Antibodies against four proteins BTF3, HINT1, NDRG1 and ODC1 were used in a prostate tissue array (> 500 individual tissue cores from 82 patients, 41 case pairs matched with one patient in each pair had biochemical recurrence). Protein expression, quantified in an unbiased manner using an automated analysis protocol in ImageJ software, was increased in malignant vs non-malignant prostate (by 2-2.5 fold, p<0.0001). Operating characteristics indicate sensitivity in the range of 0.68 to 0.74; combination of markers in a logistic regression model demonstrates further improvement in diagnostic power. Triple-labeled immunofluorescence (BTF3, HINT1 and NDRG1) in tissue array showed a significant (p<0.02) change in co-localization coefficients for BTF3 and NDRG1 co-expression in biochemical relapse vs non-relapse cancer epithelium. BTF3, HINT1, NDRG1 and ODC1 could be developed as epithelial specific biomarkers for tissue based diagnosis and stratification of prostate cancer.	[Symes, Andrew J.; Eilertsen, Marte; Nariculam, Joseph; Notara, Maria; Feneley, Mark R.; Masters, John R. W.; Ahmed, Aamir] UCL, Div Surg, Prostate Canc Res Ctr, London, England; [Millar, Michael] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Freeman, Alex] Univ Coll London Hosp, Dept Histopathol, London, England; [Patel, Hitenedra R. H.] Univ Hosp Northern Norway, Div Surg Oncol Urol & Womens Hlth, Tromso, Norway	University of London; University College London; University of Edinburgh; University College London Hospitals NHS Foundation Trust; University of London; University College London; UiT The Arctic University of Tromso; University Hospital of North Norway	Ahmed, A (corresponding author), UCL, Div Surg, Prostate Canc Res Ctr, London, England.	aamir.ahmed@ucl.ac.uk	Freeman, Alex/J-8344-2019		Prostate Cancer Research Centre charity; St Peter's Trust	Prostate Cancer Research Centre charity; St Peter's Trust	This research was funded by the Prostate Cancer Research Centre charity and St Peter's Trust. The authors are grateful to Mike Millar, Sheila MacPherson and Nancy Evans of Edinburgh University for help with staining and to Daniel Ciantar, UCL for Huygens software use. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bombari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038023; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Cangul H, 2002, CELL BIOL TOXICOL, V18, P87, DOI 10.1023/A:1015376032736; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Guo YJ, 2005, CANCER RES, V65, P1146, DOI 10.1158/0008-5472.CAN-04-3244; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Holmstrom B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3537; Hosmer W. D., 2000, APPL LOGISTIC REGRES, P143, DOI [10.1002/0471722146.ch5, DOI 10.1002/0471722146.CH5]; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kusumawidjaja G, 2007, CANCER BIOL THER, V6, P367, DOI 10.4161/cbt.6.3.3704; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Luo J, 2001, CANCER RES, V61, P4683; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Nariculam J, 2009, ASIAN J ANDROL, V11, P109, DOI 10.1038/aja.2008.22; PEARSON JD, 1990, J BIOL CHEM, V265, P4583; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Rasband W, 1997, IMAGEJ SOFTWARE VERS; Rubin MA, 2004, AM J PATHOL, V164, P831, DOI 10.1016/S0002-9440(10)63171-9; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; Tulchin N, 2010, AM J PATHOL, V176, P1203, DOI 10.2353/ajpath.2010.081063; Varma M, 2005, HISTOPATHOLOGY, V47, P1, DOI 10.1111/j.1365-2559.2005.02188.x; Wang L, 2009, INT J CANCER, V124, P1526, DOI 10.1002/ijc.24072; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Welsh JB, 2001, CANCER RES, V61, P5974; Zaytoun OM, 2011, INT J UROL, V18, P557, DOI 10.1111/j.1442-2042.2011.02798.x; Zell JA, 2009, CLIN CANCER RES, V15, P6208, DOI 10.1158/1078-0432.CCR-09-0592; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9; Zlobec I, 2006, MODERN PATHOL, V19, P1236, DOI 10.1038/modpathol.3800642	37	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84295	10.1371/journal.pone.0084295	http://dx.doi.org/10.1371/journal.pone.0084295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	24386364	Green Published, gold, Green Submitted			2022-12-27	WOS:000329117900088
J	Girolamo, F; Dallatomasina, A; Rizzi, M; Errede, M; Walchli, T; Mucignat, MT; Frei, K; Roncali, L; Perris, R; Virgintino, D				Girolamo, Francesco; Dallatomasina, Alice; Rizzi, Marco; Errede, Mariella; Waelchli, Thomas; Mucignat, Maria Teresa; Frei, Karl; Roncali, Luisa; Perris, Roberto; Virgintino, Daniela			Diversified Expression of NG2/CSPG4 Isoforms in Glioblastoma and Human Foetal Brain Identifies Pericyte Subsets	PLOS ONE			English	Article							MELANOMA-ASSOCIATED ANTIGEN; OLIGODENDROCYTE PROGENITORS; VASCULAR PERICYTES; TIGHT JUNCTIONS; NG2; ANGIOGENESIS; CELLS; PROTEOGLYCAN; GLIOMA; BARRIER	NG2/CSPG4 is a complex surface-associated proteoglycan (PG) recognized to be a widely expressed membrane component of glioblastoma (WHO grade IV) cells and angiogenic pericytes. To determine the precise expression pattern of NG2/CSPG4 on glioblastoma cells and pericytes, we generated a panel of >= 60 mouse monoclonal antibodies (mAbs) directed against the ectodomain of human NG2/CSPG4, partially characterized the mAbs, and performed a high-resolution distributional mapping of the PG in human foetal, adult and glioblastoma-affected brains. The reactivity pattern initially observed on reference tumour cell lines indicated that the mAbs recognized 48 immunologically distinct NG2/CSPG4 isoforms, and a total of 14 mAbs was found to identify NG2/CSPG4 isoforms in foetal and neoplastic cerebral sections. These were consistently absent in the adult brain, but exhibited a complementary expression pattern in angiogenic vessels of both tumour and foetal tissues. Considering the extreme pleomorphism of tumour areas, and with the aim of subsequently analysing the distributional pattern of the NG2/CSPG4 isoforms on similar histological vessel typologies, a preliminary study was carried out with endothelial cell and pericyte markers, and with selected vascular basement membrane (VBM) components. On both tumour areas characterized by 'glomeruloid' and 'garland vessels', which showed a remarkably similar cellular and molecular organization, and on developing brain vessels, spatially separated, phenotypically diversified pericyte subsets with a polarized expression of key surface components, including NG2/CSPG4, were disclosed. Interestingly, the majority of the immunolocalized NG2/CSPG4 isoforms present in glioblastoma tissue were present in foetal brain, except for one isoform that seemed to be exclusive of tumour cells, being absent in foetal brain. The results highlight an unprecedented, complex pattern of NG2/CSPG4 isoform expression in foetal and neoplastic CNS, discriminating between phenotype-specific and neoplastic versus non-neoplastic variants of the PG, thus opening up vistas for more selective immunotherapeutic targeting of brain tumours.	[Girolamo, Francesco; Rizzi, Marco; Errede, Mariella; Roncali, Luisa; Virgintino, Daniela] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy; [Dallatomasina, Alice; Perris, Roberto] Univ Parma, COMT Ctr Mol & Translat Oncol, I-43100 Parma, Italy; [Dallatomasina, Alice; Perris, Roberto] Univ Parma, Dept Biosci, I-43100 Parma, Italy; [Mucignat, Maria Teresa; Perris, Roberto] CRO IRCCS, Natl Canc Inst Aviano, SOC Expt Oncol 2, Aviano, Italy; [Waelchli, Thomas] Univ Zurich, Brain Res Inst, Dept Hlth Sci & Technol, Swiss Fed Inst Technol ETH Zurich, Zurich, Switzerland; [Waelchli, Thomas; Frei, Karl] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland	Universita degli Studi di Bari Aldo Moro; University of Parma; University of Parma; IRCCS Aviano (CRO); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Virgintino, D (corresponding author), Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy.	daniela.virgintino@uniba.it	Errede, Mariella/B-3701-2013; Mucignat, Maria Teresa/AAY-3908-2020	Mucignat, Maria Teresa/0000-0002-9601-054X; Walchli, Thomas/0000-0002-8961-6551; ERREDE, Mariella/0000-0002-8163-2338; GIROLAMO, FRANCESCO/0000-0001-8706-3386; VIRGINTINO, Daniela/0000-0003-1041-5341	MIUR (Italian Ministry for University, Education and Research); AIRC (Associazione Italiana per la Ricerca sul Cancro); POR-FESR (Creazione di Tecnopoli, Regione Emilia-Romagna)	MIUR (Italian Ministry for University, Education and Research)(Ministry of Education, Universities and Research (MIUR)); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); POR-FESR (Creazione di Tecnopoli, Regione Emilia-Romagna)	The work was supported by grants from the MIUR (Italian Ministry for University, Education and Research, PRIN 2008) to L. Roncali and R. Perris, AIRC (Associazione Italiana per la Ricerca sul Cancro) to R. Perris, and POR-FESR (Creazione di Tecnopoli, Regione Emilia-Romagna) to R. Perris. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Al-Mayhani MTF, 2011, NEURO-ONCOLOGY, V13, P830, DOI 10.1093/neuonc/nor088; Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Barrantes-Freer A, 2013, J NEUROPATH EXP NEUR, V72, P307, DOI 10.1097/NEN.0b013e31828afdbd; Bian XW, 2006, J NEURO-ONCOL, V80, P211, DOI 10.1007/s11060-006-9167-4; Chekenya M, 1999, INT J DEV NEUROSCI, V17, P421, DOI 10.1016/S0736-5748(99)00019-2; Chekenya M, 2002, J NEUROCYTOL, V31, P507, DOI 10.1023/A:1025795715377; Chekenya M, 2002, NEUROPATH APPL NEURO, V28, P367, DOI 10.1046/j.1365-2990.2002.00412.x; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Fadini GP, 2012, EXP DIABETES RES, DOI 10.1155/2012/274363; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Girolamo F, 2004, HISTOCHEM CELL BIOL, V122, P261, DOI 10.1007/s00418-004-0705-x; Girolamo F, 2011, NEUROBIOL DIS, V43, P678, DOI 10.1016/j.nbd.2011.05.021; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Ishihara H, 2008, J NEUROPATH EXP NEUR, V67, P435, DOI 10.1097/NEN.0b013e31816fd622; Ito S, 2002, JNCI-J NATL CANCER I, V94, P1080; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Jansen M, 2004, BRAIN RES REV, V45, P143, DOI 10.1016/j.brainresrev.2004.03.001; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Lippoldt A, 2000, BRAIN RES, V885, P251, DOI 10.1016/S0006-8993(00)02954-1; Liu XM, 2011, J NEURO-ONCOL, V105, P173, DOI 10.1007/s11060-011-0578-5; Liu Y, 2002, GLIA, V40, P25, DOI 10.1002/glia.10111; Maciag PC, 2008, CANCER RES, V68, P8066, DOI 10.1158/0008-5472.CAN-08-0287; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mancuso P, 2011, INT J CANCER, V129, P1344, DOI 10.1002/ijc.25816; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; SCHLINGEMANN RO, 1990, AM J PATHOL, V136, P1393; SHANDALA T, 2011, PROTEIN COTRANSLATIO, DOI DOI 10.1002/9780470015902.A0005716; Shoshan Y, 1999, P NATL ACAD SCI USA, V96, P10361, DOI 10.1073/pnas.96.18.10361; Simonavicius N, 2008, MODERN PATHOL, V21, P308, DOI 10.1038/modpathol.3801006; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Stiver SI, 2004, FRONT BIOSCI-LANDMRK, V9, P3105, DOI 10.2741/1463; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Terrile M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-550; TUNG JJ, 2012, COLD SPRING HARB PER, V4, P1; Vajkoczy P, 2000, J NEURO-ONCOL, V50, P99, DOI 10.1023/A:1006474832189; Virgintino D, 2008, J VASC RES, V45, P129, DOI 10.1159/000109965; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Virgintino D, 2013, J INHERIT METAB DIS, V36, P455, DOI 10.1007/s10545-012-9574-y; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023062; Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090; Wiranowska M, 2006, BRAIN CELL BIOL, V35, P159, DOI 10.1007/s11068-007-9009-0; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; ZHANG H, 2013, J GENET SYNDR GENE S, V3	64	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e84883	10.1371/journal.pone.0084883	http://dx.doi.org/10.1371/journal.pone.0084883			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386429	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000329116700123
J	Houben, ML; Nordkamp, MJMO; Nikkels, PGJ; van der Ent, CK; Meyaard, L; Bont, L				Houben, Michiel L.; Nordkamp, Marloes J. M. Olde; Nikkels, Peter G. J.; van der Ent, Cornelis K.; Meyaard, Linde; Bont, Louis			Soluble Leukocyte-Associated Ig-Like Receptor-1 in Amniotic Fluid Is of Fetal Origin and Positively Associates with Lung Compliance	PLOS ONE			English	Article							PASSIVE RESPIRATORY MECHANICS; INTRAUTERINE INFLAMMATION; LAIR-1; DISEASE; RISK; CYTOKINES; PULMONARY; ENDOTOXIN; RESPONSES; NEWBORNS	The soluble form of the inhibitory immune receptor leukocyte-Associated Ig-like Receptor-1 (sLAIR-1) is present in plasma, urine and synovial fluid and correlates to inflammation. We and others previously showed inflammatory protein expression in normal amniotic fluid at term. We hypothesized that sLAIR-1 is present in amniotic fluid during term parturition and is related to fetal lung function development. sLAIR-1 was detectable in all amniotic fluid samples (n=355) collected during term spontaneous deliveries. First, potential intra-uterine origins of amniotic fluid sLAIR-1 were explored. Although LAIR-1 was expressed on the surface of amniotic fluid neutrophils, LAIR-1 was not secreted upon ex vivo neutrophil stimulation with LPS, or PMA/ionomycin. Cord blood concentrations of sLAIR-1 were fourfold lower than and not related to amniotic fluid concentrations and placentas showed no or only sporadic LAIR-1 positive cells. Similarly, in post-mortem lung tissue of term neonates that died of non-pulmonary disorders LAIR-1 positive cells were absent or only sporadically present. In fetal urine samples, however, sLAIR-1 levels were even higher than in amniotic fluid and correlated with amniotic fluid sLAIR-1 concentrations. Second, the potential relevance of amniotic fluid sLAIR-1 was studied. sLAIR-1 concentrations had low correlation to amniotic fluid cytokines. We measured neonatal lung function in a convenient subset of 152 infants, using the single occlusion technique, at a median age of 34 days (IQR 30-39). The amniotic fluid concentration of sLAIR-1 was independently correlated to airway compliance (rho=0.29, P=.001). Taken together, we show the consistent presence of sLAIR-1 in amniotic fluid, which originates from fetal urine. Concentrations of sLAIR-1 in amniotic fluid during term deliveries are independent from levels of other soluble immune mediators. The positive association between concentrations of amniotic fluid sLAIR-1 and neonatal lung compliance suggests that amniotic fluid sLAIR-1 may be useful as a novel independent marker of neonatal lung maturation.	[Houben, Michiel L.; van der Ent, Cornelis K.; Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [Nordkamp, Marloes J. M. Olde; Meyaard, Linde; Bont, Louis] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bont, L (corresponding author), Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands.	L.J.Bont@umcutrecht.nl		Meyaard, Linde/0000-0003-0707-4793	European Society for Paediatric Infectious Diseases (ESPID); Wilhelmina Children's Hospital Research Fund [2004.02]; Catharijne Stichting; Dutch Asthma Foundation [3.2.07.001, 06-1-403]; Dutch Arthritis Foundation [06-1-403]	European Society for Paediatric Infectious Diseases (ESPID); Wilhelmina Children's Hospital Research Fund; Catharijne Stichting; Dutch Asthma Foundation; Dutch Arthritis Foundation	The study was funded by a fellowship award of the European Society for Paediatric Infectious Diseases (ESPID, 2005, MLH), The Wilhelmina Children's Hospital Research Fund (grant 2004.02), the Catharijne Stichting, the Dutch Asthma Foundation (grant 3.2.07.001 and grant 06-1-403), and the Dutch Arthritis Foundation (grant 06-1-403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; GLUCK L, 1973, AM J OBSTET GYNECOL, V115, P539, DOI 10.1016/0002-9378(73)90404-3; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Houben ML, 2012, PEDIATR INFECT DIS J, V31, P931, DOI 10.1097/INF.0b013e31826366e3; Houben ML, 2011, PEDIATRICS, V127, P35, DOI 10.1542/peds.2010-0581; Houben ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006572; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Katier N, 2006, PEDIATR PULM, V41, P1058, DOI 10.1002/ppul.20492; Katier N, 2005, CHEST, V128, P1822, DOI 10.1378/chest.128.3.1822; Kramer BW, 2005, BIOL NEONATE, V88, P202, DOI 10.1159/000087583; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; Lakwijk N, 1998, CLIN EXP ALLERGY, V28, P454; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Lebbink RJ, 2007, MOL IMMUNOL, V44, P2153, DOI 10.1016/j.molimm.2006.11.014; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; LESOUEF PN, 1984, AM REV RESPIR DIS, V129, P552; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Newnham JP, 2002, AM J OBSTET GYNECOL, V186, P1062, DOI 10.1067/mob.2002.122293; Nordkamp MJMO, 2011, ARTHRITIS RHEUM-US, V63, P3749, DOI 10.1002/art.30612; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; Ouyang WM, 2004, J IMMUNOL METHODS, V292, P109, DOI 10.1016/j.jim.2004.06.005; Prendergast M, 2011, ARCH DIS CHILD-FETAL, V96, pF270, DOI 10.1136/adc.2010.189480; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Simoes EAF, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-78; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Vonk JM, 2004, J ALLERGY CLIN IMMUN, V114, P270, DOI 10.1016/j.jaci.2004.03.051; WHO, 2007, TRAIN MAN WHO PACK E, P1; Wijnberger L D E, 2003, J Matern Fetal Neonatal Med, V14, P373, DOI 10.1080/14767050412331312210; Willet KE, 2002, AM J PHYSIOL-LUNG C, V282, pL411, DOI 10.1152/ajplung.00097.2001	38	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83920	10.1371/journal.pone.0083920	http://dx.doi.org/10.1371/journal.pone.0083920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386309	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700088
J	Huang, RX; Ma, YY; Holm, R; Trope, CG; Nesland, JM; Suo, ZH				Huang, Ruixia; Ma, Yuanyuan; Holm, Ruth; Trope, Claes G.; Nesland, Jahn M.; Suo, Zhenhe			Sex Hormone-Binding Globulin (SHBG) Expression in Ovarian Carcinomas and Its Clinicopathological Associations	PLOS ONE			English	Article							PROSTATE ANDROGEN RECEPTOR; CIRCULATING LEVELS; STEROID-HORMONES; GENE-EXPRESSION; INVASIVE FRONT; CANCER-RISK; MCF-7 CELLS; PROTEIN; VARIANT; LNCAP	Sex hormone-binding globulin (SHBG) is known as a carrier protein. It is classically thought to be mainly synthesized in the liver and then secreted into the circulating system, where it binds to sex steroids with a high affinity and modulates the bioavailability of the hormones. Other organs known to produce SHBG include brain, uterus, testis, prostate, breast and ovary, and the local expressed SHBG may play an important role in tumor development. However, SHBG expression status and its clinicopathological significance in ovarian cancer cells are not reported yet. In our present study, we examined and found the variable SHBG expression in four ovarian cancer cell lines (OV-90, OVCAR-3, SKOV-3 and ES-2) by immunocytochemistry and Western blotting. We then extended our study to 248 ovarian carcinoma samples, which were collected at The Norwegian Radium Hospital, Oslo University Hospital with complete clinical information, and discovered that SHBG was variably expressed in these ovarian carcinomas. Higher level of SHBG expression was significantly associated with more aggressive histological subtype (p = 0.022), higher FIGO stage (p = 0.018) and higher histological grade (grade of differentiation, p = 0.020), although association between SHBG expression and OS/PFS was not observed. Our results demonstrate that ovarian cancer cells produce SHBG and higher SHBG expression in ovarian carcinoma is associated with unfavorable clinicopathological features.	[Huang, Ruixia; Ma, Yuanyuan; Holm, Ruth; Nesland, Jahn M.; Suo, Zhenhe] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Huang, Ruixia; Ma, Yuanyuan; Nesland, Jahn M.; Suo, Zhenhe] Univ Oslo, Fac Med, Inst Clin Med, Dept Pathol, Oslo, Norway; [Trope, Claes G.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynecol, Oslo, Norway; [Trope, Claes G.] Univ Oslo, Fac Med, Inst Clin Med, Dept Gynecol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Suo, ZH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	zhenhes@medisin.uio.no		Huang, Ruixia/0000-0001-7214-647X	Inger and John Fredriksen Foundation; Radium Hospital Research Foundation; Norwegian Cancer Society	Inger and John Fredriksen Foundation; Radium Hospital Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society)	This study was funded by grants from Inger and John Fredriksen Foundation and Radium Hospital Research Foundation and The Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Avoranta ST, 2012, WORLD J GASTROENTERO, V18, P4549, DOI 10.3748/wjg.v18.i33.4549; Berndt SI, 2007, CANCER EPIDEM BIOMAR, V16, P165, DOI 10.1158/1055-9965.EPI-06-0689; Bobe J, 2008, ENDOCRINOLOGY, V149, P2980, DOI 10.1210/en.2007-1652; Bosland M C, 2000, J Natl Cancer Inst Monogr, P39; Chen WY, 2008, BEST PRACT RES CL EN, V22, P573, DOI 10.1016/j.beem.2008.08.001; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Chu LW, 2010, CANCER EPIDEM BIOMAR, V19, P1848, DOI 10.1158/1055-9965.EPI-10-0101; Chua TC, 2010, AUST NZ J OBSTET GYN, V50, P478, DOI 10.1111/j.1479-828X.2010.01201.x; Ding VDH, 1998, ENDOCRINOLOGY, V139, P213, DOI 10.1210/en.139.1.213; Elattar A, 2012, GYNECOL ONCOL, V124, P142, DOI 10.1016/j.ygyno.2011.09.004; FISSORE F, 1994, STEROIDS, V59, P661, DOI 10.1016/0039-128X(94)90023-X; Forges T, 2005, HISTOCHEM CELL BIOL, V124, P285, DOI 10.1007/s00418-005-0006-z; Forges T, 2004, MOL CELL ENDOCRINOL, V219, P61, DOI 10.1016/j.mce.2004.01.011; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Fortunati N, 1999, J STEROID BIOCHEM, V70, P73, DOI 10.1016/S0960-0760(99)00092-8; Garcia-Closas M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-60; Gregoraszczuk E L, 2011, Endocr Regul, V45, P125; HAGEN FS, 1992, FEBS LETT, V299, P23, DOI 10.1016/0014-5793(92)80091-T; Herbert Z, 2005, NEUROENDOCRINOLOGY, V81, P287, DOI 10.1159/000088170; Hryb DJ, 2002, J BIOL CHEM, V277, P26618, DOI 10.1074/jbc.M202495200; JOSEPH DR, 1991, J STEROID BIOCHEM, V40, P771, DOI 10.1016/0960-0760(91)90302-L; Kahn SM, 2008, ADV EXP MED BIOL, V617, P557, DOI 10.1007/978-0-387-69080-3_57; Langdon SP, 2009, ONKOLOGIE, V32, P623, DOI 10.1159/000246764; LARREA F, 1993, J STEROID BIOCHEM, V46, P497, DOI 10.1016/0960-0760(93)90104-5; LAU DHM, 1991, CANCER RES, V51, P5181; Lewis JG, 1999, STEROIDS, V64, P259, DOI 10.1016/S0039-128X(98)00119-6; Li AJ, 2007, GYNECOL ONCOL, V107, P420, DOI 10.1016/j.ygyno.2007.07.059; Liu ZY, 2011, J CLIN PATHOL, V64, P325, DOI 10.1136/jcp.2010.083956; Lukanova A, 2003, INT J CANCER, V104, P636, DOI 10.1002/ijc.10990; Lurie G, 2011, PLOS ONE, V6; MAHLCK CG, 1986, ACTA OBSTET GYN SCAN, V65, P533; MAHLCK CG, 1989, GYNECOL OBSTET INVES, V28, P41, DOI 10.1159/000293502; Maliqueo M, 2007, FERTIL STERIL, V87, P321, DOI 10.1016/j.fertnstert.2006.06.038; Martinez-Garcia MA, 2012, HUM REPROD; Misao R, 1995, GYNECOL ENDOCRINOL, V9, P317, DOI 10.3109/09513599509160466; MISAO R, 1995, REPROD NUTR DEV, V35, P155, DOI 10.1051/rnd:19950204; Nakhla AM, 1997, J BIOL CHEM, V272, P6838, DOI 10.1074/jbc.272.11.6838; NAKHLA AM, 1990, J CLIN ENDOCR METAB, V71, P398, DOI 10.1210/jcem-71-2-398; Nakhla AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-37; Paterson EL, 2013, NEOPLASIA, V15, P180, DOI 10.1593/neo.121828; Planaguma J, 2011, HUM PATHOL, V42, P57, DOI 10.1016/j.humpath.2010.01.025; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Rinaldi S, 2007, CANCER EPIDEM BIOMAR, V16, P23, DOI 10.1158/1055-9965.EPI-06-0755; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; SELBY C, 1990, ANN CLIN BIOCHEM, V27, P532, DOI 10.1177/000456329002700603; Selva DM, 2006, HORM METAB RES, V38, P230, DOI 10.1055/s-2006-925336; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Simo R, 2012, DIABETES, V61, P372, DOI 10.2337/db11-0727; SOLOMON M, 1979, LANCET, V1, P984; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Xita N, 2010, MOL CELL ENDOCRINOL, V316, P60, DOI 10.1016/j.mce.2009.08.025; Yusra, 2012, INT J ONCOL, V41, P201, DOI 10.3892/ijo.2012.1459; Zivanovic O, 2010, GYNECOL ONCOL, V116, P351, DOI 10.1016/j.ygyno.2009.11.022	55	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83238	10.1371/journal.pone.0083238	http://dx.doi.org/10.1371/journal.pone.0083238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386165	Green Published, Green Submitted, gold			2022-12-27	WOS:000329116700036
J	Lodha, N; Misra, G; Coombes, SA; Christou, EA; Cauraugh, JH				Lodha, Neha; Misra, Gaurav; Coombes, Stephen A.; Christou, Evangelos A.; Cauraugh, James H.			Increased Force Variability in Chronic Stroke: Contributions of Force Modulation below 1 Hz	PLOS ONE			English	Article							MUSCLE; FLUCTUATIONS; COHERENCE; DISCHARGE; DEFICITS	Increased force variability constitutes a hallmark of arm disabilities following stroke. Force variability is related to the modulation of force below 1 Hz in healthy young and older adults. However, whether the increased force variability observed post stroke is related to the modulation of force below 1 Hz remains unknown. Thus, the purpose of this study was to compare force modulation below 1 Hz in chronic stroke and age-matched healthy individuals. Both stroke and control individuals (N = 26) performed an isometric grip task to submaximal force levels. Coefficient of variation quantified force variability, and power spectrum density of force quantified force modulation below 1 Hz with a high resolution (0.07 Hz). Analyses indicated that force variability was greater for the stroke group compared with to healthy controls and for the paretic hand compared with the non-paretic hand. Force modulation below 1 Hz differentiated the stroke individuals and healthy controls, as well as the paretic and non-paretic hands. Specifically, stroke individuals (paretic hand) exhibited greater power similar to 0.2 Hz (0.07-0.35 Hz) and lesser power,0.6 Hz (0.49-0.77 Hz) compared to healthy controls (non-dominant hand). Similarly, the paretic hand exhibited greater power,0.2 Hz, and lesser power similar to 0.6 Hz than the non-paretic hand. Moreover, variability of force was strongly predicted from the modulation of specific frequencies below 1 Hz (R-2 = 0.80). Together, these findings indicate that the modulation of force below 1 Hz provides significant insight into changes in motor control after stroke.	[Lodha, Neha; Misra, Gaurav; Coombes, Stephen A.; Christou, Evangelos A.; Cauraugh, James H.] Univ Florida, Malcom Randall VA Med Ctr, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA; [Christou, Evangelos A.] Univ Florida, Malcom Randall VA Med Ctr, Dept Phys Therapy, Gainesville, FL USA; [Lodha, Neha] Univ Florida, Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr Excellence, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lodha, N (corresponding author), Univ Florida, Malcom Randall VA Med Ctr, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA.	lodhaneha@hhp.ufl.edu	Lodha, Neha/AAG-9581-2020		American Heart Association [12POST10920002, 0093013]; National Institutes of Health [R01 AG031769]; NATIONAL INSTITUTE ON AGING [R01AG031769] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by an American Heart Association Postdoctoral Fellowship (12POST10920002) to NL, National Institutes of Health grant (R01 AG031769) to EAC, and an American Heart Association grant (0093013) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Urls 1.AHA:http://my.americanheart.org/ 2.NIH:http://grants.nih.gov/grants/funding/r01.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoni J M, 1990, Int Disabil Stud, V12, P78; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Bensmail D, 2012, NEUROSCIENCE, V210, P128, DOI 10.1016/j.neuroscience.2012.03.015; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Chou LW, 2013, J NEUROPHYSIOL, V109, P2947, DOI 10.1152/jn.00615.2012; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Christou EA, 2006, AGING VARIABILITY MO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055970; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; HAGBARTH KE, 1979, BRAIN, V102, P509, DOI 10.1093/brain/102.3.509; Keogh J, 2006, EUR J APPL PHYSIOL, V97, P76, DOI 10.1007/s00421-006-0151-7; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Liang LY, 2010, J MED BIOL ENG, V30, P17; Lindberg PG, 2012, BRAIN RES, V1452, P96, DOI 10.1016/j.brainres.2012.03.007; Lodha N, 2012, CLIN NEUROPHYSIOL, V123, P787, DOI 10.1016/j.clinph.2011.08.014; Lodha N, 2010, CLIN NEUROPHYSIOL, V121, P1952, DOI 10.1016/j.clinph.2010.04.005; Marsden JF, 2000, BRAIN, V123, P1459, DOI 10.1093/brain/123.7.1459; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Mottram CJ, 2010, J NEUROPHYSIOL, V104, P3168, DOI 10.1152/jn.00463.2010; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rothwell JC, 1998, MOVEMENT DISORD, V13, P24; SIMON JR, 1969, PERCEPT MOTOR SKILL, V28, P91, DOI 10.2466/pms.1969.28.1.91; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Tracy BL, 2007, MED SCI SPORT EXER, V39, P469, DOI 10.1249/mss.0b013e31802d3ad3; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002	29	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2013	8	12							e83468	10.1371/journal.pone.0083468	http://dx.doi.org/10.1371/journal.pone.0083468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281QS	24386208	gold, Green Submitted, Green Published			2022-12-27	WOS:000329116700054
J	Krasheninnikova, A				Krasheninnikova, Anastasia			Patterned-String Tasks: Relation between Fine Motor Skills and Visual-Spatial Abilities in Parrots	PLOS ONE			English	Article							PSITTACUS-ERITHACUS; FORAGING BEHAVIOR; CEREBELLUM; PIGEON; SOLVE; BIRDS	String-pulling and patterned-string tasks are often used to analyse perceptual and cognitive abilities in animals. In addition, the paradigm can be used to test the interrelation between visual-spatial and motor performance. Two Australian parrot species, the galah (Eolophus roseicapilla) and the cockatiel (Nymphicus hollandicus), forage on the ground, but only the galah uses its feet to manipulate food. I used a set of string pulling and patterned-string tasks to test whether usage of the feet during foraging is a prerequisite for solving the vertical string pulling problem. Indeed, the two species used techniques that clearly differed in the extent of beak-foot coordination but did not differ in terms of their success in solving the string pulling task. However, when the visual-spatial skills of the subjects were tested, the galahs outperformed the cockatiels. This supports the hypothesis that the fine motor skills needed for advanced beak-foot coordination may be interrelated with certain visual-spatial abilities needed for solving patterned-string tasks. This pattern was also found within each of the two species on the individual level: higher motor abilities positively correlated with performance in patterned-string tasks. This is the first evidence of an interrelation between visual-spatial and motor abilities in non-mammalian animals.	Univ Hamburg, Biozentrum Grindel, Museum & Inst Zool, Hamburg, Germany	University of Hamburg	Krasheninnikova, A (corresponding author), Univ Hamburg, Biozentrum Grindel, Museum & Inst Zool, Hamburg, Germany.	anastacia.k@web.de		Krasheninnikova, Anastasia/0000-0001-8566-8277				Aidala Z, 2012, J COMP PHYSIOL A, V198, P495, DOI 10.1007/s00359-012-0724-3; ALTEVOGT R, 1953, BEHAVIOUR, V6, P147, DOI 10.1163/156853954X00086; Bagozkaya MS, 2010, ZH VYSSH NERV DEYAT+, V60, P321; BALASCH J, 1974, REV ESP FISIOL, V30, P15; Bates D, 2012, LME4 LINEAR MIXED EF; Bonvicino C.R., 1989, Revista Nordestina de Biologia, V6, P149; CANNON CE, 1983, BIRD BEHAV, V4, P63; Chen GH, 2004, PHYSIOL BEHAV, V83, P531, DOI 10.1016/j.physbeh.2004.09.012; CLARKE PGH, 1974, J PHYSIOL-LONDON, V243, P267, DOI 10.1113/jphysiol.1974.sp010753; Collar N.J., 1997, HDB BIRDS WORLD, V4, P280; Davis EE, 2011, BRIT J PSYCHOL, V102, P569, DOI 10.1111/j.2044-8295.2011.02018.x; Finch G, 1941, J COMP PSYCHOL, V32, P83, DOI 10.1037/h0056785; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Forshaw JM, 2010, WILDLIFE RES, DOI DOI 10.1071/WR9870105; Gagne M, 2012, ANIM COGN, V15, P1021, DOI 10.1007/s10071-012-0511-0; Halsey LG, 2006, ANIM COGN, V9, P229, DOI 10.1007/s10071-006-0016-9; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Hokkanen LSK, 2006, EUR J NEUROL, V13, P161, DOI 10.1111/j.1468-1331.2006.01157.x; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Kalashnikova L A, 2005, Neurosci Behav Physiol, V35, P773, DOI 10.1007/s11055-005-0123-0; Krasheninnikova A, 2013, ANIM COGN, V16, P755, DOI 10.1007/s10071-013-0609-z; Krasheninnikova A, 2010, BEHAVIOUR, V147, P725, DOI 10.1163/000579510X491072; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Magat M, 2009, P ROY SOC B-BIOL SCI, V276, P4155, DOI 10.1098/rspb.2009.1397; Molinari M, 2004, J NEUROL NEUROSUR PS, V75, P235; Osthaus B, 2005, ANIM COGN, V8, P37, DOI 10.1007/s10071-004-0230-2; PAULABARBOSA MM, 1976, J COMP NEUROL, V170, P365, DOI 10.1002/cne.901700307; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; PEPPERBERG IM, 1990, ANIM LEARN BEHAV, V18, P97, DOI 10.3758/BF03205244; Pepperberg IM, 2004, ANIM COGN, V7, P263, DOI 10.1007/s10071-004-0218-y; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; Petrosini L, 1998, PROG NEUROBIOL, V56, P191, DOI 10.1016/S0301-0082(98)00036-7; Pfuhl G, 2012, ANIM COGN, V15, P549, DOI 10.1007/s10071-012-0483-0; Randler C, 2011, LATERALITY, V16, P201, DOI 10.1080/13576500903513188; RDevelopment C TEAM, 2006, R LANG ENV STAT COMP; Rowley I, 1990, WHEATBELT W AUSTR; Schuck-Paim C, 2009, ANIM COGN, V12, P287, DOI 10.1007/s10071-008-0190-z; Seibt U, 2006, ETHOLOGY, V112, P493, DOI 10.1111/j.1439-0310.2005.01172.x; SKUTCH AF, 1996, MINDS BIRDS; Spence RD, 2009, EUR J NEUROSCI, V29, P1225, DOI 10.1111/j.1460-9568.2009.06685.x; Sultan F, 2005, CURR BIOL, V15, pR649, DOI 10.1016/j.cub.2005.08.043; Sultan F, 2007, CEREBELLUM, V6, P168, DOI 10.1080/14734220701332486; Tomasello M, 1997, PRIMATE COGNITION; Van Mier HI, 2002, ANN NY ACAD SCI, V978, P334; Vince M, 1961, SUCCESSFUL RESPONSE, V17, P103; Warburton LS, 2005, OSTRICH, V76, P118, DOI 10.2989/00306520509485484; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; Whitt E, 2009, ANIM COGN, V12, P739, DOI 10.1007/s10071-009-0228-x	48	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e85499	10.1371/journal.pone.0085499	http://dx.doi.org/10.1371/journal.pone.0085499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24376885	gold, Green Published, Green Submitted			2022-12-27	WOS:000328882000186
J	Wong, MCS; Ching, JYL; Hirai, HH; Lam, TYT; Griffiths, SM; Chan, FKL; Sung, JJY				Wong, Martin C. S.; Ching, Jessica Y. L.; Hirai, Hoyee H.; Lam, Thomas Y. T.; Griffiths, Sian M.; Chan, Francis K. L.; Sung, Joseph J. Y.			Perceived Obstacles of Colorectal Cancer Screening and Their Associated Factors among 10,078 Chinese Participants	PLOS ONE			English	Article								Purpose: to evaluate the proportion of self-referred screening participants having various psychological barriers and the factors associated with these barriers. Methods: A territory-wide bowel cancer screening centre sent an invitation via the media to all Hong Kong residents aged 50-70 years who were asymptomatic of CRC to join a free screening programme. Upon attendance they were requested to complete self-administered surveys on their perceived barriers of screening. Binary logistic regression analyses were used to evaluate the factors associated with these barriers. Results: From 10,078 consecutive screening participants (mean age 57.5 years; female 56.4%) completed the surveys between May 2008 to September 2012. There were high proportions who agreed or strongly agreed with the following barriers: financial difficulty (86.0%), limited service accessibility (58.2%), screening-induced bodily discomfort (55.2%), physical harm (44.4%), embarrassment (40.1%), apprehension (38.8%) and time constraints (13.9%). From regression models, older participants (aged >= 56) were less likely to have these barriers (Adjusted odds ratio [AOR] ranged from 0.738 to 0.952) but they encountered more difficulties to access to screening services (AOR ranged from 1.141 to 1.371). Female subjects were more likely to encounter most of these barriers (AOR ranged from 1.188 to 2.179). Participants who were uncertain of the necessity of CRC screening for people aged >= 50 were more likely to report these barriers (AOR ranged from 1.151 to 1.671). Conclusion: The proportions of perceptual barriers of CRC screening were high among these participants. Those with these associated factors should receive more thorough explanation of the screening test procedures.	[Wong, Martin C. S.; Ching, Jessica Y. L.; Hirai, Hoyee H.; Lam, Thomas Y. T.; Chan, Francis K. L.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Martin C. S.; Griffiths, Sian M.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; Chan, Francis K. L./F-4851-2010; Sung, Joseph J. Y./R-3203-2018	Wong, Martin/0000-0001-7706-9370; Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	The authors acknowledged the support of the Hong Kong Jockey Club Charities Trust for the full funding support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473; Berkowitz Z, 2008, J AM GERIATR SOC, V56, P307, DOI 10.1111/j.1532-5415.2007.01547.x; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Champion V L, 1984, ANS Adv Nurs Sci, V6, P73; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goulard H., 2007, EVALUATION EPIDEMIOL; Guessous I, 2010, PREV MED, V50, P3, DOI 10.1016/j.ypmed.2009.12.005; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P68; Klabunde CN, 2006, AM J PREV MED, V30, P313, DOI 10.1016/j.amepre.2005.11.006; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lewis SF, 1996, J GEN INTERN MED, V11, P542, DOI 10.1007/BF02599602; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; McCaffery K, 2001, SOC SCI MED, V53, P679, DOI 10.1016/S0277-9536(00)00375-0; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Rawl SM, 2000, CANCER PRACT, V8, P32, DOI 10.1046/j.1523-5394.2000.81006.x; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Saito H, 2006, J MED SCREEN, V13, pS6; Stacy R, 2008, J CANCER EDUC, V23, P238, DOI 10.1080/08858190802189030; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Weller D, 2007, BRIT J CANCER, V97, P1601, DOI 10.1038/sj.bjc.6604089; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1203, DOI 10.1111/j.1365-2753.2011.01776.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x	31	39	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70209	10.1371/journal.pone.0070209	http://dx.doi.org/10.1371/journal.pone.0070209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V41SG	24386367	Green Submitted, gold, Green Published			2022-12-27	WOS:000209565300001
J	Gong, ZH; Tang, JL; Xiang, TX; Zhang, LL; Liao, QH; Liu, W; Wang, YL				Gong, Zhenghua; Tang, Jialin; Xiang, Tianxin; Zhang, Lunli; Liao, Qinghua; Liu, Wei; Wang, Yalin			Association between Regulated upon Activation, Normal T Cells Expressed and Secreted (RANTES)-28C/G Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis	PLOS ONE			English	Article							DISEASE PROGRESSION; GENETIC-VARIATION; TYPE-1 INFECTION; DENDRITIC CELLS; VIRUS-INFECTION; CC-CHEMOKINES; RANTES; PROMOTER; INDIVIDUALS; ENTRY	Background: Many studies have investigated the distributions of RANTES genotypes between HIV-1 infected patients and uninfected individuals. However, no definite results have been put forward about whether the RANTES -28C/G polymorphism can affect HIV-1 susceptibility. Methods: We performed a meta-analysis of 12 studies including 7473 subjects for whom the RANTES -28C/G polymorphism was genotyped. Odds ratios (ORs) with 95% confidence intervals (CIs) were employed to assess the association of the polymorphism with HIV-1 susceptibility. By dividing the controls into healthy controls and HIV-1 exposed but seronegative (HESN) controls, we explored the both allelic and dominant genetic models. Results: By using the healthy controls, we found a marginally significant association between the -28C/G polymorphism and susceptibility to HIV-1 infection in the allelic model (OR = 0.82, 95%CI = 0.70-0.97). But sensitivity analysis suggested that the association was driven by one study. We further performed stratified analysis according to ethnicity. The -28G allele decreased susceptibility to HIV-1 infection in the allelic model among Asians (OR = 0.79, 95%CI = 0.66-0.94). By using the HESN controls, no association between the polymorphism -28C/G and the susceptibility to HIV-1 infection was revealed in either the allelic model (OR = 0.84, 95%CI = 0.60-1.17) or the dominant model (OR = 0.77, 95%CI = 0.54-1.10). Conclusions: Our findings suggested that the RANTES -28G allele might play a role in resistance to HIV-1 infection among Asians. Additional well-designed studies were required for the validation of this association.	[Gong, Zhenghua; Tang, Jialin; Liao, Qinghua; Liu, Wei; Wang, Yalin] Ctr Dis Control & Prevent Jiangxi Prov, Dept Publ Hlth, Nanchang, Peoples R China; [Xiang, Tianxin; Zhang, Lunli] Nanchang Univ, Hosp 1, Dept Infect Dis, Nanchang, Peoples R China	Nanchang University	Wang, YL (corresponding author), Ctr Dis Control & Prevent Jiangxi Prov, Dept Publ Hlth, Nanchang, Peoples R China.	yalinwang2012@hotmail.com		gong, zhenghua/0000-0002-4363-1043	National Natural Science Foundation of China [81060127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81060127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2005, WORLD J GASTROENTERO, V11, P7631, DOI 10.3748/wjg.v11.i48.7631; Aouizerat Bradley E, 2011, Curr HIV/AIDS Rep, V8, P38, DOI 10.1007/s11904-010-0065-1; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Ding DL, 2011, MOL MED REP, V4, P181, DOI 10.3892/mmr.2010.400; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; DONLON TA, 1990, GENOMICS, V6, P548, DOI 10.1016/0888-7543(90)90485-D; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Fernandez RM, 2003, AIDS RES HUM RETROV, V19, P349, DOI 10.1089/088922203765551692; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Guergnon J, 2012, IMMUNOL LETT, V145, P15, DOI 10.1016/j.imlet.2012.04.010; Jang DH, 2008, INT J IMMUNOGENET, V35, P101, DOI 10.1111/j.1744-313X.2007.00743.x; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042972; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Liu HL, 1999, AIDS, V13, P2602, DOI 10.1097/00002030-199912240-00020; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035020; [刘雪林 Liu Xuelin], 2004, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V29, P489; Loetscher P, 1996, J IMMUNOL, V156, P322; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; McDermott DH, 2000, AIDS, V14, P2671, DOI 10.1097/00002030-200012010-00006; Nair MPN, 2011, LIFE SCI, V88, P987, DOI 10.1016/j.lfs.2010.09.019; Pantaleo G, 1997, RES IMMUNOL, V148, P417, DOI 10.1016/S0923-2494(97)82875-1; Rathore A, 2008, J MED VIROL, V80, P1133, DOI 10.1002/jmv.21201; Sironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Suresh P, 2006, J CLIN IMMUNOL, V26, P476, DOI 10.1007/s10875-006-9036-0; Vidal F, 2006, JAIDS-J ACQ IMM DEF, V41, P17, DOI 10.1097/01.qai.0000188335.86466.ea; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zhao XY, 2004, EUR J IMMUNOGENET, V31, P179, DOI 10.1111/j.1365-2370.2004.00466.x	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60683	10.1371/journal.pone.0060683	http://dx.doi.org/10.1371/journal.pone.0060683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	24386362	Green Submitted, gold, Green Published			2022-12-27	WOS:000319109800087
J	Grange, LJ; Smith, CR				Grange, Laura J.; Smith, Craig R.			Megafaunal Communities in Rapidly Warming Fjords along the West Antarctic Peninsula: Hotspots of Abundance and Beta Diversity	PLOS ONE			English	Article							DEPTH-RELATED CHANGES; CLIMATE-CHANGE; SUBMARINE CANYONS; MARINE ECOSYSTEM; SEDIMENTATION; BIOMASS; VARIABILITY; SEA; MACROBENTHOS; PYCNOGONIDA	Glacio-marine fjords occur widely at high latitudes and have been extensively studied in the Arctic, where heavy meltwater inputs and sedimentation yield low benthic faunal abundance and biodiversity in inner-middle fjords. Fjord benthic ecosystems remain poorly studied in the subpolar Antarctic, including those in extensive fjords along the West Antarctic Peninsula (WAP). Here we test ecosystem predictions from Arctic fjords on three subpolar, glacio-marine fjords along the WAP. With seafloor photographic surveys we evaluate benthic megafaunal abundance, community structure, and species diversity, as well as the abundance of demersal nekton and macroalgal detritus, in soft-sediment basins of Andvord, Flandres and Barilari Bays at depths of 436-725 m. We then contrast these fjord sites with three open shelf stations of similar depths. Contrary to Arctic predictions, WAP fjord basins exhibited 3 to 38-fold greater benthic megafaunal abundance than the open shelf, and local species diversity and trophic complexity remained high from outer to inner fjord basins. Furthermore, WAP fjords contained distinct species composition, substantially contributing to beta and gamma diversity at 400-700 m depths along the WAP. The abundance of demersal nekton and macroalgal detritus was also substantially higher in WAP fjords compared to the open shelf. We conclude that WAP fjords are important hotspots of benthic abundance and biodiversity as a consequence of weak meltwater influences, low sedimentation disturbance, and high, varied food inputs. We postulate that WAP fjords differ markedly from their Arctic counterparts because they are in earlier stages of climate warming, and that rapid warming along the WAP will increase meltwater and sediment inputs, deleteriously impacting these biodiversity hotspots. Because WAP fjords also provide important habitat and foraging areas for Antarctic krill and baleen whales, there is an urgent need to develop better understanding of the structure, dynamics and climate-sensitivity of WAP subpolar fjord ecosystems.	[Grange, Laura J.; Smith, Craig R.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Grange, LJ (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	J.Grange@noc.soton.ac.uk	Grange, Laura/E-8495-2014	Grange, Laura/0000-0001-9222-6848	Office of Polar Programs (OPP), United States National Science Foundation [OPP-0636806, OPP-0732711]; Biological Oceanography Program (BIO OCE), United States National Science Foundation [BIO OCE-1155703]	Office of Polar Programs (OPP), United States National Science Foundation; Biological Oceanography Program (BIO OCE), United States National Science Foundation	This material is based upon work supported by the Office of Polar Programs (OPP), United States National Science Foundation under the LARISSA and FOODBANCS2 Projects Grant Nos. OPP-0636806 and OPP-0732711 respectively to C. R. S. Writing and publication costs were supported in part by the Biological Oceanography Program (BIO OCE), United States National Science Foundation under the BOWLs Project Grant No. BIO OCE-1155703 to C. R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; [Anonymous], 1995, GLACIAL ENV; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; ARNAUD F, 1987, ADV MAR BIOL, V24, P1; Ashley GM, 2000, GEOL SOC AM BULL, V112, P657, DOI 10.1130/0016-7606(2000)112<0657:MSAACG>2.3.CO;2; Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; Barry James P., 2003, Antarctic Research Series, V78, P327; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; Domack E.W., 1996, ANTARCT RES SER, V70, P135, DOI [10.1029/AR070p0135, DOI 10.1029/AR070P0135]; DOMACK EW, 1993, ANTAR RES S, V60, P265; DOMACK EW, 1993, GEOL SOC AM BULL, V105, P1175, DOI 10.1130/0016-7606(1993)105<1175:OAPCOM>2.3.CO;2; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Fetzer I, 2002, POLAR BIOL, V25, P303, DOI 10.1007/s00300-001-0345-8; Glud RN, 2002, MAR ECOL PROG SER, V238, P15, DOI 10.3354/meps238015; Gorley C.K., 2006, GETTING STARTED PRIM; GRIFFITH TW, 1989, MAR GEOL, V85, P181, DOI 10.1016/0025-3227(89)90153-9; Holte B, 1998, POLAR BIOL, V19, P375, DOI 10.1007/s003000050262; Hop H, 2002, POLAR RES, V21, P167, DOI 10.1111/j.1751-8369.2002.tb00073.x; Howe JA, 2010, SPECIAL PUBLICATION, V344; Jones DOB, 2007, POLAR BIOL, V30, P1579, DOI 10.1007/s00300-007-0319-6; Jones DOB, 2007, MAR BIOL RES, V3, P191, DOI 10.1080/17451000701455287; Kedra M, 2010, POLAR BIOL, V33, P1, DOI 10.1007/s00300-009-0679-1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mahon AR, 2008, MAR BIOL, V155, P315, DOI 10.1007/s00227-008-1029-5; McLeod RJ, 2010, LIMNOL OCEANOGR, V55, P2097, DOI 10.4319/lo.2010.55.5.2097; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Pabis K, 2011, POLAR BIOL, V34, P489, DOI 10.1007/s00300-010-0903-z; Pabis K, 2010, POLAR BIOL, V33, P141, DOI 10.1007/s00300-009-0692-4; Piepenburg D, 2002, POLAR BIOL, V25, P146, DOI 10.1007/s003000100322; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Renaud PE, 2007, POLAR BIOL, V30, P295, DOI 10.1007/s00300-006-0183-9; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Roman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013255; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Sicinski J, 2011, DEEP-SEA RES PT II, V58, P30, DOI 10.1016/j.dsr2.2010.09.005; Simard Y, 1999, CAN J FISH AQUAT SCI, V56, P1182, DOI 10.1139/cjfas-56-7-1182; Skold M, 2003, MAR ECOL PROG SER, V250, P163, DOI 10.3354/meps250163; Smith CR, 2012, OCEANOGRAPHY, V25, P188, DOI 10.5670/oceanog.2012.94; Starmans A, 1999, MAR BIOL, V135, P269, DOI 10.1007/s002270050624; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Sumida PYG, 2008, DEEP-SEA RES PT II, V55, P2465, DOI 10.1016/j.dsr2.2008.06.006; Syvitski J.P.M., 1987, FJORDS PROCESSES PRO; SYVITSKI JPM, 1989, ARCTIC, V42, P232; Thiele D, 2004, DEEP-SEA RES PT II, V51, P2311, DOI 10.1016/j.dsr2.2004.07.007; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Weslawski Jan Marcin, 2011, Marine Biodiversity, V41, P71, DOI 10.1007/s12526-010-0073-9; Wlodarska-Kowalczuk M, 1998, POLAR BIOL, V20, P66, DOI 10.1007/s003000050277; Wlodarska-Kowalczuk M, 2005, MAR ECOL PROG SER, V303, P31, DOI 10.3354/meps303031; Wlodarska-Kowalczuk M, 2004, POLAR BIOL, V27, P155, DOI 10.1007/s00300-003-0568-y; Wlodarska-Kowalczuk M, 2007, ESTUAR COAST SHELF S, V74, P274, DOI 10.1016/j.ecss.2007.04.017; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858	61	140	140	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e77917	10.1371/journal.pone.0077917	http://dx.doi.org/10.1371/journal.pone.0077917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24312442	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000327947800002
J	Manrique-Poyato, MI; Lopez-Leon, MD; Gomez, R; Perfectti, F; Camacho, JPM				Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Gomez, Ricardo; Perfectti, Francisco; Martinez Camacho, Juan Pedro			Population Genetic Structure of the Grasshopper Eyprepocnemis plorans in the South and East of the Iberian Peninsula	PLOS ONE			English	Article							SEQUENCE REPEAT POLYMORPHISMS; B-CHROMOSOME; ALLELIC DROPOUT; FEMALE FITNESS; RAPD MARKERS; ISSR-PCR; DIVERSITY; IDENTIFICATION; DYNAMICS; GENOME	The grasshopper Eyprepocnemis plorans subsp. plorans harbors a very widespread polymorphism for supernumerary (B) chromosomes which appear to have arisen recently. These chromosomes behave as genomic parasites because they are harmful for the individuals carrying them and show meiotic drive in the initial stages of population invasion. The rapid increase in B chromosome frequency at intrapopulation level is thus granted by meiotic drive, but its spread among populations most likely depends on interpopulation gene flow. We analyze here the population genetic structure in 10 natural populations from two regions (in the south and east) of the Iberian Peninsula. The southern populations were coastal whereas the eastern ones were inland populations located at 260-655 m altitude. The analysis of 97 ISSR markers revealed significant genetic differentiation among populations (average G(ST) = 0.129), and the Structure software and AMOVA indicated a significant genetic differentiation between southern and eastern populations. There was also significant isolation by distance (IBD) between populations. Remarkably, these results were roughly similar to those found when only the markers showing low or no dropout were included, suggesting that allelic dropout had negligible effects on population genetic analysis. We conclude that high gene flow helped this parasitic B chromosome to spread through most of the geographical range of the subspecies E. plorans plorans.	[Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Perfectti, Francisco; Martinez Camacho, Juan Pedro] Univ Granada, Dept Genet, Granada, Spain; [Inmaculada Manrique-Poyato, Maria] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Celulas Troncales, Seville, Spain; [Gomez, Ricardo] Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal, Albacete, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Universidad de Castilla-La Mancha	Camacho, JPM (corresponding author), Univ Granada, Dept Genet, Granada, Spain.	jpmcamac@ugr.es	Perfectti, Francisco/C-5087-2008; López-León, María Dolores/L-9026-2014; Camacho, Juan Pedro M/L-6869-2014; Cabrero, Josefa/L-8899-2014	Perfectti, Francisco/0000-0002-5551-213X; López-León, María Dolores/0000-0003-2337-7313; Camacho, Juan Pedro M/0000-0002-2507-9814; Cabrero, Josefa/0000-0002-5848-6985; Gomez Ladron de Guevara, Ricardo/0000-0003-3430-0346	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11917]; Spanish Ministerio de Ciencia e Innovacion; FEDER funds	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER funds(European Commission)	This study was supported by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-11917), and was partially performed by FEDER funds. MIMP was supported by a fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J, 2004, MOL MARKERS NATURAL; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; Cabrero J, 1997, CHROMOSOME RES, V5, P194, DOI 10.1023/A:1018499015091; Camacho JPM, 1997, AM NAT, V149, P1030, DOI 10.1086/286037; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Cano J, 2005, J DERMATOL SCI, V39, P17, DOI 10.1016/j.jdermsci.2005.01.016; Datwyler SL, 2004, SYST BOT, V29, P165, DOI 10.1600/036364404772974077; de Leon JH, 2005, J INSECT SCI, V5; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dirsh V. M., 1958, Proceedings of the Royal Entomological Society of London (B), V27, P33; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez ME, 2002, THEOR APPL GENET, V104, P845, DOI 10.1007/s00122-001-0848-2; Hernandez F., 1984, Boletin del Servicio de Defensa contra Plagas e Inspeccion Fitopatologica, V10, P245; Herrera JA, 1996, HEREDITY, V76, P633, DOI 10.1038/hdy.1996.90; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; JONES RN, 1991, AM NAT, V137, P430, DOI 10.1086/285175; KANTETY RV, 1995, MOL BREEDING, V1, P365, DOI 10.1007/BF01248414; Kar PK, 2005, GENETICA, V125, P173, DOI 10.1007/s10709-005-7002-z; Kojima T, 1998, THEOR APPL GENET, V96, P37, DOI 10.1007/s001220050706; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lu ZX, 2006, PLANT SCI, V170, P407, DOI 10.1016/j.plantsci.2005.09.009; Munoz E, 1998, P ROY SOC B-BIOL SCI, V265, P1903, DOI 10.1098/rspb.1998.0518; Nagaoka T, 1997, THEOR APPL GENET, V94, P597, DOI 10.1007/s001220050456; PARDO MC, 1995, HEREDITY, V74, P654, DOI 10.1038/hdy.1995.89; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P376, DOI 10.1159/000079315; Phillips CB, 2002, NEW ZEAL J AGR RES, V45, P295, DOI 10.1080/00288233.2002.9513519; Pinedo-Cancino V, 2006, AM J TROP MED HYG, V75, P238, DOI 10.4269/ajtmh.2006.75.238; Pradeep Appukuttan R., 2005, Journal of Applied Genetics, V46, P291; Ratnaparkhe MB, 1998, THEOR APPL GENET, V97, P515, DOI 10.1007/s001220050925; Ren ZM, 2008, GENETICA, V132, P103, DOI 10.1007/s10709-007-9153-6; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Sesarini C, 2008, GENETICA, V133, P295, DOI 10.1007/s10709-007-9213-y; Slatkin Montgomery, 1994, P3; Soulsbury CD, 2007, CONSERV GENET, V8, P733, DOI 10.1007/s10592-006-9194-x; Spiegelhalter DJ, 2002, J R STAT SOC B, V17, P37; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tester DJ, 2006, HEART RHYTHM, V3, P815, DOI 10.1016/j.hrthm.2006.03.016; Tsumura Y, 1996, THEOR APPL GENET, V92, P40, DOI 10.1007/BF00222949; Vandergast AG, 2009, J INSECT CONSERV, V13, P329, DOI 10.1007/s10841-008-9176-z; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vijayan K, 2006, J INSECT SCI, V6, DOI 10.1673/2006_6_30.1; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu W, 2005, BIOCHEM SYST ECOL, V33, P1141, DOI 10.1016/j.bse.2005.02.010; Zhang XP, 2006, BIOCHEM SYST ECOL, V34, P38, DOI 10.1016/j.bse.2005.05.007; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	54	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59041	10.1371/journal.pone.0059041	http://dx.doi.org/10.1371/journal.pone.0059041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520552	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900112
J	Liu, L; Boffa, MB; Koschinsky, ML				Liu, Lei; Boffa, Michael B.; Koschinsky, Marlys L.			Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System	PLOS ONE			English	Article							LYSINE-BINDING SITE; FIBRIN FRAGMENT-E; TUMOR-GROWTH; MATRIX METALLOPROTEINASES; MAMMALIAN-CELLS; NITRIC-OXIDE; RISK-FACTOR; ANGIOGENESIS; LIPOPROTEIN(A); ATHEROSCLEROSIS	Elevated plasma concentrations of lipoprotein(a) are associated with increased risk for atherothrombotic diseases. Apolipoprotein(a), the unique glycoprotein component of lipoprotein(a), is characterized by the presence of multiple kringle domains, and shares a high degree of sequence homology with the serine protease zymogen plasminogen. It has been shown that angiostatin, a proteolytic fragment of plasminogen containing kringles 1-4, can effectively inhibit angiogenesis. Moreover, proteolytic fragments of plasminogen containing kringle 5 are even more potent inhibitors of angiogenesis than angiostatin. Despite its strong similarity with plasminogen, the role of apolipoprotein(a) in angiogenesis remains controversial, with both pro-and anti-angiogenic effects reported. In the current study, we evaluated the ability of apolipoprotein(a) to inhibit VEGF-and angiopoietin-induced tube formation in human umbilical cord endothelial cells. A 17 kringle-containing form of recombinant apo(a) (17K), corresponding to a well-characterized, physiologically-relevant form of the molecule, effectively inhibited tube formation induced by either VEGF or angiopoietin-1. Using additional recombinant apolipoprotein(a) (r-apo(a)) variants, we demonstrated that this effect was dependent on the presence of an intact lysine-binding site in kringle V domain of apo(a), but not on the presence of the functional lysine-binding site in apo(a) kringle IV type 10; sequences within in the amino-terminal half of the molecule were also not required for the inhibitory effects of apo(a). We also showed that the apo(a)-mediated inhibition tube formation could be reversed, in part by the addition of plasmin or urokinase plasminogen activator, or by removal of plasminogen from the system. Further, we demonstrated that apo(a) treated with glycosidases to remove sialic acid was significantly less effective in inhibiting tube formation. This is the first report of a functional role for the glycosylation of apo(a) although the mechanisms underlying this observation remain to be determined in the context of angiogenesis.	[Liu, Lei] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Boffa, Michael B.; Koschinsky, Marlys L.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	Queens University - Canada; University of Windsor	Boffa, MB (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	mboffa@uwindsor.ca	Boffa, Michael/N-6539-2019; Liu, Lei/J-7929-2017; Gundersen, Per/B-2192-2008	Boffa, Michael/0000-0003-1211-3064; Koschinsky, Marlys/0000-0002-2643-2288; Liu, Lei/0000-0002-8063-610X; Gundersen, Per/0000-0002-9199-4033; Qu, Cunmin/0000-0003-2413-2350	Heart and Stroke Foundation of Ontario [T5916]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Funding: This work was funded by a grant (T5916) from the Heart and Stroke Foundation of Ontario to Dr. Koschinsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; Becker L, 2004, BIOCHEMISTRY-US, V43, P9978, DOI 10.1021/bi049536d; Belczewski AR, 2005, BIOCHEMISTRY-US, V44, P555, DOI 10.1021/bi048156p; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Edelstein C, 2003, J BIOL CHEM, V278, P52841, DOI 10.1074/jbc.M310425200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FLESS GM, 1986, J BIOL CHEM, V261, P8712; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Kim JS, 2004, BIOCHEM BIOPH RES CO, V313, P534, DOI 10.1016/j.bbrc.2003.11.148; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Koschinsky ML, 2009, CLIN LIPIDOLOGY COMP, P130; Kostner KM, 1996, ARTERIOSCL THROM VAS, V16, P905, DOI 10.1161/01.ATV.16.8.905; KRATZIN H, 1987, BIOL CHEM H-S, V368, P1533, DOI 10.1515/bchm3.1987.368.2.1533; Kroon Marielle E., 2002, Angiogenesis, V5, P257, DOI 10.1023/A:1024540701634; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lee K, 2006, HEPATOLOGY, V43, P1063, DOI 10.1002/hep.21149; Lim YM, 2012, DIABETES, V61, P1599, DOI 10.2337/db11-1541; Liu L, 2009, BIOCHEM J, V418, P325, DOI 10.1042/BJ20080744; Lou XJ, 1998, EXP MOL PATHOL, V65, P53, DOI 10.1006/exmp.1998.2230; Marcovina SM, 2003, CURR OPIN LIPIDOL, V14, P361, DOI 10.1097/00041433-200308000-00004; MCCANCE SG, 1994, J BIOL CHEM, V269, P32405; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Morishita R, 2002, CIRCULATION, V105, P1491, DOI 10.1161/01.CIR.0000012146.07240.FD; O'Neil CH, 2004, J BIOL CHEM, V279, P55187, DOI 10.1074/jbc.M409860200; O'Reilly M S, 1997, EXS, V79, P273; Pepper M S, 1996, Vasc Med, V1, P259; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Perri SR, 2007, MOL CANCER THER, V6, P441, DOI 10.1158/1535-7163.MCT-06-0434; Ribatti D, 1998, EUR J CLIN INVEST, V28, P533; SANGRAR W, 1994, PROTEIN ENG, V7, P723, DOI 10.1093/protein/7.5.723; Sangrar W, 1997, BIOCHEMISTRY-US, V36, P10353, DOI 10.1021/bi962433d; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Shen L, 2008, BIOL CHEM, V389, P135, DOI 10.1515/BC.2008.016; Stirk CM, 2000, GEN PHARMACOL-VASC S, V35, P261, DOI 10.1016/S0306-3623(01)00114-8; THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Yang BH, 2004, J CELL PHYSIOL, V200, P360, DOI 10.1002/jcp.20025; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027	57	242	254	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e52287	10.1371/journal.pone.0052287	http://dx.doi.org/10.1371/journal.pone.0052287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	23593427	Green Submitted, gold, Green Published			2022-12-27	WOS:000314705800014
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000181
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900080
